PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Li, HJ; Qiu, TS; Luan, SY; Song, HY; Wu, LX				Li, Houjie; Qiu, Tianshuang; Luan, Shengyang; Song, Haiyu; Wu, Linxiu			Deblurring traffic sign images based on exemplars	PLOS ONE			English	Article							REGISTRATION; MAXIMIZATION; ALGORITHMS	Motion blur appearing in traffic sign images may lead to poor recognition results, and therefore it is of great significance to study how to deblur the images. In this paper, a novel method for deblurring traffic sign is proposed based on exemplars and several related approaches are also made. First, an exemplar dataset construction method is proposed based on multiple-size partition strategy to lower calculation cost of exemplar matching. Second, a matching criterion based on gradient information and entropy correlation coefficient is also proposed to enhance the matching accuracy. Third, L-0.5-norm is introduced as the regularization item to maintain the sparsity of blur kernel. Experiments verify the superiority of the proposed approaches and extensive evaluations against state-of-the-art methods demonstrate the effectiveness of the proposed algorithm.	[Li, Houjie; Qiu, Tianshuang] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Liaoning, Peoples R China; [Li, Houjie; Wu, Linxiu] Dalian Minzu Univ, Coll Informat & Commun Engn, Dalian, Liaoning, Peoples R China; [Luan, Shengyang] Jiangsu Normal Univ, Sch Elect Engn & Automat, Xuzhou, Jiangsu, Peoples R China; [Song, Haiyu] Dalian Minzu Univ, Sch Comp Sci & Engn, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Dalian Minzu University; Jiangsu Normal University; Dalian Minzu University	Qiu, TS (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Liaoning, Peoples R China.	qiutsh@dlut.edu.cn	Song, haiyu/ABB-3879-2020; luan, shengyang/AAZ-3507-2021	luan, shengyang/0000-0002-3252-6854	National Natural Science Foundation of China [61172108]; General Scientific Research Foundation of Liaoning Educational Committee [L2014540]; Fundamental Research Funds for the Central Universities [DC201502060405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Scientific Research Foundation of Liaoning Educational Committee; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funded by National Natural Science Foundation of China 61172108 to TQ, General Scientific Research Foundation of Liaoning Educational Committee L2014540 to HL, and Fundamental Research Funds for the Central Universities DC201502060405 to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work is financially supported by National Natural Science Foundation of China (61172108), General Scientific Research Foundation of Liaoning Educational Committee (L2014540), Fundamental Research Funds for the Central Universities(DC201502060405). The authors are indebted to Dr. Jinshan Pan and Dr. Daniel Zoran for their assistance.	Cho S, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1618452.1618491; Fleyeln Masan, 2005, J VET MED, V52, P278; Fu MY, 2010, INT C WAVEL ANAL PAT, P119, DOI 10.1109/ICWAPR.2010.5576425; Gomez-Moreno H, 2010, IEEE T INTELL TRANSP, V11, P917, DOI 10.1109/TITS.2010.2054084; HaCohen Y, 2013, IEEE I CONF COMP VIS, P2384, DOI 10.1109/ICCV.2013.296; Jia J., 2014, MATH MODELS PRACTICA; Jia J., 2007, IEEE C COMP VIS PATT, P1; Joshi N., 2008, CVPR, P1; Khyati C., 2011, S JPSET, V2, P27; Krishnan D., 2011, CVPR, P2657; Lee S, 2013, SIGGRAPH AS 2013 COU; Levin A., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2657, DOI 10.1109/CVPR.2011.5995308; Levin A, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239521; Levin A, 2009, PROC CVPR IEEE, P1964, DOI 10.1109/CVPRW.2009.5206815; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Michaeli T, 2014, LECT NOTES COMPUT SC, V8691, P783, DOI 10.1007/978-3-319-10578-9_51; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pan JS, 2017, IEEE T PATTERN ANAL, V39, P342, DOI 10.1109/TPAMI.2016.2551244; Pan JS, 2016, PROC CVPR IEEE, P1628, DOI 10.1109/CVPR.2016.180; Pan JS, 2013, SIGNAL PROCESS-IMAGE, V28, P1156, DOI 10.1016/j.image.2013.05.001; Pluim JPW, 2000, IEEE T MED IMAGING, V19, P809, DOI 10.1109/42.876307; Shan Q, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360672; Xu L, 2013, PROC CVPR IEEE, P1107, DOI 10.1109/CVPR.2013.147; Xu L, 2011, ACM T GRAPHIC, V30, DOI 10.1145/2024156.2024208; Xu L, 2010, LECT NOTES COMPUT SC, V6311, P157	28	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0191367	10.1371/journal.pone.0191367	http://dx.doi.org/10.1371/journal.pone.0191367			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513677	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800005
J	Ershadi, NY; Menendez, JM; Jimenez, D				Yaghoobi Ershadi, Nastaran; Manuel Menendez, Jose; Jimenez, David			Robust vehicle detection in different weather conditions: Using MIPM	PLOS ONE			English	Article							OBJECTS; FLOW	Intelligent Transportation Systems (ITS) allow us to have high quality traffic information to reduce the risk of potentially critical situations. Conventional image-based traffic detection methods have difficulties acquiring good images due to perspective and background noise, poor lighting and weather conditions. In this paper, we propose a new method to accurately segment and track vehicles. After removing perspective using Modified Inverse Perspective Mapping (MIPM), Hough transform is applied to extract road lines and lanes. Then, Gaussian Mixture Models (GMM) are used to segment moving objects and to tackle car shadow effects, we apply a chromacity-based strategy. Finally, performance is evaluated through three different video benchmarks: own recorded videos in Madrid and Tehran (with different weather conditions at urban and interurban areas); and two well-known public datasets (KITTI and DETRAC). Our results indicate that the proposed algorithms are robust, and more accurate compared to others, especially when facing occlusions, lighting variations and weather conditions.	[Yaghoobi Ershadi, Nastaran; Manuel Menendez, Jose; Jimenez, David] Univ Politecn Madrid, ETS Ingenieros Telecomunicac, Madrid, Spain	Universidad Politecnica de Madrid; ETS de Ingenieros de Telecomunicacion	Ershadi, NY (corresponding author), Univ Politecn Madrid, ETS Ingenieros Telecomunicac, Madrid, Spain.	n.yaghoobi@alumnos.upm.es	Menéndez, José Manuel/AAS-8430-2020; Jimenez, David/AAS-2274-2020; Menendez, Jose-Manuel/L-1159-2014; Yaghoobi Ershadi, Nastaran/H-8372-2017	Jimenez, David/0000-0002-7382-4276; Menendez, Jose-Manuel/0000-0003-0584-2250; Yaghoobi Ershadi, Nastaran/0000-0002-1112-2068				Agarwal A., 2005, SURVEY PLANAR HOMOGR; Al-Smadi M., 2016, INT J APPL ENG RES, V11, P713; Alavianmehr M. A., 2014, 14 INT C TRAFF TRANS; Bakker T, 2008, COMPUT ELECTRON AGR, V60, P87, DOI 10.1016/j.compag.2007.07.006; BARRON JL, 1994, INT J COMPUT VISION, V12, P43, DOI 10.1007/BF01420984; Bertozzi M, 1998, IMAGE VISION COMPUT, V16, P585, DOI 10.1016/S0262-8856(97)00093-0; Bertozzi M., 1996, P IEEE; Bottino A, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16060813; Chin-Teng L., 2010, EURASIP J ADV SIG PR, V2010; Chintalacheruvu N., 2012, J TRANSPORTATION TEC, V2, P305, DOI DOI 10.4236/jtts.2012.24033; Collins RT, 2001, P IEEE, V89, P1456, DOI 10.1109/5.959341; Daiming Z., 2014, 2014 IEEE INT SEC PA; Forczmanski P, 2016, LECT NOTES COMPUT SC, V9972, P462, DOI 10.1007/978-3-319-46418-3_41; Forczmanski P, 2010, LECT NOTES COMPUT SC, V6374, P114, DOI 10.1007/978-3-642-15910-7_13; HARITAOGLU I, 1998, LNCS, V1406, P877; Herbon C, 2014, LECT NOTES COMPUT SC, V8753, P354, DOI 10.1007/978-3-319-11752-2_28; Hsieh JW, 2003, IMAGE VISION COMPUT, V21, P505, DOI 10.1016/S0262-8856(03)00030-1; Huang JB, 2009, PROC CVPR IEEE, P2310, DOI 10.1109/CVPRW.2009.5206629; Indrabayu Yusliana Bakti R., 2016, COMP INT CYB CYBERNE; Jiang GY, 2000, IEEE SYS MAN CYBERN, P2969, DOI 10.1109/ICSMC.2000.884452; KaewTraKulPong P., 2001, P 2 EUROPEANWORKSHOP; Kim S., 1998, P 5 WORD C INT TRANP; Leone A, 2007, PATTERN RECOGN, V40, P1222, DOI 10.1016/j.patcog.2006.09.017; Lin CC, 2012, SENSORS-BASEL, V12, P4431, DOI 10.3390/s120404431; Maddalena L, 2008, IEEE T IMAGE PROCESS, V17, P1168, DOI 10.1109/TIP.2008.924285; MALLOT HA, 1991, BIOL CYBERN, V64, P177, DOI 10.1007/BF00201978; Muad AM, 2004, TENCON IEEE REGION, pA207; Prati A, 2001, PROC CVPR IEEE, P571; Rosin PL, 1995, PROCEEDINGS OF THE 6TH BRITISH MACHINE VISION CONFERENCE 1995, VOLS 1 AND 2, P347; Sanin Andres, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P141, DOI 10.1109/ICPR.2010.43; Shan Y, 2007, PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON IMAGE AND GRAPHICS, P496, DOI 10.1109/ICIG.2007.54; Stauffer C., 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P246, DOI 10.1109/CVPR.1999.784637; Sun YD, 2004, COMPUT INFORM, V23, P215; Szwoch G., 2014, DETECTION VEHICLES S, P242; Tan S, 2006, IMAGE VISION COMPUT, V24, P153, DOI 10.1016/j.imavis.2005.09.023; Tsai VJD, 2006, IEEE T GEOSCI REMOTE, V44, P1661, DOI 10.1109/TGRS.2006.869980; Umbaugh, 1998, COMPUTER VISION IMAG; Wang C, 2012, PROCEDIA ENGINEER, V29, P1938, DOI 10.1016/j.proeng.2012.01.240; Wren CR, 1997, IEEE T PATTERN ANAL, V19, P780, DOI 10.1109/34.598236; Xia YJ, 2016, SIGNAL PROCESS, V120, P672, DOI 10.1016/j.sigpro.2014.10.035; Xidong Y., 1994, J TRANSPORTATION ENG, V120, P1861; Yuhong Jia, 2013, Intelligent Science and Intelligent Data Engineering. Third Sino-foreign-interchange Workshop, IScIDE 2012. Revised Selected Papers, P115, DOI 10.1007/978-3-642-36669-7_15	42	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0191355	10.1371/journal.pone.0191355	http://dx.doi.org/10.1371/journal.pone.0191355			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513664	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800004
J	Banning, H; Stelling, M; Konig, S; Schonberg, R; Neumann, T				Banning, Helena; Stelling, Monika; Koenig, Stephan; Schoenberg, Ronny; Neumann, Thomas			Preparation and purification of organic samples for selenium isotope studies	PLOS ONE			English	Article							ATOMIC-ABSORPTION-SPECTROMETRY; DOUBLE SPIKE; METAL-IONS; GENERATION; SE; FRACTIONATION; RATIOS; ADSORPTION; SELENATE; COPPER	Selenium (Se) is an important micronutrient but also a strong toxin with a narrow tolerance range for many organisms. As such, a globally heterogeneous Se distribution in soils is responsible for various disease patterns (i.e. Se excess and deficiency) and environmental problems, whereby plants play a key role for the Se entrance into the biosphere. Selenium isotope variations were proved to be a powerful tracer for redox processes and are therefore promising for the exploration of the species dependent Se metabolism in plants and the Se cycling within the Critical Zone. Plant cultivation setups enable systematic controlled investigations, but samples derived from them-plant tissue and phytoagar-are particularly challenging and require specific preparation and purification steps to ensure precise and valid Se isotope analytics performed with HG-MC-ICP-MS. In this study, different methods for the entire process from solid tissue preparation to Se isotope measurements were tested, optimized and validated. A particular microwave digestion procedure for plant tissue and a vacuum filtration method for phytoagar led to full Se recoveries, whereby unfavorable organic residues were reduced to a minimum. Three purification methods predominantly described in the literature were systematically tested with pure Se solution, high concentrated multi-element standard solution as well as plant and phytoagar as target matrices. All these methods efficiently remove critical matrix elements, but differ in Se recovery and organic residues. Validation tests doping Se-free plant material and phytoagar with a reference material of known Se isotope composition revealed the high impact of organic residues on the accuracy of MC-ICP-MS measurements. Only the purification method with no detectable organic residues, hydride generation and trapping, results in valid mass bias correction for plant samples with an average deviation to true delta(82/76) Se values of 0.2 parts per thousand and a reproducibility (2 SD) of +/- 0.2 parts per thousand. For phytoagar this test yields a higher deviation of 1.1 parts per thousand from the true value and a 2 SD of +/- 0.1 parts per thousand. The application of the developed methods to cultivated plants shows sufficient accuracy and precision and is a promising approach to resolve plant internal Se isotope fractionations, for which respective delta(82/76) Se values of +2.3 to +3.5 parts per thousand for selenate and +1.2 to +1.9 parts per thousand for selenite were obtained.	[Banning, Helena; Stelling, Monika] Karlsruhe Inst Technol, Inst Appl Geosci, Adenauerring 20 B, Karlsruhe, Germany; [Koenig, Stephan; Schoenberg, Ronny] Univ Tubingen, Dept Geosci, Wilhelmstr 56, Tubingen, Germany; [Neumann, Thomas] Tech Univ Berlin, Inst Appl Geosci, Appl Geochem Grp, Berlin, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Eberhard Karls University of Tubingen; Technical University of Berlin	Banning, H (corresponding author), Karlsruhe Inst Technol, Inst Appl Geosci, Adenauerring 20 B, Karlsruhe, Germany.	helena.banning@gmx.de	Davlatova, Aliya/H-7854-2018; Konig, Stephan/G-3079-2016	Konig, Stephan/0000-0001-9714-9749	"concept of the future" of KIT; ERC Starting Grant [02RIGIN, 636808]	"concept of the future" of KIT; ERC Starting Grant	The funding for our research within the Young Investigator Group was provided by the "concept of the future" of KIT within the framework of the German Excellence Initiative Funding to Monika Stelling and Helena Banning; the research cost itself was funded via the Young Investigator Group as well. Stephan Konig was funded by ERC Starting Grant (02RIGIN, 636808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We particularly acknowledge Timon Kurzawa and Elmar Reitter (Isotope Geochemistry Group, University of Tuebingen) for support in Se isotope analytics as well as Claudia Moessner for analytical support with ICP-MS, Elisabeth Eiche for contributing with plant samples from Punjab and Alexandra Nothstein for conceptual and technical advice in plant cultivation (all Institute of Applied Geosciences, Karlsruhe Institute of Technology). Furthermore we would like to thank Eva Sftieken and the anonymous reviewer for helpful advice, which significantly improved the quality of our manuscript. Our research within the Young Investigator Group was funded by the "concept of the future" of KIT within the framework of the German Excellence Initiative. Stephan Konig acknowledges an ERC Starting Grant (O2RIGIN, 636808).	Alfthan G, 2015, J TRACE ELEM MED BIO, V31, P142, DOI 10.1016/j.jtemb.2014.04.009; BELL PF, 1992, SOIL SCI SOC AM J, V56, P1818, DOI 10.2136/sssaj1992.03615995005600060035x; Bird SM, 1997, J CHROMATOGR A, V789, P349, DOI 10.1016/S0021-9673(97)00657-2; Chilimba ADC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00072; Clark SK, 2008, ENVIRON SCI TECHNOL, V42, P7850, DOI 10.1021/es801814v; DERATANI A, 1983, REACT POLYM, V1, P261; DhiLlon K.S., 2005, ARCH AGRON SOIL SCI, V51, P633, DOI DOI 10.1080/03650340500201667; Ellis AS, 2003, CHEM GEOL, V195, P119, DOI 10.1016/S0009-2541(02)00391-1; Elwaer N, 2008, J ANAL ATOM SPECTROM, V23, P733, DOI 10.1039/b801673a; Floor GH, 2011, J MASS SPECTROM, V46, P182, DOI 10.1002/jms.1880; Gao XD, 2013, APPL GEOCHEM, V38, P110, DOI 10.1016/j.apgeochem.2013.09.005; Herbel MJ, 2002, J ENVIRON QUAL, V31, P1146, DOI 10.2134/jeq2002.1146; Hultberg B, 1997, TOXICOLOGY, V117, P89, DOI 10.1016/S0300-483X(96)03554-8; Johnson TM, 1999, GEOCHIM COSMOCHIM AC, V63, P2775, DOI 10.1016/S0016-7037(99)00279-3; Joy EJM, 2014, SELENIUM ENV HUMAN H; Karadjova IB, 2006, SPECTROCHIM ACTA B, V61, P525, DOI 10.1016/j.sab.2006.03.009; Kim MJ, 2001, B ENVIRON CONTAM TOX, V67, P46, DOI 10.1007/s001280089; KIRKBRIGHT GF, 1978, ANAL CHIM ACTA, V100, P145, DOI 10.1016/S0003-2670(01)93311-2; Kopp G, 1999, E900 SE BESTIMMUNG M; Kurzawa T, 2017, CHEM GEOL, V466, P219, DOI 10.1016/j.chemgeo.2017.06.012; Layton-Matthews D, 2013, GEOCHIM COSMOCHIM AC, V117, P313, DOI 10.1016/j.gca.2013.05.002; Li HF, 2008, NEW PHYTOL, V178, P92, DOI 10.1111/j.1469-8137.2007.02343.x; Mitchell K, 2013, CHEM GEOL, V342, P21, DOI 10.1016/j.chemgeo.2013.01.017; Nothstein AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152081; Ohlendorf HM, 2002, AQUAT TOXICOL, V57, P1, DOI 10.1016/S0166-445X(01)00266-1; Olin A, 2005, CHEM THERMODYN; Pohl P, 2004, TRAC-TREND ANAL CHEM, V23, P63, DOI 10.1016/S0165-9936(04)00108-6; Pokrovsky OS, 2006, GEOCHIM COSMOCHIM AC, V70, P3325, DOI 10.1016/j.gca.2006.04.012; Rayman M. P., 2006, LANCET, V356, P23; Rouxel O, 2004, GEOCHIM COSMOCHIM AC, V68, P2295, DOI 10.1016/j.gca.2003.11.029; Rouxel O, 2002, GEOCHIM COSMOCHIM AC, V66, P3191, DOI 10.1016/S0016-7037(02)00918-3; Rudge JF, 2009, CHEM GEOL, V265, P420, DOI 10.1016/j.chemgeo.2009.05.010; Saito Y, 2008, CHEM ENG SCI, V63, P4935, DOI 10.1016/j.ces.2007.11.036; Schilling K, 2015, ENVIRON SCI TECHNOL, V49, P9690, DOI 10.1021/acs.est.5b00477; Schilling K, 2014, CHEM GEOL, V381, P125, DOI 10.1016/j.chemgeo.2014.04.014; Schilling K, 2013, CHEM GEOL, V352, P101, DOI 10.1016/j.chemgeo.2013.05.013; Schilling K, 2011, SOIL SCI SOC AM J, V75, P1354, DOI 10.2136/sssaj2010.0377; Schilling K, 2011, ENVIRON SCI TECHNOL, V45, P2670, DOI 10.1021/es102926p; Stueken EE, 2013, J ANAL ATOM SPECTROM, V28, P1734, DOI 10.1039/c3ja50186h; Stueken EE, 2015, CHEM GEOL, V410, P28, DOI 10.1016/j.chemgeo.2015.05.021; Takeno N., 2005, ATLAS EH PH DIAGRAMS; Wang ZJ, 2001, APPL GEOCHEM, V16, P1345, DOI 10.1016/S0883-2927(01)00046-4; Wasilewska M, 2002, J ANAL ATOM SPECTROM, V17, P1121, DOI 10.1039/b200644h; WELZ B, 1984, ANALYST, V109, P569, DOI 10.1039/an9840900569; WELZ B, 1981, ANAL CHIM ACTA, V131, P17, DOI 10.1016/S0003-2670(01)93529-9; Wen HJ, 2014, CHEM GEOL, V390, P164, DOI 10.1016/j.chemgeo.2014.10.022; Wen HJ, 2011, GEOCHIM COSMOCHIM AC, V75, P1411, DOI 10.1016/j.gca.2010.12.021; Weyer S, 2003, INT J MASS SPECTROM, V226, P355, DOI 10.1016/S1387-3806(03)00078-2; Yierpan A, 2018, GEOCHEM GEOPHY GEOSY, V19, P516, DOI 10.1002/2017GC007299; ZHANG PC, 1990, ENVIRON SCI TECHNOL, V24, P1848, DOI 10.1021/es00082a010; Zhu JM, 2008, CHINESE J ANAL CHEM, V36, P1385, DOI 10.1016/S1872-2040(08)60075-4; Zhu JM, 2014, GEOCHIM COSMOCHIM AC, V126, P228, DOI 10.1016/j.gca.2013.11.004; Zink S, 2010, GEOCHIM COSMOCHIM AC, V74, P5729, DOI 10.1016/j.gca.2010.07.015; Zsolnay A, 2003, GEODERMA, V113, P187, DOI 10.1016/S0016-7061(02)00361-0	54	2	2	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193826	10.1371/journal.pone.0193826	http://dx.doi.org/10.1371/journal.pone.0193826			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509798	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200034
J	Ruark, CL; Gardner, M; Mitchum, MG; Davis, EL; Sit, TL				Ruark, Casey L.; Gardner, Michael; Mitchum, Melissa G.; Davis, Eric L.; Sit, Tim L.			Novel RNA viruses within plant parasitic cyst nematodes	PLOS ONE			English	Article							SEQUENCE; GENOME; POLYPROTEINS; DISCOVERY; FAMILY; ORDER	The study of invertebrate- and particularly nematode-viruses is emerging with the advancement of transcriptome sequencing. Five single-stranded RNA viruses have now been confirmed within the economically important soybean cyst nematode (SCN; Heterodera glycines). From previous research, we know these viruses to be widespread in greenhouse and field populations of SCN. Several of the SCN viruses were also confirmed within clover (H. trifolii) and beet (H. schachtii) cyst nematodes. In the presented study, we sequenced the transcriptomes of several inbred SCN populations and identified two previously undiscovered viral-like genomes. Both of these proposed viruses are negative-sense RNA viruses and have been named SCN nyami-like virus (NLV) and SCN bunya-like virus (BLV). Finally, we analyzed publicly available transcriptome data of two potato cyst nematode (PCN) species, Globodera pallida and G. rostochiensis. From these data, a third potential virus was discovered and called PCN picorna-like virus (PLV). PCN PLV is a positive-sense RNA virus, and to the best of our knowledge, is the first virus described within PCN. The presence of these novel viruses was confirmed via qRT-PCR, endpoint PCR, and Sanger sequencing with the exception of PCN PLV due to quarantine restrictions on the nematode host. While much work needs to be done to understand the biological and evolutionary significance of these viruses, they offer insight into nematode ecology and the possibility of novel nematode management strategies.	[Ruark, Casey L.; Davis, Eric L.; Sit, Tim L.] North Carolina State Univ, Dept Entomol & Plant Pathol, Thomas Hall, Raleigh, NC 27695 USA; [Gardner, Michael; Mitchum, Melissa G.] Univ Missouri, Div Plant Sci, 371H Bond Life Sci Ctr, Columbia, MO USA; [Gardner, Michael; Mitchum, Melissa G.] Univ Missouri, Bond Life Sci Ctr, 371H Bond Life Sci Ctr, Columbia, MO USA	University of North Carolina; North Carolina State University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sit, TL (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Thomas Hall, Raleigh, NC 27695 USA.	tim@ncsu.edu		Sit, Tim/0000-0001-7302-823X	National Science Foundation [DGE-1252376]; NC State University College of Agricultural and Life Sciences' North Carolina Agricultural Research Service	National Science Foundation(National Science Foundation (NSF)); NC State University College of Agricultural and Life Sciences' North Carolina Agricultural Research Service	This work was supported by the National Science Foundation, DGE-1252376 (www.nsf.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the NC State University Genomic Sciences Laboratory for RNA sequencing as well as Ioannis Tzanetakis at the University of Arkansas for granting access to VirFind (http://virfind.org). Gratitude is extended towards Xiaohong Wang and Shiyan Chen of Cornell University for their contribution of G. rostochiensis total RNA. We thank the NC State University College of Agricultural and Life Sciences' North Carolina Agricultural Research Service for providing their facilities and support in this work. Lastly, we would like to thank the researchers from which we utilized public transcriptome data.	Bekal S, 2014, J GEN VIROL, V95, P1272, DOI 10.1099/vir.0.060889-0; Bekal S, 2011, J GEN VIROL, V92, P1870, DOI 10.1099/vir.0.030585-0; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; BROWN DJF, 1995, ANNU REV PHYTOPATHOL, V33, P223, DOI 10.1146/annurev.py.33.090195.001255; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Cotton JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep39749; de Boer JM, 1999, MOL PLANT MICROBE IN, V12, P663, DOI 10.1094/MPMI.1999.12.8.663; Donaire L, 2016, VIROLOGY, V499, P212, DOI 10.1016/j.virol.2016.09.017; Dong K, 1997, GENETICS, V146, P1311; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Fosu-Nyarko J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147511; Franz CJ, 2012, J VIROL, V86, P11940, DOI 10.1128/JVI.02025-12; Gardner M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20536-5; Gardner M, 2017, G3-GENES GENOM GENET, V7, P835, DOI 10.1534/g3.116.035964; Geng P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092107; Ho T, 2014, VIROLOGY, V471, P54, DOI 10.1016/j.virol.2014.09.019; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Longdon B, 2012, P ROY SOC B-BIOL SCI, V279, P3889, DOI 10.1098/rspb.2012.1208; Mann KS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00745; Mihindukulasuriya KA, 2009, J VIROL, V83, P5109, DOI 10.1128/JVI.02667-08; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rogers MB, 2014, AM J TROP MED HYG, V91, P159, DOI 10.4269/ajtmh.14-0076; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Ruark CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171514; Shean RC, 2017, GENOME ANNOUNC, V5; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Skantar AM, 2012, J NEMATOL, V44, P58; TOWNSHEND J. L., 1963, NEMATOLOGICA, V9, P106; Yinda CK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3632-7; Zell R, 2017, J GEN VIROL, V98, P2421, DOI 10.1099/jgv.0.000911	40	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193881	10.1371/journal.pone.0193881	http://dx.doi.org/10.1371/journal.pone.0193881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509804	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200037
J	Shanmugam, A; Usmani, M; Mayberry, A; Perkins, DL; Holcomb, DE				Shanmugam, Akshaya; Usmani, Mohammad; Mayberry, Addison; Perkins, David L.; Holcomb, Daniel E.			Imaging systems and algorithms to analyze biological samples in real-time using mobile phone microscopy	PLOS ONE			English	Article								Miniaturized imaging devices have pushed the boundaries of point-of-care imaging, but existing mobile-phone-based imaging systems do not exploit the full potential of smart phones. This work demonstrates the use of simple imaging configurations to deliver superior image quality and the ability to handle a wide range of biological samples. Results presented in this work are from analysis of fluorescent beads under fluorescence imaging, as well as helminth eggs and freshwater mussel larvae under white light imaging. To demonstrate versatility of the systems, real time analysis and post-processing results of the sample count and sample size are presented in both still images and videos of flowing samples.	[Shanmugam, Akshaya] Lumme Inc, Amherst, MA USA; [Usmani, Mohammad; Holcomb, Daniel E.] Univ Massachusetts Amherst, Elect & Comp Engn, Amherst, MA 01003 USA; [Mayberry, Addison] Univ Massachusetts Amherst, Coll Informat & Comp Sci, Amherst, MA 01003 USA; [Perkins, David L.] US Fish & Wildlife Serv, Richard Cronin Aquat Resource Ctr, Sunderland, MA USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; United States Department of the Interior; US Fish & Wildlife Service	Holcomb, DE (corresponding author), Univ Massachusetts Amherst, Elect & Comp Engn, Amherst, MA 01003 USA.	holcomb@engin.umass.edu			Hluchyj fellowship; U.S. Fish and Wildlife Service, Richard Cronin Aquatic Resource Center	Hluchyj fellowship; U.S. Fish and Wildlife Service, Richard Cronin Aquatic Resource Center	The microfluidics research presented here and Dr. Akshaya Shanmugam were partially funded by the Hluchyj Fellowship. The work on mussels was partially funded by the U.S. Fish and Wildlife Service, Richard Cronin Aquatic Resource Center to Mohammad Usmani. There was no additional funding received for this study.; The authors would like to thank Dr. Christopher Salthouse and Dr. Deepak Ganesan for their guidance and the Hluchyj fellowship for facilitating the microfluidic research presented in this work. We would also like to thank Yamin T. Tun and Omid Meh for their contributions.	[Anonymous], 2002, ACC HAART DEV WORLD; Barda B, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-271; Beucher S., 1979, INT WORKSH IM PROC R; Bogoch II, 2013, AM J TROP MED HYG, V88, P626, DOI 10.4269/ajtmh.12-0742; Bouwmans T., 2008, RECENT PATENTS COMPU, V1, P219; Bradski G., 2000, DOBBS J SOFTWARE TOO; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Coskun AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015955; Coskun AF, 2010, OPT EXPRESS, V18, P10510, DOI 10.1364/OE.18.010510; Dupont EP, 2012, SENSOR ACTUAT B-CHEM, V174, P609, DOI 10.1016/j.snb.2012.06.049; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Gupte S, 2002, IEEE T INTELL TRANSP, V3, P37, DOI 10.1109/6979.994794; Helmchen F, 2002, EXP PHYSIOL, V87, P737, DOI 10.1113/eph8702478; Hofmann M, 2012, PROC IEEE COMPUT SOC, P38, DOI [10.1109/CVPRW.2012.6238925, DOI 10.1109/CVPRW.2012.6238925]; Li W, 2011, SPECTROSCOPY MODULE, V7894; Pritchard JA, 2001, HIST ANAL MUSSEL PRO; World Health Organization, 2015, INT WORMS; ZHANG X, 1995, ELECTRON LETT, V31, P863, DOI 10.1049/el:19950574; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	20	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193797	10.1371/journal.pone.0193797	http://dx.doi.org/10.1371/journal.pone.0193797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509786	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200031
J	Selles, P; Avila, V; Martinez, T; Ysla, L				Selles, Pilar; Avila, Vicenta; Martinez, Tomas; Ysla, Liz			The skills related to the early reading acquisition in Spain and Peru	PLOS ONE			English	Article							ACADEMIC-ACHIEVEMENT; EMERGENT LITERACY; INITIAL LITERACY; PREDICTORS; VOCABULARY; PRESCHOOL; CHILDREN; KINDERGARTEN; KNOWLEDGE; LANGUAGE	This paper deals with the skills related to the early reading acquisition in two countries that share language. Traditionally on reading readiness research there is a great interest to find out what factors affect early reading ability, but differ from other academic skills that affect general school learnings. Furthermore, it is also known how the influence of pre-reading variables in two countries with the same language, affect the development of the reading. On the other hand, several studies have examined what skills are related to reading readiness (phonological awareness, alphabetic awareness, naming speed, linguistic skills, metalinguistic knowledge and basic cognitive processes), but there are no studies showing whether countries can also influence the development of these skills. Our main objective in this study was to establish whether there were differences in the degree of acquisition of these skills between Spanish (119 children) and Peruvian (128 children), five years old children assessed in their own countries and after controlling Economic, Social and Cultural Status (ESCS). The results show that there are significant differences in the degree of acquisition of these skills between these two samples. It's especially relevant, in these results, that the main predictor in a regression study was the country of origin, explaining a higher percentage of variance than other variables such as age differences, in months, or gender. These findings corroborate the results obtained in other studies with migrant population.	[Selles, Pilar] Univ Catolica Valencia, Dept Occupat Sci Speech Therapy & Dev & Educ Psyc, Valencia, Spain; [Avila, Vicenta; Martinez, Tomas] Univ Valencia, Dept Dev & Educ Psychol, Valencia, Spain; [Ysla, Liz] Private Teachers Coll Official Certificat Qual Ed, Lima, Peru	Universidad Catolica de Valencia San Vicente Martir; University of Valencia	Selles, P (corresponding author), Univ Catolica Valencia, Dept Occupat Sci Speech Therapy & Dev & Educ Psyc, Valencia, Spain.	pilar.selles@ucv.es	Nohales, Pilar Sellés/L-1125-2017; Martinez Gimenez, Tomas/L-6889-2014	Nohales, Pilar Sellés/0000-0002-3974-3376; Martinez Gimenez, Tomas/0000-0001-6165-9085				Villagran MA, 2010, PSICOTHEMA, V22, P436; Gil SA, 2012, PSICOTHEMA, V24, P573; Axpe A, 2012, REV PSICODIDACT, V17, P271, DOI 10.1387/Rev.Psicodidact.2571; Azzolini D, 2012, ANN AM ACAD POLIT SS, V643, P46, DOI 10.1177/0002716212441590; Baghban M, 1990, ADQUISICION PRECOZ L; Blanch JML, 2003, CUESTIONES FILOLOGIA, P51; Blanch JML, 2000, REV FILOL ESPAN, V80, P201; Borenstein M., 2009, HDB RES SYNTHESIS ME, VVolume 2, P221, DOI DOI 10.7758/9781610441384; Bosse ML, 2009, J RES READ, V32, P230, DOI 10.1111/j.1467-9817.2008.01387.x; Bradley RH, 2001, CHILD DEV, V72, P1868, DOI 10.1111/1467-8624.t01-1-00383; Bravo-Valdivieso L, 2006, REV LAT AM PSICOL, V38, P9; Canales RC, 2014, REV INVESTIGACION PS, V17, P107; Catts HW, 2006, J SPEECH LANG HEAR R, V49, P278, DOI 10.1044/1092-4388(2006/023); Cuetos F., 2015, Rev Pediatr Aten Primaria, V17, pe99; D'angiulli A., 2004, LEARNING DISABILITIE, V19, P202, DOI DOI 10.1111/J.1540-5826.2004.00106.X; D'Angiulli A., 2004, ED PSYCHOL, V24, P867, DOI [10.1080/0144341042000271746, DOI 10.1080/0144341042000271746]; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; Defior S., 2011, REV LOGOPEDIA FONIAT, V31, P2, DOI [DOI 10.1016/S0214-4603(11)70165-6, 10.1016/S0214-4603(11)70165-6]; Defior S, 2008, INFANC APRENDIZ, V31, P333, DOI 10.1174/021037008785702983; Diaz J, 2006, NUEVO MAPA POBREZA F; Dice JL, 2012, READ WRIT, V25, P2205, DOI 10.1007/s11145-011-9354-3; Dickinson DK, 2011, CHILD DEV, V82, P870, DOI 10.1111/j.1467-8624.2011.01576.x; Diuk Beatriz Graciela, 2014, Interdisciplinaria, V31, P25; Duncan LG, 2000, BRIT J PSYCHOL, V91, P145, DOI 10.1348/000712600161736; Ensminger ME, 2003, MON PARENT, P13; Ferreiro E., 1982, LITERACY SCH; Ferrer A, 2010, PRUEBA VALORACION VO; Filho L, 1960, TEST ABC VERIFICACIO; Florez-Romero R, 2009, AV PSICOL LATINOAM, V27, P79; Foulin J.N., 2005, READING WRITING INTE, V18, P129, DOI [10.1007/s11145-004-5892-2, DOI 10.1007/S11145-004-5892-2]; Garton A, 1991, APRENDIZAJE PROCESO, V21; Gentaz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119581; Georgiou GK, 2012, READ WRIT, V25, P321, DOI 10.1007/s11145-010-9271-x; Gil-Flores J., 2009, REV EDUCACI N, V350, P301; Harlin R, 1990, READING HORIZONS, V30, P210; Hipfner-Boucher K, 2014, FIRST LANG, V34, P178, DOI 10.1177/0142723714525945; HUBA ME, 1989, J EDUC RES, V82, P210, DOI 10.1080/00220671.1989.10885895; Huguet A, 2007, ANUARIO PSICOLOGIA, V38; Huguet A, 2008, INFANC APRENDIZ, V31, P283, DOI 10.1174/021037008785702901; Hulme C, 2012, PSYCHOL SCI, V23, P572, DOI 10.1177/0956797611435921; Inizan A, 1979, CUANDO ENSENAR LEER; Injoque-Ricle I, 2012, CUAD NEUROPSICOL, V6, P33; Instituto Nacional de Estadistica e Informatica INEI, 2016, ENC NAC HOG; Instituto Nacional de Estadistica e Informatica (Peru ), 2008, PERF SOC PER CENS NA; Jimenez Gonzalez J E, 2000, Span J Psychol, V3, P37; Jimenez J., 2008, REV IBEROAMERICANA E, V45, P2; Gonzalez-Valenzuela MJ, 2012, REV PSICODIDACT, V17, P253, DOI 10.1387/RevPsicodidact.4502; Kassow D. Z., 2006, TALARIS RES I, V1, P1; Kiuru N, 2013, READ RES QUART, V48, P349, DOI 10.1002/rrq.53; Konold TR, 2003, APPL PSYCHOLINGUIST, V24, P89, DOI 10.1017/S0142716403000055; LABERGE D, 1974, COGNITIVE PSYCHOL, V6, P293, DOI 10.1016/0010-0285(74)90015-2; Leseman PPM, 1998, READ RES QUART, V33, P294, DOI 10.1598/RRQ.33.3.3; Lonigan C. J., 2009, DEV EARLY LITERACY R; Lopez Morales H, 2006, FUTURO ESPANOL, P476; Lopez-Escribano C, 2009, SPAN J PSYCHOL, V12, P84, DOI 10.1017/S1138741600001505; Malmberg B, 1971, AM HISPANOHABLANTE U, P3; Marchesi A., 2004, INFANC APRENDIZ, V27, P307; McBride-Chang C, 2002, CHILD DEV, V73, P1392, DOI 10.1111/1467-8624.00479; Ministerio de Educacion Cultura y Deportes, 2017, CIFR ED ESP EST IND; Molina S, 1992, BADICBALE BATERIA DI; Molina S, 1988, BADIMALE BATERIA DIA; Montes R., 2002, 2 JORN INT REG MURC, P15; Mora JA, 1999, BENHALE BATERIA EVAL; Muter V, 2004, DEV PSYCHOL, V40, P665, DOI 10.1037/0012-1649.40.5.665; Nation K, 2004, J SPEECH LANG HEAR R, V47, P199, DOI 10.1044/1092-4388(2004/017); Neumann MM, 2013, READ WRIT, V26, P771, DOI 10.1007/s11145-012-9390-7; Niessen NL, 2011, COMMUN DISORD Q, V32, P93, DOI 10.1177/1525740110363624; Noble KG, 2006, COGNITIVE DEV, V21, P349, DOI 10.1016/j.cogdev.2006.01.007; Parrila R, 2004, SCI STUD READ, V8, P3, DOI 10.1207/s1532799xssr0801_2; Pearson PD, 2007, READ RES QUART, V42, P282, DOI 10.1598/RRQ.42.2.4; Piacente T., 2006, REV IBEROAM DIAGN EV, V1, P61; PISA, 2015, PROGR EV INT AL; Pisa Programa para la Evaluacin Internacional de los Alumnos, 2018, SPAN REP; Porta ME, 2012, REV ORIENTACION EDUC, P93, DOI [10.5944/reop.vol.28.num.2.2017.20117, DOI 10.5944/REOP.VOL.28.NUM.2.2017.20117]; Proctor CP, 2012, READ WRIT, V25, P1635, DOI 10.1007/s11145-011-9336-5; Ramey CT, 1998, AM PSYCHOL, V53, P109, DOI 10.1037/0003-066X.53.2.109; Robins S, 2014, READ WRIT, V27, P407, DOI 10.1007/s11145-013-9450-7; Scanlon E., 2001, J SOCIOLOGY SOCIAL W, V28, P9; Selles P, 2008, MANUAL BATERIA INICI; Selles P., 2008, BORDON, V60, P113; Senechal M, 2002, CHILD DEV, V73, P445, DOI 10.1111/1467-8624.00417; Siguan M., 1998, ESCUELA INMIGRANTES; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Speece DL, 2004, CONTEMP EDUC PSYCHOL, V29, P312, DOI 10.1016/j.cedpsych.2003.07.001; Suarez-Coalla P, 2013, INFANC APRENDIZ, V36, P77, DOI 10.1174/021037013804826537; Thomson J., 2009, J LEARNING DISABILIT, V43, P383; Tiana A, 2002, EVALUACION EDUCACION, P61; Torrado M., 2003, REV COLOMB PSICOL, V12, P85; Trías Daniel, 2009, Cienc. Psicol., V3, P177; TUNMER WE, 1988, READ RES QUART, V23, P134, DOI 10.2307/747799; Velarde E, 2010, TEST HABILIDADES PRE; Vila I., 2006, CULT EDUC, V18, P127, DOI DOI 10.1174/113564006777973888; Wei TQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096240; Wells G., 1988, APRENDER LEER ESCRIB; Welsh JA, 2010, J EDUC PSYCHOL, V102, P43, DOI 10.1037/a0016738; WHITE KR, 1982, PSYCHOL BULL, V91, P461, DOI 10.1037/0033-2909.91.3.461; Wolter Lynsey Kay, 2006, THESIS; Ysla LC, 2016, PSICOLOGIA EDUCACION, P2720; Zaretsky E, 2009, WRIT LANG LIT, V12, P52, DOI 10.1075/wll.12.1.03zar	99	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193450	10.1371/journal.pone.0193450	http://dx.doi.org/10.1371/journal.pone.0193450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY1CC	29505592	Green Published, gold, Green Submitted			2022-12-27	WOS:000426548200017
J	Drozdova, P; Lipaeva, P; Rogoza, T; Zhouravleva, G; Bondarev, S				Drozdova, Polina; Lipaeva, Polina; Rogoza, Tatyana; Zhouravleva, Galina; Bondarev, Stanislav			Overproduction of Sch9 leads to its aggregation and cell elongation in Saccharomyces cerevisiae	PLOS ONE			English	Article							MULTIPLE-MYELOMA; PROTEIN-KINASES; SHUTTLE VECTORS; YEAST; GROWTH; PRIONS; STRESS; GENE; TOR; LOCALIZATION	The Sch9 kinase of Saccharomyces cerevisiae is one of the major TOR pathway effectors and regulates diverse processes in the cell. Sch9 belongs to the AGC kinase family. In human, amplification of AGC kinase genes is connected with cancer. However, not much is known about the effects of Sch9 overproduction in yeast cells. To fill this gap, we developed a model system to monitor subcellular location and aggregation state of overproduced Sch9 or its regions fused to a fluorescent protein. With this system, we showed that Sch9-YFP forms detergent-resistant aggregates, and multiple protein regions are responsible for this. This finding corroborated the fact that Sch9-YFP is visualized as various fluorescent foci. In addition, we found that Sch9 overproduction caused cell elongation, and this effect was determined by its C-terminal region containing kinase domains. The constructs we present can be exploited to create superior yeast-based model systems to study processes behind kinase overproduction in cancers.	[Drozdova, Polina; Lipaeva, Polina; Rogoza, Tatyana; Zhouravleva, Galina; Bondarev, Stanislav] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg, Russia; [Rogoza, Tatyana] Russian Acad Sci, Vavilov Inst Gen Genet, St Petersburg Branch, St Petersburg, Russia; [Zhouravleva, Galina; Bondarev, Stanislav] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg, Russia; [Drozdova, Polina] Irkutsk State Univ, Inst Biol, Irkutsk, Russia; [Lipaeva, Polina] LLC Innova Plus, St Petersburg, Russia	Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Vavilov Institute of General Genetics; Saint Petersburg State University; Irkutsk State University	Drozdova, P; Bondarev, S (corresponding author), St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg, Russia.; Bondarev, S (corresponding author), St Petersburg State Univ, Lab Amyloid Biol, St Petersburg, Russia.; Drozdova, P (corresponding author), Irkutsk State Univ, Inst Biol, Irkutsk, Russia.	drozdovapb@gmail.com; stanislavspbgu@gmail.com	Bondarev, Stanislav/AAD-5124-2022; Drozdova, Polina/H-9490-2013; Rogoza, Tatiana/N-4437-2013	Bondarev, Stanislav/0000-0003-3137-944X; Drozdova, Polina/0000-0003-3955-6105; Rogoza, Tatiana/0000-0003-2981-0421	research resource center "Molecular and cell technologies" of the St. Petersburg State University; Russian Science Foundation [17-74-10159]; RFBR [16-04-00202]	research resource center "Molecular and cell technologies" of the St. Petersburg State University; Russian Science Foundation(Russian Science Foundation (RSF)); RFBR(Russian Foundation for Basic Research (RFBR))	The authors are grateful for Maria Cordenaz-Corona and Joanne Kingsbury for their generous gift of anti-732-743-Sch9 and anti-phospho-Thr737-Sch9 antibodies, Simon Alberti for the pAG415GPD-Hsp42-mCherry plasmid, Tobias Wilms for the JW 03 038 strain, Jorg Urban for the pJU675 plasmid and Aleksandr Rubel for the FM4-64 dye. We would like to thank Andrew Matveenko for useful advice and help with plasmid construction. The research was supported by the research resource center "Molecular and cell technologies" of the St. Petersburg State University.; The investigation of Sch9 aggregation and corresponding bioinformatic analysis was supported by Russian Science Foundation (rscf.ru) grant 17-74-10159, while the study of effects of Sch9 overproduction on cell morphology was supported by RFBR (rfbr.ru) grant 16-04-00202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AB, 2015, ALZHEIMERS DEMENT, V11, P681, DOI 10.1016/j.jalz.2014.06.007; Ahmed AB, 2013, FEBS LETT, V587, P1089, DOI 10.1016/j.febslet.2012.12.006; Alberti S, 2017, J CELL SCI, V130, P2789, DOI 10.1242/jcs.200295; Amen T, 2015, CELL MOL LIFE SCI, V72, P401, DOI 10.1007/s00018-014-1740-y; [Anonymous], 2021, LANG ENV STAT COMP; Arencibia JM, 2013, BBA-PROTEINS PROTEOM, V1834, P1302, DOI 10.1016/j.bbapap.2013.03.010; Arul N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00201; Bondarev SA, 2015, PRION, V9, P190, DOI 10.1080/19336896.2015.1044186; Brachmann CB, 1998, YEAST, V14, P115; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Caudron F, 2013, CELL, V155, P1244, DOI 10.1016/j.cell.2013.10.046; Chakrabortee S, 2016, CELL, V167, P369, DOI 10.1016/j.cell.2016.09.017; Chee MK, 2012, G3-GENES GENOM GENET, V2, P515, DOI 10.1534/g3.111.001917; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; Couch FJ, 1999, CANCER RES, V59, P1408; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fagerli UM, 2011, ONCOGENE, V30, P3198, DOI 10.1038/onc.2011.79; Halfmann R, 2008, JOVE-J VIS EXP, p20 ; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hoang B, 2016, MOL CANCER RES, V14, P397, DOI 10.1158/1541-7786.MCR-15-0422; Hollebecque A, 2014, EUR J CANCER, V50, P876, DOI 10.1016/j.ejca.2013.12.006; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kadnar ML, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000824; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaiser C., 1994, METHODS YEAST GENETI; Kingsbury JM, 2014, GENETICS, V196, P1077, DOI 10.1534/genetics.114.161646; Koh JLY, 2015, G3-GENES GENOM GENET, V5, P1223, DOI 10.1534/g3.115.017830; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lu YJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006409; Madhunapantula SV, 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/327923; Madia F, 2009, J CELL BIOL, V186, P509, DOI 10.1083/jcb.200906011; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nizhnikov AA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1127, DOI 10.1134/S0006297915090047; Pardo OE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00191; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Perez-Tenorio G, 2011, BREAST CANCER RES TR, V128, P713, DOI 10.1007/s10549-010-1058-x; Roche DB, 2017, PROTEIN SCI, V26, P1864, DOI 10.1002/pro.3225; Ryzhova TA, 2017, CURRENT GENETICS, p1 ; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segatto I, 2016, AGING-US, V8, P958, DOI 10.18632/aging.100954; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinclair CS, 2003, BREAST CANCER RES TR, V78, P313, DOI 10.1023/A:1023081624133; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Swinnen E, 2014, MOL BIOL CELL, V25, P196, DOI 10.1091/mbc.E13-06-0340; Tavares MR, 2015, LIFE SCI, V131, P1, DOI 10.1016/j.lfs.2015.03.001; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; Tong Z., 2011, BIOPROTOCOL BIO, V101, pe18; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; van Dam TJP, 2011, J MOL EVOL, V73, P209, DOI 10.1007/s00239-011-9469-9; WEINBERGER M, 2007, PLOONE PUBLIC LIB, V2, DOI DOI 10.1371/JOURNAL.PONE.0000748; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILLIAMSON DH, 1965, J CELL BIOL, V25, P517, DOI 10.1083/jcb.25.3.517; Wilms T, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006835; Wullschleger S, 2006, CELL, V127, P5, DOI 10.1016/j.cell.2006.01.016; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596	71	1	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193726	10.1371/journal.pone.0193726	http://dx.doi.org/10.1371/journal.pone.0193726			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494682	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200090
J	Benedetto, S; Caldato, C; Bazzan, E; Greenwood, DC; Pensabene, V; Actis, P				Benedetto, Simone; Caldato, Christian; Bazzan, Elia; Greenwood, Darren C.; Pensabene, Virginia; Actis, Paolo			Assessment of the Fitbit Charge 2 for monitoring heart rate	PLOS ONE			English	Article							VALIDATION; ACCURACY; EXERCISE; AGREEMENT; DISEASE	Fitness trackers are devices or applications for monitoring and tracking fitness-related metrics such as distance walked or run, calorie consumption, quality of sleep and heart rate. Since accurate heart rate monitoring is essential in fitness training, the objective of this study was to assess the accuracy and precision of the Fitbit Charge 2 for measuring heart rate with respect to a gold standard electrocardiograph. Fifteen healthy participants were asked to ride a stationary bike for 10 minutes and their heart rate was simultaneously recorded from each device. Results showed that the Fitbit Charge 2 underestimates the heart rate. Although the mean bias in measuring heart rate was a modest -5.9 bpm (95% CI: -6.1 to -5.6 bpm), the limits of agreement, which indicate the precision of individual measurements, between the Fitbit Charge 2 and criterion measure were wide (+16.8 to -28.5 bpm) indicating that an individual heart rate measure could plausibly be underestimated by almost 30 bpm.	[Benedetto, Simone; Caldato, Christian; Bazzan, Elia] TSW XP Lab, Treviso, Italy; [Greenwood, Darren C.] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England; [Greenwood, Darren C.] Univ Leeds, Leeds Inst Data Analyt, Leeds, W Yorkshire, England; [Pensabene, Virginia; Actis, Paolo] Univ Leeds, Sch Elect & Elect Engn, Leeds, W Yorkshire, England; [Pensabene, Virginia] Univ Leeds, Leeds Inst Biomed & Clin Sci, Sch Med, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; University of Leeds	Benedetto, S (corresponding author), TSW XP Lab, Treviso, Italy.	simone.benedetto@tsw.it		Benedetto, Simone/0000-0002-6053-1052; Pensabene, Virginia/0000-0002-3352-8202	TSW XP Lab	TSW XP Lab	This work was supported by TSW XP Lab, which only provided financial support in the form of authors' salaries [SB, CC, EB] and/or research materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Allen J., 2007, PHYSL MEASUREMENT, V28; Alnaeb ME, 2007, CURR VASC PHARMACOL, V5, P53, DOI 10.2174/157016107779317242; [Anonymous], FITB CHARG HR PROD M; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Cadmus-Bertram L, 2017, ANN INTERN MED, V166, P610, DOI 10.7326/L16-0353; de Zambotti M, 2016, PHYSIOL BEHAV, V158, P143, DOI 10.1016/j.physbeh.2016.03.006; Gao W, 2016, NATURE, V529, P509, DOI 10.1038/nature16521; Gillinov S, 2017, MED SCI SPORT EXER, V49, P1697, DOI 10.1249/MSS.0000000000001284; Jin H, 2016, NANO LETT, V16, P4194, DOI 10.1021/acs.nanolett.6b01066; Jo E, 2016, J SPORT SCI MED, V15, P540; Lee JMM, 2016, MED SCI SPORT EXER, V48, P786, DOI 10.1249/01.mss.0000487361.48518.aa; Murthy V, 2001 C P 23 ANN INT, DOI [10.1109/iembs.2001.1017209, DOI 10.1109/IEMBS.2001.1017209]; Nazari G, 2017, J STRENGTH CONDITION, V1; Parak J, 2014, IEEE ENG MED BIO, P3670, DOI 10.1109/EMBC.2014.6944419; Powierza CS, 2017, PM&R, V9, P1077, DOI 10.1016/j.pmrj.2017.03.012; Reisner A, 2008, ANESTHESIOLOGY, V108, P950, DOI 10.1097/ALN.0b013e31816c89e1; Shcherbina A, 2017, ACCURACY WRISTWORN S, V7; Spierer David K., 2015, Journal of Medical Engineering & Technology, V39, P264, DOI 10.3109/03091902.2015.1047536; Stahl Sarah E, 2016, BMJ Open Sport Exerc Med, V2, pe000106; Takacs J, 2014, J SCI MED SPORT, V17, P496, DOI 10.1016/j.jsams.2013.10.241; Wallen MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154420; Wang R, 2017, JAMA CARDIOL, V2, P104, DOI 10.1001/jamacardio.2016.3340; Wright SP, 2017, AM J PHYSL REGULATOR, V312	25	72	72	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192691	10.1371/journal.pone.0192691	http://dx.doi.org/10.1371/journal.pone.0192691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489850	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000038
J	Hwang, SB; Choi, JG; Wei, S; Park, BJ; Chelliah, R; Oh, DH				Hwang, Su-Bin; Choi, Jung-gu; Wei, Shuai; Park, Byung-Jae; Chelliah, Ramachandran; Oh, Deog-Hwan			In vivo screening platform for shiga toxinproducing Escherichia coli (STEC) using Caenorhabditis elegans as a model	PLOS ONE			English	Article							VIRULENCE GENES; INFECTION; PATHOGENICITY; ACTIVATION; LONGEVITY; BACTERIA; REVEALS; FOOD	Shiga toxin-producing Escherichia coli (STEC) strains are the main cause of bacillary dysentery, although STEC strains generally induce milder disease symptoms compared to Shigella species. This study aimed to determine the virulence of STEC using the nematode Caenorhabditis elegans as a model host. Worm killing, fertility and bacterial colonisation assays were performed to examine the potential difference in the virulence of STEC strains compared to that of the control E. coli OP50 strains on which worms were fed. A statistically significant difference in the survival rates of C. elegans was observed in that the STEC strains caused death in 8 +/- 10 days and the E. coli OP50 strains caused death in 15 days. STEC strains severely reduced the fertility of the worms. The intestinal load of bacteria in the adult stage nematodes harbouring the E. coli OP50 strains was found to be 3.5 log CFU mL(-1). In contrast, the STEC strains E15, E18 and E22 harboured 4.1, 4.2 and 4.7 log CFU ml(-1) per nematode, respectively. The heat-killed STEC strains significantly increased the longevity of the worms compared to the non-heated STEC strains. In addition, PCR-based genomic profiling of shiga toxin genes, viz., stx1 and stx2, identified in selected STEC strains revealed that these toxins may be associated with the virulence of the STEC strains. This study demonstrated that C. elegans is an effective model to examine and compare the pathogenicity and virulence variation of STEC strains to that of E. coli OP50 strains.	[Hwang, Su-Bin; Choi, Jung-gu; Wei, Shuai; Park, Byung-Jae; Chelliah, Ramachandran; Oh, Deog-Hwan] Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, South Korea	Kangwon National University	Oh, DH (corresponding author), Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, South Korea.	deoghwa@kangwon.ac.kr	wei, shuai/GUS-6394-2022	DeogHwan, Oh/0000-0002-7472-0436; Chelliah, Ramachandran/0000-0003-2060-9297	Ministry of Agriculture, Food and Drug Safety [14162MFDS085]; Kangwon National University [14162MFDS085]; Ministry of Agriculture, Food and Drug Safety	Ministry of Agriculture, Food and Drug Safety; Kangwon National University; Ministry of Agriculture, Food and Drug Safety	This research work was carried out with the support of research grant (14162MFDS085) to DHO from Ministry of Agriculture, Food and Drug Safety and Kangwon National University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Caenorhabdtis Genetics Center (CGC), Jinn Lee, and Young-hoon Kim for providing the C. elegans strains, and Mr. Park-Yong IK and Ms. Lee Hyun Ah of Kangwon National University, Central laboratory, for training and technical support for con focal analysis. This work was supported by a grant from the Ministry of Agriculture, Food and Drug Safety and Kangwon National University 14162MFDS085.	Abada EAE, 2007, KOREAN J GENETIC, V29, P275; Akiyama Y, 2017, JPN J INFECT DIS, V70, P181, DOI 10.7883/yoken.JJID.2016.100; Anyanful A, 2005, MOL MICROBIOL, V57, P988, DOI 10.1111/j.1365-2958.2005.04739.x; Bae WK, 2006, YONSEI MED J, V47, P437, DOI 10.3349/ymj.2006.47.3.437; Bommarius B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054456; Cheung Man Kit, 2011, BMC Res Notes, V4, P533, DOI 10.1186/1756-0500-4-533; Chou TC, 2013, CELL MICROBIOL, V15, P82, DOI 10.1111/cmi.12030; Cypser JR, 2013, MECH AGEING DEV, V134, P291, DOI 10.1016/j.mad.2013.02.003; Dallman TJ, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000029; Diaz SA, 2015, ECOL EVOL, V5, P1343, DOI 10.1002/ece3.1436; Dunne KA, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000106; Essebe CN, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00077; Ewbank JJ, 2016, CURR OPIN IMMUNOL, V38, P1, DOI 10.1016/j.coi.2015.09.005; Franz E, 2014, INT J FOOD MICROBIOL, V187, P57, DOI 10.1016/j.ijfoodmicro.2014.07.002; Fruth A, 2015, INT J MED MICROBIOL, V305, P697, DOI 10.1016/j.ijmm.2015.08.020; Fung CC, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu045; George DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106085; Golan L, 2011, DIS MODEL MECH, V4, P86, DOI 10.1242/dmm.005777; Greaney AJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00570; He YH, 2014, J PATHOL, V233, P269, DOI 10.1002/path.4350; Huang XW, 2005, RES MICROBIOL, V156, P719, DOI 10.1016/j.resmic.2005.02.006; Hwang AB, 2014, P NATL ACAD SCI USA, V111, pE4458, DOI 10.1073/pnas.1411199111; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kang D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01707; Kulshreshtha G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00421; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lan R, 2004, INFECT IMMUN, V72, P5080, DOI 10.1128/IAI.72.9.5080-5088.2004; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee JH, 2017, ENVIRON MICROBIOL, V19, P1776, DOI 10.1111/1462-2920.13649; Losada L, 2016, PLASMID, V83, P8, DOI 10.1016/j.plasmid.2015.12.001; Martin N, 2017, G3-GENES GENOM GENET, V7, P1137, DOI 10.1534/g3.117.039057; Merkx-Jacques A, 2013, APPL ENVIRON MICROB, V79, P2435, DOI 10.1128/AEM.03501-12; Michelacci V, 2017, FOOD MICROBIOL FOOD, P109, DOI 10.1007/978-3-319-43751-4_7; Miko A, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00078; Mohawk KL, 2011, BIOMED RES INT; Neuhaus K, 2017, ARCH MICROBIOL, V199, P203, DOI 10.1007/s00203-016-1291-8; Njamkepo E, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.27, 10.1038/nmicrobiol.2016.27]; Paauw A, 2015, INT J MED MICROBIOL, V305, P446, DOI 10.1016/j.ijmm.2015.04.001; Panda A, 2010, COMPARATIVE MED, V60, P31; Rivas M., 2016, Escherichia coli in the Americas, P97; Sanchez-Diener I, 2017, ANTIMICROBIAL AGENTS; Sarabhai S, 2014, MOL MECH TERMINALIAC; Sastalla I, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00300; Shen JL, 2015, FOOD MICROBIOL, V50, P20, DOI 10.1016/j.fm.2015.02.007; Shimizu T, 2011, GENE, V478, P1, DOI 10.1016/j.gene.2011.01.006; Singh P, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00029; Smati M, 2017, INT J MED MICROBIOL, V307, P44, DOI 10.1016/j.ijmm.2016.11.004; So SH, 2011, MECH AGEING DEV, V132, P210, DOI 10.1016/j.mad.2011.02.005; Stiernagle T, 2006, MAINTENANCE C ELEGAN; Taylor EV, 2013, J FOOD PROTECT, V76, P939, DOI 10.4315/0362-028X.JFP-12-503; Thompson TA, 2017, INT J INFECT DIS, V54, P72, DOI 10.1016/j.ijid.2016.11.411; Topalcengiz Z, 2017, FOOD CONTROL, V72, P73, DOI 10.1016/j.foodcont.2016.07.014; Utari PD, 2013, TRENDS MICROBIOL, V21, P315, DOI 10.1016/j.tim.2013.04.006; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wu DQ, 2006, EXP GERONTOL, V41, P261, DOI 10.1016/j.exger.2006.01.003; Yang WT, 2016, ZOOLOGY, V119, P244, DOI 10.1016/j.zool.2016.05.013; Yun EJ, 2017, PROCESS BIOCHEM, V53, P36, DOI 10.1016/j.procbio.2016.12.001; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	59	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193277	10.1371/journal.pone.0193277	http://dx.doi.org/10.1371/journal.pone.0193277			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489863	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000060
J	Wolff, M; Haase, D; Haase, A				Wolff, Manuel; Haase, Dagmar; Haase, Annegret			Compact or spread? A quantitative spatial model of urban areas in Europe since 1990	PLOS ONE			English	Article							UNITED-STATES; SPRAWL; CITIES; FORM; GROWTH; DETERMINANTS; LANDSCAPES; METRICS; FRANCE; POLICY	Changes in urban residential density represent an important issue in terms of land consumption, the conservation of ecosystems, air quality and related human health problems, as well as the consequential challenges for urban and regional planning. It is the decline of residential densities, in particular, that has often been used as the very definition of sprawl, describing a phenomenon that has been extensively studied in the United States and in Western Europe. Whilst these studies provide valuable insights into urbanization processes, only a handful of them have reflected the uneven dynamics of simultaneous urban growth and shrinkage, using residential density changes as a key indicator to uncover the underlying dynamics. This paper introduces a contrasting analysis of recent developments in both de- and re-concentration, defined as decreasing or increasing residential densities, respectively. Using a large sample of European cities, it detects differences in density changes between successional population growth/decline. The paper shows that dedensification, found in some large cities globally, is not a universal phenomenon in growing urban areas; neither the increasing disproportion between a declining demand for and an increasing supply of residential areas nor actual concentration processes in cities were found. Thus, the paper provides a new, very detailed perspective on (de) densification in both shrinking and growing cities and how they specifically contribute to current land take in Europe.	[Wolff, Manuel; Haase, Dagmar] Humboldt Univ, Dept Geog, Lab Landscape Ecol, Berlin, Germany; [Wolff, Manuel; Haase, Annegret] UFZ Helmholtz Ctr Environm Res, Dept Urban & Environm Sociol, Leipzig, Germany; [Haase, Dagmar] UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany	Humboldt University of Berlin; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Wolff, M (corresponding author), Humboldt Univ, Dept Geog, Lab Landscape Ecol, Berlin, Germany.; Wolff, M (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Urban & Environm Sociol, Leipzig, Germany.	manuel.wolff@hu-berlin.de	Wolff, Manuel/AAO-1239-2020	Wolff, Manuel/0000-0003-0820-5281; Haase, Dagmar/0000-0003-4065-5194				ALONSO William., 1964, Location and land use. Toward a general theory of land rent.; Angel S., 2010, PERSISTENT DECLINE U; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; [Anonymous], 2014, DATABASE LOCAL POPUL; Arribas-Bel D, 2011, COMPUT ENVIRON URBAN, V35, P263, DOI 10.1016/j.compenvurbsys.2010.10.002; Artmann M, 2014, J URBAN PLANNING DEV, V141; Balchin PaulN., 2000, URBAN EC GLOBAL PERS; BATTY M, 1992, URBAN STUD, V29, P1043, DOI 10.1080/00420989220081041; Batty M, 2003, CASA WORKING PAPERS; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bauer A, 2011, PERI URBAN FUTURES L; Baum-Snow N, 2007, Q J ECON, V122, P775, DOI 10.1162/qjec.122.2.775; Bretagnolle A, 2014, TECHNICAL REPORT; Bretagnolle A, 2010, FORMES VILLES EUROPE, P97; Bretagnolle A, 2008, CYBERGEO, DOI 10.4000/cybergeo.19683; Bretagnolle A, 2009, METHODS SER, V7, P197, DOI 10.1007/978-1-4020-9663-1_7; Brueckner J.K., 1987, HDB REGIONAL EC, VVol. 2, P821, DOI DOI 10.1016/S1574-0080(87)80006-8; Brueckner JK, 2000, INT REGIONAL SCI REV, V23, P160, DOI 10.1177/016001700761012710; Burchell RW, 1998, 39 TCRP NAT AC SCI; BUSSIERE R, 1970, ENVIRON PLANN, V2, P295, DOI 10.1068/a020295; Bussiere R, 1972, STATIC DYNAMIC CHARA; Buzar S, 2007, URBAN STUD, V44, P651, DOI 10.1080/00420980601185544; CHESHIRE P, 1995, URBAN STUD, V32, P1045, DOI 10.1080/00420989550012564; Cheshire PC, 2006, URBAN STUD, V43, P1231, DOI 10.1080/00420980600775600; Chin N, 2002, CASA WORKING PAPERS, V47; Civco DL, 2000, P ASPRS ANN CONV WAS; CLARK C, 1951, J ROY STAT SOC A STA, V114, P490, DOI 10.2307/2981088; Clark C, 1951, J ROY STAT SOC, V114; Couch C, 2005, EUR PLAN STUD, V13, P117, DOI 10.1080/0965431042000312433; Couch C, 2007, URBAN SPRAWL EUROPE; Couch C, 2009, PLAN PRACT RES, V24, P321, DOI 10.1080/02697450903020767; Cutsinger J, 2006, URBAN GEOGR, V27, P228, DOI 10.2747/0272-3638.27.3.228; Dijkstra L, 2012, 012012 RF REG URB PO; EDMONSTON B, 1985, URBAN STUD, V22, P209, DOI 10.1080/00420988520080351; EEA, 2009, 52009 EEA; Elmqvist T, 2013, GLOBAL URBANISATION; ESPON, 2006, URB RUR REL EUR URB; ESPON, 2014, TOWN APPL RES 2013 1; ESPON, 2012, GEOSPECS EUR PERSP S; ESPON, 2014, 2013118 ESPON B; ESPON, 2014, EU LUPA EUR LAND U C, VIV; ESPON, 2010, 201311 ESPON; European Commission, 2011, CIT TOM CHALL VIS WA; European Commission, 2016, COR LAND COV 2012 VE; European Environment Agency (EEA), 2006, 102006 EEA; European Environment Agency (EEA), 2006, 72006 EEA; European Environment Agency (EEA), 2013, COR LAND COV 1990 20; European Environment Agency (EEA), 2014, URB MORPH ZON UMZ 20; Ewing R., 2002, MEASURING SPRAWL ITS, V1; Frey H., 1999, DESIGNING CITY MORE; Frumkin H., 2004, URBAN SPRAWL PUBLIC; Fulton W., 2001, WHO SPRAWLS MOST GRO; Galster G, 2001, HOUS POLICY DEBATE, V12, P681, DOI 10.1080/10511482.2001.9521426; Glaeser E.L., 2004, HDB REGIONAL URBAN E, P2481, DOI [10.1016/S1574-0080(04)80013-0, DOI 10.1016/S1574-0080(04)80013-0]; Guerois M, 2008, ENVIRON PLANN A, V40, P2186, DOI 10.1068/a39382; Guerois M, 2012, ENVIRON PLANN B, V39, P439, DOI 10.1068/b37162; Haase A, 2015, STADT ZUKUNFT, P89; Haase A, 2013, RC21 BERL 2013 STREA; Haase A, 2013, EUROPEAN URBAN REGIO; Haase D, 2007, LANDSCAPE URBAN PLAN, V80, P1, DOI 10.1016/j.landurbplan.2006.03.011; Haase D, 2016, PLAN THEORY PRACT, V17, P276; Haase D, 2014, STRUNGMANN FORUM REP, P299; Haase D, 2014, LANDSCAPE URBAN PLAN, V132, P159, DOI 10.1016/j.landurbplan.2014.09.003; Haase D, 2010, J LAND USE SCI, V5, P123, DOI 10.1080/1747423X.2010.481079; Hall P, 1971, SPATIAL POLICY PROBL, P96; Helminen V, 2009, RESPONSE FUNCTION CO; Herfert G, 2002, RAUMFORSCHUNG RAUMOR, V6, P334, DOI DOI 10.1007/BF03184191; Huang JG, 2007, LANDSCAPE URBAN PLAN, V82, P184, DOI 10.1016/j.landurbplan.2007.02.010; Kabisch N, 2009, URBAN STUDIES, V47; Kabisch N, 2011, POPUL SPACE PLACE, V17, P236, DOI 10.1002/psp.600; Kasanko M, 2006, LANDSCAPE URBAN PLAN, V77, P111, DOI 10.1016/j.landurbplan.2005.02.003; Kotus J, 2006, CITIES, V23, P364, DOI 10.1016/j.cities.2006.02.002; Kroll F, 2010, LAND USE POLICY, V27, P726, DOI 10.1016/j.landusepol.2009.10.001; Le Gales P, 2010, CAHIER EUROPEAN POLE; Masnavi M, 2000, ACHIEVING SUSTAINABL, P64; Meinel G, 2007, REAL CORP P 2007 WIE, P645; Milego R, 2007, URBAN MORPHOLOGICAL; Mills ES, 1967, AM ECON REV, V57, P197; Muth R.F., 1969, CITIES HOUSING; NEWLING BE, 1969, GEOGR REV, V59, P242, DOI 10.2307/213456; Nilsson K, 2014, EUROPEAN J SPATIAL D; Nuissl H, 2005, CITIES, V22, P123, DOI 10.1016/j.cities.2005.01.002; Nuissl H, 2012, ENCY SUSTAINABILITY, P5785; Nuissl H, 2009, LAND USE POLICY, V26, P414, DOI 10.1016/j.landusepol.2008.05.006; Oueslati W, 2015, URBAN STUD, V52, P1594, DOI 10.1177/0042098015577773; Overberg P, 2001, US TODAY; PARR JB, 1985, URBAN STUD, V22, P289, DOI 10.1080/00420988520080531; Patacchini E., 2009, BROOKINGS WHARTON PA, V10, P125, DOI DOI 10.2307/25609561; PBL D Netherlands Environmental Assessment Agency, 2008, 1 PBL EURBANIS NEAA; Peeters D, 2011, FUNCTIONAL URBAN ARE; Phelps NA, 2003, URBAN STUD, V40, P1725, DOI 10.1080/0042098032000106573; Pirotte A, 2011, URBAN STUD, V48, P2865, DOI 10.1177/0042098010391303; Rink D., 2012, BUILT ENV, V38, P162, DOI [10.2148/benv.38.2.162, DOI 10.2148/BENV.38.2.162]; Rosenthal S.S., 2004, HDB REGIONAL URBAN E, V4, P2119, DOI [10.1016/S1574-0080(04)80006-3, DOI 10.1016/S1574-0080(04)80006-3]; Scheuer S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160471; Schmidt S, 2014, EUROPEAN PLANNING ST, V23, P1357, DOI DOI 10.1080/09654313; Schmidt S, 2011, URBAN GEOGR, V32, P105, DOI 10.2747/0272-3638.32.1.105; Schneider A, 2008, URBAN STUD, V45, P659, DOI 10.1177/0042098007087340; Schwarz N, 2010, LANDSCAPE URBAN PLAN, V96, P29, DOI 10.1016/j.landurbplan.2010.01.007; Seto K.C., 2014, RETHINKING GLOBAL LA; Seto K. C., 2016, ROUTLEDGE HDB URBANI; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Sheppard SC, 2005, DYNAMICS GLOBA UNPUB; Siedentop S, 2015, REFITTING SUBURBIA E, P23; Siedentop S, 2008, 44 ISOCARP C DAL CHI; Siedentop S, 2012, ENVIRON PLANN A, V44, P2765, DOI 10.1068/a4580; Sieverts T., 2003, CITIES CITIES INTERP; Smeed RJ, 1961, TRAFFIC PROBLEM TOWN; Stead D, 2004, CITIES, V21, P119, DOI 10.1016/j.cities.2004.01.005; Steinfuhrer A, 2007, GEOGR ANN B, V89B, P183, DOI 10.1111/j.1468-0467.2007.00247.x; Tosics I., 2010, NATL SPATIAL PLANNIN; Travisi CM, 2010, J TRANSP GEOGR, V18, P382, DOI 10.1016/j.jtrangeo.2009.08.008; Turok I, 2007, CITIES, V24, P165, DOI 10.1016/j.cities.2007.01.007; UN Habitat, 2008, STAT WORLDS CIT 2008; Westerink J, 2012, EUROPEAN PLANNING ST, V21; WHEATON WC, 1976, J URBAN ECON, V3, P31, DOI 10.1016/0094-1190(76)90056-5; WIEST K., 2005, RAUMPLANUNG, V123, P237; Wolff M, 2017, EUROPEAN URBAN REGIO; Wolff M, 2016, URBAN STUDIES, V1; Wolff M, 2017, CITIES; ZIELINSKI K, 1979, ENVIRON PLANN A, V11, P629, DOI 10.1068/a110629	121	46	46	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192326	10.1371/journal.pone.0192326	http://dx.doi.org/10.1371/journal.pone.0192326			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489851	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000023
J	Mitchell, EP; Prozesky, L; Lawrence, J				Mitchell, Emily P.; Prozesky, Leon; Lawrence, John			A new perspective on the pathogenesis of chronic renal disease in captive cheetahs (Acinonyx jubatus)	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SYSTEMIC AA-AMYLOIDOSIS; INFLAMMATORY-BOWEL-DISEASE; SOUTH-AFRICA; MOLECULAR-MECHANISMS; BLOOD VALUES; CATS; PATHOLOGY; STRESS; MORPHOLOGY	The sustainability of captive cheetah populations is limited by high mortality due to chronic renal disease. This necropsy study, conducted on 243 captive cheetahs from one institution, investigated the relationships between focal palatine erosions, gastritis, enterocolitis, glomerulosclerosis, chronic renal infarcts, renal cortical and medullary fibrosis, and renal medullary amyloidosis at death. Associations between the individual renal lesions and death due to chronic renal disease and comparisons of lesion prevalence between captive bred and wild born and between normal and king coated cheetahs were also assessed. All lesions were significantly positively correlated with age at death. Renal medullary fibrosis was the only lesion associated with the likelihood of death being due to chronic renal disease, and cheetahs with this lesion were younger, on average, than cheetahs with other renal lesions. Alimentary tract lesions were not associated with amyloidosis. All lesions, except for palatine erosions, were more common in wild born than in captive bred cheetahs; the former were older at death than the latter. Having a king coat had no clear effect on disease prevalence. These results suggest that age and renal medullary fibrosis are the primary factors influencing the pathogenesis of chronic renal disease in captive cheetahs. Apart from amyloidosis, these findings are analogous to those described in chronic renal disease in domestic cats, which is postulated to result primarily from repetitive hypoxic injury of renal tubules, mediated by age and stress. Cheetahs may be particularly susceptible to acute renal tubular injury due to their propensity for stress and their extended life span in captivity, as well as their adaptation for fecundity (rather than longevity) and adrenaline-mediated high speed prey chases. The presence of chronic renal disease in subadult cheetahs suggests that prevention, identification and mitigation of stress are critical to the successful prevention of chronic renal disease in captive cheetahs.	[Mitchell, Emily P.] Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa; [Mitchell, Emily P.; Prozesky, Leon; Lawrence, John] Univ Pretoria, Dept Paraclin Sci, Fac Vet Sci, Onderstepoort, South Africa	National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of Pretoria	Mitchell, EP (corresponding author), Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa.; Mitchell, EP (corresponding author), Univ Pretoria, Dept Paraclin Sci, Fac Vet Sci, Onderstepoort, South Africa.	emily.mitchell@up.ac.za		Lane, Emily/0000-0003-0379-3790	Ann van Dyk Cheetah Centre (AvDCC); National Zoological Gardens of South Africa	Ann van Dyk Cheetah Centre (AvDCC); National Zoological Gardens of South Africa(National Research Foundation - South Africa)	This work was funded jointly by the Ann van Dyk Cheetah Centre (AvDCC) and annual core operational funds from the National Zoological Gardens of South Africa, a facility of the National Research Foundation. The funders had no role in the study design, analysis or preparation of the manuscript. Ms Ann van Dyk and the staff of the AvDCC participated in sample and data collection and the decision to publish.	Akaike H, 1983, INT STAT I, V44, P277, DOI DOI 10.1086/PHOS.50.4.187553; Ambruzs JM, 2014, CLIN J AM SOC NEPHRO, V9, P265, DOI 10.2215/CJN.04660513; Augustus P, 2006, ZOO BIOL, V25, P383, DOI 10.1002/zoo.20097; Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012; Bechert U, 2002, J ZOO WILDLIFE MED, V33, P16, DOI 10.1638/1042-7260(2002)033[0016:DCABVO]2.0.CO;2; Bergstrom J, 2006, AMYLOID, V13, P93, DOI 10.1080/13506120600722621; BERTANI T, 1989, LAB INVEST, V60, P196; BLANCHARD PC, 1991, J NUTR, V121, pS77, DOI 10.1093/jn/121.suppl_11.S77; Bolton LA, 1999, VET PATHOL, V36, P14, DOI 10.1354/vp.36-1-14; Brodsky SV, 2010, HISTOL HISTOPATHOL, V25, P1379, DOI 10.14670/HH-25.1379; Brown CA, 2016, VET PATHOL, V53, P309, DOI 10.1177/0300985815622975; Buffington CAT, 2001, J UROLOGY, V165, P2051, DOI 10.1016/S0022-5347(05)66292-1; Burnham K, 2002, MODEL SELECTION MULT, P111; Chakrabarti S, 2013, VET PATHOL, V50, P147, DOI 10.1177/0300985812453176; Chakrabarti S, 2012, J VET INTERN MED, V26, P275, DOI 10.1111/j.1939-1676.2011.00874.x; Chen L, 2012, J HERED, V103, P115, DOI 10.1093/jhered/esr105; Chida Y, 2005, LIFE SCI, V76, P1707, DOI 10.1016/j.lfs.2004.08.032; Cianciolo RE, 2016, JUBB KENNEDY PALMERS, P425; Cianciolo RE, 2015, VET PATHOL, V53, P1; Cowgill LD, 2016, VET CLIN N AM-SMALL, V46, P995, DOI 10.1016/j.cvsm.2016.06.001; Crawford J, 1999, ROBBINS PATHOLOGIC B, P911; Delaney MA, 2016, VET PATHOL, V53, P493, DOI 10.1177/0300985815612557; Dember LM, 2006, J AM SOC NEPHROL, V17, P3458, DOI 10.1681/ASN.2006050460; Denic A, 2016, ADV CHRONIC KIDNEY D, V23, P19, DOI 10.1053/j.ackd.2015.08.004; Depauw S, 2012, ZOO BIOL, V31, P629, DOI 10.1002/zoo.20427; DIBARTOLA SP, 1986, J COMP PATHOL, V96, P387, DOI 10.1016/0021-9975(86)90034-4; DIBARTOLA SP, 1993, J AM VET MED ASSOC, V202, P744; DIBARTOLA SP, 1990, J AM VET MED ASSOC, V197, P483; Durant SM, 2017, P NATL ACAD SCI USA, V114, P528, DOI 10.1073/pnas.1611122114; EATON KA, 1993, VET PATHOL, V30, P55, DOI 10.1177/030098589303000107; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Fitch H.M., 1982, Zoo Biology, V1, P295, DOI 10.1002/zoo.1430010403; Franklin AD, 2016, J HERED, V107, P115, DOI 10.1093/jhered/esv089; Gaffney PM, 2016, VET PATHOL, V53, P637, DOI 10.1177/0300985815604725; Gamble M., 2008, THEORY PRACT HISTOL, V6th ed, P121, DOI DOI 10.1016/B978-0-443-10279-0.50037-3; Garner MM, 2007, J ZOO WILDLIFE MED, V38, P32, DOI 10.1638/06-023.1; Gillis-Germitsch N, 2017, ZOO BIOL, V36, P40, DOI 10.1002/zoo.21341; GOSSELIN SJ, 1988, VET PATHOL, V25, P48, DOI 10.1177/030098588802500107; Hudson-Lamb GC, 2016, J S AFR VET ASSOC, V87, DOI 10.4102/jsava.v87i1.1316; Hughson MD, 2002, AM J KIDNEY DIS, V39, P679, DOI 10.1053/ajkd.2002.31980; Jepson RE, 2016, VET CLIN N AM-SMALL, V46, P1015, DOI 10.1016/j.cvsm.2016.06.002; Junginger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130573; Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010; Koster LS, 2007, J S AFR VET ASSOC, V78, P133; Lane EP, 2012, ZOO BIOL, V31, P669, DOI 10.1002/zoo.20431; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lowenstine LJ, 2016, VET PATHOL, V53, P250, DOI 10.1177/0300985815612154; Ludlage E, 2005, VET PATHOL, V42, P117, DOI 10.1354/vp.42-2-117; Magy N, 2003, ARTHRITIS RHEUM, V48, P1430, DOI 10.1002/art.10964; Marker L, 2014, INT CHEETAH ACINONY, pA9; Marker LL, 2004, J MAMMAL, V85, P19, DOI 10.1644/1545-1542(2004)085<0019:DAAIOP>2.0.CO;2; McLeland SM, 2015, VET PATHOL, V52, P524, DOI 10.1177/0300985814561095; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Meuwese CL, 2013, ARCH MED RES, V44, P591, DOI 10.1016/j.arcmed.2013.10.009; Mitani S, 2013, J VET MED SCI, V75, P127, DOI 10.1292/jvms.12-0314; Mitchell E, 2017, VET PATHOL; Munson L, 2005, J WILDLIFE DIS, V41, P542, DOI 10.7589/0090-3558-41.3.542; Munson L, 1999, J ZOO WILDLIFE MED, V30, P342; MUNSON L, 1993, ZOO BIOL, V12, P105, DOI 10.1002/zoo.1430120110; Murakami T, 2014, VET PATHOL, V51, P363, DOI 10.1177/0300985813511128; Newkirk KM, 2011, VET PATHOL, V48, P698, DOI 10.1177/0300985810382089; Papendick RE, 1997, VET PATHOL, V34, P549, DOI 10.1177/030098589703400602; Phillips J. A., 1993, Madoqua, V18, P79; Schmiedt CW, 2016, VET PATHOL, V53, P87, DOI 10.1177/0300985815600500; Shoji K, 2014, CURR OPIN NEPHROL HY, V23, P161, DOI 10.1097/01.mnh.0000441049.98664.6c; Steffens A.B., 1999, P108; Terio KA, 2008, VET PATHOL, V45, P393, DOI 10.1354/vp.45-3-393; Terio KA, 2012, VET PATHOL, V49, P824, DOI 10.1177/0300985811412620; Terio KA, 2000, GASTROENTEROLOGY, V118, pA746, DOI 10.1016/S0016-5085(00)85123-9; Terio KA, 2004, J WILDLIFE DIS, V40, P259, DOI 10.7589/0090-3558-40.2.259; Terio KA, 2014, AM ASS ZOO VET ANN C, P107; Tidiere M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36361; Url A, 2016, J ZOO WILDLIFE MED, V47, P797; vanderLindeSipman JS, 1997, VET IMMUNOL IMMUNOP, V56, P1, DOI 10.1016/S0165-2427(96)05717-0; Weiss DJ, 1996, J AM VET MED ASSOC, V209, P1114; Wells A, 2004, J ZOO WILDLIFE MED, V35, P8, DOI 10.1638/02-084; Whitehouse-Tedd KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120903; Wielebnowski NC, 2002, ANIM CONSERV, V5, P291, DOI 10.1017/S1367943002004043; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105; Zordan M, 2012, ZOO BIOL, V31, P181, DOI 10.1002/zoo.20392; ZSCHIESCHE W, 1989, PHARMACOL THERAPEUT, V41, P49, DOI 10.1016/0163-7258(89)90102-2	81	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0194114	10.1371/journal.pone.0194114	http://dx.doi.org/10.1371/journal.pone.0194114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513736	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800103
J	Keyhani, S; Vali, M; Cohen, B; Woodbridge, A; Arenson, M; Eilkhani, E; Aivadyan, C; Hasin, D				Keyhani, Salomeh; Vali, Marzieh; Cohen, Beth; Woodbridge, Alexandra; Arenson, Melanie; Eilkhani, Elnaz; Aivadyan, Christina; Hasin, Deborah			A search algorithm for identifying likely users and non-users of marijuana from the free text of the electronic medical record	PLOS ONE			English	Article							ALCOHOL-USE DISORDER; PULMONARY-FUNCTION; CANNABIS USE; TOBACCO; PATIENT; RISK; PREVALENCE; SYMPTOMS; ADULTS; SMOKE	Background The harmful effects of marijuana on health and in particular cardiovascular health are understudied. To develop such knowledge, an efficient method of developing an informative cohort of marijuana users and non-users is needed. Methods We identified patients with a diagnosis of coronary artery disease using ICD-9 codes who were seen in the San Francisco VA in 2015. We imported these patients' medical record notes into an informatics platform that facilitated text searches. We categorized patients into those with evidence of marijuana use in the past 12 months and patients with no such evidence, using the following text strings: "marijuana", "mjx", and "cannabis". We randomly selected 51 users and 51 non-users based on this preliminary classification, and sent a recruitment letter to 97 of these patients who had contact information available. Patients were interviewed on marijuana use and domains related to cardiovascular health. Data on marijuana use collected from the medical record was compared to data collected as part of the interview. Results The interview completion rate was 71%. Among the 35 patients identified by text strings as having used marijuana in the previous year, 15 had used marijuana in the past 30 days (positive predictive value = 42.9%). The probability of use in the past month increased from 8.8% to 42.9% in people who have these keywords in their medical record compared to those who did not have these terms in their medical record. Conclusion Methods that combine text search strategies for participant recruitment with health interviews provide an efficient approach to developing prospective cohorts that can be used to study the health effects of marijuana.	[Keyhani, Salomeh; Vali, Marzieh; Cohen, Beth] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Keyhani, Salomeh; Cohen, Beth; Eilkhani, Elnaz] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Woodbridge, Alexandra] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Arenson, Melanie] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Aivadyan, Christina; Hasin, Deborah] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Hasin, Deborah] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Tulane University; University System of Maryland; University of Maryland College Park; New York State Psychiatry Institute; Columbia University	Keyhani, S (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.; Keyhani, S (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Salomeh.keyhani@ucsf.edu	Arenson, Melanie/K-9378-2019	Arenson, Melanie/0000-0001-6334-1548	NIH [RO1HL116522-01A1, RO1HL114563-01A1]; VAHSRD [1IP1HX001994]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VAHSRD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was not directly supported by any research funds. Dr. Keyhani is funded by grants from the NIH grants(RO1HL116522-01A1, RO1HL114563-01A1) and VAHSR&D (1IP1HX001994)	[Anonymous], 1999, MARIJUANA MED ASSESS; Bostwick JM, 2012, MAYO CLIN PROC, V87, P172, DOI 10.1016/j.mayocp.2011.10.003; Compton WM, 2016, LANCET PSYCHIAT, V3, P954, DOI 10.1016/S2215-0366(16)30208-5; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Godin G, 1997, MED SCI SPORTS EXERC, V29, P36, DOI DOI 10.1097/00005768-199706001-00009; Gustman AL, 2001, SOC SECUR BULL, V64, P66; Hammash MH, 2013, EUR J CARDIOVASC NUR, V12, P446, DOI 10.1177/1474515112468068; Hashibe M, 2005, ALCOHOL, V35, P265, DOI 10.1016/j.alcohol.2005.04.008; Hasin DS, 2016, AM J PSYCHIAT, V173, P588, DOI 10.1176/appi.ajp.2015.15070907; Hasin DS, 2016, JAMA PSYCHIAT, V73, P532, DOI 10.1001/jamapsychiatry.2015.3158; Hasin DS, 2015, JAMA PSYCHIAT, V72, P1235, DOI 10.1001/jamapsychiatry.2015.1858; Hasin DS, 2015, DRUG ALCOHOL DEPEN, V148, P40, DOI 10.1016/j.drugalcdep.2014.12.011; Hickman DE, 2003, ANN PHARMACOTHER, V37, P187; HIGGINS M, 1991, CHEST, V99, P315, DOI 10.1378/chest.99.2.315; Moir D, 2008, CHEM RES TOXICOL, V21, P494, DOI 10.1021/tx700275p; Monte AA, 2015, JAMA-J AM MED ASSOC, V313, P241, DOI 10.1001/jama.2014.17057; Patton GC, 2005, ADDICTION, V100, P1518, DOI 10.1111/j.1360-0443.2005.01220.x; Pletcher MJ, 2012, JAMA-J AM MED ASSOC, V307, P173, DOI 10.1001/jama.2011.1961; Ramo DE, 2013, J STUD ALCOHOL DRUGS, V74, P301, DOI 10.15288/jsad.2013.74.301; Rodondi N, 2006, AM J CARDIOL, V98, P478, DOI 10.1016/j.amjcard.2006.03.024; Rubinsky AD, 2013, ALCOHOL CLIN EXP RES, V37, P1380, DOI 10.1111/acer.12092; Sarafian TA, 1999, AM J RESP CELL MOL, V20, P1286, DOI 10.1165/ajrcmb.20.6.3424; Spoont MR, 2015, JAMA-J AM MED ASSOC, V314, P501, DOI 10.1001/jama.2015.7877; TASHKIN DP, 1987, AM REV RESPIR DIS, V135, P209; Thombs BD, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-124; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Welsh GH, 1999, CRIT CARE MED, V27, P1466, DOI 10.1097/00003246-199908000-00011; WU TC, 1988, NEW ENGL J MED, V318, P347, DOI 10.1056/NEJM198802113180603; Zhang ZF, 1999, CANCER EPIDEM BIOMAR, V8, P1071	29	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193706	10.1371/journal.pone.0193706	http://dx.doi.org/10.1371/journal.pone.0193706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509775	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200025
J	You, YQ; Song, L; Nonyane, BAS; Price, LB; Silbergeld, EK				You, Yaqi; Song, Li; Nonyane, Bareng A. S.; Price, Lance B.; Silbergeld, Ellen K.			Genomic differences between nasal Staphylococcus aureus from hog slaughterhouse workers and their communities	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; ANTIMICROBIAL RESISTANCE; PATHOGENICITY ISLANDS; ENTEROTOXIN GENE; HIGHLY PREVALENT; IMMUNE EVASION; S. AUREUS; METHICILLIN; SEQUENCE; TRANSMISSION	New human pathogens can emerge from the livestock-human interface and spread into human populations through many pathways including livestock products. Occupational contact with livestock is a risk factor for exposure to those pathogens and may cause further spreading of those pathogens in the community. The current study used whole genome sequencing to explore nasal Staphylococcus aureus obtained from hog slaughterhouse workers and their community members, all of whom resided in a livestock-dense region in rural North Carolina. Sequence data were analyzed for lineage distribution, pathogenicity-related genomic features, and mobile genetic elements. We observed evidence of nasal S. aureus differences between hog workers and non-workers. Nasal S. aureus from hog workers showed a greater lineage diversity than nasal S. aureus from community residents. Hog worker isolates were less likely to carry the phi Sa3 prophage and human-specific immune evasion cluster genes than community resident isolates (phi Sa3 prophage: 54.5% vs. 91.7%, Benjamini-Hochberg (BH) corrected p = 0.035; immune evasion cluster genes: 66.7% vs. 100%, BH p = 0.021). Hog worker isolates had a lower prevalence and diversity of enterotoxins than community resident isolates, particularly lacking the enterotoxin gene cluster (39.4% vs. 70.8%, BH p = 0.125). Moreover, hog worker isolates harbored more diverse antibiotic resistance genes, with a higher prevalence of carriage of multiple resistance genes, than community resident isolates (75.8% vs. 29.2%, BH p = 0.021). Phylogenetic analysis of all ST5 isolates, the most abundant lineage in the collection, further supported separation of isolates from hog workers and non-workers. Together, our observations suggest impact of occupational contact with livestock on nasal S. aureus colonization and highlight the need for further research on the complex epidemiology of S. aureus at the livestock-human interface.	[You, Yaqi; Silbergeld, Ellen K.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21218 USA; [Song, Li] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Song, Li] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Ctr Computat Biol, Baltimore, MD USA; [Nonyane, Bareng A. S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Price, Lance B.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Environm & Occupat Hlth, Washington, DC USA; [Price, Lance B.] Translat Genom Res Inst, Div Pathogen Genom, Flagstaff, AZ USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Translational Genomics Research Institute	Silbergeld, EK (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21218 USA.	esilber2@jhu.edu	Nonyane, Bareng A.S./AAC-8118-2020	Nonyane, Bareng A.S./0000-0001-5633-7487	National Institute for Occupational Safety and Health [5R210H009829]; Heinz Endowments (Pittsburgh, Pennsylvania); National Science Foundation award [IOS-1339134]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [5R01AI101371-02]; Merck; Applegate Farms LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101371] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Heinz Endowments (Pittsburgh, Pennsylvania); National Science Foundation award(National Science Foundation (NSF)); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Merck(Merck & Company); Applegate Farms LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute for Occupational Safety and Health (grant 5R210H009829) and by the Heinz Endowments (Pittsburgh, Pennsylvania) to E.K.S. L.S. was supported by a National Science Foundation award (IOS-1339134). L.B.P. was supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases (5R01AI101371-02) and received research support from Merck and general operating funds from Applegate Farms LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3717-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Ben Zakour NL, 2008, J BACTERIOL, V190, P6302, DOI 10.1128/JB.01984-07; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; De Medici D, 2003, APPL ENVIRON MICROB, V69, P3456, DOI 10.1128/AEM.69.6.3456-3461.2003; Driebe EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130955; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Gillings MR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00004; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hau SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142832; Hau SJ, 2017, APPL ENV MICROBIOL; Hiramatsu K, 2013, INFECT CHEMOTHER, V45, P117, DOI 10.3947/ic.2013.45.2.117; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Khokhlova OE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128017; Knox J, 2015, TRENDS MICROBIOL, V23, P437, DOI 10.1016/j.tim.2015.03.007; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; McCarthy AJ, 2014, GENOME BIOL EVOL, V6, P2697, DOI 10.1093/gbe/evu214; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nashev D, 2007, LETT APPL MICROBIOL, V45, P681, DOI 10.1111/j.1472-765X.2007.02254.x; Neyra RC, 2014, ENVIRON HEALTH PERSP, V122, P471, DOI 10.1289/ehp.1306741; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Nowrouzian FL, 2015, EUR J CLIN MICROBIOL, V34, P1443, DOI 10.1007/s10096-015-2371-4; Omoe K, 2002, J CLIN MICROBIOL, V40, P857, DOI 10.1128/JCM.40.3.857-862.2002; Paterson GK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7560; Peter C, 2016, J AM STAT ASSOC, V89, P1012; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; Sato'o Y, 2013, MICROBIOL IMMUNOL, V57, P91, DOI 10.1111/1348-0421.12007; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Stegger M, 2014, MBIO, V5, DOI 10.1128/mBio.01044-14; Sun JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143670; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Suzuki Y, 2015, J APPL MICROBIOL, V118, P1507, DOI 10.1111/jam.12786; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Uhlemann AC, 2014, P NATL ACAD SCI USA, V111, P6738, DOI 10.1073/pnas.1401006111; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Verkaik NJ, 2011, CLIN MICROBIOL INFEC, V17, P343, DOI 10.1111/j.1469-0691.2010.03227.x; Wardyn SE, 2015, CLIN INFECT DIS, V61, P59, DOI 10.1093/cid/civ234; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Ye XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19184; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	68	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193820	10.1371/journal.pone.0193820	http://dx.doi.org/10.1371/journal.pone.0193820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509797	Green Submitted, gold, Green Published			2022-12-27	WOS:000426813200033
J	Aumailley, L; Roux-Dalvai, F; Kelly, I; Droit, A; Lebel, M				Aumailley, Lucie; Roux-Dalvai, Florence; Kelly, Isabelle; Droit, Arnaud; Lebel, Michel			Vitamin C alters the amount of specific endoplasmic reticulum associated proteins involved in lipid metabolism in the liver of mice synthesizing a nonfunctional Werner syndrome (Wrn) mutant protein	PLOS ONE			English	Article							SYNDROME HELICASE; TPD52 EXPRESSION; CULTURED-CELLS; SYNDROME GENE; MOUSE MODEL; DNA; IDENTIFICATION; RECOMBINATION; TRANSCRIPTION; INFLAMMATION	Werner syndrome (WS) is a premature aging disorder caused by mutations in a protein containing both a DNA exonuclease and DNA helicase domain. Mice lacking the helicase domain of the Wrn protein orthologue exhibit transcriptomic and metabolic alterations, some of which are reversed by vitamin C. Recent studies on these animals indicated that the mutant protein is associated with enriched endoplasmic reticulum (ER) fractions of tissues resulting in an ER stress response. In this study, we identified proteins that exhibit actual level differences in the ER enriched fraction between the liver of wild type and Wrn mutant mice using quantitative proteomic profiling with label-free Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Multiple Reaction Monitoring (MRM) and immunoblotting were performed to validate findings in a secondary independent cohort of wild type and Wrn mutant mice. DAVID 6.7 (NIH) was used for functional annotation analysis and indicated that the identified proteins exhibiting level changes between untreated wild type, Wrn mutant, and vitamin C treated Wrn mutant mice (ANOVA P-value < 0.05) were involved in fatty acid and steroid metabolism pathways (Bonferroni P-value = 0.0137). Finally, when we compared the transcriptomic and the proteomic data of our mouse cohorts only similar to 7% of the altered mRNA profiles encoding for ER gene products were consistent with their corresponding protein profiles measured by the label-free quantification methods. These results suggest that a great number of ER gene products are regulated at the post-transcriptional level in the liver of Wrn mutant mice exhibiting an ER stress response.	[Aumailley, Lucie; Lebel, Michel] Univ Laval, CHU Quebec, Fac Med, Ctr Rech, Quebec City, PQ, Canada; [Roux-Dalvai, Florence; Kelly, Isabelle; Droit, Arnaud] Univ Laval, CHU Quebec, Fac Med, Ctr Rech,Proteom Platform Ctr, Quebec City, PQ, Canada	Laval University; Laval University	Lebel, M (corresponding author), Univ Laval, CHU Quebec, Fac Med, Ctr Rech, Quebec City, PQ, Canada.	michel.lebel@crchudequebec.ulaval.ca	Roux-Dalvai, Florence/AAY-4134-2020; ROUX-DALVAI, Florence/ABD-4524-2020; Droit, Arnaud/AGZ-6283-2022	ROUX-DALVAI, Florence/0000-0002-9961-8964; Droit, Arnaud/0000-0001-7922-790X	Canadian Institutes of Health Research (Institute of Aging) [MOP-257669]; Canadian Institutes of Health Research [MOP-257669]	Canadian Institutes of Health Research (Institute of Aging)(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to Eric Paquet (Laval University) for help with the microarray analyses. This work was supported by the Canadian Institutes of Health Research (Institute of Aging) to M.L (grant # MOP-257669). L.A. is a scholar from the Fondation du CHU de Quebec.; This work was supported by the Canadian Institutes of Health Research (grant # MOP-257669) to M L. LA is a scholar from the Fondation du CHU de Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumailley L, 2015, EXP GERONTOL, V72, P192, DOI 10.1016/j.exger.2015.10.012; Aumailley L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140292; Balajee AS, 1999, MOL BIOL CELL, V10, P2655, DOI 10.1091/mbc.10.8.2655; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Cogger VC, 2014, J GERONTOL A-BIOL, V69, P1076, DOI 10.1093/gerona/glt169; Cooper MP, 2000, GENE DEV, V14, P907; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deracinois B, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030180; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Head GA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00493; HOEFLER G, 1994, GENOMICS, V19, P60, DOI 10.1006/geno.1994.1013; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Ipsen DH, 2014, NUTRIENTS, V6, P5473, DOI 10.3390/nu6125473; Ivanova AA, 2015, DOKL BIOCHEM BIOPHYS, V463, P213, DOI 10.1134/S1607672915040043; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Johnston CS, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-35; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kamili A, 2015, J CELL SCI, V128, P3223, DOI 10.1242/jcs.167692; Labbe A, 2011, J GERONTOL A-BIOL, V66, P264, DOI 10.1093/gerona/glq184; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lebel M, 2001, CANCER RES, V61, P1816; Liebler DC, 2013, BIOCHEMISTRY-US, V52, P3797, DOI 10.1021/bi400110b; Massip L, 2006, EXP GERONTOL, V41, P157, DOI 10.1016/j.exger.2005.10.011; Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133; Nicolas-Frances V, 2014, BIOCHIMIE, V98, P86, DOI 10.1016/j.biochi.2013.11.014; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598; Seiler SE, 2014, J LIPID RES, V55, P635, DOI 10.1194/jlr.M043448; Tang WL, 2016, HUM MOL GENET, V25, P2060, DOI 10.1093/hmg/ddw079; Trapeaux J, 2013, BRIT J PHARM; Turaga RVN, 2007, AGING CELL, V6, P471, DOI 10.1111/j.1474-9726.2007.00301.x; Turaga RVN, 2009, CELL CYCLE, V8, P2080, DOI 10.4161/cc.8.13.8925; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang Y, 2016, ONCOTARGET, V7, P6323, DOI 10.18632/oncotarget.6319; Westin MAK, 2005, J BIOL CHEM, V280, P38125, DOI 10.1074/jbc.M508479200; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	42	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193170	10.1371/journal.pone.0193170	http://dx.doi.org/10.1371/journal.pone.0193170			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494634	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200027
J	Gerasimou, P; Nicolaidou, V; Skordis, N; Picolos, M; Monos, D; Costeas, PA				Gerasimou, Petroula; Nicolaidou, Vicky; Skordis, Nicos; Picolos, Michalis; Monos, Demetrios; Costeas, Paul A.			Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis	PLOS ONE			English	Article							HLA CLASS-I; GENETICS CONSORTIUM; RISING INCIDENCE; SUSCEPTIBILITY; MELLITUS; DQ; LOCI; ASSOCIATIONS; CHILDREN; ALLELES	The contribution of specific HLA Class II alleles in type 1 diabetes is determined by polymorphic amino acid epitopes that direct antigen binding therefore, along with conventional allele frequency analysis, epitope analysis can provide important insights into disease susceptibility. We analyzed the highly heterogeneous Cypriot population for the HLA class II loci of T1DM patients and controls and we report for the first time their allele frequencies. Within our patient cohort we identified a subgroup that did not carry the DRB1*03: 01-DQA1*05: 01-DQB1*02:01 and DRB1*04: xx-DQA1*03:01-DQB1*03:02 risk haplotypes but a novel recombinant one, DRB1*04: XX-DQA1*03:01-DQB1*02: 01 designated DR4-DQ2.3. Through epitope analysis we identified established susceptibility (DQB1 A(57), DRB1 H-13) and resistance (DQB1 D-57) residues as well as other novel susceptibility residues DRB1 Q(70), DQB1 L-26 and resistance residues DRB1 D-70, R-70 and DQB1 Y-47. Prevalence of susceptibility epitopes was higher in patients and was not exclusively a result of linkage disequilibrium. Residues DRB1 Q(70), DQB1 L-26 and A(57) and a 10 amino acid epitope of DQA1 were the most significant in discriminating risk alleles. An extended haplotype containing these epitopes was carried by 92% of our patient cohort. Sharing of susceptibility epitopes could also explain the absence of risk haplotypes in patients. Finally, many significantly associated epitopes were non-pocket residues suggesting that critical immune functions may exist spanning further from the binding pockets.	[Gerasimou, Petroula; Costeas, Paul A.] Karaiskakio Fdn, Nicosia, Cyprus; [Gerasimou, Petroula] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Nicolaidou, Vicky] Univ Nicosia, Sch Sci & Engn, Dept Life & Hlth Sci, Nicosia, Cyprus; [Skordis, Nicos] Paedi Ctr Specialized Paediat, Div Paediat Endocrinol, Nicosia, Cyprus; [Picolos, Michalis] Alithia Endocrinol Ctr, Nicosia, Cyprus; [Monos, Demetrios] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Cyprus; University of Nicosia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Costeas, PA (corresponding author), Karaiskakio Fdn, Nicosia, Cyprus.	paul.costeas@karaiskakio.org.cy	Nicolaidou, Vicky/AAX-4756-2021	Costeas, Paul/0000-0002-7257-4746; nicolaidou, vicky/0000-0003-1017-2677				Bahillo MP, 2007, PEDIATR DIABETES, V8, P369, DOI 10.1111/j.1399-5448.2007.00255.x; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bondinas GP, 2007, IMMUNOGENETICS, V59, P539, DOI 10.1007/s00251-007-0224-8; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Castelli EC, 2017, MOL IMMUNOL, V83, P115, DOI 10.1016/j.molimm.2017.01.020; Casu A, 2004, DIABETES CARE, V27, P1623, DOI 10.2337/diacare.27.7.1623; Cereb N, 2015, HUM IMMUNOL, V76, P923, DOI 10.1016/j.humimm.2015.09.015; Concannon P, 2005, DIABETES, V54, P2995, DOI 10.2337/diabetes.54.10.2995; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; Eike MC, 2009, GENES IMMUN, V10, P56, DOI 10.1038/gene.2008.74; Eisenbarth GS, 2010, DIABETES, p759 ; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Ettinger RA, 2006, J IMMUNOL, V176, P1988, DOI 10.4049/jimmunol.176.3.1988; Freed BM, 2011, ARTHRITIS RHEUM-US, V63, P3733, DOI 10.1002/art.30636; Gerasimou P, 2016, INT J IMMUNOGENET, V43, P135, DOI 10.1111/iji.12259; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; HORN GT, 1988, P NATL ACAD SCI USA, V85, P6012, DOI 10.1073/pnas.85.16.6012; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Hu XL, 2015, NAT GENET, V47, P898, DOI 10.1038/ng.3353; Kanterakis S, 2008, HUM IMMUNOL, V69, P522, DOI 10.1016/j.humimm.2008.05.011; KHALIL I, 1990, J CLIN INVEST, V85, P1315, DOI 10.1172/JCI114569; KOVATS S, 1995, J CLIN INVEST, V96, P217, DOI 10.1172/JCI118023; Nakayama M, 2015, P NATL ACAD SCI USA, V112, P4429, DOI 10.1073/pnas.1502967112; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Noble JA, 2002, HUM IMMUNOL, V63, P657, DOI 10.1016/S0198-8859(02)00421-4; Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x; Noble JA, 2010, DIABETES, V59, P2972, DOI 10.2337/db10-0699; Roark CL, 2014, DIABETES, V63, P323, DOI 10.2337/db13-1153; Sato AK, 1999, HUM IMMUNOL, V60, P1227, DOI 10.1016/S0198-8859(99)00120-2; Schafer P H, 1995, Semin Immunol, V7, P389, DOI 10.1006/smim.1995.0043; Silva HPV, 2016, GENES IMMUN, V17, P13, DOI 10.1038/gene.2015.45; Skordis Nicos, 2002, Pediatr Diabetes, V3, P200, DOI 10.1034/j.1399-5448.2002.30406.x; Skordis N, 2012, HORM-INT J ENDOCRINO, V11, P86, DOI 10.1007/BF03401541; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; Tait BD, 2003, TISSUE ANTIGENS, V61, P146, DOI 10.1034/j.1399-0039.2003.00013.x; TODD JA, 1988, NATURE, V333, P710, DOI 10.1038/333710a0; Tollefsen S, 2012, J BIOL CHEM, V287, P13611, DOI 10.1074/jbc.M111.320374; Toumba M, 2007, PEDIATR DIABETES, V8, P374, DOI 10.1111/j.1399-5448.2007.00262.x; Valdes AM, 2005, HUM IMMUNOL, V66, P301, DOI 10.1016/j.humimm.2004.12.001; Zerva L, 1996, J EXP MED, V183, P829, DOI 10.1084/jem.183.3.829	41	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193684	10.1371/journal.pone.0193684	http://dx.doi.org/10.1371/journal.pone.0193684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494662	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200082
J	Hou, SY; Dai, JR				Hou, Shunyu; Dai, Jianrong			Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer	PLOS ONE			English	Article							RESISTANCE	Taxol is a widely used chemotherapy drug used clinically for ovarian cancer, although the response to Taxol among individuals varies due to the heterogeneity among ovarian cancer patients. In this work, we analyzed differences in the prognostic effect of gene expression and Taxol usage in the Cancer Genome Atlas (TCGA) dataset and identified specific genes associated with the Taxol effect. Using the Cox regression model, a risk model (Taxol score) was developed to assess the outcome of ovarian cancer patients who underwent chemotherapy with Taxol. According to the results, survival was significantly associated with the Taxol score. Moreover, the patients in the high and low Taxol score group had different responses to Taxol. This result was further validated in another two independent datasets. The correlation between clinicopathological indicators was also analyzed, and we determined that the Taxol score is not associated with age, pathological stage, or Taxol treatment, while there was significant correlation with tumor size and grade. Gene Set Enrichment Analysis (GSEA) showed that various signaling pathways including ECM receptor, drug metabolism and ascorbate metabolism pathways were significantly enriched in the high Taxol score group. Collectively, these results indicate that the model is robust for predicting the effectiveness of Taxol by reflecting the various cell statuses of serous ovarian carcinoma.	[Hou, Shunyu; Dai, Jianrong] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou, Jiangsu, Peoples R China	Nanjing Medical University	Dai, JR (corresponding author), Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou, Jiangsu, Peoples R China.	daijianrong2018@163.com			Special Funds for Industrial Technology Innovation of Suzhou [SYS201567]; Clinical Medical Centers of Suzhou [SZZX201505]; Introduce Project of Clinical Medicine Experts of Suzhou [SZYJTD201707]	Special Funds for Industrial Technology Innovation of Suzhou; Clinical Medical Centers of Suzhou; Introduce Project of Clinical Medicine Experts of Suzhou	This work was supported by the Special Funds for Industrial Technology Innovation of Suzhou SYS201567 to Jianrong Dai, Clinical Medical Centers of Suzhou SZZX201505 to Jianrong Dai, Introduce Project of Clinical Medicine Experts of Suzhou SZYJTD201707 to Jianrong Dai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Gao Y, 2015, ONCOTARGET, V6, P9313, DOI 10.18632/oncotarget.3220; Hobbelen PHF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099366, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0103480, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0095422, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0095536]; Kim SK, 2014, MOL ONCOL, V8, P1653, DOI 10.1016/j.molonc.2014.06.016; Kim YW, 2014, DRUG DES DEV THER, V8, P293, DOI 10.2147/DDDT.S51969; Lisowska KM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00006; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Samra EB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/423174; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh YA, 2015, INT J ONCOL, V46, P1405, DOI 10.3892/ijo.2014.2808; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196	13	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192812	10.1371/journal.pone.0192812	http://dx.doi.org/10.1371/journal.pone.0192812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494610	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200014
J	Vilaca-Alves, J; Muller, F; Rosa, C; Payan-Carreira, R; Lund, R; Matos, F; Garrido, N; Saavedra, FJ; Reis, VM				Vilaca-Alves, Jose; Muller, Fernanda; Rosa, Claudio; Payan-Carreira, Rita; Lund, Rafael; Matos, Filipe; Garrido, Nuno; Saavedra, Francisco Jose; Reis, Victor Machado			Cardiorespiratory, enzymatic and hormonal responses during and after walking while fasting	PLOS ONE			English	Article							EXERCISE; TESTOSTERONE; CARBOHYDRATE; OXIDATION; INGESTION; CORTISOL; RATIO; DIET	The aim of the present study was to observe whether performing a low intensity endurance exercise following an overnight fasted (FAST) or fed (FED) condition promotes different cardiorespiratory, enzymatic and hormonal responses. Nine male physical active subjects, (age 21.89 +/- 2.52 years old, height 175.89 +/- 5.16 cm, weight 72.10 +/- 4.31 kg, estimated body fat 7.25 +/- 2.11%), randomly performed two sessions of 45 minutes' low intensity exercise (individual ventilator threshold) interspersed by seven days, differentiated only in whether they were provided with a standardized meal or not. The oxygen consumption (VO2) and heart rate (HR) were measured continuously at the 30-min rest, the 45-min during and the 30-min post-exercise. The testosterone (T) and cortisol (C) hormones were measured at rest, immediately post-exercise and 15-min post-exercise. The Glucose (GLU), Free fatty acids (FFA) and enzyme lipase activity (ELP) were measured at rest, 15-min and 30-min exercise, immediately, 15-min and 30-min post-exercise. Significantly lower values were observed in FED compared to FAST with: C (nmol/L) from pre (428.87 +/- 120.41; 454.62 +/- 148.33, respectively) to immediately post-exercise (285.10 +/- 85.86; 465.66 +/- 137.70, respectively) and 15-min post-exercise (248.00 +/- 87.88; 454.31 +/- 112.72, respectively) (p<0.05); and GLU at all times, with an exception at 15-min post-exercise. The testosterone/cortisol ratio (T/C) was significantly higher in the FED compared with FAST from pre (0.05 +/- 0.02, 0.05 +/- 0.01, respectively) to 15-min post-exercise (0.08 +/- 0.03, 0.05 +/- 0.02, respectively). No other significant differences were observed between conditions. We conclude that fasting prior to low intensity endurance exercise does not seem be advantageous, when it comes to fat loss, compared with the same exercise performed after a meal.	[Vilaca-Alves, Jose; Muller, Fernanda; Rosa, Claudio; Lund, Rafael; Saavedra, Francisco Jose; Reis, Victor Machado] Univ Tras os Montes & Alto Douro, Sport Sci Dept, Vila Real, Portugal; [Vilaca-Alves, Jose; Matos, Filipe; Garrido, Nuno; Saavedra, Francisco Jose; Reis, Victor Machado] CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal; [Payan-Carreira, Rita] Univ Tras os Montes & Alto Douro, CECAV, Anim & Vet Res Ctr, Vila Real, Portugal	University of Tras-os-Montes & Alto Douro; University of Tras-os-Montes & Alto Douro	Vilaca-Alves, J (corresponding author), Univ Tras os Montes & Alto Douro, Sport Sci Dept, Vila Real, Portugal.; Vilaca-Alves, J (corresponding author), CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal.	josevilaca@utad.pt	Carreira, Rita Payan/D-2757-2012; Barbosa, Tiago M./ABE-6789-2020; Lund, Rafael Guerra/B-5364-2017; Garrido, Nuno Domingos/K-6842-2014; Vilaca-Alves, Jose/I-3965-2012	Carreira, Rita Payan/0000-0001-5225-4510; Barbosa, Tiago M./0000-0001-7071-2116; Lund, Rafael Guerra/0000-0003-1006-3809; Garrido, Nuno Domingos/0000-0002-8105-7580; Saavedra, Francisco/0000-0002-0439-5420; Matos, Filipe/0000-0002-0162-8735; Vilaca-Alves, Jose/0000-0001-5399-7797	Research Center for Sports, Health and Human Development (CIDESD) [UID/DTP/04045/2013]	Research Center for Sports, Health and Human Development (CIDESD)	This work was supported by the Research Center for Sports, Health and Human Development (CIDESD) - project reference UID/DTP/04045/2013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten J, 2004, NUTRITION, V20, P716, DOI 10.1016/j.nut.2004.04.005; American College of Sports Medicine [ACSM], 2013, ACSMS GUIDELINES EXE; Antinozzi C, 2017, J ENDOCRINOL INVEST, V40, P1133, DOI 10.1007/s40618-017-0686-y; Brownlee KK, 2005, J SPORT SCI MED, V4, P76; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DAVIS JM, 1992, ADDICT BEHAV, V17, P185, DOI 10.1016/0306-4603(92)90023-O; Derave W, 2007, OBESITY, V15, P704, DOI 10.1038/oby.2007.548; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P1532, DOI 10.1249/MSS.0b013e3181ae46a1; Drummond MJ, 2005, J STRENGTH COND RES, V19, P332; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fogelholm M, 2005, DIS MANAG HEALTH OUT, V13, P9, DOI 10.2165/00115677-200513010-00002; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; GARDNER LB, 1982, P SOC EXP BIOL MED, V169, P36, DOI 10.3181/00379727-169-41303; Gillen JB, 2013, OBESITY, V21, P2249, DOI 10.1002/oby.20379; Goben W, 1990, EXERCISE INTENSITY T; Guyton C, GUYTON HALL TXB MED; Hawley JA, 1998, SPORTS MED, V25, P241, DOI 10.2165/00007256-199825040-00003; Horowitz JF, 1999, AM J PHYSIOL-ENDOC M, V276, pE828, DOI 10.1152/ajpendo.1999.276.5.E828; HOWLETT TA, 1987, CLIN ENDOCRINOL, V26, P723, DOI 10.1111/j.1365-2265.1987.tb00832.x; Jeukendrup AE, 2003, BIOCHEM SOC T, V31, P1270, DOI 10.1042/BST0311270; Karkoulias K, 2008, EUR J INTERN MED, V19, P598, DOI 10.1016/j.ejim.2007.06.032; Kim TW, 2015, J PHYS THER SCI, V27, P1929, DOI 10.1589/jpts.27.1929; Kirwan JP, 2001, METABOLISM, V50, P849, DOI 10.1053/meta.2001.24191; Lee YS, 1999, J SPORT MED PHYS FIT, V39, P341; LEMON PWR, 1980, J APPL PHYSIOL, V48, P624, DOI 10.1152/jappl.1980.48.4.624; McArdle D, SPORTS EXERCISE NUTR; Nelson L.D., 2017, LEHNINGER PRINCIPLES, V7th; Paoli A, 2011, INT J SPORT NUTR EXE, V21, P48, DOI 10.1123/ijsnem.21.1.48; Rahimi R, 2011, APUNTS-MED ESPORT, V46, P145, DOI 10.1016/j.apunts.2011.03.002; Sapata KB, 2006, REV BRAS MED ESPORTE, V12, P189, DOI DOI 10.1590/S1517-86922006000400005; Schoenfeld B, 2011, STRENGTH COND J, V33, P23, DOI 10.1519/SSC.0b013e31820396ec; Schoenfeld BJ, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/s12970-014-0054-7; Stiegler P, 2006, SPORTS MED, V36, P239, DOI 10.2165/00007256-200636030-00005; Tremblay MS, 2004, J APPL PHYSIOL, V96, P531, DOI 10.1152/japplphysiol.00656.2003; Uchida Marco Carlos, 2004, Rev Bras Med Esporte, V10, P165, DOI 10.1590/S1517-86922004000300005; Utter AC, 1999, EUR J APPL PHYSIOL O, V80, P92, DOI 10.1007/s004210050563; VANCE ML, 1989, J CLIN ENDOCR METAB, V68, P1013, DOI 10.1210/jcem-68-6-1013; Vesely Jennifer M, 2014, FP Essent, V425, P11; Vuorimaa T, 2008, SCAND J MED SCI SPOR, V18, P565, DOI 10.1111/j.1600-0838.2007.00733.x; Xu F, 1999, SPORTS MED, V27, P313, DOI 10.2165/00007256-199927050-00003	40	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193702	10.1371/journal.pone.0193702	http://dx.doi.org/10.1371/journal.pone.0193702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494664	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200087
J	Myhrvold, NP				Myhrvold, Nathan P.			Response to formal comment on Myhrvold (2016) submitted by Griebeler and Werner (2017)	PLOS ONE			English	Editorial Material							METABOLIC THEORY; TEMPERATURE-DEPENDENCE; BODY-MASS; GROWTH-PATTERNS; EVOLUTION; SIZE; ENDOTHERMY; MODEL; REPRODUCTION; SUPPORT	Griebeler and Werner offer a formal comment on Myhrvold, 2016 defending the conclusions of Werner and Griebeler, 2014. Although the comment criticizes several aspects of methodology in Myhrvold, 2016, all three papers concur on a key conclusion: the metabolism of extant endotherms and ectotherms cannot be reliably classified using growth-rate allometry, because the growth rates of extant endotherms and ectotherms overlap. A key point of disagreement is that the 2014 paper concluded that despite this general case, one can nevertheless classify dinosaurs as ectotherms from their growth rate allometry. The 2014 conclusion is based on two factors: the assertion (made without any supporting arguments) that the comparison with dinosaurs must be restricted only to extant sauropsids, ignoring other vertebrate groups, and that extant sauropsid endotherm and ectotherm growth rates in a data set studied in the 2014 work do not overlap. The Griebeler and Werner formal comment presents their first arguments in support of the restriction proposition. In this response I show that this restriction is unsupported by established principles of phylogenetic comparison. In addition, I show that the data set studied in their 2014 work does show overlap, and that this is visible in one of its figures. I explain how either point effectively invalidates the conclusion of their 2014 paper. I also address the other methodological criticisms of Myhrvold 2016, and find them unsupported.	[Myhrvold, Nathan P.] Intellectual Ventures, Bellevue, WA 98005 USA	Intellectual Ventures	Myhrvold, NP (corresponding author), Intellectual Ventures, Bellevue, WA 98005 USA.	nathanm@intven.com		Myhrvold, Nathan/0000-0003-3994-5143	company Intellectual Ventures	company Intellectual Ventures	The company Intellectual Ventures provided support in the form of salary for author NPM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	American Statistical Association Committee on Professional Ethics, 1999, ETH GUID STAT PRACT; Apanius V., 1998, AVIAN GROWTH DEV EVO; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Clarke A, 2006, FUNCT ECOL, V20, P405, DOI 10.1111/j.1365-2435.2006.01109.x; Clarke A, 2017, PRINCIPLES OF THERMAL ECOLOGY: TEMPERATURE, ENERGY AND LIFE, P1, DOI 10.1093/oso/9780199551668.001.0001; Clarke A, 2004, FUNCT ECOL, V18, P252, DOI 10.1111/j.0269-8463.2004.00842.x; Clarke A, 2014, GLOBAL ECOL BIOGEOGR, V23, P1000, DOI 10.1111/geb.12185; Clarke A, 2013, AM NAT, V182, P283, DOI 10.1086/671259; Clarke A, 2010, BIOL REV, V85, P703, DOI 10.1111/j.1469-185X.2010.00122.x; Clarke A, 2010, J ANIM ECOL, V79, P610, DOI 10.1111/j.1365-2656.2010.01672.x; Clavijo-Baquet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037069; D'Emic MD, 2015, SCIENCE, V348, DOI [10.1126/science.1260410, 10.1126/science.1260061]; Elliot MG, 2015, J THEOR BIOL, V364, P321, DOI 10.1016/j.jtbi.2014.09.033; Enquist BJ, 2015, ADV ECOL RES, V52, P249, DOI 10.1016/bs.aecr.2015.02.001; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; Erickson GM, 2014, ANNU REV EARTH PL SC, V42, P675, DOI 10.1146/annurev-earth-060313-054858; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Field DJ, 2014, EVOL DEV, V16, P189, DOI 10.1111/ede.12081; Botelho JF, 2015, EVOL BIOL, V42, P502, DOI 10.1007/s11692-015-9334-7; Geiser F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00842; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2006, FUNCT ECOL, V20, P400, DOI 10.1111/j.1365-2435.2006.01110.x; GILLOOLY JF, 2014, PEERJ, V2, DOI DOI 10.7717/PEERJ.346; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; Griebeler EM, 2016, PLOS ONE, V11; Griffin CT, 2016, P NATL ACAD SCI USA, V113, P14757, DOI 10.1073/pnas.1613813113; Hillman SS, 2015, J EXP BIOL, V218, P1143, DOI 10.1242/jeb.118372; Irmis RB, 2010, EARTH ENV SCI T R SO, V101, P397, DOI 10.1017/S1755691011020068; Isaac NJB, 2010, ECOL LETT, V13, P728, DOI 10.1111/j.1461-0248.2010.01461.x; Ji YZ, 2017, EVOL BIOL, V44, P261, DOI 10.1007/s11692-016-9405-4; Kearney MR, 2012, AM NAT, V180, P546, DOI 10.1086/667860; Klein N, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1333121; Legendre LJ, 2014, DID CROCODILES BECOM; Legendre LJ, 2016, SYST BIOL, V65, P989, DOI 10.1093/sysbio/syw033; Levesque DL, 2014, J COMP PHYSIOL B, V184, P1041, DOI 10.1007/s00360-014-0858-4; Levesque DL, 2014, J EXP BIOL, V217, P1535, DOI 10.1242/jeb.098848; Little AG, 2014, J EXP BIOL, V217, P1642, DOI 10.1242/jeb.088880; McKechnie AE, 2006, P ROY SOC B-BIOL SCI, V273, P931, DOI 10.1098/rspb.2005.3415; MCNAB BK, 1976, COMP BIOCHEM PHYS A, V55, P345, DOI 10.1016/0300-9629(76)90058-X; Meekan M., 2017, AUSTRALAS SCI CONTRO, V38, P34; Meekan MG, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00064; Myhrvold NP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163205; Myhrvold NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081917; Naya DE, 2013, EVOLUTION, V67, P1463, DOI 10.1111/evo.12042; Nespolo RF, 2017, AM NAT, V189, P13, DOI 10.1086/689598; Nespolo RF, 2014, AM NAT, V183, P74, DOI 10.1086/674093; Nespolo RF, 2011, TRENDS ECOL EVOL, V26, P414, DOI 10.1016/j.tree.2011.04.004; Nowack J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00889; O'Connor MP, 2007, OIKOS, V116, P1058, DOI 10.1111/j.2006.0030-1299.15534.x; Oelkrug R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3140; Owerkowicz Tomasz, 2015, P143; Packard GC, 2008, J EXP BIOL, V211, P3581, DOI 10.1242/jeb.023317; PAGEL M, 1993, J THEOR BIOL, V164, P191, DOI 10.1006/jtbi.1993.1148; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Price CA, 2012, ECOL LETT, V15, P1465, DOI 10.1111/j.1461-0248.2012.01860.x; Rey K, 2017, ELIFE, V6, DOI 10.7554/eLife.28589; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Rowe MF, 2013, J EXP BIOL, V216, P1774, DOI 10.1242/jeb.076521; Rowland LA, 2015, BIOL REV, V90, P1279, DOI 10.1111/brv.12157; Sato K, 2014, J EXP BIOL, V217, P3607, DOI 10.1242/jeb.109470; Seymour RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069361; Tattersall GJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500951; van der Meer J, 2006, TRENDS ECOL EVOL, V21, P136, DOI 10.1016/j.tree.2005.11.004; Wegner NC, 2015, SCIENCE, V348, P786, DOI 10.1126/science.aaa8902; Werner J, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1513-1; Werner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088834; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2008, FUNCT ECOL, V22, P616, DOI 10.1111/j.1365-2435.2008.01399.x; White CR, 2005, COMP BIOCHEM PHYS A, V142, P74, DOI 10.1016/j.cbpa.2005.07.013; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; White CR, 2012, P ROY SOC B-BIOL SCI, V279, P3616, DOI 10.1098/rspb.2012.0884; White CR, 2011, COMP BIOCHEM PHYS A, V158, P346, DOI 10.1016/j.cbpa.2010.10.004; White CR, 2009, EVOLUTION, V63, P2658, DOI 10.1111/j.1558-5646.2009.00747.x; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Witton M.P., 2013, PTEROSAURS NATURAL H, DOI DOI 10.1515/9781400847655; Wright NA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2780	88	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192912	10.1371/journal.pone.0192912	http://dx.doi.org/10.1371/journal.pone.0192912			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489880	gold, Green Submitted, Green Published			2022-12-27	WOS:000426276000046
J	Schoeppe, S; Vandelanotte, C; Rebar, AL; Hayman, M; Duncan, MJ; Alley, SJ				Schoeppe, Stephanie; Vandelanotte, Corneel; Rebar, Amanda L.; Hayman, Melanie; Duncan, Mitch J.; Alley, Stephanie J.			Do singles or couples live healthier lifestyles? Trends in Queensland between 2005-2014	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; MARITAL-STATUS; MARRIAGE; ADULTS; OBESITY; TIME; DETERMINANTS; COHABITATION; ASSOCIATIONS	Objectives To compare the frequency of and trends in healthy lifestyle factors between singles and couples. Methods Cross-sectional data from annual surveys conducted from 2005 +/- 2014 were used. The pooled sample included 15,001 Australian adults (mean age: 52.9 years, 50% male, 74% couples) who participated in the annual Queensland Social Survey via computer-assisted telephone interviews. Relationship status was dichotomised into single and couple. Binary logistic regression was used to assess associations between relationship status, and the frequency of and trends in healthy lifestyle factors. Results Compared to singles, couples were significantly more likely to be a non-smoker (OR = 1.82), and meet recommendations for limited fast food (OR = 1.12), alcohol consumption (OR = 1.27) and fruit and vegetable intake (OR = 1.24). Fruit and vegetable intake was not significantly associated with relationship status after adjusting for the other healthy lifestyle factors. Conversely, couples were significantly less likely to be within a normal weight range (OR = 0.81). In both singles and couples, the trend data revealed significant declines in the rates of normal weight (singles: OR = 0.97, couples: OR = 0.97) and viewing TV for less than 14 hours per week (singles: OR = 0.85, couples: OR = 0.84), whilst non-smoking rates significantly increased (singles: OR = 1.12, couples: OR = 1.03). The BMI trend was no longer significant when adjusting for health behaviours. Further, in couples, rates of meeting recommendations for physical activity and fruit/vegetable consumption significantly decreased (OR = 0.97 and OR = 0.95, respectively), as did rates of eating no fast food (OR = 0.96). These trends were not significant when adjusting for the other healthy lifestyle factors. In singles, rates of meeting alcohol recommendations significantly increased (OR = 1.08). Conclusions Health behaviour interventions are needed in both singles and couples, but relationship status needs to be considered in interventions targeting alcohol, fast food, smoking and BMI. Further research is needed to understand why health behaviours differ by relationship status in order to further improve interventions.	[Schoeppe, Stephanie; Vandelanotte, Corneel; Rebar, Amanda L.; Hayman, Melanie; Alley, Stephanie J.] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Phys Act Res Grp, Rockhampton, Qld, Australia; [Duncan, Mitch J.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Phys Act & Nutr, Callaghan, NSW, Australia	Central Queensland University; University of Newcastle	Schoeppe, S (corresponding author), Cent Queensland Univ, Sch Hlth Med & Appl Sci, Phys Act Res Grp, Rockhampton, Qld, Australia.	s.schoeppe@cqu.edu.au	Vandelanotte, Corneel/ABF-5580-2020; Duncan, Mitch/V-1708-2019; Taylan Ozkan, Aysegul/B-9721-2016	Duncan, Mitch/0000-0002-9166-6195; Taylan Ozkan, Aysegul/0000-0001-8421-3625; Schoeppe, Stephanie/0000-0003-1937-876X; Rebar, Amanda/0000-0003-3164-993X; Hayman, Melanie/0000-0003-1469-3496	Australian National Health and Medical Research Council [GNT1125586, GNT1105926]; National Heart Foundation of Australia [101240, 100427, 100029]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	SS (GNT1125586) and AR (GNT1105926) are supported by Early Career Fellowships from the Australian National Health and Medical Research Council. SS (ID 101240) is also supported by a Postdoctoral Fellowship from the National Heart Foundation of Australia. CV (ID 100427) and MJD (ID 100029) are supported by Future Leader Fellowships from the National Heart Foundation of Australia.	*AUSTR BUR STAT, 1998, AUSTR US THEIR TIM; Australian Bureau of Statistics, 2009, AUSTR SOC TRENDS; Australian Burreau of Statistics, 2016, 31010 AUSTR BURR STA; Australian Institute of Health and Welfare, 2013, NAT DRUG STRAT HOUS; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Berge JM, 2014, FAM SYST HEALTH, V32, P67, DOI 10.1037/fsh0000002; Brockmann H, 2004, J MARRIAGE FAM, V66, P567, DOI 10.1111/j.0022-2445.2004.00038.x; Brown A, 2007, PUBLIC HEALTH, V121, P603, DOI 10.1016/j.puhe.2007.01.008; Brownson RC, 2000, AM J PUBLIC HEALTH, V90, P264, DOI 10.2105/AJPH.90.2.264; Davies CA, 2012, PREV MED, V55, P46, DOI 10.1016/j.ypmed.2012.05.003; de Vaus D, 2015, DEMOGRAPHICS LIVING; Department of Health, 2009, OV OB; Department of Health, 2014, PHYS ACT SED BEH GUI; Dinescu D, 2016, J FAM PSYCHOL, V30, P698, DOI 10.1037/fam0000221; Duncan GJ, 2006, DEMOGRAPHY, V43, P691, DOI 10.1353/dem.2006.0032; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Elawad T., 2020, THESIS KING COLL LON; Fjeldsoe BS, 2013, HEALTH PROMOT J AUST, V24, P26, DOI 10.1071/HE12912; Freeman B, 2010, AUST NZ J PUBL HEAL, V34, P447, DOI 10.1111/j.1753-6405.2010.00588.x; Guerra F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1451-9; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Hull EE, 2010, J PHYS ACT HEALTH, V7, P577, DOI 10.1123/jpah.7.5.577; Ishii K, 2013, J EPIDEMIOL, V23, P382, DOI 10.2188/jea.JE20130008; Kamphuis CBM, 2006, BRIT J NUTR, V96, P620, DOI 10.1079/BJN20061896; Kemmer D, 1998, SOCIOL REV, V46, P48, DOI 10.1111/1467-954X.00089; King AC, 1998, ANN BEHAV MED, V20, P64, DOI 10.1007/BF02884450; Laaksonen M, 2003, SCAND J PUBLIC HEALT, V31, P37, DOI 10.1080/14034940210/33915; Lipowicz A, 2002, AM J HUM BIOL, V14, P468, DOI 10.1002/ajhb.10062; Livingston M, 2016, ADDICTION, V111, P1590, DOI 10.1111/add.13396; Macken L C, 2000, J Cardiopulm Rehabil, V20, P361, DOI 10.1097/00008483-200011000-00005; Mata J, 2015, SOC SCI MED, V138, P119, DOI 10.1016/j.socscimed.2015.06.001; McKenzie SH, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-166; Meyler D, 2007, SOC SCI MED, V64, P2297, DOI 10.1016/j.socscimed.2007.02.007; National Health and Medical Research Council, 2009, AUSTR GUID RED HLTH; National Health and Medical Research Council, 2013, AUSTR DIET GUID; O'Donoghue G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2841-3; O'Toole J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-71; Organization WH, 2009, GLOB HLTH RISKS MORT; Osler M, 2008, PSYCHOSOM MED, V70, P482, DOI 10.1097/PSY.0b013e31816f857b; OzTAM, 2016, AUSTR MULT REP; Rapp I, 2013, SOC SCI MED, V98, P197, DOI 10.1016/j.socscimed.2013.09.024; Regional TAM OzTAM Nielsen, 2015, AUSTR MULT REP; Salmon J, 2000, PREV MED, V30, P191, DOI 10.1006/pmed.1999.0619; Sobal J, 2003, SOC SCI MED, V56, P1543, DOI 10.1016/S0277-9536(02)00155-7; SOBAL J, 1992, SOC SCI MED, V35, P915, DOI 10.1016/0277-9536(92)90106-Z; The NS, 2009, OBESITY, V17, P1441, DOI 10.1038/oby.2009.97; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; VENTERS M, 1986, PREV MED, V15, P591, DOI 10.1016/0091-7435(86)90064-2; Vinther JL, 2016, SOC SCI MED, V157, P120, DOI 10.1016/j.socscimed.2016.04.004; Watt RG, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-533; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2004, JOINT FAO WHO WORKSH; World Health Organization, 2019, WHO REPORT GLOBAL TO; Worsley A, 1988, INT J BIOSOC RES, V10, P109	56	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192584	10.1371/journal.pone.0192584	http://dx.doi.org/10.1371/journal.pone.0192584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489832	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000033
J	Zamarian, L; Scherfler, C; Kremser, C; Pertl, MT; Gizewski, E; Benke, T; Delazer, M				Zamarian, Laura; Scherfler, Christoph; Kremser, Christian; Pertl, Marie-Theres; Gizewski, Elke; Benke, Thomas; Delazer, Margarete			Arithmetic learning in advanced age	PLOS ONE			English	Article							SKILL ACQUISITION; STRATEGY EXECUTION; ANGULAR GYRUS; OLDER-ADULTS; NUMBER; BRAIN; MULTIPLICATION; AUTOMATICITY; REGISTRATION; KNOWLEDGE	Acquisition of numerical knowledge and understanding of numerical information are crucial for coping with the changing demands of our digital society. In this study, we assessed arithmetic learning in older and younger individuals in a training experiment including brain imaging. In particular, we assessed age-related effects of training intensity, prior arithmetic competence, and neuropsychological variables on the acquisition of new arithmetic knowledge and on the transfer to new, unknown problems. Effects were assessed immediately after training and after 3 months. Behavioural results showed higher training effects for younger individuals than for older individuals and significantly better performance after 90 problem repetitions than after 30 repetitions in both age groups. A correlation analysis indicated that older adults with lower memory and executive functions at baseline could profit more from intensive training. Similarly, training effects in the younger group were higher for those individuals who had lower arithmetic competence and executive functions prior to intervention. In younger adults, successful transfer was associated with higher executive functions. Memory and set-shifting emerged as significant predictors of training effects in the older group. For the younger group, prior arithmetic competence was a significant predictor of training effects, while cognitive flexibility was a predictor of transfer effects. After training, a subgroup of participants underwent an MRI assessment. A voxel-based morphometry analysis showed a significant interaction between training effects and grey matter volume of the right middle temporal gyrus extending to the angular gyrus for the younger group relative to the older group. The reverse contrast (older group vs. younger group) did not yield any significant results. These results suggest that improvements in arithmetic competence are supported by temporo-parietal areas in the right hemisphere in younger participants, while learning in older people might be more widespread. Overall, our study indicates that arithmetic learning depends on the training intensity as well as on person-related factors including individual age, arithmetic competence before training, memory, and executive functions. In conclusion, we suggest that major progress can be also achieved by older participants, but that interventions have to take into account individual variables in order to provide maximal benefit.	[Zamarian, Laura; Scherfler, Christoph; Pertl, Marie-Theres; Benke, Thomas; Delazer, Margarete] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Scherfler, Christoph; Gizewski, Elke] Med Univ Innsbruck, Neuroimaging Res Core Facil, Innsbruck, Austria; [Kremser, Christian] Med Univ Innsbruck, Dept Radiol, Innsbruck, Austria; [Gizewski, Elke] Med Univ Innsbruck, Dept Neuroradiol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Zamarian, L (corresponding author), Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria.	laura.zamarian@i-med.ac.at	Zamarian, Laura/J-9575-2018	Zamarian, Laura/0000-0002-1640-4179; Gizewski, Elke Ruth/0000-0001-6859-8377; Delazer, Margarete/0000-0001-6482-4445; Scherfler, Christoph/0000-0002-4885-5265	Tiroler Wissenschaftsfonds [TWF-2010-1-993]	Tiroler Wissenschaftsfonds	This research was entirely supported by Tiroler Wissenschaftsfonds (TWF-2010-1-993) to L.Z. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional internal or external funding received for this study.	ALLEN PA, 1992, PSYCHOL AGING, V7, P536, DOI 10.1037/0882-7974.7.4.536; ANDERSON JR, 1992, AM J PSYCHOL, V105, P165, DOI 10.2307/1423026; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; ASHCRAFT MH, 1992, COGNITION, V44, P75, DOI 10.1016/0010-0277(92)90051-I; Barrouillet P, 1998, MEM COGNITION, V26, P355, DOI 10.3758/BF03201146; Bloechle J, 2016, HUM BRAIN MAPP, V37, P3061, DOI 10.1002/hbm.23226; Butterworth B, 2005, J CHILD PSYCHOL PSYC, V46, P3, DOI 10.1111/j.1469-7610.2004.00374.x; Butterworth B, 2011, SCIENCE, V332, P1049, DOI 10.1126/science.1201536; Cappelletti M, 2014, COGNITIVE PSYCHOL, V69, P25, DOI 10.1016/j.cogpsych.2013.11.004; Claros-Salinas D, 2014, RESTOR NEUROL NEUROS, V32, P463, DOI 10.3233/RNN-130342; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Delazer M, 2005, NEUROIMAGE, V25, P838, DOI 10.1016/j.neuroimage.2004.12.009; Delazer M, 2003, COGNITIVE BRAIN RES, V18, P76, DOI 10.1016/j.cogbrainres.2003.09.005; Delazer M, 2003, CLIN NEUROPSYCHOL, V17, P331, DOI 10.1076/clin.17.3.331.18092; Delazer M, 2003, STUD MATH TH LEARN, P385; Delazer M, 2013, AGING NEUROPSYCHOL C, V20, P639, DOI 10.1080/13825585.2012.750261; Dennis NA., 2011, HDB AGING COGN; Duverne S, 2005, CAN J EXP PSYCHOL, V59, P262, DOI 10.1037/h0087479; Duverne S, 2008, PSYCHOL RES-PSYCH FO, V72, P27, DOI 10.1007/s00426-006-0071-5; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Glisky E.L., 2007, BRAIN AGING MODELS M; Grabner RH, 2009, HUM BRAIN MAPP, V30, P2936, DOI 10.1002/hbm.20720; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; Ischebeck A, 2007, NEUROIMAGE, V36, P993, DOI 10.1016/j.neuroimage.2007.03.051; Ischebeck A, 2006, NEUROIMAGE, V30, P1365, DOI 10.1016/j.neuroimage.2005.11.016; Ischebeck A, 2009, NEUROIMAGE, V44, P1103, DOI 10.1016/j.neuroimage.2008.10.025; KLAPP ST, 1991, J EXP PSYCHOL LEARN, V17, P196, DOI 10.1037/0278-7393.17.2.196; LeFevre J-O, 2015, OXF HDB NUMER COGN, P895; LEMAIRE P, 1995, J EXP PSYCHOL GEN, V124, P83, DOI 10.1037/0096-3445.124.1.83; Lemaire P, 2008, AM J PSYCHOL, V121, P1, DOI 10.2307/20445440; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LOGAN GD, 1991, J EXP PSYCHOL LEARN, V17, P179, DOI 10.1037/0278-7393.17.2.179; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Rickard TC, 1997, J EXP PSYCHOL GEN, V126, P288, DOI 10.1037/0096-3445.126.3.288; Rickard TC, 2004, J EXP PSYCHOL LEARN, V30, P65, DOI 10.1037/0278-7393.30.1.65; SALTHOUSE TA, 1994, J EXP PSYCHOL LEARN, V20, P1172, DOI 10.1037/0278-7393.20.5.1172; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Semenza C, 2017, PHILOS T R SOC LON B, P373; SIEGLER RS, 1988, J EXP PSYCHOL GEN, V117, P258, DOI 10.1037/0096-3445.117.3.258; Sliwinski M, 1997, PSYCHOL AGING, V12, P38, DOI 10.1037/0882-7974.12.1.38; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023175; Touron DR, 2015, CURR DIR PSYCHOL SCI, V24, P170, DOI 10.1177/0963721414563730; Touron DR, 2011, J GERONTOL B-PSYCHOL, V66, P151, DOI 10.1093/geronb/gbq076; Touron DR, 2009, PSYCHOL AGING, V24, P574, DOI 10.1037/a0015966; Touron DR, 2004, PSYCHOL AGING, V19, P565, DOI 10.1037/0882-7974.19.4.565; Touron DR, 2001, PSYCHOL AGING, V16, P555, DOI 10.1037//0882-7974.16.4.555; Tronsky LN, 2005, MEM COGNITION, V33, P927, DOI 10.3758/BF03193086; Uittenhove K, 2015, OXF HDB NUMER COGN, P895; Willmes Klaus, 2008, Handb Clin Neurol, V88, P339, DOI 10.1016/S0072-9752(07)88017-1; Zamarian L, 2007, NEUROPSYCHOLOGIA, V45, P1511, DOI 10.1016/j.neuropsychologia.2006.11.012; Zamarian L, 2009, NEUROSCI BIOBEHAV R, V33, P909, DOI 10.1016/j.neubiorev.2009.03.005; Zamarian L., 2015, OXFORDHANDBOOK NUMER, P837, DOI [10.1093/oxfordhb/9780199642342.013.007, DOI 10.1093/OXFORDHB/9780199642342.013.007]	55	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193529	10.1371/journal.pone.0193529	http://dx.doi.org/10.1371/journal.pone.0193529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489905	gold, Green Submitted, Green Published			2022-12-27	WOS:000426276000085
J	David, M; Lecorche, P; Masse, M; Faucon, A; Abouzid, K; Gaudin, N; Varini, K; Gassiot, F; Ferracci, G; Jacquot, G; Vlieghe, P; Khrestchatisky, M				David, Marion; Lecorche, Pascaline; Masse, Maxime; Faucon, Aude; Abouzid, Karima; Gaudin, Nicolas; Varini, Karine; Gassiot, Fanny; Ferracci, Geraldine; Jacquot, Guillaume; Vlieghe, Patrick; Khrestchatisky, Michel			Identification and characterization of highly versatile peptide-vectors that bind non-competitively to the low-density lipoprotein receptor for in vivo targeting and delivery of small molecules and protein cargos	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; LDL RECEPTOR; DRUG-DELIVERY; ANTISENSE OLIGONUCLEOTIDES; LYSOSOMAL-ENZYME; NERVOUS-SYSTEM; OPTIMIZATION; TRANSCYTOSIS; CHOLESTEROL; CELLS	Insufficient membrane penetration of drugs, in particular biotherapeutics and/or low target specificity remain a major drawback in their efficacy. We propose here the rational characterization and optimization of peptides to be developed as vectors that target cells expressing specific receptors involved in endocytosis or transcytosis. Among receptors involved in receptor-mediated transport is the LDL receptor. Screening complex phage-displayed peptide libraries on the human LDLR (hLDLR) stably expressed in cell lines led to the characterization of a family of cyclic and linear peptides that specifically bind the hLDLR. The VH41 1 lead cyclic peptide allowed endocytosis of payloads such as the S-Tag peptide or antibodies into cells expressing the hLDLR. Size reduction and chemical optimization of this lead peptide-vector led to improved receptor affinity. The optimized peptide-vectors were successfully conjugated to cargos of different nature and size including small organic molecules, siRNAs, peptides or a protein moiety such as an Fc fragment. We show that in all cases, the peptide-vectors retain their binding affinity to the hLDLR and potential for endocytosis. Following i.v. administration in wild type or Idlr-!-mice, an Fc fragment chemically conjugated or fused in C-terminal to peptide-vectors showed significant biodistribution in LDLR-enriched organs. We have thus developed highly versatile peptide-vectors endowed with good affinity for the LDLR as a target receptor. These peptide-vectors have the potential to be further developed for efficient transport of therapeutic or imaging agents into cells-including pathological cells-or organs that express the LDLR.	[David, Marion; Lecorche, Pascaline; Masse, Maxime; Faucon, Aude; Abouzid, Karima; Varini, Karine; Gassiot, Fanny; Jacquot, Guillaume; Vlieghe, Patrick] VECT HORUS SAS, Marseille, France; [Gaudin, Nicolas; Varini, Karine; Khrestchatisky, Michel] Aix Marseille Univ, CNRS, NICN, Marseille, France; [Ferracci, Geraldine] Aix Marseille Univ, CNRS, CRN2M, Marseille, France; [Ferracci, Geraldine; Khrestchatisky, Michel] Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France; [Vlieghe, Patrick] SATT Sud Est, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite	Khrestchatisky, M (corresponding author), Aix Marseille Univ, CNRS, NICN, Marseille, France.; Khrestchatisky, M (corresponding author), Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.	michel.khrestchatisky@univ-amu.fr			CNRS; Aix-Marseille Universite; Direction Generale de la Competitivite, de lIndustrie et des Services (DGCIS); Fonds Unique Interministeriel (FUI/); French National Agency for Research (ANR) - A*MIDEX [UMR7259]; ANRT; Direction Generale de la Competitivite, de l'Industrie et des Services (DGCIS); French National Agency for Research (ANR) - A*MIDEX	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Direction Generale de la Competitivite, de lIndustrie et des Services (DGCIS); Fonds Unique Interministeriel (FUI/); French National Agency for Research (ANR) - A*MIDEX(French National Research Agency (ANR)); ANRT(French National Research Agency (ANR)); Direction Generale de la Competitivite, de l'Industrie et des Services (DGCIS); French National Agency for Research (ANR) - A*MIDEX(French National Research Agency (ANR))	The UMR7259 and UMR7286 laboratories acknowledge financial support from the CNRS and from Aix-Marseille Universite. Financial support to VECT-HORUS is acknowledged from the Direction Generale de la Competitivite, de lIndustrie et des Services (DGCIS) and Fonds Unique Interministeriel (FUI/) for the MEDUL project followingqualification by the Pole de Competitivite Eurobiomed. Financial support to the UMR7259 and VECT-HORUScollaborative research programs is acknowledged from the French National Agency for Research (ANR) for theDHUNE project supported by A*MIDEX, and for the following ANR projects: VECtoBrain to PV and MK, VEC2Brain to MK and NANOVECTOR to MK. KV was supported in part by a CIFRE doctoral fellowship from the ANRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The NICN and CRN2M laboratories acknowledge financial support from the CNRS and from Aix-Marseille Universite. Financial support to VECT-HORUS is acknowledged from the Direction Generale de la Competitivite, de l'Industrie et des Services (DGCIS) and Fonds Unique Interministeriel (FUI/) for the MEDUL project following qualification by the Pole de Competitivite Eurobiomed. Financial support to NICN and VECT-HORUS collaborative research programs is acknowledged from the French National Agency for Research (ANR) for the DHUNE project supported by A*MIDEX, and for the following ANR projects: VECtoBrain to PV and MK, VEC2Brain to MK and NANOVECTOR to MK." KV was supported in part by a CIFRE doctoral fellowship from the ANRT.	Abbott NJ, 1996, MOL MED TODAY, V2, P106, DOI 10.1016/1357-4310(96)88720-X; Aggarwal S, 2006, CANCER RES, V66, P9171, DOI 10.1158/0008-5472.CAN-06-1520; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Bockenhoff A, 2014, J NEUROSCI, V34, P3122, DOI 10.1523/JNEUROSCI.4785-13.2014; Brasnjevic I, 2009, PROG NEUROBIOL, V87, P212, DOI 10.1016/j.pneurobio.2008.12.002; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Chen Z, 2017, MOL PHARM, V20; Clayton D, 1999, PROTEIN SCI, V8, P1797, DOI 10.1110/ps.8.9.1797; Crooke ST, 2017, NAT BIOTECHNOL, V35, P230, DOI 10.1038/nbt.3779; Cwirla SE, 1997, SCIENCE, V276, P1696, DOI 10.1126/science.276.5319.1696; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; DEHOUCK B, 1994, J CELL BIOL, V126, P465, DOI 10.1083/jcb.126.2.465; Demeule M, 2008, J PHARMACOL EXP THER, V324, P1064, DOI 10.1124/jpet.107.131318; Demeule M, 2008, J NEUROCHEM, V106, P1534, DOI 10.1111/j.1471-4159.2008.05492.x; Dower W J, 1998, Stem Cells, V16 Suppl 2, P21; Firer MA, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-70; FIRESTONE RA, 1994, BIOCONJUGATE CHEM, V5, P105, DOI 10.1021/bc00026a002; FONG LG, 1989, J CLIN INVEST, V84, P847, DOI 10.1172/JCI114245; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Guillaumond F, 2015, P NATL ACAD SCI USA, V112, P2473, DOI 10.1073/pnas.1421601112; Harisa GI, 2014, SAUDI PHARM J, V22, P504, DOI 10.1016/j.jsps.2013.12.015; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Jacquot G, 2016, MOL PHARMACEUT, V13, P4094, DOI 10.1021/acs.molpharmaceut.6b00687; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kawamoto M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-359; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; Lalatsa A, 2014, MOL PHARMACEUT, V11, P1081, DOI 10.1021/mp400680d; Laude AJ, 2004, MOL MEMBR BIOL, V21, P193, DOI 10.1080/09687680410001700517; Lee JH, 2001, EUR J BIOCHEM, V268, P2004, DOI 10.1046/j.1432-1327.2001.02073.x; Li YH, 2001, MOL NEUROBIOL, V23, P53; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P947, DOI 10.1007/s00259-008-1045-1; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Luegmayr E, 2004, CELL DEATH DIFFER, V11, pS108, DOI 10.1038/sj.cdd.4401399; Malcor JD, 2012, J MED CHEM, V55, P2227, DOI 10.1021/jm2014919; Martinez-Olivan J, 2014, FEBS J, V281, P1534, DOI 10.1111/febs.12721; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; Molino Y, 2017, FASEB J OFFICIAL PUB, V20; Muro S, 2012, J CONTROL RELEASE, V164, P125, DOI 10.1016/j.jconrel.2012.05.052; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057; Prakash TP, 2014, NUCLEIC ACIDS RES, V42, P8796, DOI 10.1093/nar/gku531; Sorrentino NC, 2013, EMBO MOL MED, V5, P675, DOI 10.1002/emmm.201202083; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Spencer B, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00114; Spencer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016575; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; Tserentsoodol N, 2006, MOL VIS, V12, P1306; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Vlieghe P, 2013, MED RES REV, V33, P457, DOI 10.1002/med.21252; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Wu CH, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0223-x; Zhang B, 2013, BIOMATERIALS, V34, P9171, DOI 10.1016/j.biomaterials.2013.08.039	58	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0191052	10.1371/journal.pone.0191052	http://dx.doi.org/10.1371/journal.pone.0191052			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485998	Green Published, Green Submitted, gold			2022-12-27	WOS:000426242400002
J	Neves, BB; Fonseca, JRS; Amaro, F; Pasqualotti, A				Neves, Barbara Barbosa; Fonseca, Jaime R. S.; Amaro, Fausto; Pasqualotti, Adriano			Social capital and Internet use in an age-comparative perspective with a focus on later life	PLOS ONE			English	Article							OLDER-ADULTS; CUMULATIVE ADVANTAGE; NETWORKS; PEOPLE; HEALTH; INTERVENTIONS; TECHNOLOGY; SUPPORT; SCIENCE; SENIORS	Older adults (aged 65+) are still less likely to adopt the Internet when compared to other age groups, although their usage is increasing. To explore the societal effects of Internet usage, scholars have been using social capital as an analytical tool. Social capital pertains to the resources that are potentially available in one's social ties. As the Internet becomes a prominent source of information, communication, and participation in industrialized countries, it is critical to study how it affects social resources from an age-comparative perspective. Research has found a positive association between Internet use and social capital, though limited attention has been paid to older adults. Studies have also found a positive association between social capital and wellbeing, health, sociability, and social support amongst older adults. However, little is known about how Internet usage or lack thereof relates to their social capital. To address this gap, we used a mixed-methods approach to examine the relationship between Internet usage and social capital and whether and how it differs by age. For this, we surveyed a representative sample of 417 adults (18+) living in Lisbon, Portugal, of which 118 are older adults. Social capital was measured through bonding, bridging, and specific resources, and analyzed with Latent Class Modeling and logistic regressions. Internet usage was measured through frequency and type of use. Fourteen follow-up semi-structured interviews helped contextualize the survey data. Our findings show that social capital decreased with age but varied for each type of Internet user. Older adults were less likely to have a high level of social capital; yet within this age group, frequent Internet users had higher levels than other users and non-users. On the one hand, the Internet seems to help maintain, accrue, and even mobilize social capital. On the other hand, it also seems to reinforce social inequality and accumulated advantage (known as the Matthew effect).	[Neves, Barbara Barbosa] Univ Melbourne, Sch Social & Polit Sci, Melbourne, Vic, Australia; [Fonseca, Jaime R. S.; Amaro, Fausto] Univ Lisbon, Inst Super Ciencias Sociais & Polit, Ctr Adm & Polit Publ, Lisbon, Portugal; [Pasqualotti, Adriano] Univ Passo Fundo, Gerontol, Passo Fundo, Brazil	University of Melbourne; Universidade de Lisboa; Universidade de Passo Fundo	Neves, BB (corresponding author), Univ Melbourne, Sch Social & Polit Sci, Melbourne, Vic, Australia.	barbara.barbosa@unimelb.edu.au	Fonseca, Jaime R. S./L-7537-2018; Pasqualotti, Adriano/N-5715-2019; Amaro, Fausto/AAP-4180-2020; Pasqualotti, Adriano AP/A-4613-2013	Fonseca, Jaime R. S./0000-0003-2549-5823; Pasqualotti, Adriano/0000-0001-7544-9425; Pasqualotti, Adriano AP/0000-0001-7544-9425; Neves, Barbara Barbosa/0000-0002-4490-4322; Fonseca, Jaime/0000-0001-9910-8553	Portuguese Foundation for Science and Technology [SFRH/BD/37132]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Foundation for Science and Technology, grant number: SFRH/BD/37132 to BBN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajrouch KJ, 2005, J GERONTOL B-PSYCHOL, V60, pS311, DOI 10.1093/geronb/60.6.S311; Akcomak SI, 2011, REV EC I, V2, P544; Amaro F., 2016, WILEY BLACKWELL ENCY; Beacker Ron, 2014, P 16 INT ACM SIGACCE, P27, DOI [10.1145/2661334.2661375, DOI 10.1145/2661334.2661375]; Bierstedt R., 1964, EXCHANGE POWER SOCIA; Boase J, 2006, STRENGTH INTERNET TI; Bourdieu P., 1984, DISTINCTION SOCIAL C; BOURDIEU Pierre, 1980, ACTES RECH SCI SOC, V31, P29; Carlsson B, 1991, J EVOLUTIONARY EC, V1, P93, DOI [DOI 10.1007/BF01224915, 10.1007/BF01224915]; Choi NG, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2333; Coleman J. S., 1987, EC IMPERIALISM EC AP, P133; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Cornwell EY, 2009, J HEALTH SOC BEHAV, V50, P31, DOI 10.1177/002214650905000103; Cramm JM, 2013, GERONTOLOGIST, V53, P142, DOI 10.1093/geront/gns052; Dannefer D, 2003, J GERONTOL B-PSYCHOL, V58, pS327, DOI 10.1093/geronb/58.6.S327; Diamond JM, 1998, GERMS STEEL SHORT HI; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Edelbrock D, 2001, AUSTRALAS J AGEING, V20, P173, DOI 10.1111/j.1741-6612.2001.tb00382.x; Ellison NB, 2014, J COMPUT-MEDIAT COMM, V19, P855, DOI 10.1111/jcc4.12078; Erickson LB, 2011, P 17 AM C INF SYST 2; Esping-Andersen G, 2012, RES SOC STRAT MOBIL, V30, P473, DOI 10.1016/j.rssm.2012.06.001; European Commission, 2005, SPEC EUR 223 SOC CAP; Eurostat, 2020, POPULATION STRUCTURE; Eurostat, 2011, REP EUR; Eurostat, 2015, INT US IND 2014; Eurostat. Internet use, 2014, INT US 2014; Farr J, 2004, POLIT THEORY, V32, P6, DOI 10.1177/0090591703254978; Field J, 2008, KEY IDEAS, P1; Findlay RA, 2003, AGEING SOC, V23, P647, DOI 10.1017/S0144686X03001296; Fine B., 2010, THEORIES SOCIAL CAPI; Fiori KL, 2007, J GERONTOL B-PSYCHOL, V62, pP322, DOI 10.1093/geronb/62.6.P322; Flap H., 2002, CONVENTIONS STRUCTUR, P29; Fonseca JRS, 2013, INT J SOCIAL RES MET; Gittell R., 1998, COMMUNITY ORG BUILDI; Granovetter M. S., 1974, GETTING JOB STUDY CO; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Halford S, 2010, INFORM COMMUN SOC, V13, P937, DOI 10.1080/1369118X.2010.499956; Hampton KN, 2011, INFORM COMMUN SOC, V14, P130, DOI 10.1080/1369118X.2010.513417; Hogan B., 2010, B SCI TECHNOLOGY, V30, P309, DOI [DOI 10.1177/0270467610380012, 10.1177/0270467610380012]; Horrocks C., 2010, INTERVIEWS QUALITATI; Institute Nacional de Estatistica (Statistics Portugal), 2015, PORT SOC DAT 2015; Institute Nacional de Estatistica (Statistics Portugal), 2012, CENS DAT 2011; Institute Nacional de Estatistica (Statistics Portugal), 2013, PORT SOC DAT 2013; Institute Nacional de Estatistica (Statistics Portugal), 2001, CENS DAT 2001; Institute Nacional de Estatistica (Statistics Portugal), 2011, INT US 2010; Lansdale D, 2002, OLDER ADULTS, HEALTH INFORMATION, AND THE WORLD WIDE WEB, P133; Lin N., 2008, SOCIAL CAPITAL INT R, P1; Lin N., 2002, SOCIAL CAPITAL THEOR, V19; Litwin H, 2011, GERONTOLOGIST, V51, P379, DOI 10.1093/geront/gnq094; Magidson J., 2004, SAGE HDB QUANTITATIV, P175; Masi CM, 2011, PERS SOC PSYCHOL REV, V15, P219, DOI 10.1177/1088868310377394; McMellon CA, 2002, J APPL GERONTOL, V21, P157, DOI 10.1177/07364802021002002; Merton R., 2006, SOCIAL THEORY SOCIAL; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MERTON RK, 1988, ISIS, V79, P606, DOI 10.1086/354848; Muckenhuber J, 2013, AGEING SOC, V33, P853, DOI 10.1017/S0144686X12000219; Munteanu C, 2015, P S US PRIV SEC 2015, P1; Neves B.B., 2012, J COMMUNITY INFORM, V8, P1, DOI DOI 10.15353/JOCI.V8I1.3061; Neves B.B., 2017, INFORM COMMUNICATION, V21, P1681, DOI [DOI 10.1080/1369118X.2017.1348534, 10.1080/1369118X.2017.1348534]; Neves BB, 2015, INT REV SOCIOL, V25, P415, DOI 10.1080/03906701.2015.1050307; Neves BB, 2015, SOC SCI RES, V50, P15, DOI 10.1016/j.ssresearch.2014.11.002; Neves BB, 2013, SOCIOL COMPASS, V7, P599, DOI 10.1111/soc4.12059; Neves BB, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.2998; Nieminen T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-613; Ostrom E., 2003, FDN SOCIAL CAPITAL; Pajak K., 2006, P C ESA RES NETW SOC; Perc M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0378; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Purcell, 2006, NETWORKED NEIGHBOURH, P161, DOI DOI 10.1007/1-84628-601-8_8; PUTNAM RD, 1995, J DEMOCRACY, V0006; Putnam RD., 2000, BOWLING ALONE COLLAP; Quan-Haase A, 2004, SOCIAL CAPTIAL AND INFORMATION TECHNOLOGY, P113; Quan-Haase A, 2017, INFORM COMMUN SOC, V20, P967, DOI 10.1080/1369118X.2017.1305428; Rainie L, 2012, NETWORKED: THE NEW SOCIAL OPERATING SYSTEM, P1; Rawlins W.K., 1992, FRIENDSHIP MATTERS C; Rice RE, 2003, TELECOMMUN POLICY, V27, P597, DOI 10.1016/S0308-5961(03)00068-5; Rigney D, 2010, MATTHEW EFFECT ADVAN; Robinson L, 2015, INFORM COMMUN SOC, V18, P569, DOI 10.1080/1369118X.2015.1012532; Russell C, 2008, AUSTRALAS J AGEING, V27, P78, DOI 10.1111/j.1741-6612.2008.00284.x; Sabatini F, 2009, J SOCIO-ECON, V38, P429, DOI DOI 10.1016/J.SOCEC.2008.06.001; Seidman I., 2006, INTERVIEWING QUALITA; Silver MP, 2014, AGEING SOC, V34, P1019, DOI 10.1017/S0144686X12001420; Smith A., 2014, OLDER ADULTS TECHNOL; Sobel J, 2002, J ECON LIT, V40, P139; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stevens NL, 2011, J SOC PERS RELAT, V28, P24, DOI 10.1177/0265407510386191; Streeten P., 2002, J HUMAN DEV CAPABIL, V3, P7, DOI DOI 10.1080/14649880120105362; Sum S, 2008, J COMPUT-MEDIAT COMM, V14, P202, DOI 10.1111/j.1083-6101.2008.01437.x; Swindell R, 2000, AUSTRALAS J AGEING, V19, P38, DOI 10.1111/j.1741-6612.2000.tb00136.x; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Torp S, 2008, HEALTH SOC CARE COMM, V16, P75, DOI 10.1111/j.1365-2524.2007.00725.x; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP AG; Van Der Gaag M, 2005, SOC NETWORKS, V27, P1, DOI 10.1016/j.socnet.2004.10.001; van Tilburg T, 1998, J GERONTOL B-PSYCHOL, V53, pS313, DOI 10.1093/geronb/53B.6.S313; Wellman B, 2003, J COMPUTER MEDIATED; Williams D, 2006, J COMPUT-MEDIAT COMM, V11, DOI 10.1111/j.1083-6101.2006.00029.x; Wohn DY, 2013, COMPUT EDUC, V63, P424, DOI 10.1016/j.compedu.2013.01.004; Wyatt S, 2007, HANDBOOK OF SCIENCE AND TECHNOLOGY STUDIES, THIRD EDITION, P165; Zhang F, 2015, COMPUT HUM BEHAV, V51, P495, DOI 10.1016/j.chb.2015.05.034	99	40	40	19	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0192119	10.1371/journal.pone.0192119	http://dx.doi.org/10.1371/journal.pone.0192119			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX6NQ	29481556	gold, Green Published			2022-12-27	WOS:000426202700003
J	Li, XH; Yang, R; Chen, HM				Li, Xiaohui; Yang, Rui; Chen, Haimin			The Arabidopsis thaliana Mediator subunit MED8 regulates plant immunity to Botrytis Cinerea through interacting with the basic helix-loop-helix (bHLH) transcription factor FAMA	PLOS ONE			English	Article							NECROTROPHIC FUNGAL PATHOGENS; SYSTEMIC ACQUIRED-RESISTANCE; STOMATAL DEVELOPMENT; GENE-EXPRESSION; ABSCISIC-ACID; GUARD-CELLS; COMPLEX SUBUNIT16; JASMONATE; DIFFERENTIATION; DEFENSE	The Mediator complex is at the core of transcriptional regulation and plays a central role in plant immunity. The MEDIATOR25 (MED25) subunit of Arabidopsis thaliana regulates jasmonate-dependent resistance to Botrytis cinerea through interacting with the basic helixloop-helix (bHLH) transcription factor of jasmonate signaling, MYC2. Another Mediator subunit, MED8, acts independently or together with MED25 in plant immunity. However, unlike MED25, the underlying action mechanisms of MED8 in regulating B. cinerea resistance are still unknown. Here, we demonstrated that MED8 regulated plant immunity to B. cinerea through interacting with another bHLH transcription factor, FAMA, which was previously shown to control the final proliferation/differentiation switch during stomatal development. Our research demonstrates that FAMA is also an essential component of B. cinerea resistance. The fama loss-of-function mutants (fama-1 and fama-2) increased susceptibility to B. cinerea infection and reduced defense-gene expression. On the contrary, transgenic lines constitutively overexpressing FAMA showed opposite B. cinerea responses compared with the fama loss-of-function mutants. FAMA-overexpressed plants displayed enhanced resistance to B. cinerea infection and increased expression levels of defensin genes following B. cinerea treatment. Genetic analysis of MED8 and FAMA suggested that FAMA-regulated pathogen resistance was dependent on MED8. In addition, MED8 and FAMA were both associated with the G-box region in the promoter of ORA59. Our findings indicate that the MED8 subunit of the A. thaliana Mediator regulates plant immunity to B. cinerea through interacting with the transcription factor FAMA, which was discovered to be a key component in B. cinerea resistance.	[Li, Xiaohui; Yang, Rui; Chen, Haimin] Ningbo Univ, Key Lab Appl Marine Biotechnol, Ningbo, Zhejiang, Peoples R China	Ningbo University	Li, XH (corresponding author), Ningbo Univ, Key Lab Appl Marine Biotechnol, Ningbo, Zhejiang, Peoples R China.	lixiaohui@nbu.edu.cn			National Natural Science Foundation of China [31600986]; Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China; K. C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China(Ministry of Education, China - 111 Project); K. C. Wong Magna Fund in Ningbo University	This work was supported by the National Natural Science Foundation of China (31600986); Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund; National 111 Project of China; and partly sponsored by K. C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Birkenbihl RP, 2016, PLANT CELL; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bonawitz ND, 2012, J BIOL CHEM, V287, P5434, DOI 10.1074/jbc.M111.312298; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Caillaud MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001732; Cevik V, 2012, PLANT PHYSIOL, V160, P541, DOI 10.1104/pp.112.202697; Chen L, 2016, DEVELOPMENT, V143, P1600, DOI 10.1242/dev.129098; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; Chen R, 2012, PLANT CELL, V24, P2898, DOI 10.1105/tpc.112.098277; Chhun T, 2016, PLANT CELL PHYSIOL, V57, P1689, DOI 10.1093/pcp/pcw095; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Dhawan R, 2009, PLANT CELL, V21, P1000, DOI 10.1105/tpc.108.062364; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Hachez C, 2011, PLANT PHYSIOL, V155, P1458, DOI 10.1104/pp.110.167718; Hahlbrock K, 2003, P NATL ACAD SCI USA, V100, P14569, DOI 10.1073/pnas.0831246100; Hemsley PA, 2014, PLANT CELL, V20, P9812; Hsieh TF, 2001, EUR J PLANT PATHOL, V107, P571, DOI 10.1023/A:1017947328718; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Lai ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4064; Laluk K., 2010, Arabidopsis Book, V8, pe0136, DOI 10.1199/tab.0136; Lee E, 2014, PLANT J, V78, P566, DOI 10.1111/tpj.12516; Li B, 2016, CELL HOST MICROBE, V19, P641, DOI 10.1016/j.chom.2016.04.011; Li M, 2014, PLANT CELL, V26, P4053, DOI 10.1105/tpc.114.129726; Li WQ, 2015, PLANT J, V81, P282, DOI 10.1111/tpj.12725; Liao CJ, 2016, PLANT CELL, V28, P1662, DOI 10.1105/tpc.16.00105; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Matos JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03271; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nozawa K, 2017, NATURE, V545, P248, DOI 10.1038/nature22328; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Pillitteri LJ, 2007, BIOESSAYS, V29, P861, DOI 10.1002/bies.20625; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Seguela-Arnaud M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0592-4; Serna L, 2009, PLANT PHYSIOL, V149, P1625, DOI 10.1104/pp.108.133090; Shirakawa M, 2014, PLANT CELL, V26, P4039, DOI 10.1105/tpc.114.129874; Song SS, 2014, PLANT CELL, V26, P263, DOI 10.1105/tpc.113.120394; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Torii KU, 2007, PLANT SIGNAL BEHAV, V2, P311, DOI 10.4161/psb.2.4.4072; Tricker PJ, 2012, J EXP BOT, V63, P3799, DOI 10.1093/jxb/ers076; Wang CG, 2015, PLANT PHYSIOL, V169, P856, DOI 10.1104/pp.15.00351; Wang FQ, 2011, PLANT CELL REP, V30, P2117, DOI 10.1007/s00299-011-1118-7; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Xu R, 2012, PLANT SIGNAL BEHAV, V7, P182, DOI 10.4161/psb.18803; Zhai QZ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003422; Zhang XD, 2013, PLANT J, V75, P484, DOI 10.1111/tpj.12216; Zhang XD, 2012, PLANT CELL, V24, P4294, DOI 10.1105/tpc.112.103317; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhu JY, 2011, METHODS MOL BIOL MET, V876; Zhu YF, 2014, PLANT CELL, V26, P4149, DOI 10.1105/tpc.114.128611; Zou JJ, 2015, PLANT CELL, V27, P1445, DOI 10.1105/tpc.15.00144	65	16	17	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193458	10.1371/journal.pone.0193458	http://dx.doi.org/10.1371/journal.pone.0193458			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513733	Green Published, gold			2022-12-27	WOS:000426896800062
J	Liu, PD; You, XL				Liu, Peide; You, Xinli			Some linguistic neutrosophic Hamy mean operators and their application to multi-attribute group decision making	PLOS ONE			English	Article							AGGREGATION OPERATORS; SYMMETRIC FUNCTION; ENTROPY; MODEL	Linguistic neutrosophic numbers (LNNs) can easily describe the incomplete and indeterminate information by the truth, indeterminacy, and falsity linguistic variables (LVs), and the Hamy mean (HM) operator is a good tool to deal with multiple attribute group decision making (MAGDM) problems because it can capture the interrelationship among the multi-input arguments. Motivated by these ideas, we develop linguistic neutrosophic HM (LNHM) operator and weighted linguistic neutrosophic HM (WLNHM) operator. Some desirable properties and special cases of two operators are discussed in detail. Furthermore, considering the situation in which the decision makers (DMs) can't give the suitable weight of each attribute directly from various reasons, we propose the concept of entropy for linguistic neutrosophic set (LNS) to obtain the attribute weight vector objectively, and then the method for MAGDM problems with LNNs is proposed, and some examples are used to illustrate the effectiveness and superiority of the proposed method by comparing with the existing methods.	[Liu, Peide; You, Xinli] Shandong Univ Finance & Econ, Sch Management Sci & Engn, Jinan, Shandong, Peoples R China	Shandong University of Finance & Economics	Liu, PD (corresponding author), Shandong Univ Finance & Econ, Sch Management Sci & Engn, Jinan, Shandong, Peoples R China.	Peide.liu@gmail.com	Liu, Peide/D-3392-2013	Liu, Peide/0000-0001-5048-8145	National Natural Science Foundation of China [71771140, 71471172]; Special Funds of Taishan Scholars Project of Shandong Province [ts201511045]; Shandong Province Higher Educational Science and Technology Program [J16LN25, J17KA189]; National Natural Science Foundation of China [71771140, 71471172]; Special Funds of Taishan Scholars Project of Shandong Province [ts201511045]; Shandong Province Higher Educational Science and Technology Program [J16LN25, J17KA189]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds of Taishan Scholars Project of Shandong Province; Shandong Province Higher Educational Science and Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds of Taishan Scholars Project of Shandong Province; Shandong Province Higher Educational Science and Technology Program	This work is supported by the National Natural Science Foundation of China (Nos. 71771140 and 71471172), the Special Funds of Taishan Scholars Project of Shandong Province (No. ts201511045) and a Project of Shandong Province Higher Educational Science and Technology Program (Nos. J16LN25 and J17KA189).	[Anonymous], 1977, IEEE T SYST MAN CYB, V7, P495, DOI [DOI 10.1109/TSMC.1977.4309751, 10.1109/TSMC.1977.4309751]; Atanassov K., 1986, OMEGA, V20, P87; Celik E, 2014, J INTELL FUZZY SYST, V27, P2847, DOI 10.3233/IFS-141246; Chen ZC, 2015, INT J COMPUT INT SYS, V8, P747, DOI 10.1080/18756891.2015.1061394; Chu YM, 2012, J MULTIVARIATE ANAL, V105, P412, DOI 10.1016/j.jmva.2011.08.004; DELUCA A, 1972, INFORM CONTROL, V20, P301, DOI 10.1016/S0019-9958(72)90199-4; Fan CX, 2017, INFORMATION, V8, DOI 10.3390/info8030107; Fang ZB, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9070111; Guan KZ, 2006, MATH INEQUAL APPL, V9, P797, DOI 10.7153/mia-09-70; Guan KZ, 2011, J MATH ANAL APPL, V376, P494, DOI 10.1016/j.jmaa.2010.10.014; Gurbuz T, 2014, APPL SOFT COMPUT, V21, P365, DOI 10.1016/j.asoc.2014.03.025; Hara Y, 1998, J INEQUAL APPL, V2, P387; Hashemkhani Zolfani S, 2015, J BUS ECON MANAG, V16, P290, DOI 10.3846/16111699.2014.967715; Herrera F, 1996, FUZZY SET SYST, V78, P73, DOI 10.1016/0165-0114(95)00107-7; Herrera F, 2000, FUZZY SET SYST, V115, P67, DOI 10.1016/S0165-0114(99)00024-X; Jiang W. D., 2007, J MATH INEQUAL, V1, P117, DOI DOI 10.7153/JMI-01-121131.260092347710; KOSKO B, 1986, INFORM SCIENCES, V40, P165, DOI 10.1016/0020-0255(86)90006-X; Liang RX, 2018, NEURAL COMPUT APPL, V30, P3383, DOI 10.1007/s00521-017-2925-8; Liang WZ, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9080149; Liu PD, 2017, INT J INF TECH DECIS, V16, P817, DOI 10.1142/S0219622017500110; Majumdar P, 2012, ANN FUZZY MATH INFOR; Peng HG, 2018, INT J MACH LEARN CYB, V9, P1053, DOI 10.1007/s13042-016-0630-z; Peng JJ, 2017, INT J UNCERTAIN QUAN, V7, P355, DOI 10.1615/Int.J.UncertaintyQuantification.2017020126; Qin JD, 2017, GRANULAR COMPUT, V2, P249, DOI 10.1007/s41066-017-0041-x; Qin JD, 2015, J INTELL FUZZY SYST, V29, P171, DOI 10.3233/IFS-151584; Qin JD, 2015, INFORM SCIENCES, V297, P293, DOI 10.1016/j.ins.2014.11.022; Qin JD, 2014, J INTELL FUZZY SYST, V27, P2177, DOI 10.3233/IFS-141182; Rabbani A, 2014, EXPERT SYST APPL, V41, P7316, DOI 10.1016/j.eswa.2014.05.023; Shi LL, 2017, INFORMATION, V8, DOI 10.3390/info8040117; Szmidt E, 2001, FUZZY SET SYST, V118, P467, DOI 10.1016/S0165-0114(98)00402-3; Tian ZP, 2018, J INTELL FUZZY SYST, V34, P177, DOI 10.3233/JIFS-171055; Tian ZP, 2018, INT J MACH LEARN CYB, V9, P523, DOI 10.1007/s13042-016-0552-9; Wang JQ, 2018, NEURAL COMPUT APPL, V30, P1529, DOI 10.1007/s00521-016-2747-0; Wang JQ, 2018, J INTELL FUZZY SYST, V34, P381, DOI 10.3233/JIFS-171421; Wang L, 2018, INT J FUZZY SYST, V20, P13, DOI 10.1007/s40815-017-0373-3; Xu ZS, 2006, GROUP DECIS NEGOT, V15, P593, DOI 10.1007/s10726-005-9008-4; Xu ZS, 2011, IEEE T SYST MAN CY B, V41, P568, DOI 10.1109/TSMCB.2010.2072918; Xu ZS, 2004, INFORM SCIENCES, V168, P171, DOI 10.1016/j.ins.2004.02.003; Xu ZS, 2002, INT J INTELL SYST, V17, P709, DOI 10.1002/int.10045; Yager RR, 2001, IEEE T SYST MAN CY A, V31, P724, DOI 10.1109/3468.983429; YAGER RR, 1979, INT J MAN MACH STUD, V11, P189, DOI 10.1016/S0020-7373(79)80016-4; Ye J, 2017, INFORMATION, V8, DOI 10.3390/info8030110; Yu SM, 2018, INT J INTELL SYST, V33, P953, DOI 10.1002/int.21907; ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI [10.1016/0020-0255(75)90036-5, 10.1016/0020-0255(75)90046-8]; Zadeh LA, 1965, INT J GEN SYST, P129	45	32	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193027	10.1371/journal.pone.0193027	http://dx.doi.org/10.1371/journal.pone.0193027			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513697	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800030
J	Park, J; Kim, JH; Park, Y; Park, SJ; Cheon, JH; Kim, WH; Park, JS; Jeon, JY; Kim, TI				Park, Jihye; Kim, Jae Hyun; Park, Yehyun; Park, Soo Jung; Cheon, Jae Hee; Kim, Won Ho; Park, Ji Soo; Jeon, Justin Y.; Kim, Tae Il			Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence	PLOS ONE			English	Article							PERCENTAGE BODY-FAT; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; CANCER RESECTION; BETA-BLOCKER; COLON-CANCER; RISK-FACTORS; FOLLOW-UP; SURVEILLANCE; HEALTH	Background and aim High heart rate is an independent predictor of total cancer incidence and all-cause mortality in patients with cancer. We aimed to evaluate the impact of resting heart rate on the recurrence of colorectal polyp, using long-term surveillance follow-up data of colorectal cancer survivors. Methods Three hundred patients were selected from the colorectal cancer survivor cohort of Severance Hospital, Seoul, Korea. Resting heart rate, physical activity, and body composition analysis at the time of 5-year survival, and clinical data including colonoscopy surveillance results were collected for mean follow-up duration of 8 years. Results Patients with a high resting heart rate showed a significantly higher recurrence rate of advanced adenoma than those with a low resting heart rate (quartile 1, 45-66 beats per minute (b.p.m.); quartile 2, 67-73 b.p.m.; quartile 3, 74-80 b.p.m.; quartile 4, 81-120 b.p.m.; 3.8% vs. 7.9% vs. 10.0% vs. 14.7%, p for trend = 0.018). After adjustment for various risk factors, patients in the highest quartile of resting heart rate (<= 81 b.p.m.) had a significantly higher risk of advanced adenoma recurrence (hazard ratio [HR]: 6.183, 95% confidence interval [CI]: 1.181-32.373, p = 0.031), compared to those in the lowest quartile (<= 66 b.p.m.). In subgroup analysis, the association of resting heart rate with advanced adenoma recurrence appeared to be stronger among patients who had more than normal body fat mass or sedentary life style. Conclusions Elevated resting heart rate was independently associated with a higher rate of advanced adenoma recurrence in colorectal cancer survivors.	[Park, Jihye; Kim, Jae Hyun; Park, Yehyun; Park, Soo Jung; Cheon, Jae Hee; Kim, Won Ho; Kim, Tae Il] Yonsei Univ, Coll Med, Dept Internal Med, 50 Yonsei Ro, Seoul, South Korea; [Kim, Jae Hyun; Park, Yehyun; Park, Soo Jung; Cheon, Jae Hee; Kim, Won Ho; Kim, Tae Il] Yonsei Univ, Coll Med, Inst Gastroenterol, 50 Yonsei Ro, Seoul, South Korea; [Park, Ji Soo; Jeon, Justin Y.; Kim, Tae Il] Yonsei Univ, Canc Prevent Ctr, Coll Med, 50 Yonsei Ro, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, TI (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, 50 Yonsei Ro, Seoul, South Korea.; Kim, TI (corresponding author), Yonsei Univ, Coll Med, Inst Gastroenterol, 50 Yonsei Ro, Seoul, South Korea.; Jeon, JY; Kim, TI (corresponding author), Yonsei Univ, Canc Prevent Ctr, Coll Med, 50 Yonsei Ro, Seoul, South Korea.	jjeon@yonsei.ac.kr; taeilkim@yuhs.ac	Park, Yehyun/AAC-8861-2022; Cheon, Jae Hee/B-4523-2015; Park, Jihye/AAC-1333-2022	Park, Yehyun/0000-0001-8811-0631; Cheon, Jae Hee/0000-0002-2282-8904; Park, Jihye/0000-0002-5836-8735; Kim, Won Ho/0000-0002-5682-9972; Kim, Tae Il/0000-0003-4807-890X; Park, Ji Soo/0000-0002-0023-7740; Jeon, Justin/0000-0001-7978-4271	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [1631020]	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1631020).	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Anker MS, 2016, EUR J HEART FAIL, V18, P1524, DOI 10.1002/ejhf.670; Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Aune D, 2017, NUTR METAB CARDIOVAS, V27, P504, DOI 10.1016/j.numecd.2017.04.004; Bauman AE, 2006, AM J PREV MED, V31, pS57, DOI 10.1016/j.amepre.2006.06.026; Bohm M, 2015, AM J MED, V128, P219, DOI 10.1016/j.amjmed.2014.09.016; Bohm M, 2017, EUR J HEART FAIL, V19, P250, DOI 10.1002/ejhf.689; Boyle T, 2014, CANCER CAUSE CONTROL, V25, P1659, DOI 10.1007/s10552-014-0470-7; Choi CH, 2014, J CANCER RES CLIN, V140, P1179, DOI 10.1007/s00432-014-1658-7; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Custodis F, 2010, J AM COLL CARDIOL, V56, P1973, DOI 10.1016/j.jacc.2010.09.014; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Francois F, 2006, AM J GASTROENTEROL, V101, P823, DOI 10.1111/j.1572-0241.2006.00433.x; Gibson AL, 2008, AM J CLIN NUTR, V87, P332, DOI 10.1093/ajcn/87.2.332; Hassan C, 2006, DIGEST LIVER DIS, V38, P45, DOI 10.1016/j.dld.2005.09.005; Jang Hye-In, 2017, Obstet Gynecol Sci, V60, P170, DOI 10.5468/ogs.2017.60.2.170; Lee DH, 2016, BREAST CANCER RES TR, V159, P375, DOI 10.1007/s10549-016-3938-1; Lee SY, 2014, J DIGEST DIS, V15, P367, DOI 10.1111/1751-2980.12154; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Martinez ME, 2001, GASTROENTEROLOGY, V120, P1077, DOI 10.1053/gast.2001.23247; Masur K, 2001, CANCER RES, V61, P2866; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Noshirwani KC, 2000, GASTROINTEST ENDOSC, V51, P433, DOI 10.1016/S0016-5107(00)70444-5; Oh DJ, 2016, J EXERC REHABIL, V12, P42, DOI 10.12965/jer.150258; Paik JH, 2015, ANN COLOPROCTOL, V31, P182, DOI 10.3393/ac.2015.31.5.182; Park J, 2017, CANCER PREV RES, V10, P478, DOI 10.1158/1940-6207.CAPR-17-0065; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; Rex DK, 2006, GASTROENTEROLOGY, V130, P1865, DOI 10.1053/j.gastro.2006.03.013; Rosenberg L, 2006, CANCER EPIDEM BIOMAR, V15, P1438, DOI 10.1158/1055-9965.EPI-06-0079; Shin A, 2012, CANCER RES TREAT, V44, P219, DOI 10.4143/crt.2012.44.4.219; Vallance JK, 2015, J CANCER SURVIV, V9, P404, DOI 10.1007/s11764-014-0409-8; van Kruijsdijk RCM, 2014, CANCER EPIDEMIOL, V38, P715, DOI 10.1016/j.canep.2014.09.004; Verrier RL, 2009, HEART RHYTHM, V6, pS68, DOI 10.1016/j.hrthm.2009.07.017; Yang EV, 2009, BRAIN BEHAV IMMUN, V23, P267, DOI 10.1016/j.bbi.2008.10.005; Yang HI, 2016, CLIN CHIM ACTA, V455, P195, DOI 10.1016/j.cca.2016.01.006; Yoon M, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015038	36	15	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193753	10.1371/journal.pone.0193753	http://dx.doi.org/10.1371/journal.pone.0193753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499053	Green Published, Green Submitted, gold			2022-12-27	WOS:000426472300020
J	Georg, M; Fernandez-Cabada, T; Bourguignon, N; Karp, P; Penaherrera, AB; Helguera, G; Lerner, B; Perez, MS; Mertelsmann, R				Georg, Maximilian; Fernandez-Cabada, Tamara; Bourguignon, Natalia; Karp, Paola; Penaherrera, Ana B.; Helguera, Gustavo; Lerner, Betiana; Perez, Maximiliano S.; Mertelsmann, Roland			Development of image analysis software for quantification of viable cells in microchips	PLOS ONE			English	Article							PLATFORM; VISUALIZATION; MICROSCOPY; CULTURE	Over the past few years, image analysis has emerged as a powerful tool for analyzing various cell biology parameters in an unprecedented and highly specific manner. The amount of data that is generated requires automated methods for the processing and analysis of all the resulting information. The software available so far are suitable for the processing of fluorescence and phase contrast images, but often do not provide good results from transmission light microscopy images, due to the intrinsic variation of the acquisition of images technique itself (adjustment of brightness / contrast, for instance) and the variability between image acquisition introduced by operators / equipment. In this contribution, it has been presented an image processing software, Python based image analysis for cell growth (PIACG), that is able to calculate the total area of the well occupied by cells with fusiform and rounded morphology in response to different concentrations of fetal bovine serum inmicrofluidic chips, from microscopy images in transmission light, in a highly efficient way.	[Georg, Maximilian; Mertelsmann, Roland] Univ Freiburg, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany; [Fernandez-Cabada, Tamara; Bourguignon, Natalia; Penaherrera, Ana B.; Lerner, Betiana; Perez, Maximiliano S.] Natl Technol Univ UTN, Reg Fac Haedo, Buenos Aires, DF, Argentina; [Fernandez-Cabada, Tamara; Bourguignon, Natalia; Penaherrera, Ana B.; Lerner, Betiana; Perez, Maximiliano S.] Univ Buenos Aires, Fac Engn, Inst Biomed Engn, C1063ACV, Buenos Aires, DF, Argentina; [Karp, Paola; Helguera, Gustavo] Consejo Nacl Invest Cient & Tecn, Biol & Expt Med Inst IBYME, C1428ADN, Buenos Aires, DF, Argentina	University of Freiburg; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Mertelsmann, R (corresponding author), Univ Freiburg, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany.; Perez, MS (corresponding author), Natl Technol Univ UTN, Reg Fac Haedo, Buenos Aires, DF, Argentina.; Perez, MS (corresponding author), Univ Buenos Aires, Fac Engn, Inst Biomed Engn, C1063ACV, Buenos Aires, DF, Argentina.	max@fullgen.com.ar; roland.mertelsmann@uniklinik-freiburg.de	Bourguignon, Natalia/ABB-4849-2021; Fernandez Cabada, Tamara/B-5806-2018	Penaherrera, Ana/0000-0002-3886-7297; Mertelsmann, Roland/0000-0002-0294-0325; Bourguignon, Natalia/0000-0001-6359-7340; Helguera, Gustavo/0000-0003-1509-3564; Georg, Maximilian/0000-0002-5215-3899; Fernandez Cabada, Tamara/0000-0003-2930-8845	CONICET (PIP); ANPCyT [PICT-STARTUP 3772]; Florencio Fiorini grant	CONICET (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); Florencio Fiorini grant	This study was supported by CONICET (PIP2015), ANPCyT (PICT-STARTUP 3772) to MSP and Florencio Fiorini grant to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the financial support from CONICET (PIP2015), ANPCyT (PICT-STARTUP 3772) and Florencio Fiorini grant.	Arena ET, 2016, WILEY INTERDISCIP RE; Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005; Buggenthin F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-297; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Coelho L.P., 2013, JORS, V1, pe3, DOI [10.5334/jors.ac, DOI 10.5334/JORS.AC]; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Gruber D. F., 1994, CELL BIOL LAB HDB, P45; Hodneland E, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-16; JONM Ryan, 1979, EFFECT DIFFERENT FET, V15, P895; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Leclerc E, 2003, BIOMED MICRODEVICES, V5, P109, DOI 10.1023/A:1024583026925; Maki A. J., 2014, P 16 EUR C POW EL AP, P1; Paguirigan AL, 2009, INTEGR BIOL, V1, P182, DOI 10.1039/b814565b; Payes C, 2016, MICROELECTRON ENG; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Piccinini F, 2017, CELL SYST, V4, P651, DOI 10.1016/j.cels.2017.05.012; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Staines D. P P, MANAGING SERUM REQUI; Su XJ, 2013, ANAL CHEM, V85, P1562, DOI 10.1021/ac3027228; van der Valk J, 2004, TOXICOL IN VITRO, V18, P1, DOI 10.1016/j.tiv.2003.08.009; Xu ZY, 2013, BIOMATERIALS, V34, P4109, DOI 10.1016/j.biomaterials.2013.02.045; Yin ZZ, 2011, I S BIOMED IMAGING, P909, DOI 10.1109/ISBI.2011.5872551	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193605	10.1371/journal.pone.0193605	http://dx.doi.org/10.1371/journal.pone.0193605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494694	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200073
J	Xu, Y; Wang, SJ; Bai, XY; Shu, DC; Tian, YC				Xu, Yan; Wang, Shijie; Bai, Xiaoyong; Shu, Dongcai; Tian, Yichao			Runoff response to climate change and human activities in a typical karst watershed, SW China	PLOS ONE			English	Article							LAND-USE CHANGE; YELLOW-RIVER BASIN; SEDIMENT LOAD; LOESS PLATEAU; HYDROLOGICAL RESPONSE; YANGTZE-RIVER; CATCHMENT; IMPACTS; VARIABILITY; STREAMFLOW	This study aims to reveal the runoff variation characteristics of long time series in a karst region, analyse comprehensively its different driving factors, and estimate quantitatively the contribution rates of climate change and human activities to net runoff variation. Liudong river basin, a typical karst watershed in southwest China, is the study site. Statistical methods, such as linear fitting, the Morlet wavelet analysis, normalized curve and double mass curve, are applied to analyse the runoff of the watershed. Results show that the runoff in the karst watershed during the research period exhibits a three-stage change and the abrupt change points are the years 1981 and 2007: (1) 1968 +/- 1980, the runoff initially exhibited a trend of sustained decreasing and then an abrupt fluctuation. The runoff was obviously destroyed through precipitation-producing processes. Improper land utilisation and serious forest and grass destruction intensified the fluctuation variation amplitude of the runoff. (2) 1981 +/- 2006, the changing processes of runoff and precipitation exhibited good synchronism. Precipitation significantly affected runoff variation and human activities had a slight interference degree. (3) 2007 +/- 2013, the fluctuation range of runoff was considerably smaller than that of precipitation. The significant growth of forest and grassland areas and the increase in water consumption mitigated runoff fluctuation and greatly diminished runoff variation amplitude. According to calculation, the relative contribution rates of precipitation and human activities to net runoff variation with 1981 +/- 2007 as the reference period were -81% and 181% in average, respectively, during 1968 +/- 1980, and -117% and 217% in average, respectively, during 2007 +/- 2013. In general, the analysis of runoff variation trend and of the contribution rate of its main influencing factors in the typical karst watershed for nearly half a century may be significant to solve the drought problem in the karst region and for the sustainable development of the drainage basin.	[Xu, Yan; Wang, Shijie; Bai, Xiaoyong; Tian, Yichao] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Guizhou, Peoples R China; [Xu, Yan; Wang, Shijie; Bai, Xiaoyong; Tian, Yichao] Chinese Acad Sci, Puding Karst Ecosyst Res Stn, Puding, Guizhou, Peoples R China; [Xu, Yan; Tian, Yichao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Shu, Dongcai] Guizhou Prov Bur Hydrol & Water Resources, Guiyang, Guizhou, Peoples R China	Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, XY (corresponding author), Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Guizhou, Peoples R China.; Bai, XY (corresponding author), Chinese Acad Sci, Puding Karst Ecosyst Res Stn, Puding, Guizhou, Peoples R China.	994656336@qq.com	Bai, Xiaoyong/L-6885-2019	Bai, Xiaoyong/0000-0001-9705-5574	National Key Research Program of China [2016YFC0502300, 2016YFC0502102, 2013CB956700, 2014BAB03B02]; International cooperation research projects of the national natural science fund committee [41571130074, 41571130042]; Science and Technology Plan of Guizhou Province of China [2012-6015]; Agricultural Science and Technology Key Project of Guizhou Province of China [2014-3039]; Science and technology cooperation projects [2014-3]; Science and Technology Plan Projects of Guiyang Municipal Bureau of Science and Technology of China [2012-205]	National Key Research Program of China; International cooperation research projects of the national natural science fund committee; Science and Technology Plan of Guizhou Province of China; Agricultural Science and Technology Key Project of Guizhou Province of China; Science and technology cooperation projects; Science and Technology Plan Projects of Guiyang Municipal Bureau of Science and Technology of China	This research work was supported jointly by National Key Research Program of China (No. 2016YFC0502300, 2016YFC0502102, 2013CB956700 & 2014BAB03B02), International cooperation research projects of the national natural science fund committee (No. 41571130074 & 41571130042), Science and Technology Plan of Guizhou Province of China (No. 2012-6015), Agricultural Science and Technology Key Project of Guizhou Province of China (No. 2014-3039), Science and technology cooperation projects (No. 2014-3), Science and Technology Plan Projects of Guiyang Municipal Bureau of Science and Technology of China (No. 2012-205).	Bai XY, 2013, LAND DEGRAD DEV, V24, P47, DOI 10.1002/ldr.1102; Breuer L, 2009, ADV WATER RESOUR, V32, P129, DOI 10.1016/j.advwatres.2008.10.003; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Bureau of Water Conservancy Management of GuiZhou, 2005, PROCL SOIL WAT LOSS; Chang JX, 2015, QUATERN INT, V380, P169, DOI 10.1016/j.quaint.2014.03.048; [陈宏峰 Chen Hongfeng], 2005, [中国岩溶, Carsologica Sinica], V24, P300; Claessens L, 2009, AGR ECOSYST ENVIRON, V129, P157, DOI 10.1016/j.agee.2008.08.008; [戴明宏 Dai Minghong], 2015, [生态科学, Ecologic Science], V34, P189; Gao GY, 2016, SCI TOTAL ENVIRON, V557, P331, DOI 10.1016/j.scitotenv.2016.03.019; Gao Y, 2014, AGR FOREST METEOROL, V195, P32, DOI 10.1016/j.agrformet.2014.04.010; Gosling R, 2014, HYDROL RES, V45, P806, DOI 10.2166/nh.2014.148; [胡奕 Hu Yi], 2012, [水土保持学报, Journal of Soil and Water Conservation], V26, P46; [黄承标 Huang Chengbiao], 2012, [水土保持研究, Research of Soil and Water Conservation], V19, P34; Kim J, 2013, SCI TOTAL ENVIRON, V452, P181, DOI 10.1016/j.scitotenv.2013.02.005; Kong DX, 2016, ECOL ENG, V91, P566, DOI 10.1016/j.ecoleng.2016.02.023; Kong L., 2007, CARSOLOGICA SINICA, P341; Labat D, 2004, ADV WATER RESOUR, V27, P631, DOI 10.1016/j.advwatres.2004.02.020; Lee KS, 2007, HYDROL PROCESS, V21, P3046, DOI 10.1002/hyp.6513; Legesse D, 2003, J HYDROL, V275, P67, DOI 10.1016/S0022-1694(03)00019-2; [李丽娟 Li Lijuan], 2010, [地理研究, Geographical Research], V29, P1233; [李瑞 Li Rui], 2012, [水土保持通报, Bulletin of Soil and Water Conservation], V32, P132; Li S, 2014, CATENA, V116, P157, DOI 10.1016/j.catena.2013.12.013; Li SM, 2009, J FUNCT FOODS, V1, P2, DOI 10.1016/j.jff.2008.09.003; Li Z, 2009, J HYDROL, V377, P35, DOI 10.1016/j.jhydrol.2009.08.007; Liang H., 1994, Chinese Vegetables, P1; Liang W, 2015, WATER RESOUR RES, V51, P6500, DOI 10.1002/2014WR016589; Liu F, 2011, J GEOGR SCI, V21, P1047, DOI 10.1007/s11442-011-0899-5; Lorup JK, 1998, J HYDROL, V205, P147, DOI 10.1016/S0168-1176(97)00311-9; Luo GJ, 2016, SOLID EARTH, V7, P457, DOI 10.5194/se-7-457-2016; Marshall E, 2008, CLIMATIC CHANGE, V89, P263, DOI 10.1007/s10584-007-9389-2; Maurer EP, 2007, CLIMATIC CHANGE, V82, P309, DOI 10.1007/s10584-006-9180-9; Miao CY, 2010, PROG PHYS GEOG, V34, P541, DOI 10.1177/0309133310369434; Minville M, 2008, J HYDROL, V358, P70, DOI 10.1016/j.jhydrol.2008.05.033; [彭韬 PENG Tao], 2008, [地球与环境, Earth and Environment], V36, P125; [秦罗义 Qin Luoyi], 2015, [山地学报, Mountain Research], V33, P619; Qin LY, 2015, AGR WATER MANAGE, V159, P55, DOI 10.1016/j.agwat.2015.05.024; Shi HY, 2015, HYDROL PROCESS, V29, P3236, DOI 10.1002/hyp.10439; Shi P, 2010, J HYDROL ENG, V15, P370, DOI 10.1061/(ASCE)HE.1943-5584.0000206; Su X. L., 2005, EARTH ENV, P24; Tian YC, 2016, SCI TOTAL ENVIRON, V566, P1297, DOI 10.1016/j.scitotenv.2016.05.190; Viney NR, 2009, ADV WATER RESOUR, V32, P147, DOI 10.1016/j.advwatres.2008.05.006; Wang DB, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010283; Wang F., J HYDROLOGY, V527, P884; Wang SF, 2008, HYDROL PROCESS, V22, P2502, DOI 10.1002/hyp.6846; [王随继 Wang Suiji], 2012, [地理学报, Acta Geographica Sinica], V67, P388; Wang WG, 2016, J HYDROL, V541, P1042, DOI 10.1016/j.jhydrol.2016.08.014; [熊亚兰 Xiong Yalan], 2010, [水土保持研究, Research of Soil and Water Conservation], V17, P30; Xu JX, 2011, QUATERN INT, V244, P230, DOI 10.1016/j.quaint.2010.09.014; Xu XY, 2014, J HYDROL, V510, P530, DOI 10.1016/j.jhydrol.2013.12.052; Yang SL, 2002, J HYDROL, V263, P56, DOI 10.1016/S0022-1694(02)00028-8; [杨涛 YANG Tao], 2009, [地球与环境, Earth and Environment], V37, P207; Yang XL, 2012, HYDROL RES, V43, P23, DOI 10.2166/nh.2011.120; Ye XC, 2013, J HYDROL, V494, P83, DOI 10.1016/j.jhydrol.2013.04.036; Yu PT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132395; ZHAN CS, 2014, HYDROL EARTH SYST SC, V11, P2149, DOI DOI 10.5194/hessd-11-2149-2014; Zhang CQ, 2014, HYDROL PROCESS, V28, P43, DOI 10.1002/hyp.9539; [穆兴民 MU Xingmin], 2007, [泥沙研究, Journal of Sediment Research], P36; Zhang X, 2007, J TROPICAL SUBTROPIC, V15, P527; Zhao YF, 2015, SCI TOTAL ENVIRON, V536, P803, DOI 10.1016/j.scitotenv.2015.07.119; Zhou YC, 2013, AGR FOREST METEOROL, V182, P332, DOI 10.1016/j.agrformet.2013.04.018; [朱颖洁 Zhu Yingjie], 2010, [水文, Hydrology], V30, P50; Zuo DP, 2016, SCI TOTAL ENVIRON, V544, P238, DOI 10.1016/j.scitotenv.2015.11.060	62	25	27	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193073	10.1371/journal.pone.0193073	http://dx.doi.org/10.1371/journal.pone.0193073			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494602	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200021
J	Burton, KJ; Pimentel, G; Zangger, N; Vionnet, N; Drai, J; McTernan, PG; Pralong, FP; Delorenzi, M; Vergeres, G				Burton, Kathryn J.; Pimentel, Gregory; Zangger, Nadine; Vionnet, Nathalie; Drai, Jocelyne; McTernan, Philip G.; Pralong, Francois P.; Delorenzi, Mauro; Vergeres, Guy			Modulation of the peripheral blood transcriptome by the ingestion of probiotic yoghurt and acidified milk in healthy, young men	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; SWEET ACIDOPHILUS MILK; GENE-EXPRESSION; FERMENTED MILK; TRYPTOPHAN-METABOLITES; INSULIN-RESISTANCE; DAILY CONSUMPTION; DAIRY-PRODUCTS; WEIGHT-LOSS; LOW-FAT	The metabolic health benefits of fermented milks have already been investigated using clinical biomarkers but the development of transcriptomic analytics in blood offers an alternative approach that may help to sensitively characterise such effects. We aimed to assess the effects of probiotic yoghurt intake, compared to non-fermented, acidified milk intake, on clinical biomarkers and gene expression in peripheral blood. To this end, a randomised, crossover study was conducted in fourteen healthy, young men to test the two dairy products. For a subset of seven subjects, RNA sequencing was used to measure gene expression in blood collected during postprandial tests and after two weeks daily intake. We found that the postprandial response in insulin was different for probiotic yoghurt as compared to that of acidified milk. Moreover changes in several clinical biomarkers were associated with changes in the expression of genes representing six metabolic genesets. Assessment of the postprandial effects of each dairy product on gene expression by geneset enrichment analysis revealed significant, similar modulation of inflammatory and glycolytic genes after both probiotic yoghurt and acidified milk intake, although distinct kinetic characteristics of the modulation differentiated the dairy products. The aryl hydrocarbon receptor was a major contributor to the down-regulation of the inflammatory genesets and was also positively associated with changes in circulating insulin at 2h after yoghurt intake (p = 0.05). Daily intake of the dairy products showed little effect on the fasting blood transcriptome. Probiotic yoghurt and acidified milk appear to affect similar gene pathways during the postprandial phase but differences in the timing and the extent of this modulation may lead to different physiological consequences. The functional relevance of these differences in gene expression is supported by their associations with circulating biomarkers.	[Burton, Kathryn J.; Pimentel, Gregory; Vionnet, Nathalie; Pralong, Francois P.] Lausanne Univ Hosp, Serv Endocrinol Diabet & Metab, Lausanne, Switzerland; [Pimentel, Gregory; Vergeres, Guy] Agroscope, Fed Dept Econ Affairs Educ & Res EAER, Bern, Switzerland; [Zangger, Nadine; Delorenzi, Mauro] SIB Swiss Inst Bioinformat, Lausanne, Switzerland; [Drai, Jocelyne] Ctr Hosp Lyon Sud, Lab Biochim, Pierre Benite, France; [Drai, Jocelyne] Fac Med LYON SUD, Equipe Inserm CarMeN U1060, BP 12, Pierre Benite, France; [McTernan, Philip G.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Research Station Agroscope; Swiss Institute of Bioinformatics; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Nottingham Trent University	Burton, KJ (corresponding author), Lausanne Univ Hosp, Serv Endocrinol Diabet & Metab, Lausanne, Switzerland.	kathryn.burton@agroscope.admin.ch	Pimentel, Grégory/Q-8841-2017; Vionnet, Nathalie/N-6302-2017	Pimentel, Grégory/0000-0003-3687-3519; Pimentel, Kathryn/0000-0002-7314-2187; McTernan, Philip/0000-0001-9023-0261	Swiss National Science Foundation [NRP69]; University of Warwick; Higher Education Innovation Fund [5]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Warwick; Higher Education Innovation Fund	This work was supported in part by the Swiss National Science Foundation in the frame of the national research program "Healthy nutrition and sustainable food production" (NRP69) hosting the JPI HDHL project EU Food Biomarkers Alliance (FoodBAll). Endotoxin assays were financed by a collaboration with the University of Warwick using a grant received from the Higher Education Innovation Fund 5. These funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Agerholm-Larsen L, 2000, EUR J CLIN NUTR, V54, P288, DOI 10.1038/sj.ejcn.1600937; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2021, LANG ENV STAT COMP; Asemi Z, 2013, EUR J CLIN NUTR, V67, P71, DOI 10.1038/ejcn.2012.189; Bartel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005274; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bordoni A., 2015, CRIT REV FOOD SCI NU, V57, P2497, DOI [10.1080/10408398.2014.96738526287637, DOI 10.1080/10408398.2014.96738526287637]; Burton KJ, 2017, BRIT J NUTR, V117, P1312, DOI 10.1017/S0007114517000885; Busbee PB, 2013, NUTR REV, V71, P353, DOI 10.1111/nure.12024; Cervantes-Barragan L, 2017, SCIENCE; Cheng YT, 2015, DRUG METAB DISPOS, V43, P1536, DOI 10.1124/dmd.115.063677; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Dabir P, 2008, CIRC RES, V102, P1558, DOI 10.1161/CIRCRESAHA.108.176990; DiNatale BC, 2010, J BIOL CHEM, V285, P24388, DOI 10.1074/jbc.M110.118570; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Ebringer L, 2008, FOLIA MICROBIOL, V53, P378, DOI 10.1007/s12223-008-0059-1; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ejtahed HS, 2012, NUTRITION, V28, P539, DOI 10.1016/j.nut.2011.08.013; Ekstrom C., 2014, MESS MISCELLANEOUS E; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Food and Agricultural Organization (FAO) of the United Nations and World Health Organization (WHO), 2006, 85 FAO WHO; GAUDICHON C, 1995, BRIT J NUTR, V74, P251, DOI 10.1079/BJN19950128; Gaujoux R, 2013, BIOINFORMATICS, V29, P2211, DOI 10.1093/bioinformatics/btt351; Gille D, 2017, J NUTR BIOCHEM, V43, P156, DOI 10.1016/j.jnutbio.2017.02.012; GURR MI, 1987, FEMS MICROBIOL LETT, V46, P337, DOI 10.1111/j.1574-6968.1987.tb02470.x; Hubbard TD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12689; Jao CL, 2015, BIOMEDICINE-TAIWAN, V5, P9, DOI 10.7603/s40681-015-0014-9; Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165; John K, 2014, MOL CARCINOGEN, V53, P765, DOI 10.1002/mc.22032; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kaput J, 2004, PHYSIOL GENOMICS, V16, P166, DOI 10.1152/physiolgenomics.00107.2003; Kawakami Y, 2013, J NUTRIGENET NUTRIGE, V6, P154, DOI 10.1159/000354247; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Lahoti TS, 2014, J PHARMACOL EXP THER, V348, P236, DOI 10.1124/jpet.113.209726; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li LX, 2009, ARTERIOSCL THROM VAS, V29, P732, DOI 10.1161/ATVBAHA.108.183210; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liu SQ, 2003, INT J FOOD MICROBIOL, V83, P115, DOI 10.1016/S0168-1605(02)00366-5; Madjd A, 2016, AM J CLIN NUTR, V103, P323, DOI 10.3945/ajcn.115.120170; Malaguarnera L, 2005, INT IMMUNOPHARMACOL, V5, P1458, DOI 10.1016/j.intimp.2005.04.002; Marsh-Richard DM, 2009, BEHAV RES METHODS, V41, P99, DOI 10.3758/BRM.41.1.99; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Miller CA, 1997, J BIOL CHEM, V272, P32824, DOI 10.1074/jbc.272.52.32824; Mohamadshahi M, 2014, BIOIMPACTS, V4, P83, DOI 10.5681/bi.2014.007; Murray IA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33969; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Nestel PJ, 2013, BRIT J NUTR, V110, P2242, DOI 10.1017/S0007114513001621; Nickel KP, 1996, J NUTR, V126, P1406, DOI 10.1093/jn/126.5.1406; Nilsson M, 2007, AM J CLIN NUTR, V85, P996, DOI 10.1093/ajcn/85.4.996; Noguchi R, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.19; ONWULATA CI, 1989, AM J CLIN NUTR, V49, P1233, DOI 10.1093/ajcn/49.6.1233; Ostadrahimi A, 2015, IRAN J PUBLIC HEALTH, V44, P228; Ostman EM, 2001, AM J CLIN NUTR, V74, P96; Patel RD, 2006, TOXICOL SCI, V89, P75, DOI 10.1093/toxsci/kfi344; Petrov PD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155361; Philip M, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4039038; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roh E, 2015, ACTA DIABETOL, V52, P489, DOI 10.1007/s00592-014-0674-z; Sagaya FM, 2012, J NUTR BIOCHEM, V23, P1701, DOI 10.1016/j.jnutbio.2012.01.001; Sanggaard KM, 2004, BRIT J NUTR, V92, P447, DOI 10.1079/BJN20041219; SAVAIANO DA, 1984, AM J CLIN NUTR, V40, P1219, DOI 10.1093/ajcn/40.6.1219; SMITH TM, 1985, AM J CLIN NUTR, V42, P1197, DOI 10.1093/ajcn/42.6.1197; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Oostrom AJHHM, 2003, J LIPID RES, V44, P576, DOI 10.1194/jlr.M200419-JLR200; van Oostrom AJHHM, 2003, METABOLISM, V52, P199, DOI 10.1053/meta.2003.50037; Wang C, 2011, ENVIRON HEALTH PERSP, V119, P1739, DOI 10.1289/ehp.1103593; Wellek S, 2012, DTSCH ARZTEBL INT, V109, P276, DOI 10.3238/arztebl.2012.0276; Zarrati M, 2014, J AM COLL NUTR, V33, P417, DOI 10.1080/07315724.2013.874937	78	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192947	10.1371/journal.pone.0192947	http://dx.doi.org/10.1371/journal.pone.0192947			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489876	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000426276000047
J	Fife, D; Cepeda, MS; Baseman, A; Richards, H; Hu, P; Starr, HL; Sena, AG				Fife, Daniel; Cepeda, M. Soledad; Baseman, Alan; Richards, Henry; Hu, Peter; Starr, H. Lynn; Sena, Anthony G.			Medication changes after switching from CONCERTA (R) brand methylphenidate HCI to a generic long-acting formulation: A retrospective database study	PLOS ONE			English	Article							REGRESSION SHRINKAGE; SWITCHBACK RATES; SUBSTITUTION; SELECTION; IMPACT	Background Observational studies of switching from branded to generic formulations of the same drug substance often lack appropriate comparators for the subjects who switched. Three generic formulations were deemed equivalent to Concerta: an authorized generic (AG) identical except for external packaging, and two other generics (EG). Objective Compare the incidence of a combined endpoint (switching back to Concerta, changing the use of immediate release methylphenidate (MPH), stopping all long-acting methylphenidate, or starting a new medication) among people switched from Concerta to the AG versus the EG. Methods Cohort study from the Truven CCAE database of people aged 6 to 65 diagnosed with ADHD, treated with Concerta, and switched to the EG or to the AG formulation. Results In the EG arm 24.6% and in the AG arm 19.7% of subjects switched back to Concerta. The proportion of subjects meeting the combined endpoint was 39.5% in the EG arm, 32.9% in the AG arm, a crude risk ratio of 1.20 (95% CI 0.94, 1.54). After adjustment by propensity score stratification, the adjusted odds ratio (OR) was 1.23 (95% CI 0.90, 1.70). In an unplanned analysis using a different method of adjustment, the adjusted OR was 1.00 (95% CI 0.69, 1.44). Discussion This study did not detect a difference between the proportion of people who met the study endpoint in the two study arms, i.e. between those who switched to a generic formulation that was identical to Concerta except for external packaging and those who switched to the comparison generics. The high incidence of the combined endpoint in the AG arm demonstrates the need for an appropriate comparator in studies of this type.	[Fife, Daniel; Cepeda, M. Soledad; Sena, Anthony G.] Janssen Res & Dev LLC, Epidemiol, Titusville, NJ 08560 USA; [Baseman, Alan] Janssen Res & Dev LLC, Global Med Safety, Horsham, PA USA; [Richards, Henry] Janssen Res & Dev LLC, Established Prod, Titusville, NJ USA; [Hu, Peter] Janssen Res & Dev LLC, Clin Biostat, Raritan, NJ USA; [Starr, H. Lynn] Janssen Sci Affairs LLC, Titusville, NJ USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Janssen Pharmaceuticals	Fife, D (corresponding author), Janssen Res & Dev LLC, Epidemiol, Titusville, NJ 08560 USA.	DFife@jnj.com			Janssen Research & Development, LLC	Janssen Research & Development, LLC	This study was supported by Janssen Research & Development, LLC, who provided financial support for the work in the form of salaries for all the authors, and its commitment to pay the associated publishing fees. Janssen Research & Development, LLC's Standard Operating Procedures require publication of studies that, like this one, concern its products and were intended for publication when they were begun. For the present study, that intention is documented by its registration with ClinicalTrails.gov. The funding organization's Standard Operating Procedures also require that the study undergo a standard internal company review before it is submitted for publication. Internal company review is limited to roles not responsible for sales or marketing functions. Janssen Research & Development, LLC. did not have any additional role in the study design, data collection, analysis, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Andermann F, 2007, EPILEPSIA, V48, P464, DOI 10.1111/j.1528-1167.2007.01007.x; ARNOLD P, 1990, Journal of Clinical Research and Pharmacoepidemiology, V4, P139; Banaschewski T, 2016, Z KINDER JUG-PSYCH, V44, P307, DOI 10.1024/1422-4917/a000433; Cheetham TC, 2005, AM J MANAG CARE, V11, P546; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Duh MS, 2009, NEUROLOGY, V72, P2122, DOI 10.1212/WNL.0b013e3181aa5300; Erickson SC, 2011, EPILEPSIA, V52, P1365, DOI 10.1111/j.1528-1167.2011.03130.x; Halkin H, 2007, ANN PHARMACOTHER, V41, P29, DOI 10.1345/aph.1H218; Hansen RA, 2017, PHARMACOTHERAPY, V37, P429, DOI 10.1002/phar.1908; Helin-Salmivaara A, 2012, J CLIN PHARM THER, V37, P58, DOI 10.1111/j.1365-2710.2011.01250.x; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Kaptchuk TJ, 2015, NEW ENGL J MED, V373, P8, DOI 10.1056/NEJMp1504023; Lally MD, 2015, CLIN PEDIAT; LeLorier J, 2008, NEUROLOGY, V70, P2179, DOI 10.1212/01.wnl.0000313154.55518.25; Qian J, 2016, CLIN PHARM THER; Schuemie MJ, 2014, STAT MED, V33, P209, DOI 10.1002/sim.5925; Storebo OJ, 2016, Z KINDER JUG-PSYCH, V44, P334, DOI 10.1024/1422-4917/a000472; Storebo OJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009885.pub2; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Wu EQ, 2011, ANN PHARMACOTHER, V45, P441, DOI 10.1345/aph.1P482	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193453	10.1371/journal.pone.0193453	http://dx.doi.org/10.1371/journal.pone.0193453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489906	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000078
J	Ma, NL; Lah, WAC; Kadir, NA; Mustaqim, M; Rahmat, Z; Ahmad, A; Lam, SD; Ismail, MR				Ma, Nyuk Ling; Lah, Wan Afifudeen Che; Kadir, Nisrin Abd; Mustaqim, Mohamad; Rahmat, Zaidah; Ahmad, Aziz; Lam, Su Datt; Ismail, Mohd Razi			Susceptibility and tolerance of rice crop to salt threat: Physiological and metabolic inspections	PLOS ONE			English	Article							ORYZA-SATIVA L.; ANTIOXIDANT RESPONSES; ION HOMEOSTASIS; STRESS-RESPONSE; SALINITY; PLANTS; ACCUMULATION; PHOSPHATIDYLCHOLINE; GLYCINEBETAINE; POLYAMINES	Salinity threat is estimated to reduce global rice production by 50%. Comprehensive analysis of the physiological and metabolite changes in rice plants from salinity stress (i.e. tolerant versus susceptible plants) is important to combat higher salinity conditions. In this study, we screened a total of 92 genotypes and selected the most salinity tolerant line (SS1-14) and most susceptible line (SS2-18) to conduct comparative physiological and metabolome inspections. We demonstrated that the tolerant line managed to maintain their water and chlorophyll content with lower incidence of sodium ion accumulation. We also examined the antioxidant activities of these lines: production of ascorbate peroxidase (APX) and catalase (CAT) were significantly higher in the sensitive line while superoxide dismutase (SOD) was higher in the tolerant line. Partial least squares discriminant analysis (PLS-DA) score plots show significantly different response for both lines after the exposure to salinity stress. In the tolerant line, there was an upregulation of non-polar metabolites and production of sucrose, GABA and acetic acid, suggesting an important role in salinity adaptation. In contrast, glutamine and putrescine were noticeably high in the susceptible rice. Coordination of different strategies in tolerant and susceptible lines show that they responded differently after exposure to salt stress. These findings can assist crop development in terms of developing tolerance mechanisms for rice crops.	[Ma, Nyuk Ling; Lah, Wan Afifudeen Che; Kadir, Nisrin Abd; Mustaqim, Mohamad; Ahmad, Aziz] Univ Malaysia Terengganu, Sch Fundamental Sci, Kuala Terengganu, Terengganu, Malaysia; [Rahmat, Zaidah] Univ Technol Malaysia, Dept Biotechnol & Med Engn, Skudai, Johor, Malaysia; [Lam, Su Datt] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi, Selangor, Malaysia; [Lam, Su Datt] UCL, Div Biosci, Inst Struct & Mol Biol, Gower St, London, England; [Ismail, Mohd Razi] Univ Putra Malaysia, Inst Trop Agr, Serdang, Selangor, Malaysia	Universiti Malaysia Terengganu; Universiti Teknologi Malaysia; Universiti Kebangsaan Malaysia; University of London; Birkbeck University London; University College London; Universiti Putra Malaysia	Ma, NL (corresponding author), Univ Malaysia Terengganu, Sch Fundamental Sci, Kuala Terengganu, Terengganu, Malaysia.	nyukling@umt.edu.my	Ling, Nyuk/Q-1474-2018; Lam, Su Datt/A-9933-2018; Ahmad, Aziz/AAF-8909-2020; Rahmat, Zaidah/AAE-1953-2020; Che Lah, Wan Afifudeen/AAZ-9785-2021; Lam, Su Datt/AAN-2116-2020; Ahmad, Aziz/M-4919-2016	Ling, Nyuk/0000-0002-1301-4730; Lam, Su Datt/0000-0003-4772-7656; Ahmad, Aziz/0000-0002-2270-5197; Che Lah, Wan Afifudeen/0000-0002-5478-3800; Lam, Su Datt/0000-0003-4772-7656; Ahmad, Aziz/0000-0002-2270-5197; Ismail, M.R./0000-0001-5670-9279	Fundamental Research Grant Scheme (FRGS) [59342]; Long Term Research Grant Scheme (LRGS) under Abotic breeding of Rice Varieties	Fundamental Research Grant Scheme (FRGS); Long Term Research Grant Scheme (LRGS) under Abotic breeding of Rice Varieties	The works were supported by Fundamental Research Grant Scheme (FRGS) (VOT 59342) - project leader Nyuk Ling Ma; and Long Term Research Grant Scheme (LRGS) under Abotic breeding of Rice Varieties - Project leader Mohd Razi Ismail.	Afzal F, 2014, OXIDATIVE DAMAGE TO PLANTS: ANTIOXIDANT NETWORKS AND SIGNALING, P397, DOI 10.1016/B978-0-12-799963-0.00013-7; Ahmad I, 2016, J EXP BOT, V67, P2689, DOI 10.1093/jxb/erw103; Akcay N, 2012, J PLANT PHYSIOL, V169, P452, DOI 10.1016/j.jplph.2011.11.006; Amirjani MR., 2010, EUR J BIOL SCI, V3, P6; Anjula Chaudhary, 2015, Plant Archives, V15, P7; Bandeoglu E, 2004, PLANT GROWTH REGUL, V42, P69, DOI 10.1023/B:GROW.0000014891.35427.7b; Bartwal A, 2013, J PLANT GROWTH REGUL, V32, P216, DOI 10.1007/s00344-012-9272-x; Basu S, 2010, PLANT GROWTH REGUL, V60, P51, DOI 10.1007/s10725-009-9418-4; Bhoomika K, 2013, PLANT GROWTH REGUL, V71, P235, DOI 10.1007/s10725-013-9824-5; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; CLARE DA, 1984, ANAL BIOCHEM, V140, P532, DOI 10.1016/0003-2697(84)90204-5; Darwish E, 2009, PLANT CELL PHYSIOL, V50, P986, DOI 10.1093/pcp/pcp051; Demidchik V, 2007, NEW PHYTOL, V175, P387, DOI 10.1111/j.1469-8137.2007.02128.x; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Felle HH, 2005, PROTOPLASMA, V227, P17, DOI 10.1007/s00709-005-0131-5; Galvan-Ampudia CS, 2011, CURR OPIN PLANT BIOL, V14, P296, DOI 10.1016/j.pbi.2011.03.019; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Gupta AK, 2005, J BIOSCIENCES, V30, P761, DOI 10.1007/BF02703574; Hossain M. A., 2013, Australian Journal of Crop Science, V7, P1801; Jenks M.A, 2007, ADV MOL BREEDING DRO; Kakkar RK, 2000, BIOL PLANTARUM, V43, P419, DOI 10.1023/A:1026715032115; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Kishitani S, 2000, PLANT CELL ENVIRON, V23, P107, DOI 10.1046/j.1365-3040.2000.00527.x; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kronzucker HJ, 2013, PLANT SOIL, V369, P1, DOI 10.1007/s11104-013-1801-2; Krugman T, 2010, FUNCT INTEGR GENOMIC, V10, P167, DOI 10.1007/s10142-010-0166-3; Ludwig C, 2012, METABOLOMICS, V8, P8, DOI 10.1007/s11306-011-0347-7; Ma NL, 2013, INT J MOL SCI, V14, P7515, DOI 10.3390/ijms14047515; Maathuis FJM, 2014, J EXP BOT, V65, P849, DOI 10.1093/jxb/ert326; Maiale S, 2004, J PLANT PHYSIOL, V161, P35, DOI 10.1078/0176-1617-01167; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mishra P, 2013, PROTOPLASMA, V250, P3, DOI 10.1007/s00709-011-0365-3; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nahar K, 2016, FRONT PLANT SCI, V7; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Pattanagul W, 2008, INDIAN J EXP BIOL, V46, P736; Pical C, 1999, J BIOL CHEM, V274, P38232, DOI 10.1074/jbc.274.53.38232; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012571; PORRA RJ, 1990, BIOCHIM BIOPHYS ACTA, V1015, P493, DOI 10.1016/0005-2728(90)90083-G; Ramesh SA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8879; Renault H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-20; Sarkar RK, 2013, ACTA PHYSIOL PLANT, V35, P2915, DOI 10.1007/s11738-013-1322-x; Shirasawa K, 2006, ANN BOT-LONDON, V98, P565, DOI 10.1093/aob/mcl126; Silvente S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038554; Singh J, 2014, J FOOD SCI TECH MYS, V51, P67, DOI 10.1007/s13197-011-0479-9; Siringam K, 2011, AFR J BIOTECHNOL, V10, P1340; Tananuwong K, 2010, LWT-FOOD SCI TECHNOL, V43, P476, DOI 10.1016/j.lwt.2009.09.014; Tasseva G, 2004, FEBS LETT, V566, P115, DOI 10.1016/j.febslet.2004.04.015; Taylor Nicolas L, 2007, Methods Mol Biol, V372, P389, DOI 10.1007/978-1-59745-365-3_28; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xiong HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092913; Yeo AR, 1999, PLANT CELL ENVIRON, V22, P559, DOI 10.1046/j.1365-3040.1999.00418.x; Zhao JL, 2015, PHYSIOL PLANTARUM, V154, P381, DOI 10.1111/ppl.12291; Zhao X.-M., 2014, PLOS ONE, V9; Zuraida A R, 2012, J TROP AGR FD SC, V39, P167	59	49	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192732	10.1371/journal.pone.0192732	http://dx.doi.org/10.1371/journal.pone.0192732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489838	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000040
J	Amir, O; Amir, D; Shahar, Y; Hart, Y; Gal, K				Amir, Ofra; Amir, Dor; Shahar, Yuval; Hart, Yuval; Gal, Kobi			The more the merrier? Increasing group size may be detrimental to decision-making performance in nominal groups	PLOS ONE			English	Article							DEMONSTRABILITY; HEADS; CROWD; TIME	Demonstrability-the extent to which group members can recognize a correct solution to a problem-has a significant effect on group performance. However, the interplay between group size, demonstrability and performance is not well understood. This paper addresses these gaps by studying the joint effect of two factors-the difficulty of solving a problem and the difficulty of verifying the correctness of a solution-on the ability of groups of varying sizes to converge to correct solutions. Our empirical investigations use problem instances from different computational complexity classes, NP-Complete (NPC) and PSPACE-complete (PSC), that exhibit similar solution difficulty but differ in verification difficulty. Our study focuses on nominal groups to isolate the effect of problem complexity on performance. We show that NPC problems have higher demonstrability than PSC problems: participants were significantly more likely to recognize correct and incorrect solutions for NPC problems than for PSC problems. We further show that increasing the group size can actually decrease group performance for some problems of low demonstrability. We analytically derive the boundary that distinguishes these problems from others for which group performance monotonically improves with group size. These findings increase our understanding of the mechanisms that underlie group problem-solving processes, and can inform the design of systems and processes that would better facilitate collective decision-making.	[Amir, Ofra] Technion Israel Inst Technol, Haifa, Israel; [Amir, Dor; Shahar, Yuval; Gal, Kobi] Ben Gurion Univ Negev, Beer Sheva, Israel; [Hart, Yuval] Harvard Univ, Cambridge, MA 02138 USA	Technion Israel Institute of Technology; Ben Gurion University; Harvard University	Gal, K (corresponding author), Ben Gurion Univ Negev, Beer Sheva, Israel.	kobig@bgu.ac.il	Hart, Yuval/HGD-6424-2022; Shahar, Yuval/P-5185-2019	Shahar, Yuval/0000-0003-0328-2333; Gal, Kobi/0000-0001-7187-8572				Amir O., 2013, 1 AAAI C HUM COMP CR; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Boudreau KJ, 2013, HARVARD BUS REV, V91, P60; Bradley BH, 2013, SMALL GR RES, V44, P680, DOI 10.1177/1046496413507609; CALLAWAY MR, 1985, J PERS SOC PSYCHOL, V49, P949, DOI 10.1037/0022-3514.49.4.949; Campbell J, 2006, SMALL GR RES, V37, P271, DOI 10.1177/1046496406288976; Carey HR, 2011, GROUP PROCESSES INTE; Chesbrough H.W., 2006, MANAG INNOV CHANGE, V127, P34; Chesbrough H. W, 2006, OPEN INNOVATION NEW; Dessein W, 2007, CEPR DISCUSSION PAPE; Dong W., 2012, COLLECTIVE INTELLIGE; Hackman J.R., 2002, THEORY RES SMALL GRO, V4, DOI [10.1007/0-306-47144-2_12, DOI 10.1007/0-306-47144-2_12]; HARVEY JB, 1974, ORGAN DYN, V3, P63, DOI 10.1016/0090-2616(74)90005-9; HILL GW, 1982, PSYCHOL BULL, V91, P517, DOI 10.1037/0033-2909.91.3.517; Johnson D.S., 1979, COMPUTERS INTRACTABI; Kim Y., 2001, PUBLIC ADM Q, V25, P168; Kittur A, 2013, C COMPUTER SUPPORTED, P1301, DOI [DOI 10.1145/2441776.2441923, 10.1145/2441776.2441923]; Koriat A, 2012, SCIENCE, V336, P360, DOI 10.1126/science.1216549; Lakhani Karim, 2012, OPENIDEO; Laughlin P, 2006, J PERS SOC PSYCHOL, V4, P644; LAUGHLIN PR, 1986, J EXP SOC PSYCHOL, V22, P177, DOI 10.1016/0022-1031(86)90022-3; Lorge I, 1955, PSYCHOMETRIKA, V20, P139, DOI 10.1007/BF02288986; Malone T.W., 2009, HARNESSING CROWDS MA; Sapir L, 1998, THEOR DECIS, V45, P19, DOI 10.1023/A:1005094032398; Schultze T, 2012, ORGAN BEHAV HUM DEC, V118, P24, DOI 10.1016/j.obhdp.2011.12.006; Surowiecki J., 2005, WISDOM CROWDS; Visser B, 2007, Q J ECON, V122, P337, DOI 10.1162/qjec.122.1.337; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; YETTON P, 1983, ORGAN BEHAV HUM PERF, V32, P145, DOI 10.1016/0030-5073(83)90144-7; Yi SKM, 2012, COGNITIVE SCI, V36, P452, DOI 10.1111/j.1551-6709.2011.01223.x	30	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192213	10.1371/journal.pone.0192213	http://dx.doi.org/10.1371/journal.pone.0192213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7BV	29485989	Green Submitted, gold, Green Published			2022-12-27	WOS:000426242400005
J	Marshall, MS; Jakubauskas, B; Bogue, W; Stoskute, M; Hauck, Z; Rue, E; Nichols, M; DiAntonio, LL; van Breemen, RB; Kordower, JH; Saavedra-Matiz, CA; Bongarzone, ER				Marshall, Michael S.; Jakubauskas, Benas; Bogue, Wil; Stoskute, Monika; Hauck, Zane; Rue, Emily; Nichols, Matthew; DiAntonio, Lisa L.; van Breemen, Richard B.; Kordower, Jeffrey H.; Saavedra-Matiz, Carlos A.; Bongarzone, Ernesto R.			Analysis of age-related changes in psychosine metabolism in the human brain	PLOS ONE			English	Article							GLOBOID-CELL LEUKODYSTROPHY; PARKINSONS-DISEASE; KRABBE-DISEASE; GAUCHER-DISEASE; ALPHA-SYNUCLEIN; GLUCOCEREBROSIDASE; HETEROGENEITY; MUTATIONS; RISK; METAANALYSIS	alpha-Synuclein aggregation has been linked to Gaucher's disease (GD) and Krabbe's disease (KD), lysosomal conditions affecting glycosphingolipid metabolism. alpha-Synuclein pathology has been directly attributed to the dysregulation of glycosphingolipids in both conditions, specifically to increased galactosylsphingosine (psychosine) content in the context of KD. Furthermore, the gene (GALC) coding for the psychosine degrading enzyme galactosylcer-amidase (GALC), has recently been identified as a risk loci for Parkinson's disease. However, it is unknown if changes in psychosine metabolism and GALC activity in the context of the aging human brain correlate with Parkinson's disease. We investigated psychosine accumulation and GALC activity in the aging brain using fresh frozen post-mortem tissue from Parkinson's (PD, n = 10), Alzheimer's (AD, n = 10), and healthy control patients (n = 9), along with tissue from neuropsychiatric patients (schizophrenia, bipolar disorder and depression, n = 15 each). An expanded mutational analysis of PD (n = 20), AD (n = 10), and healthy controls (n = 30) examined if PD was correlated with carriers for severe GALC mutations. Psychosine content within the cerebral cortex of PD patients was elevated above control patients. Within all patients, psychosine displayed a significant (p<0.05) and robust regional distribution in the brain with higher levels in the white matter and substantia nigra. A mutational analysis revealed an increase in the incidence of severe GALC mutations within the PD patient population compared to the cohorts of Alzheimer's patients and healthy controls tested. In addition to a-synuclein pathology identified in the KD brain, control patients identified as GALC mutational carriers or possessing a GALC pathogenic variant had evidence of a-synuclein pathology, indicating a possible correlation between a-synuclein pathology and dysregulation of psychosine metabolism in the adult brain. Carrier status for GALC mutations and prolonged exposure to increased psychosine could contribute to a-synuclein pathology, supporting psychosine metabolism by galactosylceramidase as a risk factor for Parkinson's disease.	[Marshall, Michael S.; Jakubauskas, Benas; Bogue, Wil; Stoskute, Monika; Bongarzone, Ernesto R.] Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL 60607 USA; [Hauck, Zane; van Breemen, Richard B.] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL USA; [Rue, Emily; Nichols, Matthew; DiAntonio, Lisa L.; Saavedra-Matiz, Carlos A.] New York State Dept Hlth, Wadsworth Ctr, Div Genet, Newborn Screening Program, Albany, NY USA; [Kordower, Jeffrey H.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Bongarzone, Ernesto R.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Buenos Aires, DF, Argentina	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University of New York (SUNY) System; Wadsworth Center; Rush University; University of Buenos Aires	Bongarzone, ER (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Buenos Aires, DF, Argentina.	ebongarz@uic.edu	van Breemen, Richard/AAO-2875-2020; Marshall, Michael/B-9705-2015	Marshall, Michael/0000-0002-5742-2031; van Breemen, Richard/0000-0003-2016-0063	NRSA [F30NS090684]; NIH [R01 NS065808]; Legacy of Angels Foundation; Partners for Krabbe Disease Research; European Leukodystrophy Association; New York State Department of Health	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Legacy of Angels Foundation; Partners for Krabbe Disease Research; European Leukodystrophy Association; New York State Department of Health	This work was supported in part by funding through a NRSA F30NS090684 (M.S.M.); NIH (R01 NS065808), Legacy of Angels Foundation, Partners for Krabbe Disease Research, and the European Leukodystrophy Association (E. R.B.); The New York State Department of Health (C.A.S.M). https://www.ninds.nih.gov; http://www.orge;http:w//krabees.org;http://ela-assocom/eat; http://health.ny.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2013, MOVEMENT DISORD, V28, P772, DOI 10.1002/mds.25397; Alcalay RN, 2012, NEUROLOGY, V78, P1434, DOI 10.1212/WNL.0b013e318253d54b; Barrett MJ, 2013, J INHERIT METAB DIS, V36, P575, DOI 10.1007/s10545-012-9527-5; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; Bultron G, 2010, J INHERIT METAB DIS, V33, P167, DOI 10.1007/s10545-010-9055-0; Cantuti-Castelvetri L, 2015, J NEUROSCI, V35, P1606, DOI 10.1523/JNEUROSCI.2431-14.2015; Cantuti-Castelvetri L, 2012, NEUROBIOL DIS, V46, P325, DOI 10.1016/j.nbd.2012.01.013; Castelvetri LC, 2013, J NEUROSCI, V33, P10048, DOI 10.1523/JNEUROSCI.0217-13.2013; Castelvetri LC, 2011, ACTA NEUROPATHOL, V122, P35, DOI 10.1007/s00401-011-0814-2; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Debs R, 2013, J INHERIT METAB DIS, V36, P859, DOI 10.1007/s10545-012-9560-4; DeGasperi R, 1996, AM J HUM GENET, V59, P1233; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Duncan GW, 2016, MOVEMENT DISORD, V31, P103, DOI 10.1002/mds.26312; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; GIBB WRG, 1991, MOVEMENT DISORD, V6, P2, DOI 10.1002/mds.870060103; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194/jlr.M600084-JLR200; Halperin A, 2006, BLOOD CELL MOL DIS, V36, P426, DOI 10.1016/j.bcmd.2006.02.004; Jardim LB, 1999, ARCH NEUROL-CHICAGO, V56, P1014, DOI 10.1001/archneur.56.8.1014; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Marshall MS, 2016, J NEUROSCI RES, V94, P1328, DOI 10.1002/jnr.23751; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; NAGARA H, 1986, DEV BRAIN RES, V26, P79, DOI 10.1016/0165-3806(86)90009-X; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Orsini JJ, 2016, J NEUROSCI RES, V94, P1063, DOI 10.1002/jnr.23781; Reeve A, 2014, AGEING RES REV, V14, P19, DOI 10.1016/j.arr.2014.01.004; Saavedra-Matiz CA, 2016, J NEUROSCI RES, V94, P1076, DOI 10.1002/jnr.23905; Shachar T, 2011, MOVEMENT DISORD, V26, P1593, DOI 10.1002/mds.23774; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Siebert M, 2014, BRAIN, V137, P1304, DOI 10.1093/brain/awu002; Smith BR, 2014, J PATHOLOGY; SVENNERHOLM L, 1980, J LIPID RES, V21, P53; Taniike M, 1999, J NEUROPATH EXP NEUR, V58, P644, DOI 10.1097/00005072-199906000-00009; THOMAS PK, 1984, ANN NEUROL, V16, P618, DOI 10.1002/ana.410160515; Tremblay C, 2013, J NEUROL NEUROSUR PS, V84, P1265, DOI 10.1136/jnnp-2013-305021; von Coelln R, 2016, CURR OPIN NEUROL, V29, P727, DOI 10.1097/WCO.0000000000000384; Wenger DA, 2014, MOL GENET METAB, V111, P307, DOI 10.1016/j.ymgme.2013.12.009; Whyte LS, 2017, J NEUROCHEM, V140, P703, DOI 10.1111/jnc.13935; Zhu HL, 2012, ARCH PATHOL LAB MED, V136, P709, DOI 10.5858/arpa.2011-0667-LE	42	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0193438	10.1371/journal.pone.0193438	http://dx.doi.org/10.1371/journal.pone.0193438			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481565	Green Published, gold, Green Submitted			2022-12-27	WOS:000426202700011
J	Godlewska, M; Krasuska, W; Czarnocka, B				Godlewska, Marlene; Krasuska, Wanda; Czarnocka, Barbara			Biochemical properties of thyroid peroxidase (TPO) expressed in human breast and mammary-derived cell lines	PLOS ONE			English	Article							HUMAN THYROPEROXIDASE; CONFORMATIONAL EPITOPES; IMMUNODOMINANT REGION; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; MESSENGER-RNA; LACTOPEROXIDASE; AUTOIMMUNITY; ANTIBODIES; AUTOANTIBODIES	Thyroid peroxidase (TPO) is an enzyme and autoantigen expressed in thyroid and breast tissues. Thyroid TPO undergoes a complex maturation process however, nothing is known about post-translational modifications of breast-expressed TPO. In this study, we have investigated the biochemical properties of TPO expressed in normal and cancerous human breast tissues, and the maturation process and antigenicity of TPO present in a panel of human breast tissue-derived cell lines. We found that the molecular weight of breast TPO was slightly lower than that of thyroid TPO due to decreased glycosylation and as suggest results of Western blot also shorter amino acid chain. Breast TPO exhibit enzymatic activity and isoelectric point comparable to that of thyroid TPO. The biochemical properties of TPO expressed in mammary cell lines and normal thyrocytes are similar regarding glycan content, molecular weight and isoelectric point. However, no peroxidase activity and dimer formation was detected in any of these cell lines since the majority of TPO protein was localized in the cytoplasmic compartment, and the TPO expression at the cell surface was too low to detect its enzymatic activity. Lactoperoxidase, a protein highly homologous to TPO expressed also in breast tissues, does not influence the obtained data. TPO expressed in the cell lines was recognized by a broad panel of TPO-specific antibodies. Although some differences in biochemical properties between thyroid and breast TPO were observed, they do not seem to be critical for the overall three-dimensional structure. This conclusion is supported by the fact that TPO expressed in breast tissues and cell lines reacts well with conformation-sensitive antibodies. Taking into account a close resemblance between both proteins, especially high antigenicity, future studies should investigate the potential immunotherapies directed against breast-expressed TPO and its specific epitopes.	[Godlewska, Marlene; Krasuska, Wanda; Czarnocka, Barbara] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland	Czarnocka, B (corresponding author), Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland.	bczarnocka@cmkp.edu.pl	Czarnocka, Barbara/V-1048-2019; Krasuska, Wanda/U-8820-2019; Godlewska, Marlena/J-9540-2019	Czarnocka, Barbara/0000-0001-7701-760X; Krasuska, Wanda/0000-0002-4807-4864; Godlewska, Marlena/0000-0003-2337-6724	Center of Postgraduate Medical Education [501-1-25-01-16]	Center of Postgraduate Medical Education	This work was supported by the Center of Postgraduate Medical Education (grant number 501-1-25-01-16). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguiano B, 2007, THYROID, V17, P851, DOI 10.1089/thy.2007.0122; Arroyo-Helguera O, 2008, ENDOCR-RELAT CANCER, V15, P1003, DOI 10.1677/ERC-08-0125; Brandt J, 2016, BRIT J SURG, V103, P1649, DOI 10.1002/bjs.10284; Brandt J, 2015, CANCER CAUSE CONTROL, V26, P1093, DOI 10.1007/s10552-015-0602-8; CHAZENBALK GD, 1993, J CLIN INVEST, V92, P62, DOI 10.1172/JCI116600; Czarnocka B, 1997, J CLIN ENDOCR METAB, V82, P2639, DOI 10.1210/jc.82.8.2639; CZARNOCKA B, 1985, FEBS LETT, V190, P147, DOI 10.1016/0014-5793(85)80446-4; Czarnocka B, 2014, AUTOANTIBODIES, P365; Di Cristotaro J, 2006, ENDOCR-RELAT CANCER, V13, P485, DOI 10.1677/erc.1.01164; EWINS DL, 1992, AUTOIMMUNITY, V11, P141, DOI 10.3109/08916939209035148; Farahati J, 2012, CLIN CHEM LAB MED, V50, P709, DOI 10.1515/CCLM.2011.819; Fayadat L, 1998, ENDOCRINOLOGY, V139, P4277, DOI 10.1210/en.139.10.4277; Fayadat L, 2000, ENDOCRINOLOGY, V141, P959, DOI 10.1210/en.141.3.959; Fayadat L, 1999, J BIOL CHEM, V274, P10533, DOI 10.1074/jbc.274.15.10533; Ferrand M, 2003, J BIOL CHEM, V278, P3793, DOI 10.1074/jbc.M209513200; Fiore E, 2007, J ENDOCRINOL INVEST, V30, P734, DOI 10.1007/BF03350810; Fragoso MA, 2009, ARCH BIOCHEM BIOPHYS, V482, P52, DOI 10.1016/j.abb.2008.11.015; Gardas A, 2000, REDOX REP, V5, P237, DOI 10.1179/135100000101535681; GIRAUD A, 1992, J ENDOCRINOL, V132, P317, DOI 10.1677/joe.0.1320317; Giustarini E, 2006, EUR J ENDOCRINOL, V154, P645, DOI 10.1530/eje.1.02108; Godlewska M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179066; Godlewska M, 2014, THYROID, V24, P371, DOI 10.1089/thy.2013.0127; Godlewska M, 2012, AUTOIMMUNITY, V45, P476, DOI 10.3109/08916934.2012.682667; Gora M, 2004, CLIN EXP IMMUNOL, V136, P137, DOI 10.1111/j.1365-2249.2004.02422.x; Gorlewska-Roberts KM, 2004, CHEM RES TOXICOL, V17, P1659, DOI 10.1021/tx049787n; Hobby P, 2000, ENDOCRINOLOGY, V141, P2018, DOI 10.1210/en.141.6.2018; Jiskra J, 2007, ONCOL REP, V18, P1603; Jomaa B, 2015, ALTEX-ALTERN ANIM EX, V32, P191, DOI 10.14573/altex.1412201; KISO Y, 1992, AUTOIMMUNITY, V12, P259, DOI 10.3109/08916939209148468; Kopp P., 2012, WERNER INGBARS THYRO, V10th ed., P48; Le Fourn V, 2005, J BIOL CHEM, V280, P4568, DOI 10.1074/jbc.M408042200; Le Fourn V, 2004, BBA-MOL BASIS DIS, V1689, P134, DOI 10.1016/j.bbadis.2004.03.001; Le Fourn V, 2006, BIOCHEMISTRY-US, V45, P7380, DOI 10.1021/bi060415i; Le SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142615; McLachlan SM, 2007, THYROID, V17, P939, DOI 10.1089/thy.2007.0169; Mondal S, 2016, ANGEW CHEM INT EDIT, V55, P7606, DOI 10.1002/anie.201601116; Muller I, 2014, INT J CANCER, V134, P1706, DOI 10.1002/ijc.28493; Muller I, 2017, EUR THYROID J, V6, P197, DOI 10.1159/000460246; Orgiazzi J, 2012, PRESSE MED, V41, pE611, DOI 10.1016/j.lpm.2012.10.002; RUF J, 1989, ENDOCRINOLOGY, V125, P1211, DOI 10.1210/endo-125-3-1211; Sharma Sujata, 2013, Int J Biochem Mol Biol, V4, P108; Shin K, 2000, J NUTR BIOCHEM, V11, P94, DOI 10.1016/S0955-2863(99)00082-0; SIPE HJ, 1994, CARCINOGENESIS, V15, P2637, DOI 10.1093/carcin/15.11.2637; Smyth PPA, 1998, J CLIN ENDOCR METAB, V83, P2711, DOI 10.1210/jc.83.8.2711; Soriano O, 2011, ENDOCR-RELAT CANCER, V18, P529, DOI 10.1530/ERC-11-0065; Turken O, 2003, BREAST CANCER RES, V5, pR110, DOI 10.1186/bcr609	46	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193624	10.1371/journal.pone.0193624	http://dx.doi.org/10.1371/journal.pone.0193624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513734	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800065
J	Tilley, SK; Martin, EM; Smeester, L; Joseph, RM; Kuban, KCK; Heeren, TC; Dammann, OU; O'Shea, TM; Fry, RC				Tilley, Sloane K.; Martin, Elizabeth M.; Smeester, Lisa; Joseph, Robert M.; Kuban, Karl C. K.; Heeren, Tim C.; Dammann, Olaf U.; O'Shea, T. Michael; Fry, Rebecca C.			Placental CpG methylation of infants born extremely preterm predicts cognitive impairment later in life	PLOS ONE			English	Article							INFLAMMATION-RELATED PROTEINS; DNA METHYLATION; SYSTEMIC INFLAMMATION; CHILDREN BORN; BHLH FACTORS; 28TH WEEK; IN-UTERO; EXPOSURE; ROLES; AGE	Background The placenta is the central regulator of maternal and fetal interactions. Perturbations of placental structure and function have been associated with adverse neurodevelopmental outcomes later in life. Placental CpG methylation represents an epigenetic modification with the potential to impact placental function, fetal development and child health later in life. Study design Genome-wide placental CpG methylation levels were compared between spontaneous versus indicated deliveries from extremely preterm births (EPTBs) (n = 84). The association between the identified differentially methylated CpG sites and neurocognitive outcome at ten years of age was then evaluated. Results Spontaneous EPTB was associated with differential CpG methylation levels in 250 CpG sites (217 unique genes) with the majority displaying hypermethylation. The identified genes are known to play a role in neurodevelopment and are enriched for basic helix-loop-helix transcription factor binding sites. The placental CpG methylation levels for 17 of these sites predicted cognitive function at ten years of age. Conclusion A hypermethylation signature is present in DNA from placentas in infants with spontaneous EPTB. CpG methylation levels of critical neurodevelopment genes in the placenta predicted later life cognitive function, supporting the developmental origins of health and disease hypothesis (DOHaD).	[Tilley, Sloane K.; Martin, Elizabeth M.; Smeester, Lisa; Fry, Rebecca C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Joseph, Robert M.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02215 USA; [Kuban, Karl C. K.] Boston Med Ctr, Dept Pediat, Boston, MA USA; [Heeren, Tim C.] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Dammann, Olaf U.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [O'Shea, T. Michael] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; [Fry, Rebecca C.] Univ N Carolina, Sch Med, Curriculum Toxicol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Boston University; Boston Medical Center; Boston University; Massachusetts Department of Public Health; Tufts University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Fry, RC (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA.; Fry, RC (corresponding author), Univ N Carolina, Sch Med, Curriculum Toxicol, Chapel Hill, NC 27599 USA.	rfry@unc.edu		Fry, Rebecca/0000-0003-0899-9018; Joseph, Robert/0000-0001-6879-0254; Smeester, Lisa/0000-0001-5283-0485	National Institutes of Health [R01 ES019315, P42 ES005948, 1UG3OD023348-01]; National Institute of Neurologic Disorders and Stroke [5U01NS040069-05, 5U01NS040069-09, 2U01NS040069-06A2]; National Institute for Occupational Safety and Health [T42/OH-008673]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD092374] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UH3OD023348, UG3OD023348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institutes of Health (http://www.nih.gov): R01 ES019315, P42 ES005948, and 1UG3OD023348-01, from the National Institute of Neurologic Disorders and Stroke: 5U01NS040069-05, 5U01NS040069-09 and 2U01NS040069-06A2, and from the National Institute for Occupational Safety and Health: T42/OH-008673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrman RE, 2007, PRETERM BIRTH CAUSES; Beran TN, 2007, CAN J SCH PSYCHOL, V22, P128, DOI 10.1177/0829573507302967; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bilbo SD, 2012, J NEUROIMMUNE PHARM, V7, P24, DOI 10.1007/s11481-011-9299-y; Bromer C, 2013, DEV PSYCHOBIOL, V55, P673, DOI 10.1002/dev.21061; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cardenas A, 2015, EPIGENETICS-US, V10, P1054, DOI 10.1080/15592294.2015.1105424; Chan E, 2016, CHILD CARE HLTH DEV, V42, P297, DOI 10.1111/cch.12320; Conradt E, 2013, EPIGENETICS-US, V8, P1321, DOI 10.4161/epi.26634; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Fan LF, 2015, NEUROSCI LETT, V590, P178, DOI 10.1016/j.neulet.2015.02.010; Ghiani C A, 2010, Mol Psychiatry, V15, P204, DOI 10.1038/mp.2009.58; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Ghosh S, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12228; Guralnick MJ, 2016, J APPL RES INTELLECT; Hagihara K, 2009, DEV BIOL, V334, P276, DOI 10.1016/j.ydbio.2009.07.029; Heeren T, 2017, PEDIATR RES, V82, P614, DOI 10.1038/pr.2017.82; Houseman EA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1140-4; Imayoshi T, 2014, TRENDS NEUROSCI, V37, P531, DOI 10.1016/j.tins.2014.07.006; Imayoshi I, 2014, NEURON, V82, P9, DOI 10.1016/j.neuron.2014.03.018; Joeyen-Waldorf J, 2012, BIOL PSYCHIAT, V71, P627, DOI 10.1016/j.biopsych.2011.11.029; Joseph RM, 2017, AUTISM RES, V10, P224, DOI 10.1002/aur.1644; Joseph RM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4343; Joung I, 2005, BIOCHEM BIOPH RES CO, V334, P654, DOI 10.1016/j.bbrc.2005.06.138; KMKUK S., 2007, NEPSY 2 CLIN INTERPR; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Kuban KCK, 2014, J CHILD NEUROL, V29, P1692, DOI 10.1177/0883073813513335; Kuban KC, 2016, J PEDIAT, V173; Lesseur Corina, 2014, Med Epigenet, V2, P71; Leviton A, 2016, EARLY HUM DEV, V93, P25, DOI 10.1016/j.earlhumdev.2015.11.004; Lillycrop KA, 2015, INT J EPIDEMIOL, V44, P1263, DOI 10.1093/ije/dyv052; Marsit CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033794; Martin E, 2017, EPIGENOMICS-UK, V9, P267, DOI 10.2217/epi-2016-0132; Martin EM, 2016, ENVIRON EPIGENETICS, V2, DOI 10.1093/eep/dvv011; McElrath TF, 2008, AM J EPIDEMIOL, V168, P980, DOI 10.1093/aje/kwn202; Merali Z, 2014, BEHAV BRAIN RES, V263, P60, DOI 10.1016/j.bbr.2014.01.008; Monk C, 2016, AM J PSYCHIAT, V173, P705, DOI 10.1176/appi.ajp.2015.15091171; Nakamura K, 2011, PROG NEURO-PSYCHOPH, V35, P454, DOI 10.1016/j.pnpbp.2010.11.033; Nugent BM, 2015, FRONT NEUROENDOCRIN, V39, P28, DOI 10.1016/j.yfrne.2015.09.001; O'Shea TM, 2009, EARLY HUM DEV, V85, P719, DOI 10.1016/j.earlhumdev.2009.08.060; O'Shea TM, 2014, PEDIATR RES, V75, P781, DOI 10.1038/pr.2014.41; O'Shea TM, 2013, BRAIN BEHAV IMMUN, V29, P104, DOI 10.1016/j.bbi.2012.12.012; O'Shea TM, 2012, J PEDIATR-US, V160, P395, DOI 10.1016/j.jpeds.2011.08.069; Onderdonk AB, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.044; Paquette AG, 2016, EPIGENETICS-US, V11, P603, DOI 10.1080/15592294.2016.1195534; Paquette AG, 2015, EPIGENOMICS-UK, V7, P767, DOI 10.2217/epi.15.28; Paquette AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104913; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Ramamoorthi K, 2011, TRENDS MOL MED, V17, P452, DOI 10.1016/j.molmed.2011.03.003; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Saitsu H, 2016, EUR J HUM GENET, V24, P129, DOI 10.1038/ejhg.2015.92; Sanders AP, 2014, EPIGENETICS-US, V9, P212, DOI 10.4161/epi.26798; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	61	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193271	10.1371/journal.pone.0193271	http://dx.doi.org/10.1371/journal.pone.0193271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513726	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800051
J	Wilson, B; Jones, B; McGreevy, P				Wilson, Bethany; Jones, Bidda; McGreevy, Paul			Longitudinal trends in the frequency of medium and fast race winning times in Australian harness racing: Relationships with rules moderating whip use	PLOS ONE			English	Article								The use of whips in racing is subject to current debate, not least because the prospect that fatigued horses cannot respond renders the practice futile and inhumane. The racing industries maintain whip use is a form of encouragement and that the rules of racing that govern whip use safeguard horse welfare. The current study examined longitudinal trends in the frequency of medium and fast race winning times in Australian harness racing between September 2007 and August 2016 to explore relationships with a series of changes that moderated whip use. The first change, introduced January 2010, moderated whip action so that horses were struck with less force. Subsequent amendments reversed this change for the final 200m of the race except in one racing jurisdiction. However, those amendments were eventually reversed, restoring the first rule change in all geographic locations. Despite whip use being regulated from January 2010, a long-term trend of increased frequency of both fast and medium winning times over 1609m (similar to 1 mile) was noted. Even after adjusting for this trend, all whip handling codes were associated with greater odds of winning times being less than 1: 55 minutes compared with the pre-2010 period. A similar finding for times less than 2: 00 minutes did not reach statistical significance. Additionally, the periods immediately before and after introducing the most stringent regulations were compared. This revealed that, when introduced in 2010, these regulations were associated with faster winning times. Their re-introduction in 2016, was associated with no significant differences. Despite concerns that tightening of whip regulations might reduce performance, none of our analyses revealed any significant reduction in either fast or medium winning times in races following the tightening of regulations governing the use of the whip. These findings question the putative need for whips to improve racing performance.	[Wilson, Bethany; Jones, Bidda; McGreevy, Paul] Univ Sydney, Sch Vet Sci, Sydney, NSW, Australia; [Jones, Bidda] RSPCA Australia, Deakin West, ACT, Australia	University of Sydney	Wilson, B (corresponding author), Univ Sydney, Sch Vet Sci, Sydney, NSW, Australia.	bethany@cafallstats.com.au		McGreevy, Paul/0000-0001-7220-8378	RSPCA Australia	RSPCA Australia	RSPCA Australia provided the funds for this study and the costs of open access publishing. They facilitated acquisition of the raw data from Harness Racing Australia, but played no role in the study design, analysis, or decision to publish.; This work was a collaboration between the University of Sydney and RSPCA Australia. This study and the costs of publishing in open access were funded by RSPCA Australia. The authors thank Harness Racing Australia for making the data we have analysed publicly available. They also thank the reviewers of this article for their valuable comments on an earlier draft of the manuscript.	[Anonymous], 2015, AUSTRALIAN; [Anonymous], 2012, GREENS BACK RSPCA CA; Australia HR, 2017, IND NOT WHIPS; Australia HR, 2017, NAT STAK STAT STARTS; Bergmann I, 2015, PFERDEHEILKUNDE, V31, P490, DOI 10.21836/PEM20150509; British Horseracing Authority, 2011, RESP REG REV US WHIP; DEUEL NR, 1988, J EQUINE VET SCI, V8, P240, DOI 10.1016/S0737-0806(88)80016-9; Evans D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015622; Francome John, 2015, BAN WHIP US WOULD BE; Graham R, 2016, ANIMALS, V6, DOI 10.3390/ani6050032; Harness Racing Australia, 2016, TROTS HARN WHIP FREE; Harness Racing Australia, 2016, WHIP ITS YOUR DVD RE; Harness Racing Australia, 2016, WHIP RUL EFF; Harness Racing Australia, 2017, CHAIRM UPD; Harness Racing Australia, 2017, AUSTR HARN RAC RUL 9; Harness Racing Australia, 2009, WHIP RUL AM FREQ ASK; Harness Racing Victoria, 2011, HRV BOARD REV NAT WH; Harness Racing Victoria, 2010, MEMO VICT LOC RUL; Heleski CR, 2012, J VET BEHAV, V7, P169, DOI 10.1016/j.jveb.2011.08.003; Hood J, 2017, ANIMALS, V7, DOI 10.3390/ani7010004; Jones B, 2015, ANIMALS, V5, P138, DOI 10.3390/ani5010138; Jones B, 2010, J VET BEHAV, V5, P196, DOI 10.1016/j.jveb.2010.04.001; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; McGreevy PD, 2013, J VET BEHAV, V8, P395, DOI 10.1016/j.jveb.2013.03.003; McGreevy PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033398; McGreevy PD, 2011, J VET BEHAV, V6, P287, DOI 10.1016/j.jveb.2011.02.010; McLean AN, 2010, J VET BEHAV, V5, P203, DOI 10.1016/j.jveb.2010.04.003; RSPCA, 2016, RSPCA POL C05 HORS R; Taylor PM, 2016, VET ANAESTH ANALG, V43, P99, DOI 10.1111/vaa.12274; Victoria HR, 2017, 2017 HRV ANN REP 201	30	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0184091	10.1371/journal.pone.0184091	http://dx.doi.org/10.1371/journal.pone.0184091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513660	gold, Green Published, Green Submitted			2022-12-27	WOS:000426896800001
J	Cathasaigh, MO; Read, MR; Atilla, A; Schiller, T; Kwong, GPS				Cathasaigh, Micheal O.; Read, Matt R.; Atilla, Aylin; Schiller, Teresa; Kwong, Grace P. S.			Blood concentration of bupivacaine and duration of sensory and motor block following ultrasound-guided femoral and sciatic nerve blocks in dogs	PLOS ONE			English	Article							PLATEAU-LEVELING-OSTEOTOMY; PELVIC LIMB; SUPRAINGUINAL APPROACH; ORTHOPEDIC-SURGERY; PSOAS COMPARTMENT; ILIOPSOAS MUSCLE; ROPIVACAINE; LIDOCAINE; TOXICITY; PLEXUS	Peripheral nerve blocks are becoming increasingly popular for perioperative use as anesthetics and analgesics in small animals. This prospective study was performed to investigate the duration of motor and sensory blockade following use of bupivacaine for ultrasoundguided femoral and sciatic nerve blocks in dogs and to measure the plasma concentrations of bupivacaine that result from these procedures. Six dogs were anesthetized twice using a randomized cross-over design. At the first anesthetic, dogs were assigned to receive either an ultrasound-guided femoral nerve block or sciatic nerve block with 0.15 mL kg(-1) of bupivacaine 0.5%. Two months later, the other nerve block was performed during a second anesthetic. At 5, 10, 15, 20, 30 and 60 minutes after injection, arterial blood samples were collected for laboratory measurement of bupivacaine. After 60 minutes, dogs were recovered from anesthesia. Starting at two hours post-injection, video-recordings of the dogs were made every two hours for 24 hours. The videos were randomized and the degree of motor and sensory blockade was evaluated using a three-point scoring system (0 = no effect, 1 = mild effect, 2 = complete blockade) by two blinded assessors. The median (range) times to full recovery from motor blockade were 11 (6 +/- 14) hours (femoral) and 12 (4 +/- 18) hours (sciatic), and 15 (10 +/- 18) hours (femoral) and 10 (4 +/- 12) hours (sciatic) for sensory blockade. There were no differences in the median times to functional recovery for the two techniques. Plasma concentrations of bupivacaine were no different following the blocks and were less than 0.78 mu g mL(-1) at all times. These results suggest that these ultrasoundguided nerve blocks do not result in potentially toxic systemic levels of local anesthetic and that their duration of action is useful for providing anesthesia and analgesia for pelvic limb procedures.	[Cathasaigh, Micheal O.; Read, Matt R.; Atilla, Aylin; Schiller, Teresa; Kwong, Grace P. S.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Cathasaigh, Micheal O.] Univ Cambridge, Queens Vet Sch Hosp, Cambridge, England	University of Calgary; University of Cambridge	Read, MR (corresponding author), Univ Calgary, Fac Vet Med, Calgary, AB, Canada.	mattread@ucalgary.ca		O Cathasaigh, Micheal/0000-0003-0105-6965	University of Calgary Faculty of Veterinary Medicine	University of Calgary Faculty of Veterinary Medicine	This study was funded by the Intern Research Fund (2014) of the University of Calgary Faculty of Veterinary Medicine. The funding was secured by Micheal O Cathasaigh and Matt Read. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel AKG, 2016, VET ANAESTH ANALG, V43, P435, DOI 10.1111/vaa.12318; Benigni L, 2007, VET RADIOL ULTRASOUN, V48, P428, DOI 10.1111/j.1740-8261.2007.00273.x; Boscan P, 2016, J AM ANIM HOSP ASSOC, V52, P102, DOI 10.5326/JAAHA-MS-6278; Campoy L, 2012, VET ANAESTH ANALG, V39, P436, DOI 10.1111/j.1467-2995.2012.00712.x; Campoy L, 2012, VET ANAESTH ANALG, V39, P91, DOI 10.1111/j.1467-2995.2011.00673.x; Campoy L, 2010, VET ANAESTH ANALG, V37, P144, DOI 10.1111/j.1467-2995.2009.00518.x; Costa-Farre C, 2011, VET J, V187, P221, DOI 10.1016/j.tvjl.2009.10.016; Echeverry DF, 2012, VET ANAESTH ANALG, V39, P611, DOI 10.1111/j.1467-2995.2012.00750.x; Echeverry DF, 2012, VET J, V192, P333, DOI 10.1016/j.tvjl.2011.06.043; Echeverry DF, 2010, VET J, V186, P210, DOI 10.1016/j.tvjl.2009.08.005; FELDMAN HS, 1989, ANESTH ANALG, V69, P794; Graff SM, 2015, VET ANAESTH ANALG, V42, P394, DOI 10.1111/vaa.12224; Groban L, 2001, ANESTH ANALG, V92, P37; LIU P, 1982, ANESTH ANALG, V61, P317; LIU PL, 1983, ANESTH ANALG, V62, P375; Mahler SP, 2012, VET ANAESTH ANALG, V39, P550, DOI 10.1111/j.1467-2995.2012.00731.x; McCally RE, 2015, VET SURG, V44, P983, DOI 10.1111/vsu.12406; Mogicato G, 2015, VET ANAESTH ANALG, V42, P425, DOI 10.1111/vaa.12240; OCONNOR BL, 1982, J ANAT, V134, P563; Portela DA, 2013, VET ANAESTH ANALG, V40, P194, DOI 10.1111/j.1467-2995.2012.00765.x; Shilo Y, 2010, VET ANAESTH ANALG, V37, P460, DOI 10.1111/j.1467-2995.2010.00560.x; Shimada S, 2017, VET ANAESTH ANALG, V44, P1208, DOI 10.1016/j.vaa.2017.03.002; Tayari H, 2017, VET ANAESTH ANALG, V44, P1216, DOI 10.1016/j.vaa.2016.12.062; Trein TA, 2017, VET ANAESTH ANALG, V44, P144, DOI 10.1111/vaa.12399; Vettorato E, 2013, J SMALL ANIM PRACT, V54, P630, DOI 10.1111/jsap.12146; Vettorato E, 2012, VET COMP ORTHOPAED, V25, P314, DOI 10.3415/VCOT-11-08-0111	26	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193400	10.1371/journal.pone.0193400	http://dx.doi.org/10.1371/journal.pone.0193400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505566	Green Published, gold, Green Submitted			2022-12-27	WOS:000426548200014
J	Kim, DH; Cho, S; Jo, K; Shin, E; Hong, CS; Han, Y; Suh, TS; Lim, DH; Choi, DH				Kim, Dae-Hyun; Cho, Sungkoo; Jo, Kwanghyun; Shin, EunHyuk; Hong, Chae-Seon; Han, Youngyih; Suh, Tae-Suk; Lim, Do Hoon; Choi, Doo Ho			Proton range verification in inhomogeneous tissue: Treatment planning system vs. measurement vs. Monte Carlo simulation	PLOS ONE			English	Article							PENCIL BEAM ALGORITHM; RADIATION-THERAPY; DOSE CALCULATION; STOPPING POWER; BRAGG PEAK; UNCERTAINTIES; GEANT4; NOZZLE	In particle radiotherapy, range uncertainty is an important issue that needs to be overcome. Because high-dose conformality can be achieved using a particle beam, a small uncertainty can affect tumor control or cause normal-tissue complications. From this perspective, the treatment planning system (TPS) must be accurate. However, there is a well-known inaccuracy regarding dose computation in heterogeneous media. This means that verifying the uncertainty level is one of the prerequisites for TPS commissioning. We evaluated the range accuracy of the dose computation algorithm implemented in a commercial TPS, and Monte Carlo (MC) simulation against measurement using a CT calibration phantom. A treatment plan was produced for eight different materials plugged into a phantom, and two-dimensional doses were measured using a chamber array. The measurement setup and beam delivery were simulated by MC code. For an infinite solid water phantom, the gamma passing rate between the measurement and TPS was 97.7%, and that between the measurement and MC was 96.5%. However, gamma passing rates between the measurement and TPS were 49.4% for the lung and 67.8% for bone, and between the measurement and MC were 85.6% for the lung and 100.0% for bone tissue. For adipose, breast, brain, liver, and bone mineral, the gamma passing rates computed by TPS were 91.7%, 90.6%, 81.7%, 85.6%, and 85.6%, respectively. The gamma passing rates for MC for adipose, breast, brain, liver, and bone mineral were 100.0%, 97.2%, 95.0%, 98.9%, and 97.8%, respectively. In conclusion, the described procedure successfully evaluated the allowable range uncertainty for TPS commissioning. The TPS dose calculation is inefficient in heterogeneous media with large differences in density, such as lung or bone tissue. Therefore, the limitations of TPS in heterogeneous media should be understood and applied in clinical practice.	[Kim, Dae-Hyun; Cho, Sungkoo; Jo, Kwanghyun; Shin, EunHyuk; Hong, Chae-Seon; Han, Youngyih; Lim, Do Hoon; Choi, Doo Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Dae-Hyun; Suh, Tae-Suk] Catholic Univ Korea, Dept Biomed Engn, Coll Med, Seoul, South Korea; [Kim, Dae-Hyun; Suh, Tae-Suk] Catholic Univ Korea, Res Inst Biomed Engn, Coll Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Catholic University of Korea	Han, Y (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea.; Suh, TS (corresponding author), Catholic Univ Korea, Dept Biomed Engn, Coll Med, Seoul, South Korea.; Suh, TS (corresponding author), Catholic Univ Korea, Res Inst Biomed Engn, Coll Med, Seoul, South Korea.	youngyih@skku.edu; suhsanta@catholic.ac.kr		Hong, Chae-Seon/0000-0001-9120-6132	National Research Foundation - Ministry of Science, ICT and Future Planning, Republic of Korea [2013M2A2A7043507, 2012M3A9B6055201, 2016R1C1B2009258]	National Research Foundation - Ministry of Science, ICT and Future Planning, Republic of Korea	This study was supported by a grant (2013M2A2A7043507, 2012M3A9B6055201, 2016R1C1B2009258) of the National Research Foundation funded by the Ministry of Science, ICT and Future Planning, Republic of Korea.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Andreo P, 2009, PHYS MED BIOL, V54, pN205, DOI 10.1088/0031-9155/54/11/N01; Besemer A, 2013, PHYS MED BIOL, V58, P887, DOI 10.1088/0031-9155/58/4/887; Brada M, 2007, J CLIN ONCOL, V25, P965, DOI 10.1200/JCO.2006.10.0131; Carlsson AK, 1997, PHYS MED BIOL, V42, P1033, DOI 10.1088/0031-9155/42/6/004; Chung K, 2015, RADIAT ONCOL J, V33, P337, DOI 10.3857/roj.2015.33.4.337; Egashira Y, 2013, PHYS MED BIOL, V58, P1169, DOI 10.1088/0031-9155/58/4/1169; Fippel M, 2004, MED PHYS, V31, P2263, DOI 10.1118/1.1769631; GOITEIN M, 1978, RADIAT RES, V74, P217, DOI 10.2307/3574883; Hall EJ, 2006, INT J RADIAT ONCOL, V65, P1, DOI 10.1016/j.ijrobp.2006.01.027; Hong L, 1996, PHYS MED BIOL, V41, P1305, DOI 10.1088/0031-9155/41/8/005; ICRU, 46 ICRU; ICRU, 1993, 49 ICRU; International Commission on Radiation Units and Measurements (ICRU), 44 ICRU; Jiang H, 2004, MED PHYS, V31, P2811, DOI 10.1118/1.1796952; Kim DH, 2012, J KOREAN PHYS SOC, V61, P1125, DOI 10.3938/jkps.61.1125; Kimura A, 2004, IEEE NUCL SCI CONF R, P2124; Low DA, 2003, MED PHYS, V30, P2455, DOI 10.1118/1.1598711; Paganetti H, 2004, MED PHYS, V31, P2107, DOI 10.1118/1.1762792; Paganetti H, 2008, PHYS MED BIOL, V53, P4825, DOI 10.1088/0031-9155/53/17/023; Paganetti H, 2012, PHYS MED BIOL, V57, pR99, DOI 10.1088/0031-9155/57/11/R99; PETTI PL, 1992, MED PHYS, V19, P137, DOI 10.1118/1.596887; Sawakuchi GO, 2008, PHYS MED BIOL, V53, P4605, DOI 10.1088/0031-9155/53/17/010; Schneider U, 2005, MED PHYS, V32, P195, DOI 10.1118/1.1833041; Schuemann J, 2014, PHYS MED BIOL, V59, P4007, DOI 10.1088/0031-9155/59/15/4007; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; Stankovskiy A, 2009, PHYS MED BIOL, V54, P2377, DOI 10.1088/0031-9155/54/8/008; Szymanowski H, 2002, PHYS MED BIOL, V47, P3313, DOI 10.1088/0031-9155/47/18/304; Szymanowski H, 2001, MED PHYS, V28, P975, DOI 10.1118/1.1376445; URIE M, 1986, PHYS MED BIOL, V31, P1, DOI 10.1088/0031-9155/31/1/001; Warren DR, 2015, PHYS MED BIOL, V60, P4243, DOI 10.1088/0031-9155/60/11/4243; Yamashita T, 2012, PHYS MED BIOL, V57, P7673, DOI 10.1088/0031-9155/57/22/7673	32	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193904	10.1371/journal.pone.0193904	http://dx.doi.org/10.1371/journal.pone.0193904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505589	Green Submitted, Green Published, gold			2022-12-27	WOS:000426548200041
J	Liu, ZJ; Deng, CW; Li, P; Wang, JX; Ma, LJ; Li, YZ; Xu, YC				Liu, Zhongjuan; Deng, Chuiwen; Li, Ping; Wang, Jingxia; Ma, Lijuan; Li, Yongzhe; Xu, Yingchun			A reference interval for serum IgG subclasses in Chinese children	PLOS ONE			English	Article							IGG4-RELATED DISEASE; IMMUNOGLOBULIN-G; VALUES	Background Reference intervals (Rls) for serum IgG subclasses vary greatly among different geographical regions. The present study aimed to establish Rls for serum IgG subclasses in Chinese children, which is essential for interpretation of laboratory findings and making clinical decisions. Methods This study was performed in accordance with guideline C28-A3, proposed by the International Federation of Clinical Chemistry and the Clinical and Laboratory Standards Institute. In total, 607 apparently healthy Chinese children were enrolled, and serum levels of IgG subclasses were measured. Individuals were stratified by age and the Rls were determined through statistical analysis. Results Following were the median values of Rls for serum IgG subclasses in Chinese children: IgG1, 2.78 g/L; IgG2, 0.85 g/L; IgG3, 0.13 g/L; IgG4, 0.06 g/L at 1-6 months of age; IgG1, 3.64 g/L; IgG2, 0.73 g/L; IgG3, 0.19 g/L; IgG4, 0.03 g/L at 6-12 months of age; IgG1, 5.15 g/L; IgG2, 0.87 g/L; IgG3, 0.19 g/L; IgG4, 0.07 g/L at 1-2 years of age; IgG1, 5.26 g/L; IgG2, 1.23 g/L; IgG3, 0.14 g/L; IgG4, 0.11 g/L at 2-3 years of age; IgG1, 6.33 g/L; IgG2, 1.8 g/L; IgG3, 0.2 g/L; IgG4, 0.21 g/L at age 3-4 years; IgG1, 7.05 g/L; IgG2, 1.87 g/L; IgG3, 0.25 g/L; IgG4, 0.29 g/L at 4-6 years of age; IgG1, 6.19 g/L; IgG2, 1.93 g/L; IgG3, 0.2 g/L; IgG4, 0.28 g/L at 6-9 years of age; IgG1, 6.76 g/L; IgG2, 2.29 g/L; IgG3, 0.27 g/L; IgG4, 0.37 g/L at 10-12 years of age; IgG1, 7.45 g/L; IgG2, 2.92 g/L; IgG3, 0.28 g/L; IgG4, 0.38 g/L at 13-16 years of age. Conclusion To our knowledge, this study is the first to establish Rls for serum IgG subclasses exclusively in Chinese children.	[Liu, Zhongjuan; Xu, Yingchun] Beijing Union Med Coll Hosp, Chinese Acad Med Sci, Dept Clin Lab, Beijing, Peoples R China; [Liu, Zhongjuan; Deng, Chuiwen; Li, Ping; Li, Yongzhe; Xu, Yingchun] Peking Union Med Coll, Beijing, Peoples R China; [Deng, Chuiwen; Li, Ping; Li, Yongzhe] Beijing Union Med Coll Hosp, Chinese Acad Med Sci, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China; [Deng, Chuiwen; Li, Ping; Li, Yongzhe] Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China; [Wang, Jingxia; Ma, Lijuan] Capital Inst Pediat, Dept Clin Lab, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Institute of Pediatrics (CIP)	Xu, YC (corresponding author), Beijing Union Med Coll Hosp, Chinese Acad Med Sci, Dept Clin Lab, Beijing, Peoples R China.; Li, YZ; Xu, YC (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Li, YZ (corresponding author), Beijing Union Med Coll Hosp, Chinese Acad Med Sci, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China.; Li, YZ (corresponding author), Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China.	yongzhelipumch@126.com; xycpumch@139.com			Capital Characteristic Clinical Application Research [Z141107006614004]; National Science Technology Pillar Program [2014BA107600]	Capital Characteristic Clinical Application Research; National Science Technology Pillar Program	This study was supported by the Capital Characteristic Clinical Application Research (Z141107006614004 to ZL) and the National Science Technology Pillar Program in the 12nd Five-year Plan (2014BA107600 to ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu G, 2006, TURKISH J PEDIATR, V48, P19; AMBROSINO DM, 1991, J PEDIATR-US, V119, P875, DOI 10.1016/S0022-3476(05)83036-7; Bossuyt X, 2005, J ALLERGY CLIN IMMUN, V115, P872, DOI 10.1016/j.jaci.2005.01.039; Buckley Rebecca H, 2002, Curr Allergy Asthma Rep, V2, P356, DOI 10.1007/s11882-002-0067-1; Deng CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168871; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Horowitz GL, 2008, DEFINING ESTABLISHIN; Karim F, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0079-3; KLEIN F, 1985, CLIN CHIM ACTA, V150, P119, DOI 10.1016/0009-8981(85)90262-1; LAU YL, 1993, CLIN EXP IMMUNOL, V91, P337; Lepage N, 2010, CLIN BIOCHEM, V43, P694, DOI 10.1016/j.clinbiochem.2010.02.003; Li P, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0216-7; Natvig J B, 1973, Adv Immunol, V16, P1, DOI 10.1016/S0065-2776(08)60295-3; Picard C, 2015, J CLIN IMMUNOL, V35, P696, DOI 10.1007/s10875-015-0201-1; PLEBANI A, 1989, EUR J PEDIATR, V149, P164, DOI 10.1007/BF01958271; Schauer U, 2003, CLIN CHEM, V49, P1924, DOI 10.1373/clinchem.2003.022350; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; UMETSU DT, 1985, NEW ENGL J MED, V313, P1247, DOI 10.1056/NEJM198511143132002; Wahn V, 2017, PEDIAT ALLERG IMM-UK, V28, P521, DOI 10.1111/pai.12757; Wilson C, 2013, CLIN BIOCHEM, V46, P1751, DOI 10.1016/j.clinbiochem.2013.07.014	20	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0192923	10.1371/journal.pone.0192923	http://dx.doi.org/10.1371/journal.pone.0192923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505563	Green Submitted, gold, Green Published			2022-12-27	WOS:000426548200003
J	Margiotta, DPE; Basta, F; Dolcini, G; Batani, V; Lo Vullo, M; Vernuccio, A; Navarini, L; Afeltra, A				Margiotta, Domenico Paolo Emanuele; Basta, Fabio; Dolcini, Giulio; Batani, Veronica; Lo Vullo, Marina; Vernuccio, Alessia; Navarini, Luca; Afeltra, Antonella			Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISK; VALIDATION; HEALTH; MORTALITY; LEPTIN; WOMEN; INDEX; TIME	Introduction The aim of this study was to evaluate the proportion of patients with Systemic Lupus Erythematosus (SLE) who did not met the WHO recommendations for physical activity and to evaluate the amount of time spent in sedentary behavior. Methods SLE patients were consecutively enrolled in a cross sectional study. The type and the time spent in physical activity and sedentary behavior were evaluated using the IPAQ short form questionnaire. The adequate physical activity was defined according to the 2010 WHO recommendations for health and the sedentary behavior according to the 2017 SBRN consensus. We also assessed quality of life using SF-36, mood disorders using BDI and HAM-H, fatigue using Facit-Fatigue and sleep disorders using PSQI scores. Results Physical activity was not sufficient to meet WHO recommendations in 56 of 93 SLE patients (60%). SLE patients spent a median (95% range) of 180 (0 +/- 600) minutes everyday in sedentary activities. The length of daily sedentary time was more than 6 hours in 25% of SLE patients. In multivariable analysis, the factors associated to the probability of not meeting WHO criteria was only the time of exposure to antimalarials (OR 0.88, p 0.03) and the factors related to the probability of being in the upper tertile of sedentary time (more than 270 minutes) were age (OR 1.04, p 0.02), disease activity expressed by SELENA-SLEDAI score (OR 1.2, p 0.01) and Facit-fatigue score (OR 0.94, p 0.04). Conclusion A relevant proportion of SLE patients were inadequately physically active. It is essential to improve the awareness of the importance of increase physical activity and reduce sedentary time. A better control of disease activity and fatigue and a prolonged use of antimalarials could help to reach this notable goal.	[Margiotta, Domenico Paolo Emanuele; Basta, Fabio; Dolcini, Giulio; Batani, Veronica; Lo Vullo, Marina; Vernuccio, Alessia; Navarini, Luca; Afeltra, Antonella] Univ Campus Biomed Roma, Unit Allergol Clin Immunol & Rheumatol, Rome, Italy	University Campus Bio-Medico - Rome Italy	Navarini, L (corresponding author), Univ Campus Biomed Roma, Unit Allergol Clin Immunol & Rheumatol, Rome, Italy.	l.navarini@unicampus.it	Navarini, Luca/AAC-6635-2022; Margiotta, Domenico Paolo Emanuele/G-5769-2018; Navarini, Luca LN/A-7987-2011	Navarini, Luca/0000-0001-8537-1510; Margiotta, Domenico Paolo Emanuele/0000-0002-3597-8645; 				Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Apolone G, 1998, J CLIN EPIDEMIOL, V51, P1025, DOI 10.1016/S0895-4356(98)00094-8; Ayan C, 2007, LUPUS, V16, P5, DOI 10.1177/0961203306074795; Bell JA, 2014, DIABETOLOGIA, V57, P2048, DOI 10.1007/s00125-014-3323-8; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Boggi R PA, 2017, ATTIVITA FISICA NEI; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bressi C, 1996, J PSYCHOSOM RES, V41, P551, DOI 10.1016/S0022-3999(96)00228-0; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Curcio G, 2013, NEUROL SCI, V34, P511, DOI 10.1007/s10072-012-1085-y; Eriksson K, 2012, SCAND J RHEUMATOL, V41, P290, DOI 10.3109/03009742.2011.624117; Fasano S, 2017, LUPUS, V26, P1463, DOI 10.1177/0961203317722847; Giacomelli R, 2017, AUTOIMMUN REV, V16, P911, DOI 10.1016/j.autrev.2017.07.012; Gibbs BB, 2015, MED SCI SPORT EXER, V47, P1295, DOI 10.1249/MSS.0000000000000517; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Jolly M, 2016, LUPUS, V25, P735, DOI 10.1177/0961203315627200; Katzmarzyk PT, 2010, DIABETES, V59, P2717, DOI 10.2337/db10-0822; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Legge A, 2017, OPEN ACCESS RHEUMATO, V9, P191, DOI 10.2147/OARRR.S148376; Mancuso CA, 2011, LUPUS, V20, P231, DOI 10.1177/0961203310383737; Margiotta D, 2016, EUR REV MED PHARMACO, V20, P636; Margiotta DPE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187645; O'Dwyer T, 2017, SEMIN ARTHRITIS RHEU, V47, P204, DOI 10.1016/j.semarthrit.2017.04.003; Paley MA, 2017, CURR OPIN RHEUMATOL, V29, P178, DOI 10.1097/BOR.0000000000000369; Pancheri P, 2002, J AFFECT DISORDERS, V68, P41, DOI 10.1016/S0165-0327(00)00328-1; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pinto AJ, 2016, ARTHRIT CARE RES, V68, P1780, DOI 10.1002/acr.22905; Ponticelli C, 2017, EXPERT OPIN DRUG SAF, V16, P411, DOI 10.1080/14740338.2017.1269168; Reddigan JI, 2011, AM J CARDIOL, V108, P1426, DOI 10.1016/j.amjcard.2011.07.005; Ruiz-Arruza I, 2014, RHEUMATOLOGY, V53, P1470, DOI 10.1093/rheumatology/keu148; Sacco R, 2016, EUR J NEUROL, V23, P744, DOI 10.1111/ene.12932; Schuch F, 2017, J AFFECT DISORDERS, V210, P139, DOI 10.1016/j.jad.2016.10.050; Sharif K, 2017, AUTOIMMUN REV; Stamatakis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073753; SYMMONS DPM, 1988, Q J MED, V69, P927; Tang C, 2012, INTERN MED J, V42, P968, DOI 10.1111/j.1445-5994.2012.02886.x; Teychenne M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1843-x; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Urushidani S, 2015, ANN INTERN MED, V162, P875, DOI 10.7326/L15-0180; Vadacca M, 2013, INTERN EMERG MED, V8, P705, DOI 10.1007/s11739-011-0726-0; Vadacca M, 2011, CELL MOL IMMUNOL, V8, P203, DOI 10.1038/cmi.2010.75; Vadacca M, 2009, J RHEUMATOL, V36, P295, DOI 10.3899/jrheum.080503; van Vollenhoven RF, 2014, ANN RHEUM DIS, V73, P958, DOI 10.1136/annrheumdis-2013-205139; Volkmann ER, 2010, ARTHRIT CARE RES, V62, P258, DOI 10.1002/acr.20076; Webster Kimberly, 2003, Health Qual Life Outcomes, V1, P79, DOI 10.1186/1477-7525-1-79; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Young DR, 2016, CIRCULATION, V134, pE262, DOI 10.1161/CIR.0000000000000440	52	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193728	10.1371/journal.pone.0193728	http://dx.doi.org/10.1371/journal.pone.0193728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY1CC	29505598	gold, Green Submitted, Green Published			2022-12-27	WOS:000426548200027
J	Srihirun, S; Piknova, B; Sibmooh, N; Schechter, AN				Srihirun, Sirada; Piknova, Barbora; Sibmooh, Nathawut; Schechter, Alan N.			Phosphorylated vasodilator-stimulated phosphoprotein (P-VASP(Ser239)) in platelets is increased by nitrite and partially deoxygenated erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELL; OXIDE SYNTHASE; IN-VITRO; ENDOTHELIAL-CELLS; NO RELEASE; INHIBITION; BIOACTIVATION; HEMOGLOBIN; AGGREGATION; MECHANISMS	Nitrite is recognized as a bioactive nitric oxide (NO) metabolite. We have shown that nitrite inhibits platelet activation and increases platelet cGMP levels in the presence of partially deoxygenated erythrocytes. In this study, we investigated the effect of nitrite on phosphorylation of vasodilator-stimulated phosphoprotein on residue serine 239 (P-VASP(Ser239)), a marker of protein kinase G (PKG) activation, in human platelets. In platelet-rich plasma (PRP), nitrite itself had no effect on levels of P-VASP(Ser239) while DEANONOate increased P-VASP(Ser239). Deoxygenation of PRP + erythrocytes (20% hematocrit) raised baseline PVASP(Ser239) in platelets. At 20% hematocrit, nitrite (10 mu M) increased P-VASP(Ser239) in platelets about 31% at 10 +/- 20 minutes of incubation while the levels of P-VASP(Ser157), a marker of protein kinase A (PKA) activation, were not changed. Nitrite increased P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes at 20 +/- 40% hematocrit, but the effects were slightly greater at 20% hematocrit. In conclusion, our data confirm that nitrite increases P-VASP(Ser239) in platelets in the presence of deoxygenated erythrocytes. They also further support the idea that partially deoxygenated erythrocytes may modulate platelet activity, at least in part, via the NO/sGC/PKG pathway from NO formed by reduction of circulating nitrite ions.	[Srihirun, Sirada; Piknova, Barbora; Schechter, Alan N.] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Srihirun, Sirada] Mahidol Univ, Dept Pharmacol, Fac Dent, Bangkok, Thailand; [Sibmooh, Nathawut] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok, Thailand	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Mahidol University; Mahidol University	Schechter, AN (corresponding author), NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	AlanS@intra.niddk.nih.gov		Srihirun, Sirada/0000-0003-1616-9487	National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025093] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Intramural Research Program to Alan N. Schechter.	Akrawinthawong K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092435; Anfossi G, 2001, THROMB RES, V102, P319, DOI 10.1016/S0049-3848(01)00240-7; Apostoli GL, 2014, J THROMB HAEMOST, V12, P1880, DOI 10.1111/jth.12711; Benz PM, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0144-z; Bohmer A, 2015, PLATELETS, V26, P583, DOI 10.3109/09537104.2014.974024; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Dautov RF, 2014, NITRIC OXIDE-BIOL CH, V40, P36, DOI 10.1016/j.niox.2014.05.005; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Feelisch M, 1998, N-S ARCH PHARMACOL, V358, P113, DOI 10.1007/PL00005231; Fens MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101626; Gambaryan S, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0139-9; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Grossi L, 2005, J MED CHEM, V48, P2622, DOI 10.1021/jm049857n; HORSTRUP K, 1994, EUR J BIOCHEM, V225, P21, DOI 10.1111/j.1432-1033.1994.00021.x; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Kim-Shapiro DB, 2014, NITRIC OXIDE-BIOL CH, V38, P58, DOI 10.1016/j.niox.2013.11.002; Liu C, 2015, J BIOL CHEM, V290, P1281, DOI 10.1074/jbc.M114.609222; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Massberg S, 2004, BLOOD, V103, P136, DOI 10.1182/blood-2002-11-3417; Megson IL, 2000, BRIT J PHARMACOL, V131, P1391, DOI 10.1038/sj.bjp.0703731; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Ostergaard L, 2007, AM J PHYSIOL-HEART C, V293, pH2894, DOI 10.1152/ajpheart.01230.2006; Parakaw T, 2017, NITRIC OXIDE-BIOL CH, V66, P10, DOI 10.1016/j.niox.2017.02.008; Park JW, 2014, NITRIC OXIDE-BIOL CH, V40, P45, DOI 10.1016/j.niox.2014.05.006; Park JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055699; Porro B, 2014, BIOCHEM SOC T, V42, P996, DOI 10.1042/BST20140122; ROCHELLE LG, 1994, TOXICOL APPL PHARM, V128, P123, DOI 10.1006/taap.1994.1189; Salgado MT, 2015, BIOCHEMISTRY-US, V54, P6712, DOI 10.1021/acs.biochem.5b00643; Shah A, 2011, CARDIOVASC RES, V91, P625, DOI 10.1093/cvr/cvr115; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Srihirun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030380; Velmurugan S, 2013, FREE RADICAL BIO MED, V65, P1521, DOI 10.1016/j.freeradbiomed.2013.06.031; Wajih N, 2017, REDOX BIOL, V12, P1026, DOI 10.1016/j.redox.2017.05.006; Wajih N, 2016, REDOX BIOL, V8, P415, DOI 10.1016/j.redox.2016.04.004; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; WENNMALM A, 1992, BRIT J PHARMACOL, V106, P507, DOI 10.1111/j.1476-5381.1992.tb14365.x	39	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193747	10.1371/journal.pone.0193747	http://dx.doi.org/10.1371/journal.pone.0193747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505609	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200028
J	Tekalegn, Y; Addissie, A; Kebede, T; Ayele, W				Tekalegn, Yohannes; Addissie, Adamu; Kebede, Tedla; Ayele, Wondimu			Magnitude of glycemic control and its associated factors among patients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia	PLOS ONE			English	Article							CARE; COMPLICATIONS; INITIATION; THERAPY; ADULTS	Background Diabetes is increasing at an alarming rate throughout the world and about 80% of diabetic cases live in low and middle income countries. Glycemic control is the most important predictor for diabetic related complications and deaths. Identifying factors associated with glycemic control help health care providers and patients to work in the areas that reduce risks of diabetic related complications and deaths. Objectives The aim of this study is to assess the magnitude and factors associated with glycemic control among type 2 diabetic patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Methods Hospital-based cross sectional study was conducted on 412 type 2 diabetic patients who were attending in diabetic clinics at Tikur Anbessa Specialized Hospital. Data were collected through structured interview questionnaire, and data abstraction format to collect information from each patient's medical records from March to April, 2015. Data were entered and analyzed using SPSS version 20 statistical software. Both descriptive and inferential statistics were used to determine magnitude of glycemic control and factors associated with poor glycemic control. Result Median age of participants was 52 years old (IQR = 40 +/- 60 years old). From the study participants, 51.7% were females. Median duration of living with diabetes since diagnosis was 10 years (IQR: 5 +/- 16 years). About 80% of the respondents had uncontrolled fasting blood glucose level. The factors which are significantly associated with poor glycemic control were longer duration of diabetes (AOR = 2.72 95% CI: 1.16 +/- 6.32), and being on insulin therapy (AOR = 3.01 95% CI: 1.5 +/- 5.9). Conclusion A high proportion of patients had poor glycemic control. Longer duration of the disease, and being on drug regimen of insulin were associated with poor glycemic control. Appropriate attention should be given to patients with longer duration of disease and those who are on insulin therapy.	[Tekalegn, Yohannes] Univ Addis Ababa, Tikur Anbessa Specialized Hosp, Coll Hlth Sci, Addis Ababa, Ethiopia; [Addissie, Adamu; Ayele, Wondimu] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Kebede, Tedla] Univ Addis Ababa, Coll Hlth Sci, Sch Med, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University; Addis Ababa University	Tekalegn, Y (corresponding author), Univ Addis Ababa, Tikur Anbessa Specialized Hosp, Coll Hlth Sci, Addis Ababa, Ethiopia.	yohannesefa@gmail.com	TEKALEGN, YOHANNES/AAG-9451-2020	TEKALEGN, YOHANNES/0000-0001-6628-8180; Ayele, Wondimu/0000-0001-5899-347X				Abebe SM, 2015, DIABET METAB SYND OB, V8, P65, DOI 10.2147/DMSO.S75467; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Angamo MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061759; Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36; center of disease prevention and control, 2005, NAT DIAB FACT SHEET; Cho N., 2013, INT DIABETES FEDERAT; Craig ME, 2009, PEDIATR DIABETES, V10, P3, DOI 10.1111/j.1399-5448.2009.00568.x; Feleke Y, 2005, ETHIOP J HEALTH DEV, V19, P204; Gudina EK, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-19; Hailu E, 2012, AFR J PRIM HEALTH CA, V4, DOI 10.4102/phcfm.v4i1.311; Juarez DT, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120065; Karter AJ, 2005, AM J MANAG CARE, V11, P262; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Mullugeta Y, 2012, INDIAN J CLIN BIOCHE, V27, P363, DOI 10.1007/s12291-012-0225-8; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Sekhar TVDS, 2013, J CLIN DIAGN RES, V7, P857, DOI 10.7860/JCDR/2013/5726.2958; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UKPDS GROUP, 1998, LANCET, V352, P1557; Wallace TM, 2000, QJM-MON J ASSOC PHYS, V93, P369, DOI 10.1093/qjmed/93.6.369; Woldu M, 2014, ENDOCRINOL METAB SYN, V3, DOI DOI 10.4172/2161-1017.1000143	26	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193442	10.1371/journal.pone.0193442	http://dx.doi.org/10.1371/journal.pone.0193442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505602	Green Published, gold, Green Submitted			2022-12-27	WOS:000426548200016
J	Faralli, JA; Dimeo, KD; Trane, RM; Peters, D				Faralli, Jennifer A.; Dimeo, Kaylee D.; Trane, Ralph M.; Peters, Donna			Absence of a secondary glucocorticoid response in C57BL/6J mice treated with topical dexamethasone	PLOS ONE			English	Article							HUMAN TRABECULAR MESHWORK; INDUCED OCULAR HYPERTENSION; LINKED ACTIN NETWORKS; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; RECEPTOR-BETA; FLUID-DYNAMICS; HTM CELLS; EXPRESSION; CORTICOSTEROIDS	Glucocorticoids such as dexamethasone can cause an increase in intraocular pressure (IOP) in some of the population, but not all. In this paper we used a mouse model of glucocorticoid induced ocular hypertension to examine the changes in the anterior segment of the eye in mice that failed to respond to glucocorticoid treatment with a sustained increase in IOP. C57BL/6J mice were treated with either 0.1% dexamethasone sodium phosphate ophthalmic solution or sterile PBS 3 times daily for up to 5 weeks. IOP was measured weekly at approximately the same time of the day. After 3-5 weeks of treatment, eyes were enucleated and evaluated for changes associated with steroid induced glaucoma. These studies showed that IOP was significantly elevated in dexamethasone (DEX) treated mice compared to PBS treated mice after 3 weeks of treatment, but IOP in DEX treated mice returned to baseline levels after 5 weeks of treatment. All the mice demonstrated a response to the glucocorticoid treatments and showed an elevation in FKBP5 expression after both 3 and 5 weeks of DEX treatment (primary glucocorticoid response protein) and a weight loss. Western blot analysis of anterior segments from treated mice, however, did not show an increase in secondary glucocorticoid response proteins such as beta 3 integrin or myocilin. Fibronectin levels were also not statistically different. The data suggest that in mice, which do not exhibit a prolonged increase in IOP in response to the DEX treatment, there is a compensatory mechanism that can prevent or turn off the secondary glucocorticoid response.	[Faralli, Jennifer A.; Dimeo, Kaylee D.; Peters, Donna] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Trane, Ralph M.; Peters, Donna] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Peters, D (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.; Peters, D (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA.	dmpeter2@wisc.edu		Peters, Donna/0000-0002-1303-7027	National Institutes of Health [EY026009, EY017006]; Core grant to the Department of Ophthalmology and Visual Sciences grant [P30 EY016665]; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core grant to the Department of Ophthalmology and Visual Sciences grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health grants EY026009 (DP), EY017006 (DP), and a Core grant to the Department of Ophthalmology and Visual Sciences grant P30 EY016665 (DP), (https://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049532; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P492, DOI 10.1001/archopht.1963.00960050494011; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P482, DOI 10.1001/archopht.1963.00960050484010; Barathi VA, 2009, VISION RES, V49, P383, DOI 10.1016/j.visres.2008.11.005; BECKER B, 1963, ARCH OPHTHALMOL-CHIC, V70, P500; Bermudez JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169671; Clark A F, 1995, J Glaucoma, V4, P354; Clark A F, 1995, J Glaucoma, V4, P183; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; Clark AF, 2005, CELL MOTIL CYTOSKEL, V60, P83, DOI 10.1002/cm.20049; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; CLARK AF, 1995, INVEST OPHTH VIS SCI, V36, P478; Clark R, 2013, MOL CELL PROTEOMICS, V12, P194, DOI 10.1074/mcp.M112.019745; Derijk RH, 2001, J RHEUMATOL, V28, P2383; Dibas A, 2016, EUR J PHARMACOL, V787, P57, DOI 10.1016/j.ejphar.2016.06.018; DUNHAM CN, 1994, BRIT J OPHTHALMOL, V78, P38, DOI 10.1136/bjo.78.1.38; ESPILDORA J, 1981, J FR OPHTALMOL, V4, P503; Faralli JA, 2015, EXP EYE RES, V130, P9, DOI 10.1016/j.exer.2014.11.009; Faralli JA, 2013, BBA-MOL CELL RES, V1833, P3306, DOI 10.1016/j.bbamcr.2013.09.020; Filla MS, 2006, INVEST OPHTH VIS SCI, V47, P1956, DOI 10.1167/iovs.05-0626; Filla MS, 2017, EXP EYE RES, V165, P7, DOI 10.1016/j.exer.2017.08.017; Filla MS, 2011, INVEST OPHTH VIS SCI, V52, P2952, DOI 10.1167/iovs.10-6618; Filla MS, 2009, INVEST OPHTH VIS SCI, V50, P5723, DOI 10.1167/iovs.08-3215; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 2010, MOL VIS, V16, P596; FRANCOIS J, 1977, ANN OPHTHALMOL, V9, P1075; Gagen D, 2013, INVEST OPHTH VIS SCI, V54, P5000, DOI 10.1167/iovs.13-12084; Hamid QA, 1999, AM J RESP CRIT CARE, V159, P1600, DOI 10.1164/ajrccm.159.5.9804131; Hamilos DL, 2001, J ALLERGY CLIN IMMUN, V108, P59; John SWM, 1997, INVEST OPHTH VIS SCI, V38, P249; Kersey JP, 2006, EYE, V20, P407, DOI 10.1038/sj.eye.6701895; Kumar S, 2013, INVEST OPHTH VIS SCI, V54, P1280, DOI 10.1167/iovs.12-11223; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Longui CA, 2000, HORM METAB RES, V32, P401, DOI 10.1055/s-2007-978661; Mao WM, 2011, INVEST OPHTH VIS SCI, V52, P8068, DOI 10.1167/iovs.11-8133; Overby DR, 2014, INVEST OPHTH VIS SCI, V55, P4922, DOI 10.1167/iovs.14-14429; Park JM, 2013, BMB REP, V46, P454, DOI 10.5483/BMBRep.2013.46.9.234; Peotter JL, 2016, EXP CELL RES, V347, P301, DOI 10.1016/j.yexcr.2016.08.009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piltz J, 2000, AM J OPHTHALMOL, V130, P441, DOI 10.1016/S0002-9394(00)00527-4; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Qiu YG, 2014, CURR EYE RES, V39, P365, DOI 10.3109/02713683.2013.845224; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rybkin I, 2017, EXP EYE RES, V158, P51, DOI 10.1016/j.exer.2016.07.013; Savinova OV, 2001, BMC GENET, V2; Shen L, 2013, CHINESE MED J-PEKING, V126, P78, DOI 10.3760/cma.j.issn.0366-6999.20120782; Shepard AR, 2001, INVEST OPHTH VIS SCI, V42, P3173; STEELY HT, 1992, INVEST OPHTH VIS SCI, V33, P2242; Tamm ER, 1999, INVEST OPHTH VIS SCI, V40, P2577; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188302; Whitlock NA, 2010, INVEST OPHTH VIS SCI, V51, P6496, DOI 10.1167/iovs.10-5430; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Zhang XY, 2005, INVEST OPHTH VIS SCI, V46, P4607, DOI 10.1167/iovs.05-0571; Zode GS, 2014, J CLIN INVEST, V124, P1956, DOI 10.1172/JCI69774	56	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0192665	10.1371/journal.pone.0192665	http://dx.doi.org/10.1371/journal.pone.0192665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499052	Green Submitted, Green Published, gold			2022-12-27	WOS:000426472300003
J	Moen, VP; Drageset, J; Eide, GE; Gjesdal, S				Moen, Vegard Pihl; Drageset, Jorunn; Eide, Geir Egil; Gjesdal, Sturla			Dimensions and predictors of disability-A baseline study of patients entering somatic rehabilitation in secondary care	PLOS ONE			English	Article							HOSPITAL ANXIETY; GENDER-DIFFERENCES; HEALTH; DEPRESSION; MULTIMORBIDITY; MORBIDITY; PROGRESS; PEOPLE; SCALE	Purpose The purpose of this study was to investigate disability among patients who were accepted for admission to a Norwegian rehabilitation center and to identify predictors of disability. Materials and methods In a cross-sectional study including 967 adult participants, the World Health Organization Disability Assessment Schedule version 2.0 36-item version was used for assessing overall and domain-specific disability as outcome variables. Patients completed the Hospital Anxiety and Depression Scale (HADS), EuroQoL EQ-5D-5L and questions about multi-morbidity, smoking and perceived physical fitness. Additionally, the main health condition, sociodemographic and environmental variables obtained from referrals and public registers were used as predictor variables. Descriptive statistics and linear regression analyses were performed. Results The mean (standard error) overall disability score was 30.0 (0.5), domain scores ranged from 11.9 to 44.7. Neurological diseases, multi-morbidity, low education, impaired physical fitness, pain, and higher HADS depressive score increased the overall disability score. A low HADS depressive score predicted a lower disability score in all domains. Conclusions A moderate overall disability score was found among patients accepted for admission to a rehabilitation center but "life activities" and "participation in society" had the highest domain scores. This should be taken into account when rehabilitation strategies are developed.	[Moen, Vegard Pihl] Haukeland Hosp, Ctr Habilitat & Rehabil, Bergen, Norway; [Moen, Vegard Pihl; Drageset, Jorunn; Eide, Geir Egil; Gjesdal, Sturla] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Eide, Geir Egil] Haukeland Hosp, Ctr Clin Res, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Moen, VP (corresponding author), Haukeland Hosp, Ctr Habilitat & Rehabil, Bergen, Norway.; Moen, VP (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	vegard.pihl.moen@helse-bergen.no		, Jorunn/0000-0002-4773-4576				Alexandre TD, 2012, ARCH GERONTOL GERIAT, V55, P431, DOI 10.1016/j.archger.2012.04.001; Almazan-Isla J, 2014, DISABIL HEALTH J, V7, P78, DOI 10.1016/j.dhjo.2013.08.004; [Anonymous], 2011, WORLD REP DIS; [Anonymous], 2010, REH MEAS DAT; Baruth M, 2013, DISABIL HLTH J; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bruce B, 2003, J RHEUMATOL, V30, P167; Campbell D., 2006, S SOC OUTC LEARN COP; Chi WC, 2014, INT J ENV RES PUB HE, V11, P12148, DOI 10.3390/ijerph111212148; Connolly D, 2016, DISABIL REHABIL; Donmez L, 2005, ARCH GERONTOL GERIAT, V40, P213, DOI 10.1016/j.archger.2004.08.006; Fardell JE, 2011, CLIN PHARMACOL THER, V90, P366, DOI 10.1038/clpt.2011.112; Frontera WR., 2004, PHYS MED REHABILITAT; Garin N, 2014, PLOS ONE; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; Janelsins MC, 2016, J CLIN ONCOL; Janssen MF, 2013, QUAL LIFE RES; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Koukouli S, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-20; Krause ML, 2015, OPEN RHEUMATOL J; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; McDaid O, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002571; Mello AD, 2014, HLTH RELATED SOCIODE; Mercer SW, 2009, FAM PRACT, V26, P79, DOI 10.1093/fampra/cmp020; Moen VP, 2016, QUAL LIFE RES; Morris A, 2011, J HEALTH PSYCHOL, V16, P667, DOI 10.1177/1359105310386635; Murtagh KN, 2004, AM J PUBLIC HEALTH, V94, P1406, DOI 10.2105/AJPH.94.8.1406; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Olfson M, 1997, AM J PSYCHIAT, V154, P1734, DOI 10.1176/ajp.154.12.1734; Posl M, 2007, QUAL LIFE RES; Santoni G, 2011, GERONTOLOGIST, V51, P75; Sjolund BM, 2010, J AM GERIATR SOC, V58, P1855, DOI 10.1111/j.1532-5415.2010.03085.x; Statistics Norway, 2017, POP SUMM TABL; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; stun TB, 2010, B WHO; stun TBK N, 2010, MEASURING HLTH DISAB; Tas U, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-22; Von Korff M, 2005, PSYCHOSOM MED; WHO, 2001, WHO INT CLASS FUNCT; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193761	10.1371/journal.pone.0193761	http://dx.doi.org/10.1371/journal.pone.0193761			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY0AM	29499064	Green Published, Green Submitted, gold			2022-12-27	WOS:000426472300021
J	Garcia, GR; Bugel, SM; Truong, L; Spagnoli, S; Tanguay, RL				Garcia, Gloria R.; Bugel, Sean M.; Truong, Lisa; Spagnoli, Sean; Tanguay, Robert L.			AHR2 required for normal behavioral responses and proper development of the skeletal and reproductive systems in zebrafish	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; DENDRITIC GROWTH; TOXICITY; EXPRESSION; EXPOSURE; GENE; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; MUTAGENESIS; DISRUPTION; ACTIVATION	The aryl hydrocarbon receptor ( AHR) is a conserved ligand-activated transcription factor required for proper vertebrate development and homeostasis. The inappropriate activation of AHR by ubiquitous pollutants can lead to adverse effects on wildlife and human health. The zebrafish is a powerful model system that provides a vertebrate data stream that anchors hypothesis at the genetic and cellular levels to observations at the morphological and behavioral level, in a high-throughput format. In order to investigate the endogenous functions of AHR, we generated an AHR2 ( homolog of human AHR)-null zebrafish line ( ahr2(osu1)) using the clustered, regulatory interspaced, short palindromic repeats ( CRISPR)-Cas9 precision genome editing method. In zebrafish, 2,3,7,8-tetrachlorodibenzo-p-dioxin ( TCDD) mediated toxicity requires AHR2. The AHR2-null line was resistant to TCDD-induced toxicity, indicating the line can be used to investigate the biological and toxicological functions of AHR2. The AHR2-null zebrafish exhibited decreased survival and fecundity compared to the wild type line. At 36 weeks, histological evaluations of the AHR2-null ovaries revealed a reduction of mature follicles when compared to wild type ovaries, suggesting AHR2 regulates follicle growth in zebrafish. AHR2-null adults had malformed cranial skeletal bones and severely damaged fins. Our data suggests AHR2 regulates some aspect( s) of neuromuscular and/or sensory system development, with impaired behavioral responses observed in larval and adult AHR2-null zebrafish. This study increases our understanding of the endogenous functions of AHR, which may help foster a better understanding of the target organs and molecular mechanisms involved in AHR-mediated toxicities.	[Garcia, Gloria R.; Bugel, Sean M.; Truong, Lisa; Tanguay, Robert L.] Oregon State Univ, Sinnhuber Aquat Res Lab, Environm Hlth Sci Ctr, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Spagnoli, Sean] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Tanguay, RL (corresponding author), Oregon State Univ, Sinnhuber Aquat Res Lab, Environm Hlth Sci Ctr, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA.	robert.tanguay@oregonstate.edu		Truong, Lisa/0000-0003-1751-4617; Tanguay, Robyn/0000-0001-6190-3682	National Institutes of Health [P42 ES016465, R21 ES025421, T32 ES07060, F31 ES026518, K99 ES025280]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007060, F31ES026518, R21ES025421, K99ES025280, P42ES016465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health grants: [P42 ES016465 to RLT, R21 ES025421 to RLT, T32 ES07060 to RLT, F31 ES026518 to GRG, K99 ES025280 to SMB]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antkiewicz DS, 2006, TOXICOL SCI, V94, P175, DOI 10.1093/toxsci/kfl093; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Benedict JC, 2000, TOXICOL SCI, V56, P382, DOI 10.1093/toxsci/56.2.382; Billiard SM, 2002, COMP BIOCHEM PHYS B, V133, P55, DOI 10.1016/S1096-4959(02)00105-7; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; COUTURE LA, 1990, TERATOLOGY, V42, P619, DOI 10.1002/tera.1420420606; Crews ST, 2006, GENE DEV, V20, P2773, DOI 10.1101/gad.1487706; Emmons RB, 1999, DEVELOPMENT, V126, P3937; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Garcia GR, 2016, PHARMACOL THERAPEUT, V161, P11, DOI 10.1016/j.pharmthera.2016.03.009; Garcia GR, 2017, MOL PHARM; Gonzalez FJ, 1995, TOXICOL LETT, V82-3, P117, DOI 10.1016/0378-4274(95)03548-6; Goodale BC, 2015, TOXICOL SCI, V147, P397, DOI 10.1093/toxsci/kfv139; Goodale BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029346; Hahn Mark E., 2017, Current Opinion in Toxicology, V2, P58, DOI 10.1016/j.cotox.2017.02.003; Hallare A, 2006, ECOTOX ENVIRON SAFE, V63, P378, DOI 10.1016/j.ecoenv.2005.07.006; Hao N, 2013, BIOCHEM PHARMACOL, V86, P561, DOI 10.1016/j.bcp.2013.07.004; Heiden TK, 2006, TOXICOL SCI, V90, P490, DOI 10.1093/toxsci/kfj085; Henry TR, 1997, TOXICOL APPL PHARM, V142, P56, DOI 10.1006/taap.1996.8024; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Hernandez-Ochoa I, 2010, BIOL REPROD, V83, P698, DOI 10.1095/biolreprod.110.087015; Hernandez-Ochoa I, 2009, BIOCHEM PHARMACOL, V77, P547, DOI 10.1016/j.bcp.2008.09.037; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08022; Johnston RJ, 2014, SCIENCE, V343, P661, DOI 10.1126/science.1243039; Karchner SI, 2005, BIOCH J; Kimura E., 2017, PLOS ONE, V12; Kimura E, 2015, NEUROTOXICOL TERATOL, V52, P42, DOI 10.1016/j.ntt.2015.10.005; Knecht AL, 2017, TOXICOL APPL PHARM, V329, P148, DOI 10.1016/j.taap.2017.05.033; Knecht AL, 2017, NEUROTOXICOL TERATOL, V59, P27, DOI 10.1016/j.ntt.2016.10.006; Latchney SE, 2013, J NEUROCHEM, V125, P430, DOI 10.1111/jnc.12130; Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Mulero-Navarro S, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00045; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; POLAND A, 1976, FED PROC, V35, P2404; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Schneider AJ, 2014, INT J MOL SCI, V15, P17852, DOI 10.3390/ijms151017852; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Shi ZQ, 2007, BIOL REPROD, V76, P198, DOI 10.1095/biolreprod.106.053991; Tanguay RL, 1999, BBA-GENE STRUCT EXPR, V1444, P35, DOI 10.1016/S0167-4781(98)00252-8; Truong L, 2011, METHODS MOL BIOL, V691, P271, DOI 10.1007/978-1-60761-849-2_16; Tseng HP, 2005, TOXICOL APPL PHARM, V205, P247, DOI 10.1016/j.taap.2004.10.019; Varshney GK, 2016, NAT PROTOC, V11, P2357, DOI 10.1038/nprot.2016.141; Vezina CM, 2009, BIOCHEM PHARMACOL, V77, P566, DOI 10.1016/j.bcp.2008.09.039; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Watabe Y, 2010, BIOL PHARM BULL, V33, P389, DOI 10.1248/bpb.33.389; Westerfield M., 2007, GUIDE LAB USE ZEBRAF; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Wilson SR, 2013, J PHARMACOL EXP THER, V345, P419, DOI 10.1124/jpet.113.203786; Xiong KM, 2008, MOL PHARMACOL, V74, P1544, DOI 10.1124/mol.108.050435; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09	61	28	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193484	10.1371/journal.pone.0193484	http://dx.doi.org/10.1371/journal.pone.0193484			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494622	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200054
J	Donovan, TM; Katz, JE				Donovan, Therese M.; Katz, Jonathan E.			AM Models: An R package for storing models, data, and metadata to facilitate adaptive management	PLOS ONE			English	Article								Agencies are increasingly called upon to implement their natural resource management programs within an adaptive management (AM) framework. This article provides the background and motivation for the R package, AMModels. AMModels was developed under R version 3.2.2. The overall goal of AMModels is simple: To codify knowledge in the form of models and to store it, along with models generated from numerous analyses and datasets that may come our way, so that it can be used or recalled in the future. AMModels facilitates this process by storing all models and datasets in a single object that can be saved to an-RData file and routinely augmented to track changes in knowledge through time. Through this process, AMModels allows the capture, development, sharing, and use of knowledge that may help organizations achieve their mission. While AMModels was designed to facilitate adaptive management, its utility is far more general. Many R packages exist for creating and summarizing models, but to our knowledge, AMModels is the only package dedicated not to the mechanics of analysis but to organizing analysis inputs, analysis outputs, and preserving descriptive metadata. We anticipate that this package will assist users hoping to preserve the key elements of an analysis so they may be more confidently revisited at a later date.	[Donovan, Therese M.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Vermont Cooperat Fish & Wildlife Res Unit, US Geol Survey, Burlington, VT 05405 USA; [Katz, Jonathan E.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Vermont Cooperat Fish & Wildlife Res Unit, Burlington, VT USA	United States Department of the Interior; United States Geological Survey; University of Vermont; University of Vermont	Donovan, TM (corresponding author), Univ Vermont, Rubenstein Sch Environm & Nat Resources, Vermont Cooperat Fish & Wildlife Res Unit, US Geol Survey, Burlington, VT 05405 USA.	tdonovan@uvm.edu		Donovan, Therese/0000-0001-8124-9251	U. S. Bureau of Land Management	U. S. Bureau of Land Management	This work was supported by the U. S. Bureau of Land Management.	Allen CR, 2015, ADAPTIVE MANAGEMENT; [Anonymous], 2021, LANG ENV STAT COMP; Balantic C, AMMONITOR REMO UNPUB; Bolker B, 2008, ECOLOGICAL MODELS DA; Burnetas AN, 1997, MATH OPER RES, V22, P222, DOI 10.1287/moor.22.1.222; Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; Conroy M. J., 2013, DECISION MAKING NATU; DAVENPORT TH, 1994, HARVARD BUS REV, V72, P119; Fischman RL, 2016, CONSERV BIOL, V30, P268, DOI 10.1111/cobi.12616; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fontaine JJ, 2011, J ENVIRON MANAGE, V92, P1403, DOI 10.1016/j.jenvman.2010.10.015; Fuller AK, 2014, J WILDLIFE MANAGE, V78, P175, DOI 10.1002/jwmg.629; Goodwin P., 2014, DECISION ANAL MANAGE, V5th ed.; Gregory R, 2006, ECOL APPL, V16, P2411, DOI 10.1890/1051-0761(2006)016[2411:DAMCFA]2.0.CO;2; Greig LA, 2013, ECOL SOC, V18, DOI 10.5751/ES-05686-180324; Hallgren L, 2015, WILDLIFE BIOL, V21, P165, DOI 10.2981/wlb.00005; Hobbs N.T., 2015, BAYESIAN MODELS; Holling CS, 1978, ADAPTIVE ENV ASSESSM, pxviii; Jaksch T, 2010, J MACH LEARN RES, V11, P1563; Katz J, AMEXPERT DERIV UNPUB; Katz J, 2017, AMMODELS ADAPTIVE MA; Lee K., 1993, COMPASS GYROSCOPE IN, P255; MacKenzie D, 2002, OCCUPANCY ESTIMATION; Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a; Miller G, 2006, SCIENCE, V314, P1856, DOI 10.1126/science.314.5807.1856; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Plummer M., 2016, RJAGS BAYESIAN GRAPH; Rehme SE, 2011, J ENVIRON MANAGE, V92, P1360, DOI 10.1016/j.jenvman.2010.10.012; Rist L, 2013, ECOL SOC, V18, DOI 10.5751/ES-06183-180463; Royle JA, 2016, APPL HIERARCHICAL MO; Runge MC, 2011, J FISH WILDL MANAG, V2, P220, DOI 10.3996/082011-JFWM-045; Susskind L, 2012, J APPL ECOL, V49, P47, DOI 10.1111/j.1365-2664.2011.02070.x; Walters C.J., 1986, ADAPTIVE MANAGEMENT, P374; Weir LA, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P307; Westgate MJ, 2013, BIOL CONSERV, V158, P128, DOI 10.1016/j.biocon.2012.08.016; Williams B.K., 2012, ADAPTIVE MANAGEMENT; Williams BK, 2016, BIOL CONSERV, V195, P255, DOI 10.1016/j.biocon.2016.01.012; Williams BK, 2011, J ENVIRON MANAGE, V92, P1346, DOI 10.1016/j.jenvman.2010.10.041	38	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0188966	10.1371/journal.pone.0188966	http://dx.doi.org/10.1371/journal.pone.0188966			57	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489825	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000003
J	Drain, PK; Parker, RA; Robine, M; Holmes, KK				Drain, Paul K.; Parker, Robert A.; Robine, Marion; Holmes, King K.			Global migration of clinical research during the era of trial registration	PLOS ONE			English	Article							MEDICAL JOURNAL EDITORS; INTERNATIONAL COMMITTEE; CLINICALTRIALS.GOV; GLOBALIZATION; STATEMENT; AFRICA; HEALTH; INDIA; HIV	Background Since the site of human subjects research has public health, regulatory, ethical, economic, and social implications, we sought to determine the global distribution and migration of clinical research using an open-access trial registry. Methods We obtained individual clinical trial data including location of trial sites, dates of operation, funding source (United States government, pharmaceutical industry, or organization), and clinical study phase (1, 1/2, 2, 2/3, or 3) from ClinicalTrials.gov. We used the World Bank's classification of each country's economic development status ["High Income and a Member of the Organization for Economic Co-operation and Development (OECD)", "High Income and Non-Member of the OECD", "Upper-Middle Income", "Lower-Middle Income", or "Low Income"] and United Nations Populations Division data for country-specific population estimates. We analyzed data from calendar year 2006 through 2012 by number of clinical trial sites, cumulative trial site-years, trial density (trial site-years/106 population), and annual growth rate (%) for each country, and by development category, funding source, and clinical study phase. Results Over a 7-year period, 89,647 clinical trials operated 784,585 trial sites in 175 countries, contributing 2,443,850 trial site-years. Among those, 652,200 trial sites (83%) were in 25 high-income OECD countries, while 37,195 sites (5%) were in 91 lower-middle or low-income countries. Trial density (trial site-years/106 population) was 540 in the United States, 202 among other high-income OECD countries (excluding the United States), 81 among high-income non-OECD countries, 41 among upper-middle income countries, 5 among lower-middle income countries, and 2 among low-income countries. Annual compound growth rate was positive (ranging from 0.8% among low-income countries to 14.7% among lower-middle income countries) among all economic groups, except the United States (-0.5%). Overall, 29,191 trials (33%) were funded by industry, 4,059 (5%) were funded by the United States government, and 56,397 (63%) were funded by organizations. Countries with emerging economies (low-and middle-income) operated 19% of phase 3 trial sites, as compared to only 6% of phase 1 trial sites. Conclusion Human clinical research remains concentrated in high-income countries, but operational clinical trial sites, particularly for phase 3 trials, may be migrating to low-and middle-income countries with emerging economies.	[Drain, Paul K.; Holmes, King K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Drain, Paul K.; Holmes, King K.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Drain, Paul K.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Parker, Robert A.; Robine, Marion] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Parker, Robert A.] Harvard Med Sch, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA USA; [Parker, Robert A.] Massachusetts Gen Hosp, Dept Med, Biostat Ctr, Boston, MA 02114 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Drain, PK (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Drain, PK (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.; Drain, PK (corresponding author), Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA.	pkdrain@uw.edu	, Holmes/K-6215-2019	Drain, Paul/0000-0002-9569-4097	National Institutes of Health, National Institute of Allergy and Infectious Disease [K23 AI108293]; Harvard University Center for AIDS Research [P30 AI060354]; University of Washington Center for AIDS Research [P30 AI027757]; Program in AIDS Clinical Research Training Grant [T32 AI007433]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI108293, T32AI007433] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard University Center for AIDS Research; University of Washington Center for AIDS Research; Program in AIDS Clinical Research Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the the National Institutes of Health, National Institute of Allergy and Infectious Disease (K23 AI108293), the Harvard University Center for AIDS Research (P30 AI060354), the University of Washington Center for AIDS Research (P30 AI027757), and the Program in AIDS Clinical Research Training Grant (T32 AI007433). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ML, 2015, NEW ENGL J MED, V372, P1031, DOI 10.1056/NEJMsa1409364; Annas GJ, 2009, NEW ENGL J MED, V360, P2050, DOI 10.1056/NEJMp0901474; Banerjee A, 2005, EC TIMES, P5; Bhutta Z, 2010, LANCET, V376, P1375; Brooks K., CRO OUTLOOK OPPORTUN; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; De Angelis C, 2005, LANCET, V365, P1827, DOI 10.1016/S0140-6736(05)66588-9; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Devasenapathy N, 2009, CURR OPIN CARDIOL, V24, P295, DOI 10.1097/HCO.0b013e32832af21b; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Drain PK, 2014, NAT REV DRUG DISCOV, V13, P166, DOI 10.1038/nrd4260; Getz K. A., 2007, APPL CLIN TRIAL 0901; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Heger M, 2012, NAT MED, V18, P837, DOI 10.1038/nm0612-837; International Monetary Fund, 2014, WORLD EC OUTLOOK DAT; Kapiriri L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-811; Laine C, 2007, LANCET, V369, P1909, DOI 10.1016/S0140-6736(07)60894-0; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Nundy S, 2005, NEW ENGL J MED, V352, P1633, DOI 10.1056/NEJMp048361; Patulin Clin Trials Comm, 2004, INT J EPIDEMIOL, V33, P243, DOI 10.1093/ije/dyh028; Prabhakaran P, 2007, J AM COLL CARDIOL, V50, P2322, DOI 10.1016/j.jacc.2007.08.040; Rowland C, 2004, INT J HEALTH SERV, V34, P555, DOI 10.2190/N8AU-6AG6-30M9-FN6T; Schweitzer S.O, 2007, PHARM EC POLICY; Siegfried N, 2005, BRIT MED J, V331, P742, DOI 10.1136/bmj.331.7519.742; Sinha G, 2004, SCI AM, V291, P24, DOI 10.1038/scientificamerican0804-24; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Thomas C, 2009, NAT MED, V15, P855, DOI 10.1038/nm0809-855; United Nations Department of Economic and Social Affairs, 2008, 2006 DEM YB; United Nations Population Division, WORLD POP PROSP 2012; Volmink J, 2005, BMJ-BRIT MED J, V331, P705, DOI 10.1136/bmj.331.7519.705; WHO, INT CLIN TRIALS REG; World Bank, 2008, INT TRADE CLIMATE CH; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234	33	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192413	10.1371/journal.pone.0192413	http://dx.doi.org/10.1371/journal.pone.0192413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489839	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000025
J	Ko, SY; Ro, YS; Shin, SD; Song, KJ; Hong, KJ; Kong, SY				Ko, Seo Young; Ro, Young Sun; Shin, Sang Do; Song, Kyoung Jun; Hong, Ki Jeong; Kong, So Yeon			Effect of a first responder on survival outcomes after out-of-hospital cardiac arrest occurs during a period of exercise in a public place	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; SUDDEN-DEATH; ASSOCIATION; BYSTANDER; INTERVENTION; DISEASE; YOUNG	Introduction The deployment of first responders in a public place is one of the interventions that is used for increasing bystander cardiopulmonary resuscitation (CPR) of out-of-hospital cardiac arrests (OHCA). We studied the association between the presence of a first responder and the survival of OHCA that occurred during a period of exercise in a public place. Methods All of the adult OHCAs of a presumed cardiac etiology that occurred during a period of exercise in a public place and that were witnessed by a bystander between 2013 and 2015 were analyzed. The main exposure of interest was the characteristics of the bystander (first responder vs. layperson). The endpoints were the provision of bystander CPR and good neurological recovery. Multivariable logistic regression analysis, adjusting for patient-environment and prehospital factors, was performed. Results A total of 870 patients had a cardiac arrest during a period of exercise in a public place, and 58 (6.7%) patients were witnessed by the first responder. The OHCAs witnessed by first responders were more likely to result in bystander CPR than those witnessed by laypersons (89.7% vs. 75.4%, p=0.01, adjusted OR (95% CI): 3.51 (1.44-8.55)). In terms of good neurological recovery, the OHCAs witnessed by first responders had a higher likelihood than the patients witnessed by laypersons (37.9% vs, 24.0%, p = 0.02, adjusted OR (95% CI): 2.92 (1.33-6.40)). Conclusion The OHCAs occurred during a period of exercise in a public place and whom first responders witnessed were more likely to receive bystander CPR and to have a neurologically intact survival.	[Ko, Seo Young; Shin, Sang Do; Song, Kyoung Jun] Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul, South Korea; [Ko, Seo Young; Ro, Young Sun; Shin, Sang Do; Song, Kyoung Jun; Hong, Ki Jeong; Kong, So Yeon] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul, South Korea; [Hong, Ki Jeong] Seoul Natl Univ Seoul, Boramae Med Ctr, Dept Emergency Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Ro, YS (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Lab Emergency Med Serv, Seoul, South Korea.	Ro.youngsun@gmail.com	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085	National Emergency Management Agency of Korea; Korea Centers for Disease Control and Prevention (CDC; Korea CDC [2013-E33015-00, 2014-E33011-00, 2016-E33012-00]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare, Korea [H113C1964]	National Emergency Management Agency of Korea; Korea Centers for Disease Control and Prevention (CDC; Korea CDC; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare, Korea	This study was supported by the National Emergency Management Agency of Korea and the Korea Centers for Disease Control and Prevention (CDC). The study was funded by the Korea CDC (2013-2016) (Grant No.: 2013-E33015-00; 2014-E33011-00; 2016-E33012-00) to SDS. This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Korea (Grant No.: H113C1964) to YSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; Berdowski J, 2013, EUR HEART J, V34, P3616, DOI 10.1093/eurheartj/eht401; Callaham M, 1996, ANN EMERG MED, V27, P638, DOI 10.1016/S0196-0644(96)70169-5; Chan PS, 2014, CIRCULATION, V130, P1876, DOI 10.1161/CIRCULATIONAHA.114.009711; Chang I, 2017, RESUSCITATION, V111, P26, DOI 10.1016/j.resuscitation.2016.11.007; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; Edwards MJ, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000281; Fishbein MC, 2010, CARDIOVASC PATHOL, V19, P326, DOI 10.1016/j.carpath.2009.06.005; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hansen CM, 2015, JAMA-J AM MED ASSOC, V314, P255, DOI 10.1001/jama.2015.7938; MacDonald Russell D, 2002, Prehosp Emerg Care, V6, P1; Marijon E, 2011, CIRCULATION, V124, P672, DOI 10.1161/CIRCULATIONAHA.110.008979; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Myerburg RJ, 2002, CIRCULATION, V106, P1058, DOI 10.1161/01.CIR.0000028147.92190.A7; Park GJ, 2017, AM J EMERG MED, V35, P1049, DOI 10.1016/j.ajem.2017.02.033; Park YM, 2017, RESUSCITATION, V118, P55, DOI 10.1016/j.resuscitation.2017.06.024; Perkins GD, 2014, CIRCULATION; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1016/j.atherosclerosis.2016.05.037, 10.1177/2047487316653709]; Ro YS, 2017, RESUSCITATION, V115, P44, DOI 10.1016/j.resuscitation.2017.03.041; Ro YS, 2017, ANN EMERG MED, V69, P52, DOI 10.1016/j.annemergmed.2016.07.028; Ro YS, 2016, RESUSCITATION, V102, P17, DOI 10.1016/j.resuscitation.2016.02.004; Soholm H, 2014, RESUSCITATION, V85, P1612, DOI 10.1016/j.resuscitation.2014.06.033; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; van Alem AP, 2003, BMJ-BRIT MED J, V327, P1312, DOI 10.1136/bmj.327.7427.1312; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193361	10.1371/journal.pone.0193361	http://dx.doi.org/10.1371/journal.pone.0193361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489877	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000067
J	Wojan, TR; Nichols, B				Wojan, Timothy R.; Nichols, Bonnie			Design, innovation, and rural creative places: Are the arts the cherry on top, or the secret sauce?	PLOS ONE			English	Article								Objective Creative class theory explains the positive relationship between the arts and commercial innovation as the mutual attraction of artists and other creative workers by an unobserved creative milieu. This study explores alternative theories for rural settings, by analyzing establishment-level survey data combined with data on the local arts scene. The study identifies the local contextual factors associated with a strong design orientation, and estimates the impact that a strong design orientation has on the local economy. Method Data on innovation and design come from a nationally representative sample of establishments in tradable industries. Latent class analysis allows identifying unobserved subpopulations comprised of establishments with different design and innovation orientations. Logistic regression allows estimating the association between an establishment's design orientation and local contextual factors. A quantile instrumental variable regression allows assessing the robustness of the logistic regression results with respect to endogeneity. An estimate of design orientation at the local level derived from the survey is used to examine variation in economic performance during the period of recovery from the Great Recession (2010-2014). Results Three distinct innovation (substantive, nominal, and non-innovators) and design orientations (design-integrated, "design last finish," and no systematic approach to design) are identified. Innovation-and design-intensive establishments were identified in both rural and urban areas. Rural design-integrated establishments tended to locate in counties with more highly educated workforces and containing at least one performing arts organization. A quantile instrumental variable regression confirmed that the logistic regression result is robust to endogeneity concerns. Finally, rural areas characterized by design-integrated establishments experienced faster growth in wages relative to rural areas characterized by establishments using no systematic approach to design.	[Wojan, Timothy R.] ERS, Rural Econ Branch, USDA, Washington, DC 20250 USA; [Nichols, Bonnie] Natl Endowment Arts, Off Res & Anal, Washington, DC USA	United States Department of Agriculture (USDA)	Wojan, TR (corresponding author), ERS, Rural Econ Branch, USDA, Washington, DC 20250 USA.	twojan@ers.usda.gov		Wojan, Timothy/0000-0001-9863-1457				Audretsch DB, 2017, CULTURAL AMENITIES S; Bessant J, 2001, TECHNOVATION, V21, P67, DOI 10.1016/S0166-4972(00)00023-7; Brown T., 2009, CHANGE DESIGN DESIGN; Coll-Martinez E, ENV PLAN IN PRESS A; Dyer J.H, 2009, HARV BUS REV; Florida R, 2002, J ECON GEOGR, V2, P55, DOI 10.1093/jeg/2.1.55; French M., 1996, INVENTION EVOLUTION; Frolich M, 2010, STATA J, V10, P423; Gault F, 2013, ELGAR ORIG REF, P41; Goldman K.H., 2016, RES REPORT; LaMore R, 2013, ECON DEV Q, V27, P221, DOI 10.1177/0891242413486186; Lee N, 2017, ECON GEOGR, V93, P106, DOI 10.1080/00130095.2016.1249845; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Lindemann DJ, 2017, AM BEHAV SCI, V61, P1555, DOI 10.1177/0002764217734276; Masucci M., 2016, FUSION EFFECT EC RET; McGranahan DA, 2002, AM J AGR ECON, V84, P1237, DOI 10.1111/1467-8276.00384; McGranahan D, 2007, REG STUD, V41, P197, DOI 10.1080/00343400600928285; Millot V., 2015, OECD ILIBRARY, P1, DOI DOI 10.1787/5JS7P6LJ6ZQ6-EN; Molotch H, 2002, INT J URBAN REGIONAL, V26, P665, DOI 10.1111/1468-2427.00410; Mudambi R, 2008, J ECON GEOGR, V8, P699, DOI 10.1093/jeg/lbn024; National Endowment for the Arts, 2020, WHY WE ENG ATT CREAT; National Endowment for the Arts, 2013, 56 NAT END ARTS; Parker T, 2017, COUNTY TYPOLOGY CODE; Parker T., 2016, COMMUTING ZONES LABO; PESENDORFER W, 1995, AM ECON REV, V85, P771; Phelps E., 2013, MASS FLOURISHING GRA; Phelps ES, 2017, CAPITALISM SOC, V12; Root-Bernstein R., 2008, J PSYCHOL SCI TECHNO, V1, P51, DOI DOI 10.1891/1939-7054.1.2.51; Sheppard H, 2017, IND DESIGN COMPETITI; Simon H. A., 1969, SCI ARTIFICIAL; Stolarick K, 2006, ENVIRON PLANN A, V38, P1799, DOI 10.1068/a3874; Storper M, 2009, J ECON GEOGR, V9, P147, DOI 10.1093/jeg/lbn052; Sunley P, 2008, J ECON GEOGR, V8, P675, DOI 10.1093/jeg/lbn028; Tether B., 2009, 0912 DIUS U LOND TAN; Verganti R, 2006, HARVARD BUS REV, V84, P114; Walsh V, 1996, RES POLICY, V25, P509, DOI 10.1016/0048-7333(95)00847-0; Whicher A, 2012, INT DES MAN RES C AU; Wojan T, 2017, 237 EC RES SERV; Wojan T. R., 2007, Agricultural and Resource Economics Review, V36, P133; Wojan TR, 2007, J ECON GEOGR, V7, P711, DOI 10.1093/jeg/lbm029; Zambon K., 2014, SUMM AAAS FOR SCI TE	41	13	13	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192962	10.1371/journal.pone.0192962	http://dx.doi.org/10.1371/journal.pone.0192962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489884	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000049
J	Aguilar-Palacio, I; Malo, S; Feja, C; Lallana, MJ; Leon-Latre, M; Casasnovas, JA; Rabanaque, MJ; Guallar, E				Aguilar-Palacio, Isabel; Malo, Sara; Feja, Cristina; Jesus Lallana, Ma; Leon-Latre, Montserrat; Antonio Casasnovas, Jose; Jose Rabanaque, Ma; Guallar, Eliseo			Risk factors control for primary prevention of cardiovascular disease in men: Evidence from the Aragon Workers Health Study (AWHS)	PLOS ONE			English	Article							METAANALYSIS; POPULATION; ADHERENCE; ACHIEVEMENT; PREVALENCE; THERAPY; EUROPE; IMPACT; SPAIN; GOALS	Benefits of cardiovascular disease (CVD) risk factors control are well known, but goals achievement remains low. The objective of this study is to evaluate the prevalence of CVD risk factors among men ina worker's cohort with no previous CVD, to study control variations across time and the factors associated with poor control. To this end, we conducted a cohort reexamination (2010-2014) within the context of the Aragon Workers Health Study (AWHS). Data from working characteristics, analytical values and pharmacological prescription were included in the analysis. Prevalences of risk factor diagnosis and control were calculated, as well as factors associated with poor control. The prevalence of CVD risk factors was high. In 2014dyslipidaemia was the most prevalent (85.2%) followed by Hypertension (HT) (42.0%). People under treatment increased for the period analysed (p < 0.001). The proportion of people treated varied from 72.2% in Diabetes Mellitus to 31.1% in dyslipidaemia in 2014. 46.2% of the workers with HT were controlled, decreasing to 21.9% in Diabetes and 11.0% in dyslipidaemia (2014). Working in a turn different to central shift was associated with poor control, especially for those working at night with HT (Odds Ratio in 2010: 3.6; Confidence Interval 95% 1.8-7.4) and dyslipidaemia (Odds Ratio 2010: 4.7; Confidence Interval 95% 1.3-16.4). We conclude that, although CVD control has increased significantly for the period studied, there are still many people that do not receive any treatment, and control goals are normally not achieved.	[Aguilar-Palacio, Isabel; Malo, Sara; Feja, Cristina; Jose Rabanaque, Ma] Zaragoza Univ, Prevent Med & Publ Hlth Dept, Zaragoza, Spain; [Aguilar-Palacio, Isabel; Malo, Sara; Feja, Cristina; Jesus Lallana, Ma; Antonio Casasnovas, Jose; Jose Rabanaque, Ma] IIS Aragon, Aragon Inst Hlth Res, Zaragoza, Spain; [Jesus Lallana, Ma; Leon-Latre, Montserrat] Serv Aragones Salud, Primary Hlth Care, Zaragoza, Spain; [Antonio Casasnovas, Jose] Zaragoza Univ, Med Psychiat & Dermatol Dept, Zaragoza, Spain; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Epidemiol Dept, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Aguilar-Palacio, I (corresponding author), Zaragoza Univ, Prevent Med & Publ Hlth Dept, Zaragoza, Spain.; Aguilar-Palacio, I (corresponding author), IIS Aragon, Aragon Inst Hlth Res, Zaragoza, Spain.	iaguilar@unizar.es	Malo, S/J-8824-2019; Lenguas, José Antonio Casasnovas/F-4038-2010; Aguilar-Palacio, Isabel/H-6816-2017	Malo, S/0000-0002-7194-8275; Lenguas, José Antonio Casasnovas/0000-0002-9887-2629; Aguilar-Palacio, Isabel/0000-0001-7293-701X; Feja Solana, Cristina/0000-0002-2712-6709	Fondo de Investigacion Sanitaria [PI13/01668]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by the Fondo de Investigacion Sanitaria, PI13/01668 (http://www.isciii.es). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ATCC DDD IND 2016; Banegas JR, 2012, HYPERTENSION, V60, P898, DOI 10.1161/HYPERTENSIONAHA.112.193078; Banegas JR, 2011, EUR HEART J, V32, P2143, DOI 10.1093/eurheartj/ehr080; Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; Bouchard MH, 2007, BRIT J CLIN PHARMACO, V63, P698, DOI 10.1111/j.1365-2125.2006.02828.x; Casasnovas JA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-45; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chowdhury R, 2013, EUR HEART J, V34, P2940, DOI 10.1093/eurheartj/eht295; Dallongeville J, 2012, EUR J PREV CARDIOL, V19, P541, DOI 10.1177/1741826711407705; Fores R, 2017, MED CLIN-BARCELONA, V148, P107, DOI 10.1016/j.medcli.2016.09.043; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Gabriel R, 2008, REV ESP CARDIOL, V61, P1030, DOI 10.1016/S1885-5857(09)60006-2; Godin G, 2008, HEALTH PSYCHOL, V27, P179, DOI 10.1037/0278-6133.27.2.179; Grau M, 2011, REV ESP CARDIOL, V64, P295, DOI [10.1016/j.rec.2010.11.005, 10.1016/j.recesp.2010.11.005]; Guallar E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-704; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299; Baena-Diez JM, 2011, REV ESP CARDIOL, V64, P766, DOI 10.1016/j.recesp.2011.04.019; Naderi SH, 2012, AM J MED, V125, P882, DOI 10.1016/j.amjmed.2011.12.013; Navarro-Vidal B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061549; Neil-Sztramko SE, 2014, SCAND J WORK ENV HEA, V40, P543, DOI 10.5271/sjweh.3445; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1007/s12529-012-9242-5, 10.1093/eurheartj/ehs092]; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1016/j.atherosclerosis.2016.05.037, 10.1177/2047487316653709]; Quick A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2016-7; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Schmieder RE, 2012, VASC HEALTH RISK MAN, V8, P177, DOI 10.2147/VHRM.S29915; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Townsend N, 2015, EUR HEART J, V36, P2673; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193541	10.1371/journal.pone.0193541	http://dx.doi.org/10.1371/journal.pone.0193541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474499	Green Published, gold			2022-12-27	WOS:000426049500128
J	Risoy, AJ; Kjome, RLS; Sandberg, S; Solvik, UO				Risoy, Aslaug Johanne; Kjome, Reidun Lisbet Skeide; Sandberg, Sverre; Solvik, Una Orvim			Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study	PLOS ONE			English	Article							CARDIOVASCULAR MORBIDITY; HEALTH; CARE; SCORE; DIAGNOSIS; EUROQOL; QUESTIONNAIRE; POPULATION; VALIDATION	Objectives Determine the feasibility of using a diabetes risk assessment tool followed by HbA1c-measurement in a community-pharmacy setting in Norway. Methods In this longitudinal study two pharmacists in each of three community pharmacies were trained to perform risk assessments, HbA1c-measurements and counselling. Pharmacy customers who were > 18 years old and could understand and speak Norwegian or English were recruited in the pharmacies during a two-months-period. Information about the service was presented in local newspapers, social media, leaflets and posters at the pharmacy. Customers wishing to participate contacted the pharmacy staff. Participants completed a validated diabetes risk test and a background questionnaire including a validated instrument for self-rated health. A HbA1c measurement was performed for individuals with a moderate to high risk of developing diabetes. If HbA1c >= 6.5% they were recommended to visit their general practitioner for follow-up. The pharmacies performed internal and external quality control of the HbA1c instrument. Results Of the 211 included participants 97 (46%) were > 50 years old. HbA1c was measured for the 47 participants (22%) with high risk. Thirty-two (15%) had HbA1c values < 5.7%, twelve (5.4%) had values between 5.7%-6.4%, and three (1.4%) had an HbA1c >= 6.5%. Two participants with HbA1 >= 6.5% were diagnosed with diabetes by their general practitioner. The third was lost to follow-up. Results from internal and external quality control for HbA1c were within set limits. Conclusion The pharmacists were able to perform the risk assessment and measurement of HbA1c, and pharmacy customers were willing to participate. The HbA1c measurements fulfilled the requirements for analytical quality. Thus, it is feasible to implement this service in community pharmacies in Norway. In a large-scale study the inclusion criteria should be increased to 45 years in accordance with the population the risk test has been validated for.	[Risoy, Aslaug Johanne; Kjome, Reidun Lisbet Skeide; Sandberg, Sverre; Solvik, Una Orvim] Univ Bergen, Fac Med, Dept Global Hlth & Primary Care, Bergen, Norway; [Risoy, Aslaug Johanne; Kjome, Reidun Lisbet Skeide] Univ Bergen, Fac Med, Ctr Pharm, Bergen, Norway; [Sandberg, Sverre] Haraldsplass Deaconess Hosp, Norwegian Qual Improvement Lab Examinat Noklus, Bergen, Norway; [Sandberg, Sverre] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Risoy, AJ (corresponding author), Univ Bergen, Fac Med, Dept Global Hlth & Primary Care, Bergen, Norway.; Risoy, AJ (corresponding author), Univ Bergen, Fac Med, Ctr Pharm, Bergen, Norway.	aslaug.risoy@uib.no	Sandberg, Sverre/T-9304-2019	Sandberg, Sverre/0000-0001-9521-5087; Solvik, Una Orvim/0000-0003-4186-6620; Kjome, Reidun Lisbet/0000-0002-9454-5188	Norwegian Community Pharmacy Foundation; University of Bergen	Norwegian Community Pharmacy Foundation; University of Bergen	The study was financed by The Norwegian Community Pharmacy Foundation (https://www.proff.no/selskap/stiftelsen-til-fremme-av-norskapotekfarmasi/oslo/fondlegat/IG9KD0M10NC/) and the University of Bergen (http://www.uib.no). The purpose of the Norwegian Community Pharmacy Foundation is to help promote the development of Norwegian pharmacy. Siemens (https://www.siemens.com/no/no/home.html) lent the DCA Vantage Analyzer instruments to the pharmacies and provided training free of charge. The participating pharmacy chain, Apotek 1, covered expenses of the course day and paid the membership fee in Noklus. The Norwegian Community Pharmacy Foundation had no influence on how the study was conducted, the analysis or the results. Apotek 1, University of Bergen, Siemens and The Norwegian Community Pharmacy Foundation had no influence on the analysis or the results, but Apotek 1 have been given valuable input to the protocol and procedures.; We thank all the participants, the pharmacists and pharmacy who participated, as well as the Pharmacy chain Apotek 1, Noklus and Siemens that lent out DCA Vantage. This project was supported by The Norwegian Community Pharmacy Foundation and the University of Bergen.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Apotekforeningen, 2016, 3 1 APOTEKKUNDER RES; AS SH, 2017, DCA VANT AN SIEM HEA; Clarke PM, 2009, MED CARE, V47, P61, DOI 10.1097/MLR.0b013e3181844855; Collins RE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-603; Craig P, 2013, INT J NURS STUD, V50, P585, DOI 10.1016/j.ijnurstu.2012.09.009; Diabetesforbundet Helsedirektoraret., 2015, SJEKK DIN DIAB DIAB; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Echouffo-Tcheugui JB, 2015, ANN FAM MED, V13, P149, DOI 10.1370/afm.1737; Fikri-Benbrahim N, 2015, DIABETES RES CLIN PR, V108, pE49, DOI 10.1016/j.diabres.2015.03.006; Gray LJ, 2010, DIABETIC MED, V27, P887, DOI 10.1111/j.1464-5491.2010.03037.x; Hassell K, 2000, HEALTH SOC CARE COMM, V8, P40, DOI 10.1046/j.1365-2524.2000.00222.x; HealthKnowledge, 2011, DIFF SCREEN DIAG TES; Helsedirektoraret, 2016, NASJ FAGL RETN DIAB; Herman WH, 2015, DIABETES CARE, V38, P1449, DOI 10.2337/dc14-2459; Hersberger KE, 2006, PHARM WORLD SCI, V28, P171, DOI 10.1007/s11096-006-9034-6; ISO, 2006, POINT OF CAR TEST PO; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Kowall B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171152; Krass I, 2007, DIABETES RES CLIN PR, V75, P339, DOI 10.1016/j.diabres.2006.06.022; Kulkarni M, 2017, DIABETES OBESITY MET; Larsson Elin C., 2008, Pharmacy Pract (Granada), V6, P74; Lee WJ, 2012, J KOREAN MED SCI, V27, P255, DOI 10.3346/jkms.2012.27.3.255; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Najafi Behzad, 2016, Med J Islam Repub Iran, V30, P326; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; NORD E, 1991, HEALTH POLICY, V18, P25, DOI 10.1016/0168-8510(91)90141-J; Norris SL, 2008, ANN INTERN MED, V148, P855, DOI 10.7326/0003-4819-148-11-200806030-00008; Papastergiou J, 2016, INT J PHARM PRACT, V24, P189, DOI 10.1111/ijpp.12228; Papastergiou John, 2012, Can Pharm J (Ott), V145, P165, DOI 10.3821/145.4.cpj165; Pavlish CL, 2010, SOC SCI MED, V71, P353, DOI 10.1016/j.socscimed.2010.04.010; Porta M, 2014, DIABETES CARE, V37, P1668, DOI 10.2337/dc13-2101; Rahman M, 2012, DIABETOLOGIA, V55, P1651, DOI 10.1007/s00125-011-2441-9; Sherifali D., 2013, OPEN DIABETES J, V6, P1; Solvik UO, 2013, CLIN CHEM, V59, P1790, DOI 10.1373/clinchem.2013.210781; Soriguer F, 2012, MED CLIN-BARCELONA, V138, P371, DOI 10.1016/j.medcli.2011.05.025; Stene L, 2017, DIABETES NORWAY; Stiglic G, 2016, DIABETES RES CLIN PR, V120, P194, DOI 10.1016/j.diabres.2016.08.010; Suphanchaimat R, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1065-z; Thoopputra Thitaporn, 2016, Value Health Reg Issues, V9, P1, DOI 10.1016/j.vhri.2015.03.022; Waynes P, 2010, QUALITY MANAGEMENT A; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Willis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091157; World Health Organization, 2003, SCREEN TYP 2 DIAB; Wu YL, 2014, INT J MED SCI, V11, P1185, DOI 10.7150/ijms.10001	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0191316	10.1371/journal.pone.0191316	http://dx.doi.org/10.1371/journal.pone.0191316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474501	Green Submitted, Green Published, gold			2022-12-27	WOS:000426049500007
J	Chacon-Madrigal, E; Wanek, W; Hietz, P; Dullinger, S				Chacon-Madrigal, Eduardo; Wanek, Wolfgang; Hietz, Peter; Dullinger, Stefan			Is local trait variation related to total range size of tropical trees?	PLOS ONE			English	Article							INTRASPECIFIC VARIABILITY; NICHE BREADTH; LEAF TRAITS; SEED SIZE; EVOLUTION; CONSTRAINTS; WIDESPREAD; ECOLOGY; CLIMATE; DIVERSIFICATION	The reasons why the range size of closely related species often varies significantly have intrigued scientists for many years. Among other hypotheses, species with high trait variation were suggested to occupy more diverse environments, have more continuity in their distributions, and consequently have larger range sizes. Here, using 34 tree species of lowlands tropical rainforest in southern Costa Rica, we explored whether inherent trait variability expressed at the local scale in functional traits is related to the species' total geographical range size. We formed 17 congeneric pairs of one narrow endemic and one widespread species, sampled 335 individuals and measured eight functional traits: leaf area, leaf thickness, leaf dry matter content, specific leaf area, leaf nitrogen content, leaf phosphorus content, leaf nitrogen to phosphorus ratio, and wood specific gravity. We tested whether there are significant differences in the locally expressed variation of individual traits or in multidimensional trait variance between the species in congeneric pairs and whether species' range size could hence be predicted from local trait variability. However, we could not find such differences between widely distributed and narrow range species. We discuss the possible reasons for these findings including the fact that higher trait variability of widespread species may result from successive local adaptations during range expansion and may hence often be an effect rather than the cause of larger ranges.	[Chacon-Madrigal, Eduardo] Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria; [Chacon-Madrigal, Eduardo] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Wanek, Wolfgang] Univ Vienna, Dept Microbiol & Ecosyst Sci, Vienna, Austria; [Hietz, Peter] Univ Nat Resources & Life Sci, Inst Bot, Vienna, Austria	University of Vienna; Universidad Costa Rica; University of Vienna; University of Natural Resources & Life Sciences, Vienna	Chacon-Madrigal, E (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria.; Chacon-Madrigal, E (corresponding author), Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.	edchacon@gmail.com	Chacón-Madrigal, Eduardo/AAK-1048-2021; Wanek, Wolfgang/E-7001-2012	Chacón-Madrigal, Eduardo/0000-0002-8328-5456; Wanek, Wolfgang/0000-0003-2178-8258	Rufford Small Grants Foundation [15981-1]; CONICIT (Consejo Nacional para Investigaciones Cientificas y Tecnologicas de Costa Rica) [FI-183-13]; CONICIT [FI-183-13]; University of Costa Rica [OAICE-CAB-175-2014]	Rufford Small Grants Foundation; CONICIT (Consejo Nacional para Investigaciones Cientificas y Tecnologicas de Costa Rica); CONICIT; University of Costa Rica	The first author (EC) received funding for fieldwork and laboratory analysis with the fellowship 15981-1 of The Rufford Small Grants Foundation. Fieldwork was also supported by the scholarship FI-183-13 by the CONICIT (Consejo Nacional para Investigaciones Cientificas y Tecnologicas de Costa Rica) (EC). Part of the costs for laboratory analysis was covered by the Centro de Investigaciones Agronomicas (CIA) of the University of Costa Rica. The first author (EC) also was supported by the scholarships FI-183-13 by CONICIT and OAICE-CAB-175-2014 by the University of Costa Rica.	Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Alvarado A., 2015, COSTA RICAN ECOSYSTE, P64; Bagley JC, 2014, BIOL REV, V89, P767, DOI 10.1111/brv.12076; Bechtold WA, 2003, NORTH J APPL FOR, V20, P154, DOI 10.1093/njaf/20.4.154; Benavides C, 2008, EFECTO AMBIENTE DIST; Boulangeat I, 2012, J BIOGEOGR, V39, P204, DOI 10.1111/j.1365-2699.2011.02581.x; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Cadotte M, 2013, ECOL LETT, V16, P1234, DOI 10.1111/ele.12161; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Climate Coen E., 1983, COSTA RICAN NATURAL, P35; Cornejo X, 2012, BRITTONIA, V64, P76, DOI 10.1007/s12228-011-9194-0; de Souza FC, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1587; Erkens RHJ, 2007, MOL PHYLOGENET EVOL, V44, P399, DOI 10.1016/j.ympev.2007.02.017; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Feeley KJ, 2009, P NATL ACAD SCI USA, V106, P12382, DOI 10.1073/pnas.0900698106; Fine PVA, 2014, EVOLUTION, V68, P1988, DOI 10.1111/evo.12414; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Gorman CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111190; Grime J. P., 2001, PLANT STRATEGIES VEG; Grossenbacher D, 2015, ECOL LETT, V18, P706, DOI 10.1111/ele.12449; Guo QF, 2000, ECOLOGY, V81, P2149, DOI 10.1890/0012-9658(2000)081[2149:COSSOP]2.0.CO;2; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Huber W, 2008, COSTA RICA STAPFIA, V88, P97; JORDANO P, 1995, AM NAT, V145, P163, DOI 10.1086/285735; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kunstler G, 2016, NATURE, V529, P204, DOI 10.1038/nature16476; Laliberte E., 2014, PACKAGE FD MEASURING; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lasky JR, 2013, J ECOL, V101, P722, DOI 10.1111/1365-2745.12065; Lavergne S, 2004, OIKOS, V107, P505, DOI 10.1111/j.0030-1299.2004.13423.x; Leigh EG, 2014, BIOL REV, V89, P148, DOI 10.1111/brv.12048; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; Li R, 2013, SYST BOT, V38, P536, DOI 10.1600/036364413X666606; LORD J, 1995, AM NAT, V146, P349, DOI 10.1086/285804; Markesteijn L, 2011, NEW PHYTOL, V191, P480, DOI 10.1111/j.1469-8137.2011.03708.x; McKown AD, 2014, NEW PHYTOL, V201, P1263, DOI 10.1111/nph.12601; Meng H, 2017, PLANT BIOLOGY, V19, P552, DOI 10.1111/plb.12564; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Mitchell RM, 2017, OIKOS, V126, P988, DOI 10.1111/oik.04001; Mitchell RM, 2017, OECOLOGIA; Morin X, 2011, ECOGRAPHY, V34, P738, DOI 10.1111/j.1600-0587.2010.06854.x; Morueta-Holme N, 2013, ECOL LETT, V16, P1446, DOI 10.1111/ele.12184; Murray BR, 2004, AUSTRAL ECOL, V29, P287, DOI 10.1111/j.1442-9993.2004.01365.x; O'Brien MJ, 2017, J APPL ECOL, V54, P1669, DOI 10.1111/1365-2664.12874; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pateiro-Lopez B, 2010, J STAT SOFTW, V34, P1; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Pigliucci M, 2003, ECOL LETT, V6, P265, DOI 10.1046/j.1461-0248.2003.00428.x; Pinheiro J, R PACKAGE VERSION; Preston KA, 2006, NEW PHYTOL, V170, P807, DOI 10.1111/j.1469-8137.2006.01712.x; Quesada F.J., 1997, ARBOLES PENINSULA OS; R Core Team, 2015, R LANGUAGE ENV STAT; Read QD, 2014, FUNCT ECOL, V28, P37, DOI 10.1111/1365-2435.12162; Reich PB, 1996, FUNCT ECOL, V10, P768, DOI 10.2307/2390512; Sexton JP, 2017, ANNU REV ECOL EVOL S, V48, P183, DOI 10.1146/annurev-ecolsys-110316-023003; Sexton JP, 2016, AM J BOT, V103, P129, DOI 10.3732/ajb.1500224; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Sides CB, 2014, AM J BOT, V101, P56, DOI 10.3732/ajb.1300284; Siefert A, 2015, ECOL LETT, V18, P1406, DOI 10.1111/ele.12508; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Soolanayakanahally RY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00528; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Svenning JC, 2014, ECOGRAPHY, V37, P1198, DOI 10.1111/j.1600-0587.2013.00574.x; Turcotte MM, 2016, TRENDS ECOL EVOL, V31, P803, DOI 10.1016/j.tree.2016.07.013; Uriarte M, 2016, FUNCT ECOL, V30, P157, DOI 10.1111/1365-2435.12576; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; VANDERWERF A, 1993, OECOLOGIA, V94, P434, DOI 10.1007/BF00317120; Walck JL, 2001, J BIOGEOGR, V28, P1221, DOI 10.1046/j.1365-2699.2001.00620.x; Wallace AR, 1867, GEOGRAPHICAL DISTRIB; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Witkowski ETF, 1997, J BIOGEOGR, V24, P469, DOI 10.1111/j.1365-2699.1997.00131.x; Wright IJ, 2017, SCIENCE, V357, P917, DOI 10.1126/science.aal4760; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zadworny M, 2016, NEW PHYTOL, V212, P389, DOI 10.1111/nph.14048	84	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193268	10.1371/journal.pone.0193268	http://dx.doi.org/10.1371/journal.pone.0193268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513689	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800049
J	Kim, SK; Kim, JH; Jeon, SS; Hong, SM				Kim, Sung Kyun; Kim, Ji Hoon; Jeon, Seung Sik; Hong, Seok Min			Relationship between sleep quality and dizziness	PLOS ONE			English	Article							INDEX PSQI; MIGRAINE; VERSION; STIMULATION; RELIABILITY; INSOMNIA; VALIDITY; APNEA; ASSOCIATION; DYSFUNCTION	Objective Poor sleep quality has a number of significant negative effects on daytime function. However, few studies have examined sleep quality in patients with dizziness. Here, we investigated the potential association between sleep quality and various types of dizziness. Subjects and methods We examined dizziness and sleep disturbance in 237 patients experiencing dizziness using Korean versions of the Pittsburgh Sleep Quality Index (PSQI), the Insomnia Severity Index (ISI), and Dizziness Handicap Inventory (DHI). All participants were classified as having benign paroxysmal positional vertigo (BPPV), Me A niere's disease (MD), vestibular neuritis (VN), vestibular migraine (VM), psychogenic dizziness (PD), or Other. Results The mean PSQI and ISI scores were highest in the PD group. The rate of sleep disturbance was highest in the Other group when the cut-off score for each questionnaire was set differently, except ISI >= 15. The correlation between DHI and sleep disturbance indices was highest in the VM group. Multivariate regression showed that PSQI score and DHI-E score were significantly related to the PD and Other groups, while the Other group was significantly related to the ISI score. Conclusion The findings of this study strongly suggest that there are associations between sleep quality and some disease subtypes associated with dizziness. Therefore, it is important to consider sleep disturbance in patients with psychogenic dizziness, such as phobic postural vertigo and chronic subjective dizziness, or nonspecific dizziness.	[Kim, Sung Kyun; Kim, Ji Hoon; Jeon, Seung Sik; Hong, Seok Min] Hallym Univ, Dongtan Sacred Heart Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Hwaseong, South Korea	Hallym University	Hong, SM (corresponding author), Hallym Univ, Dongtan Sacred Heart Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Hwaseong, South Korea.	thece1120@gmail.com						Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Buysse D J, 1989, Psychiatry Res, V28, P193; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; Joao KAD, 2017, PSYCHIAT RES, V247, P225, DOI 10.1016/j.psychres.2016.11.042; Della Marca G, 2006, CEPHALALGIA, V26, P857, DOI 10.1111/j.1468-2982.2006.01122.x; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Furman JM, 2013, LANCET NEUROL, V12, P706, DOI 10.1016/S1474-4422(13)70107-8; Gallina S, 2010, ACTA OTORHINOLARYNGO, V30, P281; Gomez S, 2008, CLIN NEUROPHYSIOL, V119, P617, DOI 10.1016/j.clinph.2007.10.058; Haponik EF, 1996, J GEN INTERN MED, V11, P759, DOI 10.1007/BF02598994; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kayabasi S, 2015, LARYNGOSCOPE, V125, P1244, DOI 10.1002/lary.25021; Konomi U., 2014, EQUILIBRIUM RES, V73, P502, DOI DOI 10.3757/jser.73.502; Li Y, 2015, HYPERTENSION, V65, P644, DOI 10.1161/HYPERTENSIONAHA.114.04604; Marano E, 2005, HEADACHE, V45, P325, DOI 10.1111/j.1526-4610.2005.05069.x; Martin T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155067; Nakayama M, 2010, J CLIN SLEEP MED, V6, P445; Nayak C, 2016, SLEEP BREATH, V20, P263, DOI 10.1007/s11325-015-1207-x; Neuhauser HK, 2008, ARCH INTERN MED, V168, P2118, DOI 10.1001/archinte.168.19.2118; Park SY, 2015, KOREAN J FAM MED, V35, P294, DOI 10.4082/kjfm.2015.36.6.294; Sitasuwan Tullaya, 2014, Journal of the Medical Association of Thailand, V97, pS57; Soffer-Dudek N, 2009, CONSCIOUS COGN, V18, P891, DOI 10.1016/j.concog.2008.07.007; Sohn SI, 2012, SLEEP BREATH, V16, P803, DOI 10.1007/s11325-011-0579-9; Son CN, 2015, KOREAN J INTERN MED, V30, P384, DOI 10.3904/kjim.2015.30.3.384; Sowerby LJ, 2010, LARYNGOSCOPE, V120, P1274, DOI 10.1002/lary.20899; Staab JP, 2006, CURR OPIN NEUROL, V19, P41, DOI 10.1097/01.wco.0000198102.95294.1f; Sugaya N, 2017, ACTA OTO-LARYNGOL, V137, P47, DOI 10.1080/00016489.2016.1213418; Takacs J, 2016, SLEEP BREATH, V20, P1045, DOI 10.1007/s11325-016-1347-7; Vass Z, 2001, NEUROSCIENCE, V103, P189, DOI 10.1016/S0306-4522(00)00521-2; Verkasalo PK, 2005, CANCER RES, V65, P9595, DOI 10.1158/0008-5472.CAN-05-2138; Weidt S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-317	32	32	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192705	10.1371/journal.pone.0192705	http://dx.doi.org/10.1371/journal.pone.0192705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513688	Green Submitted, gold, Green Published			2022-12-27	WOS:000426896800020
J	Mondini, V; Mangia, AL; Cappello, A				Mondini, Valeria; Mangia, Anna Lisa; Cappello, Angelo			Single-session tDCS over the dominant hemisphere affects contralateral spectral EEG power, but does not enhance neurofeedbackguided event-related desynchronization of the non-dominant hemisphere's sensorimotor rhythm	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; BRAIN-COMPUTER INTERFACE; HUMAN MOTOR CORTEX; TRANSCRANIAL DIRECT; INTERHEMISPHERIC INHIBITION; CORTICAL SYNCHRONIZATION; STROKE RECOVERY; IMAGERY; EXCITABILITY; REHABILITATION	Background and objective Transcranial direct current stimulation (tDCS) and neurofeedback-guided motor imagery (MI) have attracted considerable interest in neurorehabilitation, given their ability to influence neuroplasticity. As tDCS has been shown to modulate event-related desynchronization (ERD), the neural signature of motor imagery detected for neurofeedback, a combination of the techniques was recently proposed. One limitation of this approach is that the area targeted for stimulation is the same from which the signal for neurofeedback is acquired. As tDCS may interfere with proximal electroencephalographic (EEG) electrodes, in this study our aim was to test whether contralateral tDCS could have interhemispheric effects on the spectral power of the unstimulated hemisphere, possibly mediated by transcallosal connection, and whether such effects could be used to enhance ERD magnitudes. A contralateral stimulation approach would indeed facilitate co-registration, as the stimulation electrode would be far from the recording sites. Methods Twenty right-handed healthy volunteers (aged 21 to 32) participated in the study: ten assigned to cathodal, ten to anodal versus sham stimulation. We applied stimulation over the dominant (left) hemisphere, and assessed ERD and spectral power over the non-dominant (right) hemisphere. The effect of tDCS was evaluated over time. Spectral power was assessed in theta, alpha and beta bands, under both rest and MI conditions, while ERD was evaluated in alpha and beta bands. Results Two main findings emerged: (1) contralateral alpha-ERD was reduced after anodal (p = 0.0147), but not enhanced after cathodal tDCS; (2) both stimulations had remote effects on the spectral power of the contralateral hemisphere, particularly in theta and alpha ( significant differences in the topographical t-value maps). Conclusion The absence of contralateral cathodal ERD enhancement suggests that the protocol is not applicable in the context of MI training. Nevertheless, ERD results of anodal and spectral power results of both stimulations complement recent findings on the distant tDCS effects between functionally related areas.	[Mondini, Valeria; Mangia, Anna Lisa; Cappello, Angelo] Univ Bologna, Dept Elect Elect & Informat Engn DEI, Cesena, Italy	University of Bologna	Mondini, V (corresponding author), Univ Bologna, Dept Elect Elect & Informat Engn DEI, Cesena, Italy.	valeria.mondini3@unibo.it	Coish, Elizabeth/AAU-1245-2020	Mondini, Valeria/0000-0001-7680-6199				Ang KK, 2015, ARCH PHYS MED REHAB, V96, pS79, DOI 10.1016/j.apmr.2014.08.008; Baumer T, 2007, EXP BRAIN RES, V180, P195, DOI 10.1007/s00221-007-0866-7; Baxter BS, 2016, BRAIN STIMUL, V9, P834, DOI 10.1016/j.brs.2016.07.003; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cincotti F, 2008, J NEUROSCI METH, V167, P31, DOI 10.1016/j.jneumeth.2007.06.031; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Di Lazzaro V, 2012, J NEURAL TRANSM, V119, P1499, DOI 10.1007/s00702-012-0845-4; Faller J, 2012, IEEE T NEUR SYS REH, V20, P313, DOI 10.1109/TNSRE.2012.2189584; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Gilio F, 2003, J PHYSIOL-LONDON, V551, P563, DOI 10.1113/jphysiol.2003.044313; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Hatem SM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00442; Hochberg Y, 1987, MULTIPLE COMP PROCED, pi; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Kasashima Y, 2012, EXP BRAIN RES, V221, P263, DOI 10.1007/s00221-012-3166-9; Kasashima-Shindo Y, 2015, J REHABIL MED, V47, P318, DOI 10.2340/16501977-1925; Kasuga S, 2015, LATERALITY, V20, P453, DOI 10.1080/1357650X.2014.998679; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lapenta OM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00256; Ludemann-Podubecka J, 2014, NEUROSCI BIOBEHAV R, V47, P245, DOI 10.1016/j.neubiorev.2014.07.022; Mancini M, 2016, NEUROIMAGE, V140, P57, DOI 10.1016/j.neuroimage.2016.06.003; Mancini M, 2015, IEEE ENG MED BIO, P2729, DOI 10.1109/EMBC.2015.7318956; Mangia AL, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00057; Mangia AL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00601; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Matsumoto J, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-27; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Moliadze V, 2010, CLIN NEUROPHYSIOL, V121, P2165, DOI 10.1016/j.clinph.2010.04.033; Morone G, 2015, ARCH PHYS MED REHAB, V96, pS71, DOI 10.1016/j.apmr.2014.05.026; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Notturno F, 2014, HUM BRAIN MAPP, V35, P2220, DOI 10.1002/hbm.22322; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pellicciari MC, 2013, NEUROIMAGE, V83, P569, DOI 10.1016/j.neuroimage.2013.06.076; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pichiorri F, 2015, ANN NEUROL, V77, P851, DOI 10.1002/ana.24390; Polania R, 2012, HUM BRAIN MAPP, V33, P2499, DOI 10.1002/hbm.21380; Roy A, 2014, IEEE T BIO-MED ENG, V61, P1967, DOI 10.1109/TBME.2014.2311071; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Sharbrough FW, 1991, RESEARCHGATE, V8, P200; Soekadar SR, 1991, ENHANCING HEBBIAN LE; Soekadar SR, 2015, NEUROBIOL DIS, V83, P172, DOI 10.1016/j.nbd.2014.11.025; Soekadar SR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00093; Stagg CJ, 2011, NEUROPSYCHOLOGIA, V49, P800, DOI 10.1016/j.neuropsychologia.2011.02.009; Suffczynski P, 2001, INT J PSYCHOPHYSIOL, V43, P25, DOI 10.1016/S0167-8760(01)00177-5; Tazoe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114244; Tohyama Takamichi, 2011, Keio Journal of Medicine, V60, P114; Ursino M, 2010, NEUROIMAGE, V52, P1080, DOI 10.1016/j.neuroimage.2009.12.084; van Dokkum LEH, 2015, ANN PHYS REHABIL MED, V58, P3, DOI 10.1016/j.rehab.2014.09.016; Vines BW, 2008, EUR J NEUROSCI, V28, P1667, DOI 10.1111/j.1460-9568.2008.06459.x; Vines BW, 2006, NEUROREPORT, V17, P671, DOI 10.1097/00001756-200604240-00023; Wei PF, 2013, IEEE T NEUR SYS REH, V21, P404, DOI 10.1109/TNSRE.2013.2249111; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	62	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193004	10.1371/journal.pone.0193004	http://dx.doi.org/10.1371/journal.pone.0193004			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513682	Green Submitted, Green Published, gold			2022-12-27	WOS:000426896800029
J	Gadar, L; Abonyl, J				Gadar, Laszlo; Abonyl, Janos			Graph configuration model based evaluation of the education-occupation match	PLOS ONE			English	Article							LABOR-MARKET; MULTIRESOLUTION METHODS; STATISTICAL-MECHANICS; OVEREDUCATION; RESOLUTION; MISMATCH	To study education-occupation matchings we developed a bipartite network model of education to work transition and a graph configuration model based metric. We studied the career paths of 15 thousand Hungarian students based on the integrated database of the National Tax Administration, the National Health Insurance Fund, and the higher education information system of the Hungarian Government. A brief analysis of gender pay gap and the spatial distribution of over-education is presented to demonstrate the background of the research and the resulted open dataset. We highlighted the hierarchical and clustered structure of the career paths based on the multi-resolution analysis of the graph modularity. The results of the cluster analysis can support policymakers to fine-tune the fragmented program structure of higher education.	[Gadar, Laszlo] Innopod Solut Ltd, Budapest, Hungary; [Gadar, Laszlo] Univ Pannonia, MTA PE Budapest Ranking Res Grp, Veszprem, Hungary; [Abonyl, Janos] Univ Pannonia, MTA PE Lendulet Complex Syst Monitoring Res Grp, Veszprem, Hungary	Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); University of Pannonia; University of Pannonia	Abonyl, J (corresponding author), Univ Pannonia, MTA PE Lendulet Complex Syst Monitoring Res Grp, Veszprem, Hungary.	janos@abonyilab.com	Abonyi, Janos/O-2832-2013; Gadár, László/AAU-6881-2020	Abonyi, Janos/0000-0001-8593-1493; Gadár, László/0000-0003-2581-7917	National Research, Development and Innovation Office - NKFIH [OTKA - 116674]; National Research, Development and Innovation Office-NKFIH [OTKA-116674]	National Research, Development and Innovation Office - NKFIH; National Research, Development and Innovation Office-NKFIH	The research has been supported by the National Research, Development and Innovation Office - NKFIH, through the project OTKA - 116674 (Process mining and deep learning in the natural sciences and process development). The employing company of Laszlo Gadar was not involved in the research. The "Innopod Solutions Ltd, Budapest, Hungary" did not have any role in the design of the study, the collection of the data, preparation of the manuscript, decision to publish. The company does not claim any right to the results. The data used in the publication is public and freely available without any restriction. The specific roles of these authors are articulated in the author contributions section. The funder provided support in the form of salary for the author Laszlo Gadar, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific the authors are articulated in the 'author contributions' section.; The research has been supported by the National Research, Development and Innovation Office-NKFIH, through the project OTKA-116674 (Process mining and deep learning in the natural sciences and process development)	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Barabasi A. L., 2014, NETWORK SCI GRAPH TH; BarabuYsi A.-L., 2015, NETW SCI; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Berggren C, 2010, EUR EDUC, V42, P61, DOI 10.2753/EUE1056-4934420103; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cremonini L, 2008, HIGH EDUC, V55, P373, DOI 10.1007/s10734-007-9062-8; Cunha JM, 2014, ECON EDUC REV, V42, P64, DOI 10.1016/j.econedurev.2014.06.001; Duncan GJ., 1981, EC ED REV, V1, P75, DOI [10.1016/0272-7757(81)90028-5, DOI 10.1016/0272-7757(81)90028-5]; ENQA, 2015, STAND GUID QUAL ASS, P32; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Gal A., 2013, ALLAMIGAZGATASI ADAT, P5; Garam I., 2005, FINNISH EMPLOYERS VI; Garcia-Aracil A, 2015, HIGH EDUC, V69, P735, DOI 10.1007/s10734-014-9803-4; Gillespie CS, 2015, J STAT SOFTW, V64; Groot W, 2000, ECON EDUC REV, V19, P149, DOI 10.1016/S0272-7757(99)00057-6; Hartog J, 2000, ECON EDUC REV, V19, P131, DOI 10.1016/S0272-7757(99)00050-3; Hung CY, 2008, J ASIAN ECON, V19, P125, DOI 10.1016/j.asieco.2008.02.001; Iriondo I, 2016, J POLICY MODEL, V38, P304, DOI 10.1016/j.jpolmod.2015.12.008; Kler P, 2005, EDUC ECON, V13, P47, DOI 10.1080/0964529042000325207; Kumpula JM, 2007, PROC SPIE, V6601, DOI 10.1117/12.725560; McGuinness S, 2011, ECON EDUC REV, V30, P130, DOI 10.1016/j.econedurev.2010.07.006; Morris S, 2005, PHYS0503061 ARXIV; Murillo IP, 2012, J POLICY MODEL, V34, P646, DOI 10.1016/j.jpolmod.2011.07.012; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nyusti S, 2013, DIPLOMAS PALYAKOVETE; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Saar E, 2008, INT J COMP SOCIOL, V49, P31, DOI 10.1177/0020715207088586; Sojkin B, 2012, HIGH EDUC, V63, P565, DOI 10.1007/s10734-011-9459-2; VERDUGO RR, 1989, J HUM RESOUR, V24, P629, DOI 10.2307/145998; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wallgren A., 2011, JOINT STAT M SECT SU, P357; Xiang J, 2012, PHYSICA A, V391, P4995, DOI 10.1016/j.physa.2012.05.006; Young D, 2010, AM J PUBLIC HEALTH, V100, P1208, DOI 10.2105/AJPH.2009.184705	35	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0192427	10.1371/journal.pone.0192427	http://dx.doi.org/10.1371/journal.pone.0192427			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509783	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000426813200003
J	Andrade-Silva, LE; Ferreira-Paim, K; Ferreira, TB; Vilas-Boas, A; Mora, DJ; Manzato, VM; Fonseca, FM; Buosi, K; Andrade-Silva, J; Prudente, BD; Araujo, NE; Sales-Campos, H; da Silva, MV; Rodrigues, V; Meyer, W; Silva-Vergara, ML				Andrade-Silva, Leonardo Euripedes; Ferreira-Paim, Kennio; Ferreira, Thatiana Bragine; Vilas-Boas, Anderson; Mora, Delio Jose; Manzato, Veronica Morais; Fonseca, Fernanda Machado; Buosi, Kelli; Andrade-Silva, Juliana; Prudente, Bruno da Silva; Araujo, Natalia Evelyn; Sales-Campos, Helioswilton; da Silva, Marcus Vinicius; Rodrigues Junior, Virmondes; Meyer, Wieland; Silva-Vergara, Mario Leon			Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors	PLOS ONE			English	Article							HIV-ASSOCIATED CRYPTOCOCCOSIS; VAR. GRUBII; MOLECULAR EPIDEMIOLOGY; PHOSPHOLIPASE-ACTIVITY; VIRULENCE FACTORS; MATING-TYPE; SEROTYPE-A; GATTII; POPULATION; STRAINS	Cryptococcal infections are mainly caused by members of the Cryptococcus neoformans species complex (molecular types VNI, VNII, VNB, VNIV and the AD hybrid VNIII). PCR of the mating type loci and MLST typing using the ISHAM-MLST consensus scheme were used to evaluate the genetic relationship of 102 (63 clinical and 39 environmental) C. neoformans isolates from Uberaba, Brazil and to correlate the obtained genotypes with clinical, antifungal susceptibility and virulence factor data. All isolates were mating type alpha. MLST identified 12 known and five new sequence types (ST). Fourteen STs were identified within the VNI isolates, with ST93 (57/102, 56%) and ST77 (19/102, 19%) being the most prevalent. From the nine VNII isolates previously identify by URA5-RFLP only four (ST40) were confirmed by MLST. The remaining five grouped within the VNB Glade in the phylogenetic analysis corresponding to the sequence type ST504. Other two environmental isolates also grouped within VNB Glade with the new sequence type ST527. The four VNII/ST40 isolates were isolated from CSF. The two VNIV sequence types (ST11 and ST160) were isolated from blood cultures. Two of six patients evaluated with more than one isolates had mixed infections. Amongst the VNI isolates 4 populations were identified, which showed differences in their susceptibility profiles, clinical outcome and virulence factors. These results reinforce that ST93 is the most prevalent ST in HIV-infected patients in the Southeastern region of Brazil. The finding of the VNB molecular type amongst environmental Brazilian isolates highlights that this genotype is not restricted to the African continent.	[Andrade-Silva, Leonardo Euripedes; Ferreira-Paim, Kennio; Ferreira, Thatiana Bragine; Vilas-Boas, Anderson; Mora, Delio Jose; Manzato, Veronica Morais; Buosi, Kelli; Andrade-Silva, Juliana; Prudente, Bruno da Silva; Araujo, Natalia Evelyn; Silva-Vergara, Mario Leon] Triangulo Mineiro Fed Univ, Infect Dis Dept, Uberaba, Brazil; [Andrade-Silva, Leonardo Euripedes; Ferreira-Paim, Kennio] Triangulo Mineiro Fed Univ, Clin Pathol Dept, Uberaba, Brazil; [Ferreira-Paim, Kennio; Meyer, Wieland] Univ Sydney, Marie Bashir Inst Emerging Infect Dis & Biosecur, Ctr Infect Dis & Microbiol,Sydney Med Sch,Westmea, Westmead Inst Med Res,Mol Mycol Res Lab,Westmead, Sydney, NSW, Australia; [Fonseca, Fernanda Machado] Univ Fed Piaui, Biomed Dept, Parnaiba, Brazil; [Sales-Campos, Helioswilton; da Silva, Marcus Vinicius; Rodrigues Junior, Virmondes] Triangulo Mineiro Fed Univ, Lab Immunol, Uberaba, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro; University of Sydney; Westmead Institute for Medical Research; Universidade Federal do Piaui; Universidade Federal do Triangulo Mineiro	Andrade-Silva, LE (corresponding author), Triangulo Mineiro Fed Univ, Infect Dis Dept, Uberaba, Brazil.; Andrade-Silva, LE (corresponding author), Triangulo Mineiro Fed Univ, Clin Pathol Dept, Uberaba, Brazil.	leonardoeuripedes@gmail.com	Ferreira-Paim, Kennio/A-8194-2013; andrade-silva, leonardo/AAA-4356-2020; Fonseca, Fernanda Machado/AAV-2433-2021; Fonseca, Fernanda/E-8285-2018; Fonseca, Fernanda Machado/AAV-8930-2021; Silva, Marcos Vinicius/AAY-1986-2020; Mora, Delio José/G-1614-2012; Sales-Campos, Helioswilton/O-5367-2017; FONSECA, FERNANDA/HDN-9451-2022	Ferreira-Paim, Kennio/0000-0002-6035-8392; andrade-silva, leonardo/0000-0002-0485-229X; Fonseca, Fernanda Machado/0000-0002-5326-0776; Fonseca, Fernanda/0000-0002-5326-0776; Silva, Marcos Vinicius/0000-0002-2966-7621; Sales-Campos, Helioswilton/0000-0003-3252-2834; FONSECA, FERNANDA/0000-0002-0315-6479; Rodrigues Jr, Virmondes/0000-0001-8706-4223	Grant Support Foundation of Minas Gerais (FAPEMIG) [APQ71035 / 2010]; NH MRC grant [APP1031943]	Grant Support Foundation of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NH MRC grant(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Grant Support Foundation of Minas Gerais (FAPEMIG) Grant: #APQ71035 / 2010 to MLSV, and an NH & MRC grant #APP1031943 to WM. The funders analysis, decision to publish, or preparation of the manuscript.	Andrade-Silva L, 2010, FUNGAL BIOL-UK, V114, P438, DOI 10.1016/j.funbio.2010.03.005; AOKI S, 1994, MYCOPATHOLOGIA, V128, P143, DOI 10.1007/BF01138475; Arsenijevic VA, 2014, MYCOSES, V57, P380, DOI 10.1111/myc.12171; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beale MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003847; Bertout S, 2013, CLIN MICROBIOL INFEC, V19, P763, DOI 10.1111/1469-0691.12019; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Brito-Santos F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115866; Casali AK, 2003, FEMS YEAST RES, V3, P405, DOI 10.1016/S1567-1356(03)00038-2; Cattana ME, 2013, REV ARGENT MICROBIOL, V45, P89, DOI 10.1016/S0325-7541(13)70005-1; Chang YC, 2000, J EXP MED, V191, P871, DOI 10.1084/jem.191.5.871; Chaturvedi S, 2000, J CLIN MICROBIOL, V38, P2007, DOI 10.1128/JCM.38.5.2007-2009.2000; Chen Y, 2015, MOL ECOL; Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI; CLSI, 2012, REF METH BROTH DIL A; Cogliati M, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/675213; Cogliati M, 2013, MED MYCOL, V51, P499, DOI 10.3109/13693786.2012.751642; da Silva EG, 2006, J MED MICROBIOL, V55, P139, DOI 10.1099/jmm.0.46206-0; de Oliveira MTB, 2004, J CLIN MICROBIOL, V42, P1356, DOI 10.1128/JCM.42.3.1356-1359.2004; Desalermos A, 2012, EXPERT OPIN PHARMACO, V13, P783, DOI 10.1517/14656566.2012.658773; Desnos-Ollivier M, 2015, MBIO, V6, DOI 10.1128/mBio.00311-15; Desnos-Ollivier M, 2010, MBIO, V1, DOI 10.1128/mBio.00091-10; Dou HT, 2015, EUR J CLIN MICROBIOL, V34, P753, DOI 10.1007/s10096-014-2289-2; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferreira-Paim K, 2010, GENOTYPING CRYPTOCOC; Ferreira-Paim K, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005223; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kanemitsu K, 2001, J MICROBIOL METH, V47, P11, DOI 10.1016/S0167-7012(01)00283-4; Kaocharoen S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002297; Khayhan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072222; Lengeler KB, 2000, P NATL ACAD SCI USA, V97, P14455, DOI 10.1073/pnas.97.26.14455; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Litvintseva AP, 2007, PLOS PATHOG, V3, P1109, DOI 10.1371/journal.ppat.0030114; Litvintseva AP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002495; Litvintseva AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019688; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Luo G, 2001, J CLIN MICROBIOL, V39, P2971, DOI 10.1128/JCM.39.8.2971-2974.2001; Mednick AJ, 2005, INFECT IMMUN, V73, P2012, DOI 10.1128/IAI.73.4.2012-2019.2005; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Miglia KJ, 2011, J CLIN MICROBIOL, V49, P307, DOI 10.1128/JCM.01277-10; Mihara T, 2013, MED MYCOL, V51, P252, DOI 10.3109/13693786.2012.708883; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Pappalardo MCSM, 2007, AIDS, V21, P1971, DOI 10.1097/01.aids.0000287549.79368.33; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pedroso RS, 2010, MEM I OSWALDO CRUZ, V105, P993, DOI 10.1590/S0074-02762010000800008; PRICE MF, 1982, SABOURAUDIA, V20, P7; Pritchard JK, 2000, GENETICS, V155, P945; Rhodes J, 2017, GENETICS, V207, P327, DOI 10.1534/genetics.117.203836; Rhodes J, 2017, G3-GENES GENOM GENET, V7, P1165, DOI 10.1534/g3.116.037499; Ribeiro AM, 2006, MED MYCOL, V44, P707, DOI 10.1080/13693780600917209; SAMARANAYAKE LP, 1984, SABOURAUDIA, V22, P201; Sanchez A, 2008, REV IBEROAM MICOL, V25, P145, DOI 10.1016/S1130-1406(08)70034-2; Sanchini A, 2014, MED MICROBIOL IMMUN, V203, P333, DOI 10.1007/s00430-014-0341-6; Simwami SP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001343; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; Sun S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004849; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres-Rodriguez JM, 2008, REV IBEROAM MICOL, V25, P27, DOI 10.1016/S1130-1406(08)70007-X; Tortorano AM, 1997, MYCOSES, V40, P297, DOI 10.1111/j.1439-0507.1997.tb00235.x; Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008; Umeyama T, 2013, JPN J INFECT DIS, V66, P51, DOI 10.7883/yoken.66.51; Van Wyk M, 2014, J CLIN MICROBIOL, V52, P1921, DOI 10.1128/JCM.03177-13; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Wiesner DL, 2012, MBIO, V3, DOI 10.1128/mBio.00196-12; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	74	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193237	10.1371/journal.pone.0193237	http://dx.doi.org/10.1371/journal.pone.0193237			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505557	gold, Green Published, Green Submitted			2022-12-27	WOS:000426548200009
J	Andre, EM; Daviaud, N; Sindji, L; Cayon, J; Perrot, R; Montero-Menei, CN				Andre, E. M.; Daviaud, N.; Sindji, L.; Cayon, J.; Perrot, R.; Montero-Menei, C. N.			A novel ex vivo Huntington's disease model for studying GABAergic neurons and cell grafts by laser microdissection	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; REAL-TIME PCR; ORGANOTYPIC BRAIN-SLICES; R6/2 MOUSE MODEL; CAPTURE MICRODISSECTION; NEUROTROPHIC FACTOR; ANIMAL-MODELS; GENE-EXPRESSION; CULTURE MODEL; BEHAVIORAL DEFICITS	Organotypic brain slice cultures have been recently used to study neurodegenerative disorders such as Parkinson's disease and Huntington's disease (HD). They preserve brain three-dimensional architecture, synaptic connectivity and brain cells microenvironment. Here, we developed an innovative model of Huntington's disease from coronal rat brain slices, that include all the areas involved in the pathology. HD-like neurodegeneration was obtained in only one week, in a single step, during organotypic slice preparation, without the use of neurotoxins. HD-like histopathology was analysed and after one week, a reduction of 40% of medium spiny neurons was observed. To analyse new therapeutic approaches in this innovative HD model, we developed a novel protocol of laser microdissection to isolate and analyse by RT-qPCR, grafted cells as well as surrounding tissue of fresh organotypic slices. We determined that laser microdissection could be performed on a 400 mu m organotypic slice after alcohol dehydration protocol, allowing the analysis of mRNA expression in the rat tissue as well as in grafted cells. In conclusion, we developed a new approach for modeling Huntington's disease ex vivo, and provided a useful innovative method for screening new potential therapies for neurodegenerative diseases especially when associated with laser microdissection.	[Andre, E. M.; Daviaud, N.; Sindji, L.; Montero-Menei, C. N.] Univ Angers, Univ Nantes, INSERM, CRCINA, Angers, France; [Daviaud, N.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Daviaud, N.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Cayon, J.] Angers Univ, PACEM, Angers, France; [Perrot, R.] Angers Univ, SCIAM, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Universite d'Angers; Universite d'Angers	Montero-Menei, CN (corresponding author), Univ Angers, Univ Nantes, INSERM, CRCINA, Angers, France.	claudia.montero-menei@univ-angers.tr	Daviaud, Nicolas/GRF-5681-2022; Daviaud, Nicolas/O-1727-2019	Daviaud, Nicolas/0000-0001-8105-9124; Montero-Menei, Claudia/0000-0002-1373-6987; SINDJI, Laurence/0000-0001-5449-4817	Education Audiovisual; cultural executive agency of the European Union through the NanoFar Erasmus Mundus joint Doctoral program; Angers Loire Metropole; Fondation de l'Avenir; "Inserm", France; "Region des Pays de La Loire through the "Paris Scientifiques" grant	Education Audiovisual; cultural executive agency of the European Union through the NanoFar Erasmus Mundus joint Doctoral program; Angers Loire Metropole(Region Pays de la Loire); Fondation de l'Avenir; "Inserm", France(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Region des Pays de La Loire through the "Paris Scientifiques" grant	This project is supported by the "Education Audiovisual" and the cultural executive agency of the European Union through the NanoFar Erasmus Mundus joint Doctoral program, by Angers Loire Metropole and by the "Fondation de l'Avenir" & "Inserm", France.; This project is supported by the "Education Audiovisual" and the executive cultural agency of the European Union through the NanoFar Erasmus Mundus joint Doctoral program, by Angers Loire Metropole, by "Region des Pays de La Loire through the "Paris Scientifiques" grant and by the "Fondation de l'Avenir" & "Inserm", France	Andre EM, 2016, BIOMATERIALS, V83, P347, DOI 10.1016/j.biomaterials.2015.12.008; Le AVP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12859; Arsenault Jason, 2013, BMC Res Notes, V6, P544, DOI 10.1186/1756-0500-6-544; Bullock MD, 2014, JOVE-J VIS EXP, DOI 10.3791/51475; Cavaliere F, 2010, J NEUROSCI METH, V188, P205, DOI 10.1016/j.jneumeth.2010.02.008; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Clabough Erin B. D., 2013, Yale Journal of Biology and Medicine, V86, P217; Cummings DM, 2012, J NEUROPHYSIOL, V107, P677, DOI 10.1152/jn.00762.2011; Daviaud N, 2014, NEUROSCIENCE, V256, P10, DOI 10.1016/j.neuroscience.2013.10.021; Daviaud N, 2015, STEM CELL TRANSL MED, V4, P670, DOI 10.5966/sctm.2014-0139; Daviaud N, 2013, EXP NEUROL, V248, P429, DOI 10.1016/j.expneurol.2013.07.012; Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041; Delcroix GJR, 2010, DIFFERENTIATION, V80, P213, DOI 10.1016/j.diff.2010.07.001; Dey ND, 2010, BEHAV BRAIN RES, V214, P193, DOI 10.1016/j.bbr.2010.05.023; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fink KD, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt341; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086; Indersmitten T, 2015, J NEUROPHYSIOL, V113, P2953, DOI 10.1152/jn.01056.2014; Jaderstad LM, 2010, REGEN MED, V5, P901, DOI 10.2217/RME.10.80; Jiang W, 2009, J NEUROSCI METH, V179, P219, DOI 10.1016/j.jneumeth.2009.01.033; Jin X, 2003, J NEUROSCI, V23, P5662; Johnson MA, 2006, J NEUROCHEM, V97, P737, DOI 10.1111/j.1471-4159.2006.03762.x; Kaiser A, 2014, BRAIN RES, V1566, P12, DOI 10.1016/j.brainres.2014.04.006; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kerkis I, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0248-1; Kerman IA, 2006, J NEUROSCI METH, V153, P71, DOI 10.1016/j.jneumeth.2005.10.010; Kim H, 2013, PROG NEURO-PSYCHOPH, V41, P36, DOI 10.1016/j.pnpbp.2012.11.004; Kumamaru H, 2012, NAT COMMUN, P3; Lau CG, 2012, J NEUROSCI, V32, P8521, DOI 10.1523/JNEUROSCI.1245-12.2012; Liu Angen, 2010, J Biomol Tech, V21, P120; Lynch G, 2007, J NEUROSCI, V27, P4424, DOI 10.1523/JNEUROSCI.5113-06.2007; McLeod MC, 2013, CELL TRANSPLANT, V22, P2237, DOI 10.3727/096368912X658809; Menalled L, 2014, MOVEMENT DISORD, V29, P1375, DOI 10.1002/mds.26006; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Milcheva R, 2013, ACTA HISTOCHEM, V115, P279, DOI 10.1016/j.acthis.2012.08.002; Murphy RC, 2004, MOL BRAIN RES, V121, P141, DOI 10.1016/j.molbrainres.2003.11.011; Murphy RC, 2001, MOL THER, V3, P113, DOI 10.1006/mthe.2000.0235; Navarro-Galve B, 2005, J GENE MED, V7, P18, DOI 10.1002/jgm.639; Nopoulos PC, 2016, DIALOGUES CLIN NEURO, V18, P91; Ortiz AN, 2011, NEUROSCI LETT, V492, P11, DOI 10.1016/j.neulet.2011.01.036; Ostergaard K, 1996, EXP NEUROL, V142, P340, DOI 10.1006/exnr.1996.0203; Ou Y, 2010, EXP PHYSIOL, V95, P938, DOI 10.1113/expphysiol.2009.051300; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pecho-Vrieseling E, 2014, NAT NEUROSCI, V17, P1064, DOI 10.1038/nn.3761; Philips T, 2014, MOVEMENT DISORD, V29, P1391, DOI 10.1002/mds.26010; Precious SV, 2017, NEUROCHEM INT, V106, P114, DOI 10.1016/j.neuint.2017.01.016; Proenca CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068357; Rasmussen A, 2000, NEUROPEDIATRICS, V31, P190, DOI 10.1055/s-2000-7461; Reinhart PH, 2011, NEUROBIOL DIS, V43, P248, DOI 10.1016/j.nbd.2011.03.017; Riley C, 2006, J NEURAL TRANSM, V113, P103, DOI 10.1007/s00702-005-0302-8; Rossignol J, 2011, BEHAV BRAIN RES, V217, P369, DOI 10.1016/j.bbr.2010.11.006; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Schutze K, 1998, NAT BIOTECHNOL, V16, P737, DOI 10.1038/nbt0898-737; Shannon KM, 2015, MOVEMENT DISORD, V30, P1539, DOI 10.1002/mds.26331; Shear DA, 1998, PROG NEURO-PSYCHOPH, V22, P1217, DOI 10.1016/S0278-5846(98)00070-0; Squitieri F, 2015, CLIN GENET; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Stahlberg A, 2010, METHODS, V50, P282, DOI 10.1016/j.ymeth.2010.01.002; Tanvig M, 2009, BRAIN RES, V1295, P1, DOI 10.1016/j.brainres.2009.07.075; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Vandewoestyne M, 2013, ANAL BIOCHEM, V439, P88, DOI 10.1016/j.ab.2013.04.023; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Wang LH, 2006, ACTA PHARMACOL SIN, V27, P1287, DOI 10.1111/j.1745-7254.2006.00410.x; Yhnell E, 2016, J HUNTINGTONS DIS, V5, P149, DOI 10.3233/JHD-160191; Yokota K, 2015, STEM CELL REP, V5, P264, DOI 10.1016/j.stemcr.2015.06.004; Zach S, 2007, CELL MOL NEUROBIOL, V27, P505, DOI 10.1007/s10571-007-9141-5	72	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193409	10.1371/journal.pone.0193409	http://dx.doi.org/10.1371/journal.pone.0193409			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505597	Green Published, gold, Green Submitted			2022-12-27	WOS:000426548200015
J	Trombetta, BA; Carlyle, BC; Koenig, AM; Shaw, LM; Trojanowski, JQ; Wolk, DA; Locascio, JJ; Arnold, SE				Trombetta, Bianca A.; Carlyle, Becky C.; Koenig, Aaron M.; Shaw, Leslie M.; Trojanowski, John Q.; Wolk, David A.; Locascio, Joseph J.; Arnold, Steven E.			The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease	PLOS ONE			English	Article							ACID-BINDING PROTEIN; BRAIN INSULIN-RESISTANCE; NEUROFILAMENT LIGHT; BLOOD BIOMARKERS; TAU; PATHOLOGY; DEMENTIA; MARKERS; CSF; INFLAMMATION	Objective Alzheimer's disease (AD) is a complex neurodegenerative disease driven by multiple interacting pathophysiological processes that ultimately results in synaptic loss, neuronal death, and dementia. We implemented a fit-for-purpose modeled approach to qualify a broad selection of commercially available immunoassays and evaluate the biotemporal stability of analytes across five pathophysiological domains of interest in AD, including core amyloid-beta (A beta) and tau AD biomarkers, neurodegeneration, inflammation/immune modulation, neurovascular injury, and metabolism/oxidative stress. Methods Paired baseline and eight-week CSFs from twenty participants in a clinical drug trial for mild cognitive impairment (MCI) or mild dementia due to AD were used to evaluate sensitivity, intra-assay precision, inter-assay replicability, and eight-week biotemporal stability for sixty unique analytes measured with commercially available single-and multi-plex ELISA assays. Coefficients of variation (CV) were calculated, and intraclass correlation and Wilcoxon signed rank tests were applied. Results We identified 32 biomarker candidates with good to excellent performance characteristics according to assay technical performance and CSF analyte biotemporal stability cut-off criteria. These included: 1) the core AD biomarkers A beta 1 +/- 42, A beta 1 +/- 40, A beta 1 +/- 38, and total tau; 2) non-A beta, non-tau neurodegeneration markers NfL and FABP3; 3) inflammation/immune modulation markers IL-6, IL-7, IL-8, IL-12/23p40, IL-15, IL-16, MCP-1, MDC, MIP-1 beta, and YKL-40; 4) neurovascular markers Flt-1, ICAM-1, MMP-1, MMP-2, MMP-3, MMP-10, PlGF, VCAM-1, VEGF, VEGF-C, and VEGF-D; and 5) metabolism/oxidative stress markers 24OHC, adiponectin, leptin, soluble insulin receptor, and 8-OHdG. Conclusions Assays for these CSF analytes demonstrate consistent sensitivity, reliability, and biotemporally stability for use in a multiple pathophysiological CSF biomarker panel to profile AD. Their qualification enables further investigation for use in AD diagnosis, staging and progression, disease mechanism profiling, and clinical trials.	[Trombetta, Bianca A.; Carlyle, Becky C.; Koenig, Aaron M.; Locascio, Joseph J.; Arnold, Steven E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, MGH Inst Neurodegenerat Dis, Charlestown, MA USA; [Shaw, Leslie M.] Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wolk, David A.] Univ Penn, Perelman Sch Med, Dept Neurol, Penn Memory Ctr, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Arnold, SE (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, MGH Inst Neurodegenerat Dis, Charlestown, MA USA.	searnold@mgh.harvard.edu	Carlyle, Becky/HGD-4177-2022	Carlyle, Becky/0000-0003-1491-3217; Trombetta, Bianca/0000-0001-7501-0666	BrightFocus Foundation [AHAF_A2012116]; National Institute on Aging [AG039478, AG005134, AG10124]; NATIONAL INSTITUTE ON AGING [P30AG010124] Funding Source: NIH RePORTER	BrightFocus Foundation(BrightFocus Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the BrightFocus Foundation (www.brightfocus.org < http://www.brightfocus.org/>) AHAF_A2012116 to SEA, National Institute on Aging grants AG039478 to SEA, AG005134 to SEA and AG10124 to JQT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldacci F, 2017, EXPERT REV PROTEOMIC, V14, P285, DOI 10.1080/14789450.2017.1304217; Beach TG, 2017, NEUROL THER, V6, pS5, DOI 10.1007/s40120-017-0072-x; Bettcher Brianne M, 2016, Alzheimers Dement (Amst), V3, P91, DOI 10.1016/j.dadm.2016.05.004; Boehm J, 2013, EUR J NEUROSCI, V37, P1925, DOI 10.1111/ejn.12251; Briggs CA, 2017, BIOCHEM BIOPH RES CO, V483, P988, DOI 10.1016/j.bbrc.2016.09.088; BUCHHAVE P, 2009, PLOONE PUBLIC LIB, V4; Caccamo A, 2017, NAT NEUROSCI, V20, P1236, DOI 10.1038/nn.4608; Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412; Cha E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167819; Chiasserini D, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0276-4; Chiasserini D, 2010, J ALZHEIMERS DIS, V22, P1281, DOI 10.3233/JAD-2010-101293; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cox K.L., 2004, ASSAY GUIDANCE MANUA; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Cummings J, 2014, CLIN PHARMACOL THER, V95, P67, DOI 10.1038/clpt.2013.205; Desikan RS, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-39; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fourier A, 2015, CLIN CHIM ACTA, V449, P9, DOI 10.1016/j.cca.2015.05.024; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gmitterova K, 2009, NEURODEGENER DIS, V6, P263, DOI 10.1159/000237221; Hachinski V, 2012, ARCH NEUROL-CHICAGO, V69, P169, DOI 10.1001/archneurol.2011.1698; Hall JR, 2013, J ALZHEIMERS DIS, V35, P363, DOI 10.3233/JAD-122359; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hofmann JN, 2011, CYTOKINE, V56, P145, DOI 10.1016/j.cyto.2011.06.012; Huang CW, 2015, THROMB HAEMOSTASIS, V114, P1230, DOI 10.1160/TH14-11-0938; Hughes TM, 2013, J ALZHEIMERS DIS, V33, P891, DOI 10.3233/JAD-2012-121585; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jani D, 2016, AAPS J, V18, P1, DOI 10.1208/s12248-015-9820-y; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Koenig AM, 2017, ALZ DIS ASSOC DIS, V31, P107, DOI 10.1097/WAD.0000000000000202; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Le Bastard N, 2013, J ALZHEIMERS DIS, V33, P807, DOI 10.3233/JAD-2012-110029; Lewczuk P, 2018, WORLD J BIOL PSYCHIA, V19, P244, DOI 10.1080/15622975.2017.1375556; Li Q, 2017, CELL MOL NEUROBIOL, V37, P377, DOI 10.1007/s10571-016-0386-8; Lista S, 2017, NEUROCHEM INT, V108, P355, DOI 10.1016/j.neuint.2017.05.010; Llorens F, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0226-4; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattsson N, 2016, EMBO MOL MED, V8, P1184, DOI 10.15252/emmm.201606540; Mattsson Niklas, 2015, Alzheimers Dement (Amst), V1, P412, DOI 10.1016/j.dadm.2015.09.001; Mattsson N, 2012, J ALZHEIMERS DIS, V30, P767, DOI 10.3233/JAD-2012-120019; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Mollenhauer B, 2007, NEURODEGENER DIS, V4, P366, DOI 10.1159/000105157; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Muszynski P, 2017, CURR NEUROPHARMACOL, V15, P906, DOI 10.2174/1570159X15666170208124324; Neth BJ, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00345; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; Olsson B, 2013, J ALZHEIMERS DIS, V34, P673, DOI 10.3233/JAD-121384; Pan C, 2015, J ALZHEIMERS DIS, V45, P709, DOI 10.3233/JAD-143099; Popp J, 2017, BRAIN BEHAV IMMUN, V62, P203, DOI 10.1016/j.bbi.2017.01.020; Portney L, 2000, STAT MEASURES RELIAB; R Core Team, 2016, R LANG ENV STAT COMP; Ribe EM, 2016, J INTERN MED, V280, P430, DOI 10.1111/joim.12534; Ritter A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00186; Rozga M, 2017, CLIN CHEM LAB MED, V55, P1545, DOI 10.1515/cclm-2016-1061; RStudio Team, 2016, RSTUDIO INT DEV R; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Santos Claudia Y, 2017, Alzheimers Dement (Amst), V7, P69, DOI 10.1016/j.dadm.2017.01.005; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Skillback T, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt212; Stomrud Erik, 2015, Alzheimers Dement (Amst), V1, P403, DOI 10.1016/j.dadm.2015.09.002; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Testa G, 2016, REDOX BIOL, V10, P24, DOI 10.1016/j.redox.2016.09.001; Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644; Wennstrom M, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0145-y; Wennstrom M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135458; Wu AHB, 2015, AM HEART J, V169, P674, DOI 10.1016/j.ahj.2015.01.016; Wu DL, 2017, AM J PATHOL, V187, P2620, DOI 10.1016/j.ajpath.2017.08.007; Yarchoan M, 2014, DIABETES, V63, P2253, DOI 10.2337/db14-0287; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zarrouk A, 2018, CURR ALZHEIMER RES, V15, P303, DOI DOI 10.2174/1567205014666170505101426; Zetterberg H, 2017, AM J PHYSIOL-CELL PH, V313, pC3, DOI 10.1152/ajpcell.00007.2017; Zetterberg H, 2015, CURR OPIN PSYCHIATR, V28, P402, DOI 10.1097/YCO.0000000000000179	77	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193707	10.1371/journal.pone.0193707	http://dx.doi.org/10.1371/journal.pone.0193707			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY1CC	29505610	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200026
J	Wilson, AM; van der Nest, MA; Wilken, PM; Wingfield, MJ; Wingfield, BD				Wilson, Andi M.; van der Nest, Magriet A.; Wilken, P. Markus; Wingfield, Michael J.; Wingfield, Brenda D.			Pheromone expression reveals putative mechanism of unisexuality in a saprobic ascomycete fungus	PLOS ONE			English	Article							MATING-TYPE GENES; RNA-SEQ; PODOSPORA-ANSERINA; CANDIDA-ALBICANS; PRECURSOR GENES; IDENTIFICATION; REPRODUCTION; MICROARRAY; INDUCTION; SEQUENCES	Homothallism (self-fertility) describes a wide variety of sexual strategies that enable a fungus to reproduce in the absence of a mating partner. Unisexual reproduction, a form of homothallism, is a process whereby a fungus can progress through sexual reproduction in the absence of mating genes previously considered essential for self-fertility. In this study, we consider the molecular mechanisms that allow for this unique sexual behaviour in the saprotrophic ascomycete; Huntiella moniliformis. These molecular mechanisms are also compared to the underlying mechanisms that control sex in Huntiella omanensis, a closely related, but self-sterile, species. The main finding was that H. omanensis displayed mating type dependent expression of the a- and alpha-pheromones. This was in contrast to H. moniliformis where both pheromones were co-expressed during vegetative growth and sexual development. Furthermore, H. moniliformis also expressed the receptors of both pheromones. Consequently, this fungus is likely able to recognize and respond to the endogenously produced pheromones, allowing for self-fertility in the absence of other key mating genes. Overall, these results are concomitant with those reported for other unisexual species, but represent the first detailed study considering the unisexual behaviour of a filamentous fungus.	[Wilson, Andi M.; van der Nest, Magriet A.; Wilken, P. Markus; Wingfield, Michael J.; Wingfield, Brenda D.] Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, Pretoria, South Africa	University of Pretoria	Wilson, AM (corresponding author), Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, Pretoria, South Africa.	Andi.wilson@fabi.up.ac.za	Wilson, Andi/AAT-5036-2020; Wilken, Markus/B-2049-2010; Wingfield, Brenda/B-1376-2008	Wilken, Markus/0000-0003-0827-6098; van der Nest, Magriet/0000-0001-6914-8343; Wilson, Andrea/0000-0002-3239-0045; Wingfield, Brenda/0000-0002-6189-1519	University of Pretoria; Department of Science and Technology (DST)/National Research Foundation (NRF) Centre of Excellence in Tree Health Biotechnology (CTHB); National Research Foundation of South Africa [UID 83924]; Brenda Wingfield's SARCHi grant; NRF	University of Pretoria; Department of Science and Technology (DST)/National Research Foundation (NRF) Centre of Excellence in Tree Health Biotechnology (CTHB)(Department of Science & Technology (India)); National Research Foundation of South Africa(National Research Foundation - South Africa); Brenda Wingfield's SARCHi grant; NRF	This project was financed by the University of Pretoria and the Department of Science and Technology (DST)/National Research Foundation (NRF) Centre of Excellence in Tree Health Biotechnology (CTHB). This work is based on the research supported in part by a number of grants from the National Research Foundation of South Africa (including Grant specific unique reference number, UID 83924). This research was also funded in part by Prof Brenda Wingfield's SARCHi grant. The grant holders acknowledge that opinions, findings, conclusions and/or recommendations expressed in any publication generated by the NRF supported research are that of the author(s), and that the NRF accepts no liability whatsoever in this regard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alby K, 2011, P NATL ACAD SCI USA, V108, P2510, DOI 10.1073/pnas.1017234108; Alby K, 2009, NATURE, V460, P890, DOI 10.1038/nature08252; Arnaise S, 2001, GENETICS, V159, P545; Aylward J, 2016, FUNGAL GENET BIOL, V96, P47, DOI 10.1016/j.fgb.2016.10.002; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett RJ, 2003, EMBO J, V22, P2505, DOI 10.1093/emboj/cdg235; Bobrowicz P, 2002, MOL MICROBIOL, V45, P795, DOI 10.1046/j.1365-2958.2002.03052.x; Bowden RL, 1999, PHYTOPATHOLOGY, V89, P182, DOI 10.1094/PHYTO.1999.89.2.182; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coppin E, 2005, EUKARYOT CELL, V4, P407, DOI 10.1128/EC.4.2.407-420.2005; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Feretzaki M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003688; GLASS NL, 1994, MOL GEN GENET, V244, P401, DOI 10.1007/BF00286692; Gyawali R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006772; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; HUANG W, 2010, BMC GENOMICS, V11; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Lee JK, 2008, EUKARYOT CELL, V7, P1211, DOI 10.1128/EC.00272-07; LEONARD TJ, 1968, P NATL ACAD SCI USA, V59, P745, DOI 10.1073/pnas.59.3.745; LEONARD TJ, 1973, MYCOLOGIA, V65, P809, DOI 10.2307/3758520; LESLIE JF, 1979, MOL GEN GENET, V171, P257, DOI 10.1007/BF00267580; Lin Xiaorong, 2007, P35; Lin XR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000953; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin SH, 2011, MOL BIOL EVOL, V28, P1987, DOI 10.1093/molbev/msr022; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ni M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001653; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Poggeler S, 2006, MOL GENET GENOMICS, V275, P492, DOI 10.1007/s00438-006-0107-y; Poeggeler S, 2000, CURRENTGENETICS GOTE, V37, P403; Poggeler S, 2001, GENE, V280, P9, DOI 10.1016/S0378-1119(01)00786-7; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; RAPER JR, 1958, MYCOLOGIA, V50, P707, DOI 10.2307/3756180; Roach KC, 2014, ADV GENET, V85, P255, DOI 10.1016/B978-0-12-800271-1.00005-6; Schaefer D, 2007, EUKARYOT CELL, V6, P907, DOI 10.1128/EC.00090-07; Schuerg T., 2017, CURRENT BIOTECHNOLOG, V6, P89, DOI 10.2174/2211550105666160520123504; Shen WC, 1999, FUNGAL GENET BIOL, V27, P253, DOI 10.1006/fgbi.1999.1151; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; Van der Nest MA, 2014, FUNGAL GENET BIOL, V73, P104, DOI 10.1016/j.fgb.2014.10.008; van der Nest MA, 2014, IMA FUNGUS, V5, P473, DOI 10.5598/imafungus.2014.05.02.11; van der Nest MA, 2014, IMA FUNGUS, V5, P135, DOI 10.5598/imafungus.2014.05.01.13; Wang P, 2000, MOL CELL BIOL, V20, P352, DOI 10.1128/MCB.20.1.352-362.2000; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wilson AM, 2015, FUNGAL GENET BIOL, V80, P1, DOI 10.1016/j.fgb.2015.04.008; Wilson AM, 2015, IMA FUNGUS, V6, P207, DOI 10.5598/imafungus.2015.06.01.13	57	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0192517	10.1371/journal.pone.0192517	http://dx.doi.org/10.1371/journal.pone.0192517			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505565	Green Submitted, Green Published, gold			2022-12-27	WOS:000426548200002
J	Draborg, AH; Rasmussen, NS; Larsen, JL; Jorgensen, CS; Sandhu, N; Skogstrand, K; Jacobsen, S; Houen, G				Draborg, Anette Holck; Rasmussen, Niclas Stefan; Larsen, Janni Lisander; Jorgensen, Charlotte Svmrke; Sandhu, Noreen; Skogstrand, Kristin; Jacobsen, Soren; Houen, Gunnar			Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN-HERPESVIRUS 6; DNA-POLYMERASE; INFECTION; EBV; IMMUNOASSAY; EXPRESSION; REACTIVATION; MECHANISMS; BLOCKADE	We investigated immune responses to a lytic cytomegalovirus antigen (CMVpp52), and to a lytic human herpes virus (HHV) 6 antigen (HHV6p41), in systemic lupus erythematosus (SLE) patients and healthy controls (HCs), in order to clarify if the previously established impaired responses to Epstein-Barr virus (EBV) in SLE patients is a general defect in their responses against (all) HHVs. Multiplex Luminex technology results showed a normal induction of five quantified cytokines (interferon., interleukin(IL) 12, IL17, IL10, and tumor necrosis factor a) in SLE patients compared to HCs upon stimulation with CMVpp52 and HHV6p41. However, flow cytometric results showed a reduced upregulation of the activation marker CD69 on T-cells from SLE patients (n = 17) compared to HCs (n = 17) upon stimulation with CMVpp52, indicating limited or defective CMVpp52-specific T-cells and/or poor antigen-presentation in SLE patients, and thereby possibly decreased control of the CMV infection. In conclusion, the dysfunctional immune response against EBV previously established in SLE patients does not seem to apply to the same degree regarding the immune responses against CMV or HHV6. Results designate that the main contributing HHV agent in development or exacerbation of SLE (in genetically predisposed individuals) is the previously determined uncontrolled EBV infection, and to a lesser extent CMV infection, and probably with no involvement of HHV6 infection.	[Draborg, Anette Holck; Rasmussen, Niclas Stefan; Houen, Gunnar] Statens Serum Inst, Dept Autoimmunol & Biomarkers, Artillerivej 5, Copenhagen, Denmark; [Rasmussen, Niclas Stefan; Larsen, Janni Lisander; Jacobsen, Soren] Copenhagen Univ Hosp, Copenhagen Lupus & Vasculitis Clin, Ctr Rheumatol & Spine Dis, Rigshosp, Blegdamsvej 9, Copenhagen, Denmark; [Jorgensen, Charlotte Svmrke] Statens Serum Inst, Dept Virus & Microbiol Special Diagnost, Artillerivej 5, Copenhagen, Denmark; [Sandhu, Noreen; Skogstrand, Kristin] Statens Serum Inst, Dept Congenital Disorders, Ctr Neonatal Screening, Artillerivej 5, Copenhagen, Denmark	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Statens Serum Institut; Statens Serum Institut	Houen, G (corresponding author), Statens Serum Inst, Dept Autoimmunol & Biomarkers, Artillerivej 5, Copenhagen, Denmark.	gh@ssi.dk	Jacobsen, Søren/T-2491-2019; Larsen, Janni Lisander/S-7789-2019	Jacobsen, Søren/0000-0002-5654-4993; Larsen, Janni Lisander/0000-0002-0165-6461				Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Azevedo PC, 2014, METHODS MOL BIOL, V1134, P1, DOI 10.1007/978-1-4939-0326-9_1; Berkun Y, 2009, LUPUS, V18, P1129, DOI 10.1177/0961203309345729; Blake N, 2000, J IMMUNOL, V165, P7078, DOI 10.4049/jimmunol.165.12.7078; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Braun DK, 1997, CLIN MICROBIOL REV, V10, P521, DOI 10.1128/CMR.10.3.521; Broccolo F, 2013, J MED VIROL, V85, P1925, DOI 10.1002/jmv.23670; BROZEK CM, 1988, CLIN IMMUNOL IMMUNOP, V46, P299, DOI 10.1016/0090-1229(88)90192-4; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; Chen J, 2015, CLIN RHEUMATOL, V34, P691, DOI 10.1007/s10067-015-2868-3; Doaty S, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0561-4; Draborg A, 2016, CURR OPIN RHEUMATOL, V28, P398, DOI 10.1097/BOR.0000000000000289; Draborg AH, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/535738; Draborg AH, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6473204; Draborg AH, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000015; Draborg AH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/370516; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hrycek A, 2005, AUTOIMMUNITY, V38, P487, DOI 10.1080/08916930500285667; James JA, 2001, CURR OPIN RHEUMATOL, V13, P370, DOI 10.1097/00002281-200109000-00005; Kang I, 2004, J IMMUNOL, V172, P1287, DOI 10.4049/jimmunol.172.2.1287; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Krueger G R, 1991, In Vivo, V5, P217; Larsen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002328; Lin K, 1998, VIROLOGY, V250, P210, DOI 10.1006/viro.1998.9348; Mohamed AE, 2015, INT J RHEUM DIS, V18, P452, DOI 10.1111/1756-185X.12261; Namjou B, 2007, AUTOIMMUNITY, V40, P602, DOI 10.1080/08916930701510962; NIELSEN CM, 1987, J VIROL METHODS, V16, P195, DOI 10.1016/0166-0934(87)90004-8; NIELSEN CM, 1987, J MED VIROL, V22, P67, DOI 10.1002/jmv.1890220109; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Oster B, 2002, J VIROL, V76, P7578, DOI 10.1128/JVI.76.15.7578-7586.2002; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Rasmussen NS, 2015, SCAND J RHEUMATOL, V44, P143, DOI 10.3109/03009742.2014.973061; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Rigante D, 2015, INT J MOL SCI, V16, P17331, DOI 10.3390/ijms160817331; Sarzi-Puttini P, 2005, AUTOIMMUNITY, V38, P465, DOI 10.1080/08916930500285394; Skogstrand K, 2005, CLIN CHEM, V51, P1854, DOI 10.1373/clinchem.2005.052241; Smith PP, 2010, AUTOIMMUN REV, V10, P43, DOI 10.1016/j.autrev.2010.08.016; Su BYJ, 2007, MED MICROBIOL IMMUN, V196, P165, DOI 10.1007/s00430-007-0040-7; Tackey E, 2004, LUPUS, V13, P339, DOI 10.1191/0961203304lu1023oa; Taylor GH, 2003, AM FAM PHYSICIAN, V67, P519; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Tsokos GC, 1996, ARTHRITIS RHEUM, V39, P600, DOI 10.1002/art.1780390409; WEILAND KL, 1994, VIRUS RES, V34, P191, DOI 10.1016/0168-1702(94)90124-4; Zhang Q, 1997, VIROLOGY, V230, P22, DOI 10.1006/viro.1997.8470	49	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193244	10.1371/journal.pone.0193244	http://dx.doi.org/10.1371/journal.pone.0193244			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499037	Green Published, gold, Green Submitted			2022-12-27	WOS:000426472300008
J	Kondratick, CM; Litman, JM; Shaffer, KV; Washington, MT; Dieckman, LM				Kondratick, Christine M.; Litman, Jacob M.; Shaffer, Kurt V.; Washington, M. Todd; Dieckman, Lynne M.			Crystal structures of PCNA mutant proteins defective in gene silencing suggest a novel interaction site on the front face of the PCNA ring	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; ASSEMBLY FACTOR-I; TRANSLESION DNA-SYNTHESIS; MISMATCH REPAIR; CHROMATIN; REPLICATION; YEAST; CAF-1; INHERITANCE; POLYMERASE	Proliferating cell nuclear antigen (PCNA), a homotrimeric protein, is the eukaryotic sliding clamp that functions as a processivity factor for polymerases during DNA replication. Chromatin association factor 1 (CAF-1) is a heterotrimeric histone chaperone protein that is required for coupling chromatin assembly with DNA replication in eukaryotes. CAF-1 association with replicating DNA, and the targeting of newly synthesized histones to sites of DNA replication and repair requires its interaction with PCNA. Genetic studies have identified three mutant forms of PCNA in yeast that cause defects in gene silencing and exhibit altered association of CAF-1 to chromatin in vivo, as well as inhibit binding to CAF-1 in vitro. Three of these mutant forms of PCNA, encoded by the pol30-6, pol30-8, and the pol30-79 alleles, direct the synthesis of PCNA proteins with the amino acid substitutions D41A/D42A, R61A/D63A, and L126A/I128A, respectively. Interestingly, these double alanine substitutions are located far away from each other within the PCNA protein. To understand the structural basis of the interaction between PCNA and CAF-1 and how disruption of this interaction leads to reduced gene silencing, we determined the X-ray crystal structures of each of these mutant PCNA proteins. All three of the substitutions caused disruptions of a surface cavity on the front face of the PCNA ring, which is formed in part by three loops comprised of residues 21-24, 41-44, and 118-134. We suggest that this cavity is a novel binding pocket required for the interaction between PCNA and CAF-1, and that this region in PCNA also represents a potential binding site for other PCNA-binding proteins.	[Kondratick, Christine M.; Litman, Jacob M.; Washington, M. Todd] Univ Iowa, Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Shaffer, Kurt V.; Dieckman, Lynne M.] Creighton Univ, Dept Chem, Omaha, NE 68178 USA	University of Iowa; Creighton University	Dieckman, LM (corresponding author), Creighton Univ, Dept Chem, Omaha, NE 68178 USA.	lynnedieckman@creighton.edu		Litman, Jacob/0000-0002-3256-8747; Washington, Todd/0000-0001-8680-2992	National Institute of General Medical Science of the National Institutes of Health [R01GM081433, P20-GM103427]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081433] Funding Source: NIH RePORTER	National Institute of General Medical Science of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Award Number R01GM081433 from the National Institute of General Medical Science of the National Institutes of Health to M.T.W. and Award Number P20-GM103427 from the National Institute of General Medical Science of the National Institutes of Health to L.M.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project described was supported by Award Number R01GM081433 from the National Institute of General Medical Science of the National Institutes of Health to M.T.W. and by Award Number P20-GM103427 from the National Institute of General Medical Science of the National Institutes of Health to L.M.D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. We would like to acknowledge use of resources at the Carver College of Medicine's Protein Crystallography Facility at the University of Iowa. We would also like to acknowledge Lokesh Gakhar for providing technical assistance.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanko ER, 2016, J BIOL CHEM, V291, P9203, DOI 10.1074/jbc.M115.713271; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brachet E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125965; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; De Biasio A, 2013, ADV PROTEIN CHEM STR, V91, P1, DOI 10.1016/B978-0-12-411637-5.00001-9; Dieckman LM, 2013, BIOCHEMISTRY-US, V52, P5611, DOI 10.1021/bi400378e; Dieckman LM, 2013, DNA REPAIR, V12, P367, DOI 10.1016/j.dnarep.2013.02.007; Dieckman Lynne M, 2012, Subcell Biochem, V62, P281, DOI 10.1007/978-94-007-4572-8_15; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn TD, 2010, BIOPHYS J, V98, P2984, DOI 10.1016/j.bpj.2010.02.057; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Goellner EM, 2014, MOL CELL, V55, P291, DOI 10.1016/j.molcel.2014.04.034; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; GRUSS C, 1993, EMBO J, V12, P4533, DOI 10.1002/j.1460-2075.1993.tb06142.x; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadyrova LY, 2011, P NATL ACAD SCI USA, V108, P2753, DOI 10.1073/pnas.1015914108; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Klapholz B, 2009, CHROMOSOMA, V118, P235, DOI 10.1007/s00412-008-0192-2; Kondratick CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157023; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Li X, 2016, ELIFE, V5, DOI 10.7554/eLife.15129; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mello JA, 2001, CURR OPIN GENET DEV, V11, P136, DOI 10.1016/S0959-437X(00)00170-2; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Moldovan GL, 2007, CELL; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nabatiyan A, 2004, MOL CELL BIOL, V24, P2853, DOI 10.1128/MCB.24.7.2853-2862.2004; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Quivy JP, 2008, NAT STRUCT MOL BIOL, V15, P972, DOI 10.1038/nsmb.1470; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Schnieders MJ, 2011, J CHEM THEORY COMPUT, V7, P1141, DOI 10.1021/ct100506d; Schopf B, 2012, P NATL ACAD SCI USA, V109, P1895, DOI 10.1073/pnas.1106696109; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Tsurimoto Toshiki, 1999, Frontiers in Bioscience, V4, pd849, DOI 10.2741/Tsurimoto; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhuang ZH, 2010, BBA-PROTEINS PROTEOM, V1804, P1081, DOI 10.1016/j.bbapap.2009.06.018	52	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193333	10.1371/journal.pone.0193333	http://dx.doi.org/10.1371/journal.pone.0193333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499038	Green Submitted, gold, Green Published			2022-12-27	WOS:000426472300011
J	Hu, PL; Yuan, YH; Yue, TL; Guo, CF				Hu, Peng-Li; Yuan, Ya-Hong; Yue, Tian-Li; Guo, Chun-Feng			Bile acid patterns in commercially available oxgall powders used for the evaluation of the bile tolerance ability of potential probiotics	PLOS ONE			English	Article							LACTOBACILLUS; BACTERIA; STRAINS	This study aimed to analyze the bile acid patterns in commercially available oxgall powders used for evaluation of the bile tolerance ability of probiotic bacteria. Qxgall powders purchased from Sigma-Aldrich, Oxoid and BD Difco were dissolved in distilled water, and analyzed. Conjugated bile acids were profiled by ion-pair high-performance liquid chromatography (HPLC), free bile acids were detected as their p-bromophenacyl ester derivatives using reversed-phase HPLC after extraction with acetic ether, and total bile acids were analyzed by enzymatic-colorimetric assay. The results showed that 9 individual bile acids (i.e., taurocholic acid, glycocholic acid, taurodeoxycholic acid, glycodeoxycholic acid, taurochenodeoxycholic acid, glycochenodeoxycholic acid, cholic acid, chenodeoxycholic acid, deoxycholic acid) were present in each of the oxgall powders tested. The content of total bile acid among the three oxgall powders was similar; however, the relative contents of the individual bile acids among these oxgall powders were significantly different (P < 0.001). The oxgall powder from Sigma-Aldrich was closer to human bile in the ratios of glycine-conjugated bile acids to taurine-conjugated bile acids, dihydroxy bile acids to trihydroxy bile acids, and free bile acids to conjugated bile acids than the other powders were. It was concluded that the oxgall powder from Sigma-Aldrich should be used instead of those from Oxoid and BD Difco to evaluate the bile tolerance ability of probiotic bacteria as human bile model.	[Hu, Peng-Li; Yuan, Ya-Hong; Yue, Tian-Li; Guo, Chun-Feng] Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Peoples R China	Northwest A&F University - China	Guo, CF (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Peoples R China.	gcf@nwafu.edu.cn	yue, tianli/AEY-3384-2022	yue, tianli/0000-0002-4768-5831	National Natural Science Foundation of China [31301444]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China (No. 31301444) and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli P, 2011, PHARMACOL RES, V63, P366, DOI 10.1016/j.phrs.2011.02.006; Beckingham IJ, 2001, BRIT MED J, V322, P91, DOI 10.1136/bmj.322.7278.91; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Charnchai P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157958; Dahiya DK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00563; Damodharan K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00768; Dawson PA, 2015, J LIPID RES, V56, P1085, DOI 10.1194/jlr.R054114; DESMET I, 1995, J APPL BACTERIOL, V79, P292; Enhsen A, 1998, DRUG DISCOV TODAY, V3, P409, DOI 10.1016/S1359-6446(96)10046-5; Fijalkowski K, 2016, LWT-FOOD SCI TECHNOL, V68, P322, DOI 10.1016/j.lwt.2015.12.038; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Guo CF, 2016, J FUNCT FOODS, V26, P691, DOI 10.1016/j.jff.2016.08.035; Guo CF, 2015, J FUNCT FOODS, V12, P294, DOI 10.1016/j.jff.2014.11.029; HEUMAN DM, 1989, J LIPID RES, V30, P719; Huang Y, 2013, J DAIRY SCI, V96, P2816, DOI 10.3168/jds.2012-6371; Kurdi P, 2006, J BACTERIOL, V188, P1979, DOI 10.1128/JB.188.5.1979-1986.2006; Lee J, 2011, INT J FOOD MICROBIOL, V148, P80, DOI 10.1016/j.ijfoodmicro.2011.05.003; Lee NK, 2014, LWT-FOOD SCI TECHNOL, V58, P130, DOI 10.1016/j.lwt.2014.02.028; Liu WJ, 2013, J DAIRY SCI, V96, P6807, DOI 10.3168/jds.2013-6582; MINGRONE G, 1980, J CHROMATOGR, V183, P277, DOI 10.1016/S0378-4347(00)81707-7; Munoz-Quezada S, 2013, BRIT J NUTR, V109, pS51, DOI 10.1017/S0007114512005211; Oh YJ, 2015, LWT-FOOD SCI TECHNOL, V63, P437, DOI 10.1016/j.lwt.2015.03.005; Plessas S, 2017, FOOD CHEM, V226, P102, DOI 10.1016/j.foodchem.2017.01.052; Portincasa P, 2009, CURR MED CHEM, V16, P1531, DOI 10.2174/092986709787909631; Rouhi M, 2013, CRIT REV FOOD SCI, V53, P331, DOI 10.1080/10408398.2010.531407; SCALIA S, 1994, ANAL LETT, V27, P1789, DOI 10.1080/00032719408007436; Silva BC, 2013, BENEF MICROBES, V4, P267, DOI 10.3920/BM2012.0048; STAGGERS JE, 1990, BIOCHEMISTRY-US, V29, P2028, DOI 10.1021/bi00460a011; SWOBODNIK W, 1985, J CHROMATOGR, V339, P263, DOI 10.1016/S0378-4347(00)84653-8; Tremblay S, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00942-16; Yadav R, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02116; Yadav R, 2017, CRIT REV FOOD SCI, V57, P3233, DOI 10.1080/10408398.2015.1108957; Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016	33	19	20	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192964	10.1371/journal.pone.0192964	http://dx.doi.org/10.1371/journal.pone.0192964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494656	gold, Green Submitted, Green Published			2022-12-27	WOS:000426363200018
J	Huang, J; Gao, N; Wang, SZ; Milewicz, DM; Kamm, KE; Stull, JT				Huang, Jian; Gao, Ning; Wang, Shanzhi; Milewicz, Dianna M.; Kamm, Kristine E.; Stull, James T.			Genetic approaches to identify pathological limitations in aortic smooth muscle contraction	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; PHOSPHATASE TARGETING SUBUNIT-1; SALT-INDUCED HYPERTENSION; NONMUSCLE MYOSIN; SIGNAL-TRANSDUCTION; FORCE GENERATION; DISSECTIONS; ANEURYSMS; PHOSPHORYLATION; MUTATIONS	Aortic smooth muscle contains limiting amounts of myosin light chain kinase (MLCK) for myosin regulatory light chain (RLC) phosphorylation and contraction that predisposes to thoracic aortic disease in humans containing heterozygous loss-of-function mutations in MYLK. We tested the hypothesis that thoracic aortic smooth muscle contraction may also be susceptible to variations in the smooth muscle-specific isoform of the motor protein myosin where inactivation of one Myh11 allele or the presence of one Myh11 missense variant associated with an increased risk of human aortic disease may result in a reduced force development response. Additionally, other kinds of smooth muscles may be less sensitive to the effects of mutations in one smooth muscle myosin allele, similar to results obtained with Mylk. Force development responses were reduced in aortic tissue from a conditional knockout of smooth muscle myosin heavy chain in adult mice (Myh11(+/-) or Myh11(-/-)) with a greater reduction with homozygous vs heterozygous tissues. Similar reductions in force responses were obtained with tissues containing either a heterozygous or homozygous knockin mutation in smooth muscle myosin heavy chain (Myh11(+/ R247C) or Myh11(R247C/R247C) mutations that cause human aortic disease) with no significant changes in RLC phosphorylation. Agonist-dependent force responses were not reduced significantly in urinary bladder, ileal, or tracheal tissues from Myh11(+/-) mice while only ileal tissue showed a reduced force response in Myh11(R247C/R247C) mice. Thus, heterozygous mutations in Myh11 associated with reduced myosin function result in compromised contractile function primarily in aortic smooth muscle.	[Huang, Jian; Gao, Ning; Kamm, Kristine E.; Stull, James T.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Wang, Shanzhi; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston	Stull, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu			National Institutes of Health [R01 HL112778, P01 HL110869]; Moss Heart Fund at the University of Texas Southwestern Medical Center; Bashour Distinguished Chair in Physiology at the University of Texas Southwestern Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109942, P01HL110869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund at the University of Texas Southwestern Medical Center; Bashour Distinguished Chair in Physiology at the University of Texas Southwestern Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health R01 HL112778 and P01 HL110869 (https://www.nih.gov/); Moss Heart Fund at the University of Texas Southwestern Medical Center (http://www.utsouthwestern.edu/); and Bashour Distinguished Chair in Physiology at the University of Texas Southwestern Medical Center (http://www.utsouthwestern.edu/).	Brozovich FV, 2016, PHARMACOL REV, V68, P476, DOI 10.1124/pr.115.010652; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; GABELLA G, 1984, PHYSIOL REV, V64, P455, DOI 10.1152/physrev.1984.64.2.455; Gao N, 2016, J PHYSIOL-LONDON, V594, P3209, DOI 10.1113/JP271703; Gao N, 2013, J BIOL CHEM, V288, P7596, DOI 10.1074/jbc.M112.427112; Gao YZ, 2014, AM J PHYSIOL-HEART C, V307, pH1252, DOI 10.1152/ajpheart.00392.2014; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P423; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2013, GASTROENTEROLOGY, V144, P1456, DOI 10.1053/j.gastro.2013.02.045; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Humphrey JD, 2015, CIRC RES, V116, P1448, DOI 10.1161/CIRCRESAHA.114.304936; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; KAMM KE, 1989, J BIOL CHEM, V264, P21223; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Karimi A, 2016, CAN J CARDIOL, V32, P26, DOI 10.1016/j.cjca.2015.11.004; Kitazawa T, 2012, J PHYSIOL-LONDON, V590, P5401, DOI 10.1113/jphysiol.2012.241315; Kuang SQ, 2012, CIRC RES, V110, P1411, DOI 10.1161/CIRCRESAHA.111.261743; Lofgren M, 2003, J GEN PHYSIOL, V121, P301, DOI 10.1085/jgp.200208720; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Milewicz DM, 2017, ARTERIOSCL THROM VAS, V37, P26, DOI 10.1161/ATVBAHA.116.303229; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; PERSECHINI A, 1986, J BIOL CHEM, V261, P6293; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Sehgel NL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00335; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Tsai MH, 2014, J PHYSIOL-LONDON, V592, P3031, DOI 10.1113/jphysiol.2014.273011; Tsai MH, 2012, J PHYSIOL-LONDON, V590, P5107, DOI 10.1113/jphysiol.2012.235424; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Wendling O, 2009, GENESIS, V47, P14, DOI 10.1002/dvg.20448; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Yuen SL, 2009, AM J PHYSIOL-HEART C, V297, pH191, DOI 10.1152/ajpheart.00132.2009; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	39	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193769	10.1371/journal.pone.0193769	http://dx.doi.org/10.1371/journal.pone.0193769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494672	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200096
J	Lubetzky, AV; Harel, D; Lubetzky, E				Lubetzky, Anat V.; Harel, Daphna; Lubetzky, Eyal			On the effects of signal processing on sample entropy for postural control	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; YOUNG-ADULTS; OLDER-ADULTS; COMPLEXITY; TASK; REGULARITY; BALANCE	Sample entropy, a measure of time series regularity, has become increasingly popular in postural control research. We are developing a virtual reality assessment of sensory integration for postural control in people with vestibular dysfunction and wished to apply sample entropy as an outcome measure. However, despite the common use of sample entropy to quantify postural sway, we found lack of consistency in the literature regarding center-of-pressure signal manipulations prior to the computation of sample entropy. We therefore wished to investigate the effect of parameters choice and signal processing on participants' sample entropy outcome. For that purpose, we compared center-of-pressure sample entropy data between patients with vestibular dysfunction and age-matched controls. Within our assessment, participants observed virtual reality scenes, while standing on floor or a compliant surface. We then analyzed the effect of: modification of the radius of similarity ( r) and the embedding dimension ( m); down-sampling or filtering and differencing or detrending. When analyzing the raw center-of-pressure data, we found a significant main effect of surface in medio-lateral and anterior-posterior directions across r's and m's. We also found a significant interaction group x surface in the medio-lateral direction when r was 0.05 or 0.1 with a monotonic increase in p value with increasing r in both m's. These effects were maintained with down-sampling by 2, 3, and 4 and with detrending but not with filtering and differencing. Based on these findings, we suggest that for sample entropy to be compared across postural control studies, there needs to be increased consistency, particularly of signal handling prior to the calculation of sample entropy. Procedures such as filtering, differencing or detrending affect sample entropy values and could artificially alter the time series pattern. Therefore, if such procedures are performed they should be well justified.	[Lubetzky, Anat V.] NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Phys Therapy, New York, NY 10003 USA; [Harel, Daphna] NYU, Dept Appl Stat Social Sci & Humanities, Steinhardt Sch Culture Educ & Human Dev, New York, NY USA; [Lubetzky, Eyal] NYU, Courant Inst Math Sci, New York, NY USA	New York University; New York University; New York University	Lubetzky, AV (corresponding author), NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Phys Therapy, New York, NY 10003 USA.	anat@nyu.edu		Lubetzky, Anat/0000-0001-5869-025X	Steinhardt School of Culture Education and Human Development at NYU	Steinhardt School of Culture Education and Human Development at NYU	Author Prof. Anat V. Lubetriry received the Research Development Award from the Steinhardt School of Culture Education and Human Development at NYU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa RD, 2017, ANN BIOMED ENG, V45, P726, DOI 10.1007/s10439-016-1718-z; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cone BL, 2017, EXP BRAIN RES, V235, P547, DOI 10.1007/s00221-016-4814-2; DAMICO M, 1992, MED BIOL ENG COMPUT, V30, P193, DOI 10.1007/BF02446130; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Dettmer M, 2013, HUM MOVEMENT SCI, V32, P214, DOI 10.1016/j.humov.2012.12.002; Gelman A., 2007, DATA ANAL USING REGR; Hoffmann CP, 2017, GAIT POSTURE, V54, P236, DOI 10.1016/j.gaitpost.2017.03.015; Hugentobler JA, 2016, CLIN J SPORT MED, V26, P510, DOI 10.1097/JSM.0000000000000286; Jehu D, 2017, GAIT POSTURE, V52, P227, DOI 10.1016/j.gaitpost.2016.12.006; Kirchner M, 2013, HUM MOV SCI; Landry SC, 2010, GAIT POSTURE, V32, P215, DOI 10.1016/j.gaitpost.2010.04.018; Lee IC, 2017, GAIT POSTURE, V51, P52, DOI 10.1016/j.gaitpost.2016.09.028; Lubetzky AV, 2017, MOTOR CONTROL, V21, P468, DOI 10.1123/mc.2016-0045; Lubetzky AV, 2015, SOMATOSENS MOT RES, V32, P211, DOI 10.3109/08990220.2015.1074565; Lubetzky AV, 2017, VIRTUAL REHABILITATI; Lubetzky AV, PHYSOTHER THEORY PRA; Nicholas Stergiou, NONLINEAR ANAL HUMAN; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Rhea CK, 2015, GAIT POSTURE, V41, P731, DOI 10.1016/j.gaitpost.2015.01.008; Rhea CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017696; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Roerdink M, 2011, HUM MOVEMENT SCI, V30, P203, DOI 10.1016/j.humov.2010.04.005; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; SOAMES RW, 1982, EUR J APPL PHYSIOL O, V49, P169, DOI 10.1007/BF02334065; Strang AJ, 2011, EUR J APPL PHYSIOL, V111, P1485, DOI 10.1007/s00421-010-1770-6; Yamagata M, 2017, CLIN INTERV AGING, V12, P499, DOI 10.2147/CIA.S132425; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3	31	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193460	10.1371/journal.pone.0193460	http://dx.doi.org/10.1371/journal.pone.0193460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494625	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200051
J	Taverner, D; Vallve, JC; Ferre, R; Paredes, S; Masana, L; Castro, A				Taverner, Delia; Vallve, Joan-Carles; Ferre, Raimon; Paredes, Silvia; Masana, Lluis; Castro, Antoni			Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-ARTERY-DISEASE; LOW-DENSITY-LIPOPROTEIN; C-REACTIVE PROTEIN; B-MODE ULTRASOUND; CARDIOVASCULAR-DISEASE; CAROTID PLAQUE; RISK-FACTORS; METAANALYSIS; ANTIBODIES	Objective To advance the study of variables associated with subclinical atherosclerosis in rheumatoid arthritis (RA) with special consideration for the degree of disease activity, age and gender. Methods The carotid intima-media thickness (cIMT) and the presence of carotid atherosclerotic plaques along with clinical and biochemical characteristics were determined in 214 RA patients. Results Adjusted analysis reveals that men had a 0.059 mm significantly increased cIMT compared with women (p = 0.001; R-2 = 3.8%) and that age was associated with cIMT (beta = 0.0048 mm; p = 0.0001; R-2 = 16%). Interestingly, we observed a significant interaction between gender and age. Thus, the effect of age on cIMT was significantly increased (12%) in men compared with women (p-value for interaction term = 0.041). Moreover, adjusted multivariable linear regression analysis revealed that disease activity score (DAS28) was significantly associated with cIMT in women (beta = 0.021; p = 0.018: R-2 = 0.03) but not men. In particular, women with high disease activity had a 0.079 mm increased cIMT compared with women in remission (p = 0.026). In addition, men in remission had a 0.134 mm increased cIMT compared with women in remission (p = 0.003; R-2 = 8.7%). Active patients did not exhibit differences in cIMT values. Furthermore, 43% of patients presented carotid plaques. The variables independently associated with carotid plaques were age, smoking, health assessment questionnaire, erythrocyte sedimentation rate and rheumatoid factor (p<0.0001; R-2 = 46%). Conclusion In our cohort of patients with RA, DAS28 and age are differentially associated with cIMT in men and women. Our findings could explain the contradictory results that have previously been published in the literature.	[Taverner, Delia; Paredes, Silvia] Hosp Univ Sant Joan, Inst Invest Sanitaria Pere Virgili Reus, Serv Med Interna, Seccio Reumatol, Catalonia, Spain; [Vallve, Joan-Carles] Univ Rovira & Virgili, Fac Med, CIBER Diabet & Enfermedades Metab Asociadas, Inst Invest Sanitaria Pere Virgili Reus, Catalonia, Spain; [Ferre, Raimon; Masana, Lluis; Castro, Antoni] Univ Rovira & Virgili, Hosp Univ Sant Joan,Serv Med Interna, Fac Med,Inst Invest Sanitaria Pere Virgili Reus, CIBER Diabet & Enfermedades Meta Asociadas, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Universitat Rovira i Virgili	Vallve, JC (corresponding author), Univ Rovira & Virgili, Fac Med, CIBER Diabet & Enfermedades Metab Asociadas, Inst Invest Sanitaria Pere Virgili Reus, Catalonia, Spain.	jc.vallve@urv.cat	MASANA, LUIS/M-7002-2019; Castro, Antoni/AAI-4431-2021; Vallvé, Joan-Carles/T-6742-2019	MASANA, LUIS/0000-0002-0789-4954; Castro, Antoni/0000-0001-5441-6333; Vallvé, Joan-Carles/0000-0001-8711-9618	Instituto de Salud Carlos III (ISCIII) [PI 10/02547, PI030786]; Centro de Investigacion Biomedica en Red en Diabetes y Enfermedades Metabolicas asociadas (CIBERDEM); Fondo Europeo de Desarrollo Regional (FEDER); Sociedad Espanola de Reumatologia	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red en Diabetes y Enfermedades Metabolicas asociadas (CIBERDEM); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Sociedad Espanola de Reumatologia	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) (PI 10/02547, PI030786), Centro de Investigacion Biomedica en Red en Diabetes y Enfermedades Metabolicas asociadas (CIBERDEM), Fondo Europeo de Desarrollo Regional (FEDER), and Sociedad Espanola de Reumatologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MR, 1995, CIRCULATION, V92, P2127, DOI 10.1161/01.CIR.92.8.2127; Ahlmen M, 2010, ANN RHEUM DIS, V69, P230, DOI 10.1136/ard.2008.102244; Ahmed HMMS, 2010, CLIN RHEUMATOL, V29, P1237, DOI 10.1007/s10067-010-1436-0; Ajeganova S, 2012, J RHEUMATOL, V39, P1146, DOI 10.3899/jrheum.111334; Akrout R, 2012, ANN CARDIOL ANGEIOL, V61, P267, DOI 10.1016/j.ancard.2012.04.009; Ambrosino P, 2015, THROMB HAEMOSTASIS, V113, P916, DOI 10.1160/TH14-11-0921; Arts EEA, 2015, ANN RHEUM DIS, V74, P998, DOI 10.1136/annrheumdis-2013-204531; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Ballantyne C, 2002, AM J CARDIOL, V89, p15B; Barbarroja N, 2014, ARTERIOSCL THROM VAS, V34, P2706, DOI 10.1161/ATVBAHA.114.304475; Carotti M, 2007, REUMATISMO, V59, P38, DOI 10.4081/reumatismo.2007.38; Castaneda S, 2015, SEMIN ARTHRITIS RHEU, V44, P618, DOI 10.1016/j.semarthrit.2014.12.002; Corrales A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0576-7; Cuomo G, REUMATISMO, V56, P242; del Rincon I, 2003, ARTHRITIS RHEUM, V48, P1833, DOI 10.1002/art.11078; El-Barbary AM, 2011, J RHEUMATOL, V38, P828, DOI 10.3899/jrheum.101143; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P177, DOI 10.1161/ATVBAHA.108.173609; Gabriel SE, 2003, ARTHRITIS RHEUM-US, V48, P54, DOI 10.1002/art.10705; Diaz JDG, 2008, MED CLIN-BARCELONA, V130, P210; Gerli R, 2008, ANN RHEUM DIS, V67, P724, DOI 10.1136/ard.2007.073718; Gonzalez-Gay MA, 2005, J RHEUMATOL, V32, P1219; Gonzalez-Juanatey C, 2009, SEMIN ARTHRITIS RHEU, V38, P366, DOI 10.1016/j.semarthrit.2008.01.012; Hannawi S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2323; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; Hurt-Camejo E, 2001, ARTHRITIS RHEUM, V44, P2761, DOI 10.1002/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5; Im CH, 2015, RHEUMATOLOGY, V54, P808, DOI 10.1093/rheumatology/keu376; Jonsson SW, 2001, J RHEUMATOL, V28, P2597; Kerekes G, 2012, NAT REV RHEUMATOL, V8, P224, DOI 10.1038/nrrheum.2012.16; Kumeda Y, 2002, ARTHRITIS RHEUM-US, V46, P1489, DOI 10.1002/art.10269; Liao L-J, 2017, CLIN OTOLARYNGOL; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Mohan A, 2014, INDIAN J MED RES, V140, P379; Pereira IA, ACTA REUM PORT, V34, P58; Pope Janet E, 2016, Open Rheumatol J, V10, P49; Ristic GG, 2010, RHEUMATOLOGY, V49, P1076, DOI 10.1093/rheumatology/kep456; Ruscitti P, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008180; Ruscitti P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170108; Sandoo A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4396; Scarno A, 2014, WORLD J ORTHOP, V5, P328, DOI 10.5312/wjo.v5.i3.328; Spence JD, 2002, AM J CARDIOL, V89, p10B; Stevens Robert J., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009154; Sung JH, 2014, J CARDIOVASC MED, V15, P371, DOI 10.2459/JCM.0b013e32836411d6; Tanasescu C, 2009, EUR J INTERN MED, V20, P348, DOI 10.1016/j.ejim.2008.09.005; Targonska-Stepniak B, 2011, JCR-J CLIN RHEUMATOL, V17, P249, DOI 10.1097/RHU.0b013e3182290dbf; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Tutoglu A, 2014, J PHYS THER SCI, V26, P1093, DOI 10.1589/jpts.26.1093; van Breukelen-van der Stoep DF, 2015, PLOS ONE, V10; van den Oever IAM, 2013, THER ADV MUSCULOSKEL, V5, P166, DOI 10.1177/1759720X13491025; van Halm VP, 2009, ANN RHEUM DIS, V68, P1395, DOI 10.1136/ard.2008.094151; van Sijl AM, 2011, SEMIN ARTHRITIS RHEU, V40, P389, DOI 10.1016/j.semarthrit.2010.06.006; Vazquez-Del Mercado M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/342649; Zampeli E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3757	53	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193690	10.1371/journal.pone.0193690	http://dx.doi.org/10.1371/journal.pone.0193690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494666	Green Submitted, gold, Green Published			2022-12-27	WOS:000426363200084
J	Glatz, M; Jo, JH; Kennedy, EA; Polley, EC; Segre, JA; Simpson, EL; Kong, HH				Glatz, Martin; Jo, Jay-Hyun; Kennedy, Elizabeth A.; Polley, Eric C.; Segre, Julia A.; Simpson, Eric L.; Kong, Heidi H.			Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis	PLOS ONE			English	Article							TRANSEPIDERMAL WATER-LOSS; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-SALIVARIUS; CLINICAL-TRIAL; EARLY-LIFE; DIVERSITY; CHILDREN; DISEASE; ECZEMA; CELLS	Background Emollients are a mainstay of treatment in atopic dermatitis (AD), a disease distinguished by skin bacterial dysbiosis. However, changes in skin microbiota when emollients are used as a potential AD preventative measure in infants remain incompletely characterized. Results We compared skin barrier parameters, AD development, and bacterial 16S ribosomal RNA gene sequences of cheek, dorsal and volar forearm samples from 6-month-old infants with a family history of atopy randomized to receive emollients (n = 11) or no emollients (controls, n = 12). The emollient group had a lower skin pH than the control group. The number of bacterial taxa in the emollient group was higher than in the control group at all sites. The Streptococcus salivarius proportion was higher in the emollient versus control groups at all sites. S. salivarius proportion appeared higher in infants without AD compared to infants with AD. A decrease in S. salivarius abundance was further identified in a separate larger population of older children demonstrating an inverse correlation between AD severity at sampling sites and S. salivarius proportions. Conclusions The decreased skin pH and the increased proportion of S. salivarius after long-term emollient use in infants at risk for developing AD may contribute to the preventative effects of emollients in high-risk infants.	[Glatz, Martin; Jo, Jay-Hyun; Kennedy, Elizabeth A.; Kong, Heidi H.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Polley, Eric C.] NCI, Biometr Res Branch, Div Canc Treatment & Diag, NIH, Rockville, MD USA; [Segre, Julia A.] NHGRI, Translat & Funct Genom Branch, Bethesda, MD 20892 USA; [Simpson, Eric L.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA; [Glatz, Martin] Univ Zurich, Dept Dermatol, Allergy Unit, Zurich, Switzerland; [Glatz, Martin] Univ Hosp Zurich, Zurich, Switzerland; [Polley, Eric C.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Oregon Health & Science University; University of Zurich; University of Zurich; University Zurich Hospital; Mayo Clinic	Kong, HH (corresponding author), NCI, Dermatol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.; Simpson, EL (corresponding author), Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA.	simpsone@ohsu.edu; konghe@mail.nih.gov	Kong, Heidi H/L-4856-2018	Kong, Heidi H/0000-0003-4424-064X; Kennedy, Elizabeth/0000-0001-7934-1307	National Cancer Institute; National Human Genome Research Institute; Intramural Research Program; Swiss National Science Foundation (Switzerland) [PBSK3_140118]; National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health [1K99AR059222]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI15C1095]; Mentored Patient-oriented Research Career Development Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health [5K23AR057486]; Oregon Clinical and Translational Research Institute (OCTRI); National Center for Research Resources (NCRR) [5 KL2 RR024141-04]; National Institutes of Health (NIH); NIH Roadmap for Medical Research	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Research Program; Swiss National Science Foundation (Switzerland)(Swiss National Science Foundation (SNSF)); National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Mentored Patient-oriented Research Career Development Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health; Oregon Clinical and Translational Research Institute (OCTRI); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Cancer Institute (https://www.cancer.gov/) to H.H.K. and National Human Genome Research Institute (https://www.genome.gov/) Intramural Research Program to J.A.S., by a fellowship grant from the Swiss National Science Foundation (M.G., Switzerland, PBSK3_140118, http://www.snf.ch/en/Pages/default.aspx), the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health (1K99AR059222, H.H.K.; https://www.niams.nih.gov/) and by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI15C1095; J-HJ; https://www.fic.nih.gov/programs/pages/korea-visiting-scientists.aspx). The clinical work was partly funded by a Mentored Patient-oriented Research Career Development Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health (5K23AR057486, E.L.S.). Support was also obtained from the Oregon Clinical and Translational Research Institute (OCTRI; http://www.ohsu.edu/xd/research/centers-institutes/octri/) and the National Center for Research Resources (NCRR; 5 KL2 RR024141-04; https://nexus.od.nih.gov/all/2012/01/06/working-through-the-transitions-of-ncrr-and-ncats/) to E.L.S., a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Julia Oh, Sean Conlan, and Clay Deming for their underlying efforts; Mark C. Udey for helpful discussions. J-HJ was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI15C1095). The study was carried out in Portland, Oregon and Bethesda, Maryland, USA.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Birri DJ, 2012, APPL ENVIRON MICROB, V78, P402, DOI 10.1128/AEM.06588-11; Bohme M, 2003, CLIN EXP ALLERGY, V33, P1226, DOI 10.1046/j.1365-2222.2003.01749.x; Bouwer AL, 2013, J INTERF CYTOK RES, V33, P459, DOI 10.1089/jir.2012.0116; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Cosseau C, 2008, INFECT IMMUN, V76, P4163, DOI 10.1128/IAI.00188-08; Darmstadt GL, 2014, PEDIATR INFECT DIS J, V33, P1124, DOI 10.1097/INF.0000000000000423; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eyerich K, 2013, ALLERGY, V68, P974, DOI 10.1111/all.12184; Flohr C, 2010, BRIT J DERMATOL, V163, P1333, DOI 10.1111/j.1365-2133.2010.10068.x; Flores GE, 2014, J DRUGS DERMATOL, V13, P1365; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Guglielmetti S, 2010, APPL ENVIRON MICROB, V76, P3948, DOI 10.1128/AEM.00109-10; Hill SE, 2011, AUSTRALAS J DERMATOL, V52, P27, DOI 10.1111/j.1440-0960.2010.00714.x; Hoppe T, 2015, J EUR ACAD DERMATOL, V29, P174, DOI 10.1111/jdv.12333; Horimukai K, 2014, J ALLERGY CLIN IMMUN, V134, P824, DOI 10.1016/j.jaci.2014.07.060; Inoue Y, 2013, EUR J DERMATOL, V23, P288, DOI 10.1684/ejd.2013.1960; Ismail IH, 2012, PEDIAT ALLERG IMM-UK, V23, P674, DOI 10.1111/j.1399-3038.2012.01328.x; Kaci G, 2014, APPL ENVIRON MICROB, V80, P928, DOI 10.1128/AEM.03133-13; Kelleher M, 2015, J ALLERGY CLIN IMMUN, V135, P930, DOI 10.1016/j.jaci.2014.12.013; Kobayashi T, 2015, IMMUNITY, V42, P756, DOI 10.1016/j.immuni.2015.03.014; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; LANE AT, 1993, PEDIATRICS, V92, P415; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Matsui K, 2000, MICROBIOL IMMUNOL, V44, P945, DOI 10.1111/j.1348-0421.2000.tb02587.x; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Mempel M, 1998, J INVEST DERMATOL, V111, P452, DOI 10.1046/j.1523-1747.1998.00293.x; Moore MM, 2004, PEDIATRICS, V113, P468, DOI 10.1542/peds.113.3.468; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Ong PY, 2010, IMMUNOL ALLERGY CLIN, V30, P309, DOI 10.1016/j.iac.2010.05.001; Evangelista MTP, 2014, INT J DERMATOL, V53, P100, DOI 10.1111/ijd.12339; Panther DJ, 2015, J CLIN MED, V4, P970, DOI 10.3390/jcm4050970; Park SB, 2014, ANN DERMATOL, V26, P150, DOI 10.5021/ad.2014.26.2.150; Pombert JF, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-232; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Core, 2013, R LANG ENV STAT COMP; Rippke F, 2004, AM J CLIN DERMATOL, V5, P217, DOI 10.2165/00128071-200405040-00002; Schario M, 2014, SKIN PHARMACOL PHYS, V27, P208, DOI 10.1159/000360546; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simpson E, 2013, J DERMATOL TREAT, V24, P122, DOI 10.3109/09546634.2012.713461; Simpson EL, 2014, J ALLERGY CLIN IMMUN, V134, P818, DOI 10.1016/j.jaci.2014.08.005; Simpson EL, 2010, J AM ACAD DERMATOL, V63, P587, DOI 10.1016/j.jaad.2009.11.011; Skovbjerg S, 2010, J INTERF CYTOK RES, V30, P23, DOI 10.1089/jir.2009.0033; Sliepen I, 2009, J DENT RES, V88, P1026, DOI 10.1177/0022034509347296; Sugiyama M, 2007, PEDIATRICS, V119, pE716, DOI 10.1542/peds.2006-0893; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; Verallo-Rowell VM, 2008, DERMATITIS, V19, P308, DOI 10.2310/6620.2008.08052; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Williams H, 2006, J ALLERGY CLIN IMMUN, V118, P209, DOI 10.1016/j.jaci.2006.04.043; WILLIAMS REA, 1990, BRIT J DERMATOL, V123, P493; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	59	62	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192443	10.1371/journal.pone.0192443	http://dx.doi.org/10.1371/journal.pone.0192443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489859	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000027
J	Michaud, K; de Tayrac, M; D'Astous, M; Paquet, C; Gould, PV; Saikali, S				Michaud, Karine; de Tayrac, Marie; D'Astous, Myreille; Paquet, Claudie; Gould, Peter Vincent; Saikali, Stephan			Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; PROGNOSTIC VALUE; MICROVASCULAR PROLIFERATION; CELL-PROLIFERATION; ASTROCYTIC TUMORS; ALPHA-INTERNEXIN; EXPRESSION; GLIOMAS; P16(INK4A); CANCER	Objective To study the presence of 9p deletion and p16, cyclin D1 and Myc expression and their respective diagnostic and prognostic interest in oligodendrogliomas. Methods We analyzed a retrospective series of 40 consecutive anaplastic oligodendrogliomas (OIII) from a single institution and compared them to a control series of 10 low grade oligodendrogliomas (OII). Automated FISH analysis of chromosome 9p status and immunohistochemistry for p16, cyclin D1 and Myc was performed for all cases and correlated with clinical and histological data, event free survival (EFS) and overall survival (OS). Results Chromosome 9p deletion was observed in 55% of OIII (22/40) but not in OII. Deletion was highly correlated to EFS (median = 29 versus 53 months, p<0.0001) and OS (median = 48 versus 83 months, p<0.0001) in both the total cohort and the OIII population. In 9p nondeleted oligodendrogliomas, p16 hyperexpression correlated with a shorter OS (p = 0.02 in OII and p = 0.0001 in OIII) whereas lack of p16 expression was correlated to a shorter EFS and OS in 9p deleted OIII (p = 0.001 and p = 0.0002 respectively). Expression of Cyclin D1 was significantly higher in OIII (median expression 45% versus 14% for OII, p = 0.0006) and was correlated with MIB-1 expression (p< 0.0001), vascular proliferation (p = 0.002), tumor necrosis (p = 0.04) and a shorter EFS in the total cohort (p = 0.05). Hyperexpression of Myc was correlated to grade (median expression 27% in OII versus 35% in OIII, p = 0.03), and to a shorter EFS in 9p non-deleted OIII (p = 0.01). Conclusion Chromosome 9p deletion identifies a subset of OIII with significantly worse prognosis. The combination of 9p status and p16 expression level identifies two distinct OIII populations with divergent prognosis. Hyperexpression of Bcl1 and Myc appears highly linked to anaplasia but the prognostic value is unclear and should be investigated further.	[Michaud, Karine; D'Astous, Myreille] CHU Quebec, Dept Neurosurg, Quebec City, PQ, Canada; [de Tayrac, Marie] CHU Rennes, Dept Genom & Mol Genet, Rennes, France; [Paquet, Claudie; Gould, Peter Vincent; Saikali, Stephan] CHU Quebec, Dept Pathol, Quebec City, PQ, Canada	Laval University; CHU Rennes; Laval University	Saikali, S (corresponding author), CHU Quebec, Dept Pathol, Quebec City, PQ, Canada.	stephan.saikali.cha@ssss.gouv.qc.ca	Michaud, Karine/AAM-3026-2020; de Tayrac, Marie/AAG-7800-2020	Saikali, Stephan/0000-0002-6966-7538	Fondation du CHU de Quebec [2885]	Fondation du CHU de Quebec	This work was supported by grants from Fondation du CHU de Quebec (grant #2885) to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldosari N, 2002, ARCH PATHOL LAB MED, V126, P540; Alentorn A, 2015, NEUROLOGY, V85, P1325, DOI 10.1212/WNL.0000000000002014; Bai H, 2016, NAT GENET, V48, P59, DOI 10.1038/ng.3457; Barker FG, 1997, J NEURO-ONCOL, V31, P17, DOI 10.1023/A:1005768910871; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Bortolotto S, 2000, INT J CANCER, V88, P554, DOI 10.1002/1097-0215(20001115)88:4<554::AID-IJC6>3.0.CO;2-Q; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Cavalla P, 1998, ACTA NEUROPATHOL, V95, P131, DOI 10.1007/s004010050776; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Dang CV, 2005, CANCER CELL, V8, P177, DOI 10.1016/j.ccr.2005.08.005; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Duval C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132125; Eide HA, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2104-9; Fallon KB, 2004, J NEUROPATH EXP NEUR, V63, P314, DOI 10.1093/jnen/63.4.314; Faria MH, 2008, ACTA NEUROPATHOL, V116, P87, DOI 10.1007/s00401-008-0368-0; Fiano V, 2003, NEUROSCI LETT, V347, P111, DOI 10.1016/S0304-3940(03)00615-3; Figarella-Branger D, 2014, NEURO-ONCOLOGY, V16, P1244, DOI 10.1093/neuonc/nou047; Gearhart J, 2007, NEW ENGL J MED, V357, P1469, DOI 10.1056/NEJMp078126; Giannini C, 2001, J NEUROPATH EXP NEUR, V60, P248, DOI 10.1093/jnen/60.3.248; Godraind C, 2003, NEUROPATH APPL NEURO, V29, P462, DOI 10.1046/j.1365-2990.2003.00484.x; Jenkins RB, 2012, NAT GENET, V44, P1122, DOI 10.1038/ng.2388; Jeon YK, 2007, NEUROPATHOLOGY, V27, P10, DOI 10.1111/j.1440-1789.2006.00735.x; Kamoun A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11263; Lebok P, 2016, ONCOTARGET, V7, P81322, DOI 10.18632/oncotarget.13227; Li JN, 2011, BIOCHEMISTRY-US, V50, P5566, DOI 10.1021/bi200642e; Louis, 2016, WHO CLASSIFICATION G; Louis DN, 2016, ACTA NEUROPATHOL, V5, P429; Matsumura N, 2015, BRAIN TUMOR PATHOL, V32, P261, DOI 10.1007/s10014-015-0228-2; Michaud K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168728; Miettinen H, 1999, J NEURO-ONCOL, V41, P205, DOI 10.1023/A:1006185220369; Mokhtari K, 2011, CANCER-AM CANCER SOC, V117, P3014, DOI 10.1002/cncr.25827; Odia Y, 2013, J NEURO-ONCOL, V115, P249, DOI 10.1007/s11060-013-1221-4; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Perry A, 1997, J NEUROPATH EXP NEUR, V56, P999, DOI 10.1097/00005072-199709000-00005; Preusser M, 2012, HISTOPATHOLOGY, V60, P885, DOI 10.1111/j.1365-2559.2011.04134.x; Qie S, 2016, J MOL MED, V94, P1313, DOI 10.1007/s00109-016-1475-3; Ranuncolo SM, 2004, J NEURO-ONCOL, V68, P113, DOI 10.1023/B:NEON.0000027741.19213.99; Reuss DE, 2015, ACTA NEUROPATHOL, V129, P133, DOI 10.1007/s00401-014-1370-3; Reyes-Botero G, 2014, NEURO-ONCOLOGY, V16, P662, DOI 10.1093/neuonc/not235; Sahm F, 2014, ACTA NEUROPATHOL, V128, P551, DOI 10.1007/s00401-014-1326-7; Sallinen SL, 1999, J PATHOL, V188, P289; SHIMIZU KT, 1993, RADIOLOGY, V186, P569, DOI 10.1148/radiology.186.2.8421767; Suh JH, 2013, J KOREAN MED SCI, V28, P593, DOI 10.3346/jkms.2013.28.4.593; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Swartling FJ, 2012, UPSALA J MED SCI, V117, P122, DOI 10.3109/03009734.2012.658975; Watanabe T, 2001, ACTA NEUROPATHOL, V101, P185; Wesseling P, 2015, ACTA NEUROPATHOL, V129, P809, DOI 10.1007/s00401-015-1424-1; Wiestler B, 2013, ACTA NEUROPATHOL, V126, P443, DOI 10.1007/s00401-013-1156-z; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Wolter M, 2001, J NEUROPATH EXP NEUR, V60, P1170, DOI 10.1093/jnen/60.12.1170; Zhang X, 2005, J CLIN NEUROSCI, V12, P166, DOI 10.1016/j.jocn.2004.03.036; Zlatescu MC, 2001, CANCER RES, V61, P6713	54	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193213	10.1371/journal.pone.0193213	http://dx.doi.org/10.1371/journal.pone.0193213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489901	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000058
J	Zapata-Rios, G; Branch, LC				Zapata-Rios, Galo; Branch, Lyn C.			Mammalian carnivore occupancy is inversely related to presence of domestic dogs in the high Andes of Ecuador	PLOS ONE			English	Article							FREE-ROAMING DOGS; WEASEL MUSTELA; SCENT-MARKING; THRESHOLDS; LANDSCAPE; PATTERNS; FOREST; CONSERVATION; WILDLIFE; FRAGMENTATION	Although the Andes have long been occupied by people, habitat loss, fragmentation through deforestation, and other human activities such as introduction of invasive species have increased drastically during the past century. The Ecuadorian Andes are considered a biodiversity hotspot. However, the fauna and threats to the region are poorly studied, and understanding of factors that shape the distribution of species in habitats disturbed by human activities is needed to identify and mitigate region-wide threats to wildlife. We evaluated factors associated with patterns of occurrence of Andean carnivores in landscapes of the northern Ecuadorian Andes, particularly habitat loss, fragmentation, and occupancy of domestic dogs, and determined whether thresholds occurred for these factors beyond which carnivore occurrence declined markedly. Five study areas (each 20 x 20 km) were surveyed with a total effort of 2,800 camera trap nights. Occupancies of four of the eight carnivores known from the region were best predicted by occupancy of domestic dogs rather than measures of habitat loss and fragmentation [Andean fox (Pseudalopex culpaeus), puma (Puma concolor), striped hog-nosed skunk (Conepatus semistriatus), and Andean bear (Tremarctos ornatus)]. The two largest carnivores, puma and Andean bear, demonstrated significant threshold responses to the presence of domestic dogs at two sites. Four smaller carnivores were recorded too infrequently to model occupancy, and at least two of these species appear to be in decline. The magnitude of domestic dog impacts on native species in tropical areas like the Ecuadorian Andes currently are not recognized. Results of our study indicate that small and large carnivores are in urgent need of conservation and clearly point to dogs as a significant threat to a broad range of native species.	[Zapata-Rios, Galo; Branch, Lyn C.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Zapata-Rios, Galo] Ecuador Program, Wildlife Conservat Soc, Paris, Quito, Ecuador	State University System of Florida; University of Florida	Zapata-Rios, G (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.; Zapata-Rios, G (corresponding author), Ecuador Program, Wildlife Conservat Soc, Paris, Quito, Ecuador.	gzapata@wcs.org		Zapata-Rios, Galo/0000-0003-3508-5078	Compton Foundation through Program for Tropical Studies and Conservation, University of Florida; Proyecto Paramo Andino, CONDESAN; Tropical Conservation and Development Program, University of Florida; Amazon Conservation Leadership Initiative, University of Florida; Amazon Andes Conservation Program, Wildlife Conservation Society; SENESCYT Ecuador	Compton Foundation through Program for Tropical Studies and Conservation, University of Florida; Proyecto Paramo Andino, CONDESAN; Tropical Conservation and Development Program, University of Florida; Amazon Conservation Leadership Initiative, University of Florida; Amazon Andes Conservation Program, Wildlife Conservation Society; SENESCYT Ecuador	This work was supported by: Compton Foundation through Program for Tropical Studies and Conservation, University of Florida (GZR); Proyecto Paramo Andino, CONDESAN (GZR); Tropical Conservation and Development Program, University of Florida (GZR); Amazon Conservation Leadership Initiative, University of Florida (GZR); Amazon Andes Conservation Program, Wildlife Conservation Society (GZR); and SENESCYT Ecuador (GZR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Ausband D, 2009, ORYX, V43, P73, DOI 10.1017/S0030605308001622; Bailey LL, 2009, BIOL CONSERV, V142, P2983, DOI 10.1016/j.biocon.2009.07.028; Balaguera-Reina Sergio A., 2009, Small Carnivore Conservation, V41, P35; Baquero F, 2004, VEGETACION ANDES ECU; Barea-Azcon JM, 2007, BIODIVERS CONSERV, V16, P1213, DOI 10.1007/s10531-006-9114-x; Betts MG, 2007, CONSERV BIOL, V21, P1046, DOI 10.1111/j.1523-1739.2007.00723.x; Broquet T, 2006, MOL ECOL, V15, P1689, DOI 10.1111/j.1365-294X.2006.02878.x; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Craft ME, 2017, ANIM CONSERV, V20, P193, DOI 10.1111/acv.12305; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cuesta Francisco, 2003, Ursus (Knoxville), V14, P198; Duellman WE, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P255; Elbroch M, 2009, REV CHIL HIST NAT, V82, P459; ERLINGE S, 1982, ANIM BEHAV, V30, P811, DOI 10.1016/S0003-3472(82)80154-1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Gehring TM, 2004, J MAMMAL, V85, P79, DOI 10.1644/1545-1542(2004)085&lt;0079:HRAMOL&gt;2.0.CO;2; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Goldstein I, 2006, URSUS, V17, P8, DOI 10.2192/1537-6176(2006)17[8:ABCAR]2.0.CO;2; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P9; Guenette JS, 2005, CONSERV BIOL, V19, P1168, DOI 10.1111/j.1523-1739.2005.00085.x; HESS CG, 1990, MT RES DEV, V10, P333, DOI 10.2307/3673495; Hines J., 2006, PRESENCE2 SOFTWARE E; Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005; Hutchings MR, 2000, MAMMAL REV, V30, P157, DOI 10.1046/j.1365-2907.2000.00065.x; Instituto Ecuatoriano de Estadisticas y Censos (INEC), 2014, EC CIFR POBL DEM; IUCN, 2013, IUCN RED LIST THREAT; IZOR RJ, 1978, J MAMMAL, V59, P92, DOI 10.2307/1379878; Knapp S, 2002, BOT REV, V68, P22, DOI 10.1663/0006-8101(2002)068[0022:APOPEI]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Lindenmayer DB, 2005, BIOL CONSERV, V124, P311, DOI 10.1016/j.biocon.2005.01.038; Lindenmayer DB, 2005, BIOL CONSERV, V124, P351, DOI 10.1016/j.biocon.2005.01.041; Lucherini M, 2009, J MAMMAL, V90, P1404, DOI 10.1644/09-MAMM-A-002R.1; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manor R, 2004, BIOL CONSERV, V119, P231, DOI 10.1016/j.biocon.2003.11.005; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; Muntifering JR, 2006, ANIM CONSERV, V9, P103, DOI 10.1111/j.1469-1795.2005.00008.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Novaro Andres J., 1997, Mammalian Species, V0, P1; Parsons AW, 2016, BIOL CONSERV, V203, P75, DOI 10.1016/j.biocon.2016.09.001; Parsons J. J., 1982, Mountain Research and Development, V2, P253, DOI 10.2307/3673089; Peralvo MF, 2005, URSUS, V16, P222, DOI 10.2192/1537-6176(2005)016[0222:DPHAFT]2.0.CO;2; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Radford JQ, 2004, BIOL CONSERV, V117, P375, DOI 10.1016/j.biocon.2003.08.002; Rios-Uzeda B, 2006, J ZOOL, V268, P271, DOI 10.1111/j.1469-7998.2005.00013.x; RODRIGUEZ EA, 2010, AUSTRAL ECOLOGY, V35, P765; Saito J., 2009, ECOSISTEMAS ANDES NO; Sanchez F, 2008, CALDASIA, V30, P197; Sarmiento FO, 2002, GEOGR REV, V92, P213, DOI 10.2307/4140971; Sarmiento FO, 2000, AMBIO, V29, P423, DOI 10.1639/0044-7447(2000)029[0423:BMPEEO]2.0.CO;2; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Sheffield Steven R., 1997, Mammalian Species, V570, P1; Silva-Rodriguez EA, 2012, BIOL CONSERV, V150, P103, DOI 10.1016/j.biocon.2012.03.008; Silva-Rodriguez EA, 2011, CONSERV BIOL, V25, P808, DOI 10.1111/j.1523-1739.2011.01690.x; Silva-Rodriguez EA, 2010, ORYX, V44, P97, DOI 10.1017/S0030605309990445; Smith DA, 2008, BIOL CONSERV, V141, P925, DOI 10.1016/j.biocon.2007.12.021; Smith JNM, 2002, TRENDS ECOL EVOL, V17, P397, DOI 10.1016/S0169-5347(02)02576-4; STASINOPOULOS DM, 1992, COMPUT STAT DATA AN, V13, P461, DOI 10.1016/0167-9473(92)90119-Z; Sunquist ME, 2001, CONSERV BIOL SER, V5, P399; Swihart RK, 2003, J BIOGEOGR, V30, P1259, DOI 10.1046/j.1365-2699.2003.00925.x; Tabarelli M, 2004, BIODIVERS CONSERV, V13, P1419, DOI 10.1023/B:BIOC.0000019398.36045.1b; Tirira D., 2011, LIBRO ROJO MAMIFEROS; Tirira D., 2007, MAMIFEROS ECUADOR GU; Tirira Diego G., 2009, Small Carnivore Conservation, V41, P46; Torres PC, 2010, BRAZ J BIOL, V70, P987, DOI 10.1590/S1519-69842010000500010; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Vanak AT, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P69; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; Villalba M. Lilian, 2012, Endangered Species Research, V16, P85, DOI 10.3354/esr00389; Winckell A, 1997, REGIONES PAISAJES EC; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; Wolf J., 2002, ECOTROPICOS, V15, P3; Wong DWS, 2005, STAT ANAL GEOGRAPHIC; Young JK, 2011, BIOSCIENCE, V61, P125, DOI 10.1525/bio.2011.61.2.7; Young KR, 1997, LANDSCAPE URBAN PLAN, V38, P137, DOI 10.1016/S0169-2046(97)00029-7; Zapata-Rios G, 2016, BIOL CONSERV, V193, P9, DOI 10.1016/j.biocon.2015.10.016; Zapata-Rios G, 2009, ORYX, V43, P375, DOI 10.1017/S0030605309001914; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	88	22	27	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192346	10.1371/journal.pone.0192346	http://dx.doi.org/10.1371/journal.pone.0192346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489855	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000024
J	Zhao, SW; Yang, Q; Yu, ZX; Lv, Y; Zhi, JM; Gustin, P; Zhang, WH				Zhao, Shiwei; Yang, Qi; Yu, Zhixi; Lv, You; Zhi, Jianming; Gustin, Pascal; Zhang, Wenhui			Protective effects of tiotropium alone or combined with budesonide against cadmium inhalation induced acute neutrophilic pulmonary inflammation in rats	PLOS ONE			English	Article							ACUTE LUNG INJURY; NF-KAPPA-B; INHALED CORTICOSTEROIDS; ACUTE EXACERBATIONS; SHORT-TERM; INHIBITION; BROMIDE; COPD; EXPRESSION; RELEASE	As a potent bronchodilator, the anti-inflammatory effects of tiotropium and its interaction with budesonide against cadmium-induced acute pulmonary inflammation were investigated. Compared to values obtained in rats exposed to cadmium, cytological analysis indicated a significant decrease of total cell and neutrophil counts and protein concentration in bronchoalveolar lavage fluid (BALF) in rats pretreated with tiotropium (70 mu g/15ml or 350 mu g/15ml). Zymographic tests showed a decrease of MMP-2 activity in BALF in rats pretreated only with high concentration of tiotropium. Histological examination revealed a significant decrease of the severity and extent of inflammatory lung injuries in rats pretreated with both tested concentrations of tiotropium. Though tiotropium (70 mu g/15ml) or budesonide (250 mu g/15ml) could not reduce cadmium-induced bronchial hyper-responsiveness, their combination significantly decreased bronchial contractile response to methacholine. These two drugs separately decreased the neutrophil number and protein concentration in BALF but no significant interaction was observed when both drugs were combined. Although no inhibitory effects on MMP-2 and MMP-9 was observed in rats pretreated with budesonide alone, the combination with the ineffective dose of tiotropium induced a significant reduction on these parameters. The inhibitory effect of tiotropium on lung injuries was not influenced by budesonide which alone induced a limited action on the severity and extent of inflammatory sites. Our findings show that tiotropium exerts anti-inflammatory effects on cadmium-induced acute neutrophilic pulmonary inflammation. The combination of tiotropium with budesonide inhibits cadmium-induced inflammatory injuries with a synergistic interaction on MMP-2 and MMP-9 activity and airway hyper-responsiveness.	[Zhao, Shiwei; Yang, Qi; Yu, Zhixi; Lv, You] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China; [Zhi, Jianming; Zhang, Wenhui] Shanghai Jiao Tong Univ, Sch Med, Dept Anat & Physiol, Shanghai, Peoples R China; [Gustin, Pascal] Univ Liege, Fac Vet Med, Dept Funct Sci, Liege, Belgium	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Liege	Zhang, WH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Anat & Physiol, Shanghai, Peoples R China.	i_zhangwenhui@163.com			National Natural Science Foundation of China [81373468]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 81373468) to WZ.	Arai N, 2010, EUR RESPIR J, V35, P1164, DOI 10.1183/09031936.00040709; Asano Kazuhito, 2010, Int J Chron Obstruct Pulmon Dis, V5, P277; Asano Kazuhito, 2008, Int J Chron Obstruct Pulmon Dis, V3, P781; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Blum JL, 2014, INHAL TOXICOL, V26, P48, DOI 10.3109/08958378.2013.851746; Bolognin M, 2009, VET J, V179, P443, DOI 10.1016/j.tvjl.2007.10.004; Bos IST, 2007, EUR RESPIR J, V30, P653, DOI 10.1183/09031936.00004907; Bucher H, 2016, J PHARMACOL EXP THER, V357, P606, DOI 10.1124/jpet.116.232009; Coimbra R, 2006, J TRAUMA, V60, P115, DOI 10.1097/01.ta.0000200075.12489.74; Corry DB, 2002, NAT IMMUNOL, V3, P347, DOI 10.1038/ni773; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Criner GJ, 2015, CHEST, V147, P894, DOI 10.1378/chest.14-1676; Cui Y, 2010, EUR RESPIR J, V35, P1370, DOI 10.1183/09031936.00139909; Evans DJW, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011437.pub2, 10.1002/14651858.CD011397.pub2]; Fievez L, 2009, EUR J PHARMACOL, V606, P210, DOI 10.1016/j.ejphar.2009.01.020; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Gushima Y, 2001, EUR RESPIR J, V18, P827, DOI 10.1183/09031936.01.00049201; Kataranovski M, 2009, ENVIRON TOXICOL PHAR, V28, P225, DOI 10.1016/j.etap.2009.04.008; Kim JH, 2006, AM J PHYSIOL-LUNG C, V291, pL580, DOI 10.1152/ajplung.00270.2005; Konrad FM, 2014, AM J PHYSIOL-LUNG C, V307, pL707, DOI 10.1152/ajplung.00145.2014; Kwak MS, 2015, INT J CHRONIC OBSTR, V10, P2365, DOI 10.2147/COPD.S93191; Matsuse H, 2015, EXPERT OPIN PHARMACO, V16, P1403, DOI 10.1517/14656566.2015.1045877; Mortaz E, 2008, J MOL MED, V86, P1045, DOI 10.1007/s00109-008-0360-0; Olszowski T, 2012, ACTA BIOCHIM POL, V59, P475; Pasternak Y, 2016, AM J EMERG MED, V34, P1977, DOI 10.1016/j.ajem.2016.07.003; Perng DW, 2009, EUR RESPIR J, V33, P778, DOI 10.1183/09031936.00115308; Pirrone F, 2009, VET RES COMMUN, V33, pS121, DOI 10.1007/s11259-009-9255-y; Salpeter Shelley R, 2007, Int J Chron Obstruct Pulmon Dis, V2, P11, DOI 10.2147/copd.2007.2.1.11; Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822; Shen LL, 2014, INT IMMUNOPHARMACOL, V18, P358, DOI 10.1016/j.intimp.2013.12.021; Silva PL, 2009, EUR RESPIR J, V33, P634, DOI 10.1183/09031936.00052408; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Strandberg K, 2010, PULM PHARMACOL THER, V23, P316, DOI 10.1016/j.pupt.2010.03.004; Suzaki I, 2011, INT J CHRONIC OBSTR, V6, P439, DOI 10.2147/COPD.S23695; Turner DL, 2012, BRIT J PHARMACOL, V167, P515, DOI 10.1111/j.1476-5381.2012.02016.x; Vacca G, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-24; Vogelmeier CF, 2017, ARCH BRONCONEUMOL, V53, P128, DOI 10.1016/j.arbres.2017.02.001; Wang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094701; Welte T, 2009, INT J CLIN PRACT, V63, P1136, DOI 10.1111/j.1742-1241.2009.02139.x; Wollin L, 2010, PULM PHARMACOL THER, V23, P345, DOI 10.1016/j.pupt.2010.03.008; Wang XQ, 2008, RESPIROLOGY, V13, P772, DOI 10.1111/j.1440-1843.2008.01344.x; Zhang WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109136; Zhang WH, 2010, EUR J PHARMACOL, V628, P171, DOI 10.1016/j.ejphar.2009.11.015; Zhang Y, 2014, INFLAMMATION, V37, P1654, DOI 10.1007/s10753-014-9893-2	44	8	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193610	10.1371/journal.pone.0193610	http://dx.doi.org/10.1371/journal.pone.0193610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489916	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000095
J	Hua, YJ; Qiu, W; Xiao, QY; Wu, Q				Hua, Yanjun; Qiu, Wei; Xiao, Qiuyi; Wu, Qiang			Precision (repeatability and reproducibility) of ocular parameters obtained by the Tomey OA-2000 biometer compared to the IOLMaster in healthy eyes	PLOS ONE			English	Article							PARTIAL-COHERENCE INTERFEROMETRY; STATISTICAL-METHODS; CATARACT EYES; AXIAL LENGTH; AGREEMENT; MULTICENTER; TOMOGRAPHY; COMPONENTS; DEVICES; ERROR	Purpose To assess the precision (repeatability and reproducibility) of ocular parameters measured by the Tomey OA-2000 biometer, and to compare them with those measured by the IOLMaster. Methods In this prospective study, the right eyes of 108 healthy subjects were included. Three consecutive scans were obtained by 2 observers using the Tomey OA-2000, and in the same session one observer used the IOLMaster (version 5.4.4.0006) for the measurements. About 1 week later, 3 scans were obtained by one observer using the Tomey OA-2000. The axial length (AL), central corneal thickness (CCT), anterior chamber depth (ACD), lens thickness (LT), keratometer readings, pupil diameter (PD) and corneal diameter (CD) values measured by the Tomey OA-2000 and IOLMaster were analyzed. The coefficient of variation (CoV), intraclass correlation coefficient (ICC), within subject standard deviation (Sw) and 2.77Sw were calculated to assess the repeatability and reproducibility. The paired t test and Bland-Altman plots were used to analyze the differences and agreements of parameters measured by the two devices, respectively. Results Intraobserver repeatability, and interobserver and intersession reproducibility of the AL, COT, ACD, LT, Kf, Ks, Kin, PD and CID values measured by the Tomey OA-2000 biometer showed a CoV of less than 1% except that for PD, and an ICC of more than 0.97 except that for PD and CD. The AL, Kf, Ks, Km and CD values measured by the Tomey OA-2000 were 0.058 +/- 0.094 mm, 0.088 +/- 0.150 diopters (D), 0.163 +/- 0.170 D, 0.127 +/- 0.117 D and 0.171 +/- 0.217 mm lower than those measured by the IOLMaster, respectively (all Ps < 0.05). However, the ACID values from the two devices were comparable (P = 0.169). The 95% linite of agreement (LoA) of the AL, ACD, CD and all keratometer readings were no more than 0.24 mm, 0.14 mm 0.60 mm and 0.5 D, respectively. Conclusion Except for the PD and CD, the ocular parameters measured by the Tomey OA-2000 were highly repeatable and reproducible. Except for the CD value, there was good agreement of ocular parameters measured by the Tomey OA-2000 and the IOLMaster in healthy eyes.	[Hua, Yanjun; Qiu, Wei; Xiao, Qiuyi; Wu, Qiang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ophthalmol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Hua, YJ; Wu, Q (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ophthalmol, Shanghai, Peoples R China.	hyj1860@hotmail.com; qiang.Wu@shsmu.edu.cn		HUA, YANJUN/0000-0001-6461-3576				Bland JM, 1996, BRIT MED J, V313, P744; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buckhurst PJ, 2009, BRIT J OPHTHALMOL, V93, P949, DOI 10.1136/bjo.2008.156554; Bueno-Gimeno I, 2014, OPTOMETRY VISION SCI, V91, P507, DOI 10.1097/OPX.0000000000000231; Cartwright NEK, 2010, EYE, V24, P894, DOI 10.1038/eye.2009.196; Cruysberg LPJ, 2010, BRIT J OPHTHALMOL, V94, P106, DOI 10.1136/bjo.2009.161729; Dulku S, 2013, CLIN EXP OPHTHALMOL, V41, P12, DOI 10.1111/j.1442-9071.2012.02816.x; Freeman G, 2005, ACTA OPHTHALMOL SCAN, V83, P439, DOI 10.1111/j.1600-0420.2005.00473.x; Goebels S, 2015, J CATARACT REFR SURG, V41, P2387, DOI 10.1016/j.jcrs.2015.05.028; Goebels SC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/814761; Goebels SC, 2013, CURR EYE RES, V38, P910, DOI 10.3109/02713683.2013.788722; Haigis W, 2000, GRAEF ARCH CLIN EXP, V238, P765, DOI 10.1007/s004170000188; Hill W, 2008, J CATARACT REFR SURG, V34, P920, DOI 10.1016/j.jcrs.2008.02.021; HITZENBERGER CK, 1993, INVEST OPHTH VIS SCI, V34, P1886; Ho JD, 2008, J CATARACT REFR SURG, V34, P137, DOI 10.1016/j.jcrs.2007.09.033; Hoffer KJ, 2016, J CATARACT REFR SURG, V42, P1165, DOI 10.1016/j.jcrs.2016.07.013; Hoffer KJ, 2016, J CATARACT REFR SURG, V42, P62, DOI 10.1016/j.jcrs.2015.07.041; Hoffer KJ, 2010, J CATARACT REFR SURG, V36, P644, DOI 10.1016/j.jcrs.2009.11.007; Holzer MP, 2009, BRIT J OPHTHALMOL, V93, P807, DOI 10.1136/bjo.2008.152736; Hua YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147086; Hua YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122441; Huang JH, 2017, BRIT J OPHTHALMOL, V101, P493, DOI 10.1136/bjophthalmol-2016-308352; Huang JH, 2015, J CATARACT REFR SURG, V41, P2233, DOI 10.1016/j.jcrs.2015.10.062; Huang JH, 2014, BRIT J OPHTHALMOL, V98, P1277, DOI 10.1136/bjophthalmol-2014-305150; Jasvinder S, 2011, EYE, V25, P717, DOI 10.1038/eye.2011.28; Kola M, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/739652; Liampa Z, 2010, KLIN MONATSBL AUGENH, V227, P285, DOI 10.1055/s-0029-1245182; Mandal P, 2014, BRIT J OPHTHALMOL, V98, P256, DOI 10.1136/bjophthalmol-2013-304002; McAlinden C, 2011, OPHTHAL PHYSL OPT, V31, P330, DOI 10.1111/j.1475-1313.2011.00851.x; Norrby S, 2008, J CATARACT REFR SURG, V34, P368, DOI 10.1016/j.jcrs.2007.10.031; Rohrer K, 2009, OPHTHALMOLOGY, V116, P2087, DOI 10.1016/j.ophtha.2009.04.019; Roncevic MB, 2011, GRAEF ARCH CLIN EXP, V249, P83, DOI 10.1007/s00417-010-1546-z; Santodomingo-Rubido J, 2002, BRIT J OPHTHALMOL, V86, P458, DOI 10.1136/bjo.86.4.458; Shammas HJ, 2012, AM J OPHTHALMOL, V153, P55, DOI 10.1016/j.ajo.2011.06.012; Tay E, 2013, J REFRACT SURG, V29, P838, DOI 10.3928/1081597X-20130924-01	35	19	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193023	10.1371/journal.pone.0193023	http://dx.doi.org/10.1371/journal.pone.0193023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486009	gold, Green Published, Green Submitted			2022-12-27	WOS:000426242400013
J	Chen, CY; Strobaugh, TP; Nguyen, LHT; Abley, M; Lindsey, RL; Jackson, CR				Chen, Chin-Yi; Strobaugh, Terence P., Jr.; Nguyen, Ly-Huong T.; Abley, Melanie; Lindsey, Rebecca L.; Jackson, Charlene R.			Isolation and characterization of two novel groups of kanamycin-resistance ColE1-like plasmids in Salmonella enterica serotypes from food animals	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; UNITED-STATES; ANTIMICROBIAL RESISTANCE; FOODBORNE ILLNESS; SEQUENCE; STRAINS; GENE; PROGRAMS; SEROVARS; HEALTH	While antimicrobial resistance in Salmonella enterica is mainly attributed to large plasmids, small plasmids may also harbor antimicrobial resistance genes. Previously, three major groups of ColE1-like plasmids conferring kanamycin-resistance (Kan(R)) in various S. enterica serotypes from diagnostic samples of human or animals were reported. In this study, over 200 Kan(R) S. enterica isolates from slaughter samples, collected in 2010 and 2011 as a part of the animal arm of the National Antimicrobial Resistance Monitoring System, were screened for the presence of ColE1-like plasmids. Twenty-three Kan(R) ColE1-like plasmids were successfully isolated. Restriction fragment mapping revealed five major plasmid groups with subgroups, including two new groups, X (n = 3) and Y/Y2/Y3 (n = 4), in addition to the previously identified groups A (n = 7), B (n = 6), and C/C3 (n = 3). Nearly 75% of the plasmid-carrying isolates were from turkey and included all the isolates carrying X and Y plasmids. All group X plasmids were from serotype Hadar. Serotype Senftenberg carried all the group Y plasmids and one group B plasmid. All Typhimurium isolates (n = 4) carried group A plasmids, while Newport isolates (n = 3) each carried a different plasmid group (A, B, or C). The presence of the selection bias in the NARMS strain collection prevents interpretation of findings at the population level. However, this study demonstrated that Kan(R) ColE1-like plasmids are widely distributed among different S. enterica serotypes in the NARMS isolates and may play a role in dissemination of antimicrobial resistance genes.	[Chen, Chin-Yi; Strobaugh, Terence P., Jr.; Nguyen, Ly-Huong T.] USDA ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA; [Abley, Melanie; Lindsey, Rebecca L.; Jackson, Charlene R.] USDA ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, Richard B Russell Agr Res Ctr, Athens, GA 30605 USA; [Abley, Melanie] USDA, Food Safety Inspect Serv, Washington, DC 20250 USA; [Lindsey, Rebecca L.] Ctr Dis Control & Prevent, Atlanta, GA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Centers for Disease Control & Prevention - USA	Chen, CY (corresponding author), USDA ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.	chin-yi.chen@ars.usda.gov		Chen, Chin-Yi/0000-0001-5058-0347; Lindsey, Rebecca/0000-0002-2149-7971	United States Department of Agriculture, Agricultural Research Service (USDA-ARS), National Program 108- Food Safety	United States Department of Agriculture, Agricultural Research Service (USDA-ARS), National Program 108- Food Safety	This research was funded by the United States Department of Agriculture, Agricultural Research Service (USDA-ARS), National Program 108- Food Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen PS, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00988-13; Briggs CE, 1999, ANTIMICROB AGENTS CH, V43, P846, DOI 10.1128/AAC.43.4.846; CANNON PM, 1992, PLASMID, V27, P220, DOI 10.1016/0147-619X(92)90024-5; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2001, VET RES, V32, P243, DOI 10.1051/vetres:2001122; Carattoli A, 2006, EMERG INFECT DIS, V12, P1145, DOI 10.3201/eid1207.051555; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; *CDC, 2004, ON DAY 24 28 H STAND; Chen CY, 2007, PLASMID, V57, P29, DOI 10.1016/j.plasmid.2006.05.005; Chen CY, 2011, PLASMID, V65, P246, DOI 10.1016/j.plasmid.2011.02.001; Chen CY, 2010, APPL ENVIRON MICROB, V76, P6707, DOI 10.1128/AEM.00692-10; Chen CY, 2010, PLASMID, V63, P150, DOI 10.1016/j.plasmid.2009.12.005; Clinical and Laboratory Standards Institute, 2006, 16 INF SUPPL CLSI WA; Crarey E, 2015, ANTIMICROBIAL RESIST, P259; FDA, 2013, 2011 EX REP; Fedorka-Cray PJ, 2002, ANIM BIOTECHNOL, V13, P43, DOI 10.1081/ABIO-120005769; FINNEGAN J, 1982, MOL GEN GENET, V185, P344, DOI 10.1007/BF00330810; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Gregorova D, 2004, CAN J MICROBIOL, V50, P107, DOI 10.1139/W03-113; Gregorova D, 2002, FEMS MICROBIOL LETT, V214, P195, DOI 10.1111/j.1574-6968.2002.tb11346.x; Hofinger C, 1998, J CLIN MICROBIOL, V36, P24, DOI 10.1128/JCM.36.1.24-29.1998; Jackson CR, 2007, FOODBORNE PATHOG DIS, V4, P241, DOI 10.1089/fpd.2006.0067; Klumper U, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00730; Lindsey RL, 2009, APPL ENVIRON MICROB, V75, P1908, DOI 10.1128/AEM.02228-08; NCCLS, 2004, PERFORMANCE STANDARD; Owens RC, 2011, J CLIN MICROBIOL, V49, P3406, DOI 10.1128/JCM.00993-11; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; Rychlik I, 2001, J BACTERIOL, V183, P2852, DOI 10.1128/JB.183.9.2852-2858.2001; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scharff RL, 2015, J FOOD PROTECT, V78, P1064, DOI 10.4315/0362-028X.JFP-14-505; Tollefson L, 1999, ACTA VET SCAND, P67; Tollefson L, 1998, VET CLIN N AM-FOOD A, V14, P141, DOI 10.1016/S0749-0720(15)30285-1; TOMIZAWA J, 1986, CELL, V47, P89, DOI 10.1016/0092-8674(86)90369-7; USDA, 2012, 2010 NARMS AN ARM AN; USDA, NAT ANT RES MON SYST; USDA, 2014, 2011 NARMS AN ARM AN; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wu JJ, 2008, J ANTIMICROB CHEMOTH, V62, P1269, DOI 10.1093/jac/dkn426; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zioga A, 2009, ANTIMICROB AGENTS CH, V53, P1256, DOI 10.1128/AAC.01284-08	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193435	10.1371/journal.pone.0193435	http://dx.doi.org/10.1371/journal.pone.0193435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513730	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800059
J	Choi, SS; Uehara, H; Wu, YY; Das, S; Zhang, XH; Archer, B; Carroll, L; Ambati, BK				Choi, Susie; Uehara, Hironori; Wu, Yuanyuan; Das, Subrata; Zhang, Xiaohui; Archer, Bonnie; Carroll, Lara; Ambati, Balamurali Krishna			RNA activating-double stranded RNA targeting flt-1 promoter inhibits endothelial cell proliferation through soluble FLT-1 upregulation	PLOS ONE			English	Article							RECEPTOR 1 SFLT1; GENE-EXPRESSION; MACULAR DEGENERATION; ARGONAUTE PROTEINS; CANCER; VEGF; ANGIOGENESIS; METHYLATION; THERAPY; NEOVASCULARIZATION	Short-activating RNA (saRNA), which targets gene promoters, has been shown to increase the target gene expression. In this study, we describe the use of an saRNA (Flt a-1) to target the flt-1 promoter, leading to upregulation of the soluble isoform of Flt-1 and inhibition of angiogenesis. We demonstrate that Flt a-1 increased sFlt-1 mRNA and protein levels, while reducing VEGF expression. This was associated with suppression of human umbilical vascular endothelial cell (HUVEC) proliferation and cell cycle arrest at the G(0)/G(1) phase. HUVEC migration and tube formation were also suppressed by Flt a-1. An siRNA targeting Flt-1 blocked the effects of Flt a-1. Flt a-1 effects were not mediated via argonaute proteins. However, trichostatin A and 5'-deoxy-5'-(methylthio) adenosine inhibited Flt a-1 effects, indicating that histone acetylation and methylation are mechanistically involved in RNA activation of Flt-1. In conclusion, RNA activation of sFlt-1 can be used to inhibit angiogenesis.	[Choi, Susie; Uehara, Hironori; Wu, Yuanyuan; Zhang, Xiaohui; Archer, Bonnie; Carroll, Lara; Ambati, Balamurali Krishna] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84112 USA; [Das, Subrata] Patanjali Res Inst, Haridwar, India	Utah System of Higher Education; University of Utah	Uehara, H (corresponding author), Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84112 USA.	hironori.uehara@hsc.utah.edu		zhang, xiaohui/0000-0001-7216-4256; DAS, SUBRATA/0000-0001-8608-3270	National Institutes of Health/NEI [R01EY17950]; Research to Prevent Blindness, New York, NY [RPB 2017]	National Institutes of Health/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB))	This work was supported by the National Institutes of Health/NEI (R01EY17950) and unrestricted grant (RPB 2017) from Research to Prevent Blindness, New York, NY to the Department of Ophthalmology & Visual Sciences, University of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio M, 2016, PHARMACOL RES, V103, P253, DOI 10.1016/j.phrs.2015.11.027; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carpentier G., 2012, IMAGEJ NEWS; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Cho YK, 2012, INVEST OPHTH VIS SCI, V53, P685, DOI 10.1167/iovs.11-8391; Chu YJ, 2010, NUCLEIC ACIDS RES, V38, P7736, DOI 10.1093/nar/gkq648; Constable IJ, 2016, EBIOMEDICINE, V14, P168, DOI 10.1016/j.ebiom.2016.11.016; Heier JS, 2017, LANCET, V390, P50, DOI 10.1016/S0140-6736(17)30979-0; Huang V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008848; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Jiao AL, 2014, EPIGENETICS-US, V9, P27, DOI 10.4161/epi.26942; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Lai CM, 2005, MOL THER, V12, P659, DOI 10.1016/j.ymthe.2005.04.022; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Ling H, 2016, ADV EXP MED BIOL, V937, P229, DOI 10.1007/978-3-319-42059-2_12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miyake T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24853; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; Moserle L, 2013, J INTERN MED, V273, P128, DOI 10.1111/joim.12018; Owen LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033576; Portnoy V, 2011, WIRES RNA, V2, P748, DOI 10.1002/wrna.90; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Siegfried Z, 2010, WIRES SYST BIOL MED, V2, P362, DOI 10.1002/wsbm.64; Suzuki Kazuo, 2005, J RNAi Gene Silencing, V1, P66; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Timar Jozsef, 2001, Pathology and Oncology Research, V7, P85; Uehara H, 2015, AM J OPHTHALMOL, V159, P92, DOI 10.1016/j.ajo.2014.09.036; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Verrax J, 2011, MOL PHARMACEUT, V8, P701, DOI 10.1021/mp100268t; Wang JY, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1371/J0URNAL.PPAT.1005243; Wang XL, 2012, BIOCHEM J, V443, P821, DOI 10.1042/BJ20111491; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Yue XA, 2010, NAT CHEM BIOL, V6, P621, DOI [10.1038/NCHEMBIO.400, 10.1038/nchembio.400]; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193590	10.1371/journal.pone.0193590	http://dx.doi.org/10.1371/journal.pone.0193590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509796	Green Submitted, gold, Green Published			2022-12-27	WOS:000426813200017
J	Ford, JA; Turley, R; Porter, T; Shakespeare, T; Wong, G; Jones, AP; Steel, N				Ford, John A.; Turley, Rachel; Porter, Tom; Shakespeare, Tom; Wong, Geoff; Jones, Andy P.; Steel, Nick			Access to primary care for socio-economically disadvantaged older people in rural areas: A qualitative study	PLOS ONE			English	Article							HEALTH-CARE; BARRIERS; ILLNESS; INTERVIEWS; COMMUNITY; BEHAVIOR; ELDERS	Objective We aim to explore the barriers to accessing primary care for socio-economically disadvantaged older people in rural areas. Methods Using a community recruitment strategy, fifteen people over 65 years, living in a rural area, and receiving financial support were recruited for semi-structured interviews. Four focus groups were held with rural health professionals. Interviews and focus groups were audio-recorded and transcribed. Thematic analysis was used to identify barriers to primary care access. Findings Older people's experience can be understood within the context of a patient perceived set of unwritten rules or social contract-an individual is careful not to bother the doctor in return for additional goodwill when they become unwell. However, most found it difficult to access primary care due to engaged telephone lines, availability of appointments, interactions with receptionists; breaching their perceived social contract. This left some feeling unwelcome, worthless or marginalised, especially those with high expectations of the social contract or limited resources, skills and/or desire to adapt to service changes. Health professionals' described how rising demands and expectations coupled with service constraints had necessitated service development, such as fewer home visits, more telephone consultations, triaging calls and modifying the appointment system. Conclusion Multiple barriers to accessing primary care exist for this group. As primary care is re-organised to reduce costs, commissioners and practitioners must not lose sight of the perceived social contract and models of care that form the basis of how many older people interact with the service.	[Ford, John A.; Turley, Rachel; Porter, Tom; Shakespeare, Tom; Jones, Andy P.; Steel, Nick] Univ East Anglia, Dept Publ Hlth & Primary Care, Norwich, Norfolk, England; [Wong, Geoff] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of East Anglia; University of Oxford	Ford, JA (corresponding author), Univ East Anglia, Dept Publ Hlth & Primary Care, Norwich, Norfolk, England.	John.ford@uea.ac.uk	Steel, Nicholas/K-1592-2014	Steel, Nicholas/0000-0003-1528-140X; Wong, Geoff/0000-0002-5384-4157; Ford, John/0000-0001-8033-7081	NIHR Doctoral Research Fellowship [DRF-2014-07-083]; National Institute for Health Research (NIHR)	NIHR Doctoral Research Fellowship; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This work was supported by the NIHR Doctoral Research Fellowship (DRF-2014-07-083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This article/paper/report presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Age UK, 2013, LAT LIF RUR ENGL; [Anonymous], 2015, GUID NHS COMM EQ HLT; Averill JB, 2002, J ADV NURS, V40, P654, DOI 10.1046/j.1365-2648.2002.02425.x; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bentley JM, 2003, INT J NURS STUD, V40, P9, DOI 10.1016/S0020-7489(02)00028-7; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Borders TF, 2004, J RURAL HEALTH, V20, P210, DOI 10.1111/j.1748-0361.2004.tb00031.x; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Coles R, 2010, BRIT J HEALTH PSYCH, V15, P921, DOI 10.1348/135910710X494583; Comino EJ, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-415; Cornwell J., 2012, CARE FRAIL OLDER PEO; Cornwell Jocelyn, 1984, HARD EARNED LIVES AC; Cruess SR, 2000, CAN MED ASSOC J, V162, P668; Cruess SR, 2004, AMA J ETHICS, V6, P1, DOI DOI 10.1001/VIRTUALMENT0R.2004.6.4.MS0C1-0404; Department for Environment Food and Rural Affairs, 2013, STAT DIG RUR ENGL 20; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Douthit N, 2015, PUBLIC HEALTH, V129, P611, DOI 10.1016/j.puhe.2015.04.001; Dyson B, 2014, IMPROVING GEN PRACTI; Elias T, 2014, SOCIOL HEALTH ILL, V36, P970, DOI 10.1111/1467-9566.12129; Ford JA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010652; Ford JA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009104; Ford JA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1373; Goddard M., 2008, QUALITY IN AND EQUAL; Goins RT, 2005, J RURAL HEALTH, V21, P206, DOI 10.1111/j.1748-0361.2005.tb00084.x; Goodridge D, 2011, PRIM CARE RESP J, V20, P54, DOI 10.4104/pcrj.2010.00062; Iezzoni LI, 2006, HEALTH SERV RES, V41, P1258, DOI 10.1111/j.1475-6773.2006.00534.x; Kehle SM, 2011, J GEN INTERN MED, V26, pS689, DOI 10.1007/s11606-011-1849-8; Moore A, 2013, HEALTH-LONDON, V17, P159, DOI 10.1177/1363459312451179; NHS England, 2017, IMPR ACC ALL RED IN; Office for National Statistics, 2016, RUR URB DEF ENGL WAL; QSR International Pty Ltd, 2018, NVIVO; Ricketts TC, 2005, NURS OUTLOOK, V53, P274, DOI 10.1016/j.outlook.2005.06.007; Schappert SM, 2006, VITAL HLTH STAT, V13; Sheridan NF, 2015, HEALTH EXPECT, V18, P32, DOI 10.1111/hex.12006; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vegda K, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-217; Wakerman J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-276	37	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193952	10.1371/journal.pone.0193952	http://dx.doi.org/10.1371/journal.pone.0193952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509811	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000426813200045
J	Kypta, A; Blessberger, H; Kammler, J; Nahler, A; Neeser, K; Lichtenauer, M; Edlinger, C; Kellermair, J; Kiblboeck, D; Lambert, T; Auer, J; Steinwender, C				Kypta, Alexander; Blessberger, Hermann; Kammler, Juergen; Nahler, Alexander; Neeser, Kurt; Lichtenauer, Michael; Edlinger, Christoph; Kellermair, Joerg; Kiblboeck, Daniel; Lambert, Thomas; Auer, Johannes; Steinwender, Clemens			Economic assessment of traditional surgical intervention versus use of a new innovative radiofrequency based surgical system in device replacements	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; EUROPEAN-SOCIETY; ESC GUIDELINES; TASK-FORCE; PACEMAKER; COMPLICATIONS; ASSOCIATION	Introduction Intra-operative complications like mechanical damages to the leads, infections and hematomas during generator replacements of implantable pacemakers and defibrillators contribute to additional costs for hospitals. The aim of this study was to evaluate operation room use, costs and budget impact of generator replacements using either a traditional surgical intervention (TSI) with scissors, scalpel and electrocautery vs. a new radiofrequency energy based surgical system, called PEAK PlasmaBlade (TM) (PPB). Materials and methods We conducted a retrospective analysis of a population including 508 patients with TSI and 254 patients with PPB who underwent generator replacement at the Kepler University Hospital in Linz or the St. Josef Hospital in Braunau, Austria. The economic analysis included costs of resources used for intra-operative complications (lead damages) and of procedure time for TSI vs. PPB. Results Proportion of males, mean age and type of generator replaced were similar between the two groups. Lead damages occurred significantly more frequent with TSI than with PPB (5.3% and 0.4%; p< 0.001) and the procedure time was significantly longer with TSI than with PPB (47.9 +/- 24.9 and 34.1 +/- 18.1 minutes; p<0.001). Shorter procedure time and a lower rate of lead damages with PPB resulted in per patient cost savings of (sic)81. Based on estimated 2,700 patients annually undergoing generator replacement in Austria, the use of PPB may translate into cost savings of (sic)219,600 and 621 saved operating facility hours. Conclusion PPB has the potential to minimize the risk of lead damage with more efficient utilization of the operating room. Along with cost savings and improved quality of care, hospitals may use the saved operating room hours to increase the number of daily surgeries.	[Kypta, Alexander; Blessberger, Hermann; Kammler, Juergen; Nahler, Alexander; Kellermair, Joerg; Kiblboeck, Daniel; Lambert, Thomas; Steinwender, Clemens] Kepler Univ Hosp, Dept Cardiol, Linz, Austria; [Kypta, Alexander; Lichtenauer, Michael; Edlinger, Christoph; Steinwender, Clemens] Paracelsus Med Univ Salzburg, Dept Cardiol, Salzburg, Austria; [Neeser, Kurt] Analyt Laser Int Inc, Lorrach, Germany; [Auer, Johannes] St Josef Hosp, Dept Internal Med 1, Braunau, Austria	Kepler University Hospital; Paracelsus Private Medical University	Kypta, A (corresponding author), Kepler Univ Hosp, Dept Cardiol, Linz, Austria.; Kypta, A (corresponding author), Paracelsus Med Univ Salzburg, Dept Cardiol, Salzburg, Austria.	alexander.kypta@gmail.com	Auer, Johann/AAJ-6895-2021; Kiblböck, Daniel/AAV-1448-2021; Lichtenauer, Michael/H-5139-2019	Lichtenauer, Michael/0000-0001-8403-3931; Kypta, Alexander/0000-0002-5960-7742	Kepler University Hospital	Kepler University Hospital	Kurt Neeser is an employee of the company Laser analytica (data analysis and statistics company) and was paid to perform the statistical and economic analyses for this manuscript. The money was provided by an independent research grant of our department at the Kepler University Hospital. He performed these statistical analyses and reviewed parts of the manuscript but had no role in planning the study design, data collection or decision to publish. The funding organization (Kepler University Hospital) did not have a role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTHOFF H, 1978, MED KLIN, V73, P1468; [Anonymous], 2016, J AM HEART ASSOC; BECKER AE, 1972, CIRCULATION, V46, P409, DOI 10.1161/01.CIR.46.2.409; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Hlatky MA, 2007, EUR HEART J, V28, P388, DOI 10.1093/eurheartj/ehl311; Kuck K-H., 2015, EHRA WHITE BOOK 2015; Kypta A, 2015, PACE, V38, P28, DOI 10.1111/pace.12488; Merkely B, 2010, EUROPACE, V12, P692, DOI 10.1093/europace/euq041; Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076; Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Raatikainen MJP, 2015, EUROPACE, V17, P1, DOI 10.1093/europace/euv265; ROBBOY SJ, 1969, CIRCULATION, V39, P495, DOI 10.1161/01.CIR.39.4.495; SPITTELL PC, 1992, MAYO CLIN PROC, V67, P258, DOI 10.1016/S0025-6196(12)60103-7; Uslan DZ, 2008, AM HEART J, V155, P896, DOI 10.1016/j.ahj.2007.12.022; Wilkoff BL, 2008, HEART RHYTHM, V5, P907, DOI 10.1016/j.hrthm.2008.04.013	15	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0192587	10.1371/journal.pone.0192587	http://dx.doi.org/10.1371/journal.pone.0192587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509774	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200005
J	Wang, GS; Mathew, AV; Yu, HY; Li, L; He, LY; Gao, W; Liu, XD; Guo, YH; Byun, J; Zhang, JF; Chen, YE; Pennathur, S				Wang, Guisong; Mathew, Anna Vachaparampil; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei; Liu, Xiaodan; Guo, Yanhong; Byun, Jaeman; Zhang, Jifeng; Chen, Y. Eugene; Pennathur, Subramaniam			Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX CAPACITY; APOLIPOPROTEIN-A-I; CARDIOVASCULAR-DISEASE; HEART-DISEASE; ENDOTHELIAL DYSFUNCTION; RISK-FACTOR; POPULATION; SEVERITY; SMOKING	High density lipoprotein (HDL) cholesterol levels and cholesterol efflux capacity (CEC) are inversely correlated with coronary artery disease (CAD) risk. Myeloperoxidase (MPO) derived oxidants and HDL proteome changes are implicated in HDL dysfunction in subjects with CAD in the United States; however, the effect of MPO on HDL function and HDL proteome in ethnic Chinese population is unknown. We recruited four matched ethnic Chinese groups (20 patients each): subjects with 1) low HDL levels (HDL levels in men < 40mg/dL and women < 50mg/dL) and non-CAD (identified by coronary angiography or cardiac CT angiography); 2) low HDL and CAD; 3) high HDL (men > 50mg/dL; women > 60mg/dL) with no CAD; and 4) high HDL with CAD. Serum cytokines, serum MPO levels, serum CEC, MPO-oxidized HDL tyrosine moieties, and HDL proteome were assessed by mass spectrometry individually in the four groups. The cytokines, MPO levels, and HDL proteome profiles were not significantly different between the four groups. As expected, CEC was depressed in the entire CAD group but more specifically in the CAD low-HDL group. HDL of CAD subjects had significantly higher 3-nitrotyrosine than non-CAD subjects, but the MPO-specific 3-chlorotyrosine was unchanged; CEC in the CAD low-HDL group did not correlate with either HDL 3-chlorotyrosine or 3-nitrotyrosine levels. Neither 3-chlorotyrosine, which is MPO-specific, nor 3-nitrotyrosine generated from MPO or other reactive nitrogen species was associated with CEC. MPO mediated oxidative stress and HDL proteome composition changes are not the primary cause HDL dysfunction in Chinese subjects with CAD. These studies highlight ethnic differences in HDL dysfunction between United States and Chinese cohorts raising possibility of unique pathways of HDL dysfunction in this cohort.	[Wang, Guisong; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei] Peking Univ, Hosp 3, Dept Cardiol, Beijing, Peoples R China; [Wang, Guisong; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei] Peking Univ, Hosp 3, Inst Vasc Med, Beijing, Peoples R China; [Wang, Guisong; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei] Minist Hlth, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Beijing, Peoples R China; [Wang, Guisong; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Wang, Guisong; Yu, Haiyi; Li, Lei; He, Liyun; Gao, Wei] Beijing Key Lab Cardiovasc Receptors Res, Beijing, Peoples R China; [Mathew, Anna Vachaparampil; Guo, Yanhong; Byun, Jaeman; Zhang, Jifeng; Chen, Y. Eugene; Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Liu, Xiaodan] China Med Univ, Affiliated Hosp 1, Dept Med, Nephrol, Shenyang, Liaoning, Peoples R China	Peking University; Peking University; University of Michigan System; University of Michigan; China Medical University	Pennathur, S (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	spennath@umich.edu	Mathew, Anna V/V-2511-2018; Guo, Yanhong/D-9764-2012	Mathew, Anna/0000-0002-7043-4221; Gao, Wei/0000-0003-3541-9568	University of Michigan-Peking University Joint Institute for Translational and Clinical Research; National Institutes of Health NIDDK [P30DK081943]; NHLBI [K08HL130944]; National Institutes of Health [P30DK081943, K08HL130944]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL130944] Funding Source: NIH RePORTER	University of Michigan-Peking University Joint Institute for Translational and Clinical Research; National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the University of Michigan-Peking University Joint Institute for Translational and Clinical Research (http://puuma.org/research-programs/cardiovascular-disease/dysfunctional-hdi-and-cardiovascular-disease) to to SP, EC, GW and WG; National Institutes of Health NIDDK (P30DK081943) to S.P;, and NHLBI (K08HL130944)to AVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported in part by grants from the University of Michigan-Peking University Joint Institute for Translational and Clinical Research and National Institutes of Health (P30DK081943 and K08HL130944).	Agarwala AP, 2015, ARTERIOSCL THROM VAS, V35, P1515, DOI 10.1161/ATVBAHA.115.305504; Alwaili K, 2012, BBA-MOL CELL BIOL L, V1821, P405, DOI 10.1016/j.bbalip.2011.07.013; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Feng H, 2009, CURR OPIN ENDOCRINOL, V16, P156, DOI 10.1097/MED.0b013e32832922fc; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; Gui LX, 2014, ATHEROSCLEROSIS, V237, P480, DOI 10.1016/j.atherosclerosis.2014.09.032; Jin ZM, 2006, ACTA CARDIOL, V61, P603, DOI 10.2143/AC.61.6.2017958; Kashiwagi M, 2009, CIRC J, V73, P1291, DOI 10.1253/circj.CJ-08-0968; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Ko DT, 2016, J AM COLL CARDIOL, V68, P2073, DOI 10.1016/j.jacc.2016.08.038; Krishnan S, 2015, J PROTEOME RES, V14, P5109, DOI 10.1021/acs.jproteome.5b00730; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; Li YP, 2016, J AM COLL CARDIOL, V68, P818, DOI 10.1016/j.jacc.2016.06.011; Lin CC, 2014, ATHEROSCLEROSIS, V235, P488, DOI 10.1016/j.atherosclerosis.2014.05.939; Liu CQ, 2016, ATHEROSCLEROSIS, V249, P116, DOI 10.1016/j.atherosclerosis.2015.10.111; Liu HH, 2017, ATHEROSCLEROSIS, V263, P104, DOI 10.1016/j.atherosclerosis.2017.06.013; Lu NH, 2015, CLIN CHIM ACTA, V441, P163, DOI 10.1016/j.cca.2014.12.014; Martiniuk ALC, 2006, TOB CONTROL, V15, P181, DOI 10.1136/tc.2005.013284; Messner B, 2014, ARTERIOSCL THROM VAS, V34, P509, DOI 10.1161/ATVBAHA.113.300156; Min X, 2017, BIOMED RES INT, V2017, P9; Mizia-Stec K, 2003, CORONARY ARTERY DIS, V14, P431, DOI 10.1097/00019501-200309000-00003; Monette JS, 2016, CIRC RES, V119, P83, DOI 10.1161/CIRCRESAHA.116.308357; Noori M, 2009, J CLIN LIPIDOL, V3, P39, DOI 10.1016/j.jacl.2008.11.010; Okamura DM, 2015, REDOX BIOL, V6, P495, DOI 10.1016/j.redox.2015.09.039; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Pennathur Subramaniam, 2007, Curr Diab Rep, V7, P257, DOI 10.1007/s11892-007-0041-3; Riwanto M, ALTERED ACTIVATION E; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rye KA, 2014, J LIPID RES, V55, P168, DOI 10.1194/jlr.R039297; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Siddiqi HK, 2015, CURR OPIN CARDIOL, V30, P536, DOI 10.1097/HCO.0000000000000211; Smith CK, 2014, ARTHRITIS RHEUMATOL, V66, P2532, DOI 10.1002/art.38703; Song P, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/761939; Su CS, 2015, ACTA CARDIOL SIN, V31, P528, DOI 10.6515/ACS20150421A; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Tong XL, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-27; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vivekanandan-Giri A, 2013, ANN RHEUM DIS, V72, P1725, DOI 10.1136/annrheumdis-2012-202033; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086332; Yan LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098368; Yang XL, 2016, CIRCULATION, V134, P1430, DOI 10.1161/CIRCULATIONAHA.116.022367; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; YU JJ, 1990, JAMA-J AM MED ASSOC, V264, P1575, DOI 10.1001/jama.264.12.1575; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zhao L, 2017, ONCOTARGET, V8, P66438, DOI 10.18632/oncotarget.20090; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	60	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193782	10.1371/journal.pone.0193782	http://dx.doi.org/10.1371/journal.pone.0193782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505607	Green Published, gold, Green Submitted			2022-12-27	WOS:000426548200031
J	Bukabau, JB; Sumaili, EK; Cavalier, E; Pottel, H; Kifakiou, B; Nkodila, A; Makulo, JRR; Mokoli, VM; Zinga, CV; Longo, AL; Engole, YM; Nlandu, YM; Lepira, FB; Nseka, NM; Krzesinski, JM; Delanaye, P				Bukabau, Justine B.; Sumaili, Ernest K.; Cavalier, Etienne; Pottel, Hans; Kifakiou, Bejos; Nkodila, Aliocha; Makulo, Jean Robert R.; Mokoli, Vieux M.; Zinga, Chantal V.; Longo, Augustin L.; Engole, Yannick M.; Nlandu, Yannick M.; Lepira, Francois B.; Nseka, Nazaire M.; Krzesinski, Jean Marie; Delanaye, Pierre			Performance of glomerular filtration rate estimation equations in Congolese healthy adults: The inopportunity of the ethnic correction	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; IMPROVING GLOBAL OUTCOMES; BLACK SOUTH-AFRICANS; SERUM CREATININE; CYSTATIN C; CLINICAL-PRACTICE; RENAL-FUNCTION; POSITION STATEMENT; PLASMA-CLEARANCE; PUBLIC-HEALTH	Context and objective In the estimation of glomerular filtration rate (GFR), ethnicity is an important determinant. However, all existing equations have been built solely from Caucasian and Afro-American populations and they are potentially inaccurate for estimating GFR in African populations. We therefore evaluated the performance of different estimated GFR (eGFR) equations in predicting measured GFR (mGFR). Methods In a cross-sectional study, 93 healthy adults were randomly selected in the general population of Kinshasa, Democratic Republic of the Congo, between June 2015 and April 2016. We compared mGFR by plasma clearance of iohexol with eGFR obtained with the Modified Diet in Renal Disease (MDRD) equation with and without ethnic factor, the Chronic Kidney Disease Epidemiology (CKD-EPI) serum creatinine (SCr)-based equation, with and without ethnic factor, the cystatin C-based CKD-EPI equation (CKD-EPI SCys) and with the combined equation (CKD-EPI SCrCys) with and without ethnic factor. The performance of the equations was studied by calculating bias, precision and accuracy within 30% (P30) of mGFR. Results There were 48 women and 45 men. Their mean age was 45.0 +/- 15.7 years and the average body surface area was 1.68 +/- 0.16m(2). Mean mGFR was 92.0 +/- 17.2 mL/min/1.73m(2) (range of 57 to 141 mL/min/1.73m(2)). Mean eGFRs with the different equations were 105.5 +/- 30.1 and 87.2 +/- 24.8 mL/min/1.73m(2) for MDRD with and without ethnic factor, respectively; 108.8 +/- 24.1 and 94.3x20.9 mL/min/1.73m(2) for CKD-EPI SCr with and without ethnic factor, respectively, 93.5 +/- 18.6 mL/min/1.73m(2) for CKD-EPI SCys; 93.5 +/- 18.0 and 101 +/- 19.6 mL/min/1.73m(2) for CKD-EPI SCrCys with and without ethnic factor, respectively. All equations slightly overestimated mGFR except MDRD without ethnic factor which underestimated by -3.8 +/- 23.0 mL/min /1.73m(2). Both CKD-EPI SCr and MDRD with ethnic factors highly overestimated mGFR with a bias of 17.9 +/- 19.2 and 14.5 +/- 27.1 mL/min/1.73m(2), respectively. There was a trend for better P30 for MDRD and CKD-EPI SCr without than with the ethnic factor [86.0% versus 79.6% for MDRD (p = 0.21) and 81.7% versus 73.1% for the CKD-EPI SCr equations (p = 0.057)]. CKD-EPI SCrCys and CKD-EPI SCys were more effective than creatinine-based equations. Conclusion In the Congolese healthy population, MDRD and CKD-EPI equations without ethnic factors had better performance than the same equations with ethnic factor. The equations using Cys C (alone or combined with SCr) performed better than the creatinine-based equations.	[Bukabau, Justine B.; Sumaili, Ernest K.; Kifakiou, Bejos; Nkodila, Aliocha; Makulo, Jean Robert R.; Mokoli, Vieux M.; Zinga, Chantal V.; Longo, Augustin L.; Engole, Yannick M.; Nlandu, Yannick M.; Lepira, Francois B.; Nseka, Nazaire M.] Univ Kinshasa, Kinshasa Univ Hosp, Dept Internal Med, Renal Unit, Kinshasa, DEM REP CONGO; [Cavalier, Etienne] Univ Liege, CHU Sart Tilman ULg CHU, Div Clin Chem, Liege, Belgium; [Pottel, Hans] Katholieke Univ Leuven, Div Publ Hlth & Primary Care, Campus Kulak Kortrijk, Kortrijk, Belgium; [Krzesinski, Jean Marie; Delanaye, Pierre] Univ Liege, CHU Sart Tilman ULg CHU, Div Nephrol Dialysis Transplantat, Liege, Belgium	Universite de Kinshasa; University of Liege; KU Leuven; University of Liege	Bukabau, JB (corresponding author), Univ Kinshasa, Kinshasa Univ Hosp, Dept Internal Med, Renal Unit, Kinshasa, DEM REP CONGO.	justinebuk@yahoo.fr	Cavalier, Etienne/E-8661-2011; Pottel, Hans/AAD-9444-2019; Delanaye, Pierre/T-4225-2019; Nlandu, Yannick/W-7583-2019	Cavalier, Etienne/0000-0003-0947-2226; Pottel, Hans/0000-0003-0074-8919; Delanaye, Pierre/0000-0002-1480-5761; 	University of Liege	University of Liege(University of Liege)	This study was supported by JBB and in part by funding from University of Liege particularly iohexol and serum creatinine, cystatin C dosages. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy KM, 2013, KIDNEY INT, V84, P622, DOI 10.1038/ki.2013.243; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 1998, AM J KIDNEY DIS, V32, P32, DOI 10.1053/ajkd.1998.v32.pm9669421; Delanaye P, 2016, CLIN KIDNEY J, V9, P700, DOI 10.1093/ckj/sfw071; Delanaye P, 2016, CLIN KIDNEY J, V9, P682, DOI 10.1093/ckj/sfw070; Delanaye P, 2013, NEPHROL DIAL TRANSPL, V28, P1396, DOI 10.1093/ndt/gft006; Delanaye P, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-57; Delanaye P, 2011, CLIN J AM SOC NEPHRO, V6, P906, DOI 10.2215/CJN.10931210; Eastwood JB, 2010, NEPHROL DIAL TRANSPL, V25, P2178, DOI 10.1093/ndt/gfp765; Ebert N, 2016, CLIN CHIM ACTA, V456, P115, DOI 10.1016/j.cca.2016.03.002; Fan L, 2014, NEPHROL DIAL TRANSPL, V29, P1195, DOI 10.1093/ndt/gft509; Flamant M, 2013, AM J KIDNEY DIS, V62, P182, DOI 10.1053/j.ajkd.2013.03.015; Froissart M, 2008, ANN BIOL CLIN-PARIS, V66, P269, DOI 10.1684/abc.2008.0228; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225; Goldwasser P, 1997, AM J KIDNEY DIS, V30, P16, DOI 10.1016/S0272-6386(97)90559-X; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Katz IJ, 2010, CLIN NEPHROL, V74, pS113; Kramer H, 2008, CLIN J AM SOC NEPHRO, V3, P1391, DOI 10.2215/CJN.04160907; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewis J, 2001, AM J KIDNEY DIS, V38, P744, DOI 10.1053/ajkd.2001.27691; Madala ND, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-61; Matsha TE, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-75; Nyssen L, 2016, CLIN CHIM ACTA, V463, P96, DOI 10.1016/j.cca.2016.10.021; Perico N, 2015, CLIN NEPHROL, V83, pS42, DOI 10.5414/CNP83S042; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Pottel H., 2015, INT J NEPHROLOGY KID, V1; Pottel H, 2017, NEPHROL DIAL TRANSPL, V32, P497, DOI 10.1093/ndt/gfw425; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Sterner G, 2008, SCAND J UROL NEPHROL, V42, P278, DOI 10.1080/00365590701701806; Sumaili EK, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-18; Sumaili EK, 2009, NEPHROL DIAL TRANSPL, V24, P117, DOI 10.1093/ndt/gfn469; van Deventer HE, 2008, CLIN CHEM, V54, P1197, DOI 10.1373/clinchem.2007.099085; van Deventer HE, 2011, NEPHROL DIAL TRANSPL, V26, P1553, DOI 10.1093/ndt/gfq621; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601; Yayo ES, 2016, NEPHROL THER, V12, P454, DOI 10.1016/j.nephro.2016.03.006	41	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193384	10.1371/journal.pone.0193384	http://dx.doi.org/10.1371/journal.pone.0193384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499039	gold, Green Submitted, Green Published			2022-12-27	WOS:000426472300012
J	Reza, SH; Delhomme, N; Street, NR; Ramachandran, P; Dalman, K; Nilsson, O; Minina, EA; Bozhkov, PV				Reza, Salim H.; Delhomme, Nicolas; Street, Nathaniel R.; Ramachandran, Prashanth; Dalman, Kerstin; Nilsson, Ove; Minina, Elena A.; Bozhkov, Peter V.			Transcriptome analysis of embryonic domains in Norway spruce reveals potential regulators of suspensor cell death	PLOS ONE			English	Article							SOMATIC EMBRYOGENESIS; BAX INHIBITOR-1; CATHEPSIN-B; AUXIN TRANSPORT; STRESS; EXPRESSION; FLAVONOIDS; GENES; BIOSYNTHESIS; ACCUMULATION	The terminal differentiation and elimination of the embryo-suspensor is the earliest manifestation of programmed cell death (PCD) during plant ontogenesis. Molecular regulation of suspensor PCD remains poorly understood. Norway spruce (Picea abies) embryos provide a powerful model for studying embryo development because of their large size, sequenced genome, and the possibility to obtain a large number of embryos at a specific developmental stage through somatic embryogenesis. Here, we have carried out global gene expression analysis of the Norway spruce embryo-suspensor versus embryonal mass (a gymnosperm analogue of embryo proper) using RNA sequencing. We have identified that suspensors have enhanced expression of the NAC domain-containing transcription factors, XND1 and ANAC075, previously shown to be involved in the initiation of developmental PCD in Arabidiopsis. The analysis has also revealed enhanced expression of Norway spruce homologues of the known executioners of both developmental and stress-induced cell deaths, such as metacaspase 9 (MC9), cysteine endopeptidase-1 (CEP1) and ribonuclease 3 (RNS3). Interestingly, a spruce homologue of bax inhibitor-1 (PaBI-1, for Picea abies BI-1), an evolutionarily conserved cell death suppressor, was likewise up-regulated in the embryosuspensor. Since Arabidopsis BI-1 so far has been implicated only in the endoplasmic reticulum (ER)-stress induced cell death, we investigated its role in embryogenesis and suspensor PCD using RNA interference (RNAi). We have found that PaBI-1-deficient lines formed a large number of abnormal embryos with suppressed suspensor elongation and disturbed polarity. Cytochemical staining of suspensor cells has revealed that PaBI-1 deficiency suppresses vacuolar cell death and induces necrotic type of cell death previously shown to compromise embryo development. This study demonstrates that a large number of cell-death components are conserved between angiosperms and gymnosperms and establishes a new role for BI-1 in the progression of vacuolar cell death.	[Reza, Salim H.] Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Plant Biol, Uppsala, Sweden; [Reza, Salim H.; Dalman, Kerstin; Minina, Elena A.; Bozhkov, Peter V.] Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Mol Sci, Uppsala, Sweden; [Delhomme, Nicolas; Nilsson, Ove] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden; [Street, Nathaniel R.] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden; [Ramachandran, Prashanth] Uppsala Univ, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Organismal Biol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Umea University; Umea University; Swedish University of Agricultural Sciences; Uppsala University	Reza, SH (corresponding author), Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Plant Biol, Uppsala, Sweden.; Reza, SH; Minina, EA; Bozhkov, PV (corresponding author), Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Uppsala BioCtr, Dept Mol Sci, Uppsala, Sweden.	salim.hossain.reza@slu.se; alena.minina@slu.se; peter.bozhkov@slu.se	Street, Nathaniel Robert/B-3920-2008; Delhomme, Nicolas/B-9187-2015; Bozhkov, Peter/K-3387-2012; Minina, Elena/C-9888-2017	Street, Nathaniel Robert/0000-0001-6031-005X; Delhomme, Nicolas/0000-0002-3053-0796; Minina, Elena/0000-0002-2619-1859; Bozhkov, Peter/0000-0002-8819-3884; Reza, Salim Hossain/0000-0002-3646-3440	Pehrssons Fund; Knut and Alice Wallenberg Foundation	Pehrssons Fund; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants from Pehrssons Fund and Knut and Alice Wallenberg Foundation to P.V.B.r This work was supported by grants from Pehrssons Fund and Knut and Alice Wallenberg Foundation to P.V.B. Computations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) at UPPMAX.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Argout X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512; BARIOLA PA, 1994, PLANT J, V6, P673, DOI 10.1046/j.1365-313X.1994.6050673.x; Bertolini A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0917-y; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bollhoner B, 2013, NEW PHYTOL, V200, P498, DOI 10.1111/nph.12387; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Bozhkov PV, 2011, CELL DEATH DIFFER, V18, P1239, DOI 10.1038/cdd.2011.86; Bozhkov PV, 2005, CURR TOP DEV BIOL, V67, P135, DOI 10.1016/S0070-2153(05)67004-4; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Burbulis IE, 1999, P NATL ACAD SCI USA, V96, P12929, DOI 10.1073/pnas.96.22.12929; Businge E, 2013, PHYSIOL PLANTARUM, V149, P273, DOI 10.1111/ppl.12039; Ciavatta VT, 2002, PLANTA, V215, P694, DOI 10.1007/s00425-002-0822-5; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Denay G, 2014, DEVELOPMENT, V141, P1222, DOI 10.1242/dev.103531; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dubos C, 2003, TREE PHYSIOL, V23, P169, DOI 10.1093/treephys/23.3.169; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Endo H, 2015, PLANT CELL PHYSIOL, V56, P242, DOI 10.1093/pcp/pcu134; Fendrych M, 2014, CURR BIOL, V24, P931, DOI 10.1016/j.cub.2014.03.025; Fukao T, 2004, TRENDS PLANT SCI, V9, P449, DOI 10.1016/j.tplants.2004.07.005; Ge Y, 2016, CELL DEATH DIFFER, V23, P1493, DOI 10.1038/cdd.2016.34; Gechev TS, 2004, CELL MOL LIFE SCI, V61, P1185, DOI 10.1007/s00018-004-4067-2; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilroy EM, 2007, PLANT J, V52, P1, DOI 10.1111/j.1365-313X.2007.03226.x; Godiard L, 1998, FEBS LETT, V438, P245, DOI 10.1016/S0014-5793(98)01309-X; Gong HB, 2005, PLANT MOL BIOL, V57, P53, DOI 10.1007/s11103-004-4516-1; Han Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39155; Hogberg KA, 1998, CAN J FOREST RES, V28, P1536, DOI 10.1139/cjfr-28-10-1536; Huysmans M, 2017, CURR OPIN PLANT BIOL, V35, P37, DOI 10.1016/j.pbi.2016.11.005; Ishikawa T, 2011, CELL DEATH DIFFER, V18, P1271, DOI 10.1038/cdd.2011.59; Jin J, 2017, NUCLEIC ACIDS RES, V45; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kunieda T, 2008, PLANT CELL, V20, P2631, DOI 10.1105/tpc.108.060160; Larsson E, 2008, PLANT SIGNAL BEHAV, V3, P469, DOI 10.4161/psb.3.7.5676; LEAH R, 1995, J BIOL CHEM, V270, P15789, DOI 10.1074/jbc.270.26.15789; Lee DW, 2016, MOL PLANT, V9, P1428, DOI 10.1016/j.molp.2016.06.005; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Liu Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-84; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Maruyama Y, 2013, PLANT SCI, V213, P79, DOI 10.1016/j.plantsci.2013.08.008; Mathieu M, 2006, PLANT MOL BIOL, V61, P615, DOI 10.1007/s11103-006-0036-5; McLellan H, 2009, NEW PHYTOL, V183, P408, DOI 10.1111/j.1469-8137.2009.02865.x; Minina EA, 2013, J CELL BIOL, V203, P917, DOI 10.1083/jcb.201307082; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Moschou PN, 2016, NEW PHYTOL, V212, P232, DOI 10.1111/nph.14012; Nitschke S, 2016, PLANT CELL, V28, P1616, DOI 10.1105/tpc.16.00016; Olvera-Carrillo Y, 2015, PLANT PHYSIOL, V169, P2684, DOI 10.1104/pp.15.00769; Payasi Anurag, 2009, Physiology and Molecular Biology of Plants, V15, P103, DOI 10.1007/s12298-009-0012-z; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Peer WA, 2013, J EXP BOT, V64, P2629, DOI 10.1093/jxb/ert152; Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x; Smertenko A, 2014, J EXP BOT, V65, P1343, DOI 10.1093/jxb/eru005; Smertenko AP, 2003, PLANT J, V33, P813, DOI 10.1046/j.1365-313X.2003.01670.x; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Suarez MF, 2004, CURR BIOL, V14, pR339, DOI 10.1016/j.cub.2004.04.019; Sundell D, 2015, NEW PHYTOL, V208, P1149, DOI 10.1111/nph.13557; Takasaki H, 2015, PLANT J, V84, P1114, DOI 10.1111/tpj.13067; Takuji Wada NH, 2015, PLANT SIGNAL BEHAV, V10; Tasseva G, 2004, FEBS LETT, V566, P115, DOI 10.1016/j.febslet.2004.04.015; Tesniere C, 2006, J EXP BOT, V57, P91, DOI 10.1093/jxb/erj007; Trontin JF, 2016, METHODS MOL BIOL, V1359, P167, DOI 10.1007/978-1-4939-3061-6_8; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; van Doorn WG, 2011, CELL DEATH DIFFER, V18, P1241, DOI 10.1038/cdd.2011.36; Van Durme M, 2016, CURR OPIN PLANT BIOL, V29, P29, DOI 10.1016/j.pbi.2015.10.013; Van Sandt VST, 2007, ANN BOT-LONDON, V100, P1467, DOI 10.1093/aob/mcm248; Venkatesh J, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-38; Wang FB, 2016, MOL GENET GENOMICS, V291, P1545, DOI 10.1007/s00438-016-1203-2; Wang Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.539; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Xu G, 2017, AUTOPHAGY; Yang CY, 2007, PLANT CELL, V19, P534, DOI 10.1105/tpc.106.046391; YOSHIDA S, 1986, PLANT PHYSIOL, V82, P807, DOI 10.1104/pp.82.3.807; Zhang DD, 2014, PLANT CELL, V26, P2939, DOI 10.1105/tpc.114.127282	78	9	9	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0192945	10.1371/journal.pone.0192945	http://dx.doi.org/10.1371/journal.pone.0192945			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499063	Green Submitted, Green Published, gold			2022-12-27	WOS:000426472300004
J	Jansson, DS; Brojer, C; Neimanis, A; Morner, T; Murphy, CL; Otman, F; Westermark, P				Jansson, Desiree S.; Brojer, Caroline; Neimanis, Aleksija; Morner, Torsten; Murphy, Charles L.; Otman, Faruk; Westermark, Per			Post mortem findings and their relation to AA amyloidosis in free-ranging Herring gulls (Larus argentatus)	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; PROTEIN-A; FIBRIL PROTEIN; TRANSMISSION; BIRDS	Since the late 1990s, high mortality and declining populations have been reported among sea birds including Herring gulls ( Larus argentatus) from the Baltic Sea area in Northern Europe. Repeated BoNT type C/D botulism outbreaks have occurred, but it remains unclear whether this is the sole and primary cause of mortality. Thiamine deficiency has also been suggested as a causal or contributing factor. With this study, we aimed to investigate gross and microscopic pathology in Herring gulls from affected breeding sites in Sweden in search of contributing diseases. Herring gulls from Iceland served as controls. Necropsies and histopathology were performed on 75 birds, of which 12 showed signs of disease at the time of necropsy. Parasites of various classes and tissues were commonly observed independent of host age, e.g. oesophageal capillariosis and nematode infection in the proventriculus and gizzard with severe inflammation, air sac larid pentastomes and bursal trematodiasis in pre-fledglings. Gross and microscopic findings are described. Notably, amyloidosis was diagnosed in 93 and 33% of the adult birds from Sweden and Iceland, respectively ( p<0.001), with more pronounced deposits in Swedish birds ( p<0.001). Gastrointestinal deposits were observed in the walls of arteries or arterioles, and occasionally in villi near the mucosal surface. Amyloid was identified within the intestinal lumen in one severely affected gull suggesting the possibility of oral seeding and the existence of a primed state as previously described in some mammals and chickens. This could speculatively explain the high occurrence and previously reported rapid onset of amyloidosis upon inflammation or captivity in Herring gulls. Amyloid-induced malabsorbtion is also a possibility. The Herring gull SAA/AA protein sequence was shown to be highly conserved but differed at the N-terminus from other avian species.	[Jansson, Desiree S.; Otman, Faruk] Natl Vet Inst SVA, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden; [Brojer, Caroline; Neimanis, Aleksija] Natl Vet Inst SVA, Dept Pathol & Wildlife Dis, Uppsala, Sweden; [Morner, Torsten] Natl Vet Inst SVA, Dept Dis Control & Epidemiol, Uppsala, Sweden; [Murphy, Charles L.] Univ Tennessee, Med Ctr, Dept Med, Knoxville, TN USA; [Westermark, Per] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	National Veterinary Institute SVA; National Veterinary Institute SVA; National Veterinary Institute SVA; University of Tennessee System; University of Tennessee Health Science Center; Uppsala University	Jansson, DS (corresponding author), Natl Vet Inst SVA, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden.	desiree.jansson@sva.se	Jansson, Desiree/AAO-6266-2021; Neimanis, Aleksija/E-4168-2016	Jansson, Desiree/0000-0003-1887-6054; Neimanis, Aleksija/0000-0001-7747-2290				Balk L, 2009, P NATL ACAD SCI USA, V106, P12001, DOI 10.1073/pnas.0902903106; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Bosch M, 2000, CAN J ZOOL, V78, P777, DOI 10.1139/cjz-78-5-777; BRASSARD A, 1965, CAN J COMP MED VET S, V29, P253; Bustnes JO, 2006, P ROY SOC B-BIOL SCI, V273, P3117, DOI 10.1098/rspb.2006.3687; COWAN DF, 1968, PATHOL VET, V5, P59, DOI 10.1177/030098586800500107; CROWELL WA, 1975, VET PATHOL, V12, P178, DOI 10.1177/030098587501200303; ERICSSON LH, 1987, FEBS LETT, V218, P11, DOI 10.1016/0014-5793(87)81008-6; FITZMAURICE M, 1993, MAR POLLUT BULL, V26, P64, DOI 10.1016/0025-326X(93)90092-X; Fox GA, 2007, J TOXICOL ENV HEAL A, V70, P1471, DOI 10.1080/15287390701384536; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Green M., 2017, MONITORING POPULATIO; Hampel MR, 2009, AMYLOID, V16, P122, DOI 10.1080/13506120903090759; HAWKINS PN, 1990, CLIN EXP IMMUNOL, V81, P325; HELCOM, 2013, BALT SEA ENV P; HOFFMAN AM, 1985, J AM VET MED ASSOC, V187, P1125; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; KENNEDY CR, 1989, PARASITOLOGY, V98, P439, DOI 10.1017/S0031182000061527; Kennel SJ, 2014, AMYLOID, V21, P45, DOI 10.3109/13506129.2013.876400; Kovacs BM, 2005, AMYLOID, V12, P109, DOI 10.1080/13506120500106941; Landman WJM, 1998, AVIAN PATHOL, V27, P437, DOI 10.1080/03079459808419367; Landman WJM, 1996, SCAND J IMMUNOL, V43, P210, DOI 10.1046/j.1365-3083.1996.d01-31.x; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Lundmark K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079104; Morner T, 2005, SVENSK VETERINARTIDN, V8-9, P11; Mullarney K, 1999, EUROPAS MEDELHAVSOMR; Murakami T, 2013, AMYLOID, V20, P80, DOI 10.3109/13506129.2013.783474; Neimanis A, 2007, J WILDLIFE DIS, V43, P327, DOI 10.7589/0090-3558-43.3.327; Nystrom SN, 2012, AMYLOID, V19, P138, DOI 10.3109/13506129.2012.711391; Osterblom H, 2004, IBIS, V146, P531, DOI 10.1111/j.1474-919X.2004.00266.x; ROSSEVATN K, 1992, SCAND J IMMUNOL, V35, P217, DOI 10.1111/j.1365-3083.1992.tb02853.x; Siebert U, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-43; Sipe JD, 2016, AMYLOID, V23, P209, DOI 10.1080/13506129.2016.1257986; Skarin H, 2010, AVIAN PATHOL, V39, P511, DOI 10.1080/03079457.2010.526923; Sletten K, 2003, AMYLOID, V10, P144, DOI 10.3109/13506120308998995; SLETTEN K, 1974, EUR J BIOCHEM, V41, P117, DOI 10.1111/j.1432-1033.1974.tb03251.x; Solomon A, 2007, P NATL ACAD SCI USA, V104, P10998, DOI 10.1073/pnas.0700848104; THRELFALL W, 1967, PARASITOLOGY, V57, P431, DOI 10.1017/S0031182000072334; WAALEN K, 1980, EUR J BIOCHEM, V104, P407, DOI 10.1111/j.1432-1033.1980.tb04441.x; Westermark GT, 2017, COLD SPRING IN PRESS; Westermark GT, 2015, ANNU REV PATHOL-MECH, V10, P321, DOI 10.1146/annurev-pathol-020712-163913; Westermark Gunilla T., 2004, V299, P243; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105; ZSCHIESCHE W, 1989, PHARMACOL THERAPEUT, V41, P49, DOI 10.1016/0163-7258(89)90102-2; ZSCHIESCHE W, 1989, ACTA HISTOCHEM, V86, P45, DOI 10.1016/S0065-1281(89)80046-7	45	3	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193265	10.1371/journal.pone.0193265	http://dx.doi.org/10.1371/journal.pone.0193265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494674	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200035
J	Merk, B; Litskevich, D; Gregg, R; Mount, AR				Merk, B.; Litskevich, D.; Gregg, R.; Mount, A. R.			Demand driven salt clean-up in a molten salt fast reactor - Defining a priority list	PLOS ONE			English	Article								The PUREX technology based on aqueous processes is currently the leading reprocessing technology in nuclear energy systems. It seems to be the most developed and established process for light water reactor fuel and the use of solid fuel. However, demand driven development of the nuclear system opens the way to liquid fuelled reactors, and disruptive technology development through the application of an integrated fuel cycle with a direct link to reactor operation. The possibilities of this new concept for innovative reprocessing technology development are analysed, the boundary conditions are discussed, and the economic as well as the neutron physical optimization parameters of the process are elucidated. Reactor physical knowledge of the influence of different elements on the neutron economy of the reactor is required. Using an innovative study approach, an element priority list for the salt clean-up is developed, which indicates that separation of Neodymium and Caesium is desirable, as they contribute almost 50% to the loss of criticality. Separating Zirconium and Samarium in addition from the fuel salt would remove nearly 80% of the loss of criticality due to fission products. The theoretical study is followed by a qualitative discussion of the different, demand driven optimization strategies which could satisfy the conflicting interests of sustainable reactor operation, efficient chemical processing for the salt clean-up, and the related economic as well as chemical engineering consequences. A new, innovative approach of balancing the throughput through salt processing based on a low number of separation process steps is developed. Next steps for the development of an economically viable salt clean-up process are identified.	[Merk, B.; Litskevich, D.] Univ Liverpool, Sch Engn, Liverpool, Merseyside, England; [Merk, B.; Gregg, R.] Natl Nucl Lab, Chadwick House, Warrington, Cheshire, England; [Mount, A. R.] Univ Edinburgh, EaStCHEM, Sch Chem, Edinburgh, Midlothian, Scotland	University of Liverpool; University of Edinburgh	Merk, B (corresponding author), Univ Liverpool, Sch Engn, Liverpool, Merseyside, England.; Merk, B (corresponding author), Natl Nucl Lab, Chadwick House, Warrington, Cheshire, England.	b.merk@liverpool.ac.uk		Litskevich, Dzianis/0000-0002-3207-3058	Royal Academy of Engineering; National Nuclear Laboratory of the United Kingdom	Royal Academy of Engineering(Royal Academy of Engineering - UK); National Nuclear Laboratory of the United Kingdom	The leading author wants to thank the Royal Academy of Engineering and the National Nuclear Laboratory of the United Kingdom for sponsoring the NNL/RAEng research chair position which creates space and time to develop highly innovative thinking for the future success of nuclear systems.	acatech, 2014, OPPORTUNITIES RISKS; [Anonymous], 2014, TECHNOLOGY ROADMAP U; [Anonymous], 2012, SPENT NUCL FUEL REPR; Burstall R. F., 1979, NDRD328R; Dekusar V., 2017, INT C FAST REACT REL; Gill M., 2016, THESIS; Haubenreich PN, 1970, NUCL APPL TECHNOLOGY, V8; Merk B., PLOS ONE; Merk B., ENERGIES, V8, P12557; Merk B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180703; Merk B, 2015, APPL ENERG, V147, P104, DOI 10.1016/j.apenergy.2015.02.023; Merk B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092776; Nash KL, 2015, SOLVENT EXTR ION EXC, V33, P1, DOI 10.1080/07366299.2014.985912; Nash KL, 2015, WOODHEAD PUBLISHING, V79; Romano PK, 2015, ANN NUCL ENERGY, V82, P90, DOI 10.1016/j.anucene.2014.07.048	15	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192020	10.1371/journal.pone.0192020	http://dx.doi.org/10.1371/journal.pone.0192020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494604	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200009
J	O'Brien, PP; Webber, QMR; Vander Wal, E				O'Brien, Paul P.; Webber, Quinn M. R.; Vander Wal, Eric			Consistent individual differences and population plasticity in network-derived sociality: An experimental manipulation of density in a gregarious ungulate	PLOS ONE			English	Article							NORTH-AMERICAN ELK; REACTION NORMS; BEHAVIORAL PLASTICITY; PHENOTYPIC PLASTICITY; SEXUAL SEGREGATION; PREDATION RISK; GREAT TITS; GROUP-SIZE; PERSONALITY; HABITAT	In many taxa, individual social traits appear to be consistent across time and context, thus meeting the criteria for animal personality. How these differences are maintained in response to changes in population density is unknown, particularly in large mammals, such as ungulates. Using a behavioral reaction norm ( BRN) framework, we examined how among- and within-individual variation in social connectedness, measured using social network analyses, change as a function of population density. We studied a captive herd of elk ( Cervus canadensis) separated into a group of male elk and a group of female elk. Males and females were exposed to three different density treatments and we recorded social associations between individuals with proximity-detecting radio-collars fitted to elk. We constructed social networks using dyadic association data and calculated three social network metrics reflective of social connectedness: eigenvector centrality, graph strength, and degree. Elk exhibited consistent individual differences in social connectedness across densities; however, they showed little individual variation in their response to changes in density, i.e., individuals oftentimes responded plastically, but in the same manner to changes in density. Female elk had highest connectedness at an intermediate density. In contrast, male elk increased connectedness with increasing density. Whereas this may suggest that the benefits of social connectedness outweigh the costs of increased competition at higher density for males, females appear to exhibit a threshold in social benefits ( e.g. predator detection and forage information). Our study illustrates the importance of viewing social connectedness as a density-dependent trait, particularly in the context of plasticity. Moreover, we highlight the need to revisit our understanding of density dependence as a population-level phenomenon by accounting for consistent individual differences not only in social connectedness, but likely in other ecological processes ( e.g., predator-prey dynamics, mate choice, disease transfer).	[O'Brien, Paul P.; Vander Wal, Eric] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Webber, Quinn M. R.; Vander Wal, Eric] Mem Univ Newfoundland, Cognit & Behav Ecol Interdisciplinary Program, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Webber, QMR (corresponding author), Mem Univ Newfoundland, Cognit & Behav Ecol Interdisciplinary Program, St John, NF, Canada.	webber.quinn@gmail.com			National Sciences and Engineering Research Council (NSERC); Vanier Canada Graduate Scholarship - National Sciences and Engineering Research Council (NSERC); Undergraduate Student Research Award - National Sciences and Engineering Council (NSERC)	National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vanier Canada Graduate Scholarship - National Sciences and Engineering Research Council (NSERC); Undergraduate Student Research Award - National Sciences and Engineering Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided to EVW by National Sciences and Engineering Research Council (NSERC). http://www.nserc-crsng.gc.ca/index_eng.asp, Vanier Canada Graduate Scholarship - National Sciences and Engineering Research Council (NSERC) to QMRW and Undergraduate Student Research Award - National Sciences and Engineering Council (NSERC) to PPO.	[Anonymous], R LANG ENV STAT COMP; Aplin LM, 2015, ANIM BEHAV, V108, P117, DOI 10.1016/j.anbehav.2015.07.016; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; Araya-Ajoy YG, 2017, J ANIM ECOL, V86, P227, DOI 10.1111/1365-2656.12621; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Benton TG, 2012, PHILOS T R SOC B, V367, P200, DOI 10.1098/rstb.2011.0168; Bode NWF, 2011, BEHAV ECOL SOCIOBIOL, V65, P117, DOI 10.1007/s00265-010-1111-0; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Boyland NK, 2013, BEHAV ECOL SOCIOBIOL, V67, P1877, DOI 10.1007/s00265-013-1622-6; Brashares JS, 2002, J ANIM ECOL, V71, P626, DOI 10.1046/j.1365-2656.2002.00633.x; Brennan A, 2015, J APPL ECOL, V52, P1656, DOI 10.1111/1365-2664.12514; Brent LJN, 2015, ANIM BEHAV, V103, P211, DOI 10.1016/j.anbehav.2015.01.020; Brommer JE, 2013, CURR ZOOL, V59, P485, DOI 10.1093/czoolo/59.4.485; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Casalini M, 2010, BEHAVIOUR, V147, P1035, DOI 10.1163/000579510X504879; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; CluttonBrock TH, 1997, P ROY SOC B-BIOL SCI, V264, P1509, DOI 10.1098/rspb.1997.0209; Coleing Amelia, 2009, Bioscience Horizons, V2, P32; Conner MM, 2008, ANN NY ACAD SCI, V1134, P146, DOI 10.1196/annals.1439.005; Coulson T, 2000, P ROY SOC B-BIOL SCI, V267, P1771, DOI 10.1098/rspb.2000.1209; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Cross PC, 2013, ECOLOGY, V94, P2076, DOI 10.1890/12-2086.1; Cross PC, 2010, ECOL APPL, V20, P278, DOI 10.1890/08-2062.1; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Dingemanse NJ, 2012, J EVOLUTION BIOL, V25, P485, DOI 10.1111/j.1420-9101.2011.02439.x; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Formica V, 2016, BEHAV ECOLOGY; FOWLER CW, 1981, ECOLOGY, V62, P602, DOI 10.2307/1937727; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; GOSSCUSTARD JD, 1980, ARDEA, V68, P31; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Hirsch BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075830; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jacoby DMP, 2014, BEHAV ECOL SOCIOBIOL, V68, P1995, DOI 10.1007/s00265-014-1805-9; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Krause S, 2017, BEHAV ECOL, V28, P429, DOI 10.1093/beheco/arw177; Le Galliard JF, 2015, J EVOLUTION BIOL, V28, P1144, DOI 10.1111/jeb.12641; Lea AJ, 2010, P NATL ACAD SCI USA, V107, P21587, DOI 10.1073/pnas.1009882107; Long RA, 2009, J MAMMAL, V90, P423, DOI 10.1644/08-MAMM-A-181.1; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Main MB, 1996, J MAMMAL, V77, P449, DOI 10.2307/1382821; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; Mathot KJ, 2011, ECOL LETT, V14, P1254, DOI 10.1111/j.1461-0248.2011.01698.x; MERESZCZAK IM, 1981, J RANGE MANAGE, V34, P184, DOI 10.2307/3898037; Moyle K, 2009, J WORLD AQUACULT SOC, V40, P255, DOI 10.1111/j.1749-7345.2009.00248.x; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Nicolaus M, 2013, J EVOLUTION BIOL, V26, P2031, DOI 10.1111/jeb.12210; Nicolaus M, 2016, ECOL LETT, V19, P478, DOI 10.1111/ele.12584; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Pettorelli N, 2002, P ROY SOC B-BIOL SCI, V269, P747, DOI 10.1098/rspb.2001.1791; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Rutschmann A, 2016, J ANIM ECOL, V85, P457, DOI 10.1111/1365-2656.12473; Shizuka D, 2012, ANIM BEHAV, V83, P925, DOI 10.1016/j.anbehav.2012.01.011; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Stewart KM, 2015, ECOL EVOL, V5, P709, DOI 10.1002/ece3.1397; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Toweill D.E., 2002, N AM ELK ECOLOGY MAN; UNDERWOOD AJ, 1978, OECOLOGIA, V33, P185, DOI 10.1007/BF00344847; Vander Wal E, 2015, ECOLOGY, V96, P631, DOI 10.1890/14-1320.1; Vander Wal E, 2013, CAN J ZOOL, V91, P601, DOI 10.1139/cjz-2012-0237; Vander Wal E, 2012, ECOLOGY, V93, P206, DOI 10.1890/11-0020.1; Vander Wal E, 2016, BEHAV ECOL, V27, P560, DOI 10.1093/beheco/arv193; Vander Wal E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053777; Webber QMR, 2018, J ANIM ECOL, V87, P113, DOI 10.1111/1365-2656.12773; Webber QMR, 2016, BEHAV ECOL SOCIOBIOL, V70, P701, DOI 10.1007/s00265-016-2093-3; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Wilson ADM, 2015, BEHAV ECOL SOCIOBIOL, V69, P1617, DOI 10.1007/s00265-015-1973-2; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; Wilson ADM, 2013, BEHAV ECOL SOCIOBIOL, V67, P163, DOI 10.1007/s00265-012-1428-y; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	78	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193425	10.1371/journal.pone.0193425	http://dx.doi.org/10.1371/journal.pone.0193425			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494640	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200048
J	Pluschke, AM; Williams, BA; Zhang, DG; Anderson, ST; Roura, E; Gidley, MJ				Pluschke, Anton M.; Williams, Barbara A.; Zhang, Dagong; Anderson, Stephen T.; Roura, Eugeni; Gidley, Michael J.			Male grower pigs fed cereal soluble dietary fibres display biphasic glucose response and delayed glycaemic response after an oral glucose tolerance test	PLOS ONE			English	Article							BETA-CELL FUNCTION; GLUCAGON-SECRETION; GASTRIC BYPASS; INSULIN SENSITIVITY; ARABINOXYLAN FIBER; METABOLIC SYNDROME; GHRELIN LEVELS; GIP; PLASMA; HUMANS	Acute and sustained soluble dietary fibre (SDF) consumption are both associated with improved glucose tolerance in humans and animal models (e.g. porcine). However, the effects on glucose tolerance in grower pigs, adapted to diets with a combination of SDF have not been studied previously. In this experiment, cereal SDF wheat arabinoxylan (AX) and oat beta-glucan (BG) were fed individually and in combination to determine the effect on glucose tolerance in jugular vein catheterized grower pigs. Five groups of Large White male grower pigs were fed highly digestible diets containing either 10% AX, 10% BG, 5% AX with 5% BG, a model cereal whole wheat flour (WWF), or a control wheat starch diet (WS) with no SDF. Blood was collected via jugular vein catheters over 240 minutes following a feed challenge and an oral glucose tolerance test (OGTT) on two separate days. Postprandial blood samples were used to determine plasma glucose, insulin, non-esterified fatty acids (NEFA), glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), peptide tyrosine tyrosine (PYY), ghrelin, glucagon and cortisol concentrations. No dietary effects on glycaemic response were observed following the feed challenge or the OGTT as determined by the area under the curve (AUC). A biphasic glucose and insulin response was detected for all pigs following the OGTT. The current study showed male grower pigs have tight glycaemic control and glucose tolerance regardless of diet. In addition, pigs fed the combined SDF had a reduced GIP response and delayed insulin peak following the feed challenge. Incretin (GLP-1 and GIP) secretion appeared asynchronous reflecting their different enteroendocrine cell locations and response to nutrient absorption.	[Pluschke, Anton M.; Williams, Barbara A.; Zhang, Dagong; Roura, Eugeni; Gidley, Michael J.] Univ Queensland, Ctr Nutr & Food Sci, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia; [Anderson, Stephen T.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Pluschke, AM; Gidley, MJ (corresponding author), Univ Queensland, Ctr Nutr & Food Sci, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia.	a.pluschke@uq.edu.au; m.gidley@uq.edu.au	Gidley, Mike/AAT-9543-2021; Williams, Barbara/A-9268-2011; Anderson, Stephen T/F-5281-2013; Roura, Eugeni/A-7101-2011	Williams, Barbara/0000-0002-3635-5554; Anderson, Stephen T/0000-0002-1176-4394; Roura, Eugeni/0000-0002-9073-9946	Australian Research Council Centre of Excellence in Plant Cell Walls [CE110001007]	Australian Research Council Centre of Excellence in Plant Cell Walls(Australian Research Council)	This work was supported by the Australian Research Council Centre of Excellence in Plant Cell Walls (CE110001007), http://www.plantcellwalls.org.au/. MJG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadi T, 2013, PSYCHOPHYSIOLOGY, V50, P821, DOI 10.1111/psyp.12069; Aronoff S.L, 2004, DIABETES SPECTR, V17, P183, DOI [DOI 10.2337/DIASPECT.17.3.183, 10.2337/diaspect.17.3.183]; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Beck EJ, 2010, BRIT J NUTR, V103, P1212, DOI 10.1017/S0007114509992856; Bervoets L, 2015, HORM METAB RES, V47, P445, DOI 10.1055/s-0034-1395551; Bodinham CL, 2013, BRIT J NUTR, V110, P1429, DOI 10.1017/S0007114513000731; Breneman CB, 2013, BRIT J NUTR, V110, P375, DOI 10.1017/S0007114512004953; Christensen KL, 2013, J AGR FOOD CHEM, V61, P7760, DOI 10.1021/jf400965j; de Leeuw JA, 2008, P NUTR SOC, V67, P334, DOI 10.1017/S002966510800863X; Delzenne NM, 2005, CURR OPIN CLIN NUTR, V8, P636, DOI 10.1097/01.mco.0000171124.06408.71; Garcia AL, 2007, EUR J CLIN NUTR, V61, P334, DOI 10.1038/sj.ejcn.1602525; Grundy MML, 2016, BRIT J NUTR, V116, P816, DOI 10.1017/S0007114516002610; Haenen D., 2014, ANIMAL, V8, P1; Hooda S, 2010, J NUTR, V140, P1564, DOI 10.3945/jn.110.122721; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Ito T, 2006, J ENDOCRINOL, V191, P113, DOI 10.1677/joe.1.06855; Jacobsen SH, 2012, OBES SURG, V22, P1084, DOI 10.1007/s11695-012-0621-4; Jenkins AL, 2014, J AM COLL NUTR, P1; JENKINS DJA, 1986, AM J CLIN NUTR, V43, P516, DOI 10.1093/ajcn/43.4.516; Karhunen LJ, 2008, REGUL PEPTIDES, V149, P70, DOI 10.1016/j.regpep.2007.10.008; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; KNAPPER JME, 1995, HORM METAB RES, V27, P485, DOI 10.1055/s-2007-980008; Lindqvist A, 2017, PEPTIDES, V90, P78, DOI 10.1016/j.peptides.2017.02.009; Lu ZX, 2004, EUR J CLIN NUTR, V58, P621, DOI 10.1038/sj.ejcn.1601857; Lu ZX, 2000, AM J CLIN NUTR, V71, P1123; Manell E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148896; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Meier JJ, 2006, DIABETES, V55, P1051, DOI 10.2337/diabetes.55.04.06.db05-1449; Meier JJ, 2003, DIABETOLOGIA, V46, P798, DOI 10.1007/s00125-003-1103-y; Mohling M, 2005, HORM METAB RES, V37, P303, DOI 10.1055/s-861474; Mortensen K, 2003, REGUL PEPTIDES, V114, P189, DOI 10.1016/S0167-0115(03)00125-3; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; Osaki N, 2016, EUROPEAN J NUTR, P1; PARRILLA R, 1974, DIABETES, V23, P725, DOI 10.2337/diab.23.9.725; Pluschke AM, 2017, LAB ANIM-UK, V51, P397, DOI 10.1177/0023677216682772; Ragaee S, 2006, FOOD CHEM, V98, P32, DOI 10.1016/j.foodchem.2005.04.039; Roura E, 2016, NUTR RES REV, P1; Shelat KJ, 2010, CARBOHYD POLYM, V82, P46, DOI 10.1016/j.carbpol.2010.04.019; SOCORRO M, 1989, STARCH-STARKE, V41, P69, DOI 10.1002/star.19890410208; Taborsky GJ, 1998, DIABETES, V47, P995, DOI 10.2337/diabetes.47.7.995; UNGER RH, 1976, PHYSIOL REV, V56, P778, DOI 10.1152/physrev.1976.56.4.778; Weickert MO, 2006, BRIT J NUTR, V96, P795, DOI 10.1017/BJN20061902; Wierup N, 2015, OBES SURG, V25, P180, DOI 10.1007/s11695-014-1459-8; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Yu K, 2014, ASIA PAC J CLIN NUTR, V23, P210, DOI 10.6133/apjcn.2014.23.2.01; Zijlstra RT, 2012, J ANIM SCI, V90, P49, DOI 10.2527/jas.53718	47	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193137	10.1371/journal.pone.0193137	http://dx.doi.org/10.1371/journal.pone.0193137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494594	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200025
J	Wenzlaff, F; Briken, P; Dekker, A				Wenzlaff, Frederike; Briken, Peer; Dekker, Arne			If there's a penis, it's most likely a man: Investigating the social construction of gender using eye tracking	PLOS ONE			English	Article							SEX CATEGORIZATION; SIGNAL-DETECTION; RECOGNITION; PSYCHOLOGY; MOVEMENTS; ATTENTION; PEOPLE; CHOICE; FEMALE; FACES	In their foundational work on the social construction of gender, Kessler and McKenna (1978) investigated the relationship between gender attribution and genital attribution. We used digital reproductions of the original stimuli to replicate their findings in the current social context. To further investigate the underlying decision processes we applied eye tracking. The stimuli shown varied in the composition of gender cues: from those more commonly associated with maleness to associated with femaleness. Applying the ethnomethodological approach originally used, participants were asked to decide for each stimulus whether they saw a man or a woman and to indicate subjective confidence with the decision. In line with the original results we found that the genital attribution contributed immensely to the gender attribution. Also, male gender was ascribed more often when the penis was present than was female gender when the vulva was shown. Eye tracking revealed that overall most dwell time as a proxy for important information was dedicated to the head, chest and genital areas of all the stimuli. Total dwell time depended on whether the gender attribution was made in line with the depicted genital, if the genital was a penis. Attributing female gender when a penis was present was associated with longer total dwell time, unlike attributing male gender with a vulva shown. This is indicative of higher cognitive effort and more difficulty ignoring the penis as opposed to the vulva. We interpret this finding in context of the persistent male dominance as well as to the socio-cultural understanding of the vulva as a concealed and therefore seemingly absent organ. In summary, we were able to show that the gender attribution is still closely linked to genital attribution when having a binary forced choice task and that the penis is a special cue in this attribution process.	[Wenzlaff, Frederike; Briken, Peer; Dekker, Arne] Univ Med Ctr Hamburg Eppendorf, Inst Sex Res & Forens Psychiat, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Wenzlaff, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Sex Res & Forens Psychiat, Hamburg, Germany.	f.wenzlaff@uke.de			Federal Ministry of Education and Research (BMBF)	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The positions of the first and last author are funded by the Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The positions of the first and last author are funded by the Federal Ministry of Education and Research (BMBF).	Armstrong T, 2010, BEHAV RES THER, V48, P402, DOI 10.1016/j.brat.2010.01.002; Bekhouche Y.H.R., 2015, GLOBAL GENDER GAP RE; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Blond A, 2008, BODY IMAGE, V5, P244, DOI 10.1016/j.bodyim.2008.02.003; Borji A, 2014, J VISION, V14, DOI 10.1167/14.3.29; Boroughs M, 2005, SEX ROLES, V52, P637, DOI 10.1007/s11199-005-3731-9; Braun V, 2001, J REPROD INFANT PSYC, V19, P17, DOI 10.1080/02646830020032374; Braun V, 2013, PSYCHOL WOMEN QUART, V37, P478, DOI 10.1177/0361684313492950; Brickell C, 2006, SOCIOL REV, V54, P87, DOI 10.1111/j.1467-954X.2006.00603.x; Brielmann AA, 2015, ADV COGN PSYCHOL, V11, P84, DOI 10.5709/acp-0174-y; Bruce V., 1998, EYE BEHOLDER SCI FAC; Calvo MG, 2005, J EXP PSYCHOL HUMAN, V31, P502, DOI 10.1037/0096-1523.31.3.502; Carothers BJ, 2013, J PERS SOC PSYCHOL, V104, P385, DOI 10.1037/a0030437; Cellerino A, 2004, BRAIN RES BULL, V63, P443, DOI 10.1016/j.brainresbull.2004.03.010; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Connell RW, 2005, SIGNS, V30, P1801, DOI 10.1086/427525; Cornelissen PL, 2009, EVOL HUM BEHAV, V30, P417, DOI 10.1016/j.evolhumbehav.2009.04.003; Crawford M, 2000, FEM PSYCHOL, V10, P7, DOI 10.1177/0959353500010001002; Davidenko N, 2007, J VISION, V7, DOI 10.1167/7.4.6; Dixson BJ, 2010, HUM NATURE-INT BIOS, V21, P355, DOI 10.1007/s12110-010-9100-6; Eagly AH, 2013, PERSPECT PSYCHOL SCI, V8, P340, DOI 10.1177/1745691613484767; Eagly AH, 2012, AM PSYCHOL, V67, P211, DOI 10.1037/a0027260; Fausto-Sterling A, 2000, SCIENCES, V40, P18, DOI 10.1002/j.2326-1951.2000.tb03504.x; FAUSTOSTERLING A, 1993, SCIENCES, V33, P20, DOI 10.1002/j.2326-1951.1993.tb03081.x; Findlay J. M., 2003, ACTIVE VISION PSYCHO; Fiske ST, 2010, PERSPECT PSYCHOL SCI, V5, P688, DOI 10.1177/1745691610388768; Gaetano J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148623; Gaetano J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091032; Garfinkel Harold, 1967, STUDIES ETHNOMETHODO; Gerson J, 2005, SOCIOL FORUM, V20, P179, DOI 10.1007/s11206-005-1904-5; Hall C, 2011, J SEX RES, V48, P461, DOI 10.1080/00224499.2010.521899; Hall CL, 2014, J SEX RES, V51, P184, DOI 10.1080/00224499.2012.716872; Hammarstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034193; Harrison Wendy Cealy, 2002, SEX GENDER; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Herdt G., 1994, 3 SEX 3 GENDER SEXUA; Herlitz A, 2013, VIS COGN, V21, P1306, DOI 10.1080/13506285.2013.823140; Hess U, 2009, J VISION, V9, DOI 10.1167/9.12.19; Hewig J, 2008, J NONVERBAL BEHAV, V32, P67, DOI 10.1007/s10919-007-0043-5; HILDEBRANDT KA, 1977, PERCEPT MOTOR SKILL, V45, P472, DOI 10.2466/pms.1977.45.2.472; Johnson KL, 2012, P ROY SOC B-BIOL SCI, V279, P4982, DOI 10.1098/rspb.2012.2060; Johnson KL, 2010, CHILD DEV, V81, P1346, DOI 10.1111/j.1467-8624.2010.01476.x; Johnson KL, 2005, PSYCHOL SCI, V16, P890, DOI 10.1111/j.1467-9280.2005.01633.x; Kelly DJ, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00006; Kessler S.J., 1985, GENDER ETHNOMETHODOL; Kohnen M., 2015, QUEER REPRESENTATION; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; McKenna W, 2000, FEM PSYCHOL, V10, P66, DOI 10.1177/0959353500010001010; MERRITT RD, 1995, SEX ROLES, V33, P145, DOI 10.1007/BF01544608; Mikkola M., 2016, STANFORD ENCY PHILOS; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Nummenmaa L, 2012, ARCH SEX BEHAV, V41, P1439, DOI 10.1007/s10508-012-9911-0; Orquin JL, 2016, J BEHAV DECIS MAKING, V29, P103, DOI 10.1002/bdm.1867; Orquin JL, 2013, ACTA PSYCHOL, V144, P190, DOI 10.1016/j.actpsy.2013.06.003; Pega F, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/473451; Petersen JL, 2011, J SEX RES, V48, P149, DOI 10.1080/00224499.2011.551851; Petersen JL, 2010, PSYCHOL BULL, V136, P21, DOI 10.1037/a0017504; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; Risko EF, 2011, ATTEN PERCEPT PSYCHO, V73, P291, DOI 10.3758/s13414-010-0042-1; Saunders DR, 2010, J VISION, V10, DOI 10.1167/10.11.9; Schutz A., 1964, PHENOMENOLOGY SOCIAL; STANGOR C, 1992, PSYCHOL BULL, V111, P42, DOI 10.1037/0033-2909.111.1.42; Stryker Susan, 2006, TRANSGENDER STUDIES, P253; Suschinsky K. D., 2007, EVOL PSYCHOL-US, V5, DOI DOI 10.1177/147470490700500214; Tiggemann M, 2004, PSYCHOL WOMEN Q, V28, P419; Tiggemann M, 2008, SEX ROLES, V59, P889, DOI 10.1007/s11199-008-9494-3; Wenzlaff F, 2016, J SEX RES, V53, P1008, DOI 10.1080/00224499.2015.1107524; Wild HA, 2000, J EXP CHILD PSYCHOL, V77, P269, DOI 10.1006/jecp.1999.2554; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	69	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193616	10.1371/journal.pone.0193616	http://dx.doi.org/10.1371/journal.pone.0193616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494689	Green Submitted, gold, Green Published			2022-12-27	WOS:000426363200076
J	Cramer, H; Lauche, R; Daubenmier, J; Mehling, W; Bussing, A; Saha, FJ; Dobos, G; Shields, SA				Cramer, Holger; Lauche, Romy; Daubenmier, Jennifer; Mehling, Wolf; Buessing, Arndt; Saha, Felix J.; Dobos, Gustav; Shields, Stephanie A.			Being aware of the painful body: Validation of the German Body Awareness Questionnaire and Body Responsiveness Questionnaire in patients with chronic pain	PLOS ONE			English	Article							MINDFULNESS MEDITATION; ATTENTIONAL STRATEGIES	Body awareness is an attentional focus on and awareness of internal body sensations. This study aimed to validate German versions of the Body Awareness Questionnaire (BAQ) and the Body Responsiveness Questionnaire (BRQ) in chronic pain patients and to assess their associations with pain-related variables and to assess their responsiveness to intervention. The instruments were translated to German and administered to 512 chronic pain patients (50.3-11.4 years, 91.6% female) to assess their factor structure and reliability. Cronbach's a for the BAQ total score was 0.86. Factor analysis of the BRQ revealed the two factors Importance of Interoceptive Awareness (Cronbach's alpha = 0.75) and Perceived Connection (Cronbach's a = 0.75) and the single-item Suppression of Bodily Sensations. The BAQ was independently associated with lower mindfulness, self-esteem, stress, and depression; Importance of Interoceptive Awareness with mindfulness, self-acceptance, self-esteem, and physical contact; Perceived Connection with self-acceptance, vitality, and lower sensory pain; Suppression of Bodily Sensations with lower self-esteem, physical contact, and higher depressive symptoms. After a 10-week multimodal mind-body program (n = 202), the BAQ and Importance of Interoceptive Awareness increased and pain intensity and Suppression of Bodily Sensation decreased. In conclusion, body awareness and body responsiveness are associated with pain-related variables in patients with chronic pain. Mind-body interventions may positively influence both pain and body awareness, hinting at a potential mechanism of action of these interventions to be tested in further research.	[Cramer, Holger; Lauche, Romy; Saha, Felix J.; Dobos, Gustav] Univ Duisburg Essen, Fac Med, Kliniken Essen Mitte, Dept Internal & Integrat Med, Essen, Germany; [Cramer, Holger; Lauche, Romy] Univ Technol Sydney, ARCCIM, Sydney, NSW, Australia; [Daubenmier, Jennifer; Mehling, Wolf] San Francisco State Univ, Dept Hlth Educ, Holist Hlth Studies, San Francisco, CA 94132 USA; [Daubenmier, Jennifer; Mehling, Wolf] Univ Calif San Francisco, Osher Ctr Integrat Med, San Francisco, CA 94143 USA; [Buessing, Arndt] Univ Witten Herdecke, Fac Med, Ctr Integrat Med, Herdecke, Germany; [Shields, Stephanie A.] Penn State Univ, Dept Psychol, State Coll, PA USA	Kliniken Essen-Mitte; University of Duisburg Essen; University of Technology Sydney; California State University System; San Francisco State University; University of California System; University of California San Francisco; Witten Herdecke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Cramer, H (corresponding author), Univ Duisburg Essen, Fac Med, Kliniken Essen Mitte, Dept Internal & Integrat Med, Essen, Germany.; Cramer, H (corresponding author), Univ Technol Sydney, ARCCIM, Sydney, NSW, Australia.	h.cramer@kliniken-essen-mitte.de	Lauche, Romy/AAQ-7175-2021; Cramer, Holger/AAH-1794-2019	Lauche, Romy/0000-0002-4171-7935; Bussing, Arndt/0000-0002-5025-7950; Cramer, Holger/0000-0002-3640-8046	University of Duisburg-Essen	University of Duisburg-Essen	Open access publication fees were provided by the Open Access Publication Fund of the University of Duisburg-Essen.	Baas Linda S, 2004, J Cardiovasc Nurs, V19, P32; Beck A.T., 1987, BECK DEPRESSION INVE; Benson H, 1999, WELLNESS BOOK MIND B; Bussing A, 2013, INT J MENT HEALTH SY, V7, DOI 10.1186/1752-4458-7-1; Burns JW, 2006, EMOTION, V6, P180, DOI 10.1037/1528-3542.6.2.180; CIOFFI D, 1991, PSYCHOL BULL, V109, P25, DOI 10.1037/0033-2909.109.1.25; Cramer H, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-162; Daubenmier J, 2014, APPETITE, V74, P92, DOI 10.1016/j.appet.2013.11.014; Daubenmier JJ, 2005, PSYCHOL WOMEN QUART, V29, P207, DOI 10.1111/j.1471-6402.2005.00183.x; Dillmann U, 1994, Schmerz, V8, P100, DOI 10.1007/BF02530415; Eccleston C, 1997, PAIN, V72, P209, DOI 10.1016/S0304-3959(97)00030-4; Emanuelsen L, 2015, SCAND J PSYCHOL, V56, P167, DOI 10.1111/sjop.12183; Flink IK, 2009, BEHAV RES THER, V47, P721, DOI 10.1016/j.brat.2009.05.003; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; Gard T, 2012, CEREB CORTEX, V22, P2692, DOI 10.1093/cercor/bhr352; Geissner E, 1995, Rehabilitation (Stuttg), V34, pXXXV; Hasenbring M, 2000, Prog Brain Res, V129, P525; Hasenbring MI, 2009, EUR J PAIN, V13, P620, DOI 10.1016/j.ejpain.2008.11.001; Hautzinger M, 1992, BECK DEPRESSIONSINVE; IMPETT E. A., 2006, SEX RES SOC POL, V3, P39, DOI [DOI 10.1525/SRSP.2006.3.4.39, 10.1525/srsp.2006.3.4.39]; Johnson Malcolm H, 2005, Curr Pain Headache Rep, V9, P90, DOI 10.1007/s11916-005-0044-1; Johnston NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038854; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Koteles F., 2014, MENTALHIGIENE PSZICH, V15, P373, DOI DOI 10.1556/MENTAL.15.2014.4.4; Lauche R, 2017, SPINE PHILA PA 1976; Martin R, 2013, J SPORT EXERCISE PSY, V35, P655, DOI 10.1123/jsep.35.6.655; Mehling WE, 2013, J PAIN RES, V6, P403, DOI 10.2147/JPR.S42418; Mehling WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048230; Mehling Wolf E, 2011, Philos Ethics Humanit Med, V6, P6, DOI 10.1186/1747-5341-6-6; Mehling WE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005614; Paul A, 2012, EUR J INTEGR MED, V4, pE455, DOI 10.1016/j.eujim.2012.07.980; Pfingsten M, 2007, DTSCH SCHMERZFRAGEBO; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Pohlmann K., 2008, KORPERORIENTIERTE DI; Saha FJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004152; Sherman KJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/130818; SHIELDS SA, 1989, J PERS ASSESS, V53, P802, DOI 10.1207/s15327752jpa5304_16; van der Maas LCC, 2016, CLIN J PAIN, V32, P763, DOI 10.1097/AJP.0000000000000320; Van der Maas LCC, 2015, CLIN J PAIN, V31, P660, DOI 10.1097/AJP.0000000000000138; Zeidan F, 2016, ANN NY ACAD SCI, V1373, P114, DOI 10.1111/nyas.13153; Zeidan F, 2011, J NEUROSCI, V31, P5540, DOI 10.1523/JNEUROSCI.5791-10.2011	42	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193000	10.1371/journal.pone.0193000	http://dx.doi.org/10.1371/journal.pone.0193000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489889	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000050
J	Jamalabadi, MYA; Daqiqshirazi, M; Nasiri, H; Safaei, MR; Nguyen, TK				Jamalabadi, Mohammad Yaghoub Abdollahzadeh; Daqiqshirazi, Mohammadreza; Nasiri, Hossein; Safaei, Mohammad Reza; Truong Khang Nguyen			Modeling and analysis of biomagnetic blood Carreau fluid flow through a stenosis artery with magnetic heat transfer: A transient study	PLOS ONE			English	Article							NON-NEWTONIAN BLOOD; NUMERICAL-SIMULATION; ENDOTHELIAL-CELLS; MICROPOLAR FLUID; DISTURBED FLOW; DRUG-DELIVERY; FIELD; BIFURCATION; RADIATION; DYNAMICS	We present a numerical investigation of tapered arteries that addresses the transient simulation of non-Newtonian bio-magnetic fluid dynamics (BFD) of blood through a stenosis artery in the presence of a transverse magnetic field. The current model is consistent with ferro-hydrodynamic (FHD) and magneto-hydrodynamic (MHD) principles. In the present work, blood in small arteries is analyzed using the Carreau-Yasuda model. The arterial wall is assumed to be fixed with cosine geometry for the stenosis. A parametric study was conducted to reveal the effects of the stenosis intensity and the Hartman number on a wide range of flow parameters, such as the flow velocity, temperature, and wall shear stress. Current findings are in a good agreement with recent findings in previous research studies. The results show that wall temperature control can keep the blood in its ideal blood temperature range (below 40 degrees C) and that a severe pressure drop occurs for blockages of more than 60 percent. Additionally, with an increase in the Ha number, a velocity drop in the blood vessel is experienced.	[Jamalabadi, Mohammad Yaghoub Abdollahzadeh] Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul, South Korea; [Daqiqshirazi, Mohammadreza] Univ Tehran, Coll Engn, Sch Mech Engn, Tehran, Iran; [Nasiri, Hossein] Daneshpajoohan Higher Educ Inst, Dept Mech Engn, Esfahan, Iran; [Safaei, Mohammad Reza; Truong Khang Nguyen] Ton Duc Thang Univ, Inst Computat Sci, Div Computat Phys, Ho Chi Minh City, Vietnam; [Safaei, Mohammad Reza; Truong Khang Nguyen] Ton Duc Thang Univ, Fac Elect & Elect Engn, Ho Chi Minh City, Vietnam	Dongguk University; University of Tehran; Ton Duc Thang University; Ton Duc Thang University	Safaei, MR (corresponding author), Ton Duc Thang Univ, Inst Computat Sci, Div Computat Phys, Ho Chi Minh City, Vietnam.; Safaei, MR (corresponding author), Ton Duc Thang Univ, Fac Elect & Elect Engn, Ho Chi Minh City, Vietnam.	cfd_safaei@tdt.edu.vn	Jamalabadi, Mohammad Yaghoub Abdollahzadeh/M-5838-2015; Nguyen, Truong Khang/G-4686-2015; Daqiqshirazi, Mohammadreza/P-2843-2015; NASIRI, Hossein/AAD-8260-2021; Safaei, Mohammad Reza/E-1111-2013	Jamalabadi, Mohammad Yaghoub Abdollahzadeh/0000-0002-4423-1025; Nguyen, Truong Khang/0000-0001-9654-4392; Daqiqshirazi, Mohammadreza/0000-0002-9292-7668; Safaei, Mohammad Reza/0000-0001-7301-2561				Akbar NS, 2015, PHYSICA E, V72, P70, DOI 10.1016/j.physe.2015.04.017; Akbar NS, 2014, AIN SHAMS ENG J, V5, P1307, DOI 10.1016/j.asej.2014.05.010; Akbar NS, 2015, ENTROPY-SWITZ, V17, P1411, DOI 10.3390/e17031411; Ali F, 2017, J MAGN MAGN MATER, V423, P327, DOI 10.1016/j.jmmm.2016.09.125; Alimohamadi H, 2015, INT J FLUID MECH RES, V42, P149, DOI 10.1615/InterJFluidMechRes.v42.i2.50; Alimohamadi H, 2014, INT J COMPUT METH EN, V15, P522, DOI 10.1080/15502287.2014.952848; Alimohamadi H, 2014, INT J COMPUT METH EN, V15, P390, DOI 10.1080/15502287.2014.915253; Amornsamankul S., 2006, INT J BIOL MED SCI, V1, P42; [Anonymous], 2008, INT J NUMERICAL METH; ARIMAN T, 1974, J APPL MECH-T ASME, V41, P1, DOI 10.1115/1.3423224; Behnia S, 2015, CHAOS SOLITON FRACT, V78, P194, DOI 10.1016/j.chaos.2015.07.029; Behnia S, 2013, NONLINEAR DYNAM, V74, P559, DOI 10.1007/s11071-013-0988-3; Berger SA, 2000, ANNU REV FLUID MECH, V32, P347, DOI 10.1146/annurev.fluid.32.1.347; Brenn G., 2016, ANAL SOLUTIONS TRANS; Caballero AD, 2015, COMPUT METHOD BIOMEC, V18, P1200, DOI 10.1080/10255842.2014.887698; Cebral JR, 2002, ACAD RADIOL, V9, P1286, DOI 10.1016/S1076-6332(03)80562-7; Chhabra RP, 1999, NONNEWTONIAN FLOW PR, DOI 10.1016/b978-075063770-1/50009-9; Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3; Chiu JJ, 1998, J BIOMECH ENG-T ASME, V120, P2, DOI 10.1115/1.2834303; den Harder AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171138; Ellahi R, 2014, APPL MATH INFORM SCI, V8, P1567, DOI 10.12785/amis/080410; Haghighi AR, 2015, INT J BIOMATH, V8, DOI 10.1142/S1793524515500564; HALDAR K, 1985, B MATH BIOL, V47, P545, DOI 10.1007/BF02460013; Hayat T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145525; HIGASHI T, 1993, BLOOD, V82, P1328; Houpt JC, 1996, SPINE, V21, P1808, DOI 10.1097/00007632-199608010-00018; Ikbal MA, 2009, J COMPUT APPL MATH, V230, P243, DOI 10.1016/j.cam.2008.11.010; Jamalabadi MYA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167393; Jamalabadi MYA, 2015, CHEM ENG RES DES, V102, P407, DOI 10.1016/j.cherd.2015.07.015; Jamalabadi MYA, 2015, ENTROPY-SWITZ, V17, P866, DOI 10.3390/e17020866; Jamalabadi MYA, 2015, J HYDRODYNAMICS, V14; Kalra N, 2016, INDIAN J PHYSIOTHERA, V10, P15; Karimipour A, 2017, PHYSICA E, V86, P146, DOI 10.1016/j.physe.2016.10.015; Kim D, 2000, J COMPUT PHYS, V162, P411, DOI 10.1006/jcph.2000.6546; Kim SO, 2001, KOREAN J WOMENS HLTH, V7, P610; Kischinhevsky M, BRIEF REV SIMPLE FIN; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Liu GY, 2015, COMPUT BIOL MED, V64, P117, DOI 10.1016/j.compbiomed.2015.06.009; Liu XM, 2016, J MECH MED BIOL, V16, DOI 10.1142/S0219519416500342; LOU Z, 1993, J BIOMECH, V26, P37, DOI 10.1016/0021-9290(93)90611-H; Lukacova-Medvidova M, 2008, INT J NUMER METH FL, V56, P1409, DOI 10.1002/fld.1676; Mabood F, 2016, INT J HEAT MASS TRAN, V93, P674, DOI 10.1016/j.ijheatmasstransfer.2015.10.014; Mandal PK, 2007, INT J COMPUT MATH, V84, P1059, DOI 10.1080/00207160701288881; Mandal PK, 2005, INT J NONLIN MECH, V40, P151, DOI 10.1016/j.ijnonlinmec.2004.07.007; Medhavi A, 2015, 2 PHASE ARTERIAL BLO; Mohammadpour A, 2014, J CLIN NURS, V23, P3460, DOI 10.1111/jocn.12595; Morris L, 2005, J BIOMECH ENG-T ASME, V127, P767, DOI 10.1115/1.1992521; Mosayebidorcheh S, 2015, J BRAZILIAN SOC MECH; Mousavi SM, 2016, APPL MATH MODEL, V40, P7336, DOI 10.1016/j.apm.2016.03.012; Patankar SV., 2018, NUMERICAL HEAT TRANS; Pereira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113769; PESKIN CS, 1977, J COMPUT PHYS, V25, P220, DOI 10.1016/0021-9991(77)90100-0; Pontrelli G, 2001, P I MECH ENG H, V215, P1, DOI 10.1243/0954411011533445; Sankar DS, 2011, J MECH SCI TECHNOL, V25, P2573, DOI 10.1007/s12206-011-0728-x; Sarifuddin, 2008, Journal of Medical Engineering & Technology, V32, P385, DOI 10.1080/03091900601164820; Schenck JF, 2000, J MAGN RESON IMAGING, V12, P2, DOI 10.1002/1522-2586(200007)12:1<2::AID-JMRI2>3.0.CO;2-V; Seta B, 2017, IFMBE PROC, V62, P259, DOI 10.1007/978-981-10-4166-2_39; Shadloo MS, 2011, P I MECH ENG C-J MEC, V225, P347, DOI 10.1243/09544062JMES2334; Shahidian A, 2009, IEEE T MAGN, V45, P2667, DOI 10.1109/TMAG.2009.2018954; Srivastava V.P., 2015, J SCI TECHNOL, V4, P5; SRIVASTAVA VP, 1995, RHEOL ACTA, V34, P406, DOI 10.1007/BF00367155; Tabatabaei SN, 2015, J CONTROL RELEASE, V206, P49, DOI 10.1016/j.jconrel.2015.02.027; Tanwar V K, 2012, APPL MATH SCI, V6, P5959; TRAUTMAN ED, 1983, IEEE T BIO-MED ENG, V30, P141, DOI 10.1109/TBME.1983.325098; Truskey G. A., 2004, TRANSPORT PHENOMENA; Tzirtzilakis EE, 2008, PHYSICA D, V237, P66, DOI 10.1016/j.physd.2007.08.006; Tzirtzilakis EE, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1978807; Vaalma S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168902; Varshney G., 2010, INT J ENG SCI TECHNO, P967; Villa CH, 2016, ADV DRUG DELIVERY RE; Wang DN, 2009, COMPUT MATH APPL, V58, P1030, DOI 10.1016/j.camwa.2009.02.020; White F. M., 2006, VISCOUS FLUID FLOW; Xenos M., 2013, ADV DYN SYST APPL, V8, P427	73	34	34	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192138	10.1371/journal.pone.0192138	http://dx.doi.org/10.1371/journal.pone.0192138			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489852	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000017
J	Pottgen, J; Rose, A; van de Vis, W; Engelbrecht, J; Pirard, M; Lau, S; Heesen, C; Kopke, S				Poettgen, Jana; Rose, Anita; van de Vis, Wim; Engelbrecht, Jannie; Pirard, Michelle; Lau, Stefanie; Heesen, Christoph; Koepke, Sascha		RiMS Special Interest Grp Psychol	Sexual dysfunctions in MS in relation to neuropsychiatric aspects and its psychological treatment: A scoping review	PLOS ONE			English	Review							MULTIPLE-SCLEROSIS PATIENTS; QUALITY-OF-LIFE; FEMALE-PATIENTS; WOMEN; MANAGEMENT; BLADDER; DISORDER; INTIMACY; THERAPY; DISEASE	Objective Sexual dysfunction in multiple sclerosis (MS) is a significant, but often underestimated and overlooked suffering. Interventions to treat sexual dysfunction in MS are rare. The relation between sexual dysfunction in MS and psychological as well as neuropsychological aspects is evident. However, this field of research remains markedly underdeveloped in this severe chronic illness. The aim of this scoping review is to describe the relevant knowledge in this area and to identify psychological interventions to treat sexual dysfunctions in MS. Methods A scoping review was conducted to answer the following questions: (1) Which psychological and neuropsychological factors impact on sexual dysfunction in MS and vice versa? (2) What kind of psychological interventions aiming to improve sexual dysfunctions in MS are available? A comprehensive search and review of MEDLINE, PsycINFO, and CINAHL was completed by using a recent methodological framework for scoping reviews. Results 23 publications covering a total of 13,259 people with MS and 532 healthy controls were identified. Sexual dysfunction was found to be very common in MS and there is an obvious relation to psychological disorders as e.g. depression and anxiety and also to psychological aspects as partner relationship and quality of life. The relation between sexual dysfunction in MS and neuropsychological impairment has only rarely been studied and no clear results were found. Only two studies were identified, assessing the effectiveness of psychological intervention studies on sexual dysfunction in people with MS, and a third study presenting a secondary analysis of a study targeting depression. All three studies reported significant improvements in sexual dysfunction as well as partly in psychological variables. Conclusions There is a pressing need for the development and adequate evaluation of psychological interventions for sexual dysfunctions in MS. In addition, sexual dysfunction and its impact on psychological wellbeing should be more focussed in clinical care.	[Poettgen, Jana; Lau, Stefanie; Heesen, Christoph] Univ Klinikum Hamburg Eppendorf, Inst Neuroimmunol & Multiple Sklerose, Hamburg, Germany; [Poettgen, Jana; Lau, Stefanie; Heesen, Christoph] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Neurol, Hamburg, Germany; [Rose, Anita] Raphael Med Ctr, Tonbridge, England; [van de Vis, Wim] Revalidatie Ctr Roessingh, Enschede, Netherlands; [Engelbrecht, Jannie] Sclerose Hosp Erne, Ry, Denmark; [Pirard, Michelle] Natl MS Ctr, Melsbroek, Belgium; [Koepke, Sascha] Univ Lubeck, Nursing Res Unit, Inst Social Med & Epidemiol, Lubeck, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck	Pottgen, J (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Neuroimmunol & Multiple Sklerose, Hamburg, Germany.; Pottgen, J (corresponding author), Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Neurol, Hamburg, Germany.	j.poettgen@uke.de			RIMS (Rehabilitation In MS)	RIMS (Rehabilitation In MS)	This study was funded by RIMS (Rehabilitation In MS, www.eurims.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah RT, 2007, INT J IMPOT RES, V19, P458, DOI 10.1038/sj.ijir.3901558; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; ANDERSON BJ, 1986, J CONSULT CLIN PSYCH, V54, P168, DOI 10.1037/0022-006X.54.2.168; Arksey H., 2005, SCOPING STUDIES METH; Barak Y, 1996, J PSYCHIATR NEUROSCI, V21, P255; Blackmore DE, 2011, REHABIL PSYCHOL, V56, P117, DOI 10.1037/a0023362; Borello-France D, 2004, MULT SCLER J, V10, P455, DOI 10.1191/1352458504ms1060oa; Bronner Gila, 2015, Handb Clin Neurol, V130, P297, DOI 10.1016/B978-0-444-63247-0.00017-1; Brotto L, 2016, J SEX MED, V13, P538, DOI 10.1016/j.jsxm.2016.01.019; Buhmann C, 2016, J NEURAL TRANSM; Clayton AH, 2014, EXPERT OPIN DRUG SAF, V13, P1361, DOI 10.1517/14740338.2014.951324; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Critical Appraisal Skills Programme (CASP), 2013, MAK SENS EV; Dachille G, 2008, Minerva Urol Nefrol, V60, P77; Darija KT, 2015, J NEUROL SCI, V358, P317, DOI 10.1016/j.jns.2015.09.023; DasGupta R, 2003, DRUGS, V63, P153, DOI 10.2165/00003495-200363020-00003; Demirkiran M, 2006, MULT SCLER J, V12, P209, DOI 10.1191/135248506ms1253oa; Dupont S, 1996, SEX MARITAL THER, V11, P359, DOI [10.1080/02674659608404450, DOI 10.1080/02674659608404450]; Feinstein A, 2013, MULT SCLER RELAT DIS, V2, P4, DOI 10.1016/j.msard.2012.08.001; Feinstein A, 2011, MULT SCLER J, V17, P1276, DOI 10.1177/1352458511417835; Fletcher SG, 2009, NAT CLIN PRACT UROL, V6, P96, DOI 10.1038/ncpuro1298; Foley FW, 2013, MULT SCLER J, V19, P1197, DOI 10.1177/1352458512471876; Foley FW, 2001, MULT SCLER J, V7, P417, DOI 10.1177/135245850100700612; Foley FW, 1992, MS THE FAMILY; Fragala E, 2014, J SEX MED, V11, P2406, DOI 10.1111/jsm.12635; Ghajarzadeh Mahsa, 2014, Acta Med Iran, V52, P315; Gumus H, 2014, J SEX MED, V11, P481, DOI 10.1111/jsm.12397; Hennessey A, 1999, J NEUROL, V246, P1027, DOI 10.1007/s004150050508; Kaplan HS, 1974, NEW SEX THERAPY ACTI; Kessler TM, 2009, EXPERT REV NEUROTHER, V9, P341, DOI 10.1586/14737175.9.3.341; Khakbazan Z, 2016, MULT SCLER RELAT DIS, V8, P113, DOI 10.1016/j.msard.2016.05.007; Kolzet J, 2015, SEX DISABIL, V33, P63, DOI 10.1007/s11195-014-9357-5; Krupp L., 2006, MULT SCLER, P367; Laan E, 2001, Climacteric, V4, P28, DOI 10.1080/713605033; Landtblom Anne-Marie, 2006, Expert Rev Neurother, V6, P931, DOI 10.1586/14737175.6.6.931; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Levine S., 2003, PSYCHIATRY; Lew-Starowicz M, 2013, SEX DISABIL, V31, P141, DOI 10.1007/s11195-013-9293-9; Lew-Starowicz M, 2014, J SEX MED, V11, P2172, DOI 10.1111/jsm.12622; Lombardi G, 2011, J SEX MED, V8, P1138, DOI 10.1111/j.1743-6109.2010.02161.x; Marck CH, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0735-8; Masters WH., 1966, HUMAN SEXUAL RESPONS; MATTSON D, 1995, ARCH NEUROL-CHICAGO, V52, P862, DOI 10.1001/archneur.1995.00540330040012; McCabe MP, 1996, J SEX RES, V33, P241, DOI 10.1080/00224499609551840; McCabe MP, 2003, J SEX MARITAL THER, V29, P305, DOI 10.1080/00926230390195506-2372; McCabe MP, 2002, J SEX RES, V39, P302, DOI 10.1080/00224490209552154; Mikula P, 2013, DISABIL REHABIL, P1; MINDERHOUD JM, 1984, ACTA NEUROL SCAND, V70, P299, DOI 10.1111/j.1600-0404.1984.tb00827.x; Mohammadi K, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-83; Qaderi K, 2014, SEX DISABIL, V32, P35, DOI 10.1007/s11195-013-9318-4; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Sadock BJ, 2015, CLIN PSYCHIATR, V11, P1118; Schairer LC, 2013, MULT SCLER; Simonsen U, 2016, BASIC CLIN PHARMACOL, V119, P63, DOI 10.1111/bcpt.12653; Stein J, 2013, DISABIL REHABIL, V35, P1842, DOI 10.3109/09638288.2012.754953; STENAGER E, 1992, SEMIN NEUROL, V12, P120, DOI 10.1055/s-2008-1041165; Stepleman LM, 2016, SEX DISABIL, V34, P239, DOI 10.1007/s11195-016-9444-x; Tepavcevic DK, 2008, MULT SCLER J, V14, P1131, DOI 10.1177/1352458508093619; Trudel G., 2001, SEX RELATSH THER, V16, P145, DOI DOI 10.1080/14681990120040078; Uygur D, 2005, GYNECOL ENDOCRINOL, V20, P209, DOI 10.1080/09513590400027240; VALLEROY ML, 1984, ARCH PHYS MED REHAB, V65, P125; Vitkova M, 2014, DISABIL REHABIL, V36, P987, DOI 10.3109/09638288.2013.825332; Young CA, 2016, MULT SCLER J, P1; Young CA, 2016, MULT SCLER J; Zivadinov R, 2003, J NEUROL SCI, V210, P73, DOI 10.1016/S0022-510X(03)00025-X; Zivadinov R, 1999, MULT SCLER J, V5, P428, DOI 10.1177/135245859900500i610; Zorzon M, 2003, CORRELATION SEXUAL D, P108	68	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193381	10.1371/journal.pone.0193381	http://dx.doi.org/10.1371/journal.pone.0193381			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7BV	29486006	Green Published, Green Submitted, gold			2022-12-27	WOS:000426242400018
J	Fan, CJ; Graff, P; Vihlborg, P; Bryngelsson, IL; Andersson, L				Fan, Chenjing; Graff, Pal; Vihlborg, Per; Bryngelsson, Ing-Liss; Andersson, Lena			Silica exposure increases the risk of stroke but not myocardial infarction-A retrospective cohort study	PLOS ONE			English	Article							SWEDISH IRON FOUNDRIES; QUARTZ EXPOSURE; MORTALITY; DISEASES; CANCER; NOISE	Introduction Work-related exposure to silica is a global health hazard that causes diseases such as silicosis. Some studies have also reported that silica exposure is linked to elevated cardiovascular disease mortality. However, these diagnoses have not been investigated in detail and there have been few studies on morbidity. The aim of this study is to examine morbidity and mortality from different cardiovascular diseases among silica-exposed Swedish foundry workers. Methods Historical and contemporary measurements (1968 +/- 2006) of respiratory silica exposure were matched to job categories, individual foundries, and 4 time periods (1968 +/- 1979, 1980 +/- 1989, 1990 +/- 1999, 2000 +/- 2006) using a mixed model. Morbidity and mortality data for the studied cohorts were matched against the General Population Registry. Statistical analyses were performed with SPSS and STATA, and the data were stratified by age, gender, and year. Results Mortality from cardiovascular disease (SMR 1.3; 95% CI 1.2 +/- 1.4) and stroke (SMR 1.6, 95% CI 1.2 +/- 2.1) was significantly elevated among the studied population. The cohort also exhibited significantly elevated morbidity from stroke (SIR 1.34; 95% CI 1.2 +/- 1.5) but not myocardial infarction. The mean age at the time of first morbidity from stroke was 64 years, with 36% of the cases occurring before the age of 60. Conclusions Swedish foundry workers exposed to respirable silica exhibit elevated morbidity and mortality from stroke, but not from myocardial infarction. Our results also suggest a relationship between silica exposure and morbidity from stroke at a younger age than the general population.	[Fan, Chenjing; Graff, Pal; Vihlborg, Per; Bryngelsson, Ing-Liss; Andersson, Lena] Orebro Univ, Fac Med & Hlth, Dept Occupat & Environm Med, Orebro, Sweden; [Graff, Pal] Natl Inst Occupat Hlth STAMI, Oslo, Norway	Orebro University	Graff, P (corresponding author), Orebro Univ, Fac Med & Hlth, Dept Occupat & Environm Med, Orebro, Sweden.; Graff, P (corresponding author), Natl Inst Occupat Hlth STAMI, Oslo, Norway.	pal.graff@stami.no	Graff, PÃl/E-1881-2017	Graff, PÃl/0000-0003-4928-617X				Andersson L, 2012, ANN OCCUP HYG, V56, P362, DOI 10.1093/annhyg/mer106; Andersson L, 2012, J OCCUP ENVIRON HYG, V9, P110, DOI 10.1080/15459624.2011.645397; Andersson L, 2009, J OCCUP ENVIRON HYG, V6, P9, DOI 10.1080/15459620802523943; ARRIGHI HM, 1994, EPIDEMIOLOGY, V5, P189, DOI 10.1097/00001648-199403000-00009; Babisch W, 2014, NOISE HEALTH, V16, P1, DOI 10.4103/1463-1741.127847; Chang TY, 2013, AM J EPIDEMIOL, V177, P818, DOI 10.1093/aje/kws300; CHEN JQ, 1992, J OCCUP ENVIRON MED, V34, P311, DOI 10.1097/00043764-199203000-00017; Chen W, 2005, AM J IND MED, V48, P1, DOI 10.1002/ajim.20174; Chen WG, 2012, J NANOMATER, V2012, DOI 10.1155/2012/612420; Duan JC, 2016, NANOTOXICOLOGY, V10, P575, DOI 10.3109/17435390.2015.1102981; Duan JC, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0050-8; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; KOSKELA RS, 1994, SCAND J WORK ENV HEA, V20, P286, DOI 10.5271/sjweh.1396; Liu Y, 2014, EPIDEMIOLOGY, V25, P689; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Moroni B, 2014, J EXPO SCI ENV EPID, V24, P42, DOI 10.1038/jes.2013.3; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Pollard KM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00097; Reid PJ, 1996, OCCUP ENVIRON MED, V53, P11, DOI 10.1136/oem.53.1.11; Steenland K, 2001, AM J EPIDEMIOL, V153, P695, DOI 10.1093/aje/153.7.695; 't Mannetje A, 2002, OCCUP ENVIRON MED, V59, P723, DOI 10.1136/oem.59.11.723; Toren K, 2007, OCCUP ENVIRON MED, V64, P515, DOI 10.1136/oem.2006.029488; Wang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16900; Weiner J, 2007, AM J IND MED, V50, P403, DOI 10.1002/ajim.20466; Westberg H, 2013, INT ARCH OCC ENV HEA, V86, P499, DOI 10.1007/s00420-012-0782-4; WYNDHAM CH, 1986, BRIT J IND MED, V43, P677	26	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0192840	10.1371/journal.pone.0192840	http://dx.doi.org/10.1371/journal.pone.0192840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481578	Green Submitted, Green Published, gold			2022-12-27	WOS:000426202700006
J	Boni, RAD; Paiva, CE; de Oliveira, MA; Lucchetti, G; Fregnani, JHTG; Paiva, BSR				dos Santos Boni, Robson Aparecido; Paiva, Carlos Eduardo; de Oliveira, Marco Antonio; Lucchetti, Giancarlo; Tavares Guerreiro Fregnani, Jose Humberto; Ribeiro Paiva, Bianca Sakamoto			Burnout among medical students during the first years of undergraduate school: Prevalence and associated factors	PLOS ONE			English	Article							STRESS; DEPRESSION	Objective To evaluate the prevalence and possible factors associated with the development of burnout among medical students in the first years of undergraduate school. Method A cross-sectional study was conducted at the Barretos School of Health Sciences, Dr. Paulo Prata. A total of 330 students in the first four years of medical undergraduate school were invited to participate in responding to the sociodemographic and Maslach Burnout Inventory-Student Survey (MBI-SS) questionnaires. The first-year group consisted of 150 students, followed by the second-, third-, and fourth-year groups, with 60 students each. Results Data from 265 students who answered at least the sociodemographic questionnaire and the MBI-SS were analyzed (response rate = 80.3%). One (n = 1, 0.3%) potential participant viewed the Informed Consent Form but did not agree to participate in the study. A total of 187 students (187/265, 70.6%) presented high levels of emotional exhaustion, 140 (140/265, 52.8%) had high cynicism, and 129 (129/265, 48.7%) had low academic efficacy. The two-dimensional criterion indicated that 119 (44.9%) students experienced burnout. Based on the three-dimensional criterion, 70 students (26.4%) presented with burnout. The year with the highest frequency of affected students for both criteria was the first year (p = 0.001). Personal attributes were able to explain 11% (Delta R = 0.11) of the variability of burnout under the two-dimensional criterion and 14.4% (R-2 = 0.144) under the three-dimensional criterion. Conclusion This study showed a high prevalence of burnout among medical students in a private school using active teaching methodologies. In the first years of graduation, students' personal attributes (optimism and self-perception of health) and school attributes (motivation and routine of the exhaustive study) were associated with higher levels of burnout. These findings reinforce the need to establish preventive measures focused on the personal attributes of first-year students, providing better performance, motivation, optimism, and empathy in the subsequent stages of the course.	[dos Santos Boni, Robson Aparecido] Barretos Sch Hlth Sci Dr Paulo Prata, Barretos, SP, Brazil; [dos Santos Boni, Robson Aparecido; Paiva, Carlos Eduardo; de Oliveira, Marco Antonio; Lucchetti, Giancarlo; Tavares Guerreiro Fregnani, Jose Humberto; Ribeiro Paiva, Bianca Sakamoto] Barretos Canc Hosp, Res Grp Palliat Care & Hlth Related Qual Life GPQ, Barretos, SP, Brazil; [Paiva, Carlos Eduardo; Tavares Guerreiro Fregnani, Jose Humberto; Ribeiro Paiva, Bianca Sakamoto] Barretos Canc Hosp, Teaching & Res Inst, Barretos, SP, Brazil; [Paiva, Carlos Eduardo] Barretos Canc Hosp, Dept Clin Oncol, Breast & Gynecol Div, Barretos, SP, Brazil; [Lucchetti, Giancarlo] Univ Fed Juiz de Fora, Sch Med, Juiz De Fora, MG, Brazil	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Universidade Federal de Juiz de Fora	Paiva, BSR (corresponding author), Barretos Canc Hosp, Res Grp Palliat Care & Hlth Related Qual Life GPQ, Barretos, SP, Brazil.; Paiva, BSR (corresponding author), Barretos Canc Hosp, Teaching & Res Inst, Barretos, SP, Brazil.	bsrpaiva@gmail.com	Lucchetti, Giancarlo/B-4679-2014; Paiva, Carlos E/F-4810-2012; Fregnani, José H/H-4238-2012	Lucchetti, Giancarlo/0000-0002-5384-9476; Fregnani, José H/0000-0002-5235-6469; Boni, Robson Aparecido dos Santos/0000-0002-5111-0942; , Marco Antonio de Oliveira/0000-0001-6879-2778; Paiva, Carlos Eduardo/0000-0002-7934-1451	Barretos Cancer Hospital internal research funds (PAIP)	Barretos Cancer Hospital internal research funds (PAIP)	This project was supported by Barretos Cancer Hospital internal research funds (PAIP). The funder had no role in the design of the study, in the analysis or interpretation of data, or in the writing of the manuscript.	Abdel-Khalek AM, 2006, SOC BEHAV PERSONAL, V34, P139, DOI 10.2224/sbp.2006.34.2.139; Aguiar CCT, 2010, REV PSIQUIATR CLIN, V34, P31; Almeida GD, 2016, ARCH CLIN PSYCHIAT, V43, DOI 10.1590/0101-60830000000072; Alvares J, 2012, REV SAUCLE POBLICA, V46, P816; [Anonymous], 1980, C C STAFF BURNOUT JO; Arora A, 2016, INDIAN J MED RES, V143, P101, DOI 10.4103/0971-5916.178617; ASHTON CH, 1995, MED EDUC, V29, P187, DOI 10.1111/j.1365-2923.1995.tb02828.x; Bilge F, 2014, KURAM UYGUL EGIT BIL, V14, P1721; Botelho FFR, 2017, STRESS LEVEL ASSESS, V6; Boudreau D, 2004, ANN EMERG MED, V44, pS75, DOI 10.1016/j.annemergmed.2004.07.248; Burkiewicz A, 2015, PROCD SOC BEHV, V190, P129, DOI 10.1016/j.sbspro.2015.04.926; Cardoso HF, 2017, REV PSICOL ORGAN E T, V17, P121; Carlotto Mary Sandra, 2006, Psico-USF, V11, P167; Catalyst NEJM, 2017, PHYS BURNOUT ROOT PR; Moutinho ILD, 2017, REV ASSOC MED BRAS, V63, P21, DOI 10.1590/1806-9282.63.01.21; Campos JADB, 2012, REV SAUDE PUBL, V46, P816, DOI 10.1590/S0034-89102012000500008; Dyrbye L, 2016, MED EDUC, V50, P132, DOI 10.1111/medu.12927; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Dyrbye LN, 2005, MAYO CLIN PROC, V80, P1613, DOI 10.4065/80.12.1613; Dyrbye LN, 2014, ACAD MED, V89; Fares J, 2016, N AM J MED SCI, V8, P75, DOI 10.4103/1947-2714.177299; Gracino Mariana Evangelista, 2016, Saúde debate, V40, P244, DOI 10.1590/0103-1104201611019; Heinen I, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-016-0841-8; Hojat M, 2015, INT J MED EDUC, V6, P12, DOI 10.5116/ijme.54c3.60cd; Hora WS, 2017, ENEM SCI PLENA JOVEM, V5, P37; Ishak W, 2013, CLIN TEACH, V10, P242, DOI 10.1111/tct.12014; Kilgour JM, 2016, TEACH LEARN MED, V28, P15, DOI 10.1080/10401334.2015.1107484; Koh GCH, 2008, CAN MED ASSOC J, V178, P34, DOI 10.1503/cmaj.070565; Lewis AD, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-60; Ludwig AB, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0425-z; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Moffat KJ, 2004, MED EDUC, V38, P482, DOI 10.1046/j.1365-2929.2004.01814.x; Mori Mariana Ono, 2012, Rev. bras. educ. med., V36, P536, DOI 10.1590/S0100-55022012000600013; Pagnin D, 2014, ACAD PSYCHIATR, V38, P438, DOI 10.1007/s40596-014-0093-z; Peruzzo AS, 2008, ESTRESSE E VESTIBULA, V26, P319; Prezotto AO, 2009, ASS ENTRE ESTRESSE D, P33; Prins JT, 2007, MED EDUC, V41, P788, DOI 10.1111/j.1365-2923.2007.02797.x; Puthran R, 2016, MED EDUC, V50, P456, DOI 10.1111/medu.12962; Santen SA, 2010, SOUTH MED J, V103, P758, DOI 10.1097/SMJ.0b013e3181e6d6d4; Santos DJS, 2010, PRESS J ORTHOD, V15, P121; Shanafelt TD, 2016, MAYO CLIN PROC, V91, P1667, DOI 10.1016/j.mayocp.2016.08.016; Strobel J, 2009, INTERDISCIP J PROBL-, V3, P44, DOI 10.7771/1541-5015.1046; Thomas M., 2014, RESILIENT PRACTITION; Viana G.M., 2014, REV U VALE RIO VERDE, V12, P876, DOI [10.5892/ruvrd.v12i1.1471, DOI 10.5892/RUVRD.V12I1.1471]; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X	45	71	78	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0191746	10.1371/journal.pone.0191746	http://dx.doi.org/10.1371/journal.pone.0191746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513668	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800007
J	Hernandez, D; Muriel, A; de la Nuez, PC; Alonso-Titos, J; Ruiz-Esteban, P; Duarte, A; Gonzalez-Molina, M; Palma, E; Alonso, M; Torres, A				Hernandez, Domingo; Muriel, Alfonso; Castro de la Nuez, Pablo; Alonso-Titos, Juana; Ruiz-Esteban, Pedro; Duarte, Ana; Gonzalez-Molina, Miguel; Palma, Eulalia; Alonso, Manuel; Torres, Armando			Survival in Southern European patients waitlisted for kidney transplant after graft failure: A competing risk analysis	PLOS ONE			English	Article							PROPENSITY SCORE; CARDIOVASCULAR-DISEASE; UNTREATED SUBJECTS; ALLOGRAFT FAILURE; UNITED-STATES; DIALYSIS; MORTALITY; RECIPIENTS; RETURN; OUTCOMES	Background Whether patients waitlisted for a second transplant after failure of a previous kidney graft have higher mortality than transplant-naive waitlisted patients is uncertain. Methods We assessed the relationship between a failed transplant and mortality in 3851 adult KT candidates, listed between 1984-2012, using a competing risk analysis in the total population and in a propensity score-matched cohort. Mortality was also modeled by inverse probability weighting (IPTW) competing risk regression. Results At waitlist entry 225 (5.8%) patients had experienced transplant failure. All-cause mortality was higher in the post-graft failure group (16% vs. 11%; P = 0.033). Most deaths occurred within three years after listing. Cardiovascular disease was the leading cause of death (25.3%), followed by infections (19.3%). Multivariate competing risk regression showed that prior transplant failure was associated with a 1.5-fold increased risk of mortality (95% confidence interval [ CI], 1.01-2.2). After propensity score matching (1: 5), the competing risk regression model revealed a subhazard ratio (SHR) of 1.6 (95% CI, 1.01-2.5). A similar mortality risk was observed after the IPTW analysis (SHR, 1.7; 95% CI, 1.1-2.6). Conclusions Previous transplant failure is associated with increased mortality among KT candidates after relisting. This information is important in daily clinical practice when assessing relisted patients for a retransplant.	[Hernandez, Domingo; Alonso-Titos, Juana; Ruiz-Esteban, Pedro; Duarte, Ana; Gonzalez-Molina, Miguel; Palma, Eulalia] Carlos Haya Reg Univ Hosp, Nephrol Dept, Malaga, Spain; Univ Malaga, IBIMA, REDinREN RD16 0009 0006, Malaga, Spain; [Muriel, Alfonso] Univ Autonoma Madrid, CIBERESP, Hosp Ramon y Cajal IRYCIS, Clin Biostat Unit, Madrid, Spain; [Castro de la Nuez, Pablo; Alonso, Manuel] Transplant Coordinat Ctr, Seville, Spain; [Castro de la Nuez, Pablo; Alonso, Manuel] Andalusian Hlth Serv, Seville, Spain; [Torres, Armando] Univ La Laguna, CIBICAN, Hosp Univ Canarias, Nephrol Dept,REDinREN RD16 0009 0031, Tenerife, Spain; [Torres, Armando] Inst Reina Sofia Invest Renal IRSIN, Tenerife, Spain	Hospital Carlos Haya; Universidad de Malaga; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; Universidad de la Laguna	Hernandez, D (corresponding author), Carlos Haya Reg Univ Hosp, Nephrol Dept, Malaga, Spain.	domingohernandez@gmail.com	Hernandez, Domingo/R-4041-2019; Muriel, Alfonso AM/F-9948-2015	Muriel, Alfonso AM/0000-0002-4805-4011; Ruiz Esteban, Pedro/0000-0001-7308-8697; Hernandez Marrero, Domingo Jeronimo/0000-0001-5469-2119; Torres, Armando/0000-0003-1121-5173	Spanish Ministry of Economy and Competitiveness (MINECO) from the Institute de Salud Carlos III - Fondo Europeo de Desarrollo Regional FEDER, RETICS [ICI14/00016, REDINREN RD16/0009/0006, RD16/0009/0031]	Spanish Ministry of Economy and Competitiveness (MINECO) from the Institute de Salud Carlos III - Fondo Europeo de Desarrollo Regional FEDER, RETICS	This study was supported in part by the Spanish Ministry of Economy and Competitiveness (MINECO) (grant ICI14/00016) from the Institute de Salud Carlos III co-funded by the Fondo Europeo de Desarrollo Regional FEDER, RETICS (REDINREN RD16/0009/0006, RD16/0009/0031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowicz D, 2015, NEPHROL DIAL TRANSPL, V30, P1790, DOI 10.1093/ndt/gfu216; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2010, AM J EPIDEMIOL, V172, P1092, DOI 10.1093/aje/kwq224; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Fresnedo GF, 2008, TRANSPL P, V40, P2889, DOI 10.1016/j.transproceed.2008.08.094; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gaston RS, 2009, AM J TRANSPLANT, V9, P1811, DOI 10.1111/j.1600-6143.2009.02696.x; Gill JS, 2002, KIDNEY INT, V62, P1875, DOI 10.1046/j.1523-1755.2002.00640.x; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernandez D, 2016, TRANSPLANTATION, V1; Hernandez D, 2014, TRANSPLANTATION, V98, P653, DOI 10.1097/TP.0000000000000141; Hernandez D, 2012, TRANSPLANTATION, V93, P297, DOI 10.1097/TP.0b013e31823ec0a7; Johnston O, 2007, J AM SOC NEPHROL, V18, P1331, DOI 10.1681/ASN.2006091017; Kaplan B, 2002, AM J TRANSPLANT, V2, P970, DOI 10.1034/j.1600-6143.2002.21015.x; Lopez-Gomez JM, 2004, J AM SOC NEPHROL, V15, P2494, DOI 10.1097/01.ASN.0000137879.97445.6E; Magee JC, 2007, AM J TRANSPLANT, V7, P1424, DOI 10.1111/j.1600-6143.2007.01786.x; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Marcen R, 2009, DRUGS, V69, P2227, DOI 10.2165/11319260-000000000-00000; Molnar MZ, 2013, SEMIN DIALYSIS, V26, P667, DOI 10.1111/sdi.12129; Molnar MZ, 2012, NEPHROL DIAL TRANSPL, V27, P2913, DOI 10.1093/ndt/gfs004; Mourad G, 2014, KIDNEY INT, V86, P191, DOI 10.1038/ki.2014.6; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Ojo AO, 2013, NEPHROL DIAL TRANSPL, V28, P213, DOI 10.1093/ndt/gfs287; Ojo AO, 1998, TRANSPLANTATION, V66, P1651, DOI 10.1097/00007890-199812270-00014; Perl J, 2012, NEPHROL DIAL TRANSPL, V27, P4464, DOI 10.1093/ndt/gfs386; Rao PS, 2007, AM J KIDNEY DIS, V49, P294, DOI 10.1053/j.ajkd.2006.11.022; Rao PS, 2005, NEPHROL DIAL TRANSPL, V20, P387, DOI 10.1093/ndt/gfh595; Sapir-Pichhadze R, 2016, J AM SOC NEPHROL, V27, P570, DOI 10.1681/ASN.2014090894; Schold JD, 2013, AM J TRANSPLANT, V13, P2374, DOI 10.1111/ajt.12349; Shariff SZ, 2008, J AM SOC NEPHROL, V19, P841, DOI 10.1681/ASN.2007121354; Sleiman J, 2007, TRANSPL P, V39, P2597, DOI 10.1016/j.transproceed.2007.08.030; Soveri I, 2006, NEPHROL DIAL TRANSPL, V21, P2282, DOI 10.1093/ndt/gfl095; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wong G, 2016, TRANSPLANTATION, V100, P1767, DOI 10.1097/TP.0000000000000953; Yang KS, 2013, TRANSPL P, V45, P2949, DOI 10.1016/j.transproceed.2013.08.080; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	39	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193091	10.1371/journal.pone.0193091	http://dx.doi.org/10.1371/journal.pone.0193091			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513701	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800036
J	Cazarim, MD; Pereira, LRL				Cazarim, Maurilio de Souza; Leira Pereira, Leonardo Regis			Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTORS; PREVALENCE; OUTCOMES	Introduction Only 20% of patients with systemic arterial hypertension (SAH) have blood pressure within recommended parameters. SAH has been the main risk factor for morbidity and mortality of cardiovascular diseases, which affects the burden of the Public Health System (PHS). Some studies have shown the effectiveness of Pharmaceutical Care (PC) in the care of hypertensive patients. Objective To perform a cost-effectiveness analysis to compare SAH treatment with PC management and conventional treatment for hypertensive patients offered by the PHS. Methods A cost-effectiveness study nested to a quasi-experimental study was conducted, in which 104 hypertensive patients were followed up in a PC program. Blood pressure control was considered as the outcome for the economic analysis and the costs were direct and non-direct medical costs. Results PC was dominant for two years in the post-PC period compared with the pre-PC year. The mean cost effectiveness ratio (CER) for the CERPre-PC, CERPC, and CERPost-PC periods were: US$364.65, US$415.39, and US$231.14 respectively. The incremental cost effectiveness ratio (ICER) analysis presented ICER of US$478.41 in the PC period and US$42.95 in the post PC period. Monte Carlo sensitivity analysis presented mean ICERPC and ICERPost-PC equal to US$605.09 and US$128.03, reaching US$1,725.00 and US$740.00 respectively. Conclusion Even for the highest ICER, the values were below the cost effectiveness threshold, which means that PC was a cost effective strategy for the care of hypertensive patients in the PHS.	[Cazarim, Maurilio de Souza; Leira Pereira, Leonardo Regis] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, Ribeirao Preto, SP, Brazil; [Leira Pereira, Leonardo Regis] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ctr Pesquisa Assistencia Farmaceut & Farm Clin CP, 23 Blc S,Av Cafe S-N, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Cazarim, MD (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, Ribeirao Preto, SP, Brazil.	maurilio.jf@gmail.com	Pereira, Leonardo R L/J-9322-2012	Pereira, Leonardo R L/0000-0002-8609-1390; Cazarim, Maurilio de Souza/0000-0002-2826-5903	Sao Paulo Research Foundation (FAPESP) [2014/02087-9]; FAPESP [2014/02087-9]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by funding of Sao Paulo Research Foundation (FAPESP). This organization helped with a scholarship for the author Maurilio de Souza Cazarim [grant number 2014/02087-9] from 01/08/2014 to 31/01/2016, URL (http://bvs.fapesp.br/en/pesquisador/673633/maurillo-de-souza-cazarim/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, assumptions and conclusions or recommendations expressed in this article are responsibility of the authors and do not necessarily reflect the viewpoint of FAPESP.; We thank the FAPESP funding agency for the scholarship support for the author Maurilio Souza Cazarim [grant number 2014/02087-9] from 01/08/2014 to 31/01/2016, URL (http:// bvs.fapesp.br/en/pesquisador/673633/maurilio-de-souza-cazarim/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, assumptions and conclusions or recommendations expressed in this article are the responsibility of the authors and do not necessarily reflect the viewpoint of FAPESP. We thank Estael L.C. Cruz-Cazarim, Pharmacist, employee of the Faculty of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Brazil, for the help with the costing of Pharmaceutical Care. We thank John Carpenter, Ribeirao Preto, SP, Brazil, for the English revision.	Aguwa CN, 2008, PHARM WORLD SCI, V30, P107, DOI 10.1007/s11096-007-9151-x; Alvarez JS, 2012, EVALUACION EC MEDICA; Araujo A. L. A., 2005, Revista de Ciencias Farmaceuticas Basica e Aplicada, V26, P87; Borghi C, 2015, EXPERT REV PHARM OUT, V15, P199, DOI 10.1586/14737167.2015.1018894; Brazil Brazilian Central Bank, 2013, CONS EC IND; Brazil Brazilian Central Bank, 2015, COIN CONV; Brazil Ministry of Health, 2015, SYST MAN TABL PROC M; Brazil Ministry of Health. Brazilian Network for Health Technology Assessment (BNHTA), 2009, METH GUID STUD EC A; Brazil Ministry of Health. Brazilian Network for Health Technology Assessment (BNHTA), 2014, METH GUID EC EV GU A; Brazil Ministry of Health. Secretariat of Health Surveillance Secretariat of Health Care, 2008, GUID REC INT CAR CHR; Brazilian Institute of Geography and Statistics-BIGS, 2012, CIT TOWNS RIB PRET S; Brazilian Institute of Geography and Statistics-BIGS, 2015, BRAZ SYNTH GDP PER C; Cazarim MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155204; Chinwong S, 2004, PHARM WORLD SCI, V26, P96, DOI 10.1023/B:PHAR.0000018599.47002.e7; Cipullo JP, 2010, ARQ BRAS CARDIOL, V94, P519, DOI 10.1590/S0066-782X2010005000014; Costa JSDD, 2002, SAO PAULO MED J, V120, P100; Andrade SSD, 2015, EPIDEMIOL SERV SAUDE, V24, P297, DOI 10.5123/S1679-49742015000200012; de Castro MS, 2007, ANN PHARMACOTHER, V41, P1486, DOI 10.1345/aph.1K080; de Lyra DP, 2008, REV BRAS CIENC FARM, V44, P451, DOI 10.1590/S1516-93322008000300015; Borges APD, 2011, ARQ BRAS ENDOCRINOL, V55, P686, DOI 10.1590/S0004-27302011000900003; Dib MW, 2010, REV PANAM SALUD PUBL, V27, P125, DOI 10.1590/S1020-49892010000200006; Drummond MF, 2015, METHODS EC EVALUATIO; Etemad LR, 2003, VALUE HEALTH, V6, P425, DOI 10.1046/j.1524-4733.2003.64255.x; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Pereira LRL, 2008, REV BRAS CIENC FARM, V44, P601, DOI 10.1590/S1516-93322008000400006; Machado M, 2007, ANN PHARMACOTHER, V41, P1770, DOI 10.1345/aph.1K311; Malachias Mvb, 2016, Arq Bras Cardiol, V107, P1, DOI 10.5935/abc.20160151; Malta DC, 2014, EPIDEMIOL SERV SAUDE, V23, P599, DOI [10.5123/S1679-49742014000400002, 10.5123/S1679-49742014000400017, 10.5123/S1679-49742014000300002]; Municipal Government of Ribeirao Preto, 2015, ACC 2013; Municipal Government of Ribeirao Preto. Department of Health of Ribeirao Preto, 2015, 2013 MAN REP; Municipal Government of Ribeirao Preto. Department of Health of Ribeirao Preto, 2015, PROGR SERV; Nita ME, 2009, EVALUATION HLTH TECH; Penaforte TR, 2011, THESIS; Piola SF, 2009, HLTH BRAZIL SOME QUE; Polgreen LA, 2015, HYPERTENSION, V66, P1145, DOI 10.1161/HYPERTENSIONAHA.115.06023; Pontes-Neto OM, 2008, STROKE, V39, P292, DOI 10.1161/STROKEAHA.107.493908; Rascati KL, 2014, ESSENTIALS PHARMACOE; Rodrigues FA., 2015, THESIS; Rosário Tânia Maria do, 2009, Arq. Bras. Cardiol., V93, P672, DOI 10.1590/S0066-782X2009001200018; Jardim PCBV, 2007, ARQ BRAS CARDIOL, V88, P452, DOI 10.1590/S0066-782X2007000400015; Vieira LS, 2013, THESIS; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, GLOB STAT REP NONC D; World Health Organisation, 2003, INN CAR CHRON COND B; World Health Organization, 2014, CARD DIS DEATHS PER; World Health Organization (WHO), 2013, CARD DIS CVDS; Zubioli A, 2013, BRAZ J PHARM SCI, V49, P85, DOI 10.1590/S1984-82502013000100010	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193567	10.1371/journal.pone.0193567	http://dx.doi.org/10.1371/journal.pone.0193567			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509802	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200016
J	Kaur, R; Sodhi, M; Sharma, A; Sharma, VL; Verma, P; Swami, SK; Kumari, P; Mukesh, M				Kaur, Ramneek; Sodhi, Monika; Sharma, Ankita; Sharma, Vijay Lakshmi; Verma, Preeti; Swami, Shelesh Kumar; Kumari, Parvesh; Mukesh, Manishi			Selection of suitable reference genes for normalization of quantitative RT-PCR (RT-qPCR) expression data across twelve tissues of riverine buffaloes (Bubalus bubalis)	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; INTERNAL CONTROL GENES; REAL-TIME PCR; HOUSEKEEPING GENES; RIBOSOMAL-RNA; BETA-ACTIN; IDENTIFICATION; VALIDATION; QUANTIFICATION; CELLS	Selection of reference genes has become an integral step in any real time quantitative PCR (RT-qPCR) based expression studies. The importance of this study stems from the fact that riverine buffaloes are major dairy species of Indian sub-continent and the information generated here will be of great interest to the investigators engaged in functional genomic studies of this important livestock species. In this study, an effort was made to evaluate a panel of 10 candidate reference genes (glyceraldehyde 3-phosphate dehydrogenase (GAPDH), beta-actin (ACTB), ubiquitously expressed transcript (UXT), ribosomal protein S15 (RPS15), ribosomal protein L-4 (RPL4), ribosomal protein S9 (RPS9), ribosomal protein S23 (RPS23), hydroxymethylbilane synthase (HMBS), beta 2 Microglobulin (beta 2M) and eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) across 12 tissues (mammary gland, kidney, spleen, liver, heart, intestine, ovary, lung, muscle, brain, subcutaneous fat and testis) of riverine buffaloes. In addition to overall analysis, tissue wise evaluation of expression stability of individual RG was also performed. Three different algorithms provided in geN-orm, NormFinder and BestKeeper softwares were used to evaluate the stability of 10 potential reference genes from different functional classes. The M-value given by geNorm ranged from 0.9797 (RPS9 and UXT) to 1.7362 (RPS15). From the most stable to the least stable, genes were ranked as: UXT/ RPS9> RPL4> RPS23> EEF1A1> ACTB> HMBS> GAPDH> B2M> RPS15. While NormFinder analysis ranked the genes as: UXT> RPS23> RPL4> RPS9> EEF1A1> HMBS> ACTB> beta 2M> GAPDH> RPS15. Based on the crossing point SD value and range of fold change expression, BestKeeper analysis ranked the genes as: RPS9> RPS23/UXT> RPL4> GAPDH> EEF1A1> ACTB> HMBS> beta 2M> RPS15. Overall the study has identified RPS23, RPS9, RPL4 and UXT genes to be the most stable and appropriate RGs that could be utilized for normalization of transcriptional data in various tissues of buffaloes. This manuscript thus provide useful information on panel of reference genes that could be helpful for researchers conducting functional genomic studies in riverine buffaloes.	[Kaur, Ramneek; Sodhi, Monika; Sharma, Ankita; Verma, Preeti; Swami, Shelesh Kumar; Kumari, Parvesh; Mukesh, Manishi] Natl Bur Anim Genet Resources, ICAR, Dept Anim Biotechnol, Karnal, Haryana, India; [Kaur, Ramneek; Sharma, Vijay Lakshmi] Panjab Univ, Dept Zool, Chandigarh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; Panjab University	Mukesh, M (corresponding author), Natl Bur Anim Genet Resources, ICAR, Dept Anim Biotechnol, Karnal, Haryana, India.	mmukesh_26@hotmail.com		mukesh, manishi/0000-0001-8101-3863; Sodhi, Monika/0000-0003-1356-3999	National Fellow Scheme of Indian Council of Agricultural Research, New Delhi [27(3)/2010-HRD]; ICAR; Department of Science and Technology, Govt. of India; Indian Council of Agriculture Research, New Delhi under National Fellow Scheme	National Fellow Scheme of Indian Council of Agricultural Research, New Delhi(Indian Council of Agricultural Research (ICAR)); ICAR(Indian Council of Agricultural Research (ICAR)); Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Indian Council of Agriculture Research, New Delhi under National Fellow Scheme	This work was supported under National Fellow Scheme of Indian Council of Agricultural Research, New Delhi grant number 27(3)/2010-HRD, http://www.icar.org.in/files/edu/Award-of-National-Fellow.pdf. MM, Principal Scientist and National Fellow, received the funding from ICAR. RK has received the inspire fellowship from Department of Science and Technology, Govt. of India.; The work was supported by Indian Council of Agriculture Research, New Delhi under National Fellow Scheme. The fellowship received by Ms Ramneek Kaur from DST-INSPIRE, Govt. of India is duly acknowledged.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2012, LIV CENS; Bae IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122554; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chen JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46494; Deindl E, 2002, MOL CELL BIOCHEM, V236, P139, DOI 10.1023/A:1016166127465; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jatav P, 2016, ANIM SCI J, V87, P344, DOI 10.1111/asj.12384; Kackar V, 2013, INDIAN J ANIMAL SCI, V83; Kapila N, 2013, ISRN BIOTECHNOLOGY; Kishore A, 2013, MOL CELL PROBE, V27, P140, DOI 10.1016/j.mcp.2013.02.003; Koramutla MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25883; Li QM, 2011, INT J MOL SCI, V12, P1727, DOI 10.3390/ijms12031727; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macabelli CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093287; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Radonic A, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-7; Sodhi M, 2013, J ANIM BREED GENET, V130, P106, DOI 10.1111/j.1439-0388.2012.01004.x; Spalenza V, 2011, VET J, V189, P278, DOI 10.1016/j.tvjl.2010.11.017; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Terzi V, 2010, ANIMAL, V4, P853, DOI 10.1017/S1751731110000042; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vorachek WR, 2013, INT J MOL SCI, V14, P11484, DOI 10.3390/ijms140611484; Yadav P, 2012, LIVEST SCI, V147, P72, DOI 10.1016/j.livsci.2012.04.004; Yu Zhang, 2013, ASIAN AUSTRALASIAN J, V26	33	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0191558	10.1371/journal.pone.0191558	http://dx.doi.org/10.1371/journal.pone.0191558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509770	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200002
J	Huang, YL; Zhang, SD; Fang, XY; Qin, L; Fan, Y; Ding, DD; Liu, XS; Xie, M				Huang, Yali; Zhang, Shengding; Fang, Xiaoyu; Qin, Lu; Fan, Yu; Ding, Dandan; Liu, Xiansheng; Xie, Min			Plasma miR-199a-5p is increased in neutrophilic phenotype asthma patients and negatively correlated with pulmonary function	PLOS ONE			English	Article							AIRWAY INFLAMMATION; INDUCED SPUTUM; MICRORNAS; IDENTIFICATION; BIOMARKERS; KNOWLEDGE; RNAS	Objective We investigated the relationship between plasma miRNAs levels and inflammatory characteristics in asthmatic patients. Methods Eligible adults with untreated asthma (n = 35) underwent a clinical assessment, sputum induction, and assessment of pulmonary function test and Asthma Control Test (ACT) scores. Asthma phenotypes were defined using the sputum cell count. miR-199a-5p expression was measured using quantitative real-time polymerase chain reaction (qPCR). Lipopolysaccharide (LPS) stimulation was used to detect miR-199a-5p secretion from peripheral blood-derived neutrophil, lymphocyte, macrophage and BEAS-2B cells. The correlation of miR-199a-5p expression with clinical parameters was analyzed using multiple linear regression analysis. In silico analysis predicted the target genes and signaling pathway of miR199a-5p. Transfection of miR-199a-5p mimics in human airway smooth muscle cells (HASMCs) was performed in vitro. Results The miRNA-199a-5p levels in plasma and sputum increased significantly in patients with neutrophilic asthma compared to healthy subjects (ps = 0.014 and 0.006, respectively). Expression of miR-199a-5p in the plasma of asthmatic patients positively correlated with sputum miR-199a-5p expression (r = 0.511, p = 0.021). The miR-199a-5p level was only elevated with LPS stimulation in neutrophils but not macrophages, lymphocytes, or epithelial cells from healthy controls (p < 0.01). miR-199a-5p expression increased in response to LPS (p = 0.005) and LPS combined with IL-4(p = 0.003), but not IL-4 alone. However, peripheral neutrophils from eosinophilic asthma patients did not respond to LPS with increased miR-199a-5p expression (n = 5, p > 0.05) in contrast to the significant response from neutrophilic patients (n = 4, p < 0.0001). miR-199a-5p negatively correlated with FEV1, FVC and PEF (r = -0.377, p = 0.026; r = -0.419, p = 0.012; and r = -0.392, p = 0.024, respectively). Multivariate correlation analysis confirmed that the plasma miR-199a-5p levels negatively correlated with FEV1 in patients with asthma (Adjusted R-2 = 0.164, p = 0.015). In silico analysis suggested that the WNT signaling pathway participates in miR-199a-5p mediation of smooth muscle cell hypertrophy. In vitro experiment, miR-199a-5p mimics inhibited the protein expressions of WNT2 and WNT4, decreased the c-myc expression and dramatically increased the Sm-MHC expression in HASMCs. Conclusion Plasma miR-199a-5p was increased in neutrophilic asthma and negatively correlated with pulmonary function, which suggests that miR-199a-5p actively contributes to disease pathogenesis by modulating the inflammatory process and transferring the signal from inflammatory cells to structure cells.	[Huang, Yali; Zhang, Shengding; Fang, Xiaoyu; Qin, Lu; Fan, Yu; Ding, Dandan; Liu, Xiansheng; Xie, Min] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Resp & Crit Care Med, Wuhan, Hubei, Peoples R China; [Huang, Yali] Third Peoples Hosp Wuhan, Dept Resp Med, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Xie, M (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Resp & Crit Care Med, Wuhan, Hubei, Peoples R China.	xie_m@126.com	Liu, xiansheng/GWQ-6485-2022	xie, min/0000-0003-4052-1647	National Natural Science Foundation of China [81470002, 81670020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 81470002 and 81670020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Davies AR, 2013, CURR OPIN PULM MED, V19, P60, DOI 10.1097/MCP.0b013e32835b118e; Davis JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180329; Demarche SF, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0615-9; Elbehidy RM, 2016, MOL IMMUNOL, V71, P107, DOI 10.1016/j.molimm.2015.12.015; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gheinani AH, 2015, J BIOL CHEM, V290, P7067, DOI 10.1074/jbc.M114.618694; Gibson PG, 1998, AM J RESP CRIT CARE, V158, P36, DOI 10.1164/ajrccm.158.1.9705031; Global Initiative for Asthma, 2015, GLOB STRAT ASTHM MAN; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; James Anna, 2016, Curr Treat Options Allergy, V3, P439; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kumar M, 2011, J ALLERGY CLIN IMMUN, V128, P1077, DOI 10.1016/j.jaci.2011.04.034; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZH, 2016, CARDIOVASC RES, V110, P258, DOI 10.1093/cvr/cvw052; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Milger K, 2017, ALLERGY, V72, P1962, DOI 10.1111/all.13205; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Panganiban RP, 2016, J ALLERGY CLIN IMMUN, V137, P1423, DOI 10.1016/j.jaci.2016.01.029; Panganiban RPL, 2012, AM J CLIN EXP IMMUNO, V1, P154; Quinlan S, 2017, INT REV CEL MOL BIO, V334, P309, DOI 10.1016/bs.ircmb.2017.04.002; Rebane A, 2013, J ALLERGY CLIN IMMUN, V132, P15, DOI 10.1016/j.jaci.2013.04.011; Robinson D, 2017, CLIN EXP ALLERGY, V47, P161, DOI 10.1111/cea.12880; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rupani H, 2016, AM J RESP CRIT CARE, V194, P26, DOI 10.1164/rccm.201502-0280OC; Simpson JL, 2010, RESPIRATION, V79, P147, DOI 10.1159/000245899; Tang FSM, 2016, THORAX, V71, P1039, DOI 10.1136/thoraxjnl-2015-207781; Tarlo SM, 2006, EUR RESPIR J, V27, P607, DOI 10.1183/09031936.06.00062105; Tay HL, 2014, ANN MED, V46, P633, DOI 10.3109/07853890.2014.958196; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169469; Wang SM, 2017, EPIGENETICS-US, V12, P187, DOI 10.1080/15592294.2016.1273308; Wang YH, 2015, CLIN LAB, V61, P467, DOI 10.7754/Clin.Lab.2014.141020; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Zhang SC, 2013, ARCH VIROL, V158, P2443, DOI 10.1007/s00705-013-1744-1; Zhou SR, 2017, MOL CELL BIOL, V37, DOI [10.1128/MCB.00058-17, 10.1128/mcb.00058-17]	43	18	19	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193502	10.1371/journal.pone.0193502	http://dx.doi.org/10.1371/journal.pone.0193502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505605	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200018
J	Crona, K				Crona, Kristina			Recombination and peak jumping	PLOS ONE			English	Article							EMPIRICAL FITNESS LANDSCAPES; ORDER EPISTASIS; SEX; POPULATIONS; EVOLUTION	We show that genetic recombination can be a powerful mechanism for escaping suboptimal peaks. Recent studies of empirical fitness landscapes reveal complex gene interactions and multiple peaks. However, classical work on recombination largely ignores the effect of complex gene interactions. Briefly, we restrict to fitness landscapes where the global peak is difficult to access. If the optimal genotype can be generated by shuffling genes present in the population, then recombination will produce the genotype. If, in addition, recombination is sufficiently rare, then the proportion of the genotype is expected to increase. Specifically, we consider landscapes where shuffling of suboptimal peak genotypes can produce the global peak genotype. The advantage of recombination we identify has no correspondence for 2-locus systems or for smooth landscapes. The effect of recombination indicated is sometimes extreme, also for rare recombination, in the sense that shutting off recombination could result in the organism failing to adapt. A standard question about recombination is whether the mechanism tends to accelerate or decelerate adaptation. However, we argue that extreme effects may be more important than how the majority falls. In a limited sense, our result can be considered a support for Sewall Wright's view that adaptation sometimes works better in subdivided populations.	[Crona, Kristina] Amer Univ, Washington, DC 20016 USA	American University	Crona, K (corresponding author), Amer Univ, Washington, DC 20016 USA.	kcrona@american.edu						Burke DS, 1997, EMERG INFECT DIS, V3, P253, DOI 10.3201/eid0303.970301; Crona K, 2013, SPRINGER SERIES EMER, P177; Crona K, 2013, J THEOR BIOL, V317, P1, DOI 10.1016/j.jtbi.2012.09.028; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; de Visser JAGM, 2014, NAT REV GENET, V15, P480, DOI 10.1038/nrg3744; de Visser JAGM, 2009, AM NAT, V174, pS15, DOI 10.1086/599081; Draghi J. A., 2013, EVOLUTION; Galassi M., GNU SCI LIB REFERENC; Greene D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003520; Hartl DL, 2014, CURR OPIN MICROBIOL, V21, P51, DOI 10.1016/j.mib.2014.08.001; Kauffman S. A., 1993, ORIGINS ORDER; Kim Y, 2005, GENETICS, V171, P1377, DOI 10.1534/genetics.105.045252; Kondrashov D. A., 2014, TRENDS GENETICS; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Misevic D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000510; Moradigaravand D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004439; Moradigaravand D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002735; Nowak S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003836; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Sailer ZR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005541; Sailer ZR, 2017, GENETICS, V205, P1079, DOI 10.1534/genetics.116.195214; Szendro IG, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/01/P01005; Watson RA, 2011, EVOLUTION, V65, P523, DOI 10.1111/j.1558-5646.2010.01144.x; Weinreich DM, 2013, CURR OPIN GENET DEV, V23, P700, DOI 10.1016/j.gde.2013.10.007; Weinreich DM, 2005, EVOLUTION, V59, P1165; Weissman DB, 2010, GENETICS, V186, P1389, DOI 10.1534/genetics.110.123240; Wright S, 1931, GENETICS, V16, P0097	27	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193123	10.1371/journal.pone.0193123	http://dx.doi.org/10.1371/journal.pone.0193123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494618	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200024
J	Li, QF; Chen, YG; Yue, F; Qian, W; Song, HY				Li, Qinfei; Chen, Yangui; Yue, Fang; Qian, Wei; Song, Hongyuan			Microspore culture reveals high fitness of B. napus-like gametes in an interspecific hybrid between Brassica napus and B. oleracea	PLOS ONE			English	Article							ALLOPOLYPLOID COFFEA-ARABICA; TRIAZINE RESISTANCE; GENOMIC COMPONENTS; GENETIC DIVERSITY; RAPA; INTROGRESSION; HYBRIDIZATION; MECHANISMS; EXPRESSION; EVOLUTION	The strategies of crossing B. napus with parental species play important role in broadening and improving the genetic basis of B. napus by the introgression of genetic resources from parental species. With these strategies, it is easy to select new types of B. napus, but difficult to select new types of B. rapa or B. oleracea by self-pollination. This characteristic may be a consequence of high competition with B. napus gametes. To verify the role of gamete viability in producing new B. napus individuals, the meiotic chromosome behavior of the interspecific hybrid between B. napus ( Zhongshuang 9) and B. oleracea ( 6m08) was studied, and microspore-derived ( MD) individuals were analyzed. The highest fitness of the 9: 19 ( 1.10%) pattern was observed with a 5.49-fold higher than theoretical expectation among the six chromosome segregation patterns in the hybrid. A total of 43 MD lines with more than 14 chromosomes were developed from the hybrid, and 8 ( 18.6%) of them were B. napus-like ( n = 19) type gametes, having the potential to broaden the genetic basis of natural B. napus ( GD = 0.43 +/- 0.04). It is easy to produce B. napus-like gametes with 19 chromosomes, and these gametes showed high fitness and competition in the microspore-derived lines, suggesting it might be easy to select new types of B. napus from the interspecific hybrid between B. napus and B. oleracea.	[Li, Qinfei; Song, Hongyuan] Southwest Univ, Coll Hort & Landscape, Chongqing, Peoples R China; [Li, Qinfei; Chen, Yangui; Yue, Fang; Qian, Wei] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Song, HY (corresponding author), Southwest Univ, Coll Hort & Landscape, Chongqing, Peoples R China.; Qian, W (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China.	qianwei666@hotmail.com; yuahs@163.com		LI, Qinfei/0000-0002-5353-2137	National Key Research and Development Program of China [2017YFD0101804]; China Postdoctoral Science Foundation [2015M582500]; Fundamental Research Funds for the Central Universities in China [XDJK2016C080]; Chongqing Postdoctoral Science Foundation [Xm2016029]; Science and Technology Innovation Project of Chongqing [cstc2015shms-ztzx80005, cstc2015shms-ztzx80007, cstc2015shms-zta80009]	National Key Research and Development Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities in China; Chongqing Postdoctoral Science Foundation; Science and Technology Innovation Project of Chongqing	This work was supported by the National Key Research and Development Program of China (2017YFD0101804), Hongyuan Song receive the funding; the China Postdoctoral Science Foundation (2015M582500) and the Fundamental Research Funds for the Central Universities in China (XDJK2016C080), the Chongqing Postdoctoral Science Foundation (Xm2016029), Qinfei Li receive these three funding; the Science and Technology Innovation Project of Chongqing (cstc2015shms-ztzx80005, cstc2015shms-ztzx80007 and cstc2015shms-zta80009), Hongyuan Song receive these fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181784; An DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134534; AYOTTE R, 1988, EUPHYTICA, V38, P137; AYOTTE R, 1988, EUPHYTICA, V37, P189, DOI 10.1007/BF00036857; Bardil A, 2011, NEW PHYTOL, V192, P760, DOI 10.1111/j.1469-8137.2011.03833.x; Buggs RJA, 2011, CURR BIOL, V21, P551, DOI 10.1016/j.cub.2011.02.016; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Combes MC, 2012, J HERED, V103, P36, DOI 10.1093/jhered/esr120; De Storme N, 2013, NEW PHYTOL, V198, P670, DOI 10.1111/nph.12184; Edger PP, 2017, PLANT CELL, V29, P2150, DOI 10.1105/tpc.17.00010; Fakhri Z, 2016, PLANT CELL REP, V35, P1143, DOI 10.1007/s00299-016-1951-9; Friedt W, 2005, BIOTECHNOL AGRIC FOR, V56, P191; Ge XH, 2006, PLANT CELL REP, V25, P1075, DOI 10.1007/s00299-006-0170-1; Geng XX, 2013, PLANT CELL TISS ORG, V113, P501, DOI 10.1007/s11240-013-0292-4; Girke A, 2012, GENET RESOUR CROP EV, V59, P1441, DOI 10.1007/s10722-011-9772-8; Li QF, 2014, MOL BREEDING, V34, P1955, DOI 10.1007/s11032-014-0153-9; Li QF, 2013, THEOR APPL GENET, V126, P2073, DOI 10.1007/s00122-013-2119-4; LI Z, 1995, THEOR APPL GENET, V91, P131, DOI 10.1007/BF00220869; LICHTER R, 1981, Z PFLANZENPHYSIOL, V103, P229, DOI 10.1016/S0044-328X(81)80155-9; Liu H, 2000, GENETICS BREEDING OI; Lu CM, 2001, BREEDING SCI, V51, P73, DOI 10.1270/jsbbs.51.73; Malik MR, 2008, J EXP BOT, V59, P2857, DOI 10.1093/jxb/ern149; Mason AS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0555-9; Mason AS, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-103; Mei J, 2011, EUPHYTICA, V177, P393, DOI 10.1007/s10681-010-0274-0; Mei J, 2010, GENET RESOUR CROP EV, V57, P687, DOI 10.1007/s10722-009-9504-5; Mei JQ, 2015, THEOR APPL GENET, V128, P639, DOI 10.1007/s00122-015-2459-3; Mirzaghaderi G, 2017, PLANT CELL REP, V36, P1277, DOI 10.1007/s00299-017-2152-x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nelson MN, 2009, THEOR APPL GENET, V119, P497, DOI 10.1007/s00122-009-1056-8; Qian W, 2006, THEOR APPL GENET, V113, P49, DOI 10.1007/s00122-006-0269-3; Qian W, 2005, THEOR APPL GENET, V110, P1187, DOI 10.1007/s00122-005-1932-9; Rahman H, 2015, CAN J PLANT SCI, V95, P29, DOI 10.4141/CJPS-2014-017; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; SAS Institute Inc, 1992, SAS STAT SOFTW CHANG; Schmidt A, 2015, DEVELOPMENT, V142, P229, DOI 10.1242/dev.102103; Shariatpanahi M.E., 2016, PLANT TISSUE CULT, P487, DOI [10.1007/978-981-10-1917-3_21, DOI 10.1007/978-981-10-1917-3, DOI 10.1007/978-981-10-1917-3_21]; Silkova OG, 2011, EUPHYTICA, V178, P415, DOI 10.1007/s10681-010-0325-6; Sora D, 2016, HEREDITY, V117, P440, DOI 10.1038/hdy.2016.69; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; U. N., 1935, Japanese Journal of Botany, V7, P389; Wen J, 2008, EUPHYTICA, V162, P81, DOI 10.1007/s10681-007-9566-4; Wen J, 2010, EUPHYTICA, V173, P99, DOI 10.1007/s10681-010-0129-8; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Yang S, 2016, THEOR APPL GENET, V129, P689, DOI 10.1007/s00122-015-2657-z; Younis A, 2014, PLANT CELL REP, V33, P215, DOI 10.1007/s00299-013-1534-y; Zhou Yong-Ming, 1995, Acta Botanica Sinica, V37, P848	48	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193548	10.1371/journal.pone.0193548	http://dx.doi.org/10.1371/journal.pone.0193548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494698	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200065
J	Wedding, LM; Lecky, J; Gove, JM; Walecka, HR; Donovan, MK; Williams, GJ; Jouffray, JB; Crowder, LB; Erickson, A; Falinski, K; Friedlander, AM; Kappel, CV; Kittinger, JN; McCoy, K; Norstrom, A; Nystrom, M; Oleson, KLL; Stamoulis, KA; White, C; Selkoe, KA				Wedding, Lisa M.; Lecky, Joey; Gove, Jamison M.; Walecka, Hilary R.; Donovan, Mary K.; Williams, Gareth J.; Jouffray, Jean-Baptiste; Crowder, Larry B.; Erickson, Ashley; Falinski, Kim; Friedlander, Alan M.; Kappel, Carrie V.; Kittinger, John N.; McCoy, Kaylyn; Norstrom, Albert; Nystrom, Magnus; Oleson, Kirsten L. L.; Stamoulis, Kostantinos A.; White, Crow; Selkoe, Kimberly A.			Advancing the integration of spatial data to map human and natural drivers on coral reefs	PLOS ONE			English	Article							COMMUNITY-BASED MANAGEMENT; MARINE PROTECTED AREAS; CLIMATE-CHANGE; KANEOHE BAY; ECOSYSTEM SERVICES; HAWAIIAN-ISLANDS; FISH ASSEMBLAGES; DECISION-MAKING; RESILIENCE; NORTHWESTERN	A major challenge for coral reef conservation and management is understanding how a wide range of interacting human and natural drivers cumulatively impact and shape these ecosystems. Despite the importance of understanding these interactions, a methodological framework to synthesize spatially explicit data of such drivers is lacking. To fill this gap, we established a transferable data synthesis methodology to integrate spatial data on environmental and anthropogenic drivers of coral reefs, and applied this methodology to a case study location-the Main Hawaiian Islands (MHI). Environmental drivers were derived from time series (2002-2013) of climatological ranges and anomalies of remotely sensed sea surface temperature, chlorophyll-a, irradiance, and wave power. Anthropogenic drivers were characterized using empirically derived and modeled datasets of spatial fisheries catch, sedimentation, nutrient input, new development, habitat modification, and invasive species. Within our case study system, resulting driver maps showed high spatial heterogeneity across the MHI, with anthropogenic drivers generally greatest and most widespread on O'ahu, where 70% of the state's population resides, while sedimentation and nutrients were dominant in less populated islands. Together, the spatial integration of environmental and anthropogenic driver data described here provides a first-ever synthetic approach to visualize how the drivers of coral reef state vary in space and demonstrates a methodological framework for implementation of this approach in other regions of the world. By quantifying and synthesizing spatial drivers of change on coral reefs, we provide an avenue for further research to understand how drivers determine reef diversity and resilience, which can ultimately inform policies to protect coral reefs.	[Wedding, Lisa M.; Walecka, Hilary R.; Crowder, Larry B.; Erickson, Ashley] Stanford Univ, Ctr Ocean Solut, Palo Alto, CA 94304 USA; [Lecky, Joey; Falinski, Kim; Oleson, Kirsten L. L.] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; [Lecky, Joey; Gove, Jamison M.] NOAA, Pacific Islands Fisheries Sci Ctr, Ecosyst Sci Div, Honolulu, HI USA; [Walecka, Hilary R.; Selkoe, Kimberly A.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Donovan, Mary K.; Friedlander, Alan M.; Stamoulis, Kostantinos A.] Univ Hawaii Manoa, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Williams, Gareth J.] Bangor Univ, Sch Ocean Sci, Anglesey, Wales; [Jouffray, Jean-Baptiste; Norstrom, Albert; Nystrom, Magnus] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Friedlander, Alan M.] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Kappel, Carrie V.; Selkoe, Kimberly A.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Kittinger, John N.] Ctr Oceans, Conservat Int, Honolulu, HI USA; [Kittinger, John N.] Arizona State Univ, Ctr Biodivers Outcomes, Julie Ann Wrigley Global Inst Sustainabil, Tempe, AZ USA; [Norstrom, Albert; Nystrom, Magnus] Royal Swedish Acad Sci, Global Econ Dynam & Biosphere Acad Programme, Stockholm, Sweden; [Stamoulis, Kostantinos A.] Curtin Univ, Dept Environm & Agr, Perth, WA, Australia; [White, Crow] Calif Polytech State Univ San Luis Obispo, Biol Sci Dept, San Luis Obispo, CA 93407 USA; [Selkoe, Kimberly A.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA	Stanford University; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Barbara; University of Hawaii System; University of Hawaii Manoa; Bangor University; Stockholm University; National Geographic Society; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Conservation International; Arizona State University; Arizona State University-Tempe; Royal Swedish Academy of Sciences; Global Economic Dynamics & Biosphere - The Erling-Persson Family Academy Program; Curtin University; California State University System; California Polytechnic State University San Luis Obispo; University of Hawaii System; University of Hawaii Manoa	Wedding, LM (corresponding author), Stanford Univ, Ctr Ocean Solut, Palo Alto, CA 94304 USA.	lwedding@stanford.edu	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Wedding, Lisa/GRY-3972-2022; Jouffray, Jean-Baptiste/AAN-1329-2020	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Wedding, Lisa/0000-0002-3782-915X; Jouffray, Jean-Baptiste/0000-0002-4105-6372; Williams, Dr Gareth J./0000-0001-7837-1619; Stamoulis, Kostantinos/0000-0003-2688-4695; Lecky, Joey/0000-0001-9364-4793; Norstrom, Albert/0000-0002-0706-9233	Gordon and Betty Moore Foundation [2897.01]; NOAA Coral Reef Conservation Program [NA13NOS482002, NA14NOS4820089, NA14NOS4820098]; United States Department of Agriculture, National Institute of Food and Agriculture [2014HI433B]; NOAA Hawaiian Islands Humpback Whale National Marine Sanctuary [004496-00002]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NOAA Hawaiian Islands Humpback Whale National Marine Sanctuary	This study was supported by the Gordon and Betty Moore Foundation (https://www.moore.org/), grant number 2897.01, and authors receiving funding included Lisa M. Wedding, Mary K. Donovan, Hilary R. Walecka, Larry B. Crowder, Ashley Erickson, Carrie V. Kappel, John N. Kittinger, Crow White and Kimberly A. Selkoe; NOAA Coral Reef Conservation Program (http://coralreef.noaa.gov/), grant numbers: NA13NOS482002 and NA14NOS4820089 and NA14NOS4820098, and authors receiving funding included Kirsten Oleson, Kim Falinski, Joey Lecky, and Mary Donovan; United States Department of Agriculture, National Institute of Food and Agriculture (https://nifa.usda.gov/), grant number: 2014HI433B, and authors receiving funding included Kim Falinski, Joey Lecky; and NOAA Hawaiian Islands Humpback Whale National Marine Sanctuary (http://hawaiihumpbackwhale.noaa.gov/), grant number: 004496-00002, and the author receiving funding was Joey Lecky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT I.A., 1999, MARINE RED ALGAE HAW; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Armitage D, 2011, GLOBAL ENVIRON CHANG, V21, P995, DOI 10.1016/j.gloenvcha.2011.04.006; Bahr KD, 2015, PEERJ, V3, DOI 10.7717/peerj.950; Bejarano S, 2017, FUNCTIONAL ECOLOGY; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkes F, 2009, J ENVIRON MANAGE, V90, P1692, DOI 10.1016/j.jenvman.2008.12.001; Boss E, 2003, LIMNOL OCEANOGR, V48, P346, DOI 10.4319/lo.2003.48.1_part_2.0346; Bremer LL, 2015, ENVIRON MANAGE, V55, P884, DOI 10.1007/s00267-014-0426-4; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carrier SD, 2012, OCEAN COAST MANAGE, V69, P291, DOI 10.1016/j.ocecoaman.2012.07.028; Cash DW, 2006, SCI TECHNOL HUM VAL, V31, P465, DOI 10.1177/0162243906287547; Cesar Herman S. J., 2004, Pacific Science, V58, P231, DOI 10.1353/psc.2004.0014; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cinner JE, 2016, REG ENVIRON CHANGE, V16, P1133, DOI 10.1007/s10113-015-0832-z; Costa B. M., 2016, 2016035 OCS BOEM; Dailer ML, 2010, MAR POLLUT BULL, V60, P655, DOI 10.1016/j.marpolbul.2009.12.021; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; DeMartini EE, 2004, MAR ECOL PROG SER, V271, P281, DOI 10.3354/meps271281; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; Done TJ, 1999, AM ZOOL, V39, P66; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Falinski KA, THESIS; Falinski KA, 2016, OC SCI M 2016; Friedlander A, 2003, CONSERV BIOL, V17, P1769, DOI 10.1111/j.1523-1739.2003.00338.x; Friedlander A, 2008, 73 NOAA NOS NCCOS; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Friedlander AM, 2014, ADV MAR BIOL, V69, P153, DOI 10.1016/B978-0-12-800214-8.00005-0; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 2002, J FISH BIOL, V60, P28, DOI 10.1006/jfbi.2001.1808; Friedlander AM, 1997, FISH RES, V32, P33, DOI 10.1016/S0165-7836(97)00038-6; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Friedlander AM, 2017, AQUAT CONSERV, P1; Friedlander AM, 2014, MARINE HIST ECOLOGY, V24, P91; Gove JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10581; Gove JM, 2015, MAR ECOL PROG SER, V522, P33, DOI 10.3354/meps11118; Gove JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061974; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2015, NAT COMMUN, P6; Hamel P, 2015, SCI TOTAL ENVIRON, V524, P166, DOI 10.1016/j.scitotenv.2015.04.027; Hampton SE, 2013, FRONT ECOL ENVIRON, V11, P156, DOI 10.1890/120103; Heron SF, 2014, J OPER OCEANOGR, V7, P3, DOI 10.1080/1755876X.2014.11020154; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUNTER CL, 1995, B MAR SCI, V57, P501; Izuka SK, 2010, STREAMFLOW SUSPENDED; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; KAY EA, 1987, TRENDS ECOL EVOL, V2, P183, DOI 10.1016/0169-5347(87)90017-6; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Kittinger JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123856; Kittinger JN, 2014, FRONT ECOL ENVIRON, V12, P448, DOI 10.1890/130267; Kittinger JN, 2012, ECOL SOC, V17, DOI 10.5751/ES-05115-170417; Kleypas JA, 1999, AM ZOOL, V39, P146; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Lang DJ, 2012, SUSTAIN SCI, V7, P25, DOI 10.1007/s11625-011-0149-x; Le Cornu E, 2014, CONSERV BIOL, V28, P902, DOI 10.1111/cobi.12310; Lester SE, 2013, MAR POLICY, V38, P80, DOI 10.1016/j.marpol.2012.05.022; Li N, 2016, OCEAN MODEL, V100, P78, DOI 10.1016/j.ocemod.2016.02.001; Lorenzen K, 2010, B MAR SCI, V86, P169; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; Maragos James E., 2004, Pacific Science, V58, P211, DOI 10.1353/psc.2004.0020; Mayer-Sch?nber V., 2013, BIG DATA REVOLUTION; McClanahan TR, 2007, MAR POLLUT BULL, V54, P1947, DOI 10.1016/j.marpolbul.2007.09.023; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; McCoy K., 2015, THESIS; Meyer A.L., 2008, THESIS U HAWAII HONO; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Norse Elliott A., 2005, P302; Norse EA, 2010, B MAR SCI, V86, P179; Norstrom AV, 2016, FRONT ECOL ENVIRON, V14, P490, DOI 10.1002/fee.1427; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Nystrom M, 2012, ECOSYSTEMS, V15, P695, DOI 10.1007/s10021-012-9530-6; Oleson KLL, 2017, J ENVIRON MANAGE, V191, P8, DOI 10.1016/j.jenvman.2016.12.067; Olsen E, 2011, J COAST CONSERV, V15, P257, DOI 10.1007/s11852-010-0108-1; Ostrander CE, 2008, ESTUAR COAST, V31, P192, DOI 10.1007/s12237-007-9001-z; RANDALL JE, 1987, B MAR SCI, V41, P490; Randall JE, 2007, REEF SHORE FISHES HA; Rassweiler A, 2014, P ROY SOC LOND B BIO, P281; Rocha J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0273; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Rooney John J., 2008, V1, P519, DOI 10.1007/978-1-4020-6847-8_13; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shackeroff J. M., 2009, ECOSYSTEM BASED MANA, P33; Sharp R, 2015, VEST 3 2 USERS GUIDE; Smith JE, 2005, MAR ECOL PROG SER, V302, P77, DOI 10.3354/meps302077; Smith Jennifer E., 2004, Pacific Science, V58, P325, DOI 10.1353/psc.2004.0023; Smith Jennifer E., 2002, Pacific Science, V56, P299, DOI 10.1353/psc.2002.0030; Smith M. Kimberly, 1994, U S National Marine Fisheries Service Marine Fisheries Review, V55, P34; Stamoulis KA, MARINE BIOGEOGRAPHIC, P156; Stamoulis KA, 2015, OCEAN COAST MANAGE, V116, P214, DOI 10.1016/j.ocecoaman.2015.07.011; Stamoulis KA, 2013, FISH RES, V144, P2, DOI 10.1016/j.fishres.2012.09.016; Stender Y, 2014, PEERJ, V2, DOI 10.7717/peerj.300; Stimson J, 2001, CORAL REEFS, V19, P343, DOI 10.1007/s003380000123; Storlazzi CD, 2009, MAR GEOL, V264, P140, DOI 10.1016/j.margeo.2009.05.002; Storlazzi CD, 2004, CONT SHELF RES, V24, P1397, DOI 10.1016/j.csr.2004.02.010; Tissot BN, 2009, COAST MANAGE, V37, P255, DOI 10.1080/08920750902851096; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; White C, 2012, P NATL ACAD SCI USA, V109, P4696, DOI 10.1073/pnas.1114215109; Whittier R.B., 2014, HUMAN HLTH ENV RISK; Whittier RB, 2009, HUMAN ENV RISK RANKI; Wiegner TN, 2009, LIMNOLOGY OCEANOGRAP, P54; Williams GJ, 2013, PEERJ, V1, DOI 10.7717/peerj.81; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516	115	36	37	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0189792	10.1371/journal.pone.0189792	http://dx.doi.org/10.1371/journal.pone.0189792			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494613	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200002
J	Macdiarmid, JI; Clark, H; Whybrow, S; de Ruiter, H; McNeill, G				Macdiarmid, Jennie I.; Clark, Heather; Whybrow, Stephen; de Ruiter, Henri; McNeill, Geraldine			Assessing national nutrition security: The UK reliance on imports to meet population energy and nutrient recommendations	PLOS ONE			English	Article							SELF-SUFFICIENCY; FOOD SECURITY; SUPPLIES; BALANCE	Nutrition security describes the adequacy of the food supply to meet not only energy but also macronutrient and micronutrient requirements for the population. The aim of this study was to develop a method to assess trends in national nutrition security and the contribution of imports to nutrition security, using the UK as a case study. Food supply data from FAO food balance sheets and national food composition tables were used to estimate the nutrient content of domestically produced food, imported food and exported food. Nutrition security was defined as the total nutrient supply (domestic production, minus exports, plus imports) to meet population-level nutrient requirements. The results showed that the UK was nutrition secure over the period 1961-2011 for energy, macronutrients and key micronutrients, with the exception of total carbohydrates and fibre, which may be due to the loss of fibre incurred by processing cereals into refined products. The supply of protein exceeded population requirements and could be met with domestic production alone. Even excluding all meat there was sufficient protein for population requirements. The supply of total fat, saturated fat and sugar considerably exceeded the current dietary recommendation. As regards nutrition security in 2010, the UK was reliant on imported foods to meet energy, fibre, total carbohydrate, iron, zinc and vitamin A requirements. This analysis demonstrates the importance of including nutrients other than energy to determine the adequacy of the food supply. The methodology also provides an alternative perspective on food security and self-sufficiency by assessing the dependency on imports to meet population level nutritional requirements.	[Macdiarmid, Jennie I.; Whybrow, Stephen] Univ Aberdeen, Rowett Inst, Aberdeen, Scotland; [Clark, Heather; McNeill, Geraldine] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [de Ruiter, Henri] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [de Ruiter, Henri] James Hutton Inst, Informat & Computat Sci Grp, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; James Hutton Institute	Macdiarmid, JI (corresponding author), Univ Aberdeen, Rowett Inst, Aberdeen, Scotland.	j.macdiarmid@abdn.ac.uk		McNeill, Geraldine/0000-0003-0373-650X; de Ruiter, Henri/0000-0001-7352-9317	Scottish Government's Rural and Environment Science Analytical Services Strategic Research Programme; Fondation Daniel Nina Carasso; Belmont Forum/FACCE-JPI [NE/M021327/1]; Natural Environment Research Council [NE/M021327/1] Funding Source: researchfish; NERC [NE/M021327/1] Funding Source: UKRI	Scottish Government's Rural and Environment Science Analytical Services Strategic Research Programme; Fondation Daniel Nina Carasso; Belmont Forum/FACCE-JPI; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The author(s) received no specific funding for this work. JIM and SW acknowledge funding from the Scottish Government's Rural and Environment Science Analytical Services Strategic Research Programme. HC acknowledges funding from the Fondation Daniel & Nina Carasso. This work contributes to the Belmont Forum/FACCE-JPI funded DEVIL project (Natural Environment Research Council grant number NE/M021327/1) (JIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrowicz L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165797; Alexander P, 2017, GLOB FOOD SECUR-AGR, V15, P22, DOI 10.1016/j.gfs.2017.04.001; [Anonymous], 2015, MCCANCE WIDD COMP FO; Augustin MA, 2016, TRENDS FOOD SCI TECH, V56, P115, DOI 10.1016/j.tifs.2016.08.005; Bailey R, CHOKEPOINTS VULNERAB; Beal T, 2017, PLOS ONE; Clapp J, 2017, FOOD POLICY, V66, P88, DOI 10.1016/j.foodpol.2016.12.001; D'Odorico P, 2014, EARTHS FUTURE, V2, P458, DOI 10.1002/2014EF000250; De Ruiter H, 2016, HUMAN ENVIRON INTERA, V6, P247, DOI 10.1007/978-3-319-33628-2_15; Del Gobbo LC, 2015, AM J CLIN NUTR, V101, P1038, DOI 10.3945/ajcn.114.087403; Department for Environment and Rural Affairs, 2012, JOINT ANN AGR DEP UK; Department for Environment Food and Rural Affairs, AGR UK 2015; Department for Environment Food & Rural Affairs, 2010, HOUS FOOD DRINK WAST; Department of Health, 1991, DIET REF VAL FOOD EN; FALLOWS SJ, 1982, AGR ADMIN EXT, V11, P107, DOI 10.1016/0309-586X(82)90055-3; Fischer C.G., 2016, DEV NATL HLTH SUSTAI; Food and Agriculture Organization of the United Nations, 2017, DEF CLASS COMM; Food and Agriculture Organization of the United Nations, 2001, FOOD BAL SHEETS HDB; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gomez MI, 2013, FOOD POLICY, V42, P129, DOI 10.1016/j.foodpol.2013.06.009; HALLBERG L, 1987, ANN NY ACAD SCI, V498, P324, DOI 10.1111/j.1749-6632.1987.tb23771.x; Howard Emma., 2015, GUARDIAN; Hubbard LJ, 2013, FOOD POLICY, V43, P142, DOI 10.1016/j.foodpol.2013.08.006; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Jongeneel RA, 2016, STUDY NATL FARMERS U; Joy EJM, 2014, PHYSIOL PLANTARUM, V151, P208, DOI 10.1111/ppl.12144; Lang T., 2016, HORTICULTURE UK POTE; Millward DJ, 2013, NUTR RES REV, V26, P89, DOI 10.1017/S095442241300005X; Myers SS, 2014, NATURE, V510, P139, DOI 10.1038/nature13179; Nijdam D, 2012, FOOD POLICY, V37, P760, DOI 10.1016/j.foodpol.2012.08.002; Office for National Statistics, 2010, LIV COSTS FOOD SURV; Office for National Statistics, 2017, POP EST UK ENGL WAL; OHAGAN JP, 1976, FOOD POLICY, V1, P355, DOI 10.1016/0306-9192(76)90071-3; Porkka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082714; Public Health England, 2015, NAT DIET NUTR SURV R; Scientific Advisory Committee on Nutrition, CARB HLTH REP 2015; Scientific Advisory Committee on Nutrition (SACN), 2011, DIET REF VAL EN; Serra-Majem L, 2003, J EPIDEMIOL COMMUN H, V57, P74, DOI 10.1136/jech.57.1.74; Smith MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146976; Suweis S, 2015, P NATL ACAD SCI USA, V112, P6902, DOI 10.1073/pnas.1507366112; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; UN DESA, 2015, WORLD POPULATION PRO; United Nations, SUST DEV GOALS; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wuehler SE, 2005, PUBLIC HEALTH NUTR, V8, P812, DOI 10.1079/PHN2005724	46	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192649	10.1371/journal.pone.0192649	http://dx.doi.org/10.1371/journal.pone.0192649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489830	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000037
J	Steele, JS; Bush, K; Stowe, ZN; James, GA; Smitherman, S; Kilts, CD; Cisler, J				Steele, James S.; Bush, Keith; Stowe, Zachary N.; James, George A.; Smitherman, Sonet; Kilts, Clint D.; Cisler, Josh			Implicit emotion regulation in adolescent girls: An exploratory investigation of Hidden Markov Modeling and its neural correlates	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; STROOP TASK; INDEPENDENT COMPONENTS; SPEECH RECOGNITION; ARTIFACT REMOVAL; NATIONAL SAMPLE; NETWORK MODEL; FMRI DATA	Numerous data demonstrate that distracting emotional stimuli cause behavioral slowing (i.e. emotional conflict) and that behavior dynamically adapts to such distractors. However, the cognitive and neural mechanisms that mediate these behavioral findings are poorly understood. Several theoretical models have been developed that attempt to explain these phenomena, but these models have not been directly tested on human behavior nor compared. A potential tool to overcome this limitation is Hidden Markov Modeling (HMM), which is a computational approach to modeling indirectly observed systems. Here, we administered an emotional Stroop task to a sample of healthy adolescent girls (N = 24) during fMRI and used HMM to implement theoretical behavioral models. We then compared the model fits and tested for neural representations of the hidden states of the most supported model. We found that a modified variant of the model posited by Mathews et al. (1998) was most concordant with observed behavior and that brain activity was related to the model-based hidden states. Particularly, while the valences of the stimuli themselves were encoded primarily in the ventral visual cortex, the model-based detection of threatening targets was associated with increased activity in the bilateral anterior insula, while task effort (i.e. adaptation) was associated with reduction in the activity of these areas. These findings suggest that emotional target detection and adaptation are accomplished partly through increases and decreases, respectively, in the perceived immediate relevance of threatening cues and also demonstrate the efficacy of using HMM to apply theoretical models to human behavior.	[Steele, James S.; Bush, Keith; James, George A.; Smitherman, Sonet; Kilts, Clint D.; Cisler, Josh] Univ Arkansas Med Sci, Psychiat Res Inst, Brain Imaging Res Ctr, Little Rock, AR 72205 USA; [Bush, Keith] Univ Arkansas, Dept Comp Sci, Little Rock, AR 72204 USA; [Stowe, Zachary N.] Univ Arkansas Med Sci, Psychiat Res Inst, Womens Mental Hlth Program, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas System; University of Arkansas Medical Sciences	Steele, JS (corresponding author), Univ Arkansas Med Sci, Psychiat Res Inst, Brain Imaging Res Ctr, Little Rock, AR 72205 USA.	steelejs@upmc.edu	James, George Andrew/J-6903-2015; Cisler, Josh/L-8940-2016	James, George Andrew/0000-0002-2940-2746; Steele, James/0000-0002-4773-9668; Bush, Keith/0000-0001-7919-1310	National Institute on Drug Abuse [T32 DA022981-02]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022981] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was performed in the Brain Imaging Research Center (BIRC) at the University of Arkansas for Medical Sciences. Portions of this work were supported through grant T32 DA022981-02. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors report no conflict of interest.; This work was supported by the National Institute on Drug Abuse, T32 DA022981-02 (http://www.drugabuse.gov/) to JSS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Anderson JR, 2012, HUM BRAIN MAPP, V33, P2650, DOI 10.1002/hbm.21391; Anderson JR, 2012, NEUROIMAGE, V60, P633, DOI 10.1016/j.neuroimage.2011.12.025; Anderson JR, 2010, P NATL ACAD SCI USA, V107, P7018, DOI 10.1073/pnas.1000942107; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Borst JP, 2015, NEUROIMAGE, V108, P60, DOI 10.1016/j.neuroimage.2014.12.029; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Carter CS, 2001, BRAIN COGNITION, V47, P66; Cisler JM, 2013, PSYCHIAT RES-NEUROIM, V214, P238, DOI 10.1016/j.pscychresns.2013.06.003; Cisler JM, 2011, CLIN PSYCHOL REV, V31, P817, DOI 10.1016/j.cpr.2011.03.007; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Cooke M, 2001, SPEECH COMMUN, V34, P267, DOI 10.1016/S0167-6393(00)00034-0; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Cservenka A, 2015, BRAIN COGNITION, V99, P135, DOI 10.1016/j.bandc.2015.06.002; DYER FN, 1973, MEM COGNITION, V1, P106, DOI 10.3758/BF03198078; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Etkin A, 2011, AM J PSYCHIAT, V168, P968, DOI 10.1176/appi.ajp.2011.10091290; Finkelhor D, 2007, DEV PSYCHOPATHOL, V19, P149, DOI 10.1017/S0954579407070083; Finkelhor D, 2009, PEDIATRICS, V124, P1411, DOI 10.1542/peds.2009-0467; FRIJDA NH, 1986, B BRIT PSYCHOL SOC, V39, pA75; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Grinband J, 2011, NEUROIMAGE, V57, P303, DOI 10.1016/j.neuroimage.2010.12.027; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; HANNAN EJ, 1979, J ROY STAT SOC B MET, V41, P190; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kilpatrick DG, 2003, J CONSULT CLIN PSYCH, V71, P692, DOI 10.1037/0022-006X.71.4.692; Kilpatrick DG, 2000, J CONSULT CLIN PSYCH, V68, P19, DOI 10.1037/0022-006X.68.1.19; MACKO KA, 1982, SCIENCE, V218, P394, DOI 10.1126/science.7123241; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MATHEWS A, 1994, ANNU REV PSYCHOL, V45, P25, DOI 10.1146/annurev.psych.45.1.25; Mathews A, 1998, COGNITIVE THER RES, V22, P539, DOI 10.1023/A:1018738019346; McKenna FP, 2004, J EXP PSYCHOL LEARN, V30, P382, DOI 10.1037/0278-7393.30.2.382; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Murphy K., 2001, BAYES NET TOOLBOX MA; Neta M, 2014, NEUROIMAGE, V99, P59, DOI 10.1016/j.neuroimage.2014.05.053; Nooner KB, 2012, TRAUMA VIOLENCE ABUS, V13, P153, DOI 10.1177/1524838012447698; Phaf RH, 2007, J BEHAV THER EXP PSY, V38, P184, DOI 10.1016/j.jbtep.2006.10.008; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; TZELGOV J, 1992, MEM COGNITION, V20, P727, DOI 10.3758/BF03202722; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Weinberg A, 2009, PSYCHOL ASSESSMENT, V21, P616, DOI 10.1037/a0016669; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wyble B, 2008, COGNITION EMOTION, V22, P1019, DOI 10.1080/02699930701597627; Zeman J, 2006, J DEV BEHAV PEDIATR, V27, P155, DOI 10.1097/00004703-200604000-00014; Zeng WM, 2009, NEUROIMAGE, V46, P1041, DOI 10.1016/j.neuroimage.2009.02.048	63	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192318	10.1371/journal.pone.0192318	http://dx.doi.org/10.1371/journal.pone.0192318			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489856	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000022
J	Kamal, AM; Fessler, MB; Chowdhury, SM				Kamal, Abu Hena M.; Fessler, Michael B.; Chowdhury, Saiful M.			Comparative and network-based proteomic analysis of low dose ethanol- and lipopolysaccharide-induced macrophages	PLOS ONE			English	Article							IMMUNE-RESPONSE; LIVER; ALCOHOL; PROTEINS; LPS; CONSUMPTION; SEPSIS; CELLS; PHOSPHOGLUCOMUTASE; IDENTIFICATION	Macrophages are specialized phagocytes that play an essential role in inflammation, immunity, and tissue repair. Profiling the global proteomic response of macrophages to microbial molecules such as bacterial lipopolysaccharide is key to understanding fundamental mechanisms of inflammatory disease. Ethanol is a widely abused substance that has complex effects on inflammation. Reports have indicated that ethanol can activate or inhibit the lipopolysaccharide receptor, Toll-like Receptor 4, in different settings, with important consequences for liver and neurologic inflammation, but the underlying mechanisms are poorly understood. To profile the sequential effect of low dose ethanol and lipopolysaccharide on macrophages, a gel-free proteomic technique was applied to RAW 264.7 macrophages. Five hundred four differentially expressed proteins were identified and quantified with high confidence using >= 5 peptide spectral matches. Among these, 319 proteins were shared across all treatment conditions, and 69 proteins were exclusively identified in ethanol-treated or lipopolysaccharide-stimulated cells. The interactive impact of ethanol and lipopolysaccharide on the macrophage proteome was evaluated using bioinformatics tools, enabling identification of differentially responsive proteins, protein interaction networks, disease- and function-based networks, canonical pathways, and upstream regulators. Five candidate protein coding genes (PGM2, ISYNA1, PARP1, and PSAP) were further validated by qRT-PCR that mostly related to glucose metabolism and fatty acid synthesis pathways. Taken together, this study describes for the first time at a systems level the interaction between ethanol and lipopolysaccharide in the proteomic programming of macrophages, and offers new mechanistic insights into the biology that may underlie the impact of ethanol on infectious and inflammatory disease in humans.	[Kamal, Abu Hena M.; Chowdhury, Saiful M.] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA; [Fessler, Michael B.] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	University of Texas System; University of Texas Arlington; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Chowdhury, SM (corresponding author), Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA.	schowd@uta.edu	Fessler, Michael B/C-6323-2019	Fessler, Michael B/0000-0002-8262-8613; Kamal, Abu Hena Mostafa/0000-0001-6750-0729	NIGMS, NIH [1UA5GM113216-01]; UT Proteomics Core Facility Network; Intramural Research Program of the National Institute of Environmental Health Sciences, NIH [Z01 ES102005]; University of Texas at Arlington; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102005, ZIAES102005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [UA5GM113216] Funding Source: NIH RePORTER	NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UT Proteomics Core Facility Network; Intramural Research Program of the National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Texas at Arlington; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge funding from 1UA5GM113216-01, NIGMS, NIH, and also funding from the UT Proteomics Core Facility Network for a mass spectrometer. Dr. Michael Fessler is funded by the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH (Z01 ES102005). We acknowledge start-up funding to Dr. Chowdhury from the University of Texas at Arlington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Ding, 2015, J IMMUNOL, V148, P2853; Alfonso-Loeches S, 2016, NEUROCHEM RES, V41, P193, DOI 10.1007/s11064-015-1760-5; Bala S, 2012, J LEUKOCYTE BIOL, V92, P611, DOI 10.1189/jlb.0112050; Barros FR, 2012, ALCOHOL ALCOHOLISM, V47, P677, DOI 10.1093/alcalc/ags081; Bhatty M, 2011, ALCOHOL, V45, P795, DOI 10.1016/j.alcohol.2011.07.003; Blanco AM, 2008, J NEUROCHEM, V106, P625, DOI 10.1111/j.1471-4159.2008.05425.x; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; Chakrabarty JK, 2016, ANAL CHEM, V88, P10215, DOI 10.1021/acs.analchem.6b02886; Chakravortty D, 2000, BBA-MOL BASIS DIS, V1500, P125, DOI 10.1016/S0925-4439(99)00098-8; Chhetri DR, 2012, APPL BIOCHEM BIOTECH, V167, P2269, DOI 10.1007/s12010-012-9767-8; Chowdhury SM, 2015, MOL CELL PROTEOMICS, V14, P1859, DOI 10.1074/mcp.M114.045179; Dai Q, 2006, ALCOHOL CLIN EXP RES, V30, P1436, DOI 10.1111/j.1530-0277.2006.00172.x; Dolganiuc A, 2006, ALCOHOL CLIN EXP RES, V30, P76, DOI 10.1111/j.1530-0277.2006.00003.x; Dolganiuc A, 2009, WORLD J GASTROENTERO, V15, P1168, DOI 10.3748/wjg.15.1168; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fernandez-Lizarbe S, 2008, MOL IMMUNOL, V45; Fernandez-Lizarbe S, 2013, J NEUROCHEM, V126, P261, DOI 10.1111/jnc.12276; Gadgil HS, 2003, PROTEOMICS, V3, P1767, DOI 10.1002/pmic.200300532; Gallego-Iradi MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142144; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Gu S, 2008, PROTEOMICS, V8, P3061, DOI 10.1002/pmic.200700715; Guo MM, 2015, PROTEOMICS, V15, P3169, DOI 10.1002/pmic.201400431; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; HAYASHI E, 1974, BIOCHIM BIOPHYS ACTA, V360, P146, DOI 10.1016/0005-2760(74)90164-7; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Joseph RA, 2008, HEPATOLOGY, V47, P1745, DOI 10.1002/hep.22014; Kamal AM, 2015, J PROTEOME RES, V14, P2219, DOI 10.1021/acs.jproteome.5b00007; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Karinch AM, 2008, AM J PHYSIOL-ENDOC M, V295, pE3, DOI 10.1152/ajpendo.00026.2008; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lambert JC, 2003, J PHARMACOL EXP THER, V305, P880, DOI 10.1124/jpet.102.047852; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lin JH, 2017, NUCLEIC ACIDS RES, V45, P3707, DOI 10.1093/nar/gkw1285; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Massey VL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00193; MCDONOUGH KH, 1991, AM J PHYSIOL, V260, pH1857, DOI 10.1152/ajpheart.1991.260.6.H1857; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Meyer RC, 2014, BRAIN RES, V1585, P1, DOI 10.1016/j.brainres.2014.08.022; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; MICHAELSSON E, 1995, EUR J IMMUNOL, V25, P2234, DOI 10.1002/eji.1830250818; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; O'Neill LAJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001299; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Owens T, 2005, BRAIN RES REV, V48, P178, DOI 10.1016/j.brainresrev.2004.12.007; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Patel PC, 2009, MOL CELL PROTEOMICS, V8, P2500, DOI 10.1074/mcp.M900190-MCP200; Pruett SB, 2004, ALCOHOL, V33; Pruett SB, 2010, TOXICOL SCI, V117, P314, DOI 10.1093/toxsci/kfq215; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Sanchez RG, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-40; Sardiu ME, 2009, J PROTEOME RES, V8, P2944, DOI 10.1021/pr900073d; Schaffert CS, 2009, WORLD J GASTROENTERO, V15, P1209, DOI 10.3748/wjg.15.1209; SCHENKER S, 1995, ALCOHOL CLIN EXP RES, V19, P1364, DOI 10.1111/j.1530-0277.1995.tb01626.x; Seo JY, 2005, J PHARM PHARMACOL, V57, P911, DOI 10.1211/0022357056497; Shi L, 2009, INFECT IMMUN, V77, P3227, DOI 10.1128/IAI.00063-09; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Shukla SD, 2013, ALCOHOL CLIN EXP RES, V37, P550, DOI 10.1111/acer.12011; Stuhlmuller B, 2000, ARTHRITIS RHEUM, V43, P775, DOI 10.1002/1529-0131(200004)43:4<775::AID-ANR8>3.0.CO;2-7; Suh N, 1998, CANCER, P717; Swearingen KE, 2010, J PROTEOME RES, V9, P2412, DOI 10.1021/pr901124u; Szabo G, 2010, DIGEST DIS, V28, P737, DOI 10.1159/000324281; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang WX, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev046; Wiley DJ, 2009, J BIOL CHEM, V284, P24744, DOI 10.1074/jbc.M109.010140; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Woo SH, 2014, FISH SHELLFISH IMMUN, V41, P317, DOI 10.1016/j.fsi.2014.09.012; Yokoe T, 2010, ANN SURG ONCOL, V17, P821, DOI 10.1245/s10434-009-0795-8; Zhang AH, 2013, APPL BIOCHEM BIOTECH, V170, P774, DOI 10.1007/s12010-013-0238-7; Zhang XL, 2006, ELECTROPHORESIS, V27, P1659, DOI 10.1002/elps.200500736; Zhang YQ, 2016, AM J PATHOL, V186, P3117, DOI 10.1016/j.ajpath.2016.08.016; Zhou C, 2013, ALCOHOL, V47, P231, DOI 10.1016/j.alcohol.2013.01.003; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014	81	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0193104	10.1371/journal.pone.0193104	http://dx.doi.org/10.1371/journal.pone.0193104			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481576	Green Published, Green Submitted, gold			2022-12-27	WOS:000426202700009
J	Gray, MJ; Spatz, JA; Carter, ED; Yarber, CM; Wilkes, RP; Miller, DL				Gray, Matthew J.; Spatz, Jennifer A.; Carter, E. Davis; Yarber, Christian M.; Wilkes, Rebecca P.; Miller, Debra L.			Poor biosecurity could lead to disease outbreaks in animal populations	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; RANAVIRUS INFECTION; ACINETOBACTER-BAUMANNII; NORTH-AMERICA; GLOVES; AMPHIBIANS; PATHOGENS; TADPOLES; CHYTRIDIOMYCOSIS; CONTAMINATION	Human-mediated disease outbreaks due to poor biosecurity practices when processing animals in wild populations have been suspected. We tested whether not changing nitrile gloves between processing wood frog (Lithobates sylvaticus) tadpoles and co-housing individuals increased pathogen transmission and subsequent diseased-induced mortality caused by the emerging pathogen, ranavirus. We found that not changing gloves between processing infected and uninfected tadpoles resulted in transmission of ranavirus and increased the risk of mortality of uninfected tadpoles by 30X. Co-housing tadpoles for only 15 minutes with 10% of individuals infected resulted in ranavirus transmission and 50% mortality of uninfected tadpoles. More extreme mortality was observed when the co-housing infection prevalence was >10%. Our results illustrate that human-induced disease outbreaks due to poor biosecurity practices are possible in wild animal populations.	[Gray, Matthew J.; Spatz, Jennifer A.; Carter, E. Davis; Yarber, Christian M.; Miller, Debra L.] Univ Tennessee, Inst Agr, Ctr Wildlife Hlth, Knoxville, TN 37901 USA; [Wilkes, Rebecca P.] Univ Georgia, Vet Diagnost & Invest Lab, Tifton, GA USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Georgia; University of Georgia	Gray, MJ (corresponding author), Univ Tennessee, Inst Agr, Ctr Wildlife Hlth, Knoxville, TN 37901 USA.	mgray11@utk.edu		Gray, Matthew/0000-0001-8243-9217	USDA National Institute of Food and Agriculture [1012932]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by the USDA National Institute of Food and Agriculture (Hatch Project 1012932) to MJG and DLM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, HERPETOL REV; Birnbach DJ, 2015, ANESTH ANALG, V120, P848, DOI 10.1213/ANE.0000000000000230; Brunner J.L., 2015, RANAVIRUSES LETHAL P, P71, DOI [10.1007/978-3-319-13755-1_4, DOI 10.1007/978-3-319-13755-1_4]; Brunner JL, 2017, ECOLOGY, V98, P576, DOI 10.1002/ecy.1644; Bryan LK, 2009, DIS AQUAT ORGAN, V84, P89, DOI 10.3354/dao02036; Cashins Scott D., 2008, Herpetological Review, V39, P298; Claytor SC, 2017, VIROLOGY, V511, P330, DOI 10.1016/j.virol.2017.07.028; Cox D. R., 1984, ANAL SURVIVAL DATA; Cunningham AA, 2003, J PARASITOL, V89, P78; Gerhold R, 2016, WILDLIFE SOC B, V40, P25, DOI 10.1002/wsb.638; Gosner K. L., 1960, Herpetologica, V16, P183; Gray MJ, 2012, DIS AQUAT ORGAN, V99, P1, DOI 10.3354/dao02436; Gray MJ, WETLAND TECHNIQUES, V2; Gray MJ, 2015, RANAVIRUSES LETHAL P; Gray MJ, 2015, RANAVIRUSES, P209; Greene C, 2015, AM J INFECT CONTROL, V43, P928, DOI 10.1016/j.ajic.2015.05.008; Greer Amy L., 2009, Herpetological Review, V40, P145; Gutleb AC, 2001, ENVIRON TOXICOL PHAR, V10, P119, DOI 10.1016/S1382-6689(01)00091-6; Haislip NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022307; Harp EM, 2006, J WILDLIFE DIS, V42, P307, DOI 10.7589/0090-3558-42.2.307; Hoverman JT, 2011, ECOHEALTH, V8, P301, DOI 10.1007/s10393-011-0717-7; Hoverman JT, 2010, DIS AQUAT ORGAN, V89, P97, DOI 10.3354/dao02200; Jager KJ, 2008, KIDNEY INT, V74, P560, DOI 10.1038/ki.2008.217; Johnson AF, 2014, DIS AQUAT ORGAN, V111, P129, DOI 10.3354/dao02774; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Officer K, 2014, J VET DIAGN INVEST, V26, P705, DOI 10.1177/1040638714547256; Leopardi S, 2015, CURR BIOL, V25, pR217, DOI 10.1016/j.cub.2015.01.047; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Mendez D, 2008, DIS AQUAT ORGAN, V82, P97, DOI 10.3354/dao01975; Miller DL, 2007, EMERG INFECT DIS, V13, P342, DOI 10.3201/eid1302.061073; Miller DL., 2015, RANAVIRUSES, P171, DOI DOI 10.1007/978-3-319-13755-1_7; Monaghan JM, 2016, LETT APPL MICROBIOL, V62, P299, DOI 10.1111/lam.12549; Munro J, 2016, J WILDLIFE DIS, V52, P138, DOI 10.7589/2015-02-033; Oh JK, 2016, J FOOD ENG, V187, P82, DOI 10.1016/j.jfoodeng.2016.04.018; Pedrosa PBS, 2011, INT J INFECT DIS, V15, pE366, DOI 10.1016/j.ijid.2011.03.005; Pessier A.P., 2017, MANUAL CONTROL INFEC; Phillott AD, 2010, DIS AQUAT ORGAN, V92, P175, DOI 10.3354/dao02162; Picco AM, 2007, J WILDLIFE DIS, V43, P286, DOI 10.7589/0090-3558-43.2.286; Reitzel R, 2014, AM J INFECT CONTROL, V42, P55, DOI 10.1016/j.ajic.2013.07.005; Retallick RWR, 2006, DIS AQUAT ORGAN, V72, P77, DOI 10.3354/dao072077; Robertson LS, 2013, DIS AQUAT ORGAN, V104, P225, DOI 10.3354/dao02601; Rollins-Smith LA, 2017, DEV COMP IMMUNOL, V66, P111, DOI 10.1016/j.dci.2016.07.002; Schmeller DS, 2011, LAB ANIM-UK, V45, P25, DOI 10.1258/la.2010.010101; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Tarantola A, 2006, AM J INFECT CONTROL, V34, P367, DOI 10.1016/j.ajic.2004.11.011; Tomas ME, 2015, JAMA INTERN MED, V175, P1904, DOI 10.1001/jamainternmed.2015.4535; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x; Wobeser G.A, 2006, ESSENTIALS DIS WILD; Ye D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0917-9	49	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3								10.1371/journal.pone.0193243	http://dx.doi.org/10.1371/journal.pone.0193243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513691	gold, Green Submitted, Green Published			2022-12-27	WOS:000426896800047
J	Bierings, RAJM; Kuiper, M; van Berkel, CM; Overkempe, T; Jansonius, NM				Bierings, Ronald A. J. M.; Kuiper, Marleen; van Berkel, Casper M.; Overkempe, Tom; Jansonius, Nomdo M.			Foveal light and dark adaptation in patients with glaucoma and healthy subjects: A case-control study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; AGE-RELATED-CHANGE; SENSITIVITY; FREQUENCY; SENSE	Introduction To determine whether foveal light and dark adaptation are affected in glaucoma. Methods Case-control study with 23 glaucoma patients and 51 controls. Light and dark adaptation were measured twice. After 10 minutes pre-adaptation to 0.0032 cd/m2, the background luminance increased stepwise to 320 (5 log unit step) or 10,000 cd/m2 (6.5 log unit step) for 10 minutes, then it decreased back to 0.0032 cd/m2 for 30 minutes. Foveal contrast sensitivity [CS]) as a function of time was determined using a 1.15 degree increment. Time resolution of the experiments was 30 seconds. Multiple linear regression was used to analyse the effect of glaucoma on the CS plateau and adaptation time (time to reach the plateau minus 3 dB); analyses were adjusted for age and gender. Results After light adaptation to 320 and 10,000 cd/m2, glaucoma patients had a 0.22 (P<0.001) and 0.13 (P = 0.010) log unit lower CS plateau than controls, respectively. After dark adaptation, this difference was 0.21 (P = 0.018) and 0.30 (P<0.001) log unit, respectively. Light adaptation occurred too fast to determine an accurate light adaptation time. Dark adaptation times of glaucoma patients and controls were similar, for both the 5 (7.2 versus 5.5 minutes; P = 0.10) and the 6.5 (18.2 versus 16.6 minutes; P = 0.14) log unit step. Conclusion After a sudden increase or decrease in luminance, the logCS adaptation curves of glaucoma patients are shifted downwards compared to the curves of healthy subjects. Glaucoma patients have a lower CS plateau than healthy subjects, for both light and dark adaptation; dark adaptation times are similar.	[Bierings, Ronald A. J. M.; Kuiper, Marleen; van Berkel, Casper M.; Overkempe, Tom; Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands	University of Groningen	Jansonius, NM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	n.m.jansonius@umcg.nl		Jansonius, Nomdo/0000-0002-6495-6568	Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands [2012-09, 2013-23]	Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands(Netherlands Government)	Funded by Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen, the Netherlands (NJ; grant numbers 2012-09 and 2013-23) to NMJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov I, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-20; BAKER HD, 1949, J OPT SOC AM, V39, P172, DOI 10.1364/JOSA.39.000172; Bierings RAJM, LIGHTING RE IN PRESS; Bierings RAJM, ACTA OPHTHA IN PRESS; BRABYN LB, 1979, PERCEPT PSYCHOPHYS, V26, P319, DOI 10.3758/BF03199887; Casten V, 1933, ARCH OPHTHALMOL-CHIC, V9, P52; Chauvenet W., 1906, MANUAL SPHERICAL PRA, P469; Chua BE, 2004, EYE, V18, P765, DOI 10.1038/sj.eye.6701366; Derby G S, 1926, Trans Am Ophthalmol Soc, V24, P92; Derby GS, 1929, ARCH OPHTHALMOL-CHIC, V1, P692; Duke -Elder S, 1969, SYSTEM OPHTHALMOLOGY, V11, P443; Feldman JB, 1936, ARCH OPHTHALMOL-CHIC, V15, P1004, DOI 10.1001/archopht.1936.00840180048005; GOLDTHWAITE D, 1976, CAN J OPHTHALMOL, V11, P55; Hecht S, 1937, J GEN PHYSIOL, V20, P831, DOI 10.1085/jgp.20.6.831; Hecht S, 1935, J GEN PHYSIOL, V19, P321, DOI 10.1085/jgp.19.2.321; Heeg GP, 2005, ACTA OPHTHALMOL SCAN, V83, P46, DOI 10.1111/j.1600-0420.2005.00423.x; Hu CX, 2014, AM J MED SCI, V348, P403, DOI 10.1097/MAJ.0000000000000319; Janz NK, 2001, OPHTHALMOLOGY, V108, P887, DOI 10.1016/S0161-6420(00)00624-2; JONAS JB, 1990, GRAEF ARCH CLIN EXP, V228, P321, DOI 10.1007/BF00920055; Lee BL, 1998, ARCH OPHTHALMOL-CHIC, V116, P861, DOI 10.1001/archopht.116.7.861; Mandelbaum J, 1941, ARCH OPHTHALMOL-CHIC, V26, P203, DOI 10.1001/archopht.1941.00870140053003; MOTE FA, 1951, J GEN PHYSIOL, V34, P657, DOI 10.1085/jgp.34.5.657; Nelson P, 1999, BRIT J OPHTHALMOL, V83, P546, DOI 10.1136/bjo.83.5.546; Nio YK, 2000, OPHTHAL PHYSL OPT, V20, P323, DOI 10.1016/S0275-5408(99)00103-9; Nomura H, 2003, JPN J OPHTHALMOL, V47, P299, DOI 10.1016/S0021-5155(03)00011-X; Panos GD, 2017, KLIN MONATSBL AUGENH, V234, P464, DOI 10.1055/s-0042-119562; Rufer F, 2005, CORNEA, V24, P259; Sia DIT, 2013, ACTA OPHTHALMOL, V91, P312, DOI 10.1111/j.1755-3768.2011.02379.x; Tatemichi M, 2012, ACTA OPHTHALMOL, V90, P546, DOI 10.1111/j.1755-3768.2010.01988.x; Waite JH, 1925, T OPHTHAL SOC UK, V45, P324; WERBLIN FS, 1973, SCI AM, V228, P71; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309; ZIHL J, 1990, CLIN VISION SCI, V5, P185; ZUEGE P, 1967, AM J OPHTHALMOL, V64, P56, DOI 10.1016/0002-9394(67)93343-0	34	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193663	10.1371/journal.pone.0193663	http://dx.doi.org/10.1371/journal.pone.0193663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509787	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200022
J	Bultum, JA; Yigzaw, N; Demeke, W; Alemayehu, M				Bultum, Jemal Abdella; Yigzaw, Niguse; Demeke, Wubit; Alemayehu, Mekuriaw			Alcohol use disorder and associated factors among human immunodeficiency virus infected patients attending antiretroviral therapy clinic at Bishoftu General Hospital, Oromiya region, Ethiopia	PLOS ONE			English	Article							PRIMARY-CARE PATIENTS; IDENTIFICATION TEST; SOUTH-AFRICA; HIV; HIV/AIDS; DISEASE	Background Alcohol consumption among patients with HIV/AIDS increases the burden of the disease. HIV/AIDS is an epidemic among Sub-Saharan African countries. Excessive use of alcohol causes a large degree of health problems, social and economic burden in societies. However, the prevalence and associated factors of alcohol use disorder among this group of people has not been studied very well. Therefore, this study sought to assess the magnitude and associated factors of alcohol use disorder among HIV patients attending the antiretroviral (ART) clinic. Methods A hospital based cross sectional study design was conducted at Bishoftu General Hospital from May to June 2015. Systematic random sampling technique was used to select the study participants. Data was collected by face to face interview and chart review. Alcohol Use Disorder Identification Test (AUDIT) was used to assess alcohol use disorder. Bivariate and multivariate logistic regression analysis was carried out to identify associated factors and P-value < 0.05 was taken as statistically significant. Results A total of 527 participants were enrolled in the study with a response rate of 100%. The prevalence of alcohol use disorder (AUD) was 14.2%. Factors associated with alcohol use disorder were educational status AOR = 8.5 (95% CI: 1.70, 42.99), social support AOR = 0.5 (95% CI: 0.26, 0.95), cigarette smoking AOR = 3.49(95% CI: 1.01, 12.13), khat chewing AOR = 5.11 (95% CI: 1.60, 16.33), family history of alcohol use AOR = 3.58 (95% CI: 1.52, 8.47), and missing ART drugs AOR 3.05 (95% CI: 1.302, 7.131). Conclusion The prevalence of alcohol use disorder was high as compared to similar epidemiological studies. Educational status, social support, cigarette smoking, khat chewing, and family history of alcohol use were independent predictors. Providing health education about alcohol use and proper screening of alcohol use disorder among patients with HIV/AIDS is crucial. Strengthening the referral linkage with the psychiatric unit will decrease the burdens of the problem.	[Bultum, Jemal Abdella] Bishoftu Gen Hosp, Bishoftu, Oromia Region, Ethiopia; [Yigzaw, Niguse] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Psychiat, Gondar, Ethiopia; [Demeke, Wubit] Amanuel Mental Specialized Hosp, Out Patient Dept, Addis Ababa, Ethiopia; [Alemayehu, Mekuriaw] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia	University of Gondar; University of Gondar	Yigzaw, N (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Psychiat, Gondar, Ethiopia.	neglideta@yahoo.com		Muluneh, Niguse Yigzaw/0000-0002-7507-3242	Amanuel Mental Specialized Hospital; University of Gondar	Amanuel Mental Specialized Hospital; University of Gondar	The study was supported by Amanuel Mental Specialized Hospital.; The Authors would like to acknowledge the University of Gondar and Amanuel Mental Specialized Hospital for ethical clearance and financial support. The Authors would also like to thank Bishoftu Hospital staffs and study participants	Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P77, DOI 10.1111/j.1600-0447.1999.tb10698.x; Allen JP, 2001, PREV MED, V33, P428, DOI 10.1006/pmed.2001.0910; Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Chander G, 2008, HIV MED, V9, P196, DOI 10.1111/j.1468-1293.2008.00545.x; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Chander Geetanjali, 2011, Top Antivir Med, V19, P143; deLuna J, 2014, J AIDS CLIN RES, V5; Derek D, 2011, ALCOHOL CLIN EXPRES, V35, P695; Farley John, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P218, DOI 10.1177/1545109710371133; Fekadu A., 2007, AFR J DRUG ALCOHOL S, V6, P40; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Justice A, 2010, ALCOHOL RES HEALTH, V33, P258; Kim TW, 2007, AIDS CARE, V19, P1039, DOI 10.1080/09540120701294245; Marsano LS, 2003, ALCOHOL RES HEALTH, V27, P247; Miguez-Burbano MJ, 2009, ALCOHOL ALCOHOLISM, V44, P366, DOI 10.1093/alcalc/agp024; Naimi TS, 2006, PREVENTING CHRONIC D, V3; Peltzer K, 2012, INT J ENV RES PUB HE, V9, P3245, DOI 10.3390/ijerph9093245; Pengpid S, 2011, INT J ENV RES PUB HE, V8, P2629, DOI 10.3390/ijerph8072629; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; Soboka Matiwos, 2014, BMC Res Notes, V7, P828, DOI 10.1186/1756-0500-7-828; Stein M, 2005, ALCOHOL CLIN EXP RES, V29, P837, DOI 10.1097/01.ALC.0000164363.40533.E0; WHO, 2021, NORD ALC MARK REP; Wiener C., 2012, HARRISONS PRINCIPLES, V18th; Znenbe Y, 2015, J ALCOHOL DRUG DEPEN, V3, P3	27	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0189312	10.1371/journal.pone.0189312	http://dx.doi.org/10.1371/journal.pone.0189312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509771	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200001
J	Kim, SY; Min, C; Lee, WH; Choi, HG				Kim, So Young; Min, Chanyang; Lee, Woo Hyun; Choi, Hyo Geun			Tonsillectomy increases the risk of retropharyngeal and parapharyngeal abscesses in adults, but not in children: A national cohort study	PLOS ONE			English	Article							UNITED-STATES; SERUM; RATES; AGE	Objectives The purpose of this study is to evaluate the risk of retropharyngeal and parapharyngeal abscesses (deep neck infection) after tonsillectomy in Koreans using national cohort data. Methods Using the national cohort study from the Korean Health Insurance Review and Assessment Service, participants who had undergone a tonsillectomy (5,299) and control participants (21,196) were selected and matched 1:4 (for age, sex, income, region of residence, and pre-operative upper respiratory infection visits). The Cox-proportional hazard model was used. A crude model and an adjusted model for age, sex, income, region of residence, hypertension, diabetes, and dyslipidemia were used in this analysis. For the subgroup analyses, the participants were divided into 2 groups: children (<= 14 years old) and adolescents and adults (>= 15 years old). Results The adjusted hazard ratio of deep neck infection after tonsillectomy was 1.43 (95% confidence interval, CI = 1.18-1.72, P < 0.001). In subgroup analysis, this ratio was 1.12 (95% CI = 0.86-1.47, P = 0.390) in children and 1.87 (95% CI = 1.43-2.45, P < 0.001) in adolescents and adults. The crude hazard ratios were almost the same as the adjusted ratios. Conclusion The risk of deep neck infection was higher in the tonsillectomy group. The subgroup analysis showed a similar finding in the adolescent and adult group but not in the child group.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Min, Chanyang] Hallym Univ, Coll Med, Hallym Data Sci Lab, Anyang, South Korea; [Lee, Woo Hyun] Natl Police Hosp, Dept Otorhinolaryngol, Seoul, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea)	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) from the National Research Foundation (NRF) of Korea. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Ballester JC, 2007, CLIN IMMUNOL, V123, P289, DOI 10.1016/j.clim.2007.02.004; Boss EF, 2012, J PEDIATR-US, V160, P814, DOI 10.1016/j.jpeds.2011.11.041; Burton MJ, 2014, COCHRANE DB SYST REV, V19; Chi TH, 2014, OTOLARYNG HEAD NECK, V151, P586, DOI 10.1177/0194599814542589; Choi HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169264; Choi HG, 2014, EUR ARCH OTO-RHINO-L, V271, P2293, DOI 10.1007/s00405-013-2759-7; Duval M, 2008, INT J PEDIATR OTORHI, V72, P1765, DOI 10.1016/j.ijporl.2008.07.007; FREEMAN JL, 1982, AM J PUBLIC HEALTH, V72, P488, DOI 10.2105/AJPH.72.5.488; Huang CM, 2017, J MICROBIOL IMMUNOL, V50, P627, DOI 10.1016/j.jmii.2015.08.020; Kaygusuz I, 2009, INT J PEDIATR OTORHI, V73, P445, DOI 10.1016/j.ijporl.2008.11.014; Klug TE, 2014, EUR ARCH OTO-RHINO-L, V271, P1701, DOI 10.1007/s00405-013-2667-x; Paradise JL, 2002, PEDIATRICS, V110; Suzumoto M, 2006, ACTA OTO-LARYNGOL, V126, P1164, DOI 10.1080/00016480600681593; van den Akker EH, 2006, ANN ALLERG ASTHMA IM, V97, P251, DOI 10.1016/S1081-1206(10)60022-1; van Kempen MJP, 2000, INT ARCH ALLERGY IMM, V122, P8, DOI 10.1159/000024354; Wang YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117535	16	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193913	10.1371/journal.pone.0193913	http://dx.doi.org/10.1371/journal.pone.0193913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509810	gold, Green Published, Green Submitted			2022-12-27	WOS:000426813200041
J	Milanovic, JZ; Milanovic, P; Kragic, R; Kostic, M				Milanovic, Jovana Z.; Milanovic, Predrag; Kragic, Rastislav; Kostic, Mirjana			"Do-It-Yourself" reliable pH-stat device by using open-source software, inexpensive hardware and available laboratory equipment	PLOS ONE			English	Article							TEMPO-MEDIATED OXIDATION; CELLULOSE FIBERS; NATIVE CELLULOSE; SYSTEM	In this paper, we present the construction of a reliable and inexpensive pH stat device, by using open-source "OpenPhControl" software, inexpensive hardware (a peristaltic and a syringe pump, Arduino, a step motor...), readily available laboratory devices: a pH meter, a computer, a webcam, and some 3D printed parts. We provide a methodology for the design, development and test results of each part of the device, as well as of the entire system. In addition to dosing reagents by means of a low-cost peristaltic pump, we also present carefully controlled dosing of reagents by an open-source syringe pump. The upgrading of the basic open-source syringe pump is given in terms of pump control and application of a larger syringe. In addition to the basic functions of pH stat, i.e. pH value measurement and maintenance, an improvement allowing the device to be used for potentiometric titration has been made as well. We have demonstrated the device's utility when applied for cellulose fibers oxidation with 2,2,6,6-tetramethylpiperidine-1-oxyl radical, i.e. for TEMPO-mediated oxidation. In support of this, we present the results obtained for the oxidation kinetics, the consumption of added reagent and experimental repeatability. Considering that the open-source scientific tools are available to everyone, and that researchers can construct and adjust the device according to their needs, as well as, that the total cost of the open-source pH stat device, excluding the existing laboratory equipment (pH meter, computer and glossary) was less than 150 EUR, we believe that, at a small fraction of the cost of available commercial offers, our open-source pH stat can significantly improve experimental work where the use of pH stat is necessary.	[Milanovic, Jovana Z.] Univ Belgrade, Fac Technol & Met, Innovat Ctr, Belgrade, Serbia; [Milanovic, Predrag; Kostic, Mirjana] Univ Belgrade, Fac Technol & Met, Belgrade, Serbia; [Kragic, Rastislav] Minist Min & Energy, Belgrade, Serbia	University of Belgrade; University of Belgrade	Milanovic, JZ (corresponding author), Univ Belgrade, Fac Technol & Met, Innovat Ctr, Belgrade, Serbia.	jovana@tmf.bg.ac.rs	Kostic, Mirjana/S-1905-2017	Kostic, Mirjana/0000-0001-9925-4884; Milanovic, Predrag/0000-0002-6058-6811; Milanovic, Jovana/0000-0001-5777-7302	Ministry of Education, Science and Technological Development of the Republic of Serbia [OI 172029]	Ministry of Education, Science and Technological Development of the Republic of Serbia	This study has been created as a result of the work on Project of the Ministry of Education, Science and Technological Development of the Republic of Serbia (Project OI 172029).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SENS SENS INT; [Anonymous], 1988, 2621988 ISO; Anzalone GC, 2013, SENSORS-BASEL, V13, P5338, DOI 10.3390/s130405338; Archanjo GA, 2008, PROGR SOL 3D CAD MOD, P5; Arevalo-Ramirez T, 2016, ANDESCON 2016 IEEE, P1; Bruns B, 2001, NANOTECHNOLOGY, V12, P198, DOI 10.1088/0957-4484/12/3/303; Carney GD, 2015, EUROPEAN INT J SCI T, V4, P65; Chagas AM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002702; Christian W, 2011, SCIENCE, V334, P1077, DOI 10.1126/science.1196984; Debian, UN OP SYST; Deek FP, 2008, OPEN SOURCE: TECHNOLOGY AND POLICY, P1; DENOOY AEJ, 1994, RECL TRAV CHIM PAY B, V113, P165; Dryden MDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140349; Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0; Feller Joseph, 2001, UNDERSTANDING OPEN S; Garbacz G, 2013, AAPS PHARMSCITECH, V14, P517, DOI 10.1208/s12249-013-9933-5; Honorato C, 2015, J MATER SCI, V50, P7343, DOI 10.1007/s10853-015-9291-7; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Jin LQ, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40450; Lang TD, 2011, SCIENCE, V331, P714, DOI 10.1126/science.1199349; Li B, 2015, CARBOHYD POLYM, V133, P605, DOI 10.1016/j.carbpol.2015.07.033; Litronix, 1980, DISPLAYS, V1, P181; OpenSCAD, PROGR SOL 3D CAD MOD; Pearce J.M., 2010, J SUSTAINABLE DEV, V3, P17, DOI [DOI 10.5539/JSD.V3N4P17, 10.5539/jsd.v3n4p17]; Pearce J.M., 2013, OPEN SOURCE LAB BUIL, V1st; Pearce JM, 2013, NANO TODAY, V8, P339, DOI 10.1016/j.nantod.2013.04.001; Pearce JM, 2012, NATURE, V491, P519, DOI 10.1038/491519a; Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183; Praskalo J, 2009, CARBOHYD POLYM, V77, P791, DOI 10.1016/j.carbpol.2009.02.028; ROSSOTTI FJ, 1965, J CHEM EDUC, V42, P375, DOI 10.1021/ed042p375; Rowe AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023783; Saito T, 2005, CARBOHYD POLYM, V61, P414, DOI 10.1016/j.carbpol.2005.05.014; Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769; Saito T, 2006, COLLOID SURFACE A, V289, P219, DOI 10.1016/j.colsurfa.2006.04.038; Smith R, 2007, PROC INT CONF DOC, P629, DOI 10.1109/icdar.2007.4376991; Steffens S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179636; Stokstad E, 2011, SCIENCE, V334, P308, DOI 10.1126/science.334.6054.308; Sun B, 2005, CELLULOSE, V12, P59, DOI 10.1023/B:CELL.0000049409.56806.da; Tahiri C, 2000, CELLULOSE, V7, P177, DOI 10.1023/A:1009276009711; Webcam Capture, GEN WEBC JAV API; Wijnen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107216; Xu QH, 2014, BIORESOURCES, V9, P994; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059840	43	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193744	10.1371/journal.pone.0193744	http://dx.doi.org/10.1371/journal.pone.0193744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509793	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200027
J	Ojanguren, I; Moullec, G; Hobeika, J; Miravitlles, M; Lemiere, C				Ojanguren, Inigo; Moullec, Gregory; Hobeika, Jad; Miravitlles, Marc; Lemiere, Catherine			Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SPUTUM CELL COUNTS; AIRWAY INFLAMMATION; CHALLENGES; EXPOSURE; AGENTS; TRIAL; ACOS	Introduction Although Asthma-COPD Overlap (ACO) has been described among populations of subjects with COPD or asthma, ACO has never been described among a population of subjects with occupational asthma (OA). Objectives The aims of this study were to: 1. identify ACO in a population of subjects with OA; and 2. compare the clinical characteristics between ACO and OA. Methods This retrospective study included all subjects diagnosed with OA between 2000 and 2017 in an OA referral center. Occupational Asthma-COPD Overlap (OACO) was defined as post-bronchodilator FEV1/FVC < 70% and smoking history >= 10 pack-years, along with a diagnosis of OA. Results Three hundred and four subjects were included, 262 (86.2%) were classified as OA and 42 (13.8%) as OACO. OA subjects presented higher sputum eosinophil counts after a specific-inhalation challenge than subjects with OACO (median [IQR]: 6.5 [17.0] vs 2.3 [3.5]). After adjusting for confounding factors, subjects with OACO were older (OR: 1.10 [1.05; 1.14]) and were taking higher doses of inhaled corticosteroids than OA subjects (OR, 5.20 [1.77; 16.48]). Subjects with OACO were less often atopic than OA subjects (OR, 0.19 [0.07; 0.62]). Conclusions Subjects with OACO constitute a distinct clinical and inflammatory phenotype from subjects with OA.	[Ojanguren, Inigo; Moullec, Gregory; Lemiere, Catherine] Univ Montreal, Hop Sacre Coeur Montreal, Ctr Integre Univ Sante & Serv Sociaux Nord de Ill, Montreal, PQ, Canada; [Ojanguren, Inigo; Miravitlles, Marc] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Barcelona, Spain; [Moullec, Gregory] Univ Montreal, Publ Hlth Sch, Dept Social & Prevent Med, Montreal, PQ, Canada; [Hobeika, Jad] Hop St Eustache, Ctr Integre Sante & Serv Sociaux Laurentides, St Eustache, PQ, Canada; [Miravitlles, Marc] Hosp Univ Vall dHebron, Serv Neumol, Barcelona, Spain	Universite de Montreal; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universite de Montreal; Hospital Universitari Vall d'Hebron	Lemiere, C (corresponding author), Univ Montreal, Hop Sacre Coeur Montreal, Ctr Integre Univ Sante & Serv Sociaux Nord de Ill, Montreal, PQ, Canada.	catherine.lemiere@umontreal.ca	Miravitlles, Marc/AAH-5284-2019	Miravitlles, Marc/0000-0002-9850-9520; Lemiere, Catherine/0000-0003-3667-9628; Ojanguren, Inigo/0000-0003-1270-5772	Sociedad Catalana de Pneumologia SOCAP; ERS-SEPAR Long term international fellowship [LTRF-2016-6556 D]	Sociedad Catalana de Pneumologia SOCAP; ERS-SEPAR Long term international fellowship	Dr Ojanguren received salary funding for ERS-SEPAR Long term international fellowship LTRF-2016-6556 D as well as from the Sociedad Catalana de Pneumologia SOCAP 2016.	Barrecheguren M, 2015, CURR OPIN PULM MED, V21, P74, DOI 10.1097/MCP.0000000000000118; Cahn A, 2015, CLIN EXP ALLERGY, V45, P1531, DOI 10.1111/cea.12610; Cartier A, 1999, ASTHMA WORKPLACE; Chen FJ, 2016, INT J CHRONIC OBSTR, V11, P2385, DOI 10.2147/COPD.S115378; Christenson SA, 2015, AM J RESP CRIT CARE, V191, P758, DOI 10.1164/rccm.201408-1458OC; Cosio BG, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02397-2016; Fingleton J, 2015, J ALLERGY CLIN IMMUN, V136, P601, DOI 10.1016/j.jaci.2015.01.013; Gao Jing, 2016, Int J Chron Obstruct Pulmon Dis, V11, P2457; GINA-GOLD, 2015, GLOB IN CHRON OBSTR; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Joos GF, 2003, EUR RESPIR J, V21, P1050, DOI 10.1183/09031936.03.00008403; Kobayashi S, 2016, INT J CHRONIC OBSTR, V11, P2117, DOI 10.2147/COPD.S113647; Lemiere C, 2001, J ALLERGY CLIN IMMUN, V107, P1063, DOI 10.1067/mai.2001.115486; Lemiere C, 2014, J ALLERGY CLIN IMMUN, V133, P883, DOI 10.1016/j.jaci.2013.09.005; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miravitlles M, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00068-2017; Miravitlles M, 2013, RESP MED, V107, P1053, DOI 10.1016/j.rmed.2013.03.007; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; Prince P, 2012, CHEST, V141, P1522, DOI 10.1378/chest.11-1134; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Sin DD, 2016, EUR RESPIR J, V48, P664, DOI 10.1183/13993003.00436-2016; Siva R, 2007, EUR RESPIR J, V29, P906, DOI 10.1183/09031936.00146306; Tam A, 2012, MED CLIN N AM, V96, P681, DOI 10.1016/j.mcna.2012.04.012; Tarlo SM, 2008, CHEST, V134, p1S, DOI 10.1378/chest.08-0201; Tilp C, 2016, CLIN EXP ALLERGY, V46, P957, DOI 10.1111/cea.12665; Tommola M, 2016, EUR RESPIR J, V48, P1; Wurst KE, 2016, EUR RESPIR J, V47, P1559, DOI 10.1183/13993003.02045-2015	28	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193144	10.1371/journal.pone.0193144	http://dx.doi.org/10.1371/journal.pone.0193144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499062	gold, Green Submitted, Green Published			2022-12-27	WOS:000426472300007
J	Bhogoju, S; Nahashon, S; Wang, XF; Darris, C; Kilonzo-Nthenge, A				Bhogoju, Sarayu; Nahashon, Samuel; Wang, Xiaofei; Darris, Carl; Kilonzo-Nthenge, Agnes			A comparative analysis of microbial profile of Guinea fowl and chicken using metagenomic approach	PLOS ONE			English	Article							CLOSTRIDIUM-SPIROFORME TOXIN; METABOLIZABLE ENERGY; CRUDE PROTEIN; SP-NOV; IDENTIFICATION; GROWTH; PERFORMANCE; BROILERS; FLORA; FEED	Probiotics are live microbial feed supplements that promote growth and health to the host by minimizing non-essential and pathogenic microorganisms in the host's gastrointestinal tract (GIT). The campaign to minimize excessive use of antibiotics in poultry production has necessitated development of probiotics with broad application in multiple poultry species. Design of such probiotics requires understanding of the diversity or similarity in microbial profiles among avian species of economic importance. Therefore, the objective of this research was to establish and compare the microbial profiles of the GIT of Guinea fowl and chicken and to establish the microbial diversity or similarity between the two avian species. A metagenomic approach consisting of the amplification and sequence analysis of the hypervariable regions V1-V9 of the 16S rRNA gene was used to identify the GIT microbes. Collectively, we detected more than 150 microbial families. The total number of microbial species detected in the chicken GIT was higher than that found in the Guinea Fowl GIT. Our studies also revealed phylogenetic diversity among the microbial species found in chicken and guinea fowl. The phylum Firmicutes was most abundant in both avian species whereas Phylum Actinobacteria was most abundant in chickens than Guinea fowls. The diversity of the microbial profiles found in broiler chickens and Guinea fowls suggest that the design of effective avian probiotics would require species specificity.	[Bhogoju, Sarayu; Nahashon, Samuel] Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA; [Wang, Xiaofei] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA; [Darris, Carl] Vanderbilt Univ, Dept Nephrol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kilonzo-Nthenge, Agnes] Tennessee State Univ, Dept Human Sci, Nashville, TN 37203 USA	Tennessee State University; Tennessee State University; Vanderbilt University; Tennessee State University	Nahashon, S (corresponding author), Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA.	snahashon@tnstate.edu	Bhogoju, Sarayu/I-8280-2019	Nahashon, Samuel/0000-0003-3985-3281	USDA/NIFA [2015-38814-24354]; United States Department of Agriculture-National Institute of Food and Agriculture [2015-38814-24354]	USDA/NIFA(United States Department of Agriculture (USDA)); United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Authors appreciate members of the Animal Biotechnology Laboratory at Tennessee State University for their contribution to this research. This research was funded by the USDA/NIFA Grant# 2015-38814-24354.; This research was funded by the United States Department of Agriculture-National Institute of Food and Agriculture Grant# 2015-38814-24354 (SN); https://nifa.usda.gov/programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbolosu A. A., 2012, Agriculture and Biology Journal of North America, V3, P336, DOI 10.5251/abjna.2012.3.8.336.339; AGWUNOBI LN, 1990, J SCI FOOD AGR, V52, P301, DOI 10.1002/jsfa.2740520303; Amit-Romach E, 2004, POULTRY SCI, V83, P1093, DOI 10.1093/ps/83.7.1093; BELL D.D., 2002, COMMERCIAL CHICKEN M, V5th; Boko CK, 2013, AVIAN PATHOL, V42, P1, DOI 10.1080/03079457.2012.751484; Bonds H., 1997, ALTERNATIVE FARMING; CATO EP, 1974, INT J SYST BACTERIOL, V24, P256, DOI 10.1099/00207713-24-2-256; DIERICK NA, 1989, ARCH TIERERNAHR, V39, P241, DOI 10.1080/17450398909429530; Du EC, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0055-7; Duke G. E., 1977, Dukes' physiology of domestic animals,, P313; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Harris K, 2012, J OBES, V2012, DOI 10.1155/2012/879151; Irikura D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138183; Kabir S. M. L., 2005, Biotechnology, V4, P325; KANEUCHI C, 1979, INT J SYST BACTERIOL, V29, P1, DOI 10.1099/00207713-29-1-1; Kilonzo-Nthenge A, 2008, POULTRY SCI, V87, P1841, DOI 10.3382/ps.2007-00156; Kuczynski J., 2011, CURRENT PROTOCOLS BI; Meehan CJ, 2014, PHYLOGENOMIC VIEW EC; Mon KKZ, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00061; Morotomi M, 2011, INT J SYST EVOL MICR, V61, P637, DOI 10.1099/ijs.0.023556-0; Nahashon SN, 2007, POULTRY SCI, V86, P1793, DOI 10.1093/ps/86.8.1793; Nahashon SN, 2006, POULTRY SCI, V85, P359, DOI 10.1093/ps/85.2.359; Nahashon SN, 2005, POULTRY SCI, V84, P337, DOI 10.1093/ps/84.2.337; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; POPOFF MR, 1988, BIOCHEM BIOPH RES CO, V152, P1361, DOI 10.1016/S0006-291X(88)80435-2; Scheperjans F., 2014, MOVEMENT DISORDERS; Simpson PJ, 2004, INT J SYST EVOL MICR, V54, P401, DOI 10.1099/ijs.0.02667-0; Stewart CS., 1997, RUMEN MICROBIAL ECOS, V2nd ed, P10, DOI [10.1007/978-94-009-1453-7_2, DOI 10.1007/978-94-009-1453-7_2, DOI 10.1007/978-94-009-14537%7B%5C_%7D2]; Tan B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01027; Tarnberg M, 2002, APMIS, V110, P802, DOI 10.1034/j.1600-0463.2002.1101106.x; TORTUERO F, 1973, POULTRY SCI, V52, P197, DOI 10.3382/ps.0520197; TORTUERO F, 1995, ANIM FEED SCI TECH, V53, P255, DOI 10.1016/0377-8401(94)00747-W; Vasquez A, 2002, J CLIN MICROBIOL, V40, P2746, DOI 10.1128/JCM.40.8.2746-2749.2002; Waite DW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00673; Zerehdaran S, 2004, POULTRY SCI, V83, P521, DOI 10.1093/ps/83.4.521	37	11	12	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0191029	10.1371/journal.pone.0191029	http://dx.doi.org/10.1371/journal.pone.0191029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494648	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200004
J	Chao, YJ; Wu, WH; Balazova, M; Wu, TY; Lin, J; Liu, YW; Hsu, YHH				Chao, Yu-Jen; Wu, Wen-Hsin; Balazova, Maria; Wu, Ting-Yuan; Lin, Jamie; Liu, Yi-Wen; Hsu, Yuan-Hao Howard			Chlorella diet alters mitochondrial cardiolipin contents differentially in organs of Danio rerio analyzed by a lipidomics approach	PLOS ONE			English	Article							HEART SUBMITOCHONDRIAL PARTICLES; FATTY-ACID-COMPOSITION; BARTH-SYNDROME; ACYLTRANSFERASE CONTROLS; ENDOTHELIAL LINEAGES; MASS-SPECTROMETRY; ZEBRAFISH MODEL; HUMAN-DISEASE; ATP SYNTHASE; IN-VITRO	The zebrafish (Danio rerio) is an important and widely used vertebrate model organism for the study of human diseases which include disorders caused by dysfunctional mitochondria. Mitochondria play an essential role in both energy metabolism and apoptosis, which are mediated through a mitochondrial phospholipid cardiolipin (CL). In order to examine the cardiolipin profile in the zebrafish model, we developed a CL analysis platform by using liquid chromatography-mass spectrometry (LC-MS). Meanwhile, we tested whether chlorella diet would alter the CL profile in the larval fish, and in various organs of the adult fish. The results showed that chlorella diet increased the chain length of CL in larval fish. In the adult zebrafish, the distribution patterns of CL species were similar between the adult brain and eye tissues, and between the heart and muscles. Interestingly, monolyso-cardiolipin (MLCL) was not detected in brain and eyes but found in other examined tissues, indicating a different remodeling mechanism to maintain the CL integrity. While the adult zebrafish were fed with chlorella for four weeks, the CL distribution showed an increase of the species of saturated acyl chains in the brain and eyes, but a decrease in the other organs. Moreover, chlorella diet led to a decrease of MLCL percentage in organs except the non-MLCL-containing brain and eyes. The CL analysis in the zebrafish provides an important tool for studying the mechanism of mitochondria diseases, and may also be useful for testing medical regimens targeting against the Barth Syndrome.	[Chao, Yu-Jen; Wu, Wen-Hsin; Wu, Ting-Yuan; Hsu, Yuan-Hao Howard] Tunghai Univ, Dept Chem, Taichung, Taiwan; [Balazova, Maria] Slovak Acad Sci, Ctr Biosci, Inst Anim Biochem & Genet, Bratislava, Slovakia; [Lin, Jamie; Liu, Yi-Wen] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Lin, Jamie; Liu, Yi-Wen; Hsu, Yuan-Hao Howard] Tunghai Univ, Life Sci Res Ctr, Taichung, Taiwan	Tunghai University; Slovak Academy of Sciences; Tunghai University; Tunghai University	Hsu, YHH (corresponding author), Tunghai Univ, Dept Chem, Taichung, Taiwan.; Liu, YW (corresponding author), Tunghai Univ, Dept Life Sci, Taichung, Taiwan.; Liu, YW; Hsu, YHH (corresponding author), Tunghai Univ, Life Sci Res Ctr, Taichung, Taiwan.	dlslys@thu.edu.tw; howardhsu@thu.edu.tw	liu, yi/GXE-9662-2022; Balazova, Maria/AAC-1280-2019; hsu, yuan-hao/B-5744-2009	Balazova, Maria/0000-0001-8113-6855; 	Ministry of Science and Technology, Taiwan [MOST 105-2113-M-029-009, MOST 106-2923-M-029-001-MY3, MOST 105-2313-B-029-002, MOST 106-2313-B-029-002-MY3]; National Health Research Institutes, Taiwan [NHRI-EX105-10236SC]; Slovak Academy of Sciences [SAS-MOST JRP 2016/4]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Slovak Academy of Sciences(Slovak Academy of Sciences)	The work was supported by Ministry of Science and Technology, Taiwan (MOST 105-2113-M-029-009 and MOST 106-2923-M-029-001-MY3) and National Health Research Institutes, Taiwan (NHRI-EX105-10236SC) to YHH, Ministry of Science and Technology, Taiwan (MOST 105-2313-B-029-002 and MOST 106-2313-B-029-002-MY3) to YWL and Slovak Academy of Sciences (SAS-MOST JRP 2016/4) to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Ministry of Science and Technology, Taiwan (MOST 105-2113-M-029-009 and MOST 106-2923-M-029-001-MY3) and National Health Research Institutes, Taiwan (NHRI-EX105-102365C) to YHH, Ministry of Science and Technology, Taiwan (MOST 105-2313-B-029-002 and MOST 106-2313-B-029-002-MY3) to YWL and Slovak Academy of Sciences (SAS-MOST JRP 2016/4) to MB. We would like to thank Hsin-Yu Hou for the maintenance of the zebrafish stock.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Acehan D, 2009, MITOCHONDRION, V9, P86, DOI 10.1016/j.mito.2008.12.001; Almaida-Pagan PF, 2015, J COMP PHYSIOL B, V185, P73, DOI 10.1007/s00360-014-0870-8; Baden KN, 2007, J BIOL CHEM, V282, P34839, DOI 10.1074/jbc.M703528200; Betancor MB, 2015, FISH PHYSIOL BIOCHEM, V41, P1187, DOI 10.1007/s10695-015-0079-0; Bird SS, 2011, ANAL CHEM, V83, P940, DOI 10.1021/ac102598u; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowron A, 2015, J INHERIT METAB DIS, V38, P279, DOI 10.1007/s10545-014-9747-y; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Cha KH, 2008, J AGR FOOD CHEM, V56, P10521, DOI 10.1021/jf802111x; Chao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113680; Fraher D, 2016, CELL REP, V14, P1317, DOI 10.1016/j.celrep.2016.01.016; Grammes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083213; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Khairallah RJ, 2010, BBA-BIOENERGETICS, V1797, P1555, DOI 10.1016/j.bbabio.2010.05.007; Khuchua Z, 2004, CIRCULATION, V110, P46; Khuchua Z, 2006, CIRC RES, V99, P201, DOI 10.1161/01.RES.0000233378.95325.ce; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; KONISHI F, 1985, CANCER IMMUNOL IMMUN, V19, P73; Kralovec JA, 2005, INT IMMUNOPHARMACOL, V5, P689, DOI 10.1016/j.intimp.2004.11.016; Lesnefsky EJ, 2008, BBA-BIOENERGETICS, V1777, P1020, DOI 10.1016/j.bbabio.2008.05.444; Lesnefsky EJ, 2009, J MOL CELL CARDIOL, V46, P1008, DOI 10.1016/j.yjmcc.2009.03.007; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Otles S, 2001, J AOAC INT, V84, P1708; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Paradies G, 2001, MITOCHONDRION, V1, P151, DOI 10.1016/S1567-7249(01)00011-3; Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Ramesh T, 2010, DIS MODEL MECH, V3, P652, DOI 10.1242/dmm.005538; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Soontornchaiboon W, 2012, BIOL PHARM BULL, V35, P1137, DOI 10.1248/bpb.b12-00187; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; Steele SL, 2014, TRANSL RES, V163, P79, DOI 10.1016/j.trsl.2013.08.008; Ting HC, 2015, J NUTR BIOCHEM, V26, P769, DOI 10.1016/j.jnutbio.2015.02.005; Wang CY, 2007, BLOOD, V110, P3601, DOI 10.1182/blood-2007-04-086827; Wang HM, 2010, PROCESS BIOCHEM, V45, P1865, DOI 10.1016/j.procbio.2010.05.023; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Xiong JW, 2007, CIRCULATION, V116, P71; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]	46	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193042	10.1371/journal.pone.0193042	http://dx.doi.org/10.1371/journal.pone.0193042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494608	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200019
J	Esler, TB; Kerr, RR; Tahayori, B; Grayden, DB; Meffin, H; Burkitt, AN				Esler, Timothy B.; Kerr, Robert R.; Tahayori, Bahman; Grayden, David B.; Meffin, Hamish; Burkitt, Anthony N.			Minimizing activation of overlying axons with epiretinal stimulation: The role of fiber orientation and electrode configuration	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ELECTRICAL-STIMULATION; MOUSE RETINA; PROSTHESIS; THRESHOLDS; MORPHOLOGY; DESIGN; CLASSIFICATION; MODEL; SHAPE	Currently, a challenge in electrical stimulation of the retina with a visual prosthesis (bionic eye) is to excite only the cells lying directly under the electrode in the ganglion cell layer, while avoiding excitation of axon bundles that pass over the surface of the retina in the nerve fiber layer. Stimulation of overlying axons results in irregular visual percepts, limiting perceptual efficacy. This research explores how differences in fiber orientation between the nerve fiber layer and ganglion cell layer leads to differences in the electrical activation of the axon initial segment and axons of passage. Approach. Axons of passage of retinal ganglion cells in the nerve fiber layer are characterized by a narrow distribution of fiber orientations, causing highly anisotropic spread of applied current. In contrast, proximal axons in the ganglion cell layer have a wider distribution of orientations. A four-layer computational model of epiretinal extracellular stimulation that captures the effect of neurite orientation in anisotropic tissue has been developed using a volume conductor model known as the cellular composite model. Simulations are conducted to investigate the interaction of neural tissue orientation, stimulating electrode configuration, and stimulation pulse duration and amplitude. Main results. Our model shows that simultaneous stimulation with multiple electrodes aligned with the nerve fiber layer can be used to achieve selective activation of axon initial segments rather than passing fibers. This result can be achieved while reducing required stimulus charge density and with only modest increases in the spread of activation in the ganglion cell layer, and is shown to extend to the general case of arbitrary electrode array positioning and arbitrary target volume. Significance. These results elucidate a strategy for more targeted stimulation of retinal ganglion cells with experimentally-relevant multi-electrode geometries and achievable stimulation requirements.	[Esler, Timothy B.; Kerr, Robert R.; Grayden, David B.; Burkitt, Anthony N.] Univ Melbourne, Dept Biomed Engn, Parkville, Vic, Australia; [Kerr, Robert R.] Seer Med, Melbourne, Vic, Australia; [Tahayori, Bahman] Monash Univ, Monash Inst Med Engn, Clayton, Vic, Australia; [Grayden, David B.] Univ Melbourne, Ctr Neural Engn, Parkville, Vic, Australia; [Meffin, Hamish] Australian Coll Optometry, Natl Vis Res Inst, Carlton, Vic, Australia; [Meffin, Hamish] Univ Melbourne, ARC Ctr Excellence Integrat Brain Funct Optometry, Parkville, Vic, Australia	University of Melbourne; Monash University; University of Melbourne; University of Melbourne	Esler, TB (corresponding author), Univ Melbourne, Dept Biomed Engn, Parkville, Vic, Australia.	tesler@student.unimelb.edu.au	Grayden, David B/L-5782-2018	Grayden, David B/0000-0002-5497-7234; Meffin, Hamish/0000-0003-4307-6841	Australian Postgraduate Award from the Australian Government; University of Melbourne; Gowrie Scholarship Fund of the Australian National University; IBM Research, Melbourne; Australian Research Council Centre of Excellence for Integrative Brain Function [CE140100007]; Australian Research Council's Discovery Projects funding scheme [DP140104533]; Australian National Health and Medical Research Council's Project Grant funding scheme (NHMRC) [APP1106390]; Melbourne Bioinformatics on its Peak Computing Facility at The University of Melbourne [VR0138]	Australian Postgraduate Award from the Australian Government(Australian Research CouncilAustralian Government); University of Melbourne(University of Melbourne); Gowrie Scholarship Fund of the Australian National University; IBM Research, Melbourne; Australian Research Council Centre of Excellence for Integrative Brain Function(Australian Research Council); Australian Research Council's Discovery Projects funding scheme(Australian Research Council); Australian National Health and Medical Research Council's Project Grant funding scheme (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Bioinformatics on its Peak Computing Facility at The University of Melbourne	TE was supported by an Australian Postgraduate Award from the Australian Government and The University of Melbourne, and the Gowrie Scholarship Fund of the Australian National University. TE and RRK acknowledge the support of IBM Research, Melbourne. IBM Research, Melbourne provided support in the form of a salary for RRK and an internship for TE for part of the period during which this research was completed, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. HM acknowledges funding from the Australian Research Council Centre of Excellence for Integrative Brain Function (project number CE140100007). ANB acknowledges the support of the Australian Research Council's Discovery Projects funding scheme (project number DP140104533). DBG, HM and ANB acknowledge the support of the Australian National Health and Medical Research Council's Project Grant funding scheme (NHMRC Grant APP1106390). This research was supported by Melbourne Bioinformatics on its Peak Computing Facility at The University of Melbourne (grant number VR0138).	ABRAMIAN M, 2011, J NEURAL ENG, V8; Abramian M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/025002; Ascoli GA, 2007, J NEUROSCI, V27, P9247, DOI 10.1523/JNEUROSCI.2055-07.2007; Ayton LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115239; Badea TC, 2011, VISION RES, V51, P269, DOI 10.1016/j.visres.2010.08.039; Bakkum DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3181; Behrend MR, 2008, IEEE T BIO-MED ENG, V55, P1056, DOI 10.1109/TBME.2008.915723; BRUMMER SB, 1977, IEEE T BIO-MED ENG, V24, P440, DOI 10.1109/TBME.1977.326179; Cao X, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0065-x; Chen SC, 2009, VISION RES, V49, P1493, DOI 10.1016/j.visres.2009.02.003; Colbert CM, 1996, J NEUROSCI, V16, P6676; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Cuntz H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000877; da Cruz L, 2013, BRIT J OPHTHALMOL, V97, P632, DOI 10.1136/bjophthalmol-2012-301525; Eiber CD, 2016, MED BIOL ENG COMPUT, P1; Eickenscheidt M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/036006; FitzGibbon T, 2012, JPN J OPHTHALMOL, V56, P631, DOI 10.1007/s10384-012-0185-9; Fletcher LN, 2014, J COMP NEUROL, V522, P750, DOI 10.1002/cne.23441; Frenkel S, 2005, EYE, V19, P491, DOI 10.1038/sj.eye.6701569; Fried SI, 2009, J NEUROPHYSIOL, V101, P1972, DOI 10.1152/jn.91081.2008; Fujikado T, 2011, INVEST OPHTH VIS SCI, V52, P4726, DOI 10.1167/iovs.10-6836; Gleixner R, 2006, BIOPHYS J, V90, P2600, DOI 10.1529/biophysj.105.072587; Greenberg RJ, 1999, IEEE T BIO-MED ENG, V46, P505, DOI 10.1109/10.759051; Grosberg LE, 2017, J NEUROPHYSIOL; Jeng J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036022; Jensen RJ, 2006, EXP EYE RES, V83, P367, DOI 10.1016/j.exer.2006.01.012; Jensen RJ, 2003, INVEST OPHTH VIS SCI, V44, P3533, DOI 10.1167/iovs.02-1041; Jepson LH, 2013, J NEUROSCI, V33, P7194, DOI 10.1523/JNEUROSCI.4967-12.2013; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lee S, 2007, P NATL ACAD SCI USA, V104, P12931, DOI 10.1073/pnas.0705469104; Maturana MI, 2014, J COMPUT NEUROSCI, V36, P157, DOI 10.1007/s10827-013-0463-7; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; Meffin H, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/065004; Meffin H, 2013, IEEE ENG MED BIO, P5946, DOI 10.1109/EMBC.2013.6610906; Meffin H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065005; Nanduri D, 2008, IEEE ENG MED BIO, P1785, DOI 10.1109/IEMBS.2008.4649524; Oishi A, 2009, EYE, V23, P561, DOI 10.1038/eye.2008.63; Poria D, 2015, J NEUROPHYSIOL, V113, P420, DOI 10.1152/jn.00702.2014; Radivojevic M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31332; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; Rattay F, 2004, IEEE T BIO-MED ENG, V51, P1659, DOI 10.1109/TBME.2004.828044; Rizzo JF, 2003, INVEST OPHTH VIS SCI, V44, P5362, DOI 10.1167/iovs.02-0817; Rizzo JF, 2003, INVEST OPHTH VIS SCI, V44, P5355, DOI 10.1167/iovs.02-0819; Rodger J, 2012, PLOS ONE, V7; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Snider J, 2010, NEURON, V66, P45, DOI 10.1016/j.neuron.2010.02.013; Stuart G, 1998, J NEUROSCI, V18, P3501; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; SUMBUL U, 2014, NAT COMMUN, V5; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Tahayori B, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/065005; Tahayori B, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065006; Thomson Kelsey L, 2015, Alzheimers Dement (Amst), V1, P136, DOI 10.1016/j.dadm.2015.03.001; TORIS CB, 1995, J COMP NEUROL, V352, P535, DOI 10.1002/cne.903520405; Twyford P, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/025001; Wang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066763; Weiland JD, 2011, OPHTHALMOLOGY, V118, P2227, DOI 10.1016/j.ophtha.2011.08.042; Weitz AC, 2013, J NEUROPHYSIOL, V109, P1979, DOI 10.1152/jn.00852.2012; Werginz P, 2015, MINERVA MED, V106, P65; Werginz P, 2014, NEUROSCIENCE, V266, P162, DOI 10.1016/j.neuroscience.2014.01.067; Zeck G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020810; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	64	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193598	10.1371/journal.pone.0193598	http://dx.doi.org/10.1371/journal.pone.0193598			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494655	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200072
J	Tryon, CA; Lewis, JE; Ranhorn, KL; Kwekason, A; Alex, B; Laird, MF; Marean, CW; Niespolo, E; Nivens, J; Mabulla, AZP				Tryon, Christian A.; Lewis, Jason E.; Ranhorn, Kathryn L.; Kwekason, Amandus; Alex, Bridget; Laird, Myra F.; Marean, Curtis W.; Niespolo, Elizabeth; Nivens, Joelle; Mabulla, Audax Z. P.			Middle and Later Stone Age chronology of Kisese II rockshelter (UNESCO World Heritage Kondoa Rock-Art Sites), Tanzania	PLOS ONE			English	Article							MODERN HUMAN-BEHAVIOR; SOUTHERN-HEMISPHERE CALIBRATION; OSTRICH EGGSHELL BEADS; EAST-AFRICA; MUMBA ROCKSHELTER; MODERN HUMANS; SOIL-EROSION; WESTERN CAPE; CAL BP; TRANSITION	The archaeology of East Africa during the last similar to 65,000 years plays a central role in debates about the origins and dispersal of modern humans, Homo sapiens. Despite the historical importance of the region to these discussions, reliable chronologies for the nature, tempo, and timing of human behavioral changes seen among Middle Stone Age (MSA) and Later Stone Age (LSA) archaeological assemblages are sparse. The Kisese II rockshelter in the Kondoa region of Tanzania, originally excavated in 1956, preserves a >= 6-m-thick archaeological succession that spans the MSA/LSA transition, with lithic artifacts such as Levallois and bladelet cores and backed microliths, the recurrent use of red ochre, and >5,000 ostrich eggshell beads and bead fragments. Twenty-nine radiocarbon dates on ostrich eggshell carbonate make Kisese II one of the most robust chronological sequences for understanding archaeological change over the last similar to 47,000 years in East Africa. In particular, ostrich eggshell beads and backed microliths appear by 46-42 ka cal BP and occur throughout overlying Late Pleistocene and Holocene strata. Changes in lithic technology suggest an MSA/LSA transition that began 39-34.3 ka, with typical LSA technologies in place by the Last Glacial Maximum. The timing of these changes demonstrates the time-transgressive nature of behavioral innovations often linked to the origins of modern humans, even within a single region of Africa.	[Tryon, Christian A.; Ranhorn, Kathryn L.] Harvard Univ, Dept Anthropol, Peabody Museum Archaeol & Ethnol, Cambridge, MA 02138 USA; [Lewis, Jason E.] SUNY Stony Brook, Turkana Basin Inst, Stony Brook, NY USA; [Lewis, Jason E.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY USA; [Kwekason, Amandus; Mabulla, Audax Z. P.] Natl Museum Tanzania, Shaaban Robert St, Dar Es Salaam, Tanzania; [Alex, Bridget] Harvard Univ, Dept Human Evolutionary Biol, Peabody Museum Archaeol & Ethnol, Cambridge, MA 02138 USA; [Laird, Myra F.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Marean, Curtis W.] Arizona State Univ, Inst Human Origins, Sch Human Evolut & Social Change, Tempe, AZ USA; [Marean, Curtis W.] Nelson Mandela Univ, African Ctr Coastal Palaeosci, Port Elizabeth, South Africa; [Niespolo, Elizabeth] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Niespolo, Elizabeth] Berkeley Geochronol Ctr, Berkeley, CA USA; [Nivens, Joelle] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA	Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; University of Chicago; Arizona State University; Arizona State University-Tempe; Nelson Mandela University; University of California System; University of California Berkeley; Berkeley Geochronolgy Center; New York University	Tryon, CA (corresponding author), Harvard Univ, Dept Anthropol, Peabody Museum Archaeol & Ethnol, Cambridge, MA 02138 USA.	christiantryon@fas.harvard.edu	Mabulla, Audax ZP/ABE-2455-2020	Laird, Myra/0000-0002-8636-0407; Ranhorn, Kathryn/0000-0002-9048-5966; Niespolo, Elizabeth/0000-0002-9537-3031; Tryon, Christian/0000-0002-2354-3273; Lewis, Jason/0000-0001-8325-1128	Harvard University; American School for Prehistoric Research; Leakey Foundation; New York University Cliff Jolly award; Rutgers University Byrne Seminar Research Program; NSF IGERT DGE [0801634]; Fulbright-Hays DDRA; American School of Prehistoric Research (Harvard University)	Harvard University; American School for Prehistoric Research; Leakey Foundation; New York University Cliff Jolly award; Rutgers University Byrne Seminar Research Program; NSF IGERT DGE; Fulbright-Hays DDRA; American School of Prehistoric Research (Harvard University)	We thank Adi Inskeep, Jim Simons, Carmel Schrire, and Janette Deacon for sharing their time, expertise, and memories of Ray Inskeep and the fieldwork at Kisese II, Sheila Nightingale for the artifact illustrations, Jason Ur for volume calculations, Jennifer Miller and Andrew Kandel for discussions about ostrich eggshell beads, Aidan Baker, Cyprian Broodbank, Graeme Barker, Sara Harrop, and Sara Yuriko Cerenius for assistance with searching the Inskeep archives at Cambridge University, and Jennifer Charlson for permission to publish portions of them. The comments of Mary Prendergast, Michael Petraglia, Stanley Ambrose, Pamela Willoughby, and several anonymous reviewers caused us to seriously rethink our available data, observations, and arguments, for which we are very grateful. Our research is supported by Harvard University, the American School for Prehistoric Research, the Leakey Foundation, the New York University Cliff Jolly award, the Rutgers University Byrne Seminar Research Program, NSF IGERT DGE 0801634, and a Fulbright-Hays DDRA. All necessary permits were obtained for the described study, which complied with all relevant regulations. These include research permits 2015-115-ER-2013-122, 2015-116-ER-2015-212, 2015-120-NA-2015-24 issued by the Tanzanian Commission for Science and Technology, and permit number NCST/5/002/R/576 issued by the Kenyan National Commission for Science, Technology, and Innovation.; This work received support from the following sources: Harvard University (Dean's Fund/Start-up), C.A.T.; American School of Prehistoric Research (Harvard University), C.A.T.; Leakey Foundation, leakeyfoundation.org, J.E.L.; New York University Cliff Jolly Award, to M.F.L.; Rutgers University Byrne Seminar Research Program, to J.E.L.; NSF IGERT DGE 0801634 (inert.org), supporting M.F.L.; and Fulbright-Hays DDRA (https://www2.ed.gov/programs/iegpsddrap/applicant.html) to K.R.	Ambrose S.H., 2002, THINKING SMALL GLOBA, V12, P9; Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; [Anonymous], 1975, THESIS; [Anonymous], ANN CAPE PROVINCIAL; [Anonymous], 1977, ARCHAEOLOGICAL RES A, DOI DOI 10.1080/00672707709511250; [Anonymous], 1989, THESIS U ILLINOIS UR; [Anonymous], 2003, RES AFRICAS NEW CONT; [Anonymous], 1984, THESIS; [Anonymous], 2008, SPACE TIME WHICH DIA; Barthelme J, 2009, NYAME AKUME, V71, P54; Barut S., 1997, THESIS; BEAUMONT PB, 1972, AFR STUD, V31, P155, DOI 10.1080/00020187208707381; Biittner KM, 2017, AFR ARCHAEOL REV, V34, P275, DOI 10.1007/s10437-017-9253-3; Bird MI, 2003, QUATERNARY SCI REV, V22, P1805, DOI 10.1016/S0277-3791(03)00151-3; Blegen Nick, 2017, Paleoanthropology, P139; Blegen N, 2016, QUATERNARY SCI REV, V152, P152, DOI 10.1016/j.quascirev.2016.09.020; Boeda E, 1994, CONC LEV VAR METH; Boeda E., 1996, QUATERNARIA NOVA, VVI, P465; BRAUER G, 1980, AM J PHYS ANTHROPOL, V52, P71, DOI 10.1002/ajpa.1330520110; Bretzke K., 2006, MITTEILUNGEN GESELLS, V15, P63; Brown FH, 2013, J ARCHAEOL SCI, V40, P3233, DOI 10.1016/j.jas.2013.03.011; Bwasiri EJ, 2015, AZANIA, V50, P437, DOI 10.1080/0067270X.2015.1120436; CAHEN D, 1977, NATURE, V266, P812, DOI 10.1038/266812a0; Callow W. J., 1964, Radiocarbon, V6, P25; Campbell A, 2001, AFRICAN ROCK ART PAI; Clark J.D., 1970, PREHISTORY AFRICA; Clark JD, 1957, 3 PAN AFR C PREH LIV, P228; Clarkson C, 2017, NATURE, V547, P306, DOI 10.1038/nature22968; Cole G, 1967, QUATERNARIA, V9, P153; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; Dawson JB, 2008, MEMOIR, V33; Dayet L, 2017, J ARCHAEOL SCI-REP, V13, P635, DOI 10.1016/j.jasrep.2017.05.015; Diez-Martin F, 2009, J AFR ARCHAEOL, V7, P147, DOI 10.3213/1612-1651-10136; Eerkens JW, 2005, J ANTHROPOL ARCHAEOL, V24, P316, DOI 10.1016/j.jaa.2005.08.001; Eren MI, 2013, J ARCHAEOL SCI, V40, P248, DOI 10.1016/j.jas.2012.08.012; Eriksson MG, 2000, GEOMORPHOLOGY, V36, P107, DOI 10.1016/S0169-555X(00)00054-4; Faith JT, 2013, J BIOGEOGR, V40, P359, DOI 10.1111/j.1365-2699.2012.02796.x; Faith JT, 2012, PALAEOGEOGR PALAEOCL, V361, P84, DOI 10.1016/j.palaeo.2012.08.005; Fernandez VM, 2007, J AFR ARCHAEOL, V5, P91, DOI 10.3213/1612-1651-10087; Gliganic LA, 2012, J HUM EVOL, V62, P533, DOI 10.1016/j.jhevol.2012.02.004; Gow J., 1978, MILA, V7, P17; Gramly R.M., 1975, THESIS; Groucutt HS, 2015, EVOL ANTHROPOL, V24, P149, DOI 10.1002/evan.21455; Harvey VL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150650; Heckel C. E., 2017, QUAT INT; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Inskeep RR, 1962, ACTES IVE CONGRES PA, P249; Janz L, 2009, J ARCHAEOL SCI, V36, P1982, DOI 10.1016/j.jas.2009.05.012; Johnson BJ, 1998, GEOCHIM COSMOCHIM AC, V62, P2451, DOI 10.1016/S0016-7037(98)00175-6; Kandel AW, 2005, J ARCHAEOL SCI, V32, P1711, DOI 10.1016/j.jas.2005.05.010; Kessy ET, 2013, AFR ARCHAEOL REV, V30, P225, DOI 10.1007/s10437-013-9141-4; Kiffner C, 2016, AFR J ECOL, V54, P383, DOI 10.1111/aje.12286; Kindt R., 2015, POTENTIAL NATURAL VE; Klein R., 2009, HUMAN CAREER; Klein RG, 2008, EVOL ANTHROPOL, V17, P267, DOI 10.1002/evan.20181; Kuhn S., 2006, AFR ARCHAEOL REV, P109, DOI [DOI 10.1023/A:1011032025300, 10.1023/A:1011032025300]; Kuhn S.L., 2007, RETHINKING HUMAN REV, P45; Kuhn Steven L., 2014, Biology Theory, V9, P42, DOI 10.1007/s13752-013-0156-5; Kwekason AP, 2013, AFR ARCHAEOL REV, V30, P145, DOI 10.1007/s10437-013-9132-5; Lamprey H. F., 1963, Tanganyika Notes, VNo. 60, P10; Lamprey HF., 1964, AFR J ECOL, V2; Landau M., 1991, NARRATIVES HUMAN EVO; Lane P, 2009, INT J AFR HIST STUD, V42, P457; Leakey L.S.B, 1950, TANGANYIKA NOTES REC, V29, P15; Leakey L.S.B., 1936, STONE AGE AFRICA OUT; Leakey LSB., 1931, STONE AGE CULTURES K; Leakey LSB, 1952, ACT C PAN PREH SESS, P723; Leakey M, 1983, AFRICAS VANISHING AR; Lee-Thorp JA, 2015, AFR ARCHAEOL REV, V32, P793, DOI 10.1007/s10437-015-9202-y; Logie AC., 1972, SWA JB, P87; Magee JW, 2009, QUAT GEOCHRONOL, V4, P84, DOI 10.1016/j.quageo.2008.10.001; Marean C.W., 1990, THESIS; Marean CW, 2015, ANNU REV ANTHROPOL, V44, P533, DOI 10.1146/annurev-anthro-102313-025954; MAREAN CW, 1991, NATURE, V350, P418, DOI 10.1038/350418a0; Marean CW, 1990, 6 INT C INT COUNC AR; Masao F.T., 1982, 5 NAT MUS TANZ; Masao FT, 1976, THESIS; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mehlman M.J., 1991, CULTURAL BEGINNINGS, P177; MEHLMAN MJ, 1979, WORLD ARCHAEOL, V11, P80, DOI 10.1080/00438243.1979.9979751; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Mellars P, 2013, P NATL ACAD SCI USA, V110, P10699, DOI 10.1073/pnas.1306043110; Mercader J, 2012, QUATERNARY SCI REV, V47, P116, DOI 10.1016/j.quascirev.2012.05.018; Miller G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10496; Miller J., 2012, THESIS; Miller JM, 2014, J HUM EVOL, V74, P118, DOI 10.1016/j.jhevol.2013.12.011; Nelson C. M., 1973, THESIS; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; Orton J, 2008, J ARCHAEOL SCI, V35, P1765, DOI 10.1016/j.jas.2007.11.014; Pleurdeau D, 2014, QUATERN INT, V343, P117, DOI 10.1016/j.quaint.2014.02.001; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Prendergast ME, 2013, AZANIA, V48, P498, DOI 10.1080/0067270X.2013.841927; Prendergast ME, 2007, J AFR ARCHAEOL, V5, P217, DOI 10.3213/1612-1651-10093; Prendergast ME, 2014, J AFR ARCHAEOL, V12, P89, DOI 10.3213/2191-5784-10245; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rifkin RF, 2011, J AFR ARCHAEOL, V9, P131, DOI 10.3213/2191-5784-10199; Scerri EML, 2017, J ARCHAEOL SCI-REP, V11, P639, DOI 10.1016/j.jasrep.2017.01.003; Schrire C, 2003, S AFR ARCHAEOL BULL, V58, P100; Siiriainen A, 1984, SUOMEN MUINAISMUISTO, V86; Staurset S, 2014, J HUM EVOL, V75, P153, DOI 10.1016/j.jhevol.2014.04.006; Thorp C., 1992, AZANIA, V27, P21; Timmermann A, 2016, NATURE, V538, P92, DOI 10.1038/nature19365; Tixier J., 1999, PALEO, V11, P135, DOI DOI 10.3406/PAL.1999.1174; Tribolo C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169418; Tryon CA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0238; Tryon CA, 2015, P NATL ACAD SCI USA, V112, P2682, DOI 10.1073/pnas.1417909112; Tryon CA, 2013, CURR ANTHROPOL, V54, pS234, DOI 10.1086/673752; Valcke J, 1974, LATE STEENTIJD MUNYA; Vogel JC, 2001, RADIOCARBON, V43, P133; VONSCHIRNDING Y, 1982, ARCHAEOMETRY, V24, P3, DOI 10.1111/j.1475-4754.1982.tb00643.x; Vuruku M., 1997, KENYA PRESENT, V29, P49; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Wadley L, 2015, AZANIA, V50, P155, DOI 10.1080/0067270X.2015.1039236; Wanner H, 2008, QUATERNARY SCI REV, V27, P1791, DOI 10.1016/j.quascirev.2008.06.013; Watts I, 2002, S AFR ARCHAEOL BULL, V57, P1, DOI 10.2307/3889102; Watts I, 2010, J HUM EVOL, V59, P392, DOI 10.1016/j.jhevol.2010.07.006; Wayland EJ, 1932, J R ANTHROPOL INST G, V62, P369, DOI 10.2307/2843964; Weiss C., 2000, THESIS; Wengler L, 1995, MONOGRAPHS WORLD ARC, V23, P315; White F., 1983, VEGETATION AFRICA DE; WIESSNER P, 1984, J ANTHROPOL ARCHAEOL, V3, P190, DOI 10.1016/0278-4165(84)90002-3; Wiessner P., 1997, SAMPL PAP, V7, P157; Willoughby PR, 2012, QUATERN INT, V270, P103, DOI 10.1016/j.quaint.2012.02.021; Wilmsen EN, 2015, S AFR ARCHAEOL BULL, V70, P89; Wright DK, 2017, J ARCHAEOL SCI, V77, P64, DOI 10.1016/j.jas.2016.01.014	131	42	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192029	10.1371/journal.pone.0192029	http://dx.doi.org/10.1371/journal.pone.0192029			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489827	gold, Green Published			2022-12-27	WOS:000426276000016
J	Bickler, MP; Rhodes, LJ				Bickler, Margot P.; Rhodes, Laura J.			Accuracy of detection of carboxyhemoglobin and methemoglobin in human and bovine blood with an inexpensive, pocket-size infrared scanner	PLOS ONE			English	Article							PULSE CO-OXIMETRY; BEDSIDE TEST; EMERGENCY-DEPARTMENT; MANAGEMENT; HOSPITALS; HYPOXEMIA; HYPOXIA	Detecting life-threatening common dyshemoglobins such as carboxyhemoglobin (COHb, resulting from carbon monoxide poisoning) or methemoglobin (MetHb, caused by exposure to nitrates) typically requires a laboratory CO-oximeter. Because of cost, these spectrophotometer-based instrument are often inaccessible in resource-poor settings. The aim of this study was to determine if an inexpensive pocket infrared spectrometer and smartphone (SCiO (R) Pocket Molecular Sensor, Consumer Physics Ltd., Israel) accurately detects COHb and MetHb in single drops of blood. COHb was created by adding carbon monoxide gas to syringes of heparinized blood human or cow blood. In separate syringes, MetHb was produced by addition of sodium nitrite solution. After incubation and mixing, fractional concentrations of COHb or MetHb were measured using a Radiometer ABL-90 Flex (R) CO-oximeter. Fifty microliters of the sample were then placed on a microscope slide, a cover slip applied and scanned with the SCiO spectrometer. The spectrograms were used to create simple linear models predicting [COHb] or [MetHb] based on spectrogram maxima, minima and isobestic wavelengths. Our model predicted clinically significant carbon monoxide poisoning (COHb >= 15%) with a sensitivity of 93% and specificity of 88% (regression r(2) = 0.63, slope P<0.0001), with a mean bias of 0.11% and an RMS error of 21%. Methemoglobinemia severe enough to cause symptoms (>20% MetHb) was detected with a sensitivity of 100% and specificity of 71% (regression r(2) = 0.92, slope P<0.001) mean bias 2.7% and RMS error 21%. Although not as precise as a laboratory CO-oximeter, an inexpensive pocket-sized infrared scanner/smartphone detects >15% COHb or >20% MetHb on a single drop of blood with enough accuracy to be useful as an initial clinical screening. The SCiO and similar relatively low cost spectrometers could be developed as inexpensive diagnostic tools for developing countries.	[Bickler, Margot P.; Rhodes, Laura J.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Hypoxia Res Lab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bickler, MP (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Hypoxia Res Lab, San Francisco, CA 94143 USA.	mpbickler@gmail.com			UCSF Hypoxia Research Laboratory	UCSF Hypoxia Research Laboratory	This work was supported by unrestricted funds from the UCSF Hypoxia Research Laboratory. Funding is derived from unrelated medical device testing, development and validation.	Ash-Bernal R, 2004, MEDICINE, V83, P265, DOI 10.1097/01.md.0000141096.00377.3f; Ashurst John, 2011, Del Med J, V83, P203; BIANCHI-SCARRA G, 1976, Haematologica, V61, P261; DRABKIN DL, 1946, J BIOL CHEM, V164, P703; FEIG SA, 1972, BLOOD-J HEMATOL, V39, P407, DOI 10.1182/blood.V39.3.407.407; Feiner JR, 2013, ANESTH ANALG, V117, P847, DOI 10.1213/ANE.0b013e31828610a0; Feiner JR, 2010, ANESTH ANALG, V111, P1160, DOI 10.1213/ANE.0b013e3181f46da8; Feiner JR, 2010, ANESTH ANALG, V111, P143, DOI 10.1213/ANE.0b013e3181c91bb6; Ferrari LA, 2015, FORENSIC SCI INT, V256, P46, DOI 10.1016/j.forsciint.2015.08.010; Hampson NB, 2007, UNDERSEA HYPERBAR M, V34, P163; Hampson NB, 2006, J EMERG MED, V31, P13, DOI 10.1016/j.jemermed.2005.09.010; Janik M, 2017, J FORENSIC LEG MED, V48, P23, DOI 10.1016/j.jflm.2017.04.002; Kulcke A, 2016, ANESTH ANALG, V122, P1856, DOI 10.1213/ANE.0000000000001219; RODKEY FL, 1979, CLIN CHEM, V25, P1388; Rose JJ, 2017, AM J RESP CRIT CARE, V195, P596, DOI 10.1164/rccm.201606-1275CI; ROUGHTON FJW, 1945, AM J PHYSIOL, V145, P239, DOI 10.1152/ajplegacy.1945.145.2.239; Sebbane M, 2013, RESP CARE, V58, P1614, DOI 10.4187/respcare.02313; Shihana F, 2016, B WORLD HEALTH ORGAN, V94, P622, DOI 10.2471/BLT.15.158147; Shihana F, 2016, CLIN TOXICOL, V54, P576, DOI 10.1080/15563650.2016.1177651; Shihana F, 2010, ANN EMERG MED, V55, P184, DOI 10.1016/j.annemergmed.2009.07.022; Suner S, 2009, EXPERT REV MED DEVIC, V6, P125, DOI 10.1586/17434440.6.2.125; Weaver LK, 1999, NEW ENGL J MED, V340, P1290; Wikipedia, 2017, METH; Yurtseven S, 2015, TURK J EMERG MED, V15, P159, DOI 10.1016/j.tjem.2015.05.001; Zijlstra WG, 1996, SCAND J CLIN LAB INV, V56, P27, DOI 10.3109/00365519609088623	25	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193891	10.1371/journal.pone.0193891	http://dx.doi.org/10.1371/journal.pone.0193891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513738	Green Submitted, Green Published, gold			2022-12-27	WOS:000426896800087
J	Lancelotti, C				Lancelotti, Carla			'Not all that burns is wood'. A social perspective on fuel exploitation and use during the Indus urban period (2600-1900 BC)	PLOS ONE			English	Article							CHARCOAL MACRO-REMAINS; NORTHWEST INDIA; ARCHAEOLOGICAL CONTEXTS; VARIABLE ENVIRONMENTS; GEO-ETHNOARCHAEOLOGY; WOODLAND VEGETATION; FECAL SPHERULITES; OPAL PHYTOLITHS; SOUTH-ASIA; DUNG	Ancient civilisations depended heavily on natural fuel resources for a wide array of activities, and this had an impact on such resources that can be traced in the archaeological record. At its urban apex, the populations of the Indus Civilisation (2600 +/- 1900 BC) produced a wide range of objects and crafts, several of which involved highly specialised pyrotechnology. In the wake of increasing aridity and a period of weakened monsoon rainfall that affected South Asia from 2100 BC, these activities potentially put pressure on the natural resource base that may have had to be counterbalanced by differentiation in fuel use. The combined analysis of archaeobotanical and geoarchaeological remains from four Indus urban phase archaeological sites, has enable an assessment of the mechanisms through which people exploited wood, and diversified their fuel resources to adapt to the arid to semi-arid environments in which they lived. The combined use of local wood species with alternative fuels, such as dung and crop-processing leftovers, are evidence for resilient socio-ecological practices during the 700 years of Indus urbanism and perhaps beyond.	[Lancelotti, Carla] Univ Pompeu Fabra, Dept Humanities, CaSEs Res Grp, Barcelona, Spain	Pompeu Fabra University	Lancelotti, C (corresponding author), Univ Pompeu Fabra, Dept Humanities, CaSEs Res Grp, Barcelona, Spain.	carlalancelotti@upf.edu	Lancelotti, Carla/L-2655-2014	Lancelotti, Carla/0000-0003-1099-7329	AHRC Doctoral grant [2007/131224]; St John's College; Cambridge European Trust [300469695]; University of Cambridge (Isbel-Fletcher Garden Fund); University of Cambridge (Smuts Memorial Fund) [S2007/E2007]; University of Cambridge (Anthony Wilkin Fund)	AHRC Doctoral grant(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); St John's College; Cambridge European Trust; University of Cambridge (Isbel-Fletcher Garden Fund); University of Cambridge (Smuts Memorial Fund); University of Cambridge (Anthony Wilkin Fund)	The results presented in this paper are part of the author's PhD degree obtained at the University of Cambridge, Department of Archaeology in 2010. The research was funded by AHRC Doctoral grant (2007/131224), St John's College [no grant number], Cambridge European Trust (300469695) and The University of Cambridge (Isbel-Fletcher Garden Fund [no grant number], Smuts Memorial Fund [S2007/E2007], and Anthony Wilkin Fund [no grant number]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeret O, 1999, HOLOCENE, V9, P175, DOI 10.1191/095968399666631581; Albert RM, 1999, J ARCHAEOL SCI, V26, P1249, DOI 10.1006/jasc.1999.0355; Amundson Ronald, 1991, HARAPPA EXCAVATIONS, V3, P13; Anderson S., 1998, ENVIRON ARCHAEOL, V1, P99, DOI [10.1179/env.1996.1.1.99, DOI 10.1179/env.1996.1.1.99]; [Anonymous], LINGUISTICS ARCHAEOL; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2013, MAN ENV; Asouti E, 2003, J ARCHAEOL SCI, V30, P1185, DOI 10.1016/S0305-4403(03)00015-3; Asouti E, 2005, ENVIRON ARCHAEOL, V10, P1, DOI 10.1179/env.2005.10.1.1; Bangles Parpola A., 1990, S ASIAN ARCHAEOLOGY, P263; Bates J, 2017, VEG HIST ARCHAEOBOT, V26, P25, DOI 10.1007/s00334-016-0576-9; Belcher W.B., 1998, FISH EXPLOITATION BA; Bhan KK, 2007, EXCAVATIONS SHIKARPU; Bhatnagar IML, 1965, TREE SYMBOLS WORKSHI, P89; Braadbaart F, 2008, J ARCHAEOL SCI, V35, P2434, DOI 10.1016/j.jas.2008.03.016; Bull ID, 1999, ANTIQUITY, V73, P86, DOI 10.1017/S0003598X0008786X; BullIan D.M.E., 2005, INHABITING CATALHOYU, V38, P415, DOI [10.18866/j.ctt1pk874x, DOI 10.18866/J.CTT1PK874X]; Canti MG, 2003, CATENA, V54, P339, DOI 10.1016/S0341-8162(03)00127-9; Canti MG, 1999, J ARCHAEOL SCI, V26, P251, DOI 10.1006/jasc.1998.0322; Canti MG, 1998, J ARCHAEOL SCI, V25, P435, DOI 10.1006/jasc.1997.0210; Chabal L., 1992, B SOC BOT FR, V2, P213; Chabal L., 1997, FORETS SOC LANGUEDOC; Chakrabarti Dilip K., 1999, INDIA ARCHAEOLOGICAL; Champion HG, FOREST TYPES INDIA; Charles M., 1998, ENVIRON ARCHAEOL, V1, P111, DOI [DOI 10.1179/ENV.1996.1.1.111, 10.1179/env.1996.1.1.111]; de Lernia S, 2001, J ANTHROPOL ARCHAEOL, V20, P408, DOI 10.1006/jaar.2001.0384; Delhon C, 2008, J ARCHAEOL SCI, V35, P2937, DOI 10.1016/j.jas.2008.06.007; Desai BL, 1965, TREE SYMBOL WORSHIP, P54; Dixit Y, 2014, GEOLOGY, V42, P339, DOI 10.1130/G35236.1; Eksambekar SP, FORMATION PROCESSES; Evans JA, 2006, IAWA J, P5; Evershed RP, 1997, J ARCHAEOL SCI, V24, P485, DOI 10.1006/jasc.1996.0132; Evershed RP, 1996, ACS SYM SER, V625, P157, DOI 10.1021/bk-1996-0625.ch013; FAO, 2010, GLOBAL FOREST RESOUR; FAO, 2010, TECHNICAL REPORT; Friesem DE, 2016, J ARCHAEOL SCI, V70, P145, DOI 10.1016/j.jas.2016.05.004; Gamble J. S., 1902, MANUAL INDIAN TIMBER; Ghosh A, 1959, INDIAN ARCHAEOLOGY R, P50; Gur-Arieh S, 2014, J ARCHAEOL SCI, V46, P50, DOI 10.1016/j.jas.2014.03.011; Hastorf Christine A., 1998, Journal of Ethnobiology, V18, P211; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Holliday VT, 2007, J ARCHAEOL SCI, V34, P301, DOI 10.1016/j.jas.2006.05.004; Joglekar P.P., 2017, INDIAN J ARCHAEOLOGY, V2, P25; Joglekar PP, 2016, BHARATI, V39, P1; JONES AKG, 1988, ANTIQUITY, V62, P275, DOI 10.1017/S0003598X00074007; Kenoyer J.M, 1998, ANCIENT CITIES INDUS; Kenoyer JK, 1991, S ASIAN ARCHAEOLOGY, P165; Kenoyer JM, 1998, LAHORE MUEUM B, V9, P1; Kharakwal J.S., 2007, LINGUISTICS ARCHAEOL, P21; Lal Braj Basi, 1984, FRONTIERS INDUS CIVI, P511; Lancelotti C, 2010, THESIS; Lancelotti C, 2012, J ARCHAEOL SCI, V39, P953, DOI 10.1016/j.jas.2011.11.007; Law RW, 2011, CURRENT STUDIES INDU, V8; Madella M, 1998, J ARCHAEOL SCI, V25, P801, DOI 10.1006/jasc.1997.0226; Madella M, 2011, QUATERN INT, V275, P76; Madella M., 2003, INDUS ETHNOBIOLOGY N, P201; Madella M, 2006, QUATERNARY SCI REV, V25, P1283, DOI 10.1016/j.quascirev.2005.10.012; Marinova E, 2013, ENVIRON ARCHAEOL, V18, P1, DOI 10.1179/1461410313Z.00000000023; Meadow R.H., 2002, INDIAN ARCHAEOLOGY R, V2, P391; Meadow RH, ORIGINS SPREAD AGR P; Meadow RH, 2003, INDUS ETHNOBIOLOGY N, P65; Miller HML, 2013, CONNECTIONS AND COMPLEXITY: NEW APPROACHES TO THE ARCHAEOLOGY OF SOUTH ASIA, P161; Miller N.F., 1984, J ETHNOBIOL, V4, P15; Miller NF, 1996, CURR ANTHROPOL, V37, P521, DOI 10.1086/204514; Miller NF., 1988, CURRENT PALEOETHNOBO, P72; Miller NF., 1984, PALEORIENT, V10, P71; Neumann K., 2001, WOODS SAHARA SAHEL A; Orwa C, 2009, AGROFORESTRY TREE DA; Parpola A. H. S., 1994, DECIPHERING INDUS SC; Parpola Asko, 1992, S ASIAN ARCHAEOLOGY, P227; Patel Ajita K., 2009, Anthropozoologica, V44, P173, DOI 10.5252/az2009n1a8; PEARSALL DM, 1995, ECON BOT, V49, P183, DOI 10.1007/BF02862923; Pendall E, 1990, GEOARCHAEOLOGY, V5, P301; Petrie CA, 2017, J WORLD PREHIST, V30, P81, DOI 10.1007/s10963-017-9101-z; Petrie CA, 2017, CURR ANTHROPOL, V58, P1, DOI 10.1086/690112; Picornell Gelabert L, ANTHR ARCHAEO, V30, P375; Piperno D, 2006, PHYTOLITHS COMPREHEN; Portillo M, 2017, QUATERN INT, V431, P131, DOI 10.1016/j.quaint.2015.12.040; Possehl Gregory L., 2002, INDUS CIVILIZATION C; POWERS AH, 1989, J ARCHAEOL SCI, V16, P27, DOI 10.1016/0305-4403(89)90054-X; Rajaguru S.N., 2008, OCCASIONAL PAPER, P1; Reddy S. N., 1999, PALEORIENT, V24, P61; Reddy SN, 1997, J ANTHROPOL ARCHAEOL, V16, P162, DOI 10.1006/jaar.1997.0308; Rice P., 1987, POTTERY ANAL SOURCEB; SCHELVIS J, 1992, J ARCHAEOL SCI, V19, P677, DOI 10.1016/0305-4403(92)90037-4; Schuldenrein J, 2004, J ARCHAEOL SCI, V31, P777, DOI 10.1016/j.jas.2003.10.015; Shahack-Gross R, 2003, J ARCHAEOL SCI, V30, P439, DOI 10.1006/jasc.2002.0853; Shahack-Gross R, 2008, J ARCHAEOL SCI, V35, P965, DOI 10.1016/j.jas.2007.06.019; Shahack-Gross R, 2011, J ARCHAEOL SCI, V38, P205, DOI 10.1016/j.jas.2010.09.019; Sillar B, 2000, ARCHAEOMETRY, V42, P43, DOI 10.1111/j.1475-4754.2000.tb00865.x; Simpson IA, 1998, J ARCHAEOL SCI, V25, P729, DOI 10.1006/jasc.1997.0216; Valamoti SM, 2005, VEG HIST ARCHAEOBOT, V14, P528, DOI 10.1007/s00334-005-0090-y; VANDERVEEN M, 1982, J ARCHAEOL SCI, V9, P287, DOI 10.1016/0305-4403(82)90024-3; Weber S, 1999, ANTIQUITY, V73, P813, DOI 10.1017/S0003598X00065558; Weber S.A., 1991, PLANTS HARAPPAN SUBS; Weber SA, 2001, HARAPPA ARCHAEOLOGIC; WEBER SA, 2010, MAN ENV, V35, P62; Weber SA., 2003, INDUS ETHNOBIOLOGY N, P175; Wright R.P, 2010, ANCIENT INDUS URBANI; Zapata Pena L., 2003, AFRICA PRAEHISTORICA, P163; Zomer RJ, 2007, 122 IWMI; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014; Zurro D., THESIS; Zurro D., 2017, ARCHAEOL ANTHR SCI; [No title captured]	105	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192364	10.1371/journal.pone.0192364	http://dx.doi.org/10.1371/journal.pone.0192364			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513672	Green Submitted, Green Published, gold			2022-12-27	WOS:000426896800012
J	Ma, CB; Zhang, WY; Wu, QW; Liu, Y; Wang, C; Lao, GY; Yang, LT; Liu, P				Ma, Chengbin; Zhang, Wenying; Wu, Qiongwei; Liu, Yu; Wang, Chao; Lao, Guoying; Yang, Longtao; Liu, Ping			Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE REGULATORY FACTOR; RADICAL HYSTERECTOMY; MICROVESSEL DENSITY; FACTOR EXPRESSION; CIRCADIAN GENES; CANCER; ADENOCARCINOMA; IMPACT; PROGRESSION	Background The aim of this study is to find the potential miRNA expression signature capable of predicting survival time for cervical squamous cell carcinoma (CSCC) patients. Methods The expression of 332 miRNAs was measured in 131 (Training cohort) and 130 (Validation cohort) patients with CSCC in the Cancer Genome Atlas (TCGA) data portal. The miRNA expression signature was identified by Cox Proportion Hazard regression model to the Training data set, and subsequently validated in an independent Validation set. Kaplan-Meier curves and the receiver operating characteristic analyses of 5 years were used to access the overall survival of miRNA signature. MiRNA signature-gene target analysis was performed, followed by the construction of the regulatory network. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analysis were used to explore the function of target genes of miRNA signature. Results A 2-miRNA expression signature of hsa-mir-642a and hsa-mir-378c associated with survivability was identified in CSCC. Both of them had a significant diagnostic and prognostic value of patients with CSCC. A total of 345 miRNA signature-target pairs were obtained in the miRNA signature-gene target regulatory network, in which 316 genes were targets of has-mir-378c and has-mir-642a. Functional analysis of target genes showed that MAPK signaling pathway, VEGF signaling pathway and endocytosis were the significantly enriched signal pathways that covered most genes. Conclusions The 2-miRNA signature adds to the prognostic value of CSCC. In-depth interrogation of the 2-miRNAs will provide important biological insights that finding and developing novel molecularly prediction to improve prognosis for CSCC patients.	[Ma, Chengbin; Zhang, Wenying; Wu, Qiongwei; Liu, Yu; Wang, Chao; Lao, Guoying; Yang, Longtao; Liu, Ping] Changning Matern & Infant Hlth Hosp, Dept Gynecol, Shanghai, Peoples R China		Liu, P (corresponding author), Changning Matern & Infant Hlth Hosp, Dept Gynecol, Shanghai, Peoples R China.	lupingshai@163.com						Bachtiary B, 2002, CANCER LETT, V179, P197, DOI 10.1016/S0304-3835(01)00872-2; Bibi F, 2015, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3090-7; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Braoudaki M, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0096-y; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Chen JY, 2013, INT J MOL MED, V32, P557, DOI 10.3892/ijmm.2013.1424; Chen YX, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-88; Dai HJ, 2011, BREAST CANCER RES TR, V127, P531, DOI 10.1007/s10549-010-1231-2; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fujiwaki R, 2000, ANTICANCER RES, V20, P1317; Gao LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-118; Gao LJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-384; Guo P, 2015, ONCOTARGETS THER, V8, P73, DOI 10.2147/OTT.S72832; Han Y, 2017, TRANSL ONCOL, V10, P378, DOI 10.1016/j.tranon.2017.03.005; Hennessey PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032307; Hosaka M, 2011, INT J CLIN ONCOL, V16, P33, DOI 10.1007/s10147-010-0123-0; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033762; Intaraphet S, 2013, ASIAN PAC J CANCER P, V14, P5355, DOI 10.7314/APJCP.2013.14.9.5355; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kasamatsu T, 2009, BRIT J CANCER, V100, P1400, DOI 10.1038/sj.bjc.6605048; Koenning M, 2012, J NEUROSCI, V32, P12528, DOI 10.1523/JNEUROSCI.1069-12.2012; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lehtonen S, 2008, MOL BIOL CELL, V19, P2949, DOI 10.1091/mbc.E07-05-0521; Li Z, 2017, J CELL MOL MED, V21, P177, DOI 10.1111/jcmm.12951; Liu B, 2001, BRIT J CANCER, V85, P303, DOI 10.1054/bjoc.2001.1910; Liu B, 2016, ONCOTARGET, V7, P56690, DOI 10.18632/oncotarget.10678; Liu DQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11955; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Ma D, 2013, CHINESE J CANCER RES, V25, P656, DOI 10.3978/j.issn.1000-9604.2013.11.04; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Obermair A, 1997, J NATL CANCER I, V89, P1212, DOI 10.1093/jnci/89.16.1212; Olivares AM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00788-3; Patel S, 2009, CURR OPIN OBSTET GYN, V21, P54, DOI 10.1097/GCO.0b013e32831a9890; Qin XB, 2017, INT J NANOMED, V12, P3721, DOI 10.2147/IJN.S131516; Quwaider D, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0461-8; Rana Sobia, 2010, J Circadian Rhythms, V8, P3, DOI 10.1186/1740-3391-8-3; Ribel-Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051302; Shih MC, 2006, MOL CARCINOGEN, V45, P732, DOI 10.1002/mc.20198; Suprasert P, 2005, INT J GYNECOL CANCER, V15, P995, DOI 10.1111/j.1525-1438.2005.00259.x; Tang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.518; Tian RQ, 2011, J BIOL CHEM, V286, P25556, DOI 10.1074/jbc.M111.221564; Tjalma W, 2000, EUR J OBSTET GYN R B, V92, P251, DOI 10.1016/S0301-2115(99)00295-X; Trattner M, 2001, GYNECOL ONCOL, V82, P11, DOI 10.1006/gyno.2001.6252; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04386-1; Wang SS, 2004, CANCER-AM CANCER SOC, V100, P1035, DOI 10.1002/cncr.20064; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Weng QJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01732-1; Wu Q, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/597145; Xu L, 2011, ACTA OBSTET GYN SCAN, V90, P1200, DOI 10.1111/j.1600-0412.2011.01231.x; Yeh SA, 1999, GYNECOL ONCOL, V72, P10, DOI 10.1006/gyno.1998.5217; Yeung CLA, 2011, ONCOGENE, V30, P2401, DOI 10.1038/onc.2010.613; Zhang LY, 2013, PROG MOL BIOL TRANSL, V119, P51, DOI 10.1016/B978-0-12-396971-2.00003-8; Zhang WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167449; Zhao HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083571; Zhu Y, 2011, CHRONOBIOL INT, V28, P852, DOI 10.3109/07420528.2011.618896	59	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193625	10.1371/journal.pone.0193625	http://dx.doi.org/10.1371/journal.pone.0193625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513728	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800066
J	Makkar, SR; Haynes, A; Williamson, A; Redman, S				Makkar, Steve R.; Haynes, Abby; Williamson, Anna; Redman, Sally			Organisational capacity and its relationship to research use in six Australian health policy agencies	PLOS ONE			English	Article							PUBLIC-HEALTH; SERVICES RESEARCH; MAKERS; IMPLEMENTATION; DISSEMINATION; STRATEGIES; FRAMEWORK; CULTURE	There are calls for policymakers to make greater use of research when formulating policies. Therefore, it is important that policy organisations have a range of tools and systems to support their staff in using research in their work. The aim of the present study was to measure the extent to which a range of tools and systems to support research use were available within six Australian agencies with a role in health policy, and examine whether this was related to the extent of engagement with, and use of research in policymaking by their staff. The presence of relevant systems and tools was assessed via a structured interview called ORACLe which is conducted with a senior executive from the agency. To measure research use, four policymakers from each agency undertook a structured interview called SAGE, which assesses and scores the extent to which policymakers engaged with (i. e., searched for, appraised, and generated) research, and used research in the development of a specific policy document. The results showed that all agencies had at least a moderate range of tools and systems in place, in particular policy development processes; resources to access and use research (such as journals, databases, libraries, and access to research experts); processes to generate new research; and mechanisms to establish relationships with researchers. Agencies were less likely, however, to provide research training for staff and leaders, or to have evidence-based processes for evaluating existing policies. For the majority of agencies, the availability of tools and systems was related to the extent to which policymakers engaged with, and used research when developing policy documents. However, some agencies did not display this relationship, suggesting that other factors, namely the organisation's culture towards research use, must also be considered.	[Makkar, Steve R.; Haynes, Abby; Williamson, Anna; Redman, Sally] Sax Inst, Ultimo, NSW, Australia; [Haynes, Abby] Univ Sydney, Sydney Sch Publ Hlth, Camperdown, NSW, Australia	University of Sydney; University of Sydney	Makkar, SR (corresponding author), Sax Inst, Ultimo, NSW, Australia.	stevesnakkar@saxinstitute.org.au	Haynes, Abby/ABG-5448-2021; Haynes, Abby/D-3618-2016	Haynes, Abby/0000-0001-5703-5683	Centre for Informing Policy in Health with Evidence from Research (CIPHER) an Australian National Health and Medical Research Council Centre for Research Excellence [APP1001436]; NHMRC Post-Doctoral Fellowship [510 391]	Centre for Informing Policy in Health with Evidence from Research (CIPHER) an Australian National Health and Medical Research Council Centre for Research Excellence; NHMRC Post-Doctoral Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Centre for Informing Policy in Health with Evidence from Research (CIPHER) an Australian National Health and Medical Research Council Centre for Research Excellence (APP1001436) and administered by the University of Western Sydney. The third author (AW) holds an NHMRC Post-Doctoral Fellowship (ID: 510 391). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons GA, 2007, ADM POLICY MENT HLTH, V34, P411, DOI 10.1007/s10488-007-0121-3; Albert Michael A, 2007, Health Res Policy Syst, V5, P2, DOI 10.1186/1478-4505-5-2; Amara N, 2004, SCI COMMUN, V26, P75, DOI 10.1177/1075547004267491; BEYER JM, 1982, ADMIN SCI QUART, V27, P591, DOI 10.2307/2392533; Brennan SE, DEV VALIDAT IN PRESS; Brownson RC, 2006, AM J PREV MED, V30, P164, DOI 10.1016/j.amepre.2005.10.004; Brownson RC, 2009, ANNU REV PUBL HEALTH, V30, P175, DOI 10.1146/annurev.publhealth.031308.100134; Campbell Danielle M, 2009, Aust New Zealand Health Policy, V6, P21, DOI 10.1186/1743-8462-6-21; Chagnon F, 2010, IMPLEMENT SCI, P5; Chagnon F, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-41; Chambers DA, 2016, TRANSLATIONAL BEHAV; Contandriopoulos D, 2010, MILBANK Q, V88, P444, DOI 10.1111/j.1468-0009.2010.00608.x; de Goede J, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-26; Denis Jean-Louis, 2008, J Health Serv Res Policy, V13 Suppl 1, P1, DOI 10.1258/jhsrp.2007.007123; Dobbins M, 2004, Worldviews Evid Based Nurs, V1, P120, DOI 10.1111/j.1741-6787.2004.t01-1-04009.x; Dobbins M, 2002, ONLINE J KNOWL SYN N, V9; Dobbins M, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-20; El-Jardali F, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-2; El-Jardali F, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-2; Ellen ME, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-84; Ellen ME, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-60; Ettelt S, 2011, J HEALTH SERV RES PO, V16, P48, DOI 10.1258/jhsrp.2011.011004; Evans BA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-17; Glisson C, 2002, J ORGAN BEHAV, V23, P767, DOI 10.1002/job.162; Glisson C, 2008, ADM POLICY MENT HLTH, V35, P98, DOI 10.1007/s10488-007-0148-5; Glisson Charles, 2005, Ment Health Serv Res, V7, P243, DOI 10.1007/s11020-005-7456-1; Gold M, 2009, HEALTH SERV RES, V44, P1111, DOI 10.1111/j.1475-6773.2009.00958.x; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; HAM C, 1995, BRIT MED J, V310, P71, DOI 10.1136/bmj.310.6972.71; Haynes A, 2015, INT J SOC RES METHOD, V18, P145, DOI 10.1080/13645579.2014.921457; Haynes AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032665; Hemmelgarn AL, 2001, CHILD HEALTH CARE, V30, P93, DOI 10.1207/S15326888CHC3002_2; Hemsley-Brown J., 2004, INT J PUBLIC SECTOR, V17, P534, DOI DOI 10.1108/09513550410554805; Hennink M, 2005, J HEALTH COMMUN, V10, P163, DOI 10.1080/10810730590915128; Hennink M, 2006, J HEALTH COMMUN, P10; Huckel Schneider C, PUBLIC HLTH IN PRESS; Hyder AA, 2011, HEALTH POLICY PLANN, V26, P73, DOI 10.1093/heapol/czq020; Innvaer S, 2002, J HEALTH SERV RES PO, P7; Jacobson N, 2005, MILBANK Q, V83, P299, DOI 10.1111/j.1468-0009.2005.00348.x; Jones K, 2015, J PUBLIC HEALTH-UK, V37, P364, DOI 10.1093/pubmed/fdv076; Kothari A, 2005, HEALTH POLICY, V71, P117, DOI 10.1016/j.healthpol.2004.03.010; Lavis JN, 2002, MILBANK Q, V80, P125, DOI 10.1111/1468-0009.00005; Lavis JN, 2003, MILBANK Q, P81; Lavis John, 2005, J Health Serv Res Policy, V10 Suppl 1, P35, DOI 10.1258/1355819054308549; Lavis JN, 2006, B WORLD HEALTH ORGAN, V84, P620, DOI 10.2471/BLT.06.030312; Liverani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077404; Lomas J, 2003, MILBANK Q, V81, P363, DOI 10.1111/1468-0009.t01-1-00060; Makkar SR, RES EVALUAT IN PRESS; Makkar SR, 2016, HEALTH RES POLICY SY, V14, P1; Makkar SR, IMPLEMENT SCI; Makkar SR, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0022-y; Makkar SR, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0013-z; Makkar SR, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0241-1; Meijers JMM, 2006, J ADV NURS, V55, P622, DOI 10.1111/j.1365-2648.2006.03954.x; Meissner HI, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-12; Mirzoev TN, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-30; Morrato EH, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0281-6; Nelson TD, 2007, ADM POLICY MENT HLTH, V34, P319, DOI 10.1007/s10488-006-0111-x; Norton WE, 2014, PUBLIC HEALTH REP, V129, P536, DOI 10.1177/003335491412900613; Oliver K, 2014, BMC HEALTH SERV RES, P14; Orton L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021704; Patera N, 2013, J PUBLIC HEALTH-HEID, V21, P473, DOI 10.1007/s10389-013-0556-9; Petticrew M, 2004, J EPIDEMIOL COMMUN H, V58, P811, DOI 10.1136/jech.2003.015289; Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-105; Redman S, 2015, SOC SCI MED, V136, P147, DOI 10.1016/j.socscimed.2015.05.009; Ritter A, 2009, INT J DRUG POLICY, V20, P70, DOI 10.1016/j.drugpo.2007.11.017; Ross Suzanne, 2003, J Health Serv Res Policy, V8 Suppl 2, P26, DOI 10.1258/135581903322405144; Stamatakis KA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-29; Sumner A, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S3; Trostle J, 1999, HEALTH POLICY PLANN, V14, P103, DOI 10.1093/heapol/14.2.103; Weiss C.H., 1980, SOCIAL SCI RES DECIS; WEISS CH, 1979, PUBLIC ADMIN REV, V39, P426, DOI 10.2307/3109916; WEISS CH, 1980, KNOWLEDGE, V1, P381, DOI 10.1177/107554708000100303; Williamson A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005293; World Health Organization, 2012, CHANG MINDS STRAT HL; Zardo P, 2014, SOC SCI MED, V108, P120, DOI 10.1016/j.socscimed.2014.02.046	76	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192528	10.1371/journal.pone.0192528	http://dx.doi.org/10.1371/journal.pone.0192528			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513669	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800017
J	Guidotti, R; Sinibaldi, R; De Luca, C; Conti, A; Ilmoniemi, RJ; Zevenhoven, KCJ; Magnelind, PE; Pizzella, V; Del Gratta, C; Romani, GL; Della Penna, S				Guidotti, Roberto; Sinibaldi, Raffaele; De Luca, Cinzia; Conti, Allegra; Ilmoniemi, Risto J.; Zevenhoven, Koos C. J.; Magnelind, Per E.; Pizzella, Vittorio; Del Gratta, Cosimo; Romani, Gian Luca; Della Penna, Stefania			Optimized 3D co-registration of ultra-low-field and high-field magnetic resonance images	PLOS ONE			English	Article							MICROTESLA MRI; HUMAN BRAIN; MAGNETOENCEPHALOGRAPHY; ROBUST	The prototypes of ultra-low-field (ULF) MRI scanners developed in recent years represent new, innovative, cost-effective and safer systems, which are suitable to be integrated in multi-modal (Magnetoencephalography and MRI) devices. Integrated ULF-MRI and MEG scanners could represent an ideal solution to obtain functional (MEG) and anatomical (ULF MRI) information in the same environment, without errors that may limit source reconstruction accuracy. However, the low resolution and signal-to-noise ratio (SNR) of ULF images, as well as their limited coverage, do not generally allow for the construction of an accurate individual volume conductor model suitable for MEG localization. Thus, for practical usage, a high-field (HF) MRI image is also acquired, and the HF-MRI images are co-registered to the ULF-MRI ones. We address here this issue through an optimized pipeline (SWIM-Sliding WIndow grouping supporting Mutual information). The co-registration is performed by an affine transformation, the parameters of which are estimated using Normalized Mutual Information as the cost function, and Adaptive Simulated Annealing as the minimization algorithm. The sub-voxel resolution of the ULF images is handled by a sliding-window approach applying multiple grouping strategies to down-sample HF MRI to the ULF-MRI resolution. The pipeline has been tested on phantom and real data from different ULF-MRI devices, and comparison with well-known toolboxes for fMRI analysis has been performed. Our pipeline always outperformed the fMRI toolboxes (FSL and SPM). The HF-ULF MRI co-registration obtained by means of our pipeline could lead to an effective integration of ULF MRI with MEG, with the aim of improving localization accuracy, but also to help exploit ULF MRI in tumor imaging.	[Guidotti, Roberto; Sinibaldi, Raffaele; De Luca, Cinzia; Conti, Allegra; Pizzella, Vittorio; Del Gratta, Cosimo; Romani, Gian Luca; Della Penna, Stefania] Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Guidotti, Roberto; Sinibaldi, Raffaele; De Luca, Cinzia; Conti, Allegra; Pizzella, Vittorio; Del Gratta, Cosimo; Romani, Gian Luca; Della Penna, Stefania] Univ G DAnnunzio Chieti & Pescara, Inst Adv Biomed Technol, Chieti, Italy; [Ilmoniemi, Risto J.; Zevenhoven, Koos C. J.] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Aalto, Finland; [Magnelind, Per E.] Los Alamos Natl Lab, Phys Div MS D454, Appl Modern Phys Grp, Los Alamos, NM USA; [Della Penna, Stefania] Univ Chieti Pescara G DAnnunzio, UOS Aquila, Sede Lavoro CNR SPIN, Ist SPIN,Consiglio Nazl Ric, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; Aalto University; United States Department of Energy (DOE); Los Alamos National Laboratory; Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR); G d'Annunzio University of Chieti-Pescara	Guidotti, R (corresponding author), Dept Neurosci Imaging & Clin Sci, Chieti, Italy.; Guidotti, R (corresponding author), Univ G DAnnunzio Chieti & Pescara, Inst Adv Biomed Technol, Chieti, Italy.	r.guidotti@unich.it	Ilmoniemi, Risto/E-9704-2012; Conti, Allegra/A-1465-2017	Ilmoniemi, Risto/0000-0002-3340-2618; Conti, Allegra/0000-0003-4210-5065; Della Penna, Stefania/0000-0001-5067-4327	European Union's Horizon research and innovation programme [686865]	European Union's Horizon research and innovation programme	This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 686865. The present work reflects only the authors' view; the Commission is not responsible for any use that may be made of the information it contains.	Adjamian P, 2004, CLIN NEUROPHYSIOL, V115, P691, DOI 10.1016/j.clinph.2003.10.023; Ashburner J, 2012, NEUROIMAGE, V62, P791, DOI 10.1016/j.neuroimage.2011.10.025; Cha S, 2007, CITY, V1, DOI DOI 10.1007/S00167-009-0884-Z; Choi S.S., 2010, J SYST CYBERN INFORM, V8, P43; Clarke J, 2007, ANNU REV BIOMED ENG, V9, P389, DOI 10.1146/annurev.bioeng.9.060906.152010; Del Gratta C, 2001, REP PROG PHYS, V64, P1759, DOI 10.1088/0034-4885/64/12/204; Della Penna S, 2014, SUPERCOND SCI TECH, V27, DOI 10.1088/0953-2048/27/4/044004; Fuerst B, 2014, MED IMAGE ANAL, V18, P1312, DOI 10.1016/j.media.2014.04.008; Galante A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142701; Hilschenz I, 2013, MAGN RESON IMAGING, V31, P171, DOI 10.1016/j.mri.2012.06.014; Ingber L., 1996, CONTROL CYBERN, P33; Inglis B, 2013, P NATL ACAD SCI USA, V110, P19194, DOI 10.1073/pnas.1319334110; Jahne B., 2002, DIGITAL IMAGE PROCES, P622; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Korber R, 2013, J MAGN RESON, V237, P182, DOI 10.1016/j.jmr.2013.10.011; Korber R., 2016, SUPERCOND SCI TECH, V29, P113001; Lehmann TM, 1999, IEEE T MED IMAGING, V18, P1049, DOI 10.1109/42.816070; Liao YL, 2011, MED BIOL ENG COMPUT, V49, P671, DOI 10.1007/s11517-010-0724-9; MacKay DJC, 2003, INFORM THEORY INFERE, P640; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Magnelind PE, 2011, IEEE T APPL SUPERCON, V21, P456, DOI 10.1109/TASC.2010.2088353; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; McDermott R, 2004, P NATL ACAD SCI USA, V101, P7857, DOI 10.1073/pnas.0402382101; Mercier L, 2012, MED PHYS, V39, P3253, DOI 10.1118/1.4709600; Myers RW, 2006, POTENTIAL APPL MICRO; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Sannazzari GL, 2002, BRIT J RADIOL, V75, P603, DOI 10.1259/bjr.75.895.750603; Sarkar A, 2005, MED DOSIM, V30, P20, DOI 10.1016/j.meddos.2004.10.004; Sarracanie M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15177; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinibaldi R, 2018, J TISSUE ENG REGEN M, V12, P750, DOI 10.1002/term.2494; Sinibaldi R, 2013, J BIOM GRAPH COMP, V3, P85; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Troebinger L, 2014, NEUROIMAGE, V86, P583, DOI 10.1016/j.neuroimage.2013.07.065; Vesanen PT, 2014, MAGN RESON IMAGING, V32, P766, DOI 10.1016/j.mri.2014.01.012; Vesanen PT, 2013, MAGN RESON MED, V69, P1795, DOI 10.1002/mrm.24413; Vesanen PT, 2012, IEEE T MAGN, V48, P53, DOI 10.1109/TMAG.2011.2167627; Viergever MA, 2016, MED IMAGE ANAL, V33, P140, DOI 10.1016/j.media.2016.06.030; Wolpert DH, 1995, IEEE T EVOLUTIONARY, V1, P67; Zaveri T, 2011, J PATTERN RECOGNIT R, V6, P140, DOI 10.13176/11.175; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9; Zotev VS, 2008, J MAGN RESON, V194, P115, DOI 10.1016/j.jmr.2008.06.007; Zotev VS, 2008, J MAGN RESON, V192, P197, DOI 10.1016/j.jmr.2008.02.015; Zotev VS, 2007, SUPERCOND SCI TECH, V20, pS367, DOI 10.1088/0953-2048/20/11/S13	50	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193890	10.1371/journal.pone.0193890	http://dx.doi.org/10.1371/journal.pone.0193890			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509780	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200039
J	Saetre, CL; Johnsen, A; Stensrud, E; Cramer, ERA				Saetre, Camilla Lo Cascio; Johnsen, Arild; Stensrud, Even; Cramer, Emily R. A.			Sperm morphology, sperm motility and paternity success in the bluethroat (Luscinia svecica)	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; AGE-RELATED VARIATION; FERTILIZATION SUCCESS; SEXUAL SELECTION; EVOLUTIONARY CONSEQUENCES; COMPETITION; PASSERINE; QUALITY; STORAGE; FERTILITY	Postcopulatory sexual selection may select for male primary sexual characteristics like sperm morphology and sperm motility, through sperm competition or cryptic female choice. However, how such characteristics influence male fertilization success remains poorly understood. In this study, we investigate possible correlations between sperm characteristics and paternity success in the socially monogamous bluethroat (Luscinia svecica svecica), predicting that sperm length and sperm swimming speed is positively correlated with paternity success. In total, 25% (15/61) of broods contained extra-pair offspring and 10% (33/315) of the offspring were sired by extra-pair males. Paternity success did not correlate significantly with sperm morphology or any aspects of sperm motility. Furthermore, sperm morphology and sperm motility did not correlate significantly with male morphological characters that previously have been shown to be associated with paternity success. Thus, the sperm characteristics investigated here do not appear to be strong predictors of paternity success in bluethroats.	[Saetre, Camilla Lo Cascio; Johnsen, Arild; Stensrud, Even; Cramer, Emily R. A.] Univ Oslo, Nat Hist Museum, Oslo, Norway	University of Oslo	Saetre, CL (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	c.l.c.satre@ibv.uio.no		Johnsen, Arild/0000-0003-4864-6284	Research Council of Norway [213592]	Research Council of Norway(Research Council of Norway)	This work was supported by The Research Council of Norway, grant number 213592. URL: http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, EVOLUTION, V40, P574, DOI 10.1111/j.1558-5646.1986.tb00508.x; ALLEN T. E., 1957, AUSTRALIAN JOUR AGRIC RES, V8, P788, DOI 10.1071/AR9570788; Bakst M. R., 1994, Poultry Science Reviews, V5, P117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennison C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1897; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1992, SPERM COMPETITION BI; Bitton PP, 2007, ANIM BEHAV, V74, P1777, DOI 10.1016/j.anbehav.2007.03.018; Boschetto C, 2011, BEHAV ECOL SOCIOBIOL, V65, P813, DOI 10.1007/s00265-010-1085-y; Bouwman KM, 2007, ANIM BEHAV, V73, P15, DOI 10.1016/j.anbehav.2006.01.031; Briskie JV, 1997, EVOLUTION, V51, P937, DOI 10.1111/j.1558-5646.1997.tb03674.x; Briskie JV, 1996, FUNCT ECOL, V10, P375, DOI 10.2307/2390286; BRISKIE JV, 1993, CONDOR, V95, P442, DOI 10.2307/1369366; Calhim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028809; Casselman SJ, 2006, CAN J FISH AQUAT SCI, V63, P2119, DOI 10.1139/F06-108; Cramer ERA, 2016, ECOL EVOL, V6, P1363, DOI 10.1002/ece3.1977; Cramer ERA, 2013, BEHAV ECOL SOCIOBIOL, V67, P1845, DOI 10.1007/s00265-013-1594-6; Cramer ERA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059208; Cramer ERA, 2013, J ORNITHOL, V154, P129, DOI 10.1007/s10336-012-0878-3; CROW JF, 1958, AM ANTHROPOL, V60, P1; Delmore KE, 2008, BEHAV ECOL, V19, P1243, DOI 10.1093/beheco/arn081; Denk AG, 2005, BEHAV ECOL, V16, P825, DOI 10.1093/beheco/ari065; Dobbe K., 2014, THESIS; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Edme A, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-016-2242-8; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Fossoy F, 2008, EVOLUTION, V62, P145, DOI 10.1111/j.1558-5646.2007.00284.x; Freeman-Gallant CR, 2005, EVOLUTION, V59, P422, DOI 10.1111/j.0014-3820.2005.tb01000.x; Froman D, 2003, BIOL REPROD, V69, P248, DOI 10.1095/biolreprod.102.013482; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; GAGE MJG, 1994, P ROY SOC B-BIOL SCI, V258, P247, DOI 10.1098/rspb.1994.0169; Gasparini C, 2010, J EVOLUTION BIOL, V23, P124, DOI 10.1111/j.1420-9101.2009.01889.x; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hasson O, 2009, BIOL REV, V84, P225, DOI 10.1111/j.1469-185X.2008.00068.x; Helfenstein F, 2010, BEHAV ECOL SOCIOBIOL, V64, P557, DOI 10.1007/s00265-009-0871-x; Hogner S, 2013, BEHAV ECOL SOCIOBIOL, V67, P1205, DOI 10.1007/s00265-013-1548-z; Humphries S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-319; Immler S, 2007, J EVOLUTION BIOL, V20, P1008, DOI 10.1111/j.1420-9101.2007.01302.x; Immler S, 2008, EVOLUTION, V62, P1538, DOI 10.1111/j.1558-5646.2008.00393.x; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; Johnsen A, 2003, OECOLOGIA, V136, P476, DOI 10.1007/s00442-003-1286-4; Johnsen A, 2003, ETHOLOGY, V109, P147, DOI 10.1046/j.1439-0310.2003.00861.x; Johnsen A, 2001, BEHAVIOUR, V138, P1371, DOI 10.1163/156853901317367645; Johnsen A, 2012, BEHAV ECOL SOCIOBIOL, V66, P181, DOI 10.1007/s00265-011-1265-4; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Krakauer AH, 2011, J EVOLUTION BIOL, V24, P2064, DOI 10.1111/j.1420-9101.2011.02317.x; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Laskemoen T, 2008, J AVIAN BIOL, V39, P322, DOI 10.1111/j.0908-8857.2008.04178.x; Laskemoen T, 2007, ORNIS FENNICA, V84, P131; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; Lifjeld JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013456; Lupold S, 2009, BEHAV ECOL SOCIOBIOL, V63, P899, DOI 10.1007/s00265-009-0733-6; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Mossman J, 2009, EVOLUTION, V63, P2730, DOI 10.1111/j.1558-5646.2009.00753.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Peters A, 2004, J EVOLUTION BIOL, V17, P1111, DOI 10.1111/j.1420-9101.2004.00743.x; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Powell M. J. D, 2009, 2009NA06 DAMTP U CAM; Rosengrave P, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0001; Rowe M, 2013, EMU, V113, P218, DOI 10.1071/MU12084; Rowe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015720; Rowe M, 2010, ANIM BEHAV, V79, P1239, DOI 10.1016/j.anbehav.2010.02.020; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Svensson L., 1992, IDENTIFICATION GUIDE; Webster MS, 1995, EVOLUTION, V49, P1147, DOI [10.2307/2410439, 10.1111/j.1558-5646.1995.tb04441.x]; Webster MS, 2001, BEHAV ECOL, V12, P439, DOI 10.1093/beheco/12.4.439; WETTON JH, 1991, P ROY SOC B-BIOL SCI, V245, P227, DOI 10.1098/rspb.1991.0114; Wolfson A., 1952, Bird-Banding, V23, P159; Yeates SE, 2013, EVOLUTION, V67, P3523, DOI 10.1111/evo.12208	75	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0192644	10.1371/journal.pone.0192644	http://dx.doi.org/10.1371/journal.pone.0192644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509773	Green Published, gold			2022-12-27	WOS:000426813200006
J	Syed, S; Iqbal, NT; Sadiq, K; Ma, JNZ; Akhund, T; Xin, WJ; Moore, SR; Liu, EJ; Qureshi, S; Gosselin, K; Gewirtz, A; Duggan, CP; Ali, SA				Syed, Sana; Iqbal, Najeeha T.; Sadiq, Kamran; Ma, Jennie Z.; Akhund, Tauseef; Xin, Wenjun; Moore, Sean R.; Liu, Enju; Qureshi, Shahida; Gosselin, Kerri; Gewirtz, Andrew; Duggan, Christopher P.; Ali, S. Asad			Serum anti-flagellin and anti-lipopolysaccharide immunoglobulins as predictors of linear growth faltering in Pakistani infants at risk for environmental enteric dysfunction	PLOS ONE			English	Article							PROINFLAMMATORY RESPONSE; BACTERIAL FLAGELLIN; ENTEROPATHY; PERMEABILITY; INFLAMMATION; INFECTIONS; INNATE; INDUCE	Background Environmental Enteric Dysfunction (EED) in children from low-income countries has been linked to linear growth declines. There is a critical need to identify sensitive and early EED biomarkers. Objective Determine whether levels of antibodies against bacterial components flagellin (flic) and lipopolysaccharide (LPS) predict poor growth. Design/Methods In a prospective birth cohort of 380 children in rural Pakistan blood and stool samples were obtained at ages 6 and 9 months. Linear mixed effects models were used to examine longitudinal associations between quartiles of anti-flic and anti-LPS antibodies and changes in LAZ, WAZ and WLZ scores. Spearman's correlations were measured between anti-flic and anti-LPS immunoglobulins with measures of systemic/enteric inflammation and intestinal regeneration. Results Anti-LPS IgA correlated significantly with CRP, AGP and Reg1 serum at 6mo and with MPO at 9mo. In multivariate analysis at 6mo of age, higher anti-LPS IgA levels predicted greater declines in LAZ scores over subsequent 18mo (comparing highest to lowest quartile, beta (SE) change in LAZ score/year = -0.313 (0.125), p-value = 0.013). Anti-flic Ig A in the two highest quartiles measured at 9mo of age had declines in LAZ of -0.269 (0.126), p = 0.033; and -0.306 (0.129), p = 0.018 respectively, during the subsequent 18mo of life, compared to those in the lowest quartile of anti-flic IgA. Conclusions and relevance Elevated anti-flic IgA and anti-LPS IgA antibodies at 6 and 9mo, predict declines in linear growth. Systemic and enteric inflammation correlated with anti-LPS IgA provides mechanistic considerations for potential future interventions.	[Syed, Sana; Moore, Sean R.] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Syed, Sana; Iqbal, Najeeha T.; Sadiq, Kamran; Akhund, Tauseef; Qureshi, Shahida; Ali, S. Asad] Aga Khan Univ, Dept Pediat, Karachi, Pakistan; [Syed, Sana; Liu, Enju; Gosselin, Kerri; Duggan, Christopher P.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Ma, Jennie Z.; Xin, Wenjun] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Gewirtz, Andrew] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Duggan, Christopher P.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Duggan, Christopher P.] Harvard TH Chan Sch Publ Hlth, Dept Populat, Boston, MA USA; [Duggan, Christopher P.] Harvard TH Chan Sch Publ Hlth, Nutr, Boston, MA USA	University of Virginia; Aga Khan University; Harvard University; Boston Children's Hospital; University of Virginia; University System of Georgia; Georgia State University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Ali, SA (corresponding author), Aga Khan Univ, Dept Pediat, Karachi, Pakistan.	asad.ali@aku.edu		Moore, Sean/0000-0003-1150-6632; Syed, Sana/0000-0003-0954-0583; Ali, Syed Asad/0000-0001-5274-7665	Bill and Melinda Gates Foundation [OPP1066200, OPP1066203]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK034854] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Bill and Melinda Gates Foundation Grant OPP1066200 to AA and OPP1066203 to CPD. The funder had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Ali A, 2016, CURR OPIN GASTROEN, V32, P12, DOI 10.1097/MOG.0000000000000226; BARROW PA, 1994, INT J FOOD MICROBIOL, V21, P55, DOI 10.1016/0168-1605(94)90200-3; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Crane RJ, 2015, FOOD NUTR BULL, V36, pS76, DOI 10.1177/15648265150361S113; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gewirtz AT, 2006, CURR OPIN GASTROEN, V22, P8, DOI 10.1097/01.mog.0000194791.59337.28; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Goto R, 2009, BRIT J NUTR, V101, P1509, DOI 10.1017/S0007114508083554; Guerrant RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158772; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Iqbal N, 2018, SCI REPORTS; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Kosek MN, 2017, EBIOMEDICINE, V18, P109, DOI 10.1016/j.ebiom.2017.02.024; KRUIS W, 1987, HEPATO-GASTROENTEROL, V34, P123; Lampl M, 2001, ANN HUM BIOL, V28, P403, DOI 10.1080/03014460010016662; McDonald CM, 2016, AM J CLIN NUTR; Petri WA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0187-1; Reed KA, 2002, J BIOL CHEM, V277, P13346, DOI 10.1074/jbc.M200149200; Syed S., 2016, J PEDIAT GASTROENTER; WADOLKOWSKI EA, 1988, INFECT IMMUN, V56, P1030, DOI 10.1128/IAI.56.5.1030-1035.1988; WHO, WHO CHILD GROWTH STA; world health organization, DIARRH DIS FACT SHEE; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Ziegler TR, 2008, AM J PHYSIOL-REG I, V294, pR402, DOI 10.1152/ajpregu.00650.2007	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193768	10.1371/journal.pone.0193768	http://dx.doi.org/10.1371/journal.pone.0193768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509790	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200029
J	Zhang, H; Zhao, SZ; Liu, HS; Liang, SD				Zhang, Hu; Zhao, Shuzhi; Liu, Huasheng; Liang, Shidong			Design of limited-stop service based on the degree of unbalance of passenger demand	PLOS ONE			English	Article							BUS; TIME	This paper presents a limited-stop service for a bus fleet to meet the unbalanced demand of passengers on a bus route and to improve the transit service of the bus route. This strategy includes two parts: a degree assessment of unbalanced passenger demand and an optimization of the limited-stop service. The degree assessment of unbalanced passenger demand, which is based on the different passenger demand between stations and the unbalance of passengers within the station, is used to judge whether implementing the limited- stop service is necessary for a bus route. The optimization of limited-stop service considers the influence of stop skipping action and bus capacity on the left-over passengers to determine the proper skipping stations for the bus fleet serving the entire route by minimizing both the waiting time and in-vehicle time of passengers and the running time of vehicles. A solution algorithm based on genetic algorithm is also presented to evaluate the degree of unbalanced passenger demand and optimize the limited-stop scheme. Then, the proper strategy is tested on a bus route in Changchun city of China. The threshold of degree assessment of unbalanced passenger demand can be calibrated and adapted to different passenger demands.	[Zhang, Hu; Zhao, Shuzhi; Liu, Huasheng] Jilin Univ, Coll Transportat, Changchun, Jilin, Peoples R China; [Liang, Shidong] Univ Shanghai Sci & Technol, Busines Sch, Shanghai, Peoples R China	Jilin University; University of Shanghai for Science & Technology	Liu, HS (corresponding author), Jilin Univ, Coll Transportat, Changchun, Jilin, Peoples R China.	liuhuasheng521@163.com	Zhang, Hu/P-7438-2019	Zhang, Hu/0000-0002-2254-264X	National Natural Science Foundation of China [51378237]; National Science Foundation for Young Scientists of China [51608224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Young Scientists of China	The work was supported by the National Natural Science Foundation of China (Grant No. 51378237) and the National Science Foundation for Young Scientists of China (Grant No. 51608224).	Agrawal J, 2004, J COMPUT CIVIL ENG, V18, P248, DOI 10.1061/(ASCE)0887-3801(2004)18:3(248); [Anonymous], 2016, J NANOMATER, DOI [DOI 10.1016/J.FSIGEN.2016.01.005, DOI 10.1155/2016/2358276]; [Anonymous], 1985, TRANSPORTATION RES R, DOI DOI https://doi.org/10.3141/2111-07; Bie Y, 2011, J TRANSPORTATION ENG, V138, P12; Bie YM, 2015, TRANSPORT RES C-EMER, V60, P443, DOI 10.1016/j.trc.2015.09.016; Ceder A., 1987, TRANSP RES REC, V1221, P8; Chen JX, 2015, TRANSPORT RES E-LOG, V83, P1, DOI 10.1016/j.tre.2015.08.007; Chiraphadhanakul V, 2013, PUBLIC TRANSPORT, V5, P53, DOI 10.1007/s12469-013-0067-7; Cortes CE, 2011, TRANSPORT RES A-POL, V45, P419, DOI 10.1016/j.tra.2011.02.002; Fan W, 2006, J TRANSP ENG-ASCE, V132, P40, DOI 10.1061/(ASCE)0733-947X(2006)132:1(40); Freyss M, 2013, TRANSPORT RES C-EMER, V36, P419, DOI 10.1016/j.trc.2013.07.004; Furth P.G., 1987, TRANSPORTATION RES R, V1108, P42; Ibarra-Rojas OJ, 2015, TRANSPORT RES B-METH, V77, P38, DOI 10.1016/j.trb.2015.03.002; Leiva C, 2010, TRANSPORT RES B-METH, V44, P1186, DOI 10.1016/j.trb.2010.01.003; Li Y, 2017, TRANSPORT RES C-EMER, V77, P306, DOI 10.1016/j.trc.2017.02.005; Liu ZY, 2013, TRANSPORT RES C-EMER, V35, P46, DOI 10.1016/j.trc.2013.06.004; Ma XL, 2018, J CLEAN PROD, V170, P1052, DOI 10.1016/j.jclepro.2017.09.182; Tetreault PR, 2010, TRANSPORT RES A-POL, V44, P390, DOI 10.1016/j.tra.2010.03.009; Yu B., 2015, PROMET TRAFFIC TRAFF, V27; Yu B, 2012, TRANSPORT RES A-POL, V46, P1265, DOI 10.1016/j.tra.2012.05.009; Yu H, 2017, IEEE T INTELL TRANSP, P1; Yu HY, 2016, TRANSPORT RES C-EMER, V72, P45, DOI 10.1016/j.trc.2016.09.007	22	9	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193855	10.1371/journal.pone.0193855	http://dx.doi.org/10.1371/journal.pone.0193855			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505585	gold, Green Published, Green Submitted			2022-12-27	WOS:000426548200037
J	Lee, M; Baek, H; Park, JS; Kim, S; Kyung, C; Baik, SJ; Lee, BK; Kim, JH; Ahn, CW; Kim, KR; Kang, S				Lee, Minyoung; Baek, Haeri; Park, Jong Suk; Kim, Sohee; Kyung, Chanhee; Baik, Su Jung; Lee, Byoung Kwon; Kim, Jie-Hyun; Ahn, Chul Woo; Kim, Kyung Rae; Kang, Shinae			Current Helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study	PLOS ONE			English	Article							ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK-FACTORS; MYOCARDIAL-INFARCTION; CHLAMYDIA-PNEUMONIAE; ERADICATION THERAPY; STRAINS; SEROPOSITIVITY; INFLAMMATION	Helicobacter pylori is a gastrointestinal pathogen known to be associated with cardiovascular disease (CVD). However, most analyses about the effect of H. pylori infection have been done in patients with a history of CVD but not in healthy subjects. We evaluated the association between H. pylori infection and subclinical atherosclerosis by using cardiac multidetector computed tomography (MDCT) in healthy subjects without previous CVD. From December 2007 to February 2014, 463 subjects who underwent the rapid urease test (CLO test), pulse-wave velocity (PWV) measurement, and MDCT for a self-referred health checkup were enrolled to this study. Helicobacter pylori infection was defined on the basis of CLO test positivity on endoscopic gastric biopsy. Significant coronary artery stenosis was defined as >= 50% stenosis in any of the major epicardial coronary vessel on MDCT. The CLO-positive subjects had a lower high-density lipoprotein-cholesterol (HDL-cholesterol) level compared to the CLO-negative subjects. The incidence of significant coronary stenosis was higher in the CLO-positive group (7.6% vs. 2.9%, P = 0.01). Furthermore, the number of subjects with coronary artery calcium score > 0 and log{(number of segments with plaque)+ 1} were also significantly higher in the CLO-positive group. However, there was no statistical difference in the number of subjects with coronary artery calcium score > 100, the prevalence of any plaque nor the plaque characteristics (calcified, mixed, or soft). Pulse-wave velocity (PWV) was neither associated with CLO test positivity. The CLO-positive group was 3-fold more likely to have significant coronary artery stenosis even after adjusting for confounding factors (adjusted odds ratio 2.813, 95% confidence interval 1.051-7.528, P = 0.04). In a healthy population, current H. pylori infection was associated with subclinical but significant coronary artery stenosis. The causal relationship between H. pylori infection and subclinical atherosclerosis in a "healthy" population remains to be investigated in the future.	[Lee, Minyoung; Baek, Haeri; Park, Jong Suk; Kyung, Chanhee; Ahn, Chul Woo; Kim, Kyung Rae; Kang, Shinae] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Div Endocrinol,Dept Internal Med, Seoul, South Korea; [Baek, Haeri] HPlus Yangji Gen Hosp, Dept Internal Med, Seoul, South Korea; [Park, Jong Suk; Ahn, Chul Woo; Kang, Shinae] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul, South Korea; [Kim, Sohee] Aswell Convalescent Hosp, Gwangju, South Korea; [Kyung, Chanhee] Rhin Hosp, Gyeonggi Do, South Korea; [Baik, Su Jung] Gangnam Severance Hosp, Hlth Promot Ctr, Healthcare Res Team, Seoul, South Korea; [Lee, Byoung Kwon] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Div Cardiol,Dept Internal Med, Seoul, South Korea; [Kim, Jie-Hyun] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Div Gastroenterol,Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kang, S (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Coll Med, Div Endocrinol,Dept Internal Med, Seoul, South Korea.; Kang, S (corresponding author), Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul, South Korea.	shinae95@yuhs.ac	Kim, Jie-Hyun/Q-9061-2019	Kim, Jie-Hyun/0000-0002-9198-3326; Lee, Minyoung/0000-0002-9333-7512; Kang, Shinae/0000-0002-9719-4774; Park, Jong Suk/0000-0002-5385-1373; Lee, Byoung Kwon/0000-0001-9259-2776; Baik, Su Jung/0000-0002-3790-7701; Ahn, Chul Woo/0000-0003-3733-7486	National Research Foundation of Korea (NRF) - Korea government Ministry of Science (MSIP) [2014R1A1A3051221]	National Research Foundation of Korea (NRF) - Korea government Ministry of Science (MSIP)	This work was supported by the National Research Foundation of Korea (NRF, http://www.nrf.re.kr) grant funded by the Korea government Ministry of Science (MSIP) (No. 2014R1A1A3051221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2003, J GASTROEN HEPATOL, V18, P771, DOI 10.1046/j.1440-1746.2003.03059.x; Adiloglu AK, 2005, ACTA CARDIOL, V60, P599, DOI 10.2143/AC.60.6.2004930; Al-Nozha MM, 2003, SAUDI MED J, V24, P1370; Atkinson NSS, 2016, DIGEST DIS SCI, V61, P19, DOI 10.1007/s10620-015-3877-4; Ayada K, 2007, ANN NY ACAD SCI, V1108, P594, DOI 10.1196/annals.1422.062; Blankenberg S, 2001, HERZ, V26, P9; Budoff MJ, 1996, CIRCULATION, V93, P898, DOI 10.1161/01.CIR.93.5.898; Budzynski J, 2016, INT J ANGIOL, V25, P3, DOI 10.1055/s-0035-1547385; Chen LW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003616; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Chmiela M, 2003, FEMS IMMUNOL MED MIC, V36, P187, DOI 10.1016/S0928-8244(03)00030-0; Chmiela M, 2015, WORLD J CARDIOL, V7, P187, DOI 10.4330/wjc.v7.i4.187; Chon Seung Joo, 2016, J Menopausal Med, V22, P146, DOI 10.6118/jmm.2016.22.3.146; Coskun S, 2008, PEDIATR INT, V50, P150, DOI 10.1111/j.1442-200X.2008.02542.x; Crabtree JE, 1999, J CLIN PATHOL, V52, P653, DOI 10.1136/jcp.52.9.653; de Ferranti S, 2002, CLIN CHIM ACTA, V317, P1, DOI 10.1016/S0009-8981(01)00797-5; Diomedi M, 2008, HELICOBACTER, V13, P525, DOI 10.1111/j.1523-5378.2008.00627.x; Duntas LH, 2007, THYROID, V17, P1075, DOI 10.1089/thy.2007.0116; Epstein SE, 1999, CIRCULATION, V100, pE20, DOI 10.1161/01.CIR.100.4.e20; Farsak B, 2000, J CLIN MICROBIOL, V38, P4408, DOI 10.1128/JCM.38.12.4408-4411.2000; Franceschi F, 2009, ATHEROSCLEROSIS, V202, P535, DOI 10.1016/j.atherosclerosis.2008.04.051; Haberl R, 2001, J AM COLL CARDIOL, V37, P451, DOI 10.1016/S0735-1097(00)01119-0; Huang BS, 2011, DIGEST DIS SCI, V56, P109, DOI 10.1007/s10620-010-1274-6; Ikeda A, 2013, ATHEROSCLEROSIS, V230, P67, DOI 10.1016/j.atherosclerosis.2013.06.013; Jin Seung-Won, 2007, Korean Journal of Internal Medicine, V22, P152; Kanbay M, 2005, DIGEST DIS SCI, V50, P2071, DOI 10.1007/s10620-005-3009-7; Kim DW, 2014, ORAL DIS, V20, P551, DOI 10.1111/odi.12168; Kim SK, 2014, ANN OCCUP ENVIRON ME, V26, DOI 10.1186/2052-4374-26-1; Kountouras J, 2017, INT J CARDIOL, V229, P17, DOI 10.1016/j.ijcard.2016.11.265; Kowalski M, 2002, DIGEST LIVER DIS, V34, P398, DOI 10.1016/S1590-8658(02)80036-6; Kowalski M, 2001, DIGEST LIVER DIS, V33, P222, DOI 10.1016/S1590-8658(01)80711-8; KULLER L, 1994, AM J EPIDEMIOL, V139, P1164, DOI 10.1093/oxfordjournals.aje.a116963; Kuller LH, 2006, ARCH INTERN MED, V166, P71, DOI 10.1001/archinte.166.1.71; Laurila A, 1999, ATHEROSCLEROSIS, V142, P207, DOI 10.1016/S0021-9150(98)00194-4; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu M, 2014, EUR REV MED PHARMACO, V18, P2918; Makoveichuk E, 2017, BBA-MOL CELL BIOL L, V1862, P533, DOI 10.1016/j.bbalip.2017.02.005; Manolakis A, 2007, HELICOBACTER, V12, P287, DOI 10.1111/j.1523-5378.2007.00511.x; Mason JC, 2015, EUR HEART J, V36, P482, DOI 10.1093/eurheartj/ehu403; Mayr M, 2003, STROKE, V34, P610, DOI 10.1161/01.STR.0000058481.82639.EF; MENDALL MA, 1994, BRIT HEART J, V71, P437; Mentis A, 2015, HELICOBACTER, V20, P1, DOI 10.1111/hel.12250; Mete R, 2013, EUR REV MED PHARMACO, V17, P2884; Nakagawa H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/142358; Nazligul Y, 2011, CLIN BIOCHEM, V44, P647, DOI 10.1016/j.clinbiochem.2011.03.001; Niemela S, 1996, HEART, V75, P573, DOI 10.1136/hrt.75.6.573; Ohnishi M, 2008, METABOLISM, V57, P1760, DOI 10.1016/j.metabol.2008.08.001; Okada T, 2007, J AUTOIMMUN, V29, P106, DOI 10.1016/j.jaut.2007.05.004; Park MJ, 2011, GUT LIVER, V5, P321, DOI 10.5009/gnl.2011.5.3.321; Pohjanen VM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009987; Qu BG, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43059; Quinn MJ, 1999, AM J CARDIOL, V83, P1664, DOI 10.1016/S0002-9149(99)00175-7; Rezaee-Zavareh MS, 2016, ARYA ATHEROSCLER, V12, P41; Rogha M, 2012, ARYA ATHEROSCLER, V8, P5; Schottker B, 2012, ATHEROSCLEROSIS, V220, P569, DOI 10.1016/j.atherosclerosis.2011.11.029; Sheu WHH, 2000, CLIN EXP HYPERTENS, V22, P595, DOI 10.1081/CEH-100100094; Silverman MG, 2014, JACC-CARDIOVASC IMAG, V7, P476, DOI 10.1016/j.jcmg.2014.03.005; Sun J, 2016, HELICOBACTER, V21, P11, DOI 10.1111/hel.12234; Tabata N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166240; Tobin NP, 2008, AM J PHYSIOL-HEART C, V295, pH1403, DOI 10.1152/ajpheart.00240.2008; Tsai CJ, 2000, DIGEST DIS SCI, V45, P1227, DOI 10.1023/A:1005522624004; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Yamaoka Y, 2014, FUTURE ONCOL, V10, P1487, DOI [10.2217/fon.14.29, 10.2217/FON.14.29]; Yu XJ, 2017, EXP THER MED, V13, P787, DOI 10.3892/etm.2017.4028; Zuin M, 2016, INT J CARDIOL, V223, P711, DOI 10.1016/j.ijcard.2016.08.320	65	34	42	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193646	10.1371/journal.pone.0193646	http://dx.doi.org/10.1371/journal.pone.0193646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499055	Green Submitted, Green Published, gold			2022-12-27	WOS:000426472300018
J	Nieto-Vera, R; Kahuam-Lopez, N; Meneses, A; Cruz-Martinez, Y; Anaya-Jimenez, RM; Liy-Salmeron, G; Carvajal, HG; Ponce-Lopez, MT; Ibarra, A				Nieto-Vera, Rossana; Kahuam-Lopez, Nicolas; Meneses, Alfredo; Cruz-Martinez, Yolanda; Maria Anaya-Jimenez, Rosa; Liy-Salmeron, Gustavo; Guillermo Carvajal, Horacio; Teresa Ponce-Lopez, Maria; Ibarra, Antonio			Copolymer-1 enhances cognitive performance in young adult rats	PLOS ONE			English	Article							SPINAL-CORD-INJURY; LONG-TERM-MEMORY; GLATIRAMER ACETATE; NEUROTROPHIC FACTOR; BDNF; HIPPOCAMPUS; IMMUNITY; MICE; NEUROGENESIS; IMPAIRMENT	Cognitive impairment is a dysfunction observed as a sequel of various neurodegenerative diseases, as well as a concomitant element in the elderly stages of life. In clinical settings, this malfunction is identified as mild cognitive impairment. Previous studies have suggested that cognitive impairment could be the result of a reduction in the expression of brain-derived neurotrophic factor (BDNF) and/or immune dysfunction. Copolymer-1 (Cop-1) is an FDA-approved synthetic peptide capable of inducing the activation of Th2/3 cells, which are able to release BDNF, as well as to migrate and accumulate in the brain. In this study, we evaluated the effect of Cop-1 immunization on improvement of cognition in adult rats. For this purpose, we performed four experiments. We evaluated the effect of Cop-1 immunization on learning/memory using the Morris water maze for spatial memory and autoshaping for associative memory in 3- or 6-month-old rats. BDNF concentrations at the hippocampus were determined by ELISA. Cop-1 immunization induced a significant improvement of spatial memory and associative memory in 6-month-old rats. Likewise, Cop-1 improved spatial memory and associative memory when animals were immunized at 3 months and evaluated at 6 months old. Additionally, Cop-1 induced a significant increase in BDNF levels at the hippocampus. To our knowledge, the present investigation reports the first instance of Cop-1 treatment enhancing cognitive function in normal young adult rats, suggesting that Cop-1 may be a practical therapeutic strategy potentially useful for age-or disease-related cognitive impairment.	[Nieto-Vera, Rossana; Kahuam-Lopez, Nicolas; Cruz-Martinez, Yolanda; Liy-Salmeron, Gustavo; Guillermo Carvajal, Horacio; Teresa Ponce-Lopez, Maria; Ibarra, Antonio] Univ Anahuac Mexico, Fac Ciencias Salud, Ctr Invest Ciencias Salud CICSA, Campus Norte, Huixquilucan, Estado De Mexic, Mexico; [Nieto-Vera, Rossana; Kahuam-Lopez, Nicolas; Cruz-Martinez, Yolanda; Liy-Salmeron, Gustavo; Guillermo Carvajal, Horacio; Teresa Ponce-Lopez, Maria; Ibarra, Antonio] Av Univ Anahuac 46, Huixquilucan, Estado De Mexic, Mexico; [Meneses, Alfredo; Maria Anaya-Jimenez, Rosa] IPN, CINVESTAV, Dept Farmacobiol, Mexico City, DF, Mexico	Universidad Anahuac; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Ibarra, A (corresponding author), Univ Anahuac Mexico, Fac Ciencias Salud, Ctr Invest Ciencias Salud CICSA, Campus Norte, Huixquilucan, Estado De Mexic, Mexico.; Ibarra, A (corresponding author), Av Univ Anahuac 46, Huixquilucan, Estado De Mexic, Mexico.	jose.ibarra@anahuac.mx	Cruz, Yolanda/GPT-1412-2022; Kahuam-López, Nicolás/G-1158-2018	Kahuam-López, Nicolás/0000-0003-3887-0629; Anaya-Jimenez, Rosa/0000-0003-0383-4580; Carvajal, Horacio/0000-0003-1424-8472; Cruz, Yolanda/0000-0001-5559-2339; Ponce-Lopez, Teresa/0000-0003-4789-661X	Research Center of Health Sciences (CICSA), FCS, Universidad Anahuac Mexico [CSNBIAIIAJ12070412]; Consejo Nacional de Ciencia y Tecnologia [178544]	Research Center of Health Sciences (CICSA), FCS, Universidad Anahuac Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Research Center of Health Sciences (CICSA), FCS, Universidad Anahuac Mexico (CSNBIAIIAJ12070412), and the Consejo Nacional de Ciencia y Tecnologia (178544). Al is the author who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2002, J NEUROIMMUNOL, V126, P58, DOI 10.1016/S0165-5728(02)00053-X; Aharoni R, 2014, J AUTOIMMUN, V54, P81, DOI 10.1016/j.jaut.2014.05.005; Aparicio-Nava L., 2018, BEHAV BRAIN RES; Arya A, 2016, INT J NANOMED, V11, P1159, DOI 10.2147/IJN.S102096; Azoulay D, 2005, J NEUROIMMUNOL, V167, P215, DOI 10.1016/j.jneuroim.2005.07.001; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Blanco Y, 2006, NEUROSCI LETT, V406, P270, DOI 10.1016/j.neulet.2006.07.043; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Chander RJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12755-z; Chen L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14308; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Cruz Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121854; Di Benedetto S, 2017, NEUROSCI BIOBEHAV R, V75, P114, DOI 10.1016/j.neubiorev.2017.01.044; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Gonzalez R, 2013, BEHAV BRAIN RES, V252, P246, DOI 10.1016/j.bbr.2013.05.051; Halai AD, 2018, NEUROIMAGE-CLIN, V17, P465, DOI 10.1016/j.nicl.2017.10.037; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; Meneses A, 2015, PSYCHOPHARMACOLOGY, V232, P595, DOI 10.1007/s00213-014-3693-0; Meneses A, 2003, LEARN MEMORY, V10, P363, DOI 10.1101/lm.60503; Meneses A, 2017, REV NEUROSCIENCE, V28, P455, DOI 10.1515/revneuro-2016-0079; Nandrajog P, 2016, ASIAN J NEUROSURG; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Penner MR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00009; Prat A, 2005, J AUTOIMMUN, V24, P119, DOI 10.1016/j.jaut.2005.01.004; Qian SH, 2013, CLIN EXP OPHTHALMOL, V41, P881, DOI 10.1111/ceo.12110; Ritchie K, 1996, BRIT J PSYCHIAT, V168, P470, DOI 10.1192/bjp.168.4.470; Ritchie Karen, 2004, Dialogues Clin Neurosci, V6, P401; Roberts R, 2013, CLIN GERIATR MED, V29, P753, DOI 10.1016/j.cger.2013.07.003; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Shang YC, 2016, NEUROBIOL LEARN MEM, V134, P369, DOI 10.1016/j.nlm.2016.08.016; Srey CS, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00054; Urbach A, 2017, J CEREBR BLOOD F MET, V37, P1776, DOI 10.1177/0271678X16643736; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Yano H, 2006, NAT NEUROSCI, V9, P1009, DOI 10.1038/nn1730	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192885	10.1371/journal.pone.0192885	http://dx.doi.org/10.1371/journal.pone.0192885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494605	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200016
J	Astudillo-Rubio, D; Delgado-Gaete, A; Bellot-Arcis, C; Montiel-Company, JM; Pascual-Moscardo, A; Almerich-Silla, JM				Astudillo-Rubio, Daniela; Delgado-Gaete, Andres; Bellot-Arcis, Carlos; Maria Montiel-Company, Jose; Pascual-Moscardo, Agustin; Manuel Almerich-Silla, Jose			Mechanical properties of provisional dental materials: A systematic review and metaanalysis	PLOS ONE			English	Review							INTERIM RESIN MATERIALS; FLEXURAL STRENGTH; RESTORATIVE MATERIALS; IN-VITRO; FIXED PROSTHODONTICS; FIBER REINFORCEMENT; FRACTURE-TOUGHNESS; BRIDGE MATERIALS; FPD MATERIALS; CROWN	Provisional restorations represent an important phase during the rehabilitation process, knowledge of the mechanical properties of the available materials allows us to predict their clinical performance. At present, there is no systematic review, which supports the clinicians' criteria, in the selection of a specific material over another for a particular clinical situation. The purpose of this systematic review and meta-analysis was to assess and compare the mechanical properties of dimethacrylates and monomethacrylates used in fabricating direct provisional restorations, in terms of flexural strength, fracture toughness and hardness. This review followed the PRISMA guidelines. The searches were conducted in PubMed, Embase, Web of Science, Scopus, the New York Academy of Medicine Grey Literature Report and were complemented by hand-searching, with no limitation of time or language up to January 10, 2017. Studies that assess and compare the mechanical properties of dimethacrylate-and monomethacrylate-based provisional restoration materials were selected. A quality assessment of full-text articles were performed according to modified ARRIVE and CONSORT criteria and modified Cochrane Collaboration's tool for in vitro studies. Initially, 256 articles were identified. After removing the duplicates and applying the selection criteria, 24 articles were included in the qualitative synthesis and 7 were included in the quantitative synthesis (meta-analysis). It may be concluded that dimethacrylatebased provisional restorations presented better mechanical behavior than monomethacrylate- based ones in terms of flexural strength and hardness. Fracture toughness showed no significant differences. Within the monomethacrylate group, polymethylmethacrylate showed greater flexural strength than polyethylmethacrylate.	[Astudillo-Rubio, Daniela; Delgado-Gaete, Andres] Univ Valencia, Fac Med & Dent, Dept Stomatol, Valencia, Spain; [Bellot-Arcis, Carlos] Univ Valencia, Fac Med & Dent, Dept Stomatol, Orthodont Teaching Unit, Valencia, Spain; [Maria Montiel-Company, Jose; Manuel Almerich-Silla, Jose] Univ Valencia, Fac Med & Dent, Dept Stomatol, Prevent Dent Teaching Unit, Valencia, Spain; [Pascual-Moscardo, Agustin] Univ Valencia, Fac Med & Dent, Dept Stomatol, Dent Pathol & Therapeut Teaching Unit, Valencia, Spain; [Maria Montiel-Company, Jose] Univ Valencia, Dept Stomatol, Valencia, Spain	University of Valencia; University of Valencia; University of Valencia; University of Valencia; University of Valencia	Astudillo-Rubio, D (corresponding author), Univ Valencia, Fac Med & Dent, Dept Stomatol, Valencia, Spain.	jose.maria.montiel@uv.es	Montiel-Company, José María/S-1836-2018; BELLOT-ARCIS, CARLOS/AGP-0731-2022	Montiel-Company, José María/0000-0002-3952-7681; BELLOT-ARCIS, CARLOS/0000-0003-4363-2713; Delgado Gaete, Andres/0000-0001-5586-2829; Astudillo-Rubio, Daniela/0000-0002-8154-0492				Abdulmohsen B, 2016, DENT MATER, V32, P200, DOI 10.1016/j.dental.2015.11.025; Akova T, 2006, DENT MATER, V22, P1130, DOI 10.1016/j.dental.2005.09.009; Alt V, 2011, DENT MATER, V27, P339, DOI 10.1016/j.dental.2010.11.012; Aurelio IL, 2016, DENT MATER, V32, P827, DOI 10.1016/j.dental.2016.03.021; Balkenhol M, 2008, J DENT, V36, P15, DOI 10.1016/j.jdent.2007.10.001; Balkenhol M, 2009, DENT MATER, V25, P917, DOI 10.1016/j.dental.2009.01.099; Burns DR, 2003, J PROSTHET DENT, V90, P474, DOI 10.1016/S0022-3913(03)00259-2; Diaz-Arnold AM, 1999, J PROSTHET DENT, V82, P525, DOI 10.1016/S0022-3913(99)70050-8; Gegauff AG, INT J PROSTHODONT, V8, P62; Hamza TA, 2004, J PROSTHET DENT, V91, P258, DOI 10.1016/j.prosdent.2004.01.005; Hamza TA, 2014, J PROSTHET DENT, V112, P228, DOI 10.1016/j.prosdent.2014.01.008; Haselton DR, 2002, J PROSTHET DENT, V87, P225, DOI 10.1067/mpr.2002.121406; Heintze SD, 2017, DENT MATER, V33, pE101, DOI 10.1016/j.dental.2016.11.013; Ilie N, 2017, DENT MATER, V33, P880, DOI 10.1016/j.dental.2017.04.013; Ireland MF, 1998, J PROSTHET DENT, V80, P158, DOI 10.1016/S0022-3913(98)70104-0; Jo Liju Jacob, 2011, Indian J Dent Res, V22, P71, DOI 10.4103/0970-9290.79992; Kadiyala KK, 2016, J CLIN DIAGN RES, V10, pZC91, DOI 10.7860/JCDR/2016/20020.8566; Kelly L, 2008, CAN FAM PHYSICIAN, V54, P1572; Kim SH, 2004, INT J PROSTHODONT, V17, P318; Kim SH, 2007, DENT MATER, V23, P1570, DOI 10.1016/j.dental.2007.06.023; Lang R, 2003, INT J PROSTHODONT, V16, P381; Nejatidanesh F, 2009, J PROSTHODONT, V18, P507, DOI 10.1111/j.1532-849X.2009.00473.x; Patras M, 2012, J ESTHET RESTOR DENT, V24, P26, DOI 10.1111/j.1708-8240.2011.00467.x; Penate L, 2015, J PROSTHET DENT, V114, P248, DOI 10.1016/j.prosdent.2014.12.023; Poonacha Vachan, 2013, J Clin Exp Dent, V5, pe212, DOI 10.4317/jced.51136; Ramamoorthi M, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/378368; Rayyan MM, 2015, J PROSTHET DENT, V114, P414, DOI 10.1016/j.prosdent.2015.03.007; Rekow ED, 2011, J DENT RES, V90, P937, DOI 10.1177/0022034510391795; Samadzadeh A, 1997, J PROSTHET DENT, V78, P447, DOI 10.1016/S0022-3913(97)70058-1; Thompson GA, 2014, J PROSTHET DENT, V112, P638, DOI 10.1016/j.prosdent.2014.04.008; Urrutia G, 2010, MED CLIN-BARCELONA, V135, P507, DOI 10.1016/j.medcli.2010.01.015; Yanikoglu N.D, 2014, OPEN J STOMATOL, V4, P46720, DOI [10.4236/ojst.2014.46041, DOI 10.4236/OJST.2014.46041]; Yap AUJ, 2004, DENT MATER, V20, P370, DOI 10.1016/j.dental.2003.06.001; Zortuk M, 2010, J INT DENT MED RES, V3, P25	34	43	43	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193162	10.1371/journal.pone.0193162	http://dx.doi.org/10.1371/journal.pone.0193162			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489883	gold, Green Submitted, Green Published			2022-12-27	WOS:000426276000055
J	Forte, P; Marinho, DA; Morais, JE; Morouco, PG; Barbosa, TM				Forte, Pedro; Marinho, Daniel A.; Morais, Jorge E.; Morouco, Pedro G.; Barbosa, Tiago M.			The variations on the aerodynamics of a world-ranked wheelchair sprinter in the key-moments of the stroke cycle: A numerical simulation analysis	PLOS ONE			English	Article							ENERGY-COST; DRAG; PERFORMANCE; POSITION; FORCES; WIND	Biomechanics plays an important role helping Paralympic sprinters to excel, having the aerodynamic drag a significant impact on the athlete's performance. The aim of this study was to assess the aerodynamics in different key-moments of the stroke cycle by Computational Fluid Dynamics. A world-ranked wheelchair sprinter was scanned on the racing wheelchair wearing his competition gear and helmet. The sprinter was scanned in three different positions: (i) catch (hands in the 12h position on the hand-rim); (ii) the release (hands in the 18h position on the hand-rim) and; (iii) recovery phase (hands do not touch the handrim and are hyperextended backwards). The simulations were performed at 2.0, 3.5, 5.0 and 6.5 m/s. The mean viscous and pressure drag components, total drag force and effective area were retrieved after running the numerical simulations. The viscous drag ranged from 3.35 N to 2.94 N, pressure drag from 0.38 N to 5.51 N, total drag force from 0.72 N to 8.45 N and effective area from 0.24 to 0.41 m(2). The results pointed out that the sprinter was submitted to less drag in the recovery phase, and higher drag in the catch. These findings suggest the importance of keeping an adequate body alignment to avoid an increase in the drag force.	[Forte, Pedro; Marinho, Daniel A.] Univ Beira Interior, Dept Sport Sci, Covilha, Portugal; [Forte, Pedro; Marinho, Daniel A.; Morais, Jorge E.; Barbosa, Tiago M.] Res Ctr Sports Hlth & Human Dev, Covilha, Portugal; [Morais, Jorge E.; Barbosa, Tiago M.] Polytech Inst Braganca, Dept Sport Sci, Braganca, Portugal; [Morouco, Pedro G.] Polytech Inst Leiria, Dept Sport Sci, Leiria, Portugal; [Morouco, Pedro G.] Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal; [Barbosa, Tiago M.] Nanyang Technol Univ, Natl Inst Educ, Singapore, Singapore	Universidade da Beira Interior; Instituto Politecnico de Braganca; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Forte, P (corresponding author), Univ Beira Interior, Dept Sport Sci, Covilha, Portugal.; Forte, P (corresponding author), Res Ctr Sports Hlth & Human Dev, Covilha, Portugal.	pedromiguelforte@gmail.com	Forte, Pedro/L-2858-2014; Barbosa, Tiago M./ABE-6789-2020; Morais, Jorge E./AAX-9541-2020; Morouço, Pedro/K-9545-2013; Barbosa, Tiago M./U-5335-2017	Forte, Pedro/0000-0003-0184-6780; Barbosa, Tiago M./0000-0001-7071-2116; Morais, Jorge E./0000-0002-6885-0648; Morouço, Pedro/0000-0002-5956-9790; Barbosa, Tiago M./0000-0001-7071-2116	National Funds through FCT - Portuguese Foundation for Science and Technology [UID/DTP/04045/2013]; European Fund for regional development (FEDER) by European Union through the COMPETE Programme [POCI-01-0145-FEDER-006969]; FCT Portuguese Foundation for Science and Technology [UID/DTP/04045/2013]; European Union European Fund for regional development (FEDER) under the COMPETE Programme [POCI-01-0145-FEDER-006969]	National Funds through FCT - Portuguese Foundation for Science and Technology; European Fund for regional development (FEDER) by European Union through the COMPETE Programme; FCT Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Union European Fund for regional development (FEDER) under the COMPETE Programme	This project was supported by the National Funds through FCT - Portuguese Foundation for Science and Technology (UID/DTP/04045/2013) - and the European Fund for regional development (FEDER) allocated by European Union through the COMPETE 2020 Programme (POCI-01-0145-FEDER-006969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the FCT Portuguese Foundation for Science and Technology (UID/DTP/04045/2013) and by European Union European Fund for regional development (FEDER) under the COMPETE 2020 Programme (POCI-01-0145-FEDER-006969).	ANSYS Inc, 2013, INTR US ANSYS FLUENT, P1; Barbosa TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177038; Barbosa TM, 2016, PROCEDIA ENGINEER, V147, P2, DOI 10.1016/j.proeng.2016.06.180; Barbosa TM, 2014, 1 INT C SPORTS SCI T, P749; Bixler B, 2007, SPORT BIOMECH, V6, P81, DOI 10.1080/14763140601058581; Blocken B, 2012, J BIOMECH, V43, P2281; Blocken B, 2013, COMPUT FLUIDS, V71, P435, DOI 10.1016/j.compfluid.2012.11.012; Bouillod A, 2016, 4 INT C SPORT SCI RE, P1; Candau RB, 1999, MED SCI SPORT EXER, V31, P1441, DOI 10.1097/00005768-199910000-00013; Chowdhury H., 2012, APPL AERODYNAMICS, P21; COOPER R A, 1990, Journal of Rehabilitation Research and Development, V27, P295, DOI 10.1682/JRRD.1990.07.0297; Cooper R. A., 1990, ADAPT PHYS ACT Q, V7, P74; Crouch TN, 2017, SPORTS ENG, V20, P81, DOI 10.1007/s12283-017-0234-1; Debraux P, 2011, SPORT BIOMECH, V10, P197, DOI 10.1080/14763141.2011.592209; Defraeye T, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4025792; Defraeye T, 2010, J BIOMECH, V43, P1262, DOI 10.1016/j.jbiomech.2010.01.025; DIPRAMPERO PE, 1986, INT J SPORTS MED, V7, P55, DOI 10.1055/s-2008-1025736; Edwards AG, 2007, MED SCI SPORT EXER, V39, P170, DOI 10.1249/01.mss.0000239400.85955.12; Faria EW, 2005, SPORTS MED, V35, P313, DOI 10.2165/00007256-200535040-00003; Forte P, 2017, AIP CONF PROC, V1863, DOI 10.1063/1.4992669; Forte P., 2015, NEW PERSPECTIVES FLU, P101; Fuss FK, 2009, SPORTS ENG, V12, P41, DOI 10.1007/s12283-009-0027-2; Gehlsen GM, 1990, ADAPTED PHYSICAL ACT, V7, P219; Grappe F, 1997, ERGONOMICS, V40, P1299, DOI 10.1080/001401397187388; Griffith MD, 2014, J FLUID ENG-T ASME, V136, DOI 10.1115/1.4027428; Hoffman MD, 2003, AM J PHYS MED REHAB, V82, P880, DOI 10.1097/01.PHM.0000091980.91666.58; Kennedy M. D., 2013, HDB ERGONOMICS SPORT, P115; Kulfan B, 2000, FLUIDS 2000 C EXH FL, P2; Kyle CR, 2013, HIGH TECH CYCLING, P1; Marinho DA, 2010, J APPL BIOMECH, V26, P87, DOI 10.1123/jab.26.1.87; Martin JC, 2006, MED SCI SPORT EXER, V38, P592, DOI 10.1249/01.mss.0000193560.34022.04; McLean B. D., 1994, Journal of Biomechanics, V27, P675, DOI 10.1016/0021-9290(94)91005-7; Millet GP, 2002, SCI SPORT, V17, P166, DOI 10.1016/S0765-1597(02)00139-9; Munson B.R., 1990, FUNDAMENTALS FLUID M; Paton C., 2006, SPORTSCIENCE, V10, P69; Pogni M, 2016, PROCEDIA ENGINEER, V147, P74, DOI 10.1016/j.proeng.2016.06.192; Ridgway M, 1988, ADAPTED PHYSICAL ACT, V5, P96; RYSCHON TW, 1991, MED SCI SPORT EXER, V23, P949; SANDERSON DJ, 1985, J BIOMECH, V18, P423, DOI 10.1016/0021-9290(85)90277-5; Schlichting H., 2000, BOUNDARY LAYER THEOR, V8th; Winkler A, 2010, PROCEDIA ENGINEER, V2, P2399, DOI 10.1016/j.proeng.2010.04.006	41	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193658	10.1371/journal.pone.0193658	http://dx.doi.org/10.1371/journal.pone.0193658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489904	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000100
J	Goudarzi, R; Reid, A; McDougall, JJ				Goudarzi, Ramin; Reid, Allison; McDougall, Jason J.			Evaluation of the novel avocado/soybean unsaponifiable Arthrocen to alter joint pain and inflammation in a rat model of osteoarthritis	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; DOUBLE-BLIND; GLUCOSAMINE SULFATE; 6-MONTH TREATMENT; GENE-EXPRESSION; CLINICAL-TRIAL; AVOCADO; PLACEBO; ASU; CHONDROCYTES	Background Avocado/soybean unsaponifiables such as Arthrocen have been reported to reduce cartilage catabolism and chondrocytic synthesis of inflammatory mediators associated with osteoarthritis (OA). While there is some clinical evidence that avocado/soybean unsaponifiables can reduce OA pain, no preclinical studies have corroborated this observation. The present study determined whether addition of an avocado/soybean unsaponifiable (Arthrocen) to the drinking water of OA rats reduced direct and referred joint pain. Methods OA was induced in male Wistar rats by intra-articular injection of sodium monoiodoacetate (MIA: 0.3mg) and animals were allowed to recover for 14 days. Arthrocen was added to the drinking water which was available to animals ad libitum. On day 30, joint pain was assessed by dynamic incapacitance while referred pain was determined by von Frey hair algesiometry. Results The joint damage induced by MIA injection was severe and was consistent with end-stage OA. Arthrocen consumption (approximately 35 mg/day) attenuated the joint oedema associated with MIA injection. Hindlimb weight bearing also significantly improved in Arthrocentreated rats (P<0.05); however, von Frey hair mechanosensitivity was unaffected by this treatment. Conclusions These data indicate that Arthrocen has the potential to reduce joint inflammation and pain associated with end-stage OA.	[Goudarzi, Ramin] Pharmin USA LLC, Div Res & Dev, San Jose, CA USA; [Reid, Allison; McDougall, Jason J.] Dalhousie Univ, Dept Pharmacol & Anaesthesia, Halifax, NS, Canada; [Reid, Allison; McDougall, Jason J.] Dalhousie Univ, Dept Pain Management & Perioperat Med, Halifax, NS, Canada	Dalhousie University; Dalhousie University	McDougall, JJ (corresponding author), Dalhousie Univ, Dept Pharmacol & Anaesthesia, Halifax, NS, Canada.; McDougall, JJ (corresponding author), Dalhousie Univ, Dept Pain Management & Perioperat Med, Halifax, NS, Canada.	jason.mcdougall@dal.ca	McDougall, Jason/AAK-2373-2020	Goudarzi, Ramin/0000-0003-0648-7588; McDougall, Jason/0000-0003-4529-3428	Pharmin USA LLC	Pharmin USA LLC	This work was funded by Pharmin USA LLC. R. Goudarzi was involved in the decision to publish and approved the final manuscript. The funder provided support in the form of salaries to AR and JJMcD, but did not have any additional role in study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the "Authors Contributions" section.	Appelboom T, 2001, SCAND J RHEUMATOL, V30, P242; Au RY, 2007, OSTEOARTHR CARTILAGE, V15, P1249, DOI 10.1016/j.joca.2007.07.009; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Cake MA, 2000, OSTEOARTHR CARTILAGE, V8, P404, DOI 10.1053/joca.1999.0315; Catunda IS, 2016, INT J ORAL MAX SURG, V45, P1015, DOI 10.1016/j.ijom.2016.01.008; Chou MM, 2005, EXP BIOL MED, V230, P255; Christiansen BA, 2015, CARTILAGE, V6, P30, DOI 10.1177/1947603514554992; Gluszko Piotr, 2016, Reumatologia (Warsaw), V54, P217, DOI 10.5114/reum.2016.63661; Goudarzi R, 2017, FEBS OPEN BIO, V7, P187, DOI 10.1002/2211-5463.12176; Hochberg MC, 2016, ANN RHEUM DIS, V75, P37, DOI 10.1136/annrheumdis-2014-206792; Kawcak CE, 2007, AM J VET RES, V68, P598, DOI 10.2460/ajvr.68.6.598; Krustev E, 2015, CURR OSTEOPOROS REP, V13, P216, DOI 10.1007/s11914-015-0275-y; Maheu E, 1998, ARTHRITIS RHEUM-US, V41, P81, DOI 10.1002/1529-0131(199801)41:1<81::AID-ART11>3.3.CO;2-0; McDougall JJ, 2006, PAIN, V123, P98, DOI 10.1016/j.pain.2006.02.015; Ownby SL, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-8; Roman-Blas JA, 2017, ARTHRITIS RHEUMATOL, V69, P77, DOI 10.1002/art.39819	16	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191906	10.1371/journal.pone.0191906	http://dx.doi.org/10.1371/journal.pone.0191906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489828	Green Submitted, gold, Green Published			2022-12-27	WOS:000426276000012
J	Hou, L; Ji, ZB; Wang, GZ; Wang, J; Chao, TL; Wang, JM				Hou, Lei; Ji, Zhibin; Wang, Guizhi; Wang, Jin; Chao, Tianle; Wang, Jianmin			W Identification and characterization of microRNAs in the intestinal tissues of sheep (Ovis aries)	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TAIL HAN SHEEP; MESSENGER-RNAS; KAZAKH SHEEP; BIOINFORMATICS; PATHWAY; DORSET; GENES; OVARY	Sheep are small ruminants, and their long intestines exhibit high digestive and absorptive capacity in many different rearing conditions; however, the genetic bases of this characteristic remains unclear. MicroRNAs (miRNAs) play a major role in maintaining both intestinal morphological structure as well as in regulating the physiological functions of this organ. However, no study has reported on the miRNA expression profile in the intestinal tissues of sheep. Here, we analyzed and identified the miRNA expression profile of three different intestinal tissues (i.e., duodenum, cecum, and colon) of sheep (Ovis aries) using high-throughput sequencing and bioinformatic methods. In total, 106 known miRNAs were identified, 458 conserved miRNAs were detected, 192 unannotated novel miRNAs were predicted, and 195 differentially expressed miRNAs were found between the different tissues. Additionally, 3,437 candidate target genes were predicted, and 17 non-redundant significantly enriched GO terms were identified using enrichment analysis. A total of 99 candidate target genes were found to significantly enriched in 4 KEGG biological pathways. A combined regulatory network was constructed based on 92 metabolism-related candidate target genes and 65 differentially expressed miRNAs, among which 7 miRNAs were identified as hub miRNAs. Via these mechanisms, miRNAs may play a role in maintaining intestinal homeostasis and metabolism. This study helps to further explain the mechanisms that underlie differences in tissue morphology and function in three intestinal segments of sheep.	[Hou, Lei; Ji, Zhibin; Wang, Guizhi; Wang, Jin; Chao, Tianle; Wang, Jianmin] Shandong Agr Univ, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University	Chao, TL; Wang, JM (corresponding author), Shandong Agr Univ, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China.	2398901017@qq.com; wangjm@sdau.edu.cn	WANG, Jianmin/M-2002-2016	WANG, Jianmin/0000-0001-5678-8202; tianle, chao/0000-0001-9721-0634	Funds of Shandong "Double Tops" Program [SYL2017YSTD12]; Shandong Provincial Modern Agriculture Industry Technology System [SDAIT-0901101]; National Key Technology Support Program [2015BAD03B05]; Study on Super-high Reproductive New Breed and Supporting technological system of Small-Tailed Han Sheep [SDLZ2015131x]	Funds of Shandong "Double Tops" Program; Shandong Provincial Modern Agriculture Industry Technology System; National Key Technology Support Program(National Key Technology R&D Program); Study on Super-high Reproductive New Breed and Supporting technological system of Small-Tailed Han Sheep	This work was financially supported by the Funds of Shandong "Double Tops" Program (No. SYL2017YSTD12), Shandong Provincial Modern Agriculture Industry Technology System (no. SDAIT-0901101), National Key Technology Support Program (2015BAD03B05) and Study on Super-high Reproductive New Breed and Supporting technological system of Small-Tailed Han Sheep (no. SDLZ2015131x). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bai J W, 2016, EUROPEAN REV MED PHA, V20; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Carrigan C T, 2016, GROWTH HORM IGF RES, V32, P14; Chang WH, 2015, J VET MED SCI, V77, P1617, DOI 10.1292/jvms.15-0289; Consortium T G O, 2007, NUCL ACIDS RES S1, V36, P391; Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006; DEGREGORIO RM, 1982, J ANIM SCI, V54, P855, DOI 10.2527/jas1982.544855x; FAICHNEY GJ, 1969, AUST J AGR RES, V20, P491, DOI 10.1071/AR9690491; Gao Y, 2011, NUCLEIC ACIDS RES, V39, P454, DOI 10.1093/nar/gkq782; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Jiang S, 2016, PARASITE, V23, DOI 10.1051/parasite/2016023; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kim H, 2017, ONCOTARGET, V8, P8484, DOI 10.18632/oncotarget.14298; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lagana A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143313; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LEWIS SM, 1985, APPL ENVIRON MICROB, V50, P356, DOI 10.1128/AEM.50.2.356-363.1985; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092592; Liao YL, 2013, GENES NUTR, V8, P69, DOI 10.1007/s12263-012-0297-3; Liu G, 2013, PLOS ONE, V8; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Meale SJ, 2014, J ANIM SCI, V92, P3328, DOI 10.2527/jas.2014-7710; Miao XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18470; Miao XY, 2015, GENE, V562, P188, DOI 10.1016/j.gene.2015.02.070; Miao XY, 2015, MOL CELL ENDOCRINOL, V402, P32, DOI 10.1016/j.mce.2014.12.023; Morozzi G, 2017, CELL DEATH DIFFERENT; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Qin YT, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007027; Runtsch MC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00347; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharbati J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12681; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Sun HY, 2017, CELL BIOL INT, V41, P739, DOI 10.1002/cbin.10768; Sun ZW, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0178-y; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang XiaoHui, 2012, Journal of Agricultural Biotechnology, V20, P1178; Tao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079343; Tsukerman P, 2012, CANCER RES, V72, P5463, DOI 10.1158/0008-5472.CAN-11-2671; Vienberg S., 2016, ACTA PHYSL; Wang CN, 2017, BIOL PHARM BULL, V40, P465, DOI 10.1248/bpb.b16-00898; Wang J., 2017, SCI REP, V7; Wang J, 2017, ASIAN AUSTRAL J ANIM, V30, P100, DOI 10.5713/ajas.16.0166; Wang L, 2014, N-S ARCH PHARMACOL, V387, P197, DOI 10.1007/s00210-013-0929-1; Wong LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08574-x; Yang H, 2016, ANIM REPROD SCI, V175, P18, DOI 10.1016/j.anireprosci.2016.10.004; Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005; Yu J, 2011, FUNCT INTEGR GENOMIC, V11, P203, DOI 10.1007/s10142-010-0198-8; Yuan TZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19413; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089817; Zhang S, 2013, J NANOMATER, V8, P2013, DOI DOI 10.1371/J0URNAL.P0NE.0071913; Zhou G, 2017, BIOMED RES INT, V2017	58	13	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193371	10.1371/journal.pone.0193371	http://dx.doi.org/10.1371/journal.pone.0193371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489866	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000068
J	Khan, A; Mar, KF; Schilling, J; Brown, WA				Khan, Arif; Mar, Kaysee Fahl; Schilling, Joshua; Brown, Walter A.			Does the rising placebo response impact antihypertensive clinical trial outcomes? An analysis of data from the Food and Drug Administration 1990-2016	PLOS ONE			English	Article							BLOOD-PRESSURE; ANTIDEPRESSANT TRIALS; DOUBLE-BLIND; HYPERTENSION	Background Recent studies show that placebo response has grown significantly over time in clinical trials for antidepressants, ADHD medications, antiepileptics, and antidiabetics. Contrary to expectations, trial outcome measures and success rates have not been impacted. This study aimed to see if this trend of increasing placebo response and stable efficacy outcome measures is unique to the conditions previously studied or if it occurs in trials for conditions with physiologically-measured symptoms, such as hypertension. Method For this reason, we evaluated the efficacy data reported in the US Food and Drug Administration Medical and Statistical reviews for 23 antihypertensive programs (32,022 patients, 63 trials, 142 treatment arms). Placebo and medication response, effect sizes, and drug-placebo differences were calculated for each treatment arm and examined over time using meta-regression. We also explored the relationship of sample size, trial duration, baseline blood pressure, and number of treatment arms to placebo/drug response and efficacy outcome measures. Results Like trials of other conditions, placebo response has risen significantly over time (R-2 = 0.093, p = 0.018) and effect size (R-2 = 0.013, p = 0.187) drug-placebo difference (R-2 = 0.013, p = 0.182) and success rate (134/142, 94.4%) have remained unaffected, likely due to a significant compensatory increase in antihypertensive response (R-2 = 0.086, p< 0.001). Treatment arms are likely overpowered with sample sizes increasing over time (R-2 = 0.387, p< 0.0001) and stable, large effect sizes (0.78 +/- 0.37). The exploratory analysis of sample size, trial duration, baseline blood pressure, and number of treatment arms yielded mixed results unlikely to explain the pattern of placebo response and efficacy outcomes over time. The magnitude of placebo response had no relationship to effect size (p = 0.877), antihypertensive-placebo differences (p = 0.752), or p-values (p = 0.963) but was correlated with antihypertensive response (R-2 = 0.347, p< 0.0001). Conclusions As hypothesized, this study shows that placebo response is increasing in clinical trials for hypertension without any evidence of this increase impacting trial outcomes. Attempting to control placebo response in clinical trials for hypertension may not be necessary for successful efficacy outcomes. In exploratory analysis, we noted that despite finding significant relationships, none of the trial or patient characteristics we examined offered a clear explanation of the rise in placebo and stability in outcome measures over time. Collectively, these data suggest that the phenomenon of increasing placebo response and stable efficacy outcomes may be a general trend, occurring across trials for various psychiatric and medical conditions with physiological and non-physiological endpoints.	[Khan, Arif; Mar, Kaysee Fahl] Northwest Clin Res Ctr, Bellevue, WA USA; [Khan, Arif] Duke Univ, Dept Psychiat, Sch Med, Durham, NC 27706 USA; [Schilling, Joshua] Univ Massachusetts, Baystate Med Ctr, Dept Cardiol, Springfield, MA USA; [Brown, Walter A.] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA	Duke University; Baystate Medical Center; University of Massachusetts System; Brown University	Khan, A (corresponding author), Northwest Clin Res Ctr, Bellevue, WA USA.; Khan, A (corresponding author), Duke Univ, Dept Psychiat, Sch Med, Durham, NC 27706 USA.	akhan@nwcrc.net						Andrews G, 2001, BRIT J PSYCHIAT, V178, P192, DOI 10.1192/bjp.178.3.192; [Anonymous], 2016, FDA ACC DAT; ANTIVALLE M, 1990, J HUM HYPERTENS, V4, P633; Asmar R, 2001, AM J HYPERTENS, V14, P546, DOI 10.1016/S0895-7061(00)01286-3; Felmeden DC, 2000, BLOOD PRESSURE, V9, P335; Furukawa TA, 2016, LANCET PSYCHIAT, V3, P1059, DOI 10.1016/S2215-0366(16)30307-8; GOULD BA, 1981, LANCET, V2, P1377; Khan A, 2004, AM J PSYCHIAT, V161, P2045, DOI 10.1176/appi.ajp.161.11.2045; Khan A, 2003, J NERV MENT DIS, V191, P211, DOI 10.1097/00005053-200304000-00001; Khan A, 2018, CONT CLIN TRIALS; Khan A, 2018, DIABETES CARE, V41, P994, DOI 10.2337/dc17-1316; Khan A, 2017, J PSYCHIATR RES, V94, P202, DOI 10.1016/j.jpsychires.2017.07.018; Khan A, 2017, WORLD PSYCHIATRY, V16, P181, DOI 10.1002/wps.20421; Ntineri A, 2016, BLOOD PRESS MONIT, P353; Papakostas GI, 2009, EUR NEUROPSYCHOPHARM, V19, P34, DOI 10.1016/j.euroneuro.2008.08.009; PARAN E, 1993, J HUM HYPERTENS, V7, P567; Patel HC, 2015, HYPERTENSION, V65, P401, DOI 10.1161/HYPERTENSIONAHA.114.04640; Preston RA, 2000, ARCH INTERN MED, V160, P1449, DOI 10.1001/archinte.160.10.1449; Rutherford BR, 2013, AM J PSYCHIAT, V170, P723, DOI 10.1176/appi.ajp.2012.12040474; STAESSEN JA, 1994, J HYPERTENS, V12, P1035; Stergiou GS, 2002, AM J HYPERTENS, V15, P101, DOI 10.1016/S0895-7061(01)02324-X; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Walsh BT, 2001, JAMA-J AM MED ASSOC, V287, P1840; Wilhelm M, 2016, J AM SOC HYPERTENS, V10, P917, DOI 10.1016/j.jash.2016.10.009	24	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193043	10.1371/journal.pone.0193043	http://dx.doi.org/10.1371/journal.pone.0193043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489874	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000053
J	Misiuk, B; Lecours, V; Bell, T				Misiuk, Benjamin; Lecours, Vincent; Bell, Trevor			A multiscale approach to mapping seabed sediments	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; WATER GORGONIAN CORALS; HABITAT SUITABILITY; TEXTURE CLASSES; GRAIN-SIZE; SCALE; RESOLUTION; PREDICTION; ABUNDANCE; BACKSCATTER	Benthic habitat maps, including maps of seabed sediments, have become critical spatial-decision support tools for marine ecological management and conservation. Despite the increasing recognition that environmental variables should be considered at multiple spatial scales, variables used in habitat mapping are often implemented at a single scale. The objective of this study was to evaluate the potential for using environmental variables at multiple scales for modelling and mapping seabed sediments. Sixteen environmental variables were derived from multibeam echosounder data collected near Qikiqtarjuaq, Nunavut, Canada at eight spatial scales ranging from 5 to 275 m, and were tested as predictor variables for modelling seabed sediment distributions. Using grain size data obtained from grab samples, we tested which scales of each predictor variable contributed most to sediment models. Results showed that the default scale was often not the best. Out of 129 potential scale-dependent variables, 11 were selected to model the additive log-ratio of mud and sand at five different scales, and 15 were selected to model the additive log-ratio of gravel and sand, also at five different scales. Boosted Regression Tree models that explained between 46.4 and 56.3% of statistical deviance produced multiscale predictions of mud, sand, and gravel that were correlated with cross-validated test data ( Spearman's rho(mud) = 0.77, rho(sand) = 0.71, rho(gravel) = 0.58). Predictions of individual size fractions were classified to produce a map of seabed sediments that is useful for marine spatial planning. Based on the scale-dependence of variables in this study, we concluded that spatial scale consideration is at least as important as variable selection in seabed mapping.	[Misiuk, Benjamin; Bell, Trevor] Mem Univ Newfoundland, Dept Geog, St John, NF, Canada; [Lecours, Vincent] Univ Florida, Sch Forest Resources & Conservat, Dept Fisheries & Aquat Sci, Gainesville, FL USA	Memorial University Newfoundland; State University System of Florida; University of Florida	Misiuk, B (corresponding author), Mem Univ Newfoundland, Dept Geog, St John, NF, Canada.	bmisiuk@mun.ca	Lecours, Vincent/J-5514-2019	Lecours, Vincent/0000-0002-4777-3348; Misiuk, Benjamin/0000-0001-5822-4574	Government of Nunavut Department of Environment, Fisheries and Sealing Division; ArcticNet [268150-2011]	Government of Nunavut Department of Environment, Fisheries and Sealing Division; ArcticNet	TB received support for this work by way of funding from the Government of Nunavut Department of Environment, Fisheries and Sealing Division (http://www.gov.nu.ca/environment/information/fisheries-and-sealing), in addition to funding and ship time from ArcticNet (http://www.arcticnet.ulaval.ca/; grant no. 268150-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Albani M, 2004, INT J GEOGR INF SCI, V18, P577, DOI 10.1080/13658810410001701987; [Anonymous], 2009, BIOL LETT; Bradter U, 2013, METHODS ECOL EVOL, V4, P167, DOI 10.1111/j.2041-210x.2012.00253.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Brown CJ, 2012, J SEA RES, V72, P1, DOI 10.1016/j.seares.2012.04.009; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Bucas M, 2013, ICES J MAR SCI, V70, P1233, DOI 10.1093/icesjms/fst036; Calvert J, 2015, ICES J MAR SCI, V72, P1498, DOI 10.1093/icesjms/fsu223; Chow TE, 2009, INT J GEOGR INF SCI, V23, P1277, DOI 10.1080/13658810802344127; Coggan R, 2012, ESTUAR COAST SHELF S, V111, P118, DOI 10.1016/j.ecss.2012.06.017; Copeland A, 2013, J COAST CONSERV, V17, P225, DOI 10.1007/s11852-011-0172-1; Cowan B., 2015, THESIS; Diesing M, 2015, 569 JOINT NAT CONS C; Diesing M., 2015, C5818 CTR ENV FISH A; Diesing M, 2015, J SEA RES, V100, P62, DOI 10.1016/j.seares.2014.10.013; Diesing M, 2014, CONT SHELF RES, V84, P107, DOI 10.1016/j.csr.2014.05.004; Dixon B, 2009, HYDROL PROCESS, V23, P1714, DOI 10.1002/hyp.7306; Dolan MFJ, 2014, MAR GEOD, V37, P187, DOI 10.1080/01490419.2014.902888; Dolan MFJ., 2012, 2012041 GEOL SURV NO; Downie A.L., 2016, SEMIAUTOMATED MAPPIN; Dunn DC, 2009, MAR ECOL PROG SER, V377, P1, DOI 10.3354/meps07839; Eidens C, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00002; Eigenbrod F, 2008, BIOL CONSERV, V141, P35, DOI 10.1016/j.biocon.2007.08.025; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Evans JS, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P139, DOI 10.1007/978-1-4419-7390-0_8; FOLK RL, 1954, J GEOL, V62, P344, DOI 10.1086/626171; Franklin J., 2010, MAPPING SPECIES DIST, DOI [10.1017/CBO9780511810602, DOI 10.1017/CBO9780511810602]; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Fulton R.J., 1995, GEOLOGICAL SURVEY CA; Galparsoro I, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00023; Gambi C, 2006, DEEP-SEA RES PT I, V53, P1117, DOI 10.1016/j.dsr.2006.05.003; Gilbert R, 1980, ENV STUDIES MAKTAK C; Giusti M, 2014, CONT SHELF RES, V81, P19, DOI 10.1016/j.csr.2014.03.011; Goff JA, 2000, GEO-MAR LETT, V20, P43, DOI 10.1007/s003670000032; Gottschalk TK, 2011, ECOL MODEL, V222, P3403, DOI 10.1016/j.ecolmodel.2011.07.008; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamil KAD, 2016, LANDSCAPE ECOL, V31, P7, DOI 10.1007/s10980-015-0288-z; Harris PT, 2012, ELSEV INSIGHT, P871, DOI 10.1016/B978-0-12-385140-6.00064-5; Harris PT, 2012, ELSEV INSIGHT, P3, DOI 10.1016/B978-0-12-385140-6.00001-3; Hopkins RL, 2009, LANDSCAPE ECOL, V24, P943, DOI 10.1007/s10980-009-9373-5; Lark RM, 2015, SEDIMENT GEOL, V328, P17, DOI 10.1016/j.sedgeo.2015.07.012; Lark RM, 2012, SEDIMENT GEOL, V281, P35, DOI 10.1016/j.sedgeo.2012.07.009; Lechner AM, 2012, ECOL COMPLEX, V11, P91, DOI 10.1016/j.ecocom.2012.04.002; Lecours V, 2017, REMOTE SENS ECO 0718; Lecours V., 2015, TERRAIN ATTRIBUTE SE, DOI [10.13140/RG.2.2.15014.52800, DOI 10.13140/RG.2.2.15014.52800]; Lecours V, 2017, IEEE T GEOSCI REMOTE, V55, P5391, DOI 10.1109/TGRS.2017.2707303; Lecours V, 2017, ENVIRON MODELL SOFTW, V89, P19, DOI 10.1016/j.envsoft.2016.11.027; Lecours V, 2016, HYDROL EARTH SYST SC, V20, P3207, DOI 10.5194/hess-20-3207-2016; Lecours V, 2015, MAR ECOL PROG SER, V535, P259, DOI 10.3354/meps11378; Long D, 2006, BGS DETAILED EXPLANA; Lundblad E., 2006, GEOD, V29, P89, DOI [10.1080/01490410600738021, DOI 10.1080/01490410600738021]; Margreth A, 2017, QUATERNARY SCI REV, V168, P79, DOI 10.1016/j.quascirev.2017.04.033; Martin-Fernandez JA, 2006, GEOL SOC SPEC PUBL, V264, P191, DOI 10.1144/GSL.SP.2006.264.01.14; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; Miyamoto M, 2017, MAR GEOD, V40, P205, DOI 10.1080/01490419.2017.1315543; Muggah J, 2015, 2014 MULTIBEAM SONAR; Muggah J., 2011, OMG ARCTIC METADATA; Muggah J, 2014, 2013 MULTIBEAM SONAR; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nielsen SE, 2005, ECOGRAPHY, V28, P197, DOI 10.1111/j.0906-7590.2005.04002.x; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Reiss H, 2015, ICES J MAR SCI, V72, P297, DOI 10.1093/icesjms/fsu107; Rengstorf AM, 2013, J BIOGEOGR, V40, P1702, DOI 10.1111/jbi.12123; Rengstorf AM, 2012, MAR GEOD, V35, P343, DOI 10.1080/01490419.2012.699020; Ridgeway G., 2015, GBM GEN BOOSTED REGR; Ross LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140061; Stephens D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142502; Stephens D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093950; Thurber AR, 2014, BIOGEOSCIENCES, V11, P3941, DOI 10.5194/bg-11-3941-2014; Tong RJ, 2016, CONT SHELF RES, V116, P13, DOI 10.1016/j.csr.2016.01.012; Tong RJ, 2013, ECOL INFORM, V13, P123, DOI 10.1016/j.ecoinf.2012.07.002; Tong RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043534; Wheeler J.O., 1996, 14 34 SVITAVY GEOLOG; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Wolff C, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00041; Wright D.J., 2012, ARCGIS BENTHIC TERRA; Ysebaert T, 2002, MAR ECOL PROG SER, V225, P79, DOI 10.3354/meps225079	84	34	35	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193647	10.1371/journal.pone.0193647	http://dx.doi.org/10.1371/journal.pone.0193647			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489899	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000426276000098
J	Paul, B; Annagiri, S				Paul, Bishwarup; Annagiri, Sumana			Tricks of the trade: Mechanism of brood theft in an ant	PLOS ONE			English	Article							SLAVE-MAKING ANTS; COLONY RELOCATION; GUARDING BEHAVIOR; NEST USURPATION; APIS-MELLIFERA; STINGLESS BEE; FIRE ANT; HYMENOPTERA; RECOGNITION; COEVOLUTION	Thievery is ubiquitous in the animal kingdom, social insects not being an exception. Brood is invaluable for the survival of social insect colonies and brood theft is well documented in ants. In many species the stolen brood act as slaves in the thief colony as they take up tasks related to foraging, defence and colony maintenance. Slave-making (dulotic) ants are at an advantage as they gain workforce without investing in rearing immature young, and several slave-making species have been recorded in temperate regions. In the current study we investigate brood theft in a primitively eusocial ponerine ant Diacamma indicum that inhabits the tropics. In the context of colony relocation we asked how thieves steal brood and what victim colonies do to prevent theft. While exposed nests increased colonies' vulnerability, the relocation process itself did not enhance the chances of theft. Various aggressive interactions, in particular immobilization of intruders helped in preventing theft. Thieves that acted quickly, stayed furtive and stole unguarded brood were found to be successful. This comprehensive study of behavioural mechanism of theft reveals that these are the 'tricks' adopted by thieves.	[Paul, Bishwarup; Annagiri, Sumana] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Behav & Ecol Lab, Mohanpur, W Bengal, India	Indian Institute of Science Education & Research (IISER) - Kolkata	Annagiri, S (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Behav & Ecol Lab, Mohanpur, W Bengal, India.	sumana@iiserkol.ac.in	Paul, Bishwarup/AAH-6897-2020	Paul, Bishwarup/0000-0003-3061-7418				[Anonymous], 1971, INSECT SOC; Baratte S, 2006, ANIM BEHAV, V72, P305, DOI 10.1016/j.anbehav.2005.10.025; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Blatrix R, 2003, MOL ECOL, V12, P2809, DOI 10.1046/j.1365-294X.2003.01947.x; BREED MD, 1990, OECOLOGIA, V84, P117, DOI 10.1007/BF00665604; BREED MD, 1990, BEHAV ECOL SOCIOBIOL, V27, P395, DOI 10.1007/BF00164065; Breed Michael D., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/484765; Buschinger A, 2009, MYRMECOL NEWS, V12, P219; BUTLER CG, 1952, BEHAVIOUR, V4, P262; Couvillon MJ, 2008, ANIM BEHAV, V76, P1653, DOI 10.1016/j.anbehav.2008.08.002; Cunningham JP, 2014, AM NAT, V184, P777, DOI 10.1086/678399; D'Ettorre Patrizia, 2001, Acta Ethologica, V3, P67, DOI 10.1007/s102110100038; De Carli P, 1998, ACT COLLOQ INSECT S, V11, P29; Downs SG, 2000, BEHAV ECOL, V11, P326, DOI 10.1093/beheco/11.3.326; Foitzik S, 2001, P ROY SOC B-BIOL SCI, V268, P1139, DOI 10.1098/rspb.2001.1627; Fuchikawa T, 2014, BEHAV ECOL SOCIOBIOL, V68, P1843, DOI 10.1007/s00265-014-1793-9; FUKUMOTO Y, 1989, Physiology and Ecology Japan, V26, P55; Gamboa GJ, 1996, ANIM BEHAV, V51, P625, DOI 10.1006/anbe.1996.0067; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; Holldobler B., 1990, pi; Iyengar EV, 2008, BIOL J LINN SOC, V93, P745, DOI 10.1111/j.1095-8312.2008.00954.x; Jeral JM, 1997, PHYSIOL ENTOMOL, V22, P207, DOI 10.1111/j.1365-3032.1997.tb01160.x; Kaspari M, 2003, EVOL ECOL RES, V5, P933; Kaur R., 2014, THESIS; Kaur R, 2012, ANIM BEHAV, V83, P1345, DOI 10.1016/j.anbehav.2012.02.022; Kolay S, 2015, SCI REP, P5; Kronauer DJC, 2003, P ROY SOC B-BIOL SCI, V270, P805, DOI 10.1098/rspb.2002.2288; LaPolla JS, 2002, INSECT SOC, V49, P251, DOI 10.1007/s00040-002-8310-2; LEFFELAAR D, 1985, WILSON BULL, V97, P221; LEMOLI F, 1993, INSECT SOC, V40, P433, DOI 10.1007/BF01253905; MAKINO S, 1989, INSECT SOC, V36, P116, DOI 10.1007/BF02225907; Paul B, 2016, SCI REP-UK, V6, DOI 10.1038/srep36166; PEETERS C, 1989, NATURWISSENSCHAFTEN, V76, P177, DOI 10.1007/BF00366404; Pohl S, 2011, ANIM BEHAV, V81, P61, DOI 10.1016/j.anbehav.2010.09.006; POLLOCK GB, 1989, AM NAT, V133, P61, DOI 10.1086/284901; R Development Core Team, 2009, R LANG ENV STAT COMP; SAKAGAMI SF, 1993, SOCIOBIOLOGY, V21, P237; Slager DL, 2012, WILSON J ORNITHOL, V124, P812, DOI 10.1676/1559-4491-124.4.812; Sumana A, 2012, CURR SCI INDIA, V102, P1373; Tschinkel WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112981; TSCHINKEL WR, 1992, ECOL ENTOMOL, V17, P179, DOI 10.1111/j.1365-2311.1992.tb01176.x; TSCHINKEL WR, 1992, ANN ENTOMOL SOC AM, V85, P638, DOI 10.1093/aesa/85.5.638; van Zweden JS, 2011, BEHAV ECOL SOCIOBIOL, V65, P1277, DOI 10.1007/s00265-011-1141-2; Viginier B, 2004, MOL ECOL, V13, P2095, DOI 10.1111/j.1365-294X.2004.02201.x; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025	46	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192144	10.1371/journal.pone.0192144	http://dx.doi.org/10.1371/journal.pone.0192144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489858	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000019
J	Saarnio, E; Pekkinen, M; Itkonen, ST; Kemi, V; Karp, H; Ivaska, KK; Risteli, J; Koivula, MK; Karkkainen, M; Makitie, O; Sievanen, H; Lamberg-Allardt, C				Saarnio, Elisa; Pekkinen, Minna; Itkonen, Suvi T.; Kemi, Virpi; Karp, Heini; Ivaska, Kaisa K.; Risteli, Juha; Koivula, Marja-Kaisa; Karkkainen, Merja; Makitie, Outi; Sievanen, Harri; Lamberg-Allardt, Christel			Low free 25-hydroxyvitamin D and high vitamin D binding protein and parathyroid hormone in obese Caucasians. A complex association with bone?	PLOS ONE			English	Article							D DEFICIENCY; SERUM; MASS; WOMEN; SUPPLEMENTATION; 25(OH)D; ASSAYS; GC	Background Studies have shown altered vitamin D metabolism in obesity. We assessed differences between obese and normal-weight subjects in total, free, and bioavailable 25-hydroxyvitamin D (25(OH) D, 25(OH) D-Free, and 25(OH) D-Bio, respectively), vitamin D binding protein (DBP), parathyroid hormone (PTH) and bone traits. Methods 595 37-47-year-old healthy Finnish men and women stratified by BMI were examined in this cross-sectional study. Background characteristic and intakes of vitamin D and calcium were collected. The concentrations of 25(OH) D, PTH, DBP, albumin and bone turnover markers were determined from blood. 25(OH) D-Free and 25(OH) D-Bio were calculated. pQCT was performed at radius and tibia. Results Mean +/- SE (ANCOVA) 25(OH) D-Free (10.8 +/- 0.6 vs 12.9 +/- 0.4 nmol/L; P = 0.008) and 25(OH) DBio (4.1 +/- 0.3 vs 5.1 +/- 0.1 nmol/L; P = 0.003) were lower in obese than in normal-weight women. In men, 25(OH) D (48.0 +/- 2.4 vs 56.4 +/- 2.0 nmol/L, P = 0.003), 25(OH) D-Free (10.3 +/- 0.7 vs 12.5 +/- 0.6 pmol/L; P = 0.044) and 25(OH) D-Bio (4.2 +/- 0.3 vs 5.1 +/- 0.2 nmol/L; P = 0.032) were lower in obese. Similarly in all subjects, 25(OH) D, 25(OH) D-Free and 25(OH) D-Bio were lower in obese (P<0.001). DBP (399 +/- 12 vs 356 +/- 7mg/L, P = 0.008) and PTH (62.2 +/- 3.0 vs 53.3 +/- 1.9 ng/L; P = 0.045) were higher in obese than in normal-weight women. In all subjects, PTH and DBP were higher in obese (P = 0.047 and P = 0.004, respectively). In obese women, 25(OH) D was negatively associated with distal radius trabecular density (R-2 = 0.089, P = 0.009) and tibial shaft cortical strength index (CSI) (R-2 = 0.146, P = 0.004). 25(OH) D-Free was negatively associated with distal radius CSI (R-2 = 0.070, P = 0.049), radial shaft cortical density (CorD) (R-2 = 0.050, P = 0.045), and tibial shaft CSI (R-2 = 0.113, P = 0.012). 25(OH) D-Bio was negatively associated with distal radius CSI (R-2 = 0.072, P = 0.045), radial shaft CorD (R-2 = 0.059, P = 0.032), and tibial shaft CSI (R-2 = 0.093, P = 0.024). Conclusions The associations between BMI and 25(OH) D, 25(OH) D-Free, and 25(OH) D-Bio, DBP, and PTH suggest that obese subjects may differ from normal-weight subjects in vitamin D metabolism. BMI associated positively with trabecular bone traits and CSI in our study, and slightly negatively with cortical bone traits. Surprisingly, there was a negative association of free and bioavailable 25(OH) D and some of the bone traits in obese women.	[Saarnio, Elisa; Itkonen, Suvi T.; Kemi, Virpi; Karp, Heini; Karkkainen, Merja; Lamberg-Allardt, Christel] Univ Helsinki, Dept Food & Nutr, Calcium Res Unit, Helsinki, Finland; [Pekkinen, Minna; Makitie, Outi] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland; [Pekkinen, Minna; Makitie, Outi] Helsinki Univ Cent Hosp, Childrens Hosp, Helsinki, Finland; [Pekkinen, Minna; Makitie, Outi] Univ Helsinki, Helsinki, Finland; [Ivaska, Kaisa K.] Univ Turku, Inst Biomed, Dept Cell Biol & Anat, Turku, Finland; [Risteli, Juha; Koivula, Marja-Kaisa] Univ Oulu, Dept Clin Chem, Oulu, Finland; [Risteli, Juha; Koivula, Marja-Kaisa] Northern Finland Lab Ctr Nordlab, Oulu, Finland; [Risteli, Juha; Koivula, Marja-Kaisa] Med Res Ctr, Oulu, Finland; [Koivula, Marja-Kaisa] Hosp Dist Southwest Finland, Tykslab, Turku, Finland; [Koivula, Marja-Kaisa] Univ Hosp Turku, Dept Clin Chem, Turku, Finland; [Sievanen, Harri] UKK Inst Hlth Promot Res, Tampere, Finland	University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Turku; University of Oulu; University of Turku; University of Turku; UKK Institute	Saarnio, E (corresponding author), Univ Helsinki, Dept Food & Nutr, Calcium Res Unit, Helsinki, Finland.		Saarnio, Elisa/L-2611-2019; Ivaska, Kaisa/G-1406-2012	Saarnio, Elisa/0000-0003-1227-567X; Ivaska, Kaisa/0000-0001-7482-7623; Lamberg-Allardt, Christel/0000-0001-7326-1904; Itkonen, Suvi/0000-0003-1635-8229	Academy of Finland [127536]; Doctoral school for Applied Biosciences, University of Helsinki Future Fund; Finnish Cultural Foundation; Medicinska Understodsforening Liv och Halsa; Alfred Kordelin Foundation	Academy of Finland(Academy of Finland); Doctoral school for Applied Biosciences, University of Helsinki Future Fund; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Medicinska Understodsforening Liv och Halsa; Alfred Kordelin Foundation	This work was supported by the Academy of Finland (127536), http://www.aka.fi/; Doctoral school for Applied Biosciences, University of Helsinki Future Fund, https://www.helsinki.fi/; Finnish Cultural Foundation, https://skr.fi/; Medicinska Understodsforening Liv och Halsa, http://www.livochhalsa.fi/ and Alfred Kordelin Foundation, https://kordelin.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almesri N, 2016, APPL PHYSIOL NUTR ME, V41, P345, DOI 10.1139/apnm-2015-0284; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; BELL NH, 1985, J CLIN INVEST, V76, P370, DOI 10.1172/JCI111971; Bikle D, 2017, J STEROID BIOCHEM, V173, P105, DOI 10.1016/j.jsbmb.2017.01.007; Bikle DD, 2017, ENDOCRIN METAB CLIN, V46, P901, DOI 10.1016/j.ecl.2017.07.013; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Botella-Carretero JI, 2007, CLIN NUTR, V26, P573, DOI 10.1016/j.clnu.2007.05.009; Bouillon R, 2014, NEW ENGL J MED, V370, P879, DOI 10.1056/NEJMc1315850; Bouillon R, 2013, J CLIN ENDOCR METAB, V98, pE1283, DOI 10.1210/jc.2013-1195; Denburg MR, 2016, J BONE MINER RES, V31, P1128, DOI 10.1002/jbmr.2829; Drincic A, 2013, J CLIN ENDOCR METAB, V98, P4845, DOI 10.1210/jc.2012-4103; Drincic AT, 2012, OBESITY, V20, P1444, DOI 10.1038/oby.2011.404; Gallagher JC, 2013, J STEROID BIOCHEM, V136, P195, DOI 10.1016/j.jsbmb.2012.12.003; GUHA C, 1995, HEPATOLOGY, V21, P1675; Holmlund-Suila E, 2016, CLIN ENDOCRINOL, V85, P378, DOI 10.1111/cen.13093; Itkonen ST, 2016, BRIT J NUTR, V115, P1100, DOI 10.1017/S0007114515005474; Itkonen ST, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-94; Jarvinen TL, 2003, J BONE MINER RES, V18, P1921, DOI 10.1359/jbmr.2003.18.11.1921; Johansson H, 2014, J BONE MINER RES, V29, P223, DOI 10.1002/jbmr.2017; Johnsen MS, 2014, SCAND J CLIN LAB INV, V74, P177, DOI 10.3109/00365513.2013.869701; Kakonen SM, 2000, CLIN CHEM, V46, P332; Karlsson T, 2014, EUR J NUTR, V53, P259, DOI 10.1007/s00394-013-0524-8; Konradsen S, 2008, EUR J NUTR, V47, P87, DOI 10.1007/s00394-008-0700-4; Laaksonen M.M.L., 2010, ARCH OSTEOPOROS, V5, P119, DOI [10.1007/s11657-010-0043-7, DOI 10.1007/S11657-010-0043-7]; LIEL Y, 1988, CALCIFIED TISSUE INT, V43, P199, DOI 10.1007/BF02555135; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Macdonald HM, 2011, J CLIN ENDOCR METAB, V96, P1677, DOI 10.1210/jc.2010-2032; Malmstroem S, 2017, J AOAC INT, V100, P1323, DOI 10.5740/jaoacint.17-0085; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Nordic Council of Ministers, 2013, NORD NUTR REC 2012 1; Paldanius PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063036; Popkin BM, 2010, AM J CLIN NUTR, V91, p284S, DOI 10.3945/ajcn.2009.28473C; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Saarnio E., 2016, BMC NUTR, V2, P46, DOI DOI 10.1186/S40795-016-0085-3; Sai AJ, 2011, J CLIN ENDOCR METAB, V96, pE436, DOI 10.1210/jc.2010-1886; Sievanen H, 2000, INVEST RADIOL, V35, P325, DOI 10.1097/00004424-200005000-00007; Sievanen H, 1998, J BONE MINER RES, V13, P871, DOI 10.1359/jbmr.1998.13.5.871; Taes YEC, 2006, BONE, V38, P701, DOI 10.1016/j.bone.2005.10.006; Uusi-Rasi K, 2012, OSTEOPOROSIS INT, V23, P1453, DOI 10.1007/s00198-011-1737-4; Uusi-Rasi K, 2010, J OSTEOPOROS, V2010, DOI 10.4061/2010/904806; Vanlint S, 2013, NUTRIENTS, V5, P949, DOI 10.3390/nu5030949; Walsh JS, 2016, AM J CLIN NUTR, V103, P1465, DOI 10.3945/ajcn.115.120139; Weeks BK, 2008, OSTEOPOROSIS INT, V19, P1567, DOI 10.1007/s00198-008-0606-2; Winters SJ, 2009, METABOLISM, V58, P438, DOI 10.1016/j.metabol.2008.10.017; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; YAMAMOTO N, 1993, J IMMUNOL, V151, P2794	49	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192596	10.1371/journal.pone.0192596	http://dx.doi.org/10.1371/journal.pone.0192596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489840	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000034
J	Li, YC; Qiu, RX; Jing, ST				Li, Yuancheng; Qiu, Rixuan; Jing, Sitong			Intrusion detection system using Online Sequence Extreme Learning Machine (OS-ELM) in advanced metering infrastructure of smart grid	PLOS ONE			English	Article							KEY MANAGEMENT SCHEME; SECURE COMMUNICATIONS; THEFT DETECTION; NETWORKS; ALGORITHM; ATTACK	Advanced Metering Infrastructure (AMI) realizes a two-way communication of electricity data through by interconnecting with a computer network as the core component of the smart grid. Meanwhile, it brings many new security threats and the traditional intrusion detection method can't satisfy the security requirements of AMI. In this paper, an intrusion detection system based on Online Sequence Extreme Learning Machine (OS-ELM) is established, which is used to detecting the attack in AMI and carrying out the comparative analysis with other algorithms. Simulation results show that, compared with other intrusion detection methods, intrusion detection method based on OS-ELM is more superior in detection speed and accuracy.	[Li, Yuancheng; Qiu, Rixuan; Jing, Sitong] North China Elect Power Univ, Dept Control & Comp Engn, Beijing, Peoples R China	North China Electric Power University	Qiu, RX (corresponding author), North China Elect Power Univ, Dept Control & Comp Engn, Beijing, Peoples R China.	rxqiu@ncepu.edu.cn						Akkaya K, 2015, IEEE T SMART GRID, V6, P2366, DOI 10.1109/TSG.2015.2390131; Allwood G, 2016, IEEE SENS J, V16, P5497, DOI 10.1109/JSEN.2016.2535465; Ambusaidi MA, 2016, IEEE T COMPUT, V65, P2986, DOI 10.1109/TC.2016.2519914; Amin S, 2015, IEEE CONTR SYST MAG, V35, P66, DOI 10.1109/MCS.2014.2364711; Bai X.-m, 2010, 2010 INT C POWER SYS, P1; Berthier R, 2010, INT CONF SMART GRID, P350, DOI 10.1109/SMARTGRID.2010.5622068; Buczak AL, 2016, IEEE COMMUN SURV TUT, V18, P1153, DOI 10.1109/COMST.2015.2494502; David G. H., 2008, POW EN SOC GEN M CON, P1932; Faisal MA, 2015, IEEE SYST J, V9, P31, DOI 10.1109/JSYST.2013.2294120; Gungor VC, 2013, IEEE T IND INFORM, V9, P28, DOI 10.1109/TII.2012.2218253; Gungor VC, 2011, IEEE T IND INFORM, V7, P529, DOI 10.1109/TII.2011.2166794; Ha T, 2016, IEEE NETWORK, V30, P22, DOI 10.1109/MNET.2016.1600106NM; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Liu NA, 2013, IEEE T IND ELECTRON, V60, P4746, DOI 10.1109/TIE.2012.2216237; Liu XX, 2015, IEEE T SMART GRID, V6, P2435, DOI 10.1109/TSG.2015.2418280; Maharjan S, 2016, IEEE T SMART GRID, V7, P189, DOI 10.1109/TSG.2015.2431324; McLaughlin S, 2013, IEEE J SEL AREA COMM, V31, P1319, DOI 10.1109/JSAC.2013.130714; Miao X., 2012, EL DISTR CICED CHIN, V5, P10; Nicanfar Hasen, 2011, SMART GRID COMM SMAR; Ntalampiras S, 2016, EXPERT SYST APPL, V58, P164, DOI 10.1016/j.eswa.2016.04.006; Ntalampiras S, 2015, IEEE T IND INFORM, V11, P104, DOI 10.1109/TII.2014.2367322; Pan SY, 2015, IEEE T SMART GRID, V6, P3104, DOI 10.1109/TSG.2015.2409775; Ponomarev S, 2016, IEEE T DEPEND SECURE, V13, P252, DOI 10.1109/TDSC.2015.2443793; Quilumba-Gudino FL, 2014, USING ADV METERING I; Rahman MA, 2012, IEEE INFOCOM SER, P2255, DOI 10.1109/INFCOM.2012.6195611; Wang K, 2017, INT CON ADV INFO NET, P1, DOI [10.1109/AINA.2017.29, 10.1109/INTMAG.2017.8007837]; Wang XJ, 2016, CHINA COMMUN, V13, P24, DOI 10.1109/CC.2016.7559072; Weller-Fahy DJ, 2015, IEEE COMMUN SURV TUT, V17, P70, DOI 10.1109/COMST.2014.2336610; Yi P, 2014, IEEE ICC, P1029, DOI 10.1109/ICC.2014.6883456; Yu KP, 2015, IEEE T INSTRUM MEAS, V64, P2072, DOI 10.1109/TIM.2015.2444238; Zhang YC, 2011, IEEE T SMART GRID, V2, P796, DOI 10.1109/TSG.2011.2159818	31	16	17	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192216	10.1371/journal.pone.0192216	http://dx.doi.org/10.1371/journal.pone.0192216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485990	gold, Green Published, Green Submitted			2022-12-27	WOS:000426242400006
J	Bergsten, EL; Mathiassen, SE; Larsson, J; Kwak, L				Bergsten, Eva L.; Mathiassen, Svend Erik; Larsson, Johan; Kwak, Lydia			Implementation of an ergonomics intervention in a Swedish flight baggage handling company-A process evaluation	PLOS ONE			English	Article							LEADERSHIP-BEHAVIOR; IMPACT	Objective To conduct a process evaluation of the implementation of an ergonomics training program aimed at increasing the use of loading assist devices in flight baggage handling. Methods Feasibility related to the process items recruitment, reach, context, dose delivered (training time and content); dose received (participants' engagement); satisfaction with training; intermediate outcomes (skills, confidence and behaviors); and barriers and facilitators of the training intervention were assessed by qualitative and quantitative methods. Results Implementation proved successful regarding dose delivered, dose received and satisfaction. Confidence among participants in the training program in using and talking about devices, observed use of devices among colleagues, and internal feedback on work behavior increased significantly (p<0.01). Main facilitators were self-efficacy, motivation, and perceived utility of training among the trainees. Barriers included lack of peer support, opportunities to observe and practice behaviors, and follow-up activities; as well as staff reduction and job insecurity. Conclusions In identifying important barriers and facilitators for a successful outcome, this study can help supporting the effectiveness of future interventions. Our results suggest that barriers caused by organizational changes may likely be alleviated by recruiting motivated trainees and securing strong organizational support for the implementation.	[Bergsten, Eva L.; Mathiassen, Svend Erik; Larsson, Johan] Univ Gavle, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Gavle, Sweden; [Bergsten, Eva L.] Uppsala Univ, Dept Med Sci, Occupat & Environm Med, Uppsala, Sweden; [Kwak, Lydia] Karolinska Inst, Inst Environm Med, Unit Intervent & Implementat Res, Stockholm, Sweden	University of Gavle; Uppsala University; Karolinska Institutet	Bergsten, EL (corresponding author), Univ Gavle, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Gavle, Sweden.; Bergsten, EL (corresponding author), Uppsala Univ, Dept Med Sci, Occupat & Environm Med, Uppsala, Sweden.	eva.bergsten@hig.se	Mathiassen, Svend Erik/ABF-3165-2020	Mathiassen, Svend Erik/0000-0003-1443-6211	Swedish Research Council for Health, Working Life and Welfare (FORTE) [2009-1761]	Swedish Research Council for Health, Working Life and Welfare (FORTE)	This work received funding from The Swedish Research Council for Health, Working Life and Welfare (FORTE) Grant number 2009-1761. http://forte.se/en/. Received: SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by grants from the Swedish Research Council for Health, Working Life and Welfare (FORTE Dnr 2009-1761). We gratefully acknowledge the participating baggage handling company and the Vocational Training and Working Environment Council (TYA) for collaboration. The authors would also like to thank Reidar Pettersson, Erik Alphonse, Dan Holmberg and informer baggage handlers for their contributions to the data collection. Finally, we would like to thank all the baggage handlers who participated in this study.	Baldwin TT, 1988, PERS PSYCHOL, V41, P43; Bergsten EL, 2015, BIOMED RES INT, V2015, P11; Blume BD, 2010, J MANAGE, V36, P1065, DOI 10.1177/0149206309352880; Coffeng JK, 2013, J OCCUP ENVIRON MED, V55, P1409, DOI 10.1097/JOM.0b013e3182a50053; Grossman R, 2011, INT J TRAIN DEV, V15, P103, DOI 10.1111/j.1468-2419.2011.00373.x; Kennedy C. A., 2009, J OCCUPATIONAL REHAB, V20, P127, DOI DOI 10.1007/S10926-009-9211-2; Koningsveld EAP, 2005, ERGONOMICS, V48, P559, DOI 10.1080/00140130400029136; Kristensen T S, 2005, Occup Environ Med, V62, P205, DOI 10.1136/oem.2004.016097; Larsson J, 2010, TOTAL QUAL MANAG BUS, V21, P317, DOI 10.1080/14783360903561779; Linnan L., 2002, PROCESS EVALUATION P, P1; Montano D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-135; Murta SG, 2007, AM J HEALTH PROMOT, V21, P248, DOI 10.4278/0890-1171-21.4.248; Nielsen K, 2013, EUR J WORK ORGAN PSY, V22, P601, DOI 10.1080/1359432X.2012.690556; Nielsen K, 2006, WORK STRESS, V20, P272, DOI 10.1080/02678370601022688; Nielsen K, 2010, WORK STRESS, V24, P219, DOI 10.1080/02678373.2010.519176; O'Cathain A, 2007, BMC HEALTH SERV RES, V7, P1; Pehkonen I, 2009, APPL ERGON, V40, P115, DOI 10.1016/j.apergo.2008.01.006; Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-139; Robroek SJW, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-26; Skakon J, 2010, WORK STRESS, V24, P107, DOI 10.1080/02678373.2010.495262; Taylor PJ, 2005, J APPL PSYCHOL, V90, P692, DOI 10.1037/0021-9010.90.4.692; van Eerd D, 2010, ERGONOMICS, V53, P1153, DOI 10.1080/00140139.2010.513452; Velada R, 2007, INT J TRAIN DEV, V11, P282, DOI 10.1111/j.1468-2419.2007.00286.x; Verbeek JH, 2011, COCHRANE DATABASE SY; Wahlstrom J, 2016, ANN OCCUPATIONAL HYG; Weiler MR, 2012, ERGONOMICS, V55, P1362, DOI 10.1080/00140139.2012.714474; Wells R, 2009, WORK, V34, P117, DOI 10.3233/WOR-2009-0937; Wierenga D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1190; Wijk K, 2011, SCAND J WORK ENV HEA, V37, P363, DOI 10.5271/sjweh.3159; Yukl G, 2012, ACAD MANAGE PERSPECT, V26, P66, DOI 10.5465/amp.2012.0088	30	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0191760	10.1371/journal.pone.0191760	http://dx.doi.org/10.1371/journal.pone.0191760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513671	Green Submitted, gold, Green Published			2022-12-27	WOS:000426896800008
J	Nishiyama, R				Nishiyama, Ryoji			Separability of active semantic and phonological maintenance in verbal working memory	PLOS ONE			English	Article							SHORT-TERM-MEMORY; ARTICULATORY SUPPRESSION; SERIAL-RECALL; INFORMATION; SIMILARITY; REHEARSAL; WORDS; COMPREHENSION; CONSTRAINTS; RETENTION	Models of verbal working memory that incorporate active memory maintenance, long-term memory networks, and attention control have been developed. Current studies suggest that semantic representations of words, evoked via long-term memory networks, are actively maintained until they are needed to fulfill a role. In other words, it is possible that some mechanism actively refreshes semantic representations of words, analogous to but independently from articulatory rehearsal which refreshes phonological representations. One valuable piece of evidence is a double dissociation, observed in a dual task paradigm in which manual tapping disrupted a semantic memory task while articulatory suppression disrupted a phonological memory task. However, in that study, the secondary tasks could have competed not only with the maintenance but also with the encoding activities. Additionally, the study items in the phonological memory tasks were words; hence, the discriminability of the memory tasks is doubtful. The present study, therefore, examined a potential double dissociation in situations where the secondary tasks could not compete with encoding, using a modified phonological memory task. Furthermore, this article discusses a potential mechanism for maintaining semantic representations.	[Nishiyama, Ryoji] Kyoto Univ, Grad Sch Educ, Kyoto, Japan	Kyoto University	Nishiyama, R (corresponding author), Kyoto Univ, Grad Sch Educ, Kyoto, Japan.	Ryoji.nishiyama@gmail.com						Alloway TP, 2010, EUR J COGN PSYCHOL, V22, P297, DOI 10.1080/09541440902793731; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1986, WORKING MEMORY THOUG; BADDELEY AD, 1975, J VERB LEARN VERB BE, V14, P575, DOI 10.1016/S0022-5371(75)80045-4; Barrouillet P, 2004, J EXP PSYCHOL GEN, V133, P83, DOI 10.1037/0096-3445.133.1.83; Belleville S, 2003, J MEM LANG, V48, P686, DOI 10.1016/S0749-596X(02)00532-6; BESNER D, 1982, CAN J PSYCHOL, V36, P701, DOI 10.1037/h0080665; Camos V, 2009, J MEM LANG, V61, P457, DOI 10.1016/j.jml.2009.06.002; Camos V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00900; Camos V, 2011, MEM COGNITION, V39, P231, DOI 10.3758/s13421-010-0011-x; Campoy G, 2015, Q J EXP PSYCHOL, V68, P759, DOI 10.1080/17470218.2014.966248; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Cowan N, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Cowan N., 2016, PSYCHON B REV; Cowan N., 1999, MODELS WORKING MEMOR, V20, P506, DOI DOI 10.1017/CBO9781139174909.006; ELLIS NR, 1968, J EXP PSYCHOL, V77, P613, DOI 10.1037/h0026064; Friedmann N, 2003, BRAIN LANG, V86, P23, DOI 10.1016/S0093-934X(02)00530-8; Gelman A, 2014, PERSPECT PSYCHOL SCI, V9, P641, DOI 10.1177/1745691614551642; GLANZER M, 1966, J VERB LEARN VERB BE, V5, P351, DOI 10.1016/S0022-5371(66)80044-0; Guerard K, 2009, EXP PSYCHOL, V56, P367, DOI 10.1027/1618-3169.56.5.367; Haarmann H, 2001, PSYCHON B REV, V8, P568, DOI 10.3758/BF03196193; Haarmann HJ, 2005, INT J PSYCHOPHYSIOL, V57, P115, DOI 10.1016/j.ijpsycho.2005.03.017; Haarmann HJ, 2003, J MEM LANG, V48, P320, DOI 10.1016/S0749-596X(02)00506-5; Howard D, 2005, COGN NEUROPSYCHOL, V22, P42, DOI 10.1080/02643290342000582; Hudjetz A, 2007, MEM COGNITION, V35, P1675, DOI 10.3758/BF03193501; Hutchison KA, 2007, J EXP PSYCHOL LEARN, V33, P645, DOI 10.1037/0278-7393.33.4.645; Innocenti I, 2010, NEUROIMAGE, V53, P325, DOI 10.1016/j.neuroimage.2010.06.011; Iwamoto K., TAKAO KO1841 1916; Larsen JD, 2003, Q J EXP PSYCHOL-A, V56, P1249, DOI 10.1080/02724980244000765; Loaiza VM, J EXP PSYCH IN PRESS; Majerus S, 2004, COGN NEUROPSYCHOL, V21, P491, DOI 10.1080/02643290342000104; Martin R., 1994, NEUROPSYCHOLOGY, V8, P506, DOI [10.1037/0894-4105.8.4.506, DOI 10.1037/0894-4105.8.4.506]; Martin RC, 2004, BRAIN LANG, V89, P76, DOI 10.1016/S0093-934X(03)00300-6; MCLEOD P, 1984, ATTENTION PERFORM, V10, P55; MIYAKE A, 1994, J MEM LANG, V33, P175, DOI 10.1006/jmla.1994.1009; Morey RD, PACKAGE BAYESFACTOR; Morita A, 2007, Q J EXP PSYCHOL, V60, P581, DOI 10.1080/17470210600682405; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; MURRAY DJ, 1968, J EXP PSYCHOL, V78, P679, DOI 10.1037/h0026641; NAVEHBENJAMIN M, 1984, J EXP PSYCHOL LEARN, V10, P369, DOI 10.1037/0278-7393.10.3.369; Nishiyama R, 2014, PSYCHON B REV, V21, P1583, DOI 10.3758/s13423-014-0618-1; Nishiyama R, 2013, J EXP PSYCHOL LEARN, V39, P642, DOI 10.1037/a0029160; R Development Core Team, 2016, R LANG ENV STAT COMP; Romani C, 2008, Q J EXP PSYCHOL, V61, P292, DOI 10.1080/17470210601147747; Rose NS, 2014, MEM COGNITION, V42, P689, DOI 10.3758/s13421-014-0398-x; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26; RUNDUS D, 1971, J EXP PSYCHOL, V89, P63, DOI 10.1037/h0031185; Saint-Aubin J, 1999, Q J EXP PSYCHOL-A, V52, P367, DOI 10.1080/027249899391115; Saito S, 1997, BRIT J PSYCHOL, V88, P565, DOI 10.1111/j.2044-8295.1997.tb02658.x; SAITO S, 1994, MEM COGNITION, V22, P181; Sakuma N., 2005, NTT DATABASE SERIES, V8; Shivde G, 2004, COGN AFFECT BEHAV NE, V4, P10, DOI 10.3758/CABN.4.1.10; Shivde G, 2011, J EXP PSYCHOL LEARN, V37, P1342, DOI 10.1037/a0024832; SHULMAN HG, 1970, J VERB LEARN VERB BE, V9, P499, DOI 10.1016/S0022-5371(70)80093-7; SHULMAN HG, 1972, J VERB LEARN VERB BE, V11, P221, DOI 10.1016/S0022-5371(72)80080-X; Umemoto T, 1955, JPN J PSYCHOL, V26, P148, DOI 10.4992/jjpsy.26.148; Vergauwe E, 2015, PSYCHON B REV, V22, P1001, DOI 10.3758/s13423-014-0755-6; Walker I, 1999, J EXP PSYCHOL LEARN, V25, P1256, DOI 10.1037/0278-7393.25.5.1256; WATKINS MJ, 1974, J VERB LEARN VERB BE, V13, P430, DOI 10.1016/S0022-5371(74)80021-6	60	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193808	10.1371/journal.pone.0193808	http://dx.doi.org/10.1371/journal.pone.0193808			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513731	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800077
J	Macey, PM; Haris, N; Kumar, R; Thomas, MA; Woo, MA; Harper, RM				Macey, Paul M.; Haris, Natasha; Kumar, Rajesh; Thomas, M. Albert; Woo, Mary A.; Harper, Ronald M.			Obstructive sleep apnea and cortical thickness in females and males	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INSULAR CORTEX; INTERMITTENT HYPOXIA; BRAIN MORPHOLOGY; SEX-DIFFERENCES; DEPRESSIVE SYMPTOMS; STRUCTURAL-CHANGES; MOOD DISORDERS; RESPONSES; INJURY	Introduction Obstructive sleep apnea (OSA) affects approximately 10% of adults, and alters brain gray and white matter. Psychological and physiological symptoms of the disorder are sex-specific, perhaps related to greater injury occurs in female than male patients in white matter. Our objective was to identify influences of OSA separated by sex on cortical gray matter. Methods We assessed cortical thickness in 48 mild-severe OSA patients (mean age +/- std[range] = 46.5 +/- 9.0[30.8-62.7] years; apnea-hypopnea index = 32.6 +/- 21.1[6-102] events/hour; 12 female, 36 male; OSA severity: 5 mild, 18 moderate, 25 severe) and 62 controls (mean age = 47.7 +/- 8.9[30.9-65.8] years; 22 female, 40 male). All OSA patients were recently-diagnosed via polysomnography, and control subjects screened and a subset assessed with sleep studies. We used high-resolution magnetic resonance imaging to identify OSA-related cortical thinning, based on a model with condition and sex as independent variables. OSA and OSA-by-sex interaction effects were assessed (P<0.05, corrected for multiple comparisons). Results Multiple regions of reduced cortical thickness appeared bilaterally in the superior frontal lobe in female OSA vs. all other groups. Significant thinning within the pre- and post-central gyri and the superior temporal gyrus, extending into the insula, appeared between the general OSA populations vs. control subjects. No areas showed increased thickness in OSA vs. controls or positive female OSA interaction effects. Conclusions Reduced cortical thickness likely represents tissue atrophy from long term injury, including death of neurons and supporting glia from repeated intermittent hypoxic exposure in OSA, although disease comordities may also contribute to thinning. Lack of polysomnography in all control subjects means results may be confounded by undiagnosed OSA. The greater cortical injury in cognitive areas of female OSA patients may underlie enhanced symptoms in that group. The thinning associated with OSA in male and females OSA patients may contribute to autonomic dysregulation and impaired upper airway sensori-motor function.	[Macey, Paul M.; Haris, Natasha; Woo, Mary A.] Univ Calif Los Angeles, UCLA Sch Nursing, Los Angeles, CA 90024 USA; [Macey, Paul M.; Kumar, Rajesh; Harper, Ronald M.] Univ Calif Los Angeles, Brain Res Inst, David Geffen Sch Med UCLA, Los Angeles, CA 90024 USA; [Kumar, Rajesh] Univ Calif Los Angeles, David Geffen Sch Med UCLA, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Kumar, Rajesh; Thomas, M. Albert] Univ Calif Los Angeles, David Geffen Sch Med UCLA, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Harper, Ronald M.] Univ Calif Los Angeles, David Geffen Sch Med UCLA, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Macey, PM (corresponding author), Univ Calif Los Angeles, UCLA Sch Nursing, Los Angeles, CA 90024 USA.; Macey, PM (corresponding author), Univ Calif Los Angeles, Brain Res Inst, David Geffen Sch Med UCLA, Los Angeles, CA 90024 USA.	pmacey@ucla.edu	Thomas, M. Albert/A-6176-2012; Thomas, M. Albert/J-7210-2019; Macey, Paul M./B-5037-2008	Thomas, M. Albert/0000-0001-9037-2585; Thomas, M. Albert/0000-0001-9037-2585; Macey, Paul M./0000-0003-4093-7458	National Institute of Nursing Research [NR013693]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013693] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by the National Institute of Nursing Research (NR013693).; This research was funded by the National Institute of Nursing Research NR013693. The authors thank Rebecca Harper for assistance with data collection.	Anttalainen U, 2010, ACTA OBSTET GYN SCAN, V89, P605, DOI 10.3109/00016341003681249; Asghari A, 2012, EUR ARCH OTO-RHINO-L, V269, P2549, DOI 10.1007/s00405-012-1942-6; Ball G, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00003; Baronio D, 2013, RESP PHYSIOL NEUROBI, V185, P217, DOI 10.1016/j.resp.2012.10.012; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bonner MF, 2013, J NEUROSCI, V33, P4213, DOI 10.1523/JNEUROSCI.0041-13.2013; Brodmann K, 1909, VERGLEICHENDE LOKALI, Vx; BROUILLETTE RT, 1980, J APPL PHYSIOL, V49, P801, DOI 10.1152/jappl.1980.49.5.801; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Buysse D J, 1989, Psychiatry Res, V28, P193; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; CECHETTO DF, 1990, AM J PHYSIOL, V258, pR245, DOI 10.1152/ajpregu.1990.258.1.R245; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEEGAN PC, 1995, EUR RESPIR J, V8, P1161, DOI 10.1183/09031936.95.08071161; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754; Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gennatas ED, 2017, J NEUROSCI, V37, P5065, DOI 10.1523/JNEUROSCI.3550-16.2017; Gozal D, 2002, AM J RESP CRIT CARE, V166, P1305, DOI 10.1164/rccm.2208005; Harper RM, 2009, SLEEP, V32, pA341; Harper RM, 2003, J APPL PHYSIOL, V94, P1583, DOI 10.1152/japplphysiol.00881.2002; Henderson LA, 2003, J APPL PHYSIOL, V94, P1063, DOI 10.1152/japplphysiol.00702.2002; HORNER RL, 1991, J PHYSIOL-LONDON, V436, P31, DOI 10.1113/jphysiol.1991.sp018537; Huynh NT, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00058; Joo EY, 2013, SLEEP, V36, P1153, DOI 10.5665/sleep.2876; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Joseph R, 1999, PSYCHIATRY, V62, P138, DOI 10.1080/00332747.1999.11024862; Kilicarslan R, 2014, SCI WORLD J, DOI 10.1155/2014/768415; Kim JS, 2013, PARKINSONISM RELAT D, V19, P970, DOI 10.1016/j.parkreldis.2013.06.012; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kumar R, 2008, NEUROSCI LETT, V438, P330, DOI 10.1016/j.neulet.2008.04.071; Kumar R, 2014, SLEEP, V37, P723, DOI 10.5665/sleep.3578; Kumar R, 2014, NEUROIMAGE-CLIN, V4, P383, DOI 10.1016/j.nicl.2014.01.009; Kumar R, 2012, J NEUROSCI RES, V90, P2043, DOI 10.1002/jnr.23083; Littner MR, 2007, J CLIN SLEEP MED, V3, P263; Macey KE, 2006, RESP PHYSIOL NEUROBI, V151, P44, DOI 10.1016/j.resp.2005.05.024; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2012, SLEEP, V35, P1603, DOI 10.5665/sleep.2228; Macey PM, 2012, AUTON NEUROSCI-BASIC, V168, P72, DOI 10.1016/j.autneu.2012.01.009; Macey PM, 2012, SLEEP, V35, P9, DOI 10.5665/sleep.1572; Macey PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010211; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Marques-Iturria I, 2013, PSYCHIAT RES-NEUROIM, V214, P109, DOI 10.1016/j.pscychresns.2013.06.004; Mazzola L, 2012, NEUROIMAGE, V60, P409, DOI 10.1016/j.neuroimage.2011.12.072; McCall WV, 2006, J CLIN SLEEP MED, V2, P424; Metman Leo Verhagen, 1993, Brain Topography, V6, P13, DOI 10.1007/BF01234122; Morrell MJ, 2010, THORAX, V65, P908, DOI 10.1136/thx.2009.126730; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Nijboer CHA, 2007, DEV NEUROSCI-BASEL, V29, P385, DOI 10.1159/000105479; Nijboer CHA, 2007, J CEREBR BLOOD F MET, V27, P282, DOI 10.1038/sj.jcbfm.9600342; O'Donoghue FJ, 2005, AM J RESP CRIT CARE, V171, P1185, DOI 10.1164/rccm.200406-738OC; ONAL E, 1981, J APPL PHYSIOL, V50, P1052, DOI 10.1152/jappl.1981.50.5.1052; Parpia P, 2011, NEURAL COMPUT, V23, pCP3; Pink A, 2017, J ALZHEIMERS DIS, V58, P1273, DOI 10.3233/JAD-170041; Radua J, 2010, NEUROIMAGE, V49, P939, DOI 10.1016/j.neuroimage.2009.08.030; Sanfilippo-Cohn B, 2006, SLEEP, V29, P152, DOI 10.1093/sleep/29.2.152; Santarnecchi E, 2013, J SLEEP RES, V22, P337, DOI 10.1111/jsr.12006; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; SHEFER V F, 1973, Neuroscience and Behavioral Physiology, V6, P319, DOI 10.1007/BF01182672; Shepertycky MR, 2005, SLEEP, V28, P309; Simons M, 2014, J CELL BIOL, V206, P335, DOI 10.1083/jcb.201404154; Singh-Curry V, 2009, NEUROPSYCHOLOGIA, V47, P1434, DOI 10.1016/j.neuropsychologia.2008.11.033; Somers VK, 2008, CIRCULATION, V118, P1080, DOI [10.1161/CIRCULATIONAHA.107.189420, 10.1161/CIRCULATIONAHA.107.189375]; Stevens FL, 2011, J NEUROPSYCH CLIN N, V23, P120, DOI 10.1176/appi.neuropsych.23.2.121; Tsumori T, 2006, NEUROSCI RES, V56, P261, DOI 10.1016/j.neures.2006.07.005; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Yadav SK, 2013, NEUROSCI LETT, V555, P159, DOI 10.1016/j.neulet.2013.09.033; Yang QC, 2013, NEUROPSYCH DIS TREAT, V9, P1077, DOI 10.2147/NDT.S49868; Young T, 1996, ARCH INTERN MED, V156, P2445, DOI 10.1001/archinte.156.21.2445; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705	75	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193854	10.1371/journal.pone.0193854	http://dx.doi.org/10.1371/journal.pone.0193854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509806	Green Published, gold			2022-12-27	WOS:000426813200035
J	Urselmans, L; Phelps, S				Urselmans, Linda; Phelps, Steve			A Schelling model with adaptive tolerance	PLOS ONE			English	Article							INTERGROUP CONTACT THEORY; PREJUDICE; DIVERSITY; ISSUES	We introduce a Schelling model in which people are modelled as agents following simple behavioural rules which dictate their tolerance to others, their corresponding preference for particular locations, and in turn their movement through a geographic or social space. Our innovation over previous work is to allow agents to adapt their tolerance to others in response to their local environment, in line with contemporary theories from social psychology. We show that adaptive tolerance leads to a polarization in tolerance levels, with distinct modes at either extreme of the distribution. Moreover, agents self-organize into communities of like-tolerance, just as they congregate with those of same colour. Our results are robust not only to variations in free parameters, but also experimental treatments in which migrants are dynamically introduced into the native population. We argue that this model provides one possible parsimonious explanation of the political landscape circa 2016.	[Urselmans, Linda] Univ Essex, Colchester, Essex, England; [Phelps, Steve] Kings Coll London, London, England	University of Essex; University of London; King's College London	Urselmans, L (corresponding author), Univ Essex, Colchester, Essex, England.	linda@lurselmans.me						Allport GW, 1954, NATURE PREJUDICE, V35; Ariely G, 2014, POLIT STUD-LONDON, V62, P573, DOI 10.1111/1467-9248.12068; Benenson I, 2011, GEOGR ANAL, V43, P287, DOI 10.1111/j.1538-4632.2011.00820.x; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Collier P., 2013, EXODUS MIGRATION IS, P57; Crawford JT, 2017, J PERS SOC PSYCHOL, V112, P383, DOI 10.1037/pspa0000074; Crawford JT, 2016, TRUMP BREXIT RISE PO; Elliott G, 1996, ECONOMETRICA, V64, P813, DOI 10.2307/2171846; Ford R, 2017, J DEMOCR, V28, P17, DOI 10.1353/jod.2017.0002; Goodwin MJ, 2016, POLIT QUART, V87, P323, DOI 10.1111/1467-923X.12285; Hatna E, 2015, JASSS, V18, P1; Hatna E, 2012, JASSS-J ARTIF SOC S, V15, DOI 10.18564/jasss.1873; Heath A, 2016, ATTITUDES IMMIGRATIO, V7; Kaufmann E., 2016, DIVERSITY WAVE METAA; Klabunde A, 2016, EUR J POPUL, V32, P73, DOI 10.1007/s10680-015-9362-0; Markaki Y, 2012, ISER WORKING PAPER S, P2012; Mclaren LM, 2012, CULTURAL DIVIDE EURO; Pettigrew TF, 2007, INT J INTERCULT REL, V31, P411, DOI 10.1016/j.ijintrel.2006.11.003; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Pettigrew TF, 2011, INT J INTERCULT REL, V35, P271, DOI 10.1016/j.ijintrel.2011.03.001; Pfister R, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00700; Portes A, 2015, MIGRATION EC CHANGE, P192; Putnam RD., 2000, BOWLING ALONE COLLAP; Putnam RD, 2007, SCAND POLIT STUD, V30, P137, DOI 10.1111/j.1467-9477.2007.00176.x; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Semyonov M, 2004, SOC SCI RES, V33, P681, DOI 10.1016/j.ssresearch.2003.11.003; Stephan WG., 2009, HDB PREJUDICE STEREO, P44; Stephan WG, 2002, PREJUDICE INTERGROUP, P316; Urselmans L., 2017, VISUALISATION MIGRAN; Urselmans L., 2017, SCHELLING MODEL IMMI, P13; Urselmans L., 2017, SOURCE CODE SCHELLIN	31	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193950	10.1371/journal.pone.0193950	http://dx.doi.org/10.1371/journal.pone.0193950			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509782	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200044
J	Ricotti, R; Genoni, G; Giglione, E; Monzani, A; Nugnes, M; Zanetta, S; Castagno, M; Marolda, A; Bellomo, G; Bona, G; Bellone, S; Prodam, F				Ricotti, Roberta; Genoni, Giulia; Giglione, Enza; Monzani, Alice; Nugnes, Martina; Zanetta, Sara; Castagno, Matteo; Marolda, Agostina; Bellomo, Giorgio; Bona, Gianni; Bellone, Simonetta; Prodam, Flavia			High-normal estimated glomerular filtration rate and hyperuricemia positively correlate with metabolic impairment in pediatric obese patients	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; CARDIOMETABOLIC RISK; GENERAL-POPULATION; URIC-ACID; MICROALBUMINURIA; ASSOCIATION; ADOLESCENTS; PREVALENCE; OVERWEIGHT	Background Childhood obesity represents a major health concern worldwide due to its well established detrimental effect on cardiovascular and its potential negative effect on kidney functions. However, biomarkers that can help diagnose early stages of kidney damage in obese children represent an unmet clinical need. Objectives In this study, we asked whether the prevalence of microalbuminuria, estimated glomerular filtration rate (eGFR) or hyperuricemia recorded in a wide cohort of obese children and adolescents would positively correlate with cardiometabolic dysfunction in these subjects. Methods We carried out a cross-sectional study on 360 obese children and adolescents between the ages of 3 +/- 18 years, enrolled in a tertiary care center. Clinical and biochemical evaluations including oral glucose tolerance tests (OGTTs) were performed on all patients. Microalbuminuria was defined as urinary albumin-to-creatinine ratio (u-ACR) of 30 +/- 300 mg/g. All data are expressed as mean +/- standard deviation (SD), absolute values or percentages. Sex age-specific and eGFR SDs were used for statistical analyses. Serum uric acid >= 5.5 mg/dL was considered abnormal. Results The prevalence of microalbuminuria was 6.4%. Except for a lower insulinogenic-index, no correlations between microalbuminuria and cardiometabolic risk factors were detected. eGFR was < -1 SD and > 1 SD in 1.4% and 60.8% of subjects, respectively. Subjects with an eGFR > 1 SD had higher systolic blood pressure, liver enzymes, insulin resistance, glucose and insulin during OGTT, lower insulin sensitivity and a more prevalent microalbuminuria. Hyperuricemia (27.5%) increased the odds of hypertension, HDL <= 10 th percentile and glucose <= 155.0 mg/dL after 60 minutes of OGTT. Conclusions A worse cardiometabolic profile was observed in subjects with an eGFR > 1 SD compared to other subgroups. Therefore, pediatric obese patients with eGFR > 1 SD or hyperuricemia should be closely monitored for microalbuminuria and post-challenge glucose and insulin secretion, all potential indicators of renal dysfunction in these young patients.	[Ricotti, Roberta; Genoni, Giulia; Giglione, Enza; Monzani, Alice; Nugnes, Martina; Zanetta, Sara; Castagno, Matteo; Marolda, Agostina; Bona, Gianni; Bellone, Simonetta; Prodam, Flavia] Univ Piemonte Orientale, Dept Hlth Sci, SCDU Pediat, Novara, Italy; [Bellomo, Giorgio] Univ Piemonte Orientale, Dept Hlth Sci, Clin Chem, Novara, Italy; [Bellone, Simonetta; Prodam, Flavia] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Prodam, Flavia] Univ Piemonte Orientale, Dept Translat Med, Endocrinol, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Prodam, F (corresponding author), Univ Piemonte Orientale, Dept Hlth Sci, SCDU Pediat, Novara, Italy.; Prodam, F (corresponding author), Univ Piemonte Orientale, IRCAD, Novara, Italy.; Prodam, F (corresponding author), Univ Piemonte Orientale, Dept Translat Med, Endocrinol, Novara, Italy.	FLAVIA.PRODAM@MED.UNIUPO.IT	Bellone, Simonetta/K-2196-2016; Monzani, Alice/K-2804-2016	Monzani, Alice/0000-0002-6676-5773; Prodam, Flavia/0000-0001-9660-5335	Fondazione Comunita Novarese Onlus	Fondazione Comunita Novarese Onlus	This study was supported by Fondazione Comunita Novarese Onlus. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgert TS, 2006, INT J OBESITY, V30, P273, DOI 10.1038/sj.ijo.0803136; Cho H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178716; Cindik N, 2005, ACTA PAEDIATR, V94, P1732, DOI 10.1080/08035250500277101; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cruz Martha L, 2004, Curr Diab Rep, V4, P53, DOI 10.1007/s11892-004-0012-x; Csernus K, 2005, EUR J PEDIATR, V164, P44, DOI 10.1007/s00431-004-1546-2; de Jong PE, 2002, INT J OBESITY, V26, pS21, DOI 10.1038/sj.ijo.0802213; DeBoer MD, 2012, METABOLISM, V61, P554, DOI 10.1016/j.metabol.2011.09.003; Di Bonito P, 2014, OBESITY, V22, P585, DOI 10.1002/oby.20497; Di Bonito P, 2010, ATHEROSCLEROSIS, V213, P611, DOI 10.1016/j.atherosclerosis.2010.09.017; Fadrowski JJ, 2011, CLIN J AM SOC NEPHRO, V6, P1427, DOI 10.2215/CJN.06460710; Feig DI, 2003, HYPERTENSION, V42, P247, DOI 10.1161/01.HYP.0000085858.66548.59; Fiorentino TV, 2015, J CLIN ENDOCR METAB, V100, P3744, DOI 10.1210/jc.2015-2573; Grubbs V, 2014, AM J KIDNEY DIS, V63, P590, DOI 10.1053/j.ajkd.2013.10.055; Hogg RJ, 2003, PEDIATRICS, V111, P1416, DOI 10.1542/peds.111.6.1416; Invitti C, 2006, INT J OBESITY, V30, P627, DOI 10.1038/sj.ijo.0803151; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Khan UI, 2015, CHILD OBES, V11, P289, DOI 10.1089/chi.2014.0112; Lee K, 2009, DIABETES METAB, V35, P447, DOI 10.1016/j.diabet.2009.04.011; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lytvyn Y, 2016, DIABETES CARE, V39, P611, DOI 10.2337/dc15-2345; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Muntner P, 2012, CLIN J AM SOC NEPHRO, V7, P101, DOI 10.2215/CJN.06450611; Nguyen S, 2008, PEDIATRICS, V121, P37, DOI 10.1542/peds.2007-3594; Prodam F, 2013, J ENDOCRINOL INVEST, V36, P466, DOI 10.3275/8768; Prodam F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087157; Radhakishun NNE, 2013, PEDIATR NEPHROL, V28, P1145, DOI 10.1007/s00467-013-2451-6; Sanad M, 2011, PEDIATR NEPHROL, V26, P2193, DOI 10.1007/s00467-011-1931-9; Savino A, 2011, PEDIATR NEPHROL, V26, P749, DOI 10.1007/s00467-010-1659-y; Savino A, 2010, HORM RES PAEDIAT, V73, P303, DOI 10.1159/000308161; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Storhaug HM, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0207-1; Wang X, 2015, HUANG HJSICHUAN DA X, V46, P750	35	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193755	10.1371/journal.pone.0193755	http://dx.doi.org/10.1371/journal.pone.0193755			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505614	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200030
J	Cerignoli, F; Abassi, YA; Lamarche, BJ; Guenther, G; Ana, DS; Guimet, D; Zhang, W; Zhang, J; Xi, B				Cerignoli, Fabio; Abassi, Yama A.; Lamarche, Brandon J.; Guenther, Garret; Ana, David Santa; Guimet, Diana; Zhang, Wen; Zhang, Jing; Xi, Biao			In vitro immunotherapy potency assays using real-time cell analysis	PLOS ONE			English	Article							LABEL-FREE; MEDIATED CYTOTOXICITY; CANCER-IMMUNOTHERAPY; PD-1 BLOCKADE; T-CELLS; ANTIBODIES; PD-1/PD-L1; LANDSCAPE; RELEASE	A growing understanding of the molecular interactions between immune effector cells and target tumor cells, coupled with refined gene therapy approaches, are giving rise to novel cancer immunotherapeutics with remarkable efficacy in the clinic against both solid and liquid tumors. While immunotherapy holds tremendous promise for treatment of certain cancers, significant challenges remain in the clinical translation to many other types of cancers and also in minimizing adverse effects. Therefore, there is an urgent need for functional potency assays, in vitro and in vivo, that could model the complex interaction of immune cells with tumor cells and can be used to rapidly test the efficacy of different immunotherapy approaches, whether it is small molecule, biologics, cell therapies or combinations thereof. Herein we report the development of an xCELLigence real-time cytolytic in vitro potency assay that uses cellular impedance to continuously monitor the viability of target tumor cells while they are being subjected to different types of treatments. Specialized microtiter plates containing integrated gold microelectrodes enable the number, size, and surface attachment strength of adherent target tumor cells to be selectively monitored within a heterogeneous mixture that includes effector cells, antibodies, small molecules, etc. Through surface-tethering approach, the killing of liquid cancers can also be monitored. Using NK92 effector cells as example, results from RTCA potency assay are very well correlated with end point data from image-based assays as well as flow cytometry. Several effector cells, i.e., PBMC, NK, CAR-T were tested and validated as well as biological molecules such as Bi-specific T cell Engagers (BiTEs) targeting the EpCAM protein expressed on tumor cells and blocking antibodies against the immune checkpoint inhibitor PD-1. Using the specifically designed xCELLigence immunotherapy software, quantitative parameters such as KT50 (the amount of time it takes to kill 50% of the target tumor cells) and % cytolysis are calculated and used for comparing the relative efficacy of different reagents. In summary, our results demonstrate the xCELLigence platform to be well suited for potency assays, providing quantitative assessment with high reproducibility and a greatly simplified work flow.	[Cerignoli, Fabio; Abassi, Yama A.; Lamarche, Brandon J.; Guenther, Garret; Ana, David Santa; Guimet, Diana; Zhang, Wen; Zhang, Jing; Xi, Biao] ACEA Biosci, San Diego, CA 92121 USA		Xi, B (corresponding author), ACEA Biosci, San Diego, CA 92121 USA.	bxi@aceabio.com			ACEA Biosciences	ACEA Biosciences	ACEA Biosciences provided the funding for this study in addition to providing the salaries for all authors [FC, YA, BJL, GG, DSA, DG, WZ, JZ, BX.]. The specific roles of these authors and contribution to the manuscript are articulated in the 'author contributions' section.	Abassi YA, 2004, J IMMUNOL METHODS, V292, P195, DOI 10.1016/j.jim.2004.06.022; Andrews MC, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0212-y; Chinai JM, 2015, TRENDS PHARMACOL SCI, V36, P587, DOI 10.1016/j.tips.2015.06.005; Davenport AJ, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1053684; De Wolf C, 2017, CYTOTHERAPY, V19, P784, DOI 10.1016/j.jcyt.2017.03.076; Dolan DE, 2014, CANCER CONTROL, V21, P231, DOI 10.1177/107327481402100308; Dubey P, 2012, THERANOSTICS, V2, P355, DOI 10.7150/thno.3903; Dyer A, 2017, MOL THER-ONCOLYTICS, V4, P18, DOI 10.1016/j.omto.2016.11.003; EMA, 2016, GUID POT TEST CELL B; Everson RG, 2016, NEURO-ONCOLOGY, V18, P368, DOI 10.1093/neuonc/nov153; Farkona S, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0623-5; FDA, 2017, GUID IND POT TESTS C; FDA U. S., 2017, FDA APPR BRINGS 1 GE; Fu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011867; Glamann J, 2006, ASSAY DRUG DEV TECHN, V4, P555, DOI 10.1089/adt.2006.4.555; Gonzalez-Cao M, 2015, LUNG CANCER-TARGETS, V6, P55, DOI 10.2147/LCTT.S55176; Harshman LC, 2014, CANCER IMMUNOL RES, V2, P1132, DOI 10.1158/2326-6066.CIR-14-0193; Hegde M, 2016, J CLIN INVEST, V126, P3036, DOI 10.1172/JCI83416; Hillerdal V, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0162-z; HOLDEN HT, 1977, JNCI-J NATL CANCER I, V58, P611, DOI 10.1093/jnci/58.3.611; Karimi MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089357; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kho D, 2015, BIOSENSORS-BASEL, V5, P199, DOI 10.3390/bios5020199; Kirschner A, 2016, ONCOTARGET, V7, P56584, DOI 10.18632/oncotarget.10647; Klinger M, 2016, IMMUNOL REV, V270, P193, DOI 10.1111/imr.12393; Lamarche B J., 2016, GENETIC ENG BIOTECHN, V36, P18; Liu G, 2010, J IMMUNOL, V184, P3346, DOI 10.4049/jimmunol.0903789; Liu XF, 2017, NAT PROTOC, V12, P439, DOI 10.1038/nprot.2016.174; Mahoney KM, 2015, CLIN THER, V37, P764, DOI 10.1016/j.clinthera.2015.02.018; Malyguine A, 2007, ADV EXP MED BIOL, V601, P273; Malyguine Anatoli M, 2012, Cells, V1, P111, DOI 10.3390/cells1020111; Mandel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056591; Nelson DL, 2001, CURR PROTOC IMMUNOL, V7, P27, DOI [10.1002/0471142735.im0727s08, 10.1002/0471142735.IM0727S08, DOI 10.1002/0471142735.IM0727S08]; Oberg HH, 2014, CANCER RES, V74, P1349, DOI 10.1158/0008-5472.CAN-13-0675; Ohaegbulam KC, 2015, TRENDS MOL MED, V21, P24, DOI 10.1016/j.molmed.2014.10.009; Peper JK, 2014, J IMMUNOL METHODS, V405, P192, DOI 10.1016/j.jim.2014.01.012; Pham PV, 2014, ONCOTARGETS THER, V7, P1455, DOI 10.2147/OTT.S67057; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Ruiz C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160807; Schlegel P, 2015, BONE MARROW TRANSPL, V50, pS72, DOI 10.1038/bmt.2015.100; Seidel UJE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00618; Rocca YS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00413; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Trivedi A, 2017, CTS-CLIN TRANSL SCI, V10, P147, DOI 10.1111/cts.12459; Vatsan RS, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-5; Wang W., 2014, POTENCY TESTING BIOP; Watanabe Keisuke G S, 2016, BLOOD, V128; Zaritskaya L, 2010, EXPERT REV VACCINES, V9, P601, DOI [10.1586/erv.10.49, 10.1586/ERV.10.49]; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu J, 2006, J IMMUNOL METHODS, V309, P25, DOI 10.1016/j.jim.2005.10.018	50	52	53	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193498	10.1371/journal.pone.0193498	http://dx.doi.org/10.1371/journal.pone.0193498			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499048	gold, Green Published, Green Submitted			2022-12-27	WOS:000426472300014
J	Arensman, E; Griffin, E; Daly, C; Corcoran, P; Cassidy, E; Perry, IJ				Arensman, Ella; Griffin, Eve; Daly, Caroline; Corcoran, Paul; Cassidy, Eugene; Perry, Ivan J.			Recommended next care following hospital-treated self-harm: Patterns and trends over time	PLOS ONE			English	Article							PSYCHOSOCIAL ASSESSMENT; MULTICENTER; SUICIDE; MANAGEMENT; REPETITION; METAANALYSIS; AUSTERITY; ENGLAND; ADULTS; IMPACT	Objective The specific objectives of this study were to examine variation in the care of self-harm patients in hospital settings and to identify the factors that predict recommended next care following self-harm. Methods Data on consecutive presentations to Irish emergency departments ( EDs) involving self-harm from the National Self-Harm Registry Ireland from 2004 to 2012 were utilised. Univariate and multivariate regression analyses were performed to assess the associations between patients' clinical and demographic characteristics, and recommended next care received. Results Across the study period a total 101,904 self-harm presentations were made to hospital EDs, involving 63,457 individuals. Over the course of the study there was a declining number of presentations resulting in patient admission following attendance with self-harm. Recommended next care varied according to hospital location, with general admission rates ranging from 11% to 61% across administrative health regions. Multinomial logistic regression identified that the factor which most strongly affected next care was the presenting hospital. Being male, older age, method, repeat self-harm, time of attendance and residence of the patient were all identified as influencing care received. Psychiatric admission was most common when highly lethal methods of self-harm were used ( OR = 4.00, 95% CI, 3.63 - 4.41). A relatively large proportion of patients left the ED without being seen ( 15%) and the risk of doing so was highest for self-harm repeaters ( 1.64, 1.55 - 1.74 for those with 5+ presentations). Conclusions The extensive hospital variation in recommended next care indicates that management of self-harm patients may be determined more by where they present than by the needs of the patient. The study outcomes underline the need to standardise the clinical management of self-harm patients in general hospital settings.	[Arensman, Ella; Griffin, Eve; Daly, Caroline; Corcoran, Paul] Natl Suicide Res Fdn, Cork, Ireland; [Arensman, Ella; Corcoran, Paul; Perry, Ivan J.] Univ Coll Cork, Sch Publ Hlth, Cork, Ireland; [Cassidy, Eugene] Univ Coll Cork, Dept Psychiat, Cork, Ireland; [Cassidy, Eugene] Cork Univ Hosp, Liaison Psychiat Serv, Cork, Ireland	University College Cork; University College Cork; University College Cork	Arensman, E (corresponding author), Natl Suicide Res Fdn, Cork, Ireland.; Arensman, E (corresponding author), Univ Coll Cork, Sch Publ Hlth, Cork, Ireland.	earensman@ucc.ie		Perry, Ivan/0000-0002-4965-9792; Arensman, Ella/0000-0003-0376-1203; Griffin, Eve/0000-0003-0249-6428	Irish Health Service Executive's National Office for Suicide Prevention	Irish Health Service Executive's National Office for Suicide Prevention	The National Self-Harm Registry Ireland is funded by the Irish Health Service Executive's National Office for Suicide Prevention.	Baraff LJ, 2006, ANN EMERG MED, V48, P452, DOI 10.1016/j.annemergmed.2006.06.026; Bennewith O, 2004, BMJ-BRIT MED J, V328, P1108, DOI 10.1136/bmj.328.7448.1108; Bergen H, 2010, J AFFECT DISORDERS, V127, P257, DOI 10.1016/j.jad.2010.05.001; Carroll R, 2016, SOC PSYCH PSYCH EPID, V51, P1485, DOI 10.1007/s00127-016-1247-y; Carroll R, 2014, J AFFECT DISORDERS, V168, P476, DOI 10.1016/j.jad.2014.06.027; Claassen CA, 2006, SUICIDE LIFE-THREAT, V36, P192, DOI 10.1521/suli.2006.36.2.192; Cooper J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003444; Cooper Jayne, 2008, Ann Gen Psychiatry, V7, P21, DOI 10.1186/1744-859X-7-21; Corcoran P, 2015, INT J EPIDEMIOL, V44, P969, DOI 10.1093/ije/dyv058; GUNNELL D, 2008, BMJ, V337; Hawton K, 2007, SOC PSYCH PSYCH EPID, V42, P513, DOI 10.1007/s00127-007-0199-7; Hawton K, 2016, LANCET PSYCHIAT, V3, P740, DOI 10.1016/S2215-0366(16)30070-0; Jimenez-Trevino L, 2015, ARCH SUICIDE RES, V19, P17, DOI 10.1080/13811118.2013.824841; Kapur N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070434; Kapur N, 2008, J AFFECT DISORDERS, V106, P285, DOI 10.1016/j.jad.2007.07.010; Knesper DJ., 2010, CONTINUITY CARE SUIC; Lilley R, 2008, BRIT J PSYCHIAT, V192, P440, DOI 10.1192/bjp.bp.107.043380; Mehlum L, 2010, ARCH SUICIDE RES, V14, P105, DOI 10.1080/13811111003704472; National Clinical Programme Office Health Service Executive, 2014, MAN SELF HARM PRES E; National Institute for Health and Care Excellence, 2004, SELF HARM SHORT TERM; Perry IJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031663; PLATT S, 1992, ACTA PSYCHIAT SCAND, V85, P97, DOI 10.1111/j.1600-0447.1992.tb01451.x; Sheehy C., 2014, IRISH INDEPENDENT; Suominen K, 2006, GEN HOSP PSYCHIAT, V28, P424, DOI 10.1016/j.genhosppsych.2006.03.009; Thomas S, 2014, LANCET, V383, P1545, DOI 10.1016/S0140-6736(14)60744-3; World Health Organization, 2016, PRACT MAN EST MAINT	26	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193587	10.1371/journal.pone.0193587	http://dx.doi.org/10.1371/journal.pone.0193587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494659	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200070
J	Kammerer, S; Schuelke, C; Berkemeyer, S; Velasco, A; Heindel, W; Koehler, M; Buerke, B				Kammerer, Sara; Schuelke, Christoph; Berkemeyer, Shoma; Velasco, Aglae; Heindel, Walter; Koehler, Michael; Buerke, Boris			The role of multislice computed tomography (MSCT) angiography in the diagnosis and therapy of non-occlusive mesenteric ischemia (NOMI): Could MSCT replace DSA in diagnosis?	PLOS ONE			English	Article							PELVIC CT	Objectives Evaluation of multislice-CT (MSCT) during diagnosis and therapeutic decision-making in patients with suspected non-occlusive mesenteric ischemia (NOMI). Methods Retrospective, institutional review board-approved study of 30 patients (20 men, 10 women, mean age 64.6 +/- 14.2 years, range 24-87 years) undergoing biphasic abdominal MSCT followed by digital subtraction angiography (DSA) due to suspected NOMI. MSCT and DSA were qualitatively and quantitatively evaluated independently by two radiologists with respect to the possible diagnosis of NOMI. MSCT analysis included quantitative measurements, qualitative evaluation of contrast enhancement and assessment of secondary findings (bowel wall thickening, hypo-enhancement, intestinal pneumatosis). MSCT diagnosis and secondary findings were compared against DSA diagnosis. Results NOMI was diagnosed in a total of n = 28 patients. No differences were found when comparing the R1-rated MSCT diagnosis (p = 0.09) to the "gold standard", while MSCT diagnosis was slightly inferior with R2 (p = 0.02). With R1, vessel-associated parameters revealed the best correlation, i.e. qualitative vessel width (r = -0.39; p = 0.03) and vessel contrast (r = 0.45; p = 0.01). Moderate correlations were found for quantitative vessel diameters in the middle segments (r = -0.48, p = 0.01), increasing to almost high correlations in the distal (r = -0.66; p<0.00001) superior mesenteric artery (SMA) segments. No significant correlation was apparen from secondary findings. Conclusions MSCT is an appropriate non-invasive method for diagnosing NOMI and leads to adequate and immediate therapeutic stratification.	[Kammerer, Sara; Schuelke, Christoph; Velasco, Aglae; Heindel, Walter; Koehler, Michael; Buerke, Boris] Univ Hosp Muenster, Dept Clin Radiol, Munster, Germany; [Berkemeyer, Shoma] Univ Hosp Muenster, Reference Ctr Mammog, Munster, Germany	University of Munster; University of Munster	Buerke, B (corresponding author), Univ Hosp Muenster, Dept Clin Radiol, Munster, Germany.	buerkeb@uni-muenster.de	Kluge, Sara/ABD-8878-2020; Kluge, Sara/AAG-8342-2021	Kluge, Sara/0000-0003-0387-702X				Acosta S, 2006, J INTERN MED, V259, P305, DOI 10.1111/j.1365-2796.2006.01613.x; Barmase M, 2011, EUR J RADIOL, V80, pE582, DOI 10.1016/j.ejrad.2011.09.015; Bjorck M, 2010, SEMIN VASC SURG, V23, P54, DOI 10.1053/j.semvascsurg.2009.12.009; Bourcier S, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0213-x; BRANDT LJ, 1991, ANNU REV MED, V42, P107, DOI 10.1146/annurev.med.42.1.107; Clair DG, 2016, NEW ENGL J MED, V374, P959, DOI 10.1056/NEJMra1503884; ENGEL A, 1989, FORTSCHR RONTG NEUEN, V150, P704, DOI 10.1055/s-2008-1047106; Ernst S, 2003, ROFO-FORTSCHR RONTG, V175, P515, DOI 10.1055/s-2003-38441; Franke M, 2015, ROFO-FORTSCHR RONTG, V187, P127, DOI 10.1055/s-0034-1384900; Heo SH, 2014, WORLD J GASTROENTERO, V20, P4244, DOI 10.3748/wjg.v20.i15.4244; Hundt W, 2005, J COMPUT ASSIST TOMO, V29, P140, DOI 10.1097/01.rct.0000151188.72850.0d; Iball GR, 2006, BRIT J RADIOL, V79, P62, DOI 10.1259/bjr/50019934; Kamiya Chiaki, 2014, Ann Vasc Dis, V7, P320, DOI 10.3400/avd.cr.14-00035; Kammerer S, 2015, EUR RADIOL, V25, P669, DOI 10.1007/s00330-014-3446-9; Kramer SC, 2003, ROFO-FORTSCHR RONTG, V175, P1177; Kwok HCK, 2014, CRIT CARE RESUSC, V16, P90; Lim JY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008029; Mastoraki Aikaterini, 2016, World J Gastrointest Pathophysiol, V7, P125, DOI 10.4291/wjgp.v7.i1.125; Mazzei MA, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150956; Minko P, 2012, ROFO-FORTSCHR RONTG, V184, P805, DOI 10.1055/s-0032-1312750; Mitsuyoshi A, 2007, ANN SURG, V246, P229, DOI 10.1097/01.sla.0000263157.59422.76; Nakamura Y, 2013, JAPANESE J RADIOLOGY; Oliva IB, 2013, ABDOM IMAGING, V38, P714, DOI 10.1007/s00261-012-9975-2; Palma Baro A, 2013, Semergen, V39, P279, DOI 10.1016/j.semerg.2012.03.004; Radiology ACo, 2011, ACR SPR PRACT GUID P; Rha SE, 2000, RADIOGRAPHICS, V20, P29, DOI 10.1148/radiographics.20.1.g00ja0629; Rossi UG, 2013, DIAGN INTERV RADIOL, V19, P518, DOI 10.5152/dir.2013.13226; Stockmann H, 2000, ZBL CHIR, V125, P144; Trompeter M, 2002, EUR RADIOL, V12, P1179, DOI 10.1007/s00330-001-1220-2; Tsiflikas I, 2012, EUR J RADIOL, V81, P2255, DOI 10.1016/j.ejrad.2011.08.011; van den Heijkant TC, 2013, WORLD J GASTROENTERO, V19, P1338, DOI 10.3748/wjg.v19.i9.1338; Woodhams R, 2010, EUR J RADIOL, V76, P96, DOI 10.1016/j.ejrad.2009.05.012; Yasuda T, 2003, PANCREAS, V26, P95, DOI 10.1097/00006676-200301000-00017; Yikilmaz A, 2011, EUR J RADIOL, V80, P297, DOI 10.1016/j.ejrad.2010.07.016; Yun WS, 2013, ANN VASC SURG, V27, P613, DOI 10.1016/j.avsg.2012.07.022; Zhang B, 2013, IEEE INTEL TRANSP SY, V5, P8, DOI 10.1109/MITS.2013.2245725	36	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193698	10.1371/journal.pone.0193698	http://dx.doi.org/10.1371/journal.pone.0193698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494649	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200086
J	Rasmussen, TB; Boniotti, MB; Papetti, A; Grasland, B; Frossard, JP; Dastjerdi, A; Hulst, M; Hanke, D; Pohlmann, A; Blome, S; van der Poel, WHM; Steinbach, F; Blanchard, Y; Lavazza, A; Botner, A; Belsham, GJ				Rasmussen, Thomas Bruun; Boniotti, Maria Beatrice; Papetti, Alice; Grasland, Beatrice; Frossard, Jean-Pierre; Dastjerdi, Akbar; Hulst, Marcel; Hanke, Dennis; Pohlmann, Anne; Blome, Sandra; van der Poel, Wim H. M.; Steinbach, Falko; Blanchard, Yannick; Lavazza, Antonio; Botner, Anette; Belsham, Graham J.			Full-length genome sequences of porcine epidemic diarrhoea virus strain CV777; Use of NGS to analyse genomic and sub-genomic RNAs	PLOS ONE			English	Article							UNITED-STATES; CORONAVIRUS; OUTBREAK; INFECTION; VARIANT; TABLET; SWINE; GENE	Porcine epidemic diarrhoea virus, strain CV777, was initially characterized in 1978 as the causative agent of a disease first identified in the UK in 1971. This coronavirus has been widely distributed among laboratories and has been passaged both within pigs and in cell culture. To determine the variability between different stocks of the PEDV strain CV777, sequencing of the full-length genome (ca. 28kb) has been performed in 6 different laboratories, using different protocols. Not surprisingly, each of the different full genome sequences were distinct from each other and from the reference sequence (Accession number AF353511) but they are >99% identical. Unique and shared differences between sequences were identified. The coding region for the surface-exposed spike protein showed the highest proportion of variability including both point mutations and small deletions. The predicted expression of the ORF3 gene product was more dramatically affected in three different variants of this virus through either loss of the initiation codon or gain of a premature termination codon. The genome of one isolate had a substantially rearranged 5'-terminal sequence. This rearrangement was validated through the analysis of sub-genomic mRNAs from infected cells. It is clearly important to know the features of the specific sample of CV777 being used for experimental studies.	[Rasmussen, Thomas Bruun; Botner, Anette; Belsham, Graham J.] Tech Univ Denmark, DTU Natl Vet Inst, Lindholm, Kalvehave, Denmark; [Boniotti, Maria Beatrice; Papetti, Alice; Lavazza, Antonio] IZSLER Ist Zooprofilatt Sperimentale Lombardia &, Brescia, Italy; [Grasland, Beatrice; Blanchard, Yannick] ANSES, Lab Ploufragan Plouzane, BP 53, Ploufragan, France; [Grasland, Beatrice; Blanchard, Yannick] Univ Bretagne Loire, Rennes, France; [Frossard, Jean-Pierre; Dastjerdi, Akbar; Steinbach, Falko] Anim & Plant Hlth Agcy, Dept Virol, Addlestone, Surrey, England; [Hulst, Marcel; van der Poel, Wim H. M.] Wageningen BioVet Res, Dept Virol, Lelystad, Netherlands; [Hanke, Dennis; Pohlmann, Anne; Blome, Sandra] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Greifswald, Germany	Technical University of Denmark; IZS Lombardia e Emilia; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ploufragan-Plouzane Niort Laboratory; Animal & Plant Health Agency UK; Wageningen University & Research; Friedrich Loeffler Institute	Belsham, GJ (corresponding author), Tech Univ Denmark, DTU Natl Vet Inst, Lindholm, Kalvehave, Denmark.	grbe@vet.dtu.dk	Papetti, Alice/AAG-7829-2019; Belsham, Graham J./H-8589-2019; Frossard, Jean-Pierre/D-8100-2011; Belsham, Graham/J-3132-2019; Steinbach, Falko/V-1682-2019; Boniotti, Maria Beatrice/AAD-1762-2022	Belsham, Graham J./0000-0003-1187-4873; Frossard, Jean-Pierre/0000-0003-1272-8173; Belsham, Graham/0000-0003-1187-4873; Steinbach, Falko/0000-0003-1236-2837; Boniotti, Maria Beatrice/0000-0001-6252-9848; Papetti, Alice/0000-0003-4966-2884	CoVet Lab (a partnership of national veterinary public health institutes from Denmark); CoVet Lab (a partnership of national veterinary public health institutes from France); CoVet Lab (a partnership of national veterinary public health institutes from The Netherlands); CoVet Lab (a partnership of national veterinary public health institutes from Sweden); CoVet Lab (a partnership of national veterinary public health institutes from United Kingdom); EU Horizon program (European Commission Grant) [643476]	CoVet Lab (a partnership of national veterinary public health institutes from Denmark); CoVet Lab (a partnership of national veterinary public health institutes from France); CoVet Lab (a partnership of national veterinary public health institutes from The Netherlands); CoVet Lab (a partnership of national veterinary public health institutes from Sweden); CoVet Lab (a partnership of national veterinary public health institutes from United Kingdom); EU Horizon program (European Commission Grant)	Financial support was received from the CoVet Lab (a partnership of national veterinary public health institutes from Denmark, France, The Netherlands, Sweden and the United Kingdom) to AB, WvdP, FS and YB. The study has also been funded, in part, by the EU Horizon 2020 program (European Commission Grant Agreement No. 643476 "COMPARE") for SB and YB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge financial support from the CoVet Lab (a partnership of national veterinary public health institutes from Denmark, France, The Netherlands, Sweden and the United Kingdom). At FLI and ANSES, the study has been funded, in part, by the EU Horizon 2020 program (European Commission Grant Agreement No. 643476 "COMPARE"). In addition, we are grateful for excellent technical assistance from Preben Normann (DTU), Jane Borch (DTU), Marlene D. Dalgaard (DMAC, DTU), Patrick Zitzow (FLI), Julie Peake (APHA), Richard Ellis (APHA) and Frank Harders (WBVR).	Authie E, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3877; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boniotti MB, 2016, EMERG INFECT DIS, V22, P83, DOI 10.3201/eid2201.150544; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; BRIDGEN A, 1993, J GEN VIROL, V74, P1795, DOI 10.1099/0022-1317-74-9-1795; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Chen SC, 2010, VIROLOGY, V401, P29, DOI 10.1016/j.virol.2010.02.007; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Choudhury B, 2016, VIRUS RES, V226, P40, DOI 10.1016/j.virusres.2016.09.003; Dastjerdi A, 2015, EMERG INFECT DIS, V21, P2235, DOI 10.3201/eid2112.150272; Grasland B., 2015, GENOME ANNOUNC, V3; Gurrala R, 2009, VIRUS RES, V144, P202, DOI 10.1016/j.virusres.2009.04.028; Hanke D, 2015, EMERG INFECT DIS, V21, P493, DOI 10.3201/eid2103.141165; HAVE P, 1992, VET MICROBIOL, V31, P1, DOI 10.1016/0378-1135(92)90135-G; HIERHOLZER JC, 1978, J CLIN MICROBIOL, V7, P499; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Irigoyen N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005473; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Lee C, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0421-2; LIN CM, 2015, VET RES, V46; Lohse L, 2017, TRANSBOUND EMERG DIS, V64, P1380, DOI 10.1111/tbed.12509; Madhugiri R, 2014, VIRUS RES, V194, P76, DOI 10.1016/j.virusres.2014.10.001; Masuda T, 2015, ARCH VIROL, V160, P2565, DOI 10.1007/s00705-015-2522-z; Mesquita JR, 2015, TRANSBOUND EMERG DIS, V62, P586, DOI 10.1111/tbed.12409; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Song DP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120310; Steinrigl A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0624-1; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Svitkin YV, 2001, RNA, V7, P1743; TOPLAK I, 2016, GENOME ANNOUNC, V4; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193682	10.1371/journal.pone.0193682	http://dx.doi.org/10.1371/journal.pone.0193682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494671	Green Submitted, gold, Green Published			2022-12-27	WOS:000426363200080
J	Wadhwa, S; Gupta, A; Dokania, S; Kanji, R; Bagler, G				Wadhwa, Somin; Gupta, Aishwarya; Dokania, Shubham; Kanji, Rakesh; Bagler, Ganesh			A hierarchical anatomical classification schema for prediction of phenotypic side effects	PLOS ONE			English	Article							DRUGS; DATABASE; PROFILES	Prediction of adverse drug reactions is an important problem in drug discovery endeavors which can be addressed with data-driven strategies. SIDER is one of the most reliable and frequently used datasets for identification of key features as well as building machine learning models for side effects prediction. The inherently unbalanced nature of this data presents with a difficult multi-label multi-class problem towards prediction of drug side effects. We highlight the intrinsic issue with SIDER data and methodological flaws in relying on performance measures such as AUC while attempting to predict side effects. We argue for the use of metrics that are robust to class imbalance for evaluation of classifiers. Importantly, we present a 'hierarchical anatomical classification schema' which aggregates side effects into organs, sub-systems, and systems. With the help of a weighted performance measure, using 5-fold cross-validation we show that this strategy facilitates biologically meaningful side effects prediction at different levels of anatomical hierarchy. By implementing various machine learning classifiers we show that Random Forest model yields best classification accuracy at each level of coarse-graining. The manually curated, hierarchical schema for side effects can also serve as the basis of future studies towards prediction of adverse reactions and identification of key features linked to specific organ systems. Our study provides a strategy for hierarchical classification of side effects rooted in the anatomy and can pave the way for calibrated expert systems for multi-level prediction of side effects.	[Wadhwa, Somin; Gupta, Aishwarya; Dokania, Shubham; Kanji, Rakesh; Bagler, Ganesh] Indraprastha Inst Informat Technol IIIT Delhi, Ctr Computat Biol, New Delhi 110020, India; [Wadhwa, Somin] Guru Gobind Singh Indraprastha Univ, Maharaja Agrasen Inst Technol, New Delhi 110086, India; [Gupta, Aishwarya] Indira Gandhi Delhi Tech Univ Women, New Delhi 110006, India; [Dokania, Shubham] Delhi Technol Univ, New Delhi 110042, India; [Kanji, Rakesh] Indian Inst Technol Jodhpur, Dept Biosci & Bioengn, Jodhpur 342011, Rajasthan, India	Indraprastha Institute of Information Technology Delhi; GGS Indraprastha University; Maharaja Agrasen Institute of Technology; Indira Gandhi Delhi Technical University for Women (IGDTUW); Delhi Technological University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Jodhpur	Bagler, G (corresponding author), Indraprastha Inst Informat Technol IIIT Delhi, Ctr Computat Biol, New Delhi 110020, India.	bagler@iiitd.ac.in	Bagler, Ganesh/A-1102-2009	Bagler, Ganesh/0000-0003-1924-6070	IIIT-Delhi; Ministry of Human Resource Development, Government of India; Indian Institute of Technology Jodhpur; Indraprastha Institute of Information Technology (IIIT-Delhi)	IIIT-Delhi; Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India); Indian Institute of Technology Jodhpur; Indraprastha Institute of Information Technology (IIIT-Delhi)	G.B. thanks the Indraprastha Institute of Information Technology (IIIT-Delhi) for providing computational facilities and support. S.W., A.G. and S.D. were Summer Research Interns in Dr. Bagler's lab at the Center for Computational Biology, and are thankful to IIIT-Delhi for the support and fellowship. R.K. thanks the Ministry of Human Resource Development, Government of India and Indian Institute of Technology Jodhpur for the senior research fellowship.	Atias N, 2011, J COMPUT BIOL, V18, P207, DOI 10.1089/cmb.2010.0255; Cai MC, 2015, NUCLEIC ACIDS RES, V43, pD907, DOI 10.1093/nar/gku1066; Chen LK, 2013, PAIN RES TREAT, V2013, P7, DOI DOI 10.1155/2013/485034; Cheng FX, 2013, J CHEM INF MODEL, V53, P744, DOI 10.1021/ci4000079; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Huang LC, 2013, PROTEOMICS, V13, P313, DOI 10.1002/pmic.201200337; Huang LC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S11; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kalash R, 2014, IN VIVO, V28, P147; Kanji R, 2015, MOL BIOSYST, V11, P2900, DOI 10.1039/c5mb00312a; Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Li R, 2016, CHIN CONTR CONF, P9314, DOI 10.1109/ChiCC.2016.7554838; Liu M, 2012, J AM MED INFORM ASSN, V19, pE28, DOI 10.1136/amiajnl-2011-000699; Mizutani S, 2012, BIOINFORMATICS, V28, pI522, DOI 10.1093/bioinformatics/bts383; Niu SY, 2015, J COMPUT BIOL, V22, P1108, DOI 10.1089/cmb.2015.0129; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Shaked I, 2016, CELL SYST, V2, P209, DOI 10.1016/j.cels.2016.03.001; Takarabe M, 2012, BIOINFORMATICS, V28, pI611, DOI 10.1093/bioinformatics/bts413; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Yamanishi Y, 2012, J CHEM INF MODEL, V52, P3284, DOI 10.1021/ci2005548; 황유현, 2016, [Journal of The Korea Society of Computer and Information, 한국컴퓨터정보학회논문지], V21, P115; Zhang W, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0774-y	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193959	10.1371/journal.pone.0193959	http://dx.doi.org/10.1371/journal.pone.0193959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494708	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200103
J	Weaver, CA; Armitage, AR				Weaver, Carolyn A.; Armitage, Anna R.			Nutrient enrichment shifts mangrove height distribution: Implications for coastal woody encroachment	PLOS ONE			English	Article							AVICENNIA-GERMINANS; SALT-MARSH; SPARTINA-ALTERNIFLORA; PHOSPHORUS LIMITATION; PLANT ENCROACHMENT; BLACK MANGROVE; CLIMATE-CHANGE; REGIME SHIFTS; EXPANSION; NITROGEN	Global changes, such as increased temperatures and elevated CO2, are driving shifts in plant species distribution and dominance, like woody plant encroachment into grasslands. Local factors within these ecotones can influence the rate of regime shifts. Woody encroachment is occurring worldwide, though there has been limited research within coastal systems, where mangrove (woody shrub/tree) stands are expanding into salt marsh areas. Because coastal systems are exposed to various degrees of nutrient input, we investigated how nutrient enrichment may locally impact mangrove stand expansion and salt marsh displacement over time. We fertilized naturally co-occurring Avicennia germinans (black mangrove) and Spartina alterniflora (smooth cordgrass) stands in Port Aransas, TX, an area experiencing mangrove encroachment within the Northern Gulf of Mexico mangrove-marsh ecotone. After four growing seasons (2010 +/- 2013) of continuous fertilization, Avicennia was more positively influenced by nutrient enrichment than Spartina. Most notably, fertilized plots had a higher density of taller (> 0.5 m) mangroves and mangrove maximum height was 46% taller than in control plots. Fertilization may promote an increase in mangrove stand expansion within the mangrove-marsh ecotone by shifting Avicennia height distribution. Avicennia individuals, which reach certain species-specific height thresholds, have reduced negative neighbor effects and have higher resilience to freezing temperatures, which may increase mangrove competitive advantage over marsh grass. Therefore, we propose that nutrient enrichment, which augments mangrove height, could act locally as a positive feedback to mangrove encroachment, by reducing mangrove growth suppression factors, thereby accelerating the rates of increased mangrove coverage and subsequent marsh displacement. Areas within the mangrove-marsh ecotone with high anthropogenic nutrient input may be at increased risk of a regime shift from grass to woody dominated ecosystems.	[Weaver, Carolyn A.; Armitage, Anna R.] Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA; [Armitage, Anna R.] Texas A&M Univ Galveston, Dept Marine Biol, Galveston, TX 77553 USA; [Weaver, Carolyn A.] Texas A&M Univ Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University Corpus Christi	Weaver, CA (corresponding author), Texas A&M Univ, Dept Ecosyst Sci & Management, College Stn, TX 77843 USA.; Weaver, CA (corresponding author), Texas A&M Univ Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA.	Carolyn.Weaver@tamucc.edu	Armitage, Anna/X-2773-2019	Armitage, Anna/0000-0003-1563-8026; Weaver, Carolyn/0000-0002-1447-6371	National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce [NA100AR4170099]; Tom Slick Graduate Research Fellowship; Texas A&M University at Galveston Department of Marine Biology Graduate Student Research Mini-Grant; Erma Lee and Luke Mooney Graduate Student Travel Grant; Texas A&M University at Galveston Research Advisory Council Graduate Student Research Mini-Grant	National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce(National Oceanic Atmospheric Admin (NOAA) - USA); Tom Slick Graduate Research Fellowship; Texas A&M University at Galveston Department of Marine Biology Graduate Student Research Mini-Grant; Erma Lee and Luke Mooney Graduate Student Travel Grant; Texas A&M University at Galveston Research Advisory Council Graduate Student Research Mini-Grant	This work was supported by a Institutional Grant (NA100AR4170099) to the Texas Sea Grant College Program from the National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce (http://texassseagrant.orgi/). Additional funding provided by: Tom Slick Graduate Research Fellowship, Texas A&M University at Galveston Department of Marine Biology Graduate Student Research Mini-Grant, Erma Lee and Luke Mooney Graduate Student Travel Grant, and Texas A&M University at Galveston Research Advisory Council Graduate Student Research Mini-Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2015, CURR CLIM CHANGE REP, V1, P30, DOI 10.1007/s40641-015-0002-x; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Armitage AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125404; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; BURESH RJ, 1980, ESTUARIES, V3, P111, DOI 10.2307/1351555; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Comeaux RS, 2012, ESTUAR COAST SHELF S, V96, P81, DOI 10.1016/j.ecss.2011.10.003; D'Odorico P, 2012, ECOHYDROLOGY, V5, P520, DOI 10.1002/eco.259; Darby FA, 2008, ESTUAR COAST, V31, P223, DOI 10.1007/s12237-007-9014-7; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Feller IC, 2003, BIOGEOCHEMISTRY, V62, P145, DOI 10.1023/A:1021166010892; FELLER IC, 1995, ECOL MONOGR, V65, P477, DOI 10.2307/2963499; Feller IC, 2007, ECOSYSTEMS, V10, P347, DOI 10.1007/s10021-007-9025-z; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; FOURQUREAN JW, 1992, LIMNOL OCEANOGR, V37, P162, DOI 10.4319/lo.1992.37.1.0162; Fox L, 2012, ESTUAR COAST, V35, P445, DOI 10.1007/s12237-012-9479-x; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Giri C, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122010; Guo H, 2017, ECOLOGY, V98, P762, DOI 10.1002/ecy.1698; Guo HY, 2013, GLOBAL CHANGE BIOL, V19, P2765, DOI 10.1111/gcb.12221; Kelleway JJ, 2017, GLOBAL CHANGE BIOL; KIRBY CJ, 1976, ECOLOGY, V57, P1052, DOI 10.2307/1941070; Krauss KW, 2008, AQUAT BOT, V89, P105, DOI 10.1016/j.aquabot.2007.12.014; Krauss KW, 2014, ECOHYDROLOGY, V7, P354, DOI 10.1002/eco.1353; MacTavish RM, 2017, J EXP MAR BIOL ECOL, V488, P52, DOI 10.1016/j.jembe.2016.12.009; MARKLEY JL, 1982, CAN J BOT, V60, P2704, DOI 10.1139/b82-330; Mckee KL, 2008, GLOBAL CHANGE BIOL, V14, P971, DOI 10.1111/j.1365-2486.2008.01547.x; Montagna P.A., 2011, IMPACT GLOBAL WARMIN; Naidoo G, 2009, AQUAT BOT, V90, P184, DOI 10.1016/j.aquabot.2008.10.001; Nielsen-Gammon JW., 2012, TEX WATER J, V3, P59, DOI DOI 10.21423/TWJ.V3I1.6463; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Osland MJ, 2017, ECOL MONOGR, V87, P341, DOI 10.1002/ecm.1248; Osland MJ, 2017, ECOLOGY, V98, P125, DOI 10.1002/ecy.1625; Osland MJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00042.1; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; PATTERSON CS, 1993, J COASTAL RES, V9, P801; Pennings SC, 2002, ESTUARIES, V25, P1164, DOI 10.1007/BF02692213; Perry CL, 2009, WETLANDS, V29, P396, DOI 10.1672/08-100.1; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Rogers K, 2005, ESTUARIES, V28, P551, DOI 10.1007/BF02696066; Saintilan N, 2015, NEW PHYTOL, V205, P1062, DOI 10.1111/nph.13147; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SHERROD CL, 1981, CONTRIB MAR SCI, V24, P115; SHERROD CL, 1985, CONTRIB MAR SCI, V28, P129; Simpson LT, 2013, AQUAT BOT, V104, P55, DOI 10.1016/j.aquabot.2012.09.006; Stevens Philip W., 2006, Wetlands Ecology and Management, V14, P435, DOI 10.1007/s11273-006-0006-3; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	52	18	18	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193617	10.1371/journal.pone.0193617	http://dx.doi.org/10.1371/journal.pone.0193617			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494657	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200077
J	Alyami, H; Koner, J; Huynh, C; Terry, D; Mohammed, AR				Alyami, Hamad; Koner, Jasdip; Huynh, Chi; Terry, David; Mohammed, Afzal R.			Current opinions and recommendations of paediatric healthcare professionals - The importance of tablets: Emerging orally disintegrating versus traditional tablets	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED CHILDREN; ANTIRETROVIRAL MEDICATION; ADHERENCE; PALATABILITY; FORMULATIONS; FORMS	The appropriate prescribing of paediatric dosage forms is paramount in providing the desired therapeutic effect alongside successful medication adherence with the paediatric population. Often it is the opinion of the healthcare practitioner that dictates which type of dosage form would be most appropriate for the paediatric patient, with liquids being both the most commonly available and most commonly used. Orally disintegrating tablets (ODTs) are an emerging dosage form which provide many benefits over traditional dosage forms for paediatric patients, such as rapid disintegration within the oral cavity, and the reduction in the risk of choking. However the opinion and professional use of healthcare practitioners regarding ODT's is not known. This study was designed to assess the opinions of several types of healthcare professionals (n = 41) regarding ODTs, using a survey across two hospital sites. Results reaffirmed the popularity of liquids for prescribing in paediatrics, with 58.0% of participants preferring this dosage form. ODTs emerged as the second most popular dosage form (30.0%), with healthcare practitioners indicating an increasing popularity amongst patients in the hospital setting, belief with 63.0% of practitioners agreeing that many liquid formulations could be substituted with a suitable ODT. The desired properties of an ideal ODT were also identified by healthcare practitioners preferring a small, fast disintegrating tablet (90.2% and 95.1% respectively), with the taste, disintegration time and flavour being the three most important attributes identified (29.5%, 28.7% and 21.7% respectively). This study provided a pragmatic approach in assessing healthcare professional's opinions on ODTs, highlighting the ideas and thoughts of practitioners who are on the frontline of paediatric prescribing and treatment and gave an indication to their preference for ODT properties.	[Alyami, Hamad; Koner, Jasdip; Huynh, Chi; Terry, David; Mohammed, Afzal R.] Aston Univ, Aston Pharm Sch, Birmingham, W Midlands, England; [Terry, David] Birmingham Childrens Hosp, Acad Practice Unit, Birmingham, W Midlands, England	Aston University; University of Birmingham	Huynh, C; Terry, D; Mohammed, AR (corresponding author), Aston Univ, Aston Pharm Sch, Birmingham, W Midlands, England.; Terry, D (corresponding author), Birmingham Childrens Hosp, Acad Practice Unit, Birmingham, W Midlands, England.	c.huynh3@aston.ac.uk; d.terry@aston.ac.uk; a.u.r.mohammed@aston.ac.uk		Mohammed, Afzal-Ur-Rahman/0000-0002-5212-3040; Huynh, Chi/0000-0001-6982-6642; Terry, David/0000-0001-7599-0916; Alyami, Hamad/0000-0003-3513-4976				Adams LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058303; Akram Gazala, 2012, Int J Pharm Pract, V20, P191, DOI 10.1111/j.2042-7174.2011.00179.x; Alyami H, 2016, EUROPEAN J HOSP PHAR, V24, P332; Ansah EK, 2001, TROP MED INT HEALTH, V6, P496, DOI 10.1046/j.1365-3156.2001.00740.x; Bagenda A, 2011, ANN TROP PAEDIATR, V31, P235, DOI 10.1179/1465328111Y.0000000025; Barr H., 2014, REV INTERPROFESSIONA; Bauman LJ, 2000, PROMOTING ADHERENCE TO MEDICAL TREATMENT IN CHRONIC CHILDHOOD ILLNESS: CONCEPTS, METHODS, AND INTERVENTIONS, P71; Benkert O, 2006, J CLIN PSYCHOPHARM, V26, P75, DOI 10.1097/01.jcp.0000194622.99986.d6; Brooks J, 2015, QUAL RES PSYCHOL, V12, P202, DOI 10.1080/14780887.2014.955224; Bryson SP, 2014, INT J PHARMACEUT, V469, P257, DOI 10.1016/j.ijpharm.2014.04.069; Carnaby-Mann G, 2005, ARCH OTOLARYNGOL, V131, P970, DOI 10.1001/archotol.131.11.970; Cheng A, 2007, PEDIATR EMERG CARE, V23, P384, DOI 10.1097/01.pec.0000278402.45321.f6; European Medicines Agency (EMA), 2006, REFL PAP FORM CHOIC; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Hasamnis AA, 2011, J PHARMACOL PHARMACO, V2, P119, DOI 10.4103/0976-500X.81909; Hirani JJ, 2009, TROP J PHARM RES, V8, P161; Ilieva J, 2002, INT J MARKET RES, V44, P361; Jacobsen L, 2016, PEDIATR DRUGS, V18, P65, DOI 10.1007/s40272-015-0156-y; Lajoinie A, 2014, BRIT J CLIN PHARMACO, V78, P1080, DOI 10.1111/bcp.12442; Levitan CA, 2008, CHEM SENSES, V33, P415, DOI 10.1093/chemse/bjn008; MacGregor EA, 2003, HEADACHE, V43, P19, DOI 10.1046/j.1526-4610.2003.03004.x; MATSUI D, 2007, PAEDIATR PERINAT DRU, V8, P55, DOI DOI 10.1185/146300907X178941; Michaud PA, 2004, ARCH DIS CHILD, V89, P943, DOI 10.1136/adc.2003.045377; Mukattash T, 2011, EUR J CLIN PHARMACOL, V67, P449, DOI 10.1007/s00228-010-0978-z; Paranthaman K, 2009, AIDS CARE, V21, P1025, DOI 10.1080/09540120802612857; Parkash V, 2011, J ADV PHARM TECHNOL, V2, P223, DOI 10.4103/2231-4040.90877; Patel A, 2015, PEDIATRICS, V135, P883, DOI 10.1542/peds.2014-2114; Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399; Reddington C, 2000, PEDIATR INFECT DIS J, V19, P1148, DOI 10.1097/00006454-200012000-00005; Ricci G, 2016, BRAZ J INFECT DIS, V20, P429, DOI 10.1016/j.bjid.2016.05.009; Ritchie J, 1994, ANAL QUALITATIVE DAT, P173, DOI DOI 10.4324/9780203413081; Roberts KJ, 2005, YOUTH SOC, V37, P230, DOI 10.1177/0044118X05278269; Siccama CJ, 2008, QUAL RES J, V8, P91, DOI 10.3316/QRJ0802091; Squires LA, 2013, THER INNOV REGUL SCI, V47, P533, DOI 10.1177/2168479013500288; Sumiya K, 2000, YAKUGAKU ZASSHI, V120, P652, DOI 10.1248/yakushi1947.120.7_652; Walsh D, 2005, J ADV NURS, V50, P204, DOI 10.1111/j.1365-2648.2005.03380.x	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193292	10.1371/journal.pone.0193292	http://dx.doi.org/10.1371/journal.pone.0193292			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489871	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000063
J	Guo, WH; Zhong, KH; Wei, H; Nie, CL; Yuan, Z				Guo, Wenhao; Zhong, Kunhong; Wei, Heng; Nie, Chunlai; Yuan, Zhu			Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells	PLOS ONE			English	Article							PREDICTS POOR-PROGNOSIS; COLORECTAL-CANCER; LNCRNA SPRY4-IT1; METASTASIS; EXPRESSION; CARCINOMA	Accumulating evidence has demonstrated that long non-coding RNAs (lncRNAs) play a critical role in the development of human cancers including pancreatic cancer. Long non-coding RNA SPRY4-IT1 (sprouty4-intron transcript 1) has been reported to play an oncogenic role in various types of human carcinomas. However, the role of SPRY4-IT1 in pancreatic cancer is unclear. The objective of this study was to determine the function of SPRY4-IT1 on proliferation and invasion in pancreatic cancer. In the current study, we dissected the function and mechanism of SPRY4-IT1 by multiple approaches including Real-time RT-PCR, Western blotting analysis, MTT assay, Wound healing assay, Transwell assay, and transfection. We found that down-regulation of SPRY4-IT1 inhibited cell growth and induced cell apoptosis in pancreatic cancer cells. Moreover, SPRY4-IT1 knockdown induced cell cycle arrest at G0/G1 phase. Furthermore, inhibition of SPRY4-IT1 retarded cell migration and invasion in pancreatic cancer cells. Overexpression of SPRY4-IT1 enhanced cell growth and invasion, and inhibited cell apoptosis in pancreatic cancer cells. Mechanistically, suppression of SPRY4-IT1 inhibited the expression of Cdc20 in pancreatic cancer cells. Our findings demonstrated that inhibition of SPRY4-IT1 could be a potential therapeutic approach for the treatment of pancreatic cancer.	[Guo, Wenhao] Sichuan Univ, Canc Ctr, Dept Abdominal Oncol, West China Hosp,West China Med Sch, Chengdu, Sichuan, Peoples R China; [Guo, Wenhao] Sichuan Univ, West China Med Sch, State Key Lab Biotherapy, West China Hosp, Chengdu, Sichuan, Peoples R China; [Zhong, Kunhong; Wei, Heng; Nie, Chunlai; Yuan, Zhu] Sichuan Univ, West China Hosp, Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Zhong, Kunhong; Wei, Heng; Nie, Chunlai; Yuan, Zhu] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University	Guo, WH (corresponding author), Sichuan Univ, Canc Ctr, Dept Abdominal Oncol, West China Hosp,West China Med Sch, Chengdu, Sichuan, Peoples R China.; Guo, WH (corresponding author), Sichuan Univ, West China Med Sch, State Key Lab Biotherapy, West China Hosp, Chengdu, Sichuan, Peoples R China.; Yuan, Z (corresponding author), Sichuan Univ, West China Hosp, Lab Biotherapy, Chengdu, Sichuan, Peoples R China.; Yuan, Z (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Sichuan, Peoples R China.	wenhaoguo2011@163.com; yuanzhu@scu.edu.cn			National Natural Science Foundation of China (NSFC) [81773021]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was support by National Natural Science Foundation of China (NSFC, No. 81773021 to Zhu Yuan).	Aroldi F, 2017, IMMUNOTHERAPY-UK, V9, P607, DOI 10.2217/imt-2016-0142; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Blythe AJ, 2016, BBA-GENE REGUL MECH, V1859, P46, DOI 10.1016/j.bbagrm.2015.08.009; Cao D, 2016, ONCOTARGETS THER, V9, P5417, DOI 10.2147/OTT.S111794; Cui F, 2016, TUMOR BIOL, V37, P10871, DOI 10.1007/s13277-016-4962-9; Gupta R, 2017, J SURG ONCOL, V116, P25, DOI 10.1002/jso.24623; Jing W, 2016, ONCOL REP, V36, P1085, DOI 10.3892/or.2016.4859; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; Li H, 2017, J NANOTECHNOL, V2017, P1, DOI DOI 10.1016/J.BI0PHA.2017.01.037; Li J, 2017, TUMOR BIOL, V39, DOI DOI 10.1177/101042831771140628651500; Li S., 2017, CANC GENE THER; Liu D, 2017, CANCER LETT, V388, P281, DOI 10.1016/j.canlet.2016.12.005; Liu HX, 2015, J ZHEJIANG UNIV-SC B, V16, P10, DOI 10.1631/jzus.B1400172; Mazar J, 2014, ONCOTARGET, V5, P8959, DOI 10.18632/oncotarget.1863; Peng W, 2015, TUMOR BIOL, V36, P6751, DOI 10.1007/s13277-015-3376-4; Ramos MC, 2017, EXPERT OPIN THER PAT, V27, P1251, DOI 10.1080/13543776.2017.1349106; Ru N, 2016, DNA CELL BIOL, V35, P290, DOI 10.1089/dna.2016.3226; Shen F, 2017, ONCOTARGET, V8, P14479, DOI 10.18632/oncotarget.10407; Shi YG, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0318-0; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sun M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.256; Tan WL, 2017, MED SCI MONITOR, V23, P309, DOI 10.12659/MSM.898369; Wang JJ, 2015, ONCOTARGET, V6, P17192, DOI 10.18632/oncotarget.3780; Wang LX, 2015, PHARMACOL THERAPEUT, V151, P141, DOI 10.1016/j.pharmthera.2015.04.002; Xie HW, 2014, TUMOR BIOL, V35, P7743, DOI 10.1007/s13277-014-2013-y; Xu YJ, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317711140; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Yang J, 2017, ONCOTARGET, V8, P23492, DOI 10.18632/oncotarget.15626; Yu GF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16781-9; Yu J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317709129; Zeng S, 2015, ONCOLOGIST, V20, P898, DOI 10.1634/theoncologist.2014-0475; Zhang CY, 2016, CELL BIOL TOXICOL, V32, P391, DOI 10.1007/s10565-016-9341-1; Zhang HM, 2014, INT J CLIN EXP PATHO, V7, P5801; Zhang X, 2017, ONCOTARGET; Zhao XL, 2015, INT J CLIN EXP PATHO, V8, P1954; Zhong YC, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008583; Zhou M, 2017, BIOMED PHARMACOTHER, V85, P348, DOI 10.1016/j.biopha.2016.11.035; Zhou Y, 2016, EUR REV MED PHARMACO, V20, P3035	38	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193483	10.1371/journal.pone.0193483	http://dx.doi.org/10.1371/journal.pone.0193483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489909	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000081
J	Reyes-Valdes, MH; Burgueno, J; Singh, S; Martinez, O; Sansaloni, CP				Humberto Reyes-Valdes, M.; Burgueno, Juan; Singh, Sukhwinder; Martinez, Octavio; Paola Sansaloni, Carolina			An informational view of accession rarity and allele specificity in germplasm banks for management and conservation	PLOS ONE			English	Article							ALGORITHM; DIVERSITY	Germplasm banks are growing in their importance, number of accessions and amount of characterization data, with a large emphasis on molecular genetic markers. In this work, we offer an integrated view of accessions and marker data in an information theory framework. The basis of this development is the mutual information between accessions and allele frequencies for molecular marker loci, which can be decomposed in allele specificities, as well as in rarity and divergence of accessions. In this way, formulas are provided to calculate the specificity of the different marker alleles with reference to their distribution across accessions, accession rarity, defined as the weighted average of the specificity of its alleles, and divergence, defined by the Kullback-Leibler formula. Albeit being different measures, it is demonstrated that average rarity and divergence are equal for any collection. These parameters can contribute to the knowledge of the structure of a germplasm collection and to make decisions about the preservation of rare variants. The concepts herein developed served as the basis for a strategy for core subset selection called HCore, implemented in a publicly available R script. As a proof of concept, the mathematical view and tools developed in this research were applied to a large collection of Mexican wheat accessions, widely characterized by SNP markers. The most specific alleles were found to be private of a single accession, and the distribution of this parameter had its highest frequencies at low levels of specificity. Accession rarity and divergence had largely symmetrical distributions, and had a positive, albeit non-strictly linear relationship. Comparison of the HCore approach for core subset selection, with three state-of-the-art methods, showed it to be superior for average divergence and rarity, mean genetic distance and diversity. The proposed approach can be used for knowledge extraction and decision making in germplasm collections of diploid, inbred or outbred species.	[Humberto Reyes-Valdes, M.] Univ Autonoma Agr Antonio Narro, Dept Plant Breeding, Saltillo, Coahuila, Mexico; [Burgueno, Juan; Singh, Sukhwinder; Paola Sansaloni, Carolina] Int Maize & Wheat Improvement Ctr CIMMYT, Mexico City, DF, Mexico; [Martinez, Octavio] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Guanajuato, Mexico	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Reyes-Valdes, MH (corresponding author), Univ Autonoma Agr Antonio Narro, Dept Plant Breeding, Saltillo, Coahuila, Mexico.	mathgenome@gmail.com	Martinez, Octavio/F-3951-2014	Martinez, Octavio/0000-0002-7590-0041	MasAgro Biodiversidad [2016/003]	MasAgro Biodiversidad	This research was funded by MasAgro Biodiversidad (http://masagro.mx/index.php/es/componentes/masagro-biodiversidad) to MHRV, under the agreement MAB 2016/003. Additionally, MasAgro Biodiversidad provided data and technical support. Universidad Autonoma Agraria Antonio Narro (http://www.uaaan.mx/v3index.php) provided the salary for MHRV.	Ash R.B., 1965, INFORM THEORY; Baldi P, 2010, NEURAL NETWORKS, V23, P649, DOI 10.1016/j.neunet.2009.12.007; Brown A. H. D., 1991, Genetics and conservation of rare plants.., P99; Brown AHD, 2001, CORE COLLECTIONS PLA, P3; Cormen T., 2009, INTRO ALGORITHMS; De Beukelaer H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-312; Franco J, 2005, CROP SCI, V45, P1035, DOI 10.2135/cropsci2004.0292; Frankel OH, 1984, GENETIC MANIPULATION, ppp161; GOODMAN MM, 1983, MAYDICA, V28, P169; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Hartl D., 1989, PRINCIPLES POPULATIO; Hayano-Kanashiro C, 2017, ECOL EVOL, V7, P1680, DOI 10.1002/ece3.2754; Reyes-Valdes MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079936; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Martinez O, 2008, P NATL ACAD SCI USA, V105, P9709, DOI 10.1073/pnas.0803479105; Martinez O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010398; McCouch SR, 2012, AM J BOT, V99, P407, DOI 10.3732/ajb.1100385; Mobaied S, 2015, DATA BRIEF, V3, P165, DOI 10.1016/j.dib.2015.02.015; Pacheco A., 2016, BIO R BIODIVERSITY A; Papapanagiotou Matina, 2017, JCO Precis Oncol, V1, P1, DOI 10.1200/PO.16.00070; Pellegrini PA, 2016, BIODIVERS CONSERV, V25, P2753, DOI 10.1007/s10531-016-1201-z; R Development Core Team, 2017, R LANG ENV STAT COMP; Reyes-Valdes MH, 2005, GENET RES, V85, P81, DOI 10.1017/S0016672305007354; Reyes-Valdes MH, 2012, METHOD MOL BIOL, V1006, P259; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Singh S, 2014, DARTSEQ DERIVED SNPS; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thachuk C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-243; Vikram P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26216	29	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193346	10.1371/journal.pone.0193346	http://dx.doi.org/10.1371/journal.pone.0193346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489873	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000066
J	Raizada, N; Khaparde, SD; Salhotra, VS; Rao, R; Kalra, A; Swaminathan, S; Khanna, A; Chopra, KK; Hanif, M; Singh, V; Umadevi, KR; Nair, SA; Huddart, S; Prakash, CHS; Mall, S; Singh, P; Saha, BK; Denkinger, CM; Boehme, C; Sarin, S				Raizada, Neeraj; Khaparde, Sunil D.; Salhotra, Virender Singh; Rao, Raghuram; Kalra, Aakshi; Swaminathan, Soumya; Khanna, Ashwani; Chopra, Kamal Kishore; Hanif, M.; Singh, Varinder; Umadevi, K. R.; Nair, Sreenivas Achuthan; Huddart, Sophie; Prakash, C. H. Surya; Mall, Shalini; Singh, Pooja; Saha, B. K.; Denkinger, Claudia M.; Boehme, Catharina; Sarin, Sanjay			Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; XPERT MTB/RIF TEST; CHILDHOOD TUBERCULOSIS; PULMONARY TUBERCULOSIS; ACCURACY; ASSAY	Background Diagnosis of TB in children is challenging, and is largely based on positive history of contact with a TB case, clinical and radiological findings, often without microbiological confirmation. Diagnostic efforts are also undermined by challenges in specimen collection and the limited availability of high sensitivity, rapid diagnostic tests that can be applied with a quick turnaround time. The current project was undertaken in four major cities of India to address TB diagnostic challenges in pediatric population, by offering free of cost Xpert testing to pediatric presumptive TB cases, thereby paving the way for better TB care. Methods A high throughput lab was established in each of the four project cities, and linked to various health care providers across the city through rapid specimen transportation and electronic reporting linkages. Free Xpert testing was offered to all pediatric (0 +/- 14 years) presumptive TB cases (both pulmonary and extra-pulmonary) seeking care at public and private health facilities. Results The current project enrolled 42,238 pediatric presumptive TB cases from April, 2014 to June, 2016. A total of 3,340 (7.91%, CI 7.65 +/- 8.17) bacteriologically confirmed TB cases were detected, of which 295 (8.83%, CI 7.9 +/- 9.86) were rifampicin-resistant. The level of rifampicin resistance in the project cohort was high. Overall Xpert yielded a high proportion of valid results and TB detection rates were more than three-fold higher than smear microscopy. The project provided same-day testing and early availability of results led to rapid treatment initiation and success rates and very low rates of treatment failure and loss to follow-up. Conclusion The current project demonstrated the feasibility of rolling out rapid and upfront Xpert testing for pediatric presumptive TB cases through a single Xpert lab per city in an efficient manner. Rapid turnaround testing time facilitated prompt and appropriate treatment initiation. These results suggest that the upfront Xpert assay is a promising solution to address TB diagnosis in children. The high levels of rifampicin resistance detected in presumptive pediatric TB patients tested under the project are a major cause of concern from a public health perspective which underscores the need to further prioritize upfront Xpert access to this vulnerable population.	[Raizada, Neeraj; Kalra, Aakshi; Mall, Shalini; Sarin, Sanjay] Fdn Innovat New Diagnost, New Delhi, India; [Khaparde, Sunil D.; Salhotra, Virender Singh; Rao, Raghuram] Govt India, Cent TB Div, New Delhi, India; [Swaminathan, Soumya] Indian Council Med Res, New Delhi, India; [Khanna, Ashwani] Govt NCT, State TB Off, Delhi, India; [Chopra, Kamal Kishore; Hanif, M.] New Delhi TB Ctr, New Delhi, India; [Singh, Varinder] Lady Hardinge Med Coll & Hosp, New Delhi, India; [Singh, Varinder] Assoc Kalawati Saran Childrens Hosp, New Delhi, India; [Umadevi, K. R.] Natl Inst Res TB, Madras, Tamil Nadu, India; [Nair, Sreenivas Achuthan] WHO, Country Off India, New Delhi, India; [Huddart, Sophie] McGill Univ, Montreal, PQ, Canada; [Prakash, C. H. Surya] Intermediate Reference Lab, Hyderabad, Andhra Prades, India; [Saha, B. K.] Intermediate Reference Lab, Kolkata, India; [Denkinger, Claudia M.; Boehme, Catharina] Fdn Innovat New Diagnost, Geneva, Switzerland	Foundation For Innovative New Diagnostics; Indian Council of Medical Research (ICMR); Lady Hardinge Medical College & Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization; McGill University; Foundation For Innovative New Diagnostics	Sarin, S (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	Sanjay.Sarin@finddx.org	Huddart, Sophie/AAF-8844-2020	Huddart, Sophie/0000-0001-6425-3371; Nair, Sreenivas/0000-0002-2586-6797; Singh, Pooja/0000-0001-9577-3521; Raizada, Neeraj/0000-0003-2116-332X	United States Agency for International Development (USAID) under Challenge TB project	United States Agency for International Development (USAID) under Challenge TB project(United States Agency for International Development (USAID))	The project was funded by United States Agency for International Development (USAID) under Challenge TB project. FIND was responsible for implementation, training, coordination, monitoring, data analysis and writing of the report in close coordination with Central TB Division, Ministry of Health and Family Welfare, Government of India.	Adejumo OA, 2016, J TROP PEDIATRICS, V62, P131, DOI 10.1093/tropej/fmv089; Amdekar YK, 2010, INDIAN PEDIATR, V47, P41, DOI 10.1007/s13312-010-0008-3; Arora V, 2005, TUBERCULOSIS CONTROL, V330, P115; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brent AJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/865436; Central TB Division Ministry of Health and Family Welfare, 2012, GUID PROGR MAN DRUG; Central TB Division Ministry of Health and Family Welfare, MAN RNTCP YOUR AR TR; Chow F, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-67; Cobelens FGJ, 2008, PLOS MED, V5, P1037, DOI 10.1371/journal.pmed.0050150; Connell TG, 2011, J INFECT DIS, V204, pS1151, DOI 10.1093/infdis/jir413; Dangisso MH, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0461-1; Gomez-Pastrana D, 2001, CLIN INFECT DIS, V32, P17, DOI 10.1086/317526; Hailu D, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-61; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Jenkins HE, 2016, PNEUMONIA, V8, DOI 10.1186/s41479-016-0018-6; Kalra A, 2017, INT J TUBERC LUNG D, V21, P645, DOI 10.5588/ijtld.16.0563; Kumar Mani Kant, 2015, J Nat Sci Biol Med, V6, P314, DOI 10.4103/0976-9668.159988; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Marais BJ, 2007, ARCH DIS CHILD, V92, P446, DOI 10.1136/adc.2006.104976; Nelliyanil Maria, 2012, Indian J Tuberc, V59, P207; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Pai Madhukar, 2014, Indian J Chest Dis Allied Sci, V56, P71; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Poerksen G, 2007, Malawi Med J, V19, P142; Rahman N, 2012, DAN MED J, V59; Raizada N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140375; Revised National Tuberculosis Control Program, 2014, STANDARD OPERATING P; Ritz N, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14000; Sabawoon W, 2012, MYCOBAC DIS, V2, P3; Scott LE, 2014, J CLIN MICROBIOLOGY; Shah I, 2012, INDIAN PEDIATR, V49, P741, DOI 10.1007/s13312-012-0158-6; Starke JR, 2000, PEDIATR INFECT DIS J, V19, P1095, DOI 10.1097/00006454-200011000-00015; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490; Hoang TTT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2338-5; Uria G A, 2012, RAPID DIAGNOSIS PULM, V2012, DOI DOI 10.1155/2012/932862; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, GEN DEF REP FRAM TUB, P3; World Health Organization, POL UPD AUT REAL TIM; World Health Organization, GLOB TUB REP 2013; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193194	10.1371/journal.pone.0193194	http://dx.doi.org/10.1371/journal.pone.0193194			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489887	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000056
J	Tiwari, V; Kedia, S; Garg, SK; Rampal, R; Mouli, VP; Purwar, A; Mitra, DK; Das, P; Dattagupta, S; Makharia, G; Acharya, SK; Ahuja, V				Tiwari, Veena; Kedia, Saurabh; Garg, Sushil Kumar; Rampal, Ritika; Mouli, V. Pratap; Purwar, Anuja; Mitra, D. K.; Das, Prasenjit; Dattagupta, S.; Makharia, Govind; Acharya, S. K.; Ahuja, Vineet			CD4(+) CD25(+) FOXP3(+) T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; EXPRESSION; SITE	Background Distinguishing between Crohn's Disease (CD) and Intestinal Tuberculosis (ITB) has been a challenging task for clinicians due to their similar presentation. CD4(+)FOXP3(+) T regulatory cells (Tregs) have been reported to be increased in patients with pulmonary tuberculosis. However, there is no such data available in ITB. The aim of this study was to investigate the differential expression of FOXP3(+) T cells in patients with ITB and CD and its utility as a biomarker. Methods The study prospectively recruited 124 patients with CD, ITB and controls: ulcerative colitis (UC) and patients with only haemorrhoidal bleed. Frequency of CD4(+)CD25(+)FOXP3(+) Tregs in peripheral blood (flow cytometry), FOXP3 mRNA expression in blood and colonic mucosa (qPCR) and FOXP3(+) T cells in colonic mucosa (immunohistochemistry) were compared between controls, CD and ITB patients. Results Frequency of CD4(+)CD25(+)FOXP3(+) Treg cells in peripheral blood was significantly increased in ITB as compared to CD. Similarly, significant increase in FOXP3(+) T cells and FOXP3 mRNA expression was observed in colonic mucosa of ITB as compared to CD. ROC curve showed that a value of >32.5% for FOXP3(+) cells in peripheral blood could differentiate between CD and ITB with a sensitivity of 75% and a specificity of 90.6%. Conclusion Phenotypic enumeration of peripheral CD4(+)CD25(+)FOXP3(+) Treg cells can be used as a non-invasive biomarker in clinics with a high diagnostic accuracy to differentiate between ITB and CD in regions where TB is endemic.	[Tiwari, Veena; Kedia, Saurabh; Garg, Sushil Kumar; Rampal, Ritika; Mouli, V. Pratap; Purwar, Anuja; Makharia, Govind; Acharya, S. K.; Ahuja, Vineet] All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India; [Mitra, D. K.] All India Inst Med Sci, Dept HLA & Transplant Immunol, New Delhi, India; [Das, Prasenjit; Dattagupta, S.] All India Inst Med Sci, Dept Pathol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Ahuja, V (corresponding author), All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India.	vineet.aiims@gmail.com	Ahuja, Vineet/N-1705-2019; Kedia, Saurabh/AAD-7227-2020	Ahuja, Vineet/0000-0002-5474-9709; 	Indian council of Medical Research (ICMR)	Indian council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	The study has been funded by Indian council of Medical Research (ICMR) to VA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja V, 2016, GASTROENTEROL REP, V4, P59, DOI 10.1093/gastro/gov015; Ahuja V, 2012, INDIAN J GASTROENTER, V31, P294, DOI 10.1007/s12664-012-0272-3; Ahuja V, 2010, J DIGEST DIS, V11, P134, DOI 10.1111/j.1751-2980.2010.00429.x; Ban H, 2008, MOL MED REP, V1, P647, DOI 10.3892/mmr_00000006; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Dalziel TK, 1913, BRIT MED J, V1913, P1068; Das K, 2009, DIGEST DIS SCI, V54, P1099, DOI 10.1007/s10620-008-0469-6; Diaz A, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/985302; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Feruglio SL, 2015, CLIN EXP IMMUNOL, V179, P454, DOI 10.1111/cei.12468; He XY, 2010, EUR J CLIN MICROBIOL, V29, P643, DOI 10.1007/s10096-010-0908-0; Holmen N, 2006, INFLAMM BOWEL DIS, V12, P447, DOI 10.1097/00054725-200606000-00003; Kedia S, 2015, INDIAN J GASTROENTER, V34, P135, DOI 10.1007/s12664-015-0550-y; LOGAN VSC, 1969, P ROY SOC MED, V62, P1227, DOI 10.1177/003591576906201214; Makharia GK, 2010, AM J GASTROENTEROL, V105, P642, DOI 10.1038/ajg.2009.585; Makita S, 2007, J IMMUNOL, V178, P4937, DOI 10.4049/jimmunol.178.8.4937; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Mouli VP, 2017, ALIMENT PHARM THER, V45, P27, DOI 10.1111/apt.13840; Paustian FF, 1964, GASTROEN TEROLOGY, V11, P311; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Saruta M, 2007, CLIN IMMUNOL, V125, P281, DOI 10.1016/j.clim.2007.08.003; Sharma MP, 2009, TUBERCULOSIS COMPREH, P424; Sharma PK, 2009, AM J RESP CRIT CARE, V179, P1061, DOI 10.1164/rccm.200804-529OC; Singh B, 2015, INDIAN J GASTROENTER, V34, P43, DOI 10.1007/s12664-015-0538-7; Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001; Tandon R, 2013, INFLAMM BOWEL DIS, P41; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Ueno A, 2013, INFLAMM BOWEL DIS, V19, P2522, DOI 10.1097/MIB.0b013e3182a85709; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Wang Y, 2011, J DIGEST DIS, V12, P286, DOI 10.1111/j.1751-2980.2011.00505.x; Xiao Li Feng, 2002, Curr Gastroenterol Rep, V4, P490, DOI 10.1007/s11894-002-0025-z; Yu QT, 2007, INFLAMM BOWEL DIS, V13, P191, DOI 10.1002/ibd.20053	33	16	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193433	10.1371/journal.pone.0193433	http://dx.doi.org/10.1371/journal.pone.0193433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489879	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000076
J	Yang, QH; Operario, D; Zaller, N; Huang, W; Dong, YY; Zhang, HB				Yang, Qiaohong; Operario, Don; Zaller, Nickolas; Huang, Wen; Dong, Yanyan; Zhang, Hongbo			Depression and its correlations with health risk behaviors and social capital among female migrants working in entertainment venues in China	PLOS ONE			English	Article							MENTAL-HEALTH; URBAN CHINA; INTERNAL MIGRATION; SEX WORKERS; ADOLESCENTS; SYMPTOMS; CHILDREN; WOMEN	Objectives Among the dramatic increased internal migration in China in past three decades, a considerable proportion of young females migrated to urban areas and found employment in "entertainment venues", who may be vulnerable to psychological distress. This study examines the prevalence of depression and explores its associations with health-risk behaviors and social capital among this subgroup. Methods 358 female migrants were recruited from entertainment venues in a rapidly growing urban city in China. A survey which included measures of depressive symptoms, health-risk behaviors, social capital, and socio-demographic characteristics was administered. Multivariable logistic regression was conducted to identify the independent correlates of depression. Results Of participants, 31.0% had clinically significant depressive symptoms (CES-D score >= 16). In multivariable models, greater likelihood of depressive symptoms was associated with working in massage centers/hotels (OR = 3.20, 95% CI: 1.80-5.70), having probable alcohol dependence (OR = 2.25, 95% CI: 1.22-4.16), self-reported lifetime use of illicit drugs (OR = 2.98, 95% CI: 1.26-7.06), growing up in a non-nuclear family (OR = 2.46, 95% CI: 1.18-5.16), and poor social capital (OR = 6.01, 95% CI = 2.02-17.87). Conclusion Intervention strategies to address the high prevalence of depression among female migrants are needed, and should also aim to reduce problematic alcohol and drug use, improve social capital, and target women working in massage centers or hotels.	[Yang, Qiaohong] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Operario, Don] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Zaller, Nickolas] Univ Arkansas, Fay W Boozman Coll Publ Hlth, Fayetteville, AR 72701 USA; [Huang, Wen] Shaoxing City Ctr Dis Control & Prevent, Shaoxing, Zhejiang, Peoples R China; [Dong, Yanyan] Nantong City Maternal & Child Hlth Care Hosp, Nantong, Jiangsu, Peoples R China; [Zhang, Hongbo] Anhui Med Univ, Sch Publ Hlth, Hefei, Anhui, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Brown University; University of Arkansas System; University of Arkansas Fayetteville; Anhui Medical University	Zhang, HB (corresponding author), Anhui Med Univ, Sch Publ Hlth, Hefei, Anhui, Peoples R China.	Zhanghongbo@ahmu.edu.cn			China AIDS Program Rounds 3; Global Fund; Tuberculosis and Malaria [ZY38]; Brown University Office of International Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810, P2CHD041020] Funding Source: NIH RePORTER	China AIDS Program Rounds 3; Global Fund; Tuberculosis and Malaria; Brown University Office of International Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by China AIDS Program Rounds 3, Global Fund to Fight AIDS, Tuberculosis and Malaria (No. ZY38), and a pilot grant from Brown University Office of International Affairs.	Almedom AM, 2005, SOC SCI MED, V61, P943, DOI 10.1016/j.socscimed.2004.12.025; Asian Development Bank, 2006, PEOPL REP CHIN HEF U; Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; Cao WM, 2015, AGING MENT HEALTH, V19, P418, DOI 10.1080/13607863.2014.948805; Chan J, 2010, ASIA PAC J, V37, P1; Chen XG, 2011, HUM ORGAN, V70, P22, DOI 10.17730/humo.70.1.k76047734m703500; Cheung CK, 1998, J PSYCHOL, V132, P169, DOI 10.1080/00223989809599157; Cheung NWT, 2014, HEALTH PLACE, V27, P142, DOI 10.1016/j.healthplace.2014.01.013; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Dong YY, 2015, WOMEN HEALTH, V55, P580, DOI 10.1080/03630242.2015.1022811; Du HF, 2015, ASIAN J SOC PSYCHOL, V18, P176, DOI 10.1111/ajsp.12085; Ehsan AM, 2015, J EPIDEMIOL COMMUN H, V69, P1021, DOI 10.1136/jech-2015-205868; Forsman AK, 2012, AGING MENT HEALTH, V16, P771, DOI 10.1080/13607863.2012.667784; Gaetano A. M, 2013, MOVE WOMEN RURAL URB; Goh K, 2014, LIT REV CHINAS HUKOU; Han S, 2015, ASIA-PAC J PUBLIC HE, V27, pNP2008, DOI 10.1177/1010539513496140; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Hong Y, 2008, AIDS BEHAV, V12, P623, DOI 10.1007/s10461-007-9287-7; Hong Y, 2010, J TRANSCULT NURS, V21, P29, DOI 10.1177/1043659609349063; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Hu XUJ, 2008, LANCET, V372, P1717, DOI 10.1016/S0140-6736(08)61360-4; Huang W, 2014, PREV SCI, V15, P329, DOI 10.1007/s11121-013-0423-5; Irwin J, 2008, SOC SCI MED, V67, P1935, DOI 10.1016/j.socscimed.2008.09.008; Lecerof SS, 2015, HLTH PROMOT INT; Lewis NM, 2014, HEALTH PLACE, V27, P212, DOI 10.1016/j.healthplace.2014.03.002; Li B., 2010, POPULATION RES, V34, P6; Li L, 2007, SOC PSYCH PSYCH EPID, V42, P716, DOI 10.1007/s00127-007-0221-0; Liu SH, 2011, J GEOGR SCI, V21, P35, DOI 10.1007/s11442-011-0827-8; Liu X.C., 1995, CHIN J MENT HLTH, V9, P19; Lu CY, 2012, EUR J OBSTET GYN R B, V160, P60, DOI 10.1016/j.ejogrb.2011.10.001; Lu Y, 2013, SOC NETWORKS, V35, P357, DOI 10.1016/j.socnet.2013.04.001; McPherson Kerri E, 2014, BMC Psychol, V2, P7, DOI 10.1186/2050-7283-2-7; Merrill S., 2009, INTRO SYNDEMICS CRIT; Montgomery J.L., 2012, WASH INT LAW J, V21, P591; Mou J, 2011, J COMMUNITY PSYCHOL, V39, P212, DOI 10.1002/jcop.20428; National Population and Family Planning Commission of the People's Republic of China, 2015, 2014 CHIN FLOAT POP; Qiu PY, 2011, J AFFECT DISORDERS, V134, P198, DOI 10.1016/j.jad.2011.05.043; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rattay P, 2014, BUNDESGESUNDHEITSBLA, V57, P860, DOI 10.1007/s00103-014-1988-2; Riumallo-Herr CJ, 2014, SOC SCI MED, V105, P47, DOI 10.1016/j.socscimed.2013.12.018; Stall R., 2008, UNEQUAL OPPORTUNITY; Waldfogel J, 2010, FUTURE CHILD, V20, P87; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; Wu QB, 2015, SOC SCI MED, V132, P270, DOI 10.1016/j.socscimed.2014.10.050; Wu QB, 2010, AM J COMMUN PSYCHOL, V45, P1, DOI 10.1007/s10464-009-9284-2; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914; Zaller N, 2014, ALCOHOL ALCOHOLISM, V49, P321, DOI 10.1093/alcalc/agt184; Zhong BL, 2013, SOC PSYCH PSYCH EPID, V48, P1569, DOI 10.1007/s00127-013-0672-4; Zoppei S, 2014, SOC PSYCH PSYCH EPID, V49, P1589, DOI 10.1007/s00127-014-0856-6	49	7	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191632	10.1371/journal.pone.0191632	http://dx.doi.org/10.1371/journal.pone.0191632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489826	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000009
J	Abiri, N; Pang, JL; Ou, JQ; Shi, B; Wang, XH; Zhang, SC; Sun, YX; Yang, DC				Abiri, Naghmeh; Pang, Jianlei; Ou, Jiquan; Shi, Bo; Wang, Xianghong; Zhang, Sucai; Sun, Yunxia; Yang, Daichang			Assessment of the immunogenicity of residual host cell protein impurities of OsrHSA	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; LARGE-SCALE PRODUCTION; HUMAN SERUM-ALBUMIN; RECOMBINANT PROTEINS; RICE ENDOSPERM; EXPRESSION; CULTURE; RISK; IDENTIFICATION; TRIAL	Human serum albumin (HSA) is the most abundant protein in human plasma and is widely used at high doses for treating various diseases. Recombinant HSA is an alternative approach to plasma-derived HSA, providing increased safety and an unlimited supply. However, the safety of the residual host cell proteins (HCPs) co-purified with Oryza sativa HSA (OsrHSA) remains to be determined. An animal system was used to assess the immunogenicity of OsrHSA and its residual HCPs. Low immunogenicity and immunotoxicity of the residual HCPs at a dose of 25 mu g/kg, equivalent to 25 times the clinical dosage of HSA, were observed. An anti-drug-antibody (ADA) analysis revealed that anti-HSA, anti-OsrHSA or anti-HCP antibodies developed with a low frequency in pHSA and OsrHSA treatments, but the titers were as low as 1.0-2.0. Furthermore, the titer and the incidence of the specific antibodies were not significantly different between the pHSA and OsrHSA groups, indicating that OsrHSA presents similar immunogenicity to that of pHSA. More importantly, no cytokines were stimulated after the administration of OsrHSA and the residual HCPs, suggesting that there was no risk of a cytokine storm. These results demonstrated that the residual HCPs from OsrHSA have low immunogenicity, indicating that the rice endosperm is one of the best hosts for plant molecular pharming.	[Abiri, Naghmeh; Pang, Jianlei; Wang, Xianghong; Yang, Daichang] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Hubei, Peoples R China; [Ou, Jiquan; Shi, Bo] Healthgen Biotechnol Co Ltd, Wuhan, Hubei, Peoples R China; [Zhang, Sucai; Sun, Yunxia] JOINN Labs Inc, Beijing, Peoples R China	Wuhan University	Yang, DC (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Hubei, Peoples R China.	ciyang@whu.edu.cn		Yang, Daichang/0000-0002-7488-6356; Abiri, Naghmeh/0000-0002-4686-2314	National major project for New Drug development in China [2009ZX09301-014]; National major project for Genetically modified crops in China [2011ZX08001-006]	National major project for New Drug development in China; National major project for Genetically modified crops in China	This study was granted by National major project for New Drug development in China (Grant No. 2009ZX09301-014) and National major project for Genetically modified crops in China (Grant No. 2011ZX08001-006). Those fundings were from Chinese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A.K., 2016, BASIC IMMUNOLOGY FUN; Aboul-Ata AAE, 2014, ADV VIRUS RES, V89, P1, DOI 10.1016/B978-0-12-800172-1.00001-X; Alderson P., 2004, COCHRANE DB SYST REV, P18, DOI [10.1002/14651858.CD001208.pub2, DOI 10.1002/14651858.CD001208.PUB2]; ALEXANDER MR, 1982, JAMA-J AM MED ASSOC, V247, P831, DOI 10.1001/jama.247.6.831; An N, 2013, INT J MOL SCI, V14, P3556, DOI 10.3390/ijms14023556; Andrews LB, 2005, BIOTECHNOL PROGR, V21, P946, DOI 10.1021/bp049569k; Bracewell DG, 2015, BIOTECHNOL BIOENG, V112, P1727, DOI 10.1002/bit.25628; De Groot AS, 2007, TRENDS IMMUNOL, V28, P482, DOI 10.1016/j.it.2007.07.011; Eckardt KU, 2003, NEPHROL DIAL TRANSPL, V18, P865, DOI 10.1093/ndt/gfg182; Egelkrout E, 2012, PLANT SCI, V184, P83, DOI 10.1016/j.plantsci.2011.12.005; ERSTAD BL, 1991, ARCH INTERN MED, V151, P901, DOI 10.1001/archinte.151.5.901; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Foster JR, 2001, INT J EXP PATHOL, V82, P171, DOI 10.1046/j.1365-2613.2001.00192.x; Fox J. L., 2012, Nature Biotechnology, V30, P472, DOI 10.1038/nbt0612-472; Fu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104426; Haile LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125078; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; Herzyk DJ, 2008, IMMUNOTOXICOLOGY STR; Huang N, 2008, IN VITRO CELL DEV-AN, V44, P464, DOI 10.1007/s11626-008-9136-7; Jawa V, 2016, AAPS J, V18, P1439, DOI 10.1208/s12248-016-9948-4; Krawitz DC, 2006, PROTEOMICS, V6, P94, DOI 10.1002/pmic.200500225; Ma JKC, 2015, PLANT BIOTECHNOL J, V13, P1106, DOI 10.1111/pbi.12416; Ning TT, 2008, BIOTECHNOL LETT, V30, P1679, DOI 10.1007/s10529-008-9717-2; Ou JQ, 2014, PLANT CELL REP, V33, P585, DOI 10.1007/s00299-013-1559-2; Paul M, 2011, BIOTECHNOL APPL BIOC, V58, P58, DOI 10.1002/bab.6; Peakman M., 2009, BASIC CLIN IMMUNOLOG; Shaaltiel Y, 2016, NAT BIOTECHNOL, V34, P706, DOI 10.1038/nbt.3556; Sharma AK, 2009, BIOTECHNOL ADV, V27, P811, DOI 10.1016/j.biotechadv.2009.06.004; Shin YJ, 2011, PLANT BIOTECHNOL J, V9, P1109, DOI 10.1111/j.1467-7652.2011.00636.x; Stoger E, 2014, ANNU REV PLANT BIOL, V65, P743, DOI 10.1146/annurev-arplant-050213-035850; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tekoah Y, 2015, PLANT BIOTECHNOL J, V13, P1199, DOI 10.1111/pbi.12428; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Valente KN, 2015, BIOTECHNOL BIOENG, V112, P1232, DOI 10.1002/bit.25515; Wang X, 2009, BIOTECHNOL BIOENG, V103, P446, DOI 10.1002/bit.22304; Wycoff KL, 2005, CURR PHARM DESIGN, V11, P2429, DOI 10.2174/1381612054367508; Yang DC, 2003, PLANTA, V216, P597, DOI 10.1007/s00425-002-0919-x; Yang DC, 2001, P NATL ACAD SCI USA, V98, P11438, DOI 10.1073/pnas.201411298	38	8	8	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193339	10.1371/journal.pone.0193339	http://dx.doi.org/10.1371/journal.pone.0193339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513721	gold, Green Submitted, Green Published			2022-12-27	WOS:000426896800055
J	Dobbie, F; MacKintosh, AM; Clegg, G; Stirzaker, R; Bauld, L				Dobbie, Fiona; MacKintosh, Anne Marie; Clegg, Gareth; Stirzaker, Rebecca; Bauld, Linda			Attitudes towards bystander cardiopulmonary resuscitation: Results from a cross-sectional general population survey	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; SOCIOECONOMIC-STATUS; SCHOOL-STUDENTS; CPR; SURVIVAL; INTERVENTION; KNOWLEDGE	Survival from out-of-hospital cardiac arrest (OHCA) varies across the developed world. Although not all OHCA are recoverable, the survival rate in Scotland is lower than in comparable countries, with higher average survival rates of 7.9% in England and 9% across Europe. The purpose of this paper is to explore the barriers, facilitators and public attitudes to administering bystander cardiopulmonary resuscitation (CPR) which could inform future policy and initiatives to improve the rate of bystander CPR. Data was collected via a cross-sectional general population survey of 1027 adults in Scotland. 52% of respondents had been trained in CPR. Of those who were not trained, two fifths (42%) expressed a willingness to receive CPR training. Fewer than half (49%) felt confident administering CPR, rising to 82% if they were talked through it by a call handler. Multivariate analyses identified that people in social grade C2DE were less likely than those in social grade ABC1 to be CPR trained and less confident to administer CPR if talked through by a call handler. The older a person was, the less likely they were to be CPR trained, show willingness to be CPR trained or be confident to administer bystander CPR with or without instruction from an emergency call handler. These findings are particularly relevant considering that most OHCA happen in the homes of older people. In a developed country such as Scotland with widely available CPR training, only half of the adult population reported feeling confident about administering bystander CPR. Further efforts tailored specifically for people who are older, unemployed and have a lower social grade are required to increase knowledge, confidence and uptake of training in bystander CPR.	[Dobbie, Fiona; MacKintosh, Anne Marie; Bauld, Linda] Univ Stirling, Fac Hlth Sci & Sport, Inst Social Mkt, Stirling, Scotland; [Clegg, Gareth] Univ Edinburgh, Resuscitat Res Grp, Edinburgh, Midlothian, Scotland; [Stirzaker, Rebecca] Heriot Watt Univ, Sch Social Sci, Edinburgh, Midlothian, Scotland	University of Stirling; University of Edinburgh; Heriot Watt University	Dobbie, F (corresponding author), Univ Stirling, Fac Hlth Sci & Sport, Inst Social Mkt, Stirling, Scotland.	fiona.dobbie@stir.ac.uk	Stirzaker, Rebecca/AAA-9713-2021; Dobbie, Fiona/L-5858-2016	Clegg, Gareth/0000-0002-4314-611X; Stirzaker, Rebecca/0000-0002-0962-3664; Dobbie, Fiona/0000-0002-8294-8203	Resuscitation Research Group, University of Edinburgh	Resuscitation Research Group, University of Edinburgh	The study was funded by the Resuscitation Research Group, University of Edinburgh. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg AMR, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-24; Axelsson A, 2000, RESUSCITATION, V47, P71, DOI 10.1016/S0300-9572(00)00209-4; Coons SJ, 2009, RESUSCITATION, V80, P334, DOI 10.1016/j.resuscitation.2008.11.024; Donohoe RT, 2006, RESUSCITATION, V71, P70, DOI 10.1016/j.resuscitation.2006.03.003; Fischer P, 2011, PSYCHOL BULL, V137, P517, DOI 10.1037/a0023304; Ghose R, 2010, RESUSCITATION, V81, P1488, DOI 10.1016/j.resuscitation.2010.06.012; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Hasselqvist-Ax I, 2015, NEW ENGL J MED, V372, P2307, DOI 10.1056/NEJMoa1405796; Hawkes C, 2017, RESUSCITATION, V133; Johnston TC, 2003, RESUSCITATION, V56, P67, DOI 10.1016/S0300-9572(02)00277-0; Kanstad BK, 2011, RESUSCITATION, V82, P1053, DOI 10.1016/j.resuscitation.2011.03.033; Lindner TW, 2011, RESUSCITATION, V82, P1508, DOI 10.1016/j.resuscitation.2011.06.016; Lynch B, 2010, RESUSCITATION, V81, P568, DOI 10.1016/j.resuscitation.2009.12.022; Mitchell MJ, 2009, PREHOSP EMERG CARE, V13, P478, DOI 10.1080/10903120903144833; Perkins GD, 2012, HEART, V98, P529, DOI 10.1136/heartjnl-2011-300802; Public Health Seattle & King Country Division of Emergency Medical Services, 2013, 2013 ANN REP KING CO; Riegel B, 2006, RESUSCITATION, V70, P98, DOI 10.1016/j.resuscitation.2005.10.029; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Stromsoe A, 2015, EUR HEART J, V36, P863, DOI 10.1093/eurheartj/ehu240; Swor R, 2006, ACAD EMERG MED, V13, P596, DOI 10.1197/j.aem.2005.12.021; Vaillancourt C, 2008, RESUSCITATION, V79, P417, DOI 10.1016/j.resuscitation.2008.07.012	21	34	34	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193391	10.1371/journal.pone.0193391	http://dx.doi.org/10.1371/journal.pone.0193391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513722	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800056
J	Dong, L; Cornaglia, M; Krishnamani, G; Zhang, JW; Mouchiroud, L; Lehnert, T; Auwerx, J; Gijs, MAM				Dong, Li; Cornaglia, Matteo; Krishnamani, Gopalan; Zhang, Jingwei; Mouchiroud, Laurent; Lehnert, Thomas; Auwerx, Johan; Gijs, Martin A. M.			Reversible and long-term immobilization in a hydrogel-microbead matrix for high-resolution imaging of Caenorhabditis elegans and other small organisms	PLOS ONE			English	Article							C-ELEGANS; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL DYNAMICS; BIOLOGICAL-RESEARCH; PLATFORM; NEURONS; STRESS; TRANSPORT; GENETICS; FISSION	The nematode Caenorhabditis elegans is an important model organism for biomedical research and genetic studies relevant to human biology and disease. Such studies are often based on high-resolution imaging of dynamic biological processes in the worm body tissues, requiring well-immobilized and physiologically active animals in order to avoid movement-related artifacts and to obtain meaningful biological information. However, existing immobilization methods employ the application of either anesthetics or servere physical constraints, by using glue or specific microfluidic on-chip mechanical structures, which in some cases may strongly affect physiological processes of the animals. Here, we immobilize C. elegans nematodes by taking advantage of a biocompatible and temperature-responsive hydrogel-microbead matrix. Our gel-based immobilization technique does not require a specific chip design and enables fast and reversible immobilization, thereby allowing successive imaging of the same single worm or of small worm populations at all development stages for several days. We successfully demonstrated the applicability of this method in challenging worm imaging contexts, in particular by applying it for high-resolution confocal imaging of the mitochondrial morphology in worm body wall muscle cells and for the long-term quantification of number and size of specific protein aggregates in different C. elegans neurodegenerative disease models. Our approach was also suitable for immobilizing other small organisms, such as the larvae of the fruit fly Drosophila melanogaster and the unicellular parasite Trypanosoma brucei. We anticipate that this versatile technique will significantly simplify biological assay-based longitudinal studies and long-term observation of small model organisms.	[Dong, Li; Cornaglia, Matteo; Krishnamani, Gopalan; Zhang, Jingwei; Lehnert, Thomas; Gijs, Martin A. M.] Ecole Polytech Fed Lausanne, Lab Microsyst, Lausanne, Switzerland; [Krishnamani, Gopalan; Mouchiroud, Laurent; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat Syst Physiol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Gijs, MAM (corresponding author), Ecole Polytech Fed Lausanne, Lab Microsyst, Lausanne, Switzerland.	martin.gijs@epfl.ch	Auwerx, Johan/ABE-9307-2021	Auwerx, Johan/0000-0002-5065-5393; Dong, Li/0000-0002-3034-888X	 [ERC-2012-AdG-320404]		This work is supported by ERC-2012-AdG-320404 (http://cordis.europa.eu/project/rcn/106969_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun Z. F., 2017, INTRO C ELEGANS ANAT; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Aubry G, 2015, LAB CHIP, V15, P1424, DOI 10.1039/c4lc01384k; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; Bakhtina NA, 2014, RSC ADV, V4, P4691, DOI 10.1039/c3ra43758b; Basak R, 2013, LANGMUIR, V29, P4350, DOI 10.1021/la304836e; Chan DC, 2006, DEV CELL, V11, P592, DOI 10.1016/j.devcel.2006.10.009; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Chuang H-S, 2017, SENSORS ACTUATORS B; Cornaglia M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0083-6; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Dong L, 2016, LAB CHIP, V16, P574, DOI 10.1039/c5lc01328c; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gidalevitz T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000399; Gilleland CL, 2010, NAT PROTOC, V5, P1888, DOI 10.1038/nprot.2010.143; Gokce SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113917; Gonzales DL, 2017, NATURE NANOTECHNOLOG; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gupta BP, 2016, MICROMACHINES-BASEL, V7, DOI 10.3390/mi7070123; Hulme SE, 2011, ANGEW CHEM INT EDIT, V50, P4774, DOI 10.1002/anie.201005461; Hulme SE, 2010, LAB CHIP, V10, P589, DOI 10.1039/b919265d; Hwang H, 2014, LAB CHIP, V14, P3498, DOI 10.1039/c4lc00697f; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080813; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; Krajniak J, 2013, LAB CHIP, V13, P2963, DOI 10.1039/c3lc50300c; Krajniak J, 2010, LAB CHIP, V10, P1862, DOI 10.1039/c001986k; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Lee H, 2014, LAB CHIP, V14, P4513, DOI 10.1039/c4lc00789a; LEWIS JA, 1980, GENETICS, V95, P905; Li J, 2013, EXP NEUROL, V250, P94, DOI 10.1016/j.expneurol.2013.09.024; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Massie MR, 2003, CELL STRESS CHAPERON, V8, P1, DOI 10.1379/1466-1268(2003)8<1:ETTMIS>2.0.CO;2; Melentijevic I, 2017, NATURE, V542, P367, DOI 10.1038/nature21362; Mondal S, 2011, TRAFFIC, V12, P372, DOI 10.1111/j.1600-0854.2010.01157.x; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Sebastian D., 2017, TRENDS MOL MED; Shachaf Y, 2010, BIOMATERIALS, V31, P2836, DOI 10.1016/j.biomaterials.2009.12.050; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Sivagnanam V, 2013, CHEM REV, V113, P3214, DOI 10.1021/cr200432q; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Wang JJ, 2013, SENSOR ACTUAT B-CHEM, V178, P343, DOI 10.1016/j.snb.2012.12.102; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155	50	14	14	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193989	10.1371/journal.pone.0193989	http://dx.doi.org/10.1371/journal.pone.0193989			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509812	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200048
J	Tan, BY; MacLellan, B; Mason, E; Bizheva, K				Tan, Bingyao; MacLellan, Benjamin; Mason, Erik; Bizheva, Kostadinka			Structural, functional and blood perfusion changes in the rat retina associated with elevated intraocular pressure, measured simultaneously with a combined OCT plus ERG system	PLOS ONE			English	Article							OPTIC-NERVE HEAD; B-WAVE; A-WAVE; POSTISCHEMIC REPERFUSION; OSCILLATORY POTENTIALS; COHERENCE TOMOGRAPHY; FLOW; DOPAMINE; DEFORMATION; AMPLITUDES	Acute elevation of intraocular pressure (IOP) to ischemic and non-ischemic levels can cause temporary or permanent changes in the retinal morphology, function and blood flow/blood perfusion. Previously, such changes in the retina were assessed separately with different methods in clinical studies and animal models. In this study, we used a combined OCT+ERG system in combination with Doppler OCT and OCT angiography (OCTA) imaging protocols, in order to evaluate simultaneously and correlate changes in the retinal morphology, the retinal functional response to visual stimulation, and the retinal blood flow/blood perfusion, associated with IOP elevation to ischemic and non-ischemic levels in rats. Results from this study suggest that the inner retina responds faster to IOP elevation to levels greater than 30 mmHg with significant reduction of the total retinal blood flow (TRBF), decrease of the capillaries' perfusion and reduction of the ON bipolar cells contribution to the ERG traces. Furthermore, this study showed that ischemic levels of IOP elevation cause an additional significant decrease in the ERG photoreceptor response in the posterior retina. Thirty minutes after IOP normalization, retinal morphology, blood flow and blood perfusion recovered to baseline values, while retinal function did not recover completely.	[Tan, Bingyao; MacLellan, Benjamin; Mason, Erik; Bizheva, Kostadinka] Univ Waterloo, Dept Phys & Astron, Waterloo, ON, Canada; [Bizheva, Kostadinka] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada; [Bizheva, Kostadinka] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada	University of Waterloo; University of Waterloo; University of Waterloo	Bizheva, K (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON, Canada.; Bizheva, K (corresponding author), Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada.; Bizheva, K (corresponding author), Univ Waterloo, Dept Syst Design Engn, Waterloo, ON, Canada.	kbizheva@uwaterloo.ca			NSERC [312037]; Natural Sciences and Engineering Research Council of Canada [NSERC-DG-312037]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the NSERC Discovery, Grant 312037 (http://www.nserc-crsng.gc.ca/index_eng.asp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Nancy Gibson and Jean Flanagan for assistance with the animal related procedures, and Harmen Vander Heide for assistance with the design of the custom stereotactic animal holder. This research project was funded by the Natural Sciences and Engineering Research Council of Canada: NSERC-DG-312037.	ASI H, 1992, DOC OPHTHALMOL, V79, P125, DOI 10.1007/BF00156572; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; Bui B V., 2013, J OPHTHALMOL, V2013; Choe TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113011; Choh V, 2017, DOC OPHTHALMOL; Choh V, 2016, INVEST OPHTH VIS SCI, V57, P2140, DOI 10.1167/iovs.15-18770; Creel DJ, 2016, WEBVISION ORG RETINA, P1; Fortune B, 2004, INVEST OPHTH VIS SCI, V45, P1854, DOI 10.1167/iovs.03-1411; Fortune B, 2011, INVEST OPHTH VIS SCI, V52, P6651, DOI 10.1167/iovs.11-7578; Fox DA, 2008, ENVIRON HEALTH PERSP, V116, P618, DOI 10.1289/ehp.11268; Guo L, 2005, BRIT J OPHTHALMOL, V89, P1210, DOI 10.1136/bjo.2004.058941; Gurdita A, 2017, DOC OPHTHALMOL, V134, P205, DOI 10.1007/s10633-017-9586-x; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; Hariri S, 2009, OPT EXPRESS, V17, P24304, DOI 10.1364/OE.17.024304; He Z, 2006, INVEST OPHTH VIS SCI, V47, P4872, DOI 10.1167/iovs.06-0590; He Z, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.55; He Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031104; He Z, 2011, CLIN EXP OPTOM, V94, P133, DOI 10.1111/j.1444-0938.2010.00564.x; Ishihara M, 2000, JPN J PHYSIOL, V50, P125, DOI 10.2170/jjphysiol.50.125; JAGADEESH JM, 1980, INVEST OPHTH VIS SCI, V19, P1449; Joos KM, 2010, INVEST OPHTH VIS SCI, V51, P6431, DOI 10.1167/iovs.10-5212; Kong YX, 2009, INVEST OPHTH VIS SCI, V50, P5732, DOI 10.1167/iovs.09-3814; Kornfield TE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0005-15.2015; Lavery WJ, 2012, INVEST OPHTH VIS SCI, V53, P560, DOI 10.1167/iovs.11-8429; Lim JKH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098393; Marschall S, 2013, P SOC PHOTO-OPT INS, VXXVII; MATSUI Y, 1994, BRIT J OPHTHALMOL, V78, P191, DOI 10.1136/bjo.78.3.191; Matsumoto CS, 2011, CLIN OPHTHALMOL; Matsuura K, 1998, JPN J PHYSIOL, V48, P9, DOI 10.2170/jjphysiol.48.9; Moayed AA, 2011, OPT LETT, V36, P4575, DOI 10.1364/OL.36.004575; Moayed AA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3475489; Nagahara M, 2000, BRIT J OPHTHALMOL, V84, P31, DOI 10.1136/bjo.84.1.31; OGASAWARA H, 1992, BRIT J OPHTHALMOL, V76, P275, DOI 10.1136/bjo.76.5.275; OLIVIER P, 1986, BRAIN RES BULL, V16, P751, DOI 10.1016/0361-9230(86)90148-6; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PERLMAN I, 1983, BRIT J OPHTHALMOL, V67, P443, DOI 10.1136/bjo.67.7.443; Phillips MJ, 2010, INVEST OPHTH VIS SCI, V51, P6744, DOI 10.1167/iovs.10-5421; Pinhas A, 2014, INVEST OPHTH VIS SCI, V55, P8056, DOI 10.1167/iovs.14-15136; Polska E, 2007, INVEST OPHTH VIS SCI, V48, P3768, DOI 10.1167/iovs.07-0307; REGILLO CD, 1993, OPHTHALMOLOGY, V100, P1044; Resta V, 2007, EUR J NEUROSCI, V25, P2741, DOI 10.1111/j.1460-9568.2007.05528.x; RIVA CE, 1992, EXP EYE RES, V55, P499, DOI 10.1016/0014-4835(92)90123-A; Ro F., 1998, MED IMAGE COMPUT COM, V1496, P130; Rothenberg SJ, 2002, INVEST OPHTH VIS SCI, V43, P2036; SCHNEIDER T, 1991, EXP EYE RES, V52, P425, DOI 10.1016/0014-4835(91)90038-G; SKRANDIES W, 1988, EXP BRAIN RES, V71, P231; SPEROS P, 1981, SURV OPHTHALMOL, V25, P237, DOI 10.1016/0039-6257(81)90093-X; Srinivasan VJ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076025; Srinivasan VJ, 2010, OPT EXPRESS, V18, P2477, DOI 10.1364/OE.18.002477; Sugawara R, 2006, BRIT J OPHTHALMOL, V90, P1363, DOI 10.1136/bjo.2006.097485; Tan BY, 2017, INVEST OPHTH VIS SCI, V58, P1673, DOI 10.1167/iovs.17-21543; Tayyari F, 2014, INVEST OPHTH VIS SCI, V55, P7716, DOI 10.1167/iovs.14-14430; Tsai TI, 2014, INVEST OPHTH VIS SCI, V55, P1067, DOI 10.1167/iovs.13-13003; Vielma A, 2010, EXP EYE RES, V91, P700, DOI 10.1016/j.exer.2010.08.014; Wang L, 2014, INVEST OPHTH VIS SCI, V55, P3509, DOI 10.1167/iovs.14-14020; Wang Q, 2011, INVEST OPHTH VIS SCI, V52, P6292, DOI 10.1167/iovs.10-6424; Westall Carol A., 2001, Documenta Ophthalmologica, V102, P115, DOI 10.1023/A:1017535207481; Wong VHY, 2013, INVEST OPHTH VIS SCI, V54, P2133, DOI 10.1167/iovs.13-11595; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122; Yang Q, 2011, VET OPHTHALMOL, V14, P353, DOI 10.1111/j.1463-5224.2011.00881.x; Yasuda S, 2011, INVEST OPHTH VIS SCI, V52, P5737, DOI 10.1167/iovs.10-6923; Zhao D, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12507; Zhi Z, 2015, MICROVASC RES, V101, P86, DOI 10.1016/j.mvr.2015.07.001; Zhi ZW, 2012, BIOMED OPT EXPRESS, V3, P2220, DOI 10.1364/BOE.3.002220; Zhi ZW, 2011, BIOMED OPT EXPRESS, V2, P579, DOI 10.1364/BOE.2.000579	65	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193592	10.1371/journal.pone.0193592	http://dx.doi.org/10.1371/journal.pone.0193592			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509807	Green Submitted, gold, Green Published			2022-12-27	WOS:000426813200018
J	White, RL; Eberstein, K; Scott, DM				White, Rachel L.; Eberstein, Katie; Scott, Dawn M.			Birds in the playground: Evaluating the effectiveness of an urban environmental education project in enhancing school children's awareness, knowledge and attitudes towards local wildlife	PLOS ONE			English	Article							CONSERVATION; BENEFITS; ANIMALS; IDENTIFICATION; BIODIVERSITY; EXPERIENCES; CHILDHOOD; PROGRAM; VISITS; EXTINCTION	Children nowadays, particularly in urban areas, are more disconnected from nature than ever before, leading to a large-scale "extinction of experience" with the natural world. Yet there are many potential benefits from children interacting with nature first-hand, including via outdoor learning opportunities. Urban environmental education programmes typically aim to increase awareness and knowledge of local biodiversity and to promote positive attitudes and behaviour towards the environment. However, limited research has been conducted evaluating to what extent these interventions achieve their goals. Here, we explore and assess the influence of a six-week bird-feeding and monitoring project conducted within school grounds ("Bird Buddies") on individual awareness, knowledge and attitudes towards birds by primary school children. This initiative was conducted across eight (sub-) urban primary schools within Brighton and Hove (UK), with 220 participating children (aged 7 to 10). Via pre-and post-project questionnaires, we found evidence for enhanced awareness of local biodiversity, alongside significant gains in both bird identification knowledge and attitudes, which were greatest for children with little prior exposure to nature. Many children expressed a keenness to continue improving the environmental value of their school grounds and to apply elements of the project at home. Student project evaluation scores were consistently positive. Mirroring this, participating teachers endorsed the project as a positive learning experience for their students. One year after the project, several schools were continuing to feed and watch birds. Collectively, the findings from this study highlight the multiple benefits that can be derived from engagement with a relatively short outdoor environmental activity. We therefore believe that such interventions, if repeated locally/ longer term, could enhance children's experience with nature in urban settings with combined positive environmental impact.	[White, Rachel L.; Scott, Dawn M.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England; [Eberstein, Katie] Sussex Wildlife Trust, Brighton & Hove Environm Educ, Brighton, E Sussex, England	University of Brighton	White, RL (corresponding author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.	r.white2@brighton.ac.uk		Scott, Dawn/0000-0002-9570-2739; White, Rachel/0000-0003-0694-7847	Sussex Ornithological Society's (SOS) Avifauna Award; School of Pharmacy and Biomolecular Sciences at the University of Brighton	Sussex Ornithological Society's (SOS) Avifauna Award; School of Pharmacy and Biomolecular Sciences at the University of Brighton	Funding for the project came from the Sussex Ornithological Society's (SOS) Avifauna Award (https://www.sos.org.uk/)[RLW, KE]. Additional financial support was provided by the School of Pharmacy and Biomolecular Sciences at the University of Brighton [RLW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1995, CHILDRENS ENV, V12, P256; [Anonymous], 1985, J ENVIRON EDUC, DOI DOI 10.1080/00958964.1985.9942709; Ballouard JM, 2015, INT J SCI EDUC, V37, P469, DOI 10.1080/09500693.2014.993000; Ballouard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023152; Balmford A, 2002, SCI MAG, V295, P5; Beck AM, 2001, ANTHROZOOS, V14, P19, DOI 10.2752/089279301786999599; Bentsen P, 2017, CHILDREN LEARNING OU; BHCC (Brighton & Hove City Council), 2014, BRIGHT HOV CIT SNAPS; Binngiesser J, 2013, ANTHROZOOS, V26, P325, DOI 10.2752/175303713X13697429463475; Bixler RD, 2002, ENVIRON BEHAV, V34, P795, DOI 10.1177/001391602237248; Bjerke T, 2004, ANTHROZOOS, V17, P109, DOI 10.2752/089279304786991783; Bjerke T, 2001, ANTHROZOOS, V14, P86, DOI 10.2752/089279301786999535; Bjerke T, 1998, ANTHROZOOS, V11, P79, DOI 10.2752/089279398787000742; Blair D, 2009, J ENVIRON EDUC, V40, P15, DOI 10.3200/JOEE.40.2.15-38; Blumstein DT, 2007, PLOS BIOL, V5, P973, DOI 10.1371/journal.pbio.0050120; Bogner FX, 1999, INT J SCI EDUC, V21, P1169, DOI 10.1080/095006999290138; Bradley Jennifer CAMPBELL, 1999, J ENVIRON EDUC, V30, P17, DOI [DOI 10.1080/00958969909601873, 10.1080/00958969909601873]; Braun M, 2010, INT J ENV SCI ED, V5, P151; Brewer C, 2002, CONSERV BIOL, V16, P577, DOI 10.1046/j.1523-1739.2002.01633.x; Brossard D, 2005, INT J SCI EDUC, V27, P1099, DOI 10.1080/09500690500069483; Brynjegard S., 2001, SCH GARDENS RAISING; Cardak O, 2009, SCI RES ESSAYS, V4, P1518; Chawla L, 2014, HEALTH PLACE, V28, P1, DOI 10.1016/j.healthplace.2014.03.001; Cox DTC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158717; Cox DTC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141505; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Department for Education, 2015, NAT CURR ENGL SCI PR; Duerden MD, 2010, J ENVIRON PSYCHOL, V30, P379, DOI 10.1016/j.jenvp.2010.03.007; Eagles P. F. J., 1999, J ENVIRON EDUC, V30, P33, DOI DOI 10.1080/00958969909601882; Evans C, 2005, CONSERV BIOL, V19, P589, DOI 10.1111/j.1523-1739.2005.00s01.x; Evans S, 2006, SCH SCI REV, V88, P93; Ewert A, 2005, LEISURE SCI, V27, P225, DOI 10.1080/01490400590930853; Fisman L., 2005, J ENVIRON EDUC, V36, P39, DOI [10.3200/JOEE.36.3.39-50, DOI 10.3200/JOEE.36.3.39-50]; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010; Genovart M, 2013, BIOL CONSERV, V159, P484, DOI 10.1016/j.biocon.2012.10.028; Gil D, 2014, AVIAN URBAN ECOLOGY: BEHAVIOURAL AND PHYSIOLOGICAL ADAPTATIONS, P1; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Hinds J, 2008, J ENVIRON PSYCHOL, V28, P109, DOI 10.1016/j.jenvp.2007.11.001; Huxham M, 2006, J BIOL EDUC, V41, P9, DOI 10.1080/00219266.2006.9656050; Jones DN, 2008, J AVIAN BIOL, V39, P265, DOI 10.1111/j.0908-8857.2008.04271.x; Kaiser FG, 1999, J ENVIRON PSYCHOL, V19, P1, DOI 10.1006/jevp.1998.0107; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Kidd AH, 1996, APPL ANIM BEHAV SCI, V47, P119, DOI 10.1016/0168-1591(95)01015-7; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Kubiatko M, 2017, EURASIA J MATH SCI T, V13, P1161, DOI 10.12973/eurasia.2017.00665a; Lieflander AK, 2014, J ENVIRON EDUC, V45, P105, DOI 10.1080/00958964.2013.875511; Lindemann-Matthies P, 2005, INT J SCI EDUC, V27, P655, DOI 10.1080/09500690500038116; Lindemann-Matthies P., 2002, J ENVIRON EDUC, V33, P22, DOI DOI 10.1080/00958960209600805; Lindemann-Matthies P, 2006, INT J SCI EDUC, V28, P895, DOI 10.1080/10670560500438396; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neuvonen Mario, 2007, Urban Forestry & Urban Greening, V6, P235, DOI 10.1016/j.ufug.2007.05.003; Oerke B, 2013, INT J SCI EDUC, V35, P713, DOI 10.1080/09500693.2011.566897; Patrick P, 2011, J SCI EDUC TECHNOL, V20, P630, DOI 10.1007/s10956-011-9290-7; Pergams ORW, 2006, J ENVIRON MANAGE, V80, P387, DOI 10.1016/j.jenvman.2006.02.001; Pilgrim S, 2007, ECOL APPL, V17, P1742, DOI 10.1890/06-1358.1; Pilgrim SE, 2008, ENVIRON SCI TECHNOL, V42, P1004, DOI 10.1021/es070837v; Prokop P., 2008, EURASIA J MATH SCI T, V4, P87, DOI [https://doi.org/10.12973/ejmste/75309, DOI 10.12973/EJMSTE/75309, 10.12973/ejmste/75309]; Prokop P., 2009, EURASIA J MATH SCI T, V5, P127, DOI [DOI 10.12973/ejmste/75264, 10.12973/ejmste/, DOI 10.12973/EJMSTE]; Prokop P, 2008, ANTHROZOOS, V21, P221, DOI 10.2752/175303708X332035; Prokop P, 2008, INT J SCI EDUC, V30, P431, DOI 10.1080/09500690701206686; Prokop P, 2007, RES SCI EDUC, V37, P393, DOI 10.1007/s11165-006-9031-8; Prokop P, 2010, ANTHROZOOS, V23, P21, DOI 10.2752/175303710X12627079939107; Pyle R. M., 1993, THUNDER TREE LESSONS; PYLE RM, 1977, HORTICULTURE, V55, P65; R Development Core Team, 2016, R LANG ENV STAT COMP; Randler C, 2002, J BIOL EDUC, V36, P181, DOI 10.1080/00219266.2002.9655830; Randler C., 2008, EURASIA J MATH SCI T, V4, P223, DOI [DOI 10.12973/ejmste/75344, 10.12973/ejmste/75344, DOI 10.12973/EJMSTE/75344]; Randler C., 2005, J ENVIRON EDUC, V37, P43, DOI [10.3200/JOEE.37.1.43-52, DOI 10.3200/JOEE.37.1.43-52]; Randler C, 2006, J BIOL EDUC, V40, P161, DOI 10.1080/00219266.2006.9656038; Randler C, 2010, J BALT SCI EDUC, V9, P135; Randler C, 2009, J SCI EDUC TECHNOL, V18, P138, DOI 10.1007/s10956-008-9139-x; Randler C, 2008, J BALT SCI EDUC, V7, P48; Ratcliffe E, 2013, J ENVIRON PSYCHOL, V36, P221, DOI 10.1016/j.jenvp.2013.08.004; Reynolds SJ, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00024; Rickinson M., 2001, ENVIRON EDUC RES, V7, P207, DOI [DOI 10.1080/13504620120065230, 10.1080/13504620120065230]; Rickinson M., 2004, REV RES OUTDOOR LEAR; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Serpell JA, 2004, ANIM WELFARE, V13, pS145; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Shwartz A, 2014, BIOL CONSERV, V171, P82, DOI 10.1016/j.biocon.2014.01.009; Shwartz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038642; Skelly S. M., 1998, HORTTECHNOLOGY, V8, P579; Soga M, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060529; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Sousa E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154440; Stagg BC, 2013, J BIOL EDUC, V47, P104, DOI 10.1080/00219266.2013.764341; Taylor N, 2005, ANTHROZOOS, V18, P18, DOI 10.2752/089279305785594342; Thomas M., 2005, BRIGHTON HOVE BIODIV; Thompson CW, 2008, ENVIRON BEHAV, V40, P111, DOI 10.1177/0013916507300119; Thompson TL, 2002, INT J SCI EDUC, V24, P645, DOI 10.1080/09500690110110115; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; UNESCO, 1978, INT C ENV ED TBIL US; Wells N.M., 2006, J ENVIRON PSYCHOL, V16, P1, DOI DOI 10.1016/j.jenvp.2010.10.001; Yore LB, 1997, AM BIOL TEACH, V59, P558; Zarybnicka M, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001132; Zhang WZ, 2014, BIOL CONSERV, V177, P109, DOI 10.1016/j.biocon.2014.06.011; [No title captured]	102	26	26	8	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193993	10.1371/journal.pone.0193993	http://dx.doi.org/10.1371/journal.pone.0193993			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509809	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000426813200049
J	Miyata, H; Mori, M; Kokudo, N; Gotoh, M; Konno, H; Wakabayashi, G; Matsubara, H; Watanabe, T; Ono, M; Hashimoto, H; Yamamoto, H; Kumamaru, H; Kohsaka, S; Iwanaka, T				Miyata, Hiroaki; Mori, Masaki; Kokudo, Norihiro; Gotoh, Mitsukazu; Konno, Hiroyuki; Wakabayashi, Go; Matsubara, Hisahiro; Watanabe, Toshiaki; Ono, Minoru; Hashimoto, Hideki; Yamamoto, Hiroyuki; Kumamaru, Hiraku; Kohsaka, Shun; Iwanaka, Tadashi			Association between institutional procedural preference and in-hospital outcomes in laparoscopic surgeries; Insights from a retrospective cohort analysis of a nationwide surgical database in Japan	PLOS ONE			English	Article							RISK MODEL; GASTRIC-CANCER; DISTAL GASTRECTOMY; CLINICAL DATABASE; VOLUME; FEASIBILITY; MORTALITY; SAFETY	Objective To assess the use of laparoscopic surgeries (LS) and the association between its performance and hospitals' preference for LS over open surgeries. Summary background data LS is increasingly used in many abdominal surgeries, albeit both with and without solid guideline recommendations. To date, the hospitals' preference (LS vs. open surgeries) and its association with in-hospital outcomes has not been evaluated. Methods We enrolled patients undergoing 8 types of gastrointestinal surgeries in 2011-2013 in the Japanese National Clinical Database. We assessed the use of LS and the occurrences of surgery-related morbidity and mortality during the study period. Further, for 4 typical LS procedures, we assessed the hospitals' preference for LS by modeling the propensity to perform LS (over open surgeries) from patient-level factors, and estimating each institution's observed/expected (O/E) ratio for LS use. Institutions with O/E>2 were defined as LS-dominant. Using hierarchical logistic regression models, we assessed the association between LS preference and in-hospital outcomes. Results Among 1,377,118 patients undergoing gastrointestinal procedures in 2,336 participating hospitals, use of LS increased in all 8 procedures (35.1% to 44.7% for distal gastrectomy (DG), and 27.5% to 43.2% for right hemi colectomy (RHC)). Those operated at LS-dominant hospitals were at an increased risk of operative death (OR 1.83 [95%Cl, 1.37-2.45] for DG, 1.79 [95%Cl, 1.43-2.25] for RHC) compared to standard O/E level hospitals (0.5 <= O/E<2.0). Conclusions LS use widely increased during 2011-2013 in Japan. Facilities with higher than expected LS use had higher mortality compared to other hospitals, suggesting a need for careful patient selection and dissemination of the procedure.	[Miyata, Hiroaki; Ono, Minoru; Hashimoto, Hideki; Yamamoto, Hiroyuki; Kumamaru, Hiraku; Kohsaka, Shun; Iwanaka, Tadashi] Natl Clin Database, Tokyo, Japan; [Miyata, Hiroaki] Keio Univ, Dept Hlth Policy & Management, Tokyo, Japan; [Mori, Masaki; Gotoh, Mitsukazu; Konno, Hiroyuki; Wakabayashi, Go] Japanese Soc Gastroenterol Surg, Tokyo, Japan; [Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Osaka, Japan; [Mori, Masaki; Kokudo, Norihiro; Matsubara, Hisahiro; Watanabe, Toshiaki] Japan Surg Soc, Tokyo, Japan; [Kokudo, Norihiro] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Gotoh, Mitsukazu] Osaka Gen Med Ctr, Osaka, Japan; [Konno, Hiroyuki] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan; [Wakabayashi, Go] Ageo Cent Gen Hosp, Dept Surg, Saitama, Japan; [Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan; [Watanabe, Toshiaki] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo, Japan; [Ono, Minoru] Univ Tokyo, Dept Cardiac Surg, Tokyo, Japan; [Hashimoto, Hideki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Tokyo, Japan; [Yamamoto, Hiroyuki; Kumamaru, Hiraku] Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Tokyo, Japan; [Kohsaka, Shun] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Iwanaka, Tadashi] Bur Saitama Prefectural Hosp, Saitama, Japan	Keio University; Osaka University; National Center for Global Health & Medicine - Japan; Hamamatsu University School of Medicine; Chiba University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Keio University	Miyata, H (corresponding author), Natl Clin Database, Tokyo, Japan.	hqa-adm@umin.ac.jp		Yamamoto, Hiroyuki/0000-0003-3337-7595; Kumamaru, Hiraku/0000-0002-9759-6191				Chen K, 2014, WORLD J GASTROENTERO, V20, P15867, DOI 10.3748/wjg.v20.i42.15867; Choi YY, 2013, J SURG ONCOL, V108, P550, DOI 10.1002/jso.23438; Cooper MA, 2014, BMJ-BRIT MED J, P349; Gotoh M, 2015, SURG TODAY; Japan Surgical Society, 2010, DISCL RES PROC ETH R; Katai H, 2010, GASTRIC CANCER, V13, P238, DOI 10.1007/s10120-010-0565-0; Kelly M, 2014, BRIT J SURG, V101, P750, DOI 10.1002/bjs.9472; Kenjo A, 2014, J AM COLL SURGEONS, V218, P412, DOI 10.1016/j.jamcollsurg.2013.11.007; Kimura W, 2014, ANN SURG, V259, P773, DOI 10.1097/SLA.0000000000000263; Kobayashi H, 2014, J GASTROENTEROL, V49, P1047, DOI 10.1007/s00535-013-0860-8; Kuhry E, 2008, CANCER TREAT REV, V34, P498, DOI 10.1016/j.ctrv.2008.03.011; Kurita N, 2015, ANN SURG, V262, P295, DOI 10.1097/SLA.0000000000001127; Mackenzie H, 2015, ANN SURG, V261, P338, DOI 10.1097/SLA.0000000000000651; Makino T, 2012, ANN SURG, V255, P667, DOI 10.1097/SLA.0b013e31823fbae7; Matsubara N, 2014, DIS COLON RECTUM, V57, P1075, DOI 10.1097/DCR.0000000000000176; Miskovic D, 2012, DIS COLON RECTUM, V55, P1300, DOI 10.1097/DCR.0b013e31826ab4dd; Miyata H, 2008, J THORAC CARDIOV SUR, V135, P1306, DOI 10.1016/j.jtcvs.2007.10.079; Miyata H, 2009, EUR J CARDIO-THORAC, V36, P517, DOI 10.1016/j.ejcts.2009.03.020; Nakagoe T, 2015, SURG TODAY, V45, P1233, DOI 10.1007/s00595-014-1026-x; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Reames BN, 2014, ANN SURG, V260, P244, DOI 10.1097/SLA.0000000000000375; Seto Y, 2017, ANN GASTROENT SURG, V1, P80, DOI 10.1002/ags3.12026; Takeuchi H, 2014, ANN SURG, V260, P259, DOI 10.1097/SLA.0000000000000644; Watanabe M, 2014, ANN SURG, V260, P1034, DOI 10.1097/SLA.0000000000000781	24	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193186	10.1371/journal.pone.0193186	http://dx.doi.org/10.1371/journal.pone.0193186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505561	Green Submitted, Green Published, gold			2022-12-27	WOS:000426548200007
J	Scott, AB; Singh, M; Toribio, JA; Hernandez-Jover, M; Barnes, B; Glass, K; Moloney, B; Lee, A; Groves, P				Scott, Angela Bullanday; Singh, Mini; Toribio, Jenny-Ann; Hernandez-Jover, Marta; Barnes, Belinda; Glass, Kathryn; Moloney, Barbara; Lee, Amanda; Groves, Peter			Comparisons of management practices and farm design on Australian commercial layer and meat chicken farms: Cage, barn and free range (vol 12, e0188505, 2017)	PLOS ONE			English	Correction													Singh, Mini/AAE-5906-2019; Hernandez-Jover, Marta/F-8688-2016; Toribio, Jenny-Ann LML/B-5032-2011; Moloney, Barbara Jean/G-2003-2011	Moloney, Barbara Jean/0000-0002-4416-3579; Hernandez-Jover, Marta/0000-0001-8803-9062; Barnes, Belinda/0000-0003-3295-4063				Scott AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188505	1	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0194086	10.1371/journal.pone.0194086	http://dx.doi.org/10.1371/journal.pone.0194086			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505606	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200044
J	Serino-Silva, C; Morais-Zani, K; Toyama, MH; Toyama, DD; Gaeta, HH; Rodrigues, CFB; Aguiar, WD; Tashima, AK; Grego, KF; Tanaka-Azevedo, AM				Serino-Silva, Caroline; Morais-Zani, Karen; Toyama, Marcos Hikari; Toyama, Daniela de Oliveira; Gaeta, Henrique Hesse; Bittencourt Rodrigues, Caroline Fabri; Aguiar, Weslei da Silva; Tashima, Alexandre Keiji; Grego, Kathleen Fernandes; Tanaka-Azevedo, Anita Mitico			Purification and characterization of the first gamma-phospholipase inhibitor (gamma PLI) from Bothrops jararaca snake serum	PLOS ONE			English	Article							A(2) MYOTOXIN INHIBITOR; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR-CLONING; CROTOXIN-B; VENOM; PLASMA; IDENTIFICATION; VIPERIDAE; PROTEINS	Phospholipases A(2) (PLA(2)) are enzymes acting on the cell membrane phospholipids resulting in fatty acids and lysophospholipids and deconstructing the cell membrane. This protein is commonly found in snake venoms, causing tissue inflammation in the affected area. Evidence indicates that snakes have natural resistance to their own venom due to protective properties in plasma, that inhibit the action of proteins present in their venom. Given that, this study aimed to purify and characterize a gamma PLI from Bothrops jararaca serum, named gamma BjPLI. PLA(2) inhibitor was isolated using two chromatographic steps: an ion exchange column (DEAE), followed by an affinity column (crotoxin coupled to a CNBr-activated Sepharose resin). The purity and biochemical characterization of the isolated protein were analyzed by RP-HPLC, SEC, SDS-PAGE, circular dichroism and mass spectrometry. The ability to inhibit PLA(2) was determined by enzymatic activity, neutralization of paw edema and myonecrosis. The protein purity was confirmed by RP-HPLC and SEC, whilst an apparent molecular mass of 25 kDa and 20 kDa was obtained by SDS-PAGE, under reducing and non-reducing conditions, respectively. According to mass spectrometry analysis, this protein showed 72% and 68% of coverage when aligned to amino acid sequences of two proteins already described as PLIs. Thus, the inhibitory activity of enzymatic, edema and myonecrotic activities by gamma BjPLI suggests a role of this inhibitor for protection of these snakes against self-envenomation.	[Serino-Silva, Caroline; Bittencourt Rodrigues, Caroline Fabri; Aguiar, Weslei da Silva] Univ Sao Paulo, Inst Pesquisas Tecnol, Inst Butantan, Interunidades Biotecnol, Sao Paulo, SP, Brazil; [Serino-Silva, Caroline; Morais-Zani, Karen; Bittencourt Rodrigues, Caroline Fabri; Grego, Kathleen Fernandes; Tanaka-Azevedo, Anita Mitico] Inst Butantan, Lab Herpetol, Sao Paulo, SP, Brazil; [Toyama, Marcos Hikari; Toyama, Daniela de Oliveira; Gaeta, Henrique Hesse] Univ Estadual Paulista, Inst Biociencias Litoral Paulista, Sao Vicente, SP, Brazil; [Tashima, Alexandre Keiji] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, SP, Brazil	Instituto Butantan; Universidade de Sao Paulo; Instituto Butantan; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Tanaka-Azevedo, AM (corresponding author), Inst Butantan, Lab Herpetol, Sao Paulo, SP, Brazil.	amt.azevedo@uol.com.br	Grego, Kathleen/GOV-3529-2022; Grego, Kathleen F/A-6394-2014; Morais-Zani, Karen/B-3821-2014; Tashima, Alexandre Keiji/B-8228-2015; Toyama, Marcos H/P-4673-2017; Azevedo, Anita M Tanaka/B-3429-2014	Grego, Kathleen/0000-0003-4769-5818; Grego, Kathleen F/0000-0003-4769-5818; Morais-Zani, Karen/0000-0001-9900-8384; Tashima, Alexandre Keiji/0000-0002-1332-8895; Toyama, Marcos H/0000-0001-6836-3084; Azevedo, Anita M Tanaka/0000-0002-4694-4475	Financiadora de Estudos e Projetos and Fundagao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2012/19321-9, 2016/03839-0, 2013/05357-4, 2014/11108-0, 2017/01890-0, 2017/16908-2, 2013/12826-0]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES	Financiadora de Estudos e Projetos and Fundagao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES	This work was supported by Financiadora de Estudos e Projetos and Fundagao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2012/19321-9 and 2016/03839-0 to AKT, 2013/05357-4, 2014/11108-0, 2017/01890-0 to AMTA, 2017/16908-2 to KMZ and 2013/12826-0 to CSS) and Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior-CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar W da S, ESTUDO CARACTERIZAC; Brazilian Ministry of Health, AC AN PEC NOT 2016; Calvete JJ, 2007, J MASS SPECTROM, V42, P1405, DOI 10.1002/jms.1242; Calvete JJ, 2010, J PROTEOME RES, V9, P528, DOI 10.1021/pr9008749; Campos PC, 2016, J VENOM ANIM TOXINS, V22, DOI 10.1186/s40409-016-0092-5; Cardoso JLC, 2009, ANIMAIS PECONHENTOS, V2nd; Chippaux JP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005662; Gimenes SNC, 2014, TOXICON, V81, P58, DOI 10.1016/j.toxicon.2014.01.012; CURY Y, 1994, TOXICON, V32, P1425, DOI 10.1016/0041-0101(94)90414-6; DEWIT CA, 1987, TOXICON, V25, P315, DOI 10.1016/0041-0101(87)90260-1; Estevo-Costa MI, 2008, TOXICON, V52, P122, DOI 10.1016/j.toxicon.2008.04.167; Fortes-Dias CL, 2003, TOXICON, V41, P909, DOI 10.1016/S0041-0101(03)00073-4; FORTESDIAS CL, 1991, TOXICON, V29, P997, DOI 10.1016/0041-0101(91)90082-3; Gans C, 1968, Adv Oral Biol, V3, P45; Gomes CM, 2017, PEERJ, V5, DOI 10.7717/peerj.3203; Goncalves LRC, 2000, MEDIAT INFLAMM, V9, P101, DOI 10.1080/096293500411569; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; Gutierrez JM, 1989, LOCAL TISSUE DAMAGE, P211; Gutierrez JM, 2008, TOXICON, V51, P80, DOI 10.1016/j.toxicon.2007.08.007; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; HENDON RA, 1971, P NATL ACAD SCI USA, V68, P1560, DOI 10.1073/pnas.68.7.1560; Holzer M, 1996, TOXICON, V34, P1149, DOI 10.1016/0041-0101(96)00057-8; Kinkawa K, 2010, BIOCHEM BIOPH RES CO, V395, P377, DOI 10.1016/j.bbrc.2010.04.024; KOCHVA E, 1987, TOXICON, V25, P65, DOI 10.1016/0041-0101(87)90150-4; KOGAKI H, 1989, J BIOCHEM-TOKYO, V106, P966, DOI 10.1093/oxfordjournals.jbchem.a122983; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leon IR, 2012, PROTEOMICS, V12, P2753, DOI 10.1002/pmic.201200062; Lizano S, 1997, BIOCHEM J, V326, P853, DOI 10.1042/bj3260853; LOMONTE B, 1990, REV BIOL TROP, V38, P325; Lomonte B, 2011, ACTA CHIM SLOV, V58, P647; Luna KPO, 2011, J VENOM ANIM TOXINS, V17, P130, DOI 10.1590/S1678-91992011000200003; Malaque CMS, 2003, VENOMOUS ANIMALS BRA; Gutierrez JM, 2009, TOXICON, V54, P958, DOI 10.1016/j.toxicon.2009.01.038; Gutierrez JM, 2009, TOXICON, V54, P976, DOI 10.1016/j.toxicon.2009.01.039; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Ohkura N, 1997, BIOCHEM J, V325, P527, DOI 10.1042/bj3250527; Okumura K, 2002, ARCH BIOCHEM BIOPHYS, V408, P124, DOI 10.1016/S0003-9861(02)00551-9; Okumura K, 1999, BIOCHEM J, V341, P165, DOI 10.1042/0264-6021:3410165; Oliveira CZ, 2008, BIOCHIMIE, V90, P1506, DOI 10.1016/j.biochi.2008.05.009; Oliveira CZ, 2011, CURR TOP MED CHEM, V11, P2509; Ownby CL, 1998, J TOXICOL-TOXIN REV, V17, P213, DOI 10.3109/15569549809009250; Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3; Picelli CG, 2017, INT J BIOL MACROMOL, V103, P525, DOI 10.1016/j.ijbiomac.2017.05.076; Quiros S, 2007, COMP BIOCHEM PHYS B, V146, P60, DOI 10.1016/j.cbpb.2006.09.003; Santoro ML, 2008, TOXICON, V51, P1440, DOI 10.1016/j.toxicon.2008.03.018; Santos NA, 2011, BIOCHIMIE, V93, P583, DOI 10.1016/j.biochi.2010.11.016; Service FT, 2006, BIOR PROT ASS; Shirai R, 2009, TOXICON, V53, P685, DOI 10.1016/j.toxicon.2009.02.001; Soares AM, 2003, BIOCHEM BIOPH RES CO, V302, P193, DOI 10.1016/S0006-291X(03)00155-4; Soares AM, 2001, INT J BIOCHEM CELL B, V33, P877, DOI 10.1016/S1357-2725(01)00065-6; TOMIHARA Y, 1990, TOXICON, V28, P989, DOI 10.1016/0041-0101(90)90028-6; TOMIHARA Y, 1988, TOXICON, V26, P420, DOI 10.1016/0041-0101(88)90013-X; TOMIHARA Y, 1987, TOXICON, V25, P685, DOI 10.1016/0041-0101(87)90117-6; Toyama MH, 2000, BBA-GEN SUBJECTS, V1474, P56, DOI 10.1016/S0304-4165(99)00211-1; VANDEENEN LLM, 1963, BIOCHIM BIOPHYS ACTA, V70, P538; Vieira SM, 2017, PLOS NEGLECT TROP D, V11, P1; WHO, 2007, RAB ENV NEGL PUBL HL; YU BZ, 1993, BIOCHEMISTRY-US, V32, P6485, DOI 10.1021/bi00076a024; Zelanis A., 2011, PROTEOMICA TRANSCRIP; Zhong LP, 2016, TOXICON, V122, P1, DOI 10.1016/j.toxicon.2016.09.011	60	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193105	10.1371/journal.pone.0193105	http://dx.doi.org/10.1371/journal.pone.0193105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505564	Green Published, gold, Green Submitted			2022-12-27	WOS:000426548200004
J	dos Santos, FID; Marini, N; dos Santos, RS; Hoffman, BSF; Alves-Ferreira, M; de Oliveira, AC				de Castro dos Santos, Fabiane Igansi; Marini, Naciele; dos Santos, Railson Schreinert; Fernandes Hoffman, Bianca Silva; Alves-Ferreira, Marcio; de Oliveira, Antonio Costa			Selection and testing of reference genes for accurate RT-qPCR in rice seedlings under iron toxicity	PLOS ONE			English	Article							HOUSEKEEPING GENES; PCR NORMALIZATION; EXPRESSION; IDENTIFICATION	Reverse Transcription quantitative PCR ( RT-qPCR) is a technique for gene expression profiling with high sensibility and reproducibility. However, to obtain accurate results, it depends on data normalization by using endogenous reference genes whose expression is constitutive or invariable. Although the technique is widely used in plant stress analyzes, the stability of reference genes for iron toxicity in rice ( Oryza sativa L.) has not been thoroughly investigated. Here, we tested a set of candidate reference genes for use in rice under this stressful condition. The test was performed using four distinct methods: NormFinder, BestKeeper, geNorm and the comparative Delta Ct. To achieve reproducible and reliable results, Minimum Information for Publication of Quantitative Real-Time PCR Experiments ( MIQE) guidelines were followed. Valid reference genes were found for shoot ( P2, OsGAPDH and OsNABP), root ( OsEF-1a, P8 and OsGAPDH) and root+shoot ( OsNABP, OsGAPDH and P8) enabling us to perform further reliable studies for iron toxicity in both indica and japonica subspecies. The importance of the study of other than the traditional endogenous genes for use as normalizers is also shown here.	[de Castro dos Santos, Fabiane Igansi; dos Santos, Railson Schreinert; Fernandes Hoffman, Bianca Silva; de Oliveira, Antonio Costa] Univ Fed Pelotas, Plant Genom & Breeding Ctr, Capao Do Leao, Brazil; [Marini, Naciele] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Alves-Ferreira, Marcio] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil	Universidade Federal de Pelotas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Rio de Janeiro	de Oliveira, AC (corresponding author), Univ Fed Pelotas, Plant Genom & Breeding Ctr, Capao Do Leao, Brazil.	acostol@cgfufpel.org	Oliveira, Antonio/K-5923-2019; Costa de Oliveira, Antonio/GWZ-3969-2022; Alves-Ferreira, Marcio/C-5849-2009	Oliveira, Antonio/0000-0001-8835-8071; Alves-Ferreira, Marcio/0000-0002-6107-3700	CNPq; CAPES; FAPERGS	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	Grants and fellowships were received from CNPq, CAPES and FAPERGS, all to ACdO.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/J.JMB.2010.08.039; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; da Silveira VC, BRAZILIAN J PLANT PH; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; dos Santos RS, 2017, GENET MOL BIOL, V40, P312, DOI [10.1590/1678-4685-gmb-2016-0036, 10.1590/1678-4685-GMB-2016-0036]; dos Santos RS, 2013, TROP PLANT BIOL, V6, P16, DOI 10.1007/s12042-013-9117-1; Finatto T, 2015, RICE, V8, DOI 10.1186/s12284-015-0045-6; Gomez, 1972, LAB MANUAL PHYSL STU; Guo JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07042; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kobayashi T, 2014, RICE, V7, DOI 10.1186/s12284-014-0027-0; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Liu F, 2016, REV BRAS FARMACOGN, V26, P564, DOI 10.1016/j.bjp.2016.05.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pabuayon IM, 2016, RICE, V9, P1, DOI 10.1186/s12284-016-0104-7; Petriccione M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16961; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rydbirk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37116; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha P, 2016, FRONT PLANT SCI, V6, DOI [10.3389/fpls.2015.01065, 10.3389/fpls.2015.01071]; Sperotto RA, 2007, PLANT CELL REP, V26, P1399, DOI 10.1007/s00299-007-0330-y; Storch TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120599; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WANG D, 2008, BIOMED CENTRAL, V9, DOI DOI 10.1186/1471-2164-9-44; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhou L, 2016, J AM SOC HORTIC SCI, V141, P99, DOI 10.21273/JASHS.141.2.99; Zimmermann P, 2008, MOL PLANT, V1, P851, DOI 10.1093/mp/ssn048	39	12	12	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193418	10.1371/journal.pone.0193418	http://dx.doi.org/10.1371/journal.pone.0193418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494624	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200046
J	Javeed, S; Alimgeer, KS; Javed, W; Atif, M; Uddin, M				Javeed, Shumaila; Alimgeer, Khurram Saleem; Javed, Wajahat; Atif, M.; Uddin, Mueen			A modified artificial neural network based prediction technique for tropospheric radio refractivity	PLOS ONE			English	Article							INDEX; TEMPERATURE; EXTRACTION; MOISTURE; NIGERIA	Radio refractivity plays a significant role in the development and design of radio systems for attaining the best level of performance. Refractivity in the troposphere is one of the features affecting electromagnetic waves, and hence the communication system interrupts. In this work, a modified artificial neural network (ANN) based model is applied to predict the refractivity. The suggested ANN model comprises three modules: the data preparation module, the feature selection module, and the forecast module. The first module applies pre-processing to make the data compatible for the feature selection module. The second module discards irrelevant and redundant data from the input set. The third module uses ANN for prediction. The ANN model applies a sigmoid activation function and a multi-variate auto regressive model to update the weights during the training process. In this work, the refractivity is predicted and estimated based on ten years (2002-2011) of meteorological data, such as the temperature, pressure, and humidity, obtained from the Pakistan Meteorological Department (PMD), Islamabad. The refractivity is estimated using the method suggested by the International Telecommunication Union (ITU). The refractivity is predicted for the year 2012 using the database of the previous ten years, with the help of ANN. The ANN model is implemented in MATLAB. Next, the estimated and predicted refractivity levels are validated against each other. The predicted and actual values (PMD data) of the atmospheric parameters agree with each other well, and demonstrate the accuracy of the proposed ANN method. It was further found that all parameters have a strong relationship with refractivity, in particular the temperature and humidity. The refractivity values are higher during the rainy season owing to a strong association with the relative humidity. Therefore, it is important to properly cater the signal communication system during hot and humid weather. Based on the results, the proposed ANN method can be used to develop a refractivity database, which is highly important in a radio communication system.	[Javeed, Shumaila] COMSATS Inst Informat Technol, Dept Math, Pk Rd, Islamabad, Pakistan; [Alimgeer, Khurram Saleem; Javed, Wajahat] COMSATS Inst Informat Technol, Dept Elect Engn, Pk Rd, Islamabad, Pakistan; [Atif, M.] King Saud Univ, Coll Sci, Dept Phys & Astron, Riyadh, Saudi Arabia; [Uddin, Mueen] Effat Univ, Fac Engn, Dept Informat Syst, Jeddah, Saudi Arabia	COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI); King Saud University; Effat University	Alimgeer, KS (corresponding author), COMSATS Inst Informat Technol, Dept Elect Engn, Pk Rd, Islamabad, Pakistan.	saleem.khurram@gmail.com	Saleem, Khurram/N-9547-2019; Alimgeer, Khurram S/AGW-9805-2022; Alimgeer, Khurram S/F-4911-2011; Atif, Muhammad/C-4789-2013; Uddin, Mueen/C-8588-2011; Atif, Muhammad/Z-5682-2019	Alimgeer, Khurram S/0000-0001-5732-2463; Atif, Muhammad/0000-0002-7356-4275; Uddin, Mueen/0000-0003-1919-3407; Atif, Muhammad/0000-0002-7356-4275	King Saud University [RGP-VPP-293]	King Saud University(King Saud University)	The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project No. RGP-VPP-293. The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project No. RGP-VPP-293.	Adediji TA, 2008, PROGR ELECTROMAGNE C, V4, P157; Agbo GA, 2012, J BASIC PHYS RES, V3, P24; Ahmad A, 2015, APPL SCI-BASEL, V5, P1756, DOI 10.3390/app5041756; Ali S, 2012, J ATMOS SOL-TERR PHY, V77, P96, DOI 10.1016/j.jastp.2011.12.001; Amjady N, 2009, IEEE T POWER SYST, V24, P306, DOI 10.1109/TPWRS.2008.2006997; Anderson CW, 1998, IEEE T BIO-MED ENG, V45, P277, DOI 10.1109/10.661153; [Anonymous], 2007, COMPUTATIONAL INTELL, DOI DOI 10.1002/9780470512517; Balaji SA, 2013, INT J COMPUTER SCI E, V3; Bishop CM., 1995, NEURAL NETWORKS PATT; Bogucki J., 2009, J TELECOMMUNICATIONS, P48; Pra ALD, 2015, INT J COMPUT INT SYS, V8, P28, DOI 10.1080/18756891.2015.1129589; Falodun SE, 2006, J ATMOS SOL-TERR PHY, V68, P236, DOI 10.1016/j.jastp.2005.10.002; Famorji J.O., 2013, RES DESK, V2, P334; Freeman R., 2007, RADIO SYSTEM DESIGN; Gao JD, 2008, ADV ATMOS SCI, V25, P1098, DOI 10.1007/s00376-008-1098-x; Grabner M, 2003, RADIOENGINEERING, V12, P5; Guo GJ, 2000, INT J INFRARED MILLI, V21, P1103, DOI 10.1023/A:1026452522574; Ibeh GF, 2012, GLOBAL J SCI FRONTIE, V12, P1; IHARA T, 1994, IEICE T COMMUN, VE77B, P1275; ITU-R, 2003, EFF TEMP VAR REFR RA, P131; Maitham A, 2003, ARAB J SCI ENG, V28, P3; Minsky M., 1969, CAMB TIASS HIT, V479, P480; Nel J. W., 1988, COMM SIGN PROC P COM; Okoro ON, 2016, GLOBAL J SCI FRONTIE, V12; Palade V, 2001, LECT NOTES COMPUT SC, V2206, P152; Priestley J. T., 1985, Journal of Atmospheric and Oceanic Technology, V2, P233, DOI 10.1175/1520-0426(1985)002<0233:MHFHTA>2.0.CO;2; Smith B.A., 2007, INT J COMPUTATIONAL, V3, P179; Tamo siunaite M, 2015, ELEKTRON ELEKTROTECH, V105, P9; Tom G., 2006, AMSELIETS06015; Valma E, 2015, ELEKTRON ELEKTROTECH, V106, P125; Willoughby AA, 2002, J ATMOS SOL-TERR PHY, V64, P417, DOI 10.1016/S1364-6826(01)00111-0; Zheng J, 2015, ADV ATMOS SCI, V32, P319, DOI 10.1007/s00376-014-3162-z; Zurada-Introduction to Artificial Neural Systems, 1992, INTRO ARTIFICIAL NEU	34	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192069	10.1371/journal.pone.0192069	http://dx.doi.org/10.1371/journal.pone.0192069			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494609	gold, Green Submitted, Green Published			2022-12-27	WOS:000426363200010
J	Newberg, LA; Chen, XW; Kodira, CD; Zavodszky, MI				Newberg, Lee A.; Chen, Xiaowei; Kodira, Chinnappa D.; Zavodszky, Maria I.			Computational de novo discovery of distinguishing genes for biological processes and cell types in complex tissues	PLOS ONE			English	Article							HUMAN BRAIN; EXPRESSION DECONVOLUTION; TRANSCRIPTOME; DATABASE; ATLAS; LISTS	Bulk tissue samples examined by gene expression studies are usually heterogeneous. The data gained from these samples display the confounding patterns of mixtures consisting of multiple cell types or similar cell types in various functional states, which hinders the elucidation of the molecular mechanisms underlying complex biological phenomena. A realistic approach to compensate for the limitations of experimentally separating homogenous cell populations from mixed tissues is to computationally identify cell-type specific patterns from bulk, heterogeneous measurements. We designed the CellDistinguisher algorithm to analyze the gene expression data of mixed samples, identifying genes that best distinguish biological processes and cell types. Coupled with a deconvolution algorithm that takes cell type specific gene lists as input, we show that CellDistinguisher performs as well as partial deconvolution algorithms in predicting cell type composition without the need for prior knowledge of cell type signatures. This approach is also better in predicting cell type signatures than the one-step traditional complete deconvolution methods. To illustrate its wide applicability, the algorithm was tested on multiple publicly available data sets. In each case, CellDistinguisher identified genes reflecting biological processes typical for the tissues and development stages of interest and estimated the sample compositions accurately.	[Newberg, Lee A.; Chen, Xiaowei; Kodira, Chinnappa D.; Zavodszky, Maria I.] Gen Elect Global Res Ctr, Biosci, Niskayuna, NY 12309 USA; [Newberg, Lee A.] SGS Testcom, Malta, NY USA; [Chen, Xiaowei] Amazon Com Inc, Seattle, WA USA	General Electric; Amazon.com	Zavodszky, MI (corresponding author), Gen Elect Global Res Ctr, Biosci, Niskayuna, NY 12309 USA.	zavodszm@ge.com			GE Global Research, the research and development division of General Electric company	GE Global Research, the research and development division of General Electric company	GE Global Research, the research and development division of General Electric company, funded the development of this work and approved of the decision to publish. The funder provided support in the form of salaries for authors LAN, XC, CDK and MIZ. The study design, data collection and analysis, and preparation of the manuscript was that of the authors. The specific roles of these authors are articulated in the 'author contributions' section.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Aran D, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1036-7; ARORA S., 2013, P 30 INT C MACH LEAR; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Frishberg A, 2016, BIOINFORMATICS, V32, P3842, DOI 10.1093/bioinformatics/btw535; Gaujoux R, CELLMIX 2013; Gaujoux R, 2013, BIOINFORMATICS, V29, P2211, DOI 10.1093/bioinformatics/btt351; Gaujoux R, 2012, INFECT GENET EVOL, V12, P913, DOI 10.1016/j.meegid.2011.08.014; Gong T, 2013, BIOINFORMATICS, V29, P1083, DOI 10.1093/bioinformatics/btt090; Gong T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027156; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Inkeles MS, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88843; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Repsilber D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-27; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Teschendorff AE, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1511-5; Wang NY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18909	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193067	10.1371/journal.pone.0193067	http://dx.doi.org/10.1371/journal.pone.0193067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494600	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200020
J	Tajparast, M; Frigon, D				Tajparast, Mohammad; Frigon, Dominic			Predicting the accumulation of storage compounds by Rhodococcus jostii RHA1 in the feast-famine growth cycles using genome-scale flux balance analysis	PLOS ONE			English	Article							ESCHERICHIA-COLI; METABOLIC NETWORKS; SYSTEMS; MODELS; LIPIDS	Feast-famine cycles in biological wastewater resource recovery systems select for bacterial species that accumulate intracellular storage compounds such as poly-beta-hydroxybutyrate (PHB), glycogen, and triacylglycerols (TAG). These species survive better the famine phase and resume rapid substrate uptake at the beginning of the feast phase faster than microorganisms unable to accumulate storage. However, ecophysiological conditions favouring the accumulation of either storage compounds remain to be clarified, and predictive capabilities need to be developed to eventually rationally design reactors producing these compounds. Using a genome-scale metabolic modelling approach, the storage metabolism of Rhodococcus jostii RHA1 was investigated for steady-state feast-famine cycles on glucose and acetate as the sole carbon sources. R. jostii RHA1 is capable of accumulating the three storage compounds (PHB, TAG, and glycogen) simultaneously. According to the experimental observations, when glucose was the substrate, feast phase chemical oxygen demand (COD) accumulation was similar for the three storage compounds; when acetate was the substrate, however, PHB accumulation was 3 times higher than TAG accumulation and essentially no glycogen was accumulated. These results were simulated using the genomescale metabolic model of R. jostii RHA1 (iMT1174) by means of flux balance analysis (FBA) to determine the objective functions capable of predicting these behaviours. Maximization of the growth rate was set as the main objective function, while minimization of total reaction fluxes and minimization of metabolic adjustment (environmental MOMA) were considered as the sub-objective functions. The environmental MOMA sub-objective performed better than the minimization of total reaction fluxes sub-objective function at predicting the mixture of storage compounds accumulated. Additional experiments with C-13-labelled bicarbonate (HCO3-) found that the fluxes through the central metabolism reactions during the feast phases were similar to the ones during the famine phases on acetate due to similarity in the carbon sources in the feast and famine phases (i.e., acetate and poly-beta-hydroxybutyrate, respectively); this suggests that the environmental MOMA sub-objective function could be used to analyze successive environmental conditions such as the feast and famine cycles while the metabolically similar carbon sources are taken up by microorganisms.	[Tajparast, Mohammad; Frigon, Dominic] McGill Univ, Dept Civil Engn & Appl Mech, Microbial Community Engn Lab, Montreal, PQ, Canada	McGill University	Frigon, D (corresponding author), McGill Univ, Dept Civil Engn & Appl Mech, Microbial Community Engn Lab, Montreal, PQ, Canada.	dominic.frigon@mcgill.ca	Frigon, Dominic/P-7898-2018	Frigon, Dominic/0000-0003-1587-8943	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 341393-11]; McGill Engineering Doctoral Award (MEDA); Canada Foundation of Innovation; Dr. John R. and Clara M. Fraser Memorial Trust; Terry Fox Foundation (TFF Oncometabolism Team) [116128]; McGill University	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); McGill Engineering Doctoral Award (MEDA); Canada Foundation of Innovation(Canada Foundation for Innovation); Dr. John R. and Clara M. Fraser Memorial Trust; Terry Fox Foundation (TFF Oncometabolism Team); McGill University	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant awarded to DF (RGPIN 341393-11). MT is grateful to the McGill Engineering Doctoral Award (MEDA) for the financial support of his Ph.D. study. Labelled amino acid measurements were performed at the Rosalind and Morris Goodman Cancer Research Centre Metabolomics Core Facility supported by the Canada Foundation of Innovation, The Dr. John R. and Clara M. Fraser Memorial Trust, the Terry Fox Foundation (TFF Oncometabolism Team Grant 116128), and McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez HM, 2000, APPL MICROBIOL BIOT, V54, P218, DOI 10.1007/s002530050012; Alvarez HM, 1997, FETT-LIPID, V99, P239, DOI 10.1002/lipi.19970990704; Atlas RM., 1998, MICROBIAL ECOLOGY FU, V4; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; Beun JJ, 2000, BIOTECHNOL BIOENG, V67, P379, DOI 10.1002/(SICI)1097-0290(20000220)67:4<379::AID-BIT1>3.0.CO;2-2; Dawes E A, 1973, Adv Microb Physiol, V10, P135, DOI 10.1016/S0065-2911(08)60088-0; Eaton A. D., 1998, STANDARD METHODS EXA; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Frigon D, 2006, APPL ENVIRON MICROB, V72, P2322, DOI 10.1128/AEM.72.4.2322-2330.2006; Frigon D., 2005, PROPOSED MECH EXPLAI; Goodfellow M, 1998, ANTON LEEUW INT J G, V74, P3, DOI 10.1023/A:1001730725003; Hernandez MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-600; Holzhutter HG, 2004, EUR J BIOCHEM, V271, P2905, DOI 10.1111/j.1432-1033.2004.04213.x; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Knorr AL, 2007, BIOINFORMATICS, V23, P351, DOI 10.1093/bioinformatics/btl619; Larkin MJ, 2005, CURR OPIN BIOTECH, V16, P282, DOI 10.1016/j.copbio.2005.04.007; LAW JH, 1961, J BACTERIOL, V82, P33, DOI 10.1128/JB.82.1.33-36.1961; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Maurer M, 1997, WATER RES, V31, P907, DOI 10.1016/S0043-1354(96)00369-7; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Moralejo-Garate H, 2013, BIOTECHNOL BIOENG, V110, P3148, DOI 10.1002/bit.24991; Mori M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004913; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Paganelli FL, 2011, WORLD J MICROB BIOT, V27, P773, DOI 10.1007/s11274-010-0515-3; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Poskar CH, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-295; Quek LE, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-25; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Rhine ED, 1998, SOIL SCI SOC AM J, V62, P473, DOI 10.2136/sssaj1998.03615995006200020026x; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Tajparast M, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0190-y; van Oosterwijk N, 2011, ACTA CRYSTALLOGR F, V67, P1269, DOI 10.1107/S1744309111028727; VANDERHEIJDEN RTJM, 1994, BIOTECHNOL BIOENG, V43, P11, DOI 10.1002/bit.260430104; vanLoosdrecht MCM, 1997, WATER SCI TECHNOL, V35, P41, DOI 10.1016/S0273-1223(96)00877-3; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957	39	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0191835	10.1371/journal.pone.0191835	http://dx.doi.org/10.1371/journal.pone.0191835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494607	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200006
J	Desai, RJ; Franklin, JM; Spoendlin-Allen, J; Solomon, DH; Danaei, G; Kim, SC				Desai, Rishi J.; Franklin, Jessica M.; Spoendlin-Allen, Julia; Solomon, Daniel H.; Danaei, Goodarz; Kim, Seoyoung C.			An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; MEDICARE CLAIMS; NATIONAL-HEALTH; DISEASE; HYPERURICEMIA; PREVALENCE; MANAGEMENT; METAANALYSIS; ALLOPURINOL; INHIBITORS	Objective Gout patients have a high burden of co-morbid conditions including diabetes mellitus (DM), chronic kidney disease (CKD), and cardiovascular disease (CVD). We sought to evaluate the association between changes in serum uric acid (SUA) levels over time and the risk of incident DM, CVD, and renal function decline in gout patients. Methods An observational cohort study was conducted among enrollees of private health insurance programs in the US between 2004 and 2015. Gout patients were included on the index date of a SUA measurement >= 6.8 mg/dl. The exposure of interest was cumulative change in SUA levels from baseline. Hazard ratios (HR) and 95% confidence intervals (CI) for incident DM, incident CVD, and renal function decline (>= 30% reduction in glomerular filtration rate) were derived using marginal structural models with stabilized inverse probability weights accounting for baseline confounders (age, gender, co-morbidities, co-medications) and time-varying confounders (serum creatinine, blood urea nitrogen, glycated hemoglobin). Results Among 26,341 patients with gout, the average age was 62, 75% were men, and the median baseline SUA was 8.6 mg/dl (interquartile range 7.7 to 9.5). The incidence rates/100 person-years (95% CI) were 1.63 (1.51-1.75) for DM, 0.77 (0.70-0.84) for CVD, and 4.32 (4.14-4.49) for renal function decline. The adjusted HR (95% CI) per 3 mg/dl reduction in SUA, corresponding on average to achieving the target level of <6 mg/dl in this population, was 1.04 (0.92-1.17) for DM, 1.07 (0.89-1.29) for CVD, and 0.85 (0.78-0.92) for renal function decline. Conclusions Reduction in SUA in patients with gout may be associated with a reduced risk of renal function decline, but not with DM or CVD.	[Desai, Rishi J.; Franklin, Jessica M.; Spoendlin-Allen, Julia; Solomon, Daniel H.; Kim, Seoyoung C.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Desai, Rishi J.; Franklin, Jessica M.; Spoendlin-Allen, Julia; Solomon, Daniel H.; Kim, Seoyoung C.] Harvard Med Sch, Boston, MA 02115 USA; [Solomon, Daniel H.; Kim, Seoyoung C.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA USA; [Danaei, Goodarz] Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Desai, RJ (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.; Desai, RJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	rdesai@bwh.harvard.edu	Desai, Rishi/AAH-8988-2021; Danaei, Goodarz/B-6085-2008	Kim, Seoyoung/0000-0002-2517-3579; Franklin, Jessica/0000-0002-8941-4116	National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS- R21 AR069271]; Merck; AstraZeneca; Lilly; Pfizer; Bristol-Myers Squibb; Genentech; Amgen; CORRONA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR069271] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Merck(Merck & Company); AstraZeneca(AstraZeneca); Lilly(Eli Lilly); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Genentech(Roche HoldingGenentech); Amgen(Amgen); CORRONA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS- R21 AR069271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS- R21 AR069271).; Drs. Desai & Franklin have received unrestricted research grants from Merck. Dr. Kim has received unrestricted research grants from AstraZeneca, Lilly, Pfizer, Bristol-Myers Squibb, and Genentech. Dr. Solomon receives salary support through research support to his hospital from Amgen, Pfizer, AstraZeneca, Genentech, and CORRONA. Other authors declare no conflicts.	Alderman M, 2004, CURR MED RES OPIN, V20, P369, DOI 10.1185/030079904125002982; Annemans L, 2008, ANN RHEUM DIS, V67, P960, DOI 10.1136/ard.2007.076232; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P109, DOI 10.1002/art.22466; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Hernan M, 2017, CAUSAL INFE IN PRESS; Hernan MA, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.82; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Keenan T, 2016, J AM COLL CARDIOL, V67, P407, DOI 10.1016/j.jacc.2015.10.086; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Kim SC, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.01.013; Kim SC, 2014, ARTHRITIS RHEUMATOL, V66, pS19; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kleber ME, 2015, J AM SOC NEPHROL, V26, P2831, DOI 10.1681/ASN.2014070660; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kok VC, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-108; Krishnan E, 2013, QJM-INT J MED, V106, P721, DOI 10.1093/qjmed/hct093; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Kuo CF, 2013, RHEUMATOLOGY, V52, P127, DOI 10.1093/rheumatology/kes223; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levy GD, 2014, J RHEUMATOL, V41, P955, DOI 10.3899/jrheum.131159; Lottmann K, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-011-0234-2; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104519; Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Robinson P, 2012, INTERN MED J; Roughley MJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0610-9; Singh JA, 2015, GOUT GOES HEART DOES; Singh JA, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0513-6; Singh JA, 2017, ANN RHEUM DIS, V76, P133, DOI 10.1136/annrheumdis-2015-209046; Singh JA, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1111-1; Singh JA, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0692-2; Trifiro G, 2012, ANN RHEUM DIS; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	39	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193622	10.1371/journal.pone.0193622	http://dx.doi.org/10.1371/journal.pone.0193622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489919	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000096
J	Flockhart, DTT; Coe, JB				Flockhart, D. T. Tyler; Coe, Jason B.			Multistate matrix population model to assess the contributions and impacts on population abundance of domestic cats in urban areas including owned cats, unowned cats, and cats in shelters	PLOS ONE			English	Article							TRAP-NEUTER-RETURN; FREE-ROAMING CATS; FERAL CATS; ANIMAL SHELTERS; FELIS-CATUS; SENSITIVITY-ANALYSIS; MANAGEMENT; EUTHANASIA; PROGRAMS; SURVIVAL	Concerns over cat homelessness, over-taxed animal shelters, public health risks, and environmental impacts has raised attention on urban-cat populations. To truly understand cat population dynamics, the collective population of owned cats, unowned cats, and cats in the shelter system must be considered simultaneously because each subpopulation contributes differently to the overall population of cats in a community (e.g., differences in neuter rates, differences in impacts on wildlife) and cats move among categories through human interventions (e.g., adoption, abandonment). To assess this complex socio-ecological system, we developed a multistate matrix model of cats in urban areas that include owned cats, unowned cats (free-roaming and feral), and cats that move through the shelter system. Our model requires three inputs-location, number of human dwellings, and urban area-to provide testable predictions of cat abundance for any city in North America. Model-predicted population size of unowned cats in seven Canadian cities were not significantly different than published estimates (p = 0.23). Model-predicted proportions of sterile feral cats did not match observed sterile cat proportions for six USA cities (p = 0.001). Using a case study from Guelph, Ontario, Canada, we compared model-predicted to empirical estimates of cat abundance in each subpopulation and used perturbation analysis to calculate relative sensitivity of vital rates to cat abundance to demonstrate how management or mismanagement in one portion of the population could have repercussions across all portions of the network. Our study provides a general framework to consider cat population abundance in urban areas and, with refinement that includes city-specific parameter estimates and modeling, could provide a better understanding of population dynamics of cats in our communities.	[Flockhart, D. T. Tyler; Coe, Jason B.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada; [Flockhart, D. T. Tyler] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Flockhart, D. T. Tyler] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 20742 USA	University of Guelph; University of Guelph; University System of Maryland; University of Maryland Center for Environmental Science	Flockhart, DTT (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada.; Flockhart, DTT (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada.; Flockhart, DTT (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD 20742 USA.	tyler.flockhart@umces.edu	Flockhart, D. T. Tyler/J-5374-2014	Flockhart, D. T. Tyler/0000-0002-5832-8610	Nestle A Purina PetCare Canada Chair in Communications; Nestle Purina PetCare Canada Chair in Communications	Nestle A Purina PetCare Canada Chair in Communications(Nestle SA); Nestle Purina PetCare Canada Chair in Communications(Nestle SA)	Funding support for this project was provided from the Nestle A Purina PetCare Canada Chair in Communications. We appreciate the assistance of the Guelph Cat Population Taskforce in supporting data collection and encouraging multi-stakeholder collaboration. We are also very grateful for the feedback provided on early drafts of the manuscript by Drs. A. Greer, J. Horrocks, and A. Willms. In addition, we appreciate comments and feedback by several anonymous reviewers and handling editor C. Lepczyk that have enhanced the manuscript.; Funding support for this project was provided by the Nestle Purina PetCare Canada Chair in Communications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MC, 2004, JAVMA-J AM VET MED A, V225, P1871, DOI 10.2460/javma.2004.225.1871; BAARS MA, 1979, OECOLOGIA, V41, P25, DOI 10.1007/BF00344835; Baker PJ, 2005, MAMMAL REV, V35, P302, DOI 10.1111/j.1365-2907.2005.00071.x; Barker SB, 2008, J VET MED EDUC, V35, P487, DOI 10.3138/jvme.35.4.487; Baxter PWJ, 2006, CONSERV BIOL, V20, P893, DOI 10.1111/j.1523-1739.2006.00378.x; Beck AM, 1996, ANNU REV PUBL HEALTH, V17, P247, DOI 10.1146/annurev.pu.17.050196.001335; Blancher P, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00557-080203; BRAULT S, 1993, ECOLOGY, V74, P1444, DOI 10.2307/1940073; Budke CM, 2009, J APPL ANIM WELF SCI, V12, P277, DOI 10.1080/10888700903163419; CALHOON RE, 1989, J ANIM ECOL, V58, P321, DOI 10.2307/5003; Canadian Federation of Humane Societies, 2012, CATS IN CAN; Canadian Federation of Humane Societies, 2015, AN SHELT STAT 2014; Carter TJ, 2012, MODELING DOMESTIC CA; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2007, ECOL LETT, V10, P1, DOI 10.1111/j.1461-0248.2006.01001.x; Caswell H, 2012, THEOR POPUL BIOL, V82, P329, DOI 10.1016/j.tpb.2012.03.008; Chu K, 2009, JAVMA-J AM VET MED A, V234, P1023, DOI 10.2460/javma.234.8.1023; Clancy EA, 2003, J AM VET MED ASSOC, V222, P1541, DOI 10.2460/javma.2003.222.1541; Curb LA, 2013, ANTHROZOOS, V26, P395, DOI 10.2752/175303713X13697429463673; Dabritz HA, 2006, JAVMA-J AM VET MED A, V229, P74, DOI 10.2460/javma.229.1.74; Danner RM, 2010, PAC SCI, V64, P381, DOI 10.2984/64.3.381; Devillard S, 2003, J ANIM ECOL, V72, P203, DOI 10.1046/j.1365-2656.2003.00692.x; Downes M, 2009, PREV VET MED, V92, P140, DOI 10.1016/j.prevetmed.2009.07.005; Finkler H, 2012, PREV VET MED, V104, P125, DOI 10.1016/j.prevetmed.2011.11.006; Flockhart DTT, 2016, ANIM CONSERV, V19, P472, DOI 10.1111/acv.12264; Flockhart T, PERCEPTIONS CO UNPUB; Gehrt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075718; Gerhold RW, 2013, ZOONOSES PUBLIC HLTH, V60, P189, DOI 10.1111/j.1863-2378.2012.01522.x; Gunther I, 2011, JAVMA-J AM VET MED A, V238, P1134, DOI 10.2460/javma.238.9.1134; Hall CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151962; Hunter CM, 2005, ECOL MODEL, V188, P15, DOI 10.1016/j.ecolmodel.2005.05.002; HURNI H, 1981, LAB ANIM, V15, P229, DOI 10.1258/002367781780893803; Ireland T, 2016, ECOL MODEL, V337, P123, DOI 10.1016/j.ecolmodel.2016.06.014; Janke N, 2017, EFFECT CAPACITY CARE; JEMMETT JE, 1977, J SMALL ANIM PRACT, V18, P31, DOI 10.1111/j.1748-5827.1977.tb05821.x; Kustritz MVR, 2006, THERIOGENOLOGY, V66, P145, DOI 10.1016/j.theriogenology.2006.03.018; Legge S, 2017, BIOL CONSERV, V206, P293, DOI 10.1016/j.biocon.2016.11.032; Lepczyk CA, 2010, CONSERV BIOL, V24, P627, DOI 10.1111/j.1523-1739.2009.01426.x; Levy JK, 2014, VET J, V201, P269, DOI 10.1016/j.tvjl.2014.05.001; Levy JK, 2004, JAVMA-J AM VET MED A, V225, P1354, DOI 10.2460/javma.2004.225.1354; Levy JK, 2011, THERIOGENOLOGY, V76, P1517, DOI 10.1016/j.theriogenology.2011.06.022; Lohr CA, 2013, CONSERV BIOL, V27, P64, DOI 10.1111/j.1523-1739.2012.01935.x; Longcore T, 2009, CONSERV BIOL, V23, P887, DOI 10.1111/j.1523-1739.2009.01174.x; Lord LK, 2007, JAVMA-J AM VET MED A, V230, P217, DOI 10.2460/javma.230.2.217; Lord LK, 2009, JAVMA-J AM VET MED A, V235, P160, DOI 10.2460/javma.235.2.160; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loyd KAT, 2010, ECOL SOC, V15; MANNING AM, 1992, ANTHROZOOS, V5, P192, DOI 10.2752/089279392787011368; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; McCarthy RJ, 2013, JAVMA-J AM VET MED A, V243, P502, DOI 10.2460/javma.243.4.502; Miller PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113553; Morris KN, 2014, J APPL ANIM WELF SCI, V17, P59, DOI 10.1080/10888705.2014.856250; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; NASSAR R, 1982, AM J VET RES, V43, P167; New John C. Jr, 2004, Journal of Applied Animal Welfare Science, V7, P229, DOI 10.1207/s15327604jaws0704_1; Nowicki Stacy A, 2011, STANFORD J ANIMAL LA, V4, P97; Nutter FB, 2004, JAVMA-J AM VET MED A, V225, P1399, DOI 10.2460/javma.2004.225.1399; Peterson MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044616; Pichancourt JB, 2012, J APPL ECOL, V49, P52, DOI 10.1111/j.1365-2664.2011.02093.x; Roth G, 2016, METHODS ECOL EVOL, V7, P1438, DOI 10.1111/2041-210X.12622; Scarlett J, 2012, J APPL ANIM WELF SCI, V15, P53, DOI 10.1080/10888705.2012.624902; Schmidt P.M., 2007, Wildlife Biology in Practice, V3, P18, DOI 10.2461/wbp.2007.3.3; Schmidt PM, 2007, J WILDLIFE MANAGE, V71, P915, DOI 10.2193/2006-066; Schmidt PM, 2009, WILDLIFE RES, V36, P117, DOI 10.1071/WR08018; Scott KC, 2002, J AM VET MED ASSOC, V221, P1136, DOI 10.2460/javma.2002.221.1136; SCOTT PP, 1959, NATURE, V184, P2022, DOI 10.1038/1842022a0; Shyu E, 2013, ECOL APPL, V23, P1893, DOI 10.1890/12-1712.1; Sims V, 2008, DIVERS DISTRIB, V14, P387, DOI 10.1111/j.1472-4642.2007.00444.x; Slater MR, 2008, PREV VET MED, V85, P267, DOI 10.1016/j.prevetmed.2008.02.001; Statistics Canada, 2012, POP DWELL COUNT HIGH; Statistics Canada, 2012, POP CTR CART BOUND F; Stoskopf MK, 2004, JAVMA-J AM VET MED A, V225, P1361, DOI 10.2460/javma.2004.225.1361; Stott I, 2010, METHODS ECOL EVOL, V1, P242, DOI 10.1111/j.2041-210X.2010.00032.x; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; US Census Bureau, 2010, 2010 CENS URB AR BOU; US Census Bureau, 2010, 2010 CENS URB RUR TO; van Heezik Y, 2010, BIOL CONSERV, V143, P121, DOI 10.1016/j.biocon.2009.09.013; Wald DM, 2013, BIOL CONSERV, V167, P414, DOI 10.1016/j.biocon.2013.07.034; Wallace JL, 2006, J FELINE MED SURG, V8, P279, DOI 10.1016/j.jfms.2006.02.004; Weiss Emily, 2012, Animals (Basel), V2, P301, DOI 10.3390/ani2020301; Weiss Emily, 2012, Animals (Basel), V2, P144, DOI 10.3390/ani2020144; Wenstrup J, 1999, J Appl Anim Welf Sci, V2, P303, DOI 10.1207/s15327604jaws0204_5; White SC, 2010, J APPL ANIM WELF SCI, V13, P191, DOI 10.1080/10888700903579903; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380	84	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192139	10.1371/journal.pone.0192139	http://dx.doi.org/10.1371/journal.pone.0192139			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489854	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000018
J	Ruckert, A; Allen, LN; Ramirez, RA				Ruckert, Alice; Allen, L. Niel; Ramirez, Ricardo A.			Combinations of plant water-stress and neonicotinoids can lead to secondary outbreaks of Banks grass mite (Oligonychus pratensis Banks)	PLOS ONE			English	Article							2-SPOTTED SPIDER-MITE; TETRANYCHUS-URTICAE ACARI; DROUGHT STRESS; DIFFERENTIAL INDUCTION; SEED TREATMENTS; INSECTICIDES; TEMPERATURE; RESISTANCE; TOXICITY; PHYTOSEIIDAE	Spider mites, a cosmopolitan pest of agricultural and landscape plants, thrive under hot and dry conditions, which could become more frequent and extreme due to climate change. Recent work has shown that neonicotinoids, a widely used class of systemic insecticides that have come under scrutiny for non-target effects, can elevate spider mite populations. Both water-stress and neonicotinoids independently alter plant resistance against herbivores. Yet, the interaction between these two factors on spider mites is unclear, particularly for Banks grass mite (Oligonychus pratensis; BGM). We conducted a field study to examine the effects of water-stress (optimal irrigation = 100% estimated evapotranspiration (ET) replacement, water stress = 25% of the water provided to optimally irrigated plants) and neonicotinoid seed treatments (control, clothianidin, thiamethoxam) on resident mite populations in corn (Zea mays, hybrid KSC7112). Our field study was followed by a manipulative field cage study and a parallel greenhouse study, where we tested the effects of water stress and neonicotinoids on BGM and plant responses. We found that water-stress and clothianidin consistently increased BGM densities, while thiamethoxam-treated plants only had this effect when plants were mature. Water-stress and BGM herbivory had a greater effect on plant defenses than neonicotinoids alone, and the combination of BGM herbivory with the two abiotic factors increased the concentration of total soluble proteins. These results suggest that spider mite outbreaks by combinations of changes in plant defenses and protein concentration are triggered by water-stress and neonicotinoids, but the severity of the infestations varies depending on the insecticide active ingredient.	[Ruckert, Alice; Ramirez, Ricardo A.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Allen, L. Niel] Utah State Univ, Civil & Environm Engn Dept, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Ruckert, A (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	ruckert.alice@gmail.com	Ramirez, Ricardo/AAE-8394-2021		United States Department of Agriculture [2012-67013-19346]; National Institute of Food and Agriculture and Agriculture and Food Research Initiative	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture and Agriculture and Food Research Initiative	This work was supported by the United States Department of Agriculture (https://www.usda.gov/), grant number:2012-67013-19346; and by The National Institute of Food and Agriculture and Agriculture and Food Research Initiative (https://nifa.usda.gov/program/agriculture-and-food-research-initiative-afri). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 1983, RECENT ADV PHYTOCHEM; AVERY DJ, 1968, J HORTIC SCI BIOTECH, V43, P463, DOI 10.1080/00221589.1968.11514274; Barati R, 2015, EXP APPL ACAROL, V66, P481, DOI 10.1007/s10493-015-9910-7; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blasi EAR, 2015, INT J ACAROL, V41, P10, DOI 10.1080/01647954.2014.988643; Borichenko N., 1982, LOZRSKA NAUKA HORTIC, V19, P44; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY EA, 2002, BIOCH MOL BIOL PLANT, P1158; Brodbeck B., 1987, P347; Cakir R, 2004, FIELD CROP RES, V89, P1, DOI 10.1016/j.fcr.2004.01.005; Cambier V, 2000, PHYTOCHEMISTRY, V53, P223, DOI 10.1016/S0031-9422(99)00498-7; CHANDLER LD, 1979, ENVIRON ENTOMOL, V8, P196, DOI 10.1093/ee/8.2.196; Cipollini DF, 2000, J CHEM ECOL, V26, P1411, DOI 10.1023/A:1005540107957; CROFT BA, 1988, EXP APPL ACAROL, V4, P277, DOI 10.1007/BF01196191; dal Soglio FK, 1998, BIOL CONTROL, V12, P111, DOI 10.1006/bcon.1998.0623; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Elzen GW, 2001, J ECON ENTOMOL, V94, P55, DOI 10.1603/0022-0493-94.1.55; ENGLISHLOEB GM, 1990, ECOLOGY, V71, P1401, DOI 10.2307/1938277; Fazeli F, 2007, BIOL PLANTARUM, V51, P98, DOI 10.1007/s10535-007-0020-1; FERRO DN, 1979, ENVIRON ENTOMOL, V8, P701, DOI 10.1093/ee/8.4.701; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; Gerhards M, 2016, INT J APPL EARTH OBS, V53, P27, DOI 10.1016/j.jag.2016.08.004; Gonias E., 2006, P BELTW COTT C SAN A; Gonias ED, 2008, J PLANT GROWTH REGUL, V27, P77, DOI 10.1007/s00344-007-9033-4; Gouinguene SP, 2012, PLANT PHYSIOL, V129, P1296; Gutbrodt B, 2011, OIKOS, V120, P1732, DOI 10.1111/j.1600-0706.2011.19558.x; Jaleel CA, 2007, COLLOID SURFACE B, V60, P201, DOI 10.1016/j.colsurfb.2007.06.010; James DG, 2003, EXP APPL ACAROL, V31, P275, DOI 10.1023/B:APPA.0000010383.33351.2f; Khajehali J, 2011, PEST MANAG SCI, V67, P1424, DOI 10.1002/ps.2191; Kolodziej A., 1975, P 8 INT C PLANT PROT, P217; Krischik V.A., 1983, P463; Laurino D, 2011, B INSECTOL, V64, P107; Logan JA, 1983, COLORADO AGR EXP S S, V585S, P1; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Mohammadkhani N, 2008, TURK J BIOL, V32, P23; Mondel M., 2006, J LIFE EARTH SCI, V1, P43; Moran PJ, 1999, J PHYTOPATHOL, V147, P313, DOI 10.1046/j.1439-0434.1999.147005313.x; Moser SE, 2009, BIOL CONTROL, V51, P487, DOI 10.1016/j.biocontrol.2009.09.001; National oceanic and atmospheric administration, 2014, US SEAS DROUGHT OUTL; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; PERRING TM, 1984, ENVIRON ENTOMOL, V13, P338, DOI 10.1093/ee/13.2.338; Poletti M, 2007, BIOL CONTROL, V40, P30, DOI 10.1016/j.biocontrol.2006.09.001; PRICE JF, 1982, HORTSCIENCE, V17, P895; REYNOLDS S G, 1970, Journal of Hydrology (Amsterdam), V11, P258, DOI 10.1016/0022-1694(70)90066-1; Rhoades D.F., 1983, P155; Sanchez-Hernandez C, 2004, PHYSIOL PLANTARUM, V122, P254, DOI 10.1111/j.0031-9317.2004.00398.x; Smith JF, 2013, J ECON ENTOMOL, V106, P807, DOI 10.1603/EC10125; Stavrinides MC, 2010, ENVIRON ENTOMOL, V39, P1232, DOI 10.1603/EN09288; STIEFEL VL, 1992, J ECON ENTOMOL, V85, P2170, DOI 10.1093/jee/85.6.2170; STOUT MJ, 1994, J CHEM ECOL, V20, P2575, DOI 10.1007/BF02036193; SUMMERS F M, 1972, Acarologia (Paris), V14, P170; Szczepaniec Adrianna, 2013, Arboriculture & Urban Forestry, V39, P231; Szczepaniec A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062620; Szczepaniec A, 2013, EXP APPL ACAROL, V59, P307, DOI 10.1007/s10493-012-9614-1; Szczepaniec A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020018; Tomczyk A, 1985, SPIDER MITES THEIR A, V1A, P317; Ullah MS, 2016, EXP APPL ACAROL, V69, P453, DOI 10.1007/s10493-016-0053-2; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Walker WR., 1987, SURFACE IRRIGATION T, pxiii; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; WRENSCH DL, 1975, OECOLOGIA, V18, P259, DOI 10.1007/BF00345850; Ximenez-Embun MG, 2017, J INSECT PHYSIOL, V96, P73, DOI 10.1016/j.jinsphys.2016.10.015; Ximenez-Embun MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145275; Yu LX, 1998, J PLANT PHYSIOL, V153, P745, DOI 10.1016/S0176-1617(98)80230-7	67	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191536	10.1371/journal.pone.0191536	http://dx.doi.org/10.1371/journal.pone.0191536			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489819	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000008
J	Bleedorn, JA; Hornberger, TA; Goodman, CA; Hao, ZL; Sample, SJ; Amene, E; Markel, MD; Behan, M; Muir, P				Bleedorn, Jason A.; Hornberger, Troy A.; Goodman, Craig A.; Hao, Zhengling; Sample, Susannah J.; Amene, Ermias; Markel, Mark D.; Behan, Mary; Muir, Peter			Temporal mechanically-induced signaling events in bone and dorsal root ganglion neurons after in vivo bone loading	PLOS ONE			English	Article							FUNCTIONAL ADAPTATION; GENE-EXPRESSION; TRANSCRIPTION FACTORS; RAT ULNA; STRAIN; MECHANOTRANSDUCTION; PATHWAYS; OSTEOCYTES; CELLS; OSTEOBLASTS	Mechanical signals play an integral role in the regulation of bone mass and functional adaptation to bone loading. The osteocyte has long been considered the principle mechanosensory cell type in bone, although recent evidence suggests the sensory nervous system may play a role in mechanosensing. The specific signaling pathways responsible for functional adaptation of the skeleton through modeling and remodeling are not clearly defined. In vitro studies suggest involvement of intracellular signaling through mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt), and mammalian target of rapamycin (mTOR). However, anabolic signaling responses to bone loading using a whole animal in vivo model have not been studied in detail. Therefore, we examined mechanically-induced signaling events at five time points from 0 to 24 hours after loading using the rat in vivo ulna endloading model. Western blot analysis of bone for MAPK's, PI3K/Akt, and mTOR signaling, and quantitative reverse transcription polymerase chain reaction (qRT-PCR) to estimate gene expression of calcitonin gene-related protein alpha (CGRP-alpha), brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), c-jun, and c-fos in dorsal root ganglion (DRG) of the brachial intumescence were performed. There was a significant increase in signaling through MAPK's including extracellular signal-related kinase (ERK) and c-Jun N-terminal kinase (JNK) in loaded limbs at 15 minutes after mechanical loading. Ulna loading did not significantly influence expression of the genes of interest in DRG neurons. Bone signaling and DRG gene expression from the loaded and contralateral limbs was correlated (S-R>0.4 0, P<0.05). However, bone signaling did not correlate with expression of the genes of interest in DRG neurons. These results suggest that signaling through the MAPK pathway may be involved in load-induced bone formation in vivo. Further characterization of the molecular events involved in regulation of bone adaptation is needed to understand the timing and impact of loading events, and the contribution of the neuronal signaling to functional adaptation of bone.	[Bleedorn, Jason A.; Hao, Zhengling; Sample, Susannah J.; Markel, Mark D.; Muir, Peter] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Hornberger, Troy A.; Goodman, Craig A.; Behan, Mary] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI USA; [Goodman, Craig A.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic, Australia; [Goodman, Craig A.] Victoria Univ, Australian Inst Musculoskeletal Sci AIMSS, St Albans, Vic, Australia; [Amene, Ermias] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Victoria University; Victoria University; University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	peter.muir@wisc.edu	Bleedorn, Jason A/AAE-2115-2019; Muir, Peter/AAH-8057-2021	Bleedorn, Jason A/0000-0003-2987-7722; Muir, Peter/0000-0003-0028-6005; Goodman, Craig/0000-0002-5874-7743	Graduate School, University of Wisconsin-Madison; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [AR057347]	Graduate School, University of Wisconsin-Madison; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by a grant from the Graduate School, University of Wisconsin-Madison to PM; and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number AR057347 to TAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BUCKLEY MJ, 1988, BONE MINER, V4, P225; Burr D B, 1997, Exerc Sport Sci Rev, V25, P171; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2; Cowin SC, 1998, BONE, V22, p119S, DOI 10.1016/S8756-3282(98)00011-8; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; FROST HM, 1983, CLIN ORTHOP RELAT R, P286; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Goodman CA, 2015, BONE, V80, P24, DOI 10.1016/j.bone.2015.04.014; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Gross TS, 1997, J BONE MINER RES, V12, P982, DOI 10.1359/jbmr.1997.12.6.982; HILL EL, 1991, CELL TISSUE RES, V264, P469, DOI 10.1007/BF00319037; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Jessop HL, 2002, BONE, V31, P186, DOI 10.1016/S8756-3282(02)00797-4; Kelly NH, 2016, BONE, V86, P22, DOI 10.1016/j.bone.2016.02.007; Kotha SP, 2004, J BIOMECH, V37, P541, DOI 10.1016/j.jbiomech.2003.08.009; Kyono A, 2012, J BONE MINER METAB, V30, P19, DOI 10.1007/s00774-011-0288-2; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marenzana M, 2007, BONE, V41, P206, DOI 10.1016/j.bone.2007.04.184; McKenzie JA, 2011, BONE, V48, P250, DOI 10.1016/j.bone.2010.09.005; McNamara LM, 2009, ANAT REC, V292, P355, DOI 10.1002/ar.20869; Millie H-F., 2004, SCI STKE, V2004; Mosley JR, 1997, BONE, V20, P191, DOI 10.1016/S8756-3282(96)00385-7; Muir P, 1999, BONE, V25, P571, DOI 10.1016/S8756-3282(99)00205-7; Niziolek PJ, 2009, J CELL PHYSIOL, V221, P579, DOI 10.1002/jcp.21887; NUNAMAKER DM, 1990, J ORTHOPAED RES, V8, P604, DOI 10.1002/jor.1100080417; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; PALUMBO C, 1986, CELL TISSUE RES, V246, P125; Papachristou D, 2006, EUR J ORTHODONT, V28, P20, DOI 10.1093/ejo/cji101; Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Rapanelli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008656; Riddle RC, 2009, J ORTHOP RES, V27, P143, DOI 10.1002/jor.20723; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Robling AG, 2009, CRIT REV EUKAR GENE, V19, P319, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.50; RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Sample SJ, 2008, J BONE MINER RES, V23, P1372, DOI [10.1359/jbmr.080407, 10.1359/JBMR.080407]; Sample SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113959; Sample SJ, 2010, J BONE MINER RES, V25, P2016, DOI 10.1002/jbmr.101; Saxon LK, 2005, BONE, V36, P454, DOI 10.1016/j.bone.2004.12.001; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Schriefer JL, 2005, J BIOMECH, V38, P1838, DOI 10.1016/j.jbiomech.2004.08.017; Spencer GJ, 2004, FEBS LETT, V559, P6, DOI 10.1016/S0014-5793(04)00053-5; Squillacioti C, 2009, EUR J HISTOCHEM, V53, P239, DOI 10.4081/ejh.2009.e29; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tomlinson RE, 2017, P NATL ACAD SCI USA, V114, pE3632, DOI 10.1073/pnas.1701054114; TORRANCE AG, 1994, CALCIFIED TISSUE INT, V54, P241, DOI 10.1007/BF00301686; Wadhwa S, 2002, J BONE MINER RES, V17, P266, DOI 10.1359/jbmr.2002.17.2.266; Warden SJ, 2005, J BONE MINER RES, V20, P809, DOI 10.1359/JBMR.041222; Wu Q, 2009, NEUROSCI LETT, V463, P254, DOI 10.1016/j.neulet.2009.07.078	59	0	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192760	10.1371/journal.pone.0192760	http://dx.doi.org/10.1371/journal.pone.0192760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486004	Green Published, Green Accepted, gold			2022-12-27	WOS:000426242400011
J	Wu, YM; Luna, MJ; Bonilla, LS; Ryba, NJP; Pickel, JM				Wu, Youmei; Luna, Maria Jose; Bonilla, Lauren S.; Ryba, Nicholas J. P.; Pickel, James M.			Characterization of knockin mice at the Rosa26, Tac1 and Plekhg1 loci generated by homologous recombination in oocytes	PLOS ONE			English	Article							RABIES VIRUS; WEB TOOL; GENOME; CRISPR/CAS9; EFFICIENCY; CHOPCHOP; SYSTEMS; SWEET; TASTE; RATS	Design and engineering of complex knockin mice has revolutionized the in vivo manipulation of genetically defined cells. Recently development of the bacterial clustered regularly interspersed short palindromic repeats (CRISPR) associated protein 9 (Cas9) system for single site cleavage of mammalian genomes has opened the way for rapid generation of knockin mice by targeting homology directed repair to selected cleavage sites. We used this approach to generate new lines of mice that will be useful for a variety of aspects of neuroscience research. These lines have been bred to homozygosity and details of the expression and function of the transgenes are reported. Two lines target the Rosa26-locus and have been engineered to allow Cre-dependent expression of the avian tva receptor, and Cre-dependent expression of a cell surface targeted spaghetti-monster carrying many copies of the "ollas-tag". Another line expresses red fluorescent protein and tva in Tacl-positive neurons; the fourth line targets FlpO expression to Plekhg1 expressing neurons, providing a powerful approach to modify gene expression in thalamic excitatory neurons.	[Wu, Youmei; Luna, Maria Jose; Bonilla, Lauren S.; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; [Pickel, James M.] NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Ryba, NJP (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.	nick.ryba@nih.gov	Core, Vector/CAF-4832-2022	Ryba, Nicholas/0000-0002-2060-8393; Bonilla, Lauren/0000-0002-9151-9603	National Institutes of Health, National Institute of Dental and Craniofacial Research [ZIA-DE000561]; National Institute of Mental Health [ZIA-MH002901]	National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Intramural program of the National Institutes of Health, National Institute of Dental and Craniofacial Research (N.J.P.R.) ZIA-DE000561 and the National Institute of Mental Health (J.M.P.) ZIA-MH002901. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Horii T, 2016, ENDOCR J, V63, P213, DOI 10.1507/endocrj.EJ15-0734; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaneko T, 2015, METHODS MOL BIOL, V1239, P307, DOI 10.1007/978-1-4939-1862-1_18; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Ma YW, 2016, RNA BIOL, V13, P605, DOI 10.1080/15476286.2016.1185591; Ma YW, 2014, FEBS J, V281, P3779, DOI 10.1111/febs.12935; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094; Peng YQ, 2015, NATURE, V527, P512, DOI 10.1038/nature15763; Reardon TR, 2016, NEURON, V89, P711, DOI 10.1016/j.neuron.2016.01.004; Sakuma T, 2017, METHODS MOL BIOL, V1630, P25, DOI 10.1007/978-1-4939-7128-2_2; Tan CL, 2016, CELL, V167, P47, DOI 10.1016/j.cell.2016.08.028; Viswanathan S, 2015, NAT METHODS, V12, P568, DOI 10.1038/nmeth.3365; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wu J, 2007, CELL MOL LIFE SCI, V64, P2933, DOI 10.1007/s00018-007-7206-8; Yang HY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/569325	27	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193129	10.1371/journal.pone.0193129	http://dx.doi.org/10.1371/journal.pone.0193129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485996	Green Submitted, gold, Green Published			2022-12-27	WOS:000426242400015
J	Cordoni, G; Norscia, I; Bobbio, M; Palagi, E				Cordoni, Giada; Norscia, Ivan; Bobbio, Maria; Palagi, Elisabetta			Differences in play can illuminate differences in affiliation: A comparative study on chimpanzees and gorillas	PLOS ONE			English	Article							CANIS-LUPUS-FAMILIARIS; KIBALE NATIONAL-PARK; SOCIAL PLAY; MOUNTAIN GORILLAS; WILD CHIMPANZEES; PAN-TROGLODYTES; SEX-DIFFERENCES; LIFE-HISTORY; TUMBLE PLAY; ADULT PLAY	Play behaviour reinforces social affiliation in several primate species, including humans. Via a comparative approach, we tested the hypothesis that play dynamics in a group of lowland gorillas (Gorilla gorilla gorilla) are different from those in a group of chimpanzees (Pan troglodytes) as a reflection of their difference in social affiliation and agonistic support. We selected one group of lowland gorillas and one of chimpanzees, hosted at the ZooParc de Beauval (France), managed in a similar way and living in similar enclosures. The same observers video-collected and analysed data on play behaviour in both groups, by applying identical methodological procedures. Data showed that adult play was less frequent in the group of gorillas compare to chimpanzees. Polyadic play, which involves more than two players and is characterised by the most uncertain outcome, was also less frequent in gorillas than chimpanzees. Play sessions were more unbalanced (more unidirectional patterns by one of the player towards the other) in chimpanzees than in gorillas but in the latter play escalated more frequently into serious aggression. Play asymmetry in the gorilla group increased as the number of players increased, which explains why gorillas limited their polyadic playful interactions. In conclusion, our findings on the study groups of apes can be a valuable starting point to expand the study of social play in the great apes to evaluate if inter-individual affiliative relationships really account for the differences in play distribution and dynamics.	[Cordoni, Giada; Norscia, Ivan; Bobbio, Maria; Palagi, Elisabetta] Univ Pisa, Museo Storia Nat, Pisa, Italy; [Norscia, Ivan] Univ Torino, Dept Life Sci & Syst Biol, Turin, Italy	University of Pisa; University of Turin	Palagi, E (corresponding author), Univ Pisa, Museo Storia Nat, Pisa, Italy.	elisabetta.palagi@unipi.it	Cordoni, Giada/ABE-2242-2020	Cordoni, Giada/0000-0001-7093-0025; Palagi, Elisabetta/0000-0002-2038-4596	Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Aldis O., 1975, PLAY FIGHTING; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2011, OXFORD HDB DEV PLAY; Antonacci D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013218; Arnold K, 2001, BEHAVIOUR, V138, P649, DOI 10.1163/156853901316924520; Aureli F, 1997, AM J PRIMATOL, V41, P213, DOI 10.1002/(SICI)1098-2345(1997)41:3<213::AID-AJP4>3.0.CO;2-#; Aureli F, 1997, J COMP PSYCHOL, V111, P91, DOI 10.1037/0735-7036.111.1.91; Baker Kate C., 1994, P227; Bauer EB, 2007, ANIM BEHAV, V73, P489, DOI 10.1016/j.anbehav.2006.09.006; Behncke I, 2015, CURR BIOL, V25, pR24, DOI 10.1016/j.cub.2014.11.020; Bekoff M, 2001, J CONSCIOUSNESS STUD, V8, P81; Berghanel A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500451; Biben M., 1998, ANIMAL PLAY EVOLUTIO, P161, DOI DOI 10.1017/CBO9780511608575.009; Breuer T, 2009, AM J PRIMATOL, V71, P106, DOI 10.1002/ajp.20628; BROWN SG, 1988, PRIMATES, V29, P219, DOI 10.1007/BF02381123; Burghardt GM, 2005, GENESIS OF ANIMAL PLAY: TESTING THE LIMITS, P1; Burnham K P, 2003, MODEL SELECT MULTIMO; Butovskaya M., MACAQUE SOC MODEL ST; Butovskaya ML, 1996, AM J PHYS ANTHROPOL, V101, P39; Caillaud D, 2008, AM J PHYS ANTHROPOL, V135, P379, DOI 10.1002/ajpa.20754; Caws C, 2003, INT J PRIMATOL, V24, P1077, DOI 10.1023/A:1026280329544; Ciani F, 2012, ANIM BEHAV, V84, P1313, DOI 10.1016/j.anbehav.2012.09.002; Clapham M, 2016, ACTA ETHOL, V19, P181, DOI 10.1007/s10211-016-0237-0; Clay AW, BEHAV PROC; Cordoni G, 2007, J COMP PSYCHOL, V121, P171, DOI 10.1037/0735-7036.121.2.171; Cordoni G, 2006, INT J PRIMATOL, V27, P1365, DOI 10.1007/s10764-006-9078-4; Cordoni G, 2016, BEHAVIOUR, V153, P749, DOI 10.1163/1568539X-00003326; Cordoni G, 2016, J COMP PSYCHOL, V130, P278, DOI 10.1037/com0000035; Cordoni G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027344; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; Demuru E, 2015, ANIM COGN, V18, P333, DOI 10.1007/s10071-014-0804-6; DEWAAL FBM, 1995, SCI AM, V272, P82, DOI 10.1038/scientificamerican0395-82; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; Doran Diane M., 2001, Cambridge Studies in Biological and Evolutionary Anthropology, V27, P123; Doran DM, 2002, AM J PRIMATOL, V58, P91, DOI 10.1002/ajp.10053; Dunbar RIM, 2009, ANN HUM BIOL, V36, P562, DOI 10.1080/03014460902960289; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; Fagen Robert, 1993, P182; FAY JM, 1995, J HUM EVOL, V29, P93, DOI 10.1006/jhev.1995.1048; FISCHER R B, 1978, Primates, V19, P657, DOI 10.1007/BF02373633; Frohlich M, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160278; Gatti S, 2004, AM J PRIMATOL, V63, P111, DOI 10.1002/ajp.20045; Gomes CM, 2009, P ROY SOC B-BIOL SCI, V276, P699, DOI 10.1098/rspb.2008.1324; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gruber T, 2016, EVOL ANTHROPOL, V25, P239, DOI 10.1002/evan.21501; Grueter CC, 2016, J MAMMAL, V97, P1663, DOI 10.1093/jmammal/gyw132; Grueter CC, 2016, BEHAV ECOL, V27, P766, DOI 10.1093/beheco/arv212; Harcourt A.H., 2007, GORILLA SOC CONFLICT; HAYAKI H, 1985, Primates, V26, P343, DOI 10.1007/BF02382452; Kalpers J, 2003, ORYX, V37, P326, DOI 10.1017/S0030605303000589; Kaufman AB, 2009, ANIM BEHAV, V78, P1487, DOI 10.1016/j.anbehav.2009.09.014; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koyama NF, 2006, INT J PRIMATOL, V27, P1293, DOI 10.1007/s10764-006-9074-8; Kurland JA, 1977, KIN SELECTION JAPANE; Kutsukake N, 2001, Anim Cogn, V4, P259, DOI 10.1007/s10071-001-0119-2; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; Lehmann J, 2009, ANIM BEHAV, V77, P377, DOI 10.1016/j.anbehav.2008.09.038; Llamazares-Martin C, 2017, ETHOLOGY, P123; Maestripieri D, 2004, AM J PHYS ANTHROPOL, V123, P52, DOI 10.1002/ajpa.10295; Mallavarapu S, 2006, AM J PRIMATOL, V68, P789, DOI 10.1002/ajp.20279; Mancini G, 2009, BEHAV PROCESS, V82, P286, DOI 10.1016/j.beproc.2009.07.007; Manly BFJ, 1997, RANDOMIZATION BOOTST; Maple T. L., 1982, GORILLA BEHAV; Masi S, 2009, AM J PRIMATOL, V71, P91, DOI 10.1002/ajp.20629; Matsusaka T, 2004, PRIMATES, V45, P221, DOI 10.1007/s10329-004-0090-z; MEDER A, 1989, DEV PSYCHOBIOL, V22, P357, DOI 10.1002/dev.420220404; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; Norscia I, 2011, PRIMATES, V52, P101, DOI 10.1007/s10329-010-0228-0; Nowell AA, 2008, BEHAVIOUR, V145, P171, DOI 10.1163/156853907783244747; Nowell AA, 2007, INT J PRIMATOL, V28, P441, DOI 10.1007/s10764-007-9128-6; Palagi E, 2008, ANIM BEHAV, V75, P887, DOI 10.1016/j.anbehav.2007.07.016; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P418, DOI 10.1002/ajpa.20289; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P105, DOI 10.1002/ajpa.20242; Palagi E, 1998, FOLIA PRIMATOL, V69, P28, DOI 10.1159/000021564; Palagi E, 2004, ETHOLOGY, V110, P949, DOI 10.1111/j.1439-0310.2004.01035.x; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Palagi E, 2002, INT J PRIMATOL, V23, P587, DOI 10.1023/A:1014973717945; Palagi E., 2007, J ANTHROPOL SCI, V85, P153; Palagi E, 2007, DEV PSYCHOBIOL, V49, P433, DOI 10.1002/dev.20219; Palagi E, 2006, INT J PRIMATOL, V27, P1257, DOI 10.1007/s10764-006-9071-y; Palagi E, 2016, BIOL REV, V91, P311, DOI 10.1111/brv.12172; Palagi E, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150505; Palagi E, 2014, AM J PRIMATOL, V76, P1074, DOI 10.1002/ajp.22294; Palagi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052767; PAQUETTE D, 1994, AGGRESSIVE BEHAV, V20, P49, DOI 10.1002/1098-2337(1994)20:1<49::AID-AB2480200107>3.0.CO;2-C; Pellegrini AD., 2009, ROLE PLAY HUMAN DEV, DOI [10.1093/acprof:oso/9780195367324.001.0001, DOI 10.1093/ACPROF:OSO/9780195367324.001.0001]; Pellegrini AD, 2007, DEV REV, V27, P261, DOI 10.1016/j.dr.2006.09.001; Pellis S. M., 2009, PLAYFUL BRAIN VENTUR; Pellis SM, 2007, CURR DIR PSYCHOL SCI, V16, P95, DOI 10.1111/j.1467-8721.2007.00483.x; Pellis SM, 2010, AM J PLAY, V2, P278; Pellis SM, 2002, ARCH SEX BEHAV, V31, P17, DOI 10.1023/A:1014070916047; Pellis SM, 1998, NEUROSCI BIOBEHAV R, V23, P87, DOI 10.1016/S0149-7634(97)00071-7; Pellis SM, 2000, ETHOLOGY, V106, P1083, DOI 10.1046/j.1439-0310.2000.00627.x; Preuschoft S., 1997, NONVERBAL COMMUNICAT, P171; Proctor DP, 2011, AM J PRIMATOL, V73, P989, DOI 10.1002/ajp.20964; Pusey AE, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0077; Reinhart C.J., 2010, INT J COMP PSYCHOL, V23, P166; Robbins MM, 2009, BIOL CONSERV, V142, P2886, DOI 10.1016/j.biocon.2009.07.010; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Shimada M, 2013, PRIMATES, V54, P245, DOI 10.1007/s10329-013-0348-4; Siegel S., 1988, NONPARAMETRIC STAT B; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Spinka M, 2001, Q REV BIOL, V76, P141, DOI 10.1086/393866; Stewart K, PRIMATE SOC; Stokes EJ, 2004, AM J PRIMATOL, V64, P233, DOI 10.1002/ajp.20074; Stokes EJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P329, DOI 10.1007/s00265-003-0630-3; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tacconi G, 2009, ANIM BEHAV, V78, P469, DOI 10.1016/j.anbehav.2009.06.004; Thompson KV, ANIMAL PLAY EVOLUTIO; Tutin CEG, 1998, BES S, P309; Van Hooff JARAM, 2003, ANIMAL SOCIAL COMPLEXITY, P260; Ward C, 2008, ANIM BEHAV, V76, P1187, DOI 10.1016/j.anbehav.2008.06.004; Watson L., 2000, CENTRAL AFRICAN REPU, V4, P74; Watts DP, 2006, INT J PRIMATOL, V27, P1337, DOI 10.1007/s10764-006-9081-9; Watts David P., 1996, P16, DOI 10.1017/CBO9780511752414.004; Watts David P., 1993, P148; Watts DP, 2000, INT J PRIMATOL, V21, P189, DOI 10.1023/A:1005469302911; Watts DP, 2000, INT J PRIMATOL, V21, P211, DOI 10.1023/A:1005421419749; Watts DP, 2003, CAM S BIO EVOL ANTHR, V35, P302; WATTS DP, 1995, ETHOLOGY, V100, P139; Williamson E.A., 2001, AFR PRIMATES, V5, P48; Wittig RM, 2003, BEHAVIOUR, V140, P1527, DOI 10.1163/156853903771980701; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Wrangham R., 1996, DEMONIC MALES; Yamagiwa J, 2003, PRIMATES, V44, P359, DOI 10.1007/s10329-003-0049-5	126	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193096	10.1371/journal.pone.0193096	http://dx.doi.org/10.1371/journal.pone.0193096			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513696	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800037
J	Massawe, A; Kidanto, HL; Moshiro, R; Majaliwa, E; Chacha, F; Shayo, A; Mdoe, P; Ringia, P; Azayo, M; Msemo, G; Mduma, E; Ersdal, HL; Perlman, JM				Massawe, Augustine; Kidanto, Hussein L.; Moshiro, Robert; Majaliwa, Edna; Chacha, Flora; Shayo, Aisa; Mdoe, Paschal; Ringia, Prisca; Azayo, Mary; Msemo, Georgina; Mduma, Estomih; Ersdal, Hege L.; Perlman, Jeffrey M.			A care bundle including antenatal corticosteroids reduces preterm infant mortality in Tanzania a low resource country	PLOS ONE			English	Article								Background Preterm neonatal mortality (NM) has remained high and unchanged for many years in Tanzania, a resource-limited country. Major causes of mortality include birth asphyxia, respiratory insufficiency and infections. Antenatal corticosteroids (ACS) have been shown to significantly reduce mortality in developed countries. There is inconsistent use of ACS in Tanzania. Objective To determine whether implementation of a care bundle that includes ACS, maternal antibiotics (MA), neonatal antibiotics (NA) and avoidance of moderate hypothermia (temperature < 36 degrees C) targeting infants of estimated gestational age (EGA) 28 to 34 6/7 weeks would reduce NM (<7 days) by 35%. Methods A Pre (September 2014 to May 2015) and Post (June 2015 to June 2017) Implementation strategy was used and introduced at three University-affiliated and one District Hospital. Dexamethasone, as the ACS, was added to the national formulary in May 2015, facilitating its free use down to the district level. Findings NM was reduced 26% from 166 to 122/1000 livebirths (P = 0.005) and fresh stillbirths (FSB) 33% from 162/1000 to 111/1000 (p = 0.0002) Pre versus Post Implementation. Medications including combinations increased significantly at all sites (p<0.0001). By logistic regression, combinations of ACS, maternal and NA (odds ratio (OR) 0.33), ACS and NA (OR 0.30) versus no treatment were significantly associated with reduced NM. NM significantly decreased per 250g birthweight increase (OR 0.59), and per one week increase in EGA (OR 0.87). Moderate hypothermia declined pre versus post implementation (p<0.0001) and was two-fold more common in infants who died versus survivors. Interpretation A low-cost care bundle, similar to$6 per patient, was associated with a significant reduction in NM and FSB rates. The former presumably by reducing respiratory morbidity with ACS and minimizing infections with antibiotics. If these findings can be replicated in other resource-limited settings, the potential for further reduction of <5 year mortality rates becomes enormous.	[Massawe, Augustine; Moshiro, Robert; Majaliwa, Edna] Muhimbili Univ Hlth & Allied Sci, Sch Med, Paediat & Child Hlth, Dar Es Salaam, Tanzania; [Kidanto, Hussein L.] Muhimbili Univ Hlth & Allied Sci, Obstet & Gynecol, Dar Es Salaam, Tanzania; [Chacha, Flora] Catholic Univ Hlth & Allied Sci Bugando, Paediat, Mwanza, Tanzania; [Shayo, Aisa] Kilimanjaro Christian Med Ctr, Dept Paediat, Moshi, Tanzania; [Mdoe, Paschal; Mduma, Estomih] Haydom Lutheran Hosp, Obstet & Gynecol, Haydom, Tanzania; [Ringia, Prisca] Weill Bugando Hosp, Div Obstet Nursing, Mwanza, Tanzania; [Azayo, Mary; Msemo, Georgina] Minist Hlth & Social Serv, Reprod & Child Hlth Serv, Dar Es Salaam, Tanzania; [Ersdal, Hege L.] Stavanger Univ Hosp, Dept Anaesthesiol & Intens Care, Stavanger, Norway; [Perlman, Jeffrey M.] Weill Cornell Med, Dept Pediat, New York, NY 10021 USA	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Kilimanjaro Christian Medical Centre; Stavanger University Hospital; Cornell University	Perlman, JM (corresponding author), Weill Cornell Med, Dept Pediat, New York, NY 10021 USA.	jmp2007@med.cornell.edu			Laerdal Foundation for Acute Medicine	Laerdal Foundation for Acute Medicine	Jeffrey Perlman has received a research travel award from the Laerdal Foundation for Acute Medicine for work in Tanzania but does not have any financial or personal relationships with other people or organizations. The study has been funded in part by Bloomberg Philanthropies. Bloomberg Philanthropies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/789729; Althabe F, 2015, LANCET, V385, P629, DOI 10.1016/S0140-6736(14)61651-2; American Academy of Pediatrics, HELP BAB SURV; [Anonymous], 2011, Obstet Gynecol, V117, P1472, DOI 10.1097/AOG.0b013e3182238c31; [Anonymous], 2013, MAN COMPL PREGN CHIL; Castrodale V, 2014, ADV NEONAT CARE, V14, P9, DOI 10.1097/ANC.0b013e31828d0289; GILSTRAP LC, 1995, AM J OBSTET GYNECOL, V173, P246; Laptook AR, 2007, PEDIATRICS, V119, pE643, DOI 10.1542/peds.2006-0943; Liu G, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S3; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Mullany LC, 2010, ARCH PEDIAT ADOL MED, V164, P650, DOI 10.1001/archpediatrics.2010.103; Perlman J, 2015, LANCET, V385, P1944, DOI 10.1016/S0140-6736(15)60954-0; Perlman JM, 2015, CIRCULATION, V132, pS204, DOI 10.1161/CIR.0000000000000276; Roberts D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub3; UNICEF, LEV TRENDS CHILD MOR; Verani J, 2010, MORBIDITY MORTALITY; White LJ, 2012, J R SOC INTERFACE, V9, P503, DOI 10.1098/rsif.2011.0376; World Health Organization, 1997, MEAS QUAL LIF, P1; World Health Organization, 2010, MAT NEWB CHILD AD HL; You D, 2014, LEVELS TRENDS CHILD	21	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193146	10.1371/journal.pone.0193146	http://dx.doi.org/10.1371/journal.pone.0193146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513706	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800040
J	Naik, P; Wang, JP; Sederoff, R; Chiang, V; Williams, C; Ducoste, JJ				Naik, Punith; Wang, Jack P.; Sederoff, Ronald; Chiang, Vincent; Williams, Cranos; Ducoste, Joel J.			Assessing the impact of the 4CL enzyme complex on the robustness of monolignol biosynthesis using metabolic pathway analysis	PLOS ONE			English	Article							POPULUS-TRICHOCARPA; SENSITIVITY-ANALYSIS; LIGNIN BIOSYNTHESIS; SYSTEMS BIOLOGY; TREE GROWTH; LIGASE; 4-COUMARATECOENZYME; PLANTS; LIGNIFICATION; METHODOLOGY	Lignin is a polymer present in the secondary cell walls of all vascular plants. It is a known barrier to pulping and the extraction of high-energy sugars from cellulosic biomass. The challenge faced with predicting outcomes of transgenic plants with reduced lignin is due in part to the presence of unique protein-protein interactions that influence the regulation and metabolic flux in the pathway. Yet, it is unclear why certain plants have evolved to create these protein complexes. In this study, we use mathematical models to investigate the role that the protein complex, formed specifically between Ptr4CL3 and Ptr4CL5 enzymes, have on the monolignol biosynthesis pathway. The role of this Ptr4CL3-Ptr4CL5 enzyme complex on the steady state flux distribution was quantified by performing Monte Carlo simulations. The effect of this complex on the robustness and the homeostatic properties of the pathway were identified by performing sensitivity and stability analyses, respectively. Results from these robustness and stability analyses suggest that the monolignol biosynthetic pathway is resilient to mild perturbations in the presence of the Ptr4CL3-Ptr4CL5 complex. Specifically, the presence of Ptr4CL3-Ptr4CL5 complex increased the stability of the pathway by 22%. The robustness in the pathway is maintained due to the presence of multiple enzyme isoforms as well as the presence of alternative pathways resulting from the presence of the Ptr4CL3-Ptr4CL5 complex.	[Naik, Punith; Ducoste, Joel J.] North Carolina State Univ, Civil Construct & Environm Engn, Raleigh, NC 27695 USA; [Wang, Jack P.; Sederoff, Ronald; Chiang, Vincent] North Carolina State Univ, Dept Forestry & Environm Resources, Forest Biotechnol Grp, Raleigh, NC 27695 USA; [Williams, Cranos] North Carolina State Univ, Elect & Comp Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Ducoste, JJ (corresponding author), North Carolina State Univ, Civil Construct & Environm Engn, Raleigh, NC 27695 USA.	jducoste@ncsu.edu	Ducoste, Joel/A-1964-2016; Naik, Punith/AAH-1291-2019	Ducoste, Joel/0000-0002-3021-3942; Wang, Jack P./0000-0002-5392-0076	National Science Foundation (USA) Plant Genome Research Program Grant [DBI-0922391]	National Science Foundation (USA) Plant Genome Research Program Grant	This work was supported by the National Science Foundation (USA) Plant Genome Research Program Grant (DBI-0922391) (to V.C.) (URL: https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell MM, 1996, PLANT PHYSIOL, V110, P3, DOI 10.1104/pp.110.1.3; Chen HC, 2014, PLANT CELL, V26, P876, DOI 10.1105/tpc.113.119685; Chen HC, 2013, PLANT PHYSIOL, V161, P1501, DOI 10.1104/pp.112.210971; Chiang VL, 2002, NAT BIOTECHNOL, V20, P557, DOI 10.1038/nbt0602-557; Coleman HD, 2008, PLANT PHYSIOL, V148, P1229, DOI 10.1104/pp.108.125500; Girbig D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034686; Grimbs S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100186; HELTON JC, 1985, ECOL MODEL, V28, P243, DOI 10.1016/0304-3800(85)90077-8; Higuchi T., 1997, BIOCH MOL BIOL WOOD, P1, DOI [10.1007/978-3-642-60469-0_1, DOI 10.1007/978-3-642-60469-0_1, 10.1007/978-3-642-60469-0]; Hu WJ, 1999, NAT BIOTECHNOL, V17, P808, DOI 10.1038/11758; Kajita S, 1996, PLANT CELL PHYSIOL, V37, P957, DOI 10.1093/oxfordjournals.pcp.a029045; Kajita S, 1997, PLANT PHYSIOL, V114, P871, DOI 10.1104/pp.114.3.871; Kelley CT, 2003, SOLVING NONLINEAR EQ, pxiv; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kitin P, 2010, PLANT PHYSIOL, V154, P887, DOI 10.1104/pp.110.156224; Lee D, 1997, PLANT CELL, V9, P1985, DOI 10.1105/tpc.9.11.1985; Lee Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002047; Lee Y, 2010, MATH BIOSCI, V228, P78, DOI 10.1016/j.mbs.2010.08.009; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marsh JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7394; Matisziw TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039788; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Romani A, 2014, RECENT ADV POLYPHENO; Saltelli A., 2000, WILEY SERIES PROBABI; Sarkanen K.V., 1971, LIGNIN OCCURRENCE FO; Schallau K, 2010, PLANT PHYSIOL, V152, P1763, DOI 10.1104/pp.109.149237; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Sobol I M, 1990, MATH MODEL COMPUT EX, V2, P112, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Steuer R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002218; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Sumner T, 2012, J R SOC INTERFACE, V9, P2156, DOI 10.1098/rsif.2011.0891; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; Wang JP, 2014, PLANT CELL, V26, P894, DOI 10.1105/tpc.113.120881; Zhou K., 1995, ROBUST OPTIMAL CONTR	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193896	10.1371/journal.pone.0193896	http://dx.doi.org/10.1371/journal.pone.0193896			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509777	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200040
J	Turner, M; Mutter, ST; Deeth, RJ; Platts, JA				Turner, Matthew; Mutter, Shaun T.; Deeth, Robert J.; Platts, James A.			Ligand field molecular dynamics simulation of Pt(II)-phenanthroline binding to N-terminal fragment of amyloid-beta peptide	PLOS ONE			English	Article							PLATINUM-BASED INHIBITORS; ALZHEIMERS-DISEASE; METAL-IONS; PROTEIN; COORDINATION; AGGREGATION; COMPLEXES; MECHANICS; OLIGOMERS; MONOMER	We report microsecond timescale molecular dynamics simulation of the complex formed between Pt(II)-phenanthroline and the 16 N-terminal residues of the A beta peptide that is implicated in the onset of Alzheimer's disease, along with equivalent simulations of the metal-free peptide. Simulations from a variety of starting points reach equilibrium within 100 ns, as judged by root mean square deviation and radius of gyration. Platinum-bound peptides deviate rather more from starting points, and adopt structures with larger radius of gyration, than their metal-free counterparts. Residues bound directly to Pt show smaller fluctuation, but others actually move more in the Pt-bound peptide. Hydrogen bonding within the peptide is disrupted by binding of Pt, whereas the presence of salt-bridges are enhanced.	[Turner, Matthew; Mutter, Shaun T.; Platts, James A.] Cardiff Univ, Sch Chem, Pk Pl, Cardiff, S Glam, Wales; [Deeth, Robert J.] Univ Warwick, Dept Chem, Gibbet Hill, Coventry, W Midlands, England	Cardiff University; University of Warwick	Platts, JA (corresponding author), Cardiff Univ, Sch Chem, Pk Pl, Cardiff, S Glam, Wales.	platts@cardiff.ac.uk	Platts, Jamie/A-2310-2011; Deeth, Robert J/B-8641-2009	Platts, Jamie/0000-0002-1008-6595; Deeth, Robert J/0000-0001-7933-4406	EPSRC [EP/N016858/1]; Engineering and Physical Sciences Research Council [EP/N016858/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Work was funded in part by EPSRC (https://www.epsrc.ac.uk/) under grant ref EP/N016858/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Torres J, 2015, AIP ADV, V5, DOI 10.1063/1.4921072; Ali-Torres J, 2011, J AM CHEM SOC, V133, P15008, DOI 10.1021/ja203407v; Anastasi AE, 2009, J CHEM THEORY COMPUT, V5, P2339, DOI 10.1021/ct9001569; Barnham KJ, 2008, P NATL ACAD SCI USA, V105, P6813, DOI 10.1073/pnas.0800712105; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; BURTON VJ, 1995, J AM CHEM SOC, V117, P8407, DOI 10.1021/ja00137a014; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Collin F, 2013, CHEM COMMUN, V49, P2130, DOI 10.1039/c3cc38537j; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Deeth RJ, 2005, J COMPUT CHEM, V26, P123, DOI 10.1002/jcc.20137; Deeth RJ, 2009, COORDIN CHEM REV, V253, P795, DOI 10.1016/j.ccr.2008.06.018; Dong MY, 2016, ACS CHEM NEUROSCI, V7, P599, DOI 10.1021/acschemneuro.5b00343; Frisch M.J., 2010, DJ FOX; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hureau C, 2014, DALTON T, V43, P4233, DOI 10.1039/c3dt52954a; Kenche VB, 2013, ANGEW CHEM INT EDIT, V52, P3374, DOI 10.1002/anie.201209885; Kepp KP, 2012, CHEM REV, V112, P5193, DOI 10.1021/cr300009x; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Ma GL, 2013, METALLOMICS, V5, P879, DOI 10.1039/c3mt20262c; Ma GL, 2011, CHEM-EUR J, V17, P11657, DOI 10.1002/chem.201101859; Molecular Operating Environment (MOE), 2013, MOL OP ENV MOE 2013; Nasica-Labouze J, 2015, CHEM REV, V115, P3518, DOI 10.1021/cr500638n; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Huy PDQ, 2016, ACS CHEM NEUROSCI, V7, P1348, DOI 10.1021/acschemneuro.6b00109; Raffa DF, 2007, J PHYS CHEM B, V111, P3789, DOI 10.1021/jp0689621; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Smith W, 2002, MOL SIMULAT, V28, P385, DOI 10.1080/08927020290018769; Streltsov VA, 2013, CHEM COMMUN, V49, P11364, DOI 10.1039/c3cc47326k; Tai HC, 2012, INORG CHEM, V51, P6830, DOI 10.1021/ic3005745; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Turner M, 2017, J INORG BIOCHEM, V173, P44, DOI 10.1016/j.jinorgbio.2017.05.003; Turner M, 2016, J CHEM THEORY COMPUT, V12, P1385, DOI 10.1021/acs.jctc.5b01045; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XH, 2012, CHEM SCI, V3, P1304, DOI 10.1039/c2sc01100j; Warmlander S, 2013, CHEMBIOCHEM, V14, P1692, DOI 10.1002/cbic.201300262; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039; Yong CW, 2016, J CHEM INF MODEL, V56, P1405, DOI 10.1021/acs.jcim.6b00323	44	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193668	10.1371/journal.pone.0193668	http://dx.doi.org/10.1371/journal.pone.0193668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509784	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000426813200023
J	Barry, A; Issiaka, D; Traore, T; Mahamar, A; Diarra, B; Sagara, I; Kone, D; Doumbo, OK; Duffy, P; Fried, M; Dicko, A				Barry, Amadou; Issiaka, Djibrilla; Traore, Tiangoua; Mahamar, Almahamoudou; Diarra, Boubacar; Sagara, Issaka; Kone, Diakalia; Doumbo, Ogobara K.; Duffy, Patrick; Fried, Michel; Dicko, Alassane			Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA	Background Seasonal malaria chemoprevention (SMC), the administration of complete therapeutic courses of antimalarials to children aged 3-59 months during the malaria transmission season, is a new strategy recommended by the World Health Organization (WHO) for malaria control in Sahelian countries such as Mali with seasonal transmission. The strategy is a highly cost-effective approach to reduce malaria burden in these areas. Despite the substantial benefits of SMC on malaria infection and disease, the optimal approach to deliver SMC remains to be determined. While fixed-point delivery (FPD) and non-directly observed treatment (NDOT) by community health workers are logistically attractive, these need to be evaluated and compared to other modes of delivery for maximal coverage. Methods To determine the optimal mode fixed-point (FPD) vs door-to-door delivery (DDD); directly observed treatment (DOT) vs. non-directly observed treatment (NDOT)), 31 villages in four health sub-districts were randomized to receive three rounds of SMC with Sulfadoxine-pyrimethamine plus Amodiaquine (SP+AQ) at monthly intervals using one of the following methods: FPD+DOT; FPD+NDOT; DDD+DOT; DDD+NDOT. The primary endpoint was SMC coverage assessed by cross-sectional survey of 2,035 children at the end of intervention period. Results Coverage defined as the proportion of children who received all three days of SMC treatment during the three monthly rounds based information collected by interview (primary endpoint) was significantly higher in children who received SMC using DDD 74% (95% CI 69% - 80%) compared to FPD 60% (95% CI 50% - 70%); p = 0.009. It was similar in children who received SMC using DOT or NDOT 65%, (95% CI 55% - 76%) versus 68% (95% CI 57% - 79%); p = 0.72. Conclusions In summary, door-to-door delivery of SMC provides better coverage than FPD. Directly observed therapy, which requires more time and resources, did not improve coverage with SMC.	[Barry, Amadou; Issiaka, Djibrilla; Traore, Tiangoua; Mahamar, Almahamoudou; Sagara, Issaka; Doumbo, Ogobara K.; Dicko, Alassane] Univ Sci Tech & Technol Bamako, Fac Med Pharm & Dent, Malaria Res & Training Ctr, Bamako, Mali; [Diarra, Boubacar] Reference Hlth Ctr Dist Ouelessebougou, Ouelessebougou, Mali; [Kone, Diakalia] Natl Malaria Control Program, Bamako, Mali; [Duffy, Patrick; Fried, Michel] NIAID, NIH, Lab Malaria Immunol & Vaccinol, Rockville, MD USA	University of Science & Technology of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dicko, A (corresponding author), Univ Sci Tech & Technol Bamako, Fac Med Pharm & Dent, Malaria Res & Training Ctr, Bamako, Mali.	adicko@icermail.org			U.S. President's Malaria Initiative through the USAID Partnerships for Enhanced Engagement in Research program implemented by The National Academies of Sciences, Engineering and Medicine [2000004198]; Intramural Research Program of NIAID-NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001134, ZIAAI001153] Funding Source: NIH RePORTER	U.S. President's Malaria Initiative through the USAID Partnerships for Enhanced Engagement in Research program implemented by The National Academies of Sciences, Engineering and Medicine(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Intramural Research Program of NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the U.S. President's Malaria Initiative through the USAID Partnerships for Enhanced Engagement in Research program implemented by The National Academies of Sciences, Engineering and Medicine (su bg rant contract # 2000004198) to AD (http://sites.nationalacademies.org/PGA/PEER/PEERhealth/PGA387173). Additional support was provided by the Intramural Research Program of NIAID-NIH to PD and MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bojang KA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000409; Cisse B, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002175; Diawara F, BMC INFECT IN PRESS; Dicko A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-573; Dicko A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000407; Greenwood B, 2011, TRENDS PARASITOL, V27, P477, DOI 10.1016/j.pt.2011.06.005; Kweku M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007256; Mangam K, 2016, GLOB HEALTH-SCI PRAC, V4, P222, DOI 10.9745/GHSP-D-15-00381; Ntuku HM, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1671-1; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; Rahman MM, 2008, T ROY SOC TROP MED H, V102, P861, DOI 10.1016/j.trstmh.2008.05.022; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Strachan CE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1526-9; WHO, 2012, POLICY RECOMMENDATIO	14	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193296	10.1371/journal.pone.0193296	http://dx.doi.org/10.1371/journal.pone.0193296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505578	gold, Green Published, Green Submitted			2022-12-27	WOS:000426548200010
J	Inaba, M; Inoue, Y; Akutsu, S; Takahashi, N; Yamagishi, T				Inaba, Misato; Inoue, Yumi; Akutsu, Satoshi; Takahashi, Nobuyuki; Yamagishi, Toshio			Preference and strategy in proposer's prosocial giving in the ultimatum game	PLOS ONE			English	Article							COGNITIVE REFLECTION TEST; FAIRNESS; HEURISTICS; COOPERATION; INFORMATION; INTENTIONS; BEHAVIOR	The accumulation of findings that most responders in the ultimatum game reject unfair offers provides evidence that humans are driven by social preferences such as preferences for fairness and prosociality. On the other hand, if and how the proposer's behavior is affected by social preferences remains unelucidated. We addressed this question for the first time by manipulating the knowledge that the proposer had about the responder's belief concerning the intentionality of the proposer. In a new game called the <feminine ordinal indicator> ultimatum game with ambiguous intentions of the proposer (UG(AMB))," we made the intentionality of the proposer ambiguous to the recipient. We expected and found that the proposer would make more unfair offers in this new game than in the standard ultimatum game. This expectation can be derived from either the preference-based model or the strategy model of the proposer's giving decision. The additional finding that more unfair giving in the UG(AMB) was not mediated by the proposer's expectation that the recipient would be more willing to accept unfair offers provided support for the preference-based model. Using a psychological measure of cognitive control, the preference-based model received additional support through a conceptual replication of the previous finding that cognitive control of intuitive drive for prosociality in the dictator game, rather than mind reading in the ultimatum game, is responsible for the difference in giving between the two games.	[Inaba, Misato] Kansai Univ, Ctr Expt Econ, Suita, Osaka, Japan; [Inoue, Yumi] Teikyo Univ, Fac Econ, Hachioji, Tokyo, Japan; [Akutsu, Satoshi] Hitotsubashi Univ, Grad Sch Int Corp Strategy, Chiyoda Ku, Tokyo, Japan; [Takahashi, Nobuyuki; Yamagishi, Toshio] Hokkaido Univ, Grad Sch Letters, Sapporo, Hokkaido, Japan	Kansai University; Teikyo University; Hokkaido University	Yamagishi, T (corresponding author), Hokkaido Univ, Grad Sch Letters, Sapporo, Hokkaido, Japan.	yamagishitoshio@gmail.com	; Yamagishi, Toshio/E-2384-2013	Yumi, Inoue/0000-0003-0761-8439; Yamagishi, Toshio/0000-0002-8890-1115	Japan Society for the Promotion of Science [15H05730]; Grants-in-Aid for Scientific Research [15H05730] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by #15H05730 from the Japan Society for the Promotion of Science, https://www.jsps.go.jp/.	Barreda-Tarrazona I, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00596; Bear A, 2016, P NATL ACAD SCI USA, V113, P936, DOI 10.1073/pnas.1517780113; Bellemare C, 2011, J ECON BEHAV ORGAN, V78, P349, DOI 10.1016/j.jebo.2011.01.019; Blount S, 1995, ORG BEN HUM DECIS PR, V43, P131; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Calvillo DP, 2015, JUDGM DECIS MAK, V10, P332; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; De Neys W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027107; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Falk A, 2008, GAME ECON BEHAV, V62, P287, DOI 10.1016/j.geb.2007.06.001; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E., 2005, ANAL KRITIK, V27, P6, DOI [DOI 10.1515/AUK-2005-0101, 10.1515/auk-2005-0101]; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Guroglu B, 2009, J EXP CHILD PSYCHOL, V104, P398, DOI 10.1016/j.jecp.2009.07.002; Guth W, 1998, J MATH PSYCHOL, V42, P227, DOI 10.1006/jmps.1998.1212; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Ohmura Y, 2005, PSYCHOL REP, V96, P533; Oldrati V, 2016, NEUROPSYCHOLOGIA, V91, P499, DOI 10.1016/j.neuropsychologia.2016.09.010; Ponti G, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00146; Rand DG, 2016, PSYCHOL SCI, V27, P1192, DOI 10.1177/0956797616654455; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Ruff CC, 2013, SCIENCE, V342, P482, DOI 10.1126/science.1241399; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Stanovich K.E., 2011, RATIONALITY REFLECTI; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Sun P, 2017, EXP BRAIN RES, P1; Sutter M, 2007, J ECON PSYCHOL, V28, P69, DOI 10.1016/j.joep.2006.09.001; Takagishi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108462; Takagishi H, 2010, J EXP CHILD PSYCHOL, V105, P130, DOI 10.1016/j.jecp.2009.09.005; Toplak ME, 2014, THINK REASONING, V20, P147, DOI 10.1080/13546783.2013.844729; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Welsh M. B., 2013, P 35 ANN C COGN SCI, P1587; Yamagishi T, 2017, P NATL ACAD SCI USA, V114, P6394, DOI 10.1073/pnas.1608877114; Yamagishi T, 2016, P NATL ACAD SCI USA, V113, P5582, DOI 10.1073/pnas.1523940113; Yamagishi T, 2014, PSYCHOL SCI, V25, P1699, DOI 10.1177/0956797614538065	42	11	12	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193877	10.1371/journal.pone.0193877	http://dx.doi.org/10.1371/journal.pone.0193877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY1CC	29505587	Green Submitted, gold, Green Published			2022-12-27	WOS:000426548200039
J	Sabeh, M; Duceppe, MO; St-Arnaud, M; Mimee, B				Sabeh, Michael; Duceppe, Marc-Olivier; St-Arnaud, Marc; Mimee, Benjamin			Transcriptome-wide selection of a reliable set of reference genes for gene expression studies in potato cyst nematodes (Globodera spp.)	PLOS ONE			English	Article							RT-PCR NORMALIZATION; ROSTOCHIENSIS; TOOL	Relative gene expression analyses by qRT-PCR (quantitative reverse transcription PCR) require an internal control to normalize the expression data of genes of interest and eliminate the unwanted variation introduced by sample preparation. A perfect reference gene should have a constant expression level under all the experimental conditions. However, the same few housekeeping genes selected from the literature or successfully used in previous unrelated experiments are often routinely used in new conditions without proper validation of their stability across treatments. The advent of RNA-Seq and the availability of public datasets for numerous organisms are opening the way to finding better reference genes for expression studies. Globodera rostochiensis is a plant-parasitic nematode that is particularly yield-limiting for potato. The aim of our study was to identify a reliable set of reference genes to study G. rostochiensis gene expression. Gene expression levels from an RNA-Seq database were used to identify putative reference genes and were validated with qRT-PCR analysis. Three genes, GR, PMP-3, and aaRS, were found to be very stable within the experimental conditions of this study and are proposed as reference genes for future work.	[Sabeh, Michael; Mimee, Benjamin] Agr & Agri Food Canada, St Jean Sur Richelieu Res & Dev Ctr, St Jean, PQ, Canada; [Sabeh, Michael; St-Arnaud, Marc] Univ Montreal & Jardin Bot Montreal, Inst Rech Biol Vegetale, Biodivers Ctr, Montreal, PQ, Canada; [Duceppe, Marc-Olivier] Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Ottawa, ON, Canada	Agriculture & Agri Food Canada; Universite de Montreal; Canadian Food Inspection Agency	Mimee, B (corresponding author), Agr & Agri Food Canada, St Jean Sur Richelieu Res & Dev Ctr, St Jean, PQ, Canada.	benjamin.mimee@agr.gc.ca	St-Arnaud, Marc/D-1184-2017	St-Arnaud, Marc/0000-0002-7181-9895; Sabeh, Michael/0000-0001-5496-3695	Agriculture and Agri-Food Canada (AAFC); United States Department of Agriculture (USDA) through a Coordinated Agricultural Project (CAP) titled "Risk Assessment and Eradication of Globodera spp. in U.S. Production of Potato"; National Institute for Food and Agriculture [2015-69004-23634]	Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada); United States Department of Agriculture (USDA) through a Coordinated Agricultural Project (CAP) titled "Risk Assessment and Eradication of Globodera spp. in U.S. Production of Potato"; National Institute for Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was supported by Agriculture and Agri-Food Canada (AAFC) and the United States Department of Agriculture (USDA) through a Coordinated Agricultural Project (CAP) titled "Risk Assessment and Eradication of Globodera spp. in U.S. Production of Potato", supported by award #2015-69004-23634 from the National Institute for Food and Agriculture (https://www.globodera.org/).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anonymous, 2004, Bulletin OEPP, V34, P309, DOI 10.1111/j.1365-2338.2004.00734.x; Belair G, 2005, PHYTOPROTECTION, V86, P65, DOI 10.7202/011717ar; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Castro-Quezada P, 2013, PLANT MOL BIOL REP, V31, P936, DOI 10.1007/s11105-013-0566-3; Chauvin L, 2008, CAH AGRIC, V17, P368, DOI 10.1684/agr.2008.0217; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Duceppe MO, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03871-x; Espinola SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102228; Eves-van den Akker S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0985-1; FAO, 2016, FAO STAT POCK 2015; Goellner M, 2000, J NEMATOL, V32, P154; Hofmann J, 2007, NEMATOLOGY, V9, P317, DOI 10.1163/156854107781352034; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANNERVIK B, 1987, BIOCHEM SOC T, V15, P717, DOI 10.1042/bst0150717; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Schwekendiek A, 1999, J NEMATOL, V31, P568; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Spanier B, 2005, J MOL BIOL, V352, P429, DOI 10.1016/j.jmb.2005.06.063; Taki FA, 2013, PSYCHOPHARMACOLOGY, V230, P77, DOI 10.1007/s00213-013-3139-0; Turner SJ, 1996, ANN APPL BIOL, V129, P315, DOI 10.1111/j.1744-7348.1996.tb05754.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yu Q, 2010, CAN J PLANT PATHOL, V32, P264, DOI 10.1080/07060661003740322; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	38	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193840	10.1371/journal.pone.0193840	http://dx.doi.org/10.1371/journal.pone.0193840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499068	Green Published, Green Submitted, gold			2022-12-27	WOS:000426472300024
J	Pachaiappan, R; Tamboli, E; Acharya, A; Su, CH; Gopinath, SCB; Chen, Y; Velusamy, P				Pachaiappan, Raman; Tamboli, Ekant; Acharya, Aurovind; Su, Chia-Hung; Gopinath, Subash C. B.; Chen, Yeng; Velusamy, Palaniyandi			Separation and identification of bioactive peptides from stem of Tinospora cordifolia (Willd.) Miers	PLOS ONE			English	Article							RADICAL-SCAVENGING ACTIVITIES; ANTIOXIDANT ACTIVITY; PROTEIN HYDROLYSATE; FUNCTIONAL-PROPERTIES; LIPOSOME SYSTEM; POSSIBLE MODE; DIGESTION; CHROMATOGRAPHY; PURIFICATION; MECHANISMS	Enzyme hydrolysates (trypsin, papain, pepsin, a-chymotrypsin, and pepsin-pancreatin) of Tinospora cordifolia stem proteins were analyzed for antioxidant efficacy by measuring (1) 1,1-diphenyl-2-picrylhydrazyl (DPPH center dot) radical scavenging activity, (2) 2,20-azinobis(3-ethyl-benzothiazoline- 6-sulfonic acid) (ABTS(+)) radical scavenging capacity, and (3) Fe2+ chelation. Trypsin hydrolysate showed the strongest DPPH center dot scavenging, while alpha-chymotrypsin hydrolysate exhibited the highest ABTS(+) scavenging and Fe2+ chelation. Undigested protein strongly inhibited the gastrointestinal enzymes, trypsin (50% inhibition at enzyme/substrate ratio = 1: 6.9) and a-chymotrypsin (50% inhibition at enzyme/substrate ratio = 1: 1.82), indicating the prolonged antioxidant effect after ingestion. Furthermore, gel filtration purified peptide fractions of papain hydrolysates exhibited a significantly higher ABTS(+) and superoxide radical scavenging as compared to non-purified digests. Active fraction 9 showing the highest radical scavenging ability was further purified and confirmed by MALDI-TOF MS followed by MS/MS with probable dominant peptide sequences identified are VLYSTPVKM-WEPGR, VITVVATAGSETMR, and HIGININSR. The obtained results revealed that free radical scavenging capacity of papain hydrolysates might be related to its consistently low molecular weight hydrophobic peptides.	[Pachaiappan, Raman; Tamboli, Ekant; Acharya, Aurovind; Velusamy, Palaniyandi] SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur, Tamil Nadu, India; [Su, Chia-Hung] Ming Chi Univ Technol, Dept Chem Engn, Taipei, Taiwan; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn Arau, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Inst Nano Elect Engn Kangar, Perlis, Malaysia; [Chen, Yeng] Univ Malaya, Fac Dent, Dept Oral & Craniofacial Sci, Kuala Lumpur, Malaysia; [Chen, Yeng] Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr OCRCC, Kuala Lumpur, Malaysia	SRM Institute of Science & Technology Chennai; Ming Chi University of Technology; Universiti Malaysia Perlis; Universiti Malaysia Perlis; Universiti Malaya; Universiti Malaya	Pachaiappan, R (corresponding author), SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur, Tamil Nadu, India.	pachaiappan.ra@ktr.srmuniv.ac.in	BIOTECH, SRMITE/AAW-8572-2020; Velusamy, Palaniyandi/AAA-6517-2022; Gopinath, Subash/D-2953-2015; Chen, Yeng -/A-6873-2011; Raman, Pachaiappan/O-2968-2019	Velusamy, Palaniyandi/0000-0002-6551-979X; Gopinath, Subash/0000-0002-8347-4687; Chen, Yeng -/0000-0002-0064-7678; Raman, Pachaiappan/0000-0003-2739-4882; Tamboli, Ekant/0000-0002-8649-4931; Su, Chia-Hung/0000-0002-4203-5143	University of Malaya Research grants-"MoE" [UM.C/625/1/HIR/MOE/DENT/09]; University of Malaya Research Grants (UMRG) [RG454-12HTM]	University of Malaya Research grants-"MoE"; University of Malaya Research Grants (UMRG)	Y. Chen thanks the support from University of Malaya Research grants-"MoE Grant UM.C/625/1/HIR/MOE/DENT/09". Dr. Yeng Chen would like to thank University of Malaya Research Grants (UMRG) RG454-12HTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFANASEV IB, 1989, BIOCHEM PHARMACOL, V38, P1763, DOI 10.1016/0006-2952(89)90410-3; Andrew SM, 2001, CURR PROTOC IMMUNOL, P1; Aranha I, 2012, J ETHNOPHARMACOL, V139, P366, DOI 10.1016/j.jep.2011.11.013; Arunvanan M., 2013, ASIAN J PHARM CLIN R, V6, P46; Bamdad F, 2011, J CEREAL SCI, V54, P20, DOI 10.1016/j.jcs.2011.01.006; Bayram T, 2008, TALANTA, V75, P705, DOI 10.1016/j.talanta.2007.12.007; Benov L, 2001, PROTOPLASMA, V217, P33, DOI 10.1007/BF01289410; Binsan W, 2008, FOOD CHEM, V106, P185, DOI 10.1016/j.foodchem.2007.05.065; Bourdon E, 2001, ANTIOXID REDOX SIGN, V3, P293, DOI 10.1089/152308601300185241; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Camargo ACM, 2012, C SERIES NEUROPEPTID; Chen HM, 1998, J AGR FOOD CHEM, V46, P49, DOI 10.1021/jf970649w; Cheng YH, 2006, J CENT SOUTH UNIV T, V13, P160, DOI 10.1007/s11771-006-0149-7; Cupp-Enyard C., 2008, JOVE, V19, P899, DOI [DOI 10.3791/899, 10.3791/899]; De Noni I., 2009, EFSA SCI REPORT, V231, P1, DOI DOI 10.2903/J.EFSA.2009.231R; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elias RJ, 2008, CRIT REV FOOD SCI, V48, P430, DOI 10.1080/10408390701425615; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Gupta R, 2009, INDIAN J BIOCHEM BIO, V46, P126; Hassan AB, 2007, FOOD CHEM, V102, P257, DOI 10.1016/j.foodchem.2006.04.043; Hattori M, 1998, J AGR FOOD CHEM, V46, P2167, DOI 10.1021/jf970484r; Jagetia GC, 2006, BIOL PHARM BULL, V29, P460, DOI 10.1248/bpb.29.460; Jamdar SN, 2012, J FOOD BIOCHEM, V36, P494, DOI 10.1111/j.1745-4514.2011.00562.x; Jang IC, 2010, J MED PLANTS RES, V4, P155; Jeong HJ, 2003, J AGR FOOD CHEM, V51, P7901, DOI 10.1021/jf034460y; Kangsanant S, 2014, INT J FOOD SCI TECH, V49, P1932, DOI 10.1111/ijfs.12551; Kaur M, 2014, J ADV PHARM TECHNOL, V5, P122, DOI 10.4103/2231-4040.137417; Kavitha B T, 2011, J Basic Clin Pharm, V2, P139; KLEIN IB, 1969, J BIOL CHEM, V244, P5928; Kong BH, 2006, J AGR FOOD CHEM, V54, P6059, DOI 10.1021/jf060632q; Kong BH, 2010, MEAT SCI, V85, P772, DOI 10.1016/j.meatsci.2010.04.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li B, 2007, FOOD CHEM, V102, P1135, DOI 10.1016/j.foodchem.2006.07.002; Li YH, 2008, FOOD CHEM, V106, P444, DOI 10.1016/j.foodchem.2007.04.067; Ma YY, 2010, FOOD CHEM, V118, P582, DOI 10.1016/j.foodchem.2009.05.024; Ma YY, 2009, J AGR FOOD CHEM, V57, P4372, DOI 10.1021/jf803670u; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Martos G, 2010, J AGR FOOD CHEM, V58, P5640, DOI 10.1021/jf904538w; Mendis E, 2005, J AGR FOOD CHEM, V53, P581, DOI 10.1021/jf048877v; Moller NP, 2008, EUR J NUTR, V47, P171, DOI 10.1007/s00394-008-0710-2; Moure A, 2006, PROCESS BIOCHEM, V41, P447, DOI 10.1016/j.procbio.2005.07.014; Narkhede AN, 2014, INDIAN J EXP BIOL, V52, P808; Park PJ, 2001, J AM OIL CHEM SOC, V78, P651, DOI 10.1007/s11746-001-0321-0; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Pihlanto A, 2006, INT DAIRY J, V16, P1306, DOI 10.1016/j.idairyj.2006.06.005; Rahees, 2013, IRANIAN J PHARM THER, V12, P30; Rajapakse N, 2005, J NUTR BIOCHEM, V16, P562, DOI 10.1016/j.jnutbio.2005.02.005; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Saiga A, 2003, J AGR FOOD CHEM, V51, P3661, DOI 10.1021/jf021156g; Saito K, 2003, J AGR FOOD CHEM, V51, P3668, DOI 10.1021/jf021191n; Sarmadi BH, 2010, PEPTIDES, V31, P1949, DOI 10.1016/j.peptides.2010.06.020; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Singh S. S., 2003, Indian Journal of Pharmacology, V35, P83; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Suetsuna K, 2000, J NUTR BIOCHEM, V11, P128, DOI 10.1016/S0955-2863(99)00083-2; Sun J, 2004, J AGR FOOD CHEM, V52, P6646, DOI 10.1021/jf0495136; Tang XY, 2010, J AGR FOOD CHEM, V58, P587, DOI 10.1021/jf9028656; Thomas K, 2004, REGUL TOXICOL PHARM, V39, P87, DOI 10.1016/j.yrtph.2003.11.003; Thompson VF, 2003, BBA-PROTEINS PROTEOM, V1648, P140, DOI 10.1016/S1570-9639(03)00115-8; TURNER M W, 1970, Clinical and Experimental Immunology, V7, P603; Upadhyay Avnish K, 2010, Int J Ayurveda Res, V1, P112, DOI 10.4103/0974-7788.64405; Wade AM, 1998, J NUTR BIOCHEM, V9, P308, DOI 10.1016/S0955-2863(98)00022-9; Walther B, 2011, INT J VITAM NUTR RES, V81, P181, DOI 10.1024/0300-9831/a000054; Wani IA, 2015, FOOD RES INT, V76, P11, DOI 10.1016/j.foodres.2014.08.027; Wu HC, 2005, J FOOD DRUG ANAL, V13, P176; Xie ZJ, 2008, FOOD CHEM, V111, P370, DOI 10.1016/j.foodchem.2008.03.078; Zhu LJ, 2008, J AGR FOOD CHEM, V56, P2714, DOI 10.1021/jf703697e	69	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193717	10.1371/journal.pone.0193717	http://dx.doi.org/10.1371/journal.pone.0193717			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494663	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200089
J	Stepanov, A; Karelina, T; Markevich, N; Demin, O; Nicholas, T				Stepanov, Alexander; Karelina, Tatiana; Markevich, Nikolai; Demin, Oleg; Nicholas, Timothy			A mathematical model of multisite phosphorylation of tau protein (vol 13, e0192519, 2018)	PLOS ONE			English	Correction													Stepanov, Alexander/GQY-8569-2022; markevich, nikolai i/J-9564-2014; Stepanov, Alexander/V-7287-2019	Stepanov, Alexander/0000-0002-9113-9440; Stepanov, Alexander/0000-0002-9113-9440				Stepanov A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192519	1	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0194002	10.1371/journal.pone.0194002	http://dx.doi.org/10.1371/journal.pone.0194002			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494678	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200104
J	Bouzroud, S; Gouiaa, S; Hu, N; Bernadac, A; Mila, I; Bendaou, N; Smouni, A; Bouzayen, M; Zouine, M				Bouzroud, Sarah; Gouiaa, Sandra; Hu, Nan; Bernadac, Anne; Mila, Isabelle; Bendaou, Najib; Smouni, AbdelAziz; Bouzayen, Mondher; Zouine, Mohamed			Auxin Response Factors (ARFs) are potential mediators of auxin action in tomato response to biotic and abiotic stress (Solanum lycopersicum)	PLOS ONE			English	Article							LATERAL ROOT-FORMATION; ABSCISIC-ACID; EXPRESSION ANALYSIS; GENE FAMILY; POSSIBLE INVOLVEMENT; PROFILING REVEALS; ARABIDOPSIS; TRANSCRIPTION; AUX/IAA; LEAF	Survival biomass production and crop yield are heavily constrained by a wide range of environmental stresses. Several phytohormones among which abscisic acid (ABA), ethylene and salicylic acid (SA) are known to mediate plant responses to these stresses. By contrast, the role of the plant hormone auxin in stress responses remains so far poorly studied. Auxin controls many aspects of plant growth and development, and Auxin Response Factors play a key role in the transcriptional activation or repression of auxin-responsive genes through direct binding to their promoters. As a mean to gain more insight on auxin involvement in a set of biotic and abiotic stress responses in tomato, the present study uncovers the expression pattern of SlARF genes in tomato plants subjected to biotic and abiotic stresses. In silico mining of the RNAseq data available through the public TomExpress web platform, identified several SlARFs as responsive to various pathogen infections induced by bacteria and viruses. Accordingly, sequence analysis revealed that 5' regulatory regions of these SlARFs are enriched in biotic and abiotic stress-responsive cis-elements. Moreover, quantitative qPCR expression analysis revealed that many SlARFs were differentially expressed in tomato leaves and roots under salt, drought and flooding stress conditions. Further pointing to the putative role of SlARFs in stress responses, quantitative qPCR expression studies identified some miRNA precursors as potentially involved in the regulation of their SlARF target genes in roots exposed to salt and drought stresses. These data suggest an active regulation of SlARFs at the post-transcriptional level under stress conditions. Based on the substantial change in the transcript accumulation of several SlARF genes, the data presented in this work strongly support the involvement of auxin in stress responses thus enabling to identify a set of candidate SlARFs as potential mediators of biotic and abiotic stress responses.	[Bouzroud, Sarah; Gouiaa, Sandra; Hu, Nan; Bernadac, Anne; Mila, Isabelle; Bouzayen, Mondher; Zouine, Mohamed] Univ Toulouse, GBF, INRA, Castanet Tolosan, France; [Bouzroud, Sarah; Bendaou, Najib; Smouni, AbdelAziz] Univ Mohammed V Rabat, Lab Physiol & Biotechnol Vegetales, Ctr Biotechnol Vegetale & Microbienne Biodivers, Fac Sci, Rabat, Morocco	INRAE; Mohammed V University in Rabat	Zouine, M (corresponding author), Univ Toulouse, GBF, INRA, Castanet Tolosan, France.	mohamed.zouine@ensat.fr	Bouzayen, Mondher/AFQ-0802-2022; Bouzroud, Sarah/HCI-1338-2022; SMOUNI, Abdelaziz/GQZ-1979-2022	Isabelle, Mila/0000-0002-8878-0018; Smouni, Abdelaziz/0000-0003-2456-038X; Bouzroud, Sarah/0000-0001-9430-2242	"Laboratoire d'Excellence" (LABEX) entitled TULIP [ANR-10-LABX-41]; European COST [FA1106]; ANR TomEpiSet [ANR-16-CE20-0014]; TomGEM H2020 project; Hubert-Curien partnership program Volubilis [MA/12/280-27105PL]; CMCU [08G0906]	"Laboratoire d'Excellence" (LABEX) entitled TULIP; European COST(European Cooperation in Science and Technology (COST)); ANR TomEpiSet(French National Research Agency (ANR)); TomGEM H2020 project; Hubert-Curien partnership program Volubilis; CMCU	This research was supported by the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR-10-LABX-41) and benefited from networking activities within the European COST Action FA1106, from the ANR TomEpiSet (ANR-16-CE20-0014) project, the TomGEM H2020 project, by Hubert-Curien partnership program Volubilis (MA/12/280-27105PL) and CMCU program (08G0906) granted to Dr Habib Khoudi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to L. Lemonnier, D. Saint-Martin and O. Berseille for genetic transformation and culture of tomato plants. This research was supported by the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR-10-LABX-41) and benefited from networking activities within the European COST Action FA1106, from the ANR TomEpiSet (ANR-16-CE20-0014) project, the TomGEM H2020 project, by Hubert-Curien partnership program Volubilis (MA/12/280-27105PL) and CMCU program (08G0906) granted to Dr Habib Khoudi.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Cao YR, 2008, PLANT SIGNAL BEHAV, V3, P761, DOI 10.4161/psb.3.10.5934; Causier B, 2012, PLANT SIGNAL BEHAV, V7, P325, DOI 10.4161/psb.19283; Chaabouni S, 2009, J EXP BOT, V60, P1349, DOI 10.1093/jxb/erp009; Chandler JW, 2016, PLANT CELL ENVIRON, V39, P1014, DOI 10.1111/pce.12662; Chandna R, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P181, DOI 10.1007/978-1-4614-0634-1_10; Cheng YF, 2007, J INTEGR PLANT BIOL, V49, P99, DOI 10.1111/j.1744-7909.2006.00412.x; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Ha CV, 2013, DNA RES, V20, P511, DOI 10.1093/dnares/dst027; Curaba J, 2014, J EXP BOT, V65, P1425, DOI 10.1093/jxb/eru002; Deb A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137295; Dorantes-Acosta A. E., 2012, Frontiers in Genetics, V3, P256, DOI 10.3389/fgene.2012.00256; Du H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00397; Esmon CA, 2006, P NATL ACAD SCI USA, V103, P236, DOI 10.1073/pnas.0507127103; Fu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00074; Ghanashyam C, 2009, PLANT SIGNAL BEHAV, V4, P846, DOI 10.4161/psb.4.9.9376; Gharbi I, 2007, PLANT CELL ENVIRON, V30, P508, DOI 10.1111/j.1365-3040.2007.01640.x; Goh T, 2012, PHILOS T R SOC B, V367, P1461, DOI 10.1098/rstb.2011.0232; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Guy Charles, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P231; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hendelman A, 2012, PLANT MOL BIOL, V78, P561, DOI 10.1007/s11103-012-9883-4; Hsieh TH, 2002, PLANT PHYSIOL, V130, P618, DOI 10.1104/pp.006783; HU W, 2015, FRONT PLANT SCI, V6; Dang HQ, 2011, PLANT SIGNAL BEHAV, V6, P1006, DOI 10.4161/psb.6.7.15502; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kazan K, 2013, ANN BOT-LONDON, V112, P1655, DOI 10.1093/aob/mct229; Kirch HH, 1997, PLANT MOL BIOL, V33, P897, DOI 10.1023/A:1005759925962; Krizek BA, 2011, J EXP BOT, V62, P3311, DOI 10.1093/jxb/err127; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Liu N, 2014, J EXP BOT, V65, P2507, DOI 10.1093/jxb/eru141; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Lopez-Bucio J, 2005, PLANT PHYSIOL, V137, P681, DOI 10.1104/pp.104.049577; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Mariani C, 2009, J EXP BOT; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Mun JH, 2012, MOL GENET GENOMICS, V287, P765, DOI 10.1007/s00438-012-0718-4; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nie XZ, 2002, GENOME, V45, P905, DOI [10.1139/g02-062, 10.1139/G02-062]; Nishiuchi T, 2004, J BIOL CHEM, V279, P55355, DOI 10.1074/jbc.M409674200; Okushima Y, 2005, PLANT J, V43, P29, DOI 10.1111/j.1365-313X.2005.02426.x; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Popko J, 2010, PLANT BIOLOGY, V12, P242, DOI 10.1111/j.1438-8677.2009.00305.x; Rahman A, 2013, PHYSIOL PLANTARUM, V147, P28, DOI 10.1111/j.1399-3054.2012.01617.x; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rosli HG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r139; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmelz EA, 2004, PLANT J, V39, P790, DOI 10.1111/j.1365-313X.2004.02168.x; Sohn KH, 2006, PLANT MOL BIOL, V61, P897, DOI 10.1007/s11103-006-0057-0; Song YL, 2009, PLANTA, V229, P577, DOI 10.1007/s00425-008-0853-7; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Trivedi Dipesh Kumar, 2013, Commun Integr Biol, V6, pe25260, DOI 10.4161/cib.25260; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P79, DOI 10.4161/psb.3.2.5303; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang SK, 2010, FUNCT INTEGR GENOMIC, V10, P533, DOI 10.1007/s10142-010-0174-3; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Wu J, 2011, PLANT CELL REP, V30, P2059, DOI 10.1007/s00299-011-1113-z; Xia J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-634; Xing HY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-178; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zolla G, 2010, J EXP BOT, V61, P211, DOI 10.1093/jxb/erp290; Zouine M, 2017, PLANT J, V92, P727, DOI 10.1111/tpj.13711; Zouine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084203	87	73	77	8	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193517	10.1371/journal.pone.0193517	http://dx.doi.org/10.1371/journal.pone.0193517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489914	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000083
J	Messias, LHD; Sousa, FAD; dos Reis, IGM; Ferrari, HG; Gobatto, CA; Serra, CCS; Papoti, M; Manchado-Gobatto, FB				Dalcheco Messias, Leonardo Henrique; de Barros Sousa, Filipe Antonio; Masseli dos Reis, Ivan Gustavo; Ferrari, Homero Gustavo; Gobatto, Claudio Alexandre; Saldanha Serra, Camila Caputo; Papoti, Marcelo; Manchado-Gobatto, Fulvia Barros			Novel paddle stroke analysis for elite slalom kayakers: Relationship with force parameters	PLOS ONE			English	Article							TETHERED CANOE SYSTEM; ALL-OUT TEST; COMPETITION ANALYSIS; YOUNG SWIMMERS; PERFORMANCE	This study was divided into two complementary parts. In Part 1, we proposed a novel paddle strokes analysis based on the force signal from a 30-s all-out tethered test; and compared these results with video recordings. In Part 2, we investigated the relationship between force data from the same test with paddle stroke results from both methods. Eleven male elite slalom kayakers (Brazilian national team) were evaluated. The tethered test was conducted for force parameters analysis (peak-force, mean-force, impulse). Video recording analysis was conducted, and the performed strokes (V.Number(Paddle)) was counted and frequency (V.Frequency(Paddle)) calculated by the V.Number(Paddle) divided by 30 (i.e. total time of test). The new method consisted of performed strokes and frequency achievement from a load cell force signal analysis (S.Number(Paddle) and S.Frequency(Paddle), respectively). Paired test-t did not show difference between methods results, but significant correlations were only obtained for the number of paddle strokes. Force parameters were only correlated with S. Number(Paddle) and S.Frequency(Paddle). Overall, considering the theoretical and practical application, we propose that the new method should be used as an alternative to the video recording.	[Dalcheco Messias, Leonardo Henrique; de Barros Sousa, Filipe Antonio; Masseli dos Reis, Ivan Gustavo; Ferrari, Homero Gustavo; Gobatto, Claudio Alexandre; Saldanha Serra, Camila Caputo; Manchado-Gobatto, Fulvia Barros] Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil; [Papoti, Marcelo] Univ Sao Paulo, Sch Phys Educ, Ribeirao Preto, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo	Manchado-Gobatto, FB (corresponding author), Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil.	fulvia.gobatto@fca.unicamp.br	reis, ivan GM dos/E-6889-2015; Papoti, Marcelo MP/D-1725-2012; Messias, Leonardo Henrique Dalcheco/GPX-6723-2022; dos reis, ivan/AAL-4937-2020; Manchado-Gobatto, Fúlvia B/B-9168-2012; Papoti, Marcelo/AAM-6394-2021; Sousa, Filipe A B/H-2444-2017; Messias, Leonardo Henrique Dalcheco/GQP-3084-2022; Gobatto, Claudio A/E-7388-2014; DALCHECO MESSIAS, LEONARDO HENRIQUE/GMW-9645-2022	reis, ivan GM dos/0000-0002-8025-1357; Papoti, Marcelo MP/0000-0002-3702-7149; Messias, Leonardo Henrique Dalcheco/0000-0002-8324-8866; dos reis, ivan/0000-0002-8025-1357; Manchado-Gobatto, Fúlvia B/0000-0002-1178-570X; Messias, Leonardo Henrique Dalcheco/0000-0002-8324-8866; DALCHECO MESSIAS, LEONARDO HENRIQUE/0000-0002-8324-8866	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/06355-2, 2009/08535-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [472277/2011-1]; Fundo de Apoio ao Ensino, a Pesquisa e a Extensao [756/13]; FUNCAMP [1403]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Apoio ao Ensino, a Pesquisa e a Extensao; FUNCAMP	Funded by FBMG - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - 2012/06355-2. FBMG - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - 472277/2011-1. CAG - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - 2009/08535-5. LHDM - Fundo de Apoio ao Ensino, a Pesquisa e a Extensao - 756/13. FBMG - FUNCAMP - 1403.	AITKEN DA, 1992, INT J SPORT BIOMECH, V8, P165, DOI 10.1123/ijsb.8.2.165; Sousa FAB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179378; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cohen D., 1988, STAT POWER ANAL BEHA; Croft H, 2013, PROCEDIA ENGINEER, V60, P16, DOI 10.1016/j.proeng.2013.07.038; Messias LHD, 2014, INT J PERF ANAL SPOR, V14, P24, DOI 10.1080/24748668.2014.11868700; Sousa FAD, 2017, INT J SPORTS MED, V38, P378, DOI 10.1055/s-0043-100101; dos Santos KB, 2013, INT J SPORTS MED, V34, P606, DOI 10.1055/s-0032-1327575; Ferrari HG, 2017, INT J SPORT PHYSIOL, V12, P864, DOI 10.1123/ijspp.2016-0272; Fleming N, 2012, J SPORT SCI MED, V11, P16; Gomes BB, 2015, J APPL BIOMECH, V31, P258, DOI 10.1123/jab.2014-0114; Helmer RJN, 2011, PROCEDIA ENGINEER, V13, P501, DOI 10.1016/j.proeng.2011.05.121; Hopkins W.G., 2007, SPORTSCIENCE, V11, P16; Hunter A, 2008, SPORT BIOMECH, V7, P24, DOI 10.1080/14763140701683155; Hunter A, 2007, SPORT BIOMECH, V6, P155, DOI 10.1080/14763140701324842; Hunter A, 2009, SPORT BIOMECH, V8, P105, DOI 10.1080/14763140902934837; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Kalva CA, 2017, INT J SPORTS MED, V38, P353, DOI 10.1055/s-0043-101914; Macdermid PW, 2017, SPORT MED INT OPEN, V2, P50; Manchado-Gobatto FB, 2014, SCI SPORT, V29, P55, DOI DOI 10.1016/J.SCISP0.2014.04.006; MANN RV, 1980, MED SCI SPORT EXER, V12, P183; McDonnell LK, 2012, SPORT BIOMECH, V11, P507, DOI 10.1080/14763141.2012.724701; Messias LHD, 2015, INT J SPORTS MED, V36, P803, DOI 10.1055/s-0035-1548766; Messias LHD, 2015, J SPORT SCI MED, V14, P188; Michael JS, 2009, SPORT BIOMECH, V8, P167, DOI 10.1080/14763140902745019; Nibali M, 2011, EUR J SPORT SCI, V11, P125, DOI 10.1080/17461391.2010.487121; Nilsson JE, 2014, INT J SPORT PHYSIOL, V9, P365, DOI [10.1123/IJSPP.2012-0333, 10.1123/ijspp.2012-0333]; Papoti M, 2017, INT J SPORTS MED, V38, P125, DOI 10.1055/s-0042-105017; Papoti Marcelo, 2009, Int J Exerc Sci, V2, P269; Soncin R, 2017, SPORT BIOMECH, V16, P248, DOI 10.1080/14763141.2016.1231836; Sousa F, 2015, J HUM KINET, V49, P245, DOI 10.1515/hukin-2015-0127; Sperlich J, 1992, INT S BIOM SPORTS, P1; Vieira NA, 2015, J HUM SPORT EXERC, V10, P835, DOI 10.14198/jhse.2015.104.01; Zamparo P, 2006, INT J SPORTS MED, V27, P546, DOI 10.1055/s-2005-865922	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192835	10.1371/journal.pone.0192835	http://dx.doi.org/10.1371/journal.pone.0192835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489872	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000043
J	Pleumeekers, MM; Nimeskern, L; Koevoet, JLM; Karperien, M; Stok, KS; van Osch, GJVM				Pleumeekers, M. M.; Nimeskern, L.; Koevoet, J. L. M.; Karperien, M.; Stok, K. S.; van Osch, G. J. V. M.			Trophic effects of adipose-tissue-derived and bone-marrow-derived mesenchymal stem cells enhance cartilage generation by chondrocytes in co-culture	PLOS ONE			English	Article							IN-VITRO CHONDROGENESIS; ARTICULAR CHONDROCYTES; FUNCTIONAL-PROPERTIES; ENGINEERED CARTILAGE; HUMAN EAR; DIFFERENTIATION; PROLIFERATION; HYPERTROPHY; EXPANSION; CAPACITY	Aims Combining mesenchymal stem cells (MSCs) and chondrocytes has great potential for cell based cartilage repair. However, there is much debate regarding the mechanisms behind this concept. We aimed to clarify the mechanisms that lead to chondrogenesis (chondrocyte driven MSC-differentiation versus MSC driven chondroinduction) and whether their effect was dependent on MSC-origin. Therefore, chondrogenesis of human adipose-tissue derived MSCs (hAMSCs) and bone-marrow-derived MSCs (hBMSCs) combined with bovine articular chondrocytes (bACs) was compared. Methods hAMSCs or hBMSCs were combined with bACs in alginate and cultured in vitro or implanted subcutaneously in mice. Cartilage formation was evaluated with biochemical, histological and biomechanical analyses. To further investigate the interactions between bACs and hMSCs, (1) co-culture, (2) pellet, (3) Transwell and (4) conditioned media studies were conducted. Results The presence of hMSCs either hAMSCs or hBMSCs increased chondrogenesis in culture; deposition of GAG was most evidently enhanced in hBMSC/bACs. This effect was similar when hMSCs and bAC were combined in pellet culture, in alginate culture or when conditioned media of hMSCs were used on bAC. Species-specific gene-expression analyses demonstrated that aggrecan was expressed by bACs only, indicating a predominantly trophic role for hMSCs. Collagen-10-gene expression of bACs was not affected by hBMSCs, but slightly enhanced by hAMSCs. After in-vivo implantation, hAMSC/bACs and hBMSC/bACs had similar cartilage matrix production, both appeared stable and did not calcify. Conclusions This study demonstrates that replacing 80% of bACs by either hAMSCs or hBMSCs does not influence cartilage matrix production or stability. The remaining chondrocytes produce more matrix due to trophic factors produced by hMSCs.	[Pleumeekers, M. M.; Koevoet, J. L. M.; van Osch, G. J. V. M.] Erasmus MC, Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Rotterdam, Netherlands; [Nimeskern, L.; Stok, K. S.] ETH, Inst Biomech, Zurich, Switzerland; [Koevoet, J. L. M.; van Osch, G. J. V. M.] Erasmus MC, Univ Med Ctr, Dept Orthopaed, Rotterdam, Netherlands; [Karperien, M.] Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands	Erasmus University Rotterdam; Erasmus MC; Swiss Federal Institutes of Technology Domain; ETH Zurich; Erasmus University Rotterdam; Erasmus MC; University of Twente	van Osch, GJVM (corresponding author), Erasmus MC, Univ Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Rotterdam, Netherlands.; van Osch, GJVM (corresponding author), Erasmus MC, Univ Med Ctr, Dept Orthopaed, Rotterdam, Netherlands.	g.vanosch@erasmusmc.nl	Stok, Kathryn/AAA-2667-2021; Karperien, Marcel/R-3270-2018	Stok, Kathryn/0000-0002-0522-4180; Karperien, Marcel/0000-0003-0751-0604	SenterNovem	SenterNovem	The study was performed within the framework of EuroNanoMed (EAREG-406340-131009/1) and funded by SenterNovem.	Acharya C, 2012, J CELL PHYSIOL, V227, P88, DOI 10.1002/jcp.22706; Afizah H, 2007, TISSUE ENG, V13, P659, DOI 10.1089/ten.2006.0118; Ahmed Nazish, 2007, Cell Physiol Biochem, V20, P665, DOI 10.1159/000107728; Asawa Y, 2009, TISSUE ENG PT A, V15, P1109, DOI 10.1089/ten.tea.2007.0218; Aung A, 2011, ARTHRITIS RHEUM-US, V63, P148, DOI 10.1002/art.30086; Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]; Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198; Carlesimo M, 2009, EUR J DERMATOL, V19, P640, DOI 10.1684/ejd.2009.0774; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]; Cooke ME, 2011, OSTEOARTHR CARTILAGE, V19, P1210, DOI 10.1016/j.joca.2011.07.005; de Windt TS, 2014, STEM CELL TRANSL MED, V3, P723, DOI 10.5966/sctm.2013-0207; Dmitrieva RI, 2012, CELL CYCLE, V11, P377, DOI 10.4161/cc.11.2.18858; El Sayed K, 2010, TISSUE ENG PART B-RE, V16, P603, DOI [10.1089/ten.teb.2010.0167, 10.1089/ten.TEB.2010.0167]; Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502; Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31; Farrell E, 2009, TISSUE ENG PART C-ME, V15, P285, DOI 10.1089/ten.tec.2008.0297; Farrell MJ, 2014, J BIOMECH, V47, P2173, DOI 10.1016/j.jbiomech.2013.10.030; Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565; Gharibi B, 2012, STEM CELL TRANSL MED, V1, P771, DOI 10.5966/sctm.2010-0031; HAUSELMANN HJ, 1992, MATRIX, V12, P116; Hellingman CA, 2011, CELL TRANSPLANT, V20, P925, DOI 10.3727/096368910X539119; Henderson JH, 2007, TISSUE ENG, V13, P843, DOI 10.1089/ten.2006.0256; Hendriks J, 2007, J TISSUE ENG REGEN M, V1, P170, DOI 10.1002/term.19; Hendriks JAA, 2010, SOFT MATTER, V6, P5080, DOI 10.1039/c0sm00266f; HIERCK BP, 1994, J HISTOCHEM CYTOCHEM, V42, P1499, DOI 10.1177/42.11.7930532; Hildner F, 2009, TISSUE ENG PT A, V15, P3961, DOI [10.1089/ten.tea.2009.0002, 10.1089/ten.TEA.2009.0002]; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Hubka KM, 2014, TISSUE ENG PART B-RE, V20, P641, DOI [10.1089/ten.teb.2014.0034, 10.1089/ten.TEB.2014.0034]; Hwang NS, 2007, J CELL PHYSIOL, V212, P281, DOI 10.1002/jcp.21052; Isogai N, 2006, TISSUE ENG, V12, P691, DOI 10.1089/ten.2006.12.691; Johnson TS, 2004, TISSUE ENG, V10, P1308, DOI 10.1089/1076327042500445; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Jork A, 2000, APPL MICROBIOL BIOT, V53, P224, DOI 10.1007/s002530050012; Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178; Karlsson C, 2007, J ORTHOP RES, V25, P152, DOI 10.1002/jor.20287; Kusuhara H, 2009, WOUND REPAIR REGEN, V17, P136, DOI 10.1111/j.1524-475X.2008.00451.x; Lee CSD, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt126; Lee JS, 2010, TISSUE ENG PT A, V16, P3569, DOI [10.1089/ten.tea.2010.0218, 10.1089/ten.TEA.2010.0218]; Lee J, 2007, BIOTECHNOL APPL BIOC, V48, P149, DOI 10.1042/BA20060233; Leijten JCH, 2013, TISSUE ENG PART B-RE, V19, P31, DOI [10.1089/ten.teb.2012.0273, 10.1089/ten.TEB.2012.0273]; Levorson EJ, 2014, ACTA BIOMATER, V10, P1824, DOI 10.1016/j.actbio.2013.12.026; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Liu X, 2010, BIOMATERIALS, V31, P9406, DOI 10.1016/j.biomaterials.2010.08.052; Lohan A, 2011, HISTOCHEM CELL BIOL, V136, P57, DOI 10.1007/s00418-011-0822-2; Lopa S, 2013, INT J IMMUNOPATH PH, V26, P23, DOI 10.1177/03946320130260S104; Malicev E, 2009, J ORTHOP RES, V27, P943, DOI 10.1002/jor.20833; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Maumus M, 2013, STEM CELL RES, V11, P834, DOI 10.1016/j.scr.2013.05.008; Meretoja VV, 2014, TISSUE ENG PART C-ME, V20, P514, DOI 10.1089/ten.tec.2013.0532; Meretoja VV, 2012, BIOMATERIALS, V33, P6362, DOI 10.1016/j.biomaterials.2012.05.042; Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240; Naumann A, 2004, TISSUE ENG, V10, P1695, DOI 10.1089/ten.2004.10.1695; Panossian A, 2001, PLAST RECONSTR SURG, V108, P392, DOI 10.1097/00006534-200108000-00018; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Platas J, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/357014; Pleumeekers MM, 2014, EUR CELLS MATER, V27, P264, DOI 10.22203/eCM.v027a19; Pleumeekers MM, 2015, PLAST RECONSTR SURG, V136, p762E, DOI 10.1097/PRS.0000000000001812; Pleumeekers MM, 2014, EUR CELLS MATER, V27, P78; PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5; Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110; Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572; Tsuchiya K, 2004, MAT SCI ENG C-BIO S, V24, P391, DOI 10.1016/j.msec.2003.12.014; van Osch GJVM, 2004, BIORHEOLOGY, V41, P411; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wang M., 2013, SHANDONG CHEM IND, V42, P9; Wu L., 2011, TISSUE ENG PART A, V17, P9; Wu L, 2012, TISSUE ENG PT A, V18, P1542, DOI [10.1089/ten.tea.2011.0715, 10.1089/ten.TEA.2011.0715]; Xu JW, 2004, PLAST RECONSTR SURG, V113, P1361, DOI 10.1097/01.PRS.0000111594.52661.29; Yang HN, 2009, BIOMATERIALS, V30, P6374, DOI 10.1016/j.biomaterials.2009.07.062; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Zhang L, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045012; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Zuo Q, 2013, INT ORTHOP, V37, P747, DOI 10.1007/s00264-013-1782-z	76	32	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0190744	10.1371/journal.pone.0190744	http://dx.doi.org/10.1371/journal.pone.0190744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489829	Green Published, gold, Green Accepted			2022-12-27	WOS:000426276000006
J	Egger, S; Hughes, S; Smith, DP; Chambers, S; Kahn, C; Moxey, A; O'Connell, DL				Egger, Sam; Hughes, Suzanne; Smith, David P.; Chambers, Suzanne; Kahn, Clare; Moxey, Annette; O'Connell, Dianne L.			Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors	PLOS ONE			English	Article							QUALITY-OF-LIFE; UNPROVED METHODS; MEN; HEALTH; INDEX; RELIABILITY; VALIDATION; THERAPIES; WOMEN; CAM	Objective To assess whether the use of complementary and alternative medicines therapies (CAMs) for prostate cancer and/or its treatment side effects by long-term survivors is associated with selected socio-demographic, clinical, health-related quality-of-life (HRQOL) and/or psychological factors. Design, setting and participants The Prostate Cancer Care and Outcomes Study (PCOS) is a population-based cohort study of men with prostate cancer who were aged less than 70 years at diagnosis in New South Wales, Australia. Included in these analyses were men who returned a 10-year follow-up questionnaire, which included questions about CAM use. Methods Validated instruments assessed patient's HRQOL and psychological well-being. Poisson regression with robust variance estimation was used to estimate the adjusted relative risks of current CAM use for prostate cancer according to socio-demographic, clinical, HRQOL and psychological factors. Results 996 of 1634 (61%) living PCOS participants completed the 10-year questionnaire. Of these 996 men, 168 (17%) were using CAMs for prostate cancer and 525 (53%) were using CAMs for any reason (including prostate cancer). Those using CAM for prostate cancer were more likely to be regular or occasional support group participants (vs. no participation RR = 2.02; 95%Cl 1.41-2.88), born in another country (vs. Australian born RR = 1.59; 95%Cl 1.17-2.16), have received androgen deprivation treatment (ADT) since diagnosis (RR = 1.60; 95%Cl 1.12-2.28) or in the past two years (RR = 2.34; 95%Cl 1.56-3.52). CAM use was associated with greater fear of recurrence (RR =1.29; 95%Cl 1.12-1.48), cancer-specific distress (RR = 1.15; 95%Cl 1.01-1.30), cancer -specific hyperarousal (RR = 1.17; 95%Cl 1.04-1.31), cancer locus of control (RR = 1.16; 95%Cl 1.01-1.34) and less satisfaction with medical treatments (RR = 0.86; 95%Cl 0.76-0.97), but not with intrusive thinking, cognitive avoidance, depression, anxiety or any HRQOL domains. Conclusions In this study, about one in six long term prostate cancer survivors used CAMs for their prostate cancer with use centred around ADT, country of birth, distress, cancer control, fear of recurrence and active help seeking.	[Egger, Sam; Hughes, Suzanne; Smith, David P.; Kahn, Clare; O'Connell, Dianne L.] Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia; [Smith, David P.; O'Connell, Dianne L.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Smith, David P.; Chambers, Suzanne] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Chambers, Suzanne] Canc Council Queensland, Canc Res Ctr, Brisbane, Qld, Australia; [Chambers, Suzanne] Prostate Canc Fdn Australia, Sydney, NSW, Australia; [Chambers, Suzanne] Edith Cowan Univ, Exercise Med Res Inst, Perth, WA, Australia; [Chambers, Suzanne] Univ Southern Queensland, Inst Resilient Reg, Toowoomba, Qld, Australia; [Moxey, Annette; O'Connell, Dianne L.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia	Cancer Council New South Wales; University of Sydney; Griffith University; Menzies Health Institute Queensland; Cancer Council Queensland; Edith Cowan University; University of Southern Queensland; University of Newcastle	Egger, S (corresponding author), Canc Council New South Wales, Canc Res Div, Sydney, NSW, Australia.	same@nswcc.org.au	Chambers, Suzanne K/H-5957-2012	Chambers, Suzanne K/0000-0003-2369-6111; Smith, David/0000-0002-1474-3214; Egger, Sam/0000-0003-1808-6909	Prostate Cancer Foundation of Australia [PG40]; Career Development Fellowship from the Cancer Institute NSW [15/CDF/1-10]	Prostate Cancer Foundation of Australia; Career Development Fellowship from the Cancer Institute NSW	This work was supported by the Prostate Cancer Foundation of Australia (PG40) (to Dianne O'Connell). David Smith was supported by a Career Development Fellowship from the Cancer Institute NSW (#15/CDF/1-10).	Agresti A, 2003, CATEGORICAL DATA ANA; Australian Bureau of Statistics, 2001, CENS POP HOUS SOC EC; Australian Institute of Health and Welfare, 2017, CANC SERIES, V101; Bishop FL, 2011, PROSTATE CANCER P D, V14, P1, DOI 10.1038/pcan.2010.38; Boon H, 2003, UROLOGY, V62, P849, DOI 10.1016/S0090-4295(03)00668-X; Burstein HJ, 1999, NEW ENGL J MED, V340, P1733, DOI 10.1056/NEJM199906033402206; Chambers SK, 2016, PSYCHOL MEN MASCULIN, V17, P228, DOI 10.1037/men0000018; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Diefenbach MA, 2003, J UROLOGY, V170, P166, DOI 10.1097/01.ju.0000070963.12496.cc; DOWNER SM, 1994, BRIT MED J, V309, P86, DOI 10.1136/bmj.309.6947.86; Glover J, 2002, REMOTE AREAS STAT GE; Goldsbury DE, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-253; Greenberg DB, 1997, CANCER-AM CANCER SOC, V80, P1936, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1936::AID-CNCR10>3.0.CO;2-Z; Hall JD, 2003, BJU INT, V91, P603, DOI 10.1046/j.1464-410X.2003.04181.x; Henderson JW, 2003, PSYCHO-ONCOL, V12, P59, DOI 10.1002/pon.636; Hyde MK, 2016, SEX MED-UK, V4, pE7, DOI 10.1016/j.esxm.2015.12.004; Jagtenberg T, 2006, J ALTERN COMPLEM MED, V12, P323, DOI 10.1089/acm.2006.12.323; Lee MM, 2002, AM J PUBLIC HEALTH, V92, P1606, DOI 10.2105/AJPH.92.10.1606; Lippert MC, 1999, CANCER, V86, P2642, DOI 10.1002/(SICI)1097-0142(19991215)86:12<2642::AID-CNCR8>3.3.CO;2-W; Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007; Miller M, 1998, SUPPORT CARE CANCER, V6, P337, DOI 10.1007/s005200050175; Quandt SA, 2009, J ALTERN COMPLEM MED, V15, P331, DOI 10.1089/acm.2008.0521; Schraub S, 2000, SUPPORT CARE CANCER, V8, P10; Smith DP, 2007, J CLIN ONCOL, V25, P2560, DOI 10.1200/JCO.2006.09.8046; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Steginga SK, 2004, PATIENT EDUC COUNS, V55, P70, DOI 10.1016/j.pec.2003.07.007; Szymanski KM, 2010, UROLOGY, V76, P1245, DOI 10.1016/j.urology.2010.01.027; Tascilar M, 2006, ONCOLOGIST, V11, P732, DOI 10.1634/theoncologist.11-7-732; Taylor KL, 2012, J CLIN ONCOL, V30, P2768, DOI 10.1200/JCO.2011.41.2767; Walach H, 2009, J ALTERN COMPLEM MED, V15, P1139, DOI 10.1089/acm.2009.0423; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wei JT, 2000, UROLOGY, V56, P899, DOI 10.1016/S0090-4295(00)00858-X; Weiss Daniel S., 1997, P399; Wilkinson S, 2008, EUR J CANCER CARE, V17, P492, DOI 10.1111/j.1365-2354.2007.00904.x; Yu XQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-460; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193686	10.1371/journal.pone.0193686	http://dx.doi.org/10.1371/journal.pone.0193686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513724	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000426896800068
J	Yu, C; Yang, S; Kim, W; Jung, J; Chung, KY; Lee, SW; Oh, B				Yu, Chanki; Yang, Sejung; Kim, Wonoh; Jung, Jinwoong; Chung, Kee-Yang; Lee, Sang Wook; Oh, Byungho			Acral melanoma detection using a convolutional neural network for dermoscopy images	PLOS ONE			English	Article							PIGMENTED SKIN-LESIONS; DIAGNOSIS; CLASSIFICATION; PATTERN	Background/Purpose Acral melanoma is the most common type of melanoma in Asians, and usually results in a poor prognosis due to late diagnosis. We applied a convolutional neural network to dermoscopy images of acral melanoma and benign nevi on the hands and feet and evaluated its usefulness for the early diagnosis of these conditions. Methods A total of 724 dermoscopy images comprising acral melanoma (350 images from 81 patients) and benign nevi (374 images from 194 patients), and confirmed by histopathological examination, were analyzed in this study. To perform the 2-fold cross validation, we split them into two mutually exclusive subsets: half of the total image dataset was selected for training and the rest for testing, and we calculated the accuracy of diagnosis comparing it with the dermatologist's and non-expert's evaluation. Results The accuracy (percentage of true positive and true negative from all images) of the convolutional neural network was 83.51% and 80.23%, which was higher than the non-expert's evaluation (67.84%, 62.71%) and close to that of the expert (81.08%, 81.64%). Moreover, the convolutional neural network showed area-under-the-curve values like 0.8, 0.84 and Youden's index like 0.6795, 0.6073, which were similar score with the expert. Conclusion Although further data analysis is necessary to improve their accuracy, convolutional neural networks would be helpful to detect acral melanoma from dermoscopy images of the hands and feet.	[Yu, Chanki] Sogang Univ, Grad Sch Media, Dept Media Technol, Seoul, South Korea; [Yang, Sejung] Stanford Univ, Sch Med, Dept Radiat Oncol, Med Phys Div, Palo Alto, CA 94304 USA; [Yang, Sejung; Lee, Sang Wook] Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea; [Kim, Wonoh; Jung, Jinwoong; Oh, Byungho] Keimyung Univ, Coll Med, Dept Dermatol, Daegu, South Korea; [Chung, Kee-Yang] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Chung, Kee-Yang] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea	Sogang University; Stanford University; Ewha Womans University; Keimyung University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SW (corresponding author), Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea.; Oh, B (corresponding author), Keimyung Univ, Coll Med, Dept Dermatol, Daegu, South Korea.	slee@sogang.a.c.kr; obh505@gmail.com		Chung, Kee Yang/0000-0003-3257-0297; Oh, Byung Ho/0000-0001-9575-5665	National Research Foundation of Korea [2013R1A2A2A04015894, NRF-2017R1D1A1B03033288, NRF-2015M3A9A7029725]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea, No. 2013R1A2A2A04015894, to Kee-Yang Chung (http://www.nrf.re.kr/index); National Research Foundation of Korea, NRF-2017R1D1A1B03033288, to Sang Wook Lee; and National Research Foundation of Korea, NRF-2015M3A9A7029725, to Sejung Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken JF, 1996, CANCER, V78, P252, DOI 10.1002/(SICI)1097-0142(19960715)78:2<252::AID-CNCR10>3.0.CO;2-V; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Bengio Y., 2010, P 13 INT C ART INT S, P249; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fink C, 2017, SKIN RES TECHNOL, V23, P261, DOI 10.1111/srt.12350; Franke W, 2000, MELANOMA RES, V10, P571, DOI 10.1097/00008390-200012000-00009; Garnavi R, 2012, IEEE T INF TECHNOL B, V16, P1239, DOI 10.1109/TITB.2012.2212282; GREEN A, 1994, J AM ACAD DERMATOL, V31, P958, DOI 10.1016/S0190-9622(94)70264-0; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; KATO T, 1993, CLIN EXP DERMATOL, V18, P107, DOI 10.1111/j.1365-2230.1993.tb00988.x; Kittler H, 2002, LANCET ONCOL, V3, P159, DOI 10.1016/S1470-2045(02)00679-4; Krizhevsky A., P 25 INT C NEUR INF, P1097; Lallas A, 2015, BRIT J DERMATOL, V173, P1041, DOI 10.1111/bjd.14045; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Muller MP, 2005, CLIN INFECT DIS, V40, P1079, DOI 10.1086/428577; Rajpara SM, 2009, BRIT J DERMATOL, V161, P591, DOI 10.1111/j.1365-2133.2009.09093.x; Roh MR, 2010, YONSEI MED J, V51, P562, DOI 10.3349/ymj.2010.51.4.562; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; She ZS, 2007, SKIN RES TECHNOL, V13, P25, DOI 10.1111/j.1600-0846.2007.00181.x; SZEGEDY C, 2016, PROC CVPR IEEE, P2818, DOI DOI 10.1109/CVPR.2016.308; Tajbakhsh N, 2016, IEEE T MED IMAGING, V35, P1299, DOI 10.1109/TMI.2016.2535302; Tkaczyk ER, 2017, ACTA DERM-VENEREOL, V97, P5, DOI 10.2340/00015555-2717; Tran KT, 2008, J AM ACAD DERMATOL, V59, P852, DOI 10.1016/j.jaad.2008.05.027; Vedaldi A, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P689, DOI 10.1145/2733373.2807412; Yang S, 2017, BIOMED SIGNAL PROCES, V32, P90, DOI 10.1016/j.bspc.2016.09.019; 2013, ATLAS DERMOSCOPY, P1	28	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193321	10.1371/journal.pone.0193321	http://dx.doi.org/10.1371/journal.pone.0193321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513718	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800053
J	Caudron, S; Ceyte, H; Barraud, PA; Cian, C; Guerraz, M				Caudron, Sebastien; Ceyte, Hadrien; Barraud, Pierre-Alain; Cian, Corinne; Guerraz, Michel			Perception of body movement when real and simulated displacements are combined	PLOS ONE			English	Article							ANTAGONIST MUSCLE VIBRATION; TENDON VIBRATION; POSTURAL RESPONSES; NECK MUSCLES; ORIENTATION; KINESTHESIA; AFFERENTS; SENSE; SWAY; THRESHOLDS	Muscle-tendon vibration has often been used to study the contribution of proprioception to kinesthesia and postural control. This technique is known to simulate the lengthening of the vibrated muscle and, in the presence of balance constraints, evoke compensatory postural responses. The objective of the present study was to clarify the consequences of this stimulation on the dynamic features of whole-body movement perception in upright stance and in the absence of balance constraints. Eleven participants were restrained in a dark room on a motorized backboard that was able to tilt the upright body around the ankle joints. The participants were passively tilted backwards or forwards with a maximum amplitude of four degrees and at very low acceleration (thus preventing the semicircular canals from contributing to movement perception). In half the trials, the body displacement was combined with continuous vibration of the Achilles tendons, which simulates a forward tilt. Participants used a joystick to report when and in which direction they perceived their own whole-body movement. Our results showed that during backward whole-body displacement, the movement detection threshold (i.e. the minimum angular velocity required to accurately perceive passive displacement) was higher in the presence of vibration, whereas the accuracy rate (i.e. the proportion of the overall trial duration during which the movement was correctly indicated) was lower. Conversely, the accuracy rate for forward displacements was higher in the presence of vibration. In the absence of vibration, forward movement was detected earlier than backward movement. The simulated whole-body displacement evoked by Achilles tendon vibration was therefore able to either enhance or disrupt the perception of real, slow, whole-body tilt movements, depending on the congruence between the direction of real and simulated displacements.	[Caudron, Sebastien; Ceyte, Hadrien] Univ Lorraine, EA DevAH Dev Adaptat & Disabil 3450, Vandoeuvre Les Nancy, France; [Barraud, Pierre-Alain] Univ Grenoble Alpes, CNRS, CHU Grenoble Alpes, Grenoble INP,TIMC IMAG, Grenoble, France; [Cian, Corinne] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Cian, Corinne; Guerraz, Michel] Univ Grenoble Alpes, Univ Savoie Mt Blanc, CNRS, LPNC, Grenoble, France	Universite de Lorraine; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Caudron, S (corresponding author), Univ Lorraine, EA DevAH Dev Adaptat & Disabil 3450, Vandoeuvre Les Nancy, France.	sebastien.caudron@univ-lorraine.fr	CEYTE, Hadrien/HGD-8921-2022	CEYTE, Hadrien/0000-0003-1746-5026; GUERRAZ, Michel/0000-0002-4267-6995	Ministere de la Defense (France) [07co805]	Ministere de la Defense (France)	This work was supported by grant #07co805 from Ministere de la Defense (France, http://www.defense.gouv.fr/), awarded to Corinne Cian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcova N, 2007, GAIT POSTURE, V25, P99, DOI 10.1016/j.gaitpost.2006.01.008; Barbieri G, 2008, EXP BRAIN RES, V185, P545, DOI 10.1007/s00221-007-1177-8; BIGUER B, 1988, BRAIN, V111, P1405, DOI 10.1093/brain/111.6.1405; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; Caudron S, 2008, EXP BRAIN RES, V184, P53, DOI 10.1007/s00221-007-1079-9; Caudron S, 2010, EXP BRAIN RES, V202, P935, DOI 10.1007/s00221-010-2194-6; Ceyte H, 2006, EXP BRAIN RES, V170, P136, DOI 10.1007/s00221-006-0389-7; Ceyte H, 2007, NEUROSCI LETT, V416, P71, DOI 10.1016/j.neulet.2007.01.044; COHEN LA, 1961, J NEUROPHYSIOL, V24, P1; COHEN RL, 1972, PERCEPT PSYCHOPHYS, V12, P269, DOI 10.3758/BF03207202; Cordo PJ, 2005, EXP BRAIN RES, V167, P324, DOI 10.1007/s00221-005-0034-x; EKLUND G, 1972, UPSALA J MED SCI, V77, P112, DOI 10.1517/03009734000000016; Feldman AG, 2013, NEUROPSYCHOLOGIA, V51, P2590, DOI 10.1016/j.neuropsychologia.2013.09.013; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; Gandevia SC, 2011, COMPREHENSIVE PHYSL, P128, DOI [10.1002/cphy.cp120104, DOI 10.1002/CPHY.CP120104]; GILHODES JC, 1986, EXP BRAIN RES, V61, P395; Goldberg J.M., 1984, HDB PHYSL, V3, P977, DOI [10.1002/cphy.cp010321, DOI 10.1002/CPHY.CP010321]; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; Guerraz M, 2012, NEUROSCIENCE, V223, P258, DOI 10.1016/j.neuroscience.2012.07.059; INGLIS JT, 1990, EXP BRAIN RES, V81, P573, DOI 10.1007/BF02423506; Kavounoudias A, 1999, EXP BRAIN RES, V124, P80, DOI 10.1007/s002210050602; LACKNER JR, 1979, AVIAT SPACE ENVIR MD, V50, P346; Lekhel H, 1997, BRAIN, V120, P583, DOI 10.1093/brain/120.4.583; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; MATTHEWS PBC, 1982, ANNU REV NEUROSCI, V5, P189, DOI 10.1146/annurev.ne.05.030182.001201; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; NASHNER LM, 1971, ACTA OTO-LARYNGOL, V72, P429, DOI 10.3109/00016487109122504; PAULUS W, 1989, EXP BRAIN RES, V78, P243; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Proske U, 2009, J PHYSIOL-LONDON, V587, P4139, DOI 10.1113/jphysiol.2009.175372; ROLL JP, 1988, INT CONGR SER, V812, P155; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Trousselard M, 2004, COGNITIVE BRAIN RES, V20, P355, DOI 10.1016/j.cogbrainres.2004.03.008	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193174	10.1371/journal.pone.0193174	http://dx.doi.org/10.1371/journal.pone.0193174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509762	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200011
J	Dabbaghizadeh, A; Morrow, G; Amer, YO; Chatelain, EH; Pichaud, N; Tanguay, RM				Dabbaghizadeh, Afrooz; Morrow, Genevieve; Amer, Yasmine Ould; Chatelain, Etienne Hebert; Pichaud, Nicolas; Tanguay, Robert M.			Identification of proteins interacting with the mitochondrial small heat shock protein Hsp22 of Drosophila melanogaster: Implication in mitochondrial homeostasis	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; OXIDATIVE STRESS; PREMATURE SENESCENCE; PROTEOMICS ANALYSIS; EXPRESSION; CELL; CHAPERONE; PROTEOSTASIS; DYSFUNCTION; MECHANISMS	The small heat shock protein (sHsp) Hsp22 from Drosophila melanogaster (DmHsp22) is part of the family of sHsps in this diptera. This sHsp is characterized by its presence in the mitochondrial matrix as well as by its preferential expression during ageing. Although DmHsp22 has been demonstrated to be an efficient in vitro chaperone, its function within mitochondria in vivo remains largely unknown. Thus, determining its protein-interaction network (interactome) in the mitochondrial matrix would help to shed light on its function(s). In the present study we combined immunoaffinity conjugation (IAC) with mass spectroscopy analysis of mitochondria from HeLa cells transfected with DmHsp22 in non-heat shock condition and after heat shock (HS). 60 common DmHsp22-binding mitochondrial partners were detected in two independent IACs. Immunoblotting was used to validate interaction between DmHsp22 and two members of the mitochondrial chaperone machinery; Hsp60 and Hsp70. Among the partners of DmHsp22, several ATP synthase subunits were found. Moreover, we showed that expression of DmHsp22 in transiently transfected HeLa cells increased maximal mitochondrial oxygen consumption capacity and ATP contents, providing a mechanistic link between DmHsp22 and mitochondrial functions.	[Dabbaghizadeh, Afrooz; Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, Fac Med, IBIS, Lab Genet Cellulaire & Dev, Quebec City, PQ, Canada; [Dabbaghizadeh, Afrooz; Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, Fac Med, Dept Biol Mol Biochim Med & Pathol, PROTEO, Quebec City, PQ, Canada; [Amer, Yasmine Ould; Chatelain, Etienne Hebert] Univ Moncton, Dept Biol, Lab Signalisat Mitochondriale, Moncton, NB, Canada; [Pichaud, Nicolas] Univ Moncton, Dept Chim & Biochim, Lab Biochim & Physiol Comparee, Moncton, NB, Canada	Laval University; Laval University; University of Moncton; University of Moncton	Tanguay, RM (corresponding author), Univ Laval, Fac Med, IBIS, Lab Genet Cellulaire & Dev, Quebec City, PQ, Canada.; Tanguay, RM (corresponding author), Univ Laval, Fac Med, Dept Biol Mol Biochim Med & Pathol, PROTEO, Quebec City, PQ, Canada.	robert.tanguay@fmed.ulaval.ca		Pichaud, Nicolas/0000-0002-2820-8124	Canadian Institutes of Health Research (CIHR); PROTEO; Alzheimer Society of Canada, Brain Canada; Natural Sciences and Engineering Research Council (NSERC); Canadian Breast Cancer Foundation; New Brunswick Innovation Foundation; New Brunswick Health Research Foundation; Universite de Moncton; NSERC	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); PROTEO; Alzheimer Society of Canada, Brain Canada; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); New Brunswick Innovation Foundation; New Brunswick Health Research Foundation; Universite de Moncton; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work has been supported by grants from the Canadian Institutes of Health Research (CIHR) to RMT and a scholarship from PROTEO to AD. The authors would like to thank Dr. Sylvie Bourassa from Proteomics platform of CHU de Quebec Research Center-CHUL for help with Mass Spectrometry.The work of E.Hebert-Chatelain is supported by the Alzheimer Society of Canada, Brain Canada, Natural Sciences and Engineering Research Council (NSERC), Canadian Breast Cancer Foundation, New Brunswick Innovation Foundation, New Brunswick Health Research Foundation 606 and Universite de Moncton. N. Pichaud is supported by grants from the NSERC and the Universite de Moncton.	Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Candido E Peter M, 2002, Prog Mol Subcell Biol, V28, P61; CARBAJAL EM, 1993, EXP CELL RES, V207, P300, DOI 10.1006/excr.1993.1197; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Clayton David A, 2014, Cold Spring Harb Protoc, V2014, DOI 10.1101/pdb.top074542; Colinet H, 2010, J EXP BIOL, V213, P4146, DOI 10.1242/jeb.051003; Correia-Melo C, 2015, BBA-BIOENERGETICS, V1847, P1373, DOI 10.1016/j.bbabio.2015.05.017; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; Dabbaghizadeh A, 2017, CELL STRESS CHAPERON, V22, P577, DOI 10.1007/s12192-017-0784-y; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5; Dencher NA, 2007, ANN NY ACAD SCI, V1100, P291, DOI 10.1196/annals.1395.030; Dimmer KS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-209; Eyles SJ, 2010, P NATL ACAD SCI USA, V107, P2727, DOI 10.1073/pnas.0915160107; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Ganguly G, 2017, DRUG DES DEV THER, V11, P797, DOI 10.2147/DDDT.S130514; Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214; Gregersen N, 2012, J INHERIT METAB DIS, V35, P715, DOI 10.1007/s10545-012-9480-3; Groebe K, 2007, EXP GERONTOL, V42, P887, DOI 10.1016/j.exger.2007.07.001; Groebe K, 2010, EXP GERONTOL, V45, P632, DOI 10.1016/j.exger.2010.02.006; Gruenewald C, 2009, FREE RADICAL BIO MED, V46, P1668, DOI 10.1016/j.freeradbiomed.2009.03.025; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Hill S, 2014, REDOX BIOL, V2, P936, DOI 10.1016/j.redox.2014.07.005; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hirano Y, 2012, GENES BRAIN BEHAV, V11, P79, DOI 10.1111/j.1601-183X.2011.00748.x; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jang JY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1857; Jang JY, 2006, CELL IMMUNOL, V241, P14, DOI 10.1016/j.cellimm.2006.07.006; Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006; JONES HW, 1971, OBSTET GYNECOL, V38, P945; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Kawasaki F, 2016, DIS MODEL MECH, V9, P953, DOI 10.1242/dmm.026385; Kim HJ, 2010, EXP GERONTOL, V45, P611, DOI 10.1016/j.exger.2009.12.012; Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; King V, 1999, DEV BIOL, V207, P107, DOI 10.1006/dbio.1998.9147; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Koc EC, 2012, BBA-GENE REGUL MECH, V1819, P1055, DOI 10.1016/j.bbagrm.2012.03.003; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landis G, 2012, AGING-US, V4, P768, DOI 10.18632/aging.100499; Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021; Laplante AF, 1998, J HISTOCHEM CYTOCHEM, V46, P1291, DOI 10.1177/002215549804601109; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maaroufi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081207; Mimoto T, 2012, BRAIN RES, V1446, P109, DOI 10.1016/j.brainres.2011.12.064; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Morrow G, 2016, MECH AGEING DEV, V155, P36, DOI 10.1016/j.mad.2016.02.011; Morrow G, 2016, BIOGERONTOLOGY, V17, P61, DOI 10.1007/s10522-015-9591-y; Morrow G, 2015, FRONT GENET, V6, DOI [10.3389/fgene.2015.00103, 10.3389/fpsyg.2015.01652]; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Orr WC, 2013, ANTIOXID REDOX SIGN, V19, P788, DOI 10.1089/ars.2012.5002; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Poon HF, 2006, NEUROBIOL AGING, V27, P1020, DOI 10.1016/j.neurobiolaging.2005.05.014; Poon HF, 2006, NEUROBIOL AGING, V27, P1010, DOI 10.1016/j.neurobiolaging.2005.05.006; Poon HF, 2006, ANTIOXID REDOX SIGN, V8, P381, DOI 10.1089/ars.2006.8.381; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Runkel ED, 2014, EXP GERONTOL, V56, P194, DOI 10.1016/j.exger.2014.02.013; Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Shen J, 2013, CELL CYCLE, V12, P3237, DOI 10.4161/cc.26354; Stockl P, 2007, FREE RADICAL BIO MED, V43, P947, DOI 10.1016/j.freeradbiomed.2007.06.005; Stockl P, 2006, EXP GERONTOL, V41, P674, DOI 10.1016/j.exger.2006.04.009; Sultana R, 2006, NEUROBIOL AGING, V27, P1564, DOI 10.1016/j.neurobiolaging.2005.09.021; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Tower J, 2014, J GERONTOL A-BIOL, V69, P253, DOI 10.1093/gerona/glt078; van Oosten-Hawle P, 2014, GENE DEV, V28, P1533, DOI 10.1101/gad.241125.114; Visser WF, 2002, BIOCHEM BIOPH RES CO, V299, P494, DOI 10.1016/S0006-291X(02)02663-3; Wadhwa R, 2010, J BIOL CHEM, V285, P3833, DOI 10.1074/jbc.M109.080424; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Zamora M, 2004, FEBS LETT, V563, P155, DOI 10.1016/S0014-5793(04)00293-5	85	9	9	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193771	10.1371/journal.pone.0193771	http://dx.doi.org/10.1371/journal.pone.0193771			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509794	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200030
J	Seo, JW; Han, K; Lee, J; Kim, EK; Moon, HJ; Yoon, JH; Park, VY; Baek, HM; Kwak, JY				Seo, Ji Won; Han, Kyunghwa; Lee, Jandee; Kim, Eun-Kyung; Moon, Hee Jung; Yoon, Jung Hyun; Park, Vivian Youngjean; Baek, Hyeon-Man; Kwak, Jin Young			Application of metabolomics in prediction of lymph node metastasis in papillary thyroid carcinoma	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; MAGNETIC-RESONANCE-SPECTROSCOPY; THYROGLOBULIN MEASUREMENT; BRAF MUTATION; CANCER; LACTATE; NODULES; SPECIMENS; DIAGNOSIS; SURVIVAL	Purpose The aim of this study was to find useful metabolites to predict lymph node (LN) metastasis in patients with papillary thyroid cancer (PTC) through a metabolomics approach and investigate the potential role of metabolites as a novel prognostic marker. Materials and methods Fifty-two consecutive patients (median age: 41.5 years, range 15-74 years) were enrolled who underwent total thyroidectomy and central LN dissection with or without lateral LN dissection in Severance Hospital between October 2013 and July 2015. The study specimens were provided by the Severance Hospital Gene Bank, and consisted of PTC from each patient. The specimens were prepared for proton nuclear magnetic resonance (H-1-NMR) spectroscopy. Spectral data by H-1-NMR spectroscopy were acquired, processed, and analyzed. Patients were grouped in three ways, according to the presence of LN metastasis, central LN metastasis and lateral LN metastasis. Chi-square test and the student t-test were used to analyze categorical variables and continuous variables, respectively. The Mann-Whitney U test was used for univariate analysis of metabolites. Orthogonal projections to latent structure discriminant analysis (OPLS-DA) was used for multivariate analysis to discriminate metabolic differences between the two groups. Results Among 52 patients, 32 had central LN metastasis and 19 had lateral LN metastasis. No clinical or histopathological characteristic was significantly different for all comparisons. On univariate analysis, no metabolite showed significant difference for all comparisons. On multivariate analysis, OPLS-DA did not discriminate the presence and absence of LN metastasis. Lactate was found to be the most promising metabolite. Conclusions No metabolite could discriminate the presence of LN metastasis. However, lactate was found to be the most promising metabolite for discrimination. Further studies with larger sample sizes are needed to elucidate significant metabolites which can indicate the presence of LN metastasis in patients with PTC.	[Seo, Ji Won; Han, Kyunghwa; Kim, Eun-Kyung; Moon, Hee Jung; Yoon, Jung Hyun; Park, Vivian Youngjean; Kwak, Jin Young] Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea; [Han, Kyunghwa] Yonsei Univ, Coll Med, Ctr Clin Imaging Data Sci, Seoul, South Korea; [Lee, Jandee] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Baek, Hyeon-Man] Gachon Univ, Dept Biomed Engn, Incheon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Gachon University	Kwak, JY (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea.; Baek, HM (corresponding author), Gachon Univ, Dept Biomed Engn, Incheon, South Korea.	hmbaek98@gachon.ac.kr; docjin@yuhs.ac	; Kim, Eun-Kyung/E-5211-2017	Yoon, Jung Hyun/0000-0002-2100-3513; Park, Vivian/0000-0002-5135-4058; Moon, Hee Jung/0000-0002-5643-5885; Kwak, Jin Young/0000-0002-6212-1495; Han, Kyunghwa/0000-0002-5687-7237; Kim, Eun-Kyung/0000-0002-3368-5013; Lee, Jandee/0000-0003-4090-0049	Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education [2016R1D1A1B03930375]	Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education (2016R1D1A1B03930375, https://www.nrf.re.kr/index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education (2016R1D1A1B03930375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Chung J, 2014, HEAD NECK-J SCI SPEC, V36, P795, DOI 10.1002/hed.23371; Deja S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084637; Fagin JA, 2002, MOL ENDOCRINOL, V16, P903, DOI 10.1210/me.16.5.903; Gaude E, 2012, R PACKAGE VERSION, P1; Han PA, 2016, THYROID, V26, P532, DOI 10.1089/thy.2015.0378; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Howell GM, 2013, ANN SURG ONCOL, V20, P47, DOI 10.1245/s10434-012-2611-0; Huang W, 2004, RADIOLOGY, V232, P585, DOI 10.1148/radiol.2322030547; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jordan KW, 2011, ACTA CYTOL, V55, P584, DOI 10.1159/000333271; Kelly RS, 2016, CANC EPIDEMIOLOGY BI; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Kim KH, 2004, YONSEI MED J, V45, P818, DOI 10.3349/ymj.2004.45.5.818; Kim KE, 2013, WORLD J SURG, V37, P385, DOI 10.1007/s00268-012-1826-3; Kim MJ, 2009, CLIN ENDOCRINOL, V70, P145, DOI 10.1111/j.1365-2265.2008.03297.x; King AD, 2005, EUR J RADIOL, V54, P112, DOI 10.1016/j.ejrad.2004.05.003; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Kwak JY, 2009, RADIOLOGY, V253, P854, DOI 10.1148/radiol.2533090471; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Liu RT, 2005, CLIN ENDOCRINOL, V63, P461, DOI 10.1111/j.1365-2265.2005.02367.x; Lundgren CI, 2006, CANCER, V106, P524, DOI 10.1002/cncr.21653; Miccoli P, 2012, SURGERY, V152, P1118, DOI 10.1016/j.surg.2012.08.037; Moon HJ, 2009, ANN SURG ONCOL, V16, P3125, DOI 10.1245/s10434-009-0644-9; Nikiforov YE, 2002, ENDOCR PATHOL, V13, P3, DOI 10.1385/EP:13:1:03; Podnos YD, 2005, AM SURGEON, V71, P731; Quagliariello V, 2016, J CELLULAR PHYSL; Ryoo I, 2016, SCI REP-UK, V6, DOI 10.1038/srep30075; SCHWICKERT G, 1995, CANCER RES, V55, P4757; Shang X, 2016, TUMOR BIOL, V37, P1; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; Sjobakk TE, 2008, NMR BIOMED, V21, P175, DOI 10.1002/nbm.1180; Skov T, 2006, J CHEMOMETR, V20, P484, DOI 10.1002/cem.1031; Sohn YM, 2010, AM J ROENTGENOL, V194, P38, DOI 10.2214/AJR.09.3128; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Torregrossa L, 2012, J PROTEOME RES, V11, P3317, DOI 10.1021/pr300105e; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Wada N, 2003, ANN SURG, V237, P399, DOI 10.1097/00000658-200303000-00015; Wojakowska A, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/258763; Wojtowicz W, 2016, METABOLOMICS OPEN AC, V2016; Wojtowicz W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09203-3; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Xing MZ, 2004, J CLIN ENDOCR METAB, V89, P2867, DOI 10.1210/jc.2003-032050; Yao ZZ, 2011, MOL BIOSYST, V7, P2608, DOI 10.1039/c1mb05029j	48	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193883	10.1371/journal.pone.0193883	http://dx.doi.org/10.1371/journal.pone.0193883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509799	gold, Green Published, Green Submitted			2022-12-27	WOS:000426813200038
J	Wairagkar, M; Hayashi, Y; Nasuto, SJ				Wairagkar, Maitreyee; Hayashi, Yoshikatsu; Nasuto, Slawomir J.			Exploration of neural correlates of movement intention based on characterisation of temporal dependencies in electroencephalography	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; SINGLE-TRIAL EEG; MOTOR-IMAGERY; THETA-BAND; BCI; DESYNCHRONIZATION; (DE)SYNCHRONIZATION; MODULATION; ERD/ERS; POWER	Brain computer interfaces (BCIs) provide a direct communication channel by using brain signals, enabling patients with motor impairments to interact with external devices. Motion intention detection is useful for intuitive movement-based BCI as movement is the fundamental mode of interaction with the environment. The aim of this paper is to investigate the temporal dynamics of brain processes using electroencephalography (EEG) to explore novel neural correlates of motion intention. We investigate the changes in temporal dependencies of the EEG by characterising the decay of autocorrelation during asynchronous voluntary finger tapping movement. The evolution of the autocorrelation function is characterised by its relaxation time, which is used as a robust marker for motion intention. We observed that there was reorganisation of temporal dependencies in EEG during motion intention. The autocorrelation decayed slower during movement intention and faster during the resting state. There was an increase in temporal dependence during movement intention. The relaxation time of the autocorrelation function showed significant (p < 0.05) discrimination between movement and resting state with the mean sensitivity of 78.37 +/- 8.83%. The relaxation time provides movement related information that is complementary to the well-known event-related desynchronisation (ERD) by characterising the broad band EEG dynamics which is frequency independent in contrast to ERD. It can also detect motion intention on average 0.51s before the actual movement onset. We have thoroughly compared autocorrelation relaxation time features with ERD in four frequency bands. The relaxation time may therefore, complement the well-known features used in motion-based BCI leading to more robust and intuitive BCI solutions. The results obtained suggest that changes in autocorrelation decay may involve reorganisation of temporal dependencies of brain activity over longer duration during motion intention. This opens the possibilities of investigating further the temporal dynamics of fundamental neural processes underpinning motion intention.	[Wairagkar, Maitreyee; Hayashi, Yoshikatsu; Nasuto, Slawomir J.] Univ Reading, Sch Biol Sci, Brain Embodiment Lab, Biomed Engn, Reading, Berks, England	University of Reading	Wairagkar, M (corresponding author), Univ Reading, Sch Biol Sci, Brain Embodiment Lab, Biomed Engn, Reading, Berks, England.	m.n.wairagkar@pgr.reading.ac.uk		Wairagkar, Maitreyee/0000-0002-9546-2843	University of Reading International Research Studentship [GS14-46]	University of Reading International Research Studentship	This research was funded by University of Reading International Research Studentship awarded to MW (reference number: GS14-46, URL:http://www.reading.ac.uk/).The funders had no role in study design, data collection and analysis, decision to publish, o rpreparation of the manuscript.	Amiri S, 2013, ADV HUM-COMPUT INTER, V2013, DOI 10.1155/2013/187024; Ang KK, 2017, IEEE T NEUR SYS REH, V25, P392, DOI 10.1109/TNSRE.2016.2646763; Bai O, 2011, CLIN NEUROPHYSIOL, V122, P364, DOI 10.1016/j.clinph.2010.07.010; Bashashati A, 2007, J NEURAL ENG, V4, pR32, DOI 10.1088/1741-2560/4/2/R03; Bastiaansen MCM, 2002, NEUROSCI LETT, V323, P13, DOI 10.1016/S0304-3940(01)02535-6; Blankertz B., 2008, SIGNAL PROCESSING MA, P41, DOI DOI 10.1109/MSP.2008; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Breitwieser C, 2012, IEEE T BIO-MED ENG, V59, P852, DOI 10.1109/TBME.2011.2174637; Bularka S, 2016, 2016 12TH IEEE INTERNATIONAL SYMPOSIUM ON ELECTRONICS AND TELECOMMUNICATIONS (ISETC'16), P219, DOI 10.1109/ISETC.2016.7781096; Clochon P, 1996, ELECTROEN CLIN NEURO, V98, P126, DOI 10.1016/0013-4694(95)00192-1; Crevecoeur F, 2010, J NEUROSCI METH, V192, P163, DOI 10.1016/j.jneumeth.2010.07.017; Daly I, 2015, IEEE T NEUR SYS REH, V23, P725, DOI 10.1109/TNSRE.2014.2346621; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demandt E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00065; Dimitriadis SI, 2016, CLIN NEUROPHYSIOL, V127, P2878, DOI 10.1016/j.clinph.2016.05.359; Dobkin BH, 2007, J PHYSIOL-LONDON, V579, P637, DOI 10.1113/jphysiol.2006.123067; Durka PJ, 2001, MED BIOL ENG COMPUT, V39, P315, DOI 10.1007/BF02345286; Faller J, 2012, IEEE T NEUR SYS REH, V20, P313, DOI 10.1109/TNSRE.2012.2189584; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Guger C, 2017, SPRBRIEF ELECT, P105, DOI 10.1007/978-3-319-64373-1_11; Hamedi M, 2016, NEURAL COMPUT, V28, P999, DOI 10.1162/NECO_a_00838; Hayashi Y, 2013, CONVERGING CLIN ENG, P569; He B, 2015, P IEEE, V103, P907, DOI [10.1109/JPROC.2015.2407272, 10.1109/jproc.2015.2407272]; HOLM S, 1979, SCAND J STAT, V6, P65; Hwang HJ, 2013, INT J HUM-COMPUT INT, V29, P814, DOI 10.1080/10447318.2013.780869; Ibanez J, 2014, IEEE ENG MED BIO, P1646, DOI 10.1109/EMBC.2014.6943921; Ibanez J, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056009; Jausovec N, 2001, NEUROSCI LETT, V311, P93, DOI 10.1016/S0304-3940(01)02141-3; Jin J, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa6213; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kai Keng Ang, 2013, Journal of Computing Science and Engineering, V7, P139, DOI 10.5626/JCSE.2013.7.2.139; KALCHER J, 1995, ELECTROEN CLIN NEURO, V94, P381, DOI 10.1016/0013-4694(95)00040-6; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Lew E, 2012, J FRONT NEUROENG, V5, P2012, DOI 10.3389/fneng.2012.00013; Lew EYL, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00222; Li AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116429; Liao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085192; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Lopez-Larraz E, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-153; Lotte F., 2014, GUIDE BRAIN COMPUTER, DOI [10.1007/978-1-4471-6584-2_7, DOI 10.1007/978-1-4471-6584-2_7]; Lou B, 2008, J NEURAL ENG, V5, P342, DOI 10.1088/1741-2560/5/3/007; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; McFarland DJ, 2006, IEEE T NEUR SYS REH, V14, P135, DOI 10.1109/TNSRE.2006.875637; Meng F, 2008, IEEE IJCNN, P4103, DOI 10.1109/IJCNN.2008.4634388; Mrachacz-Kersting N, 2012, J PHYSIOL-LONDON, V590, P1669, DOI 10.1113/jphysiol.2011.222851; Nam CS, 2011, CLIN NEUROPHYSIOL, V122, P567, DOI 10.1016/j.clinph.2010.08.002; Osuagwu BCA, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/6/065002; Pan CP, 2004, PHYS LETT A, V329, P130, DOI 10.1016/j.physleta.2004.06.070; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2006, PROG BRAIN RES, V159, P433, DOI 10.1016/S0079-6123(06)59028-4; Podobnik B, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/68001; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Reis PMR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00156; Robinson N, 2017, I IEEE EMBS C NEUR E, P572, DOI 10.1109/NER.2017.8008416; Scherer R, 2008, IEEE T BIO-MED ENG, V55, P675, DOI 10.1109/TBME.2007.903709; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Solis-Escalante T, 2012, CLIN NEUROPHYSIOL, V123, P1182, DOI 10.1016/j.clinph.2012.01.013; Vidaurre C, 2006, IEEE T BIO-MED ENG, V53, P1214, DOI 10.1109/TBME.2006.873542; Vidaurre C, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/935364; Vidaurre C, 2009, NEURAL NETWORKS, V22, P1313, DOI 10.1016/j.neunet.2009.07.020; Wairagkar M., 2014, INT C BRAIN COMP INT; Wairagkar M., 2017, EEG DATA VOLUNTARY F; Wairagkar M, 2015, LECT NOTES ARTIF INT, V9250, P212, DOI 10.1007/978-3-319-23344-4_21; Wang HQ, 2016, IEEE T NEUR SYS REH, V24, P532, DOI 10.1109/TNSRE.2016.2519350; Xu R, 2014, IEEE T BIO-MED ENG, V61, P288, DOI 10.1109/TBME.2013.2294203; Zhigalov A, 2016, CLIN NEUROPHYSIOL, V127, P2882, DOI 10.1016/j.clinph.2016.04.028	71	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193722	10.1371/journal.pone.0193722	http://dx.doi.org/10.1371/journal.pone.0193722			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509785	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200026
J	Chem, ED; Anong, DN; Akoachere, JFKT				Chem, Elvis Dzelamonyuy; Anong, Damian Nota; Akoachere, Jane-Francis K. T.			Prescribing patterns and associated factors of antibiotic prescription in primary health care facilities of Kumbo East and Kumbo West Health Districts, North West Cameroon	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; RESISTANCE; CHILDREN; PREDICTORS; PHYSICIANS; CENTERS; EUROPE; DRUGS	Background Inappropriate use of antibiotics is a global public health challenge and has been associated with antibiotic resistance. WHO reports show that efforts to promote rational antibiotic use in developing countries are poor. With the growing number of infections with antibiotic resistant bacteria, rational drug use becomes imperative and studies that promote rational drug use are highly necessary. Considering this, we investigated prescribing patterns and predictors of antibiotic prescription in primary health care facilities in Kumbo East (KE) and Kumbo West (KW) health districts in North West Cameroon, to contribute data which could influence policy on antibiotic use. Methods and findings A cross sectional retrospective study was conducted from April 2014 to April 2015 in 26 randomly selected primary care facilities. Questionnaires were administered to 59 antibiotic prescribers to determine factors that predict antibiotic prescribing. Data on antibiotic prescription were collected by review of consultation registers. Prescription rates and demographics, prescriber and institution factors were analyzed using ANOVA. The best predictor of prescription was determined using multiple linear regression analysis. Results A total of 30,096 prescriptions were reviewed. Overall antibiotic prescription rate was 36.71%, with a mean of 1.14 antibiotics prescribed per patient. Amoxicillin was the most prescribed (29.9%). The most prevalent indications for prescribing were respiratory tract infections (21.27%). All antibiotics prescribed were broad- spectrum. Antibiotics were prescribed for patients with malaria and also in situations where diagnosis was uncertain. Prescribing by generic name was 98.36% while 99.87% was from Essential Drug List. Use of laboratory results, patient turnout and Performance Based Financing (PBF) were significantly associated with antibiotic prescribing rates (p < 0.05). PBF moderated prescribing. Conclusion There was misuse of antibiotics in primary care facilities in study area. We recommend all primary care health facilities in study area to be included in the PBF scheme and that prescribing should only be done by physicians as the have adequate training.	[Chem, Elvis Dzelamonyuy; Anong, Damian Nota; Akoachere, Jane-Francis K. T.] Univ Buea, Fac Sci, Dept Microbiol & Parasitol, Buea, Cameroon		Akoachere, JFKT (corresponding author), Univ Buea, Fac Sci, Dept Microbiol & Parasitol, Buea, Cameroon.	jakoachere@yahoo.com		Dzelamonyuy, Chem Elvis/0000-0002-1346-8871				Akkerman AE, 2005, BRIT J GEN PRACT, V55, P114; Akoachere Jane-Francis Tatah Kihla, 2012, BMC Res Notes, V5, P219, DOI 10.1186/1756-0500-5-219; [Anonymous], 2015, NAT MAL CONTR PROGR, P22; [Anonymous], EDM RES SER; Apisarnthanarak A, 2007, AM J INFECT CONTROL, V35, P606, DOI 10.1016/j.ajic.2007.05.008; Bharathiraja R, 2005, INDIAN J PEDIATR, V72, P1; Bilal AI, BMC HLTH SERV RES, V16, P144; Cadieux G, 2007, CAN MED ASSOC J, V177, P877, DOI 10.1503/cmaj.070151; Carneiro M, 2011, REV ASSOC MED BRAS, V57, P421, DOI 10.1590/S0104-42302011000400016; Charan N, 2013, J BIOMEDICAL PHARM R, V2, P71; Chareonkul Chanin, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P418; Chung A, 2007, BMJ-BRIT MED J, V335, P429, DOI 10.1136/bmj.39274.647465.BE; Consortium AEDES/IRESCO, PERF BAS FIN IMPL MA; Costelloe Ceire, 2010, BMJ, V340, pc2096, DOI 10.1136/bmj.c2096; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Dekker ARJ, 2015, FAM PRACT, V32, P401, DOI 10.1093/fampra/cmv019; Department of human resources, 2009, REV EQ OPP WOM WORKP, P3; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; Donkor ES, INT J ENV RES PUBLIC, V9, P3519; Dyar OJ, 2016, EXPERT REV ANTI-INFE, V14, P403, DOI 10.1586/14787210.2016.1151353; Erah P. O., 2003, Tropical Journal of Pharmaceutical Research, V2, P175; Fadare JO, 2016, EXPERT REV PHARM OUT, V16, P639, DOI 10.1586/14737167.2016.1120673; Finch R, 2007, J ANTIMICROB CHEMOTH, V60, pI79, DOI 10.1093/jac/dkm165; Fitchett JR, 2016, LANCET INFECT DIS, V16, P388, DOI 10.1016/S1473-3099(15)00410-7; Gandra S, 2014, CLIN MICROBIOL INFEC, V20, P973, DOI 10.1111/1469-0691.12798; Gebeyehu E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138179; Gjelstad S, 2011, J ANTIMICROB CHEMOTH, V66, P2425, DOI 10.1093/jac/dkr295; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; HOGERZEIL HV, 1993, LANCET, V342, P1408, DOI 10.1016/0140-6736(93)92760-Q; Holloway K., 2011, WHO WORLD MED SITUAT, V3rd; Holloway KA, 2013, TROP MED INT HEALTH, V18, P656, DOI 10.1111/tmi.12123; Horwood J, 2016, BRIT J GEN PRACT, V66, pE207, DOI 10.3399/bjgp16X683821; Huang AM, 2005, CLIN INFECT DIS, V57, P1237; Jubulis J, 2015, INT J TUBERC LUNG D, V19, P823, DOI 10.5588/ijtld.14.0527; Kesah FNC, 2013, ANN TROP MED PUBLIC, V6, P446, DOI 10.4103/1755-6783.127797; Kotwani A, 2010, FAM PRACT, V27, P684, DOI 10.1093/fampra/cmq059; Laing R., 2001, W AFR J PHARM DRUG R, V18, P6, DOI [10.4314/wajpdr.v18i1.14718, DOI 10.4314/WAJPDR.V18I1.14718]; Lim Y.-P., 2012, EVID BASED COMPLEMEN, V2012, P1; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Lloyd W, 2013, ANTIBIOTIC PRESCRIBI, P2; Mahmoud R., 2014, SUDAN MED MONIT, V9, P61, DOI [10.4103/1858-5000.146575, DOI 10.4103/1858-5000.146575]; Mainous AG, 2009, ANN FAM MED, V7, P431, DOI 10.1370/afm.999; Mashalla Y, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.13042; Mbam LA, 2015, J HLTH SCI DIS, V6, P1; Mbonye AK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010632; Naseeb TA, 2005, SAUDI MED J, V26, P1436; National Institute for Health and Clinical Excellence (UK), 2008, RESP TRACT INF ANT S; Ndhlovu M, 2015, TROP MED INT HEALTH, V20, P1696, DOI 10.1111/tmi.12591; Ofori-Asenso R, BMC PUBLIC HLTH, V16, P724; Otoom S., 2010, Eastern Mediterranean Health Journal, V16, P511; Pavin M, 2003, TROP MED INT HEALTH, V8, P182, DOI 10.1046/j.1365-3156.2003.00992.x; Petersen I, 2007, J ANTIMICROB CHEMOTH, V60, pI43, DOI 10.1093/jac/dkm156; Piovani D, 2015, PHARMACOEPIDEM DR S, V24, P121, DOI 10.1002/pds.3654; Rezal RSM, 2015, EXPERT REV ANTI-INFE, V13, P665, DOI 10.1586/14787210.2015.1025057; Rudasingwa M, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1327241; Shankar Ravi Pathiyil, 2003, Ann Clin Microbiol Antimicrob, V2, P7; Smith RD, 2012, TECHNICAL REPORT; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; van den Broek d'Obrenan J, 2014, J ANTIMICROB CHEMOTH, V69, P1701, DOI 10.1093/jac/dku005; van der Velden AW, 2013, INT J CLIN PRACT, V67, P10, DOI 10.1111/ijcp.12336; Veronin MA, 2011, J PHARM HEALTH SERV, V2, P135, DOI 10.1111/j.1759-8893.2011.00059.x; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Bank, 2014, PERF BAS FIN CAM INN; Wu YQ, 2016, EUR J CLIN PHARMACOL, V72, P359, DOI 10.1007/s00228-015-1997-6	64	46	46	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193353	10.1371/journal.pone.0193353	http://dx.doi.org/10.1371/journal.pone.0193353			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505584	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200011
J	Fu, CF; Huang, JD; Wang, JT; Lin, SW; Wu, CC				Fu, Chien-Fang; Huang, Jiun-Da; Wang, Jann-Tay; Lin, Shu-Wen; Wu, Chien-Chih			The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia	PLOS ONE			English	Article							CONCENTRATION-TIME CURVE; HIGH-FLUX HEMODIALYSIS; INFECTIONS; MORTALITY; BIOFILMS; AREA	Background Vancomycin is a standard treatment for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, and its efficacy is closely linked to the recommended serum trough concentration of 15 +/- 20 mg/L. However, it is unknown how the pre-dialysis trough serum concentration (Cpre-HD) correlates with MRSA eradication in renal failure patients undergoing intermittent hemodialysis (HD). Objective To evaluate the relationship between Cpre-HD and the treatment outcomes in this population. Materials and methods A retrospective study was conducted to enroll renal failure patients undergoing HD who had received vancomycin treatment for MRSA bacteremia during January 2013 to June 2016. Treatment failure was defined as persistent bacteremia after >= 7 days of vancomycin therapy or recurrent MRSA infection within 30 days. Patient characteristics, vancomycin dosing regimen, Cpre-HD, vancomycin minimum inhibitory concentration (MIC), and subsequent culture data were reviewed. The receiver operating characteristic (ROC) curve was used to find the optimal cut-off point of Cpre-HD. Results 42 patients were enrolled and 64% had treatment failure. Although there were no significant differences in demographics or Cpre-HD between the two groups, Cpre-HD/MIC was significantly higher in the success group than that in the failure group (22.80 +/- 10.90 vs. 14.94 +/- 6.11, p = 0.019). The area under the ROC curve was 0.74, while the sensitivity, specificity, positive predictive value, and negative predictive value were 67%, 78%, 62.5%, and 81%, respectively, at the optimal Cpre-HD/MIC of. 18.6. Conclusions Cpre-HD/MIC was associated with vancomycin treatment outcome in MRSA bacteremia, and targeting to achieve a Cpre-HD/MIC of. 18.6 may improve treatment outcomes in renal failure patients who are on intermittent HD.	[Fu, Chien-Fang; Huang, Jiun-Da; Lin, Shu-Wen; Wu, Chien-Chih] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Wang, Jann-Tay] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Lin, Shu-Wen; Wu, Chien-Chih] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Lin, Shu-Wen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Pharm, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Wu, CC (corresponding author), Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan.; Wu, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan.	101440@ntuh.gov.tw		LIN, SHU-WEN/0000-0002-9940-0850; WANG, JANN-TAY/0000-0002-0924-3469; Wu, Chien Chih/0000-0002-9517-2176				Ariano RE, 2005, AM J KIDNEY DIS, V46, P681, DOI 10.1053/j.ajkd.2005.07.018; Barth RH, 1996, KIDNEY INT, V50, P929, DOI 10.1038/ki.1996.393; Brown J, 2012, ANTIMICROB AGENTS CH, V56, P634, DOI 10.1128/AAC.05609-11; Brown M, 2011, CLIN INFECT DIS, V53, P164, DOI 10.1093/cid/cir322; Centers for Disease C, 2005, MMWR-MORBID MORTAL W, V56, P197; Clinical and Laboratory Standards Institute (CLSI), 2009, CLSI PUBL, VM07-A8; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Crew P, 2015, AM J HEALTH-SYST PH, V72, P1856, DOI 10.2146/ajhp150051; DASGUPTA MK, 1991, ADV PERIT D, V7, P165; DASGUPTA MK, 1989, BLOOD PURIFICAT, V7, P144, DOI 10.1159/000169586; Holmes NE, 2013, ANTIMICROB AGENTS CH, V57, P1654, DOI 10.1128/AAC.01485-12; Jung Y, 2014, INT J ANTIMICROB AG, V43, P179, DOI 10.1016/j.ijantimicag.2013.10.017; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Lin SY, 2014, INT J ANTIMICROB AG, V43, P384, DOI 10.1016/j.ijantimicag.2014.01.002; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lodise TP, 2014, CLIN INFECT DIS, V59, P666, DOI 10.1093/cid/ciu398; Marr KA, 1997, ANN INTERN MED, V127, P275, DOI 10.7326/0003-4819-127-4-199708150-00003; Moise-Broder PA, 2004, CLIN PHARMACOKINET, V43, P925, DOI 10.2165/00003088-200443130-00005; Pai AB, 2004, AM J HEALTH-SYST PH, V61, P1812, DOI 10.1093/ajhp/61.17.1812; Raad Issam I., 1994, Middle East Journal of Anesthesiology, V12, P381; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Siala W, 2014, ANTIMICROB AGENTS CH, V58, P6385, DOI 10.1128/AAC.03482-14; Song KH, 2015, INT J ANTIMICROB AG, V46, P689, DOI 10.1016/j.ijantimicag.2015.09.010; Steinkraus G, 2007, J ANTIMICROB CHEMOTH, V60, P788, DOI 10.1093/jac/dkm258; van Hal SJ, 2012, CLIN INFECT DIS, V54, P755, DOI 10.1093/cid/cir935; Vandecasteele SJ, 2011, CLIN INFECT DIS, V53, P124, DOI 10.1093/cid/cir337	26	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193585	10.1371/journal.pone.0193585	http://dx.doi.org/10.1371/journal.pone.0193585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505620	Green Submitted, Green Published, gold			2022-12-27	WOS:000426548200022
J	Rivera, MG; Hair, PS; Cunnion, KM; Krishna, NK				Rivera, Magdielis Gregory; Hair, Pamela S.; Cunnion, Kenji M.; Krishna, Neel K.			Peptide Inhibitor of Complement C1 (PIC1) demonstrates antioxidant activity via single electron transport (SET) and hydrogen atom transfer (HAT)	PLOS ONE			English	Article							MECHANISMS; INJURY	Reactive oxygen species (ROS) are natural byproducts of oxidative respiration that are toxic to organs and tissues. To mitigate ROS damage, organisms have evolved a variety of antioxidant systems to counteract these harmful molecules, however in certain pathological conditions these protective mechanisms can be overwhelmed. We have recently demonstrated that Peptide Inhibitor of Complement C1 (PIC1) mitigates peroxidase activity of the heme bearing proteins myeloperoxidase, hemoglobin, and myoglobin through a reversible process. To determine if this property of PIC1 was antioxidant in nature, we tested PIC1 in a number of well-established antioxidant assays. PIC1 showed dose-dependent antioxidant activity in a total antioxidant (TAC) assay, hydroxyl radical antioxidant capacity (HORAC) assay, oxygen radical antioxidant capacity (ORAC) assay as well as the thiobarbituric acid reactive substances (TBARS) assay to screen for PIC1 antioxidant activity in human plasma. The antioxidant activity of PIC1 in the TAC assay, as well as the HORAC/ORAC assay demonstrated that this peptide acts via the single electron transport (SET) and hydrogen atom transfer (HAT) mechanisms, respectively. Consistent with this mechanism of action, PIC1 did not show activity in a metal chelating activity (MCA) assay. PIC1 contains two vicinal cysteine residues and displayed similar antioxidant activity to the well characterized cysteine-containing tripeptide antioxidant molecule glutathione (GSH). Consistent with the role of the cysteine residues in the antioxidant activity of PIC1, oxidation of these residues significantly abrogated antioxidant activity. These results demonstrate that in addition to its described complement inhibiting activity, PIC1 displays in vitro antioxidant activity.	[Rivera, Magdielis Gregory; Cunnion, Kenji M.; Krishna, Neel K.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Hair, Pamela S.; Cunnion, Kenji M.; Krishna, Neel K.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA USA; [Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Norfolk, VA USA	Eastern Virginia Medical School; Eastern Virginia Medical School	Krishna, NK (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.; Krishna, NK (corresponding author), Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA.	krishnnk@evms.edu		Krishna, Neel/0000-0002-4615-4035	Children's Health Foundation, Children's Hospital of the King's Daughters, Norfolk, Virginia, USA [7364]	Children's Health Foundation, Children's Hospital of the King's Daughters, Norfolk, Virginia, USA	Funded by Children's Health Foundation, Children's Hospital of the King's Daughters, Norfolk, Virginia, USA. Grant #7364 to KMC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2011, FREE RADICAL BIO MED, V50, P1659, DOI 10.1016/j.freeradbiomed.2011.03.012; Billings FT, 2011, FREE RADICAL BIO MED, V50, P1480, DOI 10.1016/j.freeradbiomed.2011.02.011; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Elias RJ, 2008, CRIT REV FOOD SCI, V48, P430, DOI 10.1080/10408390701425615; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Hair PS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170203; Hair PS, INT J PEPT; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kumar PS, 2016, TRANSFUSION, V56, P2133, DOI 10.1111/trf.13674; Liang NJ, 2014, MOLECULES, V19, P19180, DOI 10.3390/molecules191119180; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Sharp JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132446; Sharp JA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00406; Sudhakar S, 2015, LWT-FOOD SCI TECHNOL, V64, P593, DOI 10.1016/j.lwt.2015.06.031; Tian M, 2015, DAIRY SCI TECHNOL, V95, P451, DOI 10.1007/s13594-015-0226-5; Tipple Trent E, 2012, Methods Mol Biol, V889, P315, DOI 10.1007/978-1-61779-867-2_20; Wong FC, 2014, IRAN J PHARM RES, V13, P1409; Zou TB, 2016, MOLECULES, V21, DOI 10.3390/molecules21010072	20	5	5	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193931	10.1371/journal.pone.0193931	http://dx.doi.org/10.1371/journal.pone.0193931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499069	gold, Green Submitted, Green Published			2022-12-27	WOS:000426472300027
J	Yu, KKH; Taylor, JT; Pathmanaban, ON; Youshani, AS; Beyit, D; Dutko-Gwozdz, J; Benson, R; Griffiths, G; Peers, I; Cueppens, P; Telfer, BA; Williams, KJ; McBain, C; Kamaly-Asl, ID; Bigger, BW				Yu, Kenny Kwok-Hei; Taylor, Jessica T.; Pathmanaban, Omar N.; Youshani, Amir Saam; Beyit, Deniz; Dutko-Gwozdz, Joanna; Benson, Roderick; Griffiths, Gareth; Peers, Ian; Cueppens, Peter; Telfer, Brian A.; Williams, Kaye J.; McBain, Catherine; Kamaly-Asl, Ian D.; Bigger, Brian W.			High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma	PLOS ONE			English	Article							PHASE-II TRIAL; CENTRAL-NERVOUS-SYSTEM; STEM-LIKE CELLS; RECURRENT GLIOBLASTOMA; IN-VITRO; DRUG-RESISTANCE; GLIOMA; TEMOZOLOMIDE; TUMOR; BORTEZOMIB	Background Glioblastoma (GBM) is the most common primary brain malignancy in adults, yet survival outcomes remain poor. First line treatment is well established, however disease invariably recurs and improving prognosis is challenging. With the aim of personalizing therapy at recurrence, we have established a high content screening (HCS) platform to analyze the sensitivity profile of seven patient-derived cancer stem cell lines to 83 FDA-approved chemotherapy drugs, with and without irradiation. Methods Seven cancer stem cell lines were derived from patients with GBM and, along with the established cell line U87-MG, each patient-derived line was cultured in tandem in serum-free conditions as adherent monolayers and three-dimensional neurospheres. Chemotherapeutics were screened at multiple concentrations and cells double-stained to observe their effect on both cell death and proliferation. Sensitivity was classified using high-throughput algorithmic image analysis. Results Cell line specific drug responses were observed across the seven patient-derived cell lines. Few agents were seen to have radio-sensitizing effects, yet some drug classes showed a marked difference in efficacy between monolayers and neurospheres. In vivo validation of six drugs suggested that cell death readout in a three-dimensional culture scenario is a more physiologically relevant screening model and could be used effectively to assess the chemosensitivity of patient-derived GBM lines. Conclusion The study puts forward a number of non-standard chemotherapeutics that could be useful in the treatment of recurrent GBM, namely mitoxantrone, bortezomib and actinomycin D, whilst demonstrating the potential of HCS to be used for personalized treatment based on the chemosensitivity profile of patient tumor cells.	[Yu, Kenny Kwok-Hei; Taylor, Jessica T.; Youshani, Amir Saam; Bigger, Brian W.] Univ Manchester, Stem Cell & Neurotherapies Lab, Brain Tumour Res Grp, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England; [Pathmanaban, Omar N.] Salford Royal Hosp, Manchester Acad Hlth Sci Ctr, Manchester Ctr Clin Neurosci, Salford, Lancs, England; [Beyit, Deniz; Dutko-Gwozdz, Joanna; Benson, Roderick; Griffiths, Gareth] Imagen Therapeut, Manchester, Lancs, England; [Peers, Ian; Cueppens, Peter] Inferstats Consulting, Alderley Pk, Biohub, Cheshire, England; [Telfer, Brian A.; Williams, Kaye J.] Univ Manchester, Sch Biol Med & Hlth, Div Pharm & Optometry, Manchester, Lancs, England; [McBain, Catherine] Christie NHS FT, Dept Clin Oncol, Manchester, Lancs, England; [Kamaly-Asl, Ian D.] Royal Manchester Childrens Hosp, CBTRN, Manchester, Lancs, England; [Kamaly-Asl, Ian D.] Royal Manchester Childrens Hosp, Manchester Acad Hlth Sci Ctr, Dept Neurosurg, Manchester, Lancs, England	University of Manchester; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Christie NHS Foundation Trust; Royal Manchester Children's Hospital; Royal Manchester Children's Hospital; University of Manchester	Bigger, BW (corresponding author), Univ Manchester, Stem Cell & Neurotherapies Lab, Brain Tumour Res Grp, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England.	brian.bigger@manchester.ac.uk		Taylor, Jessica/0000-0001-8565-8589; Yu, Kenny/0000-0002-2394-4990; Telfer, Brian/0000-0003-1857-5120; Pathmanaban, Omar/0000-0002-5083-9416	Christie Charitable Fund; BBSRC; Wellcome; University of Manchester Strategic Fund	Christie Charitable Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome; University of Manchester Strategic Fund	ONP was The Brain Tumour Charity Christopher Clarke Fellow. JTT, ONP and BWB received grant funding from the Christie Charitable Fund. Imagen Therapeutics provided support in the form of salaries for authors DB, JDG, RB & GG, and Inferstats Consulting provided support in the form of salaries for authors IP & PC. Neither of these commercial companies had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The Bioimaging Facility microscopes used in this study were purchased with grants from BBSRC, Wellcome and the University of Manchester Strategic Fund.	Agarwal S, 2013, DRUG METAB DISPOS, V41, P33, DOI 10.1124/dmd.112.048322; Badr CE, 2011, ASSAY DRUG DEV TECHN, V9, P281, DOI 10.1089/adt.2010.0324; Benesch M, 2014, BONE MARROW TRANSPL, V49, P370, DOI 10.1038/bmt.2013.208; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Boiardi A, 2008, J NEURO-ONCOL, V88, P105, DOI 10.1007/s11060-008-9540-6; Bota DA, 2013, J NEUROSURG, V119, P1415, DOI 10.3171/2013.7.JNS1323; Chowdhary SA, 2015, J NEURO-ONCOL, V122, P367, DOI 10.1007/s11060-015-1724-2; Cisternino S, 2004, CANCER RES, V64, P3296, DOI 10.1158/0008-5472.CAN-03-2033; De Bacco F, 2016, EMBO MOL MED, V8, P550, DOI 10.15252/emmm.201505890; Friday BB, 2012, NEURO-ONCOLOGY, V14, P215, DOI 10.1093/neuonc/nor198; Friedman HS, 1999, J CLIN ONCOL, V17, P1516, DOI 10.1200/JCO.1999.17.5.1516; GREEN RM, 1988, J NEURO-ONCOL, V6, P75, DOI 10.1007/BF00163544; Gunness P, 2013, TOXICOL SCI, V133, P67, DOI 10.1093/toxsci/kft021; Hasselbalch B, 2010, NEURO-ONCOLOGY, V12, P508, DOI 10.1093/neuonc/nop063; Hirst TC, 2013, BRIT J CANCER, V108, P64, DOI 10.1038/bjc.2012.504; Hongisto V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077232; Jackson M, 2015, CARCINOGENESIS, V36, P177, DOI 10.1093/carcin/bgu243; Jiang PF, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-13; LEVI F, 1994, INT J CANCER, V59, P543, DOI 10.1002/ijc.2910590418; Lieber J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-362; Liffers K, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/427518; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; MATTERN J, 1988, BRIT J CANCER, V58, P30, DOI 10.1038/bjc.1988.155; Narita Y, 2000, CANCER CHEMOTH PHARM, V45, P149, DOI 10.1007/s002800050023; Castro GN, 2015, CELL STRESS CHAPERON, V20, P253, DOI 10.1007/s12192-014-0537-0; Odia Y, 2015, J NEURO-ONCOL, V125, P191, DOI 10.1007/s11060-015-1894-y; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Park JK, 2010, J CLIN ONCOL, V28, P3838, DOI 10.1200/JCO.2010.30.0582; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Pitz MW, 2011, J NEURO-ONCOL, V104, P629, DOI 10.1007/s11060-011-0564-y; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Quartararo CE, 2015, ACS MED CHEM LETT, V6, P948, DOI 10.1021/acsmedchemlett.5b00128; Raghunand N, 2001, NEOPLASIA, V3, P227, DOI 10.1038/sj.neo.7900151; Raizer JJ, 2016, J NEURO-ONCOL, V129, P139, DOI 10.1007/s11060-016-2156-3; Rosso L, 2009, CANCER RES, V69, P120, DOI 10.1158/0008-5472.CAN-08-2356; Schmidt F, 2006, NEUROLOGY, V66, P587, DOI 10.1212/01.wnl.0000197792.73656.c2; Sengupta R, 2015, ONCOTARGET, V6, P18282, DOI 10.18632/oncotarget.4957; Sergijenko A, 2013, MOL THER, V21, P1938, DOI 10.1038/mt.2013.141; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Tzaridis T, 2016, ONCOTARGET, V7, P61860, DOI 10.18632/oncotarget.11452; Vogelbaum MA, 2015, NEURO-ONCOLOGY, V17, pII3, DOI 10.1093/neuonc/nou354; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wolff JEA, 1999, J CANCER RES CLIN, V125, P481, DOI 10.1007/s004320050305; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225	46	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193694	10.1371/journal.pone.0193694	http://dx.doi.org/10.1371/journal.pone.0193694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499065	Green Published, gold, Green Submitted			2022-12-27	WOS:000426472300019
J	De Tomasi, LC; Campos, DHS; Sant'Ana, PG; Okoshi, K; Padovani, CR; Murata, GM; Nguyen, S; Kolwicz, SC; Cicogna, AC				De Tomasi, Loreta Casquel; Salome Campos, Dijon Henrique; Sant'Ana, Paula Grippa; Okoshi, Katashi; Padovani, Carlos Roberto; Murata, Gilson Masahiro; Nguyen, Son; Kolwicz, Stephen C., Jr.; Cicogna, Antonio Carlos			Pathological hypertrophy and cardiac dysfunction are linked to aberrant endogenous unsaturated fatty acid metabolism	PLOS ONE			English	Article							HEART-FAILURE; PRESSURE-OVERLOAD; ADIPOSE-TISSUE; DIET; OXIDATION; STRESS; IMPROVES; DISEASE; OBESITY; RATS	Pathological cardiac hypertrophy leads to derangements in lipid metabolism that may contribute to the development of cardiac dysfunction. Since previous studies, using high saturated fat diets, have yielded inconclusive results, we investigated whether provision of a high-unsaturated fatty acid ( HUFA) diet was sufficient to restore impaired lipid metabolism and normalize diastolic dysfunction in the pathologically hypertrophied heart. Male, Wistar rats were subjected to supra-valvar aortic stenosis ( SVAS) or sham surgery. After 6 weeks, diastolic dysfunction and pathological hypertrophy was confirmed and both sham and SVAS rats were treated with either normolipidic or HUFA diet. At 18 weeks post-surgery, the HUFA diet failed to normalize decreased E/A ratios or attenuate measures of cardiac hypertrophy in SVAS animals. Enzymatic activity assays and gene expression analysis showed that both normolipidic and HUFA-fed hypertrophied hearts had similar increases in glycolytic enzyme activity and down-regulation of fatty acid oxidation genes. Mass spectrometry analysis revealed depletion of unsaturated fatty acids, primarily linoleate and oleate, within the endogenous lipid pools of normolipidic SVAS hearts. The HUFA diet did not restore linoleate or oleate in the cardiac lipid pools, but did maintain body weight and adipose mass in SVAS animals. Overall, these results suggest that, in addition to decreased fatty acid oxidation, aberrant unsaturated fatty acid metabolism may be a maladaptive signature of the pathologically hypertrophied heart. The HUFA diet is insufficient to reverse metabolic remodeling, diastolic dysfunction, or pathologically hypertrophy, possibly do to preferentially partitioning of unsaturated fatty acids to adipose tissue.	[De Tomasi, Loreta Casquel; Salome Campos, Dijon Henrique; Sant'Ana, Paula Grippa; Okoshi, Katashi; Cicogna, Antonio Carlos] Sao Paulo State Univ, Dept Internal Med, Botucatu, SP, Brazil; [De Tomasi, Loreta Casquel; Nguyen, Son; Kolwicz, Stephen C., Jr.] Univ Washington, Dept Anesthesiol & Pain Med, Mitochondria & Metab Ctr, Seattle, WA 98195 USA; [Padovani, Carlos Roberto] Sao Paulo State Univ, Dept Biostat, Botucatu, SP, Brazil; [Murata, Gilson Masahiro] Univ Sao Paulo, Dept Biochem, Sao Paulo, SP, Brazil; [Kolwicz, Stephen C., Jr.] Ursinus Coll, Hlth & Exercise Physiol Dept, Heart & Muscle Metab Lab, Collegeville, PA 19426 USA	Universidade Estadual Paulista; University of Washington; University of Washington Seattle; Universidade Estadual Paulista; Universidade de Sao Paulo	De Tomasi, LC (corresponding author), Sao Paulo State Univ, Dept Internal Med, Botucatu, SP, Brazil.; De Tomasi, LC (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Mitochondria & Metab Ctr, Seattle, WA 98195 USA.	loreta@fmb.unesp.br	Kolwicz, Stephen/GRF-6823-2022; Okoshi, Katashi/A-3955-2011	Okoshi, Katashi/0000-0001-8980-8839; Kolwicz Jr, Stephen/0000-0002-1164-9556; Nguyen, Son/0000-0003-0735-850X; Cicogna, Antonio Carlos/0000-0002-4402-6523	American Heart Association [14SDG18590020]; Sao Paulo Research Foundation [2012/19679-0, 2014/06030-1]	American Heart Association(American Heart Association); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the American Heart Association (14SDG18590020 to SCK) and the Sao Paulo Research Foundation (2012/19679-0; 2014/06030-1 to LCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SK, 2012, BBA-BIOMEMBRANES, V1818, P1309, DOI 10.1016/j.bbamem.2012.01.011; Ablorh NAD, 2014, J BIOL CHEM, V289, P29397, DOI 10.1074/jbc.M114.556621; Akki A, 2009, CARDIOVASC RES, V81, P610, DOI 10.1093/cvr/cvn316; Banack HR, 2015, ANN EPIDEMIOL, V25, P342, DOI 10.1016/j.annepidem.2015.02.008; Baum SJ, 2012, J CLIN LIPIDOL, V6, P216, DOI 10.1016/j.jacl.2012.04.077; Baylin A, 2005, AM J EPIDEMIOL, V162, P373, DOI 10.1093/aje/kwi213; Berthiaume JM, 2010, AM J PHYSIOL-HEART C, V299, pH410, DOI 10.1152/ajpheart.00270.2010; BEYNEN AC, 1980, AM J CLIN NUTR, V33, P81, DOI 10.1093/ajcn/33.1.81; Boluyt MO, 2005, AM J HYPERTENS, V18, P202, DOI 10.1016/j.amjhyper.2004.08.034; Bregagnollo EA, 2007, INT J CARDIOL, V117, P109, DOI 10.1016/j.ijcard.2006.06.006; Bruininx E, 2011, J NUTR, V141, P1657, DOI 10.3945/jn.111.142562; Chess DJ, 2008, J CARD FAIL, V14, P82, DOI 10.1016/j.cardfail.2007.09.004; Chess DJ, 2009, AM J PHYSIOL-HEART C, V297, pH1585, DOI 10.1152/ajpheart.00599.2009; DeLany JP, 2000, AM J CLIN NUTR, V72, P905; Duda MK, 2008, J CARD FAIL, V14, P327, DOI 10.1016/j.cardfail.2007.11.003; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Garland M, 1998, AM J CLIN NUTR, V67, P25, DOI 10.1093/ajcn/67.1.25; Jones PJH, 2008, METABOLISM, V57, P1198, DOI 10.1016/j.metabol.2008.04.012; Kolwicz SC, 2016, BBA-MOL CELL BIOL L, V1861, P1472, DOI 10.1016/j.bbalip.2016.03.028; Kolwicz SC, 2015, DIABETES, V64, P2817, DOI 10.2337/db14-1943; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Lahey R, 2014, CIRCULATION, V130, P1790, DOI 10.1161/CIRCULATIONAHA.114.011687; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lavie CJ, 2014, J AM COLL CARDIOL, V63, P1345, DOI 10.1016/j.jacc.2014.01.022; Le CH, 2014, CIRC-HEART FAIL, V7, P172, DOI 10.1161/CIRCHEARTFAILURE.113.000744; Leopoldo AS, 2010, CAN J CARDIOL, V26, P423, DOI 10.1016/S0828-282X(10)70440-2; LITWIN SE, 1995, CIRCULATION, V91, P2642, DOI 10.1161/01.CIR.91.10.2642; Mendes OD, 2010, ARQ BRAS CARDIOL, V94, P62, DOI 10.1590/S0066-782X2010000100011; Mills GD, 2006, AM J PHYSIOL-HEART C, V291, pH61, DOI 10.1152/ajpheart.01353.2005; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mulligan CM, 2012, CARDIOVASC RES, V94, P460, DOI 10.1093/cvr/cvs118; O'Donnell JM, 2008, J MOL CELL CARDIOL, V44, P315, DOI 10.1016/j.yjmcc.2007.11.006; Okere IC, 2005, CLIN EXP PHARMACOL P, V32, P825, DOI 10.1111/j.1440-1681.2005.04272.x; Okere IC, 2006, HYPERTENSION, V48, P1116, DOI 10.1161/01.HYP.0000248430.26229.0f; Picklo MJ, 2017, PROSTAG LEUKOTR ESS, V119, P25, DOI 10.1016/j.plefa.2017.03.001; Ribeiro Henrique Barbosa, 2003, Arq. Bras. Cardiol., V81, P569, DOI 10.1590/S0066-782X2003001400003; Timmers S, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.7	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193553	10.1371/journal.pone.0193553	http://dx.doi.org/10.1371/journal.pone.0193553			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494668	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200066
J	Kapusta, A; Kuczynska, B; Puppel, K				Kapusta, Aleksandra; Kuczynska, Beata; Puppel, Kamila			Relationship between the degree of antioxidant protection and the level of malondialdehyde in high-performance Polish Holstein-Friesian cows in peak of lactation	PLOS ONE			English	Article							CHOLESTEROL OXIDATION-PRODUCTS; DAIRY-COWS; STRESS; MILK; STABILITY; MALONALDEHYDE; CAROTENOIDS; PLASMA; PERIOD; STAGE	Lipid peroxidation can be described as a process under which free radicals attack carbon double bonds of omega-3 and omega-6 fatty acids. Whereas the end products of this process are reactive aldehydes, such as malondialdehyde ( MDA). Lipid peroxidation leads to adverse changes in the nutritional value of milk; therefore, higher degree of antioxidant protection ( DAP) ensures higher stability of dairy products by effecting their high antioxidative potential. Therefore, the purpose of this study was to demonstrate the relationship between the DAP and the level of MDA in high-performance Polish Holstein-Friesian cows in peak of lactation. Sixty-three Polish Holstein-Friesian cows were selected to the experiment according to: parity ( all in the 2nd lactation), phase of lactation ( peak of lactation), cytological quality of milk ( somatic cell count < 150 thousand/ml) and without diagnosed metabolic diseases. The data obtained were analyzed statistically by two-way ANOVA, and Tukey's post-hoc test. After analysis of performance the cows were divided into 3 groups ( twenty one cows in each group) based on milk yield and MDA concentration. The study revealed a significant effect of the lactation performance of cows on MDA levels in milk ( P <= 0.01). The highest concentration of MDA ( 61.137 nM/mL) was shown in milk of cows yielding between 50.00 and 55.80 kg/day. The highest concentration of fat was found in milk in which the MDA level ranged from 48 to 86 nM/mL. Whereas, the inverse relationship was demonstrated in case of protein concentration. The highest level of protein was found in cows with MDA levels in the range of 18-28 nM/ mL ( P <= 0.01). The lowest MDA level ( in the range of 18-28 nM/mL) was associated with the highest concentration of vitamin E, beta-carotene, total antioxidant status ( TAS) and DAP, measured in both milk and plasma. The obtained results show that lipid peroxidation leads to adverse changes in the nutritional value of milk; the highest DAP ( 7.89 x 10(-3)) was found in the cows with the lowest MDA concentration in milk.	[Kapusta, Aleksandra; Kuczynska, Beata; Puppel, Kamila] Warsaw Univ Life Sci, Anim Breeding & Prod Dept, Cattle Breeding Div, Warsaw, Poland	Warsaw University of Life Sciences	Puppel, K (corresponding author), Warsaw Univ Life Sci, Anim Breeding & Prod Dept, Cattle Breeding Div, Warsaw, Poland.	kamila_puppel@sggw.pl	Beata, Kuczyńska/ABB-3267-2020; Kuczyńska, Beata/AAC-7166-2022	Beata, Kuczyńska/0000-0002-9093-9905; Puppel, Kamila/0000-0003-2909-2087	National Science Center;  [NN 311 55 8840]	National Science Center(National Science Centre, Poland); 	This research was supported by the National Science Center and realized within the project NN 311 55 8840 entitled 'Relationship between concentration of bioactive substances in milk during standard lactation and blood biochemical parameters of high yielding Polish Holstein-Friesian cows'.	[Anonymous], 5509 ISO; Armonk N, 2017, IBM SPSS STAT WINDOW; Association of Official Analytical Chemists, 1990, OFFICIAL METHODS ANA, V1; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BENDICH A, 1990, ANN NY ACAD SCI, V587, P168, DOI 10.1111/j.1749-6632.1990.tb00144.x; Castillo C, 2006, RES VET SCI, V80, P133, DOI 10.1016/j.rvsc.2005.06.003; Celi P, 2011, IMMUNOPHARM IMMUNOT, V33, P233, DOI 10.3109/08923973.2010.514917; Chew BP, 1993, J ANIM SCI, P710; Diplock AT, 1981, SELENIUM BIOL MED, P303; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Gabryszuk M, 2013, FOOD SCI TECHNOL QUA, V3, P16; Havemose MS, 2006, J DAIRY SCI, V89, P1970, DOI 10.3168/jds.S0022-0302(06)72264-0; Havemose MS, 2004, INT DAIRY J, V14, P563, DOI 10.1016/j.idairyj.2003.11.005; Heidarpour M, 2012, REV MED VET-TOULOUSE, V163, P628; Ingvartsen KL, 2003, LIVEST PROD SCI, V83, P277, DOI 10.1016/S0301-6226(03)00110-6; Kaneai N., 2012, Advances in Bioscience and Biotechnology, V3, P1199, DOI 10.4236/abb.2012.38146; Krzyzewski J., 2012, ZYWN-NAUK TECHNOL JA, P3; Manuelian CL, 2017, J DAIRY SCI, V100, P3384, DOI 10.3168/jds.2016-12059; Mayasari N, 2017, J DAIRY SCI, V100, P4961, DOI 10.3168/jds.2016-11857; Min JS, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0074-6; Noziere P, 2006, ANIM FEED SCI TECH, V131, P418, DOI 10.1016/j.anifeedsci.2006.06.018; O'Grady MN, 2001, J ANIM SCI, V79, P2827; Oltenacu PA, 2010, ANIM WELFARE, V19, P39; Pintea A, 2006, B U AGR MED VET M-VE, V63, P130; Pizzoferrato L, 2007, J DAIRY SCI, V90, P4569, DOI 10.3168/jds.2007-0093; Pressman AH, 2006, ZAKTAD POLIGRATICZNO; Puppel K, 2017, J FOOD SCI, V82, P523, DOI 10.1111/1750-3841.13594; Puppel K, 2016, J SCI FOOD AGR, V96, P2240, DOI 10.1002/jsfa.7341; Puppel K, 2015, J SCI FOOD AGR, V95, P2179, DOI 10.1002/jsfa.7015; Puppel K, 2013, ARCH TIERZUCHT, V56, P178, DOI 10.7482/0003-9438-56-017; RiceEvans CA, 1997, FREE RADICAL RES, V26, P381, DOI 10.3109/10715769709097818; SANDER BD, 1988, J DAIRY SCI, V71, P3173, DOI 10.3168/jds.S0022-0302(88)79921-X; Sharma N, 2011, ASIAN AUSTRAL J ANIM, V24, P479, DOI 10.5713/ajas.2011.10220; Son J, 1996, J DAIRY SCI, V79, P822, DOI 10.3168/jds.S0022-0302(96)76430-5; Strzalkowska N, 2009, ANIM SCI PAP REP, V27, P95; Suriyasathaporn W, 2010, J SCI TECHNOL, V32, P23; Tomaszewski A., 2005, AR WE WROC O AWIU, P235; Turk R., 2003, Proceedings of the IV Central European Buiatric Congress, Zagreb, Croatia, 23-27 April 2003, P400; Vu HV, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-87; Wartanowicz M., 1999, GASTROENTR HEP ZYW D, V1, P97; WONG SHY, 1987, CLIN CHEM, V33, P214	41	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193512	10.1371/journal.pone.0193512	http://dx.doi.org/10.1371/journal.pone.0193512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494660	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200058
J	Sprinz, C; Altmayer, S; Zanon, M; Watte, G; Irion, K; Marchiori, E; Hochhegger, B				Sprinz, Clarice; Altmayer, Stephan; Zanon, Matheus; Watte, Guilherme; Irion, Klaus; Marchiori, Edson; Hochhegger, Bruno			Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review	PLOS ONE			English	Review							STANDARDIZED UPTAKE VALUE; FDG UPTAKE; UPTAKE VALUES; LIVER; SUV; HYPERGLYCEMIA	Purpose To perform a systematic review of the effect of blood glucose levels on 2-Deoxy-2-[18F] fluoro-D-glucose (18F-FDG) uptake in normal organs. Methods We searched the MEDLINE, EMBASE and Cochrane databases through 22 April 2017 to identify all relevant studies using the keywords "PET/CT" (positron emission tomography/computed tomography), "standardized uptake value" (SUV), "glycemia," and "normal." Analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses recommendations. Maximum and mean SUVs and glycemia were the main parameters analyzed. To objectively measure the magnitude of the association between glycemia and 18F-FDG uptake in different organs, we calculated the effect size (ES) and the coefficient of determination (R-2) whenever possible. Results The literature search yielded 225 results, and 14 articles met the inclusion criteria; studies included a total of 2714 (range, 51-557) participants. The brain SUV was related significantly and inversely to glycemia (ES = 1.26; R-2 0.16-0.58). Although the liver and mediastinal blood pool were significantly affected by glycemia, the magnitudes of these associations were small (ES = 0.24-0.59, R-2 = 0.01-0.08) and negligible (R-2 = 0.02), respectively. Lung, bone marrow, tumor, spleen, fat, bowel, and stomach 18F-FDG uptakes were not influenced by glycemia. Individual factors other than glycemia can also affect 18F-FDG uptake in different organs, and body mass index appears to be the most important of these factors. Conclusion The impact of glycemia on SUVs in most organs is either negligible or too small to be clinically significant. The brain SUV was the only value largely affected by glycemia.	[Sprinz, Clarice] Hosp Mae Deus, Dept Nucl Med, Porto Alegre, RS, Brazil; [Altmayer, Stephan; Zanon, Matheus; Watte, Guilherme; Hochhegger, Bruno] Irmandade Santa Casa Misericordia Porto Alegre, Dept Radiol, Porto Alegre, RS, Brazil; [Altmayer, Stephan; Zanon, Matheus; Hochhegger, Bruno] Fed Univ Hlth Sci Porto Alegre, Dept Diagnost Methods, Porto Alegre, RS, Brazil; [Irion, Klaus] Cent Manchester Univ Hosp, Dept Radiol, Manchester Royal Infirm, Manchester, Lancs, England; [Marchiori, Edson] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, RJ, Brazil	University of Manchester; Universidade Federal do Rio de Janeiro	Altmayer, S (corresponding author), Irmandade Santa Casa Misericordia Porto Alegre, Dept Radiol, Porto Alegre, RS, Brazil.; Altmayer, S (corresponding author), Fed Univ Hlth Sci Porto Alegre, Dept Diagnost Methods, Porto Alegre, RS, Brazil.	stephanaltmayer@gmail.com	Hochhegger, Bruno/AAH-9945-2019; Marchiori, Edson/C-1205-2013; Watte, G./ABC-7864-2020; Irion, Klaus/AAE-6089-2021; Zanon, Matheus/AAP-3630-2020	Watte, G./0000-0002-6948-3982; Irion, Klaus/0000-0002-7860-7879; Hochhegger, Bruno/0000-0003-1984-4636; Altmayer, Stephan/0000-0001-9214-1916				Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Boellaard R, 2015, EUR J NUCL MED MOL I, V42, P328, DOI 10.1007/s00259-014-2961-x; Busing KA, 2013, NUCL MED BIOL, V40, P206, DOI 10.1016/j.nucmedbio.2012.10.014; Claeys J, 2010, ANN NUCL MED, V24, P501, DOI 10.1007/s12149-010-0359-9; CRANE PD, 1983, J NEUROCHEM, V40, P160, DOI 10.1111/j.1471-4159.1983.tb12666.x; de Groot M, 2005, EUR J NUCL MED MOL I, V32, P98, DOI 10.1007/s00259-004-1670-2; Delbeke D, 2006, J NUCL MED, V47, P885; Geworski L, 2002, J NUCL MED, V43, P635; Gikas A, 2009, PRIM CARE DIABETES, V3, P111, DOI 10.1016/j.pcd.2009.05.004; Graham MM, 2000, NUCL MED BIOL, V27, P647, DOI 10.1016/S0969-8051(00)00143-8; Groheux D, 2013, CLIN NUCL MED, V38, P422, DOI 10.1097/RLU.0b013e3182872f0e; Israel O, 2007, J NUCL MED, V48, P234; Kaneta T, 2006, ANN NUCL MED, V20, P203, DOI 10.1007/BF03027431; Kawasaki K, 2008, ANN NUCL MED, V22, P191, DOI 10.1007/s12149-007-0099-7; Keramida G, 2015, EUR RADIOL, V25, P2701, DOI 10.1007/s00330-015-3659-6; Krak NC, 2003, EUR J NUCL MED MOL I, V30, P674, DOI 10.1007/s00259-003-1127-z; Kubota K, 2011, NUCL MED BIOL, V38, P347, DOI 10.1016/j.nucmedbio.2010.09.004; Kuruva M, 2012, INDIAN J NUCL MED, V27, P20, DOI 10.4103/0972-3919.108835; Lindholm H, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-50; Mahmud MH, 2015, QUANT IMAG MED SURG, V5, P700, DOI 10.3978/j.issn.2223-4292.2015.05.02; Malladi A, 2013, J MED IMAG RADIAT ON, V57, P169, DOI 10.1111/1754-9485.12015; Moher D, 2010, INT J SURG, V8, P658, DOI 10.1016/j.ijsu.2010.07.299; Nozawa A, 2015, NUCL MED COMMUN, V36, P573, DOI 10.1097/MNM.0000000000000288; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Varrone A, 2009, EUR J NUCL MED MOL I, V36, P2103, DOI 10.1007/s00259-009-1264-0; Viglianti BL, 2017, BIOMED PHARMACOTHER, V88, P1038, DOI 10.1016/j.biopha.2017.01.166; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Webb RL, 2015, NUCL MED COMMUN, V36, P717, DOI 10.1097/MNM.0000000000000319; Yeung HW, 2002, EUR J NUCL MED, V29, P61, DOI 10.1007/s00259-001-0662-8; ZASADNY KR, 1993, RADIOLOGY, V189, P847, DOI 10.1148/radiology.189.3.8234714; Zeng Xiantao, 2015, J Evid Based Med, V8, P2, DOI 10.1111/jebm.12141	32	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193140	10.1371/journal.pone.0193140	http://dx.doi.org/10.1371/journal.pone.0193140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486008	Green Submitted, Green Published, gold			2022-12-27	WOS:000426242400016
J	Ambrosetti, D; Dufies, M; Dadone, B; Durand, M; Borchiellini, D; Amiel, J; Pouyssegur, J; Rioux-Leclercq, N; Pages, G; Burel-Vandenbos, F; Mazure, NM				Ambrosetti, Damien; Dufies, Maeva; Dadone, Berengere; Durand, Matthieu; Borchiellini, Delphine; Amiel, Jean; Pouyssegur, Jacques; Rioux-Leclercq, Nathalie; Pages, Gilles; Burel-Vandenbos, Fanny; Mazure, Nathalie M.			The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; LACTATE/H+ SYMPORTERS MCT1; INDUCIBLE FACTOR 1-ALPHA; OXIDATIVE-PHOSPHORYLATION; MATRIX-METALLOPROTEINASE; INDEPENDENT PREDICTOR; CANCER-CELLS; EXPRESSION; PROGRESSION; HIF-1	Background Clear-cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. Although ccRCC is characterized by common recurrent genetic abnormalities, including inactivation of the von Hippel-Lindau (vhl) tumor suppressor gene resulting in stabilization of hypoxia-inducible factors (HIFs), the tumor aggressiveness and outcome of ccRCC is variable. New biomarkers are thus required to improve ccRCC diagnosis, prognosis and therapeutic options. This work aims to investigate the expression of HIF and proteins involved in metabolism and pH regulation. Their correlation to histoprognostic parameters and survival was analyzed. Methods ccRCC of 45 patients were analyzed. HIF-l alpha, HIF-2 alpha, HAF, GLUT1, MCT1, MCT4, CAIX and CAXII expression was assessed by immunohistochemistry in a semi-quantitative and qualitative manner. The GLUT1, MCT1, MCT4, CAIX and CAXII mRNA levels were analyzed in an independent cohort of 43 patients. Results A significant correlation was observed between increased GLUT1, MCT1, CAXII protein expression and a high Fuhrman grade in ccRCC patients. Moreover, while HIF-l alpha, HIF-2 alpha and HAF expression was heterogenous within tumors, we observed and confirmed that HIF-2 alpha co-localized with HAF. We confirmed, in an independent cohort, that GLUT1, MCT1 and CAXII mRNA levels correlated with the Fuhrman grade. Moreover, we demonstrated that the high mRNA level of both MCT1 and GLUT1 correlated with poor prognosis. Conclusions This study demonstrates for the first time a link between the aggressiveness of high-Fuhrman grade ccRCC and metabolic reprogramming. It also confirms the role of HIF-2 alpha and HAF in tumor invasiveness. Finally, these results demonstrate that MCT1 and GLUT1 are strong prognostic markers and promising therapeutic targets.	[Ambrosetti, Damien; Dadone, Berengere; Burel-Vandenbos, Fanny] Nice Univ Hosp, Dept Pathol, Nice, France; [Ambrosetti, Damien; Dufies, Maeva; Pouyssegur, Jacques; Pages, Gilles; Mazure, Nathalie M.] UCA, Nice Sophia Antipolis, Inst Res Canc & Aging Nice, CNRS UMR 7284 Inserm U1081, Nice, France; [Dufies, Maeva; Pouyssegur, Jacques] CSM, Monaco, Monaco; [Durand, Matthieu; Amiel, Jean] Nice Univ Hosp, Dept Urol, Nice, France; [Borchiellini, Delphine] Antoine Lacassagne Canc Ctr, Dept Oncol, Nice, France; [Rioux-Leclercq, Nathalie] Rennes Univ Hosp, Dept Pathol, Rennes, France	CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UNICANCER; Centre Antoine Lacassagne; CHU Rennes; Universite de Rennes	Ambrosetti, D (corresponding author), Nice Univ Hosp, Dept Pathol, Nice, France.; Ambrosetti, D (corresponding author), UCA, Nice Sophia Antipolis, Inst Res Canc & Aging Nice, CNRS UMR 7284 Inserm U1081, Nice, France.	ambrosetti.d@chu-nice.fr	Pages, Gilles/N-7135-2017; Ambrosetti, Damien/E-2131-2015; Dadone-Montaudié, Bérengère/AAI-3177-2021; PAGES, jean-marie/F-2555-2013	Ambrosetti, Damien/0000-0001-8665-0546; PAGES, jean-marie/0000-0001-7092-7977; Dufies, Maeva/0000-0003-1732-0388				Baldewijns MM, 2007, BRIT J CANCER, V96, P1888, DOI 10.1038/sj.bjc.6603796; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheville JC, 2002, CANCER, V94, P2180, DOI 10.1002/cncr.10433; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Hao J, 2010, BRIT J CANCER, V103, P1008, DOI 10.1038/sj.bjc.6605839; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim Y, 2015, HUM PATHOL, V46, P104, DOI 10.1016/j.humpath.2014.09.013; Klatte T, 2007, CLIN CANCER RES, V13, P7388, DOI 10.1158/1078-0432.CCR-07-0411; Klatte T, 2009, J CLIN ONCOL, V27, P746, DOI 10.1200/JCO.2007.15.8345; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Koh MY, 2015, CANCER RES, V75, P316, DOI 10.1158/0008-5472.CAN-13-2190; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Leibovich BC, 2007, J CLIN ONCOL, V25, P4757, DOI 10.1200/JCO.2007.12.1087; Lidgren A, 2008, BJU INT, V101, P480, DOI 10.1111/j.1464-410X.2007.07238.x; Lim HY, 2015, BIOCHEM BIOPH RES CO, V460, P938, DOI 10.1016/j.bbrc.2015.03.130; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Ozcan A, 2007, AM J CLIN PATHOL, V128, P245, DOI 10.1309/HV6NJVRQKK4QHM9F; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; Pinheiro C, 2008, INT J GYNECOL PATHOL, V27, P568, DOI 10.1097/PGP.0b013e31817b5b40; Pinheiro C, 2010, HISTOPATHOLOGY, V56, P860, DOI 10.1111/j.1365-2559.2010.03560.x; Pinthus JH, 2011, CUAJ-CAN UROL ASSOC, V5, P274, DOI 10.5489/cuaj.10196; Rafajova M, 2004, INT J ONCOL, V24, P995; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sandlund J, 2007, BJU INT, V100, P556, DOI 10.1111/j.1464-410X.2007.07006.x; Sera T, 2008, EUR J CANCER, V44, P600, DOI 10.1016/j.ejca.2008.01.008; Walenta S, 2000, CANCER RES, V60, P916; Younes M, 1996, CANCER RES, V56, P1164; Yu LL, 2017, CANCER RES, V77, P1564, DOI 10.1158/0008-5472.CAN-16-2074	37	28	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0193477	10.1371/journal.pone.0193477	http://dx.doi.org/10.1371/journal.pone.0193477			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481555	Green Published, Green Submitted, gold			2022-12-27	WOS:000426202700013
J	Latchere, O; Mehn, V; Gaertner-Mazouni, N; Le Moullac, G; Fievet, J; Belliard, C; Cabral, P; Saulnier, D				Latchere, Oihana; Mehn, Vincent; Gaertner-Mazouni, Nabila; Le Moullac, Gilles; Fievet, Julie; Belliard, Corinne; Cabral, Philippe; Saulnier, Denis			Influence of water temperature and food on the last stages of cultured pearl mineralization from the black-lip pearl oyster Pinctada margaritifera	PLOS ONE			English	Article							ACIDIC MATRIX PROTEIN; ENVIRONMENTAL CONTROLS; GROWTH-RATES; SHELL GROWTH; EXPRESSION; COLOR; IRIDESCENCE; ACCLIMATION; RESPONSES; INSIGHTS	Environmental parameters, such as food level and water temperature, have been shown to be major factors influencing pearl oyster shell growth and molecular mechanisms involved in this biomineralization process. The present study investigates the effect of food level (i.e., microalgal concentration) and water temperature, in laboratory controlled conditions, on the last stages of pearl mineralization in order to assess their impact on pearl quality. To this end, grafted pearl oysters were fed at different levels of food and subjected to different water temperatures one month prior to harvest to evaluate the effect of these factors on 1) pearl and shell deposition rate, 2) expression of genes involved in biomineralization in pearl sacs, 3) nacre ultrastructure (tablet thickness and number of tablets deposited per day) and 4) pearl quality traits. Our results revealed that high water temperature stimulates both shell and pearl deposition rates. However, low water temperature led to thinner nacre tablets, a lower number of tablets deposited per day and impacted pearl quality with better luster and fewer defects. Conversely, the two tested food level had no significant effects on shell and pearl growth, pearl nacre ultrastructure or pearl quality. However, one gene, Aspein, was significantly downregulated in high food levels. These results will be helpful for the pearl industry. A wise strategy to increase pearl quality would be to rear pearl oysters at a high water temperature to increase pearl growth and consequently pearl size; and to harvest pearls after a period of low water temperature to enhance luster and to reduce the number of defects.	[Latchere, Oihana; Mehn, Vincent; Le Moullac, Gilles; Fievet, Julie; Belliard, Corinne; Saulnier, Denis] IFREMER, Ctr Pacifique, Labex Corail, UMR Ecosyst Insulaires Oceaniens 241, Tahiti, French Polynesi, France; [Latchere, Oihana; Gaertner-Mazouni, Nabila] Univ Polynesie Francaise, Labex Corail, UMR Ecosyst Insulaires Oceaniens 241, Tahiti, French Polynesi, France; [Cabral, Philippe] Gauguins Pearl Farm, Rangiroa, French Polynesi, France	Ifremer; Ifremer	Saulnier, D (corresponding author), IFREMER, Ctr Pacifique, Labex Corail, UMR Ecosyst Insulaires Oceaniens 241, Tahiti, French Polynesi, France.	denis.saulnier@ifremer.fr	saulnier, denis/A-6690-2011	saulnier, denis/0000-0003-1422-0242; Le Moullac, Gilles/0000-0003-3749-8239	ANR [ANR-11-AGRO-006]; IFREMER; Direction des Ressources Marines; TripaGEN	ANR(French National Research Agency (ANR)); IFREMER; Direction des Ressources Marines; TripaGEN	This work was financially supported by ANR funding (POLYPERL project, reference ANR-11-AGRO-006). This study was also supported by grants from IFREMER, the Direction des Ressources Marines, and private partners through the TripaGEN project (2015-2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarsmawi K, 1984, MANUAL PEARL CULTURE; ALAGARSWAMI K, 1975, Indian Journal of Fisheries, V22, P300; Alagarswami K., 1987, CMFRI B, V39, P107; Anestis A, 2007, AM J PHYSIOL-REG I, V293, pR911, DOI 10.1152/ajpregu.00124.2007; Arnaud-Haond S, 2007, MAR BIOTECHNOL, V9, P113, DOI 10.1007/s10126-006-6033-5; Asakura T, 2006, BIOMACROMOLECULES, V7, P1996, DOI 10.1021/bm060155k; Bayne ABL, 2011, INT ASS ECOL, V37, P137; Blay C, 2014, INFLUENCE NACRE DEPO, P937; Blay C, 2016, ESTUAR COAST SHELF S, V182, P254, DOI 10.1016/j.ecss.2016.05.020; Cuif JP, 2011, AQUAT LIVING RESOUR, V24, P411, DOI 10.1051/alr/2011149; DELRIOPORTILLA MA, 1992, MAR ECOL PROG SER, V89, P221, DOI 10.3354/meps089221; Ellis S, 1999, AQUAFARMER INF SHEET, P1; Haws M., 2002, USITC PUBL, V127; Isowa Y, 2012, J MOL EVOL, V75, P11, DOI 10.1007/s00239-012-9514-3; Joubert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103944; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Kishore P, 2016, AQUAC RES, V47, P2215, DOI 10.1111/are.12674; Kishore P, 2015, AQUAC RES, V46, P769, DOI 10.1111/are.12228; Kocot KM, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0155-z; Ky C, 2016, PHENOTYPIC INDICATOR, P1; Ky CL, 2013, AQUAT LIVING RESOUR, V26, P133, DOI 10.1051/alr/2013055; Laing I, 2000, AQUACULTURE, V183, P325, DOI 10.1016/S0044-8486(99)00262-8; Larsen JB, 2005, MAR BIOL, V146, P1119, DOI 10.1007/s00227-004-1524-2; Latchere O, 2017, AQUACULTURE, V479, P176, DOI 10.1016/j.aquaculture.2017.05.046; Le Moullac G, 2016, ESTUAR COAST SHELF S, V182, P261, DOI 10.1016/j.ecss.2016.04.011; Le Moullac G, 2013, AQUAC RES, V44, P404, DOI 10.1111/j.1365-2109.2011.03045.x; Le Pabic L, 2016, ESTUAR COAST SHELF S, V182, P294, DOI 10.1016/j.ecss.2016.03.009; Lemer S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1776-x; Linard C., 2010, ECOPHYSIOLOGY SHELL; Linard C, 2011, AQUACULTURE, V313, P149, DOI 10.1016/j.aquaculture.2011.01.008; Liu Y, 1999, OPT EXPRESS, V4, P177, DOI 10.1364/OE.4.000177; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marin F, 2012, FRONT BIOSCI S, VS4, P321; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Matsui Y., 1958, PERSPECTIVES MARINE; Mavuti KM, 2005, AFR J MAR SCI, V27, P567, DOI 10.2989/18142320509504117; McGinty EL, 2012, MAR GENOM, V5, P27, DOI 10.1016/j.margen.2011.08.006; Menzel W., 1991, ESTUARINE MARINE BIV; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Montagnani C, 2011, CHEMBIOCHEM, V12, P2033, DOI 10.1002/cbic.201100216; Muhammad G, 2017, AQUACULTURE, V477, P35, DOI 10.1016/j.aquaculture.2017.04.032; NIELSEN MV, 1988, J EXP MAR BIOL ECOL, V123, P227, DOI 10.1016/0022-0981(88)90044-5; Olson IC, 2012, J AM CHEM SOC, V134, P7351, DOI 10.1021/ja210808s; Pouvreau S, 2000, AQUACULTURE, V186, P117, DOI 10.1016/S0044-8486(99)00373-7; Saucedo PE, 2004, AQUACULTURE, V229, P377, DOI 10.1016/S0044-8486(03)00327-2; Schone BR, 2003, MAR BIOL, V142, P473, DOI 10.1007/s00227-002-0970-y; Schone BR, 2005, PALAIOS, V20, P78, DOI 10.2110/palo.2003.p03-101; Shi YW, 2013, J SHELLFISH RES, V32, P271, DOI 10.2983/035.032.0204; Snow MR, 2004, AM MINERAL, V89, P1353; Southgate PC, 2008, PEARL OYSTER, P303, DOI 10.1016/B978-0-444-52976-3.00009-7; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Tayale A, 2012, AQUAT LIVING RESOUR, V25, P269, DOI 10.1051/alr/2012034; Taylor J, 2008, PEARL OYSTER, P273, DOI 10.1016/B978-0-444-52976-3.00008-5; Thebault J, 2008, AQUAT LIVING RESOUR, V21, P45, DOI 10.1051/alr:2008021; Tomaru Y, 2002, AQUAC RES, V33, P109, DOI 10.1046/j.1365-2109.2002.00653.x; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Wada K, 1999, J GEMMOL SOC JPN, V20, P47; Yukihira H, 1998, MAR ECOL PROG SER, V171, P71, DOI 10.3354/meps171071	61	11	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193863	10.1371/journal.pone.0193863	http://dx.doi.org/10.1371/journal.pone.0193863			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505601	Green Published, gold			2022-12-27	WOS:000426548200038
J	Lee, MJ; Kim, HJ				Lee, Mi Jin; Kim, Ho Jin			Development of an immunoaffinity chromatography and LC-MS/MS method for the determination of 6 zearalenones in animal feed	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; MYCOTOXINS; METABOLITES; VALIDATION; CEREALS; OPTIMIZATION; GUIDELINES; CHICKEN; MAIZE; HPLC	A novel and simple method for detecting 6 zearalenones in animal feed using liquid chromatography coupled with triple quadrupole mass spectrometry (LC-MS/MS) and immunoaffinity columns (IAC) was developed. The chromatographic peaks of the 6 zearalenones were successfully identified by comparing their retention times and mass spectrum with reference standards. The mobile phase was composed of mobile phase A (water) and B (0.5% formic acid in ACN). Method validation was performed with linearity, sensitivity, selectivity, accuracy and precision. The limits of detection (LODs) for the instrument used to study zearalenones ranged from 0.3 to 1.1 mu g/kg, and the limits of quantification (LOQs) ranged from 1.0 to 2.2 mu g/kg. Average recoveries of the 6 zearalenones ranged from 82.5% to 106.4%. Method replication resulted in intra-day and inter-day peak area variation of < 3.8%. The developed method was specific and reliable and is suited for the routine analysis of zearalenones in animal feed.	[Lee, Mi Jin; Kim, Ho Jin] Natl Agr Prod Qual Management Serv, Kimchun, South Korea		Kim, HJ (corresponding author), Natl Agr Prod Qual Management Serv, Kimchun, South Korea.	rex7878@korea.kr		Kim, Ho Jin/0000-0001-5296-0618				Bae IK, 2015, FOOD CHEM, V172, P469, DOI 10.1016/j.foodchem.2014.09.050; Belhassen H, 2014, J CHROMATOGR B, V962, P68, DOI 10.1016/j.jchromb.2014.05.019; Berthiller F, 2007, INT J FOOD MICROBIOL, V119, P33, DOI 10.1016/j.ijfoodmicro.2007.07.022; Branch SK, 2005, J PHARMACEUT BIOMED, V38, P798, DOI 10.1016/j.jpba.2005.02.037; Cavaliere C, 2007, FOOD CHEM, V105, P700, DOI 10.1016/j.foodchem.2006.12.057; De Baere S, 2012, ANAL CHIM ACTA, V756, P37, DOI 10.1016/j.aca.2012.10.027; Ferreira I, 2012, FOOD CONTROL, V27, P188, DOI 10.1016/j.foodcont.2012.03.014; Geary PA, 2016, FOOD CONTROL, V68, P337, DOI 10.1016/j.foodcont.2016.04.018; Iqbal SZ, 2014, FOOD CONTROL, V43, P98, DOI 10.1016/j.foodcont.2014.02.046; Kim HJ, 2016, FOOD CHEM, V196, P1144, DOI 10.1016/j.foodchem.2015.10.014; Kinani S, 2008, J CHROMATOGR A, V1190, P307, DOI 10.1016/j.chroma.2008.02.115; Molina-Molina JM, 2014, FOOD CHEM TOXICOL, V74, P233, DOI 10.1016/j.fct.2014.10.008; Ok HE, 2014, FOOD CHEM, V163, P252, DOI 10.1016/j.foodchem.2014.04.111; Onji Y, 1998, J CHROMATOGR A, V815, P59, DOI 10.1016/S0021-9673(98)00357-4; Qian MR, 2015, FOOD CHEM, V166, P23, DOI 10.1016/j.foodchem.2014.05.133; Tanaka K, 2007, INT J FOOD MICROBIOL, V119, P59, DOI 10.1016/j.ijfoodmicro.2007.08.002; Tanaka T, 2000, J CHROMATOGR A, V882, P23, DOI 10.1016/S0021-9673(00)00063-7; Thompson M, 2002, PURE APPL CHEM, V74, P835, DOI 10.1351/pac200274050835	18	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193584	10.1371/journal.pone.0193584	http://dx.doi.org/10.1371/journal.pone.0193584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505591	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200021
J	Rubio, M; Bustamante, M; Hernandez-Ferrer, C; Fernandez-Orth, D; Pantano, L; Sarria, Y; Pique-Borras, M; Vellve, K; Agramunt, S; Carreras, R; Estivill, X; Gonzalez, JR; Mayor, A				Rubio, Mercedes; Bustamante, Mariona; Hernandez-Ferrer, Caries; Fernandez-Orth, Dietmar; Pantano, Lorena; Sarria, Yaris; Pique-Borras, Maria; Vellve, Kilian; Agramunt, Silvia; Carreras, Ramon; Estivill, Xavier; Gonzalez, Juan R.; Mayor, Alfredo			Circulating miRNAs, isomiRs and small RNA clusters in human plasma and breast milk	PLOS ONE			English	Article							NONCODING RNAS; MICRORNA; BIOMARKERS; REGULATORS; SIGNATURES; ABUNDANT; DISEASE; PIRNAS; GENES; BLOOD	Circulating small RNAs, including miRNAs but also isomiRs and other RNA species, have the potential to be used as non-invasive biomarkers for communicable and non-communicable diseases. This study aims to characterize and compare small RNA profiles in human biofluids. For this purpose, RNA was extracted from plasma and breast milk samples from 15 healthy postpartum mothers. Small RNA libraries were prepared with the NEBNext (R) small RNA library preparation kit and sequenced in an Illumina HiSeq2000 platform. miRNAs, isomiRs and clusters of small RNAs were annotated using seqBuster/seqCluster framework in 5 plasma and 10 milk samples that passed the initial quality control. The RNA yield was 81 ng/mL [standard deviation (SD): 41] and 3985 ng/mL (SD: 3767) for plasma and breast milk, respectively. Mean number of good quality reads was 4.04 million (M) (40.01% of the reads) in plasma and 12.5M (89.6%) in breast milk. One thousand one hundred eighty two miRNAs, 12,084 isomiRs and 1,053 small RNA clusters that included piwi-interfering RNAs (piRNAs), tRNAs, small nucleolar RNAs (snoRNA) and small nuclear RNAs (snRNAs) were detected. Samples grouped by biofluid, with 308 miRNAs, 1,790 isomiRs and 778 small RNA clusters differentially detected. In summary, plasma and milk showed a different small RNA profile. In both, miRNAs, piRNAs, tRNAs, snRNAs, and snoRNAs were identified, confirming the presence of non-miRNA species in plasma, and describing them for the first time in milk.	[Rubio, Mercedes; Mayor, Alfredo] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Bustamante, Mariona; Hernandez-Ferrer, Caries; Gonzalez, Juan R.] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Bustamante, Mariona] CRG, Genom & Dis Grp, Bioinformat & Genom Program, Barcelona, Spain; [Bustamante, Mariona; Hernandez-Ferrer, Caries; Fernandez-Orth, Dietmar; Gonzalez, Juan R.] UPF, Barcelona, Spain; [Bustamante, Mariona; Hernandez-Ferrer, Caries; Fernandez-Orth, Dietmar; Gonzalez, Juan R.] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Pantano, Lorena] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Sarria, Yaris] IMIM Hosp Mar Med Res Inst, Microarray Anal Serv, Barcelona, Spain; [Pique-Borras, Maria] Univ Basel, Dept Biomed, Lab Childhood Leukemia, Basel, Switzerland; [Pique-Borras, Maria] Basel Univ, Childrens Hosp, Hebelestr, Basel, Switzerland; [Vellve, Kilian; Agramunt, Silvia; Carreras, Ramon] Hosp Mar, Obstet & Gynaecol Dept, Parc Salut Mar, Barcelona, Spain; [Carreras, Ramon] Univ Autonoma Barcelona, Pediat Obstet & Gynecol & Prevent Med Dept, Barcelona, Spain; [Estivill, Xavier] Sidra Med & Res Ctr, Res Dept, Genet Child & Womans Hlth Grp, Doha, Qatar; [Estivill, Xavier] Dexeus Womans Hlth, Genet Unit, Barcelona, Spain; [Mayor, Alfredo] CISM, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; ISGlobal; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Harvard University; Harvard T.H. Chan School of Public Health; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Basel; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Sidra Medical & Research Center; Centro de Investigacao em Saude de Manhica	Mayor, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.; Gonzalez, JR (corresponding author), ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain.; Gonzalez, JR (corresponding author), UPF, Barcelona, Spain.; Gonzalez, JR (corresponding author), CIBER Epidemiol & Salud Publ, Barcelona, Spain.; Mayor, A (corresponding author), CISM, Maputo, Mozambique.	juanr.gonzalez@isglobal.org; alfredo.mayor@isglobal.org	Bustamante, Mariona/ABB-9142-2021; Hernandez-Ferrer, Carles/HIA-0007-2022; Mayor, Alfredo/H-7488-2017; Gonzalez, Juan R/B-7860-2018; Martinez, Mercedes Rubio/N-3636-2014; Orth, Dietmar Fernandez/P-2925-2019; Rubio, Mercedes/K-9249-2015; Hernandez-Ferrer, Carles/AAH-2040-2019; Estivill, Xavier/A-3125-2013	Bustamante, Mariona/0000-0003-0127-2860; Hernandez-Ferrer, Carles/0000-0002-8029-7160; Mayor, Alfredo/0000-0003-3890-2897; Gonzalez, Juan R/0000-0003-3267-2146; Martinez, Mercedes Rubio/0000-0002-4331-3280; Orth, Dietmar Fernandez/0000-0002-1237-3192; Hernandez-Ferrer, Carles/0000-0002-8029-7160; Estivill, Xavier/0000-0002-0723-2256; Vellve, Kilian/0000-0002-2376-7664	ISCIII-Subdireccion General de Evaluacion Plan Nacional I+D+I; Fondo Europeo de Desarrollo Regional [FEDER] [PI13/01478]; Departament d'Universitats i Recerca de la Generalitat de Catalunya (Agenda de Gestion de Ayudas Universitarias y de Investigacion (AGAUR)) [2014SGR263]; CERCA Institutes Integration Program (SUMA); CERCA Institutes Integration Program (Secretaria de Universidades e Investigacion del Departamento de Economia y Conocimiento de la Generalidad de Cataluna); CERCA Institutes Integration Program (AGAUR); CERCA Institutes Integration Program (Fundacion Institucio dels Centres de Recerca de Catalunya);  [CES10/021-I3SNS]	ISCIII-Subdireccion General de Evaluacion Plan Nacional I+D+I; Fondo Europeo de Desarrollo Regional [FEDER](European Commission); Departament d'Universitats i Recerca de la Generalitat de Catalunya (Agenda de Gestion de Ayudas Universitarias y de Investigacion (AGAUR)); CERCA Institutes Integration Program (SUMA); CERCA Institutes Integration Program (Secretaria de Universidades e Investigacion del Departamento de Economia y Conocimiento de la Generalidad de Cataluna); CERCA Institutes Integration Program (AGAUR); CERCA Institutes Integration Program (Fundacion Institucio dels Centres de Recerca de Catalunya); 	This work was supported by ISCIII-Subdireccion General de Evaluacion Plan Nacional I+D+I 2013-2016 (grant PI13/01478 cofunded by the Fondo Europeo de Desarrollo Regional [FEDER] and CES10/021-I3SNS to AM), the Departament d'Universitats i Recerca de la Generalitat de Catalunya (Agenda de Gestion de Ayudas Universitarias y de Investigacion (AGAUR); grant 2014SGR263 to AM) and the CERCA Institutes Integration Program (SUMA 2013 to JRG, AM; Secretaria de Universidades e Investigacion del Departamento de Economia y Conocimiento de la Generalidad de Cataluna, AGAUR and Fundacion Institucio dels Centres de Recerca de Catalunya). ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya.	Alsaweed M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20680; Alsaweed M, 2015, INT J ENV RES PUB HE, V12, P13981, DOI 10.3390/ijerph121113981; Alsaweed M, 2015, J CELL BIOCHEM, V116, P2397, DOI 10.1002/jcb.25207; Amorim M, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1025-3; Bagci C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145065; Balzano F, 2015, MOLECULES, V20, P19030, DOI 10.3390/molecules201019030; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bilsland Alan E., 2013, Critical Reviews in Oncogenesis, V18, P373; Clark JP, 2014, ADV EXP MED BIOL, V825, P159, DOI 10.1007/978-1-4939-1221-6_5; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Dhahbi Joseph M, 2014, Biomark Cancer, V6, P37, DOI 10.4137/BIC.S20764; Dhahbi JM, 2014, AGEING RES REV, V17, P86, DOI 10.1016/j.arr.2014.02.005; Dhahbi JM, 2013, PHYSIOL GENOMICS, V45, P990, DOI 10.1152/physiolgenomics.00129.2013; Duy J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1299-5; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Follert P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00005; Freedman JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11106; Gebetsberger J, 2013, RNA BIOL, V10, P1798, DOI 10.4161/rna.27177; Ghai V, 2016, ARCH TOXICOL, V90, P2959, DOI 10.1007/s00204-016-1828-2; Hakimi MA, 2011, TRENDS PARASITOL, V27, P481, DOI 10.1016/j.pt.2011.07.001; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Isaacs SR, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0819-2; Karlsson O, 2016, EPIGENETICS-US, V11, P721, DOI 10.1080/15592294.2016.1216285; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Keam SP, 2014, NUCLEIC ACIDS RES, V42, P8984, DOI 10.1093/nar/gku620; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kowalski MP, 2015, INT J BIOCHEM CELL B, V66, P20, DOI 10.1016/j.biocel.2015.07.003; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Omran A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/291826; Pantano L, 2016, BIOINFORMATICS, V32, P673, DOI 10.1093/bioinformatics/btv632; Pantano L, 2011, BIOINFORMATICS, V27, P3202, DOI 10.1093/bioinformatics/btr527; Pantano L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1127; Panwar B., 2017, BIOINFORMATICS; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Pua HH, 2015, CURR OPIN IMMUNOL, V36, P101, DOI 10.1016/j.coi.2015.07.006; Shah JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153200; Siddeek B, 2014, MUTAT RES-GEN TOX EN, V764, P46, DOI 10.1016/j.mrgentox.2014.01.010; Silver MJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0660-y; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Simpson MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143496; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Spornraft M, 2015, BIOTECHNOL LETT, V37, P1165, DOI 10.1007/s10529-015-1788-2; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Tam S, 2015, BRIEF BIOINFORM, V16, P950, DOI 10.1093/bib/bbv019; Tan GC, 2015, MALAY J PATHOL, V37, P73; Thakral S, 2015, CURR GENE THER, V15, P142, DOI 10.2174/1566523214666141224095610; Tonge DP, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0057-9; Vickers KC, 2013, J LIPID RES, V54, P1182, DOI 10.1194/jlr.R034801; Vrijens K, 2015, ENVIRON HEALTH PERSP, V123, P399, DOI 10.1289/ehp.1408459; Wang SQ, 2016, GENE, V584, P167, DOI 10.1016/j.gene.2016.02.020; Wang YC, 2016, ONCOL LETT, V12, P1635, DOI 10.3892/ol.2016.4901; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Xie T, 2016, CELL PHYSIOL BIOCHEM, V40, P62, DOI 10.1159/000452525; Yeri A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44061; Zempleni J, 2016, J NUTR; Zhang JH, 2013, PLANTA, V237, P1047, DOI 10.1007/s00425-012-1823-7; Zhang P, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau110; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	64	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193527	10.1371/journal.pone.0193527	http://dx.doi.org/10.1371/journal.pone.0193527			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505615	Green Published, gold, Green Submitted			2022-12-27	WOS:000426548200019
J	Saraiva, JF; Souto, RNP; Scarpassa, VM				Saraiva, Jose Ferreira; Picanco Souto, Raimundo Nonato; Scarpassa, Vera Margarete			Molecular taxonomy and evolutionary relationships in the Oswaldoi-Konderi complex (Anophelinae: Anopheles: Nyssorhynchus) from the Brazilian Amazon region	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; SENSU-LATO DIPTERA; AN. NYS. OSWALDOI; PLASMODIUM-FALCIPARUM; MALARIA VECTORS; RIBOSOMAL DNA; COMPARATIVE SUSCEPTIBILITY; PHYLOGENETIC INFERENCE; SPECIES DELIMITATION; COMPUTER-PROGRAM	Recent studies have shown that Anopheles oswaldoi sensu lato comprises a cryptic species complex in South America. Anopheles konderi, which was previously raised to synonymy with An. oswaldoi, has also been suggested to form a species complex. An. oswaldoi has been incriminated as a malaria vector in some areas of the Brazilian Amazon, Colombia, Peru and Venezuela, but was not recognized as a vector in the remaining regions in its geographic distribution. The role of An. konderi as a malaria vector is unknown or has been misattributed to An. oswaldoi. The focus of this study was molecular identification to infer the evolutionary relationships and preliminarily delimit the geographic distribution of the members of these complexes in the Brazilian Amazon region. The specimens were sampled from 18 localities belonging to five states in the Brazilian Amazon and sequenced for two molecular markers: the DNA barcode region (COI gene of mitochondrial DNA) and Internal Transcribed Spacer 2 (ITS2 ribosomal DNA). COI (83 sequences) and ITS2 (27 sequences) datasets generated 43 and 10 haplotypes, respectively. Haplotype networks and phylogenetic analyses generated with the barcode region (COI gene) recovered five groups corresponding to An. oswaldoi s. s., An. oswaldoi B, An. oswaldoi A, An. konderi and An. sp. nr. konderi; all pairwise genetic distances were greater than 3%. The group represented by An. oswaldoi A exhibited three strongly supported lineages. The molecular dating indicated that the diversification process in these complexes started approximately 2.8 Mya, in the Pliocene. These findings confirm five very closely related species and present new records for these species in the Brazilian Amazon region. The paraphyly observed for the An. oswaldoi complex suggests that An. oswaldoi and An. konderi complexes may comprise a unique species complex named Oswaldoi-Konderi. Anopheles oswaldoi B may be a potential malaria vector in the extreme north of the Brazilian Amazon, whereas evidence of sympatry for the remaining species in other parts of the Brazilian Amazon (Acre, Amazonas, Para A and Rondo A nia) precluded identification of probable vectors in those areas.	[Saraiva, Jose Ferreira; Scarpassa, Vera Margarete] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Lab Genet Populacoes & Evolucao Mosquitos Vetores, Manaus, Amazonas, Brazil; [Picanco Souto, Raimundo Nonato] Univ Fed Amapa, Dept Ciencias Biol & Saude, Lab Arthropoda, Macapa, Amapa, Brazil	Institute Nacional de Pesquisas da Amazonia; Fundacao Universidade Federal do Amapa	Scarpassa, VM (corresponding author), Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Lab Genet Populacoes & Evolucao Mosquitos Vetores, Manaus, Amazonas, Brazil.	vera@inpagov.br	Saraiva, José Ferreira/S-8376-2016; Scarpassa, Vera M./H-4125-2013; Picanço Souto, Raimundo Nonato/GOV-5047-2022; Saraiva, Jose Ferreira/X-9256-2018	Saraiva, José Ferreira/0000-0002-7813-2607; Picanço Souto, Raimundo Nonato/0000-0002-8795-1217; Saraiva, Jose Ferreira/0000-0002-7813-2607; Scarpassa, Vera/0000-0003-1607-9246	MCTIC/INPA; Amazonas Research Foundation (FAPEAM) [1501/2008, 3111/2012-Universal, 062.01832/2015-PAPAC-FAPEAM]; INCT-CENBAM/CNPq/FAPEAM/INPA [722069/2009]; CNPQ-BR-BOL; PRO-EQUIPAMENT/CAPES, Brazil; CAPES, Brazil	MCTIC/INPA; Amazonas Research Foundation (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); INCT-CENBAM/CNPq/FAPEAM/INPA; CNPQ-BR-BOL; PRO-EQUIPAMENT/CAPES, Brazil; CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by MCTIC/INPA and grants from the Amazonas Research Foundation (FAPEAM), process numbers 1501/2008, 3111/2012-Universal and 062.01832/2015-PAPAC-FAPEAM granted to VMS, from the INCT-CENBAM/CNPq/FAPEAM/INPA, process number 722069/2009, granted to William Ernest Magnusson, from the CNPQ-BR-BOL granted to Fernando Araujo Monteiro and from the PRO-EQUIPAMENT/CAPES, Brazil. JFS received a fellowship from the CAPES, Brazil. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], CHROM LIT SOFTW; Arrivillaga JC, 2002, INFECT GENET EVOL, V2, P83, DOI 10.1016/S1567-1348(02)00087-4; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bergo ES, 2007, MEM I OSWALDO CRUZ, V102, P373, DOI 10.1590/S0074-02762007005000053; FARAN M E, 1980, Contributions of the American Entomological Institute, V15, P1; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bourke BP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-111; BRANQUINHO MS, 1993, T ROY SOC TROP MED H, V87, P391, DOI 10.1016/0035-9203(93)90008-E; Branquinho MS, 1996, T ROY SOC TROP MED H, V90, P233, DOI 10.1016/S0035-9203(96)90225-4; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Bush Mark B., 2006, Biota Neotrop., V6, P0, DOI 10.1590/S1676-06032006000100002; Causey OR, 1944, AM J HYG, V39, P1; Causey OR, 1946, MONOGR SER AM J HYG, V18, P21; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Conn JE, 2007, HEREDITY, V99, P245, DOI 10.1038/sj.hdy.6801002; Correa MM, 2014, 8 CUB C MICR PAR 5 N; Barbosa LMC, 2016, ACTA TROP, V164, P216, DOI 10.1016/j.actatropica.2016.09.018; Barbosa LMC, 2014, REV SOC BRAS MED TRO, V47, P313, DOI 10.1590/0037-8682-0239-2013; Costa Lima A. da., 1928, Supplemento das Memorias Instituto Oswaldo Cruz Rio de Janeiro, V3, P91; Crabtree MB, 1997, J MED ENTOMOL, V34, P532, DOI 10.1093/jmedent/34.5.532; Curry DP, 1932, AM J HYG, V15, P566, DOI 10.1093/oxfordjournals.aje.a117832; da Rocha JAM, 2008, AM J TROP MED HYG, V78, P872, DOI 10.4269/ajtmh.2008.78.872; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DEANE L. M., 1948, REV SERV ESPECIAL SAUDE PUBLICA, V1, P827; DEARRUDA M, 1986, AM J TROP MED HYG, V35, P873, DOI 10.4269/ajtmh.1986.35.873; DEOLIVEIRAFERREIRA J, 1990, AM J TROP MED HYG, V43, P6, DOI 10.4269/ajtmh.1990.43.1.TM0430010006; dos Santos RL, 2005, REV SOC BRAS MED TRO, V38, P202, DOI 10.1590/S0037-86822005000200018; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Dusfour I, 2012, MEM I OSWALDO CRUZ, V107, P429, DOI 10.1590/S0074-02762012000300021; Dyar HG, 1925, MONTHLY J ENTOMOLOGY, V13, P101; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Emerson KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130773; Ezard T., 2009, SPLITS SPECIES LIMIT; FARAN M E, 1981, Mosquito Systematics, V13, P1; Flores-Mendoza C, 2004, P ENTOMOL SOC WASH, V106, P118; Foley DH, 2007, MOL PHYLOGENET EVOL, V43, P283, DOI 10.1016/j.ympev.2006.10.008; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foster PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054063; Galvao A. L. Ayroza, 1942, FOLIA CLINICA ET BIOL [SAO PAULO], V14, P115; Galvao AL, 1937, AN FAC MED U SAO PAU, V13, P211; Garros C, 2004, AM J TROP MED HYG, V70, P260, DOI 10.4269/ajtmh.2004.70.260; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Harbach RE, 2007, ZOOTAXA, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HAYES J, 1987, J AM MOSQUITO CONTR, V3, P418; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KITZMILLER JB, 1973, B WORLD HEALTH ORGAN, V48, P435; KLEIN TA, 1991, AM J TROP MED HYG, V44, P598, DOI 10.4269/ajtmh.1991.44.598; KLEIN TA, 1990, J AM MOSQUITO CONTR, V6, P700; LANE J., 1953, Neotropical Culioidae. Volumes I & II.; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loaiza JR, 2012, INFECT GENET EVOL, V12, P1, DOI 10.1016/j.meegid.2011.08.004; Lounibos L. Philip, 2000, American Entomologist, V46, P238; Lounibos LP, 1998, J MED ENTOMOL, V35, P830, DOI 10.1093/jmedent/35.5.830; Lounibos LP, 1997, J MED ENTOMOL, V34, P136, DOI 10.1093/jmedent/34.2.136; Marrelli MT, 2006, MEM I OSWALDO CRUZ, V101, P817, DOI 10.1590/S0074-02762006000800002; Marrelli MT, 1999, T ROY SOC TROP MED H, V93, P381, DOI 10.1016/S0035-9203(99)90123-2; Marrelli MT, 1999, J MED ENTOMOL, V36, P679, DOI 10.1093/jmedent/36.6.679; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Mayr E., 1998, ED UNB, V1, P1107; McKeon SN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-271; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mirabello L, 2008, MED VET ENTOMOL, V22, P109, DOI 10.1111/j.1365-2915.2008.00731.x; Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x; Moreno M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-47; Motoki MT, 2009, NEOTROP ENTOMOL, V38, P144, DOI 10.1590/S1519-566X2009000100017; Motoki MT, 2011, J AM MOSQUITO CONTR, V27, P191, DOI 10.2987/10-6094.1; Motoki Maysa Tiemi, 2007, Zootaxa, V1588, P31; NATAL D, 1992, REV SAUDE PUBL, V26, P129, DOI 10.1590/S0034-89101992000200010; Peryassu A., 1922, Folha Medica Rio de Janeiro, V3, P179; PORTER CH, 1991, AM J TROP MED HYG, V45, P271, DOI 10.4269/ajtmh.1991.45.271; Povoa MM, 2001, MEM I OSWALDO CRUZ, V96, P179, DOI 10.1590/S0074-02762001000200008; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Quantum GIS Development Team, 2014, QUANT GIS GEOGR INF; Quinones ML, 2006, MEM I OSWALDO CRUZ, V101, P617, DOI 10.1590/S0074-02762006000600007; Rambaut A., 2008, FIGTREE TREE FIGURE; Ramirez CCL, 2000, GENOME, V43, P143, DOI 10.1139/gen-43-1-143; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Rona LDP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-60; Rosa-Freitas MG, 1998, MEM I OSWALDO CRUZ, V93, P651, DOI 10.1590/S0074-02761998000500016; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Rubio-Palis Y, 2013, MEM I OSWALDO CRUZ, V108, P220, DOI 10.1590/0074-0276108022013015; RUBIOPALIS Y, 1994, AM J TROP MED HYG, V50, P420, DOI 10.4269/ajtmh.1994.50.420; RUBIOPALIS Y, 1992, MED VET ENTOMOL, V6, P325, DOI 10.1111/j.1365-2915.1992.tb00628.x; Ruiz F, 2005, MEM I OSWALDO CRUZ, V100, P155, DOI 10.1590/S0074-02762005000200008; Ruiz F, 2010, MEM I OSWALDO CRUZ, V105, P899, DOI 10.1590/S0074-02762010000700010; Ruiz-Lopez F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-324; Ruiz-Lopez F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-44; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Russell D. W., 2001, MOL CLONING LAB MANU, V1, P2100; Sallum MAM, 2008, J MED ENTOMOL, V45, P970, DOI 10.1603/0022-2585(2008)45[970:IIANDC]2.0.CO;2; Scarpassa VM, 2006, GENET MOL RES, V5, P493; Scarpassa VM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1217-6; Scarpassa VM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-258; Scarpassa VM, 2011, AM J TROP MED HYG, V85, P857, DOI 10.4269/ajtmh.2011.11-0150; Scarpassa VM, 2005, J MED ENTOMOL, V42, P319, DOI 10.1603/0022-2585(2005)042[0319:ISIAOS]2.0.CO;2; Senevet G., 1938, Arch Inst Pasteur Alger Algiers, V16, P486; SHANNON RAYMOND C., 1939, AMER JOUR TROP MED, V19, P131; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; TADEI W P, 1983, Acta Amazonica, V13, P103; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Tadei WP, 1993, BASES CIENTIFICAS ES, P167; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; WEBB SD, 1995, SCIENCE, V269, P361, DOI 10.1126/science.269.5222.361; Wilkerson RC, 1995, MEM I OSWALDO CRUZ, V90, P721, DOI 10.1590/S0074-02761995000600013; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zwickl DJ, GARLI GENETIC ALGORI	120	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193591	10.1371/journal.pone.0193591	http://dx.doi.org/10.1371/journal.pone.0193591			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505595	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200023
J	Farras, M; Chandwe, K; Mayneris-Perxachs, J; Amadi, B; Louis-Auguste, J; Besa, E; Zyambo, K; Guerrant, R; Kelly, P; Swann, JR				Farras, Marta; Chandwe, Kanta; Mayneris-Perxachs, Jordi; Amadi, Beatrice; Louis-Auguste, John; Besa, Ellen; Zyambo, Kanekwa; Guerrant, Richard; Kelly, Paul; Swann, Jonathan Richard			Characterizing the metabolic phenotype of intestinal villus blunting in Zambian children with severe acute malnutrition and persistent diarrhea	PLOS ONE			English	Article							PERMEABILITY; ENTEROPATHY; UNDERNUTRITION; MORTALITY; TIME; DIET; HIV	Background Environmental enteric dysfunction (EED) is widespread throughout the tropics and in children is associated with stunting and other adverse health outcomes. One of the hallmarks of EED is villus damage. In children with severe acute malnutrition (SAM) the severity of enteropathy is greater and short term mortality is high, but the metabolic consequences of enteropathy are unknown. Here, we characterize the urinary metabolic alterations associated with villus health, classic enteropathy biomarkers and anthropometric measurements in severely malnourished children in Zambia. Methods/Principal findings We analysed 20 hospitalised children with acute malnutrition aged 6 to 23 months in Zambia. Small intestinal biopsies were assessed histologically (n = 15), anthropometric and gut function measurements were collected and the metabolic phenotypes were characterized by H-1 nuclear magnetic resonance (NMR) spectroscopy. Endoscopy could not be performed on community controls children. Growth parameters were inversely correlated with enteropathy biomarkers (p = 0.011) and parameters of villus health were inversely correlated with translocation and permeability biomarkers (p = 0.000 and p = 0.015). Shorter villus height was associated with reduced abundance of metabolites related to gut microbial metabolism, energy and muscle metabolism (p = 0.034). Villus blunting was also related to increased sucrose excretion (p = 0.013). Conclusions/Significance Intestinal villus blunting is associated with several metabolic perturbations in hospitalized children with severe undernutrition. Such alterations include altered muscle metabolism, reinforcing the link between EED and growth faltering, and a disruption in the biochemical exchange between the gut microbiota and host. These findings extend study are the lack of comparative control group and gut microbiota characterization.	[Farras, Marta; Mayneris-Perxachs, Jordi; Swann, Jonathan Richard] Imperial Coll, Div Surg & Canc, Computat & Syst Med Grp, London, England; [Farras, Marta] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain; [Chandwe, Kanta; Amadi, Beatrice; Louis-Auguste, John; Besa, Ellen; Zyambo, Kanekwa; Kelly, Paul] Univ Zambia, Sch Med, Trop Gastroenterol & Nutr Grp, Lusaka, Zambia; [Louis-Auguste, John; Kelly, Paul] Queen Mary Univ London, Barts & London Sch Med, London, England; [Guerrant, Richard] Univ Virginia, Charlottesville, VA USA	Imperial College London; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Zambia; University of London; Queen Mary University London; University of Virginia	Farras, M; Swann, JR (corresponding author), Imperial Coll, Div Surg & Canc, Computat & Syst Med Grp, London, England.; Farras, M (corresponding author), CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Barcelona, Spain.	m.farras-mane@imperial.ac.uk; j.swann@imperial.ac.uk	Farràs, Marta/AAA-9418-2021; Mayneris-Perxachs, Jordi/B-2589-2018	Mayneris-Perxachs, Jordi/0000-0003-3788-3815; Besa, Ellen/0000-0001-5606-9435; Kelly, Paul/0000-0003-0844-6448; Swann, Jonathan/0000-0002-6485-4529; Chandwe, Kanta/0000-0003-1403-8432; Farras Mane, Marta/0000-0001-9776-3773	GIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN) is an initiative of the Institute de Salud Carlos III, Madrid, Spain; CIBEROBN; BBSRC [BB/M006484/1] Funding Source: UKRI	GIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN) is an initiative of the Institute de Salud Carlos III, Madrid, Spain; CIBEROBN; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	GIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN) is an initiative of the Institute de Salud Carlos III, Madrid, Spain. M.F. received a short-term stay fellowship from the CIBEROBN to work in this project. http://www.ciberobn.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi B, 2005, J TROP PEDIATRICS, V51, P5, DOI 10.1093/tropej/fmh064; Amadi B, 2001, J PEDIATR GASTR NUTR, V32, P550, DOI 10.1097/00005176-200105000-00011; Amadi B, 2017, EBIOMEDICINE, V22, P191, DOI 10.1016/j.ebiom.2017.07.017; Amadi B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149218; Attia S, 2016, AM J CLIN NUTR, V104, P1441, DOI 10.3945/ajcn.116.130518; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brown EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8806; Burgstad CM, 2013, CRIT CARE MED, V41, P1221, DOI 10.1097/CCM.0b013e31827ca2fa; Central Statistical Office (CSO) Ministry of Health (MOH) Tropical Diseases Research Centre (TDRC) University of Zambia and Macro International Inc, 2015, ZAMB DEM HLTH SURV 2; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Clark RH, 2000, JPEN-PARENTER ENTER, V24, P133, DOI 10.1177/0148607100024003133; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Eley, 2007, AM J PHYSL ENDOCRINO; Eley HL, 2008, AM J PHYSIOL-ENDOC M, V295, pE1417, DOI 10.1152/ajpendo.90567.2008; Ghosh TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095547; Giorgio V, 2014, DIGEST LIVER DIS, V46, P556, DOI 10.1016/j.dld.2014.02.010; Guerrant RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158772; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; Kelly P, 1997, GUT, V41, P811, DOI 10.1136/gut.41.6.811; Kelly P, 2004, AM J TROP MED HYG, V70, P412; Kelly P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004600; Kerac M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096030; Keusch GT, 2014, CLIN INFECT DIS, V59, pS207, DOI 10.1093/cid/ciu485; Lenters LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S23; Louis-Auguste J, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-15; Mayneris-Perxachs J, 2016, AM J CLIN NUTR, V104, P1253, DOI 10.3945/ajcn.116.131797; Mayneris-Perxachs J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19780; Mujagic Z, 2014, ALIMENT PHARM THER, V40, P288, DOI 10.1111/apt.12829; Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636; Prendergast AJ, 2016, CURR OPIN INFECT DIS, V29, P229, DOI 10.1097/QCO.0000000000000261; Shaikh M, 2015, CLIN CHIM ACTA, V442, P24, DOI 10.1016/j.cca.2014.12.040; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Trehan I, 2016, ARCH DIS CHILD, V101, P741, DOI 10.1136/archdischild-2015-309534; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; World Health Organization, 2013, WHO GUID UPD MAN SEV	35	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0192092	10.1371/journal.pone.0192092	http://dx.doi.org/10.1371/journal.pone.0192092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499047	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000426472300002
J	Adjepong, M; Pickens, CA; Jain, R; Harris, WS; Annan, RA; Fenton, JI				Adjepong, Mary; Pickens, C. Austin; Jain, Raghav; Harris, William S.; Annan, Reginald A.; Fenton, Jenifer I.			Association of whole blood n-6 fatty acids with stunting in 2-to-6-year-old Northern Ghanaian children: A cross-sectional study	PLOS ONE			English	Article							LINEAR GROWTH; MEAD ACID; PLASMA; DEFICIENCY; METABOLISM	In Northern Ghana, 33% of children are stunted due to economic disparities. Dietary fatty acids ( FA) are critical for growth, but whether blood FA levels are adequate in Ghanaian children is unknown. The objective of this study was to determine the association between whole blood FAs and growth parameters in Northern Ghanaian children 2-6 years of age. A drop of blood was collected on an antioxidant treated card and analyzed for FA composition. Weight and height were measured and z-scores were calculated. Relationships between FAs and growth parameters were analyzed by Spearman correlations, linear regressions, and factor analysis. Of the 307 children who participated, 29.7% were stunted and 8% were essential FA deficient ( triene/tetraene ratio>0.02). Essential FA did not differ between stunted and non-stunted children and was not associated with height-for-age z-score ( HAZ) or weight-for-age z-score ( WAZ). In hemoglobin adjusted regression models, both HAZ and WAZ were positively associated with arachidonic acid ( p <= 0.01), dihomo-gamma-linolenic acid ( DGLA, p <= 0.05), docosatetraenoic acid ( p <= 0.01) and the ratio of DGLA/linoleic acid ( p <= 0.01). These data add to the growing body of evidence indicating n-6 FAs are critical in childhood linear growth. Our findings provide new insights into the health status of an understudied Northern Ghanaian population.	[Adjepong, Mary; Pickens, C. Austin; Jain, Raghav; Fenton, Jenifer I.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Harris, William S.] Univ South Dakota, Sanford Sch Med, Sioux Falls, SD USA; [Harris, William S.] Omega Quant Analyt LLC, Sioux Falls, SD USA; [Annan, Reginald A.] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana	Michigan State University; University of South Dakota; Kwame Nkrumah University Science & Technology	Fenton, JI (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	imigjeni@msu.edu	Harris, William Stephen/T-1674-2019	Harris, William Stephen/0000-0003-3042-9353; Annan, Reginald Adjetey/0000-0002-6559-1636; Fenton, Jenifer/0000-0002-8875-3239; Jain, Raghav/0000-0002-1284-6762	Borlaug Higher Education in Research and Agricultural Development (BHEARD); Borlaug Leadership Enhancement and Agricultural Program (LEAP)	Borlaug Higher Education in Research and Agricultural Development (BHEARD); Borlaug Leadership Enhancement and Agricultural Program (LEAP)	This project was funded by Borlaug Higher Education in Research and Agricultural Development (BHEARD) and Borlaug Leadership Enhancement and Agricultural Program (LEAP) to MA, all of USAID. No research funds or salary support were provided by OmegaQuant for this project or for Dr. Harris at the time this study was conducted.	Adjepong M, 2016, FASEB J, P30; Adu-Afarwuah S, 2007, FASEB J, V21, pA99; Adu-Afarwuah S., 2015, FASEB J, V29; Ahmed SF, 2010, J ENDOCRINOL, V206, P249, DOI 10.1677/JOE-10-0045; Alhassan L., 2008, NUTR STATUS STATUS P; [Anonymous], 2015, NAT NUTR DAT STAND R; Araujo P, 2008, J CHROMATOGR A, V1212, P106, DOI 10.1016/j.chroma.2008.10.006; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Burdge GC, 2000, J CELL BIOCHEM, V80, P266; CARLSON SE, 1993, P NATL ACAD SCI USA, V90, P1073, DOI 10.1073/pnas.90.3.1073; Cormier H, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0437-z; Damsgaard CT, 2012, PEDIATR RES, V71, P713, DOI 10.1038/pr.2012.28; Feingold KR, 2014, BBA-MOL CELL BIOL L, V1841, P280, DOI 10.1016/j.bbalip.2013.11.007; Fokkema MR, 2002, PROSTAG LEUKOTR ESS, V67, P345, DOI 10.1054/plef.2002.0440; FULCO AJ, 1959, J BIOL CHEM, V234, P1411; Fumagalli IM, 2015, SCIENCE, V349; Fumagalli M, 2015, SCIENCE, V349, P1343, DOI 10.1126/science.aab2319; Ghana Statistical Service Accra G Ghana Health Service Accra Ghana, 2014, GHAN DEM HLTH SURV K; Ghana Statistical Service GHS ICF Macro, 2008, GHAN DEM HLTH SURV 2; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Gurzell EA, 2014, PROSTAG LEUKOTR ESS, V91, P87, DOI 10.1016/j.plefa.2014.04.001; Hadley KB, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040216; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Ho PP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003831; Holman RT, 1960, J NUTR, V70; Ichi I, 2014, BBA-MOL CELL BIOL L, V1841, P204, DOI 10.1016/j.bbalip.2013.10.013; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Issaka AI, 2015, PUBLIC HEALTH NUTR, V18, P669, DOI 10.1017/S1368980014000834; Jumbe T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154715; Kuipers RS, 2011, PROSTAG LEUKOTR ESS, V85, P387, DOI 10.1016/j.plefa.2011.06.004; Ling PR, 2002, DIGEST DIS SCI, V47, P1679, DOI 10.1023/A:1016415805637; Martin-Venegas R, 2006, J LIPID RES, V47, P1416, DOI 10.1194/jlr.M500564-JLR200; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; METSS U, 2017, SAV NANT; Min YJ, 2011, PROSTAG LEUKOTR ESS, V84, P13, DOI 10.1016/j.plefa.2010.10.002; MORRISON WR, 1964, J LIPID RES, V5, P600; NATIONS FAAOOTU, 2009, GHAN NUTR PROF NUTR; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Pickens CA, 2015, PROSTAG LEUKOTR ESS, V95, P31, DOI 10.1016/j.plefa.2014.12.001; Polreis J, 2016, ANN CLIN LAB RES, V4; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Service GS, 2014, POP HOUS CENS SAV DA; Siguel E, 1998, CIRCULATION, V97, P2580, DOI 10.1161/01.CIR.97.25.2580; SIGUEL EN, 1987, CLIN CHEM, V33, P1869; Simko V., 2017, R PACKAGE CORRPLOT V; Smit EN, 2004, PROSTAG LEUKOTR ESS, V71, P241, DOI 10.1016/j.plefa.2004.03.019; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; van der Merwe LF, 2013, AM J CLIN NUTR, V97, P45, DOI 10.3945/ajcn.112.042267; WENE JD, 1975, J CLIN INVEST, V56, P127, DOI 10.1172/JCI108061; WHO. WHO anthro for personal computers, 2016, WHO ANTHR PERS COMP, V3; World Health Organization, 2013, GUID UPD MAN SEV AC; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS	53	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193301	10.1371/journal.pone.0193301	http://dx.doi.org/10.1371/journal.pone.0193301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494645	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200036
J	Carvalho, S; Leijenaar, RTH; Troost, EGC; van Timmeren, JE; Oberije, C; van Elmpt, W; de Geus-Oei, LF; Bussink, J; Lambin, P				Carvalho, Sara; Leijenaar, Ralph T. H.; Troost, Esther G. C.; van Timmeren, Janna E.; Oberije, Cary; van Elmpt, Wouter; de Geus-Oei, Lioe-Fee; Bussink, Johan; Lambin, Philippe			F-18-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUE; FDG-PET RADIOMICS; F-18-FDG PET; TEXTURE ANALYSIS; CT TEXTURE; SURVIVAL; FEATURES; HETEROGENEITY; INFORMATION; QUANTIFICATION	Background Lymph node stage prior to treatment is strongly related to disease progression and poor prognosis in non-small cell lung cancer (NSCLC). However, few studies have investigated metabolic imaging features derived from pre-radiotherapy F-18-fluorodeoxyglucose (FDG) positron-emission tomography (PET) of metastatic hilar/mediastinal lymph nodes (LNs). We hypothesized that these would provide complementary prognostic information to FDG-PET descriptors to only the primary tumor (tumor). Methods Two independent cohorts of 262 and 50 node-positive NSCLC patients were used for model development and validation. Image features (i.e. Radiomics) including shape and size, first order statistics, texture, and intensity-volume histograms (IVH) (http://www.radiomics.io/) were evaluated by univariable Cox regression on the development cohort. Prognostic modeling was conducted with a 10-fold cross-validated least absolute shrinkage and selection operator (LASSO), automatically selecting amongst FDG-PET-Radiomics descriptors from (1) tumor, (2) LNs or (3) both structures. Performance was assessed with the concordance-index. Development data are publicly available at www.cancerdata.org and Dryad (doi:10.5061/dryad.752153b). Results Common SUV descriptors (maximum, peak, and mean) were significantly related to overall survival when extracted from LNs, as were LN volume and tumor load (summed tumor and LNs' volumes), though this was not true for either SUV metrics or tumor's volume. Feature selection exclusively from imaging information based on FDG-PET-Radiomics, exhibited performances of (1) 0.53-external 0.54, when derived from the tumor, (2) 0.62-external 0.56 from LNs, and (3) 0.62-external 0.59 from both structures, including at least one feature from each sub-category, except IVH. Conclusion Combining imaging information based on FDG-PET-Radiomics features from tumors and LNs is desirable to achieve a higher prognostic discriminative power for NSCLC.	[Carvalho, Sara; Leijenaar, Ralph T. H.; Troost, Esther G. C.; van Timmeren, Janna E.; Oberije, Cary; van Elmpt, Wouter; Lambin, Philippe] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol,MAASTRO, Maastricht, Netherlands; [Troost, Esther G. C.] Helmholtz Zentrum Dresden Rossendorf, OncoRay, Inst Radiooncol, Dresden, Germany; [Troost, Esther G. C.] Tech Univ Dresden, Med Fac, Dept Radiotherapy & Radiat Oncol, Dresden, Germany; [Troost, Esther G. C.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Troost, Esther G. C.] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Med Fac, Natl Ctr Radiat Res Oncol,OncoRay, Dresden, Germany; [Troost, Esther G. C.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [de Geus-Oei, Lioe-Fee] Radboud UMC, Dept Radiol & Nucl Med, Nijmegen, Netherlands; [de Geus-Oei, Lioe-Fee] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [de Geus-Oei, Lioe-Fee] Univ Twente, MIRA Inst, Biomed Photon Imaging Grp, Enschede, Netherlands; [Bussink, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands	Maastricht University; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Twente; Radboud University Nijmegen	Lambin, P (corresponding author), Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol,MAASTRO, Maastricht, Netherlands.	sarajbc@gmail.com	de Geus-Oei, L.F./B-2716-2014; van Timmeren, Janita/AAL-4456-2020; Oberije, Cary/ABA-6178-2020; Bussink, Jan/N-3584-2014	de Geus-Oei, L.F./0000-0003-1817-2743; van Timmeren, Janita/0000-0002-8166-6853; Oberije, Cary/0000-0003-0749-5117; Bussink, Johan/0000-0002-5751-4796; Lambin, Philippe/0000-0001-7961-0191	ERC advanced grant (ERC-ADG) [694812]; QuIC-ConCePT project; EFPI A companies; Innovative Medicine Initiative Joint Undertaking (IMI JU) [115151]; Dutch technology Foundation STW [10696 DuCAT, P14-19 Radiomics STRaTegy]; Technology Programme of the Ministry of Economic Affairs; EU 7th framework program [257144, 601826]; SME Phase 2 (EU) [673780 RAIL]; EUROSTARS (SeDI); EUROSTARS (CloudAtlas); EUROSTARS (DART); European Program H (BD2Decide) [PHC30-689715]; European Program H (ImmunoSABR) [733008]; Interreg V-A Euregio Meuse-Rhine ("Euradiomics"); Kankeronderzoekfonds Limburg from the Health Foundation Limburg; Alpe d'HuZes-KWF (DESIGN); Zuyderland-MAASTRO grant; Dutch Cancer Society	ERC advanced grant (ERC-ADG); QuIC-ConCePT project; EFPI A companies; Innovative Medicine Initiative Joint Undertaking (IMI JU); Dutch technology Foundation STW(Technologiestichting STW); Technology Programme of the Ministry of Economic Affairs; EU 7th framework program(European Commission); SME Phase 2 (EU); EUROSTARS (SeDI); EUROSTARS (CloudAtlas); EUROSTARS (DART); European Program H (BD2Decide); European Program H (ImmunoSABR); Interreg V-A Euregio Meuse-Rhine ("Euradiomics"); Kankeronderzoekfonds Limburg from the Health Foundation Limburg; Alpe d'HuZes-KWF (DESIGN); Zuyderland-MAASTRO grant; Dutch Cancer Society(KWF Kankerbestrijding)	Authors acknowledge financial support from ERC advanced grant (ERC-ADG-2015, no 694812 - Hypoximmuno) and the QuIC-ConCePT project, which is partly funded by EFPI A companies and the Innovative Medicine Initiative Joint Undertaking (IMI JU) under Grant Agreement No. 115151. This research is also supported by the Dutch technology Foundation STW (grant no 10696 DuCAT & no P14-19 Radiomics STRaTegy), which is the applied science division of NWO, and the Technology Programme of the Ministry of Economic Affairs. Authors also acknowledge financial support from the EU 7th framework program (ARTFORCE - no 257144, REQUITE - no 601826), SME Phase 2 (EU proposal 673780 RAIL), EUROSTARS (SeDI, CloudAtlas, DART), the European Program H2020-2015-17 (BD2Decide - PHC30-689715 and ImmunoSABR - no 733008), Interreg V-A Euregio Meuse-Rhine ("Euradiomics"), Kankeronderzoekfonds Limburg from the Health Foundation Limburg, Alpe d'HuZes-KWF (DESIGN), the Zuyderland-MAASTRO grant and the Dutch Cancer Society.; Authors acknowledge financial support from ERC advanced grant (ERC-ADG-2015, no 694812-Hypoximmuno) and the QuIC-ConCePT project, which is partly funded by EFPI A companies and the Innovative Medicine Initiative Joint Undertaking (IMI JU) under Grant Agreement No. 115151. This research is also supported by the Dutch technology Foundation STW (grant no 10696 DuCAT & no P14-19 Radiomics STRaTegy), which is the applied science division of NWO, and the Technology Programme of the Ministry of Economic Affairs. Authors also acknowledge financial support from the EU 7th framework program (ART-FORCE no 257144, REQUITE no 601826), SME Phase 2 (EU proposal 673780 -RAIL), EUROSTARS (SeDI, CloudAtlas, DART), the European Program H2020-2015-17 (BD2Decide-PHC30-689715 and ImmunoSABR no 733008), Interreg V-A Euregio Meuse-Rhine ("Euradiomics"), Kankeronderzoekfonds Limburg from the Health Foundation Limburg, Alpe d'HuZes-KWF (DESIGN), the Zuyderland-MAASTRO grant and the Dutch Cancer Society. The authors report no conflicts of interest.	Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Carvalho S, 2013, ACTA ONCOL, V52, P1398, DOI 10.3109/0284186X.2013.812795; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; de Groot PM, 2015, CLIN CHEST MED, V36, P179, DOI 10.1016/j.ccm.2015.02.004; De Ruysscher D, 2005, INT J RADIAT ONCOL, V62, P988, DOI 10.1016/j.ijrobp.2004.12.019; Deasy JO, 2003, MED PHYS, V30, P979, DOI 10.1118/1.1568978; Dehing-Oberije C, 2008, INT J RADIAT ONCOL, V70, P1039, DOI 10.1016/j.ijrobp.2007.07.2323; Dehing-Oberije C, 2009, INT J RADIAT ONCOL, V74, P355, DOI 10.1016/j.ijrobp.2008.08.052; Desseroit MC, 2017, J NUCL MED, V58, P406, DOI 10.2967/jnumed.116.180919; Desseroit MC, 2016, EUR J NUCL MED MOL I, V43, P1477, DOI 10.1007/s00259-016-3325-5; Duan XY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-546; Giron J, 2016, J THORAC ONCOL, V11, pE77, DOI 10.1016/j.jtho.2016.01.026; Grootjans W, 2015, NAT REV CLIN ONCOL, V12, P395, DOI 10.1038/nrclinonc.2015.75; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hellwig D, 2007, J NUCL MED, V48, P1761, DOI 10.2967/jnumed.107.044362; Lambin P, 2017, NAT REV CLIN ONCOL, V14, P749, DOI 10.1038/nrclinonc.2017.141; Lambin P, 2015, ACTA ONCOL, V54, P1289, DOI 10.3109/0284186X.2015.1062136; Lambin P, 2013, NAT REV CLIN ONCOL, V10, P27, DOI 10.1038/nrclinonc.2012.196; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Lambin P, 2010, RADIOTHER ONCOL, V96, P145, DOI 10.1016/j.radonc.2010.07.001; Lee AY, 2014, NUCL MED MOLEC IMAG, V48, P41, DOI 10.1007/s13139-013-0244-2; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; Li HS, 2015, MED PHYS, V42, P4727, DOI 10.1118/1.4926755; Markovina S, REGIONAL LYMPH NODE; Mirsadraee S, 2012, WORLD J RADIOL, V4, P128, DOI 10.4329/wjr.v4.i4.128; Nguyen NC, 2011, ACTA ONCOL, V50, P670, DOI 10.3109/0284186X.2010.550933; Oberije C, 2014, RADIOTHER ONCOL, V112, P37, DOI 10.1016/j.radonc.2014.04.012; Paesmans M, 2015, EUR RESPIR J, V46, P1751, DOI 10.1183/13993003.00099-2015; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Peeters ST, 2016, RADIOTHER ONCOL, V120, P273, DOI 10.1016/j.radonc.2016.05.023; Pettersen EO, 2015, J ENZYM INHIB MED CH, V30, P689, DOI 10.3109/14756366.2014.966704; Prabhu RS, 2015, HEAD NECK-J SCI SPEC, V37, P777, DOI 10.1002/hed.23662; Rao SX, 2014, UNITED EUR GASTROENT, V2, P530, DOI 10.1177/2050640614552463; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Schuurbiers OCJ, 2014, J THORAC ONCOL, V9, P1485, DOI 10.1097/JTO.0000000000000286; Fortuny MS, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0338-6; Shen GH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173104; Taylor MD, 2009, J THORAC CARDIOV SUR, V137, P43, DOI 10.1016/j.jtcvs.2008.10.014; Team RC, 2015, R LANG ENV STAT COMP; Teran MD, 2014, J THORAC DIS, V6, P230, DOI 10.3978/j.issn.2072-1439.2013.12.18; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Van Baardwijk A, 2007, INT J RADIAT ONCOL, V68, P771, DOI 10.1016/j.ijrobp.2006.12.067; Wang YH, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0014-2; Zegers CML, 2014, CLIN CANCER RES, V20, P6389, DOI 10.1158/1078-0432.CCR-14-1524; Zhang HW, 2013, RADIOLOGY, V269, P801, DOI 10.1148/radiol.13130110	50	38	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192859	10.1371/journal.pone.0192859	http://dx.doi.org/10.1371/journal.pone.0192859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494598	Green Published, gold			2022-12-27	WOS:000426363200015
J	Ferrer, RA; Klein, WMP; Avishai, A; Jones, K; Villegas, M; Sheeran, P				Ferrer, Rebecca A.; Klein, William M. P.; Avishai, Aya; Jones, Katelyn; Villegas, Megan; Sheeran, Paschal			When does risk perception predict protection motivation for health threats? A person-by-situation analysis	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; METAANALYSIS; VULNERABILITY; INTENTIONS; FEELINGS; BEHAVIOR; THINKING; PEOPLE; WORRY	Although risk perception is a key concept in many health behavior theories, little research has explicitly tested when risk perception predicts motivation to take protective action against a health threat (protection motivation). The present study tackled this question by (a) adopting a multidimensional model of risk perception that comprises deliberative, affective, and experiential components (the TRIRISK model), and (b) taking a person-by-situation approach. We leveraged a highly intensive within-subjects paradigm to test features of the health threat (i.e., perceived severity) and individual differences (e.g., emotion reappraisal) as moderators of the relationship between the three types of risk perception and protection motivation in a within-subjects design. Multi-level modeling of 2968 observations (32 health threats across 94 participants) showed interactions among the TRIRISK components and moderation both by person-level and situational factors. For instance, affective risk perception better predicted protection motivation when deliberative risk perception was high, when the threat was less severe, and among participants who engage less in emotional reappraisal. These findings support the TRIRISK model and offer new insights into when risk perceptions predict protection motivation.	[Ferrer, Rebecca A.] NCI, Basic Biobehav & Psychol Sci Branch, Behav Res Program, Bethesda, MD 20892 USA; [Klein, William M. P.] NCI, Behav Res Program, Bethesda, MD 20892 USA; [Avishai, Aya; Jones, Katelyn; Villegas, Megan; Sheeran, Paschal] Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill	Sheeran, P (corresponding author), Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC 27599 USA.	psheeran@email.unc.edu	Sheeran, Paschal/Y-3370-2019; /AAD-2466-2020					Abraham C, 2015, PREDICTING CHANGING, Vthird; Aiken L.S., 1991, MULTIPLE REGRESSION; [Anonymous], 1994, DAMASIO DESCARTES ER; Appel M, 2012, J PERS ASSESS, V94, P418, DOI 10.1080/00223891.2012.666921; BECKER MH, 1974, HEALTH EDUC QUART, V2, P409, DOI 10.1177/109019817400200407; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; DENESRAJ V, 1994, J PERS SOC PSYCHOL, V66, P819, DOI 10.1037/0022-3514.66.5.819; Epstein S, 1996, J PERS SOC PSYCHOL, V71, P390, DOI 10.1037/0022-3514.71.2.390; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferrer RA, 2016, ANN BEHAV MED; Ferrer RA, 2015, CURR OPIN PSYCHOL; Ferrer RA, 2013, J HEALTH COMMUN, V18, P397, DOI 10.1080/10810730.2012.727954; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gerrard M, 2008, DEV REV, V28, P29, DOI 10.1016/j.dr.2007.10.001; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; Janssen E, 2014, J BEHAV MED, V37, P11, DOI 10.1007/s10865-012-9462-9; Janssen E, 2012, PSYCHOL HEALTH, V27, P767, DOI 10.1080/08870446.2011.580846; Janssen E, 2011, BRIT J HEALTH PSYCH, V16, P92, DOI 10.1348/135910710X514120; Kapelner A., 2010, CROWDCONF SAN FRANCS; Klein WMP, 2011, J EXP SOC PSYCHOL, V47, P1237, DOI 10.1016/j.jesp.2011.05.005; Leventhal H., 1970, ADV EXP SOC PSYCHOL, V5, P119, DOI [https://doi.org/10.1016/S0065-2601(08)60091-X, DOI 10.1016/S0065-2601(08)60091-X]; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Mills B, 2008, PSYCHOL SCI, V19, P429, DOI 10.1111/j.1467-9280.2008.02104.x; Milne S, 2002, BRIT J HEALTH PSYCH, V7, P163, DOI 10.1348/135910702169420; Nerenz, 1980, CONTRIBUTIONS MED PS, V2, P7, DOI DOI 10.1093/GERONJ/46.4.P181; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Ostrove JM, 2000, HEALTH PSYCHOL, V19, P613, DOI 10.1037/0278-6133.19.6.613; Persoskie A, 2014, J BEHAV MED, V37, P977, DOI 10.1007/s10865-013-9537-2; Portnoy DB, 2014, J RISK RES, V17, P177, DOI 10.1080/13669877.2013.794153; Reyna VF, 2012, VACCINE, V30, P3790, DOI 10.1016/j.vaccine.2011.11.070; Rimal RN, 2010, J APPL SOC PSYCHOL, V40, P287, DOI 10.1111/j.1559-1816.2009.00574.x; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [10.1080/14792772143000003, DOI 10.1080/14792772143000003]; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Sinclair M, 2010, J MANAGE ORGAN, V16, P382; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; SLOVIC P, 1964, PSYCHOL BULL, V61, P220, DOI 10.1037/h0043608; Snijders Tom, 2005, ENCY STAT BEHAV SCI; von Neumann J, 1974, THEORY GAMES EC BEHA; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355; Weinstein ND, 2000, HEALTH PSYCHOL, V19, P65, DOI 10.1037/0278-6133.19.1.65; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; Weinstein ND, 2007, ANN BEHAV MED, V33, P1, DOI 10.1207/s15324796abm3301_1; Windschitl PD, 2002, J BEHAV DECIS MAKING, V15, P19, DOI 10.1002/bdm.401; Witte K., 1998, FEAR MOTIVATOR TEAR; Zanna M.P., 1982, CONSISTENCY SOCIAL B, P283	53	59	61	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0191994	10.1371/journal.pone.0191994	http://dx.doi.org/10.1371/journal.pone.0191994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494705	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200008
J	Kanemura, A; Yoshikawa, Y; Fukuda, W; Tsumoto, K; Kenmotsu, T; Yoshikawa, K				Kanemura, Ai; Yoshikawa, Yuko; Fukuda, Wakao; Tsumoto, Kanta; Kenmotsu, Takahiro; Yoshikawa, Kenichi			Opposite effect of polyamines on In vitro gene expression: Enhancement at low concentrations but inhibition at high concentrations	PLOS ONE			English	Article							INDUCED DNA CONDENSATION; TRANSCRIPTIONAL ACTIVITY; CONFORMATIONAL TRANSITION; GIANT DNA; MOLECULES; COMPACTION; SPERMINE	Background Polyamines have various biological functions including marked effects on the structure and function of genomic DNA molecules. Changes in the higher-order structure of DNA caused by polyamines are expected to be closely related to genetic activity. To clarify this issue, we examined the relationship between gene expression and the higher-order structure of DNA under different polyamine concentrations. Principal findings We studied the effects of polyamines, spermidine SPD(3+) and spermine SP(4+), on gene expression by a luciferase assay. The results showed that gene expression is increased by ca. 5-fold by the addition of SPD(3+) at 0.3 mM, whereas it is completely inhibited above 2 mM. Similarly, with SP(4+), gene expression is maximized at 0.08 mM and completely inhibited above 0.6 mM. We also performed atomic force microscopy (AFM) observations on DNA under different polyamine concentrations. AFM revealed that a flower-like conformation is generated at polyamine concentrations associated with maximum expression as measured by the luciferase assay. On the other hand, DNA molecules exhibit a folded compact conformation at polyamine concentrations associated with the complete inhibition of expression. Based on these results, we discuss the plausible mechanism of the opposite effect, i.e., enhancement and inhibition, of polyamines on gene expression. Conclusion and significance It was found that polyamines exert opposite effect, enhancement and inhibition, on gene expression depending on their concentrations. Such an opposite effect is argued in relation to the conformational change of DNA: enhancement is due to the parallel ordering of DNA segments that is accompanied by a decrease in the negative charge of double-stranded DNA, and inhibition is caused by the compaction of DNA into a tightly packed state with almost perfect charge-neutralization.	[Kanemura, Ai; Yoshikawa, Yuko; Kenmotsu, Takahiro; Yoshikawa, Kenichi] Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan; [Fukuda, Wakao] Ritsumeikan Univ, Coll Life Sci, Shiga, Japan; [Tsumoto, Kanta] Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie, Japan	Doshisha University; Ritsumeikan University; Mie University	Yoshikawa, K (corresponding author), Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan.	keyoshik@mail.doshisha.ac.jp	Yoshikawa, Kenichi/N-1867-2019; Tsumoto, Kanta/AAK-2684-2021	Yoshikawa, Kenichi/0000-0002-2751-7136; Tsumoto, Kanta/0000-0002-7882-3635	JSPS KAKENHI Grant [15H02121, 25103012]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported by JSPS KAKENHI Grant Number 15H02121 and 25103012 (https://www.jsps.go.jp/english/e-grants/) to KY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEZA I, 1987, BIOCHEMISTRY-US, V26, P6387, DOI 10.1021/bi00394a012; Bloomfield VA, 1996, CURR OPIN STRUC BIOL, V6, P334, DOI 10.1016/S0959-440X(96)80052-2; CHELM BK, 1979, NUCLEIC ACIDS RES, V7, P1851, DOI 10.1093/nar/7.7.1851; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Cortini R, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.025002; De Carlo S, 2003, J MOL BIOL, V329, P891, DOI 10.1016/S0022-2836(03)00510-2; Estevez-Torres A, 2011, SOFT MATTER, V7, P6746, DOI 10.1039/c1sm05373f; Fang Y, 1998, J AM CHEM SOC, V120, P8903, DOI 10.1021/ja981332v; FENLEY MO, 1990, BIOPOLYMERS, V30, P1191, DOI 10.1002/bip.360301305; Garrett RH., 2013, BIOCHEMISTRY-US, V5th; Gevrekci AO, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2370-y; GOSULE LC, 1978, J MOL BIOL, V121, P311, DOI 10.1016/0022-2836(78)90366-2; Hibino K, 2006, CHEM PHYS LETT, V426, P405, DOI 10.1016/j.cplett.2006.05.120; Korolev N, 2009, NUCLEIC ACIDS RES, V37, P7137, DOI 10.1093/nar/gkp683; Luckel F, 2005, FEBS LETT, V579, P5119, DOI 10.1016/j.febslet.2005.07.095; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Muramatsu A, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4972066; Oosawa F., 1971, POLYELECTROLYTES; Ou ZY, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1940054; Pelta J, 1996, BIOPHYS J, V71, P48, DOI 10.1016/S0006-3495(96)79232-9; Qiu XY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.228101; Raspaud E, 2005, BIOPHYS J, V88, P392, DOI 10.1529/biophysj.104.040113; Saminathan M, 2002, NUCLEIC ACIDS RES, V30, P3722, DOI 10.1093/nar/gkf503; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Takahashi M, 1997, J PHYS CHEM B, V101, P9396, DOI 10.1021/jp9716391; Tongu C, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4950749; Tsumoto K, 2003, BIOPHYS CHEM, V106, P23, DOI 10.1016/S0301-4622(03)00138-8; Turner D., 2000, BLOOMFIELD, P259; Vijayanathan V, 2001, BIOCHEMISTRY-US, V40, P13644, DOI 10.1021/bi010993t; Vilfan ID, 2006, BIOCHEMISTRY-US, V45, P8174, DOI 10.1021/bi060396c; Yamada A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1937990; Yamasaki Y, 2001, BIOPHYS J, V80, P2823, DOI 10.1016/S0006-3495(01)76249-2; Yoshikawa K, 1996, PHYS REV LETT, V76, P3029, DOI 10.1103/PhysRevLett.76.3029; Yoshikawa Y, 2013, ANGEW CHEM INT EDIT, V52, P3712, DOI 10.1002/anie.201209144; Yoshikawa Y, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3666845	36	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193595	10.1371/journal.pone.0193595	http://dx.doi.org/10.1371/journal.pone.0193595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494707	Green Submitted, gold, Green Published			2022-12-27	WOS:000426363200071
J	Schrapers, KT; Sponder, G; Liebe, F; Liebe, H; Stumpff, F				Schrapers, Katharina T.; Sponder, Gerhard; Liebe, Franziska; Liebe, Hendrik; Stumpff, Friederike			The bovine TRPV3 as a pathway for the uptake of Na+, Ca2+, and NH4+	PLOS ONE			English	Article							SHEEP RUMEN EPITHELIUM; GATED ION-CHANNEL; CATION CHANNEL; ACTIVE-TRANSPORT; PATCH-CLAMP; DAIRY-COWS; AMINO-ACID; AMMONIA; METABOLISM; EXPRESSION	Absorption of ammonia from the gastrointestinal tract results in problems that range from hepatic encephalopathy in humans to poor nitrogen efficiency of cattle with consequences for the global climate. Previous studies on epithelia and cells from the native ruminal epithelium suggest functional involvement of the bovine homologue of TRPV3 ( bTRPV3) in ruminal NH4+ transport. Since the conductance of TRP channels to NH4+ has never been studied, bTRPV3 was overexpressed in HEK-293 cells and investigated using the patch-clamp technique and intracellular calcium imaging. Control cells contained the empty construct. Divalent cations blocked the conductance for monovalent cations in both cell types, with effects higher in cells expressing bTRPV3. In bTRPV3 cells, but not in controls, menthol, thymol, carvacrol, or 2-APB stimulated whole cell currents mediated by Na+, Cs+, NH4+, and K+, with a rise in intracellular Ca2+ observed in response to menthol. While only 25% of control patches showed single-channel events ( with a conductance of 40.8 +/- 11.9 pS for NH4+ and 25.0 +/- 5.8 pS for Na+), 90% of bTRPV3 patches showed much larger conductances of 127.8 +/- 4.2 pS for Na+, 240.1 +/- 3.6 pS for NH4+, 34.0 +/- 1.7 pS for Ca2+, and similar to 36 pS for NMDG(+). Open probability, but not conductance, rose with time after patch excision. In conjunction with previous research, we suggest that bTRPV3 channels may play a role in the transport of Na+, K+, Ca2+ and NH4+ across the rumen with possible repercussions for understanding the function of TRPV3 in other epithelia.	[Schrapers, Katharina T.; Sponder, Gerhard; Liebe, Franziska; Liebe, Hendrik; Stumpff, Friederike] Free Univ Berlin, Fac Vet Med, Inst Vet Physiol, Berlin, Germany	Free University of Berlin	Stumpff, F (corresponding author), Free Univ Berlin, Fac Vet Med, Inst Vet Physiol, Berlin, Germany.	stumpff@zedat.fu-berlin.de		Liebe, Franziska/0000-0002-4722-3709	German Science Foundation [DFG Stu258/7-1]; Akademie fur Tiergesundheit; Sonnenfeld-Stiftung	German Science Foundation(German Research Foundation (DFG)); Akademie fur Tiergesundheit; Sonnenfeld-Stiftung	This study was performed for purely scientific reasons within a conventional academic framework. Friederike Stumpff was the co-holder of a patent which was transferred to a startup company which now employs Katharina Schrapers. This publication will have no impact on the commercial success or failure of that enterprise and there is no conflict of interest. Funding was provided by the German Science Foundation (DFG Stu258/7-1, Franziska Liebe), the Akademie fur Tiergesundheit (Katharina T. Schrapers) and the Sonnenfeld-Stiftung (Hendrik Liebe).	Abdoun K, 2005, AM J PHYSIOL-GASTR L, V289, pG508, DOI 10.1152/ajpgi.00436.2004; Amarouch MY, 2013, NEUROSCI LETT, V541, P105, DOI 10.1016/j.neulet.2013.02.011; Balemans D, 2017, AM J PHYSIOL-GASTR L, V312, pG635, DOI 10.1152/ajpgi.00401.2016; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Behera SN, 2013, ENVIRON SCI POLLUT R, V20, P8092, DOI 10.1007/s11356-013-2051-9; Billen B, 2015, J BIOL CHEM, V290, P12964, DOI 10.1074/jbc.M114.628925; Bodeker D, 1996, COMP BIOCHEM PHYS A, V114, P305, DOI 10.1016/0300-9629(96)00012-6; Bouwman AF, 1997, GLOBAL BIOGEOCHEM CY, V11, P561, DOI 10.1029/97GB02266; Bugaj V, 2005, J BIOL CHEM, V280, P16790, DOI 10.1074/jbc.M500192200; BURCKHARDT BC, 1992, PFLUG ARCH EUR J PHY, V420, P83, DOI 10.1007/BF00378645; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Delgado-Elorduy A, 2002, J DAIRY SCI, V85, P148, DOI 10.3168/jds.S0022-0302(02)74063-0; DOBSON A, 1959, J PHYSIOL-LONDON, V146, P235, DOI 10.1113/jphysiol.1959.sp006191; Doerner JF, 2011, J GEN PHYSIOL, V137, P271, DOI 10.1085/jgp.200910388; Ferreira LGB, 2016, J BIOENERG BIOMEMBR, V48, P1, DOI 10.1007/s10863-015-9634-8; Gartner K, 1964, Dtsch Tierarztl Wochenschr, V71, P57; Georgi MI, 2014, PFLUG ARCH EUR J PHY, V466, P1689, DOI 10.1007/s00424-013-1386-x; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARMEYER J, 1980, J DAIRY SCI, V63, P1707, DOI 10.3168/jds.S0022-0302(80)83132-8; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hsu YJ, 2007, BBA-MOL BASIS DIS, V1772, P928, DOI 10.1016/j.bbadis.2007.02.001; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Janssens A, 2016, ELIFE, V5, DOI 10.7554/eLife.17240; JERLING L, 1982, HOLARCTIC ECOL, V5, P405; Jiang B, 2002, MOL CELL BIOCHEM, V238, P69, DOI 10.1023/A:1019907104763; Kim SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059593; Lang I, 1999, AM J PHYSIOL-GASTR L, V277, pG609, DOI 10.1152/ajpgi.1999.277.3.G609; Leonhard-Marek S, 2005, AM J PHYSIOL-GASTR L, V288, pG630, DOI 10.1152/ajpgi.00275.2004; Leonhard-Marek S, 2010, ANIMAL, V4, P1037, DOI 10.1017/S1751731110000261; Leonhard-Marek S, 2002, J COMP PHYSIOL B, V172, P635, DOI 10.1007/s00360-002-0292-x; LeonhardMarek S, 1996, AM J PHYSIOL-GASTR L, V271, pG1034, DOI 10.1152/ajpgi.1996.271.6.G1034; Luo JL, 2012, J INVEST DERMATOL, V132, P2158, DOI 10.1038/jid.2012.144; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Marini J. C., 2006, P155; MEIJER GAL, 1993, METABOLISM, V42, P358, DOI 10.1016/0026-0495(93)90087-5; Metges CC, 1999, AM J CLIN NUTR, V70, P1046; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Montell C, 2011, PFLUG ARCH EUR J PHY, V461, P499, DOI 10.1007/s00424-010-0920-3; Nagaraja TN, 1998, AM J PHYSIOL-CELL PH, V274, pC883, DOI 10.1152/ajpcell.1998.274.4.C883; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Nilius B, 2014, J PHYSIOL-LONDON, V592, P295, DOI 10.1113/jphysiol.2013.255968; Oehlschlaeger V, 2014, ANIM PROD SCI, V54, P1394, DOI 10.1071/AN14344; Ott P, 2014, METABOLIC BRAIN DIS; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Ramezani A, 2016, AM J KIDNEY DIS, V67, P483, DOI 10.1053/j.ajkd.2015.09.027; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reynolds C K, 2008, J Anim Sci, V86, pE293; Rosendahl J, 2016, PFLUG ARCH EUR J PHY, V468, P1333, DOI 10.1007/s00424-016-1835-4; Sarria I, 2011, J NEUROPHYSIOL, V106, P3056, DOI 10.1152/jn.00544.2011; Schweigel M, 2008, MAGNESIUM RES, V21, P118; SELLERS A. F., 1960, RES VET SCI, V1, P95; Stumpff F, 2013, J COMP PHYSIOL B, V183, P1053, DOI 10.1007/s00360-013-0771-2; Stumpff F, 2011, J EXP BIOL, V214, P2871, DOI 10.1242/jeb.055582; Taylor L, 2004, BIOCHEM MOL BIOL EDU, V32, P291, DOI 10.1002/bmb.2004.494032050388; Ueda T, 2009, BIOCHEM BIOPH RES CO, V383, P130, DOI 10.1016/j.bbrc.2009.03.143; Varghese A, 2006, PROG BIOPHYS MOL BIO, V90, P26, DOI 10.1016/j.pbiomolbio.2005.05.002; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Vriens J, 2008, CURR NEUROPHARMACOL, V6, P79, DOI 10.2174/157015908783769644; WEBER A, 1989, PFLUG ARCH EUR J PHY, V414, P564, DOI 10.1007/BF00580992; Weiner ID, 2017, PHYSIOL REV, V97, P465, DOI 10.1152/physrev.00011.2016; Wilkens MR, 2009, VET J, V182, P294, DOI 10.1016/j.tvjl.2008.06.020; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200	73	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193519	10.1371/journal.pone.0193519	http://dx.doi.org/10.1371/journal.pone.0193519			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494673	Green Submitted, gold, Green Published			2022-12-27	WOS:000426363200060
J	Thong, MY; Manrique, YJ; Steadman, KJ				Thong, Min Yew; Manrique, Yady J.; Steadman, Kathryn J.			Drug loss while crushing tablets: Comparison of 24 tablet crushing devices	PLOS ONE			English	Article							DOSAGE FORM MODIFICATION; AGED-CARE; MEDICATIONS; TUBES	This study investigated 24 tablet crushing devices for drug loss using different methods to recover the crushed tablet. 24 devices were compared: 3 with disposable cups, 6 with disposable bags, 12 without separate vessels and 3 types of mortar and pestle. One paracetamol tablet was crushed and recovered by tapping the powder out. Where appropriate, depending on crusher size and manufacturer instructions, the powder was also recovered by mixing with water or food. Paracetamol recovery (quantity that can be delivered to a patient) and leftover (quantity remaining in the device) were measured using a validated UV method and the entire experiment was replicated 3 times. Drug recovery ranged from 86.7-98.1% when the crushed tablet was tapped out of the crushers (average loss 5.8%). Significant losses were measured for 18 crushers, particularly manually operated hand-twist crushers with a serrated crushing surface, and some devices with disposable bags or cups. Rinsing the crushed powder with water once resulted in an average of 24.2% drug loss, and this was reduced to 4.2% after a second rinse. If crushing is unavoidable, maximizing medication delivery to the patient is essential. Rinsing twice resulted in similar paracetamol recovery to tapping the powder out; however only water rinses have the potential for direct consumption by the patient, minimizing drug loss across the entire crushing and transfer process.	[Thong, Min Yew; Manrique, Yady J.; Steadman, Kathryn J.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia	University of Queensland	Steadman, KJ (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	k.steadman@uq.edu.au	Steadman, Kathryn/C-3401-2008	Steadman, Kathryn/0000-0001-7357-330X				[Anonymous], 2005, BMJ-BRIT MED J, V330, P20; Bourdenet G, 2015, FUND CLIN PHARMACOL, V29, P316, DOI 10.1111/fcp.12116; Christiansen N, 2008, PHARM WORLD SCI, V30, P550, DOI 10.1007/s11096-008-9208-5; CLARKSCHMIDT AL, 1990, AM J HOSP PHARM, V47, P2034, DOI 10.1093/ajhp/47.9.2034; Crean B, 2013, DRUGS R&D, V13, P153, DOI 10.1007/s40268-013-0018-4; FDA, 2013, FOOD DRUG ADM; Griffith R., 2005, NURSE PRESCR, V3, P201, DOI DOI 10.12968/NPRE.2005.3.5.19851; Ifrah A, 2016, INT J CLIN PHARM-NET, V38, P543; International Conference on Harmonisation of Technical Requirements for Registration oof Pharmaceuticals for Human Use (ICH), 1996, ICH FORM PREP SPEC M; Kawai M, 2004, JAPANESE J PHARM HLT, V30, P261; Kelly Jennifer, 2009, Nurs Stand, V23, P62; Kotake T, 2006, J CLIN PHARM THER, V31, P237, DOI 10.1111/j.1365-2710.2006.00730.x; Manessis A, 2008, JPEN-PARENTER ENTER, V32, P197, DOI 10.1177/0148607108314770; Marquis J, 2013, INT J CLIN PHARM-NET, V35, P1130, DOI 10.1007/s11096-013-9836-2; Mercovich N, 2014, AUSTRALAS J AGEING, V33, P180, DOI 10.1111/ajag.12037; Nissen Lisa M., 2009, Journal of Pharmacy Practice and Research, V39, P129; Palese A, 2010, J CLIN NURS, V19, P2970, DOI 10.1111/j.1365-2702.2010.03281.x; Paradiso LM, 2002, AUSTRALAS J AGEING, V21, P123, DOI 10.1111/j.1741-6612.2002.tb00432.x; Ruzsikova A, 2015, INT J PHARMACEUT, V478, P368, DOI 10.1016/j.ijpharm.2014.11.065; Salmon D, 2013, INT J PHARMACEUT, V443, P146, DOI 10.1016/j.ijpharm.2012.12.038; Steele CM, 2015, DYSPHAGIA, V30, P2, DOI 10.1007/s00455-014-9578-x; Steele CM, GUIDANCE IND Q2B VAL; Stubbs J, 2008, INT PSYCHOGERIATR, V20, P616, DOI 10.1017/S1041610207006047; van Riet-Nales DA, 2014, INT J PHARMACEUT, V466, P44, DOI 10.1016/j.ijpharm.2014.02.031	24	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193683	10.1371/journal.pone.0193683	http://dx.doi.org/10.1371/journal.pone.0193683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494695	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200081
J	Dennison, L; Brown, M; Kirby, S; Galea, I				Dennison, Laura; Brown, Martina; Kirby, Sarah; Galea, Ian			Do people with multiple sclerosis want to know their prognosis? A UK nationwide study	PLOS ONE			English	Article							COMMUNICATING PROGNOSIS; NATURAL-HISTORY; LONG; DISEASE; CANCER; DEPRESSION; PREDICTION; ANXIETY; STYLE; END	Background Multiple sclerosis (MS) has a varied and uncertain trajectory. The recent development of analytical processing tools that draw on large longitudinal patient databases facilitates personalised long-term prognosis estimates. This has the potential to improve both shared treatment decision-making and psychological adjustment. However, there is limited research on how people with MS feel about prognosis communication and forecasting. This study investigated the prognosis communication experiences and preferences of people with MS and explored whether clinical, demographic and psychological factors are associated with prognosis information preferences. Methods 3175 UK MS Register members (59% of those with active accounts) completed an online survey containing 17 questions about prognosis communication experiences, attitudes and preferences. Participants also completed validated questionnaires measuring coping strategies, tendencies to seek out ('monitor) or avoid ('blunt') information in threatening situations, and MS risk perceptions and reported their clinical and sociodemographic characteristics. Data already held on the MS Register about participants' quality of life, anxiety and depression symptoms and MS impact were obtained and linked to the survey data. Results 53.1% of participants had never discussed long-term prognosis with healthcare professionals. 54.2% lacked clarity about their long-term prognosis. 76% had strong preferences for receiving long-term prognosis information. 92.8% were interested in using tools that generate personalised predictions. Most participants considered prognostication useful for decision-making. Participants were more receptive to receiving prognosis information at later time-points, versus at diagnosis. A comprehensive set of sociodemographic, clinical and psychological variables predicted only 7.9% variance in prognosis information preferences. Conclusions People with MS have an appetite for individualised long-term prognosis forecasting and their need for information is frequently unmet. Clinical studies deploying and evaluating interventions to support prognostication in MS are now needed. This study indicates suitable contexts and patient preferences for initial trials of long-term prognosis tools in clinical settings.	[Dennison, Laura; Kirby, Sarah] Univ Southampton, Dept Psychol, Ctr Clin & Community Applicat Hlth Psychol, Southampton, Hants, England; [Brown, Martina] Univ Southampton, Hlth Sci, Southampton, Hants, England; [Galea, Ian] Univ Southampton, Fac Med, Clin Neurosci Clin & Expt Sci, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton	Galea, I (corresponding author), Univ Southampton, Fac Med, Clin Neurosci Clin & Expt Sci, Southampton, Hants, England.	I.Galea@soton.ac.uk	Galea, Ian/B-7997-2011; Kirby, Sarah/M-6390-2015	Galea, Ian/0000-0002-1268-5102; Dennison, Laura/0000-0003-0122-6610; Kirby, Sarah/0000-0003-1759-1356	UK MS Society; NIHR	UK MS Society; NIHR(National Institute for Health Research (NIHR))	The UK MS Register https://ukmsregister.org/Portal/Home is funded by the UK MS Society. MB was funded by NIHR to complete an MRes degree and she conducted data collection for this study as part of her degree.	Arribas-Ayllon M, 2011, BRIT MED BULL, V100, P7, DOI 10.1093/bmb/ldr023; Beran TM, 2009, J GENET COUNS, V18, P265, DOI 10.1007/s10897-009-9223-2; Bergamaschi R, 2007, J NEUROL NEUROSUR PS, V78, P757, DOI 10.1136/jnnp.2006.107052; Bernat JL, 2004, NEUROCRIT CARE, V1, P107, DOI 10.1385/NCC:1:1:107; Boeije HR, 2004, SOC SCI MED, V59, P861, DOI 10.1016/j.socscimed.2003.11.040; Buecken R, 2012, PATIENT EDUC COUNS, V88, P318, DOI 10.1016/j.pec.2012.03.010; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cook SA, 2009, EYE, V23, P581, DOI 10.1038/eye.2008.54; Degenhardt A, 2009, NAT REV NEUROL, V5, P672, DOI 10.1038/nrneurol.2009.178; Dennison L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158982; Dennison L, 2009, CLIN PSYCHOL REV, V29, P141, DOI 10.1016/j.cpr.2008.12.001; Duncan LR, 2013, J CANCER EDUC, V28, P119, DOI 10.1007/s13187-012-0431-3; Finlayson M., 2005, BRIT J OCCUPATIONAL, V68, P117, DOI DOI 10.1177/030802260506800304; Galea I, 2013, EUR J NEUROL, V20, P1107, DOI 10.1111/ene.12016; Gourraud PA, 2014, ANN NEUROL, V76, P633, DOI 10.1002/ana.24282; Hagerty RG, 2005, ANN ONCOL, V16, P1005, DOI 10.1093/annonc/mdi211; Heesen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059042; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Holloway RG, 2013, NEUROLOGY, V80, P764, DOI 10.1212/WNL.0b013e318282509c; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; Mohr DC, 2001, J CLIN PSYCHOL, V57, P479, DOI 10.1002/jclp.1042; Osborne LA, 2014, PHYS THER REV, V19, P24, DOI 10.1179/1743288X13Y.0000000094; Rich BA, 2001, THEOR MED BIOETH, V22, P177, DOI 10.1023/A:1011466711211; Roberts JS, 2013, PROG NEUROBIOL, V110, P89, DOI 10.1016/j.pneurobio.2013.02.005; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Schuermeyer I, 2016, JAMA OPHTHALMOL, V134, P51, DOI 10.1001/jamaophthalmol.2015.4343; Solari A, 2014, MULT SCLER J, V20, P397, DOI 10.1177/1352458514523061; Somerset Maggie, 2002, J Health Serv Res Policy, V7, P151, DOI 10.1258/135581902760082454; STEPTOE A, 1989, BRIT J CLIN PSYCHOL, V28, P183, DOI 10.1111/j.2044-8260.1989.tb00830.x; Synnot AJ, 2016, HEALTH EXPECT, V19, P727, DOI 10.1111/hex.12253; Tams R, 2016, NEUROREHABILITATION, V38, P257, DOI 10.3233/NRE-161317; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193407	10.1371/journal.pone.0193407	http://dx.doi.org/10.1371/journal.pone.0193407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489869	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000426276000072
J	Linn, SN; Boeer, M; Scheumann, M				Linn, Sabrina N.; Boeer, Michael; Scheumann, Marina			First insights into the vocal repertoire of infant and juvenile Southern white rhinoceros	PLOS ONE			English	Article							CERATOTHERIUM-SIMUM; GROUP COORDINATION; BEHAVIOR; PRIMATE; AROUSAL; CALLS; VOCALIZATIONS; ACOUSTICS; CONTEXT; CUES	Describing vocal repertoires represents an essential step towards gaining an overview about the complexity of acoustic communication in a given species. The analysis of infant vocalisations is essential for understanding the development and usage of species- specific vocalisations, but is often underrepresented, especially in species with long interbirth intervals such as the white rhinoceros. Thus, this study aimed for the first time to characterise the infant and juvenile vocal repertoire of the Southern white rhinoceros and to relate these findings to the adult vocal repertoire. The behaviour of seven motherreared white rhinoceros calves (two males, five females) and one hand- reared calf (male), ranging from one month to four years, was simultaneously audio and video- taped at three zoos. Normally reared infants and juveniles uttered four discriminable call types (Whine, Snort, Threat, and Pant) that were produced in different behavioural contexts. All call types were also uttered by the hand- reared calf. Call rates of Whines, but not of the other call types, decreased with age. These findings provide the first evidence that infant and juvenile rhinoceros utter specific call types in distinct contexts, even if they grow up with limited social interaction with conspecifics. By comparing our findings with the current literature on vocalisations of adult white rhinoceros and other solitary rhinoceros species, we discuss to which extent differences in the social lifestyle across species affect acoustic communication in mammals.	[Linn, Sabrina N.; Scheumann, Marina] Univ Vet Med Hannover, Inst Zool, Bunteweg 17, Hannover, Germany; [Linn, Sabrina N.] Serengeti Pk Hodenhagen GmbH, Safaripk 1, Hodenhagen, Germany; [Boeer, Michael] Osnabruck Zoo, Klaus Strick Weg 12, Osnabruck, Germany	University of Veterinary Medicine Hannover, Foundation	Linn, SN (corresponding author), Univ Vet Med Hannover, Inst Zool, Bunteweg 17, Hannover, Germany.; Linn, SN (corresponding author), Serengeti Pk Hodenhagen GmbH, Safaripk 1, Hodenhagen, Germany.	sabrina.linn@gmx.de		Scheumann, Marina/0000-0002-4091-9500	Serengeti-Park-Stiftung; Studienstiftung des Deutschen Volkes; Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover	Serengeti-Park-Stiftung; Studienstiftung des Deutschen Volkes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover	This study was financially supported by the Serengeti-Park-Stiftung (MS; hftp://www.serengeti-park-stiftung.de/) and the Studienstiftung des Deutschen Volkes (SL; https://www.studienstiftung.de/). Furthermore, this publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amman H, 1986, CONTRIBUTIONS ECOLOG; Baotic A, 2014, BIOACOUSTICS, V23, P15, DOI 10.1080/09524622.2013.798744; Barros KS, 2011, ETHOLOGY, V117, P83, DOI 10.1111/j.1439-0310.2010.01853.x; BENSON BN, 1992, J MAMMAL, V73, P106, DOI 10.2307/1381871; BINZ H, 1989, BEHAVIOUR, V109, P142, DOI 10.1163/156853989X00196; Boeer M, 1996, ZOOL GART, V66, P349; Boersma P., 2001, GLOT INT, V5, P341; Braune P, 2005, BEHAV ECOL SOCIOBIOL, V58, P587, DOI 10.1007/s00265-005-0944-4; Briefer EF, 2012, ANIM BEHAV, V83, P991, DOI 10.1016/j.anbehav.2012.01.020; Budde C, 2003, MAMM BIOL, V68, P42, DOI 10.1078/1616-5047-00060; Cao DD, 2016, ANIM BIOL, V66, P145, DOI 10.1163/15707563-00002493; Cinkova I, 2016, ANIM COGN, V19, P375, DOI 10.1007/s10071-015-0940-7; Cinkova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098475; Dunlop RA, 2007, J ACOUST SOC AM, V122, P2893, DOI 10.1121/1.2783115; Egnor SER, 2004, TRENDS NEUROSCI, V27, P649, DOI 10.1016/j.tins.2004.08.009; Esser KH, 2003, SPEECH COMMUN, V41, P179, DOI 10.1016/S0167-6393(02)00102-4; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fischer J, 2002, FOLIA PRIMATOL, V73, P32, DOI 10.1159/000060417; Haccou P, 1994, STAT ANAL BEHAV DATA; Hanson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040782; Hazarika B.C., 2010, NeBIO, V1, P62; Herler A, 2012, BEHAVIOUR, V149, P575, DOI 10.1163/156853912X648516; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Knornschild M, 2010, ACTA CHIROPTEROL, V12, P205, DOI 10.3161/150811010X504707; LAURIE A, 1982, J ZOOL, V196, P307; Lea AJ, 2011, ETHOLOGY, V117, P839, DOI 10.1111/j.1439-0310.2011.01947.x; Lemasson A, 2014, J MAMMAL, V95, P128, DOI 10.1644/12-MAMM-A-313.1; Muggenthaler E, 2003, J ACOUST SOC AM, V113, P2277; Mumm CAS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112562; Owen-Smith N, 1973, BEHAV ECOLOGY WHITE; OWEN-SMITH R N, 1975, Zeitschrift fuer Tierpsychologie, V38, P337; Owen-Smith R.N., 1974, IUCN Publs (New Series), VNo. 24, P341; Passilongo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063841; Pfefferle D, 2011, INT J PRIMATOL, V32, P992, DOI 10.1007/s10764-011-9517-8; Pokrovskaya L, 2013, BIOACOUSTICS, V22, P229, DOI 10.1080/09524622.2013.785023; Policht R, 2008, BIOACOUSTICS, V18, P69, DOI 10.1080/09524622.2008.9753591; Ramanankirahina R, 2016, AM J PHYS ANTHROPOL, V159, P466, DOI 10.1002/ajpa.22898; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Roper KM, 2014, AM J PRIMATOL, V76, P192, DOI 10.1002/ajp.22221; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Schenkel R., 1969, Acta Tropica, V26, P97; Schenkel R, 1969, HDB ZOOLOGIE, V8, P1; Schenkel R., 1969, ECOLOGY BEHAV BLACK; Scheumann M, 2007, DEV PSYCHOBIOL, V49, P708, DOI 10.1002/dev.20234; Scheumann M, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-36; Schibler F, 2007, ANIM BEHAV, V74, P1259, DOI 10.1016/j.anbehav.2007.02.026; Schneiderova I, 2012, NATURWISSENSCHAFTEN, V99, P55, DOI 10.1007/s00114-011-0870-4; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; Shrader AM, 2002, BEHAV ECOL SOCIOBIOL, V52, P255, DOI 10.1007/s00265-002-0506-y; Skinner JD, 2006, ONDERSTEPOORT J VET, V73, P237; Soltis J, 2005, ANIM BEHAV, V70, P579, DOI 10.1016/j.anbehav.2004.11.015; Stoeger AS, 2012, ETHOLOGY, V118, P896, DOI 10.1111/j.1439-0310.2012.02080.x; Stoeger AS, 2011, J ACOUST SOC AM, V130, P1700, DOI 10.1121/1.3605538; Stoeger-Horwath AS, 2007, J ACOUST SOC AM, V121, P3922, DOI 10.1121/1.2722216; Tajuddin binAbdullah M, 1987, J WILDLIFE PARKS MAL, V6, P39; Volodin IA, 2015, ETHOLOGY, V121, P103, DOI 10.1111/eth.12321; Volodin IA, 2014, ANIM COGN, V17, P349, DOI 10.1007/s10071-013-0666-3; von Muggenthaler E, 2003, ACOUST RES LETT ONL, V4, P83, DOI 10.1121/1.1588271; Zahari ZZ, 2005, ANIM REPROD SCI, V85, P327, DOI 10.1016/j.anireprosci.2004.04.041; Zaytseva AS, 2015, BEHAV PROCESS, V118, P130, DOI 10.1016/j.beproc.2015.06.012	62	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192166	10.1371/journal.pone.0192166	http://dx.doi.org/10.1371/journal.pone.0192166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513670	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800011
J	Wood, PL; Tippireddy, S; Feriante, J; Woltjer, RL				Wood, Paul L.; Tippireddy, Soumya; Feriante, Joshua; Woltjer, Randall L.			Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; TARGETED LIPIDOMICS; PHOSPHOLIPASE-D; GLUCOCEREBROSIDASE MUTATIONS; CERAMIDE METABOLISM; GAUCHER-DISEASE; WHITE-MATTER; DEMENTIA; INVOLVEMENT	Background Research from our laboratory, and that of other investigators, has demonstrated augmented levels of diacylglycerols (DAG) in the frontal cortex and plasma of subjects with Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). We have extended these observations to investigate the frontal cortex of subjects with Parkinson's disease (PD) and Lewy Body Disease (LBD), with and without coexisting pathologic features of AD. Methods/Principal findings Utilizing a high-resolution mass spectrometry analytical platform, we clearly demonstrate that DAG levels are significantly increased in the frontal cortex of subjects with PD, LBD with intermediate neocortical AD neuropathology, and in LBD with established neocortical AD neuropathology. In the case of the PD cohort, increases in cortical DAG levels were detected in cases with no neocortical pathology but were greater in subjects with neocortical pathology. These data suggest that DAG changes occur early in the disease processes and are amplified as cortical dysfunction becomes more established. Conclusions These findings suggest that altered DAG synthesis/metabolism is a common feature of neurodegenerative diseases, characterized by proteinopathy, that ultimately result in cognitive deficits. With regard to the mechanism responsible for these biochemical alterations, selective decrements in cortical levels of phosphatidylcholines in LBD and PD suggest that augmented degradation and/or decreased synthesis of these structural glycerophospholipids may contribute to increases in the pool size of free DAGs. The observed augmentation of DAG levels may be phospholipase-driven since neuroinflammation is a consistent feature of all disease cohorts. If this conclusion can be validated it would support utilizing DAG levels as a biomarker of the early disease process and the investigation of early intervention with anti-inflammatory agents.	[Wood, Paul L.] Lincoln Mem Univ, Coll Vet Med, Metabol Unit, Cumberland Gap Pkwy, Harrogate, TN 37752 USA; [Tippireddy, Soumya; Feriante, Joshua] Lincoln Mem Univ, DeBusk Coll Osteopath Med, Cumberland Gap Pkwy, Harrogate, TN USA; [Woltjer, Randall L.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR USA; [Woltjer, Randall L.] Portland VA Med Ctr, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Wood, PL (corresponding author), Lincoln Mem Univ, Coll Vet Med, Metabol Unit, Cumberland Gap Pkwy, Harrogate, TN 37752 USA.	paul.wood@lmunet.edu		Feriante, Joshua/0000-0003-3482-254X	Lincoln Memorial University [AG08017]; NIA [AG08017]; NATIONAL INSTITUTE ON AGING [P30AG008017] Funding Source: NIH RePORTER	Lincoln Memorial University; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funding sources had no influence on data collection or interpretation. This work was funded by Lincoln Memorial University and the NIA (AG08017) to RLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SK, 2014, MOVEMENT DISORD, V29, P518, DOI 10.1002/mds.25729; Aflaki E, 2017, NEURON, V93, P737, DOI 10.1016/j.neuron.2017.01.018; Bachstetter AD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0209-z; Blanc F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127396; Boutin M, 2016, ANAL CHEM, V88, P1856, DOI 10.1021/acs.analchem.5b04227; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Cosgrove J, 2015, POSTGRAD MED J, V91, P212, DOI 10.1136/postgradmedj-2015-133247; Donaghy PC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt274; Downing AE, 1992, LAB METHODS HISTOTEC, P88; Erten-Lyons D, 2013, NEUROLOGY, V81, P977, DOI 10.1212/WNL.0b013e3182a43e45; Evangelisti C, 2006, EUR J HISTOCHEM, V50, P9; Ferrazza R, 2016, BIOCHEM BIOPH RES CO, V478, P1141, DOI 10.1016/j.bbrc.2016.08.082; Frohman MA, 2015, TRENDS PHARMACOL SCI, V36, P137, DOI 10.1016/j.tips.2015.01.001; Fujishiro H, 2015, GERIATR GERONTOL INT, V15, P817, DOI 10.1111/ggi.12466; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Gonzalez-Dominguez R, 2015, TALANTA, V131, P480, DOI 10.1016/j.talanta.2014.07.075; Goodall EF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00178; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Imbimbo BP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00019; Irwin D, 2017, LANCET NEUROL, V16, P55, DOI 10.1016/S1474-4422(16)30291-5; Kim Dana, 2014, Exp Neurobiol, V23, P352, DOI 10.5607/en.2014.23.4.352; Klein J, 2005, J NEUROCHEM, V94, P1473, DOI 10.1111/j.1471-4159.2005.03315.x; Lam SM, 2014, NEUROBIOL AGING, V35, P2369, DOI 10.1016/j.neurobiolaging.2014.02.025; Lichtenstein MP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00142; Liu AKL, 2015, ACTA NEUROPATHOL, V129, P527, DOI 10.1007/s00401-015-1392-5; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Mata IF, 2008, ARCH NEUROL-CHICAGO, V65, P379, DOI 10.1001/archneurol.2007.68; Melzer TR, 2012, J NEUROL NEUROSUR PS, V83, P188, DOI 10.1136/jnnp-2011-300828; Mrak RE, 2007, J NEUROPATH EXP NEUR, V66, P683, DOI 10.1097/nen.0b013e31812503e1; Mukaetova-Ladinska EB, 2013, J NEUROPATH EXP NEUR, V72, P53, DOI 10.1097/NEN.0b013e31827c5710; Peng X, 2012, ACTA PHYSIOL, V204, P219, DOI 10.1111/j.1748-1716.2011.02298.x; PERRY EK, 1991, ANN NY ACAD SCI, V640, P197; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Shin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077983; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Streit WJ, 2016, BRAIN BEHAV IMMUN, V55, P191, DOI 10.1016/j.bbi.2015.10.012; STROSZNAJDER J, 1979, BIOCHIM BIOPHYS ACTA, V574, P48, DOI 10.1016/0005-2760(79)90083-3; Tagliafierro L., 2017, ALZHEIMERS DEMENT; Tanabe F, 2014, BIOCHEM BIOPH RES CO, V446, P933, DOI 10.1016/j.bbrc.2014.03.038; Trubiani O, 2016, CELL SIGNAL, V28, P1631, DOI 10.1016/j.cellsig.2016.07.012; Tsuang D, 2012, NEUROLOGY, V79, P1944, DOI 10.1212/WNL.0b013e3182735e9a; Tsuchiya R, 2015, BBA-MOL CELL RES, V1853, P361, DOI 10.1016/j.bbamcr.2014.11.011; Walker L, 2015, ACTA NEUROPATHOL, V129, P729, DOI 10.1007/s00401-015-1406-3; Wood P., 2014, JSM ALZHEIMERS DIS R, V1, P1001; Wood P. L., 2014, J PARKINSONS DIS ALZ, V1, P4; Wood P, 2017, NEUROMETHODS, V125, P13, DOI 10.1007/978-1-4939-6946-3_2; Wood Paul L., 2003, P3; Wood PL, 2016, BBA CLIN, V5, P25, DOI 10.1016/j.bbacli.2015.11.004; Wood PL, 2015, J ALZHEIMERS DIS, V48, P537, DOI 10.3233/JAD-150336; Wood PL, 2015, ACTA NEUROPSYCHIATR, V27, P270, DOI 10.1017/neu.2015.18; Wood PL, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt103; Wood PL, 2010, J PSYCHIATR NEUROSCI, V35, P59, DOI 10.1503/jpn.090059; Zhang QS, 2017, TOXICOL LETT, V265, P30, DOI 10.1016/j.toxlet.2016.11.002; Zilberter Y, 2017, J NEUROSCI RES	59	33	33	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0191815	10.1371/journal.pone.0191815	http://dx.doi.org/10.1371/journal.pone.0191815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513680	Green Submitted, Green Published, gold			2022-12-27	WOS:000426896800009
J	Adroher, ND; Prodinger, B; Fellinghauer, CS; Tennant, A				Adroher, Nuria Duran; Prodinger, Birgit; Fellinghauer, Carolina Saskia; Tennant, Alan			All metrics are equal, but some metrics are more equal than others: A systematic search and review on the use of the term 'metric'	PLOS ONE			English	Review							ITEM RESPONSE THEORY; DIFFERENTIAL ITEM; RASCH ANALYSIS; PSYCHOLOGICAL-MEASUREMENT; MODEL; HEALTH; SCALE; PSYCHOMETRICS; DEPRESSION; MATHEMATICS	Objective To examine the use of the term 'metric' in health and social sciences' literature, focusing on the interval scale implication of the term in Modern Test Theory (MTT). Materials and methods A systematic search and review on MTT studies including 'metric' or 'interval scale' was performed in the health and social sciences literature. The search was restricted to 2001-2005 and 2011-2015. A Text Mining algorithm was employed to operationalize the eligibility criteria and to explore the uses of 'metric'. The paradigm of each included article (Rasch Measurement Theory (RMT), Item Response Theory (IRT) or both), as well as its type (Theoretical, Methodological, Teaching, Application, Miscellaneous) were determined. An inductive thematic analysis on the first three types was performed. Results 70.6% of the 1337 included articles were allocated to RMT, and 68.4% were application papers. Among the number of uses of 'metric', it was predominantly a synonym of 'scale'; as adjective, it referred to measurement or quantification. Three incompatible themes 'only RMT/all MTT/no MTT models can provide interval measures' were identified, but 'interval scale' was considerably more mentioned in RMT than in IRT. Conclusion 'Metric' is used in many different ways, and there is no consensus on which MTT metric has interval scale properties. Nevertheless, when using the term 'metric', the authors should specify the level of the metric being used (ordinal, ordered, interval, ratio), and justify why according to them the metric is at that level.	[Adroher, Nuria Duran; Prodinger, Birgit; Fellinghauer, Carolina Saskia; Tennant, Alan] Swiss Parapleg Res, Nottwil, Switzerland; [Adroher, Nuria Duran; Prodinger, Birgit; Fellinghauer, Carolina Saskia; Tennant, Alan] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland; [Prodinger, Birgit] Univ Appl Sci Rosenheim, Fac Appl Hlth & Social Sci, Rosenheim, Germany	Swiss Paraplegic Research; University of Lucerne	Adroher, ND (corresponding author), Swiss Parapleg Res, Nottwil, Switzerland.; Adroher, ND (corresponding author), Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland.	nuria.duranadroher@paraplegie.ch		Tennant, Alan/0000-0002-0728-2130; Adroher, Nuria D/0000-0003-2668-1820				Andrews G, 2002, COGNITIVE PSYCHOL, V45, P153, DOI 10.1016/S0010-0285(02)00002-6; Andrich D, 2004, MED CARE, V42, P7, DOI 10.1097/01.mlr.0000103528.48582.7c; Andrich D, 2012, J EDUC BEHAV STAT, V37, P387, DOI 10.3102/1076998611411913; Andrich D, 2011, EXPERT REV PHARM OUT, V11, P571, DOI [10.1586/ERP.11.59, 10.1586/erp.11.59]; Arnould C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001807; Arons AMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089091; Bai JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160644; Bakhsh H, 2014, INT J REHABIL RES, V37, P361, DOI 10.1097/MRR.0000000000000086; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Behmke DA, 2013, CHEM EDUC RES PRACT, V14, P247, DOI 10.1039/c3rp20153h; Beltyukova Svetlana A, 2004, J Appl Meas, V5, P62; Betemps Elizabeth J, 2003, J Appl Meas, V4, P59; Bjorner JB, 2003, QUAL LIFE RES, V12, P981, DOI 10.1023/A:1026123400242; Black P, 2011, MEAS-INTERDISCIP RES, V9, P71, DOI 10.1080/15366367.2011.591654; Blanton H, 2006, AM PSYCHOL, V61, P27, DOI 10.1037/0003-066X.61.1.27; Bolt DM, 2014, J EDUC MEAS, V51, P141, DOI 10.1111/jedm.12039; Borsboom D, 2004, THEOR PSYCHOL, V14, P105, DOI 10.1177/0959354304040200; Braun V., 2022, THEMATIC ANAL PRACTI; Briggs DC, 2013, J EDUC BEHAV STAT, V38, P551, DOI 10.3102/1076998613508317; Briggs DC, 2013, J EDUC MEAS, V50, P204, DOI 10.1111/jedm.12011; BROGDEN HE, 1977, PSYCHOMETRIKA, V42, P631, DOI 10.1007/BF02295985; Bureau International des Poids et Mesures, 2008, INT VOC METR BAS GEN; Carle AC, 2011, CHILD INDIC RES, V4, P101, DOI 10.1007/s12187-010-9075-1; Carvalho Lucas de Francisco, 2012, Trends Psychiatry Psychother., V34, P101; Cella D, 2014, QUAL LIFE RES, V23, P2651, DOI 10.1007/s11136-014-0732-6; Childs RA, 2004, PARE, V9; Cieza A., 2015, PLOS ONE, V10; Cieza A, 2015, INT J EPIDEMIOL, V44, P229, DOI 10.1093/ije/dyu182; Cohen AS, 2001, APPL PSYCH MEAS, V25, P136, DOI 10.1177/01466210122031966; Commons Michael Lamport, 2008, J Appl Meas, V9, P182; Cook KF, 2005, HEALTH SERV RES, V40, P1694, DOI 10.1111/j.1475-6773.2005.00446.x; COOMBS CH, 1950, PSYCHOL REV, V57, P145, DOI 10.1037/h0060984; Crane PK, 2008, J CLIN EPIDEMIOL, V61, P1018, DOI 10.1016/j.jclinepi.2007.11.011; da Rocha NS, 2013, J PSYCHIATR RES, V47, P141, DOI 10.1016/j.jpsychires.2012.09.014; De Boeck P, 2005, PSYCHOL REV, V112, P129, DOI 10.1037/0033-295X.112.1.129; DeMars CE, 2015, EDUC PSYCHOL MEAS, V75, P610, DOI 10.1177/0013164414554082; DeMars CE, 2011, APPL MEAS EDUC, V24, P189, DOI 10.1080/08957347.2011.580255; Dencker A, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0213-9; Domingue B, 2014, PSYCHOMETRIKA, V79, P1, DOI 10.1007/s11336-013-9342-4; Dupuis M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00629; Erdogan BD, 2016, J RHEUMATOL, V43, P194, DOI 10.3899/jrheum.141150; Ewing MT, 2005, J ADVERTISING, V34, P17, DOI 10.1080/00913367.2005.10639181; Fisher WP, 2003, THEOR PSYCHOL, V13, P791, DOI 10.1177/0959354303136003; Forero CG, 2014, J CLIN EPIDEMIOL, V67, P1364, DOI 10.1016/j.jclinepi.2014.06.017; Golino H. F., 2014, BEHAV DEV B, V19, P37, DOI [10.1037/h0100589, DOI 10.1037/H0100589]; Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x; Hadzibajramovic E, 2015, SCAND J PUBLIC HEALT, V43, P825, DOI 10.1177/1403494815601552; Hambleton R.K., 1991, FUNDAMENTALS ITEM RE; Hartig J, 2012, EDUC PSYCHOL MEAS, V72, P665, DOI 10.1177/0013164411430707; Harwell MR, 2001, REV EDUC RES, V71, P105, DOI 10.3102/00346543071001105; Hays RD, 2015, J GEN INTERN MED, V30, P1511, DOI 10.1007/s11606-015-3290-x; Heene M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00246; Humphry Stephen, 2012, J Appl Meas, V13, P165; Humphry SM, 2013, THEOR PSYCHOL, V23, P770, DOI 10.1177/0959354313499638; Hung M, 2012, FOOT ANKLE INT, V33, P621, DOI 10.3113/FAI.2012.0621; Kahler E, 2008, J CLIN EPIDEMIOL, V61, P475, DOI 10.1016/j.jclinepi.2007.05.019; Kemmler G, 2002, QUAL LIFE RES, V11, P223, DOI 10.1023/A:1015207400490; Knebelman MS, 1929, P NATL ACAD SCI USA, V15, P376, DOI 10.1073/pnas.15.4.376; Krause MS, 2013, REV GEN PSYCHOL, V17, P318, DOI 10.1037/a0032292; Kucukdeveci AA, 2011, J REHABIL MED, V43, P661, DOI 10.2340/16501977-0844; Kyngdon Andrew, 2006, J Appl Meas, V7, P369; Kyngdon Andrew, 2007, J Appl Meas, V8, P1; Kyngdon A, 2011, MEAS-INTERDISCIP RES, V9, P55, DOI 10.1080/15366367.2011.558791; Kyngdon A, 2013, THEOR PSYCHOL, V23, P227, DOI 10.1177/0959354312468221; La Porta F, 2011, J REHABIL MED, V43, P435, DOI 10.2340/16501977-0797; Liegl G, 2016, J CLIN EPIDEMIOL, V71, P25, DOI 10.1016/j.jclinepi.2015.10.006; Lopes P, 2014, ADDICT BEHAV, V39, P1500, DOI 10.1016/j.addbeh.2014.05.014; Lovaglio PG, 2012, QUAL LIFE RES, V21, P1643, DOI 10.1007/s11136-011-0071-9; Lovelace M, 2013, CBE-LIFE SCI EDUC, V12, P606, DOI 10.1187/cbe.12-11-0197; LUCE RD, 1964, J MATH PSYCHOL, V1, P1, DOI 10.1016/0022-2496(64)90015-X; Massof RW, 2011, OPHTHAL EPIDEMIOL, V18, P1, DOI 10.3109/09286586.2010.545501; McGrane JA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00431; McGrath RE, 2005, J PERS ASSESS, V85, P141, DOI 10.1207/s15327752jpa8502_06; Michell J, 2002, AUST J PSYCHOL, V54, P99, DOI 10.1080/00049530210001706563; Michell Joel, 2003, J Appl Meas, V4, P298; Michell J, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00261; Michell J, 2012, THEOR PSYCHOL, V22, P255, DOI 10.1177/0959354311434656; Miguel JP, 2013, J VOCAT BEHAV, V82, P116, DOI 10.1016/j.jvb.2012.12.001; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Morse BJ, 2012, APPL PSYCH MEAS, V36, P122, DOI 10.1177/0146621612438725; Ndosi M, 2011, BMC MUSCULOSKEL DIS, P12; Noventa S, 2014, PSYCHOMETRIKA, V79, P377, DOI 10.1007/s11336-013-9348-y; Odegaard F, 2014, PROD OPER MANAG, V23, P2191, DOI 10.1111/poms.12242; Oude Voshaar Martijn A H, 2014, PLoS One, V9, pe92367, DOI 10.1371/journal.pone.0092367; Pae HK, 2012, EDUC RES EVAL, V18, P211, DOI 10.1080/13803611.2011.650921; Penfield Randall D, 2004, J Appl Meas, V5, P115; Perdices M, 2014, BRAIN IMPAIR, V15, P223, DOI 10.1017/BrImp.2014.26; Petrillo J, 2015, VALUE HEALTH, V18, P25, DOI 10.1016/j.jval.2014.10.005; Popp S. E., 2005, RES EVALUAT, V10, P1, DOI DOI 10.7275/68DY-Z131; Oreja-Rodriguez JR, 2012, J CLEAN PROD, V29-30, P64, DOI 10.1016/j.jclepro.2012.02.012; Rasch G., 1960, PROBABILISTIC MODELS; Reeve Bryce B, 2003, Expert Rev Pharmacoecon Outcomes Res, V3, P131, DOI 10.1586/14737167.3.2.131; Reise SP, 2005, CURR DIR PSYCHOL SCI, V14, P95, DOI 10.1111/j.0963-7214.2005.00342.x; Reise SP, 2005, J PERS ASSESS, V84, P228, DOI 10.1207/s15327752jpa8403_02; Reise SP, 2003, J PERS ASSESS, V81, P93, DOI 10.1207/S15327752JPA8102_01; Robinson JP, 2011, AM EDUC RES J, V48, P268, DOI 10.3102/0002831210372249; Salzberger T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00075; Sanchez-Garcia M, 2015, PSYCHOL ASSESSMENT, V27, P524, DOI 10.1037/pas0000064; Schalet BD, 2015, J GEN INTERN MED, V30, P1524, DOI 10.1007/s11606-015-3453-9; Scheiblechner H, 1999, PSYCHOMETRIKA, V64, P295, DOI 10.1007/BF02294297; Schuman E. L., 1954, Human Biology, V26, P239; Seel RT, 2012, ARCH PHYS MED REHABI, V93; Siemons L, 2014, CLIN EXP RHEUMATOL, V32, P581; Sijtsma K, 2012, THEOR PSYCHOL, V22, P786, DOI 10.1177/0959354312454353; Simone A, 2011, INT J REHABIL RES, V34, P131, DOI 10.1097/MRR.0b013e328343d4d3; Smith E V Jr, 2001, J Appl Meas, V2, P281; Smith Richard M, 2004, J Appl Meas, V5, P229; Stark S, 2004, J APPL PSYCHOL, V89, P497, DOI 10.1037/0021-9010.89.3.497; Stevens S. S., 1951, HDB EXPT PSYCHOL, P1; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; Stiff WP, 1862, BMJ-BRIT MED J, V2, P458; Sudweeks R., 2004, ASSESS WRIT, V9, P239, DOI [10.1016/j.asw.2004.11.001, DOI 10.1016/J.ASW.2004.11.001]; Svensson E, 2001, STAT MED, V20, P3831, DOI 10.1002/sim.1148; TAKANE Y, 1977, PSYCHOMETRIKA, V42, P7, DOI 10.1007/BF02293745; Tang K, 2011, J CLIN EPIDEMIOL, V64, P1242, DOI 10.1016/j.jclinepi.2011.02.002; Tulsky DS, 2015, J SPINAL CORD MED, V38, P251, DOI [10.1179/2045772315Y.0000000035, 10.1179/2045772315Y.0000000023]; Vanhoutte EK, 2015, J PERIPHER NERV SYST, V20, P260, DOI 10.1111/jns.12122; Vilagut G, 2015, J PSYCHIATR RES, V68, P140, DOI 10.1016/j.jpsychires.2015.06.009; Wahl I, 2014, J CLIN EPIDEMIOL, V67, P73, DOI 10.1016/j.jclinepi.2013.04.019; Yusoff R, 2014, SAGE OPEN, V4, DOI 10.1177/2158244013516768	120	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193861	10.1371/journal.pone.0193861	http://dx.doi.org/10.1371/journal.pone.0193861			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509813	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200036
J	Stroustrup, A; Bragg, JB; Andra, SS; Curtin, PC; Spear, EA; Sison, DB; Just, AC; Arora, M; Gennings, C				Stroustrup, Annemarie; Bragg, Jennifer B.; Andra, Syam S.; Curtin, Paul C.; Spear, Emily A.; Sison, Denise B.; Just, Allan C.; Arora, Manish; Gennings, Chris			Neonatal intensive care unit phthalate exposure and preterm infant neurobehavioral performance	PLOS ONE			English	Article							MATERNAL LIFE-STYLE; LOW-BIRTH-WEIGHT; PRENATAL EXPOSURE; MEDICAL DEVICES; CHILDREN BORN; HUMAN URINE; MONO(2-ETHYLHEXYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; METABOLITES; DEHP	Every year in the United States, more than 300,000 infants are admitted to neonatal intensive care units (NICU) where they are exposed to a chemical-intensive hospital environment during a developmentally vulnerable period. The neurodevelopmental impact of environmental exposure to phthalates during the NICU stay is unknown. As phthalate exposure during the third trimester developmental window has been implicated in neurobehavioral deficits in term-born children that are strikingly similar to a phenotype of neurobehavioral morbidity common among children born premature, the role of early-life phthalate exposure on the neurodevelopmental trajectory of premature infants may be clinically important. In this study, premature newborns with birth weight < 1500g were recruited to participate in a prospective environmental health cohort study, NICU-HEALTH (Hospital Exposures and Long-Term Health), part of the DINE (Developmental Impact of NICU Exposures) cohort of the ECHO (Environmental influences on Child Health Outcomes) program. Seventy-six percent of eligible infants enrolled in the study. Sixty-four of 81 infants survived and are included in this analysis. 164 urine specimens were analyzed for phthalate metabolites using highperformance liquid chromatography/tandem mass spectrometry. The NICU Network Neurobehavioral Scale (NNNS) was performed prior to NICU discharge. Linear and weighted quantile sum regression quantified associations between phthalate biomarkers and NNNS performance, and between phthalate biomarkers and intensity of medical intervention. The sum of di(2-ethylhexyl) phthalate metabolites (SDEHP) was associated with improved performance on the Attention and Regulation scales. Specific mixtures of phthalate biomarkers were also associated with improved NNNS performance. More intense medical intervention was associated with higher SDEHP exposure. NICU-based exposure to phthalates mixtures was associated with improved attention and social response. This suggests that the impact of phthalate exposure on neurodevelopment may follow a non-linear trajectory, perhaps accelerating the development of certain neural networks. The long-term neurodevelopmental impact of NICU-based phthalate exposure needs to be evaluated.	[Stroustrup, Annemarie; Bragg, Jennifer B.; Spear, Emily A.; Sison, Denise B.] Icahn Sch Med Mt Sinai, Dept Pediat, Div Newborn Med, New York, NY 10029 USA; [Stroustrup, Annemarie] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Stroustrup, Annemarie; Andra, Syam S.; Curtin, Paul C.; Just, Allan C.; Arora, Manish; Gennings, Chris] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Stroustrup, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, Div Newborn Med, New York, NY 10029 USA.; Stroustrup, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA.; Stroustrup, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA.	annemarie.stroustrup@mssm.edu	Stroustrup, Annemarie/ABB-5846-2020; ANDRA, SYAM/B-4693-2011	Stroustrup, Annemarie/0000-0002-5667-6195; ANDRA, SYAM/0000-0003-2839-6417; Just, Allan/0000-0003-4312-5957	National Institutes of Environmental Health Sciences (NIEHS) [K23ES022268]; National Institutes of Health for the Environmental Influences on Child Health Outcomes (ECHO) program [UG3OD023320]; Passport Foundation; Mount Sinai Children's Environmental Health Center; NIEHS [P30ES023515]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES022268, P30ES023515, R00ES023450] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023320, UH3OD023320] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health for the Environmental Influences on Child Health Outcomes (ECHO) program; Passport Foundation; Mount Sinai Children's Environmental Health Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Stroustrup is supported by a career development award, K23ES022268, from the National Institutes of Environmental Health Sciences (NIEHS) and a cooperative agreement, UG3OD023320, from the National Institutes of Health for the Environmental Influences on Child Health Outcomes (ECHO) program. Additional funding for the investigators and this project came through pilot grants from the Passport Foundation, the Mount Sinai Children's Environmental Health Center, and an NIEHS center grant P30ES023515. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Ahlsson F, 2015, EPIDEMIOLOGY, V26, P106, DOI 10.1097/EDE.0000000000000171; Anderson WAC, 2011, FOOD CHEM TOXICOL, V49, P2022, DOI 10.1016/j.fct.2011.05.013; Andrews B, 2012, ACTA PAEDIATR, V101, P574, DOI 10.1111/j.1651-2227.2012.02609.x; [Anonymous], 2009, 4 CDCP; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bernard L, 2014, TALANTA, V129, P39, DOI 10.1016/j.talanta.2014.04.069; Boukydis CFZ, 2004, PEDIATRICS, V113, P679; Calafat AM, 2006, INT J ANDROL, V29, P166, DOI 10.1111/j.1365-2605.2005.00570.x; Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429; Calafat AM, 2015, ENVIRON HEALTH PERSP, V123, pA166, DOI 10.1289/ehp.1510041; Carrico C, 2014, J AGR BIOL IN PRESS; Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376; Conrad AL, 2010, PEDIATRICS, V125, pE83, DOI 10.1542/peds.2009-0634; de Jong M, 2015, EARLY HUM DEV, V91, P761, DOI 10.1016/j.earlhumdev.2015.08.015; de Jong M, 2012, SEMIN FETAL NEONAT M, V17, P163, DOI 10.1016/j.siny.2012.02.003; Delobel-Ayoub M, 2009, PEDIATRICS, V123, P1485, DOI 10.1542/peds.2008-1216; Donauer S, 2015, J PEDIATR-US, V166, P736, DOI 10.1016/j.jpeds.2014.11.021; Downey LC, 2015, J PEDIATR-US, V166, P20, DOI 10.1016/j.jpeds.2014.08.004; Ejaredar M, 2015, ENVIRON RES, V142, P51, DOI 10.1016/j.envres.2015.06.014; Elgen SK, 2015, EUR CHILD ADOLES PSY, V24, P463, DOI 10.1007/s00787-014-0597-9; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001; Factor-Litvak P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114003; Frederiksen H, 2014, ENVIRON HEALTH PERSP, V122, P998, DOI 10.1289/ehp.1307569; Gennings C, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-66; Glover Vivette, 2015, Adv Neurobiol, V10, P269, DOI 10.1007/978-1-4939-1372-5_13; Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/ehp.7932; Grizenko N, 2015, J CAN ACAD CHILD ADO, V24, P92; Guy A, 2015, J PEDIATR-US, V166, P269, DOI 10.1016/j.jpeds.2014.10.053; Harrison W, 2015, JAMA PEDIATR, V169, P855, DOI 10.1001/jamapediatrics.2015.1305; Johnson S, 2011, PEDIATR RES, V69, p11R, DOI 10.1203/PDR.0b013e318212faa0; Kapellou O, 2006, PLOS MED, V3, P1382, DOI 10.1371/journal.pmed.0030265; Kessler W, 2012, TOXICOL APPL PHARM, V264, P284, DOI 10.1016/j.taap.2012.08.009; Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178; Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4; Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008; Kraft AD, 2016, NEUROTOXICOL TERATOL, V55, P38, DOI 10.1016/j.ntt.2016.03.005; Latini G, 2010, CURR MED CHEM, V17, P2979, DOI 10.2174/092986710792064992; Latini G, 2009, NEONATOLOGY, V95, P317, DOI 10.1159/000181161; Lejeune F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23329; Lester BM, 2014, JOVE-J VIS EXP, DOI 10.3791/3368; Lester BM, 2004, PEDIATRICS, V113, P641; Lester BM, 2004, PEDIATRICS, V113, P668; Lester BM, 2004, PEDIATRICS, V113, P634; Lester BM, 2002, PEDIATRICS, V110, P1182, DOI 10.1542/peds.110.6.1182; Lester BM, 2004, NICU NETWORK NEUROBE; Lien YJ, 2015, ENVIRON HEALTH PERSP, V123, P95, DOI 10.1289/ehp.1307154; Linsell L, 2015, JAMA PEDIATR, V169, P1162, DOI 10.1001/jamapediatrics.2015.2175; Liu J, 2010, PEDIATRICS, V125, pE90, DOI 10.1542/peds.2009-0204; Madlinger-Lewis L, 2014, RES DEV DISABIL, V35, P490, DOI 10.1016/j.ridd.2013.11.019; Mallow EB, 2014, J PERINATOL, V34, P892, DOI 10.1038/jp.2014.157; Martin Joyce A, 2015, NCHS Data Brief, P1; Martinez-Arguelles DB, 2016, ANDROLOGY-US, V4, P573, DOI 10.1111/andr.12175; Meredith RM, 2015, NEUROSCI BIOBEHAV R, V50, P180, DOI 10.1016/j.neubiorev.2014.12.001; Monnier M, 2014, ARCH PEDIATRIE, V21, P944, DOI 10.1016/j.arcped.2014.04.032; Montagna A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00080; Montirosso R, 2012, PEDIATRICS, V129, pE1129, DOI 10.1542/peds.2011-0813; Mueller CA, 2015, COMP BIOCHEM PHYS A, V184, P113, DOI 10.1016/j.cbpa.2015.02.013; Mundy WR, 2015, NEUROTOXICOL TERATOL, V52, P25, DOI 10.1016/j.ntt.2015.10.001; Park S, 2014, INT J ENV RES PUB HE, V11, P6743, DOI 10.3390/ijerph110706743; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Philippat C, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0024-9; Polanska K, 2014, EARLY HUM DEV, V90, P477, DOI 10.1016/j.earlhumdev.2014.06.006; Posner J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.146; Sampson J, 2011, TRANSFUSION MED, V21, P73, DOI 10.1111/j.1365-3148.2010.01056.x; Scheinost D, 2016, PEDIAT RES; Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023; Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038; Skinner MK, 2016, NAT REV ENDOCRINOL, V12, P68, DOI 10.1038/nrendo.2015.206; Smith JR, 2014, ADV NEONAT CARE, V14, P187, DOI 10.1097/ANC.0000000000000093; Stroustrup A, 2017, JAMA PEDIATR, V171, P1139, DOI 10.1001/jamapediatrics.2017.3230; Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, P461; Testa C, 2012, ASN NEURO, V4, P223, DOI 10.1042/AN20120015; Textor J, 2011, GESUNDHEITSWESEN, V73, P897, DOI 10.1055/s-0031-1291197; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Treyvaud K, 2013, J CHILD PSYCHOL PSYC; Tronick E, 2013, J CHILD ADOL PS NURS, V26, P193, DOI 10.1111/jcap.12042; Tronick EZ, 2004, PEDIATRICS, V113, P676; Udagawa Jun, 2016, Nihon Eiseigaku Zasshi, V71, P188; Van Vliet EDS, 2011, J PERINATOL, V31, P551, DOI 10.1038/jp.2010.208; Ventrice P, 2013, ENVIRON TOXICOL PHAR, V36, P88, DOI 10.1016/j.etap.2013.03.014; Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926; Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705; Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x; Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007; Yolton K, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-79; Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003	89	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193835	10.1371/journal.pone.0193835	http://dx.doi.org/10.1371/journal.pone.0193835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY1CC	29505594	gold, Green Submitted, Green Published			2022-12-27	WOS:000426548200034
J	Lim, YH; Kwon, DH; Kim, J; Park, WJ; Kook, H; Kim, YK				Lim, Yeong-Hwan; Kwon, Duk-Hwa; Kim, Jaetaek; Park, Woo Jin; Kook, Hyun; Kim, Young-Kook			Identification of long noncoding RNAs involved in muscle differentiation	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; CELLS IN-VITRO; STEM-CELLS; PHENOTYPIC MODULATION; RESPONSE FACTOR; HUMAN GENOME; VIVO; PROLIFERATION; HOMEOSTASIS; EXPRESSION	Long noncoding RNAs (lncRNAs) are a large class of regulatory RNAs with diverse roles in cellular processes. Thousands of lncRNAs have been discovered; however, their roles in the regulation of muscle differentiation are unclear because no comprehensive analysis of lncRNAs during this process has been performed. In the present study, by combining diverse RNA sequencing datasets obtained from public database, we discovered lncRNAs that could behave as regulators in the differentiation of smooth or skeletal muscle cells. These analyses confirmed the roles of previously reported lncRNAs in this process. Moreover, we discovered dozens of novel lncRNAs whose expression patterns suggested their possible involvement in the phenotypic switch of vascular smooth muscle cells. The comparison of lncRNA expression change suggested that many lncRNAs have common roles during the differentiation of smooth and skeletal muscles, while some lncRNAs may have opposite roles in this process. The expression change of lncRNAs was highly correlated with that of their neighboring genes, suggesting that they may function as cis-acting lnc RNAs. Furthermore, within the lncRNA sequences, there were binding sites for miRNAs with expression levels inversely correlated with the expression of corresponding lncRNAs during differentiation, suggesting a possible role of these lncRNAs as competing endogenous RNAs. The lncRNAs identified in this study will be a useful resource for future studies of gene regulation during muscle differentiation.	[Lim, Yeong-Hwan; Kwon, Duk-Hwa; Kim, Jaetaek; Park, Woo Jin; Kook, Hyun; Kim, Young-Kook] Chonnam Natl Univ, Med Sch, Basic Res Lab Cardiac Remodeling Res Lab, Jeollanam Do, South Korea; [Lim, Yeong-Hwan; Kim, Young-Kook] Chonnam Natl Univ, Med Sch, Dept Biochem, Jeollanam Do, South Korea; [Lim, Yeong-Hwan; Kook, Hyun; Kim, Young-Kook] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Dept Biomed Sci, Jeollanam Do, South Korea; [Kwon, Duk-Hwa; Kook, Hyun] Chonnam Natl Univ, Med Sch, Dept Pharmacol, Jeollanam Do, South Korea; [Kim, Jaetaek] Chung Ang Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Park, Woo Jin] GIST, Coll Life Sci, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chung Ang University; Chung Ang University Hospital; Gwangju Institute of Science & Technology (GIST)	Kim, YK (corresponding author), Chonnam Natl Univ, Med Sch, Basic Res Lab Cardiac Remodeling Res Lab, Jeollanam Do, South Korea.; Kim, YK (corresponding author), Chonnam Natl Univ, Med Sch, Dept Biochem, Jeollanam Do, South Korea.; Kim, YK (corresponding author), Chonnam Natl Univ, Ctr Creat Biomed Scientists, Dept Biomed Sci, Jeollanam Do, South Korea.	ykk@jnu.ac.kr	Kim, Jaetaek/AAE-7147-2020; Kim, Young-Kook/AAE-8306-2020; Kook, Hyun/AAR-5405-2021	Kim, Jaetaek/0000-0001-5247-0408; Kim, Young-Kook/0000-0001-6434-2235; Kook, Hyun/0000-0002-0740-1806; Kim, Young Kook/0000-0002-6037-8449; Kwon, Duk-hwa/0000-0001-6424-0300	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2015R1C 1A1A02036313, NRF-2016R1A4A1009895]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was financially supported by the grants from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (NRF-2015R1C 1A1A02036313, NRF-2016R1A4A1009895 to YKK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne MD, 2016, CIRCULATION, V133, P2050, DOI 10.1161/CIRCULATIONAHA.115.021019; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bell RD, 2014, ARTERIOSCL THROM VAS, V34, P1249, DOI 10.1161/ATVBAHA.114.303240; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brock M, 2017, EXP BIOL MED, V242, P487, DOI 10.1177/1535370216685434; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Coletti D, 2016, EUR J TRANSL MYOL, V26, P87, DOI 10.4081/ejtm.2016.6008; Coll-Bonfill N, 2016, PFLUG ARCH EUR J PHY, V468, P1071, DOI 10.1007/s00424-016-1821-x; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cui RR, 2012, CARDIOVASC RES, V96, P320, DOI 10.1093/cvr/cvs258; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong SH, 2013, MOL MED REP, V8, P407, DOI 10.3892/mmr.2013.1538; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fei J, 2016, CIRC RES, V119, P463, DOI 10.1161/CIRCRESAHA.116.309003; Gheinani AH, 2015, J BIOL CHEM, V290, P7067, DOI 10.1074/jbc.M114.618694; Hao Y, 2016, NPINTER V3 0 UPGRADE; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hellbach N, 2014, HUM MOL GENET, V23, P6177, DOI 10.1093/hmg/ddu338; Huang Y, 2013, STEM CELLS, V31, P906, DOI 10.1002/stem.1324; Iaconetti C, 2015, CARDIOVASC RES, V107, P522, DOI 10.1093/cvr/cvv141; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Jeong G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3252-7; Kim Young-Kook, 2015, Chonnam Med J, V51, P51, DOI 10.4068/cmj.2015.51.2.51; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li W, 2014, J CLIN INVEST, V124, P755, DOI 10.1172/JCI69942; Martone J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10488; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Ounzain S, 2015, J MOL CELL CARDIOL, V89, P98, DOI 10.1016/j.yjmcc.2015.09.016; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Song J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00227; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; van Oevelen C, 2010, MOL CELL BIOL, V30, P5686, DOI 10.1128/MCB.00975-10; Wang G, 2012, J BIOL CHEM, V287, P2896, DOI 10.1074/jbc.M111.297028; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang TM, 2017, J CELL MOL MED, V21, P3592, DOI 10.1111/jcmm.13269; Yu X, 2015, CELL DEATH DIFFER, V22, P1170, DOI 10.1038/cdd.2014.206; Zhao JJ, 2017, FASEB J, V31, P2576, DOI 10.1096/fj.201601021R; Zhou L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10026; Zong Y, 2017, CIRC J, V81, P567, DOI 10.1253/circj.CJ-16-0751	45	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193898	10.1371/journal.pone.0193898	http://dx.doi.org/10.1371/journal.pone.0193898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499054	Green Published, Green Submitted, gold			2022-12-27	WOS:000426472300026
J	Yang, M; Feng, YH; Yue, CH; Xu, B; Chen, LJ; Jiang, JT; Lu, BF; Zhu, YB				Yang, Min; Feng, Yuehua; Yue, Cuihua; Xu, Bin; Chen, Lujun; Jiang, Jingting; Lu, Binfeng; Zhu, Yibei			Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; CD8(+) T; COLORECTAL-CANCER; MAST-CELLS; NK CELLS; METASTASIS; ACTIVATION; MICROENVIRONMENT; PROMOTE; INNATE	Objective Lung cancer is one of the deadliest malignancies. The immune checkpoint-blockade (ICB) tumor therapy has led to striking improvement of long-term survival for some lung cancer patients. However, the response rate of immunotherapy is still low for lung cancer. Studying the tumor microenvironment (TME) should shed light on improvement of immunotherapy of lung cancer. Interleukin-33 (IL-33), an "alarmin" cytokine, has been implicated in tumor associated immune responses and inflammatory diseases of the lung. The role of IL-33 in lung cancer progression, however, remains elusive. This study is designed to characterize IL-33 expression in lung tumor tissues and establish the clinical significance of IL-33 in non-small cell lung cancer lung cancer (NSCLC). Materials and methods Tumor tissue specimens from patients suffering from NSCLC were analyzed for expression of IL-33 protein by immunohistochemistry and expression of IL-33 and ST2 mRNA by RT-quantitative PCR (RT-QPCR). The expression data were analyzed for their association with clinical and pathological parameters of NSCLC. In addition, the association between expression levels of IL-33 mRNA and patient survival was determined using 5 independent expression profiling datasets of human lung cancer. Results and conclusion The expression levels of IL-33 and ST2 were significantly down-regulated in both adenocarcinoma and squamous cell carcinoma of the lung when compared to adjacent normal lung tissues. In addition, the level of IL-33 protein was inversely correlated with tumor grade and size. Moreover, analysis of TCGA and GEO lung cancer expression datasets revealed that higher expression levels of IL-33 mRNA were correlated with longer overall survival of patients suffering from adenocarcinoma of the lung. These data indicate that the expression levels of IL-33 are inversely associated with lung cancer progression, consistent with the hypothesis that IL-33 is involved in immune surveillance of NSCLC.	[Yang, Min; Yue, Cuihua; Zhu, Yibei] Soochow Univ, Sch Biol & Basic Med Sci, Dept Immunol, Suzhou, Peoples R China; [Yang, Min; Yue, Cuihua; Lu, Binfeng] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA; [Yang, Min; Yue, Cuihua; Xu, Bin; Chen, Lujun; Jiang, Jingting] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou, Peoples R China; [Feng, Yuehua] Soochow Univ, Affiliated Hosp 3, Comprehens Lab, Changzhou, Peoples R China; [Jiang, Jingting; Zhu, Yibei] Soochow Univ, Inst Cell Therapy, Suzhou, Peoples R China; [Zhu, Yibei] Soochow Univ, Jiangsu Key Lab Clin Immunol, Suzhou, Peoples R China	Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Zhu, YB (corresponding author), Soochow Univ, Sch Biol & Basic Med Sci, Dept Immunol, Suzhou, Peoples R China.; Lu, BF (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA.; Zhu, YB (corresponding author), Soochow Univ, Inst Cell Therapy, Suzhou, Peoples R China.; Zhu, YB (corresponding author), Soochow Univ, Jiangsu Key Lab Clin Immunol, Suzhou, Peoples R China.	binfeng@pitt.edu; xlyb99@163.com			National Natural Science Foundation of China [31670916, 81273208, 31729001]; Suzhou industrial technology innovation special fund [SS201664]; NIH [R21CA205727]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou industrial technology innovation special fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was mainly supported by the National Natural Science Foundation of China (Grants 31670916, 81273208 to Y.Z., 31729001 to B.L., http://www.nsfc.gov.cn/), Suzhou industrial technology innovation special fund (SS201664 to Y.Z.), and partly supported by NIH R21CA205727 (https://www.nih.gov/) to B.L.	Blatner NR, 2010, P NATL ACAD SCI USA, V107, P6430, DOI 10.1073/pnas.0913683107; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Cheon EC, 2011, CANCER RES, V71, P1627, DOI 10.1158/0008-5472.CAN-10-1923; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dominguez D, 2017, J IMMUNOL, V198, P1365, DOI 10.4049/jimmunol.1501399; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Fang M, 2017, CANCER RES, V77, P2735, DOI 10.1158/0008-5472.CAN-16-1602; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P268, DOI 10.1016/j.coi.2013.02.009; Gao K, 2013, CANCER LETT, V335, P463, DOI 10.1016/j.canlet.2013.03.002; Gao X, 2015, J IMMUNOL, V194, P438, DOI 10.4049/jimmunol.1401344; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Hanna Jennifer M, 2013, J Carcinog, V12, P6, DOI 10.4103/1477-3163.109033; He ZX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05716-z; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jovanovic I, 2011, EUR J IMMUNOL, V41, P1902, DOI 10.1002/eji.201141417; Jovanovic IP, 2014, INT J CANCER, V134, P1669, DOI 10.1002/ijc.28481; KLEIN G, 1966, ANNU REV MICROBIOL, V20, P223, DOI 10.1146/annurev.mi.20.100166.001255; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Liu J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00141; Lu BF, 2016, J MOL MED, V94, P535, DOI 10.1007/s00109-016-1397-0; Mainardi S, 2014, P NATL ACAD SCI USA, V111, P255, DOI 10.1073/pnas.1320383110; Malik A, 2016, J CLIN INVEST, V126, P4469, DOI 10.1172/JCI88625; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Maywald RL, 2015, P NATL ACAD SCI USA, V112, pE2487, DOI 10.1073/pnas.1422445112; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; O'Donnell C, 2016, BRIT J CANCER, V114, P37, DOI 10.1038/bjc.2015.433; OLD LJ, 1964, ANNU REV MED, V15, P167, DOI 10.1146/annurev.me.15.020164.001123; Rowbotham SP, 2014, P NATL ACAD SCI USA, V111, P4745, DOI 10.1073/pnas.1401955111; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Wang CH, 2016, BIOCHEM BIOPH RES CO, V479, P461, DOI 10.1016/j.bbrc.2016.09.081; Wang KL, 2017, ONCOTARGET, V8, P68571, DOI 10.18632/oncotarget.19786; Xu CX, 2014, CANCER CELL, V25, P590, DOI 10.1016/j.ccr.2014.03.033; Yang QT, 2011, EUR J IMMUNOL, V41, P3351, DOI 10.1002/eji.201141629; Zhang Y, 2017, MOL CARCINOGEN, V56, P272, DOI 10.1002/mc.22491	39	23	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193428	10.1371/journal.pone.0193428	http://dx.doi.org/10.1371/journal.pone.0193428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499051	gold, Green Published, Green Submitted			2022-12-27	WOS:000426472300013
J	Ferrarini, A; Forcato, C; Buson, G; Tononi, P; del Monaco, V; Terracciano, M; Bolognesi, C; Fontana, F; Medoro, G; Neves, R; Mohlendick, B; Rihawi, K; Ardizzoni, A; Sumanasuriya, S; Flohr, P; Lambros, M; de Bono, J; Stoecklein, NH; Manaresi, N				Ferrarini, Alberto; Forcato, Claudio; Buson, Genny; Tononi, Paola; del Monaco, Valentina; Terracciano, Mario; Bolognesi, Chiara; Fontana, Francesca; Medoro, Gianni; Neves, Rui; Moehlendick, Birte; Rihawi, Karim; Ardizzoni, Andrea; Sumanasuriya, Semini; Flohr, Penny; Lambros, Maryou; de Bono, Johann; Stoecklein, Nikolas H.; Manaresi, Nicolo			A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; C-MYC ONCOGENE; CENTROSOME DEFECTS; BREAST-TUMORS; CANCER; GENE; DNA; EXPRESSION; RECURRENT; IDENTIFICATION	Chromosomal instability and associated chromosomal aberrations are hallmarks of cancer and play a critical role in disease progression and development of resistance to drugs. Single-cell genome analysis has gained interest in latest years as a source of biomarkers for targeted-therapy selection and drug resistance, and several methods have been developed to amplify the genomic DNA and to produce libraries suitable for Whole Genome Sequencing (WGS). However, most protocols require several enzymatic and cleanup steps, thus increasing the complexity and length of protocols, while robustness and speed are key factors for clinical applications. To tackle this issue, we developed a single-tube, single-step, streamlined protocol, exploiting ligation mediated PCR (LM-PCR) Whole Genome Amplification (WGA) method, for low-pass genome sequencing with the Ion Torrent T platform and copy number alterations (CNAs) calling from single cells. The method was evaluated on single cells isolated from 6 aberrant cell lines of the NCI-H series. In addition, to demonstrate the feasibility of the workflow on clinical samples, we analyzed single circulating tumor cells (CTCs) and white blood cells (WBCs) isolated from the blood of patients affected by prostate cancer or lung adenocarcinoma. The results obtained show that the developed workflow generates data accurately representing whole genome absolute copy number profiles of single cell and allows alterations calling at resolutions down to 100 Kbp with as few as 200,000 reads. The presented data demonstrate the feasibility of the Ampli1 (TM) WGA-based lowpass workflow for detection of CNAs in single tumor cells which would be of particular interest for genome-driven targeted therapy selection and for monitoring of disease progression.	[Ferrarini, Alberto; Forcato, Claudio; Buson, Genny; Tononi, Paola; del Monaco, Valentina; Terracciano, Mario; Bolognesi, Chiara; Fontana, Francesca; Medoro, Gianni; Manaresi, Nicolo] Menarini Silicon Biosyst Spa, Bologna, Italy; [Neves, Rui; Moehlendick, Birte; Stoecklein, Nikolas H.] Heinrich Heine Univ Dusseldorf, Univ Hosp, Med Fac, Dept Gen Visceral & Pediat Surg, Dusseldorf, Germany; [Rihawi, Karim; Ardizzoni, Andrea] Policlin St Orsola Malpighi, Unita Operat Oncol Med, Bologna, Italy; [Sumanasuriya, Semini; Flohr, Penny; Lambros, Maryou; de Bono, Johann] Inst Canc Res, London, England; [Sumanasuriya, Semini; Flohr, Penny; Lambros, Maryou; de Bono, Johann] Royal Marsden NHS Fdn Trust, London, England	Heinrich Heine University Dusseldorf; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Manaresi, N (corresponding author), Menarini Silicon Biosyst Spa, Bologna, Italy.	nmanaresi@siliconbiosystems.com	ardizzoni, andrea/AAC-4337-2021; t, lf/AAJ-4924-2020; Rihawi, Karim/AAC-5431-2021; Neves, Rui/AAF-9626-2021	ardizzoni, andrea/0000-0003-2678-0714; Neves, Rui/0000-0002-4515-739X; de Bono, Johann S/0000-0002-2034-595X; Mohlendick, Birte/0000-0001-9093-8585; rihawi, karim/0000-0002-3915-466X	CANCER-ID - Innovative Medicines Joint Undertaking (IMI JU); CANCER-ID [115749]	CANCER-ID - Innovative Medicines Joint Undertaking (IMI JU); CANCER-ID	This work was supported by CANCER-ID, a project funded by the Innovative Medicines Joint Undertaking (IMI JU) in conjunction with CANCER-ID [Grant Agreement #115749]. The funder (Menarini Silicon Biosystems S.p.A.) provided support in the form of salaries for authors AF, CF, GB, CB, VDM, PT, MT, FB, FF, GM, NM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Anders S, 2014, BIOINFORMATICS, V2014, P1, DOI 10.1093/bioinformatics/btu638; Arason A, 1998, J MED GENET, V35, P446, DOI 10.1136/jmg.35.6.446; BAKER SJ, 1990, CANCER RES, V50, P7717; BAKER VV, 1990, GYNECOL ONCOL, V38, P340, DOI 10.1016/0090-8258(90)90069-W; Baslan T, 2015, GENOME RES, V25, P714, DOI 10.1101/gr.188060.114; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; Carter L, 2016, NAT MED; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Cheung VG, 1996, P NATL ACAD SCI USA, V93, P14676, DOI 10.1073/pnas.93.25.14676; Cryz ZT, 2014, PLOS ONE, V9; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Du P, 2006, BIOINFORMATICS, V22, P2059, DOI 10.1093/bioinformatics/btl355; Glasspool RM, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.TPS5603; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gusnanto A, 2012, BIOINFORMATICS, V28, P40, DOI 10.1093/bioinformatics/btr593; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Huang J, 2007, BIOINFORMATICS, V23, P2463, DOI 10.1093/bioinformatics/btm359; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Hyman E, 2002, CANCER RES, V62, P6240; Illei PB, 2003, CLIN CANCER RES, V9, P2108; Jenkins RB, 1997, CANCER RES, V57, P524; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Lee YS, 2008, TAIWAN J OBSTET GYNE, V47, P32, DOI 10.1016/S1028-4559(08)60052-2; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Y, 2014, BIOINFORMATICS, V30, P2121, DOI 10.1093/bioinformatics/btu174; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Meric-Bernstam F., 2015, JNCI-J NATL CANCER I, V107, P1; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mohlendick B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067031; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Normand E, 2016, PRENATAL DIAG, V36, P823, DOI 10.1002/pd.4866; Oesper L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r80; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Pihan GA, 2001, CANCER RES, V61, P2212; Pihan GA, 1998, CANCER RES, V58, P3974; Polzer B, 2014, EMBO MOL MED, V6, P1371, DOI 10.15252/emmm.201404033; Pompetti F, 1996, J CELL BIOCHEM, V63, P37; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rieber N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066621; Roh W, 2017, SCI TRANSL MED, V9; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Sato N, 1999, CLIN CANCER RES, V5, P963; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Seo AN, 2014, BRIT J CANCER, V110, P2688, DOI 10.1038/bjc.2014.218; Silverman B., 1986, CHAPMAN HALL, V37, P1, DOI [10.2307/2347507, DOI 10.2307/2347507]; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Stoecklein NH, 2002, AM J PATHOL, V161, P43, DOI 10.1016/S0002-9440(10)64155-7; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wong A, 1986, SCIENCE, V233; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zafarana G, 2012, CANCER-AM CANCER SOC, V118, P4053, DOI 10.1002/cncr.26729; Zhang WG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12619; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	71	15	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193689	10.1371/journal.pone.0193689	http://dx.doi.org/10.1371/journal.pone.0193689			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494651	gold, Green Published			2022-12-27	WOS:000426363200083
J	Lee, WH; Kim, JW; Lim, JS; Kong, IG; Choi, HG				Lee, Woo Hyun; Kim, Jeong-Whun; Lim, Jae-Sung; Kong, Il Gyu; Choi, Hyo Geun			Chronic rhinosinusitis increases the risk of hemorrhagic and ischemic stroke: A longitudinal follow-up study using a national sample cohort	PLOS ONE			English	Article							INTRACRANIAL COMPLICATIONS; CIGARETTE-SMOKING; SINUSITIS; HEART; EPIDEMIOLOGY; ASSOCIATION; INFARCTION; COUNTRIES; DISEASE; HEALTH	Background Several studies have reported that chronic rhinosinusitis (CRS) increases the risk of stroke. The aim of this study is to elucidate the putative association between CRS and stroke (ischemic or hemorrhagic) using large population-based national health insurance data. Methods Using the national cohort study from the Korean Health Insurance Review and Assessment Service, CRS patients (n = 22,959) and control participants (n = 91,836) were selected and matched at a rate of 1: 4 (age, sex, income, region, hypertension, diabetes, and dyslipidemia). A Cox-proportional hazard model was used to analyze the hazard ratio (HR) of CRS for hemorrhagic stroke and ischemic stroke. We divided the participants according to age and gender for the subgroup analysis. Results The HR for hemorrhagic and ischemic stroke was significantly increased in the CRS patients compared to that in the controls (adjusted HR = 2.43, 95% confidence interval [CI] = 2.10-2.80 for hemorrhagic stroke; adjusted HR = 1.76, 95% CI = 1.61-1.92 for ischemic stroke) after adjusting for age, sex, income, region of residence, hypertension, diabetes, dyslipidemia, ischemic heart disease, migraine, chronic kidney disease, depression, sleep disorder, and chronic obstructive pulmonary disorder. In the subgroup analysis, the HR of hemorrhagic stroke was significantly increased in the CRS group regardless of age and gender. The HR of ischemic stroke was also significantly increased in all subgroups of the CRS group. Conclusion CRS consistently increased the risk of ischemic and hemorrhagic stroke regardless of age and gender.	[Lee, Woo Hyun] Kangwon Natl Univ Hosp, Dept Otolaryngol, Chunchon, South Korea; [Kim, Jeong-Whun] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol, Seongnam, South Korea; [Lim, Jae-Sung] Hallym Univ, Sacred Heart Hosp, Dept Neurol, Anyang, South Korea; [Kong, Il Gyu; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol, Dept Head & Neck Surg, Anyang, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol, Dept Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Lim, Jae-Sung/D-5555-2012; Choi, Hyo Geun/K-4461-2019	Lim, Jae-Sung/0000-0001-6157-2908; Choi, Hyo Geun/0000-0003-1655-9549				Arslan H, 1999, Auris Nasus Larynx, V26, P39, DOI 10.1016/S0385-8146(98)00024-8; Barreto MP, 2000, ANN OTO RHINOL LARYN, V109, P227, DOI 10.1177/000348940010900220; Bayonne E, 2009, RHINOLOGY, V47, P59; Benninger MS, 2003, OTOLARYNG HEAD NECK, V129, pS1, DOI 10.1016/S0194-5998(03)01397-4; Bhat VM, 2008, STROKE, V39, P2439, DOI 10.1161/STROKEAHA.107.510073; Chen Y, 2003, LARYNGOSCOPE, V113, P1199, DOI 10.1097/00005537-200307000-00016; Danesh J, 2007, EUR J EPIDEMIOL, V22, P129, DOI 10.1007/s10654-006-9096-8; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens W, 2007, RHINOLOGY, P1; Giannoni C, 1998, AM J RHINOL, V12, P173, DOI 10.2500/105065898781390127; Giannoni CM, 1997, LARYNGOSCOPE, V107, P863, DOI 10.1097/00005537-199707000-00005; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2; Hurst RW, 2001, AM J NEURORADIOL, V22, P858; Kang JH, 2013, LARYNGOSCOPE, V123, P835, DOI 10.1002/lary.23829; Kim J, 2013, INT J CHRONIC OBSTR, V8, P561, DOI 10.2147/COPD.S48577; Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16; Lee WH, 2015, INT FORUM ALLERGY RH, V5, P937, DOI 10.1002/alr.21553; Lieu JEC, 2000, ARCH OTOLARYNGOL, V126, P940, DOI 10.1001/archotol.126.8.940; Mayberg MR, 1998, NEUROSURG CLIN N AM, V9, P615; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pleis JR, 2006, VITAL HLTH STAT, V10; Righini Christian Adrien, 2009, Ear Nose Throat J, V88, pE23; Rochat P, 2001, RHINOLOGY, V39, P173; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Salerno SM, 2005, ARCH INTERN MED, V165, P1686, DOI 10.1001/archinte.165.15.1686; Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706; TOKUSHIGE E, 1994, LARYNGOSCOPE, V104, P1245; Wu CW, 2012, AM J RHINOL ALLERGY, V26, P278, DOI [10.2500/ajra.2012.26.3783, 10.2500/ajra.2012.26.3783a]; Yildirim Yavuz Selim, 2011, Kulak Burun Bogaz Ihtis Derg, V21, P266, DOI 10.5606/kbbihtisas.2011.039; Yoon BW, 2007, NEUROLOGY, V68, P146, DOI 10.1212/01.wnl.0000250351.38999.f2	31	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193886	10.1371/journal.pone.0193886	http://dx.doi.org/10.1371/journal.pone.0193886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494700	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200099
J	Zhu, ZZ; Anttila, V; Smoller, JW; Lee, PH				Zhu, Zhaozhong; Anttila, Verneri; Smoller, Jordan W.; Lee, Phil H.			Statistical power and utility of meta-analysis methods for cross-phenotype genome-wide association studies	PLOS ONE			English	Article							WEIGHTED Z-TEST; COMBINING PROBABILITIES; SHARED CONTROLS; DISEASES; TRAITS; LOCI; PLEIOTROPY; MULTIPLE	Advances in recent genome wide association studies ( GWAS) suggest that pleiotropic effects on human complex traits are widespread. A number of classic and recent meta-analysis methods have been used to identify genetic loci with pleiotropic effects, but the overall performance of these methods is not well understood. In this work, we use extensive simulations and case studies of GWAS datasets to investigate the power and type-I error rates of ten meta-analysis methods. We specifically focus on three conditions commonly encountered in the studies of multiple traits: ( 1) extensive heterogeneity of genetic effects; ( 2) characterization of trait-specific association; and ( 3) inflated correlation of GWAS due to overlapping samples. Although the statistical power is highly variable under distinct study conditions, we found the superior power of several methods under diverse heterogeneity. In particular, classic fixed-effects model showed surprisingly good performance when a variant is associated with more than a half of study traits. As the number of traits with null effects increases, ASSET performed the best along with competitive specificity and sensitivity. With opposite directional effects, CPASSOC featured the first-rate power. However, caution is advised when using CPASSOC for studying genetically correlated traits with overlapping samples. We conclude with a discussion of unresolved issues and directions for future research.	[Zhu, Zhaozhong; Smoller, Jordan W.; Lee, Phil H.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Zhu, Zhaozhong; Smoller, Jordan W.; Lee, Phil H.] Harvard Med Sch, Boston, MA 02114 USA; [Zhu, Zhaozhong; Lee, Phil H.] Harvard TH Chan Sch Publ Hlth, Program Quantitat Genom, Boston, MA 02115 USA; [Anttila, Verneri; Smoller, Jordan W.; Lee, Phil H.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Lee, PH (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.; Lee, PH (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Lee, PH (corresponding author), Harvard TH Chan Sch Publ Hlth, Program Quantitat Genom, Boston, MA 02115 USA.; Lee, PH (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.	PLEE0@mgh.harvard.edu	; Smoller, Jordan/K-3719-2015	Lee, Phil/0000-0003-1770-3100; Smoller, Jordan/0000-0002-0381-6334; Anttila, Verneri/0000-0002-0073-4675	National Institute of Mental Health [R00MH101367, R01MH085542, R01MH085545, K24MH094614]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml). The grants include R00MH101367 (PHL), R01MH085542 (JWS), R01MH085545 (JWS), and K24MH094614 (JWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anney RJL, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0137-9; Anttila V., 2018, SCIENCE, V360, peaap8757; Begum F, 2012, NUCLEIC ACIDS RES, V40, P3777, DOI 10.1093/nar/gkr1255; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Charney AW, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.242; Chen Z, 2011, J EVOLUTION BIOL, V24, P926, DOI 10.1111/j.1420-9101.2010.02226.x; Chen ZX, 2015, SCI REP-UK, V5, DOI 10.1038/srep16983; Chen ZX, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S17-S3; Chen ZX, 2014, COMPUT STAT DATA AN, V70, P387, DOI 10.1016/j.csda.2013.09.005; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Day FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9842; Demontis D., 2017, BIORXIV; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Hagenaars SP, 2016, MOL PSYCHIATR, V21, P1624, DOI 10.1038/mp.2015.225; Han B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002555; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Kar SP, 2016, CANCER DISCOV, V6, P1052, DOI 10.1158/2159-8290.CD-15-1227; Lee PH, 2011, HUM HERED, V72, P10, DOI 10.1159/000327158; Li YR, 2015, NAT MED, V21, P1018, DOI 10.1038/nm.3933; O'Donovan MC, 2015, WORLD PSYCHIATRY, V14, P291, DOI 10.1002/wps.20270; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pfeiffer R, 2010, COMBINING DATA GENOM; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sakoda LC, 2013, NAT GENET, V45, P345, DOI 10.1038/ng.2587; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Turley P, 2018, NAT GENET; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Zaykin DV, 2010, GENET EPIDEMIOL, V34, P725, DOI 10.1002/gepi.20536; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zhu XF, 2015, AM J HUM GENET, V96, P21, DOI 10.1016/j.ajhg.2014.11.011; Zhu Z, 2017, BIORXIV	41	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193256	10.1371/journal.pone.0193256	http://dx.doi.org/10.1371/journal.pone.0193256			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494641	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200034
J	Abdel-Moneim, AS; Mahfouz, ME; Zytouni, DM				Abdel-Moneim, Ahmed S.; Mahfouz, Mohammad E.; Zytouni, Dalia M.			Detection of human bocavirus in Saudi healthy blood donors	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN PARVOVIRUSES; PLASMA; GENOTYPE-1; PARV4	Human bocavirus is associated with respiratory disease worldwide, mainly in children. There are conflicting results, however, regarding the existence of the HBoV in blood donors. Three hundred whole blood samples from non-immunodeficient healthy blood donors were screened for the presence of HBoV by polymerase chain reaction. The HBoV genotype of positive samples was determined using direct gene sequencing. Twenty-one out of the three hundred blood samples were found to be positive for HBoV. Sequence analysis of the positive samples revealed that all the strains were related to the HBoV-1 type with a low rate of variation among the detected sequences. It was concluded that there is a considerable risk of contracting HBoV from a blood transfusion from normal healthy individuals.	[Abdel-Moneim, Ahmed S.] Taif Univ, Coll Med, Dept Microbiol, Al Taif, Saudi Arabia; [Abdel-Moneim, Ahmed S.] Beni Suef Univ, Fac Vet Med, Virol Dept, Bani Suwayf, Egypt; [Mahfouz, Mohammad E.] Taif Univ, Coll Med, Dept Surg, Al Taif, Saudi Arabia; [Mahfouz, Mohammad E.; Zytouni, Dalia M.] King Faisal Hosp, Al Taif, Saudi Arabia	Taif University; Egyptian Knowledge Bank (EKB); Beni Suef University; Taif University	Abdel-Moneim, AS (corresponding author), Taif Univ, Coll Med, Dept Microbiol, Al Taif, Saudi Arabia.; Abdel-Moneim, AS (corresponding author), Beni Suef Univ, Fac Vet Med, Virol Dept, Bani Suwayf, Egypt.	asa@tu.edu.sa	Abdel-Moneim, Ahmed S./G-7445-2012; Mahfouz, Mohammad Eid M/T-5874-2018	Abdel-Moneim, Ahmed S./0000-0002-3148-6782; 	Taif University [4912-437-1]	Taif University	This work was supported by the Taif University, Project Number 4912-437-1 to ASA. The funder had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Abdel-Moneim AS, 2017, J MED MICROBIOL, V66, P245, DOI 10.1099/jmm.0.000432; Abdel-Moneim AS, 2016, ARCH VIROL, V161, P2095, DOI 10.1007/s00705-016-2885-9; Abdel-Moneim AS, 2016, J VIROL METHODS, V228, P108, DOI 10.1016/j.jviromet.2015.11.023; Abdel-Moneim AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055500; Adami V, 2004, CLIN MICROBIOL INFEC, V10, P1075, DOI 10.1111/j.1469-0691.2004.01025.x; [Anonymous], 2016, VIRUS TAXONOMY CLASS; Assal A, 2009, TRANSFUSION, V49, P289, DOI 10.1111/j.1537-2995.2008.01965.x; Bonvicini F, 2011, DIAGN MICR INFEC DIS, V71, P460, DOI 10.1016/j.diagmicrobio.2011.08.019; Cassinotti P, 2000, EUR J CLIN MICROBIOL, V19, P886, DOI 10.1007/s100960000384; Costa C, 2009, J CLIN VIROL, V45, P81, DOI 10.1016/j.jcv.2009.02.008; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; Eis-Hubinger AM, 2010, TRANSFUSION, V50, P266, DOI 10.1111/j.1537-2995.2009.02433.x; Foglieni B, 2011, TRANSFUSION, V51, P719, DOI 10.1111/j.1537-2995.2010.02942.x; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Fryer JF, 2007, TRANSFUSION, V47, P1054, DOI 10.1111/j.1537-2995.2007.01235.x; Garbino J, 2009, THORAX, V64, P399, DOI 10.1136/thx.2008.105155; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Lefrere JJ, 1999, J VIROL METHODS, V80, P33, DOI 10.1016/S0166-0934(99)00028-2; Li HX, 2015, TRANSFUSION, V55, P154, DOI 10.1111/trf.12785; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Ma YY, 2012, VOX SANG, V103, P183, DOI 10.1111/j.1423-0410.2012.01605.x; Modrow S, 2011, VOX SANG, V100, P351, DOI 10.1111/j.1423-0410.2010.01445.x; Norja P, 2012, BRIT J HAEMATOL, V159, P385, DOI 10.1111/bjh.12060; Qiu JM, 2017, CLIN MICROBIOL REV, V30, P43, DOI 10.1128/CMR.00040-16; Schenk T, 2007, EMERG INFECT DIS, V13, P1425, DOI 10.3201/eid1309.070318; Shyamala V, 2014, ISBT SCI SERIES, V9, P315, DOI DOI 10.1111/VOXS.12106	27	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193594	10.1371/journal.pone.0193594	http://dx.doi.org/10.1371/journal.pone.0193594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489915	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000093
J	de Souza, AF; Pieri, NCG; Roballo, KCS; Bressan, FF; Casals, JB; Ambrosio, CE; Perecin, F; Martins, DS				de Souza, Aline F.; Godoy Pieri, Naira C.; Roballo, Kelly C. S.; Bressan, Fabiana F.; Casals, Juliana B.; Ambrosio, Carlos E.; Perecin, Felipe; Martins, Daniele S.			Dynamics of male canine germ cell development	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DOGS; EXPRESSION; GENERATION; DERIVATION; MARKERS; EMBRYO; GENOME; OCT-4; SRY	Primordial germ cells (PGCs) are precursors of gametes that can generate new individuals throughout life in both males and females. Additionally, PGCs have been shown to differentiate into embryonic germ cells (EGCs) after in vitro culture. Most studies investigating germinative cells have been performed in rodents and humans but not dogs (Canis lupus familiaris). Here, we elucidated the dynamics of the expression of pluripotent (POU5F1 and NANOG), germline (DDX4, DAZL and DPPA3), and epigenetic (5mC, 5hmC, H3K27me3 and H3K9me2) markers that are important for the development of male canine germ cells during the early (22 +/- 30 days post-fertilization (dpf)), middle (35 +/- 40 dpf) and late (45 +/- 50 dpf) gestational periods. We performed sex genotype characterization, immunofluorescence, immunohistochemistry, and quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) analyses. Furthermore, in a preliminary study, we evaluated the capacity of canine embryo PGCs (30 dpf) to differentiate into EGCs. To confirm the canine EGCs phenotype, we performed alkaline phosphatase detection, immunohistochemistry, electron and transmission scanning microscopy and RT-qPCR analyses. The PGCs were positive for POU5F1 and H3K27me3 during all assessed developmental periods, including all periods between the gonadal tissue stage and foetal testes development. The number of NANOG, DDX4, DAZL, DPPA3 and 5mC-positive cells increased along with the developing cords from 35 +/- 50 dpf. Moreover, our results demonstrate the feasibility of inducing canine PGCs into putative EGCs that present pluripotent markers, such as POU5F1 and the NANOG gene, and exhibit reduced expression of germinative genes and increased expression of H3K27me3. This study provides new insight into male germ cell development mechanisms in dogs.	[de Souza, Aline F.; Bressan, Fabiana F.; Casals, Juliana B.; Ambrosio, Carlos E.; Perecin, Felipe; Martins, Daniele S.] Univ Sao Paulo, Fac Vet Med & Anim Sci, Dept Surg, Sao Paulo, SP, Brazil; [de Souza, Aline F.; Roballo, Kelly C. S.; Bressan, Fabiana F.; Ambrosio, Carlos E.; Perecin, Felipe; Martins, Daniele S.] Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil; [Godoy Pieri, Naira C.] Univ Sao Paulo, Fac Vet Med, Dept Reprod, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Martins, DS (corresponding author), Univ Sao Paulo, Fac Vet Med & Anim Sci, Dept Surg, Sao Paulo, SP, Brazil.; Martins, DS (corresponding author), Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil.	daniele@usp.br	Bressan, Fabiana F./C-6679-2012; Ambrosio, Carlos Eduardo/F-3402-2010; Pieri, Naira/AAH-2843-2019; dos Santos Martins, Daniele/C-9004-2013; dos Santos Martins, Daniele/ABH-1262-2020; Perecin, Felipe/C-7268-2012; Roballo, Kelly C/I-6557-2015; De Souza, Aline Fernanda/F-8649-2017	Bressan, Fabiana F./0000-0001-9862-5874; Ambrosio, Carlos Eduardo/0000-0002-8224-5022; Pieri, Naira/0000-0002-6800-6025; dos Santos Martins, Daniele/0000-0002-6277-4664; dos Santos Martins, Daniele/0000-0002-6277-4664; Perecin, Felipe/0000-0003-2009-5863; Roballo, Kelly C/0000-0001-8420-9159; De Souza, Aline Fernanda/0000-0002-5702-1166	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/10542-5, 2012/05609-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was graciously funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant numbers, 2013/10542-5 and 2012/05609-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no competing interests to declare.; We acknowledge Dr. Andre Furugen Cesar de Andrade of the Laboratory of Swine Reproduction at the Faculty of Veterinary Medicine and Animal Sciences at the University of Sao Paulo for his technical support with the fluorescence microscopy. We also acknowledge Dra. Susana M. Chuva Sousa Lopes at the Department of Anatomy and Embryology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands, for her intellectual support. This study was graciously funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant numbers, 2013/10542-5 and 2012/05609-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no competing interests to declare.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Chastant-Maillard S, 2010, REPROD FERT DEVELOP, V22, P1049, DOI 10.1071/RD09270; Cinalli RM, 2008, CELL, V132, P559, DOI 10.1016/j.cell.2008.02.003; Cooke PS, 2015, ASIAN J ANDROL, V17, P441, DOI 10.4103/1008-682X.151401; De Felici M, 2000, INT J DEV BIOL, V44, P575; Durcova-Hills G, 2001, DIFFERENTIATION, V68, P220, DOI 10.1046/j.1432-0436.2001.680409.x; Durcova-Hills Gabriela, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01a03s5; FUJIMOTO T, 1977, ANAT REC, V188, P315, DOI 10.1002/ar.1091880305; Gaskell TL, 2004, BIOL REPROD, V71, P2012, DOI 10.1095/biolreprod.104.028381; Gier H. T., 1969, Biology of Reproduction Suppl, VNo. 1, P1, DOI 10.1095/biolreprod1.Supplement_1.1; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hatoya S, 2006, MOL REPROD DEV, V73, P298, DOI 10.1002/mrd.20392; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Hayashi Y, 2012, FERTIL STERIL, V97, P1250, DOI 10.1016/j.fertnstert.2012.04.037; Hayes B, 2008, STEM CELLS, V26, P465, DOI 10.1634/stemcells.2007-0640; Heeren AM, 2016, BIOL OPEN, V5, P185, DOI 10.1242/bio.013847; Heeren AM, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0054-0; Hendriks S, 2015, HUM REPROD UPDATE, P1; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lee KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088497; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Lopes SMCD, 2010, DIFFERENTIATION, V79, P131, DOI 10.1016/j.diff.2009.11.003; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Mancanares CAF, 2015, THERIOGENOLOGY, P1; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Martins AA, 2016, REPROD DOMEST ANIM, V51, P804, DOI 10.1111/rda.12759; Martins DS, 2011, REPROD DOMEST ANIM, V46, pe62, DOI 10.1111/j.1439-0531.2010.01631.x; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Miglino MA, 2006, THERIOGENOLOGY, V66, P1699, DOI 10.1016/j.theriogenology.2006.02.027; Mollgard K, 2010, MOL HUM REPROD, V16, P621, DOI 10.1093/molehr/gaq052; Murakami K, 2016, NATURE, V529, P403, DOI 10.1038/nature16480; Nagamatsu G, 2013, METHODS MOL BIOL, V1052, P49, DOI 10.1007/7651_2013_24; Nakashima H, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105932; Nowacka J, 2005, J HERED, V96, P797, DOI 10.1093/jhered/esi106; Nowacka-Woszuk J, 2007, ANIM REPROD SCI, V98, P371, DOI 10.1016/j.anireprosci.2006.04.051; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Petkov SG, 2011, STEM CELL RES, V6, P226, DOI 10.1016/j.scr.2011.01.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piedrahita JA, 1998, BIOL REPROD, V58, P1321, DOI 10.1095/biolreprod58.5.1321; Pieri NCG, 2015, REPROD DOMEST ANIM, V50, P625, DOI 10.1111/rda.12539; Pieri NCG, 2016, REPROD DOMEST ANIM, V51, P1; R Core Team, 2015, R LANGUAGE ENV STAT; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Starkey Mike P., 2005, Briefings in Functional Genomics & Proteomics, V4, P112; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Tilgner K, 2008, STEM CELLS, V26, P3075, DOI 10.1634/stemcells.2008-0289; Turnpenny L, 2006, STEM CELLS, V24, P212, DOI 10.1634/stemcells.2005-0255; Whyte A, 2009, ANIM REPROD SCI, V115, P328, DOI 10.1016/j.anireprosci.2008.11.008; Wilhelm D, 2013, MAMMALIAN SEX DETERM	62	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193026	10.1371/journal.pone.0193026	http://dx.doi.org/10.1371/journal.pone.0193026			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489867	gold, Green Submitted, Green Published			2022-12-27	WOS:000426276000052
J	Monahan, WB; Theobald, DM				Monahan, William B.; Theobald, David M.			Climate change adaptation benefits of potential conservation partnerships	PLOS ONE			English	Article							PROTECTED AREAS; STRATEGIES; VULNERABILITY; CHALLENGES; PRIORITIES; RANGES; WORLDS; SHIFTS; LANDS	We evaluate the world terrestrial network of protected areas (PAs) for its partnership potential in responding to climate change. That is, if a PA engaged in collaborative, trans-boundary management of species, by investing in conservation partnerships with neighboring areas, what climate change adaptation benefits might accrue? We consider core tenets of conservation biology related to protecting large areas with high environmental heterogeneity and low climate change velocity and ask how a series of biodiversity adaptation indicators change across spatial scales encompassing potential PA and non-PA partners. Less than 1% of current world terrestrial PAs equal or exceed the size of established and successful conservation partnerships. Partnering at this scale would increase the biodiversity adaptation indicators by factors up to two orders of magnitude, compared to a null model in which each PA is isolated. Most partnership area surrounding PAs is comprised of non-PAs (70%), indicating the importance of looking beyond the current network of PAs when promoting climate change adaptation. Given monumental challenges with PA-based species conservation in the face of climate change, partnerships provide a logical and achievable strategy for helping areas adapt. Our findings identify where strategic partnering efforts in highly vulnerable areas of the world may prove critical in safeguarding biodiversity.	[Monahan, William B.] Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO 80525 USA; [Theobald, David M.] Conservat Sci Partners Inc, Ft Collins, CO USA; [Monahan, William B.] Forest Serv, USDA, Forest Hlth Protect, Ft Collins, CO 80526 USA	United States Department of the Interior; United States Department of Agriculture (USDA); United States Forest Service	Monahan, WB (corresponding author), Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO 80525 USA.; Monahan, WB (corresponding author), Forest Serv, USDA, Forest Hlth Protect, Ft Collins, CO 80526 USA.	wmonahan@fs.fed.us			NASA Applied Sciences program [10-BIOCLIM10-0034]	NASA Applied Sciences program(National Aeronautics & Space Administration (NASA))	This work was supported by the NASA Applied Sciences program through award number 10-BIOCLIM10-0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; [Anonymous], 2014, CLIMATE CHANGE 2014, P1; [Anonymous], 2011, US GEOLOGICAL SURVEY; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Aycrigg JL, 2016, BIOSCIENCE, V66, P774, DOI 10.1093/biosci/biw090; Barr LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024707; Beever EA, 2014, CONSERV BIOL, V28, P302, DOI 10.1111/cobi.12233; Butchart S.H.M., 2015, CONSERV LETT; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Columbia Law School, 2015, CLIM CHANG LAWS WORL; Curtin C. G., 2015, SCI OPEN SPACES THEO; Dallimer M, 2015, TRENDS ECOL EVOL, V30, P132, DOI 10.1016/j.tree.2014.12.004; Gillingham PK, 2015, BIOL J LINN SOC, V115, P707, DOI 10.1111/bij.12506; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hannah L, 2002, GLOBAL ECOL BIOGEOGR, V11, P485, DOI 10.1046/j.1466-822X.2002.00306.x; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; International Union for Conservation of Nature, 2015, IUCN RED LIST THREAT; International Union for Conservation of Nature and United Nations Environment Programme-World Conservation Management Center, 2015, WORLD DAT PROT AR WD; Jenkins CN, 2015, P NATL ACAD SCI USA, V112, P5081, DOI 10.1073/pnas.1418034112; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004279; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; Krosby M, 2010, CONSERV BIOL, V24, P1686, DOI 10.1111/j.1523-1739.2010.01585.x; Lehner B, 2013, HYDROL PROCESS, V27, P2171, DOI 10.1002/hyp.9740; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Maciejewski K, 2015, ECOL APPL, V25, P11, DOI 10.1890/13-2240.1; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ordonez A, 2014, NAT CLIM CHANGE, V4, P811, DOI [10.1038/nclimate2337, 10.1038/NCLIMATE2337]; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Secretary of the Interior, 2009, 3289 SECR INT US DEP; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Tingley MW, 2014, ANN NY ACAD SCI, V1322, P92, DOI 10.1111/nyas.12484; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; UNEP-WCMC, 2015, WORLD DAT PROT AR US; Urban MC, 2016, SCIENCE, V353, P1113, DOI 10.1126/science.aad8466; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Watson JEM, 2013, NAT CLIM CHANGE, V3, P989, DOI [10.1038/NCLIMATE2007, 10.1038/nclimate2007]; Watson JEM, 2012, ADV CLIM CHANG RES, V3, P1, DOI 10.3724/SP.J.1248.2012.00001	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191468	10.1371/journal.pone.0191468	http://dx.doi.org/10.1371/journal.pone.0191468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489817	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000007
J	Thieme, S; Holzbaur, A; Wiedemuth, R; Binner, A; Navratiel, K; Anastassiadis, K; Brenner, S; Richter, C				Thieme, Sebastian; Holzbaur, Alexander; Wiedemuth, Ralf; Binner, Aline; Navratiel, Katrin; Anastassiadis, Konstantinos; Brenner, Sebastian; Richter, Cornelia			The Dox-pDC - A murine conditionally immortalized plasmacytoid dendritic cell line with native immune profile	PLOS ONE			English	Article							NAIVE T-CELLS; NK-CELLS; IN-VIVO; CPG-DNA; ACTIVATION; ANTIGEN; INTERFERON; TYPE-1; LIGAND; IL-10	Plasmacytoid dendritic cells (pDC) constitute a very rare blood cell population and play a significant role in immune response and immune-mediated disorders. Investigations on primary pDCs are hindered not only due to their rarity but also because they represent a heterogeneous cell population which is difficult to culture ex vivo. We generated a conditionally immortalized pDC line (Dox-pDC) from mice with Doxycycline-inducible SV40 Large T Antigen with a comparable immune profile to primary pDCs. The Dox-pDC secrete pro-and anti-inflammatory cytokines upon Toll-like receptor 9 stimulation and upregulate their MHCI, MHCII and costimulatory molecules. Further, the Dox-pDC activate and polarize naive T cells in vivo and in vitro in response to the model antigen Ovalbumin. Due to their long-term culture stability and their robust proliferation Dox-pDC represent a reliable alternative to primary mouse pDC.	[Thieme, Sebastian; Holzbaur, Alexander; Wiedemuth, Ralf; Binner, Aline; Navratiel, Katrin; Brenner, Sebastian; Richter, Cornelia] Univ Clin Carl Gustav Carus Dresden, Dept Pediat, Dresden, Germany; [Anastassiadis, Konstantinos] Tech Univ Dresden, Stem Cell Engn, BIOTEC, Dresden, Germany; [Brenner, Sebastian] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden	Brenner, S; Richter, C (corresponding author), Univ Clin Carl Gustav Carus Dresden, Dept Pediat, Dresden, Germany.; Brenner, S (corresponding author), Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany.	sebastian.brenner@uniklinikum-dresden.de; cornelia.richter@uniklinikum-dresden.de	Anastassiadis, Konstantinos/A-8944-2010	Anastassiadis, Konstantinos/0000-0002-9814-0559; Richter, Cornelia/0000-0003-4559-5696	Collaborative Research Grant (DFG) from the DFG-Center for Regenerative Therapies Dresden [SFB-655]; Saxon State Ministry for Higher Education, Research and the Arts; DFG-Center for Regenerative Therapies Dresden	Collaborative Research Grant (DFG) from the DFG-Center for Regenerative Therapies Dresden; Saxon State Ministry for Higher Education, Research and the Arts; DFG-Center for Regenerative Therapies Dresden	This work was supported by the Collaborative Research Grant SFB-655 (DFG, SFB-655 project B6 to SB, project B1 to KA; www.dfg.de), the seed grants from the DFG-Center for Regenerative Therapies Dresden (to S.B.; www.crt-dresden.de) and the Saxon State Ministry for Higher Education, Research and the Arts (to C.R. and S.T.; www.sachsen.de/en/1218.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Andras Nagy (Mount Sinai Hospital, Toronto, Canada) for providing the Rosa-rtTA mice. This work was supported by the Collaborative Research Grant SFB-655 (DFG, SFB-655 project B6 to SB, project B1 to KA), the seed grants from the DFG-Center for Regenerative Therapies Dresden (to S.B.) and the Saxon State Ministry for Higher Education, Research and the Arts (to C.R. and S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis K, 2010, GENESIS, V48, P220, DOI 10.1002/dvg.20605; Bauer M, 2001, J IMMUNOL, V166, P5000, DOI 10.4049/jimmunol.166.8.5000; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Contractor N, 2007, J IMMUNOL, V179, P2690, DOI 10.4049/jimmunol.179.5.2690; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Liu YC, 2010, J IMMUNOL, V184, P3367, DOI 10.4049/jimmunol.0903079; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mach N, 2000, CANCER RES, V60, P3239; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Mouries J, 2008, BLOOD, V112, P3713, DOI 10.1182/blood-2008-03-146290; Narita M, 2009, LEUKEMIA RES, V33, P1224, DOI 10.1016/j.leukres.2009.03.047; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Richter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062621; Romagnani C, 2005, EUR J IMMUNOL, V35, P2452, DOI 10.1002/eji.200526069; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192437	10.1371/journal.pone.0192437	http://dx.doi.org/10.1371/journal.pone.0192437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489861	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000026
J	Murata, M; Ishii, A; Fujimoto, H; Nishimura, K; Kosaka, T; Mori, H; Yamada, M				Murata, Masayuki; Ishii, Ayana; Fujimoto, Hiroko; Nishimura, Kaori; Kosaka, Tomoyuki; Mori, Hirotada; Yamada, Mamoru			Update of thermotolerant genes essential for survival at a critical high temperature in Escherichia coil	PLOS ONE			English	Article							COLI	Previous screening of a single-gene knockout library consisting of 3,908 disrupted-mutant strains allowed us to identify 51 thermotolerant genes that are essential for survival at a critical high temperature (CHT) in Escherichia coli [Murata M, Fujimoto H, Nishimura K, Charoensuk K, Nagamitsu H, Raina S, Kosaka T, Oshima T, Ogasawara N, Yamada M (2011) PLoS ONE 6: e20063]. In this study, we identified another 21 thermotolerant genes. E. coli thus has 72 thermotolerant genes in total. The genes are classified into 8 groups: genes for energy metabolism, outer membrane organization, DNA double-strand break repair, tRNA modification, protein quality control, translation control, cell division and transporters. This classification and physiological analysis indicate the existence of fundamental strategies for survival at a CHT, which seems to exclude most of the heat shock responses.	[Murata, Masayuki; Ishii, Ayana; Fujimoto, Hiroko; Nishimura, Kaori; Kosaka, Tomoyuki; Yamada, Mamoru] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Life Sci, Ube, Yamaguchi, Japan; [Kosaka, Tomoyuki; Yamada, Mamoru] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi, Japan; [Kosaka, Tomoyuki; Yamada, Mamoru] Yamaguchi Univ, Res Ctr Thermotolerant Microbial Resources, Yamaguchi, Japan; [Mori, Hirotada] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University; Nara Institute of Science & Technology	Yamada, M (corresponding author), Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Life Sci, Ube, Yamaguchi, Japan.; Yamada, M (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi, Japan.; Yamada, M (corresponding author), Yamaguchi Univ, Res Ctr Thermotolerant Microbial Resources, Yamaguchi, Japan.	m-yamada@yamaguchi-u.ac.jp		Yamada, Mamoru/0000-0003-4354-7324; Kosaka, Tomoyuki/0000-0002-8181-9127	Japan Society for the Promotion of Science, MEXT/JSPS Kakenhi [25250028]; Advanced Low Carbon Technology Research and Development Program, Japan Science and Technology Agency (JST); Scientific Cooperation Program; National Research Council of Thailand (NRCT)	Japan Society for the Promotion of Science, MEXT/JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Advanced Low Carbon Technology Research and Development Program, Japan Science and Technology Agency (JST); Scientific Cooperation Program; National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT))	This work was supported by the Japan Society for the Promotion of Science, MEXT/JSPS Kakenhi (25250028 to HM and MY) and the Advanced Low Carbon Technology Research and Development Program, Japan Science and Technology Agency (JST). This work was also partially performed as collaborative researches in the Asian Core Program and in the Core to Core Program, which was supported by the Scientific Cooperation Program agreed by the Japan Society for the Promotion of Science (JSPS), the National Research Council of Thailand (NRCT) and universities involved in the program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA H, 1981, J BIOL CHEM, V256, P1905; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barak R, 1998, J BACTERIOL, V180, P985, DOI 10.1128/JB.180.4.985-988.1998; Cassey B, 1998, FEMS MICROBIOL LETT, V159, P325; CHANG S, 1979, MOL GEN GENET, V168, P111, DOI 10.1007/BF00267940; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; HAYDON DJ, 1993, FEBS LETT, V336, P43, DOI 10.1016/0014-5793(93)81605-Y; LYNGSTADAAS A, 1995, MOL GEN GENET, V247, P546, DOI 10.1007/BF00290345; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Noor R, 2009, J MOL MICROB BIOTECH, V17, P177, DOI 10.1159/000236029; Soemphol W, 2011, BIOSCI BIOTECH BIOCH, V75, P1921, DOI 10.1271/bbb.110310; Tsunedomi R, 2003, J BACTERIOL, V185, P1783, DOI 10.1128/JB.185.6.1783-1795.2003; Yamamoto Y, 1997, DNA Res, V4, P91, DOI 10.1093/dnares/4.2.91	13	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0189487	10.1371/journal.pone.0189487	http://dx.doi.org/10.1371/journal.pone.0189487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485997	Green Submitted, gold, Green Published			2022-12-27	WOS:000426242400001
J	Mallhi, TH; Khan, AH; Adnan, AS; Sarriff, A; Khan, YH; Gan, SH				Mallhi, Tauqeer Hussain; Khan, Amer Hayat; Adnan, Azreen Syazril; Sarriff, Azmi; Khan, Yusra Habib; Gan, Siew Hua			Short-term renal outcomes following acute kidney injury among dengue patients: A follow-up analysis from large prospective cohort	PLOS ONE			English	Article							VIRAL-INFECTION; RECOVERY; EPIDEMIOLOGY; BIOMARKERS; IMPACT; RIFLE; AKI	Background Despite myriad improvements in the care of dengue patients, acute kidney injury (AKI) remained least appreciated intricacy of dengue infection. Exiting literature does not provide any information on renal outcomes among dengue patients surviving an episode of AKI. Methods Dengue patients who developed AKI were followed up for post-discharge period of three months and renal recovery was assessed by using recovery criteria based on different thresholds of serum creatinine (SCr) and estimated glomerular filtration rates (eGFR). Results Out of the 526 dengue participants, AKI was developed in 72 (13.7%) patients. Renal recovery was assessed among AKI survivors (n = 71). The use of less (+/- 50% recovery to baseline) to more (+/- 5% recovery to baseline) stringent definitions of renal recovery yielded recovery rates from 88.9% to 2.8% by SCr and 94.4% to 5.6% by eGFR, as renal function biomarkers. At the end of study, eight patients had AKI with AKIN-II (n = 7) and AKIN-III (n = 1). Approximately 50% patients (n = 36/71) with AKI had eGFR primitive to CKD stage 2, while 18.3% (n = 13/71) and 4.2% (n = 3/71) patients had eGFR corresponding to advanced stages of CKD (stage 3 & 4). Factors such as renal insufficiencies at hospital discharge, multiple organ involvements, advance age, female gender and diabetes mellitus were associated with poor renal outcomes. Conclusions We conclude that dengue patients with AKI portend unsatisfactory short-term renal outcomes and deserve a careful and longer follow-up, especially under nephrology care.	[Mallhi, Tauqeer Hussain] Govt Coll Univ Faisalabad, Fac Pharmaceut Sci, Dept Pharm Practice, Faisalabad, Pakistan; [Mallhi, Tauqeer Hussain; Khan, Amer Hayat; Sarriff, Azmi] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Adnan, Azreen Syazril] Univ Sains Malaysia, Sch Med Sci, Chron Kidney Dis Resource Ctr, Hlth Campus, Kubang Kerain, Kelantan, Malaysia; [Khan, Yusra Habib] Women Univ, Lahore Coll, Inst Pharmaceut Sci, Dept Pharm Practice, Lahore, Pakistan; [Gan, Siew Hua] Monash Univ Malaysia, Sch Pharm, Bandar Sunway, Malaysia	Government College University Faisalabad; Universiti Sains Malaysia; Universiti Sains Malaysia; Monash University; Monash University Sunway	Mallhi, TH (corresponding author), Govt Coll Univ Faisalabad, Fac Pharmaceut Sci, Dept Pharm Practice, Faisalabad, Pakistan.; Mallhi, TH; Khan, AH (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia.	tauqeer.hussain.mallhi@hotmali.com; dramer2006@gmail.com	Khan, Yusra Habib/AFK-9024-2022; Khan, Amer Hayat/O-5310-2018; gan, siew hua/A-6266-2011; Mallhi, Tauqeer Hussain/W-5155-2017	Khan, Yusra Habib/0000-0002-9479-6147; Khan, Amer Hayat/0000-0003-4802-6181; gan, siew hua/0000-0001-6470-3651; Mallhi, Tauqeer Hussain/0000-0001-9957-5362				Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Bagshaw SM, 2006, CURR OPIN CRIT CARE, V12, P544; Basu G, 2011, NEPHROL DIAL TRANSPL, V26, P524, DOI 10.1093/ndt/gfq477; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Goldstein SL, 2014, CRIT CARE, V18, DOI 10.1186/cc13180; Herath Nalaka J, 2014, BMC Res Notes, V7, P398, DOI 10.1186/1756-0500-7-398; Hoste EAJ, 2006, CURR OPIN CRIT CARE, V12, P531, DOI 10.1097/MCC.0b013e3280102af7; Kashani K, 2015, CURR OPIN NEPHROL HY, V24, P21, DOI 10.1097/MNH.0000000000000090; Khalil MAM, 2012, CLIN KIDNEY J, V5, P390, DOI 10.1093/ckj/sfs117; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kularatne S. A. M., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P686; Kumar V, 2015, RENAL INVOLVEMENT TR; Kuo MC, 2008, CLIN J AM SOC NEPHRO, V3, P1350, DOI 10.2215/CJN.00020108; Kute V B, 2012, Indian J Nephrol, V22, P33, DOI 10.4103/0971-4065.83737; Laoprasopwattana K, 2010, J PEDIATR-US, V157, P303, DOI 10.1016/j.jpeds.2010.02.008; Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149; Lee K., AM J TROP MED HYG, V80, P651; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Macedo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036388; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; Magden K, 2013, HIPPOKRATIA, V17, P239; Mallhi TH, 2016, POSTGRAD MED J, V92, P78, DOI 10.1136/postgradmedj-2015-133582; Mallhi TH, 2015, JCPSP-J COLL PHYSICI, V25, P828, DOI 11.2015/JCPSP.828834; Mallhi TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138465; Mallhi TH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1141-3; Mehra N, 2012, TROP DOCT, V42, P160, DOI 10.1258/td.2012.120023; Nejat M, 2012, KIDNEY INT, V81, P1254, DOI 10.1038/ki.2012.23; Pannu N, 2013, CLIN J AM SOC NEPHRO, V8, P194, DOI 10.2215/CJN.06480612; Oliveira JFP, 2015, CLIN KIDNEY J, V8, P681, DOI 10.1093/ckj/sfv106; Pôncio Luana, 2015, Braz. J. Nephrol., V37, P115, DOI 10.5935/0101-2800.20150016; Sawhney S, 2015, BMJ OPEN, V5; Schetz M, 2015, INTENS CARE MED, V41, P1648, DOI 10.1007/s00134-015-3946-3; Schetz M, 2014, INTENS CARE MED, V40, P1709, DOI 10.1007/s00134-014-3487-1; Schortgen F, 2015, INTENS CARE MED, V41, P1993, DOI 10.1007/s00134-015-4033-5; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; WHO/SEARO, 2011, COMPR GUID PREV CONT	36	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0192510	10.1371/journal.pone.0192510	http://dx.doi.org/10.1371/journal.pone.0192510			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481564	Green Published, gold, Green Submitted			2022-12-27	WOS:000426202700004
J	Kaida, K; Abe, T				Kaida, Kosuke; Abe, Takashi			Attentional lapses are reduced by repeated stimuli having own-name during a monotonous task	PLOS ONE			English	Article							PSYCHOMOTOR VIGILANCE PERFORMANCE; IN-CAR COUNTERMEASURES; DRIVER SLEEPINESS; OBJECTIVE PERFORMANCE; BRIGHT LIGHT; 20-MIN NAP; TEST PVT; ALERTNESS; NIGHT; SENSITIVITY	The goal of the present study was to examine the effect of listening to self-relevant words (i.e., one's own name) on vigilant attention, arousal, and subjective sleepiness during performance of a psychomotor vigilance test (PVT). Twenty-one participants aged 20-26 years (22.2 +/- 1.76) performed a PVT in four experimental conditions: one in which their own full name was pronounced every 20 s in the stimuli epochs, one in which their full name was pronounced in inverted form, one in which beeps were played, and a control condition with no stimuli. Listening to personal names reduced attentional lapses during the PVT (i.e., the number of reaction times no less than 500 ms). The results are a first step in applying the name effect to technologies and devices aimed at maintaining arousal levels and preventing accidents during a monotonous task, such as driving.	[Kaida, Kosuke; Abe, Takashi] Natl Inst Adv Ind Sci & Technol, Automot Human Factors Res Ctr, Tsukuba, Ibaraki, Japan; [Abe, Takashi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Kaida, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Automot Human Factors Res Ctr, Tsukuba, Ibaraki, Japan.	kaida.kosuke@aist.go.jp	Abe, Takashi/AAJ-9367-2020; Kaida, Kosuke/A-9979-2017	Abe, Takashi/0000-0002-4100-1427; Kaida, Kosuke/0000-0002-8975-4794	JSPS KAKENHI [16K13511]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from JSPS KAKENHI, Grant Number 16K13511 (http://www.jsps.go.jp/english/) to KK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Anund A, 2008, J SLEEP RES, V17, P16, DOI 10.1111/j.1365-2869.2008.00633.x; Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; BERLAD I, 1995, EVOKED POTENTIAL, V96, P472, DOI 10.1016/0168-5597(95)00116-A; Buckley RJ, 2016, CONSCIOUS COGN, V45, P174, DOI 10.1016/j.concog.2016.09.002; Carleton RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058067; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Dinges DF, 1997, SLEEP, V20, P267; DRORY A, 1985, HUM FACTORS, V27, P201, DOI 10.1177/001872088502700207; Fan W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080289; Fischer T, 2008, J COGNITIVE NEUROSCI, V20, P1443, DOI 10.1162/jocn.2008.20101; Garbarino S, 2004, SLEEP, V27, P1295, DOI 10.1093/sleep/27.7.1295; Hayashi M, 1999, INT J PSYCHOPHYSIOL, V32, P173, DOI 10.1016/S0167-8760(99)00009-4; Hayashi M, 1998, PSYCHIAT CLIN NEUROS, V52, P203, DOI 10.1111/j.1440-1819.1998.tb01031.x; Horne J, 1999, OCCUP ENVIRON MED, V56, P289, DOI 10.1136/oem.56.5.289; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Horne JA, 2004, PSYCHOPHYSIOLOGY, V41, P161, DOI 10.1046/j.1469-8986.2003.00130.x; Horne JA, 1996, PSYCHOPHYSIOLOGY, V33, P306, DOI 10.1111/j.1469-8986.1996.tb00428.x; ISHIHARA K, 1986, JPN J PSYCHOL, V57, P87, DOI 10.4992/jjpsy.57.87; Johnson AJ, 2012, PHYSIOL BEHAV, V105, P815, DOI 10.1016/j.physbeh.2011.10.020; Kaida K, 2006, SLEEP, V29, P462, DOI 10.1093/sleep/29.4.462; Kaida K, 2007, CLIN NEUROPHYSIOL, V118, P1324, DOI 10.1016/j.clinph.2007.03.004; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Levin I, 2005, APPL PSYCHOLINGUIST, V26, P463, DOI 10.1017/S0142716405050253; Matsumoto Y, 2002, NEUROSCI LETT, V326, P133, DOI 10.1016/S0304-3940(02)00335-X; Maycock G, 1996, J SLEEP RES, V5, P229, DOI 10.1111/j.1365-2869.1996.00229.x; McVay JC, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00570; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Oron-Gilad T, 2008, ACCIDENT ANAL PREV, V40, P851, DOI 10.1016/j.aap.2007.09.026; Peiris MTR, 2006, J SLEEP RES, V15, P291, DOI 10.1111/j.1365-2869.2006.00545.x; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Pfaff D, 2008, ANN NY ACAD SCI, V1129, P11, DOI 10.1196/annals.1417.019; Phipps-Nelson J, 2003, SLEEP, V26, P695, DOI 10.1093/sleep/26.6.695; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reyner LA, 1998, SLEEP, V21, P46; Reyner LA, 1997, PSYCHOPHYSIOLOGY, V34, P721, DOI 10.1111/j.1469-8986.1997.tb02148.x; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schmidt EA, 2009, ACCIDENT ANAL PREV, V41, P1087, DOI 10.1016/j.aap.2009.06.007; Schwarz JFA, 2012, J SLEEP RES, V21, P595, DOI 10.1111/j.1365-2869.2012.01009.x; Shapiro KL, 1997, J EXP PSYCHOL HUMAN, V23, P504, DOI 10.1037/0096-1523.23.2.504; Stawarczyk D, 2014, ACTA PSYCHOL, V148, P25, DOI 10.1016/j.actpsy.2014.01.007; Tacikowski P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00194; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Zhao K, 2009, NEUROSCI LETT, V464, P57, DOI 10.1016/j.neulet.2009.07.017; Zhou X, 2012, J SLEEP RES, V21, P40, DOI 10.1111/j.1365-2869.2011.00924.x	48	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0194065	10.1371/journal.pone.0194065	http://dx.doi.org/10.1371/journal.pone.0194065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513737	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800099
J	Mao, G; Srivastava, AS; Wu, SY; Kosek, D; Lindell, M; Kirsebom, LA				Mao, Guanzhong; Srivastava, Abhishek S.; Wu, Shiying; Kosek, David; Lindell, Magnus; Kirsebom, Leif A.			Critical domain interactions for type A RNase P RNA catalysis with and without the specificity domain	PLOS ONE			English	Article							CLEAVAGE-SITE SELECTION; METAL-ION BINDING; RIBONUCLEASE-P; ESCHERICHIA-COLI; MEDIATED CLEAVAGE; FUNCTIONAL RECONSTITUTION; PROTEIN COFACTORS; SUBSTRATE; RIBOZYME; ARCHITECTURE	The natural trans-acting ribozyme RNase P RNA (RPR) is composed of two domains in which the catalytic (C-) domain mediates cleavage of various substrates. The C-domain alone, after removal of the second specificity (S-) domain, catalyzes this reaction as well, albeit with reduced efficiency. Here we provide experimental evidence indicating that efficient cleavage mediated by the Escherichia coli C-domain (Eco CP RPR) with and without the C5 protein likely depends on an interaction referred to as the "P6-mimic". Moreover, the P18 helix connects the C-and S-domains between its loop and the P8 helix in the S-domain (the P8/P18-interaction). In contrast to the "P6-mimic", the presence of P18 does not contribute to the catalytic performance by the C-domain lacking the S-domain in cleavage of an all ribo model hairpin loop substrate while deletion or disruption of the P8/P18-interaction in full-size RPR lowers the catalytic efficiency in cleavage of the same model hairpin loop substrate in keeping with previously reported data using precursor tRNAs. Consistent with that P18 is not required for cleavage mediated by the C-domain we show that the archaeal Pyrococcus furiosus RPR C-domain, which lacks the P18 helix, is catalytically active in trans without the S-domain and any protein. Our data also suggest that the S-domain has a larger impact on catalysis for E. coli RPR compared to P. furiosus RPR. Finally, we provide data indicating that the absence of the S-domain and P18, or the P8/P18-interaction in full-length RPR influences the charge distribution near the cleavage site in the RPR-substrate complex to a small but reproducible extent.	[Mao, Guanzhong; Srivastava, Abhishek S.; Wu, Shiying; Kosek, David; Lindell, Magnus; Kirsebom, Leif A.] Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden; [Srivastava, Abhishek S.] AstraZeneca R&D, Discovery Sci, Cambridge Sci Pk, Cambridge, England	AstraZeneca	Kirsebom, LA (corresponding author), Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden.	Leif.Kirsebom@icm.uu.se		, Leif/0000-0002-5092-512X; Kosek, David/0000-0002-0192-4761	Swedish Research Council (N/T) [621-2011-5848, 2016-04602]; Uppsala RNA Research Center (Swedish Research Council Linneus support) [349-2008-6593]; Carl Tryggers Foundation for Research [CTS 12:240]; Swedish Research Council (N/T); Uppsala RNA Research Center (Swedish Research Council Linneus support); Carl Tryggers Foundation for Research	Swedish Research Council (N/T)(Swedish Research Council); Uppsala RNA Research Center (Swedish Research Council Linneus support); Carl Tryggers Foundation for Research; Swedish Research Council (N/T)(Swedish Research Council); Uppsala RNA Research Center (Swedish Research Council Linneus support); Carl Tryggers Foundation for Research	This work was supported by the Swedish Research Council (N/T), Grant numbers 621-2011-5848 and 2016-04602, Uppsala RNA Research Center (Swedish Research Council Linneus support), Grant number 349-2008-6593 and the Carl Tryggers Foundation for Research Grant number CTS 12:240. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our colleagues for discussions throughout this work. Dr V. Gopalan and Ms T. Bergfors are acknowledged for critical reading of the manuscript. We thank Dr A. C. Forster for discussions about the title. This work was supported by the Swedish Research Council (N/T), Uppsala RNA Research Center (Swedish Research Council Linneus support) and the Carl Tryggers Foundation for Research. LAK is a shareholder in Bioimics AB.	Brannvall M, 2007, J MOL BIOL, V372, P1149, DOI 10.1016/j.jmb.2007.07.030; Brannvall M, 2004, NUCLEIC ACIDS RES, V32, P5418, DOI 10.1093/nar/gkh883; Brannvall M, 1999, J MOL BIOL, V292, P53, DOI 10.1006/jmbi.1999.3048; Brannvall M, 2001, P NATL ACAD SCI USA, V98, P12943, DOI 10.1073/pnas.221456598; Brown JW, 1999, NUCLEIC ACIDS RES, V27, P314, DOI 10.1093/nar/27.1.314; Chan PP, 2012, RNA BIOL, V9, P1155, DOI 10.4161/rna.21502; Chen WY, 2010, NUCLEIC ACIDS RES, V38, P8316, DOI 10.1093/nar/gkq668; Cho IM, 2010, P NATL ACAD SCI USA, V107, P14573, DOI 10.1073/pnas.1005556107; Christian EL, 2006, RNA, V12, P1463, DOI 10.1261/rna.158606; CIESIOLKA J, 1994, EUR J BIOCHEM, V219, P49, DOI 10.1111/j.1432-1033.1994.tb19913.x; DOWD JE, 1965, J BIOL CHEM, V240, P863; Feltens R, 2003, P NATL ACAD SCI USA, V100, P5724, DOI 10.1073/pnas.0931462100; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Green CJ, 1996, NUCLEIC ACIDS RES, V24, P1497, DOI 10.1093/nar/24.8.1497; GUERRIERTAKADA C, 1992, P NATL ACAD SCI USA, V89, P1266, DOI 10.1073/pnas.89.4.1266; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Haas ES, 1998, NUCLEIC ACIDS RES, V26, P4093, DOI 10.1093/nar/26.18.4093; HAAS ES, 1994, P NATL ACAD SCI USA, V91, P2527, DOI 10.1073/pnas.91.7.2527; HAAS ES, 1991, SCIENCE, V254, P853, DOI 10.1126/science.1719634; Hardt WD, 1996, J MOL BIOL, V259, P422, DOI 10.1006/jmbi.1996.0329; Hofstee BHJ., 1952, EVALUATION CONSTANTS; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Kikovska E, 2006, J MOL BIOL, V359, P572, DOI 10.1016/j.jmb.2006.03.040; Kikovska E, 2012, NUCLEIC ACIDS RES, V40, P2224, DOI 10.1093/nar/gkr1001; KIRSEBOM LA, 1994, EMBO J, V13, P4870, DOI 10.1002/j.1460-2075.1994.tb06814.x; Kirsebom LA, 2007, BIOCHIMIE, V89, P1183, DOI 10.1016/j.biochi.2007.05.009; Krummel DAP, 1999, P NATL ACAD SCI USA, V96, P11200, DOI 10.1073/pnas.96.20.11200; Kufel J, 1996, J MOL BIOL, V263, P685, DOI 10.1006/jmbi.1996.0608; Kufel J, 1998, RNA, V4, P777, DOI 10.1017/S1355838298970923; Lai LB, 2010, P NATL ACAD SCI USA, V107, P22493, DOI 10.1073/pnas.1013969107; Lai LB, 2010, FEBS LETT, V584, P287, DOI 10.1016/j.febslet.2009.11.048; Li D, 2011, CHEMBIOCHEM, V12, P1536, DOI 10.1002/cbic.201100054; Li D, 2009, NUCLEIC ACIDS RES, V37, P231, DOI 10.1093/nar/gkn915; Loria A, 1999, BIOCHEMISTRY-US, V38, P8612, DOI 10.1021/bi990691f; Marszalkowski M, 2008, RNA, V14, P127, DOI 10.1261/rna.762508; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Persson T, 2003, J BIOL CHEM, V278, P43394, DOI 10.1074/jbc.M305939200; Pulukkunat DK, 2008, NUCLEIC ACIDS RES, V36, P4172, DOI 10.1093/nar/gkn360; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; SCHLEGL J, 1994, EMBO J, V13, P4863, DOI 10.1002/j.1460-2075.1994.tb06813.x; Sinapah S, 2011, NUCLEIC ACIDS RES, V39, P1105, DOI 10.1093/nar/gkq732; Stage-Zimmermann TK, 1998, RNA, V4, P875, DOI 10.1017/S1355838298980876; Tsai HY, 2006, P NATL ACAD SCI USA, V103, P16147, DOI 10.1073/pnas.0608000103; VIOQUE A, 1988, J MOL BIOL, V202, P835, DOI 10.1016/0022-2836(88)90562-1; Walczyk D, 2016, RNA, V22, P1699, DOI 10.1261/rna.057422.116; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Wu SY, 2014, NUCLEIC ACIDS RES, V42, P631, DOI 10.1093/nar/gkt853; Wu SY, 2012, J MOL BIOL, V422, P204, DOI 10.1016/j.jmb.2012.05.020; Wu SY, 2011, J MOL BIOL, V411, P384, DOI 10.1016/j.jmb.2011.05.049; Zahler NH, 2005, J MOL BIOL, V345, P969, DOI 10.1016/j.jmb.2004.10.080; 2010, PROTEIN REVIEWS, V10, P1	55	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0192873	10.1371/journal.pone.0192873	http://dx.doi.org/10.1371/journal.pone.0192873			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509761	gold, Green Published, Green Submitted			2022-12-27	WOS:000426813200007
J	Fisher, JRB; Montambault, J; Burford, KP; Gopalakrishna, T; Masuda, YJ; Reddy, SMW; Torphy, K; Salcedo, AI				Fisher, Jonathan R. B.; Montambault, Jensen; Burford, Kyle P.; Gopalakrishna, Trisha; Masuda, Yuta J.; Reddy, Sheila M. W.; Torphy, Kaitlin; Salcedo, Andrea I.			Knowledge diffusion within a large conservation organization and beyond	PLOS ONE			English	Article							PUBLIC-GOODS GAME; BIODIVERSITY-CONSERVATION; INNOVATION; NETWORKS; COOPERATION; CONTAGION; EXAMPLE; GROWTH; FIRMS; SIZE	The spread and uptake of new ideas (diffusion of innovations) is critical for organizations to adapt over time, but there is little evidence of how this happens within organizations and to their broader community. To address this, we analyzed how individuals accessed information about a recent science innovation at a large, international, biodiversity conservation non-profit-The Nature Conservancy-and then traced the flow of how this information was shared within the organization and externally, drawing on an exceptionally data-rich environment. We used surveys and tracking of individual internet activity to understand mechanisms for early-stage diffusion (knowledge seeking and sharing) following the integration of social science and evidence principles into the institutional planning framework: Conservation by Design (CbD 2.0). Communications sent to all employees effectively catalyzed 56.4% to exhibit knowledge seeking behavior, measured by individual downloads from and visits to a restricted-access site. Individuals who self-reported through a survey that they shared information about CbD 2.0 internally were more likely to have both received and sought out information about the framework. Such individuals tended to hold positions within a higher job grade, were more likely to train others on CbD as part of their job, and to enroll in other online professional development offerings. Communication strategies targeting external audiences did not appear to influence information seeking behavior. Staff who engaged in internal knowledge sharing and adopting "evidence" practices from CbD 2.0 were more likely to have shared the document externally. We found a negative correlation with external sharing behavior and in-person trainings. Our findings suggest repeated, direct email communications aimed at wide audiences can effectively promote diffusion of new ideas. We also found a wide range of employee characteristics and circumstances to be associated with knowledge diffusion behavior (at both an organizational and individual level).	[Fisher, Jonathan R. B.; Montambault, Jensen; Burford, Kyle P.; Gopalakrishna, Trisha; Masuda, Yuta J.; Reddy, Sheila M. W.] Nature Conservancy, 1815 N Lynn St, Arlington, VA 22209 USA; [Torphy, Kaitlin] Michigan State Univ, Coll Educ, E Lansing, MI 48824 USA; [Salcedo, Andrea I.] Nature Conservancy, Quito, Ecuador	Nature Conservancy; Michigan State University	Fisher, JRB (corresponding author), Nature Conservancy, 1815 N Lynn St, Arlington, VA 22209 USA.	jon_fisher@tnc.org		Fisher, Jonathan/0000-0001-5094-9730	David and Lucile Packard Foundation [2014-40349]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	Our sincere thanks to the David and Lucile Packard Foundation (Grant #2014-40349) (JM) for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CHALLENGES DEMOCRATI; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Armsworth PR, 2012, BIOSCIENCE, V62, P271, DOI 10.1525/bio.2012.62.3.8; Atwell RC, 2009, ECOL SOC, V14; Bock G. -W., 2001, PACIS 2001 P; Bremer LL, 2016, ECOSYST SERV, V17, P217, DOI 10.1016/j.ecoser.2015.12.006; CCNet (Conservation Coaches Network), 2010, CONS COACH NETW E NE; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Collins CJ, 2006, ACAD MANAGE J, V49, P544, DOI 10.5465/AMJ.2006.21794671; Conservation Measures Partnership (CMP), 2016, CONS MEAS PARTN MEMB; CONSTANT D, 1994, INFORM SYST RES, V5, P400, DOI 10.1287/isre.5.4.400; Coriat B, 2002, RES POLICY, V31, P273, DOI 10.1016/S0048-7333(01)00141-X; Ernst D, 2002, RES POLICY, V31, P1417, DOI 10.1016/S0048-7333(02)00072-0; Frank KA, 2013, AM J SOCIOL, V119, P216, DOI 10.1086/672081; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Groves CR, 2002, BIOSCIENCE, V52, P499, DOI 10.1641/0006-3568(2002)052[0499:PFBCPC]2.0.CO;2; Hansen MT, 1999, ADMIN SCI QUART, V44, P82, DOI 10.2307/2667032; Hustad Eli, 2012, Electronic Journal of Knowledge Management, V10, P121; Korhonen K, 2013, FOREST POLICY ECON, V26, P82, DOI 10.1016/j.forpol.2012.08.010; Levin D. Z., 2002, ACAD MANAGEMENT P, V2002, pD1; Meade N, 2006, INT J FORECASTING, V22, P519, DOI 10.1016/j.ijforecast.2006.01.005; Melo S, 2015, HUM RESOUR DEV Q, V26, P155, DOI 10.1002/hrdq.21207; NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14; Padel S, 2001, SOCIOL RURALIS, V41, P40, DOI 10.1111/1467-9523.00169; Perey R, 2015, ORGAN ENVIRON, V28, P458, DOI 10.1177/1086026615621110; Poiani KA, 1998, LANDSCAPE URBAN PLAN, V43, P143, DOI 10.1016/S0169-2046(97)00086-8; Rogers EM., 1983, DIFFUSION INNOVATION; Schumpeter J. A., 1934, THE THEORY OF ECONOM; Schwartz MW, 2012, BIOL CONSERV, V155, P169, DOI 10.1016/j.biocon.2012.06.014; Singh J, 2005, MANAGE SCI, V51, P756, DOI 10.1287/mnsc.1040.0349; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; Team RC., 2022, LANG ENV STAT COMP; The Nature Conservancy, 2016, CONSERVATION DESIGN; Valente T W, 1995, Sci Commun, V16, P242, DOI 10.1177/1075547095016003002; van Kerkhoff L, 2010, P NAT AC SCI USA, P1; Wang CJ, 2017, APPL MATH COMPUT, V293, P18, DOI 10.1016/j.amc.2016.06.026; Young HP, 2009, AM ECON REV, V99, P1899, DOI 10.1257/aer.99.5.1899; Zakaria N., 2004, CREATIVITY INNOVATIO, V13, P15, DOI [10.1111/j.1467-8691.2004.00290.x, DOI 10.1111/J.1467-8691.2004.00290.X]	38	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193716	10.1371/journal.pone.0193716	http://dx.doi.org/10.1371/journal.pone.0193716			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494644	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200088
J	Pokhrel, V; DeLisi, NA; Danka, RG; Walker, TW; Ottea, JA; Healy, KB				Pokhrel, Vivek; DeLisi, Nicholas A.; Danka, Robert G.; Walker, Todd W.; Ottea, James A.; Healy, Kristen B.			Effects of truck-mounted, ultra low volume mosquito adulticides on honey bees (Apis mellifera) in a suburban field setting	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; NOZZLE SYSTEM; INSECTICIDE; EXPOSURE; HYMENOPTERA; APIDAE; PRODUCTIVITY; PYRETHROIDS; POPULATIONS; PESTICIDES	Few studies have examined the impact of mosquito adulticides on honey bees under conditions that reflect actual field exposure. Whereas several studies have evaluated the toxicity of mosquito control products on honey bees, most have been laboratory based and have focused solely on acute mortality as a measure of impact. The goal of this study was to determine effects of routine applications of truck-based ultra-low volume ( ULV) mosquito adulticides ( i.e., Scourge, Duet, and Deltagard) on honey bees in a suburban setting. The mosquito adulticides used in this study were pyrethroids with active ingredients resmethrin ( Scourge), prallethrin and sumithrin ( Duet), and deltamethrin ( Deltagard), in which resmethrin, prallethrin, and sumithrin were synergized with piperonyl butoxide. We measured and compared mortality and detoxification enzyme activities ( esterase and glutathione S-transferase) from sentinel beehives within and outside of mosquito control areas. Concurrently, colony health ( i.e., number of adult bees, brood quantity and brood quality) was compared throughout the study period. No significant differences were observed in honey bee mortality, colony health or detoxification enzyme activities between treated ( five sprayed areas each received one to three insecticide treatment) and control sites ( four unsprayed areas that did not receive insecticide treatment) over the seven week study period. However, our laboratory study showed that exposure to resmethrin, the active ingredient in Scourge, caused significant inhibition of esterase activity compared with the control group. Our findings suggest that proper application of truck based insecticides for mosquito control results in little or no exposure and therefore minimal effects on domestic honey bees.	[Pokhrel, Vivek; Ottea, James A.; Healy, Kristen B.] Louisiana State Univ, Agr Ctr, Dept Entomol, Baton Rouge, LA 70803 USA; [DeLisi, Nicholas A.] St Tammany Parish Mosquito Abatement Dist, Slidell, LA USA; [Danka, Robert G.] USDA ARS, Honey Bee Breeding Genet & Physiol Lab, Baton Rouge, LA USA; [Walker, Todd W.] East Baton Rouge Parish Mosquito Abatement & Rode, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA)	Pokhrel, V (corresponding author), Louisiana State Univ, Agr Ctr, Dept Entomol, Baton Rouge, LA 70803 USA.	vpokhr1@lsu.edu		Healy, Kristen/0000-0002-3208-6537	US Environmental Protection Agency (EPA) [83558201]; Louisiana State University Agricultural Center	US Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Louisiana State University Agricultural Center	This work was funded by a grant from the US Environmental Protection Agency to assess the effects of mosquito adulticides on honey bees (EPA Grant#83558201 to KBH, TWW, and JAO) and by the Louisiana State University Agricultural Center. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaleke J, 2009, PEST MANAG SCI, V65, P1147, DOI 10.1002/ps.1807; Atkins E, P PAP ANN C CAL MOSQ; Badawy MEI, 2015, APIDOLOGIE, V46, P177, DOI 10.1007/s13592-014-0315-0; Badiou-Beneteau A, 2012, ECOTOX ENVIRON SAFE, V82, P22, DOI 10.1016/j.ecoenv.2012.05.005; Bisset JA, 2013, J MED ENTOMOL, V50, P352, DOI 10.1603/ME12064; BOOTH J, 1961, BIOCHEM J, V79, P516, DOI 10.1042/bj0790516; Boyce WM, 2007, J AM MOSQUITO CONTR, V23, P335, DOI 10.2987/8756-971X(2007)23[335:NEOTMA]2.0.CO;2; BOYER TD, 1989, HEPATOLOGY, V9, P486, DOI 10.1002/hep.1840090324; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGETT M, 1985, J ECON ENTOMOL, V78, P1154, DOI 10.1093/jee/78.5.1154; CARON DM, 1979, J ECON ENTOMOL, V72, P148, DOI 10.1093/jee/72.1.148; Carvalho RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062268; Carvalho SM, 2013, ENVIRON TOXICOL CHEM, V32, P2117, DOI 10.1002/etc.2288; Chaskopoulou A, 2014, J MED ENTOMOL, V51, P720, DOI 10.1603/ME13242; Colburn R, 1970, MOSQUITO NEWS, V30; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Dauterman W., 1976, INSECTICIDE BIOCH PH, P149; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ding YC, 2005, BIOCHEM J, V387, P879, DOI 10.1042/BJ20041850; Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181; GOMORI G, 1952, INT REV CYTOL, V1, P323, DOI 10.1016/S0074-7696(08)60016-9; GRANT DF, 1989, INSECT BIOCHEM, V19, P741, DOI 10.1016/0020-1790(89)90055-3; Hashimoto JH, 2003, SOCIOBIOL, V42; Hendriksma HP, 2010, J APICULT RES, V49, P215, DOI 10.3896/IBRA.1.49.2.13; Hester PG, 2001, J AM MOSQUITO CONTR, V17, P2; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; LOUCIF-AYAD W, 2008, EUR J SCI RES, V21, P642; Lu CS, 2014, B INSECTOL, V67, P125; Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305; Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; PANKIW T, 1992, J ECON ENTOMOL, V85, P687, DOI 10.1093/jee/85.3.687; Rinkevich FD, 2017, B ENTOMOL RES, P1; Rumpf S, 1997, J ECON ENTOMOL, V90, P102, DOI 10.1093/jee/90.1.102; Sanchez- Bayo F, 2017, ENV RISK ASSESSMENT; Seeley T. D., 2009, WISDOM HIVE SOCIAL P; Stark J, 2005, DECIS ENG, P1; Steinhauer N, COLONY LOSS 2014 201, P26; TERRIERE LC, 1984, ANNU REV ENTOMOL, V29, P71, DOI 10.1146/annurev.en.29.010184.000443; Tew J., 1998, ALABAMA A M U AUBURN; VANASPEREN K, 1962, J INSECT PHYSIOL, V8, P401, DOI 10.1016/0022-1910(62)90074-4; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Womeldorf D.J., 1974, California Vector Views, V21, P51; Zhong H, 2004, J ECON ENTOMOL, V97, P1, DOI 10.1603/0022-0493-97.1.1; Zhong H, 2003, ARCH ENVIRON CON TOX, V45, P216, DOI 10.1007/s00244-002-0185-8	46	6	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193535	10.1371/journal.pone.0193535	http://dx.doi.org/10.1371/journal.pone.0193535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494661	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200062
J	Singh, M; Toribio, JA; Scott, AB; Groves, P; Barnes, B; Glass, K; Moloney, B; Black, A; Hernandez-Jover, M				Singh, Mini; Toribio, Jenny-Ann; Scott, Angela Bullanday; Groves, Peter; Barnes, Belinda; Glass, Kathryn; Moloney, Barbara; Black, Amanda; Hernandez-Jover, Marta			Assessing the probability of introduction and spread of avian influenza (AI) virus in commercial Australian poultry operations using an expert opinion elicitation	PLOS ONE			English	Article							HIGH-PATHOGENICITY; WILD BIRDS; CHICKENS; OUTBREAK; SURVEILLANCE; H5N1; EPIDEMIOLOGY; TRANSMISSION; FARMS; WATER	The objective of this study was to elicit experts' opinions and gather estimates on the perceived probability of introduction and spread of avian influenza (AI) virus in the Australian broiler and layer industry. Using a modified Delphi method and a 4-step elicitation process, 11 experts were asked to give initial individual estimates for the various pathways and practices in the presented scenarios using a questionnaire. Following this, a workshop was conducted to present group averages of estimates and discussion was facilitated to obtain final individual estimates. For each question, estimates for all experts were combined using a discrete distribution, with weights allocated representing the level of expertise. Indirect contact with wild birds either via a contaminated water source or fomites was considered the most likely pathway of introduction of low pathogenic avian influenza (LPAI) on poultry farms. Presence of a water body near the poultry farm was considered a potential pathway for introduction only when the operation type was free range and the water body was within 500m distance from the shed. The probability that LPAI will mutate to highly pathogenic avian influenza (HPAI) was considered to be higher in layer farms. Shared personnel, equipment and aerosol dispersion were the most likely pathways of shed to shed spread of the virus. For LPAI and HPAI spread from farm to farm, shared pick-up trucks for broiler and shared egg trays and egg pallets for layer farms were considered the most likely pathways. Findings from this study provide an insight on most influential practices on the introduction and spread of AI virus among commercial poultry farms in Australia, as elicited from opinions of experts. These findings will be used to support parameterization of a modelling study assessing the risk of AI introduction and spread among commercial poultry farms in Australia.	[Singh, Mini; Toribio, Jenny-Ann; Scott, Angela Bullanday; Groves, Peter] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia; [Barnes, Belinda] Dept Agr & Water Resources, Quantitat Sci, Canberra, ACT, Australia; [Glass, Kathryn] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia; [Moloney, Barbara] NSW Dept Primary Ind, Orange, NSW, Australia; [Black, Amanda] NSW Dept Primary Ind, Menangle, NSW, Australia; [Hernandez-Jover, Marta] Charles Sturt Univ, Graham Ctr Agr Innovat, Locked Bag 588, Wagga Wagga, NSW, Australia; [Hernandez-Jover, Marta] Charles Sturt Univ, Sch Anim & Vet Sci, NSW Dept Primary Ind, Locked Bag 588, Wagga Wagga, NSW, Australia; [Hernandez-Jover, Marta] Charles Sturt Univ, Sch Anim & Vet Sci, Locked Bag 588, Wagga Wagga, NSW, Australia	University of Sydney; Australian National University; NSW Department of Primary Industries; NSW Department of Primary Industries; Charles Sturt University; Charles Sturt University; NSW Department of Primary Industries; Charles Sturt University	Singh, M (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia.	mini.singh@sydney.edu.au	Hernandez-Jover, Marta/F-8688-2016; Toribio, Jenny-Ann LML/B-5032-2011; Singh, Mini/AAE-5906-2019; Moloney, Barbara Jean/G-2003-2011	Moloney, Barbara Jean/0000-0002-4416-3579; Groves, Peter/0000-0002-8984-3156; Glass, Kathryn/0000-0001-5905-1310; Barnes, Belinda/0000-0003-3295-4063; Hernandez-Jover, Marta/0000-0001-8803-9062	Poultry Cooperative Research Centre (CRC) [1.5.7]; Woolworths Limited; Poultry CRC; Woolworths; Australian Government's Cooperative Research Centers Program	Poultry Cooperative Research Centre (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Woolworths Limited; Poultry CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Woolworths; Australian Government's Cooperative Research Centers Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This study was supported by Poultry Cooperative Research Centre (CRC), (Grant no: 1.5.7) and Woolworths Limited, https.//www.woolworths.com.au/. The Poultry CRC provided the majority of funding for this project included postdoc activities and a stipend for the PhD student, while Woolworths provided additional financial support for the project and a top up to the stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was conducted within the Poultry CRC, established and supported under the Australian Government's Cooperative Research Centers Program. The authors would also like to acknowledge financial support by Woolworths Limited. Finally, the authors would like to thank all the experts who participated in this study.	Adegboye OA, 2014, EPIDEMIOL INFECT, V142, P940, DOI 10.1017/S0950268813002136; AECL, 2016, AUSTR EGG CORP LTD A; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Arzey G, 2005, AUST VET J, V83, P445, DOI 10.1111/j.1751-0813.2005.tb13090.x; Australia B, 2002, IMP FRESH BAN PHIL D; Bano S, 2003, AVIAN DIS, V47, P817, DOI 10.1637/0005-2086-47.s3.817; Bataille A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002094; Berhane Y, 2010, AVIAN DIS, V54, P1275, DOI 10.1637/9422-061410-Reg.1; Berhane Y, 2009, EMERG INFECT DIS, V15, P1492, DOI 10.3201/eid1509.080231; Bos MEH, 2007, VET RES, V38, P493, DOI 10.1051/vetres:2007008; Bowes VA, 2004, AVIAN DIS, V48, P928, DOI 10.1637/7218-060304R; Comin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035956; de Jong MCM, 2009, REV SCI TECH OIE, V28, P333; Dunn PA, 2003, AVIAN DIS, V47, P812, DOI 10.1637/0005-2086-47.s3.812; Edmunds KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072279; Fusaro A, 2016, J VIROLOGY; Gigerenzer G., 2002, RECKONING RISK LEARN; Gonzales JL, 2014, PREV VET MED, V117, P251, DOI 10.1016/j.prevetmed.2014.08.015; Grillo VL, 2015, AUST VET J, V93, P387, DOI 10.1111/avj.12379; Guerrini L, 2014, GEOSPATIAL HEALTH, V8, P445, DOI 10.4081/gh.2014.33; Haase M, 2010, INFECT GENET EVOL, V10, P1075, DOI 10.1016/j.meegid.2010.07.005; Hamilton SA, 2009, AUST VET J, V87, P165, DOI 10.1111/j.1751-0813.2009.00423.x; Hamilton SE., 2011, IMPACT SHRIMP FARMIN; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Haynes L, 2009, AUST VET J, V87, P266, DOI 10.1111/j.1751-0813.2009.00446.x; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Hernandez-Jover M, 2015, PREV VET MED, V118, P128, DOI 10.1016/j.prevetmed.2014.11.018; Hop GE, 2010, PREV VET MED, V97, P270, DOI 10.1016/j.prevetmed.2010.09.016; Jeong J, 2014, VET MICROBIOL, V173, P249, DOI 10.1016/j.vetmic.2014.08.002; Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011; Kapczynski DR, 2013, J VIROL, V87, P9086, DOI 10.1128/JVI.00666-13; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kuster K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144533; Marangon S, 2006, DEV BIOLOGICALS, V124, P109; Marche S, 2014, TRANSBOUND EMERG DIS, V61, P526, DOI 10.1111/tbed.12056; MARKWELL DD, 1982, APPL ENVIRON MICROB, V43, P110, DOI 10.1128/AEM.43.1.110-115.1982; Nishiguchi A, 2005, REV SCI TECH OIE, V24, P933, DOI 10.20506/rst.24.3.1623; Nishiguchi A, 2009, J VET MED SCI, V71, P979, DOI 10.1292/jvms.71.979; Poolkhet C, 2013, RES VET SCI, V95, P82, DOI 10.1016/j.rvsc.2013.02.016; Rebel JMJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-10; Saito T, 2015, REV MED VIROL, V25, P388, DOI 10.1002/rmv.1857; Schaal T., 2016, AUSTR POULTR SCI S S, P190; Selleck PW, 2003, AVIAN DIS, V47, P806, DOI 10.1637/0005-2086-47.s3.806; Selleck PW, 1997, AUST VET J, V75, P289, DOI 10.1111/j.1751-0813.1997.tb10099.x; Shigematsu S, 2014, INFLUENZA OTHER RESP, V8, P123, DOI 10.1111/irv.12179; Shoham Dany, 2012, Influenza Res Treat, V2012, P912326, DOI 10.1155/2012/912326; Sims L.D., 2016, AVIAN INFLUENZA, DOI 10.1002/9781118924341.ch12; SIVANANDAN V, 1991, AVIAN DIS, V35, P974, DOI 10.2307/1591638; Spackman E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-331; Speirs-Bridge A, 2010, RISK ANAL, V30, P512, DOI 10.1111/j.1539-6924.2009.01337.x; Spickler AR, 2008, AVIAN PATHOL, V37, P555, DOI 10.1080/03079450802499118; Ssematimba A, 2013, PREV VET MED, V109, P106, DOI 10.1016/j.prevetmed.2012.09.001; Stebler N, 2015, PREV VET MED, V121, P165, DOI 10.1016/j.prevetmed.2015.05.006; Suarez D. L., 2008, AVIAN INFLUENZA, P3; Thomas ME, 2005, PREV VET MED, V69, P1, DOI 10.1016/j.prevetmed.2004.12.001; Vieira AR, 2009, AVIAN DIS, V53, P55, DOI 10.1637/8364-051608-Reg.1; Vose D., 2008, RISK ANAL QUANTITATI; Wakawa A. M., 2012, Sokoto Journal of Veterinary Sciences, V10, P40; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yoon H, 2005, J VET MED B, V52, P428, DOI 10.1111/j.1439-0450.2005.00891.x; Zhang HB, 2014, J GEN VIROL, V95, P1430, DOI 10.1099/vir.0.063438-0; Zhang HB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-42	63	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193730	10.1371/journal.pone.0193730	http://dx.doi.org/10.1371/journal.pone.0193730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494696	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200091
J	Chavez, G; Richman, IB; Kaimal, R; Bentley, J; Yasukawa, LA; Altman, RB; Periyakoil, VS; Chen, JH				Chavez, Gustavo; Richman, Ilana B.; Kaimal, Rajani; Bentley, Jason; Yasukawa, Lee Ann; Altman, Russ B.; Periyakoil, Vyjeyanthi S.; Chen, Jonathan H.			Reversals and limitations on high-intensity, life-sustaining treatments	PLOS ONE			English	Article							NOT-RESUSCITATE ORDERS; CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; LIVING WILLS; CARE; PREFERENCES; WITHDRAWAL; DECISIONS; OUTCOMES; DNR	Importance Critically ill patients often receive high-intensity life sustaining treatments (LST) in the intensive care unit (ICU), although they can be ineffective and eventually undesired. Determining the risk factors associated with reversals in LST goals can improve patient and provider appreciation for the natural history and epidemiology of critical care and inform decision making around the (continued) use of LSTs. Methods This is a single institution retrospective cohort study of patients receiving life sustaining treatment in an academic tertiary hospital from 2009 to 2013. Deidentified patient electronic medical record data was collected via the clinical data warehouse to study the outcomes of treatment limiting Comfort Care and do-not-resuscitate (DNR) orders. Extended multivariable Cox regression models were used to estimate the association of patient and clinical factors with subsequent treatment limiting orders. Results 10,157 patients received life-sustaining treatment while initially Full Code (allowing all resuscitative measures). Of these, 770 (8.0%) transitioned to Comfort Care (with discontinuation of any life-sustaining treatments) while 1,669 (16%) patients received new DNR orders that reflect preferences to limit further life-sustaining treatment options. Patients who were older (Hazard Ratio(HR) 1.37 [95% CI 1.28-1.47] per decade), with cerebrovascular disease (HR 2.18 [95% CI 1.69-2.81]), treated by the Medical ICU (HR 1.92 [95% CI 1.49-2.49]) and Hematology-Oncology (HR 1.87 [95% CI 1.27-2.74]) services, receiving vasoactive infusions (HR 1.76 [95% CI 1.28, 2.43]) or continuous renal replacement (HR 1.83 [95% CI 1.34, 2.48]) were more likely to transition to Comfort Care. Any new DNR orders were more likely for patients who were older (HR 1.43 [95% CI 1.38-1.48] per decade), female (HR 1.30 [95% CI 1.17-1.44]), with cerebrovascular disease (HR 1.45 [95% CI 1.25-1.67]) or metastatic solid cancers (HR 1.92 [95% CI 1.48-2.49]), or treated by Medical ICU (HR 1.63 [95% CI 1.42-1.86]), Hematology-Oncology (HR 1.63 [95% CI 1.33-1.98]) and Cardiac Care Unit-Heart Failure (HR 1.41 [95% CI 1.15-1.72]). Conclusion Decisions to reverse or limit treatment goals occurs after more than 1 in 13 trials of LST, and is associated with older female patients, receiving non-ventilator forms of LST, cerebrovascular disease, and treatment by certain medical specialty services.	[Chavez, Gustavo] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Richman, Ilana B.] Yale Med, Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Kaimal, Rajani; Bentley, Jason] Stanford Quantitat Sci, Stanford, CA USA; [Yasukawa, Lee Ann] Stanford Ctr Clin Informat, Stanford, CA USA; [Altman, Russ B.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Periyakoil, Vyjeyanthi S.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Periyakoil, Vyjeyanthi S.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Chen, Jonathan H.] Stanford Univ, Ctr Biomed Informat Res, Sch Med, Stanford, CA 94305 USA; [Chen, Jonathan H.] Stanford Univ, Dept Med, Sch Med, Div Hosp Med, Stanford, CA 94305 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University	Chen, JH (corresponding author), Stanford Univ, Ctr Biomed Informat Res, Sch Med, Stanford, CA 94305 USA.; Chen, JH (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Hosp Med, Stanford, CA 94305 USA.	jonc101@stanford.edu		Altman, Russ/0000-0003-3859-2905; Chen, Jonathan H./0000-0002-4387-8740	Stanford University School of Medicine Center of Excellence; Stanford University School of Medicine Medical Scholars Research Program; NIH Big Data 2 Knowledge Award through the National Institutes of Health and National Institute of Environmental Health Sciences [K01ES026837]; US Department of Veterans Affairs Office of Academic Affiliations and Health Services Research and Development Service Research Funds; Department of Veterans Affairs; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 RR025744];  [R25 MD006857];  [5U54MD010724]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES026837] Funding Source: NIH RePORTER	Stanford University School of Medicine Center of Excellence; Stanford University School of Medicine Medical Scholars Research Program; NIH Big Data 2 Knowledge Award through the National Institutes of Health and National Institute of Environmental Health Sciences; US Department of Veterans Affairs Office of Academic Affiliations and Health Services Research and Development Service Research Funds; Department of Veterans Affairs(US Department of Veterans Affairs); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Gustavo A. Chavez was supported by Stanford University School of Medicine Center of Excellence and Stanford University School of Medicine Medical Scholars Research Program. Jonathan H. Chen was supported by NIH Big Data 2 Knowledge Award Number K01ES026837 through the National Institutes of Health and National Institute of Environmental Health Sciences. Ilana Richman was supported by the US Department of Veterans Affairs Office of Academic Affiliations and Health Services Research and Development Service Research Funds. Vyjeyanthi S. Periyakoil's time is supported in part by grants R25 MD006857, 5U54MD010724 and the Department of Veterans Affairs. Patient data extracted and de-identified by Gomathi Krishnan and Lee Ann Yasukawa of the STRIDE (Stanford Translational Research Integrated Database Environment) project, a research and development project at Stanford University to create a standards-based informatics platform supporting clinical and translational research. The STRIDE project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grant UL1 RR025744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WG, 2011, J GEN INTERN MED, V26, P359, DOI 10.1007/s11606-010-1568-6; [Anonymous], 2011, METR TRANSP COMM GA; [Anonymous], 2015, DYING IN AMERICA IMP; Auriemma CL, 2014, JAMA INTERN MED, V174, P1085, DOI 10.1001/jamainternmed.2014.1183; Bailey FA, 2012, J PALLIAT MED, V15, P751, DOI 10.1089/jpm.2011.0321; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Boerner K, 2013, J GERONTOL B-PSYCHOL, V68, P246, DOI 10.1093/geronb/gbs161; Boyd K, 1996, ARCH INTERN MED, V156, P1821, DOI 10.1001/archinte.156.16.1821; Bureau UC, 2014, 2009 2013 5 YEAR AM; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; Diem SJ, 1996, NEW ENGL J MED, V334, P1578, DOI 10.1056/NEJM199606133342406; Downar J, 2011, J GEN INTERN MED, V26, P582, DOI 10.1007/s11606-010-1616-2; Einav S, 2012, EMERG MED J, V29, P709, DOI 10.1136/emermed-2011-200206; Elmer J, 2016, RESUSCITATION, V102, P127, DOI 10.1016/j.resuscitation.2016.01.016; Field M.J, 1997, APPROACHING DEATH IM; Frank C, 2003, CAN MED ASSOC J, V169, P795; Garland A, 2007, J PALLIAT MED, V10, P1298, DOI 10.1089/jpm.2007.0061; Goodlin SJ, JAMA, V282, P2333; Jawa RS, 2015, AM J SURG, V210, P814, DOI 10.1016/j.amjsurg.2015.04.007; Jayes RL, 1996, CHEST, V110, P1332, DOI 10.1378/chest.110.5.1332; Kelly WF, 2002, CHEST, V121, P957, DOI 10.1378/chest.121.3.957; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kostoulakos NM, 1997, PERCEPT MOTOR SKILL, V84, P1409, DOI 10.2466/pms.1997.84.3c.1409; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Love A, 2014, PALLIATIVE MED, V28, P1026, DOI 10.1177/0269216314531313; Lowe Henry J, 2009, AMIA Annu Symp Proc, V2009, P391; Mirarchi FL, 2007, J EMERG MED, V33, P299, DOI 10.1016/j.jemermed.2007.02.026; Mirarchi FL, 2015, J PATIENT SAF, V11, P1, DOI 10.1097/PTS.0000000000000165; Mirarchi FL, 2012, J EMERG MED, V42, P511, DOI 10.1016/j.jemermed.2011.07.015; Mirarchi FL, 2017, J PATIENT SAF, P1; Moore KA, 2016, JAMA-J AM MED ASSOC, V315, P259, DOI 10.1001/jama.2015.17362; Periyakoil VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098246; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rajan S, 2016, RESUSCITATION, V105, P45, DOI 10.1016/j.resuscitation.2016.05.004; Roberts D, 2000, AM J EMERG MED, V18, P465, DOI 10.1053/ajem.2000.7338; Siracuse JJ, 2015, ANN VASC SURG, V29, P1339, DOI 10.1016/j.avsg.2015.05.014; US Census, 2015, ED ATT US 2015; Van den Bulck Jan J M, 2002, Eur J Emerg Med, V9, P325; Zingmond DS, 2005, ARCH INTERN MED, V165, P1705, DOI 10.1001/archinte.165.15.1705	39	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0190569	10.1371/journal.pone.0190569	http://dx.doi.org/10.1371/journal.pone.0190569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489814	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000005
J	Zhang, MP; Zhao, ZJ; Duan, XL; Deng, T; Cai, C; Wu, WQ; Zeng, GH				Zhang, Mengping; Zhao, Zhijian; Duan, Xiaolu; Deng, Tuo; Cai, Chao; Wu, Wenqi; Zeng, Guohua			Partial versus radical nephrectomy for T1b-20N0M0 renal tumors: A propensity score matching study based on the SEER database	PLOS ONE			English	Article							CELL CARCINOMA SUBTYPES; CLINICAL T1B; OUTCOMES; T2; MASSES	Purpose Controversy continues on the tailored therapy for patients with larger renal cell carcinoma (RCC). We investigated whether partial nephrectomy (PN) can improve patient prognosis compared to radical nephrectomy (RN) and the indications for each approach in patients with T1b-2N0M0 RCC. Materials and methods A total of 9907 patients were identified from the Surveillance, Epidemiology, and End Results database from 2004 to 2012. Propensity scores were used to balance the selection bias of undergoing PN. Overall (OS) and cancer-specific survival (CSS) of patients undergoing PN and RN were compared. Cases were subdivided to investigate the advantages of each procedure. Results Overall, 1418 (14.3%) patients underwent PN. Before matching, PN led to better OS and CSS than RN in both Kaplan-Meier analysis and Cox regression (each p<0.01). For 1412 matched cohorts, PN was no longer associated with significantly better OS (HR: 1.19, 95% CI: 0.98-1.44), but still with a better CSS (HR: 1.66, 95% CI: 1.18-2.27) compared with RN. Further subgroup analysis indicated that patients, who were male, single living, old than 65 years, with T1b stage or clear-cell histologic type, may obtained more oncologic benefit from PN compared to RN. Conclusions When tumor localization and technical feasibility have been taken into account, similar long-term survival was achieved in overall among two nephrectomy modalities, but patients, who were male, old than 65 years, with T1b stage or clear-cell histologic type, got a better survival after receiving PN compared to RN.	[Zhang, Mengping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Zhao, Zhijian; Duan, Xiaolu; Deng, Tuo; Cai, Chao; Wu, Wenqi; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University	Wu, WQ; Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China.	wwqwml@163.com; gzgyzgh@vip.tom.com			National Natural Science Foundation of China [81670643, 81370804, 81600542]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (No. 81670643, 81370804 and 81600542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanee S, 2016, CURR UROL REP, V17, DOI 10.1007/s11934-015-0558-y; An JY, 2017, UROLOGY, V100, P151, DOI 10.1016/j.urology.2016.10.047; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Becker F, 2006, EUR UROL, V49, P1058, DOI 10.1016/j.eururo.2006.03.003; Berger A, 2009, J UROLOGY, V182, P2172, DOI 10.1016/j.juro.2009.07.047; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Braunagel M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45400; Breau RH, 2010, J UROLOGY, V183, P903, DOI 10.1016/j.juro.2009.11.037; Brierley JD, 2017, TNM CLASSIFICATION M, P199; Jeldres C, 2009, UROLOGY, V73, P1300, DOI 10.1016/j.urology.2008.08.492; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kopp RP, 2015, UROLOGY, V86, P312, DOI 10.1016/j.urology.2015.02.067; Kopp RP, 2014, BJU INT, V114, P708, DOI 10.1111/bju.12580; Liu N, 2017, UROL ONCOL; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Mir MC, 2017, EUR UROL, V71, P606, DOI 10.1016/j.eururo.2016.08.060; Nakajima R, 2017, EUR RADIOL; National Cancer Institute, SURV EP END RES; Panesar SS, 2009, INT J SURG, V7, P291, DOI 10.1016/j.ijsu.2009.05.004; Thompson RH, 2009, J UROLOGY, V182, P2601, DOI 10.1016/j.juro.2009.08.087; Van Poppel H, 2011, EUR UROL, V60, P662, DOI 10.1016/j.eururo.2011.06.040; Weight CJ, 2010, UROLOGY, V76, P631, DOI 10.1016/j.urology.2009.11.087; Yoo S, 2017, J CANC RES CLIN ONCO; Young JR, 2017, ACAD RADIOL, V24, P1226, DOI 10.1016/j.acra.2017.03.017	24	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193530	10.1371/journal.pone.0193530	http://dx.doi.org/10.1371/journal.pone.0193530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489911	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000086
J	Kasyap, AK; Sah, SK; Chaudhary, S				Kasyap, Akhilesh Kumar; Sah, Shiv Kumar; Chaudhary, Sitaram			Clinical spectrum and risk factors associated with asymptomatic erosive esophagitis as determined by Los Angeles classification: A cross-sectional study	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; ENDOSCOPIC ASSESSMENT; NATURAL-HISTORY; POPULATION; PREVALENCE; EPIDEMIOLOGY; DISORDERS; CHINESE	Background Gastro esophageal reflux disease (GERD) is a chronic and recurrent disease, and it varies in regions. However, to date, there are no reports available on clinical features and the risk factors for the asymptomatic reflux esophagitis in Nepalese adults. Methods Data were gathered from 142 erosive patients who had undergone endoscopy at Bir Hospital, Kathmandu. Los Angeles classification was used to grade the severity of the disease. Patients were interviewed to find out the presence of various reflux symptoms. Results Based on the Los Angeles classification, the severity of the disease assessed was; grade A 31.8% (31/142), grade B 39.4% (56/142), grade C 33.8% (48/142), and grade D 4.9% (7/142). One hundred and twenty six (88.7%) subjects had reflux symptoms. Prevalence of asymptomatic esophagitis was 16(11.3%). Age was independently linked to asymptomatic esophagitis (P<0.05), and the odd of being asymptomatic appeared lower in younger adults (P<0.05; OR: 0.118; CI: 0.014-.994). Conclusion A low prevalence of asymptomatic reflux esophagitis (RE) was seen. Most subjects experienced mild to moderate RE. Age remained an independent factor associated with reflux esophagitis, and the odds of being asymptomatic was lower in younger age.	[Kasyap, Akhilesh Kumar; Chaudhary, Sitaram] Bir Hosp Mahabauddha, Natl Acad Med Sci, Dept Med, Gastroenterol Unit, Kathmandu, Nepal; [Sah, Shiv Kumar] Purbanchal Univ, Little Buddha Coll Hlth Sci, Fac Pharmaceut Sci, Kathmandu, Nepal		Sah, SK (corresponding author), Purbanchal Univ, Little Buddha Coll Hlth Sci, Fac Pharmaceut Sci, Kathmandu, Nepal.	phrshiv@gmail.com		Sah, Shiv Kumar/0000-0002-8284-5925				A Gallup Organization National Survey, 1988, HEARTB AM; Agreus L, 2001, AM J GASTROENTEROL, V96, P2905; Armstrong D, 1996, GASTROENTEROLOGY, V111, P85, DOI 10.1053/gast.1996.v111.pm8698230; Chakour MC, 1996, PAIN, V64, P143, DOI 10.1016/0304-3959(95)00102-6; Chang CS, 1997, AM J GASTROENTEROL, V92, P668; Chen TS, 2007, J CLIN GASTROENTEROL, V41, P819, DOI 10.1097/01.mcg.0000225658.30803.79; Cho JH, 2011, J GASTROEN HEPATOL, V26, P1034, DOI 10.1111/j.1440-1746.2011.06686.x; Fass Ronnie, 2006, Curr Gastroenterol Rep, V8, P195, DOI 10.1007/s11894-006-0075-8; Franceschi M, 2009, BEST PRACT RES CL GA, V23, P839, DOI 10.1016/j.bpg.2009.10.004; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Inamori M, 2003, J GASTROEN HEPATOL, V18, P172, DOI 10.1046/j.1440-1746.2003.02932.x; Johnsson F J B, 1987, GASTROENTEROLOGY, V2, P714; Jung HK, 2011, J NEUROGASTROENTEROL, V17, P14, DOI 10.5056/jnm.2011.17.1.14; Jung SH, 2014, TURK J GASTROENTEROL, V25, P248, DOI 10.5152/tjg.2014.5033; Lee SJ, 2001, J GASTROEN HEPATOL, V16, P373, DOI 10.1046/j.1440-1746.2001.02464.x; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Nagahara A, 2012, J GASTROEN HEPATOL, V27, P53, DOI 10.1111/j.1440-1746.2012.07073.x; Nozu T, 2008, J GASTROENTEROL, V43, P27, DOI 10.1007/s00535-007-2120-2; Ronkainen J, 2005, SCAND J GASTROENTERO, V40, P275, DOI 10.1080/00365520510011579; Uetake T, 2000, SHOKAKIKA, V30, P139; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Wang FW, 2010, DIGEST DIS SCI, V55, P1320, DOI 10.1007/s10620-009-0888-z	22	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192739	10.1371/journal.pone.0192739	http://dx.doi.org/10.1371/journal.pone.0192739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486003	gold, Green Published, Green Submitted			2022-12-27	WOS:000426242400010
J	Yoshikawa, T; Fujii, H; Okutani, A; Shibamura, M; Omura, N; Egawa, K; Kato, H; Inagakil, T; Haradal, S; Yamada, S; Morikawa, S; Saijol, M				Yoshikawa, Tomoki; Fujii, Hikaru; Okutani, Akiko; Shibamura, Miho; Omura, Natsumi; Egawa, Kazutaka; Kato, Hirofumi; Inagakil, Takuya; Haradal, Shizuko; Yamada, Souichi; Morikawa, Shigeru; Saijol, Masayuki			Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS GENOME; SMALLPOX VACCINE; ESCHERICHIA-COLI; DNA; SEQUENCE; RECOMBINATION; MUTAGENESIS; PROTECTION; CLONING; STRAIN	LC16m8 (m8), a highly attenuated vaccinia virus (VAC) strain, was developed as a smallpox vaccine, and its safety and immunogenicity have been confirmed. Here, we aimed to develop a system that recovers infectious m8 from a bacterial artificial chromosome (BAC) that retains the full-length viral genomic DNA (m8-BAC system). The infectious virus was successfully recovered from a VAC-BAC plasmid, named pLC16m8-BAC. Furthermore, the bacterial replicon-free virus was generated by intramolecular homologous recombination and was successfully recovered from a modified VAC-BAC plasmid, named pLC16m8.8S-BAC. Also, the growth of the recovered virus was indistinguishable from that of authentic m8. The full genome sequence of the plasmid, which harbors identical inverted terminal repeats (ITR) to that of authentic m8, was determined by long-read next-generation sequencing (NGS). The ITR contains x 18 to 32 of the 70 and x 30 to 45 of 54 base pair tandem repeats, and the number of tandem repeats was different between the ITR left and right. Since the virus recovered from pLC16m8.8S-BAC was expected to retain the identical viral genome to that of m8, including the ITR, a reference-based alignment following a short-read NGS was performed to validate the sequence of the recovered virus. Based on the pattern of coverage depth in the ITR, no remarkable differences were observed between the virus and m8, and the other region was confirmed to be identical as well. In summary, this new system can recover the virus, which is geno- and phenotypically indistinguishable from authentic m8.	[Yoshikawa, Tomoki; Fujii, Hikaru; Shibamura, Miho; Omura, Natsumi; Egawa, Kazutaka; Kato, Hirofumi; Inagakil, Takuya; Haradal, Shizuko; Yamada, Souichi; Saijol, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, Toyama, Tokyo, Japan; [Okutani, Akiko; Morikawa, Shigeru] Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Toyama, Tokyo, Japan; [Omura, Natsumi; Inagakil, Takuya] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Wakamatsu Cho, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Waseda University	Saijol, M (corresponding author), Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, Toyama, Tokyo, Japan.	msaijo@nih.go.jp		MORIKAWA, SHIGERU/0000-0001-6249-6716; Saijo, Masayuki/0000-0001-5458-7298; Yoshikawa, Tomoki/0000-0001-7601-4036	Ministry of Health, Labor and Welfare of Japan [H26-Sinkogyousei-Shitei-002, H29-Sinkogyousei-Shitei-002]; Japan Agency for Medical Research and Development (AMED)	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	TY, SM and MS greatly acknowledge financial support by the Ministry of Health, Labor and Welfare of Japan (Grant No. H26-Sinkogyousei-Shitei-002, and H29-Sinkogyousei-Shitei-002), and Japan Agency for Medical Research and Development (AMED).	Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Aragon TJ, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-26; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; BAROUDY BM, 1982, NUCLEIC ACIDS RES, V10, P5673, DOI 10.1093/nar/10.18.5673; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Borst Eva-Maria, 2004, Methods Mol Biol, V256, P221; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cottingham Matthew G, 2012, Methods Mol Biol, V890, P37, DOI 10.1007/978-1-61779-876-4_3; Cottingham MG, 2010, J VIROL METHODS, V168, P233, DOI 10.1016/j.jviromet.2010.04.012; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Domi A, 2005, NAT METHODS, V2, P95, DOI 10.1038/NMETH734; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Empig C, 2006, VACCINE, V24, P3686, DOI 10.1016/j.vaccine.2005.03.029; Gilbert SC, 2013, VACCINE, V31, P4241, DOI 10.1016/j.vaccine.2013.03.020; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kenner J, 2006, VACCINE, V24, P7009, DOI 10.1016/j.vaccine.2006.03.087; Kidokoro M, 2005, P NATL ACAD SCI USA, V102, P4152, DOI 10.1073/pnas.0406671102; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Meeting of the Strategic Advisory Group of Experts on Immunization, 2014, WKLY EPIDEMIOL REC, V89, P1, DOI DOI 10.1016/j.compfluid.2013.10.031; Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005; MORITA M, 1977, ARCH VIROL, V53, P197, DOI 10.1007/BF01314664; MOSS B, 1981, P NATL ACAD SCI-BIOL, V78, P1614, DOI 10.1073/pnas.78.3.1614; Moss B., 2013, COLD SPRING HARB PER, V5; Nagel CH, 2008, J VIROL, V82, P3109, DOI 10.1128/JVI.02124-07; Richards AL, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0295-4; Roth SJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-3; Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05; Smith GA, 2000, P NATL ACAD SCI USA, V97, P4873, DOI 10.1073/pnas.080502497; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; SUGIMOTO M, 1985, MICROBIOL IMMUNOL, V29, P421, DOI 10.1111/j.1348-0421.1985.tb00843.x; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Tischer BK, 2007, J VIROL, V81, P13200, DOI 10.1128/JVI.01148-07; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Walsh SR, 2011, EXPERT REV VACCINES, V10, P1221, DOI [10.1586/ERV.11.79, 10.1586/erv.11.79]; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Yamaguchi M, 1975, CLIN VIROL, V3, P269; Yokote H, 2014, CLIN VACCINE IMMUNOL, V21, P1261, DOI 10.1128/CVI.00199-14; Yu D, 2002, J VIROL, V76, P2316, DOI 10.1128/JVI.76.5.2316-2328.2002; Yuan M, 2015, J VIROL, V89, P5176, DOI 10.1128/JVI.00339-15	47	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192725	10.1371/journal.pone.0192725	http://dx.doi.org/10.1371/journal.pone.0192725			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474493	gold, Green Published, Green Submitted			2022-12-27	WOS:000426049500032
J	Diele-Viegas, LM; Vitt, LJ; Sinervo, B; Colli, GR; Werneck, FP; Miles, DB; Magnusson, WE; Santos, JC; Sette, CM; Caetano, GHO; Pontes, E; Avila-Pires, TCS				Diele-Viegas, Luisa M.; Vitt, Laurie J.; Sinervo, Barry; Colli, Guarino R.; Werneck, Fernanda P.; Miles, Donald B.; Magnusson, William E.; Santos, Juan C.; Sette, Carla M.; Caetano, Gabriel H. O.; Pontes, Emerson; Avila-Pires, Teresa C. S.			Thermal physiology of Amazonian lizards (Reptilia: Squamata)	PLOS ONE			English	Article							LOWLAND RAIN-FOREST; LIFE-HISTORY; CLIMATE-CHANGE; FOOD ASSIMILATION; BODY-TEMPERATURE; PHENOTYPIC PLASTICITY; TRANSITIONAL FOREST; WESTERN AMAZON; ROCK OUTCROPS; FENCE LIZARD	We summarize thermal-biology data of 69 species of Amazonian lizards, including mode of thermoregulation and field-active body temperatures (T-b). We also provide new data on preferred temperatures (T-pref), voluntary and thermal-tolerance ranges, and thermal-performance curves (TPC's) for 27 species from nine sites in the Brazilian Amazonia. We tested for phylogenetic signal and pairwise correlations among thermal traits. We found that species generally categorized as thermoregulators have the highest mean values for all thermal traits, and broader ranges for T-b, critical thermal maximum (CTmax) and optimal (T-opt) temperatures. Species generally categorized as thermoconformers have large ranges for Tpref, critical thermal minimum (CTmin), and minimum voluntary (VTmin) temperatures for performance. Despite these differences, our results show that all thermal characteristics overlap between both groups and suggest that Amazonian lizards do not fit into discrete thermoregulatory categories. The traits are all correlated, with the exceptions of (1) T-opt, which does not correlate with CTmax, and (2) CTmin, and correlates only with T-opt. Weak phylogenetic signals for T-b, T-pref and VTmin indicate that these characters may be shaped by local environmental conditions and influenced by phylogeny. We found that open-habitat species perform well under present environmental conditions, without experiencing detectable thermal stress from high environmental temperatures induced in lab experiments. For forest-dwelling lizards, we expect warming trends in Amazonia to induce thermal stress, as temperatures surpass the thermal tolerances for these species.	[Diele-Viegas, Luisa M.; Avila-Pires, Teresa C. S.] Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [Vitt, Laurie J.] Univ Oklahoma, Sam Noble Museum, Norman, OK 73019 USA; [Sinervo, Barry; Sette, Carla M.; Caetano, Gabriel H. O.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Colli, Guarino R.] Univ Brasilia, Brasilia, DF, Brazil; [Werneck, Fernanda P.; Magnusson, William E.; Pontes, Emerson] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Miles, Donald B.] Ohio Univ, Athens, OH 45701 USA; [Santos, Juan C.] Brigham Young Univ, Provo, UT 84602 USA; [Diele-Viegas, Luisa M.] Univ Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Santos, Juan C.] St Johns Univ, Queens, NY USA	Museu Paraense Emilio Goeldi; University of Oklahoma System; University of Oklahoma - Norman; University of California System; University of California Santa Cruz; Universidade de Brasilia; Institute Nacional de Pesquisas da Amazonia; University System of Ohio; Ohio University; Brigham Young University; Universidade do Estado do Rio de Janeiro; Saint John's University	Diele-Viegas, LM (corresponding author), Museu Paraense Emilio Goeldi, Belem, Para, Brazil.; Diele-Viegas, LM (corresponding author), Univ Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil.	luisa.mviegas@gmail.com	Diele-Viegas, Luisa Maria/ABI-2494-2020; Colli, Guarino Rinaldi/A-5368-2008; Diele-Viegas, Luisa M./D-8930-2018; Werneck, Fernanda P./J-9629-2013; Miles, Donald B./AFW-0480-2022	Diele-Viegas, Luisa Maria/0000-0002-9225-4678; Colli, Guarino Rinaldi/0000-0002-2628-5652; Diele-Viegas, Luisa M./0000-0002-9225-4678; Werneck, Fernanda P./0000-0002-8779-2607; Miles, Donald/0000-0001-5768-179X; Sette, Carla/0000-0001-7105-7512	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [475559/2013-4]; CNPq; Fundacao de Amparo a Pesquisa do Amazonas (FAPEAM) [062.00665/2015]; U.S. National Academy of Sciences; U.S. Agency of International Development (PEER NAS/USAID PGA) [2000005316]; Fundacao de Amparo a Pesquisa do Para - ICAAF [011/2012]; Fundacao deAmparo a Pesquisa do Distrito Federal (FAPDF); National Science Foundation [1241885]; National Science Foundation Emerging Frontiers [241848]; Emerging Frontiers [1241848] Funding Source: National Science Foundation	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Amazonas (FAPEAM); U.S. National Academy of Sciences; U.S. Agency of International Development (PEER NAS/USAID PGA)(United States Agency for International Development (USAID)); Fundacao de Amparo a Pesquisa do Para - ICAAF; Fundacao deAmparo a Pesquisa do Distrito Federal (FAPDF)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Emerging Frontiers; Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - graduate fellowship to LDV and financial support to GRC (http://www.capes.gov.br/): Allowed the development of the research and the data collection. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - research fellowship to TAP and financial support to FPW (475559/2013-4) (http//cnpq.br/): Allowed the data collection. PVE (Pesquisador Visitante Especial) grant from CNPq (http://cnpq.br/) - BRS: Allowed the development of the research. Fundacao de Amparo a Pesquisa do Amazonas financial support to FPW and WM (FAPEAM, 062.00665/2015) (http.//www.fapeam.am.gov.br/): Allowed the study design and decision to publish. Partnerships for Enhanced Engagement in Research from the U.S. National Academy of Sciences and U.S. Agency of International Development (PEER NAS/USAID PGA 2000005316) financial support to GRC and FPW (http://sites.nationalacademies.org/pga/peer/index. htm): Allowed the development of the research and the decision to publish. Fundacao de Amparo a Pesquisa do Para - ICAAF number 011/2012 SISBIOTA Herpeto-Helminto financial support to LDV and TAP (http://www.fapespa.pa.gov.br/): Allowed the data collection. *Fundacao deAmparo a Pesquisa do Distrito Federal (FAPDF)- financial support to GRC (http://www.fap.df.gov.br/ <http://www.fap.df.gov.br/>)* -Allowed the data collection. National Science Foundation Emerging Frontiers [grant number 1241885, Collaborative Research: "Quantifying Climate-forced Extinction Risks for Lizards, Amphibians, Fishes, and Plants"] LDV, BRS, GRC and FPW (https://www.nsf.gov/): Allowed the data collection, analysis and reparation of the manuscript. National Science Foundation Emerging Frontiers [grant number 241848] BRS and DBM: Allowed the data collection, analysis and preparation of the manuscript. Research Council via a George Lynn Cross Research Professorship of the University of Oklahoma and the Sam Noble Museum support to LJV (http://samnoblemuseum.ou.edu/): Allowed the decision to publish.	ADOLPH SC, 1993, AM NAT, V142, P273, DOI 10.1086/285538; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; Avila-Pires T.C.S., 1995, Zoologische Verhandelingen (Leiden), V299, P1; Bartholomew G .A., 1958, Publications of the American Association for the Advancement of Science, V51, P81; BENNETT AF, 1980, ANIM BEHAV, V28, P752, DOI 10.1016/S0003-3472(80)80135-7; BENNETT AF, 1990, AM J PHYSIOL, V259, pR253, DOI 10.1152/ajpregu.1990.259.2.R253; BEUCHAT CA, 1987, ECOL MONOGR, V57, P45, DOI 10.2307/1942638; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; BRATTSTROM BH, 1965, AM MIDL NAT, V73, P376, DOI 10.2307/2423461; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Cheng H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2415; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; Colli GR, 2003, J HERPETOL, V37, P694, DOI 10.1670/180-02A; D'Apolito C, 2013, QUATERNARY SCI REV, V76, P140, DOI 10.1016/j.quascirev.2013.07.013; DEWITT CB, 1967, PHYSIOL ZOOL, V40, P49, DOI 10.1086/physzool.40.1.30152438; DIXON J R, 1975, Milwaukee Public Museum Contributions in Biology and Geology, V4, P1; Du WG, 2000, J THERM BIOL, V25, P197, DOI 10.1016/S0306-4565(99)00022-4; Eva H., 2005, PROPOSAL DEFINING GE; Fearnside PM, 2009, OECOLOGIA BRASILIENS, V13, P609, DOI DOI 10.4257/0EC0.2009.1304.05; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P3606, DOI 10.1111/gcb.12012; Feldpausch TR, 2016, GLOBAL BIOGEOCHEM CY, V30, P964, DOI 10.1002/2015GB005133; Felenstein J, 2004, INFERRING PHYLOGENIE; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Salazar LF, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043538; Fitch H. S., 1968, Herpetologica, V24, P35; GASNIER TR, 1994, J HERPETOL, V28, P187, DOI 10.2307/1564619; Henderson R.W., 2009, NATURAL HIST W INDIA; Hoorn C, 2017, GLOBAL PLANET CHANGE, V153, P51, DOI 10.1016/j.gloplacha.2017.02.005; Huey R.B., 1982, Biology of Reptilia, V12, P25; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; HUEY RB, 1979, AM ZOOL, V19, P357; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; HUEY RB, 1993, AM NAT, V142, pS21, DOI 10.1086/285521; Huey RB, 2011, NATURE, V470, P479; Huey RB, 1975, THESIS; IPCC, 2014, CONTRIBUTION WORKING; Irschick DJ, 2001, ANNU REV ECOL SYST, V32, P367, DOI 10.1146/annurev.ecolsys.32.081501.114048; Ji X, 1997, NETH J ZOOL, V47, P103; Ji X, 1996, J THERM BIOL, V21, P155, DOI 10.1016/0306-4565(95)00037-2; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Killeen TJ, 2008, PHILOS T R SOC B, V363, P1881, DOI 10.1098/rstb.2007.0018; Kohlsdorf T, 2006, EVOL ECOL, V20, P549, DOI 10.1007/s10682-006-9116-x; Kubisch EL, 2016, CAN J ZOOL, V94, P49, DOI 10.1139/cjz-2015-0024; Licht P., 1966, Copeia, V1966, P97; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; MAGNUSSON WE, 1985, HERPETOLOGICA, V41, P324; MAGNUSSON WE, 1993, J HERPETOL, V27, P53, DOI 10.2307/1564905; Mesquita DO, 2006, COPEIA, P460, DOI 10.1643/0045-8511(2006)2006[460:EOACLA]2.0.CO;2; Mesquita DO, 2006, J HERPETOL, V40, P221, DOI 10.1670/123-05A.1; Mesquita DO, 2003, COPEIA, P285; Miranda JP, 2010, ZOOLOGIA-CURITIBA, V27, P35, DOI 10.1590/S1984-46702010000100006; Nobre CA, 2016, P NATL ACAD SCI USA, V113, P10759, DOI 10.1073/pnas.1605516113; NUNES V S, 1984, Papeis Avulsos de Zoologia (Sao Paulo), V35, P147; Paranjpe DA, 2012, P MEAS BEH 2012 8 IN; Paranjpe DA, 2013, EVOL ECOL; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pianka E R, 1994, LIZARD MAN SPEAKS, P26; Pough F.H., 1982, Biology of Reptilia, V12, P17; R Development Core Team, 2009, R LANG ENV STAT COMP; Recoder Renato, 2012, Herpetology Notes, V5, P49; Revell LJ, 2012, METHODS ECOL EVOL; Ribeiro-Junior Marco, 2016, Neotropical Biodiversity, V2, P195; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rocha Carlos Frederico D., 2009, Oecologia Brasiliensis, V13, P115; Sartorius SS, 1999, BIOL CONSERV, V90, P91, DOI 10.1016/S0006-3207(99)00019-1; Savage J.M., 2002, AMPHIBIANS REPTILES; Sears MW, 2016, P NATL ACAD SCI USA, V113, P10595, DOI 10.1073/pnas.1604824113; Sears MW, 2011, INTEGR COMP BIOL, V51, P666, DOI 10.1093/icb/icr111; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Simmons PM, 2005, HERPETOLOGICA, V61, P124, DOI 10.1655/04-24; SINERVO B, 1990, OECOLOGIA, V83, P228, DOI 10.1007/BF00317757; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; STAMPS JA, 1976, COPEIA, P467; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; VANDAMME R, 1991, FUNCT ECOL, V5, P507; Vitt Laurie J., 2007, PHYLLOMEDUSA, V6, P11; Vitt LJ, 2008, COPEIA, P144, DOI 10.1643/CP-06-251; Vitt Laurie J., 1995, Occasional Papers of the Oklahoma Museum of Natural History, V1, P1; Vitt LJ, 1998, COPEIA, P570, DOI 10.2307/1447787; Vitt LJ, 2005, HERPETOL MONOGR, V19, P137, DOI 10.1655/0733-1347(2005)019[0137:SIABWE]2.0.CO;2; VITT LJ, 1995, COPEIA, P305; Vitt LJ, 2003, J HERPETOL, V37, P276, DOI 10.1670/0022-1511(2003)037[0276:SARTEO]2.0.CO;2; Vitt LJ, 1996, HERPETOLOGICA, V52, P121; Vitt LJ, 1996, CAN J ZOOL, V74, P1313, DOI 10.1139/z96-147; Vitt LJ, 1997, CAN J ZOOL, V75, P1876, DOI 10.1139/z97-817; Vitt LJ, 2003, CAN J ZOOL, V81, P142, DOI 10.1139/Z02-230; Vitt LJ, 1996, J TROP ECOL, V12, P81, DOI 10.1017/S0266467400009329; VITT LJ, 1993, CAN J ZOOL, V71, P2370, DOI 10.1139/z93-333; VITT LJ, 1993, J HERPETOL, V27, P46, DOI 10.2307/1564904; VITT LJ, 1991, J HERPETOL, V25, P79, DOI 10.2307/1564798; Vitt LJ, 2003, CAN J ZOOL, V81, P302, DOI 10.1139/Z03-004; VITT LJ, 1991, COPEIA, P916, DOI 10.2307/1446087; Vitt LJ, 2002, COPEIA, P275; Vitt LJ, 1997, HERPETOLOGICA, V53, P165; Vitt LJ, 2001, CAN J ZOOL, V79, P1855, DOI 10.1139/cjz-79-10-1855; VITT LJ, 1992, CAN J ZOOL, V70, P1995, DOI 10.1139/z92-270; VITT LJ, 1995, CAN J ZOOL, V73, P691, DOI 10.1139/z95-081; VITT LJ, 1991, CAN J ZOOL, V69, P2791, DOI 10.1139/z91-393; Vitt LJ, 2001, COPEIA, P401, DOI 10.1643/0045-8511(2001)001[0401:LOTLLT]2.0.CO;2; Vitt LJ, 1998, J TROP ECOL, V14, P63, DOI 10.1017/S0266467498000066; Vitt LJ, 2000, COPEIA, V2000, P3; Vrcibradic D, 1998, J HERPETOL, V32, P229, DOI 10.2307/1565302; Wang XF, 2017, NATURE, V541, P204, DOI 10.1038/nature20787; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yannas S, 1995, PASCOOL HDB DESIGNIN; Zajitschek SRK, 2012, BIOL J LINN SOC, V107, P573, DOI 10.1111/j.1095-8312.2012.01963.x; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009; Zuur Alain F., 2009, P1	114	25	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192834	10.1371/journal.pone.0192834	http://dx.doi.org/10.1371/journal.pone.0192834			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513695	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800023
J	Roberts, CP; Uden, DR; Allen, CR; Twidwell, D				Roberts, Caleb P.; Uden, Daniel R.; Allen, Craig R.; Twidwell, Dirac			Doublethink and scale mismatch polarize policies for an invasive tree	PLOS ONE			English	Article							REDCEDAR JUNIPERUS-VIRGINIANA; TALLGRASS PRAIRIE; BIOLOGICAL INVASIONS; MANAGEMENT; FIRE; CONSEQUENCES; PLANTS; CONVERSION; DYNAMICS; INVADERS	Mismatches between invasive species management policies and ecological knowledge can lead to profound societal consequences. For this reason, natural resource agencies have adopted the scientifically-based density-impact invasive species curve to guide invasive species management. We use the density-impact model to evaluate how well management policies for a native invader (Juniperus virginiana) match scientific guidelines. Juniperus virginiana invasion is causing a sub-continental regime shift from grasslands to woodlands in central North America, and its impacts span collapses in endemic diversity, heightened wildfire risk, and crashes in grazing land profitability. We (1) use land cover data to identify the stage of Juniperus virginiana invasion for three ecoregions within Nebraska, USA, (2) determine the range of invasion stages at individual land parcel extents within each ecoregion based on the density-impact model, and (3) determine policy alignment and mismatches relative to the density-impact model in order to assess their potential to meet sustainability targets and avoid societal impacts as Juniperus virginiana abundance increases. We found that nearly all policies evidenced doublethink and policy-ecology mismatches, for instance, promoting spread of Juniperus virginiana regardless of invasion stage while simultaneously managing it as a native invader in the same ecoregion. Like other invasive species, theory and literature for this native invader indicate that the consequences of invasion are unlikely to be prevented if policies fail to prioritize management at incipient invasion stages. Theory suggests a more realistic approach would be to align policy with the stage of invasion at local and ecoregion management scales. There is a need for scientists, policy makers, and ecosystem managers to move past ideologies governing native versus non-native invader classification and toward a framework that accounts for the uniqueness of native species invasions, their anthropogenic drivers, and their impacts on ecosystem services.	[Roberts, Caleb P.; Twidwell, Dirac] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [Roberts, Caleb P.; Uden, Daniel R.] Univ Nebraska, Sch Nat Resources, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA; [Allen, Craig R.] Univ Nebraska, US Geol Survey, Sch Nat Resources, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln	Roberts, CP (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.; Roberts, CP (corresponding author), Univ Nebraska, Sch Nat Resources, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA.	caleb.powell.roberts@gmail.com			Department of Defense Strategic Environmental Research Development Program [W912HQ-15-C-0018]; Nebraska Game & Parks Commission [W-125-R-1]; University of Nebraska-Lincoln's Institute of Agriculture and Natural Resources; U.S. Geological Survey; Nebraska Game and Parks Commission,; University of Nebraska Agricultural Research Division, Lincoln, Nebraska; United States Fish and Wildlife Service; Wildlife Management Institute	Department of Defense Strategic Environmental Research Development Program; Nebraska Game & Parks Commission; University of Nebraska-Lincoln's Institute of Agriculture and Natural Resources; U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission,; University of Nebraska Agricultural Research Division, Lincoln, Nebraska; United States Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute	This work was supported by Department of Defense Strategic Environmental Research Development Program W912HQ-15-C-0018 (https://www.serdp-estcp.org/), Nebraska Game & Parks Commission W-125-R-1 (http://outdoornebraska.gov/) and the University of Nebraska-Lincoln's Institute of Agriculture and Natural Resources. The Nebraska Cooperative Fish and Wildlife Research Unit is jointly supported by Hatch Act funds through a cooperative agreement between the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska Agricultural Research Division, Lincoln, Nebraska, the United States Fish and Wildlife Service and the Wildlife Management Institute. We thank the Eastern Redcedar Working Group for conceptual development assistance. We extend special thanks to the Rainwater Basin Joint Venture for use of their land classification data. We also thank Ritch Nelson for management policy information. Any use of trade, firm or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ENV QUAL INC PROGR; [Anonymous], 2015, ACT NOW PAY LATER EV; [Anonymous], 2014, E RED PROBL OPP; Bessey C. E., 1899, FORESTS FOREST TREES; Bidwell T. G., 1990, INVASION OKLAHOMA RA; Bishop A., 2011, RAINWATER BASIN JOIN; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Briggs JM, 2002, ECOSYSTEMS, V5, P578, DOI 10.1007/s10021-002-0187-4; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; Chaffin BC, 2016, J ENVIRON MANAGE, V183, P399, DOI 10.1016/j.jenvman.2016.04.040; Charles E, BESSEY TREE NURSERY; Coppedge BR, 2001, ECOL APPL, V11, P47, DOI 10.1890/1051-0761(2001)011[0047:ARTLCI]2.0.CO;2; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Crooks Jeffrey A., 1999, Population and Community Biology Series, V24, P103; Cumming GS, 2013, LANDSCAPE ECOL, V28, P1139, DOI 10.1007/s10980-012-9725-4; Donovan V. M., PREDICTORS AFFORESTA; Engle D. M., 2008, ECOL STUD-ANAL SYNTH, P253; Epanchin-Niell RS, 2015, ECOL ECON, V116, P146, DOI 10.1016/j.ecolecon.2015.04.014; Epanchin-Niell RS, 2012, ECOL LETT, V15, P803, DOI 10.1111/j.1461-0248.2012.01800.x; Epanchin-Niell RS, 2010, ECOL LETT, V13, P528, DOI 10.1111/j.1461-0248.2010.01440.x; Fremont JC., 1845, REPORT EXPLORING EXP; Fuhlendorf S.D., 2008, ECOL STU AN, P219; Fuhlendorf S. D., ECOLOGICAL MODELLING, V90, P245; Ganguli Amy C., 2008, Rangelands, V30, P27, DOI 10.2111/1551-501X-30.6.27; Garmestani A. S., 2013, ECOLOGY SOC, V18; Head L, 2015, CONSERV SOC, V13, P311, DOI 10.4103/0972-4923.170411; Horncastle VJ, 2005, J MAMMAL, V86, P1144, DOI 10.1644/05-MAMM-A-015R1.1; Institute of Agriculture and Natural Resources University of Nebraska-Lincoln, E RED SCI LIT PROJ; Johnsgard P., 2005, NATURE NEBRASKA ECOL; Lawson E.R., 1990, SILVICS N AM, V1, P131; Limb RF, 2010, RANGELAND ECOL MANAG, V63, P638, DOI 10.2111/REM-D-09-00056.1; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Meneguzzo DM, 2015, J FOREST, V113, P325, DOI 10.5849/jof.14-093; Nackley LL, 2017, TRENDS ECOL EVOL, V32, P814, DOI 10.1016/j.tree.2017.08.003; Nebraska Department of Natural Resources, EL DAT; Nebraska Forest Service, FUELS RED FOR REST; Nebraska Forest Service, WINDBR DES; Nebraska Invasive Species Council, NEBR INV SPEC PROGR; Nel JL, 2004, S AFR J SCI, V100, P53; OWENSBY CE, 1973, J RANGE MANAGE, V26, P256, DOI 10.2307/3896570; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Ratajczak Z, 2016, RANGELAND ECOL MANAG, V69, P280, DOI 10.1016/j.rama.2016.03.004; Schneider R., 2011, NEBRASKA NATURAL LEG; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Simberloff D, 2013, INVASIVE SPECIES WHA; Simberloff D, 2012, ECOLOGY, V93, P598, DOI 10.1890/11-1232.1; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Stewart-Koster B, 2015, J APPL ECOL, V52, P366, DOI 10.1111/1365-2664.12395; Streit Krug A., 2017, ECOLOGY SOC IN PRESS; Twidwell D., 2013, FRONTIERS ECOLOGY EN, V11; Twidwell D, 2017, COMMUNICATION; Twidwell D, 2016, ECOSYSTEMS, V19, P356, DOI 10.1007/s10021-015-9937-y; Twidwell D, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00124.1; Twidwell D, 2013, J APPL ECOL, V50, P603, DOI 10.1111/1365-2664.12063; U. S. Geological Survey, N AM CLIM MONTHL MEA; Uden DR, 2015, BIOL INVASIONS, V17, P2831, DOI 10.1007/s10530-015-0914-3; United States Forest Service, DEC MEM MCKELVIE WOO; United States Forest Service, BESS WOOD ENCR PROJ; Van Wilgen B. W., DIVERSITY DISTRIBUTI, V17, P1060; van Wilgen BW, 2012, BIOL CONSERV, V148, P28, DOI 10.1016/j.biocon.2011.12.035; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vitkova M, 2017, FOREST ECOL MANAG, V384, P287, DOI 10.1016/j.foreco.2016.10.057; Ware Eugene F., 1960, INDIAN WAR 1864; Wittmann MJ, 2014, OIKOS, V123, P441, DOI 10.1111/j.1600-0706.2013.01025.x; Yokomizo H, 2009, ECOL APPL, V19, P376, DOI 10.1890/08-0442.1	65	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0189733	10.1371/journal.pone.0189733	http://dx.doi.org/10.1371/journal.pone.0189733			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513675	gold, Green Published			2022-12-27	WOS:000426896800002
J	Vitek, NS				Vitek, Natasha S.			Delineating modern variation from extinct morphology in the fossil record using shells of the Eastern Box Turtle (Terrapene carolina)	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; CLINAL VARIATION; SUBSPECIFIC DIVERSIFICATION; PHENOTYPIC DIVERGENCE; POPULATION-STRUCTURE; GEOGRAPHIC-VARIATION; AVIAN POPULATIONS; MEASUREMENT ERROR; FRESH-WATER; PLEISTOCENE	Characterization of morphological variation in the shells of extant Eastern Box Turtles, Terrapene carolina, provides a baseline for comparison to fossil populations. It also provides an example of the difficulties inherent to recognizing intraspecific diversity in the fossil record. The degree to which variation in fossils of T. carolina can be accommodated by extant variation in the species has been disagreed upon for over eighty years. Using morphometric analyses of the carapace, I address the relationship between modern and fossil T. carolina in terms of sexual dimorphism, geographic and subspecific variation, and allometric variation. Modern T. carolina display weak male-biased sexual size dimorphism. Sexual shape dimorphism cannot be reliably detected in the fossil record. Rather than a four-part subspecific division, patterns of geographic variation are more consistent with clinal variation between various regions in the species distribution. Allometric patterns are qualitatively similar to those documented in other emydid turtles and explain a significant amount of shape variation. When allometric patterns are accounted for, Holocene specimens are not significantly different from modern specimens. In contrast, several geologically older specimens have significantly different carapace shape with no modern analogue. Those large, fossilized specimens represent extinct variation occupying novel portions of morphospace. This study highlights the need for additional documentation of modern osteological variation that can be used to test hypotheses of intraspecific evolution in the fossil record.	[Vitek, Natasha S.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Vitek, Natasha S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Vitek, Natasha S.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA	University of Texas System; University of Texas Austin; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Vitek, NS (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.; Vitek, NS (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.; Vitek, NS (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	nvitek@ufl.edu		Vitek, Natasha/0000-0003-0587-8907	James M. and Thomas J. M. Schopf Award from the Paleontological Society; Paleontological Society of Austin Research Grant; Lundelius Scholarship; Jackson School of Geosciences; National Science Foundation [DGE-1315138]	James M. and Thomas J. M. Schopf Award from the Paleontological Society; Paleontological Society of Austin Research Grant; Lundelius Scholarship; Jackson School of Geosciences; National Science Foundation(National Science Foundation (NSF))	Funding was provided by a James M. and Thomas J. M. Schopf Award from the Paleontological Society, a Paleontological Society of Austin Research Grant, a Lundelius Scholarship, funding from the Jackson School of Geosciences, and the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1315138 to NSV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D.C., 2017, GEOMORPH SOFTWARE GE; [Anonymous], 1861, ORIGIN SPECIES MEANS; ARCHIBALD JD, 1994, SYST BIOL, V43, P27, DOI 10.2307/2413579; AUFFENBERG W, 1967, COPEIA, P319, DOI 10.2307/1442120; AUFFENBERG WALTER, 1958, BULL FLORIDA STATE MUS BIOL SER, V3, P53; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; BALL RM, 1992, AUK, V109, P626; BARBOUR THOMAS, 1931, BULL MUS COMP ZOOL, V72, P293; BASKIN JA, 1991, J PALEONTOL, V65, P995, DOI 10.1017/S0022336000033308; Becker OS, 2016, MAPS DRAW GEOGRAPHIC; Bell Christopher J., 2004, P232; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENTLEY CC, 1994, BRIMLEYANA, P1; Bentley CC, 1998, TURTLES TESTUDINES A, P25; BERRY JF, 1980, OECOLOGIA, V44, P185, DOI 10.1007/BF00572678; Bivand R, 2015, COMP IMPLEMENTATIONS; BLAIR W F, 1976, Southwestern Naturalist, V21, P89, DOI 10.2307/3670328; Braby MF, 2012, BIOL J LINN SOC, V106, P699, DOI 10.1111/j.1095-8312.2012.01909.x; Brenneman RA, 2016, INT J PRIMATOL, V37, P460, DOI 10.1007/s10764-016-9911-3; Budischak SA, 2006, SOUTHEAST NAT, V5, P191, DOI 10.1656/1528-7092(2006)5[191:NHOTCB]2.0.CO;2; Butler JM, 2011, BIOL J LINN SOC, V102, P889, DOI 10.1111/j.1095-8312.2011.01625.x; Campos PF, 2012, ANN ANAT, V194, P7, DOI 10.1016/j.aanat.2011.07.003; Cardini A, 2007, ZOOMORPHOLOGY, V126, P121, DOI 10.1007/s00435-007-0036-2; Cardini A, 2007, J BIOGEOGR, V34, P1663, DOI 10.1111/j.1365-2699.2007.01731.x; Cardini A, 2016, SYST BIOL, V65, P1096, DOI 10.1093/sysbio/syw043; Congdon JD, 2013, EVOL ECOL, V27, P445, DOI 10.1007/s10682-012-9595-x; Cullingham CI, 2008, CAN J ZOOL, V86, P947, DOI 10.1139/Z08-072; Dodd CK, 2008, J ZOOL, V275, P18, DOI 10.1111/j.1469-7998.2007.00402.x; Dodd CK, 2012, CHELONIAN CONSERV BI, V11, P44, DOI 10.2744/CCB-0927.1; Dodd C. Kenneth Jr, 1993, Herpetological Review, V24, P47; Dodd CK, 1997, CAN J ZOOL, V75, P1495, DOI 10.1139/z97-773; DODD CK, 2001, N AM BOX TURTLES NAT; Donald PF, 2017, IBIS, V159, P699, DOI 10.1111/ibi.12487; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dupuis J.R., 2016, NEWS LEPIDOPTERISTSS, V58, P202; Ehret D, 2011, J VERTEBRATE PALEONT, V104; Ehret Dana J., 2013, Bulletin of Zoological Nomenclature, V70, P193; Ennen JR, 2014, BIOL J LINN SOC, V111, P810, DOI 10.1111/bij.12234; Ernst Carl H., 1998, Chelonian Conservation and Biology, V3, P99; Fields SE, 2010, GROUND SLOTH MEGALON; Fitzpatrick John W., 2010, Ornithological Monographs, V67, P54; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Franz Richard, 2005, Bulletin of the Florida Museum of Natural History, V45, P179; Fritz U, 2007, AMPHIBIA-REPTILIA, V28, P97, DOI 10.1163/156853807779799135; Fritz U, 2014, ZOOTAXA, V3835, P295, DOI 10.11646/zootaxa.3835.2.10; Frost Darrel R., 1992, Herpetological Review, V23, P46; FROST DR, 1990, HERPETOLOGICA, V46, P87; Fruciano C, 2016, DEV GENES EVOL, V226, P139, DOI 10.1007/s00427-016-0537-4; Fuller TL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1237; Fulton R., 1987, G OGRAPHIE PHYS QUAT, V41, P181, DOI DOI 10.7202/032676AR; Gibbons J.W., 1990, Herpetological Monographs, P1; Gidley JW, 1927, SMITHSONIAN MISCELLA, V78, P168; GILMORE CHARLES W., 1927, PROC U S NATION MUS, V71, P1; Gingerich PD, 2000, J THEOR BIOL, V204, P201, DOI 10.1006/jtbi.2000.2008; GOODWIN HT, 1995, J MAMMAL, V76, P100, DOI 10.2307/1382319; Graham R.W., 1976, THESIS; Grossnickle DM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2110; Groves Colin P., 1992, Archaeology in Oceania, V27, P153; Guilday JE., 1978, B CARN MUS NAT HIST, V11, P1; Gut H. J., 1963, Quarterly Journal of the Florida Academy of Sciences, V26, P315; Haber A., 2011, OSYMM; Hadly EA, 1997, BIOL J LINN SOC, V60, P277; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; Haig S. M., 2010, ORNITHOLOGICAL MONOG, V67, P172, DOI DOI 10.1525/0M.2010.67.1.172; Haig SM, 2006, CONSERV BIOL, V20, P1584, DOI 10.1111/j.1523-1739.2006.00530.x; Hay OP, 1906, B AM MUS NAT HIST, V22, P27; Hay OP., 1916, FL GEOL SURV ANN REP, V8, P39; Hendges CD, 2016, BIOL J LINNEAN SOC; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hijmans R., 2016, GEOSPHERE SPHERICAL; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; Holman JA, 2005, HERPETOL J, V15, P81; HOLMAN JA, 1978, HERPETOLOGICA, V34, P228; Hone DWE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0947; Hulbert RC, 2001, FOSSIL VERTEBRATEF; Inger RF, 1961, VERTEBRATE SPECIATIO, P262; Jass CN, 2011, J VERTEBR PALEONTOL, V31, P684, DOI 10.1080/02724634.2011.563764; Jones MT, 2016, J HERPETOL, V50, P94, DOI 10.1670/13-149; Joyce WG, 2012, J PALEONTOL, V86, P177, DOI 10.1666/11-073.1; Kahle D, 2013, R J, V5, P144; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; Kiester AR, 2015, CONSERVATION BIOL FR; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Koch PL, 2004, PALAEOGEOGR PALAEOCL, V207, P331, DOI 10.1016/j.palaeo.2003.09.034; Kohn MJ, 2005, GEOLOGY, V33, P649, DOI 10.1130/G21476.1; Kowalewski M, 2010, QUANTITATIVE METHODS; LANYON WE, 1982, AUK, V99, P603; Legendre SD, 2016, PACKFOR FORWARD SELE, P46; Legler JM, 2013, TURTLES OF MEXICO: LAND AND FRESHWATER FORMS, P1; Lemon J., 2006, R R NEWS, V6, P12; Letts B, 2012, METHODS MOL BIOL, V840, P87, DOI 10.1007/978-1-61779-516-9_12; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Lundelius Jr I.L., 1972, U TEXAS BUR EC GEOL, V77, P1; Macfadden BJ, 2012, J VERTEBR PALEONTOL, V32, P708, DOI 10.1080/02724634.2012.655639; Martin BT, 2013, MOL PHYLOGENET EVOL, V68, P119, DOI 10.1016/j.ympev.2013.03.006; Martin PR, 2008, EVOLUTION, V62, P2775, DOI 10.1111/j.1558-5646.2008.00489.x; MAYR E, 1982, AUK, V99, P593; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; McGee Ray M., 1994, FLORIDA ANTHR, V47, P333; Meloro C, 2017, J ZOOL SYST EVOL RES, V55, P269, DOI 10.1111/jzs.12171; Mihailova M, 2014, ANIM BEHAV, V95, P155, DOI 10.1016/j.anbehav.2014.07.012; MILSTEAD W W, 1969, Bulletin of the Florida State Museum Biological Sciences, V14, P1; Milstead W. W., 1965, COPEIA, V4, P513; MILSTEAD WILLIAM W., 1956, COPEIA, V1956, P162, DOI 10.2307/1439631; Minx P, 1996, HERPETOLOGICA, V52, P584; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; MONTANUCCI R R, 1992, Herpetological Review, V23, P9; Morgan Gary S., 1995, Bulletin of the Florida Museum of Natural History, V37, P1; MOSIMANN J. E., 1958, REV CANADIENNE BIOL, V17, P137; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Neuwirth E., 2014, RCOLORBREWER COLORBR; Nichols J.T., 1939, COPEIA, V1939, P14, DOI DOI 10.2307/1436010; Nichols JT., 1917, COPEIA, V46, P66; Oksanen J, 2017, VEGAN COMMUNITY ECOL; Otvos E.G., 1996, T GULF COAST ASS GEO, V46, P333; Oyler-McCance Sara J., 2010, Ornithological Monographs, V67, P114; Patten MA, 2002, AUK, V119, P26, DOI 10.1642/0004-8038(2002)119[0026:DVMDOS]2.0.CO;2; Patten Michael A., 2010, Ornithological Monographs, V67, P35; Patterson DB, 2012, SOUTHEAST NAT, V11, P163, DOI 10.1656/058.011.0201; Patton JL, 2017, J MAMMAL, V98, P1010, DOI 10.1093/jmammal/gyx074; Perez SI, 2010, J EVOLUTION BIOL, V23, P237, DOI 10.1111/j.1420-9101.2009.01905.x; Phillimore AB, 2008, MOL ECOL, V17, P2839, DOI 10.1111/j.1365-294X.2008.03794.x; Phillimore AB, 2007, EVOLUTION, V61, P942, DOI 10.1111/j.1558-5646.2007.00068.x; Pilgrim Melissa A., 1997, Chelonian Conservation and Biology, V2, P483; Pluckhahn TJ, 2012, J FIELD ARCHAEOL, V37, P289, DOI 10.1179/0093469012Z.00000000026; Polly PD, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1111225; Polly PD, 2003, J MAMMAL, V84, P369, DOI 10.1644/1545-1542(2003)084<0369:PTTOGD>2.0.CO;2; Polly PD, 2001, GENETICA, V112, P339, DOI 10.1023/A:1013395907225; Pratt H.D., 2010, AVIAN SUBSPECIES, V67, P78, DOI DOI 10.1525/0M.2010.67.1.79; Purdy B. A., 2015, PALEOAMERICA, V1, P266; Railsback LB, 2015, QUATERNARY SCI REV, V111, P94, DOI 10.1016/j.quascirev.2015.01.012; Ram K., 2015, WESANDERSON W ANDERS; Ramakrishnan U, 2009, MOL ECOL, V18, P1310, DOI 10.1111/j.1365-294X.2009.04092.x; Rohlf, 2010, TPSDIG2 VERSION 216; Rohlf F.J., 1990, SPECIAL PUBLICATION, V2, p[227, 380]; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; Rohlf FJ, 2010, TPSRELW VERSION 1 49, P11794; Ross JD, 2014, AUK, V131, P298, DOI 10.1642/AUK-13-246.1; Ryan PG, 2008, BIRD CONSERV INT, V18, P20, DOI 10.1017/S095927090800004X; Schwartz C.W., 1974, 3 TOED BOX TURTLE CE; Schwartz ER, 1984, 3 TOED BOX TURTLE CE; Schweizer RM, 2016, MOL ECOL, V25, P380, DOI 10.1111/mec.13364; Scrucca L, 2016, R J, V8, P289; Sheets HD, 2014, CVAGEN 8; Skalski JR, 2008, J AGR BIOL ENVIR ST, V13, P199, DOI 10.1198/108571108X310771; Sol D, 2005, EVOLUTION, V59, P2669, DOI 10.1111/j.0014-3820.2005.tb00978.x; St Clair RC, 1998, OECOLOGIA, V115, P501, DOI 10.1007/s004420050547; Stayton CT, 2011, ZOOLOGY, V114, P213, DOI 10.1016/j.zool.2011.03.002; Stewart TD, 1946, REEXAMANIATION HUMAN; Steyer JS, 2000, B SOC GEOL FR, V171, P127; STICKEL LF, 1950, ECOL MONOGR, V20, P353, DOI 10.2307/1943570; STICKEL LF, 1989, J HERPETOL, V23, P216, DOI 10.2307/1564442; STORER RW, 1982, AUK, V99, P599; Team RC., 2013, R LANG ENV STAT COMP; Trewick SA, 2016, IBIS, V158, P747, DOI 10.1111/ibi.12398; Van Bocxlaer B, 2013, P NATL ACAD SCI USA, V110, P13892, DOI 10.1073/pnas.1308588110; Verdon E, 2005, J HERPETOL, V39, P572, DOI 10.1670/131-04A.1; Vitek NS, 2012, J VERTEBR PALEONTOL, V32, P189; Walker D, 1998, ANNU REV ECOL SYST, V29, P23, DOI 10.1146/annurev.ecolsys.29.1.23; Webb S.D., 1974, P5; West JM, 2016, HERPETOL CONSERV BIO, V11, P459; Wickham H., 2016, SCALES SCALE FUNCTIO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson DS, 2003, HERPETOLOGICA, V59, P178, DOI 10.1655/0018-0831(2003)059[0178:EAOTFG]2.0.CO;2; Winker Kevin, 2010, Ornithological Monographs, V67, P6; Yann LT, 2014, PALAEOGEOGR PALAEOCL, V414, P370, DOI 10.1016/j.palaeo.2014.09.020; Yann LT, 2016, PALAEOGEOGRAPHY PALA; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617; Zink RM, 2016, AUK, V133, P59, DOI 10.1642/AUK-15-63.1; Zug G.R., 1991, Society for the Study of Amphibians and Reptiles Herpetological Circular, P1; ZUSI RL, 1982, AUK, V99, P606	175	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193437	10.1371/journal.pone.0193437	http://dx.doi.org/10.1371/journal.pone.0193437			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513709	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800060
J	Huang, YY; Hu, Y; Chen, LC; Yang, T; Huang, HF; Shi, RP; Lu, P; Zhong, CH				Huang, Yaoyao; Hu, Yang; Chen, Lvcun; Yang, Tao; Huang, Hanfang; Shi, Runping; Lu, Peng; Zhong, Chenghua			Selective biosorption of thorium (IV) from aqueous solutions by ginkgo leaf	PLOS ONE			English	Article							NITRIC-ACID SOLUTION; SOLID-PHASE EXTRACTION; HEAVY-METAL IONS; SOLVENT-EXTRACTION; SACCHAROMYCES-CEREVISIAE; RARE-EARTHS; WHEAT BRAN; ADSORPTION; URANIUM; REMOVAL	Low-cost biosorbents (ginkgo leaf, osmanthus leaf, banyan leaf, magnolia leaf, holly leaf, walnut shell, and grapefruit peel) were evaluated in the simultaneous removal of La3+, Ce3+, Pr3+, Nd3+, Sm3+, Eu3+, Gd3+, Yb3+, Lu3+, UO22+, Th4+, Y3+, Co2+, Zn2+, Ni2+, and Sr2+ from aqueous solutions. In single metal systems, all adsorbents exhibited good to excellent adsorption capacities toward lanthanides and actinides. In a simulated multicomponent mixed solution study, higher selectivity and efficiency were observed for Th4+ over other metal cations, with ginkgo leaves providing the highest adsorptivity (81.2%) among the seven biosorbents. Through optimization studies, the selectivity of Th4+ biosorption on ginkgo leaf was found to be highly pH-dependent, with optimum Th4+ removal observed at pH 4. Th4+ adsorption was found to proceed rapidly with an equilibrium time of 120 min and conform to pseudo-second-order kinetics. The Langmuir isotherm model best described Th4+ biosorption, with a maximum monolayer adsorption capacity of 103.8 mg g(-1). Thermodynamic calculations indicated that Th4+ biosorption was spontaneous and endothermic. Furthermore, the physical and chemical properties of the adsorbent were determined by scanning electron microscopy, Brunauer-Emmett-Teller, X-ray powder diffraction, and Fourier transform infrared analysis. The biosorption of Th from a real sample (monazite mineral) was studied and an efficiency of 90.4% was achieved from nitric acid at pH 4 using ginkgo leaves.	[Huang, Yaoyao; Chen, Lvcun; Huang, Hanfang; Shi, Runping; Lu, Peng; Zhong, Chenghua] Chongqing Technol & Business Univ, Coll Environm & Resources, Chongqing, Peoples R China; [Hu, Yang; Yang, Tao; Zhong, Chenghua] Chongqing Univ, Coll Urban Construct & Environm Engn, Chongqing, Peoples R China	Chongqing Technology & Business University; Chongqing University	Zhong, CH (corresponding author), Chongqing Technol & Business Univ, Coll Environm & Resources, Chongqing, Peoples R China.; Zhong, CH (corresponding author), Chongqing Univ, Coll Urban Construct & Environm Engn, Chongqing, Peoples R China.	zhongchenghua2007@163.com	huang, yao/GWR-5388-2022	zhong, cheng hua/0000-0002-5510-7564	Innovative Entrepreneurship Training Program of Chongqing [201711799019]; Innovative project from Chongqing Technology and Business University (CTBU) [yjscxx2017-066-66]; Science and Technology Innovation Fund projects from CTBU [173020, 179028]; Science and Technology Research Project of Chongqing Municipal Education Commission [KJ130704]	Innovative Entrepreneurship Training Program of Chongqing; Innovative project from Chongqing Technology and Business University (CTBU); Science and Technology Innovation Fund projects from CTBU; Science and Technology Research Project of Chongqing Municipal Education Commission	This research was financially supported by the Innovative Entrepreneurship Training Program of Chongqing (201711799019), the Innovative project from Chongqing Technology and Business University (CTBU) (yjscxx2017-066-66), and the Science and Technology Innovation Fund projects from CTBU (173020 and 179028), and the Science and Technology Research Project of Chongqing Municipal Education Commission (KJ130704).The funders had no role in study	Abbasizadeh S, 2013, CHEM ENG J, V220, P161, DOI 10.1016/j.cej.2013.01.029; Akkaya R, 2013, J ENVIRON RADIOACTIV, V120, P58, DOI 10.1016/j.jenvrad.2012.11.015; Aksu Z, 2001, SEP PURIF TECHNOL, V21, P285, DOI 10.1016/S1383-5866(00)00212-4; Amer TE, 2013, INT J MINER PROCESS, V125, P106, DOI 10.1016/j.minpro.2013.10.004; Anirudhan TS, 2013, J ENVIRON RADIOACTIV, V116, P141, DOI 10.1016/j.jenvrad.2012.10.001; [Anonymous], [No title captured]; Arisaka M, 2011, SOLVENT EXTR ION EXC, V29, P72, DOI 10.1080/07366299.2011.539127; Avivar J, 2012, J ANAL ATOM SPECTROM, V27, P327, DOI 10.1039/c2ja10304d; Bagherifam S, 2010, J RADIOANAL NUCL CH, V283, P289, DOI 10.1007/s10967-009-0348-4; Baybas D, 2011, APPL CLAY SCI, V51, P138, DOI 10.1016/j.clay.2010.11.020; Berry L, 2017, MINER ENG, V109, P32, DOI 10.1016/j.mineng.2017.02.007; Bhainsa KC, 2009, J HAZARD MATER, V165, P670, DOI 10.1016/j.jhazmat.2008.10.033; Bhatnagar A, 2015, CHEM ENG J, V270, P244, DOI 10.1016/j.cej.2015.01.135; Bishay AF, 2010, J RADIOANAL NUCL CH, V286, P81, DOI 10.1007/s10967-010-0620-7; Bursali EA, 2010, J RADIOANAL NUCL CH, V283, P471, DOI 10.1007/s10967-009-0365-3; Chen SH, 2012, BIORESOURCE TECHNOL, V113, P114, DOI 10.1016/j.biortech.2011.11.110; Cho NS, 1999, J WOOD SCI, V45, P266, DOI 10.1007/BF01177738; Chu HZ, 2014, J HAZARD MATER, V264, P211, DOI 10.1016/j.jhazmat.2013.11.021; Das D, 2014, MINER ENG, V69, P40, DOI 10.1016/j.mineng.2014.06.013; Deb AKS, 2013, J RADIOANAL NUCL CH, V295, P1161, DOI 10.1007/s10967-012-1899-3; El-Ashtoukhy ESZ, 2008, DESALINATION, V223, P162, DOI 10.1016/j.desal.2007.01.206; Faghihian H, 2012, J RADIOANAL NUCL CH, V293, P463, DOI 10.1007/s10967-012-1814-y; Fang YY, 2015, DALTON T, V44, P14584, DOI 10.1039/c5dt00089k; Farinella NV, 2007, BIORESOURCE TECHNOL, V98, P1940, DOI 10.1016/j.biortech.2006.07.043; Farooq U, 2010, BIORESOURCE TECHNOL, V101, P5043, DOI 10.1016/j.biortech.2010.02.030; GADD GM, 1989, ENVIRON POLLUT, V61, P187, DOI 10.1016/0269-7491(89)90240-6; Gnanasambandam R, 2000, FOOD CHEM, V68, P327, DOI 10.1016/S0308-8146(99)00191-0; Guo XY, 2008, J HAZARD MATER, V151, P134, DOI 10.1016/j.jhazmat.2007.05.065; He LT, 2013, J CHEM TECHNOL BIOT, V88, P1930, DOI 10.1002/jctb.4055; Hinwood AL, 2015, ENVIRON POLLUT, V204, P256, DOI 10.1016/j.envpol.2015.04.024; Ho YS, 2006, BIOCHEM ENG J, V30, P117, DOI 10.1016/j.bej.2006.02.012; Hritcu D, 2012, CARBOHYD POLYM, V87, P1185, DOI 10.1016/j.carbpol.2011.08.095; Hu C, 2016, J RADIOANAL NUCL CH, V308, P251, DOI 10.1007/s10967-015-4306-z; Huang H, 2014, SEP PURIF TECHNOL, V138, P65, DOI 10.1016/j.seppur.2014.10.008; Huang H, 2014, SEP PURIF TECHNOL, V123, P235, DOI 10.1016/j.seppur.2013.12.039; Iqbal M, 2009, J HAZARD MATER, V164, P161, DOI 10.1016/j.jhazmat.2008.07.141; Jacobs BP, 2000, AM J MED, V108, P341, DOI 10.1016/S0002-9343(00)00290-4; Raju CSK, 2007, SEP PURIF TECHNOL, V55, P16, DOI 10.1016/j.seppur.2006.10.013; Keshtkar AR, 2014, KOREAN J CHEM ENG, V31, P289, DOI 10.1007/s11814-013-0220-7; KHAN SA, 1995, WASTE MANAGE, V15, P271, DOI 10.1016/0956-053X(95)00025-U; Kul M, 2008, HYDROMETALLURGY, V93, P129, DOI 10.1016/j.hydromet.2007.11.008; Kutahyali C, 2010, J NUCL MATER, V396, P251, DOI 10.1016/j.jnucmat.2009.11.018; Lara E, 2015, RADIAT PHYS CHEM, V116, P317, DOI 10.1016/j.radphyschem.2015.02.017; Li L, 2017, SEP PURIF TECHNOL, V188, P485, DOI 10.1016/j.seppur.2017.07.003; Li Q, 2010, CHEM ENG J, V158, P489, DOI 10.1016/j.cej.2010.01.033; Li Q, 2012, J RADIOANAL NUCL CH, V293, P67, DOI 10.1007/s10967-012-1720-3; Li RF, 2017, SEP PURIF TECHNOL, V188, P219, DOI 10.1016/j.seppur.2017.07.038; Li XL, 2013, J RADIOANAL NUCL CH, V298, P47, DOI 10.1007/s10967-013-2617-5; Liao XP, 2004, J RADIOANAL NUCL CH, V260, P619, DOI 10.1023/B:JRNC.0000028222.85988.40; Lugo-Lugo V, 2009, J HAZARD MATER, V161, P1255, DOI 10.1016/j.jhazmat.2008.04.087; Mastren T, 2018, ANAL CHIM ACTA, V998, P75, DOI 10.1016/j.aca.2017.10.020; Mastren T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08506-9; Minamisawa M, 2004, J AGR FOOD CHEM, V52, P5606, DOI 10.1021/jf0496402; Mitrovic B, 2016, ENVIRON POLLUT, V215, P273, DOI 10.1016/j.envpol.2016.05.031; Mohanta TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032822; Monji AB, 2015, J RADIOANAL NUCL CH, V303, P949, DOI 10.1007/s10967-014-3559-2; Monji AB, 2008, SEP SCI TECHNOL, V43, P597, DOI 10.1080/01496390701787453; Monji AB, 2016, J HAZARD TOXIC RADIO, V20, DOI 10.1061/(ASCE)HZ.2153-5515.0000296; Mu JX, 2012, APPL MECH MATER, V130-134, P829, DOI 10.4028/www.scientific.net/AMM.130-134.829; Nakajima A., 2002, J NUCL SCI TECHNOL, V39, P528, DOI [10.1080/00223131.2002.10875523, DOI 10.1080/00223131.2002.10875523]; Ngah WSW, 2011, CARBOHYD POLYM, V83, P1446, DOI 10.1016/j.carbpol.2010.11.004; Nilchi A, 2013, DESALINATION, V321, P67, DOI 10.1016/j.desal.2012.06.022; Oyewo OA, 2016, J ENVIRON RADIOACTIV, V164, P369, DOI 10.1016/j.jenvrad.2016.08.014; Pool JA, 2005, J AM CHEM SOC, V127, P1338, DOI 10.1021/ja044153o; Radchenko V, 2017, TALANTA, V175, P318, DOI 10.1016/j.talanta.2017.07.057; Rao A, 2016, SEP PURIF TECHNOL, V161, P159, DOI 10.1016/j.seppur.2016.01.027; Seydoux-Guillaume AM, 2002, CHEM GEOL, V191, P165, DOI 10.1016/S0009-2541(02)00155-9; Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036; Tan ML, 2015, SEP PURIF TECHNOL, V146, P192, DOI 10.1016/j.seppur.2015.03.027; Torab-Mostaedi M, 2015, RES CHEM INTERMEDIAT, V41, P559, DOI 10.1007/s11164-013-1210-4; Torun FE, 2006, J HAZARD MATER, V137, P293, DOI 10.1016/j.jhazmat.2006.02.003; Vearrier D, 2009, CLIN TOXICOL, V47, P393, DOI 10.1080/15563650902997849; Vijayalakshmi R, 2001, HYDROMETALLURGY, V61, P75, DOI 10.1016/S0304-386X(00)00159-6; Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002; Wang GH, 2009, J HAZARD MATER, V168, P1053, DOI 10.1016/j.jhazmat.2009.02.157; Wen J, 2016, CHEM-ASIAN J, V11, P49, DOI 10.1002/asia.201500834; Wen J, 2013, J HAZARD MATER, V263, P638, DOI 10.1016/j.jhazmat.2013.10.025; Xie F, 2014, MINER ENG, V56, P10, DOI 10.1016/j.mineng.2013.10.021; Yaftian MR, 2003, SEP PURIF TECHNOL, V31, P261, DOI 10.1016/S1383-5866(02)00203-4; Yang S, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0307-1; Yuan LY, 2014, ACS APPL MATER INTER, V6, P4786, DOI 10.1021/am405584h; Zehra T, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5255-8; Zhu L, 2016, J POLYM ENVIRON, V24, P148, DOI 10.1007/s10924-016-0757-8; Zhu M, 2016, J RADIOANAL NUCL CH, V310, P1; Zhu XK, 1999, CONTRIB MINERAL PETR, V137, P351, DOI 10.1007/s004100050555; Zou WH, 2012, J RADIOANAL NUCL CH, V292, P1303, DOI 10.1007/s10967-011-1602-0	86	23	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193659	10.1371/journal.pone.0193659	http://dx.doi.org/10.1371/journal.pone.0193659			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509801	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200021
J	Noblet, T; Marriott, J; Graham-Clarke, E; Shirley, D; Rushton, A				Noblet, Timothy; Marriott, John; Graham-Clarke, Emma; Shirley, Debra; Rushton, Alison			Clinical and cost-effectiveness of non-medical prescribing: A systematic review of randomised controlled trials	PLOS ONE			English	Review							VIEWS	Objective To evaluate the clinical and cost-effectiveness of non-medical prescribing (NMP). Design Systematic review. Two reviewers independently completed searches, eligibility assessment and assessment of risk of bias. Data sources Pre-defined search terms/combinations were utilised to search electronic databases. In addition, hand searches of reference lists, key journals and grey literature were employed alongside consultation with authors/experts. Eligibility criteria for included studies Randomised controlled trials (RCTs) evaluating clinical or cost-effectiveness of NMP. Measurements reported on one or more outcome(s) of: pain, function, disability, health, social impact, patient-safety, costs-analysis, quality adjusted life years (QALYs), patient satisfaction, clinician perception of clinical and functional outcomes. Results Three RCTs from two countries were included (n = 932 participants) across primary and tertiary care settings. One RCT was assessed as low risk of bias, one as high risk of bias and one as unclear risk of bias. All RCTs evaluated clinical effectiveness with one also evaluating cost-effectiveness. Clinical effectiveness was evaluated using a range of safety and patient-reported outcome measures. Participants demonstrated significant improvement in outcomes when receiving NMP compared to treatment as usual (TAU) in all RCTs. An associated cost analysis showed NMP to be more expensive than TAU (regression coefficient p = 0.0000), however experimental groups generated increased QALYs compared to TAU. Conclusion Limited evidence with overall unclear risk of bias exists evaluating clinical and cost-effectiveness of NMP across all professions and clinical settings. GRADE assessment revealed moderate quality evidence. Evidence suggests that NMP is safe and can provide beneficial clinical outcomes. Benefits to the health economy remain unclear, with the cost-effectiveness of NMP assessed by a single pilot RCT of low risk of bias. Adequately powered low risk of bias RCTs evaluating clinical and cost effectiveness are required to evaluate NMP across clinical specialities, professions and settings.	[Noblet, Timothy; Rushton, Alison] Univ Birmingham, Ctr Precis Rehabil Spinal Pain, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Marriott, John; Graham-Clarke, Emma] Univ Birmingham, Coll Med & Dent Sci, Inst Clin Sci, Birmingham, W Midlands, England; [Shirley, Debra] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia	University of Birmingham; University of Birmingham; University of Sydney	Noblet, T (corresponding author), Univ Birmingham, Ctr Precis Rehabil Spinal Pain, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England.	TDN818@bham.ac.uk	Graham-Clarke, Emma/U-1559-2019; Noblet, Tim/AAK-9611-2021; Graham-Clarke, Emma/GZG-8429-2022; Rushton, Alison/V-1260-2017	Graham-Clarke, Emma/0000-0001-5657-778X; Rushton, Alison/0000-0001-8114-7669; Noblet, Timothy/0000-0002-7032-9966	Academically Accredited Course funding grant - Chartered Society of Physiotherapy, UK (CSP)	Academically Accredited Course funding grant - Chartered Society of Physiotherapy, UK (CSP)	This systematic review was supported by an Academically Accredited Course funding grant awarded by the Chartered Society of Physiotherapy, UK (CSP). The CSP will accept no responsibility for content and have played no role in study design, methodology, data collection, data analysis/interpretation or report writing.	Akers J, 2009, CRDS GUIDANCE UNDERT; [Anonymous], 2016, NONMEDICAL PRESCRIBI; APA, 2015, PHYS PRESCR PATHW PR; Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Australian Commission on Safety and Quality in Health Care, 2010, PAT CENTR CAR IMPR Q; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bhanbhro S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-330; Bowling A., 2001, RES METHODS HLTH INV; Bruhn H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002361; Carey N, 2010, J CLIN NURS, V19, P498, DOI 10.1111/j.1365-2702.2009.02874.x; Courtenay M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-138; Deloitte Access Economics, 2015, EC AN IMPL PHYS PRES; Dorer, 2010, EVALUATION NURSE PHA; Fewtrell MS, 2008, ARCH DIS CHILD, V93, P458, DOI 10.1136/adc.2007.127316; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Hale AR, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003027; Hicks C., 1999, RES METHODS CLIN THE; Higgins JG, 2011, S COCHRANE HDB SYSTE; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; i5 Health, 2015, NONM PRESCR NMP EC E; Kroezen M, 2012, INT J NURS STUD, V49, P1002, DOI 10.1016/j.ijnurstu.2012.02.002; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MacLure K, 2013, INT J CLIN PHARM-NET, V35, P704, DOI 10.1007/s11096-013-9792-x; Marotti SB, 2011, ANAESTH INTENS CARE, V39, P1064, DOI 10.1177/0310057X1103900613; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Neilson AR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006874; NPC, 2012, SINGL COMP FRAM ALL; Routledge PA, 2012, BRIT J CLIN PHARMACO, V74, P676, DOI 10.1111/j.1365-2125.2012.04367.x; Stenner KL, 2011, INT J NURS STUD, V48, P37, DOI 10.1016/j.ijnurstu.2010.06.006; Weeks G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011227.pub2	32	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193286	10.1371/journal.pone.0193286	http://dx.doi.org/10.1371/journal.pone.0193286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509763	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200012
J	Page-Shipp, L; Lewis, JJ; Velen, K; Senoge, S; Zishiri, E; Popane, F; Chihota, VN; Clark, D; Churchyard, GJ; Charalambous, S				Page-Shipp, Liesl; Lewis, James J.; Velen, Kavindhran; Senoge, Sedikanelo; Zishiri, Elizabeth; Popane, Flora; Chihota, Violet N.; Clark, Dave; Churchyard, Gavin J.; Charalambous, Salome			Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV; TUBERCULOSIS; METAANALYSIS; SITES	Background In South Africa, TB household contact tracing provides an opportunity for increased TB and HIV case finding. We aimed to determine the effect of two new potential interventions for TB contact tracing programmes: Point of Care CD4 (PoC CD4) on HIV linkage to care and household Isoniazid Preventive Therapy (IPT) provision on uptake and retention of IPT. Methods A pragmatic, three-arm, cluster-randomized trial was undertaken. TB Household contacts were randomised to 3 arms: 1) Standard of Care TB and HIV testing (SOC); 2) SOC with POC CD4 for those testing HIV positive; 3) SOC with POC CD4 and IPT for eligible household members. Linkage to care within 90 days was assessed either through patient visits (at 10 weeks and 6 months) or via telephonic contact. Results 2,243 index TB patients and 3,012 contacts (64,3% female, median age 30 years) were enrolled. On self-report, 26(1.2%) were currently receiving TB treatment and 1816 (60.3%) reported a prior HIV test. HIV testing uptake was 34.7% in the SoC arm, 40.2% in the PoC CD4 arm (RR1.16, CI 0.99 +/- 1.36, p-value = 0.060) and 39.9% in the PoC CD4 + HH-IPT arm (RR = 1.15, CI 0.99 +/- 1.35, p-value = 0.075). Linkage to care within 3 months was 30.8% in the SoC arm and 42.1% in the POC CD4 arms (RR 1.37; CI: 0.68 +/- 2.76, p-value = 0.382). 20/ 21 contacts (95.2%) initiated IPT in the PoC CD4 + HH-IPT arm, compared to 3/20 (15.0%) in the PoC CD4 arm (p = 0.004; p-value from Fisher's exact test < 0.001). Among 3,008 contacts screened for tuberculosis, 15 (3.4%) had bacteriologically confirmed TB with an overall yield of TB of 0.5% (95% CI: 0.3%, 0.8%). Conclusions Household PoC CD4 testing and IPT initiation is feasible. There was only weak evidence that PoCCD4 led to a small increase in HCT uptake and no evidence for an increase in link-age-to-care. IPT initiation and completion was increased by the household intervention. Although feasible, these interventions had low impact due to the low uptake of HIV testing in households.	[Page-Shipp, Liesl; Velen, Kavindhran; Senoge, Sedikanelo; Zishiri, Elizabeth; Popane, Flora; Chihota, Violet N.; Clark, Dave; Churchyard, Gavin J.; Charalambous, Salome] Aurum Inst, Johannesburg, South Africa; [Lewis, James J.; Velen, Kavindhran; Churchyard, Gavin J.] London Sch Hyg & Trop Med, London, England; [Churchyard, Gavin J.; Charalambous, Salome] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Churchyard, Gavin J.; Charalambous, Salome] MRC, Collaborating Ctr Excellence, Adv Care & Treatment TB & HIV, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand	Page-Shipp, L (corresponding author), Aurum Inst, Johannesburg, South Africa.	liesl.pageshipp@ird.global	Chihota, Violet/DWH-9372-2022; Velen, Kavi/AAY-9855-2020	Velen, Kavi/0000-0001-8577-3915; Charalambous, Salome/0000-0001-7143-1009; Chihota, Violet/0000-0003-1444-9266; Lewis, James/0000-0002-8603-2761; Churchyard, Gavin/0000-0002-4269-3699	Sanofi Espoir Foundation; Sanofi South Africa; UK Medical Research Council (MRC) [MR/K012126/1]; UK Department for International Development (DFID) under the MRC/DFID Concordat agreement [MR/K012126/1]; EDCTP2 programme - European Union; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K012126/1, MR/K007467/1] Funding Source: researchfish	Sanofi Espoir Foundation; Sanofi South Africa(Sanofi-Aventis); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; EDCTP2 programme - European Union; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was partially funded by Sanofi Espoir Foundation (http://fondation-sanofi-espoir.com/en/) and Sanofi South Africa (http://www.sanofi.co.za). James Lewis was partially supported by grant number MR/K012126/1, jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement (https://www.mrc.ac.uk/funding/science-areas/international-global-health-research/funding-partnerships/mrc-dfid-concordat/) and is also part of the EDCTP2 (http://www.edctp.org/) programme supported by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Bristow CC, 2012, INT J TUBERC LUNG D, V16, P1020, DOI 10.5588/ijtld.11.0744; Deery CB, 2014, INT J TUBERC LUNG D, V18, P534, DOI 10.5588/ijtld.13.0587; Dorman SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041538; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Lala SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137518; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Lebina L, 2016, TUBERC RES TREAT, V2016; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Pillay Y, 2010, IMPLEMENTATION PHC R; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Thind D, 2012, INT J TUBERC LUNG D, V16, P1643, DOI 10.5588/ijtld.12.0074; UNAIDS, 2014, 90 90 90 AMB TREATM; Velen K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155688; Wachira J, 2014, JAIDS-J ACQ IMM DEF, V65, pE58, DOI 10.1097/QAI.0b013e3182a14f9e; WHO, 2013, WHOHTMTB201304; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0192089	10.1371/journal.pone.0192089	http://dx.doi.org/10.1371/journal.pone.0192089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499060	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000426472300001
J	Livi, S; Theodorou, A; Rullo, M; Cinque, L; Alessandri, G				Livi, Stefano; Theodorou, Annalisa; Rullo, Marika; Cinque, Luigi; Alessandri, Guido			The rocky road to prosocial behavior at work: The role of positivity and organizational socialization in preventing interpersonal strain	PLOS ONE			English	Article							NEWCOMER SOCIALIZATION; CITIZENSHIP BEHAVIORS; INTERACTIONIST PERSPECTIVE; PERFORMANCE; BURNOUT; METAANALYSIS; ORIENTATION; FUTURE; CONSEQUENCES; PERCEPTIONS	Among relevant consequences of organizational socialization, a key factor is the promotion of organizational citizenship behaviors toward individuals ( i.e. OCBI). However, the relation between organizational socialization and OCBI has received little attention. This study tests the validity of a moderated mediation model in which we examine the mediating effect of a decreased interpersonal strain on the relationship between organizational socialization and OCBI, and the moderation role of a positive personal resource in reducing interpersonal strain when an unsuccessful socialization subsists. A cross-sectional study was conducted on 765 new recruits of the Guardia di Finanza-a military Police Force reporting to the Italian Minister of Economy. Findings confirm our hypothesis that interpersonal strain mediates the relationship between organizational socialization and OCBI. The index of moderated mediation results significant, showing that this effect exists at different levels of positivity. Theoretical and practical implications for promoting pro-organizational behaviors are discussed.	[Livi, Stefano; Theodorou, Annalisa] Univ Rome Sapienza, Dept Social & Dev Psychol, Rome, Italy; [Rullo, Marika] Univ Lausanne, Inst Psychol, Lausanne, Switzerland; [Cinque, Luigi; Alessandri, Guido] Univ Rome Sapienza, Dept Psychol, Rome, Italy	Sapienza University Rome; University of Lausanne; Sapienza University Rome	Livi, S (corresponding author), Univ Rome Sapienza, Dept Social & Dev Psychol, Rome, Italy.	stefano.livi@uniroma1.it	Livi, Stefano/H-5348-2012; Theodorou, Annalisa/AAO-3803-2020; Alessandri, Guido/K-7863-2018	Theodorou, Annalisa/0000-0003-0759-764X; Alessandri, Guido/0000-0003-4731-5248; Livi, Stefano/0000-0001-5656-0267; rullo, marika/0000-0003-0642-5985	Sapienza Universita di Roma [1081/2016]	Sapienza Universita di Roma	GA received grant Progetto di Ateneo, No. 1081/2016 from Sapienza Universita di Roma. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri G, 2015, J HAPPINESS STUD, V16, P767, DOI 10.1007/s10902-014-9533-4; Alessandri G, 2012, MULTIVAR BEHAV RES, V47, P341, DOI 10.1080/00273171.2012.673954; Alessandri G, 2012, EUR PSYCHOL, V17, P44, DOI 10.1027/1016-9040/a000070; Antonovsky A., 1979, HLTH STRESS COPING; Bakker AB, 2000, J ORGAN BEHAV, V21, P425, DOI 10.1002/(SICI)1099-1379(200006)21:4<425::AID-JOB21>3.0.CO;2-#; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bauer T.N., 2012, OXFORD HDB ORG SOCIA, P97, DOI DOI 10.1093/OXFORDHB/9780199763672.013.0006; Bauer TN, 2007, J APPL PSYCHOL, V92, P707, DOI 10.1037/0021-9010.92.3.707; Bauer TN, 2006, J APPL PSYCHOL, V91, P298, DOI 10.1037/0021-9010.91.2.298; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Birnbaum M.H., 2000, PSYCHOL EXPT INTERNE; Borgogni L, 2012, EUR J WORK ORGAN PSY, V21, P875, DOI 10.1080/1359432X.2011.598653; Caprara GV, 2012, PSYCHOL ASSESSMENT, V24, P701, DOI 10.1037/a0026681; Caprara GV, 2009, BEHAV GENET, V39, P277, DOI 10.1007/s10519-009-9267-y; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; Cavus MF, 2012, WORK, V43, P361, DOI 10.3233/WOR-2012-1372; Chang CH, 2007, WORK STRESS, V21, P312, DOI 10.1080/02678370701758124; CHAO GT, 1994, J APPL PSYCHOL, V79, P730, DOI 10.1037/0021-9010.79.5.730; Chiaburu DS, 2008, J APPL PSYCHOL, V93, P1082, DOI 10.1037/0021-9010.93.5.1082; Cooper-Thomas H. D., 2006, J MANAGE PSYCHOL, V21, P492, DOI [10.1108/02683940610673997, DOI 10.1108/02683940610673997]; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Feldman D. C., 1981, ACAD MANAGE REV, V6, P309, DOI [10.5465/amr.1981.4287859., DOI 10.5465/AMR.1981.4287859, DOI 10.2307/257888]; Gorgievski M.J., 2008, HDB STRESS BURNOUT H, P7; Haueter JA, 2003, J VOCAT BEHAV, V63, P20, DOI 10.1016/S0001-8791(02)00017-9; Hayes, 2012, CISC VIS NETW IND GL; Hayes AF, 2015, MULTIVAR BEHAV RES, V50, P1, DOI 10.1080/00273171.2014.962683; Hobfoll S.E., 2011, OXFORD HDB STRESS HL, P127, DOI [10.1093/oxfordhb/9780195375343.013.0007, DOI 10.1093/OXFORDHB/9780195375343.013.0007, DOI 10.1093/OICFORDHB/9780195375343.013.0007]; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Hurst C., 2012, OXFORD HDB ORG SOCIA, P115; Joardar A, 2007, J INT MANAG, V13, P513, DOI 10.1016/j.intman.2007.02.002; Jokisaari M, 2012, OXFORD HDB ORG SOCIA; Kammeyer-Mueller JD, 2005, J APPL PSYCHOL, V90, P644, DOI 10.1037/0021-9010.90.4.644; Kammeyer-Mueller J, 2013, ACAD MANAGE J, V56, P1104, DOI 10.5465/amj.2010.0791; Lefever S, 2007, BRIT J EDUC TECHNOL, V38, P574, DOI 10.1111/j.1467-8535.2006.00638.x; Li N, 2011, J APPL PSYCHOL, V96, P1317, DOI 10.1037/a0024029; Liang SC, 2008, SOC BEHAV PERSONAL, V36, P197, DOI 10.2224/sbp.2008.36.2.197; Livi S., 2014, GIORNALE ITALIANO PS, V41, P505, DOI [10.1421/78500, DOI 10.1421/78500]; Livi S., 2016, MILITARY SOCIA UNPUB; Livi S, 2015, PERS INDIV DIFFER, V85, P230, DOI 10.1016/j.paid.2015.05.015; LOUIS MR, 1980, ADMIN SCI QUART, V25, P226, DOI 10.2307/2392453; Luthans F, 2002, J ORGAN BEHAV, V23, P695, DOI 10.1002/job.165; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Moreland R.L., 2006, SMALL GROUPS KEY REA, P469; Moreland RL, 1984, ROLE TRANSITIONS EXP, P181; MORRISON EW, 1994, ACAD MANAGE J, V37, P1543, DOI 10.2307/256798; MORRISON EW, 1993, ACAD MANAGE J, V36, P557, DOI 10.2307/256592; Organ D. W., 1988, ORGANISATIONAL CITIZ; Pavot W., 2008, J POSIT PSYCHOL, V3, P137, DOI [10.1080/17439760701756946, DOI 10.1080/17439760701756946]; Podsakoff NP, 2009, J APPL PSYCHOL, V94, P122, DOI 10.1037/a0013079; Podsakoff PM, 2000, J MANAGE, V26, P513, DOI 10.1177/014920630002600306; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; REICHERS AE, 1987, ACAD MANAGE REV, V12, P278; Saks AM, 2007, J VOCAT BEHAV, V70, P413, DOI 10.1016/j.jvb.2006.12.004; Saks AM, 1997, J VOCAT BEHAV, V51, P234, DOI 10.1006/jvbe.1997.1614; Salavati A., 2011, INTERDISCIPLINARY J, V3, P395; SCHNEIDER B, 1994, ORGAN DYN, V23, P17, DOI 10.1016/0090-2616(94)90085-X; Stamper CL, 2002, J ORGAN BEHAV, V23, P875, DOI 10.1002/job.175; Stamper CL, 2001, J ORGAN BEHAV, V22, P517, DOI 10.1002/job.100; Taormina R J, 2000, J Nurs Manag, V8, P89; Tepper BJ, 2001, J APPL PSYCHOL, V86, P789, DOI 10.1037/0021-9010.86.4.789; Thomas CH, 2009, HUM RESOUR MANAGE-US, V48, P417, DOI 10.1002/hrm.20288; Van Maanen J., 1979, RES ORGAN BEHAV, V1, P209, DOI [DOI 10.1108/S2046-410X(2013)0000001006, 10.1111/j.1468-2885.2009.01355.x, DOI 10.1111/J.1468-2885.2009.01355.X]; Van Scotter JR, 2000, J APPL PSYCHOL, V85, P526, DOI 10.1037/0021-9010.85.4.526; Wanberg C.R., 2012, OXFORD HDB SOCIALISA; WANOUS JP, 1992, J APPL PSYCHOL, V77, P288, DOI 10.1037/0021-9010.77.3.288; WILLIAMS LJ, 1991, J MANAGE, V17, P601, DOI 10.1177/014920639101700305	67	100	101	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193508	10.1371/journal.pone.0193508	http://dx.doi.org/10.1371/journal.pone.0193508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494621	Green Published, gold			2022-12-27	WOS:000426363200056
J	Zou, ML; Zhou, GF; Angessa, TT; Zhang, XQ; Li, CD				Zou, Meilin; Zhou, Gaofeng; Angessa, Tefera Tolera; Zhang, Xiao-Qi; Li, Chengdao			Polymorphism of floral type gene Cly1 and its association with thermal stress in barley	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SELF-POLLINATION; CLEISTOGAMY; ALLELE; QTL; IDENTIFICATION; AMPLIFICATION; INHERITANCE; EXPRESSION; PATTERNS	Cleistogamy refers to a type of sexual breeding system with closed flowers. Cleistogamous flowers shed their pollen before flower opening, which leads to autogamy. Two SNPs in the open reading frame region of the Cly1 gene are associated with floral type. In the present study, we investigated the floral type of 436 barley accessions. Molecular markers were developed to genotype these barley accessions based on the two SNPs in the Cly1 gene region. The molecular markers explained floral type in 90% of the accessions. The Cly1 gene was sequenced in accessions with inconsistent genotype and phenotype. Thirteen SNPs were detected with ten new SNPs in the gene region. We further investigated whether floral type was associated with temperature stress tolerance in four field trials. One site experienced frost stress with a minimum temperature of -3.4 degrees C during flowering. Grain fertility rates as low as 85% were observed at this site but ranged from 92-96% at the other three sites. The relationship between grain fertility rate and floral type under temperature stress was inconclusive. Some lines with higher grain fertility rates were identified under frost stress, and would be useful for frost stress studies in barley.	[Zou, Meilin; Zhou, Gaofeng; Angessa, Tefera Tolera; Zhang, Xiao-Qi; Li, Chengdao] Murdoch Univ, Western Barley Genet Alliance, Murdoch, WA, Australia; [Zou, Meilin; Zhou, Gaofeng; Angessa, Tefera Tolera; Zhang, Xiao-Qi; Li, Chengdao] Murdoch Univ, Western Australian State Agr Biotechnol Ctr, Murdoch, WA, Australia	Murdoch University; Murdoch University	Li, CD (corresponding author), Murdoch Univ, Western Barley Genet Alliance, Murdoch, WA, Australia.; Li, CD (corresponding author), Murdoch Univ, Western Australian State Agr Biotechnol Ctr, Murdoch, WA, Australia.	C.li@murdoch.edu.au	Angessa, Tefera/GLU-7090-2022	Angessa, Tefera Tolera/0000-0002-2400-1732	Australian Grains Research and Development Corporation [UMU00049]	Australian Grains Research and Development Corporation(Grains R&D Corp)	CL reveived the funding (UMU00049) from Australian Grains Research and Development Corporation (https://grdc.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abdel-Ghani AH, 2004, THEOR APPL GENET, V109, P588, DOI 10.1007/s00122-004-1657-1; Abiko M, 2005, SEX PLANT REPROD, V18, P91, DOI 10.1007/s00497-005-0004-2; Ball MP, 2009, NAT BIOTECHNOL, V27, P485, DOI 10.1038/nbt0509-485b; BILLADEAU D, 1991, BLOOD, V78, P3021; Calderini DF, 2001, EUPHYTICA, V119, P199, DOI 10.1023/A:1017597923568; Chen A, 2009, THEOR APPL GENET, V118, P1465, DOI 10.1007/s00122-009-0995-4; Cheplick Gregory P., 2007, Aliso, V23, P286; CHHABRA AK, 1991, EUPHYTICA, V55, P147, DOI 10.1007/BF00025227; Culley TM, 2007, BOT REV, V73, P1, DOI 10.1663/0006-8101(2007)73[1:TCBSAR]2.0.CO;2; Culley TM, 2002, INT J PLANT SCI, V163, P113, DOI 10.1086/324180; Dahleen LS, 2012, PLANT BREEDING, V131, P237, DOI 10.1111/j.1439-0523.2012.01952.x; Daniell H, 2002, NAT BIOTECHNOL, V20, P843, DOI 10.1038/nbt0802-843c; Fujii M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1726; Furukawa J, 2007, PLANT CELL PHYSIOL, V48, P1081, DOI 10.1093/pcp/pcm091; Honda I, 2005, PHYSIOL PLANTARUM, V124, P524, DOI 10.1111/j.1399-3054.2005.00541.x; Hori K, 2006, BREEDING SCI, V56, P25, DOI 10.1270/jsbbs.56.25; HOWARD PL, 1991, TRANSFUSION, V31, P441, DOI 10.1046/j.1537-2995.1991.31591263200.x; JOHANSEN B, 1994, SEX PLANT REPROD, V7, P259, DOI 10.1007/BF00227707; Karsai I, 2013, ANN APPL BIOL, V162, P309, DOI 10.1111/aab.12023; Koike S, 2015, PLANT PROD SCI, V18, P111, DOI 10.1626/pps.18.111; Liu XQ, 2008, J MULTIVARIATE ANAL, V99, P1503, DOI 10.1016/j.jmva.2008.01.004; LO ESF, 1991, HEPATOLOGY, V14, pA66; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Ma San-mei, 2004, Yichuan, V26, P556; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Matsui T, 2003, ANN BOT-LONDON, V91, P473, DOI 10.1093/aob/mcg045; MERWINE NC, 1981, CROP SCI, V21, P953, DOI 10.2135/cropsci1981.0011183X002100060036x; Morinaga S, 2008, J ECOL, V96, P1086, DOI 10.1111/j.1365-2745.2008.01392.x; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Peter CI, 2006, ANN BOT-LONDON, V97, P345, DOI 10.1093/aob/mcj041; PINDER SJ, 1990, BIOCHEM SOC T, V18, P675, DOI 10.1042/bst0180675; Reinheimer JL, 2004, THEOR APPL GENET, V109, P1267, DOI 10.1007/s00122-004-1736-3; SARKAR G, 1990, ANAL BIOCHEM, V186, P64, DOI 10.1016/0003-2697(90)90573-R; SILVERMAN LM, 1991, AM J HUM GENET, V49, P204; SUZUKI Y, 1991, ANAL BIOCHEM, V192, P82, DOI 10.1016/0003-2697(91)90188-Y; Takahashi R, 2001, J HERED, V92, P89, DOI 10.1093/jhered/92.1.89; Turuspekov Y, 2004, THEOR APPL GENET, V109, P480, DOI 10.1007/s00122-004-1673-1; Visioni A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-424; Wang N, 2015, GENETICS, V199, P95, DOI 10.1534/genetics.114.171652; Wang N, 2013, THEOR APPL GENET, V126, P2753, DOI 10.1007/s00122-013-2169-7; Yoshida H, 2007, PLANT BIOTECHNOL J, V5, P835, DOI 10.1111/j.1467-7652.2007.00291.x	41	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193390	10.1371/journal.pone.0193390	http://dx.doi.org/10.1371/journal.pone.0193390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494631	Green Published, gold			2022-12-27	WOS:000426363200042
J	Guo, YX; Walsh, AM; Canavan, M; Wechalekar, MD; Cole, S; Yin, XF; Scott, B; Loza, M; Orr, C; McGarry, T; Bombardieri, M; Humby, F; Proudman, SM; Pitzalis, C; Smith, MD; Friedman, JR; Anderson, I; Madakamutil, L; Veale, DJ; Fearon, U; Nagpal, S				Guo, Yanxia; Walsh, Alice M.; Canavan, Mary; Wechalekar, Mihir D.; Cole, Suzanne; Yin, Xuefeng; Scott, Brittney; Loza, Mathew; Orr, Carl; McGarry, Trudy; Bombardieri, Michele; Humby, Frances; Proudman, Susanna M.; Pitzalis, Costantino; Smith, Malcolm D.; Friedman, Joshua R.; Anderson, Ian; Madakamutil, Loui; Veale, Douglas J.; Fearon, Ursula; Nagpal, Sunil			Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression	PLOS ONE			English	Article							T-CELL RESPONSES; SOLUBLE PD-1; INFLAMMATORY ARTHRITIS; ABERRANT REGULATION; NIVOLUMAB; FAMILY; ACTIVATION; MOLECULES; ANTI-PD-1; RECEPTOR	Immune checkpoint blockade with therapeutic anti-cytotoxic T lymphocyte-associated antigen (CTLA)-4 (Ipilimumab) and anti-programmed death (PD)-1 (Nivolumab and Pembrolizumab) antibodies alone or in combination has shown remarkable efficacy in multiple cancer types, concomitant with immune-related adverse events, including arthralgia and inflammatory arthritis (IA) in some patients. Herein, using Nivolumab (anti-PD-1 antagonist)-responsive genes along with transcriptomics of synovial tissue from multiple stages of rheumatoid arthritis (RA) disease progression, we have interrogated the activity status of PD-1 pathway during RA development. We demonstrate that the expression of PD-1 was increased in early and established RA synovial tissue compared to normal and OA synovium, whereas that of its ligands, programmed death ligand-1 (PD-L1) and PD-L2, was increased at all the stages of RA disease progression, namely arthralgia, IA/undifferentiated arthritis, early RA and established RA. Further, we show that RA patients expressed PD-1 on a majority of synovial tissue infiltrating CD4(+) and CD8(+) T cells. Moreover, enrichment of Nivolumab gene signature was observed in IA and RA, indicating that the PD-1 pathway was downregulated during RA disease progression. Furthermore, serum soluble (s) PD-1 levels were increased in autoantibody positive early RA patients. Interestingly, most of the early RA synovium tissue sections showed negative PD-L1 staining by immunohistochemistry. Therefore, downregulation in PD-1 inhibitory signaling in RA could be attributed to increased serum sPD-1 and decreased synovial tissue PD-L1 levels. Taken together, these data suggest that agonistic PD1 anti-body-based therapeutics may show efficacy in RA treatment and interception.	[Guo, Yanxia; Walsh, Alice M.; Cole, Suzanne; Yin, Xuefeng; Scott, Brittney; Loza, Mathew; Friedman, Joshua R.; Anderson, Ian; Madakamutil, Loui; Nagpal, Sunil] Janssen Res, Immunol, Horsham, PA 19044 USA; [Canavan, Mary; McGarry, Trudy; Fearon, Ursula] Trinity Coll Dublin, Trinity Biomed Sci Inst, Mol Rheumatol, Dublin, Ireland; [Wechalekar, Mihir D.; Smith, Malcolm D.] Repatriat Gen Hosp, Rheumatol Unit, Adelaide, SA, Australia; [Wechalekar, Mihir D.; Smith, Malcolm D.] Flinders Univ S Australia, Adelaide, SA, Australia; [Orr, Carl; Veale, Douglas J.] Univ Coll Dublin, St Vincents Univ Hosp, Ctr Arthrit & Rheumat Dis, Elm Pk, Dublin, Ireland; [Bombardieri, Michele; Humby, Frances; Pitzalis, Costantino] Queen Mary Univ London, Charterhouse Sq, London, England; [Proudman, Susanna M.] Royal Adelaide Hosp, Rheumatol Unit, Adelaide, SA, Australia; [Proudman, Susanna M.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	Trinity College Dublin; Flinders University South Australia; Flinders University South Australia; University College Dublin; Saint Vincent's University Hospital; University of London; Queen Mary University London; Royal Adelaide Hospital; University of Adelaide	Nagpal, S (corresponding author), Janssen Res, Immunol, Horsham, PA 19044 USA.; Fearon, U (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Mol Rheumatol, Dublin, Ireland.	ursula.fearon@ucd.ie; snagpal2@its.jnj.com	humby, frances/GSE-3706-2022; Friedman, Joshua/Q-9367-2019; Wechalekar, Mihir/H-8114-2013; humby, frances/AAG-1787-2019	Friedman, Joshua/0000-0001-9382-8429; Wechalekar, Mihir/0000-0001-6668-9638; humby, frances/0000-0003-1280-9133; Fearon, Ursula/0000-0001-8084-0429; Walsh, Alice/0000-0001-5905-5768; Loza, Matthew/0000-0002-8609-118X; Canavan, Mary/0000-0003-2310-2563; Pitzalis, Costantino/0000-0003-1326-5051; Veale, Douglas/0000-0003-2802-4971	Johnson Johnson; MRC [G0800648] Funding Source: UKRI	Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by funding from Johnson & Johnson. The funder provided support in the form of funding for data generation and salaries for authors [YG, AMW, SC, XY, BS, ML, JRF, IA, LM, SN], but did not have any additional role in the study design, decision to publish, or preparation of the manuscript.	Amancha PK, 2013, J IMMUNOL, V191, P6060, DOI 10.4049/jimmunol.1302044; BANKHURST AD, 1976, ARTHRITIS RHEUM, V19, P555, DOI 10.1002/art.1780190307; Bommarito D, 2017, CLIN EXP IMMUNOL, V188, P455, DOI 10.1111/cei.12949; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Cappelli LC, 2017, ANN RHEUM DIS, V76, P43, DOI 10.1136/annrheumdis-2016-209595; Chan MMK, 2015, J IMMUNOTHER, V38, P37, DOI 10.1097/CJI.0000000000000060; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Choueiri TK, 2016, CLIN CANCER RES, V22, P5461, DOI 10.1158/1078-0432.CCR-15-2839; Dai SY, 2014, CELL IMMUNOL, V290, P72, DOI 10.1016/j.cellimm.2014.05.006; De Felice KM, 2015, MELANOMA RES, V25, P321, DOI 10.1097/CMR.0000000000000165; Deane KD, 2012, ARTHRITIS RHEUM-US, V64, P1708, DOI 10.1002/art.34445; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Greisen SR, 2014, SCAND J RHEUMATOL, V43, P101, DOI 10.3109/03009742.2013.823517; Guo Y, 2017, J IMMUNOL; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hatachi S, 2003, J RHEUMATOL, V30, P1410; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Isaacs JD, 2008, RHEUMATOLOGY, V47, P1461, DOI 10.1093/rheumatology/ken163; Keating GM, 2013, DRUGS, V73, P1095, DOI 10.1007/s40265-013-0080-9; Law-Ping-Man S, 2016, RHEUMATOLOGY, V55, P2087, DOI 10.1093/rheumatology/kew281; Liu CP, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0859-z; Moret FM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0497-x; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Onlamoon N, 2008, IMMUNOLOGY, V124, P277, DOI 10.1111/j.1365-2567.2007.02766.x; Pitzalis C, 2013, CURR OPIN RHEUMATOL, V25, P334, DOI 10.1097/BOR.0b013e32835fd8eb; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Raptopoulou AP, 2010, ARTHRITIS RHEUM-US, V62, P1870, DOI 10.1002/art.27500; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shin SP, 2013, MOL THER, V21, P688, DOI 10.1038/mt.2012.252; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wu HJ, 2009, IMMUNOL INVEST, V38, P408, DOI 10.1080/08820130902912332; Zhu XX, 2017, ONCOTARGET, V8, P97671, DOI 10.18632/oncotarget.18311; Zimmer L, 2016, EUR J CANCER, V60, P210, DOI 10.1016/j.ejca.2016.02.024	39	68	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192704	10.1371/journal.pone.0192704	http://dx.doi.org/10.1371/journal.pone.0192704			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489833	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000039
J	Huang, J; Zhao, ZJ; AlSmadi, JK; Liang, XF; Zhong, FL; Zeng, T; Wu, WZ; Deng, T; Lai, YC; Liu, LH; Zeng, GH; Wu, WQ				Huang, Jian; Zhao, Zhijian; AlSmadi, Jad Khaled; Liang, Xiongfa; Zhong, Fangling; Zeng, Tao; Wu, Weizhou; Deng, Tuo; Lai, Yongchang; Liu, Luhao; Zeng, Guohua; Wu, Wenqi			Use of the ureteral access sheath during ureteroscopy: A systematic review and meta-analysis	PLOS ONE			English	Review							STONES; OUTCOMES; QUALITY; BIAS	The debate still rages on for the usefulness of ureteral access sheath (UAS). Therefore, a meta-analysis to discuss the effects of applying UAS during ureteroscopy was performed. The protocol for the review is available on PROSPERO (CRD42017052327). A literature search was conducted up to November, 2017 using the Web of science, PUBMED, EMBASE and Cochrane Library. The quality of articles was assessed by the Jadad scale and Newcastle Ottawa Scale (NOS). Egger's test and the trim-and-fill method were used to evaluate publication bias. Effect sizes were calculated by pooled odds ratio (ORs) and mean differences (MDs). Sensitivity analyses and subgroup analyses were performed to explore the origin of heterogeneity. Eight trials with a total of 3099 patients and 3127 procedures were identified. Results showed no significant difference in stone-free rate (SFR) (OR = 0.83, 95% CI 0.52-1.33, P = 0.45), intraoperative complications (OR = 1.16, 95% CI 0.81-7.69, P = 0.88), operative time (MD = 4.09, 95% CI -15.08-23.26, P = 0.68) and hospitalization duration (MD = -0.13, 95% CI -0.32-0.06, P = 0.18). However, the incidence of postoperative complications was higher in UAS group (OR = 1.46, 95% CI 1.06-2.00, P = 0.02). Evidence from meta-analysis indicated that the use of UAS during ureteroscopy did not manifest advantages. However, given the intrinsic restrictions of the quality of selected articles, more randomized controlled trials (RCTs) are warranted to update the findings of this analysis.	[Huang, Jian; Zhao, Zhijian; AlSmadi, Jad Khaled; Liang, Xiongfa; Zhong, Fangling; Zeng, Tao; Wu, Weizhou; Deng, Tuo; Lai, Yongchang; Liu, Luhao; Zeng, Guohua; Wu, Wenqi] Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Key Lab Urol, Dept Urol,Minimally Invas Surg Ctr,Guangzhou Inst, Guangzhou, Guangdong, Peoples R China; [Liu, Luhao] Guangzhou Med Univ, Affiliated Hosp 2, Dept Organ Transplantat, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Wu, WQ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Key Lab Urol, Dept Urol,Minimally Invas Surg Ctr,Guangzhou Inst, Guangzhou, Guangdong, Peoples R China.	wwqwml@163.com	wu, weizhou/C-2399-2018; AlSmadi, Jad/AAE-7481-2022; AlSmadi, Jad/AFK-0587-2022	AlSmadi, Jad/0000-0002-4393-7405; 	National Natural Science Foundation of China [81570633]; Science and Technology Planning Project of Guangzhou City, China [201604020001, 201607010359]; General Guide Project of Guangzhou City Bureau of Education [1201410963]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangzhou City, China; General Guide Project of Guangzhou City Bureau of Education	This work was financed by The National Natural Science Foundation of China (No.81570633); Science and Technology Planning Project of Guangzhou City, China (No.201604020001, 201607010359) and General Guide Project of Guangzhou City Bureau of Education (No.1201410963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams HM, 2004, UROL CLIN N AM, V31, P83, DOI 10.1016/S0094-0143(03)00085-5; Berquet G, 2014, WORLD J UROL, V32, P229, DOI 10.1007/s00345-013-1181-5; Breda A, 2016, CURR OPIN UROL, V26, P70, DOI 10.1097/MOU.0000000000000233; Breda A, 2009, EUR UROL, V55, P1190, DOI 10.1016/j.eururo.2008.06.019; De Sio M, 2004, UROL INT, V72, P55, DOI 10.1159/000076595; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Geraghty RM, 2016, SCAND J UROL, V50, P216, DOI 10.3109/21681805.2015.1121407; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Kaplan AG, 2016, NAT REV UROL, V13, P135, DOI 10.1038/nrurol.2015.271; Kourambas J, 2001, J UROLOGY, V165, P789, DOI 10.1016/S0022-5347(05)66527-5; L'Esperance JO, 2005, UROLOGY, V66, P252, DOI 10.1016/j.urology.2005.03.019; Lallas CD, 2002, J ENDOUROL, V16, P583, DOI 10.1089/089277902320913288; Lildal SK, 2017, J ENDOUROL, V31, P307, DOI 10.1089/end.2016.0773; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Monga M, 2001, J ENDOUROL, V15, P831, DOI 10.1089/089277901753205843; Pardalidis NP, 2006, UROL RES, V34, P211, DOI 10.1007/s00240-006-0044-6; Rehman J, 2003, UROLOGY, V61, P713, DOI 10.1016/S0090-4295(02)02440-8; Rizkala Emad R, 2013, Indian J Urol, V29, P244, DOI 10.4103/0970-1591.117287; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; TAKAYASU H, 1974, J UROLOGY, V112, P176, DOI 10.1016/S0022-5347(17)59675-5; Traxer O, 2015, WORLD J UROL, V33, P2137, DOI 10.1007/s00345-015-1582-8; Traxer O, 2013, J UROLOGY, V189, P580, DOI 10.1016/j.juro.2012.08.197; Vanlangendonck R, 2004, UROL CLIN N AM, V31, P71, DOI 10.1016/S0094-0143(03)00095-8; Wang HH, 2011, J UROLOGY, V186, P1728, DOI 10.1016/j.juro.2011.03.072; Wells G., NEWCASTLE OTTAWA SCA; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	30	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193600	10.1371/journal.pone.0193600	http://dx.doi.org/10.1371/journal.pone.0193600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489912	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000094
J	Kolie, D; Camara, BS; Delamou, A; Beavogul, AH; Hermans, V; Edwards, JK; Benedetti, G; Muller, CP; van Griensven, J; Zachariah, R				Kolie, Delphin; Camara, Bienvenu S.; Delamou, Alexandre; Beavogul, Abdoul H.; Hermans, Veerle; Edwards, Jeffrey K.; Benedetti, Guido; Muller, Claude P.; van Griensven, Johan; Zachariah, Rony			The Ebola-effect in Guinea 2014-15: Tangled trends of malaria care in children under-five	PLOS ONE			English	Article							OUTBREAK	Introduction The 2014-15 Ebola outbreak in West Africa was disruptive for the general health services in the affected countries. This study assessed the impact of the outbreak on the reported number and management of malaria in children under-five in rural Guinea. Materials and methods A retrospective cross-sectional study was conducted in nineteen health centres in two rural, malaria-endemic health districts, one at the epicentre of the outbreak (Gueckedou) and one (Koubia) spared by Ebola. Routine surveillance data at health facility level were compared over similar periods of high malaria transmission in both districts before, during and after the outbreak. Results There were significant declines in the number of visits during the Ebola outbreak (3,700) in Gueckedou compared to before (4,616) and after it (4,195), while this trend remained more stable within the three periods for Koubia. Differences were nonetheless significant in both districts (p<0.001). In 2014, during the peak of the outbreak, the overall number of malaria cases treated exceeded the number of confirmed malaria cases in Gueckedou. There were decreases in antimalarial treatment provision in August and November 2014. In contrast, during 2015 and 2016, the proportion of malaria positive cases and those treated were closely aligned. During the peak of the Ebola outbreak, there was a significant decrease in oral antimalarial drug administration, which corresponded to an increase in injectable antimalarial treatments. Stock-outs in rapid diagnostic tests were evident and prolonged in Gueckedou during the outbreak, while more limited in Koubia. Conclusion The Ebola outbreak of 2014-15 in Guinea had a significant impact on the admission and management of malaria in children under-five. This study identifies potential challenges in the delivery of care for those at highest risk for malaria mortality during an Ebola outbreak and the need to improve preparedness strategies pre-Ebola and health systems recovery post-Ebola.	[Kolie, Delphin; Camara, Bienvenu S.; Delamou, Alexandre; Beavogul, Abdoul H.] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea; [Delamou, Alexandre; Beavogul, Abdoul H.] Gamal Univ Conakry, Dept Publ Hlth, Conakry, Guinea; [Delamou, Alexandre] Woman & Child Hlth Res Ctr, Inst Trop Med, Antwerp, Belgium; [Hermans, Veerle; Edwards, Jeffrey K.; Benedetti, Guido; Zachariah, Rony] Operat Ctr Brussels, Med Sans Frontieres, Med Dept Operat Res, Luxembourg, Luxembourg; [Edwards, Jeffrey K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Muller, Claude P.] Luxembourg Inst Hlth, Dept Infect & Immun, Esch Sur Alzette, Luxembourg; [Muller, Claude P.] Lab Natl Sante, Dudelange, Luxembourg; [van Griensven, Johan] Inst Trop Med, Clin Sci Dept, Antwerp, Belgium	Institute of Tropical Medicine (ITM); Doctors Without Borders; University of Washington; University of Washington Seattle; Luxembourg Institute of Health; Institute of Tropical Medicine (ITM)	Kolie, D (corresponding author), Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea.	dkolie@maferinyah.org	Camara, Bienvenu/HGA-3369-2022	Hermans, Veerle/0000-0002-5232-992X; Benedetti, Guido/0000-0002-0788-8562; zachariah, rony/0000-0002-2915-9328	SORT-IT programme	SORT-IT programme	Open access publication cost was covered by the SORT-IT programme. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Barry M, 2014, MED MALADIES INFECT, V44, P491, DOI 10.1016/j.medmal.2014.09.009; Bolkan HA, 2014, PLOS CURR, DOI 10. 1371/currents. outbreaks. 0307d588df619f9c9447f8ead5b72b2d.; Camara BS, 2017, PUBLIC HEALTH ACTION, V7, P161, DOI 10.5588/pha.16.0120; Coordination Nationale Ebola en Guinee, 2015, RAPP HEBD SIT MAL EB; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Guilavogui T, 2016, IMPLEMENTING SEASONA; Guinean Ministry of Heath and World Health Organization, 2016, EB SIT REP; Hermans V, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0786-z; Leuenberger D, 2015, AIDS, V29, P1883, DOI 10.1097/QAD.0000000000000784; MOH, DEM HLTH SURV 2012; MOH, 2014, GUID TREATM MAL GUIN; Moisan F, 2016, EPIDEMIOL INFECT, V144, P2338, DOI 10.1017/S0950268816000728; Piot P, 2014, LANCET INFECT DIS; Plucinski MM, 2015, LANCET INFECT DIS; Ribacke KJB, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00222; Siekmans K, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-4012-y; Skrable K, 2017, NATURAL HIST ACUTE E; Thiam AB, 2015, PAN AFR MED J, V20, DOI [10.11694/pamj.supp.2015.22.1.6626, 10.11604/pamj.2015.20.379.6070]; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Waxman M, 2017, LANCET INFECT DIS, V17, P654, DOI 10.1016/S1473-3099(17)30112-3; WHO, EB RESP ROADM SIT RE; WHO, WORLD MAL REP 2016; 2013, SEAS MAL CHEM SULF, P1	24	11	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192798	10.1371/journal.pone.0192798	http://dx.doi.org/10.1371/journal.pone.0192798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489836	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000042
J	Merk, S; Rosman, T; Ruess, J; Syring, M; Schneider, J				Merk, Samuel; Rosman, Tom; Ruess, Julia; Syring, Marcus; Schneider, Juergen			Pre-service teachers' perceived value of general pedagogical knowledge for practice: Relations with epistemic beliefs and source beliefs (vol 12, e0184971, 2017)	PLOS ONE			English	Correction																		Merk S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184971	1	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193632	10.1371/journal.pone.0193632	http://dx.doi.org/10.1371/journal.pone.0193632			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474491	Green Published, Green Submitted, gold			2022-12-27	WOS:000426049500137
J	Boffa, J; Mayan, M; Ndlovu, S; Mhlaba, T; Williamson, T; Sauve, R; Fisher, D				Boffa, Jody; Mayan, Maria; Ndlovu, Sithembile; Mhlaba, Tsholofelo; Williamson, Tyler; Sauve, Reginald; Fisher, Dina			The role of agency in the implementation of Isoniazid Preventive Therapy (IPT): Lessons from oMakoti in uMgungundlovu District, South Africa	PLOS ONE			English	Article							ANTHROPOLOGY; BURDEN	Introduction In response to revisions in global and national policy in 2011, six-month isoniazid preventive therapy (IPT) became freely available as a preventive measure for people living with HIV in the uMgungundlovu District of KwaZulu-Natal province, South Africa. Given a difference in uptake and completion by sex, we sought to explore the reasons why Zulu women were more likely to accept and complete IPT compared to men in an effort to inform future implementation. Methods Utilising a community-based participatory research approach and ethnographic methods, we undertook 17 individual and group interviews, and met regularly with grassroots community advisory teams in three Zulu communities located in uMgungundlovu District between March 2012 December 2016. Findings & discussion Three categories described women's willingness to initiate IPT: women are caregivers, women are obedient, and appearance is important. The findings suggest that the success of IPT implementation amongst clinic-utilising women of uMgungundlovu is related to the cultural gender norms of uMakoti, isiZulu for "the bride" or "the wife." We invoke the cultural concept of inhlonipho, meaning "to show respect," to discuss how the cultural values of uMakoti may conflict with biomedical expectations of adherence. Such conflict can result in misinterpretations by healthcare providers or patients, and lead some patients to fear the repercussions of asking questions or contemplating discontinuation with the provider, preferring instead to appear obedient. We propose a shift in emphasis from adherence-focussed strategies, characteristic of the current biomedical approach, to practices that promote patient agency in an effort to offer IPT more appropriately. Implications Building on existing tools, namely the harm reduction model and the use of mini-ethnography, we provide guidance on how to support women to participate as agents in the decision to initiate or continue IPT, decisions which may also impact the health and choices of the family.	[Boffa, Jody; Williamson, Tyler; Sauve, Reginald; Fisher, Dina] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Boffa, Jody] Stellenbosch Univ, Desmond Tutu TB Ctr, Cape Town, Western Cape, South Africa; [Mayan, Maria] Univ Alberta, Fac Extens, Community Univ Partnerships, Edmonton, AB, Canada; [Ndlovu, Sithembile] Izlmbali Zesizwe, Pietermaritzburg, KwaZulu Natal, South Africa; [Mhlaba, Tsholofelo] Univ KwaZulu Natal, Div Publ Hlth Med, Durban, KwaZulu Natal, South Africa; [Sauve, Reginald] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Fisher, Dina] Univ Calgary, Dept Med, Calgary, AB, Canada	University of Calgary; Stellenbosch University; University of Alberta; University of Kwazulu Natal; University of Calgary; University of Calgary	Boffa, J (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.; Boffa, J (corresponding author), Stellenbosch Univ, Desmond Tutu TB Ctr, Cape Town, Western Cape, South Africa.	jboffa@sun.ac.za		Boffa, Jody/0000-0002-8183-6461	International Development Research Centre; Canadian Institutes of Health Research (CIHR) [278917]	International Development Research Centre; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The International Development Research Centre provided a Doctoral Research Grant (idrc. ca) to JB and Canadian Institutes of Health Research provided Catalyst funding (CIHR No. 278917) to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUID INT TUB CAS FIN; Apers L, 2009, TUBERCULOSIS COMPREH, P780; Beckmann N, 2013, ANTHROPOL MED, V20, P160, DOI 10.1080/13648470.2013.800805; Bhana D, 2016, CROSSCULT R HLTH ILL, P127, DOI 10.1007/978-3-319-29936-5_7; Boffa J, PLOS ONE; Boffa J, 2016, INT J TUBERC LUNG S1, V20, pS109; Boffa J, 2015, INT J TUBERC LUNG S2, V19, pS279; Cote L, 2005, MED TEACH, V27, P71, DOI 10.1080/01421590400016308; Dawson S., 1993, MANUAL USE FOCUS GRO; De Laine M., 1997, ETHNOGRAPHY THEORY A; Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250; Frieden Thomas R, 2007, World Hosp Health Serv, V43, P30; Health Service Executive, 2016, CLIN GUID OP SUBST T; Holloway I., 2003, QUAL RES, V3, P345, DOI [https://doi.org/10.1177/1468794103033004, DOI 10.1177/1468794103033004, 10.1177/1468794103033004]; Hunter M., 2010, LOVE TIME AIDS; Kielmann K, 2010, AIDS CARE, V22, P21, DOI 10.1080/09540121003721000; Kleinman A, 2006, PLOS MED, V3, P1673, DOI 10.1371/journal.pmed.0030294; Kvale S, 2009, INTERVIEWS LEARNING, P143; Lawn SD, 2009, TUBERCULOSIS COMPREH, P96; Marlatt GA, 1996, ADDICT BEHAV, V21, P779, DOI 10.1016/0306-4603(96)00042-1; Mayan M., 2009, ESSENTIALS QUALITATI; Menzies D, 2006, REICHMAN HERSHFIELDS; Minkler M, 2008, COMMUNITY BASED PART; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Municipalities of South Africa, UMG DISTR MUN DEM IN; Nardell E, 2011, NEW ENGL J MED, V365, P79, DOI 10.1056/NEJMe1105555; Ngozo J., 2016, FAITH LEAD S 18 JUL; Ngwenya T., 2006, SO AFRICAN LINGUISTI, V24, P165; Posel D, 2014, AFR STUD REV, V57, P51, DOI 10.1017/asr.2014.47; Rifkin S., 2001, PARTNERS PLANNING; Robins S, 2006, AM ANTHROPOL, V108, P312, DOI 10.1525/aa.2006.108.2.312; Rudwick S, 2009, AGENDA-EMPOWER WOMEN, V23, P66, DOI 10.1080/10130950.2009.9676276; Rudwick Stephanie Inge, 2008, NORDIC J AFRICAN STU, V17, P152; Savage J, 2000, BMJ-BRIT MED J, V321, P1400, DOI 10.1136/bmj.321.7273.1400; Shefer T, 2016, GLOB PUBLIC HEALTH, V11, P211, DOI 10.1080/17441692.2015.1029959; South Africa Department of Health, 2010, GUID TUB PREV THER H; Statistics South Africa, STAT PLAC CENS 2011; Stop TB Partnership, 2015, PAR SHIFT GLOB PLAN; uMgungundlovu District Health Office, 2015, DISTR HLTH PLAN 2015; United Nations Joint Programme on HIV/AIDS (UNAIDS), 2015, S AFR HIV AIDS EST; Wickstrom A, 2010, J ROY ANTHROPOL INST, V16, P532, DOI 10.1111/j.1467-9655.2010.01638.x; World Health Organisation, 2008, WHO 3 M INT CAS FIND; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, END TB STRAT GLOB ST; World Health Organization, 2017, TUB FACT SHEET	45	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193571	10.1371/journal.pone.0193571	http://dx.doi.org/10.1371/journal.pone.0193571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513719	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800064
J	Budai, D; Vizvari, AD; Bali, ZK; Marki, B; Nagy, LV; Konya, Z; Madarasz, D; Henn-Mike, N; Varga, C; Hernadi, I				Budai, Denes; Vizvari, Attila D.; Bali, Zsolt K.; Marki, Balazs; Nagy, Lili V.; Konya, Zoltan; Madarasz, Daniel; Henn-Mike, Nora; Varga, Csaba; Hernadi, Istvan			A novel carbon tipped single micro-optrode for combined optogenetics and electrophysiology	PLOS ONE			English	Article							NEURONS IN-VIVO; MILLISECOND-TIMESCALE; NEURAL INTERFACES; BRAIN STRUCTURES; OPTICAL CONTROL; MOTOR CORTEX; DOPAMINE; MICROELECTRODES; VOLTAMMETRY; STRIATUM	Optical microelectrodes (optrodes) are used in neuroscience to transmit light into the brain of a genetically modified animal to evoke and record electrical activity from light-sensitive neurons. Our novel micro-optrode solution integrates a light-transmitting 125 micrometer optical fiber and a 9 micrometer carbon monofilament to form an electrical lead element, which is contained in a borosilicate glass sheathing coaxial arrangement ending with a micrometersized carbon tip. This novel unit design is stiff and slender enough to be used for targeting deep brain areas, and may cause less tissue damage compared with previous models. The center-positioned carbon fiber is less prone to light-induced artifacts than side-lit metal microelectrodes previously presented. The carbon tip is capable of not only recording electrical signals of neuronal origin but can also provide valuable surface area for electron transfer, which is essential in electrochemical (voltammetry, amperometry) or microbiosensor applications. We present details of design and manufacture as well as operational examples of the newly developed single micro-optrode, which includes assessments of 1) carbon tip length-impedance relationship, 2) light transmission capabilities, 3) photoelectric artifacts in carbon fibers, 4) responses to dopamine using fast-scan cyclic voltammetry in vivo, and 5) optogenetic stimulation and spike or local field potential recording from the rat brain transfected with channelrhodopsin- 2. With this work, we demonstrate that our novel carbon tipped single microoptrode may open up new avenues for use in optogenetic stimulation when needing to be combined with extracellular recording, electrochemical, or microbiosensor measurements performed on a millisecond basis.	[Budai, Denes; Vizvari, Attila D.; Marki, Balazs] Kation Sci LLC, Minneapolis, MN 55413 USA; [Bali, Zsolt K.; Nagy, Lili V.; Henn-Mike, Nora; Varga, Csaba; Hernadi, Istvan] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Bali, Zsolt K.; Nagy, Lili V.; Henn-Mike, Nora; Varga, Csaba; Hernadi, Istvan] Univ Pecs, Ctr Neurosci, Pecs, Hungary; [Bali, Zsolt K.; Nagy, Lili V.; Hernadi, Istvan] Univ Pecs, Dept Expt Neurobiol, Pecs, Hungary; [Konya, Zoltan; Madarasz, Daniel] Univ Szeged, Dept Appl & Environm Chem, Szeged, Hungary; [Henn-Mike, Nora; Varga, Csaba] Univ Pecs, Dept Physiol, NAP B Entorhinal Microcircuits Res Grp, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; Szeged University; University of Pecs	Budai, D (corresponding author), Kation Sci LLC, Minneapolis, MN 55413 USA.	denes@kationscientific.com	Konya, Zoltan/C-2492-2009; Bali, Zsolt Kristóf/L-1653-2014	Konya, Zoltan/0000-0002-9406-8596; Bali, Zsolt Kristóf/0000-0003-0712-0788; Varga, Csaba/0000-0002-9188-1282; Budai, Denes/0000-0001-6204-236X	"Comprehensive Development for Implementing Smart Specialization Strategies at the University of Pecs [EFOP-3.6.1.-16-2016-00004]; The role of neuro-inflammation in neurodegeneration [EFOP-3.6.2-16-2017-00008]	"Comprehensive Development for Implementing Smart Specialization Strategies at the University of Pecs; The role of neuro-inflammation in neurodegeneration	ZKB, LVN and IH were supported by the EFOP-3.6.1.-16-2016-00004 grant; Comprehensive Development for Implementing Smart Specialization Strategies at the University of Pecs. NHM and CV were supported by the grant The role of neuro-inflammation in neurodegeneration: from molecules to clinics, EFOP-3.6.2-16-2017-00008. Kation Scientific LLC provided support in the form of salaries for the authors DB, ADV, and BM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the author contributions section.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; ARMSTRONGJAMES M, 1979, J NEUROSCI METH, V1, P279, DOI 10.1016/0165-0270(79)90039-6; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Belle AM, 2013, ACS CHEM NEUROSCI, V4, P761, DOI 10.1021/cn400031v; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Budai Denes, 2001, Acta Biologica Szegediensis, V45, P65; Budai D, 2010, INTELLIGENT AND BIOSENSORS, P269; Canales A, 2015, NAT BIOTECHNOL, V33, P277, DOI 10.1038/nbt.3093; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Chaves-Coira I, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00028; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; CRESPI F, 1992, J NEUROSCI METH, V42, P149, DOI 10.1016/0165-0270(92)90094-T; Dai J, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.031202; Danis L, 2015, ANAL CHEM, V87, P2565, DOI 10.1021/ac503767n; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dufour S, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.031205; Dufour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057703; Dugue GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105941; Fan B, 2015, LAB CHIP, V15, P3838, DOI 10.1039/c5lc00588d; Garris PA, 2003, NEUROSCIENCE, V118, P819, DOI 10.1016/S0306-4522(03)00005-8; Garris PA, 1997, J NEUROCHEM, V68, P152; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hoffmann P, 1995, ULTRAMICROSCOPY, V61, P165, DOI 10.1016/0304-3991(95)00122-0; Iseri E, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa60b3; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Kozai TDY, 2015, J MATER CHEM B, V3, P4965, DOI 10.1039/c5tb00108k; Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]; Kravitz AV, 2013, BRAIN RES, V1511, P21, DOI 10.1016/j.brainres.2012.11.018; Kruse W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105589; LeChasseur Y, 2011, NAT METHODS, V8, P319, DOI 10.1038/NMETH.1572; Lu C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600955; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Millar J, 2001, J NEUROSCI METH, V110, P1, DOI 10.1016/S0165-0270(01)00411-3; Robinson DL, 2002, J NEUROSCI, V22, P10477; Roitman MF, 2010, PHARMACOL BIOCHEM BE, V97, P138, DOI 10.1016/j.pbb.2010.05.010; Smith AR, 2015, J CHEM NEUROANAT, V66-67, P28, DOI 10.1016/j.jchemneu.2015.04.002; Stauffer WR, 2016, CELL, V166, P1564, DOI 10.1016/j.cell.2016.08.024; SUGIYAMA K, 1994, J NEUROSCI METH, V53, P73, DOI 10.1016/0165-0270(94)90146-5; Tamura K, 2012, J NEUROSCI METH, V211, P49, DOI 10.1016/j.jneumeth.2012.08.004; Warden MR, 2014, ANNU REV BIOMED ENG, V16, P103, DOI 10.1146/annurev-bioeng-071813-104733; Yorgason JT, 2011, J NEUROSCI METH, V202, P158, DOI 10.1016/j.jneumeth.2011.03.001; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007	46	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193836	10.1371/journal.pone.0193836	http://dx.doi.org/10.1371/journal.pone.0193836			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513711	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000426896800081
J	Uppugunduri, SR; Rasheed, MA; Richhariya, A; Jana, S; Chhablani, J; Vupparaboina, KK				Uppugunduri, Sushmitha Rao; Rasheed, Mohammed Abdul; Richhariya, Ashutosh; Jana, Soumya; Chhablani, Jay; Vupparaboina, Kiran Kumar			Automated quantification of Haller's layer in choroid using swept-source optical coherence tomography	PLOS ONE			English	Article							OCT IMAGES; SEGMENTATION; THICKNESS; HEALTHY; EYES; FEATURES; SPECKLE; AGE	Objective To develop an algorithm for automated quantification of Haller's layer in choroid using swept-source optical coherence tomography (OCT). Background So far, to understand the association of various diseases with structural changes of choroid, only gross indicators such as thickness, volume and vascularity index have been examined. However, certain diseases affect specific sublayers of the choroid. Accordingly, a need for targeted quantitation arises. In particular, there is significant interest in understanding Haller's layer, a choroidal sublayer comprising relatively large blood vessels. Unfortunately, its intricate vasculature makes, manual quantitation difficult, tedious, and error-prone. To surmount this difficulty, it is imperative to develop an algorithmic method. Methodology The primary contribution of this work consists in developing an approach for detecting the boundary between Haller's and Sattler's layers, the latter comprising medium-sized vessels. The proposed algorithm estimates vessel cross-sections using exponentiation-based binarization, and labels a vessel large if its cross-section exceeds certain statistically determined threshold. Finally, the desired boundary is obtained as a smooth curve joining the innermost points of such large vessels. On 50 OCT B-scans (of 50 healthy eyes), our algorithm was validated both qualitatively and quantitatively, by comparing with intra-observer variability. Extensive statistical analysis was performed using metrics including Dice coefficient (DC), correlation coefficient (CC) and absolute difference (AD). Results The proposed algorithm achieved a mean DC of 89.48% (SD: 5.03%) in close agreement with the intra-observer repeatability of 89.12% (SD: 5.68%). Corresponding mean AD and mean CC were of 17.54 mu m (SD: 16.45 mu m) and 98.10% (SD: 1.60%) which too approximate the respective intra-observer repeatability values 19.19 mu m (SD: 17.69 mu m) and 98.58% (SD: 1.12%). Conclusion High correlation between algorithmic and manual delineations indicates suitability of our algorithm for clinically analyzing choroid in greater finer details, especially, in diseased eyes.	[Uppugunduri, Sushmitha Rao] Birla Inst Technol & Sci Pilani, Dept Elect & Elect Engn, Hyderabad, Telangana, India; [Rasheed, Mohammed Abdul] Univ Hyderabad, Sch Med Sci, Hyderabad, Telangana, India; [Richhariya, Ashutosh; Vupparaboina, Kiran Kumar] Srujana Ctr Innovat, LV Prasad Eye Inst, Engn Grp, Hyderabad, Telangana, India; [Jana, Soumya; Vupparaboina, Kiran Kumar] Indian Inst Technol Hyderabad, Dept Elect Engn, Hyderabad, Telangana, India; [Chhablani, Jay] Smt Kanuri Santhamma Retina Vitreous Ctr, LV Prasad Eye Inst, Hyderabad, Telangana, India	Birla Institute of Technology & Science Pilani (BITS Pilani); University of Hyderabad; L. V. Prasad Eye Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Hyderabad; L. V. Prasad Eye Institute	Vupparaboina, KK (corresponding author), Srujana Ctr Innovat, LV Prasad Eye Inst, Engn Grp, Hyderabad, Telangana, India.; Vupparaboina, KK (corresponding author), Indian Inst Technol Hyderabad, Dept Elect Engn, Hyderabad, Telangana, India.	kiran1559@gmail.com	Jana, Soumya/AAQ-7977-2020	IIT Hyderabad, EE Department/0000-0002-5880-4023; Chhablani, Jay/0000-0003-1772-3558; Abdul Rasheed, Mohammed/0000-0002-6417-2552				Adhi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133080; Adhi M, 2013, JAMA OPHTHALMOL, V131, P1267, DOI 10.1001/jamaophthalmol.2013.4321; Adler FH, 2011, ELSEVIER HLTH SCI; Alm A, 2009, EXP EYE RES, V88, P760, DOI 10.1016/j.exer.2008.12.012; Alonso-Caneiro D, 2013, BIOMED OPT EXPRESS, V4, P2795, DOI 10.1364/BOE.4.002795; Alshareef Rayan A, 2017, Int J Retina Vitreous, V3, P28, DOI 10.1186/s40942-017-0081-z; Barteselli G, 2012, OPHTHALMOLOGY, V119, P2572, DOI 10.1016/j.ophtha.2012.06.065; BILL A, 1983, INT OPHTHALMOL, V6, P101, DOI 10.1007/BF00127638; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Chhablani J, 2015, INDIAN J OPHTHALMOL, V63, P384, DOI 10.4103/0301-4738.159861; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; Dhoot DS, 2013, BRIT J OPHTHALMOL, V97, P66, DOI 10.1136/bjophthalmol-2012-301917; Esmaeelpour M, 2014, INVEST OPHTH VIS SCI, V55, P5074, DOI 10.1167/iovs.14-14646; Esmaeelpour M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099690; Gabriel M, 2017, GRAEF ARCH CLIN EXP, V255, P1957, DOI 10.1007/s00417-017-3723-9; Garvin MK, 2009, IEEE T MED IMAGING, V28, P1436, DOI 10.1109/TMI.2009.2016958; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P7738, DOI 10.1167/iovs.10-6925; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Hu ZH, 2013, INVEST OPHTH VIS SCI, V54, P1722, DOI 10.1167/iovs.12-10578; Ibrahim MN, 2017, 2017 IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL & HEALTH INFORMATICS (BHI), P113, DOI 10.1109/BHI.2017.7897218; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Kajic V, 2012, BIOMED OPT EXPRESS, V3, P86, DOI 10.1364/BOE.3.000086; Lu HQ, 2013, IEEE ENG MED BIO, P5869, DOI 10.1109/EMBC.2013.6610887; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Ozcan A, 2007, J OPT SOC AM A, V24, P1901, DOI 10.1364/JOSAA.24.001901; PARVER L M, 1991, Eye (London), V5, P181; Quillen DA, 2002, CLIN RETINA, V1; Ruiz-Moreno JM, 2013, INVEST OPHTH VIS SCI, V54, P353, DOI 10.1167/iovs.12-10863; Savastano MC, 2015, OSLI RETINA, V46, P561, DOI 10.3928/23258160-20150521-07; Savastano MC, 2017, RETINA PHILADELPHIA; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitt JM, 1999, J BIOMED OPT, V4, P95, DOI 10.1117/1.429925; Sim DA, 2013, INVEST OPHTHALMOL; Tian J, 2013, BIOMED OPT EXPRESS, V4, P397, DOI 10.1364/BOE.4.000397; VANNORREN D, 1986, VISION RES, V26, P313, DOI 10.1016/0042-6989(86)90028-3; Vupparaboina K. K., 2016, IEEE INT C SIGN INF, P1; Vupparaboina KK, 2015, COMPUT MED IMAG GRAP, V46, P315, DOI 10.1016/j.compmedimag.2015.09.008; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; Zhang L, 2012, INVEST OPHTH VIS SCI, V53, P7510, DOI 10.1167/iovs.12-10311	39	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193324	10.1371/journal.pone.0193324	http://dx.doi.org/10.1371/journal.pone.0193324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513735	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000426896800054
J	Mercado, CI; Gregg, E; Gillespie, C; Loustalot, F				Mercado, Carla I.; Gregg, Edward; Gillespie, Cathleen; Loustalot, Fleetwood			Trends in lipid profiles and descriptive characteristics of US adults with and without diabetes and cholesterol-lowering medication use-National Health and Nutrition Examination Survey, 2003-2012, United States	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; DYSLIPIDEMIA; MANAGEMENT; COMPLICATIONS; METAANALYSIS; INDIVIDUALS; MORTALITY; MELLITUS	Background With a cholesterol-lowering focus for diabetic adults and in the age of polypharmacy, it is important to understand how lipid profile levels differ among those with and without diabetes. Objective Investigate the means, differences, and trends in lipid profile measures [TC, total cholesterol; LDL-c, low-density lipoprotein; HDL-c, high-density lipoprotein; and TG, triglycerides] among US adults by diabetes status and cholesterol-lowering medication. Methods Population number and proportion of adults aged >= 21 years with diabetes and taking cholesterol-lowering medication were estimated using data on 10,384 participants from NHANES 2003-2012. Age-standardized means, trends, and differences in lipid profile measures were estimated by diabetes status and cholesterol medication use. For trends and differences, linear regression analysis were used adjusted for age, gender, and race/ethnicity. Results Among diabetic adults, 52% were taking cholesterol-lowering medication compared to the 14% taking cholesterol-lowering medication without diabetes. Although diabetic adults had significantly lower TC and LDL-c levels than non-diabetic adults [% difference (95% confidence interval): TC = -5.2% (-6.8--3.5), LDL-c = -8.0% (-10.4--5.5)], the percent difference was greater among adults taking cholesterol medication [TC = -8.0% (-10.3--5.7); LDL-c = -13.7% (-17.1--10.2)] than adults not taking cholesterol medication [TC = -3.5% (-5.2 +/- -1.6); LDL-c = -4.3% (-7.1--1.5)] (interaction p-value: TC = < 0.001; LDL-c = < 0.001). From 2003-2012, mean TC and HDL-c significantly decreased among diabetic adults taking cholesterol medication [% difference per survey cycle (p-value for linear trend): TC = -2.3% (0.003) and HDL-c = -2.3% (0.033)]. Mean TC, HDL-c, and LDL-c levels did not significantly change from 2003 to 2012 in non-diabetic adults taking cholesterol medication or for adults not taking cholesterol medications. Conclusions Diabetic adults were more likely to have lower lipid levels, except for triglyceride levels, than non-diabetic adults with profound differences when considering cholesterol medication use, possibly due to the positive effects from clinical diabetes management.	[Mercado, Carla I.; Gregg, Edward] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, Atlanta, GA 30333 USA; [Gillespie, Cathleen; Loustalot, Fleetwood] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Mercado, CI (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Diabet Translat, Atlanta, GA 30333 USA.	CMercado@cdc.gov		Gregg, Edward/0000-0003-2381-6822; Mercado, Carla/0000-0002-0490-9532				Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Andersson C, 2014, AM HEART J, V168, P878, DOI 10.1016/j.ahj.2014.08.007; [Anonymous], 2016, Diabetes Care, V39 Suppl 1, pS4, DOI 10.2337/dc16-S003; [Anonymous], 2014, VITAL HLTH STAT; Bowyer N., 2001, OPTOMETRY VISION SCI, V78, P253; Chehade JM, 2013, DRUGS, V73, P327, DOI 10.1007/s40265-013-0023-5; Eliasson B, 2014, EUR J PREV CARDIOL, V21, P1420, DOI 10.1177/2047487313494292; Eliasson B, 2011, DIABETES CARE, V34, P2095, DOI 10.2337/dc11-0209; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Martin SS, 2014, CIRCULATION, V129, P77, DOI 10.1161/CIRCULATIONAHA.113.003625; Massing MW, 2003, DIABETES CARE, V26, P991, DOI 10.2337/diacare.26.4.991; Mercado C, 2015, MMWR-MORBID MORTAL W, V64, DOI 10.15585/mmwr.mm6447a1; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519; Reasner CA, 2005, ATHEROSCLEROSIS SUPP, V6, P21, DOI 10.1016/j.atherosclerosissup.2005.06.005; Siebel AL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00258; Simmons RK, 2014, DIABETIC MED, V31, P1577, DOI 10.1111/dme.12574; Sone H, 2012, DIABETES CARE, V35, P1150, DOI 10.2337/dc11-1412; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tohidi M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-6; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193756	10.1371/journal.pone.0193756	http://dx.doi.org/10.1371/journal.pone.0193756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509776	gold, Green Published			2022-12-27	WOS:000426813200028
J	Preiss, A; Nagel, AC; Praxenthaler, H; Maier, D				Preiss, Anette; Nagel, Anja C.; Praxenthaler, Heiko; Maier, Dieter			Complex genetic interactions of novel Suppressor of Hairless alleles deficient in corepressor binding	PLOS ONE			English	Article							NOTCH SIGNALING PATHWAY; ASYMMETRIC CELL-DIVISION; ORGAN PRECURSOR CELLS; DROSOPHILA-MELANOGASTER; DEFAULT REPRESSION; EXPRESSION; ACTIVATION; RECEPTOR; HOMOLOG; PROTEIN	Throughout the animal kingdom, the Notch signalling pathway allows cells to acquire diversified cell fates. Notch signals are translated into activation of Notch target genes by CSL transcription factors. In the absence of Notch signals, CSL together with co-repressors functions as a transcriptional repressor. In Drosophila, repression of Notch target genes involves the CSL homologue Suppressor of Hairless (Su(H)) and the Notch (N) antagonist Hairless (H) that together form a repressor complex. Guided by crystal structure, three mutations Su (H)(LL), Su(H)(LLF) and Su(H)(LLL) were generated that specifically affect interactions with the repressor H, and were introduced into the endogenous Su(H) locus by gene engineering. In contrast to the wild type isoform, these Su(H) mutants are incapable of repressor complex formation. Accordingly, Notch signalling activity is dramatically elevated in the homozygotes, resembling complete absence of H activity. It was noted, however, that heterozygotes do not display a dominant H loss of function phenotype. In this work we addressed genetic interactions the three H-binding deficient Su(H) mutants display in combination with H and N null alleles. We included a null mutant of Delta (Dl), encoding the ligand of the Notch receptor, as well as of Su(H) itself in our genetic analyses. H, N or Dl mutations cause dominant wing phenotypes that are sensitive to gene dose of the others. Moreover, H heterozygotes lack bristle organs and develop bristle sockets instead of shafts. The latter phenotype is suppressed by Su(H) null alleles but not by H-binding deficient Su(H) alleles which we attribute to the socket cell specific activity of Su(H). Modification of the dominant wing phenotypes of either H, N or Dl, however, suggested some lack of repressor activity in the Su(H) null allele and likewise in the H-binding deficient Su(H) alleles. Overall, Su(H) mutants are recessive perhaps reflecting self-adjusting availability of Su(H) protein.	[Preiss, Anette; Nagel, Anja C.; Praxenthaler, Heiko; Maier, Dieter] Univ Hohenheim, Inst Genet 240, Stuttgart, Germany; [Praxenthaler, Heiko] Heidelberg Univ Hosp, Res Ctr Expt Orthopaed, Heidelberg, Germany	University Hohenheim; Ruprecht Karls University Heidelberg	Maier, D (corresponding author), Univ Hohenheim, Inst Genet 240, Stuttgart, Germany.	dieter.maier@uni-hohenheim.de	Nagel, Anja/AAA-4254-2022	Nagel, Anja/0000-0002-2733-3249	DFG grant [MA 1328/11-1]; University of Hohenheim; National Science Foundation	DFG grant(German Research Foundation (DFG)); University of Hohenheim; National Science Foundation(National Science Foundation (NSF))	This work was funded by a DFG grant MA 1328/11-1 (http://www.dfg.de) to DM and by the University of Hohenheim. Some Drosophila fly stocks were obtained from the Bloomington Drosophila Stock Center BDSC, funded by the National Science Foundation (http://flystocks.bio.Indiana.edu/lnst/funding.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; ASHBURNER M, 1982, GENETICS, V101, P447; BANG AG, 1991, DEVELOPMENT, V111, P89; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; Barolo S, 2002, GENE DEV, V16, P1964, DOI 10.1101/gad.987402; Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bridges C. B., 1923, Carnegie Institution Publication, V327, P1; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; Chandler CH, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007075; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; De Celis JF, 1998, INT J DEV BIOL, V42, P335; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; DECELIS JF, 1994, GENETICS, V136, P183; deCelis JF, 1997, DEVELOPMENT, V124, P3241; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Furriols M, 2000, DEV BIOL, V227, P520, DOI 10.1006/dbio.2000.9923; FURUKAWA T, 1995, JPN J GENET, V70, P505, DOI 10.1266/jjg.70.505; Gho M, 1996, DEVELOPMENT, V122, P1673; Gho M, 1999, DEVELOPMENT, V126, P3573; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hartenstein V., 2005, P379; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; HOUSE VL, 1959, ANAT REC, V134, P581; Kavaler J, 1999, DEVELOPMENT, V126, P2261; Klein T, 2000, DEVELOPMENT, V127, P3553; Koelzer S, 2006, DEV BIOL, V289, P77, DOI 10.1016/j.ydbio.2005.10.008; Koelzer S, 2003, DEVELOPMENT, V130, P1973, DOI 10.1242/dev.00426; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2017, DEV CELL, V41, P228, DOI 10.1016/j.devcel.2017.04.001; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Lees AD, 1942, PROC R SOC SER B-BIO, V131, P87, DOI 10.1098/rspb.1942.0019; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lindsley DL, 1968, CARNEGIE I WASHINGTO, V627; LYMAN DF, 1995, GENETICS, V141, P1491; MAIER D, 1992, MECH DEVELOP, V38, P143, DOI 10.1016/0925-4773(92)90006-6; Maier D, 2006, HEREDITAS, V143, P212, DOI 10.1111/j.2007.0018-0661.01971.x; Maier D, 2011, MOL BIOL CELL, V22, P3242, DOI 10.1091/mbc.E11-05-0420; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Miller SW, 2009, DEV BIOL, V329, P386, DOI 10.1016/j.ydbio.2009.02.009; Mohler JD, 1956, DROS INFORM SERV, V30, P78; Mohr O. L., 1923, Z INDUKT ABSTAMM VER, V32, P108; Morel V, 2000, GENE DEV, V14, P377; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Nagel AC, 2000, MECH DEVELOP, V94, P3, DOI 10.1016/S0925-4773(00)00319-1; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Nagel AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151477; Nagel AC, 2011, HEREDITAS, V148, P77, DOI 10.1111/j.1601-5223.2011.02221.x; NASH D, 1970, GENETICS, V64, P471; NASH D, 1965, GENET RES, V6, P175, DOI 10.1017/S0016672300004079; Plunkett CR, 1926, J EXP ZOOL, V46, P181, DOI 10.1002/jez.1400460204; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; Praxenthaler H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006774; Praxenthaler H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140007; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Schweisguth F, 2015, WIRES DEV BIOL, V4, P299, DOI 10.1002/wdev.175; SIREN M, 1989, GENET RES, V54, P23, DOI 10.1017/S0016672300028330; Skalska L, 2015, EMBO J, V34, P1889, DOI 10.15252/embj.201489923; VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325; Wang SW, 1997, DEVELOPMENT, V124, P4435; Yuan ZY, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002509	66	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193956	10.1371/journal.pone.0193956	http://dx.doi.org/10.1371/journal.pone.0193956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509808	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200046
J	Rimoldi, S; Terova, G; Ascione, C; Giannico, R; Brambilla, F				Rimoldi, Simona; Terova, Genciana; Ascione, Chiara; Giannico, Riccardo; Brambilla, Fabio			Next generation sequencing for gut microbiome characterization in rainbow trout (Oncorhynchus mykiss) fed animal by-product meals as an alternative to fishmeal protein sources	PLOS ONE			English	Article							SALMON SALMO-SALAR; MORONE-SAXATILIS MALE; HYBRID STRIPED BASS; EUROPEAN SEA BASS; CHAIN FATTY-ACIDS; INTESTINAL MICROBIOTA; GROWTH-PERFORMANCE; SOYBEAN-MEAL; GASTROINTESTINAL MICROBIOTA; ANTINUTRITIONAL FACTORS	Animal by-product meals from the rendering industry could provide a sustainable and commercially viable alternative to fishmeal (FM) in aquaculture, as they are rich in most essential amino acids and contain important amounts of water-soluble proteins that improve feed digestibility and palatability. Among them, poultry by-product meal (PBM) have given encouraging results in rainbow trout (Oncorhynchus mykiss). However, the introduction of new ingredients in the diet needs to be carefully evaluated since diet is one of the main factors affecting the gut microbiota, which is a complex community that contributes to host metabolism, nutrition, growth, and disease resistance. Accordingly, we investigated the effects of partial replacement of dietary FM with a mix of animal by-product meals and plant proteins on intestinal microbiota composition of rainbow trout in relation to growth and feeding efficiency parameters. We used 1540 trout with an initial mean body weight of 94.6 +/- 14.2 g. Fish were fed for 12 weeks with 7 different feed formulations. The growth data showed that trout fed on diets rich in animal by-product meals grew as well as fish fed on control diet, which was rich in FM (37.3%) and PBM-free. High-throughput 16S rRNA gene amplicon sequencing (MiSeq platform, Illumina) was utilised to study the gut microbial community profile. After discarding Cyanobacteria (class Chloroplast) and mitochondria reads a total of 2,701,274 of reads taxonomically classified, corresponding to a mean of 96,474 +/- 68,056 reads per sample, were obtained. Five thousand three hundred ninety-nine operational taxonomic units (OTUs) were identified, which predominantly mapped to the phyla of Firmicutes, Proteobacteria, Bacteroidetes and Actinobacteria. The ratio between vegetable and animal proteins proved to play a central role in determining microbiome profiles and Firmicutes and Proteobacteria phyla were particularly discriminatory for diet type in trout. Plant ingredients favoured a higher Firmicutes: Proteobacteria ratio than animal proteins. Acceptable abundance of Firmicutes was guaranteed by including at least 25% of vegetable proteins in the diet regardless of animal protein source and percentage. In summary animal by-product meals, as replacements to FM, gave good results in terms of growth performances and did not induce significant changes in gut microbial richness, thus proving to be a suitable protein source for use in rainbow trout aqua feed.	[Rimoldi, Simona; Terova, Genciana; Ascione, Chiara] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Terova, Genciana] Polytech Univ Milan, Interuniv Ctr Res Prot Biotechnol Prot Factory, Varese, Italy; [Terova, Genciana] Univ Insubria, Varese, Italy; [Giannico, Riccardo] Fdn Parco Tecnol Padano, Lodi, Italy; [Brambilla, Fabio] VRM Srl Naturalleva, Verona, Italy	University of Insubria; Polytechnic University of Milan; University of Insubria	Terova, G (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy.; Terova, G (corresponding author), Polytech Univ Milan, Interuniv Ctr Res Prot Biotechnol Prot Factory, Varese, Italy.; Terova, G (corresponding author), Univ Insubria, Varese, Italy.	genciana.terova@uninsubria.it	Brambilla, Fabio/ABC-9259-2021; Terova, Genciana/AAL-6412-2021; Terova, Genciana/G-1779-2010	Brambilla, Fabio/0000-0002-3711-3370; Terova, Genciana/0000-0002-7532-7951; Terova, Genciana/0000-0002-7532-7951; Ascione, Chiara/0000-0002-3823-6399; Rimoldi, Simona/0000-0002-1995-263X	Naturalleva	Naturalleva	We declare that the commercial company "Naturalleva" employs one of the authors, Fabio Brambilla, who receives a salary. We declare that Naturalleva provided support by manufacturing the fish diets and conducting fish feeding trial, but did not have any additional role in the study design, microbiota data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of Fabio Brambilla is articulated in the 'author contributions' section.	Andrews S., 2010, FASTQC QUALITY CONTR; Apper E, 2016, AQUACULTURE, V453, P40, DOI 10.1016/j.aquaculture.2015.11.018; Araujo C, 2015, ANAEROBE, V32, P7, DOI 10.1016/j.anaerobe.2014.11.001; Askarian F, 2011, AQUACULT NUTR, V17, P488, DOI 10.1111/j.1365-2095.2010.00826.x; Badillo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107523; Barlow S., 2000, GLOBAL AQUACULT ADVO, V4, P85; Barreto-Curiel F, 2016, LAT AM J AQUAT RES, V44, P327, DOI 10.3856/vol44-issue2-fulltext-13; Batista S, 2016, AQUACULTURE, V458, P149, DOI 10.1016/j.aquaculture.2016.03.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolnick DI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5500; Burr GS, 2012, AQUACULTURE, V334, P110, DOI 10.1016/j.aquaculture.2011.12.044; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12.1519, 10.3748/wjg.v17.i12. 1519]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CASTELL JD, 1972, J NUTR, V102, P77, DOI 10.1093/jn/102.1.77; Cheng ZJJ, 2002, J WORLD AQUACULT SOC, V33, P458, DOI 10.1111/j.1749-7345.2002.tb00025.x; Choi WM, 2016, ENVIRON SCI POLLUT R, V23, P7178, DOI 10.1007/s11356-015-5465-8; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Davies SJ, 2009, AQUAC RES, V40, P1759, DOI 10.1111/j.1365-2109.2009.02281.x; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Dong C, 2016, J OCEAN U CHINA, V15, P561, DOI 10.1007/s11802-016-2898-8; El-Haroun ER, 2009, AQUACULTURE, V290, P269, DOI 10.1016/j.aquaculture.2009.02.014; Estruch G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136389; Etyemez M, 2015, RES VET SCI, V100, P8, DOI 10.1016/j.rvsc.2015.03.026; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Gajardo K, APPL ENV MICROBIOLOG, V83; Galfi P, 2002, FOOD RES INT, V345, P81; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gaylord TG, 2017, AQUACULT NUTR, V23, P1319, DOI 10.1111/anu.12507; Ghanbari M, 2015, AQUACULTURE, V448, P464, DOI 10.1016/j.aquaculture.2015.06.033; Givens CE, 2015, MAR ECOL PROG SER, V518, P209, DOI 10.3354/meps11034; Gomez GD, 2008, FEMS IMMUNOL MED MIC, V52, P145, DOI 10.1111/j.1574-695X.2007.00343.x; Granada CE, 2018, RENEW ENERG, V118, P840, DOI 10.1016/j.renene.2017.11.077; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hartviksen M, 2014, AQUACULT NUTR, V20, P381, DOI 10.1111/anu.12087; Hartviksen M, 2014, FISH PHYSIOL BIOCHEM, V40, P1621, DOI 10.1007/s10695-014-9953-4; Heikkinen J, 2006, AQUACULTURE, V261, P259, DOI 10.1016/j.aquaculture.2006.07.012; Hernandez C, 2010, AQUACULT NUTR, V16, P44, DOI 10.1111/j.1365-2095.2008.00639.x; Hovda MB, 2007, AQUACULTURE, V272, P581, DOI 10.1016/j.aquaculture.2007.08.045; Hu H, PLOS ONE, V11; Ingerslev HC, 2014, AQUACULTURE, V424, P24, DOI [10.1016/j.actuaculture.2013.12.032, 10.1016/j.aquaculture.2013.12.032]; Ingerslev HC, 2014, FISH SHELLFISH IMMUN, V40, P624, DOI 10.1016/j.fsi.2014.08.021; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kim SK, 2012, ADV FOOD NUTR RES, V65, P353, DOI 10.1016/B978-0-12-416003-3.00023-8; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kristofersson D, 2006, MAR POLICY, V30, P721, DOI 10.1016/j.marpol.2005.11.004; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; LEE DJ, 1967, J NUTR, V92, P93, DOI 10.1093/jn/92.1.93; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li J, 2014, J APPL MICROBIOL, V117, P1750, DOI 10.1111/jam.12663; LIU HJ, 1995, J AOAC INT, V78, P736; Llewellyn MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00207; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Balcazar JL, 2007, BRIT J NUTR, V97, P522, DOI 10.1017/S0007114507432986; Lyons PP, 2017, J APPL MICROBIOL, V122, P347, DOI 10.1111/jam.13347; Lyons PP, 2017, AQUAC RES, V48, P2438, DOI 10.1111/are.13080; Mansfield GS, 2010, AQUACULTURE, V307, P95, DOI 10.1016/j.aquaculture.2010.07.014; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Matis G, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-12; Morris PC, 2005, AQUACULTURE, V248, P147, DOI 10.1016/j.aquaculture.2005.04.021; National Research Council, 2011, NUTR REQ FISH SHRIMP; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Pares-Sierra G, 2014, AQUAC RES, V45, P1459, DOI 10.1111/are.12092; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; Pike I. H., 2005, International Aquafeed, V8, P38; Rawles SD, 2006, AQUACULTURE, V259, P377, DOI 10.1016/j.aquaculture.2006.05.053; Rawles SD, 2009, J WORLD AQUACULT SOC, V40, P141, DOI 10.1111/j.1749-7345.2009.00238.x; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Refstie S, 2005, AQUACULTURE, V246, P331, DOI 10.1016/j.aquaculture.2005.01.001; Rimoldi Simona, 2016, Fisheries and Aquatic Sciences, V19, P40, DOI 10.1186/s41240-016-0041-9; Ringo E, 1998, AQUACULTURE, V160, P177, DOI 10.1016/S0044-8486(97)00299-8; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Rosenlund G, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.10; Santigosa E, 2011, AQUAC RES, V42, P962, DOI 10.1111/j.1365-2109.2010.02679.x; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Savas S, 2005, ISR J AQUACULT-BAMID, V57, P3; SHANTHA NC, 1990, J CHROMATOGR-BIOMED, V533, P1, DOI 10.1016/S0378-4347(00)82182-9; Shepherd CJ, 2013, J FISH BIOL, V83, P1046, DOI 10.1111/jfb.12224; Subhadra B, 2006, AQUACULTURE, V260, P221, DOI 10.1016/j.aquaculture.2006.06.029; Sun H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01558; Tacon AGJ, 2004, AQUAT RESOUR CULT DE, V1, P3; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Terova G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160332; Toden S, 2007, CANCER BIOL THER, V6, P253, DOI 10.4161/cbt.6.2.3627; Twibell RG, 2012, AQUACULTURE, V360, P69, DOI 10.1016/j.aquaculture.2012.07.019; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wong S, 2013, APPL ENVIRON MICROB, V79, P4974, DOI 10.1128/AEM.00924-13; YU TC, 1979, AQUACULTURE, V16, P31, DOI 10.1016/0044-8486(79)90169-8; Yu Y, 2007, ALTERNATIVE PROTEIN, P51; Zhang JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058115, 10.1371/journal.pone.0076378]; Zhou QC, 2011, AQUACULTURE, V322, P122, DOI 10.1016/j.aquaculture.2011.09.042; Zoetendal EG, 2014, CURR OPIN GASTROEN, V30, P189, DOI 10.1097/MOG.0000000000000048	98	73	76	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193652	10.1371/journal.pone.0193652	http://dx.doi.org/10.1371/journal.pone.0193652			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509788	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200020
J	Tassi, F; Fazi, S; Rossetti, S; Pratesi, P; Ceccotti, M; Cabassi, J; Capecchiacci, F; Venturi, S; Vaselli, O				Tassi, Franco; Fazi, Stefano; Rossetti, Simona; Pratesi, Paolo; Ceccotti, Marco; Cabassi, Jacopo; Capecchiacci, Francesco; Venturi, Stefania; Vaselli, Orlando			The biogeochemical vertical structure renders a meromictic volcanic lake a trap for geogenic CO2 (Lake Averno, Italy)	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; ANAEROBIC METHANE OXIDATION; CRATER LAKES; MT. VULTURE; GAS BUILDUP; GEN. NOV.; WATER; NYOS; BACTERIAL; CAMEROON	Volcanic lakes are characterized by physicochemical favorable conditions for the development of reservoirs of C- bearing greenhouse gases that can be dispersed to air during occasional roll-over events. By combining a microbiological and geochemical approach, we showed that the chemistry of the CO2- and CH4-rich gas reservoir hosted within the meromictic Lake Averno (Campi Flegrei, southern Italy) are related to the microbial niche differentiation along the vertical water column. The simultaneous occurrence of diverse functional groups of microbes operating under different conditions suggests that these habitats harbor complex microbial consortia that impact on the production and consumption of greenhouse gases. In the epilimnion, the activity of aerobic methanotrophic bacteria and photosynthetic biota, together with CO2 dissolution at relatively high pH, enhanced CO2- and CH4 consumption, which also occurred in the hypolimnion. Moreover, results from computations carried out to evaluate the dependence of the lake stability on the CO2/CH4 ratios, suggested that the water density vertical gradient was mainly controlled by salinity and temperature, whereas the effect of dissolved gases was minor, excepting if extremely high increases of CH4 are admitted. Therefore, biological processes, controlling the composition of CO2 and CH4, contributed to stabilize the lake stratification of the lake. Overall, Lake Averno, and supposedly the numerous worldwide distributed volcanic lakes having similar features (namely bio- activity lakes), acts as a sink for the CO2 supplied from the hydrothermal/magmatic system, displaying a significant influence on the local carbon budget.	[Tassi, Franco; Pratesi, Paolo; Cabassi, Jacopo; Capecchiacci, Francesco; Venturi, Stefania; Vaselli, Orlando] Univ Florence, Dept Earth Sci, Via G La Pira 4, Florence, Italy; [Tassi, Franco; Cabassi, Jacopo; Venturi, Stefania; Vaselli, Orlando] Natl Res Council Italy, CNR, IGG, Inst Geosci & Earth Resources, Via La Pira 4, Florence, Italy; [Fazi, Stefano; Rossetti, Simona; Ceccotti, Marco] Natl Res Council Italy, CNR Water Res Inst, IRSA, Via Salaria, Rome, Italy	University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca sulle Acque (IRSA-CNR)	Tassi, F (corresponding author), Univ Florence, Dept Earth Sci, Via G La Pira 4, Florence, Italy.; Tassi, F (corresponding author), Natl Res Council Italy, CNR, IGG, Inst Geosci & Earth Resources, Via La Pira 4, Florence, Italy.	franco.tassi@unifi.it	Vaselli, Orlando/A-4268-2016; FAZI, STEFANO/L-3976-2017; Cabassi, Jacopo/B-1231-2016; FAZI, STEFANO/AAX-5609-2020; Tassi, Franco/G-7857-2012	FAZI, STEFANO/0000-0001-7688-7179; Cabassi, Jacopo/0000-0001-7778-8498; FAZI, STEFANO/0000-0001-7688-7179; Tassi, Franco/0000-0002-3319-4257; Rossetti, Simona/0000-0001-9474-0496; Vaselli, Orlando/0000-0001-8121-4438	Italian National Flag program RITMARE [SP3-WP2-AZ2-U05]	Italian National Flag program RITMARE	The Italian National Flag program RITMARE SP3-WP2-AZ2-U05 financed the costs of the fieldtrip and microbiological analysis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; Allgaier M, 2006, AQUAT MICROB ECOL, V45, P115, DOI 10.3354/ame045115; Amalfitano S, 2014, WATER RES, V65, P384, DOI 10.1016/j.watres.2014.08.004; Atekwana EA, 1998, J HYDROL, V205, P265; Bergen B, 2014, ENV MICROBIOL REP, V6, P625, DOI 10.1111/1758-2229.12178; Bhattarai S, 2012, MICROB ECOL, V64, P291, DOI 10.1007/s00248-012-0034-x; Bianchi L, 2010, INT J HYDROGEN ENERG, V35, P12216, DOI 10.1016/j.ijhydene.2010.08.038; Boehrer B, 2010, LIMNOL OCEANOGR-METH, V8, P567, DOI 10.4319/lom.2010.8.0567; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolognesi L., 1986, STUDIO CHIMICO ISOTO, V41, P281; Cabassi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102456; Cabassi J, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-012-0683-0; Caliro S, 2007, GEOCHIM COSMOCHIM AC, V71, P3040, DOI 10.1016/j.gca.2007.04.007; Caliro S, 2008, J VOLCANOL GEOTH RES, V178, P305, DOI 10.1016/j.jvolgeores.2008.06.023; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caracausi A, 2013, GEOCHEM GEOPHY GEOSY, V14, P1411, DOI 10.1002/ggge.20111; Caracausi A, 2009, TERRA NOVA, V21, P83, DOI 10.1111/j.1365-3121.2008.00858.x; Carapezza ML, 2008, J VOLCANOL GEOTH RES, V178, P297, DOI 10.1016/j.jvolgeores.2008.06.031; Carpenter JR, 2012, J PHYS OCEANOGR, V42, P840, DOI 10.1175/JPO-D-11-0118.1; Chandler DP, 2013, APPL ENVIRON MICROB, V79, P799, DOI 10.1128/AEM.02664-12; Chau HF, 1996, J GEOPHYS RES-SOL EA, V101, P28253, DOI 10.1029/96JB01904; Christenson B, 2015, ADV VOLCANOL, P125, DOI 10.1007/978-3-642-36833-2_5; Cotel AJ, 1999, J VOLCANOL GEOTH RES, V88, P343, DOI 10.1016/S0377-0273(99)00017-7; Di Vito MA, 2011, B VOLCANOL, V73, P295, DOI 10.1007/s00445-010-0417-0; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; EVANS WC, 1994, GEOCHEM J, V28, P139, DOI 10.2343/geochemj.28.139; EVANS WC, 1993, APPL GEOCHEM, V8, P207, DOI 10.1016/0883-2927(93)90036-G; Faure G., 1986, INORGANIC GEOCHEMIST, P627; Fazi S, 2007, SYST APPL MICROBIOL, V30, P463, DOI 10.1016/j.syapm.2007.03.003; Fazi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064109; Fillol M, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv020; Funiciello R, 2003, J VOLCANOL GEOTH RES, V123, P43, DOI 10.1016/S0377-0273(03)00027-1; Garrity G, BERGEYS MANUAL SYSTE, V2; GIGGENBACH WF, 1990, J VOLCANOL GEOTH RES, V42, P337, DOI 10.1016/0377-0273(90)90031-A; GUGLIELMINETTI M, 1986, GEOTHERMICS, V15, P781, DOI 10.1016/0375-6505(86)90091-X; Hahn MW, 2007, INT J SYST EVOL MICR, V57, P936, DOI 10.1099/ijs.0.64807-0; Halbwachs M., 2004, EOS, V85, P281, DOI [10.1029/2004EO300001, DOI 10.1029/2004EO300001]; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; Hatamoto M, 2011, BIORESOURCE TECHNOL, V102, P10299, DOI 10.1016/j.biortech.2011.08.099; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Hirslund F, 2012, J LIMNOL, V71, P45, DOI 10.4081/jlimnol.2012.e4; Illumina I., 2015, OAISTER; Karr EA, 2005, APPL ENVIRON MICROB, V71, P6353, DOI 10.1128/AEM.71.10.6353-6359.2005; Karst SM, 2016, WASTEWATER TREATMENT, P301; Kling GW, 2005, P NATL ACAD SCI USA, V102, P14185, DOI 10.1073/pnas.0502274102; KLING GW, 1987, SCIENCE, V237, P1022, DOI 10.1126/science.237.4818.1022; KLING GW, 1989, J VOLCANOL GEOTH RES, V39, P151, DOI 10.1016/0377-0273(89)90055-3; KLING GW, 1987, SCIENCE, V236, P169, DOI 10.1126/science.236.4798.169; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kojima H, 2011, INT J SYST EVOL MICR, V61, P1651, DOI 10.1099/ijs.0.024968-0; Kusakabe M, 2000, J VOLCANOL GEOTH RES, V97, P241, DOI 10.1016/S0377-0273(99)00170-5; Kusakabe M, 1996, MONITORING MITIGATIO, P573; Kusakabe M, 2008, GEOCHEM J, V42, P93, DOI 10.2343/geochemj.42.93; LEGUERN F, 1989, J VOLCANOL GEOTH RES, V39, P97; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McGinnis DF, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006557; McNichols AP, NUCL INSTRUM METH B; Millero FJ, 2002, DEEP-SEA RES PT I, V49, P1705, DOI 10.1016/S0967-0637(02)00093-6; Montegrossi G, 2006, APPL GEOCHEM; Moreira S, 2016, HYDROL EARTH SYST SC, V20, P2975, DOI 10.5194/hess-20-2975-2016; Mortimer C. H., 1953, AQUAT SCI, V15, P94, DOI DOI 10.1007/BF02486219; Mott RW, 2010, J VOLCANOL GEOTH RES, V192, P151, DOI 10.1016/j.jvolgeores.2010.02.009; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Noguchi T, 2010, J FLUID MECH, V651, P443, DOI 10.1017/S0022112009994150; Orlygsson J., 2014, PROKARYOTES ALPHAPRO, P859, DOI DOI 10.1007/978-3-642-30197-1_244; Oswald K, 2016, LIMNOL OCEANOGR, V61, pS101, DOI 10.1002/lno.10312; Oswald K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132574; Paganin P, 2013, FEMS MICROBIOL ECOL, V84, P176, DOI 10.1111/1574-6941.12048; Parkhurst D., 1999, WATER RESOURCES INVE, V99, P4259; Pasche N, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001690; Pasternack GB, 1997, B VOLCANOL, V58, P528, DOI 10.1007/s004450050160; Quero GM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01053; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; Rice A, 2000, J VOLCANOL GEOTH RES, V97, P233, DOI 10.1016/S0377-0273(99)00179-1; Rouwet D, 2014, J VOLCANOL GEOTH RES, V272, P78, DOI 10.1016/j.jvolgeores.2013.12.009; Sabroux JC, 1987, P INT C LAK NYOS GAS; Salata GG, 2000, MAR CHEM, V69, P153, DOI 10.1016/S0304-4203(99)00102-4; Schmid M, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000892; Schmid M, 2002, ACTA VULCANOL, V14, P115, DOI DOI 10.1400/19084; Schmid M, 2010, LIMNOL OCEANOGR, V55, P225, DOI 10.4319/lo.2010.55.1.0225; SCHOELL M, 1980, GEOCHIM COSMOCHIM AC, V44, P649, DOI 10.1016/0016-7037(80)90155-6; SCHOELL M, 1988, CHEM GEOL, V71, P257, DOI 10.1016/0009-2541(88)90119-2; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Shivlata L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01014; SHY SS, 1990, J FLUID MECH, V214, P1, DOI 10.1017/S0022112090000015; SIGURDSSON H, 1987, J VOLCANOL GEOTH RES, V31, P1, DOI 10.1016/0377-0273(87)90002-3; Siniscalchi LAB, 2015, ENV TECHNOL, V36; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Takai K, 1999, GENETICS, V152, P1285; Takeuchi M, 2014, INT J SYST EVOL MICR, V64, P3240, DOI 10.1099/ijs.0.063503-0; Tanaka M, 2001, METROLOGIA, V38, P301, DOI 10.1088/0026-1394/38/4/3; Tassi F, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002191; Tassi F., 2008, INT REP, P11; Tassi F, 2014, J LIMNOL, V73, P55, DOI 10.4081/jlimnol.2014.836; TAZIEFF H, 1989, J VOLCANOL GEOTH RES, V39, P109, DOI 10.1016/0377-0273(89)90051-6; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Tietze K., 1980, GEOL RUNDSCH, V69, P452, DOI [DOI 10.1007/BF02104549, 10.1007/BF02104549]; Valentine DL, 2002, ANTON LEEUW INT J G, V81, P271, DOI 10.1023/A:1020587206351; Valentino GM, 2004, J VOLCANOL GEOTH RES, V133, P261, DOI 10.1016/S0377-0273(03)00402-5; van Teeseling MCF, 2014, APPL ENVIRON MICROB, V80, P6782, DOI 10.1128/AEM.01838-14; Vaselli O., 2006, ACTA VULCANOL, V18, P65; Von Rohden C, 2010, HYDROL EARTH SYST SC, V6, P7483; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2005, APPL ENVIRON MICROB, V71, P5551, DOI 10.1128/AEM.71.9.5551-5559.2005; Watanabe T, 2014, SYST APPL MICROBIOL, V37, P387, DOI 10.1016/j.syapm.2014.05.010; Wetzel RG, LIMNOLOGY LAKE RIVER, P3; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WILHELM E, 1977, CHEM REV, V77, P219, DOI 10.1021/cr60306a003; Woods AW, 1999, J VOLCANOL GEOTH RES, V92, P259, DOI 10.1016/S0377-0273(99)00028-1; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/0016-7037(95)91550-D; Zhang YX, 2006, ANNU REV EARTH PL SC, V34, P293, DOI 10.1146/annurev.earth.34.031405.125001; Zhang YX, 1998, B VOLCANOL, V59, P281, DOI 10.1007/s004450050192; Zhang YX, 1996, NATURE, V379, P57, DOI 10.1038/379057a0	118	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193914	10.1371/journal.pone.0193914	http://dx.doi.org/10.1371/journal.pone.0193914			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509779	Green Submitted, Green Published, gold			2022-12-27	WOS:000426813200042
J	Acar, S; Bin Essai, HA; Demir, K; Al-Rijjal, RA; Zou, M; Catli, G; Anik, A; Al-Enezi, AF; Ozisik, S; Al-Faham, MSA; Abaci, A; Dundar, B; Kattan, WE; Alsagob, M; Kavukcu, S; Tamimi, HE; Meyer, BF; Bober, E; Shi, Y				Acar, Sezer; Bin Essai, Huda A.; Demir, Korcan; Al-Rijjal, Roua A.; Zou, Minjing; Catli, Gonul; Anik, Ahmet; Al-Enezi, Anwar F.; Ozisik, Secil; Al-Faham, Manar S. A.; Abaci, Ayhan; Dundar, Bumin; Kattan, Walaa E.; Alsagob, Maysoon; Kavukcu, Salih; Tamimi, Hamdi E.; Meyer, Brian F.; Bober, Ece; Shi, Yufei			Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia: Novel Mutations in PHEX and SLC34A3	PLOS ONE			English	Article							PEX GENE; PHOSPHATE HOMEOSTASIS; RICKETS; HYPERCALCIURIA; CLCN5; DMP1; HETEROGENEITY; EXPRESSION; DISORDERS; SECRETION	Background Hereditary hypophosphatemia is a group of rare renal phosphate wasting disorders. The diagnosis is based on clinical, radiological, and biochemical features, and may require genetic testing to be confirmed. Methodology Clinical features and mutation spectrum were investigated in patients with hereditary hypophosphatemia. Genomic DNA of 23 patients from 15 unrelated families were screened sequentially by PCR-sequencing analysis for mutations in the following genes: PHEX, FGF23, DMP1, ENPP1, CLCN5, SLC34A3 and SLC34A1. CytoScan HD Array was used to identify large deletions. Results Genetic evaluation resulted in the identification of an additional asymptomatic but intermittent hypophosphatemic subject. Mutations were detected in 21 patients and an asymptomatic sibling from 13 families (86.6%, 13/15). PHEX mutations were identified in 20 patients from 12 families. Six of them were novel mutations present in 9 patients: c.983_987dupCTACC, c.1586+2T>G, c.1206delA,c.436+1G>T,c.1217G>T, and g.22,215,887 +/- 22,395,767del (179880 bp deletion including exon 16 +/- 22 and ZNF645). Six previously reported mutations were found in 11 patients. Among 12 different PHEX mutations, 6 were de novo mutations. Patients with de novo PHEX mutations often had delayed diagnosis and significantly shorter in height than those who had inherited PHEX mutations. Novel compound heterozygous mutations in SLC34A3 were found in one patient and his asymptomatic sister: c.1335+2T>A and c.1639_1652del14. No mutation was detected in two families. Conclusions This is the largest familial study on Turkish patients with hereditary hypophosphatemia. PHEX mutations, including various novel and de novo variants, are the most common genetic defect. More attention should be paid to hypophosphatemia by clinicians since some cases remain undiagnosed both during childhood and adulthood.	[Acar, Sezer; Demir, Korcan; Abaci, Ayhan; Bober, Ece] Dokuz Eylul Univ, Sch Med, Div Pediat Endocrinol, Izmir, Turkey; [Bin Essai, Huda A.; Al-Rijjal, Roua A.; Zou, Minjing; Al-Enezi, Anwar F.; Al-Faham, Manar S. A.; Kattan, Walaa E.; Alsagob, Maysoon; Tamimi, Hamdi E.; Meyer, Brian F.; Shi, Yufei] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia; [Catli, Gonul; Dundar, Bumin] Katip Celebi Univ, Sch Med, Div Pediat Endocrinol, Izmir, Turkey; [Anik, Ahmet] Adnan Menderes Univ, Sch Med, Div Pediat Endocrinol, Izmir, Turkey; [Ozisik, Secil] Dokuz Eylul Univ, Sch Med, Dept Endocrinol, Izmir, Turkey; [Kavukcu, Salih] Dokuz Eylul Univ, Sch Med, Div Pediat Nephrol, Izmir, Turkey	Dokuz Eylul University; King Faisal Specialist Hospital & Research Center; Izmir Katip Celebi University; Adnan Menderes University; Dokuz Eylul University; Dokuz Eylul University	Shi, Y (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia.	yufei@kfshrc.edu.sa	Abaci, Ayhan/A-4356-2016; kavukcu, salih/K-3336-2019; demir, korcan/F-5371-2012; Catli, Gönül/AFT-1499-2022; Shi, Yufei/ABG-5228-2020; Hamdi Tamimi, MBBS/AAZ-6176-2020; Acar, Sezer/ACD-4928-2022	Abaci, Ayhan/0000-0002-1812-0321; kavukcu, salih/0000-0002-9959-881X; demir, korcan/0000-0002-8334-2422; Shi, Yufei/0000-0002-6999-0191; 	KACST [13-MED1765-20]	KACST	The study is supported by a KACST grant 13-MED1765-20 to YS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatschek S, 2010, EUR J CLIN INVEST, V40, P552, DOI 10.1111/j.1365-2362.2010.02286.x; Bastepe M, 2008, REV ENDOCR METAB DIS, V9, P171, DOI 10.1007/s11154-008-9075-3; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Beck-Nielsen SS, 2012, J HUM GENET, V57, P453, DOI 10.1038/jhg.2012.56; Beck-Nielsen SS, 2009, EUR J ENDOCRINOL, V160, P491, DOI 10.1530/EJE-08-0818; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Bergwitz C, 2009, ENDOCR DEV, V16, P133, DOI 10.1159/000223693; Capelli S, 2015, BONE, V79, P143, DOI 10.1016/j.bone.2015.05.040; Carpenter TO, 1997, PEDIATR CLIN N AM, V44, P443, DOI 10.1016/S0031-3955(05)70485-5; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Dasgupta D, 2014, J AM SOC NEPHROL, V25, P2366, DOI 10.1681/ASN.2013101085; Menezes Filho Hamilton de, 2006, Arq Bras Endocrinol Metab, V50, P802, DOI 10.1590/S0004-27302006000400025; Du L, 1996, GENOMICS, V36, P22, DOI 10.1006/geno.1996.0421; Durmaz E, 2013, BONE, V52, P286, DOI 10.1016/j.bone.2012.10.012; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Filisetti D, 1999, EUR J HUM GENET, V7, P615, DOI 10.1038/sj.ejhg.5200341; FISHER SE, 1995, GENOMICS, V29, P598, DOI 10.1006/geno.1995.9960; Francis F, 1997, GENOME RES, V7, P573, DOI 10.1101/gr.7.6.573; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Guven A, 2017, CLIN ENDOCRINOL, V87, P103, DOI 10.1111/cen.13347; Hoopes RR, 2004, KIDNEY INT, V65, P1615, DOI 10.1111/j.1523-1755.2004.00571.x; Ichikawa S, 2008, BONE, V43, P663, DOI 10.1016/j.bone.2008.06.002; Ichikawa S, 2014, BONE, V59, P53, DOI 10.1016/j.bone.2013.10.018; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Larsson T, 2005, J CLIN ENDOCR METAB, V90, P2424, DOI 10.1210/jc.2004-2238; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Liu Shuang, 2014, Zhongguo Dang Dai Er Ke Za Zhi, V16, P518; Liu YQ, 2010, ASIAN J ANDROL, V12, P658, DOI 10.1038/aja.2010.54; Lorenz-Depiereux B, 2006, AM J HUM GENET, V78, P193, DOI 10.1086/499410; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Magen D, 2010, NEW ENGL J MED, V362, P1102, DOI 10.1056/NEJMoa0905647; Morey M, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-116; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Razali NN, 2015, J PEDIATR ENDOCR MET, V28, P1009, DOI 10.1515/jpem-2014-0366; Rowe PSN, 1997, HUM MOL GENET, V6, P539, DOI 10.1093/hmg/6.4.539; Schlingmann KP, 2016, J AM SOC NEPHROL, V27, P604, DOI 10.1681/ASN.2014101025; Streeten EA, 2011, NEW ENGL J MED, V365, P1741, DOI 10.1056/NEJMc1110226; Strom TM, 2008, CURR OPIN NEPHROL HY, V17, P357, DOI 10.1097/MNH.0b013e3282fd6e5b; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamamoto K, 2000, J AM SOC NEPHROL, V11, P1460, DOI 10.1681/ASN.V1181460; Zou MJ, 2015, LAB INVEST, V95, P1269, DOI 10.1038/labinvest.2015.90; Zou MJ, 2015, J PEDIATR ENDOCR MET, V28, P211, DOI 10.1515/jpem-2014-0103	45	12	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193388	10.1371/journal.pone.0193388	http://dx.doi.org/10.1371/journal.pone.0193388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505567	Green Submitted, Green Published, gold			2022-12-27	WOS:000426548200013
J	Richie, DL; Wang, LS; Chan, H; De Pascale, G; Six, DA; Wei, JR; Dean, CR				Richie, Daryl L.; Wang, Lisha; Chan, Helen; De Pascale, Gianfranco; Six, David A.; Wei, Jun-Rong; Dean, Charles R.			A pathway-directed positive growth restoration assay to facilitate the discovery of lipid A and fatty acid biosynthesis inhibitors in Acinetobacter baumannii	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; SYNTHASE-III FABH; ESCHERICHIA-COLI; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PSEUDOMONAS-AERUGINOSA; CHAIN SPECIFICITY; LPXC INHIBITORS; REDUCTASE FABI	Acinetobacter baumannii ATCC 19606 can grow without lipooligosaccharide (LOS). Lack of LOS can result from disruption of the early lipid A biosynthetic pathway genes lpxA, lpxC or lpxD. Although LOS itself is not essential for growth of A. baumannii ATCC 19606, it was previously shown that depletion of the lipid A biosynthetic enzyme LpxK in cells inhibited growth due to the toxic accumulation of lipid A pathway intermediates. Growth of LpxK-depleted cells was restored by chemical inhibition of LOS biosynthesis using CHIR-090 (LpxC) and fatty acid biosynthesis using cerulenin (FabB/F) and pyridopyrimidine (acetylCoA-carboxylase). Here, we expand on this by showing that inhibition of enoyl-acyl carrier protein reductase (FabI), responsible for converting trans-2-enoyl-ACP into acyl-ACP during the fatty acid elongation cycle also restored growth during LpxK depletion. Inhibition of fatty acid biosynthesis during LpxK depletion rescued growth at 37 degrees C, but not at 30 degrees C, whereas rescue by LpxC inhibition was temperature independent. We exploited these observations to demonstrate proof of concept for a targeted medium-throughput growth restoration screening assay to identify small molecule inhibitors of LOS and fatty acid biosynthesis. The differential temperature dependence of fatty acid and LpxC inhibition provides a simple means by which to separate growth stimulating compounds by pathway. Targeted cell-based screening platforms such as this are important for faster identification of compounds inhibiting pathways of interest in antibacterial discovery for clinically relevant Gram-negative pathogens.	[Richie, Daryl L.; Wang, Lisha; Chan, Helen; De Pascale, Gianfranco; Six, David A.; Wei, Jun-Rong; Dean, Charles R.] Novartis Inst BioMed Resd, Emeryville, CA 94608 USA		Richie, DL (corresponding author), Novartis Inst BioMed Resd, Emeryville, CA 94608 USA.	Daryl.Richie@novartis.com	Six, David A/D-6523-2011	Six, David A/0000-0002-9013-1711	Novartis organization	Novartis organization	Funding of this research was provided solely within the Novartis organization as per standard research activities. The funder provided support in the form of salaries for authors [DLR, LW, HC, GP, DAS, J-RW, CRD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altinok I, 2016, FISH SHELLFISH IMMUN, V55, P21, DOI 10.1016/j.fsi.2016.04.018; Babinski KJ, 2002, J BIOL CHEM, V277, P25937, DOI 10.1074/jbc.M204067200; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; Bainbridge BW, 2008, J BACTERIOL, V190, P4549, DOI 10.1128/JB.00234-08; Banevicius MA, 2013, J CHEMOTHERAPY, V25, P26, DOI 10.1179/1973947812Y.0000000061; Bartling CM, 2008, BIOCHEMISTRY-US, V47, P5290, DOI 10.1021/bi800240r; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Bogdanovich T, 2007, ANTIMICROB AGENTS CH, V51, P4191, DOI 10.1128/AAC.00550-07; Bojkovic J, 2016, J BACTERIOL, V198, P731, DOI 10.1128/JB.00639-15; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bos MP, 2005, INFECT IMMUN, V73, P6194, DOI 10.1128/IAI.73.9.6194-6197.2005; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Botos I, 2016, STRUCTURE, V24, P965, DOI 10.1016/j.str.2016.03.026; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Brown DG, 2016, BIOORGAN MED CHEM, V24, P6320, DOI 10.1016/j.bmc.2016.05.004; Chen WL, 2009, ACS CHEM BIOL, V4, P893, DOI 10.1021/cb900259w; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Cram ED, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0992-8; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; DeLucia AM, 2011, MBIO, V2, DOI 10.1128/mBio.00142-11; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Eichberg MJ, 2015, HEALTH SECUR, V13, P156, DOI 10.1089/hs.2014.0081; Emiola A, 2016, P NATL ACAD SCI USA, V113, P3108, DOI 10.1073/pnas.1521168113; Emiola A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121216; Flamm RK, 2015, ANTIMICROB AGENTS CH, V59, P2583, DOI 10.1128/AAC.05119-14; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Fuhrer F, 2006, MOL MICROBIOL, V59, P1025, DOI 10.1111/j.1365-2958.2005.04994.x; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Gu YH, 2015, STRUCTURE, V23, P496, DOI 10.1016/j.str.2015.01.001; Harding CM, 2015, MOL MICROBIOL, V96, P1023, DOI 10.1111/mmi.12986; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; Jenkins RJ, 2014, J BIOL CHEM, V289, P15527, DOI 10.1074/jbc.M114.564278; Jenkins RJ, 2012, ACS CHEM BIOL, V7, P1170, DOI 10.1021/cb300094a; Kalinin DV, 2017, EXPERT OPIN THER PAT, V27, P1227, DOI 10.1080/13543776.2017.1360282; Kaplan N, 2013, EUR J PHARM SCI, V50, P440, DOI 10.1016/j.ejps.2013.08.019; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; KAROW M, 1992, J BACTERIOL, V174, P702, DOI 10.1128/jb.174.3.702-710.1992; KAROW M, 1992, J BACTERIOL, V174, P7407, DOI 10.1128/jb.174.22.7407-7418.1992; Kawai T, 2017, BIOORG MED CHEM LETT, V27, P1045, DOI 10.1016/j.bmcl.2016.12.059; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Lee SH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7364; Lemaitre N, 2017, MBIO, V8, DOI 10.1128/mBio.00674-17; Lin L, 2012, MBIO, V3, DOI 10.1128/mBio.00312-12; Machutta CA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16081; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; Matano LM, 2016, BIOORGAN MED CHEM, V24, P6307, DOI 10.1016/j.bmc.2016.08.003; May J.M., 2015, PHILOS T R SOC LON B, V370; Moche M, 2001, J MOL BIOL, V305, P491, DOI 10.1006/jmbi.2000.4272; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Musayev F, 2005, J MOL BIOL, V346, P1313, DOI 10.1016/j.jmb.2004.12.044; Nayar AS, 2015, J BACTERIOL, V197, P1726, DOI 10.1128/JB.02552-14; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Park HS, 2007, J ANTIMICROB CHEMOTH, V60, P568, DOI 10.1093/jac/dkm236; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Peng DX, 2005, INFECT IMMUN, V73, P7569, DOI 10.1128/IAI.73.11.7569-7577.2005; Piizzi G, 2017, J MED CHEM, V60, P5002, DOI 10.1021/acs.jmedchem.7b00377; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Qiu XY, 2005, PROTEIN SCI, V14, P2087, DOI 10.1110/ps.051501605; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Schulz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062768; Sengyee S, 2017, AM J TROP MED HYG, V97, P62, DOI 10.4269/ajtmh.16-0858; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Simpson B.W., 2015, PHILOS T R SOC LON B, V370; Singh SB, 2017, BIOCHEM PHARMACOL, V133, P63, DOI 10.1016/j.bcp.2017.01.003; Sperandeo P, 2016, STRUCTURE, V24, P847, DOI 10.1016/j.str.2016.05.005; Steeghs L, 2001, EMBO J, V20, P6937, DOI 10.1093/emboj/20.24.6937; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Sweet CR, 2002, J BIOL CHEM, V277, P18281, DOI 10.1074/jbc.M201057200; Sweet CR, 2001, J BIOL CHEM, V276, P19565, DOI 10.1074/jbc.M101868200; Swoboda JG, 2009, ACS CHEM BIOL, V4, P875, DOI 10.1021/cb900151k; Wallace J, 2015, ANTIMICROB AGENTS CH, V59, P5775, DOI 10.1128/AAC.00686-15; Walsh AG, 2000, MOL MICROBIOL, V35, P718, DOI 10.1046/j.1365-2958.2000.01741.x; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Weber BS, 2016, J BACTERIOL, V198, P880, DOI 10.1128/JB.00906-15; Wei JR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00199-17; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Yao J., 2016, BIOCH BIOPHYS ACTA; Yao JW, 2016, J BIOL CHEM, V291, P171, DOI 10.1074/jbc.M115.699462; Yao JW, 2015, J BIOL CHEM, V290, P5940, DOI 10.1074/jbc.R114.636241; Yao ZZ, 2012, P NATL ACAD SCI USA, V109, pE2561, DOI 10.1073/pnas.1209742109; Yum JH, 2007, ANTIMICROB AGENTS CH, V51, P2591, DOI 10.1128/AAC.01562-06; Zhang J, 2017, BIOORG MED CHEM LETT, V27, P1670, DOI 10.1016/j.bmcl.2017.03.006; Zhao X, 2002, J BIOL CHEM, V277, P4722, DOI 10.1074/jbc.M107803200; Zuo K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050761	92	8	8	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193851	10.1371/journal.pone.0193851	http://dx.doi.org/10.1371/journal.pone.0193851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505586	Green Published, gold, Green Submitted			2022-12-27	WOS:000426548200036
J	Fievet, L; Sornette, D				Fievet, Lucas; Sornette, Didier			Calibrating emergent phenomena in stock markets with agent based models	PLOS ONE			English	Article							FINANCIAL-MARKETS; INVESTOR SENTIMENT; ADAPTIVE SYSTEMS; GAMES; MINORITY; DETERMINISM; PERSISTENCE; MECHANISM; BEHAVIOR; CYCLES	Since the 2008 financial crisis, agent-based models (ABMs), which account for out-of-equilibrium dynamics, heterogeneous preferences, time horizons and strategies, have often been envisioned as the new frontier that could revolutionise and displace the more standard models and tools in economics. However, their adoption and generalisation is drastically hindered by the absence of general reliable operational calibration methods. Here, we start with a different calibration angle that qualifies an ABM for its ability to achieve abnormal trading performance with respect to the buy-and-hold strategy when fed with real financial data. Starting from the common definition of standard minority and majority agents with binary strategies, we prove their equivalence to optimal decision trees. This efficient representation allows us to exhaustively test all meaningful single agent models for their potential anomalous investment performance, which we apply to the NASDAQ Composite index over the last 20 years. We uncover large significant predictive power, with anomalous Sharpe ratio and directional accuracy, in particular during the dotcom bubble and crash and the 2008 financial crisis. A principal component analysis reveals transient convergence between the anomalous minority and majority models. A novel combination of the optimal single-agent models of both classes into a two-agents model leads to remarkable superior investment performance, especially during the periods of bubbles and crashes. Our design opens the field of ABMs to construct novel types of advanced warning systems of market crises, based on the emergent collective intelligence of ABMs built on carefully designed optimal decision trees that can be reversed engineered from real financial data.	[Fievet, Lucas; Sornette, Didier] ETH, Dept Management Technol & Econ, Zurich, Switzerland; [Sornette, Didier] Swiss Finance Inst, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Fievet, L (corresponding author), ETH, Dept Management Technol & Econ, Zurich, Switzerland.	lfievet@ethz.ch			ETH Zurich [0-20029-14]	ETH Zurich(ETH Zurich)	This work was supported by ETH Zurich (https://www.ethz.ch) under Grant 0-20029-14.	Alfarano S., 2005, Computational Economics, V26, P19, DOI 10.1007/s10614-005-6415-1; Alfi V, 2009, EUR PHYS J B, V67, P385, DOI 10.1140/epjb/e2009-00028-4; Andersen JV, 2005, EUROPHYS LETT, V70, P697, DOI 10.1209/epl/i2005-10033-3; Andersen JV, 2003, EUR PHYS J B, V31, P141, DOI 10.1140/epjb/e2003-00017-7; ARTHUR WB, 1994, AM ECON REV, V84, P406; Arthur WB, 1997, EC EVOLVING COMPLEX; Axelrod R., 2005, HDB EC SERIES, V2; Barberis N, 1998, J FINANC ECON, V49, P307, DOI 10.1016/S0304-405X(98)00027-0; Barde S, 2016, J ECON DYN CONTROL, V73, P329, DOI 10.1016/j.jedc.2016.10.005; Bishop C.M., 2006, PATTERN RECOGN; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Boswijk HP, 2007, J ECON DYN CONTROL, V31, P1938, DOI 10.1016/j.jedc.2007.01.001; Brock WA, 1997, ECONOMETRICA, V65, P1059, DOI 10.2307/2171879; Challet D, 2000, PHYS REV LETT, V84, P1824, DOI 10.1103/PhysRevLett.84.1824; Challet D, 1998, PHYSICA A, V256, P514, DOI 10.1016/S0378-4371(98)00260-X; De Martino A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025104; Ehrentreich N, 2008, LECT NOTES ECON MATH, V602, P1, DOI 10.1007/978-3-540-73879-4; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Feng L, 2012, P NATL ACAD SCI USA, V109, P8388, DOI 10.1073/pnas.1205013109; Fievet L, 2017, QUANTITATIVE F UNPUB; Friedman J, 2001, SPRINGER SERIES STAT, V1, P337; Ghonghadze J, 2016, J EMPIR FINANC, V37, P1, DOI 10.1016/j.jempfin.2016.02.002; Goetzmann WN, 2002, J FINANC QUANT ANAL, V37, P375, DOI 10.2307/3594985; Grazzini J, 2017, J ECON DYN CONTROL, V77, P26, DOI 10.1016/j.jedc.2017.01.014; Hommes CH, 2006, HANDB ECON, V13, P1109; Hommes CH, 2002, P NATL ACAD SCI USA, V99, P7221, DOI 10.1073/pnas.082080399; Jefferies P, 2001, EUR PHYS J B, V20, P493, DOI 10.1007/s100510170228; Kaizoji T, 2015, J ECON BEHAV ORGAN, V112, P289, DOI 10.1016/j.jebo.2015.02.001; Kukacka J, 2016, ESTIMATION FINANCIAL; Lamper D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017902; LUX T, 1995, ECON J, V105, P881, DOI 10.2307/2235156; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Lux T, 2012, J ECON DYN CONTROL, V36, P1284, DOI 10.1016/j.jedc.2012.03.012; Marsili M, 2000, PHYSICA A, V280, P522, DOI 10.1016/S0378-4371(99)00610-X; Marsili M, 2001, PHYSICA A, V299, P93, DOI 10.1016/S0378-4371(01)00285-0; Patzelt F, 2013, SCI REP-UK, V3, DOI 10.1038/srep02784; Recchioni MC, 2015, J ECON DYN CONTROL, V60, P1, DOI 10.1016/j.jedc.2015.08.003; Romano JP, 2016, STAT PROBABIL LETT, V113, P38, DOI 10.1016/j.spl.2016.02.012; Romano JP, 2005, ECONOMETRICA, V73, P1237, DOI 10.1111/j.1468-0262.2005.00615.x; Satinover JB, 2012, QUANT FINANC, V12, P1065, DOI 10.1080/14697688.2012.670261; Satinover JB, 2012, QUANT FINANC, V12, P1051, DOI 10.1080/14697688.2012.670260; SHARPE WF, 1994, J PORTFOLIO MANAGE, V21, P49, DOI 10.3905/jpm.1994.409501; Sornette D, 2006, PHYSICA A, V370, P704, DOI 10.1016/j.physa.2006.02.022; Sornette D, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/6/062001; Tedeschi G, 2016, WORKING PAPERS; White H, 2000, ECONOMETRICA, V68, P1097, DOI 10.1111/1468-0262.00152; Zhou WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024391	47	7	7	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193290	10.1371/journal.pone.0193290	http://dx.doi.org/10.1371/journal.pone.0193290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY0AM	29499049	Green Published, Green Submitted, gold			2022-12-27	WOS:000426472300010
J	Iima, M; Kataoka, M; Kanao, S; Kawai, M; Onishi, N; Koyasu, S; Murata, K; Ohashi, A; Sakaguchi, R; Togashi, K				Iima, Mami; Kataoka, Masako; Kanao, Shotaro; Kawai, Makiko; Onishi, Natsuko; Koyasu, Sho; Murata, Katsutoshi; Ohashi, Akane; Sakaguchi, Rena; Togashi, Kaori			Variability of non-Gaussian diffusion MRI and intravoxel incoherent motion (IVIM) measurements in the breast	PLOS ONE			English	Article							GADOLINIUM DEPOSITION; CLINICAL-APPLICATIONS; DIAGNOSTIC-ACCURACY; MENSTRUAL-CYCLE; WEIGHTED MRI; LESIONS; CANCER; REPRODUCIBILITY; REPEATABILITY; PROSTATE	We prospectively examined the variability of non-Gaussian diffusion magnetic resonance imaging ( MRI) and intravoxel incoherent motion ( IVIM) measurements with different numbers of b-values and excitations in normal breast tissue and breast lesions. Thirteen volunteers and fourteen patients with breast lesions ( seven malignant, eight benign; one patient had bilateral lesions) were recruited in this prospective study ( approved by the Internal Review Board). Diffusion-weighted MRI was performed with 16 b-values ( 0-2500 s/mm(2) with one number of excitations [ NEX]) and five b-values ( 0-2500 s/mm(2), 3 NEX), using a 3T breast MRI. Intravoxel incoherent motion ( flowing blood volume fraction [ fIVIM] and pseudo-diffusion coefficient [ D*]) and non-Gaussian diffusion ( theoretical apparent diffusion coefficient [ ADC] at b value of 0 sec/mm(2) [ ADC(0)] and kurtosis [ K]) parameters were estimated from IVIM and Kurtosis models using 16 b-values, and synthetic apparent diffusion coefficient ( sADC) values were obtained from two key b-values. The variabilities between and within subjects and between different diffusion acquisition methods were estimated. There were no statistical differences in ADC(0), K, or sADC values between the different b-values or NEX. A good agreement of diffusion parameters was observed between 16 b-values ( one NEX), five b-values ( one NEX), and five b-values ( three NEX) in normal breast tissue or breast lesions. Insufficient agreement was observed for IVIM parameters. There were no statistical differences in the non-Gaussian diffusion MRI estimated values obtained from a different number of b-values or excitations in normal breast tissue or breast lesions. These data suggest that a limited MRI protocol using a few b-values might be relevant in a clinical setting for the estimation of non-Gaussian diffusion MRI parameters in normal breast tissue and breast lesions.	[Iima, Mami; Kataoka, Masako; Kanao, Shotaro; Kawai, Makiko; Onishi, Natsuko; Koyasu, Sho; Ohashi, Akane; Sakaguchi, Rena; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Iima, Mami] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan; [Murata, Katsutoshi] Siemens Healthcare KK, Shinagawa Ku, Tokyo, Japan	Kyoto University; Kyoto University; Siemens AG	Iima, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan.; Iima, M (corresponding author), Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan.	mamiiima@kuhp.kyoto-u.ac.jp	Iima, Mami/W-2390-2019; Kataoka, Masako/AAA-3475-2019; Koyasu, Sho/I-5747-2019	Iima, Mami/0000-0002-1991-2494; Kataoka, Masako/0000-0002-6212-3351; Koyasu, Sho/0000-0002-6690-7460; Ohashi, Akane/0000-0003-0291-3893; Onishi, Natsuko/0000-0003-4495-9187	Hakubi Project; Japan Society for Promotion of Science [15K19786]	Hakubi Project; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Hakubi Project and the Japan Society for Promotion of Science Grant-in-Aid for Young Scientists (B) (15K19786). The funder (Hakubi Project) provided support in the form of salaries for authors [Mami lima], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliu SO, 2014, TRANSL ONCOL, V7, P130, DOI 10.1593/tlo.13841; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Cho GY, 2016, EUR RADIOL, V26, P2547, DOI 10.1007/s00330-015-4087-3; Clendenen TV, 2013, MAGN RESON IMAGING, V31, P1, DOI 10.1016/j.mri.2012.06.022; Giannotti E, 2015, EUR J RADIOL, V84, P1729, DOI 10.1016/j.ejrad.2015.05.032; Iima M., 2017, RADIOLOGY; Iima M, 2016, RADIOLOGY, V278, P13, DOI 10.1148/radiol.2015150244; Iima M, 2015, INVEST RADIOL, V50, P205, DOI 10.1097/RLI.0000000000000094; Jambor I, 2014, J MAGN RESON IMAGING, V39, P1213, DOI 10.1002/jmri.24271; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kanda T, 2016, MAGN RESON IMAGING, V34, P1346, DOI 10.1016/j.mri.2016.08.024; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Liu CL, 2013, EUR J RADIOL, V82, pE782, DOI 10.1016/j.ejrad.2013.08.006; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Meeus EM, 2017, J MAGN RESON IMAGING, V45, P1325, DOI 10.1002/jmri.25411; Nissan N, 2014, RADIOLOGY, V271, P672, DOI 10.1148/radiol.14132084; O'Flynn EAM, 2012, EUR RADIOL, V22, P1512, DOI 10.1007/s00330-012-2399-0; Partridge SC, 2017, J MAGN RESON IMAGING, V45, P337, DOI 10.1002/jmri.25479; Partridge SC, 2001, J MAGN RESON IMAGING, V14, P433, DOI 10.1002/jmri.1204; Richard R, 2013, EUR RADIOL, V23, P2420, DOI 10.1007/s00330-013-2850-x; Rosenkrantz AB, 2012, RADIOLOGY, V264, P126, DOI 10.1148/radiol.12112290; Sigmund EE, 2011, MAGN RESON MED, V65, P1437, DOI 10.1002/mrm.22740; Spick C, 2016, NMR BIOMED, V29, P1445, DOI 10.1002/nbm.3596; Sun K, 2015, RADIOLOGY, V277, P46, DOI 10.1148/radiol.15141625; Thomassin-Naggara I, 2013, EUR J RADIOL, V82, P435, DOI 10.1016/j.ejrad.2012.03.002; Tofts PS, 2000, MAGN RESON MED, V43, P368, DOI 10.1002/(SICI)1522-2594(200003)43:3<368::AID-MRM8>3.0.CO;2-B; Woodhams R, 2011, RADIOGRAPHICS, V31, P1059, DOI 10.1148/rg.314105160; Wu DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113240	28	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193444	10.1371/journal.pone.0193444	http://dx.doi.org/10.1371/journal.pone.0193444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494639	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200050
J	Ladrera, R; Goma, J; Prat, N				Ladrera, Ruben; Goma, Joan; Prat, Narcis			Effects of Didymosphenia geminata massive growth on stream communities: Smaller organisms and simplified food web structure	PLOS ONE			English	Article							DIATOM DIDYMOSPHENIA; BIODIVERSITY; ASSEMBLAGES; SCHMIDT; ECOLOGY; HABITAT; QUALITY; DIPTERA; BIOLOGY; ALTERS	This study aims to contribute to the understanding of the impact of Didymosphenia geminata massive growths upon river ecosystem communities' composition and functioning. This is the first study to jointly consider the taxonomic composition and functional structure of diatom and macroinvertebrate assemblages in order to determine changes in community structure, and the food web alterations associated with this invasive alga. This study was carried out in the Lumbreras River ( Ebro Basin, La Rioja, Northern Spain), which has been affected by a considerable massive growth of D. geminata since 2011. The study shows a profound alteration in both the river community composition and in the food web structure at the sites affected by the massive growth, which is primarily due to the alteration of the environmental conditions, thus demonstrating that D. geminata has an important role as an ecosystem engineer in the river. Thick filamentous mats impede the movement of large invertebrates D especially those that move and feed up on it D and favor small, opportunistic, herbivorous organisms, mainly chironomids, that are capable of moving between filaments and are aided by the absence of large trophic competitors and predators - prey release effect-. Only small predators, such as hydra, are capable of surviving in the new environment, as they are favored by the increase in chironomids, a source of food, and by the reduction in both their own predators and other midge predators - mesopredator release-. This change in the top-down control affects the diatom community, since chironomids may feed on large diatoms, increasing the proportion of small diatoms in the substrate. The survival of small and fast-growing pioneer diatoms is also favored by the mesh of filaments, which offers them a new habitat for colonization. Simultaneously, D. geminata causes a significant reduction in the number of diatoms with similar ecological requirements ( those attached to the substrate). Overall, D. geminata creates a community dominated by small organisms that is clearly different from the existing communities in the same stream where there is an absence of massive growths.	[Ladrera, Ruben; Goma, Joan; Prat, Narcis] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Freshwater Ecol & Management FEM Res Grp, Barcelona, Catalonia, Spain	University of Barcelona	Ladrera, R (corresponding author), Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Freshwater Ecol & Management FEM Res Grp, Barcelona, Catalonia, Spain.	rubenladreraf@hotmail.com	Ladrera, Rubén/AAE-5460-2019	Ladrera, Rubén/0000-0002-5172-3271	Government of La Rioja; Ebro Hydrographic Confederation (CHE)	Government of La Rioja; Ebro Hydrographic Confederation (CHE)	This study was partially supported by the Government of La Rioja and the Ebro Hydrographic Confederation (CHE).	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Albertson LK, 2016, FRESHW SCI, V35, P644, DOI 10.1086/685860; ALLAN JD, 1993, BIOSCIENCE, V43, P32, DOI 10.2307/1312104; Anderson IJ, 2015, SW NAT, V59, P389; Anderson M.J., 2008, PRIMER PERMANOVA GU; [Anonymous], 1991, BACILLARIOPHYCEAE 3; [Anonymous], 1988, SUSSWASSERFLORA MITT; Beltrami ME, 2008, PLANT BIOSYST, V142, P126, DOI 10.1080/11263500701872788; Bhatt JP, 2008, AQUAT ECOL, V42, P347, DOI 10.1007/s10452-007-9106-2; Birk S, 2012, ECOL INDIC, V18, P31, DOI 10.1016/j.ecolind.2011.10.009; Bonada N, 2006, ANNU REV ENTOMOL, V51, P495, DOI 10.1146/annurev.ento.51.110104.151124; Bonada N, 2007, GLOBAL CHANGE BIOL, V13, P1658, DOI 10.1111/j.1365-2486.2007.01375.x; Bothwell ML, 2014, DIATOM RES, V29, P229, DOI 10.1080/0269249X.2014.889041; CHEVENET F, 1994, FRESHWATER BIOL, V31, P295, DOI 10.1111/j.1365-2427.1994.tb01742.x; Cranston PS, 2005, AUST J ENTOMOL, V44, P252, DOI 10.1111/j.1440-6055.2005.00465.x; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Cullis James D. S., 2012, Journal of Geophysical Research: Biogeosciences, V117, DOI 10.1029/2011JG001891; Ector L., 2005, P7; Edlund MB, 1999, J FRESHWATER ECOL, V14, P293, DOI 10.1080/02705060.1999.9663684; Floder S, 2009, BIODIVERS CONSERV, V18, P3809, DOI 10.1007/s10531-009-9681-8; Garcia-Berthou E., 2015, Ecosistemas, V24, P36, DOI 10.7818/ECOS.2015.24-1.07; Gillis CA, 2014, DIATOM RES, V29, P281, DOI 10.1080/0269249X.2014.924437; Gillis CA, 2010, HYDROBIOLOGIA, V647, P63, DOI 10.1007/s10750-009-9832-7; Gozlan RE, 2010, AQUAT INVASIONS, V5, P231, DOI 10.3391/ai.2010.5.3.02; Hayes JW, 2000, T AM FISH SOC, V129, P315, DOI 10.1577/1548-8659(2000)129<0315:DATOAW>2.0.CO;2; HOAGLAND KD, 1982, AM J BOT, V69, P188, DOI 10.2307/2443006; Jellyman PG, 2016, BIOL INVASIONS, V18, P3419, DOI 10.1007/s10530-016-1233-z; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kawecka B, 2003, HYDROBIOLOGIA, V495, P193, DOI 10.1023/A:1025469500265; Kilroy C, 2009, FRESHWATER BIOL, V54, P1990, DOI 10.1111/j.1365-2427.2009.02247.x; Kilroy C, 2016, FRESHWATER BIOL, V61, P1550, DOI 10.1111/fwb.12798; Kilroy C, 2014, DIATOM RES, V29, P237, DOI 10.1080/0269249X.2014.889043; Kovacevic G, 2012, INT J DEV BIOL, V56, P627, DOI 10.1387/ijdb.123510gk; Krammer K., 1985, BIBLIOTHECA DIATOMOL, V9; Krammer K., 1986, BACILLARIOPHYCEAE; Krammer K., 1997, BIBLIOTHECA DIATOMOL, V36; Ladrera R, 2014, PAGINAS INF AMBIENT, V43, P24; Ladrera R, 2016, AQUAT INVASIONS, V11, P355, DOI 10.3391/ai.2016.11.4.02; Ladrera R, 2015, RIVER RES APPL, V31, P216, DOI 10.1002/rra.2731; Ladrera R, 2013, LIMNETICA, V32, P353; Lange-Bertalot H., 1989, BIBLIOTHECA DIATOMOL, V18; Larson AM, 2007, RELATIONSHIPS NUISAN; Maceda-Veiga A, 2013, REV FISH BIOL FISHER, V23, P1, DOI 10.1007/s11160-012-9275-5; Marker AF, 1986, P 9 DIAT S, P143; Munne A, 2003, AQUAT CONSERV, V13, P147, DOI 10.1002/aqc.529; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; NUNEZ M., 2010, TECNOLOGIA AGUA, V320, P46; Pardo Isabel, 2002, Limnetica, V21, P115; Prat N, 2014, LIMNETICA, V33, P47; Reichardt E., 1999, GOMPHONEMA ICONOGRAP; Rimet F, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012018; Rodriguez-Lozano P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117630; ROEMER SC, 1984, CAN J BOT, V62, P1799, DOI 10.1139/b84-244; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanmiguel A, 2016, BIOL INVASIONS, V18, P1467, DOI 10.1007/s10530-016-1095-4; Spaulding S., 2007, INCREASE NUISANCE BL; Statzner B, 2004, ECOGRAPHY, V27, P470, DOI 10.1111/j.0906-7590.2004.03836.x; Statzner B, 2010, FRESHWATER BIOL, V55, P80, DOI 10.1111/j.1365-2427.2009.02369.x; Tachet H, 2006, INVERTEBRES EAU DOUC; Whitton BA, 2009, HYDROBIOLOGIA, V630, P1, DOI 10.1007/s10750-009-9753-5; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2	62	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193545	10.1371/journal.pone.0193545	http://dx.doi.org/10.1371/journal.pone.0193545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494699	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200063
J	Ni, J; Dong, LX; Jiang, ZF; Yang, XL; Chen, ZY; Wu, YH; Xu, MJ				Ni, Jun; Dong, Lixiang; Jiang, Zhifang; Yang, Xiuli; Chen, Ziying; Wu, Yuhuan; Xu, Maojun			Comprehensive transcriptome analysis and flavonoid profiling of Ginkgo leaves reveals flavonoid content alterations in day-night cycles	PLOS ONE			English	Article							CIRCADIAN CLOCKS; RNA-SEQ; BILOBA; BIOSYNTHESIS; GENE; EXPRESSION; GROWTH; ACCUMULATION; ALIGNMENT; EXTRACT	Ginkgo leaves are raw materials for flavonoid extraction. Thus, the timing of their harvest is important to optimize the extraction efficiency, which benefits the pharmaceutical industry. In this research, we compared the transcriptomes of Ginkgo leaves harvested at midday and midnight. The differentially expressed genes with the highest probabilities in each step of flavonoid biosynthesis were down-regulated at midnight. Furthermore, real-time PCR corroborated the transcriptome results, indicating the decrease in flavonoid biosynthesis at midnight. The flavonoid profiles of Ginkgo leaves harvested at midday and midnight were compared, and the total flavonoid content decreased at midnight. A detailed analysis of individual flavonoids showed that most of their contents were decreased by various degrees. Our results indicated that circadian rhythms affected the flavonoid contents in Ginkgo leaves, which provides valuable information for optimizing their harvesting times to benefit the pharmaceutical industry.	[Ni, Jun; Dong, Lixiang; Jiang, Zhifang; Yang, Xiuli; Chen, Ziying; Wu, Yuhuan; Xu, Maojun] Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Qual & Safety Agr Prod, Hangzhou, Zhejiang, Peoples R China; [Ni, Jun; Dong, Lixiang; Jiang, Zhifang; Yang, Xiuli; Xu, Maojun] Hangzhou Normal Univ, Zhejiang Prov Key Lab Genet Improvement & Qual Co, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Hangzhou Normal University	Ni, J; Xu, MJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Qual & Safety Agr Prod, Hangzhou, Zhejiang, Peoples R China.; Ni, J; Xu, MJ (corresponding author), Hangzhou Normal Univ, Zhejiang Prov Key Lab Genet Improvement & Qual Co, Hangzhou, Zhejiang, Peoples R China.	nijun@hznu.edu.cn; maojunxu@163.com			Zhejiang Provincial Natural Science Foundation of China [LY18C060008]; Independent Projects for Agricultural Research [20170432607]; National Natural Science Foundation of China [81673539, 81373907]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Independent Projects for Agricultural Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by Zhejiang Provincial Natural Science Foundation of China (Grant No. LY18C060008) (JN), Independent Projects for Agricultural Research (Grant No. 20170432607) (JN), National Natural Science Foundation of China (Grant No. 81673539 and 81373907) (MX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barnes PW, 2016, OECOLOGIA, V181, P55, DOI 10.1007/s00442-016-3558-9; Chen Y, 2014, ACTA PHYSIOL PLANT, V36, P3173, DOI 10.1007/s11738-014-1684-8; Cheng H, 2011, PLANT CELL REP, V30, P49, DOI 10.1007/s00299-010-0943-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; DeFeudis FV, 2003, PHARMACOPSYCHIATRY, V36, pS2; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Du SH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00871; Fan Yimei, 1998, Zhongguo Zhongyao Zazhi, V23, P267; Farre EM, 2012, CURR OPIN PLANT BIOL, V15, P293, DOI 10.1016/j.pbi.2012.01.013; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Guan R, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0154-1; Han SM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0868-8; He B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00819; Jacobs BP, 2000, AM J MED, V108, P341, DOI 10.1016/S0002-9343(00)00290-4; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kang SZ, 2004, J EXP BOT, V55, P2437, DOI 10.1093/jxb/erh249; Kaur P, 2012, CHEM BIODIVERS, V9, P409, DOI 10.1002/cbdv.201100082; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu XG, 2015, J PHARMACEUT BIOMED, V113, P212, DOI 10.1016/j.jpba.2015.03.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Ni J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00920; Pang YZ, 2005, PLANT SCI, V168, P1525, DOI 10.1016/j.plantsci.2005.02.003; Pang YZ, 2004, DNA SEQUENCE, V15, P283, DOI 10.1080/10425170412331283814; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rimbach G, 2001, BIOFACTORS, V15, P39, DOI 10.1002/biof.5520150104; Schulz E, 2015, PLANT CELL ENVIRON, V38, P1658, DOI 10.1111/pce.12518; Shen GA, 2006, BIOSCIENCE REP, V26, P19, DOI 10.1007/s10540-006-9007-y; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; Sun MY, 2010, INNOV FOOD SCI EMERG, V11, P672, DOI 10.1016/j.ifset.2010.08.006; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tobin EM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00261; Veit M, 1996, J PLANT PHYSIOL, V148, P478, DOI 10.1016/S0176-1617(96)80282-3; Wang Gui-bin, 2013, Yingyong Shengtai Xuebao, V24, P3077; Wang L, 2016, GINKGO BILOBA, V47, P377; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Warren JM, 2003, TREE PHYSIOL, V23, P527, DOI 10.1093/treephys/23.8.527; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie HY, 2014, MOLECULES, V19, P4466, DOI 10.3390/molecules19044466; Xu F, 2014, FUNCT INTEGR GENOMIC, V14, P177, DOI 10.1007/s10142-013-0352-1; Xu F, 2012, MOL BIOL REP, V39, P2285, DOI 10.1007/s11033-011-0978-9; Xu MJ, 2012, ENVIRON EXP BOT, V75, P114, DOI 10.1016/j.envexpbot.2011.09.005; Xu MJ, 2009, PLANT CELL ENVIRON, V32, P960, DOI 10.1111/j.1365-3040.2009.01976.x; Xu Y, 2014, NEW FOREST, V45, P765, DOI 10.1007/s11056-014-9435-7; Yerushalmi S, 2011, MOL ECOL, V20, P1155, DOI 10.1111/j.1365-294X.2010.04962.x; Zhang YY, 2015, J EXP BOT, V66, P2535, DOI 10.1093/jxb/erv043; Zhou ZY., 2009, PALAEOWORLD, V18, P1, DOI [10.1016/j.palwor.2009.01.001, DOI 10.1016/j.palwor.2009.01.001]; Zoratti L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00534	54	23	25	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193897	10.1371/journal.pone.0193897	http://dx.doi.org/10.1371/journal.pone.0193897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494702	gold, Green Submitted, Green Published			2022-12-27	WOS:000426363200101
J	Cameron, MF; Frost, KJ; Ver Hoef, JM; Breed, GA; Whiting, AV; Goodwin, J; Boveng, PL				Cameron, Michael F.; Frost, Kathryn J.; Ver Hoef, Jay M.; Breed, Greg A.; Whiting, Alex V.; Goodwin, John; Boveng, Peter L.			Habitat selection and seasonal movements of young bearded seals (Erignathus barbatus) in the Bering Sea	PLOS ONE			English	Article							ST-LAWRENCE ISLAND; ANIMAL MOVEMENT; RESOURCE SELECTION; CHUKCHI SEAS; TELEMETRY DATA; MODEL; ABUNDANCE; DIET; LACTATION; BEHAVIOR	The first year of life is typically the most critical to a pinniped's survival, especially for Arctic phocids which are weaned at only a few weeks of age and left to locate and capture prey on their own. Their seasonal movements and habitat selection are therefore important factors in their survival. During a cooperative effort between scientists and subsistence hunters in October 2004, 2005, and 2006, 13 female and 13 male young (i.e., age <2) bearded seals (Erignathus barbatus) were tagged with satellite-linked dive recorders (SDRs) in Kotzebue Sound, Alaska. Shortly after being released, most seals moved south with the advancing sea-ice through the Bering Strait and into the Bering Sea where they spent the winter and early spring. The SDRs of 17 (8 female and 9 male) seals provided frequent high-quality positions in the Bering Sea; their data were used in our analysis. To investigate habitat selection, we simulated 20 tracks per seal by randomly selecting from the pooled distributions of the absolute bearings and swim speeds of the tagged seals. For each point in the observed and simulated tracks, we obtained the depth, sea-ice concentration, and the distances to sea-ice, open water, the shelf break and coastline. Using logistic regression with a stepwise model selection procedure, we compared the simulated tracks to those of the tagged seals and obtained a model for describing habitat selection. The regression coefficients indicated that the bearded seals in our study selected locations near the ice edge. In contrast, aerial surveys of the bearded seal population, predominantly composed of adults, indicated higher abundances in areas farther north and in heavier pack ice. We hypothesize that this discrepancy is the result of behavioral differences related to age. Ice concentration was also shown to be a statistically significant variable in our model. All else being equal, areas of higher ice concentration are selected for up to about 80%. The effects of sex and bathymetry were not statistically significant. The close association of young bearded seals to the ice edge in the Bering Sea is important given the likely effects of climate warming on the extent of sea-ice and subsequent changes in ice edge habitat.	[Cameron, Michael F.; Ver Hoef, Jay M.; Boveng, Peter L.] NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98177 USA; [Frost, Kathryn J.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Breed, Greg A.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Whiting, Alex V.; Goodwin, John] Native Village Kotzebue, Kotzebue, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Cameron, MF (corresponding author), NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98177 USA.	michael.cameron@noaa.gov	Hoef, Jay M Ver/C-8577-2017	Cameron, Michael/0000-0002-5961-6796	Tribal Wildlife Grants Program of the U.S. Fish and Wildlife Service [U-4-IT]; NOAAs National Marine Fisheries Service	Tribal Wildlife Grants Program of the U.S. Fish and Wildlife Service; NOAAs National Marine Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was funded by the Tribal Wildlife Grants Program of the U.S. Fish and Wildlife Service (https://www.fws.gov/nativeamerican/grants.html; Grant no. U-4-IT awarded to AVW and KJF) and received significant additional support from NOAAs National Marine Fisheries Service.; This project was designed as a cooperative effort, combining the expertise of biologists' at data analysis, handling and tagging seals, and the knowledge of Kotzebue-area Alaska Natives about the local distribution and habits of bearded seals and traditional hunting methods. Many people and institutions were involved in this project and were critical to its success. In particular, we would like to thank Willie Goodwin, Ross Schaeffer, John Goodwin, Chuck Schaeffer, Rob Delong, Gay Sheffield, Cyrus Harris, Doc Harris, Grover Harris, Lee Harris, Brenda Goodwin, Pearl Goodwin, Dan Savetilik, Tom Jones, Lloyd Lowry, the Alaska Department of Fish and Game and the Selawik National Wildlife Refuge. This study was funded by the Tribal Wildlife Grants Program of the U.S. Fish and Wildlife Service (https://www.fws.gov/nativearnerican/grants.html; Grant no. U-4-IT awarded to AVW and KJF) and received significant additional support from NOAA's National Marine Fisheries Service. All work was conducted in accordance with and under the authority of United States Marine Mammal Protection Act Scientific Research Permits 358-1585 and 358-1787. The project was reviewed and approved by the State of Alaska Institutional Animal Care and Use Committee (IACUC) Permit No. 06-16 in 2007-2009. All satellite telemetry and associated metadata are archived and available through the Research Workspace DataONE member node at https://dx.doi.org/10. 24431/rw1k118 [69]. More detailed project information, along with maps and field photos pictures can be found at: www.kotzebueira.org/environmental-projects/young-bearded-seal/index/html	ANTONELIS GA, 1994, ARCTIC, V47, P74; Barnard G., 1963, J R STAT SOC B, V25, P294; Blackwell PG, 1997, ECOL MODEL, V100, P87, DOI 10.1016/S0304-3800(97)00153-1; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Boyd JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063051; Braham HW, 1981, DISTRIBUTION DENSITY; Burns J.J., 1981, P145; Burns JJ, 1983, ENV ASSESSMENT ALASK, V19, P311; Burns JJ, 1979, 02500253 AL DEP FISH; Burns JJ, 1967, PACIFIC BEARDED SEAL; BURNS JJ, 2002, ENCY MARINE MAMMALS, P39; Burns JJ, 1977, ENV ASSESSMENT ALASK, V1, P58; Cameron M, 2017, SATELLITE TELEMETRY; Cavalieri D. J., 2004, AMSR E AQUA DAILY L3; Christ A, 2008, ENVIRON ECOL STAT, V15, P27, DOI 10.1007/s10651-007-0036-x; CLS, 2013, ARG US MAN; Conn PB, 2014, METHODS ECOL EVOL, V5, P1280, DOI 10.1111/2041-210X.12127; Cooper LW, 2002, MAR ECOL PROG SER, V226, P13, DOI 10.3354/meps226013; Crawford JA, 2015, PROG OCEANOGR, V136, P133, DOI 10.1016/j.pocean.2015.05.011; Crawford JA, 2012, POLAR BIOL, V35, P241, DOI 10.1007/s00300-011-1067-1; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Eisner L, 2013, POLAR BIOL, V36, P87, DOI 10.1007/s00300-012-1241-0; FAY FH, 1974, OCEANOGRAPHY BERING, P383; Fedoseev G.A., 1984, P130; Fedoseev G. A., 2000, POPULATION BIOL ICE; Fedoseev GA, 1965, IZV TINRO, V65, P212; FELTZ ET, 1966, CRYOBIOLOGY, V3, P261, DOI 10.1016/S0011-2240(66)80020-2; Fetterer F., 2016, **DATA OBJECT**; FINLEY KJ, 1983, ARCTIC, V36, P82; Fiscus CH, 1976, BASELINE CHARACTERIZ; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Frost KJ, 2005, P 16 BIENN C BIOL MA, P98; Gjertz I, 2000, POLAR BIOL, V23, P559, DOI 10.1007/s003000000121; Grebmeier J, 2009, PACMARS SURFACE SEDI; Grebmeier JM, 2015, PROG OCEANOGR, V136, P92, DOI 10.1016/j.pocean.2015.05.006; Heptner LVG, 1976, MAMMALS SOVIET UNI 3, VII, P166; Hoef JMV, 2014, STAT METHODOL, V17, P46, DOI 10.1016/j.stamet.2013.03.001; Hooten M. B., 2017, ANIMAL MOVEMENT STAT; Hooten MB, 2010, J AGR BIOL ENVIR ST, V15, P523, DOI 10.1007/s13253-010-0038-2; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KINGSLEY MCS, 1985, CAN J FISH AQUAT SCI, V42, P1189, DOI 10.1139/f85-147; Kosygin G. M., 1971, IZV TINRO, V75, P144; Kovacs K. M., 2002, ENCY MARINE MAMMALS, P84; Krafft BA, 2000, CAN J ZOOL, V78, P1408, DOI 10.1139/cjz-78-8-1408; Lauth R, 2011, RESULTS 2010 E NO BE; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; LOWRY LF, 1980, ARCTIC, V33, P330; LOWRY LF, 1987, CAN FIELD NAT, V101, P6; Lydersen C, 1999, MAR ECOL PROG SER, V187, P265, DOI 10.3354/meps187265; Manly B.F.J., 2002, RESOURCE SELECTION A; Manly BFJ, 1997, RANDOMIZATION BOOTST; McClintock BT, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0021-6; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; National Marine Fisheries Service, 2012, FED REGISTER, P76739; NELSON RR, 1984, MARINE MAMMAL SPECIE, V7, P1; Potts JR, 2014, METHODS ECOL EVOL, V5, P253, DOI 10.1111/2041-210X.12150; Quakenbush L. T., 2011, BIOL BEARDED SEAL ER; R Core Development Team, 2015, R LANG ENV STAT COMP; Simpkins MA, 2003, POLAR BIOL, V26, P577, DOI 10.1007/s00300-003-0527-7; Smith TG., 1981, 1042 DEP FISH OC ARC; Team RC., 2022, LANG ENV STAT COMP; Waring GT, 2010, STATUS REV BEARDED S; Whiting A., 2011, COMBINING INUPIAQ SC; Young BG, 2010, POLAR BIOL, V33, P153, DOI 10.1007/s00300-009-0693-3	68	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192743	10.1371/journal.pone.0192743	http://dx.doi.org/10.1371/journal.pone.0192743			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489846	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000041
J	Dona, D; Zingarella, S; Gastaldi, A; Lundin, R; Perilongo, G; Frigo, AC; Hamdy, RF; Zaoutis, T; Da Dalt, L; Giaquinto, C				Dona, Daniele; Zingarella, Silvia; Gastaldi, Andrea; Lundin, Rebecca; Perilongo, Giorgio; Frigo, Anna Chiara; Hamdy, Rana F.; Zaoutis, Theoklis; Da Dalt, Liviana; Giaquinto, Carlo			Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia	PLOS ONE			English	Article							ANTIBACTERIAL DRUG-USE; KLEBSIELLA-PNEUMONIAE; CHILDREN; RESISTANCE; EPIDEMIOLOGY; INFECTIONS; MANAGEMENT; RISK	Background Italian pediatric antimicrobial prescription rates are among the highest in Europe. As a first step in an Antimicrobial Stewardship Program, we implemented a Clinical Pathway (CP) for Community Acquired Pneumonia with the aim of decreasing overall prescription of antibiotics, especially broad-spectrum. Materials and methods The CP was implemented on 10/01/2015. We collected antibiotic prescribing and outcomes data from children aged 3 months-15 years diagnosed with CAP from 10/15/2014 to 04/15/2015 (pre-intervention period) and from 10/15/2015 to 04/15/2016 (post-intervention period). We assessed antibiotic prescription differences pre-and post-CP, including rates, breadth of spectrum, and duration of therapy. We also compared length of hospital stay for inpatients and treatment failure for inpatients and outpatients. Chi-square and Fisher's exact test were used to compare categorical variables and Wilcoxon rank sum test was used to compare quantitative outcomes. Results 120 pre-and 86 post-intervention clinic visits were identified with a diagnosis of CAP. In outpatients, we observed a decrease in broad-spectrum regimens (50% pre-CP vs. 26.8% post-CP, p = 0.02), in particular macrolides, and an increase in narrow-spectrum (amoxicillin) post-CP. Post-CP children received fewer antibiotic courses (median DOT from 10 pre-CP to 8 post-CP, p<0.0001) for fewer days (median LOT from 10 pre-CP to 8 post-CP, p<0.0001) than their pre-CP counterparts. Physicians prescribed narrow-spectrum mono-therapy more frequently than broad-spectrum combination therapy (DOT/LOT ratio 1.157 pre-CP vs. 1.065 post-CP). No difference in treatment failure was reported before and after implementation (2.3% pre-CP vs. 11.8% post-CP, p = 0.29). Among inpatients we also noted a decrease in broad-spectrum regimens (100% pre-CP vs. 66.7% post-CP, p = 0.02) and the introduction of narrow-spectrum regimens (0% pre-CP vs. 33.3% post-CP, p = 0.02) post-CP. Hospitalized patients received fewer antibiotic courses post-CP (median DOT from 18.5 pre-CP to 10 post-CP, p = 0.004), while there was no statistical difference in length of therapy (median LOT from 11 pre-CP to 10 post-CP, p = 0.06). Days of broad spectrum therapy were notably lower post-CP (median bsDOT from 17 pre-CP to 4.5 postCP, p<0.0001). No difference in treatment failure was reported before and after CP implementation (16.7% pre-CP vs. 15.4% post-CP, p = 1). Conclusions Introduction of a CP for CAP in a Pediatric Emergency Department led to reduction of broad-spectrum antibiotic prescriptions, of combination therapy and of duration of treatment both for outpatients and inpatients.	[Dona, Daniele; Zaoutis, Theoklis] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Dona, Daniele; Zaoutis, Theoklis] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA; [Dona, Daniele; Gastaldi, Andrea; Giaquinto, Carlo] Univ Padua, Div Pediat Infect Dis, Dept Woman & Child Hlth, Padua, Italy; [Dona, Daniele; Lundin, Rebecca; Giaquinto, Carlo] PENTA Fdn, Padua, Italy; [Zingarella, Silvia] Univ Padua, Dept Woman & Child Hlth, Pediat Emergency Dept, Padua, Italy; [Perilongo, Giorgio] Univ Padua, Dept Woman & Child Hlth, Padua, Italy; [Frigo, Anna Chiara] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Biostat Epidemiol & Publ Hlth Unit, Padua, Italy; [Hamdy, Rana F.] Childrens Natl Hlth Syst, Dept Pediat, Washington, DC USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Padua; University of Padua; University of Padua; University of Padua; Children's National Health System	Dona, D (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.; Dona, D (corresponding author), Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA.; Dona, D (corresponding author), Univ Padua, Div Pediat Infect Dis, Dept Woman & Child Hlth, Padua, Italy.; Dona, D (corresponding author), PENTA Fdn, Padua, Italy.	daniele.dona@phd.unipd.it	Giaquinto, Carlo/AAB-5016-2020; Donà, Daniele/W-7088-2019	Donà, Daniele/0000-0001-7105-2105; Gastaldi, Andrea/0000-0002-8110-210X; Lundin, Rebecca/0000-0002-8380-4834; PERILONGO, GIORGIO/0000-0002-3712-0386; GIAQUINTO, CARLO/0000-0001-9365-0413				Ambroggio L, 2013, PEDIATRICS, V131, pE1623, DOI 10.1542/peds.2012-2635; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Bradley JS, 2010, PEDIATR INFECT DIS J, V29, P1043, DOI 10.1097/INF.0b013e3181f42a53; Bratu S, 2005, ANTIMICROB AGENTS CH, V49, P3018, DOI 10.1128/AAC.49.7.3018-3020.2005; Center for Disease Control and Prevention, 2015, AMB HLTH CAR DAT; Clavenna A, 2011, ARCH DIS CHILD, V96, P590, DOI 10.1136/adc.2010.183541; De Luca M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154662; Don M, 2010, ACTA PAEDIATR, V99, P1602, DOI 10.1111/j.1651-2227.2010.01924.x; Frei CR, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-188; Gagliotti C, 2014, USO ANTIBIOTICI RESI; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hasegawa J, 2015, PEDIATR INT, V57, P582, DOI 10.1111/ped.12587; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Jenkins TC, 2013, AM J MED, V126, P327, DOI 10.1016/j.amjmed.2012.10.027; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Launay E, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0661-3; Leyenaar JK, 2014, J PEDIATR-US, V165, P585, DOI 10.1016/j.jpeds.2014.04.062; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Nascimento-Carvalho CM, 2008, PEDIATR INFECT DIS J, V27, P939, DOI 10.1097/INF.0b013e3181723751; Pakyz AL, 2008, ARCH INTERN MED, V168, P2254, DOI 10.1001/archinte.168.20.2254; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Polk RE, 2011, CLIN INFECT DIS, V53, P1100, DOI 10.1093/cid/cir672; Polk RE, 2007, CLIN INFECT DIS, V44, P664, DOI 10.1086/511640; Rosenblut A, 2006, ANN OTO RHINOL LARYN, V115, P186, DOI 10.1177/000348940611500305; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Samore MH, 2005, JAMA-J AM MED ASSOC, V294, P2305, DOI 10.1001/jama.294.18.2305; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Simbalista R, 2011, CLINICS, V66, P95, DOI 10.1590/S1807-59322011000100017; Smith J, 2012, PEDIATRICS, V129, pE1326, DOI 10.1542/peds.2011-2412; South M, 2003, MED J AUSTRALIA, V178, P207, DOI 10.5694/j.1326-5377.2003.tb05163.x; Stein RT, 2007, PEDIATR PULM, V42, P1095, DOI 10.1002/ppul.20652; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; WATANABE M, 1991, ANTIMICROB AGENTS CH, V35, P147, DOI 10.1128/AAC.35.1.147; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	36	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193581	10.1371/journal.pone.0193581	http://dx.doi.org/10.1371/journal.pone.0193581			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489898	Green Published, gold			2022-12-27	WOS:000426276000092
J	Duckers, MLA; Thormar, SB; Juen, B; Ajdukovic, D; Newlove-Eriksson, L; Olff, M				Duckers, Michel L. A.; Thormar, Sigridur B.; Juen, Barbara; Ajdukovic, Dean; Newlove-Eriksson, Lindy; Olff, Miranda			Measuring and modelling the quality of 40 post-disaster mental health and psychosocial support programmes	PLOS ONE			English	Article							EUROPE; CARE	Disasters can have an enormous impact on the health and well-being of those affected. Internationally, governments and service providers are often challenged to address complex psychosocial problems. Ideally, the potentially broad range of support activities include a coherent, high-quality mental health and psychosocial support (MHPSS) programme. We present a theory-driven quantitative analysis of the quality of 40 MHPSS programmes, mostly implemented in European disaster settings. The objective is to measure quality domains recognized as relevant in the literature and to empirically test associations. During the EU project "Operationalizing Psychosocial Support in Crisis" (OPSIC) an evaluation survey was designed and developed for this purpose and completed by 40 MHPSS programme coordinators involved in different mass emergencies and disasters. We analysed the survey data in two steps. Firstly, we used the data to operationalize quality domains of a MHPSS programme, tested constructs and assessed their internal consistency reliability. A total of 26 out of 44 survey items clustered into three of the four domains identified within the theoretical framework: "planning and delivery system" (Cronbach's alpha 0.82); "general evaluation criteria" (Cronbach's alpha 0.82); and "essential psychosocial principles" (Cronbach's alpha 0.75). "Measures and interventions applied", theoretically a potential fourth domain, could not be confirmed to empirically cluster together. Secondly, several models with associations between domains and measures and interventions were tested and compared. The model with the best fit suggests that in MHPSS programmes with a higher planning and delivery systems score, a larger number of measures and interventions from evidence informed guidelines are applied. In such programmes, coordinators are more positive about general evaluation criteria and the realization of essential psychosocial principles. Moreover, the analyses showed that some measures and interventions are more likely to be applied in programmes with more evolved planning and delivery systems, yet for most measures and interventions the likelihood of being applied is not linked to planning and delivery system status, nor to coordinator perceptions concerning psychosocial principles and evaluation criteria. Further research is necessary to validate and expand the findings and to learn more about success factors and obstacles for MHPSS programme implementation.	[Duckers, Michel L. A.] Impact Natl Knowledge & Advice Ctr Psychosocial C, Diemen, Netherlands; [Duckers, Michel L. A.] NIVEL Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Duckers, Michel L. A.; Olff, Miranda] Arq Psychotrauma Expert Grp, Diemen, Netherlands; [Thormar, Sigridur B.; Olff, Miranda] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Juen, Barbara] Univ Innsbruck, Dept Psychol, Innsbruck, Austria; [Ajdukovic, Dean] Univ Zagreb, Dept Psychol, Zagreb, Croatia; [Newlove-Eriksson, Lindy] Swedish Def Univ, CRISMART Crisis Management Res & Training, Stockholm, Sweden; [Newlove-Eriksson, Lindy] KTH, Royal Inst Technol, Stockholm, Sweden	Netherlands Institute for Health Services Research; Arq Psychotrauma Expert Group; University of Amsterdam; Academic Medical Center Amsterdam; University of Innsbruck; University of Zagreb; Royal Institute of Technology	Duckers, MLA (corresponding author), Impact Natl Knowledge & Advice Ctr Psychosocial C, Diemen, Netherlands.; Duckers, MLA (corresponding author), NIVEL Netherlands Inst Hlth Serv Res, Utrecht, Netherlands.; Duckers, MLA (corresponding author), Arq Psychotrauma Expert Grp, Diemen, Netherlands.	mduckers@impact.arq.org	Olff, Miranda/S-6235-2019; Ajdukovic, Dean/X-2308-2019	Olff, Miranda/0000-0003-1016-9515; Duckers, Michel/0000-0001-7746-053X	European Union's FP7 Security Programme [312783]	European Union's FP7 Security Programme	This work is funded by European Union's FP7 Security Programme, contract number 312783. The funder has not contributed to the views expressed in this paper.	[Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; Benedek DM, 2007, PSYCHIATRY, V70, P345, DOI 10.1521/psyc.2007.70.4.345; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Berwick DM, 2002, HEALTH AFFAIR, V21, P80, DOI 10.1377/hlthaff.21.3.80; Bisson JI, 2010, BRIT J PSYCHIAT, V196, P69, DOI 10.1192/bjp.bp.109.066266; Bonanno George A, 2010, Psychol Sci Public Interest, V11, P1, DOI 10.1177/1529100610387086; Bonde JP, 2016, BRIT J PSYCHIAT, V208, P330, DOI 10.1192/bjp.bp.114.157859; Brake HT, 2009, NURS HEALTH SCI, V11, P336, DOI 10.1111/j.1442-2018.2009.00491.x; Browne MW., 1993, SOCIOL METHOD RES, V154, P136; Byrne B. M., 2001, STRUCTURAL EQUATION; Dieltjens T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114714; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Donabedian A., 1980, EXPLORATIONS QUALITY; Duckers MLA, 2017, ADM POLICY MENT HLTH, V44, P470, DOI 10.1007/s10488-015-0671-8; Duckers MLA, 2015, NURS HEALTH SCI, V17, P159, DOI 10.1111/nhs.12162; Duckers MLA, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21914; Duckers MLA, 2017, RISK HAZARDS CRISIS, V8, P94, DOI 10.1002/rhc3.12113; Eccles MP, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-18; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Juen B, 2005, COMPREHENSIVE GUIDEL; Kazlauskas E, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.29450; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Little TD, 2013, PSYCHOL METHODS, V18, P285, DOI 10.1037/a0033266; McFarlane AC, 2006, METHODS DISASTER MEN; Noji E K, 2000, Prehosp Disaster Med, V15, P147; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; REIFELS L, 2013, EUR J PSYCHOTRAUMATO, V4, DOI DOI 10.3402/EJPT.V4I0.22897; Schnyder U, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.28186; Schnyder U, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.31179; StataCorp, 2013, STRUCT EQ MOD REF MA; Suzuki Y, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-7; Te Brake H, 2013, EUR J PSYCHOTRAUMATO, V4; Thormar SB, 2010, J NERV MENT DIS, V198, P529, DOI 10.1097/NMD.0b013e3181ea1fa9; Witteveen AB, 2012, SOC SCI MED, V75, P1708, DOI 10.1016/j.socscimed.2012.06.017; Yzermans C.J., 2009, MENTAL HLTH DISASTER, P67	37	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193285	10.1371/journal.pone.0193285	http://dx.doi.org/10.1371/journal.pone.0193285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489888	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000061
J	Evangelista, LS; Cho, WK; Kim, Y				Evangelista, Lorraine S.; Cho, Won-Kyung; Kim, Youngmee			Obesity and chronic kidney disease: A population-based study among South Koreans	PLOS ONE			English	Article							BODY-MASS INDEX; ASSOCIATION; RISK; CKD; TRENDS; ADOLESCENTS; PREVALENCE; OVERWEIGHT; MORTALITY; MEN	Obesity and chronic kidney disease (CKD) are major global health problems. There are very little data concerning the prevalence and its associated factors of obesity in non-dialyzed patients who have different stages of CKD. Therefore, in this study, we examined the prevalence of obesity and its associated factors according to the stages of CKD. We used nationwide representative data from the Korean National Health and Nutrition Examination Survey, which was conducted over a 7-year period from 2008 to 2014 by the Korea Centers for Disease Control and Prevention. The results indicated that: (1) general obesity and abdominal obesity were more prevalent in patients with CKD compared to those without CKD; (2) the prevalence of general obesity and abdominal obesity was highest in stage 2 CKD; (3) stages 3a and 3b were the factors associated with general obesity, and stage 3a was significantly associated with abdominal obesity; (4) the association between general obesity/abdominal obesity and CKD disappeared in people with advanced stage 4/5 CKD; and (5) the presence of comorbidities contributed to the development of both general obesity and abdominal obesity. The findings of this study might support the idea that weight loss is a good potential intervention for the prevention of disease progression in moderate CKD (stage 3), but not severe CKD (stage 4/5).	[Evangelista, Lorraine S.] Univ Calif Irvine, Sue & Bill Gross Sch Nursing, Irvine, CA USA; [Cho, Won-Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Int Hlth Care Ctr, Seoul, South Korea; [Kim, Youngmee] Chung Ang Univ, Red Cross Coll Nursing, Seoul, South Korea	University of California System; University of California Irvine; University of Ulsan; Asan Medical Center; Chung Ang University	Cho, WK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Int Hlth Care Ctr, Seoul, South Korea.; Kim, Y (corresponding author), Chung Ang Univ, Red Cross Coll Nursing, Seoul, South Korea.	wonkyungcho@hotmail.com; youngkim234@gmail.com		Evangelista, Lorraine/0000-0003-1708-4186; Cho, Won-Kyung/0000-0003-1540-545X; Kim, Youngmee/0000-0002-0206-7300	Chung-Ang University Research Grant	Chung-Ang University Research Grant	This study was supported by the 2015 Chung-Ang University Research Grant. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddhu S, 2003, J AM SOC NEPHROL, V14, P2366, DOI 10.1097/01.ASN.0000083905.72794.E6; Burton JO, 2012, NEPHROL DIAL TRANSPL, V27, P1860, DOI 10.1093/ndt/gfr574; Chang A, 2013, AM J KIDNEY DIS, V62, P267, DOI 10.1053/j.ajkd.2013.02.363; Cheung WW, 2010, INT J PEPT, V2010; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Gunta SS, 2013, PEDIATR NEPHROL, V28, P611, DOI 10.1007/s00467-012-2380-9; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kim MK, 2014, ENDOCRINOL METAB, V29, P405, DOI 10.3803/EnM.2014.29.4.405; Kopple JD, 2011, J RENAL NUTR, V21, P66, DOI 10.1053/j.jrn.2010.10.009; Korea Centers for Disease Control and Prevention(KCDC), 2016, WORK SHOP REP GUID U; Kovesdy CP, 2007, AM J KIDNEY DIS, V49, P581, DOI 10.1053/j.ajkd.2007.02.277; Kramer H, 2005, AM J KIDNEY DIS, V46, P587, DOI 10.1053/j.ajkd.2005.06.007; Lamas O, 2002, EUR J CLIN NUTR, V56, pS42, DOI 10.1038/sj.ejcn.1601484; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Lu JL, 2014, J AM SOC NEPHROL, V25, P2088, DOI 10.1681/ASN.2013070754; Munkhaugen J, 2009, AM J KIDNEY DIS, V54, P638, DOI 10.1053/j.ajkd.2009.03.023; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85	28	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193559	10.1371/journal.pone.0193559	http://dx.doi.org/10.1371/journal.pone.0193559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489920	gold, Green Published			2022-12-27	WOS:000426276000090
J	Holtzman, O; Usherwood, T				Holtzman, Orit; Usherwood, Tim			Australian general practitioners' knowledge, attitudes and practices towards breastfeeding	PLOS ONE			English	Article							PHYSICIANS; PEDIATRICIANS; LACTATION; EDUCATION; RISK; GYNECOLOGISTS; EXPERIENCES; BELIEFS; WOMEN	The aim of this study was to explore the knowledge, attitudes and practices of established general practitioners (GPs) in relation to breastfeeding. 10 GPs in the Australian Nepean Blue Mountains Health District were interviewed and the interviews transcribed and analyzed thematically. Emergent themes from each interview were identified and then compared between and across the 10 interviews. Five themes emerged following the analysis: breastfeeding knowledge and training; attitudes towards breastfeeding; GPs' role in relation to breast feeding; GPs' practices; influence of male gender. All the GPs interviewed had positive attitudes towards breastfeeding, however they were often lacking in knowledge and conviction to be able to provide strong support to women during their breastfeeding journey. Some reported ambivalence in their encouragement of breastfeeding due to their desire to maintain a good relationship with women who chose not to feed this way. Nine of the GPs had little or no formal breastfeeding training and relied mainly on personal experience. Their clinics did not provide formal breastfeeding support including a written breastfeeding friendly policy and most GPs were not proactive in creating such an environment. We hope that the results from this study will assist in developing breastfeeding policies and professional education to support GPs in this role.	[Holtzman, Orit; Usherwood, Tim] Univ Sydney, Dept Gen Practice, Sydney Med Sch Westmead, Sydney, NSW, Australia; [Holtzman, Orit] Hornsby Ku Ring Gai Hosp, Hornsby, NSW, Australia	University of Sydney	Holtzman, O (corresponding author), Univ Sydney, Dept Gen Practice, Sydney Med Sch Westmead, Sydney, NSW, Australia.; Holtzman, O (corresponding author), Hornsby Ku Ring Gai Hosp, Hornsby, NSW, Australia.	ohol8210@uni.sydney.edu.au			GP Synergy medical student scholarship	GP Synergy medical student scholarship	Orit Holtzman's work was supported by GP Synergy medical student scholarship (https://gpsynergy.com.au/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nassaj H H, 2004, East Mediterr Health J, V10, P871; Amir LH, 2009, MED J AUSTRALIA, V191, P126, DOI 10.5694/j.1326-5377.2009.tb02712.x; Anchondo I, 2012, SOUTH MED J, V105, P243, DOI 10.1097/SMJ.0b013e3182522927; Australian Institute of Health and Welfare, 2011, 2010 AUSTR NAT INF F; Ayton J, 2015, AUST J PRIM HEALTH, V21, P299, DOI 10.1071/PY13152; BARNETT E, 1995, BIRTH-ISS PERINAT C, V22, P15; Bentley M E, 1999, J Hum Lact, V15, P27, DOI 10.1177/089033449901500109; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Brodribb W E, 2007, Rural Remote Health, V7, P737; Brodribb W, 2008, J HUM LACT, V24, P422, DOI 10.1177/0890334408323547; Brodribb W, 2008, MATERN CHILD NUTR, V4, P264, DOI 10.1111/j.1740-8709.2008.00141.x; Brodribb W, 2007, AUST FAM PHYSICIAN, V36, P283; Brodribb Wendy, 2010, Breastfeed Rev, V18, P5; Brodribb W, 2009, AUST FAM PHYSICIAN, V38, P26; Brodribb WE, 2014, MATERN CHILD HLTH J, V18, P1591, DOI 10.1007/s10995-013-1398-3; Burglehaus MJ, 1997, CAN J PUBLIC HEALTH, V88, P383, DOI 10.1007/BF03403911; Burt S, 2006, MATERN CHILD NUTR, V2, P91, DOI 10.1111/j.1740-8709.2006.00046.x; Chen Chao-Huei, 2001, Acta Paediatrica Taiwanica, V42, P207; COUNSILMAN JJ, 1983, AUST NZ J OBSTET GYN, V23, P208, DOI 10.1111/j.1479-828X.1983.tb00580.x; DEWEY KG, 1993, AM J CLIN NUTR, V58, P162, DOI 10.1093/ajcn/58.2.162; DiGirolamo AM, 2003, BIRTH-ISS PERINAT C, V30, P94, DOI 10.1046/j.1523-536X.2003.00227.x; Finneran B, 2004, Ir Med J, V97, P268; FREED GL, 1995, JAMA-J AM MED ASSOC, V273, P472, DOI 10.1001/jama.273.6.472; FREED GL, 1995, J FAM PRACTICE, V40, P263; Goldstein A O, 1993, Fam Med, V25, P524; Grawey AE, 2013, BREASTFEED MED, V8, P237, DOI 10.1089/bfm.2013.9994; Guise JM, 2000, BIRTH-ISS PERINAT C, V27, P49, DOI 10.1046/j.1523-536x.2000.00049.x; Holmes AV, 2012, BREASTFEED MED, V7, P403, DOI 10.1089/bfm.2012.0028; Ingram J, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-9; Kim HS, 1996, SOUTHERN MED J, V89, P684, DOI 10.1097/00007611-199607000-00007; Li L, 2004, J HUM LACT, V20, P188, DOI 10.1177/0890334404263992; Lu MC, 2001, OBSTET GYNECOL, V97, P290, DOI 10.1016/S0029-7844(00)01116-9; Meyers D, 2001, AM FAM PHYSICIAN, V64, P931; Nakar S, 2007, ACTA PAEDIATR, V96, P848, DOI 10.1111/j.1651-2227.2007.00310.x; Newcomb C, 2009, NEW BEGINNINGS, V299, P56; NEWCOMB PA, 1994, NEW ENGL J MED, V330, P81, DOI 10.1056/NEJM199401133300201; ROSENBLATT KA, 1993, INT J EPIDEMIOL, V22, P192, DOI 10.1093/ije/22.2.192; ROSENBLATT KA, 1995, INT J EPIDEMIOL, V24, P499, DOI 10.1093/ije/24.3.499; Scott J., 2003, BREASTFEEDING OPINIO; Sulaiman Z, 2016, J ADV NURS, V72, P825, DOI 10.1111/jan.12884; Taveras EM, 2003, PEDIATRICS, V112, P108, DOI 10.1542/peds.112.1.108; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO (World Health Organization), 2011, EXCLUSIVE BREASTFEED; WILLIAMS EL, 1995, AM J PREV MED, V11, P26, DOI 10.1016/S0749-3797(18)30497-5; World Health Organization, 2007, P CONCL CONS M WASH	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191854	10.1371/journal.pone.0191854	http://dx.doi.org/10.1371/journal.pone.0191854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489841	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000011
J	Kong, TH; Yu, S; Jung, B; Choi, JS; Seo, YJ				Kong, Tae Hoon; Yu, Sunkon; Jung, Byungjo; Choi, Jin Sil; Seo, Young Joon			Monitoring blood-flow in the mouse cochlea using an endoscopic laser speckle contrast imaging system	PLOS ONE			English	Article							INFERIOR CEREBELLAR ARTERY; SENSORINEURAL HEARING-LOSS; GERBIL COCHLEA; GUINEA-PIGS; ISCHEMIA; FLOWGRAPHY; OCCLUSION; PATHOLOGY; EXPOSURE; DOPPLER	Laser speckle contrast imaging (LSCI) enables continuous high-resolution assessment of microcirculation in real-time. We applied an endoscope to LSCI to measure cochlear blood-flow in an ischemia-reperfusion mouse model. We also explored whether using xenon light in combination with LSCI facilitates visualization of anatomical position. Based on a previous preliminary study, the appropriate wavelength for penetrating the thin bony cochlea was 830 nm. A 2.7-mm-diameter endoscope was used, as appropriate for the size of the mouse cochlea. Our endoscopic LSCI system was used to illuminate the right cochlea after dissection of the mouse. We observed changes in the speckle signals when we applied the endoscopic LSCI system to the ischemia-reperfusion mouse model. The anatomical structure of the mouse cochlea and surrounding structures were clearly visible using the xenon light. The speckle signal of the cochlea was scattered, with an intensity that varied between that of the stapes (with the lowest signal), the negative control, and the stapedial artery (with the highest signal), the positive control. In the cochlear ischemia-reperfusion mouse model, the speckle signal of the cochlea decreased during the ischemic phase, and increased during the reperfusion phase, clearly reflecting cochlear blood-flow. The endoscopic LSCI system generates high-resolution images in real-time, allowing visualization of blood-flow and its changes in the mouse cochlea. Anatomical structures were clearly matched using LSCI along with visible light.	[Kong, Tae Hoon; Choi, Jin Sil; Seo, Young Joon] Yonsei Univ, Wonju Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Wonju, South Korea; [Yu, Sunkon; Jung, Byungjo] Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, South Korea	Yonsei University; Yonsei University	Seo, YJ (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Wonju, South Korea.	okas2000@hanmail.net	KONG, TAEHOON/AAG-5079-2020; Seo, Young Joon/AAS-6148-2021	Kong, Taehoon/0000-0002-5612-5705; Seo, Young Joon/0000-0002-2839-4676	Gangwon Institute for Regional Program Evaluation - Korea government (Ministry of Trade, Industry and Energy) [R0005797]; Ministry of Trade, Industry & Energy (MOTIE, Korea) [10070232]	Gangwon Institute for Regional Program Evaluation - Korea government (Ministry of Trade, Industry and Energy); Ministry of Trade, Industry & Energy (MOTIE, Korea)	This work was supported by the Gangwon Institute for Regional Program Evaluation grant funded by the Korea government (Ministry of Trade, Industry and Energy) (No. R0005797) and by the Technology Innovation Program (or Industrial Strategic Technology Development Program (10070232) funded By the Ministry of Trade, Industry & Energy (MOTIE, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Gangwon Institute for Regional Program Evaluation grant funded by the Korea government (Ministry of Trade, Industry and Energy) (No. R0005797) and by the Technology Innovation Program (or Industrial Strategic Technology Development Program(10070232) funded By the Ministry of Trade, Industry & Energy(MOTIE, Korea).	Ambrus R, 2016, EUR SURG RES, V56, P87, DOI 10.1159/000442790; Badr-el-Dine M, 2002, OTOL NEUROTOL, V23, P631, DOI 10.1097/00129492-200209000-00004; Bennett ML, 2016, OTOL NEUROTOL, V37, P362, DOI 10.1097/MAO.0000000000000988; Bezemer R, 2010, MICROVASC RES, V79, P139, DOI 10.1016/j.mvr.2010.01.004; Cantos R, 2000, P NATL ACAD SCI USA, V97, P11707, DOI 10.1073/pnas.97.22.11707; Davis MA, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086001; Dziennis S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106003; Hakuba N, 2000, J COMP NEUROL, V418, P217, DOI 10.1002/(SICI)1096-9861(20000306)418:2<217::AID-CNE7>3.0.CO;2-L; Iwase T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001256; Kim JS, 1999, NEUROLOGY, V52, P40, DOI 10.1212/WNL.52.1.40; KIMURA R., 1958, ANN OTOL RHINOL AND LARYNGOL, V67, P5; Luft N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168190; Makino Kouji, 1994, Auris Nasus Larynx, V21, P75; MCCABE BF, 1979, ANN OTO RHINOL LARYN, V88, P585, DOI 10.1177/000348947908800501; MILLER JM, 1995, OTOLARYNG HEAD NECK, V112, P101, DOI 10.1016/S0194-5998(95)70308-X; Mom T, 2001, J ACOUST SOC AM, V110, P1477, DOI 10.1121/1.1390337; Mosnier I, 2011, AUDIOL NEURO-OTOL, V16, P55, DOI 10.1159/000312640; Nakashima T, 2006, CLIN OTOLARYNGOL, V31, P110, DOI 10.1111/j.1749-4486.2006.01151.x; Nakashima T, 2003, BRAIN RES REV, V43, P17, DOI 10.1016/S0165-0173(03)00189-9; Nakashima T, 2001, HEARING RES, V162, P85, DOI 10.1016/S0378-5955(01)00372-0; Nuttall Alfred L., 1999, Noise Health, V2, P17; Ogawa K, 1996, ACTA OTO-LARYNGOL, V116, P253, DOI 10.3109/00016489609137835; PERLMAN H B, 1959, Laryngoscope, V69, P591; Ponticorvo A, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.090501; Reif R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052041; Ren TY, 1995, HEARING RES, V92, P30, DOI 10.1016/0378-5955(95)00192-1; REN TY, 1994, J APPL PHYSIOL, V76, P212, DOI 10.1152/jappl.1994.76.1.212; SANTI PA, 1978, OTOLARYNG HEAD NECK, V86, P354, DOI 10.1177/019459987808600229; Santi PA, 2008, HEARING RES, V243, P11, DOI 10.1016/j.heares.2008.04.014; SEIDMAN MD, 1992, EUR ARCH OTO-RHINO-L, V249, P332; Shi XR, 2011, HEARING RES, V282, P10, DOI 10.1016/j.heares.2011.08.006; Shiga Y, 2016, CURR EYE RES, V41, P1447, DOI 10.3109/02713683.2015.1127974; Shiga Y, 2013, CURR EYE RES, V38, P691, DOI 10.3109/02713683.2012.758292; Shim HS, 2017, J AUDIOL OTOL, V21, P33, DOI 10.7874/jao.2017.21.1.33; Spicer SS, 2002, HEARING RES, V172, P172, DOI 10.1016/S0378-5955(02)00581-6; Subhash HM, 2011, IEEE T MED IMAGING, V30, P224, DOI 10.1109/TMI.2010.2072934; Suzuki T, 1998, ANN OTO RHINOL LARYN, V107, P648, DOI 10.1177/000348949810700803; THORNE PR, 1987, HEARING RES, V27, P1, DOI 10.1016/0378-5955(87)90021-9; VAN DISHOECK H A, 1957, Ann Otol Rhinol Laryngol, V66, P963; Vaz Pedro G, 2016, IEEE Rev Biomed Eng, V9, P106, DOI 10.1109/RBME.2016.2532598; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Yamamoto H, 2003, HEARING RES, V186, P69, DOI 10.1016/S0378-5955(03)00310-1; Yazawa Y, 1998, ORL J OTO-RHINO-LARY, V60, P4, DOI 10.1159/000027554	43	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191978	10.1371/journal.pone.0191978	http://dx.doi.org/10.1371/journal.pone.0191978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489849	gold, Green Submitted, Green Published			2022-12-27	WOS:000426276000013
J	Clow, KM; Ogden, NH; Lindsay, LR; Russell, CB; Michel, P; Pearl, DL; Jardine, CM				Clow, Katie M.; Ogden, Nicholas H.; Lindsay, L. Robbin; Russell, Curtis B.; Michel, Pascal; Pearl, David L.; Jardine, Claire M.			A field-based indicator for determining the likelihood of Ixodes scapularis establishment at sites in Ontario, Canada	PLOS ONE			English	Article							AMBLYOMMA-AMERICANUM ACARI; PASSIVE SURVEILLANCE; BORRELIA-BURGDORFERI; LONG POINT; ANAPLASMA-PHAGOCYTOPHILUM; RELATIVE-HUMIDITY; RANGE EXPANSION; IXODIDAE; HABITAT; INFECTION	The emergence of the vector Ixodes scapularis in Ontario, Canada poses a significant public health risk. Both passive and active surveillance approaches have been employed by public health professionals (i.e., government employees) to monitor for the range expansion of this tick. Field surveillance using drag sampling for questing ticks is a recognized and effective method to identify reproducing tick populations. The degree of effort (i.e., number of visits per site) can enhance the sensitivity and specificity of surveillance, but increased effort conflicts with the cost to public health for field surveillance. Here we developed an indicator to determine the likelihood of I. scapularis establishment based on field sampling results. Field data from two established populations of I. scapularis in Ontario were incorporated with previous analyses of surveillance data to create the indicator, which is in the form of a scoring system. The life stage(s) collected, overall abundance and past surveillance findings from a site are all considered and a level is assigned for the likelihood of I. scapularis establishment based on current field sampling results. The likelihood levels are non-zero (i.e., no I. scapularis detected, but risk still present due to adventitious ticks), low, medium or high, and recommendations for future surveillance and public health measures are provided. The indicator was validated against field sampling results from five other established sites in the province and correctly categorized all five areas as high likelihood of establishment. The indicator was also applied to field sampling results from 36 sites of unknown status that were visited twice during the period of 2014-2016. There was substantial agreement of levels between measurements, as calculated using a weighted kappa. The indicator can assist public health professionals with the interpretation of field sampling results and direct their efforts for ongoing surveillance and public health interventions for I. scapularis-borne diseases, including Lyme disease.	[Clow, Katie M.; Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON, Canada; [Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada; [Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Russell, Curtis B.] Publ Hlth Ontario, Enter Zoonot & Vector Borne Dis, Communicable & Infect Dis Prevent & Control, Toronto, ON, Canada; [Michel, Pascal] Publ Hlth Agcy Canada, Off Chief Sci Officer, Ottawa, ON, Canada; [Pearl, David L.] Univ Guelph, Dept Populat Med, Ontario Vet Coll, Guelph, ON, Canada; [Jardine, Claire M.] Univ Guelph, Ontario Vet Coll, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada	University of Guelph; Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada; University of Guelph; University of Guelph	Clow, KM (corresponding author), Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON, Canada.	kclow@uoguelph.ca			Public Health Agency of Canada; Natural Sciences and Engineering Research Council; Canadian Wildlife Health Cooperative; Ontario Veterinary College Fellowship; Blake Graham Fellowship	Public Health Agency of Canada; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Wildlife Health Cooperative; Ontario Veterinary College Fellowship; Blake Graham Fellowship	This work was supported by the Public Health Agency of Canada, www.phac-aspc.gc.ca; Natural Sciences and Engineering Research Council, http://www.nserc-crsng.gc.ca; Canadian Wildlife Health Cooperative, www.cwhc-rcsf.ca. KMC received stipend support from an Ontario Veterinary College Fellowship, a PostGraduate Scholarship-Doctoral from the Natural Sciences and Engineering Research Council and a Blake Graham Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NHO, LRL and PM are all employees of the PHAC and CMJ is affiliated with CWHC, but they were not directly instructed by the funders.	[Anonymous], 1991, Can J Infect Dis, V2, P49; Berger KA, 2014, J MED ENTOMOL, V51, P769, DOI 10.1603/ME13186; Clow KM, 2017, TICKS TICK-BORNE DIS, V8, P554, DOI 10.1016/j.ttbdis.2017.03.003; Clow KM, 2016, VECTOR-BORNE ZOONOT, V16, P215, DOI 10.1089/vbz.2015.1890; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Dibernardo A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-183; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Dobson ADM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-344; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Koffi JK, 2012, J MED ENTOMOL, V49, P400, DOI 10.1603/ME11210; Kulkarni MA, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.33; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Lindquist EE., 2016, HDB TICKS CANADA IXO, DOI DOI 10.3752/9780968932186; Lindsay LR, 1999, J MED ENTOMOL, V36, P255, DOI 10.1093/jmedent/36.3.255; Lindsay LR, 1998, J MED ENTOMOL, V35, P189, DOI 10.1093/jmedent/35.3.189; Lindsay LR, 1999, J MED ENTOMOL, V36, P243, DOI 10.1093/jmedent/36.3.243; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; McPherson M, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP57, 10.1289/ehp57]; Nakajima R, 2009, J VET MED SCI, V71, P55, DOI 10.1292/jvms.71.55; Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417; Ogden N H, 2014, Can Commun Dis Rep, V40, P74; Ogden N H, 2015, Can Commun Dis Rep, V41, P132; Ogden N H, 2014, Can Commun Dis Rep, V40, P83; Ogden NH, 2004, J MED ENTOMOL, V41, P622, DOI 10.1603/0022-2585-41.4.622; Ogden NH, 2006, J MED ENTOMOL, V43, P403, DOI 10.1603/0022-2585(2006)043[0403:IOGLAR]2.0.CO;2; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2016, ONT LYM DIS MAP EST; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2015, ACT TICK DRAGG STAND; SCHOLTEN T, 1977, CAN J PUBLIC HEALTH, V68, P494; Schulze TL, 2005, J MED ENTOMOL, V42, P285, DOI 10.1603/0022-2585(2005)042[0285:IOMAMH]2.0.CO;2; Schulze TL, 2001, ENVIRON ENTOMOL, V30, P568, DOI 10.1603/0046-225X-30.3.568; Sider D, 2012, TECHNICAL REPORT; Vail SG, 2002, J MED ENTOMOL, V39, P842, DOI 10.1603/0022-2585-39.6.842	38	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193524	10.1371/journal.pone.0193524	http://dx.doi.org/10.1371/journal.pone.0193524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486007	Green Published, gold, Green Submitted			2022-12-27	WOS:000426242400020
J	Ferguson, R; Subramanian, V				Ferguson, Ross; Subramanian, Vasanta			The cellular uptake of angiogenin, an angiogenic and neurotrophic factor is through multiple pathways and largely dynamin independent	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; BREFELDIN-A; NUCLEAR TRANSLOCATION; ENDOCYTIC PATHWAY; TRANSFER-RNA; INHIBITOR; TRANSPORT; LOCALIZATION; RIBONUCLEASE; MICROTUBULE	Angiogenin (ANG), a member of the RNase superfamily (also known as RNase 5) has neurotrophic, neuroprotective and angiogenic activities. Recently it has also been shown to be important in stem cell homeostasis. Mutations in ANG are associated with neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and Fronto-temporal dementia (FTD). ANG is a secreted protein which is taken up by cells and translocated to the nucleus. However, the import pathway/s through which ANG is taken up is/are still largely unclear. We have characterised the uptake of ANG in neuronal, astrocytic and microglial cell lines as well as primary neurons and astrocytes using pharmacological agents as well as dominant negative dynamin and Rab5 to perturb uptake and intracellular trafficking. We find that uptake of ANG is largely clathrin/dynamin independent and microtubule depolymerisation has a marginal effect. Perturbation of membrane ruffling and macropinocytosis significantly inhibited ANG uptake suggesting an uptake mechanism similar to RNase A. Our findings shed light on why mutations which do not overtly affect RNase activity but cause impaired localization are associated with neurodegenerative disease.	[Ferguson, Ross; Subramanian, Vasanta] Univ Bath, Dept Biol & Biochem, Bath, Avon, England	University of Bath	Subramanian, V (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.	bssvss@bath.ac.uk						ACHARYA KR, 1994, P NATL ACAD SCI USA, V91, P2915, DOI 10.1073/pnas.91.8.2915; ALBERTS AW, 1988, AM J CARDIOL, V62, pJ10, DOI 10.1016/0002-9149(88)90002-1; ALEXIANU ME, 1994, J NEUROCHEM, V63, P2365; ALLIOT F, 1984, BRAIN RES, V306, P283, DOI 10.1016/0006-8993(84)90377-9; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Banach-Orlowska M, 2009, BIOCHEM J, V423, P389, DOI 10.1042/BJ20090086; BIEDLER JL, 1973, CANCER RES, V33, P2643; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bosch M, 2004, BIOCHEMISTRY-US, V43, P2167, DOI 10.1021/bi035729+; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Chao TY, 2011, BIOCHEMISTRY-US, V50, P8374, DOI 10.1021/bi2009079; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004; Cobbold C, 2004, MOL MEMBR BIOL, V21, P59, DOI 10.1080/096870310001607350; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; Cronin S, 2006, NEUROLOGY, V67, P1833, DOI 10.1212/01.wnl.0000244466.46020.47; DEBRABANDER MJ, 1976, CANCER RES, V36, P905; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Elfenbein A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002495; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Fan TC, 2007, TRAFFIC, V8, P1778, DOI 10.1111/j.1600-0854.2007.00650.x; FETT JW, 1994, BIOCHEMISTRY-US, V33, P5421, DOI 10.1021/bi00184a010; Glotzer JB, 2001, J VIROL, V75, P2421, DOI 10.1128/JVI.75.5.2421-2434.2001; Goncalves KA, 2016, CELL, V166, P894, DOI 10.1016/j.cell.2016.06.042; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Haigis MC, 2003, J CELL SCI, V116, P313, DOI 10.1242/jcs.00214; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; HU GF, 1994, P NATL ACAD SCI USA, V91, P12096, DOI 10.1073/pnas.91.25.12096; HU GF, 1993, P NATL ACAD SCI USA, V90, P1217, DOI 10.1073/pnas.90.4.1217; Hu GF, 1997, P NATL ACAD SCI USA, V94, P2204, DOI 10.1073/pnas.94.6.2204; Humphries WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026626; Irwin ME, 2011, J CELL PHYSIOL, V226, P2316, DOI 10.1002/jcp.22570; Jones SM, 1997, J CELL BIOL, V139, P339, DOI 10.1083/jcb.139.2.339; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; King MC, 2004, P NATL ACAD SCI USA, V101, P8957, DOI 10.1073/pnas.0403167101; Kjeken R, 2001, BIOCHEM J, V357, P497, DOI 10.1042/0264-6021:3570497; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Ledoux S, 2002, CIRC RES, V90, P420, DOI 10.1161/hh0402.105668; Li RS, 1997, BIOCHEM BIOPH RES CO, V238, P305, DOI 10.1006/bbrc.1997.7290; Lixin R, 2001, BIOCHEM BIOPH RES CO, V284, P185, DOI 10.1006/bbrc.2001.4953; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Peng Y, 2014, CELL SIGNAL, V26, P2782, DOI 10.1016/j.cellsig.2014.08.021; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; PRYDZ K, 1992, J CELL BIOL, V119, P259, DOI 10.1083/jcb.119.2.259; Rodriguez M, 2007, J CELL SCI, V120, P1405, DOI 10.1242/jcs.03427; Saponaro C, 2012, IMMUNOPHARM IMMUNOT, V34, P858, DOI 10.3109/08923973.2012.665461; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sever S, 2013, TRAFFIC, V14, P1194, DOI 10.1111/tra.12116; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P2238, DOI 10.1073/pnas.84.8.2238; Sierra A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106048; Skorupa A, 2012, J NEUROSCI, V32, P5024, DOI 10.1523/JNEUROSCI.6366-11.2012; Soncin F, 1997, J BIOL CHEM, V272, P9818; SONCIN F, 1994, J BIOL CHEM, V269, P8999; STENSETH K, 1989, EUR J CELL BIOL, V49, P326; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095; Szymanski CJ, 2011, ANALYST, V136, P3527, DOI 10.1039/c0an00855a; Thiyagarajan N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2126; Trouillon R, 2011, CHEM COMMUN, V47, P3421, DOI 10.1039/c0cc04527f; UHLINHANSEN L, 1995, BIOCHEM J, V310, P271, DOI 10.1042/bj3100271; van Es MA, 2009, NEUROLOGY, V72, P287, DOI 10.1212/01.wnl.0000339487.84908.00; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wang YZ, 2000, TRAFFIC, V1, P952, DOI 10.1034/j.1600-0854.2000.011205.x; Wha-Soo Kim, 2006, Communication Sciences and Disorders, V11, P47; Won JS, 2008, J NEUROCHEM, V105, P1536, DOI 10.1111/j.1471-4159.2008.05283.x; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yea C, 2007, J VIROL, V81, P6899, DOI 10.1128/JVI.02330-05; Yoder A, 2011, J VIROL, V85, P3020, DOI 10.1128/JVI.02462-10; Yuyama K, 2006, FEBS LETT, V580, P6972, DOI 10.1016/j.febslet.2006.11.072; Zhang JZ, 2002, NUCLEIC ACIDS RES, V30, P1169, DOI 10.1093/nar/30.5.1169	82	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193302	10.1371/journal.pone.0193302	http://dx.doi.org/10.1371/journal.pone.0193302			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486010	gold, Green Published, Green Submitted			2022-12-27	WOS:000426242400017
J	Jin, JF; Lu, ZY; Li, YC; Cowart, LA; Lopes-Virella, MF; Yan, H				Junfei Jin; Zhongyang Lu; Yanchun Li; Cowart, L. Ashley; Lopes-Virella, Maria F.; Yan Huang			Docosahexaenoic acid antagonizes the boosting effect of palmitic acid on LPS inflammatory signaling by inhibiting gene transcription and ceramide synthesis	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; FACTOR-KAPPA-B; SPHINGOLIPID METABOLISM; DEFICIENT MICE; MACROPHAGES; PATHWAY; LIPOPOLYSACCHARIDE; CELLS; OBESITY; STRESS	It is well known that saturated fatty acids (SFAs) and unsaturated fatty acid, in particular omega-3 polyunsaturated fatty acids (n-3 PUFAs), have different effects on inflammatory signaling: SFAs are pro-inflammatory but n-3 PUFAs have strong anti-inflammatory properties. We have reported that palmitic acid (PA), a saturated fatty acid, robustly amplifies lipopolysaccharide (LPS) signaling to upregulate proinflammatory gene expression in macrophages. We also reported that the increased production of ceramide (CER) via sphingomyelin (SM) hydrolysis and CER de novo synthesis plays a key role in the synergistic effect of LPS and PA on proinflammatory gene expression. However, it remains unclear if n-3 PUFAs are capable of antagonizing the synergistic effect of LPS and PA on gene expression and CER production. In this study, we employed the above macrophage culture system and lipidomical analysis to assess the effect of n-3 PUFAs on proinflammatory gene expression and CER production stimulated by LPS and PA. Results showed that DHA strongly inhibited the synergistic effect of LPS and PA on proinflammatory gene expression by targeting nuclear factor kappa B (NFKB)-dependent gene transcription. Results also showed that DHA inhibited the cooperative effect of LPS and PA on CER production by targeting CER de novo synthesis, but not SM hydrolysis. Furthermore, results showed that myriocin, a specific inhibitor of serine palmitoyltransferase, strongly inhibited both LPS-PA-stimulated CER synthesis and proinflammatory gene expression, indicating that CER synthesis is associated with proinflammatory gene expression and that inhibition of CER synthesis contributes to DHA-inhibited proinflammatory gene expression. Taken together, this study demonstrates that DHA antagonizes the boosting effect of PA on LPS signaling on proinflammatory gene expression by targeting both NFKB-dependent transcription and CER de novo synthesis in macrophages.	[Junfei Jin; Yanchun Li; Lopes-Virella, Maria F.; Yan Huang] Med Univ South Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29401 USA; [Zhongyang Lu; Lopes-Virella, Maria F.; Yan Huang] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Cowart, L. Ashley] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Junfei Jin] Guilin Med Univ, Guangxi Key Lab Mol Med Liver Injury & Repair, Affiliated Hosp, Lab Liver Biliary Tract Pancreas Surg, Guilin, Guangxi, Peoples R China; [Cowart, L. Ashley] Virginia Commonwealth Univ, Dept Biochem, Coll Med, Richmond, VA USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Guilin Medical University; Virginia Commonwealth University	Yan, H (corresponding author), Med Univ South Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29401 USA.; Yan, H (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA.	huangyan@musc.edu	li, yan/GTI-4638-2022	Jin, Junfei/0000-0002-9237-9024; Lu, Zhongyang/0000-0002-2182-7854	Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs [BX000854]; NIH [DE016353]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE027070] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000854] Funding Source: NIH RePORTER	Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Merit Review grant BX000854 from the Biomedical Laboratory Research and Development Program of the Department of Veterans Affairs (Yan Huang) and NIH grant DE016353 (Yan Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire J, 2016, AM J CLIN NUTR, V104, P280, DOI 10.3945/ajcn.116.131896; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Chang ZQ, 2011, PROSTAG OTH LIPID M, V94, P44, DOI 10.1016/j.prostaglandins.2010.12.003; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Das Mithun, 2010, J Cardiovasc Dis Res, V1, P130, DOI 10.4103/0975-3583.70911; De Boer AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085037; Demarchi F, 2005, CELL DEATH DIFFER, V12, P512, DOI 10.1038/sj.cdd.4401592; Gomes JMG, 2017, METABOLISM, V68, P133, DOI 10.1016/j.metabol.2016.12.009; Green CD, 2011, AM J PHYSIOL-ENDOC M, V300, pE640, DOI 10.1152/ajpendo.00544.2010; Hamblin M, 2009, ANTIOXID REDOX SIGN, V11, P1415, DOI [10.1089/ars.2008.2280, 10.1089/ARS.2008.2280]; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Hellmann J, 2013, J IMMUNOL, V191, P1383, DOI 10.4049/jimmunol.1203369; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Jin JF, 2013, AM J PHYSIOL-ENDOC M, V305, pE853, DOI 10.1152/ajpendo.00251.2013; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Komatsu W, 2003, FREE RADICAL BIO MED, V34, P1006, DOI 10.1016/S0891-5849(03)00027-3; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Li H, 2005, KIDNEY INT, V67, P867, DOI 10.1111/j.1523-1755.2005.00151.x; Lu ZY, 2017, ATHEROSCLEROSIS, V265, P231, DOI 10.1016/j.atherosclerosis.2017.09.008; Memon RA, 2001, J LIPID RES, V42, P452; Mullen A, 2010, J NUTR BIOCHEM, V21, P444, DOI 10.1016/j.jnutbio.2009.02.008; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Novotny NM, 2008, CYTOKINE, V43, P215, DOI 10.1016/j.cyto.2008.05.015; Pinel A, 2014, J PHYSIOL BIOCHEM, V70, P647, DOI 10.1007/s13105-013-0303-2; Qi HY, 2011, J IMMUNOL, V187, P5286, DOI 10.4049/jimmunol.1004004; Robinson LE, 2013, LIPIDS, V48, P319, DOI 10.1007/s11745-013-3774-6; Ruiz-Nunez B, 2016, J NUTR BIOCHEM, V36, P1, DOI 10.1016/j.jnutbio.2015.12.007; Sasset L, 2016, TRENDS ENDOCRIN MET, V27, P807, DOI 10.1016/j.tem.2016.07.005; Schilling JD, 2013, J BIOL CHEM, V288, P2923, DOI 10.1074/jbc.M112.419978; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Stiban J, 2006, APOPTOSIS, V11, P773, DOI 10.1007/s10495-006-5882-8; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Xue BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045990; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225	43	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193343	10.1371/journal.pone.0193343	http://dx.doi.org/10.1371/journal.pone.0193343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474492	gold, Green Published, Green Submitted			2022-12-27	WOS:000426049500090
J	Van Os, JMC; Mintline, EM; DeVries, TJ; Tucker, CB				Van Os, Jennifer M. C.; Mintline, Erin M.; DeVries, Trevor J.; Tucker, Cassandra B.			Domestic cattle (Bos taurus taurus) are motivated to obtain forage and demonstrate contrafreeloading	PLOS ONE			English	Article							SUBACUTE RUMINAL ACIDOSIS; FEED-SORTING BEHAVIOR; LACTATING DAIRY-COWS; SHORT-COMMUNICATION; DIET SELECTION; RUMEN FILL; INGESTIVE BEHAVIOR; BEEF-CATTLE; TIME; HEIFERS	Domestic cattle (Bos taurus taurus) are adapted to digest high-roughage diets, but in confinement they are commonly fed low-roughage, high-energy diets. This practice may leave cattle with an unfulfilled need to consume forage. A way to quantify motivation is to require animals to work to access a resource. Using this method, we evaluated cattle motivation to obtain forage when fed high-or low-roughage diets during and 30 d before the study. Individual heifers were fed Sudan grass (Sorghum x drummondii) hay (high roughage, n = 6) or a diet with 12% forage (as fed, low roughage, n = 6) in an open feed trough. In a second trough, 200 g/d of Sudan grass hay were fed behind a push gate, to which additional weight was added daily until heifers no longer pushed. We predicted heifers would push heavier weights, show a shorter latency, and spend more time pushing the gate when fed a low-vs. high-roughage diet. Indeed, heifers fed a low-roughage diet pushed the gate immediately after hay delivery (1.7 min) and much sooner than those fed a high-roughage diet (75.7 min). On the day before they no longer pushed the gate, latency for heifers in the low-roughage treatment remained only 3.2 min after hay delivery. The suddenness with which they ceased pushing the next day suggests they were unable to move heavier weights to express their motivation. This may explain why maximum weight pushed and time spent pushing the gate did not differ between treatments. The gate pushing by heifers with unrestricted hay access is the first demonstration by cattle of contrafreeloading: performing work to obtain a resource that is simultaneously available for free. In conclusion, consuming forage is important to cattle and is affected by both their primary diet and an internal motivation to work to obtain feed.	[Van Os, Jennifer M. C.; Mintline, Erin M.; Tucker, Cassandra B.] Univ Calif Davis, Dept Anim Sci, Ctr Anim Welf, Davis, CA 95616 USA; [DeVries, Trevor J.] Univ Guelph, Dept Anim Biosci, Guelph, ON, Canada; [Van Os, Jennifer M. C.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA	University of California System; University of California Davis; University of Guelph; University of Wisconsin System; University of Wisconsin Madison	Tucker, CB (corresponding author), Univ Calif Davis, Dept Anim Sci, Ctr Anim Welf, Davis, CA 95616 USA.	cbtucker@ucelavis.edu	DeVries, Trevor/AAE-5538-2019	Van Os, Jennifer/0000-0002-7107-2867; DeVries, Trevor/0000-0001-9364-2456; Tucker, Cassandra/0000-0002-6014-444X	United States Department of Agriculture (USDA) [NC 1029]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	The study was funded by the United States Department of Agriculture (USDA) Multistate Research Project NC 1029: Applied Animal Behavior and Welfare to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean D, 1999, BEHAVIOUR, V136, P1267, DOI 10.1163/156853999500712; Beauchemin KA, 2008, J DAIRY SCI, V91, P2077, DOI 10.3168/jds.2007-0726; BELOVSKY GE, 1994, J MAMMAL, V75, P816, DOI 10.2307/1382464; Chilibroste P, 1997, GRASS FORAGE SCI, V52, P249, DOI 10.1111/j.1365-2494.1997.tb02355.x; Cooper MD, 2010, J VET BEHAV, V5, P75, DOI 10.1016/j.jveb.2009.09.045; Costa JHC, 2016, J DAIRY SCI, V99, P5635, DOI 10.3168/jds.2015-10052; de Jonge FH, 2008, APPL ANIM BEHAV SCI, V114, P359, DOI 10.1016/j.applanim.2008.03.006; DeVries TJ, 2008, J DAIRY SCI, V91, P3958, DOI 10.3168/jds.2008-1347; DeVries TJ, 2014, ANIM PROD SCI, V54, P1238, DOI 10.1071/AN14227; DeVries TJ, 2014, J ANIM SCI, V92, P1728, DOI 10.2527/jas.2013-7252; DeVries TJ, 2005, J DAIRY SCI, V88, P625, DOI 10.3168/jds.S0022-0302(05)72726-0; Forkman B, 1996, BEHAVIOUR, V133, P129, DOI 10.1163/156853996X00071; Fraser D., 2011, Animal welfare, P183, DOI 10.1079/9781845936594.0183; Galyean ML, 2003, CAN J ANIM SCI, V83, P13, DOI 10.4141/A02-061; Gonzalez LA, 2009, J ANIM SCI, V87, P2709, DOI 10.2527/jas.2008-1709; Gregorini P, 2009, J DAIRY SCI, V92, P2095, DOI 10.3168/jds.2008-1803; Greter AM, 2015, J DAIRY SCI, V98, P1248, DOI 10.3168/jds.2014-8879; Hagen K, 2004, APPL ANIM BEHAV SCI, V85, P203, DOI 10.1016/j.applanim.2003.11.007; Hessle A, 2008, APPL ANIM BEHAV SCI, V111, P108, DOI 10.1016/j.applanim.2007.05.017; Hessle Anna, 2014, International Journal of Biodiversity Science Ecosystem Services & Management, V10, P334, DOI 10.1080/21513732.2014.968805; Hollenbeck A., 1978, OBSERVING BEHAVIOR, VII, P79; INGLIS IR, 1986, ANIM BEHAV, V34, P614, DOI 10.1016/S0003-3472(86)80136-1; Inglis IR, 1997, ANIM BEHAV, V53, P1171, DOI 10.1006/anbe.1996.0320; James SM, 2002, BRIT J NUTR, V88, P81, DOI 10.1079/BJN2002589; JENSEN GD, 1963, J EXP PSYCHOL, V65, P451, DOI 10.1037/h0049174; Kelly AK, 2010, J ANIM SCI, V88, P109, DOI 10.2527/jas.2009-2196; Keunen JE, 2002, J DAIRY SCI, V85, P3304, DOI 10.3168/jds.S0022-0302(02)74419-6; Kilgour RJ, 2012, APPL ANIM BEHAV SCI, V138, P1, DOI 10.1016/j.applanim.2011.12.002; Kirkden RD, 2006, APPL ANIM BEHAV SCI, V100, P29, DOI 10.1016/j.applanim.2006.04.009; Krause KM, 2006, ANIM FEED SCI TECH, V126, P215, DOI 10.1016/j.anifeedsci.2005.08.004; Kyriazakis I, 1999, P NUTR SOC, V58, P765, DOI 10.1017/S0029665199001044; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langbein J, 2009, APPL ANIM BEHAV SCI, V120, P150, DOI 10.1016/j.applanim.2009.07.006; Lindqvist CES, 2002, BEHAVIOUR, V139, P1195, DOI 10.1163/15685390260437335; Lindstrom T, 2000, APPL ANIM BEHAV SCI, V70, P83, DOI 10.1016/S0168-1591(00)00148-9; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Mason GJ, 2001, NATURE, V410, P35, DOI 10.1038/35065157; Munksgaard L, 2005, APPL ANIM BEHAV SCI, V92, P3, DOI 10.1016/j.applanim.2004.11.005; Nagaraja TG, 2007, VET CLIN N AM-FOOD A, V23, P333, DOI 10.1016/j.cvfa.2007.04.002; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Ogura T, 2011, ANIM COGN, V14, P427, DOI 10.1007/s10071-010-0377-y; Owens FN, 1998, J ANIM SCI, V76, P275; PROVENZA FD, 1987, APPL ANIM BEHAV SCI, V18, P211, DOI 10.1016/0168-1591(87)90218-8; Redbo I, 1997, APPL ANIM BEHAV SCI, V53, P193, DOI 10.1016/S0168-1591(96)01145-8; REDBO I, 1990, APPL ANIM BEHAV SCI, V26, P57, DOI 10.1016/0168-1591(90)90087-T; SAS Institute Inc, 2014, SAS STAT 13 2 US GUI; Schutz KE, 2008, APPL ANIM BEHAV SCI, V114, P307, DOI 10.1016/j.applanim.2008.04.001; Schutz K, 2006, APPL ANIM BEHAV SCI, V101, P253, DOI 10.1016/j.applanim.2006.02.008; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; SINGH D, 1970, J COMP PHYSIOL PSYCH, V73, P320, DOI 10.1037/h0030222; Spinka M., 2011, Animal welfare, P27, DOI 10.1079/9781845936594.0027; TARTE RD, 1981, PSYCHOL REP, V49, P859, DOI 10.2466/pr0.1981.49.3.859; Toaff-Rosenstein RL, 2016, APPL ANIM BEHAV SCI, V181, P49, DOI 10.1016/j.applanim.2016.05.016; USDA. Feedlot, 2011, 6260313 USDAAPHIS 1; Van Os JMC, 2017, APPL ANIM BEHAV SCI, V197, P68, DOI 10.1016/j.applanim.2017.09.001; Webb LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088778; Weiss WP, 1998, J DAIRY SCI, V81, P830, DOI 10.3168/jds.S0022-0302(98)75641-3; Wood KM, 2011, ANIM FEED SCI TECH, V165, P23, DOI 10.1016/j.anifeedsci.2011.02.011	58	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193109	10.1371/journal.pone.0193109	http://dx.doi.org/10.1371/journal.pone.0193109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513705	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800038
J	Xiong, XL; Zhang, ZG; Ren, J; Zhang, J; Pan, XY; Zhang, L; Gong, SW; Jin, S				Xiong, Xiaolei; Zhang, Zhiguo; Ren, Jing; Zhang, Jie; Pan, Xiaoyun; Zhang, Liang; Gong, Shiwei; Jin, Si			Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China	PLOS ONE			English	Article							HEALTH-INSURANCE; CARE; QUALITY; PERFORMANCE; BURDEN; ACCESS; REFORM	Background China's universal medical insurance system (UMIS) is designed to promote social fairness through improving access to medical services and reducing out-of-pocket (OOP) costs for all Chinese. However, it is still not known whether UMIS has a significant impact on the accessibility of medical service supply and the affordability, as well as the seeking-care choice, of patients in China. Methods Segmented time-series regression analysis, as a powerful statistical method of interrupted time series design, was used to estimate the changes in the quantity and quality of medical service supply before and after the implementation of UMIS. The rates of catastrophic payments and seeking-care choices for UMIS beneficiaries were selected to measure the affordability and medical service flow of patients after the implementation of UMIS. Results China's UMIS was established in 2008. After that, the trending increase of the expenditure of the UMIS was higher than that of increase in revenue compared to previous years. Up to 2014, the UMIS had covered 97.5% of the entire population in China. After introduction of the UMIS, there were significant increases in licensed physicians, nurses, and hospital beds per 1000 individuals. In addition, hospital outpatient visits and inpatient visits per year increased compared to the pre-UMIS period. The average fatality rate of inpatients in the overall hospital and general hospital and the average fatality rate due to acute myocardial infarction (AMI) in general hospitals was significantly decreased. In contrast, no significant and prospective changes were observed in rural physicians per 1000 individuals, inpatient visits and inpatient fatality rate in the community centers and township hospitals compared to the pre-UMIS period. After 2008, the rates of catastrophic payments for UMIS inpatients at different income levels were declining at three levels of hospitals. Whichever income level, the rate of catastrophic payments for inpatients of Urban Employee's Basic Medical Insurance was the lowest. For the low-income patients, a single hospitalization at a tertiary hospital can lead to catastrophic payments. It is needless to say what the economic burden could be if patients required multiple hospitalizations within a year. UMIS beneficiaries showed the intention of growth to seek hospitalization services in tertiary hospitals. Conclusions Introduction of the UMIS contributed to an increase in available medical services and the use thereof, and a decrease in fatality rate. The affordability of UMIS beneficiaries for medical expenses was successfully ameliorated. The differences in patients' affordability are mainly manifested in different medical insurance schemes and different seeking-care choices. The ability of the poor patients covered by UMIS to resist catastrophic medical payments is still relatively weak. Therefore, the current UMIS should reform the insurance payment model to promote the integration of medical services and the formation of a tiered treatment system. UMIS also should establish supplementary medical insurance packages for the poor.	[Xiong, Xiaolei; Gong, Shiwei] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Dept Pharm Business & Adm, Wuhan, Hubei, Peoples R China; [Zhang, Zhiguo; Zhang, Liang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, Wuhan, Hubei, Peoples R China; [Ren, Jing] Natl Hlth & Family Planning Commiss, New Rural Cooperat Med Res Ctr, Beijing, Peoples R China; [Zhang, Jie] Minist Human Resources & Social Secur, Hlth Insurance Res Assoc, Beijing, Peoples R China; [Pan, Xiaoyun] West Virginia Univ, Sch Pharm, Dept Pharmaceut Syst & Policy, Morgantown, WV 26506 USA; [Jin, Si] Huazhong Univ Sci & Technol, Liyuan Hosp, Tongji Med Coll, Inst Geriatr Med,Dept Endocrinol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; West Virginia University; Huazhong University of Science & Technology	Gong, SW (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Dept Pharm Business & Adm, Wuhan, Hubei, Peoples R China.	shwgong@hust.edu.cn		Gong, Shiwei/0000-0003-3556-8512	National Natural Science Foundation of China [71373089, 71273100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China (No: 71373089, 71273100). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANCET, V379, P777; Babiarz KS, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5617; Baozhen W, 2016, CHINA SOCIAL SECURIT, V05, P82; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Barber SL, 2010, 37 WHO; Centers For Medicare Medicaid Services US, 2006, HOSP QUAL ALL HQA 20; Chen G, 2014, PHARMACOECONOMICS, V32, P277, DOI 10.1007/s40273-013-0097-7; Copnell B, 2009, INTERN MED J, V39, P352, DOI 10.1111/j.1445-5994.2009.01961.x; Cui B, 2014, VALUE HEALTH, V17, pA721, DOI 10.1016/j.jval.2014.08.022; DAVIS CK, 1988, HEALTH POLICY, V9, P117, DOI 10.1016/0168-8510(88)90029-2; European Commission EU, 2017, HLTH INT HLTH SERV E; Fang P Q, 2009, WUHAN U J PHILOS SOC, V62, P201; Filipski MJ, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0871-7; Guo J., 2016, DEV DISCUSSION PUBLI, V30, P32; Hildreth C., 1960, DEMAND RELATIONS AUT; Huang Y, 2011, FOREIGN AFF, V90, P119; KOENKER R, 1981, J ECONOMETRICS, V17, P107, DOI 10.1016/0304-4076(81)90062-2; Lal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137448; Li C, 2011, SOC SCI MED, V73, P359, DOI 10.1016/j.socscimed.2011.06.002; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Liang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033861; Liu K, 2014, SOC SCI MED, V113, P95, DOI 10.1016/j.socscimed.2014.05.011; Liu XY, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-10; Liu YL, 2002, HEALTH POLICY, V60, P133, DOI 10.1016/S0168-8510(01)00207-X; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Ma JD, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0361-5; Meng QY, 2015, LANCET, V386, P1484, DOI 10.1016/S0140-6736(15)00342-6; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Ministry of Human Resources and Social Security China, 2011, PROP FURTH ADV REF P; Ministry of Human Resources and Social Security China, 1998, STAT B CHIN LAB SOC; National Bureau of Statistics China, 2015, REV EXP URB BAS MED; National Bureau of Statistics China, 2016, CHIN STAT YB 2003 20; National Health And Family Planning Commission China, 2012, PROP PROM REF PAYM M; National Health And Family Planning Commission China, 2003, AN REP 3 NAT HLTH SE; National Health And Family Planning Commission China, 2016, CHIN HLTH STAT YB 20; National Health And Family Planning Commission China, 2015, YB CHIN HLTH FAM PLA; Organisation For Economic Co-operation And Development, 2017, HEALTHC QUAL IND; Pan XF, 2016, LANCET, V387, P1274, DOI 10.1016/S0140-6736(16)30021-6; Tian X., 1990, CHINESE HLTH EC, V09, P11; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Xu L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-37; Yang X., 2016, PLOS ONE, V11; Yip W, 2004, SOC SCI MED, V58, P267, DOI 10.1016/S0277-9536(03)00010-8; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; You XD, 2009, HEALTH POLICY, V91, P1, DOI 10.1016/j.healthpol.2008.11.012; Yu H, 2015, HEALTH POLICY, V119, P1145, DOI 10.1016/j.healthpol.2015.07.008; Zhang L., 2015, ASIA-PAC J PUBLIC HE, P28; Zhang Y, 2009, NEW ENGL J MED, V361, P52, DOI 10.1056/NEJMsa0807998; Zhou ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112918; Zou J, 2015, INT HLTH, V8	52	39	39	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193273	10.1371/journal.pone.0193273	http://dx.doi.org/10.1371/journal.pone.0193273			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513712	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800052
J	Mastop, M; Reinhard, NR; Zuconelli, CR; Terwey, F; Gadella, TWJ; van Unen, J; Adjobo-Hermans, MJW; Goedhart, J				Mastop, Marieke; Reinhard, Nathalie R.; Zuconelli, Cristiane R.; Terwey, Fenna; Gadella, Theodorus W. J., Jr.; van Unen, Jakobus; Adjobo-Hermans, Merel J. W.; Goedhart, Joachim			A FRET-based biosensor for measuring G alpha 13 activation in single cells	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; RESONANCE ENERGY-TRANSFER; SUBUNIT DISSOCIATION; SIGNALING PATHWAYS; THROMBIN RECEPTOR; ALPHA; RHO; EXTENSION; FAMILY; ASSAY	Fo E rster Resonance Energy Transfer (FRET) provides a way to directly observe the activation of heterotrimeric G-proteins by G-protein coupled receptors (GPCRs). To this end, FRET based biosensors are made, employing heterotrimeric G-protein subunits tagged with fluorescent proteins. These FRET based biosensors complement existing, indirect, ways to observe GPCR activation. Here we report on the insertion of mTurquoise2 at several sites in the human G alpha 13 subunit, aiming to develop a FRET-based G alpha 13 activation biosensor. Three fluorescently tagged G alpha 13 variants were found to be functional based on i) plasma membrane localization and ii) ability to recruit p115-RhoGEF upon activation of the LPA2 receptor. The tagged G alpha 13 subunits were used as FRET donor and combined with cp173Venus fused to the G gamma 2 subunit, as the acceptor. We constructed G alpha 13 biosensors by generating a single plasmid that produces G alpha 13-mTurquoise2, G ss 1 and cp173Venus-G gamma 2. The G alpha 13 activation biosensors showed a rapid and robust response when used in primary human endothelial cells that were exposed to thrombin, triggering endogenous protease activated receptors (PARs). This response was efficiently inhibited by the RGS domain of p115-RhoGEF and from the biosensor data we inferred that this is due to GAP activity. Finally, we demonstrated that the G alpha 13 sensor can be used to dissect heterotrimeric G-protein coupling efficiency in single living cells. We conclude that the G alpha 13 biosensor is a valuable tool for live-cell measurements that probe spatiotemporal aspects of G alpha 13 activation.	[Mastop, Marieke; Reinhard, Nathalie R.; Terwey, Fenna; Gadella, Theodorus W. J., Jr.; van Unen, Jakobus; Goedhart, Joachim] Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy, Sect Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Zuconelli, Cristiane R.; Adjobo-Hermans, Merel J. W.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, Nijmegen, Netherlands; [van Unen, Jakobus] Univ Bern, Inst Cell Biol, Dept Biol, Bern, Switzerland	University of Amsterdam; Radboud University Nijmegen; University of Bern	Goedhart, J (corresponding author), Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy, Sect Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	j.goedhart@uva.nl	Zuconelli, Cristiane/G-6213-2016; Zuconelli, Cristiane/Q-4717-2019; Adjobo-Hermans, Merel/AAN-5989-2020; Adjobo-Hermans, M.J.W./L-4170-2015	Zuconelli, Cristiane/0000-0002-6316-3937; Zuconelli, Cristiane/0000-0002-6316-3937; Adjobo-Hermans, Merel/0000-0002-5947-2876; Adjobo-Hermans, M.J.W./0000-0002-5947-2876; Gadella, Theodorus/0000-0002-7639-219X; van Unen, Jakobus/0000-0002-7931-0989	NWO Chemical Sciences ECHO [711.013.009]; Brazilian research funding agency CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) [BEX 13247/13-1]	NWO Chemical Sciences ECHO; Brazilian research funding agency CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior)	JG was supported by a NWO Chemical Sciences ECHO grant (711.013.009). MJWA was supported financially by the Brazilian research funding agency CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) (grant: BEX 13247/13-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; Bodmann EL, 2017, FASEB J, V31, P3663, DOI 10.1096/fj.201700026R; Clister T, 2015, J BIOL CHEM, V290, P6681, DOI 10.1074/jbc.R114.616391; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Goedhart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027321; Goyet E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28231; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Janetopoulos C, 2002, METHODS, V27, P366, DOI 10.1016/S1046-2023(02)00095-6; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Levitzki A, 2002, CHEMBIOCHEM, V3, P815, DOI 10.1002/1439-7633(20020902)3:9<815::AID-CBIC815>3.0.CO;2-E; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Mastop M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12212-x; Meyer BH, 2008, J CELL BIOCHEM, V104, P1660, DOI 10.1002/jcb.21732; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Navenot JM, 2009, MOL PHARMACOL, V75, P1300, DOI 10.1124/mol.109.055095; Reinhard NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25502; Reinhard NR, 2017, MOL BIOL CELL; RENSDOMIANO S, 1995, FASEB J, V9, P1059, DOI 10.1096/fasebj.9.11.7649405; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Salahpour Ali, 2012, Front Endocrinol (Lausanne), V3, P105, DOI 10.3389/fendo.2012.00105; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Strange PG, 2010, BRIT J PHARMACOL, V161, P1238, DOI 10.1111/j.1476-5381.2010.00963.x; Takefuji M, 2012, CIRCULATION, V126, P1972, DOI 10.1161/CIRCULATIONAHA.112.109256; van Unen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36825; van Unen J, 2016, MOL PHARMACOL, V90, P162, DOI 10.1124/mol.116.104505; van Unen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146789; van Unen J, 2015, MOL PHARMACOL, V88, P589, DOI 10.1124/mol.115.098897; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193705	10.1371/journal.pone.0193705	http://dx.doi.org/10.1371/journal.pone.0193705			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505611	gold, Green Published, Green Submitted			2022-12-27	WOS:000426548200025
J	Zhao, LG; Hang, ZZ; Yang, JZ; Qi, H				Zhao, Longgang; Hang, Zhongzhi; Yang, Jinzhong; Qi, Hua			Single seed precise sowing of maize using computer simulation	PLOS ONE			English	Article								In order to test the feasibility of computer simulation in field maize planting, the selection of the method of single seed precise sowing in maize is studied based on the quadratic function model Y = Ax(D-Dm)(2) + Ym, which depicts the relationship between maize yield and planting density. And the advantages and disadvantages of the two planting methods under the condition of single seed sowing are also compared: Method 1 is optimum density planting, while Method 2 is the ideal seedling emergence number planting. It is found that the yield reduction rate and yield fluctuation of Method 2 are all lower than those of Method 1. The yield of Method 2 increased by at least 0.043 t/hm(2), and showed more advantages over Method 1 with higher yield level. Further study made on the influence of seedling emergence rate on the yield of maize finds that the yields of the two methods are both highly positively correlated with the seedling emergence rate and the standard deviations of their yields are both highly negatively correlated with the seedling emergence rate. For the study of the break-up problem of sparse caused by the method of single seed precise sowing, the definition of seedling missing spots is put forward. The study found that the relationship between number of hundred-dot spot and field seedling emergence rate is as the parabola function y = -189.32x(2) + 309.55x - 118.95 and the relationship between number of spot missing seedling and field seedling emergence rate is as the negative exponent function y = 395.69e(-6.144x). The results may help to guide the maize seeds production and single seed precise sowing to some extent.	[Zhao, Longgang; Qi, Hua] Shenyang Agr Univ, Agron Coll, Shenyang, Liaoning, Peoples R China; [Hang, Zhongzhi] Qingdao Agr Univ, Coll Informat Sci & Engn, Qingdao, Peoples R China; [Yang, Jinzhong] Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Peoples R China	Shenyang Agricultural University; Qingdao Agricultural University; Qingdao Agricultural University	Qi, H (corresponding author), Shenyang Agr Univ, Agron Coll, Shenyang, Liaoning, Peoples R China.	qihua09@163.com			National Key Research and Development Program of China [2016YFD0300103]	National Key Research and Development Program of China	The corresponding author, Qi Hua, received the National Key Research and Development Program of China (2016YFD0300103) for this work.	[Anonymous], 2008, 440412008 GB, P12; Bock M, 2010, B MATH BIOL, V72, P1696, DOI 10.1007/s11538-009-9498-3; Butzen Steve, 2014, CROP INSIGHTS CORN S; Chu Jie, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P34; DONG Xue, 2011, J HARBIN U COMMERCE, V27, P867; Drury CF, 1999, AGRON J, V91, P101, DOI 10.2134/agronj1999.00021962009100010016x; DUNCAN W. G., 1958, Agronomy Journal, V50, P82; Gu W. L., 1985, J SHENYANG AGR COLL, V16, P1; Han ZhongZhi, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P17; Li Dong, 2013, SEED WORLD, V12, P35; [李凤海 LI Fenghai], 2007, [种子, Seed], V26, P77; Li Hui, 2012, INT SOC OPTICS PHOTO; [刘帅 Liu Shuai], 2014, [生态学报, Acta Ecologica Sinica], V34, P1436; [彭云玲 Peng Yunling], 2014, [干旱地区农业研究, Agricultural Research in the Arid Areas], V32, P25; Reem D, 2011, COMPUTATIONAL GEOMETRY (SCG 11), P254; [肖继兵 Xiao Jibing], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1917; Yang JinZhong, 2013, Acta Agronomica Sinica, V39, P515, DOI 10.3724/SP.J.1006.2013.00515; YANG Jinzhong, 2015, J BIOMATHEMATICS, V30, P243; [朱金城 Zhu Jincheng], 2013, [中国农业大学学报, Journal of China Agricultural University], V18, P34	19	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193750	10.1371/journal.pone.0193750	http://dx.doi.org/10.1371/journal.pone.0193750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505619	gold, Green Submitted, Green Published			2022-12-27	WOS:000426548200029
J	Nicoletto, BB; Pedrollo, EF; Carpes, LS; Coloretti, NG; Krolikowski, TC; Souza, GC; Goncalves, LFS; Manfro, RC; Canani, LH				Nicoletto, Bruna Bellincanta; Pedrollo, Elis Forcellini; Carpes, Larissa Salomoni; Coloretti, Natalia Gomes; Krolikowski, Thaiana Cirino; Souza, Gabriela Correa; Santos Goncalves, Luiz Felipe; Manfro, Roberto Ceratti; Canani, Luis Henrique			Progranulin serum levels in human kidney transplant recipients: A longitudinal study	PLOS ONE			English	Article							PLASMA ADIPONECTIN CONCENTRATION; INSULIN-RESISTANCE; GROWTH-FACTOR; CIRCULATING PROGRANULIN; EPITHELIN PRECURSOR; ADIPOSE-TISSUE; ADIPOKINE; LEPTIN; PGRN; FAT	Background The adipokine progranulin has metabolic proprieties, playing a role in obesity and insulin resistance. Its levels seems to be dependent of renal function, since higher progranulin concentration is observed in patients with end-stage kidney disease. However, the effect of kidney transplantation on progranulin remains unknown. Objective To assess the serum progranulin levels in kidney transplant recipients before and after kidney transplantation. Methods Forty-six prospective kidney transplant recipients were included in this longitudinal study. They were evaluated before transplantation and at three and twelve months after transplantation. Clinical, anthropometric and laboratorial measurements were assessed. Progranulin was determined with enzyme-linked immunosorbent assays. Results Serum progranulin significantly decreased in the early period after transplantation (from 72.78 +/- 2.86 ng/mL before transplantation to 40.65 +/- 1.49 ng/mL at three months; p<0.01) and increased at one year (53.15 +/- 2.55 ng/mL; p<0.01 vs. three months), remaining significantly lower than before transplantation (p< 0.01) (p(over time) <0.01). At one year after transplantation, there was a significant increase in body mass index, trunk fat and waist circumference compared to immediate period after transplantation. Progranulin was associated with waist circumference and fasting plasma glucose after adjusted for age, gender, study period, glomerular filtration rate, interleukin-6, high sensitivity C reactive protein and adiponectin. Conclusion Progranulin serum levels are increased before transplantation and a reduction is observed in the early period after transplantation, possibly attributed to an improvement in renal function. At one year after transplantation, an increment in progranulin is observed, seems to be independent of glomerular filtration, and remained significantly lower than before transplantation.	[Nicoletto, Bruna Bellincanta; Pedrollo, Elis Forcellini; Carpes, Larissa Salomoni; Coloretti, Natalia Gomes; Krolikowski, Thaiana Cirino; Canani, Luis Henrique] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil; [Nicoletto, Bruna Bellincanta] UCS, Life Sci Knowledge Area, Caxias Do Sul, Brazil; [Souza, Gabriela Correa] Univ Fed Rio Grande do Sul, Fac Med, Dept Nutr, Porto Alegre, RS, Brazil; [Santos Goncalves, Luiz Felipe; Manfro, Roberto Ceratti] Hosp Clin Porto Alegre, Div Nephrol, Porto Alegre, RS, Brazil; [Canani, Luis Henrique] Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Caxias do Sul; Universidade Federal do Rio Grande do Sul	Nicoletto, BB (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil.; Nicoletto, BB (corresponding author), UCS, Life Sci Knowledge Area, Caxias Do Sul, Brazil.	brunanicoletto@gmail.com	Canani, Luis H/G-9686-2012; MANFRO, ROBERTO/U-7338-2019; SOUZA, GABRIELA/R-4846-2019	Canani, Luis H/0000-0002-1813-4491; Nicoletto Gehrke, Bruna/0000-0001-9378-1130; Salomoni Carpes, Larissa/0000-0002-0818-5383	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [474645/2013-4]; Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre [14-0254]; CNPq; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq www.cnpq.br) (474645/2013-4) and Fundo de Incentivo a Pesquisa e Eventos (FIPE) (14-0254) at the Hospital de Clinicas de Porto Alegre (www.hcpa.edu.br). BBN, LSC, NGC and LHC are recipients of scholarships from CNPq. TCK is recipient of scholarship from Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS - www.fapergs.rs.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bluher M, 2012, DIABETES CARE, V35, P342, DOI 10.2337/dc11-1267; Cantarin MPM, 2014, NEPHROL DIAL TRANSPL, V29, P2268, DOI 10.1093/ndt/gfu249; Cantarin MPM, 2013, KIDNEY INT, V83, P487, DOI 10.1038/ki.2012.421; Chudek J, 2003, TRANSPL P, V35, P2186, DOI 10.1016/j.transproceed.2003.08.001; Davidson J, 2003, TRANSPLANTATION, V75, pSS3, DOI 10.1097/01.TP.0000069952.49242.3E; Ebert T, 2015, KIDNEY INT, V88, P1197, DOI 10.1038/ki.2015.266; Fu Y, 2017, HYPERTENSION, V69, P259, DOI 10.1161/HYPERTENSIONAHA.116.08154; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Idorn T, 2012, TRANSPL INT, V25, P1194, DOI 10.1111/j.1432-2277.2012.01560.x; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li HX, 2014, ENDOCRINOLOGY, V155, P3493, DOI 10.1210/en.2014-1058; Liu JL, 2015, MOL ENDOCRINOL, V29, P528, DOI 10.1210/me.2014-1266; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Nagy K, 2016, CLIN KIDNEY J, V9, P359, DOI 10.1093/ckj/sfv156; Nazemian Fatemeh, 2005, Exp Clin Transplant, V3, P329; Nguyen AD, 2013, TRENDS ENDOCRIN MET, V24, P597, DOI 10.1016/j.tem.2013.08.003; Nicoletto BB, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0112-6; Nicoletto BB, 2012, J RENAL NUTR, V22, P440, DOI 10.1053/j.jrn.2011.09.003; Nicoletto BB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165177; Nigro E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/658913; Ocak N, 2016, RENAL FAILURE, V38, P1639, DOI 10.1080/0886022X.2016.1229965; Pedrollo EF, 2016, TRANSPL INT, V29, P1059, DOI 10.1111/tri.12805; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Pirsch JD, 2008, TRANSPLANTATION, V85, P1387, DOI 10.1097/TP.0b013e31816f1d58; Qu H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/360190; Richter J, 2013, DIABETES CARE, V36, P410, DOI 10.2337/dc12-0220; Roubicek T, 2009, NUTRITION, V25, P762, DOI 10.1016/j.nut.2008.12.012; Sharif A, 2010, NAT REV NEPHROL, V6, P415, DOI 10.1038/nrneph.2010.66; Souza GC, 2008, J RENAL NUTR, V18, P479, DOI 10.1053/j.jrn.2008.05.008; Taherimahmoudi M, 2010, TRANSPL P, V42, P797, DOI 10.1016/j.transproceed.2010.03.029; Tanaka Y, 2014, ENDOCR J, V61, P1191, DOI 10.1507/endocrj.EJ14-0210; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Van den Ham ECH, 1999, J AM SOC NEPHROL, V10, P1067; Wang BC, 2015, PROTEIN CELL, V6, P792, DOI 10.1007/s13238-015-0213-x; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 2017, BOD MASS IND CLASS; Xu L, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/357279; Xu XY, 2016, INT IMMUNOPHARMACOL, V38, P409, DOI 10.1016/j.intimp.2016.06.022; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Zhou B, 2015, J MOL ENDOCRINOL, V55, P231, DOI 10.1530/JME-15-0075; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zhou M, 2015, KIDNEY INT, V87, P918, DOI 10.1038/ki.2014.403	48	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0192959	10.1371/journal.pone.0192959	http://dx.doi.org/10.1371/journal.pone.0192959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499059	gold, Green Published, Green Submitted			2022-12-27	WOS:000426472300005
J	Jung, HY; Kim, SH; Jang, HM; Lee, S; Kim, YS; Kang, SW; Yang, CW; Kim, NH; Choi, JY; Cho, JH; Kim, CD; Park, SH; Kim, YL				Jung, Hee-Yeon; Kim, Su Hee; Jang, Hye Min; Lee, Sukyung; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Park, Sun-Hee; Kim, Yong-Lim			Individualized prediction of mortality using multiple inflammatory markers in patients on dialysis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR MORTALITY; RISK STRATIFICATION; DECISION-MAKING; SERUM-ALBUMIN; DISEASE; BIOMARKERS	This study aimed to evaluate whether the combination of inflammatory markers could provide predictive powers for mortality in individual patients on dialysis and develop a predictive model for mortality according to dialysis modality. Data for inflammatory markers were obtained at the time of enrollment from 3,309 patients on dialysis from a prospective multicenter cohort. Net reclassification index ( NRI) and integrated discrimination improvement ( IDI) were calculated. Cox proportional hazards regression analysis was used to derive a prediction model of mortality and the integrated area under the curve (iAUC) was calculated to compare the predictive accuracy of the models. The incremental additions of albumin, high-sensitive C-reactive protein ( hsCRP), white blood count ( WBC), and ferritin to the conventional risk factors showed the highest predictive powers for all-cause mortality in the entire population ( NRI, 21.0; IDI, 0.045) and patients on peritoneal dialysis ( NRI, 25.7; IDI, 0.061). The addition of albumin and hsCRP to the conventional risk factors markedly increased predictive powers for all-cause mortality in HD patients ( NRI, 19.0; IDI, 0.035). The prediction model for all-cause mortality using conventional risk factors and combination of inflammatory markers with highest NRI value (iAUC, 0.741; 95% CI, 0.722-0.761) was the most accurate in the entire population compared with a model including conventional risk factors alone ( iAUC, 0.719; 95% CI, 0.700-0.738) or model including only significant conventional risk factors and inflammatory markers ( iAUC, 0.734; 95% CI, 0.714-0.754). Using multiple inflammatory markers practically available in a clinic can provide higher predictive power for all-cause mortality in patients on dialysis. The predictive model for mortality based on combinations of inflammatory markers enables a stratified risk assessment. However, the optimal combination for the predictive model was different in each dialysis modality.	[Jung, Hee-Yeon; Kim, Su Hee; Lee, Sukyung; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Park, Sun-Hee; Kim, Yong-Lim] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea; [Jung, Hee-Yeon; Kim, Su Hee; Lee, Sukyung; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Park, Sun-Hee; Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Daegu, South Korea; [Jung, Hee-Yeon; Kim, Su Hee; Jang, Hye Min; Lee, Sukyung; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Choi, Ji-Young; Cho, Jang-Hee; Kim, Chan-Duck; Park, Sun-Hee; Kim, Yong-Lim] Clin Res Ctr End Stage Renal Dis, Daegu, South Korea; [Jang, Hye Min] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea; [Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Dept Biomed Sci, Plus KNU Biomed Convergence Program Bk21, Daegu, South Korea	Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University; Kyungpook National University	Park, SH; Kim, YL (corresponding author), Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea.; Park, SH; Kim, YL (corresponding author), Kyungpook Natl Univ, Sch Med, Daegu, South Korea.; Park, SH; Kim, YL (corresponding author), Clin Res Ctr End Stage Renal Dis, Daegu, South Korea.; Kim, YL (corresponding author), Kyungpook Natl Univ, Dept Biomed Sci, Plus KNU Biomed Convergence Program Bk21, Daegu, South Korea.	sh-park@knu.ac.kr; ylkim@knu.ac.kr	Park, Sun/GSD-9620-2022; Jung, Hee-Yeon/AFB-8578-2022; Cho, Jang-hee/ABD-3534-2020	Jung, Hee-Yeon/0000-0003-0232-7202; Cho, Jang-hee/0000-0002-7031-5214	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0001, HC15C1129, HI13C1232]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health & Welfare, Republic of Korea (HI15C0001 and HC15C1129 to YLK and HI13C1232 to CDK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargnoux AS, 2013, CLIN CHEM LAB MED, V51, P1865, DOI 10.1515/cclm-2012-0664; Bazeley J, 2011, CLIN J AM SOC NEPHRO, V6, P2452, DOI 10.2215/CJN.00710111; Coe CL, 2011, BRAIN BEHAV IMMUN, V25, P494, DOI 10.1016/j.bbi.2010.11.013; Cohen LM, 2010, CLIN J AM SOC NEPHRO, V5, P72, DOI 10.2215/CJN.03860609; Cohen SD, 2010, NEPHROL DIAL TRANSPL, V25, P1239, DOI 10.1093/ndt/gfp625; Couchoud CG, 2015, KIDNEY INT, V88, P1178, DOI 10.1038/ki.2015.245; Hallen J, 2011, SCAND J UROL NEPHROL, V45, P151, DOI 10.3109/00365599.2010.529819; Herzig KA, 2001, J AM SOC NEPHROL, V12, P814, DOI 10.1681/ASN.V124814; Hung SC, 2012, CLIN J AM SOC NEPHRO, V7, P1257, DOI 10.2215/CJN.08410811; Ishii J, 2015, CIRC J, V79, P656, DOI 10.1253/circj.CJ-14-0915; Johnson DW, 2005, KIDNEY INT, V67, P738, DOI 10.1111/j.1523-1755.2005.67135.x; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V37, P564, DOI 10.1053/ajkd.2001.22433; Kato A, 2010, HEMODIAL INT, V14, P226, DOI 10.1111/j.1542-4758.2009.00432.x; Maruyama Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143430; Mehrotra R, 2011, AM J KIDNEY DIS, V58, P418, DOI 10.1053/j.ajkd.2011.03.018; Oldroyd JC, 2009, ATHEROSCLEROSIS, V207, P227, DOI 10.1016/j.atherosclerosis.2009.03.045; Park SH, 2012, J RENAL NUTR, V22, P120, DOI 10.1053/j.jrn.2011.10.021; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Reddan DN, 2003, NEPHROL DIAL TRANSPL, V18, P1167, DOI 10.1093/ndt/gfg066; Shoji T, 2016, CLIN EXP NEPHROL; Thamer M, 2015, AM J KIDNEY DIS, V66, P1024, DOI 10.1053/j.ajkd.2015.05.014; Tsirpanlis G, 2004, NEPHROL DIAL TRANSPL, V19, P150, DOI 10.1093/ndt/gfg486; Westra WM, 2007, PERITON DIALYSIS INT, V27, P192; Wick JP, 2016, AM J KIDNEY DIS; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yeun JY, 2000, AM J KIDNEY DIS, V35, P469, DOI 10.1016/S0272-6386(00)70200-9	26	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193511	10.1371/journal.pone.0193511	http://dx.doi.org/10.1371/journal.pone.0193511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494637	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200057
J	Cooke, M; Ullman, AJ; Ray-Barruel, G; Wallis, M; Corley, A; Rickard, CM				Cooke, Marie; Ullman, Amanda J.; Ray-Barruel, Gillian; Wallis, Marianne; Corley, Amanda; Rickard, Claire M.			Not "just" an intravenous line: Consumer perspectives on peripheral intravenous cannulation (PIVC). An international cross-sectional survey of 25 countries	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PATIENT EDUCATION MODEL; VENOUS ACCESS; SECUREMENT METHODS; CATHETER FAILURE; DECISION-MAKING; HEALTH; CARE; ULTRASOUND; PARTICIPATION	Peripheral intravascular cannula/catheter (PIVC) insertion is a common invasive procedure, but PIVC failure before the end of therapy is unacceptably high. As PIVC failure disrupts treatment and reinsertion can be distressing for the patient, prevention of PIVC failure is an important patient outcome. Consumer participation in PIVC care to prevent failure is an untapped resource. This study aimed to understand consumers' PIVC experience; establish aspects of PIVC insertion and care relevant to them; and to compare experiences of adult consumers to adult carers of a child. An international, web-based, cross-sectional survey was distributed via social media inviting adult consumers and adult carers of a child under 18 years who had experienced having a PIVC in the last five years (one survey each for adults and adult carers) to complete a 10-item survey. As such, sampling bias is a limitation and results should be carefully considered in light of this. There were 712 respondents from 25 countries, mainly female (87.1%) and adults (80%). A little over 50% of adults described insertion as moderately painful or worse, with level of insertion difficulty (0-10 scale) identified as moderate (median 4, IQR 1, 7). Adult carers reported significantly more pain during insertion and insertion difficulty (both p < 0.001). Rates of first insertion attempt failure were higher in children compared with adults (89/139 [64%] vs 221/554 [40%]; p < 0.001), and 23% of children required >= 4 attempts, compared with 9% of adults (p < 0.0001). Three themes from open-ended question emerged: Significance of safe and consistent PIVC care; Importance of staff training and competence; and Value of communication. The PIVC experience can be painful, stressful and frustrating for consumers. Priorities for clinicians and policy makers should include use of pain relief as standard practice to reduce the pain associated with PIVC insertion and developing strategies to increase first PIVC insertion attempt success particularly for children and older consumers.	[Cooke, Marie; Ullman, Amanda J.; Ray-Barruel, Gillian; Wallis, Marianne; Corley, Amanda; Rickard, Claire M.] Griffith Univ, Menzies Hlth Inst Queensland, AVATAR, Brisbane, Qld, Australia; [Cooke, Marie; Ullman, Amanda J.; Rickard, Claire M.] Griffith Univ, Sch Nursing & Midwifery, Brisbane, Qld, Australia; [Wallis, Marianne] Univ Sunshine Coast, Sch Nursing Midwifery & Paramed, Sippy Downs, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Griffith University; University of the Sunshine Coast	Cooke, M (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, AVATAR, Brisbane, Qld, Australia.; Cooke, M (corresponding author), Griffith Univ, Sch Nursing & Midwifery, Brisbane, Qld, Australia.	m.cooke@griffith.edu.au	Wallis, Marianne/AAF-9899-2021; Rickard, Claire M./C-3440-2008; Wallis, Marianne C/C-5452-2013; Ray-Barruel, Gillian/B-9305-2008	Wallis, Marianne/0000-0003-2753-1066; Rickard, Claire M./0000-0002-6341-7415; Wallis, Marianne C/0000-0003-2753-1066; Ray-Barruel, Gillian/0000-0001-8875-7523; Corley, Amanda/0000-0002-4250-4077; Ullman, Amanda/0000-0001-8860-5319; Cooke, Marie/0000-0002-9928-4685				Agency for Healthcare Research and Quality, 2013, GUIDE PATIENT FAMILY; [Anonymous], 2003, J ASS VASCULAR ACCES, DOI DOI 10.2309/155288503774651805; Australian Commission on Safety and Quality in Health Care, 2014, NAT SAF QUAL HLTH SE; Bahl A, 2016, AM J EMERG MED, V34, P1950, DOI 10.1016/j.ajem.2016.06.098; Benkhadra M, 2012, PEDIATR ANESTH, V22, P449, DOI 10.1111/j.1460-9592.2012.03830.x; Blignault I, 2017, AUST J PRIM HEALTH, V23, P531, DOI 10.1071/PY16103; Bolton D., 2010, BRIT J NURSING, V19, P8; Bolton Debbie, 2010, Br J Nurs, V19, P1348; Bond M, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0252-8; Boyd S, 2011, J HOSP INFECT, V77, P37, DOI 10.1016/j.jhin.2010.09.011; Care Quality Commission, 2014, OUR STRAT ENG PUBL C; Carr PJ, 2016, J VASC ACCESS, V17, P182, DOI 10.5301/jva.5000487; Chernecky C, 2001, Oncol Nurs Forum, V28, P1613; Coleman EA, 2004, J AM GERIATR SOC, V52, P1817, DOI 10.1111/j.1532-5415.2004.52504.x; Couet N, 2015, HEALTH EXPECT, V18, P542, DOI 10.1111/hex.12054; Crawford MJ, 2002, BRIT MED J, V325, P1263, DOI 10.1136/bmj.325.7375.1263; Cummings EA, 1996, PAIN, V68, P25, DOI 10.1016/S0304-3959(96)03163-6; Cuper NJ, 2012, PEDIATR ANESTH, V22, P223, DOI 10.1111/j.1460-9592.2011.03685.x; Filbet M, 2017, BMC PALLIAT CARE, V16, DOI 10.1186/s12904-016-0180-x; Gabriel J., 2000, J VASCULAR ACCESS DE, V5, P26, DOI 10.2309/108300800775891454; Gorski L, 2016, J INFUS NURS S1, V39, P159; Grayson ML, 2011, MED J AUSTRALIA, V195, P615, DOI 10.5694/mja11.10747; Griffith RJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009484.pub2; Hallam Carole, 2016, J Infect Prev, V17, P65, DOI 10.1177/1757177415624752; HARWOOD IR, 1992, PEDIATR PULM, V12, P233, DOI 10.1002/ppul.1950120407; Helm RE, 2015, J INFUS MURS, V38, P189, DOI 10.1097/NAN.0000000000000100; Henselmans I, 2013, PSYCHO-ONCOLOGY, V22, P961, DOI 10.1002/pon.3099; Horsfield Claire, 2014, J Infect Prev, V15, P82, DOI 10.1177/1757177413502245; Intravenous Nursing New Zealand Incorporated Society, 2012, PROV INF THER STAND; Jacobson AF, 2005, HEART LUNG, V34, P345, DOI 10.1016/j.hrtlng.2005.04.002; Kennedy Robert M, 2008, Pediatrics, V122 Suppl 3, pS130, DOI 10.1542/peds.2008-1055e; Keogh S, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1470-6; Kosa SD, 2016, J VASC ACCESS, V17, P313, DOI 10.5301/jva.5000560; Larsen EN, 2016, J VASC ACCESS, V17, P40; Legare F, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006732.pub3; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; Malyon L, 2014, EMERG MED AUSTRALAS, V26, P602, DOI 10.1111/1742-6723.12305; Marsh N, 2015, J VASC ACCESS, V16, P237, DOI 10.5301/jva.5000348; McGuckin M, 1999, AM J INFECT CONTROL, V27, P309, DOI 10.1016/S0196-6553(99)70049-0; McGuckin M, 2001, J HOSP INFECT, V48, P222, DOI 10.1053/jhin.2001.0983; McGuckin M, 2004, AM J INFECT CONTROL, V32, P235, DOI 10.1016/j.ajic.2003.10.005; McHugh SM, 2011, INFECT CONT HOSP EP, V32, P95, DOI 10.1086/657630; Miller CL, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0171-2; Moller T, 2010, CANCER NURS, V33, P426, DOI 10.1097/NCC.0b013e3181dc1908; Moureau NL, 2012, J VASC ACCESS, V13, P351, DOI 10.5301/jva.5000042; Mutti C, 2016, ASSIST INFERM RIC, V35, P180, DOI 10.1702/2621.26951; Nicholson Jackie, 2013, Br J Nurs, V22, pS16; Nilsen ES, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004563.pub2; Norwood SL, 2010, RES ESSENTIALS FDN E; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Rickard CM, 2012, LANCET, V380, P1066, DOI 10.1016/S0140-6736(12)61082-4; Rickard CM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-53; Robinson-Reilly M, 2016, SUPPORT CARE CANCER, V24, P1181, DOI 10.1007/s00520-015-2900-9; Royal College of Nursing,, 2016, STAND INF THER; Rycroft-Malone J, 2004, J ADV NURS, V47, P81, DOI 10.1111/j.1365-2648.2004.03068.x; SARRAMIFOROUSHANI, 2014, BMC HEALTH SERV RES, V14, DOI DOI 10.1186/1472-6963-14-402; Sharp R, 2014, CONTEMP NURSE, V48, P26, DOI 10.5172/conu.2014.48.1.26; Smith B, 2006, J INFUS MURS, V29, P14, DOI 10.1097/00129804-200601000-00004; Stolz LA, 2015, J VASC ACCESS, V16, P321, DOI 10.5301/jva.5000346; Wallis MC, 2014, INFECT CONT HOSP EP, V35, P63, DOI 10.1086/674398; Webster J, 2008, BMJ-BRIT MED J, V337, pCP1, DOI 10.1136/bmj.a339; Weiner SG, 2013, J EMERG MED, V44, P653, DOI 10.1016/j.jemermed.2012.08.021; Weingart SN, 2011, INT J QUAL HEALTH C, V23, P269, DOI 10.1093/intqhc/mzr002; Zempsky William T, 2008, Pediatrics, V122 Suppl 3, pS121, DOI 10.1542/peds.2008-1055c; Zingg Walter, 2009, Int J Antimicrob Agents, V34 Suppl 4, pS38, DOI 10.1016/S0924-8579(09)70565-5	65	65	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193436	10.1371/journal.pone.0193436	http://dx.doi.org/10.1371/journal.pone.0193436			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489908	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000077
J	Ismail, SR; Maarof, SK; Ali, SS; Ali, A				Ismail, Sophia Rasheeqa; Maarof, Siti Khuzaimah; Ali, Syazwani Siedar; Ali, Azizan			Systematic review of palm oil consumption and the risk of cardiovascular disease	PLOS ONE			English	Review							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; DIETARY PATTERNS; FATTY-ACIDS; MEDITERRANEAN DIET; HEMORRHAGIC STROKE; SATURATED FAT; FOLLOW-UP; METAANALYSIS; ASSOCIATION	Background The high amount of saturated fatty acids (SFA) coupled with the rising availability and consumption of palm oil have lead to the assumption that palm oil contributes to the increased prevalence of cardiovascular diseases worldwide. We aimed at systematically synthesising the association of palm oil consumption with cardiovascular disease risk and cardiovascular disease-specific mortality. Methods We systematically searched Central, Medline and Embase databases up to June 2017 without restriction on setting or language. We performed separate searches based on the outcomes: coronary heart disease and stroke, using keywords related to these outcomes and palm oil. We searched for published interventional and observational studies in adults (Age: > 18 years old). Two investigators extracted data and a consensus was reached with involvement of a third. Only narrative synthesis was performed for all of the studies, as the data could not be pooled. Results Our search retrieved 2,738 citations for stroke with one included study and 1,777 citations for coronary heart disease (CHD) with four included studies. Palmitic acid was reported to be associated with risk of myocardial infarction (MI) (OR 2.76; 95% CI = 1.39-5.47). Total SFA intake was reported to be not significant for risk of MI. Varying intake of fried foods, highest contributor to total SFA with 36% of households using palm oil for frying, showed no significant associations to risk of MI. Odds of developing first non-fatal acute MI was higher in palm oil compared to soybean oil with 5% trans-fat (OR = 1.33; 95% CI = 1.09-1.62) than palm oil compared to soybean oil with 22% trans-fat (OR = 1.16; 95% CI = 0.86-1.56). Nevertheless, these risk estimates were non-significant and imprecise. The trend amongst those taking staple pattern diet (characterised by higher palm oil, red meat and added sugar consumption) was inconsistent across the factor score quintiles. During the years of 1980 and 1997, for every additional kilogram of palm oil consumed per-capita annually, CHD mortality risk was 68 deaths per 100,000 (95% CI = 21-115) in developing countries and 17 deaths per 100,000 (95% CI = 5.3-29) in high-income countries, whereas stroke was associated with 19 deaths per 100,000 (95% CI = -12-49) and 5.1 deaths per 100,000 (95% CI: -1.2-11) respectively. The evidence for the outcomes of this review were all graded as very low. The findings of this review should be interpreted with some caution, owing to the lack of a pooled effect estimate of the association, significant bias in selection criteria and confounding factors, inclusion of other food items together with palm oil, and the possible out-dated trend in the ecological study. Conclusion In view of the abundance of palm oil in the market, quantifying its true association with CVD outcomes is challenging. The present review could not establish strong evidence for or against palm oil consumption relating to cardiovascular disease risk and cardiovascular disease-specific mortality. Further studies are needed to establish the association of palm oil with CVD. A healthy overall diet should still be prioritised for good cardiometabolic health.	[Ismail, Sophia Rasheeqa; Ali, Azizan] Cardiovasc Diabet & Nutr Res Ctr, Inst Med Res, Kuala Lumpur, Malaysia; [Maarof, Siti Khuzaimah; Ali, Syazwani Siedar] Herbal Med Res Ctr, Inst Med Res, Kuala Lumpur, Malaysia	Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia	Ismail, SR (corresponding author), Cardiovasc Diabet & Nutr Res Ctr, Inst Med Res, Kuala Lumpur, Malaysia.	Sophia.rasheeqa@imr.gov.my	Ismail, Sophia Rasheeqa/AAE-1089-2022	Ismail, Sophia Rasheeqa/0000-0002-4271-0241				[Anonymous], 2003, DIET NUTR PREV CHON; Bhogal RK, 2005, J CLIN INVEST, V115, P2962, DOI 10.1172/JCI26845; BLACKET R B, 1965, Med J Aust, V1, P59; Carol Lefebvre EM, 2011, 6 4 11 1 COCHRANE HI; Chen BK, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-45; Chong Y H, 1991, Med J Malaysia, V46, P41; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; de Waure C, 2013, AM J PREV MED, V45, P207, DOI 10.1016/j.amepre.2013.03.020; Deb P, PATHOPHYSIOLOGY, V17, P197; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/s0140-6736(17)32252-3, 10.1016/S0140-6736(17)32252-3]; Dontas AS, 2007, CLIN INTERV AGING, V2, P109, DOI 10.2147/ciia.2007.2.1.109; Ellie Brown MFJ, 2005, CRUEL OIL PALM OIL H; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Fattore E, 2013, INT J FOOD SCI NUTR, V64, P648, DOI 10.3109/09637486.2013.768213; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Grech ED, 2003, BRIT MED J, V326, P1027, DOI 10.1136/bmj.326.7397.1027; Hamley S, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0254-5; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Hemmingsen B, 2011, BMJ, V343; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holub BJ, 2002, CAN MED ASSOC J, V166, P608; Hou L, 2015, INT J CLIN EXP MED, V8, P781; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Imoisi O. B., 2015, Journal of Applied Sciences and Environmental Management, V19, P127, DOI 10.4314/jasem.v19i1.17; Janssen V, 2013, EUR J PREV CARDIOL, V20, P620, DOI 10.1177/2047487312462824; Kabagambe EK, 2005, J NUTR, V135, P2674, DOI 10.1093/jn/135.11.2674; Kabagambe EK, 2003, EUR J CLIN NUTR, V57, P1447, DOI 10.1038/sj.ejcn.1601709; Kritchevsky D, 2002, ASIA PAC J CLIN NUTR, V11, pS393, DOI 10.1046/j.1440-6047.2001.00401.x; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Martinez-Ortiz JA, 2006, EUR J CLIN NUTR, V60, P770, DOI 10.1038/sj.ejcn.1602381; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mirmiran P, 2017, APPL PHYSIOL NUTR ME, V42, P326, DOI 10.1139/apnm-2016-0508; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Odia OJ, 2015, WORLD J CARDIOL, V7, P144, DOI 10.4330/wjc.v7.i3.144; PAGE IH, 1957, CIRCULATION, V16, P163, DOI 10.1161/01.CIR.16.2.163; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Peters SAE, 2013, STROKE, V44, P2821, DOI 10.1161/STROKEAHA.113.002342; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Sun Y, 2014, CIRC C AM HEART ASS, V129; Sun Y, 2015, J NUTR, V145, P1549, DOI 10.3945/jn.115.210575; Tse LA, 2012, PUBLIC HEALTH, V126, P960, DOI 10.1016/j.puhe.2012.07.010; USDA. United States Department od Agriculture, 2016, OILS WORLD MARK TRAD; Vallyathan Val, 2002, Antioxid Redox Signal, V4, P957, DOI 10.1089/152308602762197498; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang XY, 2015, NUTRIENTS, V7, P6582, DOI 10.3390/nu7085300	50	48	49	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193533	10.1371/journal.pone.0193533	http://dx.doi.org/10.1371/journal.pone.0193533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489910	gold, Green Submitted, Green Published			2022-12-27	WOS:000426276000087
J	Joshi, SS; Jiang, SL; Unni, E; Goding, SR; Fang, T; Antony, PA; Hornyak, TJ				Joshi, Sandeep S.; Jiang, Shunlin; Unni, Emmanuel; Goding, Stephen R.; Fang, Tao; Antony, Paul A.; Hornyak, Thomas J.			17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model	PLOS ONE			English	Article							CD4(+) T-CELLS; B-RAF; ESTABLISHED MELANOMA; SIGNALING PATHWAY; HSP90 INHIBITORS; HUMAN CANCER; WILD-TYPE; IN-VITRO; BRAF; PROTEIN	Heat shock protein 90 (HSP90) is a molecular chaperone which stabilizes client proteins with important roles in tumor growth. 17-allylamino-17-demethoxygeldanamycin (17-AAG), an inhibitor of HSP90 ATPase activity, occupies the ATP binding site of HSP90 causing a conformational change which destabilizes client proteins and directs them towards proteosomal degradation. Malignant melanomas have active RAF-MEK-ERK signaling which can occur either through an activating mutation in BRAF (BRAF(V600E)) or through activation of signal transduction upstream of BRAF. Prior work showed that 17-AAG inhibits cell growth in BRAF(V600E) and BRAF wildtype (BRAF(WT)) melanomas, although there were conflicting reports about the dependence of BRAF(V600E) and BRAF(WT) upon HSP90 activity for stability. Here, we demonstrate that BRAF(WT) and CRAF are bound by HSP90 in BRAF(WT), NRAS mutant melanoma cells. HSP90 inhibition by 17-AAG inhibits ERK signaling and cell growth by destabilizing CRAF but not BRAF(WT) in the majority of NRAS mutant melanoma cells. The highly-selective BRAF(V600E) inhibitor, PLX4032 (vemurafenib), inhibits ERK signaling and cell growth in mutant BRAF melanoma cells, but paradoxically enhances signaling in cells with wild-type BRAF. In our study, we examined whether 17-AAG could inhibit PLX4032-enhanced ERK signaling in BRAF(WT) melanoma cells. As expected, PLX4032 alone enhanced ERK signaling in the BRAF(WT) melanoma cell lines Mel-Juso, SK-Mel-2, and SK-Mel-30, and inhibited signaling and cell growth in BRAF(V600E) A375 cells. However, HSP90 inhibition by 17-AAG inhibited PLX4032-enhanced ERK signaling and inhibited cell growth by destabilizing CRAF. Surprisingly, 17-AAG also stimulated melanin production in SK-Mel-30 cells and enhanced TYRP1 and DCT expression without stimulating TYR production in all three BRAF(WT) cell lines studied as well as in B16F10 mouse melanoma cells. In vivo, the combination of 17-AAG and cellular immunotherapy directed against Tyrp1 enhanced the inhibition of tumor growth compared to either therapy alone. Our studies support a role for 17-AAG and HSP90 inhibition in enhancing cellular immunotherapy for melanoma.	[Joshi, Sandeep S.; Unni, Emmanuel; Hornyak, Thomas J.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Jiang, Shunlin; Fang, Tao; Hornyak, Thomas J.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Goding, Stephen R.; Antony, Paul A.; Hornyak, Thomas J.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Hornyak, Thomas J.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Hornyak, Thomas J.] VA Maryland Hlth Care Syst, Res & Dev Serv, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Hornyak, TJ (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.; Hornyak, TJ (corresponding author), NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Hornyak, TJ (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Hornyak, TJ (corresponding author), Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA.; Hornyak, TJ (corresponding author), VA Maryland Hlth Care Syst, Res & Dev Serv, Baltimore, MD USA.	thornyak@som.umaryland.edu			Intramural Research Program, Center for Cancer Research, NCI, NIH; NIH/NIAMS [R01 AR064810, RO1 AR064810]; US Department of Health and Human Services; United States Department of Veteran Affairs Biomedical Laboratory Research and Development Service [1 I01BX002582]	Intramural Research Program, Center for Cancer Research, NCI, NIH; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US Department of Health and Human Services; United States Department of Veteran Affairs Biomedical Laboratory Research and Development Service	This research was supported in part by the Intramural Research Program, Center for Cancer Research, NCI, NIH, and by NIH/NIAMS R01 AR064810. US Department of Health and Human Services and Merit Review Award 1 I01BX002582, United States Department of Veteran Affairs Biomedical Laboratory Research and Development Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the assistance of Oleg Chertov (Protein Chemistry Lab, SAIC-Frederick) for mass spectroscopic analysis of BRAF binding partners. We also acknowledge Len Neckers and Jane Trepel (CCR, NCI, NIH) for providing 17-AAG and for helpful discussions. This research was supported in part by the Intramural Research Program, Center for Cancer Research, NCI, NIH, and by NIH/NIAMS RO1 AR064810. US Department of Health and Human Services and Merit Review Award 1 I01BX002582, United States Department of Veteran Affairs Biomedical Laboratory Research and Development Service. The contents do not represent the views of US Department of Veteran Affairs, the US Department of Health and Human Services and the US government.	An WG, 2000, CELL GROWTH DIFFER, V11, P355; Babchia N, 2008, INVEST OPHTH VIS SCI, V49, P2348, DOI 10.1167/iovs.07-1305; Banerji U, 2008, MOL CANCER THER, V7, P737, DOI 10.1158/1535-7163.MCT-08-0145; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Basso AD, 2002, ONCOGENE, V21, P1159, DOI 10.1038/sj.onc.1205184; Burger AM, 2004, ANTI-CANCER DRUG, V15, P377, DOI 10.1097/00001813-200404000-00011; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Diwakar G, 2008, J CELL SCI, V121, P167, DOI 10.1242/jcs.013912; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Englaro W, 1998, J BIOL CHEM, V273, P9966, DOI 10.1074/jbc.273.16.9966; Fukuyo Y, 2008, CANCER RES, V68, P6324, DOI 10.1158/0008-5472.CAN-07-6602; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Goding SR, 2013, J IMMUNOL, V190, P4899, DOI 10.4049/jimmunol.1300271; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Hearing Vincent J, 2011, J Invest Dermatol, V131, pE8, DOI 10.1038/skinbio.2011.4; HEARING VJ, 1992, PIGM CELL RES, V5, P264, DOI 10.1111/j.1600-0749.1992.tb00547.x; Hingorani SR, 2003, CANCER RES, V63, P5198; Hu DN, 2008, PHOTOCHEM PHOTOBIOL, V84, P645, DOI 10.1111/j.1751-1097.2007.00228.x; Jaiswal RK, 1996, J BIOL CHEM, V271, P23626, DOI 10.1074/jbc.271.39.23626; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mbofung RM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00449-z; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Nissan MH, 2014, CANCER RES, V74, P2340, DOI 10.1158/0008-5472.CAN-13-2625; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pacey S, 2012, INVEST NEW DRUG, V30, P341, DOI 10.1007/s10637-010-9493-4; Paraiso KHT, 2012, CLIN CANCER RES, V18, P2502, DOI 10.1158/1078-0432.CCR-11-2612; Phadke M, 2015, J INVEST DERMATOL, V135, P2542, DOI 10.1038/jid.2015.205; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Schulte TW, 1997, BIOCHEM BIOPH RES CO, V239, P655, DOI 10.1006/bbrc.1997.7527; SEPPLORENZINO L, 1995, J BIOL CHEM, V270, P16580, DOI 10.1074/jbc.270.28.16580; Smith V, 2005, CANCER CHEMOTH PHARM, V56, P126, DOI 10.1007/s00280-004-0947-2; Smyth T, 2014, MOL CANCER THER, V13, P2793, DOI 10.1158/1535-7163.MCT-14-0452; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Su F, 2012, CANCER RES, V72, P969, DOI 10.1158/0008-5472.CAN-11-1875; TSUKAMOTO K, 1992, EMBO J, V11, P519, DOI 10.1002/j.1460-2075.1992.tb05082.x; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang RF, 1996, J EXP MED, V184, P2207, DOI 10.1084/jem.184.6.2207; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0191264	10.1371/journal.pone.0191264	http://dx.doi.org/10.1371/journal.pone.0191264			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481571	gold, Green Submitted, Green Published			2022-12-27	WOS:000426202700002
J	Basile, L; de la Fuente, MO; Torner, N; Martinez, A; Jane, M				Basile, Luca; Oviedo de la Fuente, Manuel; Torner, Nuria; Martinez, Ana; Jane, Mireia			Real-time predictive seasonal influenza model in Catalonia, Spain	PLOS ONE			English	Article							CONTROL STRATEGIES; EPIDEMIC	Influenza surveillance is critical to monitoring the situation during epidemic seasons and predictive mathematic models may aid the early detection of epidemic patterns. The objective of this study was to design a real-time spatial predictive model of ILI (Influenza Like Illness) incidence rate in Catalonia using one- and two-week forecasts. The available data sources used to select explanatory variables to include in the model were the statutory reporting disease system and the sentinel surveillance system in Catalonia for influenza incidence rates, the official climate service in Catalonia for meteorological data, laboratory data and Google Flu Trend. Time series for every explanatory variable with data from the last 4 seasons (from 2010-2011 to 2013-2014) was created. A pilot test was conducted during the 2014-2015 season to select the explanatory variables to be included in the model and the type of model to be applied. During the 2015-2016 season a real-time model was applied weekly, obtaining the intensity level and predicted incidence rates with 95% confidence levels one and two weeks away for each health region. At the end of the season, the confidence interval success rate (CISR) and intensity level success rate (ILSR) were analysed. For the 2015-2016 season a CISR of 85.3% at one week and 87.1% at two weeks and an ILSR of 82.9% and 82% were observed, respectively. The model described is a useful tool although it is hard to evaluate due to uncertainty. The accuracy of prediction at one and two weeks was above 80% globally, but was lower during the peak epidemic period. In order to improve the predictive power, new explanatory variables should be included.	[Basile, Luca; Torner, Nuria; Martinez, Ana; Jane, Mireia] Publ Hlth Agcy Catalonia, Barcelona, Spain; [Oviedo de la Fuente, Manuel] Technol Inst Ind Math ITMATI, Campus Vida, Santiago De Compostela, Spain; [Oviedo de la Fuente, Manuel] Univ Santiago de Compostela, Dept Stat Math Anal & Optimizat, MODESTYA Grp, Santiago De Compostela, Spain; [Torner, Nuria] Univ Barcelona Barcelona, Dept Med, Barcelona, Spain; [Torner, Nuria; Martinez, Ana; Jane, Mireia] Carlos III Hlth Inst, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Torner, N (corresponding author), Publ Hlth Agcy Catalonia, Barcelona, Spain.; Torner, N (corresponding author), Univ Barcelona Barcelona, Dept Med, Barcelona, Spain.; Torner, N (corresponding author), Carlos III Hlth Inst, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	nuria.torner@gencat.cat	, Nuria/AAG-8951-2019; de la Fuente, Manuel Oviedo/AAB-8040-2019	, Nuria/0000-0003-0143-5295; de la Fuente, Manuel Oviedo/0000-0001-7360-3249; Basile, Luca/0000-0002-4707-2621	GIBER epidemiologia y Salud Publica CIBERESP; Ministerio de Economia y Competitividad [MTM2016-76969-P]	GIBER epidemiologia y Salud Publica CIBERESP; Ministerio de Economia y Competitividad(Spanish Government)	This work was partially funded by GIBER epidemiologia y Salud Publica CIBERESP and Ministerio de Economia y Competitividad (grant number MTM2016-76969-P; recipient Manuel Oviedo de la Fuente).	Agencia de Salut PUblica de Catalunya, 2016, PLA INF INF RESP AG; Agencia de Salut Publica de Catalunya, 2017, MOD PRED ACT GRIP; Agencia de Salut PUblica de Catalunya, 2017, MAL DECL OBL BROTS E; Ajelli M, 2011, EPIDEMIOL INFECT, V139, P68, DOI 10.1017/S0950268810001317; Balcan D, P NATLACAD SCI US, V106, P21484; Bento AI, 2016, CLIN INFECT DIS, V63, pS205, DOI 10.1093/cid/ciw557; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Brauer F., 2012, MATH MODELS POPULATI, V2; Chatterjee C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004726; Chen SC, 2006, INDOOR AIR, V16, P469, DOI 10.1111/j.1600-0668.2006.00443.x; Dugas AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056176; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Goufo EF, 2014, FRACTIONAL SEIR EPID; Havers F, 2014, CLIN INFECT DIS, V59, P774, DOI 10.1093/cid/ciu422; Held L, BIOMJ, V54, P824; Hervas D, 2015, EUR J CLIN MICROBIOL, V34, P439, DOI 10.1007/s10096-014-2243-3; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908; Kariya T, 2004, GEN LEAST SQUARES; Legrand J, 2004, EPIDEMIOL INFECT, V132, P19, DOI 10.1017/S0950268803001390; Liccardo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063935; Martin R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-532; Martinez-Beneito MA, 2008, STAT MED, V27, P2874, DOI 10.1002/sim.3103; Meteocat, 2017, SERV MET CAT; Muller HG, 2005, ANN STAT, V33, P774, DOI 10.1214/009053604000001156; Nsoesie EO, 2014, INFLUENZA OTHER RESP, V8, P309, DOI 10.1111/irv.12226; Oviedo M, 2016, PREDICTING SEASONAL; Pica N, 2014, PEDIATR INFECT DIS J, V33, P311, DOI 10.1097/INF.0000000000000235; Pinheiro J, 2001, MIXED EFFECTS MODELS; Roberts MG, 2000, EPIDEMIOL INFECT, V124, P279, DOI 10.1017/S0950268899003556; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Team Rs, 2017, RSTUDIO INT DEV R; Torner N, 2015, HUM VACC IMMUNOTHER, V11, P225, DOI 10.4161/hv.36155; Van Der Zander B, 2009, TEXSTUDIO; Vega T, 2013, INFLUENZA OTHER RESP, V7, P546, DOI 10.1111/j.1750-2659.2012.00422.x; Yang S, P NATL ACAD SCI US, V112, P14473; Yang W, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003583; Yu Hye-Kyung, 2013, Osong Public Health Res Perspect, V4, P358, DOI 10.1016/j.phrp.2013.10.009	39	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193651	10.1371/journal.pone.0193651	http://dx.doi.org/10.1371/journal.pone.0193651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513710	Green Submitted, gold, Green Published			2022-12-27	WOS:000426896800067
J	Dugas, M; Crowley, K; Gao, GG; Xu, T; Agarwal, R; Kruglanski, AW; Steinle, N				Dugas, Michelle; Crowley, Kenyon; Gao, Guodong Gordon; Xu, Timothy; Agarwal, Ritu; Kruglanski, Arie W.; Steinle, Nanette			Individual differences in regulatory mode moderate the effectiveness of a pilot mHealth trial for diabetes management among older veterans	PLOS ONE			English	Article							SELF-MANAGEMENT; WEIGHT-LOSS; MOBILE APPLICATIONS; LOCOMOTION; DISEASE; ORIENTATIONS; PSYCHOLOGY; TIME; CARE; INTERVENTION	mHealth tools to help people manage chronic illnesses have surged in popularity, but evidence of their effectiveness remains mixed. The aim of this study was to address a gap in the mHealth and health psychology literatures by investigating how individual differences in psychological traits are associated with mHealth effectiveness. Drawing from regulatory mode theory, we tested the role of locomotion and assessment in explaining why mHealth tools are effective for some but not everyone. A 13-week pilot study investigated the effectiveness of an mHealth app in improving health behaviors among older veterans (n = 27) with poorly controlled Type 2 diabetes. We developed a gamified mHealth tool (DiaSocial) aimed at encouraging tracking of glucose control, exercise, nutrition, and medication adherence. Important individual differences in longitudinal trends of adherence, operationalized as points earned for healthy behavior, over the course of the 13-week study period were found. Specifically, low locomotion was associated with unchanging levels of adherence during the course of the study. In contrast, high locomotion was associated with generally stronger adherence although it exhibited a quadratic longitudinal trend. In addition, high assessment was associated with a marginal, positive trend in adherence over time while low assessment was associated with a marginal, negative trend. Next, we examined the relationship between greater adherence and improved clinical outcomes, finding that greater adherence was associated with greater reductions in glycated hemoglobin (HbA1c) levels. Findings from the pilot study suggest that mHealth technologies can help older adults improve their diabetes management, but a "one size fits all" approach may yield suboptimal outcomes.	[Dugas, Michelle; Kruglanski, Arie W.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Dugas, Michelle; Crowley, Kenyon; Gao, Guodong Gordon; Agarwal, Ritu] Univ Maryland, Robert H Smith Sch Business, Ctr Hlth Informat & Decis Syst, College Pk, MD 20742 USA; [Crowley, Kenyon] Univ Maryland, Coll Informat Studies, College Pk, MD 20742 USA; [Gao, Guodong Gordon; Agarwal, Ritu] Univ Maryland, Decis Operat & Informat Technol, Robert H Smith Sch Business, College Pk, MD 20742 USA; [Xu, Timothy] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Steinle, Nanette] Maryland Vet Adm Hlth Care Ctr, Baltimore, MD USA; [Steinle, Nanette] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Emory University; University System of Maryland; University of Maryland Baltimore	Dugas, M (corresponding author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.; Dugas, M (corresponding author), Univ Maryland, Robert H Smith Sch Business, Ctr Hlth Informat & Decis Syst, College Pk, MD 20742 USA.	mdugas@rhsmith.umd.edu	Gao, Guodong/HCH-4969-2022	Gao, Guodong/0000-0002-2336-9682; Dugas, Michelle/0000-0003-1400-4515	Dr. Theo and Friedl Scholler Research Center for Business and Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER	Dr. Theo and Friedl Scholler Research Center for Business and Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported in part by funding from the Dr. Theo and Friedl Scholler Research Center for Business and Society.	AARP: Project Catalyst, 2015, BUILD BETT TRACK OLD; Ahola AJ, 2013, DIABETIC MED, V30, P413, DOI 10.1111/dme.12105; Amato C, 2014, INT J PSYCHOL, V49, P192, DOI 10.1002/ijop.12047; Anderson K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156164; Archer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076632; Avnet T, 2003, J EXP SOC PSYCHOL, V39, P525, DOI 10.1016/S0022-1031(03)00027-1; Azar KMJ, 2013, AM J PREV MED, V45, P583, DOI 10.1016/j.amepre.2013.07.005; Barnes CS, 2004, DIABETES EDUCATOR, V30, P126, DOI 10.1177/014572170403000120; Becker S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116980; Borrelli B, 2015, HEALTH PSYCHOL, V34, P1205, DOI 10.1037/hea0000323; Bourgeois FT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155948; Burke LE, 2011, OBESITY, V19, P338, DOI 10.1038/oby.2010.208; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Centers for Disease Control, 2020, NATL DIABETES STAT R; Cole-Lewis H, 2010, EPIDEMIOL REV, V32, P56, DOI 10.1093/epirev/mxq004; Crane D, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4060; De Carlo NA, 2014, J APPL SOC PSYCHOL, V44, P725, DOI 10.1111/jasp.12263; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Gandapur Y, 2016, EUR HEART J-QUAL CAR, V2, P237, DOI 10.1093/ehjqcco/qcw018; Guerci B, 2003, DIABETES METAB, V29, P587, DOI 10.1016/S1262-3636(07)70073-3; Hamine Saee, 2015, J Med Internet Res, V17, pe52, DOI 10.2196/jmir.3951; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Higgins ET, 2003, ADV EXP SOC PSYCHOL, V35, P293, DOI 10.1016/S0065-2601(03)01005-0; Hood M, 2016, J BEHAV MED, V39, P981, DOI 10.1007/s10865-016-9765-3; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; Jackson SL, 2015, LANCET DIABETES ENDO, V3, P173, DOI 10.1016/S2213-8587(14)70267-0; Jerant AF, 2005, PATIENT EDUC COUNS, V57, P300, DOI 10.1016/j.pec.2004.08.004; Kaplan RM, 2013, ANNU REV PSYCHOL, V64, P471, DOI 10.1146/annurev-psych-113011-143736; Katz R, 2012, J HEALTH COMMUN, V17, P67, DOI 10.1080/10810730.2012.650613; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Klein WMP, 2015, PERS SOC PSYCHOL REV, V19, P77, DOI 10.1177/1088868314539852; Klein WMP, 2013, HEALTH PSYCHOL, V32, P457, DOI 10.1037/a0032386; Kruglanski AW, 2013, SOC PERSONAL PSYCHOL, V7, P79, DOI 10.1111/spc3.12015; Kruglanski AW, 2000, J PERS SOC PSYCHOL, V79, P793, DOI 10.1037/0022-3514.79.5.793; Liang X, 2011, DIABETIC MED, V28, P455, DOI 10.1111/j.1464-5491.2010.03180.x; McMahon SK, 2016, JMIR MHEALTH UHEALTH, V4, P594, DOI 10.2196/mhealth.5120; Miller AS, 2016, HEALTH INFORM J, V22, P184, DOI 10.1177/1460458214537511; Monnier L, 2016, REV ENDOCR METAB DIS, V17, P91, DOI 10.1007/s11154-016-9325-8; Ong SW, 2016, CLIN J AM SOC NEPHRO, V11, P1054, DOI 10.2215/CJN.10681015; Orehek E, 2012, J PERS SOC PSYCHOL, V102, P22, DOI 10.1037/a0025881; Panno A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143147; Peugh J. L, 2005, EDUC PSYCHOL MEAS, V65, P717, DOI DOI 10.1177/0013164405278558; Pew Research Center, 2014, OLDER ADULTS TECHNOL; Pierro A, 2008, J EXP SOC PSYCHOL, V44, P321, DOI 10.1016/j.jesp.2007.06.002; Pierro A, 2013, MOTIV EMOTION, V37, P213, DOI 10.1007/s11031-012-9300-y; Pierro A, 2011, J PERS SOC PSYCHOL, V101, P1317, DOI 10.1037/a0025943; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Quinn CC, 2008, DIABETES TECHNOL THE, V10, P160, DOI 10.1089/dia.2008.0283; Rothman AJ, 2012, OXFORD HDB PERSONALI, P729; Selim AJ, 2004, J AM GERIATR SOC, V52, P1271, DOI 10.1111/j.1532-5415.2004.52355.x; Tatara N, 2013, JMIR MHEALTH UHEALTH, V1, DOI 10.2196/mhealth.2432; Vigersky Robert A, 2011, J Diabetes Sci Technol, V5, P245; Wayne N, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3180; Zhang SL, 2015, SOC INDIC RES, V123, P585, DOI 10.1007/s11205-014-0742-3	55	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192807	10.1371/journal.pone.0192807	http://dx.doi.org/10.1371/journal.pone.0192807			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513683	gold, Green Published			2022-12-27	WOS:000426896800022
J	Epstein, D; Berger, G; Barda, N; Marcusohn, E; Barak-Corren, Y; Muhsen, K; Balicer, RD; Azzam, ZS				Epstein, Danny; Berger, Gidon; Barda, Noam; Marcusohn, Erez; Barak-Corren, Yuval; Muhsen, Khitam; Balicer, Ran D.; Azzam, Zaher S.			The incidence of acute pulmonary embolism following syncope in anticoagulant-naive patients: A retrospective cohort study	PLOS ONE			English	Article							POPULATION-BASED-COHORT; VENOUS THROMBOEMBOLISM; EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; DIAGNOSIS; MANAGEMENT; PREDICTORS; OUTCOMES; CT	Background A recently published, large prospective study showed unexpectedly high prevalence of acute pulmonary embolism (APE) among patients hospitalized for syncope. In such a case, a high incidence of recurrent pulmonary embolism is expected among patients who were discharged without APE workup. Objectives To determine the incidence of symptomatic APE among patients hospitalized for a first episode of syncope and discharged without APE workup or anticoagulation. Methods This retrospective cohort study included patients hospitalized at Rambam Health Care Campus between January 2006 and February 2017 with a primary admission diagnosis of syncope, who were not investigated for APE and were not taking anticoagulants. The patients were followed up for up to three years after discharge. The occurrence of venous thromboembolism (VTE) during the follow-up period was documented. Results The median follow-up duration was 33 months. 1,126 subjects completed a three-year follow-up. During this period, 38 patients (3.38%) developed VTE, 17 (1.51%) of them had APE. The cumulative incidence of VTE and APE was 1.9% (95% CI 1.3%-2.5%) and 0.9% (95% CI 0.4%-1.3%) respectively. Only seven subjects developed APE during the first year of follow-up. The median times from the event of syncope to the development of APE and VTE were 18 and 19 months respectively. Conclusions The cumulative incidence of VTE during a three-year follow-up period after an episode of syncope is low. In the absence of clinical suspicion, a routine diagnostic workup for APE in patients with syncope cannot be recommended.	[Epstein, Danny; Berger, Gidon; Marcusohn, Erez; Azzam, Zaher S.] Dept Internal Med B, Rambam Hlth Care Campus, Haifa, Israel; [Berger, Gidon] Div Pulm Med, Rambam Hlth Care Campus, Haifa, Israel; [Barda, Noam; Balicer, Ran D.] Clalit Res Inst, Chief Phys Off, Clalit Hlth Serv, Tel Aviv, Israel; [Barak-Corren, Yuval] Boston Childrens Hosp, Predict Med Grp, Boston, MA USA; [Barak-Corren, Yuval] Shaare Tzedek Med Ctr, Jerusalem, Israel; [Muhsen, Khitam] Tel Aviv Univ, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Sackler Fac Med, Tel Aviv, Israel; [Balicer, Ran D.] Ben Gurion Univ Negev, Epidemiol Dept, Beer Sheva, Israel; [Azzam, Zaher S.] Technion Inst, Rappaports Fac Med, Haifa, Israel	Rambam Health Care Campus; Rambam Health Care Campus; Clalit Health Services; Harvard University; Boston Children's Hospital; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Technion Israel Institute of Technology	Epstein, D (corresponding author), Dept Internal Med B, Rambam Hlth Care Campus, Haifa, Israel.	danyep@gmail.com	Barda, Noam/AAC-9434-2020	Barda, Noam/0000-0002-3400-235X; Marcusohn, Erez/0000-0003-1004-0826				Altinsoy B, 2016, THER CLIN RISK MANAG, V12, P1023, DOI 10.2147/TCRM.S105722; BARRITT DW, 1960, LANCET, V1, P1309; Costantino G, 2018, JAMA INT MED; D'Ascenzo F, 2013, INT J CARDIOL, V167, P57, DOI 10.1016/j.ijcard.2011.11.083; DAGAN N, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.I6755; Desai SR, 2007, THORAX, V62, P470, DOI 10.1136/thx.2006.067884; Engelke C, 2006, RADIOLOGY, V239, P563, DOI 10.1148/radiol.2392050118; Gandhi R, 2012, J ARTHROPLASTY, V27, P730, DOI 10.1016/j.arth.2011.10.019; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Heit JA, 2012, AM J HEMATOL, V87, pS63, DOI 10.1002/ajh.23128; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Martinez C, 2014, THROMB HAEMOSTASIS, V112, P255, DOI 10.1160/TH13-09-0793; O'Connell C, 2015, BLOOD, V125, P1877, DOI 10.1182/blood-2014-08-551879; Pollack CV, 2011, J AM COLL CARDIOL, V57, P700, DOI 10.1016/j.jacc.2010.05.071; Prandoni P, 2016, NEW ENGL J MED, V375, P1524, DOI 10.1056/NEJMoa1602172; Raskob GE, 2016, THROMB HAEMOSTASIS, V115, P1; Runser LA, 2017, AM FAM PHYSICIAN, V95, P303; Ruwald MH, 2013, EUROPACE, V15, P595, DOI 10.1093/europace/eus359; Saklani P, 2013, CIRCULATION, V127, P1330, DOI 10.1161/CIRCULATIONAHA.112.138396; Shen W-K, 2017, HEAR RHYTHM, V8, P122; Solbiati M, 2015, EUROPACE, V17, P300, DOI 10.1093/europace/euu327; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Spyropoulos AC, 2009, THROMB HAEMOSTASIS, V102, P951, DOI 10.1160/TH09-02-0073; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; THAMES MD, 1977, JAMA-J AM MED ASSOC, V238, P2509, DOI 10.1001/jama.238.23.2509; Verma A, 2017, JAMA INTERN MED, V15, P595; Wiener RS, 2011, ARCH INTERN MED, V171, P1827; Yusuf Hussain R., 2012, Morbidity and Mortality Weekly Report, V61, P401	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193725	10.1371/journal.pone.0193725	http://dx.doi.org/10.1371/journal.pone.0193725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513729	gold, Green Published, Green Submitted			2022-12-27	WOS:000426896800072
J	Huang, J; Wei, HL; Li, LB; Yu, SX				Huang, Juan; Wei, Hengling; Li, Libei; Yu, Shuxun			Transcriptome analysis of nitric oxide-responsive genes in upland cotton (Gossypium hirsutum)	PLOS ONE			English	Article							ABIOTIC STRESS; CELL-DEATH; ARABIDOPSIS; ACID; ACCUMULATION; IDENTIFICATION; EXPRESSION; GENERATION; PATHWAYS; PATHOGEN	Nitric oxide (NO) is an important signaling molecule with diverse physiological functions in plants. It is therefore important to characterize the downstream genes and signal transduction networks modulated by NO. Here, we identified 1,932 differentially expressed genes (DEGs) responding to NO in upland cotton using high throughput tag sequencing. The results of quantitative real-time polymerase chain reaction (qRT-PCR) analysis of 25 DEGs showed good consistency. Gene Ontology (GO) and KEGG pathway were analyzed to gain a better understanding of these DEGs. We identified 157 DEGs belonging to 36 transcription factor (TF) families and 72 DEGs related to eight plant hormones, among which several TF families and hormones were involved in stress responses. Hydrogen peroxide and malondialdehyde (MDA) contents were increased, as well related genes after treatment with sodium nitroprusside (SNP) (an NO donor), suggesting a role for NO in the plant stress response. Finally, we compared of the current and previous data indicating a massive number of NO-responsive genes at the large-scale transcriptome level. This study evaluated the landscape of NO-responsive genes in cotton and identified the involvement of NO in the stress response. Some of the identified DEGs represent good candidates for further functional analysis in cotton.	[Huang, Juan] Guizhou Normal Univ, Res Ctr Buckwheat Ind Technol, Guiyang, Guizhou, Peoples R China; [Huang, Juan; Wei, Hengling; Li, Libei; Yu, Shuxun] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Guizhou Normal University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yu, SX (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	yu@cricaas.com.cn		Li, Libei/0000-0003-1138-134X	National Natural Science Foundation of China [31301366]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is financially supported by the National Natural Science Foundation of China (grant 31301366), http://www.nsfc.gov.cn/.r This research was financially supported by the National Natural Science Foundation of China (grant 31301366).	Ahlfors R, 2009, PLANT J, V58, P1, DOI 10.1111/j.1365-313X.2008.03756.x; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; Begara-Morales JC, 2014, PLANT CELL PHYSIOL, V55, P1080, DOI 10.1093/pcp/pcu044; Besson-Bard A, 2009, PLANT PHYSIOL, V149, P1302, DOI 10.1104/pp.108.133348; Besson-Bard A, 2009, PLANT SCI, V177, P302, DOI 10.1016/j.plantsci.2009.06.006; Chen J, 2007, J ENVIRON SCI, V19, P44, DOI 10.1016/S1001-0742(07)60007-2; Chen WW, 2010, PLANT PHYSIOL, V154, P810, DOI 10.1104/pp.110.161109; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Desikan R, 2002, P NATL ACAD SCI USA, V99, P16314, DOI 10.1073/pnas.252461999; Ferrarini A, 2008, MOL PLANT MICROBE IN, V21, P781, DOI 10.1094/MPMI-21-6-0781; Garcia MJ, 2011, PLANT PHYSIOL BIOCH, V49, P537, DOI 10.1016/j.plaphy.2011.01.019; Garcia-Mata C, 2007, NITRIC OXIDE-BIOL CH, V17, P143, DOI 10.1016/j.niox.2007.08.001; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hu XQ, 2015, INT J MOL SCI, V16, P28582, DOI 10.3390/ijms161226117; Hussain A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00975; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Liu WW, 2015, BIOL PLANTARUM, V59, P115, DOI 10.1007/s10535-014-0466-x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manjunatha G, 2012, PLANT SIGNAL BEHAV, V7, P476, DOI 10.4161/psb.19523; Meng YY, 2011, J PROTEOME RES, V10, P5416, DOI 10.1021/pr200671d; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Murgia I, 2002, PLANT J, V30, P521, DOI 10.1046/j.1365-313X.2002.01312.x; Niu YH, 2012, J INTEGR PLANT BIOL, V54, P516, DOI 10.1111/j.1744-7909.2012.01140.x; Ohama N, 2016, PLANT CELL, V28, P181, DOI 10.1105/tpc.15.00435; Palmieri MC, 2008, J EXP BOT, V59, P177, DOI 10.1093/jxb/erm345; Parani M, 2004, PLANT BIOTECHNOL J, V2, P359, DOI 10.1111/j.1467-7652.2004.00085.x; Perezrodriguez P, 2010, NUCLEIC ACIDS RES, P38; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Polverari A, 2003, MOL PLANT MICROBE IN, V16, P1094, DOI 10.1094/MPMI.2003.16.12.1094; Roy S, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1117723; Shao HB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00902; Simontacchi M, 2013, PLANT CELL REP, V32, P853, DOI 10.1007/s00299-013-1434-1; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Tewari RK, 2012, PLANTA, V235, P99, DOI 10.1007/s00425-011-1495-8; Van Ree K, 2011, PLANT J, V68, P225, DOI 10.1111/j.1365-313X.2011.04680.x; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie YJ, 2008, PLANT CELL ENVIRON, V31, P1864, DOI 10.1111/j.1365-3040.2008.01888.x; Xie ZD, 2010, PLANT J, V64, P731, DOI 10.1111/j.1365-313X.2010.04364.x; Xuan Y, 2010, PLANT PHYSIOL, V153, P1895, DOI 10.1104/pp.110.160424; Zago E, 2006, PLANT PHYSIOL, V141, P404, DOI 10.1104/pp.106.078444; Zeier J, 2004, PLANT PHYSIOL, V136, P2875, DOI 10.1104/pp.104.042499; Zeng F, 2014, PLOS ONE, V9; Zhang HY, 2011, PLANT CELL REP, V30, P1153, DOI 10.1007/s00299-011-1024-z; Zhu SH, 2007, FOOD CHEM, V100, P1517, DOI 10.1016/j.foodchem.2005.12.022	49	15	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192367	10.1371/journal.pone.0192367	http://dx.doi.org/10.1371/journal.pone.0192367			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513679	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800013
J	Moreira, TF; Facury, EJ; Carvalho, AU; Strube, ML; Nielsen, MW; Klitgaard, K; Jensen, TK				Moreira, Tiago F.; Facury Filho, Elias J.; Carvalho, Antonio U.; Strube, Mikael L.; Nielsen, Martin W.; Klitgaard, Kirstine; Jensen, Tim K.			Pathology and bacteria related to digital dermatitis in dairy cattle in all year round grazing system in Brazil	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; DICHELOBACTER-NODOSUS; GUGGENHEIMELLA-BOVIS; TREPONEMA SPP.; FOOT DISORDERS; RIBOSOMAL-RNA; LESIONS; COWS; RESERVOIRS; INFECTION	Digital dermatitis (DD) is one of the main causes of lameness in dairy cattle worldwide, and it is frequently reported in high-yielding, free stall dairy herds from regions with a temperate climate. However, DD is also observed with high prevalence in grazing cattle with a low milk yield in tropical regions. To clarify whether these differences have an impact on the etiology of the disease, we studied DD lesions from all year round grazing cattle of mixed breed in Brazil using high-throughput 16S rRNA gene sequencing and fluorescent in situ hybridization. The study included samples from 66 skin lesions and 5 healthy skins collected from five farms. Both techniques showed Treponema spp. to be the most abundant bacteria, present in all but one of the samples with minimal epidermal alterations. We identified eleven different Treponema strains belonging to the six major phylotypes of Treponema which have all previously been identified in DD lesions. Furthermore, we identify Dichelobacter nodosus in DD lesions by gene sequencing and also by fluorescent in situ hybridization in almost half of biopsy specimens in areas with mild epithelial damage and together with Treponema. The present data support the hypothesis that Treponema constitutes the main pathogen responsible for DD, independent of the environment and region where cows are kept, and it further suggests D. nodosus as another potentially important pathogen.	[Moreira, Tiago F.; Facury Filho, Elias J.; Carvalho, Antonio U.] Univ Fed Minas Gerais, Sch Vet Med, Dept Vet Clin & Surg, Belo Horizonte, MG, Brazil; [Strube, Mikael L.; Nielsen, Martin W.; Klitgaard, Kirstine; Jensen, Tim K.] Tech Univ Denmark, Natl Vet Inst, Copenhagen, Denmark	Universidade Federal de Minas Gerais; Technical University of Denmark	Moreira, TF (corresponding author), Univ Fed Minas Gerais, Sch Vet Med, Dept Vet Clin & Surg, Belo Horizonte, MG, Brazil.	tiagofacuryvet@gmail.com	Strube, Mikael/G-7949-2016; Moreira, Tiago/AAK-4190-2020	Strube, Mikael/0000-0003-0905-5705; Klitgaard, Kirstine/0000-0002-8379-9430; Moreira, Tiago Facury/0000-0002-0808-1955; Jensen, Tim Kare/0000-0002-8048-4695				Berry SL, 2012, VET J, V193, P654, DOI 10.1016/j.tvjl.2012.06.048; Borges J, 1992, ARQU ARQ ESC MED VET, V1992, P15; Bruijnis MRN, 2012, ANIMAL, V6, P962, DOI 10.1017/S1751731111002606; Capion N., 2013, Open Journal of Veterinary Medicine, V3, P192, DOI 10.4236/ojvm.2013.32030; Cruz CEF, 2005, VET REC, V157, P834, DOI 10.1136/vr.157.26.834; Dopfer D, 1997, VET REC, V140, P620, DOI 10.1136/vr.140.24.620; Evans NJ, 2016, VET J, V211, P3, DOI 10.1016/j.tvjl.2015.10.028; Evans NJ, 2008, VET MICROBIOL, V130, P141, DOI 10.1016/j.vetmic.2007.12.019; Evans NJ, 2012, VET MICROBIOL, V156, P102, DOI 10.1016/j.vetmic.2011.09.029; Haskell MJ, 2006, J DAIRY SCI, V89, P4259, DOI 10.3168/jds.S0022-0302(06)72472-9; Klitgaard K, 2008, J CLIN MICROBIOL, V46, P3012, DOI 10.1128/JCM.00670-08; Klitgaard K, 2014, APPL ENVIRON MICROB, V80, P4427, DOI 10.1128/AEM.00873-14; Klitgaard K, 2013, J CLIN MICROBIOL, V51, P2212, DOI 10.1128/JCM.00320-13; Krull AC, 2014, INFECT IMMUN, V82, P3359, DOI 10.1128/IAI.02077-14; Marcatili P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3341-7; Moreira T. F., 2012, P 27 WORLD BUIATR C, P265; Nascimento LV, 2015, J CLIN MICROBIOL, V53, P1935, DOI 10.1128/JCM.03586-14; Nielsen MW, 2016, VET MICROBIOL, V186, P139, DOI 10.1016/j.vetmic.2016.03.003; Palmer MA, 2015, ANIMALS, V5, P512, DOI 10.3390/ani5030369; Rasmussen M, 2012, VET MICROBIOL, V160, P151, DOI 10.1016/j.vetmic.2012.05.018; Schlafer S, 2008, VET MICROBIOL, V128, P118, DOI 10.1016/j.vetmic.2007.09.024; Silveira JAS, 2009, PESQUI VET BRASIL, V29, P905, DOI 10.1590/S0100-736X2009001100007; Sullivan LE, 2015, J CLIN MICROBIOL, V53, P1628, DOI 10.1128/JCM.00180-15; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; Wyss C, 2005, INT J SYST EVOL MICR, V55, P667, DOI 10.1099/ijs.0.63116-0; Yano T, 2010, VET MICROBIOL, V143, P352, DOI 10.1016/j.vetmic.2009.12.009; Zinicola M, 2015, PLOS ONE, V10, P1	27	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193870	10.1371/journal.pone.0193870	http://dx.doi.org/10.1371/journal.pone.0193870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513739	gold, Green Published, Green Submitted			2022-12-27	WOS:000426896800084
J	Ogawa-Akiyama, A; Sugiyama, H; Kitagawa, M; Tanaka, K; Onishi, A; Yamanari, T; Morinaga, H; Uchida, HA; Nakamura, K; Ito, H; Wade, J				Ogawa-Akiyama, Ayu; Sugiyama, Hitoshi; Kitagawa, Masashi; Tanaka, Keiko; Onishi, Akifumi; Yamanari, Toshio; Morinaga, Hiroshi; Uchida, Haruhito Adam; Nakamura, Kazufumi; Ito, Hiroshi; Wade, Jun			Serum cystatin C is an independent biomarker associated with the renal resistive index in patients with chronic kidney disease	PLOS ONE			English	Article							DOPPLER ULTRASONOGRAPHY; VASCULAR DAMAGE; CARDIOVASCULAR EVENTS; HEART-FAILURE; ATHEROSCLEROSIS; ULTRASOUND; NEPHROPATHY; MARKER; RISK; HYPERTENSION	Cystatin C is a cysteine protease inhibitor that is produced by nearly all human cells. The serum level of cystatin C is a stronger predictor of the renal outcome and the risk of cardiovascular events than the creatinine level. The resistive index (RI) on renal Doppler ultrasonography is a good indicator of vascular resistance as well as the renal outcomes in patients with chronic kidney disease (CKD). However, it is unclear whether serum cystatin C is associated with signs of vascular dysfunction, such as the renal RI. We measured the serum cystatin C levels in 101 CKD patients and investigated the relationships between cystatin C and markers of vascular dysfunction, including the renal RI, ankle-brachial pulse wave velocity (baPWV), intima-media thickness (IMT), and cardiac function. The renal RI was significantly correlated with the serum cystatin C level (p < 0.0001, r = 0.6920). The serum cystatin C level was found to be a significant determinant of the renal RI (p < 0.0001), but not the baPWV, in a multivariate regression analysis. The multivariate odds ratio of the serum cystatin C level for a renal RI of more than 0.66 was statistically significant (2.92, p = 0.0106). The area under the receiver-operating characteristic curve comparing the sensitivity and specificity of cystatin C for predicting an RI of more than 0.66 was 0.882 (cutoff value: 2.04 mg/L). In conclusion, the serum cystatin C level is an independent biomarker associated with the renal RI in patients with CKD.	[Ogawa-Akiyama, Ayu; Sugiyama, Hitoshi; Kitagawa, Masashi; Tanaka, Keiko; Onishi, Akifumi; Yamanari, Toshio; Morinaga, Hiroshi; Uchida, Haruhito Adam; Wade, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Sugiyama, Hitoshi; Onishi, Akifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Resource Dev Dialysis Therapy Kidney D, Okayama, Japan; [Uchida, Haruhito Adam] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Chron Kidney Dis & Cardiovasc Dis, Okayama, Japan; [Nakamura, Kazufumi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan	Okayama University; Okayama University; Okayama University; Okayama University	Sugiyama, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan.; Sugiyama, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Resource Dev Dialysis Therapy Kidney D, Okayama, Japan.	hitashis@md.okayama-u.ac.jp	Sugiyama, Hitoshi/B-2252-2011; WADA, Jun/B-2023-2011	Sugiyama, Hitoshi/0000-0002-4127-6471; WADA, Jun/0000-0003-1468-5170				Bige N, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-139; Boddi M, 2006, AM J NEPHROL, V26, P16, DOI 10.1159/000090786; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Delsart P, 2015, J ENDOVASC THER, V22, P801, DOI 10.1177/1526602815599964; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Doi Y, 2012, HYPERTENSION, V60, P770, DOI 10.1161/HYPERTENSIONAHA.112.196717; Hamano K, 2008, DIABETES CARE, V31, P1853, DOI 10.2337/dc08-0168; HANDA N, 1990, STROKE, V21, P1567, DOI 10.1161/01.STR.21.11.1567; Heine GH, 2007, NEPHROL DIAL TRANSPL, V22, P163, DOI 10.1093/ndt/gfl484; Iida N, 2016, JACC-HEART FAIL, V4, P674, DOI 10.1016/j.jchf.2016.03.016; Ikee R, 2005, AM J KIDNEY DIS, V46, P603, DOI 10.1053/j.ajkd.2005.06.006; Ix JH, 2007, CIRCULATION, V115, P173, DOI 10.1161/CIRCULATIONAHA.106.644286; Izumi M, 2000, AM J KIDNEY DIS, V35, P713, DOI 10.1016/S0272-6386(00)70020-5; Kawai T, 2011, NEPHROL DIAL TRANSPL, V26, P3256, DOI 10.1093/ndt/gfr054; Kimura N, 2015, CLIN EXP NEPHROL; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; Kitagawa M, 2011, NEPHRON EXTRA, V1, P166, DOI 10.1159/000333801; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Menon V, 2007, ANN INTERN MED, V147, P19, DOI 10.7326/0003-4819-147-1-200707030-00004; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nakamura A, 2005, DIABETES CARE, V28, P2890, DOI 10.2337/diacare.28.12.2890; Nosaka Kazumasa, 2013, Congest Heart Fail, V19, pE35, DOI 10.1111/chf.12039; Odden MC, 2010, NEPHROL DIAL TRANSPL, V25, P463, DOI 10.1093/ndt/gfp474; Ohta Y, 2005, J HYPERTENS, V23, P1905, DOI 10.1097/01.hjh.0000181323.44162.01; Parolini C, 2009, RADIOLOGY, V252, P888, DOI 10.1148/radiol.2523080351; Petersen LJ, 1997, NEPHROL DIAL TRANSPL, V12, P1376, DOI 10.1093/ndt/12.7.1376; PLANIOL T, 1974, REV EEG NEUROPHYSIOL, V4, P221, DOI 10.1016/S0370-4475(74)80006-7; Prats M, 2010, BLOOD PRESSURE, V19, P20, DOI 10.3109/08037050903416386; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak MG, 2006, CURR OPIN NEPHROL HY, V15, P270, DOI 10.1097/01.mnh.0000222694.07336.92; Sugiura T, 2004, CLIN NEPHROL, V61, P119; Sugiura T, 2011, CLIN EXP NEPHROL, V15, P114, DOI 10.1007/s10157-010-0371-3; Sugiura T, 2009, NEPHROL DIAL TRANSPL, V24, P2780, DOI 10.1093/ndt/gfp121; Toledo C, 2015, HYPERTENSION, V66, P382, DOI 10.1161/HYPERTENSIONAHA.115.05536; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Yamashita H, 2013, J ATHEROSCLER THROMB, V20, P548, DOI 10.5551/jat.13193; Yuksel UC, 2012, J INVASIVE CARDIOL, V24, P504; 2004, AM J KIDNEY DIS S1, V43, pS1	41	12	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193695	10.1371/journal.pone.0193695	http://dx.doi.org/10.1371/journal.pone.0193695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513723	gold, Green Published, Green Submitted			2022-12-27	WOS:000426896800069
J	Ghosh, S; Chisholm, SA; Dans, M; Lakkavaram, A; Kennedy, K; Ralph, SA; Counihan, NA; de Koning-Ward, TF				Ghosh, Sreejoyee; Chisholm, Scott A.; Dans, Madeline; Lakkavaram, Asha; Kennedy, Kit; Ralph, Stuart A.; Counihan, Natalie A.; de Koning-Ward, Tania F.			The cysteine protease dipeptidyl aminopeptidase 3 does not contribute to egress of Plasmodium falciparum from host red blood cells	PLOS ONE			English	Article							MALARIA PARASITE; IDENTIFICATION; LOCALIZATION; RHOPTRIES; INVASION; RUPTURE; ANTIGEN; PLAYS	The ability of Plasmodium parasites to egress from their host red blood cell is critical for the amplification of these parasites in the blood. Previous forward chemical genetic approaches have implicated the subtilisin-like protease (SUB1) and the cysteine protease dipeptidyl aminopeptidase 3 (DPAP3) as key players in egress, with the final step of SUB1 maturation thought to be due to the activity of DPAP3. In this study, we have utilized a reverse genetics approach to engineer transgenic Plasmodium falciparum parasites in which dpap3 expression can be conditionally regulated using the glmS ribozyme based RNA-degrading system. We show that DPAP3, which is expressed in schizont stages and merozoites and localizes to organelles distinct from the micronemes, rhoptries and dense granules, is not required for the trafficking of apical proteins or processing of SUB1 substrates, nor for parasite maturation and egress from red blood cells. Thus, our findings argue against a role for DPAP3 in parasite egress and indicate that the phenotypes observed with DPAP3 inhibitors are due to off-target effects.	[Ghosh, Sreejoyee; Chisholm, Scott A.; Dans, Madeline; Lakkavaram, Asha; Counihan, Natalie A.; de Koning-Ward, Tania F.] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Kennedy, Kit; Ralph, Stuart A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic, Australia	Deakin University; University of Melbourne	de Koning-Ward, TF (corresponding author), Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia.	taniad@deakin.edu.au	Chisholm, Scott/K-2661-2019; Ghosh, Sreejoyee/AAQ-8421-2020; Ralph, Stuart/C-8590-2014; de Koning-Ward, Tania/N-3572-2017	Chisholm, Scott/0000-0002-3833-8854; Ralph, Stuart/0000-0003-0114-7808; Dans, Madeline/0000-0001-9386-0648; de Koning-Ward, Tania/0000-0001-5810-8063	Australian National Health and Medical Research Council [1082157]; National Health and Medical Research Council (NHMRC) of Australia [1082157]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	TFdeK-W was the recipient of an Australian National Health and Medical Research Council project grant 1082157 (www.nhmrc.gov.au) that funded this project. However, the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ross Coppel, Robin Anders and James Beeson for antibodies used in the study and the Australian Red Cross for red blood cells and serum. This work was supported by a grant from the National Health and Medical Research Council (NHMRC) of Australia (Project 1082157).	Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Blackman MJ, 2013, CURR OPIN MICROBIOL, V16, P459, DOI 10.1016/j.mib.2013.04.008; Bowyer PW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001636; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; BUSHELL GR, 1988, MOL BIOCHEM PARASIT, V28, P105, DOI 10.1016/0166-6851(88)90057-6; Collins CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006453; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Das S, 2015, CELL HOST MICROBE, V18, P433, DOI 10.1016/j.chom.2015.09.007; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Hale VL, 2017, P NATL ACAD SCI USA, V114, P3439, DOI 10.1073/pnas.1619441114; Howard RF, 1998, MOL BIOCHEM PARASIT, V92, P111, DOI 10.1016/S0166-6851(97)00238-7; Janse CJ, 2011, TRENDS PARASITOL, V27, P31, DOI 10.1016/j.pt.2010.06.016; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Miller SK, 2002, J BIOL CHEM, V11; Nasamu AS, 2017, SCIENCE, V358, P518, DOI 10.1126/science.aan1478; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; SCHOFIELD L, 1986, MOL BIOCHEM PARASIT, V18, P183, DOI 10.1016/0166-6851(86)90037-X; Schwach F, 2015, NUCLEIC ACIDS RES, V43, pD1176, DOI 10.1093/nar/gku1143; Stallmach R, 2015, MOL MICROBIOL, V96, P368, DOI 10.1111/mmi.12941; Tanaka TQ, 2013, ANTIMICROB AGENTS CH, V57, P4645, DOI 10.1128/AAC.02495-12; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Weiss GE, 2016, TRENDS PARASITOL, V32, P284, DOI 10.1016/j.pt.2015.12.007; WHO, 2016, WORLD MALARIA REPORT; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193538	10.1371/journal.pone.0193538	http://dx.doi.org/10.1371/journal.pone.0193538			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509772	gold, Green Submitted, Green Published			2022-12-27	WOS:000426813200015
J	Riviere, F; Aubert, S; Omorou, AY; Ainsworth, BE; Vuillemin, A				Riviere, Fabien; Aubert, Salome; Omorou, Abdou Yacoubou; Ainsworth, Barbara E.; Vuillemin, Anne			Taxonomy-based content analysis of sedentary behavior questionnaires: A systematic review	PLOS ONE			English	Review							PHYSICAL-ACTIVITY QUESTIONNAIRE; TEST-RETEST RELIABILITY; CRITERION-RELATED VALIDITY; SELF-REPORTED MEASURE; PAST-DAY RECALL; OLDER-ADULTS; SITTING TIME; SHORT-FORM; PSYCHOMETRIC PROPERTIES; ACTIVITY CHECKLIST	Background Health effects of sedentary behaviors (SB) may vary depending on their characteristics such as type, purpose, duration, and intensity of the behavior. While a growing number of questionnaires assess sedentary behaviors, it is unclear which characteristics of SB are measured. The aim of this review was to examine the content of self-report SB questionnaires. Methods Three databases were searched for sedentary behavior questionnaires published before January 1 st, 2016. Based on the inclusion criteria, 82 articles out of 1369 were retrieved for a total of 60 questionnaires. For each questionnaire, the sedentary behavior characteristics identified were reported and analyzed. Results Most of the questionnaires assessed the time (n = 60), posture (n = 54), purpose (n = 46) and the types (n = 45) of SB performed. Fewer questionnaires assessed the environment (n = 20) social context (n = 11), status (n = 2), and associated behaviors (n = 2) related to sedentary behaviors. All the questionnaires except two assessed time spent in SB with 17 assessing frequency and 6 assessing breaks in SB. The most frequent characteristics identified in the questionnaires were the categories of sitting (90%), a day (95%), watching television (65%) and using a computer (55%). Many characteristics of SB were not measured. Conclusions By knowing the breadth of SB included in questionnaires, this review provides support to shape the design of new questionnaires designed to reduce the gaps in measuring sedentary behaviors.	[Riviere, Fabien; Omorou, Abdou Yacoubou; Vuillemin, Anne] Paris Descartes Univ, Univ Lorraine, EA APEMAC 4360, Nancy, France; [Aubert, Salome] Childrens Hosp, Eastern Ontario Res Inst, Hlth Act Living & Obes Res, Ottawa, ON, Canada; [Omorou, Abdou Yacoubou] CHRU Nancy, INSERM, CIC Clin Epidemiol 1433, Nancy, France; [Ainsworth, Barbara E.] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ USA; [Vuillemin, Anne] Univ Cote dAzur, LAMHESS, Nice, France	UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; University of Ottawa; Children's Hospital of Eastern Ontario; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Arizona State University; Arizona State University-Downtown Phoenix; UDICE-French Research Universities; Universite Cote d'Azur	Vuillemin, A (corresponding author), Paris Descartes Univ, Univ Lorraine, EA APEMAC 4360, Nancy, France.; Vuillemin, A (corresponding author), Univ Cote dAzur, LAMHESS, Nice, France.	anne.vuillemin@unice.fr	Salome, Aubert/AAY-9407-2020; Vuillemin, Anne/B-5019-2016	Vuillemin, Anne/0000-0002-5778-0285; Aubert, Salome/0000-0002-6127-2398				Aadahl M, 2003, MED SCI SPORT EXER, V35, P1196, DOI 10.1249/01.MSS.0000074446.02192.14; Adami F, 2013, REV SAUDE PUBL, V47, P488, DOI 10.1590/S0034-8910.2013047004018; Adami F, 2011, REV SAUDE PUBL, V45, P321, DOI 10.1590/S0034-89102011000200011; Aguilar-Farias N, 2015, J SCI MED SPORT, V18, P662, DOI 10.1016/j.jsams.2014.08.004; Ainsworth BE, 2012, J PHYS ACT HEALTH, V9, pS76, DOI 10.1123/jpah.9.s1.s76; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Anjana RM, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0196-2; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Becker MW, 2013, CYBERPSYCH BEH SOC N, V16, P132, DOI 10.1089/cyber.2012.0291; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Bonn SE, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.3896; Boulos R, 2012, PHYSIOL BEHAV, V107, P146, DOI 10.1016/j.physbeh.2012.05.022; Brown TD, 2004, PERCEPT MOTOR SKILL, V99, P1099, DOI 10.2466/pms.99.3f.1099-1102; Brown WJ, 2004, J SCI MED SPORT, V7, P205, DOI 10.1016/S1440-2440(04)80010-0; Buchowski MS, 2012, J PHYS ACT HEALTH, V9, P765, DOI 10.1123/jpah.9.6.765; Carson V, 2016, APPL PHYSIOL NUTR ME, V41, pS240, DOI 10.1139/apnm-2015-0630; Carson V, 2015, PREV MED, V78, P115, DOI 10.1016/j.ypmed.2015.07.016; Cerin E, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-142; Cerin E, 2012, J AGING PHYS ACTIV, V20, P402, DOI 10.1123/japa.20.4.402; Chang L, 2010, PUBLIC OPIN Q; Chastin SFM, 2014, PHYSIOL MEAS, V35, P2319, DOI 10.1088/0967-3334/35/11/2319; Chastin SFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082313; Chau JY, 2012, MED SCI SPORT EXER, V44, P118, DOI 10.1249/MSS.0b013e3182251060; Chau JY, 2011, BRIT J SPORT MED, V45, P1216, DOI 10.1136/bjsports-2011-090214; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Chinapaw MJM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-58; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Clark BK, 2016, J SCI MED SPORT, V19, P237, DOI 10.1016/j.jsams.2015.02.001; Clark BK, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0309-y; Clark BK, 2013, MED SCI SPORT EXER, V45, P1198, DOI 10.1249/MSS.0b013e3182837f57; Clark BK, 2011, MED SCI SPORT EXER, V43, P1907, DOI 10.1249/MSS.0b013e31821820a2; Clark BK, 2009, OBES REV, V10, P7, DOI 10.1111/j.1467-789X.2008.00508.x; Cleland CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1255; Clemes SA, 2012, J PHYS ACT HEALTH, V9, P533, DOI 10.1123/jpah.9.4.533; Criniere L, 2011, J PHYS ACT HEALTH, V8, P858, DOI 10.1123/jpah.8.6.858; Csizmadi I, 2014, AM J EPIDEMIOL, V180, P424, DOI 10.1093/aje/kwu150; Curry WB, 2015, EUR J SPORT SCI, V15, P655, DOI 10.1080/17461391.2014.957728; Dahl-Petersen IK, 2013, MED SCI SPORT EXER, V45, P728, DOI 10.1249/MSS.0b013e31827a6b40; De Abajo S, 2001, J SPORT MED PHYS FIT, V41, P479; Dollman J, 2016, J SPORT SCI, V34, P1154, DOI 10.1080/02640414.2015.1094185; Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Fjeldsoe BS, 2009, MED SCI SPORT EXER, V41, P1020, DOI 10.1249/MSS.0b013e31819461c2; Gardiner PA, 2011, MED SCI SPORT EXER, V43, P2127, DOI 10.1249/MSS.0b013e31821b94f7; Gennuso KR, 2015, J PHYS ACT HEALTH, V12, P727, DOI 10.1123/jpah.2013-0546; Golubic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092829; Guimarães Roseane de Fátima, 2013, Rev. bras. cineantropom. desempenho hum., V15, P276, DOI 10.5007/1980-0037.2013v15n3p276; Hagstromer M, 2010, J PHYS ACT HEALTH, V7, P541, DOI 10.1123/jpah.7.4.541; Hansen AW, 2014, J PHYS ACT HEALTH, V11, P654, DOI 10.1123/jpah.2012-0040; Hardy LL, 2007, PREV MED, V45, P71, DOI 10.1016/j.ypmed.2007.03.014; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Herrmann SD, 2013, MEAS PHYS EDUC EXERC, V17, P221, DOI 10.1080/1091367X.2013.805139; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Hoos T, 2012, J PHYS ACT HEALTH, V9, P698, DOI 10.1123/jpah.9.5.698; Jancey J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-762; Johansen KL, 2015, J RENAL NUTR, V25, P25, DOI 10.1053/j.jrn.2014.06.012; Kikuchi H, 2014, PREV MED, V67, P335, DOI 10.1016/j.ypmed.2014.08.011; Kolbe-Alexander TL, 2006, J AGING PHYS ACTIV, V14, P98, DOI 10.1123/japa.14.1.98; Kurtze N, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-63; Lindamer LA, 2008, SCHIZOPHR RES, V104, P294, DOI 10.1016/j.schres.2008.04.040; Lynch BM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-899; Marmeleira J, 2013, J VISUAL IMPAIR BLIN, V107, P375, DOI 10.1177/0145482X1310700506; Marshall AL, 2010, MED SCI SPORT EXER, V42, P1094, DOI 10.1249/MSS.0b013e3181c5ec18; McCormack G, 2003, AUST NZ J PUBL HEAL, V27, P428, DOI 10.1111/j.1467-842X.2003.tb00422.x; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Munguia-Izquierdo D, 2013, CLIN EXP RHEUMATOL, V31, pS22; Neilson HK, 2013, J PHYS ACT HEALTH, V10, P379, DOI 10.1123/jpah.10.3.379; Offer S, 2011, AM SOCIOL REV, V76, P809, DOI 10.1177/0003122411425170; Oostdam N, 2013, J SCI MED SPORT, V16, P412, DOI 10.1016/j.jsams.2012.09.001; Orsini N, 2007, EUR J EPIDEMIOL, V22, P363, DOI 10.1007/s10654-006-9102-1; Ota Erika, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P562; Oyeyemi AL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005820; Oyeyemi AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087233; Oyeyemi AL, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-156; Papathanasiou George, 2009, Hellenic J Cardiol, V50, P283; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; Pedisic Z, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1249; Pettee KK, 2009, OBESITY, V17, P487, DOI 10.1038/oby.2008.554; Rey-Lopez JP, 2012, EUR J PUBLIC HEALTH, V22, P373, DOI 10.1093/eurpub/ckr040; Roman-Vinas B, 2010, EUR J SPORT SCI, V10, P297, DOI 10.1080/17461390903426667; Rosenberg DE, 2010, J PHYS ACT HEALTH, V7, P697, DOI 10.1123/jpah.7.6.697; Rosenberg DE, 2008, J PHYS ACT HEALTH, V5, pS30, DOI 10.1123/jpah.5.s1.s30; Sallis JF, 1996, MED SCI SPORT EXER, V28, P840, DOI 10.1097/00005768-199607000-00011; Sallis JF, 2000, ANN BEHAV MED, V22, P294, DOI 10.1007/BF02895665; Saunders TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079143; Schmitz KH, 2004, J SCHOOL HEALTH, V74, P370, DOI 10.1111/j.1746-1561.2004.tb06632.x; Scholes S, 2014, AM J EPIDEMIOL, V179, P1493, DOI 10.1093/aje/kwu087; Segura-Jimenez V., 2013, CLIN EXPT RHEUMA S79, V31, P2; Shuval K, 2014, BRIT J SPORT MED, V48, P250, DOI 10.1136/bjsports-2013-092901; Simpson K, 2015, J PHYS ACT HEALTH, V12, P116, DOI 10.1123/jpah.2013-0013; Strugnell C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-122; Tessier S, 2007, SCI SPORT, V22, P224, DOI 10.1016/j.scispo.2007.07.002; Tran DV, 2013, HEALTH PROMOT J AUST, V24, P126, DOI 10.1071/HE13012; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Valkenburg PM, 2006, CYBERPSYCHOL BEHAV, V9, P584, DOI 10.1089/cpb.2006.9.584; Van Cauwenberg J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-734; Van Dyck D, 2015, J SPORT MED PHYS FIT, V55, P776; Visser M, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-80; Wang C, 2013, RES Q EXERCISE SPORT, V84, pS80, DOI 10.1080/02701367.2013.850991; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Whitfield GP, 2013, RES Q EXERCISE SPORT, V84, P323, DOI 10.1080/02701367.2013.814041; Wijndaele K, 2014, MED SCI SPORT EXER, V46, P1248, DOI 10.1249/MSS.0000000000000214	105	8	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193812	10.1371/journal.pone.0193812	http://dx.doi.org/10.1371/journal.pone.0193812			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509791	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200032
J	Medic, S; Katsilieris, M; Lozanov-Crvenkovic, Z; Siettos, CI; Petrovic, V; Milosevic, V; Brkic, S; Andrews, N; Ubavic, M; Anastassopoulou, C				Medic, Snezana; Katsilieris, Michalis; Lozanov-Crvenkovic, Zagorka; Siettos, Constantinos I.; Petrovic, Vladimir; Milosevic, Vesna; Brkic, Snezana; Andrews, Nick; Ubavic, Milan; Anastassopoulou, Cleo			Varicella zoster virus transmission dynamics in Vojvodina, Serbia	PLOS ONE			English	Article							SEROEPIDEMIOLOGY; INFECTION; VACCINE; MEASLES; FORCE; WOMEN	This study aimed at establishing baseline key epidemiological parameters for varicella zoster virus (VZV) infection in Vojvodina, Serbia, with the ultimate goal to quantify the VZV transmission potential in the population. Seroprevalence data generated during the first large cross-sectional VZV serosurvey were modelled, using a two-tiered modelling approach to calculate age-specific forces of infection (FOI), the basic reproduction number (R-0) and herd immunity threshold (H). Seroprevalence and modelling data were compared with corresponding pre-vaccination epidemiological parameters from 11 countries participating in the European Sero-Epidemiology Network 2 (ESEN2) project. Serbia fits into the general dynamic VZV transmission patterns in Europe in the pre-vaccine era, with estimated R-0 = 4.12, (95% CI: 2.69 +/- 7.07) and H = 0.76 (95% CI: 0.63 +/- 0.86). The highest VZV transmission occurs among preschool children, as evidenced by the estimation of the highest FOI (0.22, 95% CI: 0.11 +/- 0.34) in the 0.5 +/- 4 age group, with a peak FOI of 0.25 at 2.23 years. Seroprevalence was consistently lower in 5 +/- 14 year-olds, resulting in considerable shares of VZV-susceptible adolescents (7.3%), and young adults (6%), resembling the situation in a minority of European countries. The obtained key epidemiological parameters showed most intense VZV transmission in preschool children aged < 4 years, justifying the consideration of universal childhood immunization in the future. National immunization strategy should consider programs for VZV serologic screening and immunization of susceptible groups, including adolescents and women of reproductive age. This work is an important milestone towards the evaluation of varicella immunization policy options in Serbia.	[Medic, Snezana; Petrovic, Vladimir; Milosevic, Vesna] Inst Publ Hlth Vojvodina, Ctr Dis Control & Prevent, Novi Sad, Serbia; [Medic, Snezana; Petrovic, Vladimir; Milosevic, Vesna; Brkic, Snezana] Univ Novi Sad, Fac Med, Novi Sad, Serbia; [Katsilieris, Michalis; Siettos, Constantinos I.] Natl Tehn Univ Athens, Sch Appl Math & Phys Sci, Athens, Greece; [Lozanov-Crvenkovic, Zagorka] Univ Novi Sad, Fac Sci, Dept Math & Comp Sci, Novi Sad, Serbia; [Brkic, Snezana] Clin Ctr Vojvodina, Clin Infect Dis, Novi Sad, Serbia; [Andrews, Nick] Publ Hlth England, Stat Modelling & Econ Dept, Natl Infect Serv, London, England; [Ubavic, Milan] Hlth Inst, Medlab, Novi Sad, Serbia; [Anastassopoulou, Cleo] Univ Patras, Dept Biol, Div Genet Cell & Dev Biol, Patras, Greece	University of Novi Sad; University of Novi Sad; Public Health England; University of Patras	Medic, S (corresponding author), Inst Publ Hlth Vojvodina, Ctr Dis Control & Prevent, Novi Sad, Serbia.; Medic, S (corresponding author), Univ Novi Sad, Fac Med, Novi Sad, Serbia.	snezana.medic@izjzv.org.rs	Anastassopoulou, Cleo/AAO-8539-2020; Petrovic, Vladimir/L-7149-2018	Anastassopoulou, Cleo/0000-0001-7666-9198; Petrovic, Vladimir/0000-0002-2052-6232; N.Medic, Sneza/0000-0002-5778-9861	Institute of Public Health of Vojvodina; Serbian Ministry of Education, Science and Technological Development [174019]	Institute of Public Health of Vojvodina; Serbian Ministry of Education, Science and Technological Development	This work was supported by Institute of Public Health of Vojvodina (SM, VP, VM), Serbian Ministry of Education, Science and Technological Development (ZL-C, Grant number 174019 for the period 2011-2017).	ANDERSON R M, 1991; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P265; [Anonymous], VAR VACC EUR UN; Batut Milan Jovanovic, 2017, ANN REPORT IMMUNIZAT; Baxter R, 2013, PEDIATRICS, V131, pE1389, DOI 10.1542/peds.2012-3303; Bonanni P, 2009, BMC MED, V7, P26, DOI DOI 10.1186/1741-7015-7-26; Bonanni P, 2013, PEDIATR INFECT DIS J, V32, pE305, DOI 10.1097/INF.0b013e31828b7def; Carrillo-Santisteve P, 2014, CLIN MICROBIOL INFEC, V20, P86, DOI 10.1111/1469-0691.12580; Cohen DI, 2006, INFECTION, V34, P208, DOI 10.1007/s15010-006-6604-4; de Ory F, 2006, J CLIN VIROL, V36, P111, DOI 10.1016/j.jcv.2006.01.017; Del Fava E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163636; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811; Farrington CP, 2001, J R STAT SOC C-APPL, V50, P251, DOI 10.1111/1467-9876.00233; GERSHON AA, 1976, PEDIATRICS, V58, P692; Gershon AA, 2013, CLIN MICROBIOL REV, V26, P728, DOI 10.1128/CMR.00052-13; GRIFFITHS DA, 1974, ROY STAT SOC C-APP, V23, P330; Helmuth IG, 2015, VACCINE, V33, P2406, DOI 10.1016/j.vaccine.2015.03.055; Institute of Public Health of of Vojvodina, 2016, ANN REPORT; Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1; Mossong J, 2004, EPIDEMIOL INFECT, V132, P1121, DOI 10.1017/S0950268804002754; Nardone A, 2007, VACCINE, V25, P7866, DOI 10.1016/j.vaccine.2007.07.036; REMME J, 1984, INT J EPIDEMIOL, V13, P332, DOI 10.1093/ije/13.3.332; Riera-Montes M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2445-2; Santermans E, 2015, EPIDEMICS-NETH, V11, P14, DOI 10.1016/j.epidem.2014.12.005; Socan M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-360; Statistical Office of the Republic of Serbia, 2015, STAT YB REP SERB; StatSoft Inc, STAT 13; Vilibic-Cavlek T, 2012, ARCH GYNECOL OBSTET, V286, P901, DOI 10.1007/s00404-012-2398-z; Vujic S, 2012, INVESTING EARLY ED E; Wilson SE, 2012, CAN MED ASSOC J, V184, pE70, DOI 10.1503/cmaj.110506; Xiao X, 2016, EPIDEMICS-NETH, V17, P1, DOI 10.1016/j.epidem.2016.08.001	33	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193838	10.1371/journal.pone.0193838	http://dx.doi.org/10.1371/journal.pone.0193838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505590	gold, Green Published, Green Submitted			2022-12-27	WOS:000426548200035
J	Cerqueira-Rodrigues, B; Mendes, A; Correia-Neves, M; Nobrega, C				Cerqueira-Rodrigues, Bruno; Mendes, Ana; Correia-Neves, Margarida; Nobrega, Claudia			Ag85-focused T-cell immune response controls Mycobacterium avium chronic infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TUBERCULOSIS INFECTION; FACTOR-ALPHA; MICE; ANTIGEN; EXPRESSION; CD4(+); GENE; MACROPHAGES; REPERTOIRE	CD4(+) T cells are essential players for the control of mycobacterial infections. Several mycobacterial antigens have been identified for eliciting a relevant CD4(+) T cell mediated-immune response, and numerous studies explored this issue in the context of Mycobacterium tuberculosis infection. Antigen 85 (Ag85), a highly conserved protein across Mycobacterium species, is secreted at the early phase of M. tuberculosis infection leading to the proliferation of Ag85-specific CD4(+) T cells. However, in the context of Mycobacterium avium infection, little is known about the expression of this antigen and the elicited immune response. In the current work, we investigated if a T cell receptor (TCR) repertoire mostly, but not exclusively, directed at Ag85 is sufficient to mount a protective immune response against M. avium. We show that P25 mice, whose majority of T cells express a transgenic TCR specific for Ag85, control M. avium infection at the same level as wild type (WT) mice up to 20 weeks post-infection (wpi). During M. avium infection, Ag85 antigen is easily detected in the liver of 20 wpi mice by immunohistochemistry. In spite of the propensity of P25 CD4(+) T cells to produce higher amounts of interferon-gamma (IFN gamma) upon ex vivo stimulation, no differences in serum IFN gamma levels are detected in P25 compared to WT mice, nor enhanced immunopathology is detected in P25 mice. These results indicate that a T cell response dominated by Ag85-specific T cells is appropriate to control M. avium infection with no signs of immunopathology.	[Cerqueira-Rodrigues, Bruno; Mendes, Ana; Correia-Neves, Margarida; Nobrega, Claudia] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, Campus Gualtar, Braga, Portugal; [Cerqueira-Rodrigues, Bruno; Mendes, Ana; Correia-Neves, Margarida; Nobrega, Claudia] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal	Universidade do Minho	Nobrega, C (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, Campus Gualtar, Braga, Portugal.; Nobrega, C (corresponding author), PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal.	claudianobrega@med.uminho.pt	Mendes, Ana/T-5165-2018; Claudia, Nobrega/D-7537-2014; Correia-Neves, Margarida/C-9122-2009; Correia-Neves, Margarida/AAH-4636-2020; Nóbrega, Cláudia/T-6430-2018	Mendes, Ana/0000-0003-4724-0784; Claudia, Nobrega/0000-0002-0282-9619; Correia-Neves, Margarida/0000-0002-2202-5431; Correia-Neves, Margarida/0000-0002-2202-5431; Nóbrega, Cláudia/0000-0002-0282-9619	Northern Portugal Regional Operational Programme (NORTE), through the European Regional Development Fund (FEDER) [NORTE-01-0145-FEDER-000013]; Portuguese Foundation for Science and Technoloy (FCT) [SFRH/BD/80352/2011, SFRH/BPD/112001/2015]	Northern Portugal Regional Operational Programme (NORTE), through the European Regional Development Fund (FEDER); Portuguese Foundation for Science and Technoloy (FCT)	This work was developed under the scope of the project NORTE-01-0145-FEDER-000013, supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER). Fellowships from the Portuguese Foundation for Science and Technoloy (FCT) were attributed to BCR (SFRH/BD/80352/2011; QREN-POPH through the Fundo Social Europeu (FSE) and national funds from MEC] and to CN (SFRH/BPD/112001/2015; POPH through FSE and national funds from MCTES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2012, CLIN IMMUNOL, V143, P99, DOI 10.1016/j.clim.2012.01.015; APPELBERG R, 1995, INFECT IMMUN, V63, P1145; Bean AGD, 1999, J IMMUNOL, V162, P3504; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Du G, 2010, J IMMUNOL, V185, P3940, DOI 10.4049/jimmunol.1001222; Florido M, 2006, IMMUNOLOGY, V118, P122, DOI 10.1111/j.1365-2567.2006.02350.x; Florido M, 2004, INFECT IMMUN, V72, P6139, DOI 10.1128/IAI.72.10.6139-6141.2004; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gomes MS, 1999, J IMMUNOL, V162, P6734; Grace PS, 2016, J IMMUNOL, V196, P357, DOI 10.4049/jimmunol.1501494; Huygen K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00321; Islam N, 2004, J INFECT DIS, V190, P341, DOI 10.1086/421522; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; Karbalaei M, 2017, BIOLOGY IMMUNE PATHO; Kariyone A, 1999, INFECT IMMUN, V67, P4312, DOI 10.1128/IAI.67.9.4312-4319.1999; Luo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048117; Moguche AO, 2017, CELL HOST MICROBE, V21, P695, DOI 10.1016/j.chom.2017.05.012; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Nobrega C, 2013, J IMMUNOL, V190, P1646, DOI 10.4049/jimmunol.1202412; Nunes-Alves C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004849; Pais TF, 2000, INFECT IMMUN, V68, P4805, DOI 10.1128/IAI.68.8.4805-4810.2000; Rogerson BJ, 2006, IMMUNOLOGY, V118, P195, DOI 10.1111/j.1365-2567.2006.02355.x; Rosseels V, 2006, INFECT IMMUN, V74, P202, DOI 10.1128/IAI.74.1.202-212.2006; Tamura T, 2004, INT IMMUNOL, V16, P1691, DOI 10.1093/intimm/dxh170; Thomsen BV, 2001, J COMP PATHOL, V125, P137, DOI 10.1053/jcpa.2001.0491; Tully G, 2005, J IMMUNOL, V174, P2174, DOI 10.4049/jimmunol.174.4.2174; Wilkinson RJ, 2001, MOL MICROBIOL, V39, P813, DOI 10.1046/j.1365-2958.2001.02280.x; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Yahagi A, 2010, INT IMMUNOL, V22, P307, DOI 10.1093/intimm/dxq010; Yanagisawa S, 1997, INT IMMUNOL, V9, P227, DOI 10.1093/intimm/9.2.227	36	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193596	10.1371/journal.pone.0193596	http://dx.doi.org/10.1371/journal.pone.0193596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499041	Green Submitted, Green Published, gold			2022-12-27	WOS:000426472300017
J	Lin, YH				Lin, Yuhui			AFT survival model to capture the rate of aging and age-specific mortality trajectories among first-allogeneic hematopoietic stem cells transplant patients	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ADVANTAGE	Accelerated failure time (AFT) model is commonly applied in engineering studies to address the failure rate of a machine. In humans, survival profile of transplant patients is among the rare scenarios whereby AFT is applicable. To date, it is uncertain whether reliable risk estimates and age-specific mortality trajectories have been published using conventional statistics approach. By investigating mortality trajectory, the rate of aging d(log(mu(x)))/dx of Hematopoietic Stem Cells Transplants (HSCTs) patients who had underwent first-allogeneic transplants can be obtained, and to unveil the possibility of elasticity of human aging rate in HSCTs. A modified parametric frailty survival model was introduced to the survival profiles of 11,160 patients who had underwent first-allogeneic HSCTs in the United States between 1995 and 2006; data was shared by Center for International Bone and Marrow Transplant Research. In comparison to stratification, the modification permits two entities in relation to time to be presented; age and calendar time. To consider its application in empirical studies, the data contains arbitrary right-censoring, a statistical condition which is preferred by choice in many transplant studies. The finalized multivariate AFT model was adjusted for clinical and demographic covariates, and age-specific mortality trajectories were presented by donor source and post-transplant time-lapse intervals. Two unexpected findings are presented: i) an inverse J-shaped hazard in unrelated donor-source t <= 100-day; ii) convergence of unrelated-related hazard lines in 100-day<t <= 365-day suggests maximum manifestation of senescence among survivors. Analyses of long-term survivors (t> 365-day) must consider for periodic medical improvements, and transplant year as a standalone time-variable is not sufficient for statistical adjustment in the finalized multivariate model. In relevance to clinical studies, biennial event-history analysis and age-specific mortality trajectories of long-term survivors provide a more relevant intervention audit report for transplant protocols than the popular statistical presentation; i.e. survival probabilities among donor-source.	[Lin, Yuhui] The Waterhouse, NaoRococo, Singapore, Singapore		Lin, YH (corresponding author), The Waterhouse, NaoRococo, Singapore, Singapore.	yuhui.linney@gmail.com		Lin, Yuhui/0000-0001-6597-1885	Waterhouse; Max Planck Institution for Demographic Research	Waterhouse; Max Planck Institution for Demographic Research	The commercial affiliation, NaoRococo, The Waterhouse provided support in the form of salary for Y Lin, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Max Planck Institution for Demographic Research provided scholarship stipend support to Y Lin during her doctorate studies. The specific roles of the author are articulated in the author contributions section.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; BOXENBAUM H, 1991, ARCH GERONTOL GERIAT, V13, P125, DOI 10.1016/0167-4943(91)90055-U; Brunner AM, 2013, BIOL BLOOD MARROW TR, V19, P1374, DOI 10.1016/j.bbmt.2013.06.008; Burra P, 2010, LDOTS TRANSPLANT; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Finch CE, 1996, J GERONTOL A-BIOL, V51, pB183, DOI 10.1093/gerona/51A.3.B183; Giaimo S., 2013, J THEOR BIOL; Giebel S, 2003, BLOOD, V102, P814, DOI 10.1182/blood-2003-01-0091; Golubev A, 2009, J THEOR BIOL, V258, P1, DOI 10.1016/j.jtbi.2009.01.009; Gondos A, 2013, TRANSPLANTATION, V95, P267, DOI 10.1097/TP.0b013e3182708ea8; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Koopman JJE, 2011, AGING CELL, V10, P233, DOI 10.1111/j.1474-9726.2010.00659.x; Lin YH, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010965; Nayor Matthew E DM, 2016, CIRC-HEART FAIL, V9; Olshansky SJ, 1997, DEMOGRAPHY, V34, P1, DOI 10.2307/2061656; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Weisdorf D, 2012, BIOL BLOOD MARROW TR, V18, P1727, DOI 10.1016/j.bbmt.2012.06.014; Wienke A, 2001, Twin Res, V4, P266, DOI 10.1375/twin.4.4.266; Wienke A., 2003, DEMOGR RES, V49; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Yashin AI, 1997, DEMOGRAPHY, V34, P31, DOI 10.2307/2061658; Yashin AI, 2008, THEOR POPUL BIOL, V73, P1, DOI 10.1016/j.tpb.2007.09.001	24	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193287	10.1371/journal.pone.0193287	http://dx.doi.org/10.1371/journal.pone.0193287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY0AM	29499050	Green Published, gold, Green Submitted			2022-12-27	WOS:000426472300009
J	Garay, J; Csiszar, V; Mori, TF; Szilagyi, A; Varga, Z; Szamado, S				Garay, Jozsef; Csiszar, Villo; Mori, Tamas F.; Szilagyi, Andras; Varga, Zoltan; Szamado, Szabolcs			Juvenile honest food solicitation and parental investment as a life history strategy: A kin demographic selection model	PLOS ONE			English	Article							TRADE-OFF; NEED; EVOLUTION; SIGNALS; HUNGER; CONFLICT; QUESTION; QUALITY; BIRDS	Parent-offspring communication remains an unresolved challenge for biologist. The difficulty of the challenge comes from the fact that it is a multifaceted problem with connections to life-history evolution, parent-offspring conflict, kin selection and signalling. Previous efforts mainly focused on modelling resource allocation at the expense of the dynamic interaction during a reproductive season. Here we present a two-stage model of begging where the first stage models the interaction between nestlings and parents within a nest and the second stage models the life-history trade-offs. We show in an asexual population that honest begging results in decreased variance of collected food between siblings, which leads to mean number of surviving offspring. Thus, honest begging can be seen as a special bet-hedging against informational uncertainty, which not just decreases the variance of fitness but also increases the arithmetic mean.	[Garay, Jozsef; Szilagyi, Andras] Eotvos Lorand Univ, Dept Plant Systemat Ecol & Theoret Biol, MTA ELTE Res Grp Theoret Biol & Evolutionary Ecol, Budapest, Hungary; [Garay, Jozsef; Szilagyi, Andras; Szamado, Szabolcs] MTA Ctr Ecol Res, Evolutionary Syst Res Grp, Tihany, Hungary; [Csiszar, Villo; Mori, Tamas F.] Eotvos Lorand Univ, Dept Probabil Theory & Stat, Budapest, Hungary; [Varga, Zoltan] Szent Istvan Univ, Dept Math, Godollo, Hungary; [Szamado, Szabolcs] MTA Ctr Social Sci, RECENS Lendulet Res Grp, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand University; Hungarian University of Agriculture & Life Sciences; Hungarian Academy of Sciences; Hungarian Centre for Social Sciences	Garay, J (corresponding author), Eotvos Lorand Univ, Dept Plant Systemat Ecol & Theoret Biol, MTA ELTE Res Grp Theoret Biol & Evolutionary Ecol, Budapest, Hungary.; Garay, J (corresponding author), MTA Ctr Ecol Res, Evolutionary Syst Res Grp, Tihany, Hungary.	garayj@caesar.elte.hu	Varga, Zoltán/W-6418-2018; Varga, Zoltan/AAA-9201-2019; Móri, Tamás F/N-1283-2019; Számadó, Szabolcs/A-9804-2013; Csiszár, Villő/I-8546-2018; Móri, Tamás F/B-5507-2012	Varga, Zoltan/0000-0002-4889-3376; Móri, Tamás F/0000-0002-9328-7471; Számadó, Szabolcs/0000-0003-2204-9705; Csiszár, Villő/0000-0002-7021-3162; Móri, Tamás F/0000-0002-9328-7471; Garay, Jozsef/0000-0003-0860-2252; Szilagyi, Andras/0000-0002-6894-4652	Hungarian National Research, Development and Innovation Office NKFIH [K 125569, K 108974, K 119347]; European Structural and Investment Funds (ESIF) in Hungary [GINOP 2.3.2-15-2016-00057]; European Research Council [648693]	Hungarian National Research, Development and Innovation Office NKFIH; European Structural and Investment Funds (ESIF) in Hungary; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Hungarian National Research, Development and Innovation Office NKFIH: K 125569 (T.M.), K 108974 (J.G. and SZ.SZ), K 119347 (A.SZ) (http://nkfih.gov.hu/english); European Structural and Investment Funds (ESIF) in Hungary (GINOP 2.3.2-15-2016-00057) (https://www.palyazat.gov.hu/evaluation); and European Research Council (No 648693) (https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebbington K, 2017, EVOL LETT, V1, P132, DOI 10.1002/evl3.18; Bossan B, 2013, P R SOC B; Caro SM, 2016, P NATL ACAD SCI USA, V113, P13803, DOI 10.1073/pnas.1606378113; Caro SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10985; Dugas M. B., 2016, P NATL ACAD SCI USA; Garay J, 2016, ECOL MODEL, V334, P51, DOI 10.1016/j.ecolmodel.2016.05.001; Garay J, 2012, B MATH BIOL, V74, P2676, DOI 10.1007/s11538-012-9772-7; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Grantham ME, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0654; Hinde CA, 2011, BEHAV ECOL, V22, P1147, DOI 10.1093/beheco/arr117; Johnstone RA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P1, DOI 10.1007/0-306-47660-6_1; Johnstone RA, 2011, BEHAV ECOL, V22, P918, DOI 10.1093/beheco/arr095; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kolliker M, 2011, BEHAV ECOL, V22, P919, DOI 10.1093/beheco/arr081; Mas F, 2008, ANIM BEHAV, V76, P1121, DOI 10.1016/j.anbehav.2008.06.011; Mock DW, 2011, BEHAV ECOL, V22, P909, DOI 10.1093/beheco/arr091; Noldeke G, 1999, J THEOR BIOL, V197, P527, DOI 10.1006/jtbi.1998.0893; Olofsson H, 2009, P ROY SOC B-BIOL SCI, V276, P2963, DOI 10.1098/rspb.2009.0500; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; Ripa J, 2010, P ROY SOC B-BIOL SCI, V277, P1153, DOI 10.1098/rspb.2009.2023; Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wright J, 2011, BEHAV ECOL, V22, P920, DOI 10.1093/beheco/arr080	24	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193420	10.1371/journal.pone.0193420	http://dx.doi.org/10.1371/journal.pone.0193420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494630	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000426363200047
J	Hussain, A; Yong, C; Tkaczuk, KHR; Qian, Y; Arellano, J; Mullins, CD; Onukwugha, E				Hussain, Arif; Yong, Candice; Tkaczuk, Katherine H. R.; Qian, Yi; Arellano, Jorge; Mullins, C. Daniel; Onukwugha, Eberechukwu			Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; BONE METASTASES; PROSTATE-CANCER; ZOLEDRONIC ACID; COMPETING RISKS; DOUBLE-BLIND; EVENTS; STATISTICS; CARCINOMA; MORTALITY	Objective Real-world data regarding patient factors associated with the occurrence of spinal cord compression (SCC) or pathological fracture (PF), or need for bone surgery (BS), or use of radiation therapy (RAD) (i.e. skeletal complications and radiation therapy; SCRT) are limited for women with metastatic breast cancer (BCa). Given the substantial clinical and economic burden of these events in advanced BCa, we conducted the present study to understand the prevalence and identify the risk factors associated with these events among elderly women presenting with de novo metastatic BCa. Methods Using linked Surveillance, Epidemiology, and End Results and Medicare data, we identified women with incident metastatic BCa diagnosed during 2005 +/- 2009. Associations between patient demographics and select clinically relevant factors, and SCRT were examined using the Cox proportional hazards model, accounting for death as a competing risk. Results Of 3,731 Medicare beneficiaries with incident metastatic BCa, 1,808 (48.5%) experienced at least one SCRT event during a median follow-up of 13.2 months; a majority (69%) experienced a subsequent SCRT event. The proportions of women who had RAD, PF, BS, and SCC were: 32%, 28%, 8%, and 4%. Older women (80+ years), or those with more comorbid conditions (CCI >= 2) had a statistically significant lower risk of SCRT (HR 0.78 [CI: 0.67- 0.92, p<0.01]; HR 0.77 [CI: 0.67-0.89, p<0.01], respectively), primarily due to lower frequency of radiotherapy (p<0.01). Compared to Caucasians, African Americans had lower risk of SCRT (HR 0.70 [CI: 0.60-0.82, p<0.01]), as well as all SCRT subtypes defining this group except for SCC, which was the same for both race groups. Conclusion This study highlights that certain patient characteristics and clinical factors are associated with the risk of spinal cord compression or pathologic fractures, or need for bone surgery or radiation among women with metastatic BCa. In future studies, it will also be important to consider the clinical and economic burden based on these components of skeletal complications and radiation therapy use in order to guide and improve the management of women with advanced BCa.	[Hussain, Arif; Tkaczuk, Katherine H. R.] Univ Maryland, Med Ctr, Dept Med, Baltimore, MD 21201 USA; [Hussain, Arif] Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Yong, Candice; Mullins, C. Daniel; Onukwugha, Eberechukwu] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Qian, Yi; Arellano, Jorge] Amgen Inc, Thousand Oaks, CA 91320 USA; [Yong, Candice] AstraZeneca, Gaithersburg, MD USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Maryland; University of Maryland Baltimore; Amgen; AstraZeneca	Hussain, A (corresponding author), Univ Maryland, Med Ctr, Dept Med, Baltimore, MD 21201 USA.; Hussain, A (corresponding author), Vet Affairs Med Ctr, Baltimore, MD 21201 USA.	ahussain@som.umaryland.edu			Amgen Inc.; Merit Review Award [101 BX000545]; Department of Veterans Affairs; California Department of Public Health [103885]; National Cancer Institute's Surveillance, Epidemiology and End Results Program [HHSN261201000140C, HHSN261201000035C, HHSN261201000034C]; Centers for Disease Control and Prevention's National Program of Cancer Registries [U58DP003862-01]; Medical Research Service, Department of Veterans Affairs; Veterans Affairs [I01BX000545] Funding Source: NIH RePORTER	Amgen Inc.(Amgen); Merit Review Award(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); California Department of Public Health; National Cancer Institute's Surveillance, Epidemiology and End Results Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	Financial support for this study was provided by a contract with Amgen Inc. The funding agreement ensured the authors' independence in designing the study, collecting the data, interpreting the data, writing the paper, and submitting the paper for publication. Part of author AH's time was supported by a Merit Review Award (101 BX000545), Department of Veterans Affairs. There was no additional external funding received for this study. Amgen Inc. provided support in the form of salaries for authors YQ and JA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Pharmaceutical Research Computing for programming assistance on the primary datasets. This study used the linked SEER-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the Applied Research Program, NCI; the Office of Research, Development and Information, CMS; Information Management Services (IMS), Inc.; and the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in the creation of the SEER -Medicare database. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement # U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author(s) and endorsement by the State of California Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred. Part of AH's research time was supported by a Merit Review Award (I01 BX000545), Medical Research Service, Department of Veterans Affairs.	Abdulhalim AM, 2014, 2014 GEN CANC S SAN; AJCC, 2002, MANUAL STAGING CANC; Body Jean-Jacques, 2013, J Med Econ, V16, P539, DOI 10.3111/13696998.2013.774279; Choksi P, 2017, J CLIN ENDOCR METAB, V102, P1254, DOI 10.1210/jc.2016-3906; Costa L, 2008, SUPPORT CARE CANCER, V16, P879, DOI 10.1007/s00520-008-0418-0; Delea Thomas, 2006, J Support Oncol, V4, P341; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Duran I, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12452; Hagiwara May, 2014, J Med Econ, V17, P223, DOI 10.3111/13696998.2014.890937; Hussain A, 2016, CANCER MED-US, V5, P3300, DOI 10.1002/cam4.914; Lipton A, 2000, CANCER, V88, P1082, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1082::AID-CNCR20>3.0.CO;2-Z; Lipton A, 2012, EUR J CANCER, V48, P3082, DOI 10.1016/j.ejca.2012.08.002; McDougall JA, 2016, ONCOLOGIST, V21, P320, DOI 10.1634/theoncologist.2015-0327; McKay R, 2017, PROSTATE CANCER P D, V20, P276, DOI 10.1038/pcan.2017.4; Onukwugha Eberechukwu, 2017, PLoS One, V12, pe0175956, DOI 10.1371/journal.pone.0175956; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rosen LS, 2003, CANCER-AM CANCER SOC, V98, P1735, DOI 10.1002/cncr.11701; Sathiakumar N, 2012, BREAST CANCER RES TR, V131, P231, DOI 10.1007/s10549-011-1721-x; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Svendsen Marie Louise, 2013, Clin Epidemiol, V5, P97, DOI 10.2147/CLEP.S42325; Wagner DR, 2000, AM J CLIN NUTR, V71, P1392; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056; Yong M, 2011, BREAST CANCER RES TR, V129, P495, DOI 10.1007/s10549-011-1475-5	24	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193661	10.1371/journal.pone.0193661	http://dx.doi.org/10.1371/journal.pone.0193661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494653	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200078
J	Sekita-Hatakeyama, Y; Nishikawa, T; Takeuchi, M; Morita, K; Takeda, M; Hatakeyama, K; Nakai, T; Uchiyama, T; Itami, H; Fujii, T; Mitoro, A; Sho, M; Ohbayashi, C				Sekita-Hatakeyama, Yoko; Nishikawa, Takeshi; Takeuchi, Mao; Morita, Kouhei; Takeda, Maiko; Hatakeyama, Kinta; Nakai, Tokiko; Uchiyama, Tomoko; Itami, Hiroe; Fujii, Tomomi; Mitoro, Akira; Sho, Masayuki; Ohbayashi, Chiho			K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							TERM-FOLLOW-UP; GENE MUTATION; PROGNOSTIC VALUE; KRAS MUTATION; CANCER; NEOPLASMS; METAANALYSIS; BIOMARKERS; CARCINOMA; BIOPSIES	Background Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) technology is widely used for the diagnosis of pancreatic masses. However, in some cases, inadequate tissue volume or difficulty of morphological diagnosis are constraining factors for adequate cytopathological evaluation. K-ras mutation is the most frequently acquired genetic abnormality, occurring in approximately 90% of all patients with pancreatic ductal adenocarcinoma (PDAC). In the present study, the clinical utility of residual liquid-based cytology (LBC) specimens obtained using EUS-FNA for K-ras mutation analysis was evaluated. Methods In this study, 81 patients with pancreatic lesions were examined. The cell block (CB) specimens separated from EUS-FNA samples were morphologically evaluated by hematoxylin-eosin (HE) staining. Final diagnoses were confirmed by CB specimens, surgical resection specimens, diagnostic imaging, and clinical follow-up. Genomic DNA of residual LBC specimens stored at 4 degrees C for several months were extracted and assessed for K-ras mutations using a fluorescence resonance energy transfer-based preferential homoduplex formation assay. Results K-ras mutation analysis using residual LBC samples was successful in all cases. The sensitivity, specificity, and accuracy of CB examination alone were 77.4%, 100%, and 81.3%, respectively, and those of the combination of CB examination and K-ras mutation analysis were 90.3%, 92.3%, and 90.7%, respectively. Furthermore, K-ras mutations were detected in 8 (57.1%) of 14 PDAC samples for which the CB results were inconclusive. Conclusion These findings suggest that K-ras mutation analysis using residual LBC specimens improves the diagnostic accuracy of EUS-FNA.	[Sekita-Hatakeyama, Yoko; Nishikawa, Takeshi; Takeuchi, Mao; Morita, Kouhei; Takeda, Maiko; Hatakeyama, Kinta; Nakai, Tokiko; Uchiyama, Tomoko; Itami, Hiroe; Fujii, Tomomi; Ohbayashi, Chiho] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara, Japan; [Mitoro, Akira] Nara Med Univ, Dept Internal Med 3, Kashihara, Nara, Japan; [Sho, Masayuki] Nara Med Univ, Dept Surg, Kashihara, Nara, Japan	Nara Medical University; Nara Medical University; Nara Medical University	Hatakeyama, K (corresponding author), Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara, Japan.	kpathol@naramed-u.ac.jp						Abraham SC, 2002, AM J PATHOL, V160, P1361, DOI 10.1016/S0002-9440(10)62563-1; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bournet B, 2009, ENDOSCOPY, V41, P552, DOI 10.1055/s-0029-1214717; Brunetti O, 2015, ONCOTARGET, V6, P23323, DOI 10.18632/oncotarget.4492; Buscail L, 2006, PANCREATOLOGY, V6, P7, DOI 10.1159/000090022; Frampton AE, 2015, EUR J CANCER, V51, P1389, DOI 10.1016/j.ejca.2015.04.006; Furuya N, 1997, GASTROENTEROLOGY, V113, P593, DOI 10.1053/gast.1997.v113.pm9247481; GUDJONSSON B, 1987, CANCER, V60, P2284, DOI 10.1002/1097-0142(19871101)60:9<2284::AID-CNCR2820600930>3.0.CO;2-V; Haba S, 2013, J GASTROENTEROL, V48, P973, DOI 10.1007/s00535-012-0695-8; Hashimoto S, 2017, DIGEST ENDOSC, V29, P608, DOI 10.1111/den.12827; Hijioka S, 2017, CLIN CANCER RES, V23, P4625, DOI 10.1158/1078-0432.CCR-16-3135; Huang JQ, 2015, CLIN CHEM, V61, P1408, DOI 10.1373/clinchem.2015.238543; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kamisawa T, 2011, HEPATO-GASTROENTEROL, V58, P174; Kim WY, 2016, DIAGN CYTOPATHOL, V44, P450, DOI 10.1002/dc.23441; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kloppel G, 2014, SEMIN DIAGN PATHOL, V31, P452, DOI 10.1053/j.semdp.2014.08.005; Kwon H, 2016, ENDOCRINOL METAB, V31, P586, DOI 10.3803/EnM.2016.31.4.586; LeBlanc JK, 2014, PANCREAS, V43, P440, DOI 10.1097/MPA.0000000000000047; Linder J, 1998, DIAGN CYTOPATHOL, V18, P24, DOI 10.1002/(SICI)1097-0339(199801)18:1<24::AID-DC5>3.0.CO;2-U; Lohr M, 2005, NEOPLASIA, V7, P17, DOI 10.1593/neo.04445; Ma MZ, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-71; Malapelle U, 2012, J CLIN PATHOL, V65, P87, DOI 10.1136/jclinpath-2011-200296; Moris D, 2017, ANTICANCER RES, V37, P2185, DOI 10.21873/anticanres.11553; Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2; Park JK, 2017, ONCOTARGET, V8, P64440, DOI 10.18632/oncotarget.16135; Park JK, 2017, ONCOTARGET, V8, P3519, DOI 10.18632/oncotarget.13864; Qin SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108762; Rossi ED, 2013, CANCER CYTOPATHOL, V121, P291, DOI 10.1002/cncy.21258; Rossi ED, 2013, EUR J ENDOCRINOL, V168, P853, DOI 10.1530/EJE-13-0023; Springer S, 2015, GASTROENTEROLOGY, V149, P1501, DOI 10.1053/j.gastro.2015.07.041; Tada M, 2002, AM J GASTROENTEROL, V97, P2263; TADA M, 1991, GASTROENTEROLOGY, V100, P233, DOI 10.1016/0016-5085(91)90606-L; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Zhao H, 2017, ONCOTARGET, V8	37	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193692	10.1371/journal.pone.0193692	http://dx.doi.org/10.1371/journal.pone.0193692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494669	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200085
J	Bartonkova, I; Kallay, E; Dvorak, Z				Bartonkova, Iveta; Kallay, Enikoe; Dvorak, Zdenek			Effects of human interleukins in the transgenic gene reporter cell lines IZ-VDRE and IZ-CYP24 designed to assess the transcriptional activity of vitamin D receptor	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; PREGNANE-X-RECEPTOR; ANDROGEN RECEPTOR; GLUCOCORTICOID RESISTANCE; D METABOLISM; EXPRESSION; ACTIVATION; DEPRESSION; RELEVANCE; CYTOKINES	The role of vitamin D receptor (VDR) in immune responses has been broadly studied and it has been shown that activated VDR alters the levels of some interleukins (ILs). In this study, we studied the opposite, i.e. whether 13 selected pro-inflammatory and anti-inflammatory ILs influence the transcriptional activity of human VDR. The experimental models of choice were two human stably transfected gene reporter cell lines IZ-VDRE and IZ-CYP24, which were designed to evaluate the transcriptional activity of VDR. The gene reporter assays revealed inhibition of calcitriol-induced luciferase activity by IL-4 and IL-13, when 1 ng/mL of these two compounds decreased the effect of calcitriol down to 60% of the control value. Consistently, calcitriol-induced expression of CYP24A1 mRNA was also significantly decreased by IL-4 and IL-13. The expression of VDR and CYP27B1 mRNAs was not influenced by any of the 13 tested ILs. These data suggest possible cross-talk between the VDR signalling pathway and IL-4- and IL-13-mediated cell signalling.	[Bartonkova, Iveta; Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, Olomouc, Czech Republic; [Kallay, Enikoe] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria	Palacky University Olomouc; Medical University of Vienna	Dvorak, Z (corresponding author), Palacky Univ, Fac Sci, Dept Cell Biol & Genet, Olomouc, Czech Republic.	moulin@email.cz		Kallay, Eniko/0000-0002-4996-0104	Czech Science Foundation GACR [P303/12/G163]; Palacky University [PrF-2017-004, PrF-2018-005]; Operational Programme Research, Development and Education Regional Development Fund of the Ministry of Education, Youth and Sports of the Czech Republic [CZ.02.1.01/0.0/0.0/16_019/0000754]	Czech Science Foundation GACR(Grant Agency of the Czech Republic); Palacky University; Operational Programme Research, Development and Education Regional Development Fund of the Ministry of Education, Youth and Sports of the Czech Republic	Our laboratory is supported by a grant from the Czech Science Foundation GACR P303/12/G163, by the student grants from Palacky University (Grant no. PrF-2017-004 and No. PrF-2018-005) and by the Operational Programme Research, Development and Education Regional Development Fund, project no. CZ.02.1.01/0.0/0.0/16_019/0000754 of the Ministry of Education, Youth and Sports of the Czech Republic (all received by Zdenek Dvorak).	AXEN E, 1995, BIOCHEM BIOPH RES CO, V215, P136, DOI 10.1006/bbrc.1995.2443; Bartonkova I, 2016, CHEM RES TOXICOL, V29, P1211, DOI 10.1021/acs.chemrestox.6b00170; BHALLA AK, 1986, CELL IMMUNOL, V98, P311, DOI 10.1016/0008-8749(86)90291-1; Biola A, 2001, MOL ENDOCRINOL, V15, P1062, DOI 10.1210/me.15.7.1062; Cross HS, 2011, MOL CELL ENDOCRINOL, V347, P70, DOI 10.1016/j.mce.2011.07.022; Hii CS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030135; Hobisch A, 1998, CANCER RES, V58, P4640; Hummel DM, 2014, J STEROID BIOCHEM, V144, P91, DOI 10.1016/j.jsbmb.2013.09.017; Kallay E, 2005, CARCINOGENESIS, V26, P1581, DOI 10.1093/carcin/bgi124; Lin DL, 2001, CLIN CANCER RES, V7, P1773; Marcotorchino J, 2012, MOL NUTR FOOD RES, V56, P1771, DOI 10.1002/mnfr.201200383; Miller AH, 1999, ADV EXP MED BIOL, V461, P107; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Pascussi JM, 2005, J CLIN INVEST, V115, P177, DOI 10.1172/JCI200521867; Pascussi JM, 2000, BIOCHEM BIOPH RES CO, V274, P707, DOI 10.1006/bbrc.2000.3219; Rostkowska-Nadolska B, 2010, ADV MED SCI-POLAND, V55, P86, DOI 10.2478/v10039-010-0012-9; Schrumpf JA, 2012, INFECT IMMUN, V80, P4485, DOI 10.1128/IAI.06224-11; TSOUKAS CD, 1984, SCIENCE, V224, P1438, DOI 10.1126/science.6427926; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Wobke TK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00244; Yang L, 2003, BIOCHEM BIOPH RES CO, V305, P462, DOI 10.1016/S0006-291X(03)00792-7	22	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193655	10.1371/journal.pone.0193655	http://dx.doi.org/10.1371/journal.pone.0193655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489902	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000099
J	Chang, JH; Zhao, JH; Tian, XL				Chang, Juhua; Zhao, Jianhua; Tian, Xiaoli			In silico prediction of neuropeptides in Hymenoptera parasitoid wasps	PLOS ONE			English	Article							SULFATED INSECT NEUROPEPTIDE; RED FLOUR BEETLE; PROTEIN HORMONES; PEPTIDE-HORMONES; FOOD-INTAKE; EVOLUTION; LEUCOSULFAKININ; IDENTIFICATION; PHYLOGENY; RECEPTORS	Parasitoid wasps of the order Hymenoptera, the most diverse groups of animals, are important natural enemies of arthropod hosts in natural ecosystems and can be used in biological control. To date, only one neuropeptidome of a parasitoid wasp, Nasonia vitripennis, has been identified. This study aimed to identify more neuropeptides of parasitoid wasps, by using a well-established workflow that was previously adopted for predicting insect neuropeptide sequences. Based on publicly accessible databases, totally 517 neuropeptide precursors from 24 parasitoid wasp species were identified; these included five neuropeptides (CNMamide, FMRFamide-like, ITG-like, ion transport peptide-like and orcokinin B) that were identified for the first time in parasitoid wasps, to our knowledge. Next, these neuropeptides from parasitoid wasps were compared with those from other insect species. Phylogenetic analysis suggested the divergence of AST-CCC within Hymenoptera. Further, the encoding patterns of CAPA/PK family genes were found to be different between Hymenoptera species and other insect species. Some neuropeptides that were not found in some parasitoid superfamilies (e.g., sulfakinin), or considerably divergent between different parasitoid superfamilies (e.g., sNPF) might be related to distinct physiological processes in the parasitoid life. Information of neuropeptide sequences in parasitoid wasps can be useful for better understanding the phylogenetic relationships of Hymenoptera and further elucidating the physiological functions of neuropeptide signaling systems in parasitoid wasps.	[Chang, Juhua; Tian, Xiaoli] Yangtze Univ, Coll Life Sci, Jingzhou, Peoples R China; [Chang, Juhua] Yangtze Univ, Pesticide Res Inst, Jingzhou, Peoples R China; [Zhao, Jianhua] Vegetable Technol Ctr Xiyang Cty, Xiyang, Peoples R China	Yangtze University; Yangtze University	Chang, JH (corresponding author), Yangtze Univ, Coll Life Sci, Jingzhou, Peoples R China.; Chang, JH (corresponding author), Yangtze Univ, Pesticide Res Inst, Jingzhou, Peoples R China.	juhua1756@163.com			National Natural Science Foundation of China [31601672]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31601672) (Dr. Juhua Chang).; Financial support was provided by National Natural Science Foundation of China (31601672).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Audsley N, 2015, PEPTIDES, V68, P33, DOI 10.1016/j.peptides.2014.08.006; Boerjan B, 2010, NEUROPHARMACOLOGY, V58, P248, DOI 10.1016/j.neuropharm.2009.06.026; Caers Jelle, 2012, Front Endocrinol (Lausanne), V3, P151, DOI 10.3389/fendo.2012.00151; Christie AE, 2017, GEN COMP ENDOCR, V243, P22, DOI 10.1016/j.ygcen.2016.10.008; Christie AE, 2016, GEN COMP ENDOCR, V230, P1, DOI 10.1016/j.ygcen.2016.03.008; Christie AE, 2015, GEN COMP ENDOCR, V224, P69, DOI 10.1016/j.ygcen.2015.06.006; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Derst C, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0621-4; Gade G, 2016, AMINO ACIDS, V48, P1677, DOI 10.1007/s00726-016-2229-9; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Huybrechts J, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00951.x; Jiang HB, 2013, P NATL ACAD SCI USA, V110, pE3526, DOI 10.1073/pnas.1310676110; Kean L, 2002, AM J PHYSL REGUL INT, V282; LaSalle J., 1991, Redia, V74, P315; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; MATSUMOTO S, 1989, INSECT BIOCHEM, V19, P277, DOI 10.1016/0020-1790(89)90073-5; NACHMAN RJ, 1986, BIOCHEM BIOPH RES CO, V140, P357, DOI 10.1016/0006-291X(86)91098-3; NACHMAN RJ, 1986, SCIENCE, V234, P71, DOI 10.1126/science.3749893; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Ons S, 2011, INSECT MOL BIOL, V20, P29, DOI 10.1111/j.1365-2583.2010.01050.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Predel R, 2012, SYST BIOL, V61, P609, DOI 10.1093/sysbio/sys003; Predel R, 2012, PEPTIDES, V34, P39, DOI 10.1016/j.peptides.2011.10.008; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Roller L, 2016, CELL TISSUE RES, V364, P499, DOI 10.1007/s00441-015-2352-z; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Roth S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-50; Schmitt F, 2015, J PROTEOME RES, V14, P1504, DOI 10.1021/pr5011636; Spit J, 2012, CAN J ZOOL, V90, P489, DOI 10.1139/Z2012-014; Sterkel M, 2011, J PROTEOME RES, V10, P3363, DOI 10.1021/pr2001012; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka Y, 2014, PEPTIDES, V53, P125, DOI 10.1016/j.peptides.2013.07.027; TAUSSIG R, 1984, P NATL ACAD SCI-BIOL, V81, P4988, DOI 10.1073/pnas.81.15.4988; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Uchiyama H, GEN COMP ENDOCRINOL; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; Veenstra JA, 2016, GEN COMP ENDOCR, V230, P153, DOI 10.1016/j.ygcen.2016.04.013; Veenstra JA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00454; Veenstra JA, 2012, PEPTIDES, V35, P122, DOI 10.1016/j.peptides.2012.02.019; Whitfield JB, 1998, ANNU REV ENTOMOL, V43, P129, DOI 10.1146/annurev.ento.43.1.129; Xu G, 2016, SCI REP-UK, V6, DOI 10.1038/srep28976; Yu N, 2013, PEPTIDES, V41, P107, DOI 10.1016/j.peptides.2012.12.005; Zitnan D., 2012, INSECT ENDOCNNOLOGY, P253, DOI DOI 10.1016/B978-0-12-384749-2.10007-X	48	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193561	10.1371/journal.pone.0193561	http://dx.doi.org/10.1371/journal.pone.0193561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489917	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000091
J	Deng, YX; Peng, QQ; Yang, S; Jian, D; Wang, B; Huang, YX; Xie, HF; Li, J				Deng, Yuxuan; Peng, Qinqin; Yang, Sai; Jian, Dan; Wang, Ben; Huang, Yingxue; Xie, Hongfu; Li, Ji			The Rosacea-specific Quality-of-Life instrument (RosQol): Revision and validation among Chinese patients	PLOS ONE			English	Article							VERSION; RELIABILITY; VALIDITY; CARE	Rosacea is a common chronic facial disorder that affects patients' health-related quality of life; the only questionnaire designed specifically for rosacea is the Rosacea-specific Quality-of-Life instrument (RosQol). However, the questionnaire has not been validated among Chinese patients. This study aimed to validate the Chinese version of the RosQol. First, we translated the questionnaire into Chinese. Then, rosacea patients completed the RosQol and Dermatology Life Quality Index, indicating the disease's impact on their lives. We also collected patients' demographic and clinical data, including symptom self-evaluation scores and rosacea severity scores. Internal consistency was determined by using Cronbach's alpha, test-retest reliability, and Spearman's correlation. Criterion-related validity and internal construct validity were also determined. Most RosQol items showed good internal consistency. However, items 13 and 19 were not sufficiently sensitive for use in the Chinese population; we deleted them and constructed the adjusted Chinese-version RosQol, which had good reliability and validity. When patients' clinical symptoms changed, the scores on the relevant dimensions of the adjusted RosQol also changed. Some RosQol items were not suitable for use in the Chinese sample. The adjusted Chinese-version RosQol was easy to complete, well received by patients, and demonstrated acceptable validity and reliability.	[Deng, Yuxuan; Peng, Qinqin; Yang, Sai; Jian, Dan; Wang, Ben; Huang, Yingxue; Xie, Hongfu; Li, Ji] Cent S Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China	Central South University	Xie, HF; Li, J (corresponding author), Cent S Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China.	xiehongfu1964@aliyun.com; liji_xy@csu.edu.cn						Aksoy B, 2010, BRIT J DERMATOL, V163, P719, DOI 10.1111/j.1365-2133.2010.09894.x; Bastos JL, 2012, REV SAUDE PUBL, V46, P269, DOI 10.1590/S0034-89102012000200009; Chren MM, 2001, J CUTAN MED SURG, V5, P105, DOI 10.1007/s102270000010; Chren MM, 1997, ARCH DERMATOL, V133, P1433, DOI 10.1001/archderm.133.11.1433; Crawford GH, 2004, J AM ACAD DERMATOL, V51, P327, DOI 10.1016/j.jaad.2004.03.030; Cullen DL, 2003, CHEST, V123, P1284, DOI 10.1378/chest.123.4.1284; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; FULLER BF, 1984, PSYCHOL MED, V14, P159, DOI 10.1017/S0033291700003160; Ghanem VC, 2003, CORNEA, V22, P230, DOI 10.1097/00003226-200304000-00009; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Gupta MA, 2005, BRIT J DERMATOL, V153, P1176, DOI 10.1111/j.1365-2133.2005.06895.x; Jankovic S, 2013, QUAL LIFE RES, V22, P161, DOI 10.1007/s11136-012-0136-4; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Kligman Albert M, 2006, J Cosmet Dermatol, V5, P77, DOI 10.1111/j.1473-2165.2006.00228.x; Lazaridou E, 2011, J EUR ACAD DERMATOL, V25, P1428, DOI 10.1111/j.1468-3083.2011.03995.x; Lee SY, 2014, SKIN RES TECHNOL, V20, P341, DOI 10.1111/srt.12124; Michel JL, 2003, ANN DERMATOL VENER, V130, P20; Nicholson K, 2007, J AM ACAD DERMATOL, V57, P213, DOI 10.1016/j.jaad.2007.01.048; Park J, 2012, J ENDOUROL, V26, P1518, DOI 10.1089/end.2012.0235; Pelle MT, 2004, J AM ACAD DERMATOL, V51, P499, DOI 10.1016/j.jaad.2004.03.033; Renzi C, 2005, J EUR ACAD DERMATOL, V19, P712, DOI 10.1111/j.1468-3083.2005.01301.x; Salamon Malgorzata, 2008, Przegl Lek, V65, P385; Spoendlin J, 2012, BRIT J DERMATOL, V167, P598, DOI 10.1111/j.1365-2133.2012.11037.x; Strauss ME, 2005, PSYCHOL ASSESSMENT, V17, P395, DOI 10.1037/1040-3590.17.4.395; Tan J, 2013, J AM ACAD DERMATOL, V69, pS27, DOI 10.1016/j.jaad.2013.04.043; Valero A, 2008, J INVEST ALLERG CLIN, V18, P426; Webster GF, 2009, MED CLIN N AM, V93, P1183, DOI 10.1016/j.mcna.2009.08.007; Wilkin J, 2002, J AM ACAD DERMATOL, V46, P584, DOI 10.1067/mjd.2002.120625	28	15	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192487	10.1371/journal.pone.0192487	http://dx.doi.org/10.1371/journal.pone.0192487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489857	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000029
J	Cunha, CCDB; Gama, AR; Cintra, LC; Bataus, LAM; Ulhoa, CJ				de Queiroz Brito Cunha, Carolina Candida; Gama, Aline Rodrigues; Cintra, Lorena Cardoso; Mendes Bataus, Luiz Artur; Ulhoa, Cirano Jose			Improvement of bread making quality by supplementation with a recombinant xylanase produced by Pichia pastoris	PLOS ONE			English	Article							MICROBIAL XYLANASES; PROTEIN EXPRESSION; ENDOXYLANASES; PERSPECTIVES; PURIFICATION; FAMILIES; ENZYMES; IMPACT; FOOD	Xylanases (EC 3.2.1.8) are hydrolytic enzymes, which randomly cleave the beta-1,4-linked xylose residues from xylan. The synthetic gene xynBS27 from Streptomyces sp. S27 was successfully cloned and expressed in Pichia pastoris. The full-length gene consists of 729 bp and encodes 243 amino acids including 51 residues of a putative signal peptide. This enzyme was purified in two steps and was shown to have a molecular weight of 20 kDa. The purified r-XynBS27 was active against beechwood xylan and oat spelt xylan as expected for GH 11 family. The optimum pH and temperature values for the enzyme were 6.0 and 75 degrees C, respectively. The Km and Vmax were 12.38 mg/mL and 13.68 mu mol min/mg, respectively. The r-XynBS27 showed high xylose tolerance and was inhibited by some metal ions and by SDS. r-XynBS27 was employed as an additive in the bread making process. A decrease in firmness, stiffness and consistency, and improvements in specific volume and reducing sugar content were recorded.	[de Queiroz Brito Cunha, Carolina Candida; Gama, Aline Rodrigues; Cintra, Lorena Cardoso; Mendes Bataus, Luiz Artur; Ulhoa, Cirano Jose] Univ Fed Goias, Campus Samambaia, Goiania, Go, Brazil; [Cintra, Lorena Cardoso; Ulhoa, Cirano Jose] Univ Brasilia, Campus Darcy Ribeiro, Brasilia, DF, Brazil	Universidade Federal de Goias; Universidade de Brasilia	Ulhoa, CJ (corresponding author), Univ Fed Goias, Campus Samambaia, Goiania, Go, Brazil.; Ulhoa, CJ (corresponding author), Univ Brasilia, Campus Darcy Ribeiro, Brasilia, DF, Brazil.	ulhoa@ufg.br	Cintra, Lorena/AAF-3468-2020; Ulhoa, CIRANO/AAV-9374-2020	Cardoso Cintra, Lorena/0000-0002-6348-9005; Ulhoa, Cirano/0000-0002-4171-6465	Research Foundation of the State of Goias (FAPEG, GO, Brazil); National Council for Scientific and Technological Development (CNPq, Brazil) [407804/2013-7]; National Council for Scientific and Technological Development (CNPq, Brazil)	Research Foundation of the State of Goias (FAPEG, GO, Brazil); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work of CCQBC, ARG and LCC was funded by Research Foundation of the State of Goias (FAPEG, GO, Brazil) and National Council for Scientific and Technological Development (CNPq, Brazil; grant 407804/2013-7 to CJU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work of CCQBC, ARG and LCC was funded by Research Foundation of the State of Goias (FAPEG, GO, Brazil) and National Council for Scientific and Technological Development (CNPq, Brazil). The authors wish to thank Dr. Robert Pogue for the English revision of the text and for fruitful discussions.	Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; BASTAWDE KB, 1992, WORLD J MICROB BIOT, V8, P353, DOI 10.1007/BF01198746; Beaugrand J, 2004, CARBOHYD RES, V339, P2529, DOI 10.1016/j.carres.2004.08.012; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bull AT, 2005, ANTON LEEUW INT J G, V87, P65, DOI 10.1007/s10482-004-6562-8; Butt MS, 2008, FOOD TECHNOL BIOTECH, V46, P22; Celik E, 2012, BIOTECHNOL ADV, V30, P1108, DOI 10.1016/j.biotechadv.2011.09.011; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chakdar H., 2016, BIO-TECHNOL, V3, P6; Choi JH, 2006, J MICROBIOL BIOTECHN, V16, P57; Cintra LC, 2017, INT J BIOL MACROMOL; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Courtin CM, 2001, J CEREAL SCI, V33, P301, DOI 10.1006/jcrs.2000.0354; Brito-Cunha CCD, 2013, APPL BIOCHEM BIOTECH, V170, P598, DOI 10.1007/s12010-013-0193-3; Deesukon W, 2013, MOL BIOTECHNOL, V54, P37, DOI 10.1007/s12033-012-9541-8; Ergun BG, 2016, BIOPROC BIOSYST ENG, V39, P1, DOI 10.1007/s00449-015-1476-6; Gokmen V, 2008, EUR FOOD RES TECHNOL, V226, P1031, DOI 10.1007/s00217-007-0628-6; Goesaert H, 2005, TRENDS FOOD SCI TECH, V16, P12, DOI 10.1016/j.tifs.2004.02.011; Juturu V, 2012, BIOTECHNOL ADV, V30, P1219, DOI 10.1016/j.biotechadv.2011.11.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li N, 2009, APPL BIOCHEM BIOTECH, V159, P521, DOI 10.1007/s12010-008-8411-0; Luo L, 2016, J CHEM TECHNOL BIOT, V91, P1093, DOI 10.1002/jctb.4690; Mander P, 2014, PROCESS BIOCHEM, V49, P451, DOI 10.1016/j.procbio.2013.12.011; MartinezAnaya MA, 1997, Z LEBENSM UNTERS F A, V205, P209, DOI 10.1007/s002170050152; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Ning L, 2008, J MICROBIOL BIOTECHN, V18, P410; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Poutanen K, 1997, TRENDS FOOD SCI TECH, V8, P300, DOI 10.1016/S0924-2244(97)01063-7; Pradeep GC, 2013, PROCESS BIOCHEM, V48, P1188, DOI 10.1016/j.procbio.2013.06.007; Puls J, 1997, MACROMOL SYMP, V120, P183, DOI 10.1002/masy.19971200119; Qiu ZH, 2010, ENZYME MICROB TECH, V46, P506, DOI 10.1016/j.enzmictec.2010.02.003; Spohner SC, 2015, J BIOTECHNOL, V202, P118, DOI 10.1016/j.jbiotec.2015.01.027; Wanderley MSO, 2013, CHEM PAP, V67, P682, DOI 10.2478/s11696-013-0363-3; Xu B, 2016, J MICROBIOL BIOTECHN, V26, P9, DOI 10.4014/jmb.1504.04021; Xu Y, 2016, J IND MICROBIOL BIOT, V43, P663, DOI 10.1007/s10295-016-1736-8; Yan QJ, 2009, J MOL CATAL B-ENZYM, V58, P72, DOI 10.1016/j.molcatb.2008.11.010; Yegin S, 2017, FOOD CHEM, V221, P67, DOI 10.1016/j.foodchem.2016.10.003	39	16	18	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0192996	10.1371/journal.pone.0192996	http://dx.doi.org/10.1371/journal.pone.0192996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481569	Green Published, Green Submitted, gold			2022-12-27	WOS:000426202700007
J	Gevaert, AB; Witvrouwen, I; Vrints, CJ; Heidbuchel, H; Van Craenenbroeck, EM; Van Laere, SJ; Van Craenenbroeck, AH				Gevaert, Andreas B.; Witvrouwen, Isabel; Vrints, Christiaan J.; Heidbuchel, Hein; Van Craenenbroeck, Emeline M.; Van Laere, Steven J.; Van Craenenbroeck, Amaryllis H.			MicroRNA profiling in plasma samples using qPCR arrays: Recommendations for correct analysis and interpretation	PLOS ONE			English	Article							NORMALIZATION; CANCER; VARIANCE; GENES; MIRNA	MicroRNA (miRNA) regulate gene expression through posttranscriptional mRNA degradation or suppression of translation. Many (pre) analytical issues remain to be resolved for miRNA screening with TaqMan Low Density Arrays (TLDA) in plasma samples, such as optimal RNA isolation, preamplification and data normalization. We optimized the TLDA protocol using three RNA isolation protocols and preamplification dilutions. By using 100 mu L elution volume during RNA isolation and adding a preamplification step without dilution, 49% of wells were amplified. Informative target miRNA were defined as having quantification cycle values <= 35 in at least 20% of samples and low technical variability (CV across 2 duplicates of 1 sample <4%). A total of 218 miRNA was considered informative (= 59% of all target miRNA). Different normalization strategies were compared: exogenous Ath-miR-159a, endogenous RNA U6, and three mathematical normalization techniques: geNorm (Qbase, QB) and NormFinder (NF) normalization algorithms, and global mean calculation. To select the best normalization method, technical variability, biological variability, stability, and the extent to which the normalization method reduces data dispersion were calculated. The geNorm normalization algorithm reduced data dispersion to the greatest extent, while endogenous RNA U6 performed worst. In conclusion, for miRNA profiling in plasma samples using TLDA cards we recommend: 1. Implementing a preamplification step in the TLDA protocol without diluting the final preamplification product 2. A stepwise approach to exclude non-informative miRNA based on quality control parameters 3. Against using snoRNA U6 as normalization method for relative quantification 4. Using the geNorm algorithm as normalization method for relative quantification.	[Gevaert, Andreas B.; Witvrouwen, Isabel; Vrints, Christiaan J.; Heidbuchel, Hein; Van Craenenbroeck, Emeline M.; Van Craenenbroeck, Amaryllis H.] Univ Antwerp, Dept Translat Pathophysiol Res, Lab Cellular & Mol Cardiol, Res Grp Cardiovasc Dis, Antwerp, Belgium; [Gevaert, Andreas B.; Witvrouwen, Isabel; Vrints, Christiaan J.; Heidbuchel, Hein; Van Craenenbroeck, Emeline M.] Antwerp Univ Hosp UZA, Dept Cardiol, Edegem, Belgium; [Van Laere, Steven J.] Univ Antwerp, Dept Med Oncol, Translat Canc Res Unit, Antwerp, Belgium; [Van Craenenbroeck, Amaryllis H.] Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium; [Van Craenenbroeck, Amaryllis H.] Antwerp Univ Hosp UZA, Dept Nephrol, Edegem, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp	Gevaert, AB (corresponding author), Univ Antwerp, Dept Translat Pathophysiol Res, Lab Cellular & Mol Cardiol, Res Grp Cardiovasc Dis, Antwerp, Belgium.; Gevaert, AB (corresponding author), Antwerp Univ Hosp UZA, Dept Cardiol, Edegem, Belgium.	andreas.gevaert@uantwerpen.be	Van Craenenbroeck, Amaryllis/M-1241-2019; Van Craenenbroeck, Emeline/AAG-4540-2020; Heidbuchel, Hein/C-2331-2019; Heidbuchel, Hein/AAU-2711-2021; Gevaert, Andreas B./B-2484-2017	Van Craenenbroeck, Emeline/0000-0001-7686-2668; Heidbuchel, Hein/0000-0001-9301-8127; Heidbuchel, Hein/0000-0001-9301-8127; Gevaert, Andreas B./0000-0002-1338-4133	Antwerp University [BOF DOCPRO 31495]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [1194918N]	Antwerp University; Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO)	This work was supported by a grant from Antwerp University (BOF DOCPRO 31495, http://uantwerpen.be/) (EMVC). IW holds a PhD fellowship of the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (1194918N, http://www.two.be/). EMVC is a Fonds voor Wetenschappelijk Onderzoek Vlaanderen senior clinical investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; De Ronde MWJ, 2017, RNA, V23, P811, DOI 10.1261/rna.059063.116; de Ronde MWJ, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.12.05; Dellett M, 2016, EXPERT REV MOL DIAGN, V16, P407, DOI 10.1586/14737159.2016.1152184; Deo A, 2011, J BIOINF COMPUT BIOL, V9, P795, DOI 10.1142/S0219720011005793; Dudoit S, 2002, STAT SINICA, V12, P111; Goswami RS, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-47; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Korenkova V, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0033-9; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Latet SC, 2017, CARDIOLOGY, V138, P91, DOI 10.1159/000477235; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Meyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038222; Okino Steven T, 2016, Biomol Detect Quantif, V6, P13, DOI 10.1016/j.bdq.2015.12.001; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Peschansky VJ, 2014, EPIGENETICS-US, V9, P3, DOI 10.4161/epi.27473; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Stoorvogel W, 2012, BLOOD, V119, P646, DOI 10.1182/blood-2011-11-389478; Suo C, 2010, RNA, V16, P2293, DOI 10.1261/rna.2345710; Van Craenenbroeck AH, 2016, NEPHROL DIAL TRANSPL, V31, P2064, DOI 10.1093/ndt/gfw303; Van Craenenbroeck AH, 2015, AM J PHYSIOL-HEART C, V309, pH2008, DOI 10.1152/ajpheart.00346.2015; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vegter EL, 2016, EUR J HEART FAIL, V18, P457, DOI 10.1002/ejhf.495	34	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193173	10.1371/journal.pone.0193173	http://dx.doi.org/10.1371/journal.pone.0193173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474497	gold, Green Published			2022-12-27	WOS:000426049500064
J	Alemayehu, M; Deyessa, N; Medihin, G; Fekadu, A				Alemayehu, Melkam; Deyessa, Negussie; Medihin, Girmay; Fekadu, Abebaw			A descriptive analysis of depression and pain complaints among patients with cancer in a low income country	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; ETHIOPIA; PREVALENCE; ANXIETY; ASSOCIATION; HEALTH; IMPACT	Background In high income countries, cancer is one of the leading causes of death, with co-morbid depression contributing to the risk of increased mortality. However, both cancer and depression are neglected conditions in low income countries. The current study assessed the magnitude of depression and the association of pain complaints with depression among patients with cancer in a low income country. Method In this cross-sectional study participants were 390 patients with established diagnosis of cancer, who were recruited consecutively when visiting a tertiary treatment centre in Addis Ababa, Ethiopia. The occurrence of depression was determined using the nine items Patient Health Questionnaire (PHQ-9). Major depressive disorder was confirmed: (1) when five or more of the PHQ-9 symptoms were endorsed as occurring for at least 'more than seven days', with the exception of suicidal ideation item which counted as a positive rating if it had occurred even once in the previous fifteen days. (2) one of the symptoms has to be either depressed mood or loss of interest. Pain complaint was measured by Numeral Rating Scale (NRS) and severity of pain was assessed using Verbal Rating Scale (VRS). Results The prevalence of major depressive disorder was 16.4% (95%Cl: 13.1%, 20.4%), and subthreshold depression was 17.4% (95%Cl: 14.0%, 21.5%). Pain complaints occurred in 69.0% (95%Cl: 64.3%, 73.4%) of the participants. The odds of having a major depressive symptom was over four times higher among participants who had pain. Limitations The study was cross sectional and liable to recall bias. Recruitment was carried out in a tertiary referral hospital, which might lead to the selection of more economically well-off and educated participants limiting generalizability of the study. Moreover, we did not control for cancer types, which may be related to pain and the experience of depression. Some of the somatic symptoms in PHQ9 may also be related to the cancer itself. Conclusions This study highlights the clinical significance of both depression and pain complaints in patients with cancer in a low income country. Exploration of the impact of depressive disorders on quality of life and outcome of cancer is an important area for further research in low income countries.	[Alemayehu, Melkam; Fekadu, Abebaw] Addis Ababa Univ, Sch Med, Dept Psychiat, Coll Hlth Sci, Addis Ababa, Ethiopia; [Deyessa, Negussie] Addis Ababa Univ, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Medihin, Girmay] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Fekadu, Abebaw] Addis Ababa Univ, Coll Hlth Sci, Ctr Innovat Drug Dev & Therapeut Trials Africa CD, Addis Ababa, Ethiopia; [Fekadu, Abebaw] Univ Sussex, Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Brighton, E Sussex, England; [Fekadu, Abebaw] Kings Coll London, Inst Psychiat, Dept Psychol Med, Ctr Affect Disorders, London, England	Addis Ababa University; Addis Ababa University; Addis Ababa University; Addis Ababa University; University of Brighton; University of Sussex; University of London; King's College London	Alemayehu, M (corresponding author), Addis Ababa Univ, Sch Med, Dept Psychiat, Coll Hlth Sci, Addis Ababa, Ethiopia.	melkish2002@gmail.com		Kebede, Melkam/0000-0003-0710-3435; Wassie, Abebaw Fekadu/0000-0003-2219-0952	MRC [MR/M025470/1] Funding Source: UKRI; Medical Research Council [MR/M025470/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AFCRN, 2017, ADD AB CIT CANC REG; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Awas M, 1999, ACTA PSYCHIAT SCAND, V100, P56, DOI 10.1111/j.1600-0447.1999.tb10695.x; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; Brown LF, 2010, PSYCHO-ONCOLOGY, V19, P734, DOI 10.1002/pon.1627; Brunelli C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-42; Cancer Research UK, 2012, WORLDW CANC MORT STA; Chen ML, 2000, J ADV NURS, V32, P944, DOI 10.1046/j.1365-2648.2000.01560.x; Ciaramella A, 2001, PSYCHO-ONCOLOGY, V10, P156, DOI 10.1002/pon.505; Cousins S., 2013, MIDDLE E N AFRICA SU; Deyessa N, 2008, SCAND J PUBLIC HEALT, V36, P589, DOI 10.1177/1403494808086976; Dogar I., 2009, MED SCI, V25; Drug Administration and Control Authority of Ethiopia (DACA), 2004, STAND TREATM GUID DI; EPHA, 2011, BASELINE EVALUATION, V1; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Everdingen MHJVDBV, 2007, PAIN, V132, P312, DOI 10.1016/j.pain.2007.08.022; Ferreira-Valente M. P-RJ A, 2011, VALIDITY 4 PAIN INTE, V152, P6; Gasto-Johansson F., 1997, CANCER PRACT, V7, P240; GBD, 2015, LANCET, V388, P65; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; GLOBOCAN, 2012, EST CANC INC MORT PR; Hailemariam S, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-23; Hanlon C, 2010, BRIT J PSYCHIAT, V197, P468, DOI 10.1192/bjp.bp.109.076497; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Hanna T., 2009, BMC INT HLTH HUMAN R, V10; Hjermstad MJ FP, 2011, J PAIN SYMPTOM MANAG, V41, P20; Jadoon NA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-594; Katon W, 2002, J PSYCHOSOM RES, V53, P859, DOI 10.1016/S0022-3999(02)00313-6; Klien ND, 2009, J AM ACAD CHILD PSY, V48, P7; Kroenke K., 2001, J GED INTER MED, V16; Kroenke K, 2010, J PAIN SYMPTOM MANAG, V40, P327, DOI 10.1016/j.jpainsymman.2009.12.023; Lakew Serawit, 2015, BMC Res Notes, V8, P657, DOI 10.1186/s13104-015-1630-x; Massie M., 2004, J NATL CANC I MONOGR; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Mogga S, 2006, BRIT J PSYCHIAT, V189, P241, DOI 10.1192/bjp.bp.105.013417; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Ng C., 2010, J AFRICAN DISORDERS, V131; Nuhu FT, 2009, AFR J PSYCHIATRY, V12, P64; Pandey M., 2005, WORLD J SURG ONCOLOG; Pinquart M, 2010, PSYCHOL MED, V40, P1797, DOI 10.1017/S0033291709992285; Satin J., 2009, DEPRESSION PREDICT D, V10; Sherif T., 2001, Eastern Mediterranean Health Journal, V7, P502; SPIEGEL D, 1994, CANCER, V74, P2570, DOI 10.1002/1097-0142(19941101)74:9<2570::AID-CNCR2820740927>3.0.CO;2-3; Spoletini I., 2009, SURG ONCOLOGY, V10; Tavoli A., 2007, BMC CANCER, V8, P1471; Tavoli A, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-28; Walker J, 2013, ANN ONCOL, V24, P895, DOI 10.1093/annonc/mds575; Woldeamanuel YW, 2013, LANCET ONCOL, V14, P289, DOI 10.1016/S1470-2045(12)70399-6; World Health Organization, 2011, CANC FACT SHEET; World Health Organization: Regional Office for Africa, 2012, ETH COUNTR HLTH PROF	52	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							0193713	10.1371/journal.pone.0193713	http://dx.doi.org/10.1371/journal.pone.0193713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513716	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000426896800071
J	Edmunds, K; Gislason, M; Sigurdsson, S; Gudnason, V; Harris, T; Carraro, U; Gargiulo, P				Edmunds, Kyle; Gislason, Magnus; Sigurdsson, Sigurdur; Gudnason, Vilmundur; Harris, Tamara; Carraro, Ugo; Gargiulo, Paolo			Advanced quantitative methods in correlating sarcopenic muscle degeneration with lower extremity function biometrics and comorbidities	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; HUMAN SKELETAL-MUSCLE; COMPUTED-TOMOGRAPHY; PHYSICAL FUNCTION; TISSUE CHANGES; OLDER-PEOPLE; AGE; HEALTH; STRENGTH; MORTALITY	Sarcopenic muscular degeneration has been consistently identified as an independent risk factor for mortality in aging populations. Recent investigations have realized the quantitative potential of computed tomography (CT) image analysis to describe skeletal muscle volume and composition; however, the optimum approach to assessing these data remains debated. Current literature reports average Hounsfield unit (HU) values and/or segmented soft tissue cross-sectional areas to investigate muscle quality. However, standardized methods for CT analyses and their utility as a comorbidity index remain undefined, and no existing studies compare these methods to the assessment of entire radiodensitometric distributions. The primary aim of this study was to present a comparison of nonlinear trimodal regression analysis (NTRA) parameters of entire radiodensitometric muscle distributions against extant CT metrics and their correlation with lower extremity function (LEF) biometrics (normal/fast gait speed, timed up-and-go, and isometric leg strength) and biochemical and nutritional parameters, such as total solubilized cholesterol (SCHOL) and body mass index (BMI). Data were obtained from 3,162 subjects, aged 66-96 years, from the population-based AGES-Reykjavik Study. 1-D k-means clustering was employed to discretize each biometric and comorbidity dataset into twelve subpopulations, in accordance with Sturges' Formula for Class Selection. Dataset linear regressions were performed against eleven NTRA distribution parameters and standard CT analyses (fat/muscle cross-sectional area and average HU value). Parameters from NTRA and CT standards were analogously assembled by age and sex. Analysis of specific NTRA parameters with standard CT results showed linear correlation coefficients greater than 0.85, but multiple regression analysis of correlative NTRA parameters yielded a correlation coefficient of 0.99 (P<0.005). These results highlight the specificities of each muscle quality metric to LEF biometrics, SCHOL, and BMI, and particularly highlight the value of the connective tissue regime in this regard.	[Edmunds, Kyle; Gislason, Magnus; Gargiulo, Paolo] Reykjavik Univ, Inst Biomed & Neural Engn, Reykjavik, Iceland; [Sigurdsson, Sigurdur; Gudnason, Vilmundur] Iceland Heart Assoc Hjartavernd, Kopavogur, Iceland; [Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Harris, Tamara] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Carraro, Ugo] IRRCS Fdn Osped San Camillo, Venice, Italy; [Gargiulo, Paolo] Landspitali, Dept Rehabil, Reykjavik, Iceland	Reykjavik University; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); IRCCS Ospedale San Camillo	Edmunds, K (corresponding author), Reykjavik Univ, Inst Biomed & Neural Engn, Reykjavik, Iceland.	kyle14@ru.is	Gudnason, Vilmundur/AAE-7126-2019; Gíslason, Magnús/AAB-6761-2020	Gudnason, Vilmundur/0000-0001-5696-0084; Carraro, Ugo/0000-0002-0924-4998; Gargiulo, Paolo/0000-0002-5049-4817; Edmunds, Kyle/0000-0002-6591-4116	Landspitali Scientific Fund [A-2014-072]	Landspitali Scientific Fund	This work was funded by the Landspitali Scientific Fund, PI: Paolo Gargiulo, A-2014-072 (http://www.landspitali.is/).	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; BROOKS SV, 1994, MED SCI SPORT EXER, V26, P432; Buford TW, 2012, EXP GERONTOL, V47, P38, DOI 10.1016/j.exger.2011.10.001; Carraro U, 2015, EUR J TRANSL MYOL, V25, P129, DOI 10.4081/ejtm.2015.5133; Carraro U, 2015, EUR J TRANSL MYOL, V25, P77, DOI 10.4081/ejtm.2015.4832; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Chang M, 2013, J AM GERIATR SOC, V61, P237, DOI 10.1111/jgs.12077; COOPER R, 2010, BMJ-BRIT MED J, V341, DOI DOI 10.1136/BMJ.C4467; De Roos AM, 2008, ECOL LETT, V11, P1, DOI 10.1111/j.1461-0248.2007.01121.x; Ding J, 2015, JAMA NEUROL, V72, P682, DOI 10.1001/jamaneurol.2015.0174; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Edmunds KJ, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/8932950; Edmunds KJ, 2015, EUR J TRANSL MYOL, V25, P63, DOI 10.4081/ejtm.2015.4847; Edmunds KJ, 2016, EUR J TRANSL MYOL, V26, P93, DOI 10.4081/ejtm.2016.6015; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b; Gargiulo P, 2010, NEUROL RES, V32, P13, DOI 10.1179/016164109X12536042424171; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Goodpaster BH, 2000, J APPL PHYSIOL, V89, P104, DOI 10.1152/jappl.2000.89.1.104; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Helgason T, 2005, ARTIF ORGANS, V29, P440, DOI 10.1111/j.1525-1594.2005.29073.x; Hicks GE, 2005, J GERONTOL A-BIOL, V60, P882, DOI 10.1093/gerona/60.7.882; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Johannesdottir F, 2012, CALCIFIED TISSUE INT, V90, P354, DOI 10.1007/s00223-012-9585-6; Jubrias SA, 1997, PFLUG ARCH EUR J PHY, V434, P246, DOI 10.1007/s004240050392; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072, DOI 10.1152/jappl.2000.89.3.1072; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lang T, 2008, BONE, V42, P798, DOI 10.1016/j.bone.2007.12.002; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Lang T, 2010, J BONE MINER RES, V25, P513, DOI 10.1359/jbmr.090807; Larsson L, 1997, AM J PHYSIOL-CELL PH, V272, pC638, DOI 10.1152/ajpcell.1997.272.2.C638; LARSSON L, 1978, ACTA PHYSIOL SCAND, V103, P31, DOI 10.1111/j.1748-1716.1978.tb06187.x; Lynch G S, 2001, Exerc Sport Sci Rev, V29, P141, DOI 10.1097/00003677-200110000-00002; Mah P, 2010, DENTOMAXILLOFAC RAD, V39, P323, DOI 10.1259/dmfr/19603304; Maslove DM, 2013, J AM MED INFORM ASSN, V20, P544, DOI 10.1136/amiajnl-2012-000929; MAUGHAN RJ, 1983, J PHYSIOL-LONDON, V338, P37, DOI 10.1113/jphysiol.1983.sp014658; Mercuri E, 2002, NEUROMUSCULAR DISORD, V12, P631, DOI 10.1016/S0960-8966(02)00023-8; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Newman AB, 2003, J AM GERIATR SOC, V51, P1602, DOI 10.1046/j.1532-5415.2003.51534.x; Overend TJ, 1992, J GERONTOLOGY, V47; Petursson Edmunds KJ, 2015, COMP MATH MATH PHYS; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rantanen T, 1999, J GERONTOL A-BIOL, V54, pM172, DOI 10.1093/gerona/54.4.M172; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; REED RL, 1991, J AM GERIATR SOC, V39, P555, DOI 10.1111/j.1532-5415.1991.tb03592.x; Reinders I, 2016, AM J EPIDEMIOL, V183, P53, DOI 10.1093/aje/kwv153; Safran C, 2007, J AM MED INFORM ASSN, V14, P1, DOI 10.1197/jamia.M2273; Sayer AA, 2013, AGE AGEING, V42, P145, DOI 10.1093/ageing/afs191; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Scott D, 2016, MED J AUSTRALIA, V205, P329, DOI 10.5694/mja16.00446; SIGURDSSON E, 1993, EUR HEART J, V14, P584, DOI 10.1093/eurheartj/14.5.584; Sigurdsson G, 2006, BONE, V39, P644, DOI 10.1016/j.bone.2006.03.020; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Sur MD, 2015, ANN SURG ONCOL, V22, P3897, DOI 10.1245/s10434-015-4763-1; SWASH M, 1995, MUSCLE NERVE, V18, P708, DOI 10.1002/mus.880180706; Volpi E, 2004, CURR OPIN CLIN NUTR, V7, P405, DOI 10.1097/01.mco.0000134362.76653.b2; von Bonsdorff MB, 2013, AGE, V35, P1401, DOI 10.1007/s11357-012-9427-5; Wang HZ, 2011, R J, V3, P29, DOI 10.32614/rj-2011-015; YOUNG A, 1984, EUR J CLIN INVEST, V14, P282, DOI 10.1111/j.1365-2362.1984.tb01182.x	70	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193241	10.1371/journal.pone.0193241	http://dx.doi.org/10.1371/journal.pone.0193241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513690	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800046
J	Kong, HH; Lee, SW; You, SH; Ahn, CK				Kong, Hyun Ho; Lee, Seo Won; You, Sung Hyun; Ahn, Choon Ki			Novel vehicle detection system based on stacked DoG kernel and AdaBoost	PLOS ONE			English	Article							TRACKING	This paper proposes a novel vehicle detection system that can overcome some limitations of typical vehicle detection systems using AdaBoost-based methods. The performance of the AdaBoost-based vehicle detection system is dependent on its training data. Thus, its performance decreases when the shape of a target differs from its training data, or the pattern of a preceding vehicle is not visible in the image due to the light conditions. A stacked Difference of Gaussian (DoG)-based feature extraction algorithm is proposed to address this issue by recognizing common characteristics, such as the shadow and rear wheels beneath vehicles of vehicles under various conditions. The common characteristics of vehicles are extracted by applying the stacked DoG shaped kernel obtained from the 3D plot of an image through a convolution method and investigating only certain regions that have a similar patterns. A new vehicle detection system is constructed by combining the novel stacked DoG feature extraction algorithm with the AdaBoost method. Experiments are provided to demonstrate the effectiveness of the proposed vehicle detection system under different conditions.	[Kong, Hyun Ho; You, Sung Hyun; Ahn, Choon Ki] Korea Univ, Sch Elect Engn, Seoul, South Korea; [Lee, Seo Won] Korea Univ, Dept Automot Convergence, Seoul, South Korea	Korea University; Korea University	Ahn, CK (corresponding author), Korea Univ, Sch Elect Engn, Seoul, South Korea.	hironaka@korea.ac.kr	Ahn, Choon Ki/I-2737-2012	Ahn, Choon Ki/0000-0003-0993-9658	NRF through the Ministry of Science, ICT, and Future Planning [NRF-2017R1A1A1A05001325]; "Human Resources program in Energy Technology" of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry AMP; Energy, Requblic of Korea [20174030201820]	NRF through the Ministry of Science, ICT, and Future Planning; "Human Resources program in Energy Technology" of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry AMP; Energy, Requblic of Korea	This work was supported partially by the NRF through the Ministry of Science, ICT, and Future Planning under Grant NRF-2017R1A1A1A05001325, and partially by "Human Resources program in Energy Technology" of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry & Energy, Requblic of Korea (No. 20174030201820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CK, 2016, IEEE T CIRCUITS-I, V63, P1210, DOI 10.1109/TCSI.2016.2573281; Ahn CK, 2015, IEEE T AUTOMAT CONTR, V60, P1745, DOI 10.1109/TAC.2015.2398887; Chang WC, 2010, IEEE T SYST MAN CY B, V40, P892, DOI 10.1109/TSMCB.2009.2032527; Di Cairano S, 2013, IEEE T CONTR SYST T, V21, P1236, DOI 10.1109/TCST.2012.2198886; Fu Z, 2012, MEASUREMENT, V45; Gwang Yul Song, 2008, 2008 IEEE Intelligent Vehicles Symposium (IV), P428, DOI 10.1109/IVS.2008.4621139; Han J, 2011, INT J AUTOMOTIVE TEC, V17, P483; Jin LS, 2006, PROCEEDINGS OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON VEHICULAR ELECTRONICS AND SAFETY, P356; Kim G, 2012, OPT REV, V19, P388, DOI 10.1007/s10043-012-0063-1; Kosaka N, 2015, IEEE T INTELL TRANSP, V16, P2599, DOI 10.1109/TITS.2015.2413971; Krose B., 1996, INTRO NEURAL NETWORK, VEighth; Lin BF, 2012, IEEE T INTELL TRANSP, V13, P737, DOI 10.1109/TITS.2011.2182649; Ling Mao, 2010, 2010 International Conference on Communications, Circuits and Systems (ICCCAS), P354, DOI 10.1109/ICCCAS.2010.5581983; Liu JX, 2018, IEEE T SYST MAN CY-S, V48, P1771, DOI 10.1109/TSMC.2017.2758598; Liu JX, 2017, IEEE T IND INFORM, V13, P1742, DOI 10.1109/TII.2017.2654323; Liu JX, 2017, IEEE T IND ELECTRON, V64, P22, DOI 10.1109/TIE.2016.2610400; Liu LC, 2017, IEEE T INTELL TRANSP, V18, P937, DOI 10.1109/TITS.2016.2597299; Liu SM, 2013, INT J ADV ROBOT SYST, V10, DOI 10.5772/57382; Motai Y, 2012, SIGNAL PROCESS-IMAGE, V27, P83, DOI 10.1016/j.image.2011.06.005; Mukhtar A, 2015, IEEE T INTELL TRANSP, V16, P2318, DOI 10.1109/TITS.2015.2409109; Pak JM, 2016, IEEE T CONTR SYST T, V24, P1052, DOI 10.1109/TCST.2015.2472990; Pak JM, 2015, IEEE T IND INFORM, V11, P1089, DOI 10.1109/TII.2015.2462771; Sivaraman S, 2013, IEEE T INTELL TRANSP, V14, P1773, DOI 10.1109/TITS.2013.2266661; Sivaraman S, 2013, IEEE T INTELL TRANSP, V14, P906, DOI 10.1109/TITS.2013.2246835; Sivaraman S, 2010, IEEE T INTELL TRANSP, V11, P267, DOI 10.1109/TITS.2010.2040177; Sum Z, 2002, IEEE WORKSH APPL COM; Sun C, 2015, IEEE T CONTR SYST T, V23, P1197, DOI 10.1109/TCST.2014.2359176; Sun X, 2012, IEEE ICC, P6371, DOI 10.1109/ICC.2012.6364925; Sun ZH, 2002, DSP 2002: 14TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING PROCEEDINGS, VOLS 1 AND 2, P1019, DOI 10.1109/ICDSP.2002.1028263; Teoh SS, 2012, MACH VISION APPL, V23, P831, DOI 10.1007/s00138-011-0355-7; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wu C, 2009, INT C INF ENG COMP S; Xue-Fei Y, 2017, IEEE INT C DIG SIGN; 송광열, 2009, [Transactions of KSAE, 한국자동차공학회 논문집], V17, P1	35	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193733	10.1371/journal.pone.0193733	http://dx.doi.org/10.1371/journal.pone.0193733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513727	gold, Green Published, Green Submitted			2022-12-27	WOS:000426896800074
J	Dell'Arti, L; Barteselli, G; Riva, L; Carini, E; Graziadei, G; Benatti, E; Invernizzi, A; Cappellini, MD; Viola, F				Dell'Arti, Laura; Barteselli, Giulio; Riva, Lorenzo; Carini, Elisa; Graziadei, Giovanna; Benatti, Eleonora; Invernizzi, Alessandro; Cappellini, Maria D.; Viola, Francesco			Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RETINOPATHY; DISEASE; PATHOGENESIS; ISCHEMIA; AGE	Purpose To identify systemic risk factors for sickle cell maculopathy, and to analyze the microstructure of the macula of Sickle Cell Disease ( SCD) patients by using automated segmentation of individual retinal layers. Methods Thirty consecutive patients with SCD and 30 matched controls underwent spectral-domain optical coherence tomography ( SD-OCT) and automated thickness measurement for each retinal layer; thicknesses for SCD patients were then compared to normal controls. Demographic data, systemic data, and lab results were collected for each SCD patient; multivariate logistic regression analysis was used to identify potential risk factors for sickle cell maculopathy. Results Ongoing chelation treatment ( p = 0.0187) was the most predictive factor for the presence of sickle cell maculopathy; the odds were 94.2% lower when chelation was present. HbF level tended to influence sickle cell maculopathy ( p = 0.0775); the odds decreased by 12.9% when HbF increased by 1%. Sickle cell maculopathy was detected in 43% of SCD patients as patchy areas of retinal thinning on SD-OCT thickness map, mostly located temporally to the macula, especially in eyes with more advanced forms of sickle cell retinopathy ( p = 0.003). In comparison to controls, SCD patients had a subtle thinning of the overall macula and temporal retina compared to controls ( most p<0.0001), involving inner and outer retinal layers. Thickening of the retinal pigment epithelium was also detected in SCD eyes ( p<0.0001). Conclusions Chronic chelation therapy and, potentially, high levels of HbF are possible protective factors for the presence of sickle cell maculopathy, especially for patients with more advanced forms of sickle cell retinopathy. A subtle thinning of the overall macula occurs in SCD patients and involves multiple retinal layers, suggesting that ischemic vasculopathy may happen in both superficial and deep capillary plexi. Thinning of the outer retinal layers suggests that an ischemic insult of the choriocapillaris may also occur in SCD patients.	[Dell'Arti, Laura; Cappellini, Maria D.; Viola, Francesco] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Dell'Arti, Laura; Riva, Lorenzo; Carini, Elisa; Benatti, Eleonora; Viola, Francesco] Osped Maggiore Policlin, IRCCS, Ca Granda Fdn, Ophthalmol Unit, Milan, Italy; [Barteselli, Giulio] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Graziadei, Giovanna] Osped Maggiore Policlin, IRCCS, Ca Granda Fdn, Rare Dis Ctr,Dept Med & Med Specialties, Milan, Italy; [Invernizzi, Alessandro] Univ Milan, Luigi Sacco Hosp, Eye Clin, Dept Biomed & Clin Sci L Sacco, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Roche Holding; Genentech; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Luigi Sacco Hospital	Viola, F (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.; Viola, F (corresponding author), Osped Maggiore Policlin, IRCCS, Ca Granda Fdn, Ophthalmol Unit, Milan, Italy.	francesco.viola@unimi.it	viola, francesco/AAK-5583-2020; Dell'Arti, Laura/AAB-9520-2019; CAPPELLINI, MARIA DOMENICA/B-4475-2017	viola, francesco/0000-0003-1208-913X; Dell'Arti, Laura/0000-0001-7710-7867; Graziadei, Giovanna/0000-0002-6801-5730; Barteselli, Giulio/0000-0003-0533-1135; CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864				Barteselli G, 2012, OPHTHALMOLOGY, V119, P2572, DOI 10.1016/j.ophtha.2012.06.065; Brasileiro F, 2015, RETINA-J RET VIT DIS, V35, P257, DOI 10.1097/IAE.0000000000000309; BUNN HF, 1982, P NATL ACAD SCI-BIOL, V79, P7527, DOI 10.1073/pnas.79.23.7527; Chen H, 2009, INVEST OPHTH VIS SCI, V50, P1895, DOI 10.1167/iovs.08-2850; Chhablani J, 2012, INVEST OPHTH VIS SCI, V53, P2274, DOI 10.1167/iovs.12-9435; Cruz PRS, 2015, BLOOD CELL MOL DIS, V54, P33, DOI 10.1016/j.bcmd.2014.08.003; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; DIZON RV, 1979, SURV OPHTHALMOL, V23, P297, DOI 10.1016/0039-6257(79)90159-0; Elagouz M, 2010, SURV OPHTHALMOL, V55, P359, DOI 10.1016/j.survophthal.2009.11.004; Estepp JH, 2013, BRIT J HAEMATOL, V161, P402, DOI 10.1111/bjh.12238; FOX PD, 1990, BRIT J OPHTHALMOL, V74, P172, DOI 10.1136/bjo.74.3.172; Ghasemi Falavarjani K, 2016, RETINA; Gnana-Prakasam JP, 2009, BIOCHEM J, V424, P243, DOI 10.1042/BJ20090424; GOLDBAUM MH, 1978, AM J OPHTHALMOL, V86, P45, DOI 10.1016/0002-9394(78)90013-2; GOLDBERG MF, 1971, AM J OPHTHALMOL, V71, P649, DOI 10.1016/0002-9394(71)90429-6; Han IC, 2017, AM J OPHTHALMOL; Hoang QV, 2011, AM J OPHTHALMOL, V151, P990, DOI 10.1016/j.ajo.2010.12.010; Jung JJ, 2016, RETIN CASES BRIEF RE; LEE CM, 1987, BRIT J OPHTHALMOL, V71, P540, DOI 10.1136/bjo.71.7.540; Lee MT, 2006, BLOOD, V108, P847, DOI 10.1182/blood-2005-10-009506; Martin GC, 2017, JAMA OPHTHALMOL, V135, P1100, DOI 10.1001/jamaophthalmol.2017.3008; Mathew R, 2015, BRIT J OPHTHALMOL, V99, P967, DOI 10.1136/bjophthalmol-2014-305532; Minvielle W, 2016, AM J OPHTHALMOL, V164, P137, DOI 10.1016/j.ajo.2015.12.023; Oberwahrenbrock T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137316; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Romayanada N, 1973, T AM ACAD OPHTHALMOL, V77; Sanfilippo Christian J, 2015, Retin Cases Brief Rep, V9, P360, DOI 10.1097/ICB.0000000000000210; STEIN MR, 1970, ARCH OPHTHALMOL-CHIC, V84, P485, DOI 10.1001/archopht.1970.00990040487017; Tan CS, 2016, BRIT J OPHTHALMOL, V100, P235, DOI 10.1136/bjophthalmol-2015-306652; Tan CSH, 2012, INVEST OPHTH VIS SCI, V53, P1639, DOI 10.1167/iovs.12-9566; Yu SQ, 2015, AM J OPHTHALMOL, V159, P53, DOI 10.1016/j.ajo.2014.09.027	31	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193582	10.1371/journal.pone.0193582	http://dx.doi.org/10.1371/journal.pone.0193582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494697	gold, Green Published			2022-12-27	WOS:000426363200069
J	Dibra, D; Xia, XQ; Gagea, M; Lozano, G; Li, SL				Dibra, Denada; Xia, Xueqing; Gagea, Mihai; Lozano, Guillermina; Li, Shulin			A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA(-/-) and mutant-p53	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ARTHRITIS; OSTEOCLASTOGENESIS; SPONDYLITIS	Spondyloarthropathies, the second most frequently occurring form of chronic inflammatory arthritis, affects young adults in particular. However, a proper model with which to study the biology of this disease and to develop therapeutics is lacking. One of the most accepted animal models for this disease uses HLA-B27/Hu-beta 2m transgenic rats; however, only 30%-50% of male HLA-B27/Hu-beta 2m rats develop spontaneous, clinically apparent spondylitis and have a variable time until disease onset. Here, we report a high-incidence, low-variation spontaneous mouse model that delineates how the combination of inflammatory cytokine interleukin-27 ( IL-27) signaling deficiency and mitogenic signaling ( mutant p53(R172H)) in vivo, leads to bone loss in the vertebral bodies and ossification of the cartilage in the intervertebral discs. In this human disease-like mouse model, bone loss and pathogenic bone development are seen as early as 4 months of age in the absence of inflammatory aggregates in the enthesis or intervertebral disc.	[Dibra, Denada; Lozano, Guillermina] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Xia, Xueqing; Li, Shulin] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Gagea, Mihai] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dibra, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.; Li, SL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA.	ddibra@mdanderson.org; sli4@mdanderson.org	Li, Shulin/D-6478-2011	Li, Shulin/0000-0001-5657-4183	National Cancer Institute [R01 CM 20985]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grant R01 CM 20985 to SL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos IE, 2013, CYTOKINE GROWTH F R, V24, P115, DOI 10.1016/j.cytogfr.2012.10.001; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Bankson JA, 2008, J MAGN RESON IMAGING, V27, P57, DOI 10.1002/jmri.21221; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Edwards CK, 2006, ARTHRITIS RHEUM-US, V54, P2872, DOI 10.1002/art.22077; Goldberg R, 2004, J IMMUNOL, V173, P1171, DOI 10.4049/jimmunol.173.2.1171; Gupta R, 2009, CLIN EXP NEPHROL, V13, P667, DOI 10.1007/s10157-009-0217-z; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Kalliolias GD, 2010, ARTHRITIS RHEUM-US, V62, P402, DOI 10.1002/art.27200; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Lozano G, 2007, CURR OPIN GENET DEV, V17, P66, DOI 10.1016/j.gde.2006.12.003; McHugh J, 2017, NAT REV RHEUMATOL, V13, P3, DOI [10.1038/nrrheum.2017.94, 10.1038/nrrheum.2016.199]; Moon SJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.89; Nash P, 2017, LANCET, V389, P2317, DOI 10.1016/S0140-6736(17)31429-0; Phillips KLE, 2013, ANN RHEUM DIS, V72, P1860, DOI 10.1136/annrheumdis-2012-202266; Rudwaleit M, 2002, ANN RHEUM DIS, V61, P968, DOI 10.1136/ard.61.11.968; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; SHU KH, 1986, CLIN NEPHROL, V25, P169; Tran TM, 2006, ARTHRITIS RHEUM-US, V54, P1317, DOI 10.1002/art.21740; van Duivenvoorde LM, 2012, ARTHRITIS RHEUM-US, V64, P3210, DOI 10.1002/art.34600; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Yang JF, 2008, EUR J IMMUNOL, V38, P1204, DOI 10.1002/eji.200838145; Zhang SZ, 2011, FASEB J, V25, P2387, DOI 10.1096/fj.10-175299	28	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193485	10.1371/journal.pone.0193485	http://dx.doi.org/10.1371/journal.pone.0193485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494633	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200055
J	Phung, D; Nguyen, HX; Nguyen, HLT; Luong, AM; Do, CM; Tran, QD; Chu, C				Dung Phung; Huong Xuan Nguyen; Huong Lien Thi Nguyen; Anh Mai Luong; Cuong Manh Do; Quang Dai Tran; Chu, Cordia			The effects of socioecological factors on variation of communicable diseases: A multiple-disease study at the national scale of Vietnam	PLOS ONE			English	Article							HIGH-TEMPERATURE; PREDICTION MODEL; DENGUE; HUMIDITY; HOSPITALIZATIONS; TRANSMISSION; ASSOCIATION; DIARRHEA; RISK; SEASONALITY	Objective To examine the effects of socioecological factors on multiple communicable diseases across Vietnam. Methods We used the Moran's I tests to evaluate spatial clusters of diseases and applied multilevel negative binomial regression models using the Bayesian framework to analyse the association between socioecological factors and the diseases queried by oral, airborne, vector-borne, and animal transmission diseases. Results and significance The study found that oral-transmission diseases were spatially distributed across the country; whereas, the airborne-transmission diseases were more clustered in the Northwest and vector-borne transmission diseases were more clustered in the South. Most of diseases were sensitive with climatic factors. For instance, a 1 degrees C increase in average temperature is significantly associated with 0.4% ( 95CI, 0.3 +/- 0.5), 2.5% ( 95% CI, 1.4 +/- 3.6), 0.9% ( 95% CI, 0.6 +/- 1.4), 1.1% ( 95% CI), 5% ( 95% CI, 3-.7.4), 0.4% ( 95% CI, 0.2 +/- 0.7), and 2% ( 95% CI, 1.5 +/- 2.8) increase in risk of diarrhoea, shigellosis, mumps, influenza, dengue, malaria, and rabies respectively. The influences of socio-economic factors on risk of communicable diseases are varied by factors with the biggest influence of population density. The research findings reflect an important implication for the climate change adaptation strategies of health sectors. A development of weather-based early warning systems should be considered to strengthen communicable disease prevention in Vietnam.	[Dung Phung; Chu, Cordia] Griffith Univ, Menzies Hlth Inst Queensland, Ctr Environm & Populat Hlth, Brisbane, Qld, Australia; [Huong Xuan Nguyen] Da Nang Univ Med Technol & Pharm, Da Nang, Vietnam; [Huong Lien Thi Nguyen; Anh Mai Luong; Cuong Manh Do] Minist Hlth, Hlth Environm Management Agcy, Hanoi, Vietnam; [Quang Dai Tran] Minist Hlth, Gen Dept Prevent Med, Hanoi, Vietnam	Griffith University; Menzies Health Institute Queensland; Danang University of Medical Technology & Pharmacy	Phung, D (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Ctr Environm & Populat Hlth, Brisbane, Qld, Australia.	d.phung@griffith.edu.au	Xuan Huong, Nguyen/GRR-6055-2022; Phung, Dung/ABC-9218-2021	Phung, Dung/0000-0002-1615-3234; Chu, Cordia/0000-0002-3683-5638				Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bentham G., 2001, INT J BIOMETEOROL; Black R, 1995, EPIDEMIOLOGY DIARRHO, P13; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-77; Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552; Chaudhry P., 2008, CLIMATE CHANGE HUMAN; Christophers SR, 1960, AEDES AEGYPTY YELLOW; Chuang TW, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1874-0; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; D'Souza RM, 2008, EPIDEMIOL INFECT, V136, P56, DOI 10.1017/S0950268807008229; Phung D, 2018, SCI TOTAL ENVIRON, V610, P983, DOI 10.1016/j.scitotenv.2017.08.158; Phung D, 2017, SCI TOTAL ENVIRON, V580, P805, DOI 10.1016/j.scitotenv.2016.12.027; Phung D, 2015, ACTA TROP, V141, P88, DOI 10.1016/j.actatropica.2014.10.005; Phung D, 2014, ENVIRON RES, V135, P212, DOI 10.1016/j.envres.2014.08.035; Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Epstein PR, 2000, SCI AM, V283, P50, DOI 10.1038/scientificamerican0800-50; GSO, 2014, GEN STAT OFF STAT YB; Hashizume M, 2007, INT J EPIDEMIOL, V36, P1030, DOI 10.1093/ije/dym148; Ho YC, 2015, HUM VACC IMMUNOTHER, V11, P1406, DOI 10.1080/21645515.2015.1029687; Hondula DM, 2014, ENVIRON HEALTH PERSP, V122, P831, DOI 10.1289/ehp.1307496; INPONRE, 2009, VIETN ASS REP CLIM C; IPCC, 2014, CLIM CHANG 2014 IM F; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Kabaria CW, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1694-2; Kamigaki T, 2016, PLOS ONE, V11, P1; Kelly-Hope LA, 2007, AM J TROP MED HYG, V76, P706, DOI 10.4269/ajtmh.2007.76.706; Kipruto EK, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1848-2; Kuhn K., 2005, USING CLIMATE PREDIC; Lee Hahn-Ey, 2013, J Biomark, V2013, P413853, DOI 10.1155/2013/413853; Levy K, 2016, ENVIRON SCI TECHNOL, V50, P4905, DOI 10.1021/acs.est.5b06186; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Ministry of Health, 2013, HLTH STAT YB; MOE K, 1982, ARCH VIROL, V72, P179, DOI 10.1007/BF01348963; Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010; Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556; Onozuka D, 2011, EPIDEMIOL INFECT, V139, P1692, DOI 10.1017/S0950268810002967; Ostfeld RS, 2015, PHILOS T R SCO LON B, V370, P140; Paynter S, 2015, EPIDEMIOL INFECT, V143, P1110, DOI 10.1017/S0950268814002702; Thai PQ, 2015, EPIDEMICS-NETH, V13, P65, DOI 10.1016/j.epidem.2015.06.002; Phung D, 2015, INT J BIOMETEOROL; Phung D, 2017, ENV POLLUTION; Phung D., 2015, EPIDEMIOL INFECT, V2015, P1; Phung D, 2016, TROP MED INT HEALTH, V21, P1324, DOI 10.1111/tmi.12754; Phung D, 2016, ENVIRON INT, V92-93, P77, DOI 10.1016/j.envint.2016.03.034; Rifakis Pedro M, 2006, Int J Biomed Sci, V2, P1; Rodo X, 2013, CLIMATIC CHANGE, V118, P625, DOI 10.1007/s10584-013-0744-1; Semenza JC, 2009, LANCET INFECT DIS, V8, P92; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Soebiyanto RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100659; Thompson CN, 2015, HEALTH PLACE, V35, P147, DOI 10.1016/j.healthplace.2015.08.001; Tian HY, 2015, P NATL ACAD SCI USA, V112, P172, DOI 10.1073/pnas.1405216112; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Ud-Dean SMM, 2010, J THEOR BIOL, V264, P822, DOI 10.1016/j.jtbi.2010.03.013; UNEP, 2009, ASS REP CLIM CHANG; VN MONRE, 2016, CLIM CHANG IMP AD EF; Wu XX, 2014, SCI CHINA EARTH SCI, V57, P189, DOI 10.1007/s11430-013-4635-0; Yang WH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045233, 10.1371/journal.pone.0046789, 10.1371/journal.pone.0053429]; Yao HW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003502; Yusuf A, 2009, EEPSEA SPECIAL TECHN; Zhang YM, 2017, SCI TOTAL ENVIRON, V598, P71, DOI 10.1016/j.scitotenv.2017.04.112	62	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193246	10.1371/journal.pone.0193246	http://dx.doi.org/10.1371/journal.pone.0193246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494623	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200032
J	Pretorius, E; Page, MJ; Mbotwe, S; Kell, DB				Pretorius, Etheresia; Page, Martin J.; Mbotwe, Sthembile; Kell, Douglas B.			Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; EXTRACELLULAR ALPHA-SYNUCLEIN; SCANNING-ELECTRON-MICROSCOPY; THIOFLAVIN-T BINDING; SYSTEMS BIOLOGY; CLOT STRUCTURE; MOLECULAR-MECHANISM; NETWORK STRUCTURE; IRON; ALZHEIMERS	The thrombin-induced polymerisation of fibrinogen to form fibrin is well established as a late stage of blood clotting. It is known that Parkinson's Disease (PD) is accompanied by dysregulation in blood clotting, but it is less widely known as a coagulopathy. In recent work, we showed that the presence of tiny amounts of bacterial lipopolysaccharide (LPS) in healthy individuals could cause clots to adopt an amyloid form, and this could be observed via scanning electron microscopy (SEM) or via the fluorescence of thioflavin-T. This could be prevented by the prior addition of lipopolysaccharide-binding protein (LBP). We had also observed by SEM this unusual clotting in the blood of patients with Parkinson's Disease. We hypothesised, and here show, that this too can be prevented by LBP in the context of PD. This adds further evidence implicating inflammatory microbial cell wall products as an accompaniment to the disease, and may be part of its aetiology. This may lead to novel treatment strategies in PD designed to target microbes and their products.	[Pretorius, Etheresia; Page, Martin J.; Kell, Douglas B.] Stellenbosch Univ, Fac Sci, Dept Physiol Sci, Stellenbosch, South Africa; [Mbotwe, Sthembile] Univ Pretoria, Fac Hlth Sci, Dept Physiol, Arcadia, South Africa; [Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester, Lancs, England; [Kell, Douglas B.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England	Stellenbosch University; University of Pretoria; University of Manchester; University of Manchester	Pretorius, E; Kell, DB (corresponding author), Stellenbosch Univ, Fac Sci, Dept Physiol Sci, Stellenbosch, South Africa.; Kell, DB (corresponding author), Univ Manchester, Sch Chem, Manchester, Lancs, England.; Kell, DB (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	resiap@sun.ac.za; dbk@manchester.ac.uk	Page, Martin/AAB-7740-2019; Page, Martin/P-2348-2019; Pretorius, Etheresia/ACH-6368-2022; Kell, Douglas/E-8318-2011	Page, Martin/0000-0002-2479-9182; Pretorius, Etheresia/0000-0002-9108-2384; Kell, Douglas/0000-0001-5838-7963; Sibanda, Sthembile/0000-0002-5897-660X	National Research Foundation [91548]; Biotechnology and Biological Sciences Research Council [BB/L025752/1]; BBSRC [BB/L025752/1] Funding Source: UKRI	National Research Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the National Research Foundation grant 91548: Competitive Program and South African Medical Research Council to EP, and the Biotechnology and Biological Sciences Research Council Grant BB/L025752/1 to DBK. Some reagent funds were supplied as a philanthropic gift by an anonymous donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Research Foundation grant 91548: Competitive Program and South African Medical Research Council to EP. Biotechnology and Biological Sciences Research Council Grant BB/L025752/1 to DBK. Some reagent funds were supplied as a philanthropic gift by an anonymous donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Alzahrani SH, 2010, DIABETES VASC DIS RE, V7, P260, DOI 10.1177/1479164110383723; Alzahrani SH, 2012, J CLIN ENDOCR METAB, V97, pE2282, DOI 10.1210/jc.2012-2128; Antony PMA, 2013, FEBS J, V280, P5981, DOI 10.1111/febs.12335; Averett LE, 2008, LANGMUIR, V24, P4979, DOI 10.1021/la703264x; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Berg D, 2008, FUTUR NEUROL, V3, P447, DOI 10.2217/14796708.3.4.447; Bester J, 2015, ONCOTARGET, V6, P35284, DOI 10.18632/oncotarget.6074; Bhattacharjee P, 2014, FRAMEWORK WIRELESS N, P1; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Campbell RA, 2010, THROMB HAEMOSTASIS, V104, P1281, DOI 10.1160/TH10-07-0442; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dickneite G, 2015, THROMB HAEMOSTASIS, V113, P686, DOI 10.1160/TH14-07-0625; Domingue GJ, 2010, DISCOV MED, V10, P234; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Double KL, 2000, ADV RES NEURODEGENER, V8, P37; Dunn EJ, 2004, HERZ, V29, P470, DOI 10.1007/s00059-004-2607-z; Dunn EJ, 2005, DIABETOLOGIA, V48, P1198, DOI 10.1007/s00125-005-1742-2; Dunn EJ, 2006, DIABETOLOGIA, V49, P1071, DOI 10.1007/s00125-006-0197-4; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Freire S, 2014, DYES PIGMENTS, V110, P97, DOI 10.1016/j.dyepig.2014.05.004; Friedman A, 2012, J NEURAL TRANSM, V119, P1507, DOI 10.1007/s00702-012-0894-8; Fujita KA, 2014, MOL NEUROBIOL, V49, P88, DOI 10.1007/s12035-013-8489-4; Funke C, 2013, NEUROCHEM INT, V62, P637, DOI 10.1016/j.neuint.2012.11.015; Gabrielli M, 2011, MOVEMENT DISORD, V26, P889, DOI 10.1002/mds.23566; Gerlach Manfred, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS185, DOI 10.1016/j.parkreldis.2008.04.028; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Haidinger M, 2013, AMYLOID, V20, P72, DOI 10.3109/13506129.2013.781998; Hare DJ, 2014, CHEM SCI, V5, P2160, DOI 10.1039/c3sc53461h; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Infante J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.026; Itzhaki RF, 2016, J ALZHEIMERS DIS, V51, P979, DOI 10.3233/JAD-160152; Jameson GNL, 2011, MONATSH CHEM, V142, P325, DOI 10.1007/s00706-011-0475-9; Jones BC, 2007, AM J PHYSIOL-REG I, V293, pR116, DOI 10.1152/ajpregu.00608.2006; Jones BC, 2013, NEUROTOXICOLOGY, V37, P26, DOI 10.1016/j.neuro.2013.03.010; Jorneskog G, 1996, DIABETOLOGIA, V39, P1519, DOI 10.1007/s001250050607; Kakkar AK, 2015, EUR J PHARMACOL, V750, P74, DOI 10.1016/j.ejphar.2015.01.030; Kalia LV, 2015, MOVEMENT DISORD, V30, P1442, DOI 10.1002/mds.26354; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kalia LV, 2015, CURR OPIN NEUROL, V28, P375, DOI 10.1097/WCO.0000000000000215; KAPRELYANTS AS, 1993, FEMS MICROBIOL LETT, V104, P271, DOI 10.1016/0378-1097(93)90600-7; Karlsen KH, 2000, J NEUROL NEUROSUR PS, V69, P584, DOI 10.1136/jnnp.69.5.584; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; Kell DB, 2017, SEMINARS THROMBOSIS; Kell Douglas, 2015, F1000Res, V4, P179, DOI 10.12688/f1000research.6709.2; Kell DB, 2017, PROG BIOPHYS MOL BIO, V123, P16, DOI 10.1016/j.pbiomolbio.2016.08.006; Kell DB, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00060; Kell DB, 2015, INTEGR BIOL-UK, V7, P1339, DOI 10.1039/c5ib00158g; Kell DB, 2015, INTEGR BIOL-UK, V7, P24, DOI 10.1039/c4ib00173g; Kell DB, 2014, METALLOMICS, V6, P748, DOI 10.1039/c3mt00347g; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Kelly LP, 2014, MOVEMENT DISORD, V29, P999, DOI 10.1002/mds.25736; Kim KS, 2012, J BIOL CHEM, V287, P24862, DOI 10.1074/jbc.M112.348128; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Krishna A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1154; La Corte ALC, 2011, ADV PROTEIN CHEM STR, V83, P75, DOI 10.1016/B978-0-12-381262-9.00003-3; Levenson CW, 2003, NUTR REV, V61, P311, DOI 10.1301/nr.2003.sept.311-313; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005631.pub2; Litvinov RI, 2012, BIOPHYS J, V103, P1020, DOI 10.1016/j.bpj.2012.07.046; Maji SK, 2009, FEBS LETT, V583, P2610, DOI 10.1016/j.febslet.2009.07.003; Mattman L., 2001, CELL WALL DEFICIENT; McDowall JS, 2016, METALLOMICS, V8, P385, DOI 10.1039/c6mt00026f; Nielsen VG, 2014, BLOOD COAGUL FIBRIN, V25, P845, DOI 10.1097/MBC.0000000000000160; Olanow CW, 2013, MOVEMENT DISORD, V28, P31, DOI 10.1002/mds.25373; Oshiro S., 2011, ADV PHARM SCI, V2011, DOI DOI 10.1155/2011/378278; Park SM, 2013, PRION, V7, P121, DOI 10.4161/pri.22850; Perez Carlos A, 2008, Curr Bioact Compd, V4, P150, DOI 10.2174/157340708786305952; Picken MM, 2010, BLOOD, V115, P2985, DOI 10.1182/blood-2009-12-236810; Pieters M, 2006, THROMB HAEMOSTASIS, V96, P623, DOI 10.1160/TH06-07-0390; Potgieter M, 2015, FEMS MICROBIOL REV, V39, P567, DOI 10.1093/femsre/fuv013; Pretorius E, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00257; Pretorius E, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0624-5; Pretorius E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09860-4; Pretorius E, 2017, EXP BIOL MED, V242, P355, DOI 10.1177/1535370216681549; Pretorius E, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0539; Pretorius E, 2016, CELL PHYSIOL BIOCHEM, V39, P1977, DOI 10.1159/000447895; Pretorius E, 2016, J ALZHEIMERS DIS, V53, P1237, DOI 10.3233/JAD-160318; Pretorius E, 2016, BLOOD REV, V30, P263, DOI 10.1016/j.blre.2016.01.001; Pretorius E, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0192-5; Pretorius E, 2014, AGING-US, V6, P788, DOI 10.18632/aging.100695; Pretorius E, 2014, INTEGR BIOL-UK, V6, P486, DOI 10.1039/c4ib00025k; Pretorius E, 2014, RHEUMATOL INT, V34, P1005, DOI 10.1007/s00296-013-2817-x; Pretorius E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085271; Pretorius E, 2013, TOXICOL MECH METHOD, V23, P352, DOI 10.3109/15376516.2012.762082; Pretorius E, 2013, MICROSC RES TECHNIQ, V76, P268, DOI 10.1002/jemt.22163; Pretorius E, 2011, BLOOD COAGUL FIBRIN, V22, P696, DOI 10.1097/MBC.0b013e32834bdb32; Pretorius E, 2011, BLOOD COAGUL FIBRIN, V22, P463, DOI 10.1097/MBC.0b013e3283468a0d; Pretorius E, 2012, RHEUMATOL INT, V32, P1611, DOI 10.1007/s00296-011-1805-2; Pretorius E, 2011, J THROMB THROMBOLYS, V31, P507, DOI 10.1007/s11239-010-0538-5; Protopopova AD, 2015, J THROMB HAEMOST, V13, P570, DOI 10.1111/jth.12785; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Rodriguez-Violante M, 2015, NEUROLOGIA, V30, P257, DOI 10.1016/j.nrl.2014.01.008; Rosenbaum H, 2013, SEMIN THROMB HEMOST, V39, P928, DOI 10.1055/s-0033-1357485; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sato Y, 2003, J NEUROL SCI, V212, P55, DOI 10.1016/S0022-510X(03)00101-1; Schrag A, 2000, MOVEMENT DISORD, V15, P1112, DOI 10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Serpell LC, 2007, AMYLOID, V14, P199, DOI 10.1080/13506120701461111; Stangou AJ, 2010, BLOOD, V115, P2998, DOI 10.1182/blood-2009-06-223792; Stocchi F, 1997, J NEUROL NEUROSUR PS, V62, P507, DOI 10.1136/jnnp.62.5.507; Sulatskaya AI, 2011, J PHYS CHEM B, V115, P11519, DOI 10.1021/jp207118x; Tipping KW, 2015, TRENDS BIOCHEM SCI, V40, P719, DOI 10.1016/j.tibs.2015.10.002; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Weigandt KM, 2012, BIOPHYS J, V103, P2399, DOI 10.1016/j.bpj.2012.10.036; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Wolberg AS, 2012, CURR OPIN HEMATOL, V19, P349, DOI 10.1097/MOH.0b013e32835673c2; Yermolenko IS, 2011, BIOMACROMOLECULES, V12, P370, DOI 10.1021/bm101122g; Zhmurov A, 2011, STRUCTURE, V19, P1615, DOI 10.1016/j.str.2011.08.013; Zhmurov A, 2012, J AM CHEM SOC, V134, P20396, DOI 10.1021/ja3076428	122	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192121	10.1371/journal.pone.0192121	http://dx.doi.org/10.1371/journal.pone.0192121			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494603	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200011
J	Willfuhr, KP; Johow, J; Voland, E				Willfuehr, Kai Pierre; Johow, Johannes; Voland, Eckart			When the mother-in-law is just as good-Differential mortality of reproductive females by family network composition	PLOS ONE			English	Article							DISCRIMINATIVE GRANDPARENTAL SOLICITUDE; RESOURCE COMPETITION; MATRILATERAL BIASES; MATERNAL MORTALITY; SURVIVAL; KIN; COOPERATION; INVESTMENT; FERTILITY; CONFLICT	Motivated by the cooperative breeding hypothesis, we investigate the effect of having kin on the mortality of reproductive women based on family reconstitutions for the Krummhorn region ( East Frisia, Germany, 1720-1874). We rely on a combination of Cox clustered hazard models and hazard models stratified at the family level. In order to study behavior-related effects, we run a series of models in which only kin who lived in the same parish are considered. To investigate structural, non-behavior-related effects, we run a different model series that include all living kin, regardless their spatial proximity. We find that women of reproductive age who had a living mother had a reduced mortality risk. It appears that having living sisters had an ambivalent impact on women's mortality: i.e., depending on the socioeconomic status of the family, the effect of having living sisters ranged between representing a source of competition and representing a source of support. Models which are clustered at the family level suggest that the presence of a living mother-in-law was associated with reduced mortality among her daughters-in-law especially among larger-scale farm families. We interpret this finding as a consequence of augmented consanguineous marriages among individuals of higher social strata. For instance, in first cousin marriages, the mother-in-law could also be a biological aunt. Thus, it appears that among the wealthy elite, the genetic in-law conflict was neutralized to some extent by family solidarity. This result further suggests that the tipping point of the female trade-off between staying with the natal family and leaving the natal family to join an economically well-established in-law family might have been reached very quickly among women living under the socioeconomic conditions of the Krummhorn region.	[Willfuehr, Kai Pierre] Max Planck Inst Demog Res, Rostock, Germany; [Willfuehr, Kai Pierre] Carl von Ossietzky Univ Oldenburg, Oldenburg, Germany; [Voland, Eckart] Univ Giessen, Inst Philosophy, Giessen, Germany	Max Planck Society; Carl von Ossietzky Universitat Oldenburg; Justus Liebig University Giessen	Willfuhr, KP (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.; Willfuhr, KP (corresponding author), Carl von Ossietzky Univ Oldenburg, Oldenburg, Germany.	willfuehr@demogr.mpg.de		Johow, Johannes/0000-0003-3494-4264; Willfuhr, Kai Pierre/0000-0003-4207-3016				Alison P., 2009, FIXED EFFECTS REGRES; Allison PD., 2014, QUANTITATIVE APPL SO; Beise J, 2001, THESIS; Beise J., 2002, DEMOGR RES, DOI [10.4054/DemRes.2002.7.13, DOI 10.4054/DEMRES.2002.7.13]; Beise J, 2008, AM J HUM BIOL, V20, P325, DOI 10.1002/ajhb.20730; Burton-Chellew MN, 2011, CURR ANTHROPOL, V52, P741, DOI 10.1086/661288; Cant MA, 2012, EVOLUTION OF PARENTAL CARE, P206; COX DR, 1972, J R STAT SOC B, V34, P187; Danielsbacka M, 2011, EVOL PSYCHOL-US, V9, P3, DOI 10.1177/147470491100900102; Donrovich R, 2014, DEMOGR RES, V31, P1167, DOI 10.4054/DemRes.2014.31.38; Euler HA, 1996, HUM NATURE-INT BIOS, V7, P39, DOI 10.1007/BF02733489; Fox JF, 2016, HIST FAMILY; Gaulin SJC, 1997, HUM NATURE-INT BIOS, V8, P139, DOI 10.1007/s12110-997-1008-4; Hammel EA, 2004, POP STUD-J DEMOG, V58, P145, DOI 10.1080/0032472042000213703; Hawkes K., EVOLUTION HUMAN LIFE; Helfrecht C, 2015, AM J HUMAN BIOL; Hoier S., 2001, Z DIFFERENTIELLE DIA, V22, P206; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Hunt Linda M, 2002, Health Care Women Int, V23, P98, DOI 10.1080/073993302753428465; Imhof A E, 1981, Z Bevolkerungswiss, V7, P343; Jeon J, 2007, P R SOC B, V274, P1181, DOI 10.1098/rspb.2006.0366; Ji T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0081; Johow J., UNPUB; Johow J, 2012, HUM NATURE-INT BIOS, V23, P341, DOI 10.1007/s12110-012-9147-7; Klopper R, 1949, DTSCH GEOGR BLATTER, V45, P37; Kramer K. L., 2015, EMERGING TRENDS SOCI, P1, DOI [10.1002/9781118900772.etrds0055, DOI 10.1002/9781118900772.ETRDS0055]; Kramer KL, 2016, PLOS ONE; Leonetti D., 2005, GRANDMOTHERHOOD EVOL, P194; Leonetti DL, 2007, CURR ANTHROPOL, V48, P861, DOI 10.1086/520976; Mace R, 2013, EVOL ANTHROPOL, V22, P251, DOI 10.1002/evan.21374; McBurney DH, 2002, HUM NATURE-INT BIOS, V13, P391, DOI 10.1007/s12110-002-1022-5; Michalski RL, FAMILY RELATIONS EVO; Mulder MB, 2009, AM J HUM BIOL, V21, P478, DOI 10.1002/ajhb.20885; Nitsch A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2313; Ohling G. D., 1963, ACHT IHRE SIEBEN SIE, P17; Omran AR, 2005, MILBANK Q, V83, P731, DOI 10.1111/j.1468-0009.2005.00398.x; Pashos A, 2000, EVOL HUM BEHAV, V21, P97, DOI 10.1016/S1090-5138(99)00030-6; Penn DJ, 2007, P NATL ACAD SCI USA, V104, P553, DOI 10.1073/pnas.0609301103; Pollet TV, OXFORD HDB PSYCHOL; Reiches MW, 2009, AM J HUM BIOL, V21, P421, DOI 10.1002/ajhb.20906; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rutstein SO., 1984, INFANT CHILD MORTALI; Scalone F, 2014, POP STUD-J DEMOG, V68, P217, DOI 10.1080/00324728.2013.821153; Scelza BA, 2011, HUM NATURE-INT BIOS, V22, P108, DOI 10.1007/s12110-011-9112-x; Scelza BA, 2011, HUM NATURE-INT BIOS, V22, P377, DOI 10.1007/s12110-011-9125-5; Sear R, 2003, EVOL HUM BEHAV, V24, P25, DOI 10.1016/S1090-5138(02)00105-8; Sear R, 2008, HUM NATURE-INT BIOS, V19, P277, DOI 10.1007/s12110-008-9042-4; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Sheppard P, 2016, GUATEMALA PATERNAL G, V3; Snopkowski K, 2015, SOC SCI MED, V128, P105, DOI 10.1016/j.socscimed.2015.01.012; Strassmann BI, 2011, HUM NATURE-INT BIOS, V22, P201, DOI 10.1007/s12110-011-9114-8; Strassmann BI, 2011, P NATL ACAD SCI USA, V108, P10894, DOI 10.1073/pnas.1100306108; Tanskanen AO, 2015, J SOCIAL PERSONAL RE; Tymicki K, 2008, INTL STUDIES POPULAT, V7, P135, DOI 10.1007/978-1-4020-6733-4_6; van Lenthe FJ, 2004, EUR J PUBLIC HEALTH, V14, P63, DOI 10.1093/eurpub/14.1.63; van Olinga Krine Klaassen, 1628, KRINE KLAASSEN OLING; Voland E, 2002, BEHAV ECOL SOCIOBIOL, V52, P435, DOI 10.1007/s00265-002-0539-2; VOLAND E, 1995, HUM NATURE-INT BIOS, V6, P33, DOI 10.1007/BF02734134; VOLAND E, 2005, GRANDMOTHERHOOD EVOL, P239; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Willfuhr K. P., 2015, HIST LIFE COURSE STU, V2, P58	61	9	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193252	10.1371/journal.pone.0193252	http://dx.doi.org/10.1371/journal.pone.0193252			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494690	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000426363200033
J	Helfenberger, KE; Villalba, NM; Buchholz, B; Boveris, A; Poderoso, JJ; Gelpi, RJ; Poderoso, C				Helfenberger, Katia E.; Villalba, Nerina M.; Buchholz, Bruno; Boveris, Alberto; Jose Poderoso, Juan; Gelpi, Ricardo J.; Poderoso, Cecilia			Subcellular distribution of ERK phosphorylation in tyrosine and threonine depends on redox status in murine lung cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASES; DEPHOSPHORYLATION; TRANSLOCATION; SPECIFICITY; APOPTOSIS; LINE	Activation of ERK1/2 implies the phosphorylation of tyrosine (pTyr) and threonine (pThr) by MEK1/2; both reactions were thought to be cytoplasmic, promoting ERK to reach the nucleus where it activates several transcription factors. In addition, H2O2 concentrations are known to modulate ERK intracellular translocation, which impacts on cellular proliferation. In this context, the objective of this work was to study the sequence of ERK phosphorylation under two redox conditions and to analyze a putative mitochondrial contribution to this process, in LP07 murine lung cells. A time-course of H2O2 administration was used and ERK phosphorylation was analyzed in cytosol, mitochondria and nuclei. At 1 mu M H2O2, a proliferative redox stimulus, immunoblot revealed a fast and transient increase in cytosol pTyr and a sustained increase in mitochondrial pTyr content. The detection for pThr/pTyrERK (2pERK) showed in cytosol a marked increase at 5 minutes with a fast dephosphorylation after that time, for both H2O2 concentrations. However, at 50 mu M H2O2, an anti-proliferative condition, 2pERK was gradually retained in mitochondria. Interestingly, these results were confirmed by in vivo experiments using mice treated with a highly oxidizing agent [H2O2]. By the use of two ERK2 mutant constructions, where Tyr and Thr were replaced by alanine, we confirmed that 2pERK relied almost completely on pThr183. Confocal microscopy confirmed ERK subcellular distribution dependence on the incidence of cytosolic pTyr and mitochondrial pThr at 1 mu M H2O2. This work shows for the first time, both in vitro and in vivo, an ERK cycle involving a cross-talk between cytosol and mitochondria phosphorylation events, which may play a significant role in cell cycle progression, proliferation or differentiation under two different redox conditions.	[Helfenberger, Katia E.; Poderoso, Cecilia] Univ Buenos Aires, Fac Med, Dept Bioquim Humana, Buenos Aires, DF, Argentina; [Helfenberger, Katia E.; Poderoso, Cecilia] Univ Buenos Aires, CONICET, Inst Invest Biomed INBIOMED, Buenos Aires, DF, Argentina; [Villalba, Nerina M.; Jose Poderoso, Juan] Univ Buenos Aires, Fac Med, Hosp Clin Jose de San Martin, Lab Metab Oxigeno, Buenos Aires, DF, Argentina; [Villalba, Nerina M.; Jose Poderoso, Juan] Univ Buenos Aires, CONICET, Inst Imunol Genet & Metabolismo INIGEM, Buenos Aires, DF, Argentina; [Buchholz, Bruno; Boveris, Alberto; Gelpi, Ricardo J.] Univ Buenos Aires, Fac Med, Dept Patol, Buenos Aires, DF, Argentina; [Buchholz, Bruno; Boveris, Alberto; Gelpi, Ricardo J.] Univ Buenos Aires, CONICET, Inst Bioquim & Med Mol IBIMOL, Buenos Aires, DF, Argentina; [Villalba, Nerina M.] Univ Buenos Aires, Fac Med, CONICET, IBCN, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Poderoso, C (corresponding author), Univ Buenos Aires, Fac Med, Dept Bioquim Humana, Buenos Aires, DF, Argentina.; Poderoso, C (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Biomed INBIOMED, Buenos Aires, DF, Argentina.	cepoderos@yahoo.com	Buchholz, Bruno/AAJ-1916-2021	Buchholz, Bruno/0000-0001-6712-8103; Villalba, Nerina Mariel/0000-0003-0397-3409; Poderoso, Cecilia/0000-0001-8606-2840	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-2010-2430]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 5495]; Universidad de Buenos Aires (UBA)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBA)(University of Buenos Aires)	Funding was provided by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, www.agencia.mincyt.gob.ar) PICT-2010-2430, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, www.conicet.gov.ar) (PIP 5495) and Universidad de Buenos Aires (UBA, www.uba.ar) to J.J.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Arciuch VGA, 2009, ADV DRUG DELIVER REV, V61, P1234, DOI 10.1016/j.addr.2009.04.025; Arciuch VGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007523; Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bendetz-Nezer S, 2007, J BIOL CHEM, V282, P25114, DOI 10.1074/jbc.M703120200; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Boveris A, 2000, ANN NY ACAD SCI, V899, P121; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Busca R, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00053; Butch ER, 1996, J BIOL CHEM, V271, P4230; Carreras Maria C., 2004, Molecular Aspects of Medicine, V25, P125, DOI 10.1016/j.mam.2004.02.014; Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Galli S, 2003, CANCER RES, V63, P6370; Galli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002379; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Kidger AM, 2016, SEMIN CELL DEV BIOL, V50, P125, DOI 10.1016/j.semcdb.2016.01.009; Kim JY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-27; Kreft M, 2004, COMPUT METH PROG BIO, V74, P63, DOI 10.1016/S0169-2607(03)00071-3; LENORMAND P, 1993, ADV SEC MESS PHOSPH, V28, P237; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Paz C, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00060; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Poderoso C, 2008, PLOS ONE, V3; Ramsey MR, 2006, NAT CELL BIOL, V8, P1213, DOI 10.1038/ncb1106-1213; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Satoh Y, 2011, J NEUROSCI, V31, P1149, DOI 10.1523/JNEUROSCI.2243-10.2011; Urtreger AJ, 2001, INT J ONCOL, V18, P639; Woolley JF, 2013, ANTIOXID REDOX SIGN, V19, P1815, DOI 10.1089/ars.2012.5028; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	36	4	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193022	10.1371/journal.pone.0193022	http://dx.doi.org/10.1371/journal.pone.0193022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489891	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000051
J	Kesler, MA; Kaul, R; Loutfy, M; Myers, T; Brunetta, J; Remis, RS; Gesink, D				Kesler, Maya A.; Kaul, Rupert; Loutfy, Mona; Myers, Ted; Brunetta, Jason; Remis, Robert S.; Gesink, Dionne			Prosecution of non-disclosure of HIV status: Potential impact on HIV testing and transmission among HIV-negative men who have sex with men	PLOS ONE			English	Article							SEROSTATUS DISCLOSURE; PREVENTION; RISK; EXPOSURE; LAWS; ENGAGEMENT; INFECTION; ATTITUDES; BEHAVIOR; CANADA	Background Non-disclosure criminal prosecutions among gay, bisexual and other men who have sex with men (MSM) are increasing, even though transmission risk is low when effective antiretroviral treatment (ART) is used. Reduced HIV testing may reduce the impact of HIV "test and treat" strategies. We aimed to quantify the potential impact of non-disclosure prosecutions on HIV testing and transmission among MSM. Methods MSM attending an HIV and primary care clinic in Toronto completed an audio computer-assisted self-interview questionnaire. HIV-negative participants were asked concern over non-disclosure prosecution altered their likelihood of HIV testing. Responses were characterized using cross-tabulations and bivariate logistic regressions. Flow charts modelled how changes in HIV testing behaviour impacted HIV transmission rates controlling for ART use, condom use and HIV status disclosure. Results 150 HIV-negative MSM were recruited September 2010 to June 2012. 7% (9/124) were less or much less likely to be tested for HIV due to concern over future prosecution. Bivariate regression showed no obvious socio/sexual demographic characteristics associated with decreased willingness of HIV testing to due concern about prosecution. Subsequent models estimated that this 7% reduction in testing could cause an 18.5% increase in community HIV transmission, 73% of which was driven by the failure of HIV-positive but undiagnosed MSM to access care and reduce HIV transmission risk by using ART. Conclusions Fear of prosecution over HIV non-disclosure was reported to reduce HIV testing willingness by a minority of HIV-negative MSM in Toronto; however, this reduction has the potential to significantly increase HIV transmission at the community level which has important public health implications.	[Kesler, Maya A.; Myers, Ted; Remis, Robert S.; Gesink, Dionne] Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Epidemiol, Toronto, ON, Canada; [Kaul, Rupert] Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Loutfy, Mona] Womens Coll Hosp, Toronto, ON, Canada; [Loutfy, Mona; Brunetta, Jason] Maple Leaf Med Clin, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Kesler, MA (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Epidemiol, Toronto, ON, Canada.	maya.kesler@alum.utoronto.ca		Kaul, Rupert/0000-0002-1586-4093	Canadian Institute of Health Research, Canada; Canadian Institutes of Health Research, Canada [HET 85518]	Canadian Institute of Health Research, Canada(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research, Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research, Canada, Doctoral Research Award: MK, http://www.cihr-irsc.gc.ca/e/ 193.html; Canadian Institutes of Health Research, Canada, Emerging Team Grant: grant number HET 85518, RK, RR, http://www.cihr-irsc.gc.cate/193. html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COCHRANE DATABASE SY; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Burchell AN, 2015, JAIDS-J ACQ IMM DEF, V70, pE10, DOI 10.1097/QAI.0000000000000690; Burris S, 2007, ARIZONA STATE LAW J; Cameron Edwin, 2009, HIV AIDS POLICY LAW, V14, P1; Canadian HIV/AIDS Legal Network, HIV NOND CRIM LAW AN; Canadian HIV/AIDS Legal Network, CRIM LAW HIV NOND CA; Canadian HIV/AIDS Legal Network HIV/AIDS Legal Clinic Ontario (HALCO) Coalition des organismes communautaires quebecois de lutte contre le sida (COCQ-SIDA) Positive Living Society of British Columbia (Positive Living BC) Canadian AIDS Society (CAS) Toronto People With AIDS Foundation (PWA), UNJ SUPR COURT RUL C; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; Fox J, 2009, HIV MED, V10, P432, DOI 10.1111/j.1468-1293.2009.00708.x; Galletly CL, 2008, J LAW MED ETHICS, V36, P577, DOI 10.1111/j.1748-720X.2008.306.x; Galletly CL, 2012, AM J PUBLIC HEALTH, V102, P2135, DOI 10.2105/AJPH.2012.300664; Galletly CL, 2012, AIDS CARE, V24, P174, DOI 10.1080/09540121.2011.603493; Grulich AE, 2015, C RETR OPP INF CROI; Hermann Donald H J, 1990, St Louis Univ Public Law Rev, V9, P351; Horvath KJ, 2010, AIDS CARE, V22, P1221, DOI 10.1080/09540121003668078; Horvath KJ, 2016, AIDS BEHAV; Kesler MA, 2016, BMC PUBLIC IN PRESS; Lazzarini Z, 2002, J LAW MED ETHICS, V30, P239, DOI 10.1111/j.1748-720X.2002.tb00390.x; Lehman JS, 2014, AIDS BEHAV, V18, P997, DOI 10.1007/s10461-014-0724-0; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Myers T, MALE CALL CANADA TEC; Mykhalovskiy E., 2010, HIV NONDISCLOSURE CR; Mykhalovskiy E., 2016, RACIALIZATION IMMIGR; Mykhalovskiy E, 2012, CAN J LAW SOC, V27, P31, DOI 10.3138/cjls.27.1.031; O'Byrne P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-94; O'Byrne P, 2013, J ASSOC NURSE AIDS C, V24, P81, DOI 10.1016/j.jana.2012.01.009; O'Connell AA, 2015, AIDS BEHAV, V19, P283, DOI 10.1007/s10461-014-0848-2; Ontario Advisory Committee on HIV/ AIDS, 2017, HIV AIDS STRAT 2026; Patterson SE, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20572; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Public Health Agency of Canada, 2015, SUMM EST HIV INC PRE; Remis RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158090; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Shimeles H, 2011, AFRICAN CAIBBEAN BLA; Smith DK, 2015, JAIDS-J ACQ IMM DEF, V68, P337, DOI 10.1097/QAI.0000000000000461; Smith K, 2011, CURR OPIN HIV AIDS, V6, P315, DOI 10.1097/COH.0b013e32834788e7; Tanner Z, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1926-z; Wainberg MA, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-108; Wilson C., 2013, HLTH TOMORROW, V1, P109	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193269	10.1371/journal.pone.0193269	http://dx.doi.org/10.1371/journal.pone.0193269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489890	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000059
J	Molcho, L; Ben-Zur, T; Barhum, Y; Offen, D				Molcho, Lior; Ben-Zur, Tali; Barhum, Yael; Offen, Daniel			DJ-1 based peptide, ND-13, promote functional recovery in mouse model of focal ischemic injury	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ZINC SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; PARKINSONS-DISEASE; CEREBRAL-ISCHEMIA; GLUTAMATE NEUROTOXICITY; STROKE REHABILITATION; MOTOR RECOVERY; NEURONAL DEATH; CELL-DEATH	Stroke is a leading cause of death worldwide and inflicts serious long-term damage and disability. The vasoconstrictor Endothelin-1, presenting long-term neurological deficits associated with excitotoxicity and oxidative stress is being increasingly used to induce focal ischemic injury as a model of stroke. A DJ-1 based peptide named ND-13 was shown to protect against glutamate toxicity, neurotoxic insults and oxidative stress in various animal models. Here we focus on the benefits of treatment with ND-13 on the functional outcome of focal ischemic injury. Wild type C57BL/6 mice treated with ND-13, after ischemic induction in this model, showed significant improvement in motor function, including improved body balance and motor coordination, and decreased motor asymmetry. We found that DJ-1 knockout mice are more sensitive to Endothelin-1 ischemic insult than wild type mice, contributing thereby additional evidence to the widely reported relevance of DJ-1 in neuroprotection. Furthermore, treatment of DJ-1 knockout mice with ND-13, following Endothelin-1 induced ischemia, resulted in significant improvement in motor functions, suggesting that ND-13 provides compensation for DJ-1 deficits. These preliminary results demonstrate a possible basis for clinical application of the ND-13 peptide to enhance neuroprotection in stroke patients.	[Molcho, Lior; Offen, Daniel] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Ben-Zur, Tali; Barhum, Yael; Offen, Daniel] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Lab Neurosci, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Offen, D (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Offen, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Lab Neurosci, Tel Aviv, Israel.	danioffen@gmail.com			UGH Pharma, Inc. [ND-13]	UGH Pharma, Inc.	UGH Pharma, Inc. supplied the peptide (ND-13) used in the studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2002, MOL BIOL CELL GARLAN; Aleyasin H, 2007, P NATL ACAD SCI USA, V104, P18748, DOI 10.1073/pnas.0709379104; BEEM KM, 1974, J BIOL CHEM, V249, P7298; Brooks SP, 2011, NEUROMETHODS, V61, P65, DOI 10.1007/978-1-61779-298-4_5; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chao NJ, 2014, CURR MED CHEM, V21, P2043, DOI 10.2174/0929867321666131228204533; Chehaibi K, 2016, J STROKE CEREBROVASC; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Deng P, 2011, J CEREBR BLOOD F MET, V31, P1823, DOI 10.1038/jcbfm.2011.88; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doeppner TR, 2010, EXP NEUROL, V223, P548, DOI 10.1016/j.expneurol.2010.02.001; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fisher M, 1996, NEUROLOGY, V47, P884, DOI 10.1212/WNL.47.4.884; FUXE K, 1989, ACTA PHYSIOL SCAND, V137, P155, DOI 10.1111/j.1748-1716.1989.tb08733.x; Girotto S, 2014, J BIOL CHEM, V289, P10887, DOI 10.1074/jbc.M113.535112; Glat MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148170; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Gou X, 2010, TAT NEP1 40 NOVEL TH; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; Horie N, 2008, J NEUROSCI METH, V173, P286, DOI 10.1016/j.jneumeth.2008.06.013; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kaneko Y, 2014, CNS NEUROSCI THER, V20, P275, DOI 10.1111/cns.12208; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitamura Y, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-48; KUROSAWA M, 1991, J CARDIOVASC PHARM, V17, pS340, DOI 10.1097/00005344-199100177-00097; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127549; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; MELLORS A, 1966, J BIOL CHEM, V241, P4353; MELLORS A, 1966, LIPIDS, V1, P282, DOI 10.1007/BF02531617; Milani P, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/836760; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nguemeni C, 2015, J NEUROSCI METH, V242, P72, DOI 10.1016/j.jneumeth.2015.01.005; O'Dell MW, 2009, ANNU REV MED, V60, P55, DOI 10.1146/annurev.med.60.042707.104248; Pantcheva P, 2014, NEURAL REGEN RES, V9, P1430, DOI 10.4103/1673-5374.139458; Runden-Pran E, 2002, NEUROSCIENCE, V112, P277, DOI 10.1016/S0306-4522(02)00092-1; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schwenk J, 2008, J BIOL CHEM, V283, P18937, DOI 10.1074/jbc.M800976200; Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7; Shalit T, 2015, J PROTEOME RES, V14, P1979, DOI 10.1021/pr501045t; Singh P, 2003, MOL CELL BIOCHEM, V243, P139, DOI 10.1023/A:1021668314070; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Tao F, 2008, MOL THER, V16, P1776, DOI 10.1038/mt.2008.192; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; van der Merwe C, 2015, EUR J NEUROSCI, V41, P1113, DOI 10.1111/ejn.12872; Van Vranken JG, 2014, CELL METAB, V20, P241, DOI 10.1016/j.cmet.2014.05.012; Vergun O, 2001, J PHYSIOL-LONDON, V531, P147, DOI 10.1111/j.1469-7793.2001.0147j.x; Vonk WIM, 2010, J BIOL CHEM, V285, P28991, DOI 10.1074/jbc.M110.101477; Waak J, 2009, FASEB J, V23, P2478, DOI 10.1096/fj.08-125153; WADE DT, 1992, CURR OPIN NEUROL NEU, V5, P682; WAHL F, 1992, STROKE, V23, P267, DOI 10.1161/01.STR.23.2.267; Wang YQ, 2015, AUTOPHAGY, V11, P595, DOI 10.1080/15548627.2015.1034408; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; Yanagisawa D, 2008, J CEREBR BLOOD F MET, V28, P563, DOI 10.1038/sj.jcbfm.9600553	70	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192954	10.1371/journal.pone.0192954	http://dx.doi.org/10.1371/journal.pone.0192954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489843	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000048
J	NoeI-MacDonnell, JR; Usset, J; Goode, EL; Fridley, BL				NoeI-MacDonnell, Janelle R.; Usset, Joseph; Goode, Ellen L.; Fridley, Brooke L.			Assessment of data transformations for model-based clustering of RNA-Seq data	PLOS ONE			English	Article							GRADE	Quality control, global biases, normalization, and analysis methods for RNA-Seq data are quite different than those for microarray-based studies. The assumption of normality is reasonable for microarray based gene expression data; however, RNA-Seq data tend to follow an over-dispersed Poisson or negative binomial distribution. Little research has been done to assess how data transformations impact Gaussian model-based clustering with respect to clustering performance and accuracy in estimating the correct number of clusters in RNA-Seq data. In this article, we investigate Gaussian model-based clustering performance and accuracy in estimating the correct number of clusters by applying four data transformations (i.e., naive, logarithmic, Blom, and variance stabilizing transformation) to simulated RNA-Seq data. To do so, an extensive simulation study was carried out in which the scenarios varied in terms of: how genes were selected to be included in the clustering analyses, size of the clusters, and number of clusters. Following the application of the different transformations to the simulated data, Gaussian model-based clustering was carried out. To assess clustering performance for each of the data transformations, the adjusted rand index, clustering error rate, and concordance index were utilized. As expected, our results showed that clustering performance was gained in scenarios where data transformations were applied to make the data appear "more" Gaussian in distribution.	[NoeI-MacDonnell, Janelle R.; Usset, Joseph; Fridley, Brooke L.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA; [NoeI-MacDonnell, Janelle R.] Childrens Mercy Hosp, Dept Hlth Serv & Outcomes Res, Kansas City, MO 64108 USA; [Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Fridley, Brooke L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA	University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital; Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute	Fridley, BL (corresponding author), Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA.; Fridley, BL (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA.	Brooke.Fridley@moffitt.org	Fridley, Brooke/D-8315-2015	Fridley, Brooke/0000-0001-7739-7956; Usset, Joseph/0000-0002-5820-9881				Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Beasley TM, 2009, BEHAV GENET, V39, P580, DOI 10.1007/s10519-009-9281-0; Durbin B P, 2002, Bioinformatics, V18 Suppl 1, pS105; Earp MA, 2017, ONCOTARGET; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2012, 597 U WASH; Fraley C, 2007, J STAT SOFTW, V18; GREEN PJ, 1984, J R STAT SOC B, V46, P149; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; JIANG D, 2004, IEEE T KNOWLEDGE DAT, V16; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Makretsov NA, 2004, CLIN CANCER RES, V10, P6143, DOI 10.1158/1078-0432.CCR-04-0429; Qu Y, 2004, BIOINFORMATICS, V20, P1905, DOI 10.1093/bioinformatics/bth177; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; R Development Core Team, 2016, R LANG ENV STAT COMP; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Shannon W, 2003, PHARMACOGENOMICS, V4, P41, DOI 10.1517/phgs.4.1.41.22581; Si Y, 2013, BIOINFORMATICS; Sibru A, 2012, PLOS ONE; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Wang C, 2017, CLIN CANCER RES, V23, P4077, DOI 10.1158/1078-0432.CCR-17-0246; Way GP, 2016, G3-GENES GENOM GENET, V6, P4097, DOI 10.1534/g3.116.033514; Witten DM, 2011, ANN APPL STAT, V5, P2493, DOI 10.1214/11-AOAS493; Yee TW, 2003, STAT MODEL, V3, P15, DOI 10.1191/1471082X03st045oa; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Zwiener I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085150	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0191758	10.1371/journal.pone.0191758	http://dx.doi.org/10.1371/journal.pone.0191758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485993	gold, Green Published, Green Submitted			2022-12-27	WOS:000426242400003
J	Schottle, D; Schimmelmann, BG; Ruppelt, F; Bussopulos, A; Frieling, M; Nika, E; Nawara, LA; Golks, D; Kerstan, A; Lange, M; Schodlbauer, M; Daubmann, A; Wegscheider, K; Rohenkohl, A; Sarikaya, G; Sengutta, M; Luedecke, D; Wittmann, L; Ohm, G; Meigel-Schleiff, C; Gallinat, J; Wiedemann, K; Bock, T; Karow, A; Lambert, M				Schoettle, Daniel; Schimmelmann, Benno G.; Ruppelt, Friederike; Bussopulos, Alexandra; Frieling, Marietta; Nika, Evangelia; Nawara, Luise Antonia; Golks, Dietmar; Kerstan, Andrea; Lange, Matthias; Schoedlbauer, Michael; Daubmann, Anne; Wegscheider, Karl; Rohenkohl, Anja; Sarikaya, Gizem; Sengutta, Mary; Luedecke, Daniel; Wittmann, Linus; Ohm, Gunda; Meigel-Schleiff, Christina; Gallinat, Juergen; Wiedemann, Klaus; Bock, Thomas; Karow, Anne; Lambert, Martin			Effectiveness of integrated care including therapeutic assertive community treatment in severe schizophrenia-spectrum and bipolar I disorders: Four-year follow-up of the ACCESS II study	PLOS ONE			English	Article							PARK MULTIDIAGNOSTIC INSTRUMENT; RANDOMIZED MULTICENTER TRIAL; QUALITY-OF-LIFE; 1ST EPISODE; SERVICE DISENGAGEMENT; STANDARD TREATMENT; EARLY INTERVENTION; BASE-LINE; PSYCHOSIS; 1ST-EPISODE	The ACCESS-model offers integrated care including assertive community treatment to patients with psychotic disorders. ACCESS proved more effective compared to standard care (ACCESS-I study) and was successfully implemented into clinical routine (ACCESS-Il study). In this article, we report the 4-year outcomes of the ACCESS-Il study. Between May 2007 and December 2013,115 patients received continuous ACCESS-care. We hypothesized that the low 2-year disengagement and hospitalization rates and significant improvements in psychopathology, functioning, and quality of life could be sustained over 4 years. Over 4 years, only 10 patients disengaged from ACCESS. Another 23 left for practical reasons and were successfully transferred to other services. Hospitalization rates remained low (13.0% in year 3; 9.1% in year 4). Involuntary admissions decreased from 35% in the 2 years prior to ACCESS to 8% over 4 years in ACCESS. Outpatient contacts remained stably high at 2.0-2.4 per week. We detected significant improvements in psychopathology (effect size d = 0.79), illness severity (d = 1.29), level of functioning (d = 0.77), quality of life (d = 0.47) and stably high client satisfaction (d = 0.02) over 4 years. Most positive effects were observed within the first 2 years with the exception of illness severity, which further improved from year 2 to 4. Within continuous intensive 4-year ACCESS-care, sustained improvements in psychopathology, functioning, quality of life, low service disengagement and re-hospitalization rates, as well as low rates of involuntary treatment, were observed in contrast to other studies, which reported a decline in these parameters once a specific treatment model was stopped. Yet, stronger evidence to prove these results is required.	[Schoettle, Daniel; Ruppelt, Friederike; Bussopulos, Alexandra; Frieling, Marietta; Nika, Evangelia; Nawara, Luise Antonia; Golks, Dietmar; Kerstan, Andrea; Lange, Matthias; Schoedlbauer, Michael; Rohenkohl, Anja; Sarikaya, Gizem; Sengutta, Mary; Luedecke, Daniel; Wittmann, Linus; Wiedemann, Klaus; Bock, Thomas; Karow, Anne; Lambert, Martin] Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Psychosis Ctr, Ctr Psychosocial Med, Hamburg, Germany; [Schimmelmann, Benno G.] Univ Bern, Univ Hosp Child & Adolescent Psychiat, Bern, Switzerland; [Schimmelmann, Benno G.] Univ Med Ctr Hamburg Eppendorf, Univ Hosp Child & Adolescent Psychiat, Hamburg, Germany; [Daubmann, Anne; Wegscheider, Karl] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Ohm, Gunda] Strategic Univ, Univ Med Ctr, Dev Ctr, Hamburg, Germany; [Gallinat, Juergen] Univ Ctr Psychosocial Med, Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bern; University Hospital of Bern; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schottle, D (corresponding author), Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Psychosis Ctr, Ctr Psychosocial Med, Hamburg, Germany.	d.schoettle@uke.de	Wittmann, Linus/AAJ-9012-2021	Wittmann, Linus/0000-0002-0210-8360				APA, 1994, DIAGN STAT MAN MENT; Austin SF, 2013, SCHIZOPHR RES, V150, P163, DOI 10.1016/j.schres.2013.07.031; Benabarre A, 2001, EUR PSYCHIAT, V16, P167, DOI 10.1016/S0924-9338(01)00559-4; Bertelsen M, 2008, ARCH GEN PSYCHIAT, V65, P762, DOI 10.1001/archpsyc.65.7.762; Conus P, 2010, SCHIZOPHR RES, V118, P256, DOI 10.1016/j.schres.2010.01.032; Cortina J.M., 2000, EFFECT SIZE ANOVA DE; Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; First MB, 2002, STRUCTURED CLIN INTE; Gold PB, 2006, SCHIZOPHRENIA BULL, V32, P378, DOI 10.1093/schbul/sbi056; Guy W, 1976, ECDEU ASSESSMENT MAN; Hafner H, 2013, NERVENARZT, V84, P1093, DOI 10.1007/s00115-013-3788-6; Hafner H, 2013, NERVENARZT, V84, P6; JORGENSEN B, 1987, J ROY STAT SOC B MET, V49, P127; Juckel G, 2015, PSYCHIAT PRAX, V42, P133, DOI 10.1055/s-0034-1369866; Kane JA, 2003, J CLIN PSYCHIAT, V64, P5; Karow A, 2012, J CLIN PSYCHIAT, V73, pE402, DOI 10.4088/JCP.11m06875; Kreyenbuhl J, 2009, SCHIZOPHRENIA BULL, V35, P696, DOI 10.1093/schbul/sbp046; Lambert M, 2010, J CLIN PSYCHIAT, V71, P1313, DOI 10.4088/JCP.09m05113yel; Lambert M, 2010, J CLIN PSYCHOPHARM, V30, P565, DOI 10.1097/JCP.0b013e3181f058a0; Latalova K, 2011, PSYCHIAT DANUB, V23, P21; Marshall M, 2000, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001089, DOI 10.1002/14651858.CD001089]; McGarvey EL, 2013, PSYCHIAT SERV, V64, P120, DOI 10.1176/appi.ps.000692012; MCGORRY PD, 1990, SCHIZOPHRENIA BULL, V16, P517, DOI 10.1093/schbul/16.3.517; MCGORRY PD, 1990, SCHIZOPHRENIA BULL, V16, P501, DOI 10.1093/schbul/16.3.501; Nguyen T D, 1983, Eval Program Plann, V6, P299, DOI 10.1016/0149-7189(83)90010-1; NICE, 2014, PSYCH SCHIZ AD NICE; Nordentoft Merete, 2006, Ugeskr Laeger, V168, P381; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Petersen L, 2005, BRIT J PSYCHIAT, V187, pS98, DOI 10.1192/bjp.187.48.s98; Petersen L, 2005, BMJ-BRIT MED J, V331, P602, DOI 10.1136/bmj.38565.415000.E01; Ritsner M, 2005, QUAL LIFE RES, V14, P1693, DOI 10.1007/s11136-005-2816-9; Schimmelmann BG, 2008, J PSYCHIATR RES, V42, P982, DOI 10.1016/j.jpsychires.2007.12.001; Schimmelmann BG, 2006, J AM ACAD CHILD PSY, V45, P990, DOI 10.1097/01.chi.0000223015.29530.65; Schottle D, 2014, J CLIN PSYCHIAT, V75, P1371, DOI 10.4088/JCP.13m08817; Schottle D, 2013, CURR OPIN PSYCHIATR, V26, P384, DOI 10.1097/YCO.0b013e328361ec3b; Secher RG, 2015, SCHIZOPHRENIA BULL, V41, P617, DOI 10.1093/schbul/sbu155; STEIN LI, 1980, ARCH GEN PSYCHIAT, V37, P392; Stowkowy J, 2012, SCHIZOPHR RES, V136, P7, DOI 10.1016/j.schres.2012.01.027; Sytema S, 2007, ACTA PSYCHIAT SCAND, V116, P105, DOI 10.1111/j.1600-0447.2007.01021.x; Teague GB, 1998, AM J ORTHOPSYCHIAT, V68, P216, DOI 10.1037/h0080331; Tohen M, 2000, AM J PSYCHIAT, V157, P220, DOI 10.1176/appi.ajp.157.2.220; Treuer T, 2010, EUR PSYCHIAT, V25, P328, DOI 10.1016/j.eurpsy.2009.11.012; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123	43	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192929	10.1371/journal.pone.0192929	http://dx.doi.org/10.1371/journal.pone.0192929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7BV	29485988	Green Submitted, Green Published, gold			2022-12-27	WOS:000426242400012
J	Lee, K; Park, N; Jung, H; Rim, YA; Nam, Y; Lee, J; Park, SH; Ju, H				Lee, Kijun; Park, Narae; Jung, Hyerin; Rim, Yeri Alice; Nam, Yoojun; Lee, Jennifer; Park, Sung-Hwan; Ju, Hyeon			Mesenchymal stem cells ameliorate experimental arthritis via expression of interleukin-1 receptor antagonist	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; TH17 CELLS; GM-CSF; IL-1; CYTOKINE; COLLAGEN; PATHOGENESIS; PATHWAYS; ANAKINRA	Human bone marrow-derived mesenchymal stem cells (MSCs) have been observed to inhibit arthritis in experimental animal models such as collagen-induced arthritis. However, the exact anti-inflammatory mechanisms remain poorly understood. Interleukin-1 receptor antagonist (IL-1Ra) is an anti-inflammatory cytokine produced by immune and stromal cells. We postulated that MSCs could produce IL-1Ra and attenuate experimental arthritis. In this study, 5x10(6) MSCs were injected into the peritoneal cavity of IL-1Ra knockout (IL-1RaKO) mice. MSCs reduced the severity of the arthritis by histology and decreased pro-inflammatory cytokine levels in IL-1RaKO mice. The ratio of splenic T helper 17 (Th17) cells to regulatory T cells (Treg) was significantly decreased in MSC-injected IL-1RaKO mice. Purified splenic CD4+ T cells from mice in each of the treatment groups were cultured under Th17 polarizing conditions and analyzed by flow cytometry. Less expansion of the Th17 population was observed in the MSC-treated group. Interestingly, MSCs expressed inducible IL-1Ra against inflammatory environmental stimuli. Human recombinant IL-1Ra could suppress Th17 cells differentiation under Th17 polarizing conditions. These results indicate that IL-1Ra expressed by MSCs can inhibit Th17 polarization and decrease the immune response in IL-1RaKO mice. Therefore, MSC-derived IL-1Ra may inhibit inflammation in IL-1RaKO mice via effects on Th17 differentiation.	[Lee, Kijun; Park, Narae; Jung, Hyerin; Rim, Yeri Alice; Nam, Yoojun; Ju, Hyeon] Catholic Univ Korea, Coll Med, Catholic iPSC Res Ctr, Seoul, South Korea; [Lee, Jennifer; Park, Sung-Hwan; Ju, Hyeon] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Rheumatol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Ju, H (corresponding author), Catholic Univ Korea, Coll Med, Catholic iPSC Res Ctr, Seoul, South Korea.; Ju, H (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Rheumatol,Dept Internal Med, Seoul, South Korea.	juji@catholic.ac.kr		Ju, Ji Hyeon/0000-0002-1381-5466	Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [HI16C2177]; Ministry of Food and Drug Safety [14172MFDS974]	Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This work was supported by a grant of the Korea Healthcare Technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (HI16C2177) and by a grant (14172MFDS974) from Ministry of Food and Drug Safety.	Arend WP, 2001, SEMIN ARTHRITIS RHEU, V30, P1, DOI 10.1053/sarh.2001.23693; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Ben-Ami E, 2011, AUTOIMMUN REV, V10, P410, DOI 10.1016/j.autrev.2011.01.005; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Chiang CY, 1999, INFECT IMMUN, V67, P4231, DOI 10.1128/IAI.67.8.4231-4236.1999; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Cohen SB, 2004, RHEUM DIS CLIN N AM, V30, P365, DOI 10.1016/j.rdc.2004.01.005; Cunnane G, 2001, RHEUMATOLOGY, V40, P62, DOI 10.1093/rheumatology/40.1.62; De Miguel MP, 2012, CURR MOL MED, V12, P574; DEBLECOURT J, 1961, ANN RHEUM DIS, V20, P215, DOI 10.1136/ard.20.3.215; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Figueroa FE, 2012, BIOL RES, V45, P269, DOI 10.4067/S0716-97602012000300008; Fleischmann R, 2004, EXPERT OPIN BIOL TH, V4, P1333, DOI 10.1517/14712598.4.8.1333; Gabay C, 1998, SPRINGER SEMIN IMMUN, V20, P229, DOI 10.1007/s002810050032; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gathungu G, 2013, INFLAMM BOWEL DIS, V19, P1671, DOI 10.1097/MIB.0b013e318281f506; GEIGER T, 1993, CLIN EXP RHEUMATOL, V11, P515; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Goolaerts A, 2014, AM J PHYSIOL-LUNG C, V306, pL975, DOI 10.1152/ajplung.00242.2013; Haddad CS, 2016, AUTOIMMUNITY, V49, P298, DOI 10.1080/08916934.2016.1183657; Herder C, 2009, DIABETES CARE, V32, P421, DOI 10.2337/dc08-1161; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Ikeda S, 2014, J IMMUNOL, V192, P1449, DOI 10.4049/jimmunol.1300387; Kean TJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/732742; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552; Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305; Luz-Crawford P, 2016, STEM CELLS, V34, P483, DOI 10.1002/stem.2254; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Malyak M, 1998, J IMMUNOL, V161, P2004; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Park N, 2017, SCI REP-UK, V7, DOI 10.1038/srep39593; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Schett G, 2016, NAT REV RHEUMATOL, V12, P14, DOI 10.1038/nrrheum.2016.166; Schiff MH, 2000, ANN RHEUM DIS, V59, P103, DOI 10.1136/ard.59.suppl_1.i103; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Volarevic V, 2010, AUTOIMMUNITY, V43, P255, DOI 10.3109/08916930903305641; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Walker JG, 1999, RHEUMATOLOGY, V38, P1050, DOI 10.1093/rheumatology/38.11.1050; Wilson T, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/345806; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762	46	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0193086	10.1371/journal.pone.0193086	http://dx.doi.org/10.1371/journal.pone.0193086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481574	Green Published, gold, Green Submitted			2022-12-27	WOS:000426202700008
J	Bertoni, M; Corazzini, L				Bertoni, Marco; Corazzini, Luca			Asymmetric affective forecasting errors and their correlation with subjective well-being	PLOS ONE			English	Article							LIFE-SATISFACTION; LOSS AVERSION; INCOME; EXPECTATIONS; ASPIRATIONS; HAPPINESS; ADULTHOOD; CHOICES; HEALTH	Aims Social scientists have postulated that the discrepancy between achievements and expectations affects individuals' subjective well-being. Still, little has been done to qualify and quantify such a psychological effect. Our empirical analysis assesses the consequences of positive and negative affective forecasting errors-the difference between realized and expected subjective well-being-on the subsequent level of subjective well-being. Data We use longitudinal data on a representative sample of 13,431 individuals from the German Socio-Economic Panel. In our sample, 52% of individuals are females, average age is 43 years, average years of education is 11.4 and 27% of our sample lives in East Germany. Subjective well-being (measured by self-reported life satisfaction) is assessed on a 0-10 discrete scale and its sample average is equal to 6.75 points. Methods We develop a simple theoretical framework to assess the consequences of positive and negative affective forecasting errors-the difference between realized and expected subjective well-being-on the subsequent level of subjective well-being, properly accounting for the endogenous adjustment of expectations to positive and negative affective forecasting errors, and use it to derive testable predictions. Given the theoretical framework, we estimate two panel-data equations, the first depicting the association between positive and negative affective forecasting errors and the successive level of subjective well-being and the second describing the correlation between subjective well-being expectations for the future and hedonic failures and successes. Our models control for individual fixed effects and a large battery of time-varying demographic characteristics, health and socio-economic status. Results and conclusions While surpassing expectations is uncorrelated with subjective well-being, failing to match expectations is negatively associated with subsequent realizations of subjective well-being. Expectations are positively (negatively) correlated to positive (negative) forecasting errors.We speculate that in the first case the positive adjustment in expectations is strong enough to cancel out the potential positive effects on subjective well-being of beaten expectations, while in the second case it is not, and individuals persistently bear the negative emotional consequences of not achieving expectations.	[Bertoni, Marco] Univ Padua, Dept Econ & Management, Padua, Italy; [Corazzini, Luca] Univ Venice Ca Foscari, Dept Econ Sci, Venice, Italy	University of Padua; Universita Ca Foscari Venezia	Corazzini, L (corresponding author), Univ Venice Ca Foscari, Dept Econ Sci, Venice, Italy.	luca.carazzini@unive.it	Bertoni, M/AAC-2893-2022	Corazzini, Luca/0000-0002-0567-8457; bertoni, marco/0000-0003-0783-3972	Fondazione CARIPARO	Fondazione CARIPARO(Fondazione Cariparo)	Funds from the Fondazione CARIPARO is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhassani M, 2013, ECONOMIST-NETHERLAND, V161, P349, DOI 10.1007/s10645-013-9209-1; Alonso-Carrera J, 2007, ECON J, V117, P813, DOI 10.1111/j.1468-0297.2007.02051.x; Angelini V, 2017, J R STAT SOC A STAT, V180, P225, DOI 10.1111/rssa.12190; Angelini V, 2014, OXFORD B ECON STAT, V76, P643, DOI 10.1111/obes.12039; Angelini V, 2011, J R STAT SOC A STAT, V174, P621, DOI 10.1111/j.1467-985X.2011.00705.x; Arkes HR, 2008, ORGAN BEHAV HUM DEC, V105, P67, DOI 10.1016/j.obhdp.2007.04.005; Arkes HR, 2010, ORGAN BEHAV HUM DEC, V112, P99, DOI 10.1016/j.obhdp.2010.02.002; Boyce CJ, 2013, PSYCHOL SCI, V24, P2557, DOI 10.1177/0956797613496436; Bruni L., 2005, EC HAPPINESS FRAMING; CAMPBELL A, 1976, AM PSYCHOL, V31, P117, DOI 10.1037/0003-066X.31.2.117; Clark AE, 2008, ECON J, V118, pF222, DOI 10.1111/j.1468-0297.2008.02150.x; Das M, 1997, J ECON BEHAV ORGAN, V32, P137, DOI 10.1016/S0167-2681(96)00023-6; Das M, 1999, J ECON BEHAV ORGAN, V40, P409, DOI 10.1016/S0167-2681(99)00062-1; Davidson R, 1993, ESTIMATION INFERENCE; Deaton A., 2017, WELFARE HAPPIN UNPUB; Deaton A, 2008, J ECON PERSPECT, V22, P53, DOI 10.1257/jep.22.2.53; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; Easterlin R. A., 1974, NATIONS HOUSEHOLDS E, P89, DOI [DOI 10.1016/B978-0-12-205050-3.50008-7, 10.1016/b978-0-12-205050-3.50008-7]; Easterlin RA, 2001, ECON J, V111, P465, DOI 10.1111/1468-0297.00646; Easterlin RA, 2010, P NATL ACAD SCI USA, V107, P22463, DOI 10.1073/pnas.1015962107; Ekici T, 2016, APPL RES QUAL LIFE, V11, P539, DOI 10.1007/s11482-014-9380-9; Frederick S., 1999, WELL BEING FDN HEDON, P302; Frey B., 2002, WORLD ECON, V3, P25; Frey B.S., 2002, HAPPINESS EC EC I AF; Frey BS, 2002, J ECON LIT, V40, P402, DOI 10.1257/002205102320161320; Frijters P, 2012, J ECON BEHAV ORGAN, V81, P159, DOI 10.1016/j.jebo.2011.09.007; Frijters P, 2009, CAN J ECON, V42, P1326, DOI 10.1111/j.1540-5982.2009.01547.x; Graham C, 2011, BROOK FOCUS BK; Graham C., 2017, HAPPINESS ALL UNEQUA; Groot W, 2000, SOC INDIC RES, V50, P315, DOI 10.1023/A:1007085500976; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Karlsson N, 2004, J ECON PSYCHOL, V25, P753, DOI 10.1016/j.joep.2003.07.003; Kermer DA, 2006, PSYCHOL SCI, V17, P649, DOI 10.1111/j.1467-9280.2006.01760.x; Koszegi B, 2006, Q J ECON, V121, P1133, DOI 10.1093/qje/121.4.1133; Lang FR, 2013, PSYCHOL AGING, V28, P249, DOI 10.1037/a0030797; Levy-Garboua L., 2009, R BOUDON LIFE SOCIOL, V3, P1; LOOMES G, 1986, REV ECON STUD, V53, P271, DOI 10.2307/2297651; Lyubomirsky S., 2011, OXFORD HDB STRESS HL, P200, DOI DOI 10.1093/OXFORDHB/9780195375343.013.0011; Mason R., 1977, SOCIAL INDICATORS RE, V5, P133; MICHALOS AC, 1980, SOC INDIC RES, V8, P385, DOI 10.1007/BF00461152; MUTH JF, 1961, ECONOMETRICA, V29, P315, DOI 10.2307/1909635; Odermatt R., 2015, 787 SOEP; Page L, 2007, ECON EDUC REV, V26, P747, DOI 10.1016/j.econedurev.2007.06.001; Schoon I, 2001, INT J BEHAV DEV, V25, P124, DOI 10.1080/01650250042000186; Schwandt H, 2016, J ECON BEHAV ORGAN, V122, P75, DOI 10.1016/j.jebo.2015.11.011; Sen A., 1999, COMMODITIES CAPABILI; Sen A., 1985, STANDARD LIVING TANN; Senik C, 2008, J ECON BEHAV ORGAN, V68, P140, DOI 10.1016/j.jebo.2008.03.004; Stutzer A, 2004, J ECON BEHAV ORGAN, V54, P89, DOI 10.1016/j.jebo.2003.04.003; van Dijk WW, 2003, J ECON PSYCHOL, V24, P505, DOI 10.1016/S0167-4870(02)00211-8; van Praag B.M.S., 2008, HAPPINESS QUANTIFED, DOI [10.1093/acprof:oso/9780199226146.001.0001, DOI 10.1093/ACPROF:OSO/9780199226146.001.0001]; Wagner G. G., 2007, SCHMOLLERS JB, V127, P139, DOI DOI 10.2139/SSRN.1028709; Wilson TD, 2003, ADV EXP SOC PSYCHOL, V35, P345, DOI 10.1016/S0065-2601(03)01006-2	57	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192941	10.1371/journal.pone.0192941	http://dx.doi.org/10.1371/journal.pone.0192941			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513685	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800025
J	Raizada, N; Khaparde, SD; Swaminathan, S; Sarin, S; Salhotra, VS; Kalra, A; Khanna, A; Chopra, KK; Hanif, M; Umadevi, KR; Hissar, S; Nair, SA; Prakash, CHS; Saha, BK; Rao, R; Denkinger, C; Boehme, C				Raizada, Neeraj; Khaparde, Sunil D.; Swaminathan, Soumya; Sarin, Sanjay; Salhotra, Virender Singh; Kalra, Aakshi; Khanna, Ashwani; Chopra, K. K.; Hanif, M.; Umadevi, K. R.; Hissar, Syed; Nair, Sreenivas Achuthan; Prakash, C. H. Surya; Saha, B. K.; Rao, Raghuram; Denkinger, Claudia; Boehme, Catharina			Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India	PLOS ONE			English	Article							CHILDHOOD TUBERCULOSIS; XPERT MTB/RIF; RESISTANT TUBERCULOSIS; ADVOCACY; CHILDREN; IMPACT	Background Unlike in adults, diagnosis of TB can be challenging in children, as signs and symptoms of paediatric TB can be very non-specific and similar to other common childhood chest infections, which may lead to under or delayed diagnosis of TB disease. In spite of the increasing availability of rapid high-sensitivity diagnostics in public and private sectors, majority of paediatric TB cases are empirically diagnosed, without laboratory confirmation. To address these diagnostic challenges, World Health Organization (WHO) has recommended upfront Xpert MTB/RIF (Xpert) testing for the diagnosis of TB in paediatric presumptive pulmonary and extra-pulmonary TB (EPTB) cases. However, in spite of the increasing availability of rapid high-sensitivity diagnostics, a significant gap exists in its application with Xpert being rarely used as an upfront diagnostic among patients presumed to have TB. Under an ongoing paediatric project since April 2014, which provided free-of-cost upfront Xpert testing, several low-cost outreach and education interventions were undertaken to increase the diagnostic uptake by different providers catering to the paediatric population, thereby increasing adherence to global guidance. Methods Providers catering to paediatric population in the project cities were systematically mapped and contacted using different outreach strategies. The focus of outreach efforts was to increase provider literacy and increase their awareness of the availability of free rapid diagnostic services with the goal of changing their diagnostic approaches. Results From April 2014 to June 2016, more than 5,700 providers/facilities were mapped and 3,670 of them were approached. The number of providers/facilities engaged under the project increased more than 10-fold (43 in April, 2014 to 466 in June, 2016), with significant increase in project uptake, both from public and private sector. Overall 42,238 paediatric presumptive TB cases were enrolled in the project, across the four cities. Over the project period, quarterly diagnostic uptake and paediatric TB cases detection rates increased more than two-fold. TB detection rates were similar in patients from public and private sectors. Conclusions Ongoing efforts in scaling up new rapid diagnostics involves significant investments. These efforts need to be complemented with proactive provider engagement to ensure provider-literacy and awareness, for maximizing impact of this scale-up. The current project demonstrated the usefulness of outreach and education interventions for the effective uptake of newer diagnostics.	[Raizada, Neeraj; Sarin, Sanjay; Kalra, Aakshi] Fdn Innovat New Diagnost, New Delhi, India; [Khaparde, Sunil D.; Salhotra, Virender Singh; Rao, Raghuram] Govt India, Cent TB Div, New Delhi, India; [Swaminathan, Soumya] Indian Council Med Res, New Delhi, India; [Khanna, Ashwani] Govt NCT, State TB Off, New Delhi, India; [Chopra, K. K.; Hanif, M.] New Delhi TB Ctr, New Delhi, India; [Umadevi, K. R.; Hissar, Syed] Natl Inst Res TB, Madras, Tamil Nadu, India; [Nair, Sreenivas Achuthan] World Hlth Org, Country Off India, New Delhi, India; [Prakash, C. H. Surya] Intermediate Reference Lab, Hyderabad, Andhra Pradesh, India; [Saha, B. K.] Intermediate Reference Lab, Kolkata, India; [Denkinger, Claudia; Boehme, Catharina] Fdn Innovat New Diagnost, Geneva, Switzerland	Foundation For Innovative New Diagnostics; Indian Council of Medical Research (ICMR); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization; Foundation For Innovative New Diagnostics	Kalra, A (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	aakshi.kalra@finddx.org		Nair, Sreenivas/0000-0002-2586-6797; Raizada, Neeraj/0000-0003-2116-332X	United States Agency for International Development (USAID) under Challenge TB project	United States Agency for International Development (USAID) under Challenge TB project(United States Agency for International Development (USAID))	The project was funded by United States Agency for International Development (USAID) under Challenge TB project. FIND was responsible for implementation, training, coordination, monitoring, data analysis and writing of the reporting in close coordination with Central TB Division, Ministry of Health and Family Welfare, Government of India.	Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016; Cao H, 2012, J BIOL DYNAM, V6, P663, DOI 10.1080/17513758.2012.677483; Central TB Division; Government of India, 2017, TB IND 2017, V2017, P1; Cruz AT, 2014, LANCET GLOBAL HLTH, V2; DeLuca A, 2014, LANCET RESP MED, V2, P258, DOI 10.1016/S2213-2600(14)70035-9; Dodd PJ, 2014, LANCET GLOB HLTH, V2; Donald PR, 2002, CURR OPIN PULM MED, V8, P178, DOI 10.1097/00063198-200205000-00005; Hanrahan CF, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw068; Hsiang E, 2016, INT J TUBERC LUNG D, V20, P1212, DOI 10.5588/ijtld.16.0200; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; Kalra A, 2017, INT J TUBERC LUNG D, V21, P645, DOI 10.5588/ijtld.16.0563; Kamineni VV, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-463; Kr S, 2014, COCHRANE LIB; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Lolekha R, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-94; Mahendradhata Y, 2007, TROP MED INT HEALTH, V12, P315, DOI 10.1111/j.1365-3156.2007.01816.x; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nguyen TQN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-31; Nicol MP, 2011, PAEDIATR RESPIR REV, V12, P16, DOI 10.1016/j.prrv.2010.09.008; Organisation W. H., 2013, GLOB TUB REP 2013, P306; Pai M, 2012, INT J TUBERC LUNG D, V16, P1281, DOI 10.5588/ijtld.12.0391; Pantoja A, 2013, EUR RESPIR J, V42, P708, DOI 10.1183/09031936.00147912; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Raizada N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116721; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105346; Sekadde MP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-133; UNITAID Diagnostics Technology and Market Landscape, 2014, UNITAID DIAGN TECHN; Uplekar M, 2003, TUBERCULOSIS, V83, P156, DOI 10.1016/S1472-9792(02)00073-2; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; WHO, 2013, STATE SCI ENDOCRINE, p[1, 5]; Wikipedia, 2016, PAR PRINC, P5; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193341	10.1371/journal.pone.0193341	http://dx.doi.org/10.1371/journal.pone.0193341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509803	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000426813200013
J	Lin, FY; Yang, YC; Lin, CL; Lee, LJH				Lin, Fu-Yu; Yang, Yi-Chien; Lin, Cheng-Li; Lee, Lukas Jyuhn-Hsiarn			Increased risk of overactive bladder in patients with idiopathic Parkinson's disease: Insight from a nationwide population-based cohort study	PLOS ONE			English	Article							URINARY-TRACT DYSFUNCTION; SYMPTOMS; PREVALENCE; MANAGEMENT; INCONTINENCE; EPIDEMIOLOGY; DEGENERATION	Background Idiopathic Parkinson's disease (IPD) is a progressive neurodegenerative disorder characterized by typical motor impairment. However, lower urinary tract symptoms, including urinary urgency or frequency, which are non-motor phenomena, occur frequently among patients with IPD. In this study, we assess the risk of overactive bladder (OAB) in patients with IPD. Methods The National Health Insurance Research Database of Taiwan was used to identify patients with IPD (IPD cohort) and four-fold controls (non-IPD cohort) from 2000 to 2010. The non-IPD cohort was matched according to age, sex, and baseline comorbidities, including benign prostate hyperplasia, stress incontinence, diabetes, and cerebrovascular diseases. The occurrence of OAB was monitored until the end of 2011. Hazard ratios of OAB were estimated using Cox proportional hazards regression models. Results In total, 4,571 and 18,255 patients were included in IPD and non-IPD cohorts, respectively. Results showed a significantly higher overall incidence rate of OAB in the IPD cohort compared with the non-IPD cohort (14.5 vs. 6.37 per 10,000 person-years), with a 2.3-fold increased risk of OAB (95% confidence interval [CI] = 1.51-3.51) after controlling for benign prostate hyperplasia and stress incontinence. The mean follow-up period for the IPD cohort was 5.0 years. This cohort study showed that the cumulative incidence of OAB was 0.65% at the fifth year and 1.54% at the tenth year after IPD diagnosis; this risk was highest in the age group 65-74 years. Conclusion This study reveals that IPD is independently associated with an increased risk of OAB in patients with IPD. The probability of OAB was 1.54% over a 10-year period after IPD diagnosis; the risk of OAB is considered to be age-dependent and most substantial in patients aged 65-74 years.	[Lin, Fu-Yu; Yang, Yi-Chien] China Med Univ, China Med Univ Hosp, Sch Med, Dept Neurol, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lee, Lukas Jyuhn-Hsiarn] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan; [Lee, Lukas Jyuhn-Hsiarn] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Lee, Lukas Jyuhn-Hsiarn] Kaohsiung Med Univ, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; Kaohsiung Medical University	Lee, LJH (corresponding author), Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli, Taiwan.; Lee, LJH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan.; Lee, LJH (corresponding author), Kaohsiung Med Univ, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan.	lukasneuro@gmail.com	Lee, Lukas Jyuhn-Hsiarn/AAB-6424-2021	Lee, Lukas Jyuhn-Hsiarn/0000-0003-1095-6877	China Medical University Hospital [DMR-106-171]; Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW106-TDU-B-212-113004]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10601010036]; Taiwan Clinical Trial Consortium for Stroke [MOST 106-2321-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	China Medical University Hospital; Taiwan Ministry of Health and Welfare Clinical Trial Center; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; Taiwan Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by China Medical University Hospital (DMR-106-171), Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW106-TDU-B-212-113004), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10601010036), Taiwan Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Blackett H, 2009, PARKINSONISM RELAT D, V15, P81, DOI 10.1016/j.parkreldis.2007.10.016; Bonnet AM, 1997, MOVEMENT DISORD, V12, P509, DOI 10.1002/mds.870120406; Campos-Sousa RN, 2003, ARQ NEURO-PSIQUIAT, V61, P359, DOI 10.1590/S0004-282X2003000300007; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Goetz CG, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a008862; GRAY R, 1995, AGE AGEING, V24, P499, DOI 10.1093/ageing/24.6.499; Hu WS, 2017, MAYO CLIN PROC, V92, P370, DOI 10.1016/j.mayocp.2016.08.019; McDonald C, 2017, PARKINSONISM RELAT D, V35, P8, DOI 10.1016/j.parkreldis.2016.10.024; Pearce N, 2007, OCCUP ENVIRON MED, V64, P562, DOI 10.1136/oem.2006.026690; Ruffion A, 2013, NEUROEPIDEMIOLOGY, V41, P146, DOI 10.1159/000353274; Sakakibara R, 2014, INT J UROL, V21, P638, DOI 10.1111/iju.12421; Sakakibara R, 2012, NEUROBIOL DIS, V46, P565, DOI 10.1016/j.nbd.2011.10.002; Sakakibara R, 2010, MOVEMENT DISORD, V25, P2, DOI 10.1002/mds.22519; Shen TC, 2017, LIVER INT, V37, P862, DOI 10.1111/liv.13330; Tagliaferro P, 2016, J PARKINSON DIS, V6, P1, DOI 10.3233/JPD-150769; Walter U, 2006, EUR J NEUROL, V13, P1291, DOI 10.1111/j.1468-1331.2006.01463.x; Wenning GK, 1999, J NEUROL NEUROSUR PS, V67, P620, DOI 10.1136/jnnp.67.5.620; Winge K, 2006, MOVEMENT DISORD, V21, P737, DOI 10.1002/mds.20867; Yeo L, 2012, INT UROL NEPHROL, V44, P415, DOI 10.1007/s11255-011-9969-y	19	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							SICI e0193783	10.1371/journal.pone.0193783	http://dx.doi.org/10.1371/journal.pone.0193783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499067	Green Published, gold, Green Submitted			2022-12-27	WOS:000426472300022
J	Metghalchi, S; Vandestienne, M; Haddad, Y; Esposito, B; Dairou, J; Tedgui, A; Mallat, Z; Potteaux, S; Taleb, S				Metghalchi, Sarvenaz; Vandestienne, Marie; Haddad, Yacine; Esposito, Bruno; Dairou, Julien; Tedgui, Alain; Mallat, Ziad; Potteaux, Stephane; Taleb, Soraya			Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSMS; IN-VIVO; ATHEROSCLEROSIS; EXPRESSION; ELASTASE; LESIONS; MODELS; CELLS	Aims Abdominal aortic aneurysm (AAA) is an age-associated disease characterized by chronic inflammation, vascular cell apoptosis and metalloproteinase-mediated extracellular matrix degradation. Despite considerable progress in identifying targets involved in these processes, therapeutic approaches aiming to reduce aneurysm growth and rupture are still scarce. Indoleamine 2-3 dioxygenase 1 (IDO) is the first and rate-limiting enzyme involved in the conversion of tryptophan (Trp) into kynurenine (Kyn) pathway. In this study, we investigated the role of IDO in two different models of AAA in mice. Methods and results Mice with deficiencies in both low density receptor-deficient (Ldlr(-/-)) and IDO (Ldlr(-/-)Ido1(-/-)) were generated by cross-breeding Ido1(-/-) mice with Ldlr(-/-) mice. To induce aneurysm, these mice were infused with angiotensin II (Ang II) (1000 ng/min/kg) and fed with high fat diet (HFD) during 28 days. AAAs were present in almost all Ldlr(-/-) infused with AngII, but only in 50% of Ldlr(-/-)Ido1(-/-) mice. Immunohistochemistry at an early time point (day 7) revealed no changes in macrophage and T lymphocyte infiltration within the vessel wall, but showed reduced apoptosis, as assessed by TUNEL assay, and increased a-actin staining within the media of Ldlr(-/-)Ido1(-/-) mice, suggesting enhanced survival of vascular smooth muscle cells (VSMCs) in the absence of IDO. In another model of elastase-induced AAA in C57Bl/6 mice, IDO deficiency had no effect on aneurysm formation. Conclusion Our study showed that the knockout of IDO prevented VSMC apoptosis in AngII-treated Ldlr(-/-) mice fed with HFD, suggesting a detrimental role of IDO in AAA formation and thus would be an important target for the treatment of aneurysm.	[Metghalchi, Sarvenaz; Vandestienne, Marie; Haddad, Yacine; Esposito, Bruno; Tedgui, Alain; Mallat, Ziad; Potteaux, Stephane; Taleb, Soraya] Paris Cardiovasc Res Ctr, Inst Natl Sante & Rech Med Inserm, Paris, France; [Metghalchi, Sarvenaz; Vandestienne, Marie; Haddad, Yacine; Esposito, Bruno; Tedgui, Alain; Mallat, Ziad; Potteaux, Stephane; Taleb, Soraya] Univ Paris 05, Paris, France; [Dairou, Julien] Univ Paris 05, Sorbonne Paris Cite, UMR CNRS 8601, Lab Chim & Biochim Pharmacol & Toxicol, Paris, France; [Mallat, Ziad] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Taleb, S (corresponding author), Paris Cardiovasc Res Ctr, Inst Natl Sante & Rech Med Inserm, Paris, France.; Taleb, S (corresponding author), Univ Paris 05, Paris, France.	soraya.taleb@inserm.fr	Mallat, Ziad/D-4041-2012; Taleb, Soraya/K-8176-2017	Mallat, Ziad/0000-0003-0443-7878; Taleb, Soraya/0000-0002-6650-619X; Potteaux, Stephane/0000-0003-3068-8769	INSERM; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by INSERM, Fondation pour la Recherche Medicale and Agence Nationale de la Recherche (S.T.).	Ait-Oufella H, 2013, ARTERIOSCL THROM VAS, V33, P2374, DOI 10.1161/ATVBAHA.113.301280; Bhamidipati CM, 2012, SURGERY, V152, P238, DOI 10.1016/j.surg.2012.02.010; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; Cole JE, 2015, P NATL ACAD SCI USA, V112, P13033, DOI 10.1073/pnas.1517820112; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Eussen SJPM, 2015, INT J CARDIOL, V189, P18, DOI 10.1016/j.ijcard.2015.03.413; Hellmann DB, 2007, JAMA-J AM MED ASSOC, V297, P395, DOI 10.1001/jama.297.4.395; Lu H, 2017, ARTERIOSCL THROM VAS, V37, pE59, DOI 10.1161/ATVBAHA.117.309578; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Metghalchi S, 2015, CELL METAB, V22, P460, DOI 10.1016/j.cmet.2015.07.004; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Pedersen ER, 2014, ARTERIOSCLER TH 1218; Pedersen ER, 2011, ARTERIOSCL THROM VAS, V31, P698, DOI 10.1161/ATVBAHA.110.219329; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Thompson RW, 1996, ANN NY ACAD SCI, V800, P157, DOI 10.1111/j.1749-6632.1996.tb33307.x; Van Vickle-Chavez SJ, 2006, J VASC SURG, V43, P1010, DOI 10.1016/j.jvs.2006.01.004; Wang QX, 2017, CIRCULATION, V136, P2271, DOI 10.1161/CIRCULATIONAHA.117.030972; Wang QX, 2014, CIRC RES, V114, P480, DOI 10.1161/CIRCRESAHA.114.302113; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092	21	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193737	10.1371/journal.pone.0193737	http://dx.doi.org/10.1371/journal.pone.0193737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494675	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200093
J	Saraiva, C; Talhada, D; Rai, A; Ferreira, R; Ferreira, L; Bernardino, L; Ruscher, K				Saraiva, Claudia; Talhada, Daniela; Rai, Akhilesh; Ferreira, Raquel; Ferreira, Lino; Bernardino, Liliana; Ruscher, Karsten			MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivo	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; BLOOD-BRAIN-BARRIER; SUBVENTRICULAR ZONE; CEREBRAL-ISCHEMIA; INFLAMMATION; MACROPHAGES; ACTIVATION; MICRORNAS; MICROGLIA; MIR-124	There is a high quest for novel therapeutic strategies to enhance recovery after stroke. MicroRNA-124 (miR-124) has been described as neuroprotective and anti-inflammatory molecule. Moreover, miR-124 is a well described enhancer of adult neurogenesis that could offer potentially beneficial effects. Herein, we used miR-124-loaded nanoparticles (miR-124 NPs) to evaluate their therapeutic potential in an in vitro and in vivo model of stroke. For that, neuroprotective and neurogenic responses were assessed in an in vitro model of stroke. Here, we found that miR-124 NPs decreased cell death and improved neuronal differentiation of subventricular zone (SVZ) neural stem cell cultures after oxygen and glucose deprivation. In contrast, intravenous injection of miR-124 NPs immediately after permanent focal ischemia induced by photothrombosis (PT) did not provide a better neurological outcome. In addition, treatment did not affect the number of 5-bromo2'- deoxyuridine (BrdU)-and doublecortin/BrdU-positive cells in the SVZ at the study endpoint of 14 days after PT. Likewise, the ischemic insult did not affect the numbers of neuronal progenitors in the SVZ. However, in PT mice miR-124 NPs were able to specifically augment interleukin-6 levels at day 2 post-stroke. Furthermore, we also showed that NPs reached the brain parenchyma and were internalized by brain resident cells. Although, promising in vitro data could not be verified in vivo as miR-124 NPs treatment did not improve functional outcome nor presented beneficial actions on neurogenesis or poststroke inflammation, we showed that our NP formulation can be a safe alternative for drug delivery into the brain.	[Saraiva, Claudia; Talhada, Daniela; Ferreira, Raquel; Bernardino, Liliana] Univ Beira Interior, Fac Hlth Sci, Hlth Sci Res Ctr, Covilha, Portugal; [Saraiva, Claudia; Talhada, Daniela; Ruscher, Karsten] Lund Univ, Wallenberg Neurosci Ctr, Dept Clin Sci, Div Neurosurg,Lab Expt Brain Res, Lund, Sweden; [Saraiva, Claudia] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Caparica, Portugal; [Rai, Akhilesh; Ferreira, Lino] CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Ferreira, Lino] Univ Coimbra, Fac Med, IIIUC, Coimbra, Portugal	Universidade da Beira Interior; Lund University; Universidade Nova de Lisboa; Universidade de Coimbra; Universidade de Coimbra	Bernardino, L (corresponding author), Univ Beira Interior, Fac Hlth Sci, Hlth Sci Res Ctr, Covilha, Portugal.; Ruscher, K (corresponding author), Lund Univ, Wallenberg Neurosci Ctr, Dept Clin Sci, Div Neurosurg,Lab Expt Brain Res, Lund, Sweden.	libernardino@fcsaude.ubi.pt; karsten.ruscher@med.lu.se	Rai, Akhilesh/ABE-9904-2021; Saraiva, Cláudia/AAT-6772-2020; Ferreira, Raquel/AAA-7401-2021	Rai, Akhilesh/0000-0001-5352-5415; Saraiva, Cláudia/0000-0003-4866-8790; Ferreira, Raquel/0000-0003-1014-0499; Talhada, Daniela/0000-0002-5424-1438; Ruscher, Karsten/0000-0001-7211-2499; Bernardino, Liliana/0000-0003-3395-5973; ferreira, lino/0000-0001-8985-9302	FEDER funds through the POCI - COMPETE Operational Programme Competitiveness and Internationalisation in Axis I - Strengthening research, technological development and innovation [POCI-01-0145-FEDER-007491, 3386]; National Funds by FCT - Foundation for Science and Technology [SFRH/BD/90365/2012, UID/Multi/00709/2013]; Swedish Brain Fund; Crafoord Foundation; Swedish Research Council; Sveriges Stroke Riksfbrbundet; Hans-Christian and Alice Wachtmeister Foundation; Stiftelsen Sven-Olof Jansons livsverk	FEDER funds through the POCI - COMPETE Operational Programme Competitiveness and Internationalisation in Axis I - Strengthening research, technological development and innovation; National Funds by FCT - Foundation for Science and Technology; Swedish Brain Fund; Crafoord Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sveriges Stroke Riksfbrbundet; Hans-Christian and Alice Wachtmeister Foundation; Stiftelsen Sven-Olof Jansons livsverk	This work was supported by FEDER funds through the POCI - COMPETE 2020 Operational Programme Competitiveness and Internationalisation in Axis I - Strengthening research, technological development and innovation (Project POCI-01-0145-FEDER-007491; Project 3386 - "StrokeTherapy") and National Funds by FCT - Foundation for Science and Technology (grant SFRH/BD/90365/2012 and Project UID/Multi/00709/2013) to LB, the Swedish Brain Fund, the Crafoord Foundation to KR, the Swedish Research Council, Sveriges Stroke Riksfbrbundet to KR, the Hans-Christian and Alice Wachtmeister Foundation and the Stiftelsen Sven-Olof Jansons livsverk to KR.; This work was supported by FEDER funds through the POCI-COMPETE 2020-Operational Programme Competitiveness and Internationalisation in Axis I-Strengthening research, technological development and innovation (Project POCI-01-0145-FEDER-007491; Project 3386 - "StrokeTherapy") and National Funds by FCT-Foundation for Science and Technology (grant SFRH/BD/90365/2012 and Project UID/Multi/00709/2013), the Swedish Brain Fund, the Crafoord Foundation, the Swedish Research Council, Sveriges Stroke Riksforbundet, the Hans-Christian and Alice Wachtmeister Foundation and the Stiftelsen Sven-Olof Jansons livsverk. We thank Professor Tadeusz Wieloch and Niklas Marklund for valuable discussions and Cai Owain Birch for critical revision of the manuscript.	Agasse F, 2008, REJUV RES, V11, P187, DOI 10.1089/rej.2007.0600; Akerblom M, 2012, J NEUROSCI, V32, P8879, DOI 10.1523/JNEUROSCI.0558-12.2012; Anrather J, 2016, NEUROTHERAPEUTICS, V13, P661, DOI 10.1007/s13311-016-0483-x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Brennan GP, 2016, CELL REP, V14, P2402, DOI 10.1016/j.celrep.2016.02.042; Chapman KZ, 2009, J CEREBR BLOOD F MET, V29, P1764, DOI 10.1038/jcbfm.2009.113; Chen Y, 2015, PHARMAZIE, V70, P147, DOI 10.1691/ph.2015.4774; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Diederich K, 2012, STROKE, V43, P1931, DOI 10.1161/STROKEAHA.112.654806; Doeppner TR, 2013, ACTA NEUROPATHOL, V126, P251, DOI 10.1007/s00401-013-1142-5; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Gomes RSM, 2013, ACS NANO, V7, P3362, DOI 10.1021/nn400171w; Hoff EI, 2005, J NEUROSCI METH, V141, P135, DOI 10.1016/j.jneumeth.2004.06.004; Jang JW, 2014, J NEUROL SCI, V339, P75, DOI 10.1016/j.jns.2014.01.024; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kuric E, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0145-z; Lagace DC, 2012, BEHAV BRAIN RES, V227, P426, DOI 10.1016/j.bbr.2011.08.045; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lindvall O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019034; Liu X., 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0023461; Liu XR, 2013, STROKE, V44, P1973, DOI 10.1161/STROKEAHA.111.000613; Liu YP, 2015, J CLIN NEUROSCI, V22, P291, DOI 10.1016/j.jocn.2014.05.042; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Maia J, 2011, ACS NANO, V5, P97, DOI 10.1021/nn101724r; Marlier Q, 2015, FRONT NEUROSCI, P9; Nahirney PC, 2015, J CEREB BLOOD FLOW M; Osman AM, 2011, STROKE, V42, P3559, DOI 10.1161/STROKEAHA.111.627802; Paxinos G, 2002, MOUSE BRAIN STEREOTA, V1st; Piao MS, 2009, ACTA NEUROCHIR, V151, P1649, DOI 10.1007/s00701-009-0431-1; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Ponomarev ED, 2013, GLIA, V61, P91, DOI 10.1002/glia.22363; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Qiu SW, 2015, J IMMUNOL, V194, P1021, DOI 10.4049/jimmunol.1400106; Rainer TH, 2016, CLIN BIOCHEM, V49, P663, DOI 10.1016/j.clinbiochem.2016.02.016; Ruscher K, 2013, J CEREBR BLOOD F MET, V33, P1225, DOI 10.1038/jcbfm.2013.71; Ruscher K, 2009, J CEREBR BLOOD F MET, V29, P1796, DOI 10.1038/jcbfm.2009.96; Santos T, 2012, ACS NANO, V6, P10463, DOI 10.1021/nn304541h; Saraiva C, 2016, J CONTROL RELEASE, V235, P291, DOI 10.1016/j.jconrel.2016.06.005; Saraiva C, 2016, J CONTROL RELEASE, V235, P34, DOI 10.1016/j.jconrel.2016.05.044; Simats A, 2016, EXPERT REV NEUROTHER, V16, P1013, DOI 10.1080/14737175.2016.1219252; Sun Y, 2016, ACTA PHARMACOL SIN, V37, P889, DOI 10.1038/aps.2016.16; Sun Y, 2013, CELL RES, V23, P1270, DOI 10.1038/cr.2013.116; Sun Y, 2013, CNS NEUROSCI THER, V19, P813, DOI 10.1111/cns.12142; Taj SH, 2016, J NEUROIMMUNE PHARM, V11, P733, DOI 10.1007/s11481-016-9700-y; Taj SH, 2016, BIOMATERIALS, V91, P151, DOI 10.1016/j.biomaterials.2016.03.025; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; van der Maten G, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-016-0325-0; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Walter HL, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0232-1; Weng HC, 2011, BIOMED RES-TOKYO, V32, P135, DOI 10.2220/biomedres.32.135; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhao Y, 2016, J CROHNS COLITIS, V10, P703, DOI 10.1093/ecco-jcc/jjw010; Zhu F, 2014, J MOL NEUROSCI, V52, P148, DOI 10.1007/s12031-013-0155-9	56	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193609	10.1371/journal.pone.0193609	http://dx.doi.org/10.1371/journal.pone.0193609			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494665	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200074
J	Koo, YC; Chang, JS; Chen, YC				Koo, Yu-Chin; Chang, Jung-Su; Chen, Yi Chun			Food claims and nutrition facts of commercial infant foods	PLOS ONE			English	Article							FEEDING GUIDELINES; MAGAZINES; PARENTS; HEALTHY; SODIUM; SUGAR	Composition claim, nutrition claim and health claim are often found on the commercial complementary food packaging. The introduction of complementary foods (CFs) to infants is a turning point in the development of their eating behavior, and their commercial use for Taiwanese infants is growing. In Taiwan, lots of the advertisements for CFs employed health or nutrition claims to promote the products, but the actual nutritional content of these CFs is not clear. The aim of this study was to compare the food claims of commercial complementary food products with their actual nutrition facts. A sample of 363 commercial CFs was collected from websites, local supermarkets, and other food stores, and their nutrition-related claims were classified into composition, nutrition, and health categories. Although the World Health Organization recommends that infants should be exclusively breastfed for the first 6 months, 48.2% of the commercial CFs were targeted at infants younger than 6 months. Therefore, marketing regulations should be implemented to curb early weaning as a result of products targeted at infants younger than 6 months. More than 50% of Taiwanese commercial CFs have high sugar content and more than 20% were high in sodium. Products with health claims, such as "provides good nutrition to children" or "improves appetite," have higher sodium or sugar content than do those without such claims. Moreover, products with calcium or iron content claims did not contain more calcium or iron than products without such claims. Additionally, a significantly greater proportion of the products with "no added sugar" claims were classified as having high sugar content as compared to those without such claims. Parents cannot choose the healthiest food products for their children by simply focusing on food claims. Government should regulate the labeling of nutrition facts and food claims for foods targeted at infants younger than 12 months.	[Koo, Yu-Chin; Chang, Jung-Su; Chen, Yi Chun] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan	Taipei Medical University	Chen, YC (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan.	yichun@tmu.edu.tw			National Science Council [MOST103-2511-S-038-004-MY2 (2-2)]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council [grant number MOST103-2511-S-038-004-MY2 (2-2)].	Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Butte N, 2004, J AM DIET ASSOC, V104, P442, DOI 10.1016/j.jada.2004.01.027; Canadian Food Inspection Agency, 2014, FOOD LAB IND COMP QU; Carstairs SA, 2016, MATERN CHILD NUTR, V12, P860, DOI 10.1111/mcn.12185; Cavaliere A, 2015, FOOD QUAL PREFER, V41, P44, DOI 10.1016/j.foodqual.2014.11.002; Chen YC, 2015, J HUM LACT, V31, P458, DOI 10.1177/0890334415576513; Codex Alimentarius Commission, 1997, 231997 CACGL WHO FAO; Cogswell ME, 2015, PEDIATRICS, V135, P416, DOI 10.1542/peds.2014-3251; Colby SE, 2010, J NUTR EDUC BEHAV, V42, P92, DOI 10.1016/j.jneb.2008.11.002; Dixon H, 2011, PUBLIC HEALTH NUTR, V14, P1071, DOI 10.1017/S1368980010003691; Eidelman AI, 2012, PEDIATRICS, V129, pE827, DOI 10.1542/peds.2011-3552; Elliott C, 2008, OBES REV, V9, P368, DOI 10.1111/j.1467-789X.2007.00418.x; Elliott CD., 2011, J PUBLIC HLTH, V33, P36; FDA (Food and Drug Administration), 2013, GUID IND FOOD LAB GU, P127; Frerichs L, 2006, WOMEN HEALTH, V44, P95, DOI 10.1300/J013v44n01_06; Garcia AL, 2013, ARCH DIS CHILD, V98, P793, DOI 10.1136/archdischild-2012-303386; Garcia AL, 2016, MATERN CHILD NUTR, V12, P838, DOI 10.1111/mcn.12208; Hamilton K, 2012, J HEALTH PSYCHOL, V17, P121, DOI 10.1177/1359105311409786; Harris JL, 2011, PUBLIC HEALTH NUTR, V14, P2207, DOI 10.1017/S1368980011001741; Klienman RE., 2014, PEDIAT NUTR, V7th ed., P123; Lin JR, 2011, ASIA PAC J CLIN NUTR, V20, P337; Ministry of Health and Welfare, 2014, REG NUTR LAB PREP FO; Ministry of Health and Welfare, 2014, CHILDR HLTH BOOKL; Munsell CR, 2016, PUBLIC HEALTH NUTR, V19, P46, DOI 10.1017/S1368980015000397; New Zealand Ministry of Health, 2013, EAT HLTH BAB TODDL; Nicklaus S, 2011, APPETITE, V57, P812, DOI 10.1016/j.appet.2011.05.321; Sahoo Krushnapriya, 2015, J Family Med Prim Care, V4, P187, DOI 10.4103/2249-4863.154628; Sim J, 2005, PHYS THER, V85, P257; (WHO) World Health Organisation, 2015, GUID SUG INT AD CHIL; Wong CL, 2013, AM J CLIN NUTR, V97, P1288, DOI 10.3945/ajcn.112.052910; World Alliance for Breastfeeding Action, 2006, COD WATCH 25 YEARS P; World Health Assembly, 2016, WHA699; World Health Organization, 2016, INF YOUNG CHILD NUTR; World Health Organization, 2009, INF YOUNG CHILD FEED, P23; World Health Organization, 2016, MARK BREAST MILK SUB	35	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191982	10.1371/journal.pone.0191982	http://dx.doi.org/10.1371/journal.pone.0191982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489848	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000014
J	Schlott, F; Steubl, D; Ameres, S; Moosmann, A; Dreher, S; Heemann, U; Hosel, V; Busch, DH; Neuenhahn, M				Schlott, Fabian; Steubl, Dominik; Ameres, Stefanie; Moosmann, Andreas; Dreher, Stefan; Heemann, Uwe; Hoesel, Volker; Busch, Dirk H.; Neuenhahn, Michael			Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8(+) T cells	PLOS ONE			English	Article							STEM-CELL; KIDNEY-TRANSPLANTATION; ADOPTIVE TRANSFER; IMMUNITY; LYMPHOCYTES; INFECTION; CMV; DONOR; RECIPIENTS; RECEPTORS	Human Cytomegalovirus (CMV) reactivation remains a major source of morbidity in patients after solid organ and hematopoietic stem cell transplantation (HSCT). Adoptive T cell therapy (ACT) with CMV-specific T cells is a promising therapeutic approach for HSCT recipients, but might be counteracted by CMV's immune evasion strategies. HLA-C*07:02 is less susceptible to viral immune evasion suggesting HLA-C*07:02-restricted viral epitopes as promising targets for ACT. For a better understanding of HLA-C*07: 02-restricted CMV-specific T cells we used recently generated reversible HLA-C*07:02/IE-1 multimers (Streptamers) recognizing a CMV-derived Immediate-Early-1 (IE-1) epitope and analyzed phenotypic and functional T cell characteristics. Initially, we detected very high frequencies of HLA-C*07:02/IE-1 multimer(+) T cells (median = 11.35%), as well as robust functional responses after stimulation with IE-1 peptide (IFN gamma(+); median = 5.02%) in healthy individuals. However, MHC-multimer(+) and IFN gamma-secreting T cell frequencies showed a relatively weak correlation (r(2) = 0.77), which could be attributed to an unexpected contribution of CMV-epitope-independent KIR2DL2/3-binding of HLA-C*07:02/IE-1 multimers. Therefore, we developed a MHC-multimer double-staining approach against a cancer epitope-specific HLA-C* 07: 02 multimer to identify truly HLA-C*07:02/IE-1 epitope-specific T cells. The frequencies of these truly HLA-C*07:02/IE-1 multimer(+) T cells were still high (median = 6.86%) and correlated now strongly (r(2) = 0.96) with IFN gamma-secretion. Interestingly, HLA-C*07:02/IE-1-restricted T cells contain substantial numbers with a central memory T cell phenotype, indicating high expansion potential e.g. for ACT. In line with that, we developed a clinical enrichment protocol avoiding epitope-independent KIR-binding to make HLA-C* 07: 02/IE-1-restricted T cells available for ACT. Initial depletion of KIR-expressing CD8(+) T cells followed by HLA-C*07:02/IE-1 Streptamer positive selection using paramagnetic labeling techniques allowed to enrich successfully HL-AC* 07:02/IE-1-restricted T cells. Such specifically enriched populations of functional HL-AC* 07:02/IE-1-restricted T cells with significant central memory T cell content could become a potent source for ACT.	[Schlott, Fabian; Dreher, Stefan; Busch, Dirk H.; Neuenhahn, Michael] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Schlott, Fabian; Moosmann, Andreas; Heemann, Uwe; Busch, Dirk H.; Neuenhahn, Michael] DZIF Natl Ctr Infect Res, Munich, Germany; [Steubl, Dominik; Heemann, Uwe] Tech Univ Munich, Klinikum Rechts Isar, Dept Nephrol, Munich, Germany; [Ameres, Stefanie; Moosmann, Andreas] Helmholtz Zentrum Munchen, Res Unit Gene Vectors, DZIF Res Grp Host Control Viral Latency & Reactiv, Munich, Germany; [Hoesel, Volker] Tech Univ Munich, Chair Biomath, Garching, Germany	Technical University of Munich; German Center for Infection Research; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Neuenhahn, M (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany.; Neuenhahn, M (corresponding author), DZIF Natl Ctr Infect Res, Munich, Germany.	michael.neuenhahn@tum.de		Moosmann, Andreas/0000-0001-8044-5146	German Center for Infection Research (DZIF) [TTU 07.801]; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich TR36-A10]	German Center for Infection Research (DZIF); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the German Center for Infection Research (DZIF, TTU 07.801) (MN), and the Deutsche Forschungsgemeinschaft (DFG) through Sonderforschungsbereich TR36-A10 (MN and DHB).	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Ameres S, 2014, J IMMUNOL, V192, P5894, DOI 10.4049/jimmunol.1302281; Ameres S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003383; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Brestrich G, 2009, AM J TRANSPLANT, V9, P1679, DOI 10.1111/j.1600-6143.2009.02672.x; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; Gerna G, 2006, AM J TRANSPLANT, V6, P2356, DOI 10.1111/j.1600-6143.2006.01488.x; Giulieri S, 2011, EXPERT REV MOL DIAGN, V11, P17, DOI [10.1586/erm.10.109, 10.1586/ERM.10.109]; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Jacobsen T, 2010, AM J HEALTH-SYST PH, V67, P1417, DOI 10.2146/ajhp090424; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Lucia M, 2014, TRANSPL INT, V27, P643, DOI 10.1111/tri.12318; McMahon CW, 2001, CURR OPIN IMMUNOL, V13, P465, DOI 10.1016/S0952-7915(00)00242-9; Mees ST, 2014, SURG INFECT, V15, P274, DOI 10.1089/sur.2013.083; Moretta A, 1997, IMMUNOL REV, V155, P105, DOI 10.1111/j.1600-065X.1997.tb00943.x; Neudorfer J, 2007, J IMMUNOL METHODS, V320, P119, DOI 10.1016/j.jim.2007.01.001; Neuenhahn M, 2017, LEUKEMIA, V31, P2161, DOI 10.1038/leu.2017.16; Odendahl M, 2014, CYTOTHERAPY, V16, P1245, DOI 10.1016/j.jcyt.2014.05.023; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Peggs KS, 2011, CLIN INFECT DIS, V52, P49, DOI 10.1093/cid/ciq042; QUINNAN GV, 1984, REV INFECT DIS, V6, P156; QUINNAN GV, 1982, NEW ENGL J MED, V307, P7, DOI 10.1056/NEJM198207013070102; Reischig T, 2012, J AM SOC NEPHROL, V23, P1588, DOI 10.1681/ASN.2012010100; Scheinberg P, 2009, BLOOD, V114, P5071, DOI 10.1182/blood-2009-04-214684; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Schmitt A, 2011, TRANSFUSION, V51, P591, DOI 10.1111/j.1537-2995.2010.02940.x; Shabir S, 2013, J AM SOC NEPHROL, V24, P1698, DOI 10.1681/ASN.2013040340; Stemberger C, 2014, BLOOD, V124, P628, DOI 10.1182/blood-2013-12-547349; Stemberger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035798; Sund F, 2010, CLIN TRANSPLANT, V24, P401, DOI 10.1111/j.1399-0012.2009.00976.x; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Yao JX, 2008, CLIN INFECT DIS, V46, pE96, DOI 10.1086/587749	40	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193554	10.1371/journal.pone.0193554	http://dx.doi.org/10.1371/journal.pone.0193554			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489900	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000089
J	Stumpf, MJ; Schaefer, CA; Krycki, J; Schueler, R; Pizarro, C; Nickenig, G; Steinmetz, M; Skowasch, D; Tuleta, I				Stumpf, Max Jonathan; Schaefer, Christian Alexander; Krycki, Jan; Schueler, Robert; Pizarro, Carmen; Nickenig, Georg; Steinmetz, Martin; Skowasch, Dirk; Tuleta, Izabela			Impairment of vascular strain in patients with obstructive sleep apnea	PLOS ONE			English	Article							INCREASED ARTERIAL STIFFNESS; SPECKLE-TRACKING; CAROTID-ARTERY; INFLAMMATORY MARKERS; INTERMITTENT HYPOXIA; ENDOTHELIAL DYSFUNCTION; METABOLIC CONSEQUENCES; RISK-FACTOR; ATHEROSCLEROSIS; OBESITY	Background Obstructive sleep apnea (OSA) is an independent risk factor for the development of cardiovascular diseases. Aim of this present study was to evaluate and extend recent research on the influence of obstructive sleep apnea on vascular strain. Methods A total number of 98 patients were integrated in the study. Patients were grouped according to the Apnea-Hypopnea-lndex (AHI) in patients with mild-to-moderate OSA (5/h < AHI < 30/ h), severe OSA (AHI > 30/h) and controls (AHI < 5/h). Groups were matched in age, body mass-index and cardiovascular risks. Vascular strain of common carotid arteries was assessed by ultrasound speckle-tracking. A minor group of 30 patients and controls further underwent assessment of vascular strain of brachial and femoral arteries. Additionally, all patients underwent blood testing to reveal potential influences of inflammatory markers on arterial stiffness. In additional analysis we examined the effect of statin therapy on vascular strain. Results Patients with OSA showed significantly reduced values of vascular strain of common carotid arteries. Radial and circumferential strains were significantly lower in both patients with mild-to-moderate (p =.05) and patients with severe OSA (p =.001) compared to control. Vascular strain parameters of brachial and femoral arteries showed no consistent results. There were no significant correlations of inflammatory markers with vascular strain parameters. No significant differences in vascular strain were detected between statin and nonstatin groups. Conclusion Patients with OSA show significantly reduced vascular strain assessed by ultrasound-based speckle-tracking. Vascular stiffness increases with the severity of the disease. Target	[Stumpf, Max Jonathan; Schaefer, Christian Alexander; Krycki, Jan; Schueler, Robert; Pizarro, Carmen; Nickenig, Georg; Steinmetz, Martin; Skowasch, Dirk; Tuleta, Izabela] Univ Bonn, Dept Internal Med Cardiol Pulmonol & Angiol 2, Bonn, Germany	University of Bonn	Tuleta, I (corresponding author), Univ Bonn, Dept Internal Med Cardiol Pulmonol & Angiol 2, Bonn, Germany.	izat@gmx.de	Schueler, Robert/Z-1059-2019	Steinmetz, Martin/0000-0002-5452-6687; Stumpf, Max Jonathan/0000-0003-4558-1833				Alvarez-Martins I, 2016, PFLUG ARCH EUR J PHY, V468, P919, DOI 10.1007/s00424-016-1797-6; Archontogeorgis K, 2014, PULMONARY MED, V2014, P15; Arnardottir ES, 2012, SLEEP, V35, P921, DOI 10.5665/sleep.1952; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bjallmark A, 2010, EUR J ECHOCARDIOGR, V11, P630, DOI 10.1093/ejechocard/jeq033; Bouloukaki Izolde, 2015, World J Exp Med, V5, P77, DOI 10.5493/wjem.v5.i2.77; Buratti L, 2016, CNS NEUROL DISORD-DR, V15, P678, DOI 10.2174/1871527315666160518123930; Buratti L, 2014, J ALZHEIMERS DIS, V38, P445, DOI 10.3233/JAD-131046; Charwat-Resl S, 2016, ULTRASCHALL MED, V37, P503, DOI 10.1055/s-0035-1553299; Cho JG, 2011, SLEEP, V34, P751, DOI 10.5665/SLEEP.1042; Choi JB, 2006, SLEEP BREATH, V10, P155, DOI 10.1007/s11325-006-0064-z; Ciccone MM, 2014, MOLECULES, V19, P1651, DOI 10.3390/molecules19021651; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Drager LF, 2010, CURR OPIN ENDOCRINOL, V17, P161, DOI 10.1097/MED.0b013e3283373624; Drakatos P, 2016, J CLIN SLEEP MED, V12, P195, DOI 10.5664/jcsm.5484; Elkind MS, 2005, ATHEROSCLEROSIS, V180, P181, DOI 10.1016/j.atherosclerosis.2004.11.015; Gharibeh T, 2010, NAT SCI SLEEP, V2, P233, DOI 10.2147/NSS.S6844; Hammerstingl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076352; Joyeux-Faure M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/423120; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Larsson M, 2015, ULTRASONICS, V56, P399, DOI 10.1016/j.ultras.2014.09.005; Lee SA, 2008, SLEEP, V31, P1207; Li J, 2005, INTERMITTENT HYPOXIA; Nadeem R, 2013, J CLIN SLEEP MED, V9, P1003, DOI 10.5664/jcsm.3070; Patinkin ZW, 2017, CHILD OBES, V13, P102, DOI 10.1089/chi.2016.0248; Podgorski M, 2015, ARCH MED SCI, V11, P122, DOI 10.5114/aoms.2015.49205; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Ryan S, 2009, THORAX, V64, P631, DOI 10.1136/thx.2008.105577; Sahlman J, 2010, J SLEEP RES, V19, P341, DOI 10.1111/j.1365-2869.2009.00787.x; Schaefer CA, 2015, CLIN RES CARDIOL, V104, P719, DOI 10.1007/s00392-015-0834-3; Schaefer CA, 2017, VASA, V46, P108, DOI 10.1024/0301-1526/a000596; Schwartz Alan R, 2008, Proc Am Thorac Soc, V5, P185, DOI 10.1513/pats.200708-137MG; Seetho IW, 2014, J SLEEP RES, V23, P700, DOI 10.1111/jsr.12156; Totoson P, 2013, EXP BIOL MED, V238, P223, DOI 10.1177/1535370212473696; Tuleta I, 2016, ADV EXP MED BIOL, V910, P9, DOI 10.1007/5584_2016_215; Tuleta I, 2015, ADV EXP MED BIOL, V858, P1, DOI 10.1007/5584_2015_114; Tuleta I, 2014, ATHEROSCLEROSIS, V236, P400, DOI 10.1016/j.atherosclerosis.2014.08.021; Tuleta I, 2011, EPMA J, V2, P39, DOI 10.1007/s13167-011-0070-5; Wang JY, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002454; Wang YY, 2017, MED SCI MONITOR, V23, P1069, DOI 10.12659/MSM.899716; Wendell CR, 2012, STROKE, V43, P3319, DOI 10.1161/STROKEAHA.112.672527	41	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193397	10.1371/journal.pone.0193397	http://dx.doi.org/10.1371/journal.pone.0193397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489881	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000070
J	Li, Y; Wang, SP; Pan, CX; Xue, FS; Xian, JF; Huang, YQ; Wang, XY; Li, TZ; He, HG				Li, Yun; Wang, Shengpei; Pan, Chuxiong; Xue, Fushan; Xian, Junfang; Huang, Yaqi; Wang, Xiaoyi; Li, Tianzuo; He, Huiguang			Comparison of NREM sleep and intravenous sedation through local information processing and whole brain network to explore the mechanism of general anesthesia	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; PROPOFOL ANESTHESIA; HUMANS; CONNECTIVITY; PRECUNEUS; CINGULATE; NEURONS; INDEX; RAT	Background The mechanism of general anesthesia (GA) has been explored for hundreds of years, but unclear. Previous studies indicated a possible correlation between NREM sleep and GA. The purpose of this study is to compare them by in vivo human brain function to probe the neuromechanism of consciousness, so as to find out a clue to GA mechanism. Methods 24 healthy participants were equally assigned to sleep or propofol sedation group by sleeping ability. EEG and Ramsay Sedation Scale were applied to determine sleep stage and sedation depth respectively. Resting-state functional magnetic resonance imaging (RS-fMRI) was acquired at each status. Regional homogeneity (ReHo) and seed-based whole brain functional connectivity maps (WB-FC maps) were compared. Results During sleep, ReHo primarily weakened on frontal lobe (especially preoptic area), but strengthened on brainstem. While during sedation, ReHo changed in various brain areas, including cingulate, precuneus, thalamus and cerebellum. Cingulate, fusiform and insula were concomitance of sleep and sedation. Comparing to sleep, FCs between the cortex and subcortical centers (centralized in cerebellum) were significantly attenuated under sedation. As sedation deepening, cerebellum-based FC maps were diminished, while thalamus-and brainstem-based FC maps were increased. Conclusion There're huge distinctions in human brain function between sleep and GA. Sleep mainly rely on brainstem and frontal lobe function, while sedation is prone to affect widespread functional network. The most significant differences exist in the precuneus and cingulate, which may play important roles in mechanisms of inducing unconciousness by anesthetics.	[Li, Yun; Pan, Chuxiong; Li, Tianzuo] Capital Med Univ, Beijing Tongren Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Wang, Shengpei; He, Huiguang] Chinese Acad Sci, Inst Automat, Res Ctr Brain Inspired Intelligence, Beijing, Peoples R China; [Wang, Shengpei] Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China; [Xue, Fushan] Chinese Acad Med Sci, Plast Surg Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Xue, Fushan] Peking Union Med Coll, Beijing, Peoples R China; [Xian, Junfang] Beijing Tongren Hosp, Dept Radiol, Beijing, Peoples R China; [Huang, Yaqi] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China; [Wang, Xiaoyi] Beijing Tongren Hosp, Dept Laryngol, Sleep Med Ctr, Beijing, Peoples R China; [Li, Tianzuo] Capital Med Univ, Beijing Shijitan Hosp, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Li, TZ (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Anesthesiol, Beijing, Peoples R China.; He, HG (corresponding author), Chinese Acad Sci, Inst Automat, Res Ctr Brain Inspired Intelligence, Beijing, Peoples R China.; Li, TZ (corresponding author), Capital Med Univ, Beijing Shijitan Hosp, Beijing, Peoples R China.	trmzltz@outlook.com; huiguang.he@ia.ac.cn	He, Huiguang/AAD-7643-2020; Xue, Fu-Shan/ADO-0664-2022	He, Huiguang/0000-0002-0684-1711; Li, Yun/0000-0002-2869-1451	National Science and Technology Pillar Program of China [2012BAI05B03]; National Natural Science Foundation of China [81171422, 61271151, 91520202]; Youth Innovation Promotion Association CAS	National Science and Technology Pillar Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association CAS	This study was supported by the National Science and Technology Pillar Program of China (2012BAI05B03), the National Natural Science Foundation of China (81171422, 61271151, 91520202), Youth Innovation Promotion Association CAS. All the funders were used for compensation to subjects. This study was supported by the National Science and Technology Pillar Program of China (2012BAI05B03), the National Natural Science Foundation of China (81171422, 61271151, and 91520202), Youth Innovation Promotion Association CAS.	Adapa RM, 2012, ANAESTHESIA, V67, P33, DOI 10.1111/j.1365-2044.2011.06917.x; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Bonhomme V, 2001, J NEUROPHYSIOL, V85, P1299, DOI 10.1152/jn.2001.85.3.1299; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CAVAZZUTI M, 1991, BRIT J ANAESTH, V66, P490, DOI 10.1093/bja/66.4.490; Chisholm CJ, 2006, MAYO CLIN PROC, V81, P46, DOI 10.4065/81.1.46; Engbers FH, 2010, BRIT J ANAESTH, V104, P261, DOI 10.1093/bja/aep385; Fiset P, 1999, J NEUROSCI, V19, P5506; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Gaus SE, 2002, NEUROSCIENCE, V115, P285, DOI 10.1016/S0306-4522(02)00308-1; Gili T, 2013, J NEUROSCI, V33, P4024, DOI 10.1523/JNEUROSCI.3480-12.2013; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Liu XP, 2013, NEUROIMAGE, V83, P581, DOI 10.1016/j.neuroimage.2013.07.003; Luo T, 2011, ANESTHESIOLOGY, V115, P36, DOI 10.1097/ALN.0b013e3182207655; Maquet P, 2000, J SLEEP RES, V9, P207; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Martuzzi R, 2011, NEUROIMAGE, V58, P1044, DOI 10.1016/j.neuroimage.2011.06.075; Meuret P, 2000, ANESTHESIOLOGY, V93, P708, DOI 10.1097/00000542-200009000-00020; Mulert C, 2005, INT J PSYCHOPHYSIOL, V56, P65, DOI 10.1016/j.ijpsycho.2004.10.002; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Novelli L, 2010, J SLEEP RES, V19, P238, DOI 10.1111/j.1365-2869.2009.00785.x; Pal D, 2016, ANESTHESIOLOGY, V125, P929, DOI 10.1097/ALN.0000000000001342; Picchioni Dante, 2014, Sleep, V37, P387, DOI 10.5665/sleep.3422; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Rosenorn-Lanng D, 2010, J NEUROSCIENCE, P1529; Solt K, 2007, CURR OPIN ANESTHESIO, V20, P300, DOI 10.1097/ACO.0b013e32816678a5; Upadhyay J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027839; Vargo J, 2009, CLIN GASTROENTEROL H, V7, P156, DOI 10.1016/j.cgh.2008.09.004; Veselis RA, 2005, ANESTHESIOLOGY, V102, P26, DOI 10.1097/00000542-200501000-00008; Yamada M, 2006, ACTA ANAESTH SCAND, V50, P875, DOI 10.1111/j.1399-6576.2006.01033.x; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030	33	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192358	10.1371/journal.pone.0192358	http://dx.doi.org/10.1371/journal.pone.0192358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486001	Green Published, Green Submitted, gold			2022-12-27	WOS:000426242400008
J	van Schaik, JE; Hunnius, S				van Schaik, Johanna E.; Hunnius, Sabine			Modulating mimicry: Exploring the roles of inhibitory control and social understanding in 5-year-olds' behavioral mimicry	PLOS ONE			English	Article							EXECUTIVE FUNCTION; CHILDREN; AFFILIATION; MIND; COLLABORATION; COORDINATION; CHAMELEON; OSTRACISM; FIDELITY	During adult interactions, behavioral mimicry, the implicit copying of an interaction partner's postures and mannerisms, communicates liking and affiliation. While this social behavior likely develops during early childhood, it is unclear which factors contribute to its emergence. Here, the roles of inhibitory control and social understanding on 5-year-olds' behavioral mimicry were investigated. Following a social manipulation in which one experimenter shared a sticker with the child and the other experimenter kept two stickers for herself, children watched a video in which these experimenters each told a story. During this story session, children in the experimental group(n = 28) observed the experimenters perform face and hand rubbing behaviors whereas the control group (n = 23) did not see these behaviors. Children's inhibitory control was assessed using the day-night task and their social understanding was measured through a parental questionnaire. Surprisingly, group-level analyses revealed that the experimental group performed the behaviors significantly less than the control group (i.e. a negative mimicry effect) for both the sticker-sharer and sticker-keeper. Yet, the hypothesized effects of inhibitory control and social understanding were found. Inhibitory control predicted children's selective mimicry of the sticker-keeper versus sticker sharer and children's overall mimicry was correlated with social understanding. These results provide the first indications to suggest that factors of social and cognitive development dynamically influence the emergence and specificity of behavioral mimicry during early childhood.	[van Schaik, Johanna E.; Hunnius, Sabine] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [van Schaik, Johanna E.] Leiden Univ, Educ & Child Studies, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC	van Schaik, JE (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.; van Schaik, JE (corresponding author), Leiden Univ, Educ & Child Studies, Leiden, Netherlands.	j.e.van.schaik@fsw.leidenuniv.nl	Hunnius, Sabine/D-5834-2012	van Schaik, Johanna E/0000-0001-5865-4523	Donders Institute for Brain, Cognition, and Behaviour	Donders Institute for Brain, Cognition, and Behaviour	JEvS was funded by an internal PhD grant of the Donders Institute for Brain, Cognition, and Behaviour.	Caputi M, 2012, DEV PSYCHOL, V48, P257, DOI 10.1037/a0025402; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Catmur C, 2013, COGNITIVE SCI, V37, P1541, DOI 10.1111/cogs.12071; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng CM, 2003, J PERS SOC PSYCHOL, V85, P1170, DOI 10.1037/0022-3514.85.6.1170; Chernyak N, 2016, SOC DEV, V25, P340, DOI 10.1111/sode.12136; Emanuel L. L., 2012, THESIS; Endedijk HM, 2015, SOC DEV, V24, P521, DOI 10.1111/sode.12106; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Grange LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077917, 10.1371/journal.pone.0084448]; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; Hogeveen J, 2012, J NEUROSCI, V32, P5984, DOI 10.1523/JNEUROSCI.5938-11.2012; Hughes C, 2007, DEV PSYCHOL, V43, P1447, DOI 10.1037/0012-1649.43.6.1447; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Ladd GW, 1999, ANNU REV PSYCHOL, V50, P333, DOI 10.1146/annurev.psych.50.1.333; Lakin JL, 2008, PSYCHOL SCI, V19, P816, DOI 10.1111/j.1467-9280.2008.02162.x; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Leander NP, 2012, PSYCHOL SCI, V23, P772, DOI 10.1177/0956797611434535; LoBue V, 2011, SOC DEV, V20, P154, DOI 10.1111/j.1467-9507.2009.00560.x; Meyer M, 2015, J EXP CHILD PSYCHOL, V139, P203, DOI 10.1016/j.jecp.2015.06.005; Meyer M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0371; Montgomery DE, 2010, DEV REV, V30, P308, DOI 10.1016/j.dr.2010.07.001; Oostenbroek J, 2015, J EXP CHILD PSYCHOL, V139, P234, DOI 10.1016/j.jecp.2015.05.009; Paulus M, 2013, J EXP CHILD PSYCHOL, V116, P78, DOI 10.1016/j.jecp.2012.12.014; Plotner M, 2015, J EXP CHILD PSYCHOL, V139, P161, DOI 10.1016/j.jecp.2015.05.008; Tahiroglu D, 2014, DEV PSYCHOL, V50, P2485, DOI 10.1037/a0037914; van Baaren RB, 2004, J PERS SOC PSYCHOL, V86, P453, DOI 10.1037/0022-3514.86.3.453; Van Schaik J.E., 2013, P 35 ANN C COGN SCI, P1516; van Schaik JE, 2016, J EXP CHILD PSYCHOL, V147, P71, DOI 10.1016/j.jecp.2016.03.003; van Schaik JE, 2016, FRONT PSYCHOL, V7, DOI [10.3389/fpsyg.7016.00321, 10.3389/fpsyg.2016.00321]; Watson-Jones RE, 2016, PSYCHOL SCI, V27, P34, DOI 10.1177/0956797615607205; Watson-Jones RE, 2014, EVOL HUM BEHAV, V35, P204, DOI 10.1016/j.evolhumbehav.2014.01.004; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; Yabar Y, 2006, J NONVERBAL BEHAV, V30, P97, DOI 10.1007/s10919-006-0010-6	35	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0194102	10.1371/journal.pone.0194102	http://dx.doi.org/10.1371/journal.pone.0194102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513741	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800102
J	Pizzitutti, F; Pan, W; Feingold, B; Zaitchik, B; Alvarez, CA; Mena, CF				Pizzitutti, Francesco; Pan, William; Feingold, Beth; Zaitchik, Ben; Alvarez, Carlos A.; Mena, Carlos F.			Out of the net: An agent-based model to study human movements influence on local-scale malaria transmission	PLOS ONE			English	Article							ANOPHELES-DARLINGI; SEASONAL DISTRIBUTION; PLASMODIUM-VIVAX; EPIDEMIOLOGY; BEHAVIOR; ELIMINATION; STRATEGIES; INFECTION; MOSQUITOS; POPULATION	Though malaria control initiatives have markedly reduced malaria prevalence in recent decades, global eradication is far from actuality. Recent studies show that environmental and social heterogeneities in low-transmission settings have an increased weight in shaping malaria micro-epidemiology. New integrated and more localized control strategies should be developed and tested. Here we present a set of agent-based models designed to study the influence of local scale human movements on local scale malaria transmission in a typical Amazon environment, where malaria is transmission is low and strongly connected with seasonal riverine flooding. The agent-based simulations show that the overall malaria incidence is essentially not influenced by local scale human movements. In contrast, the locations of malaria high risk spatial hotspots heavily depend on human movements because simulated malaria hotspots are mainly centered on farms, were laborers work during the day. The agent-based models are then used to test the effectiveness of two different malaria control strategies both designed to reduce local scale malaria incidence by targeting hotspots. The first control scenario consists in treat against mosquito bites people that, during the simulation, enter at least once inside hotspots revealed considering the actual sites where human individuals were infected. The second scenario involves the treatment of people entering in hotspots calculated assuming that the infection sites of every infected individual is located in the household where the individual lives. Simulations show that both considered scenarios perform better in controlling malaria than a randomized treatment, although targeting household hotspots shows slightly better performance.	[Pizzitutti, Francesco; Mena, Carlos F.] Univ San Francisco Quito, Inst Geog, Quito, Ecuador; [Pizzitutti, Francesco; Pan, William] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Feingold, Beth] SUNY Albany, Sch Publ Hlth, Albany, NY USA; [Zaitchik, Ben] Johns Hopkins Univ, Morton K Blaustein Dept Earth & Planetary Sci, Baltimore, MD USA; [Alvarez, Carlos A.] DIRESA Loreto, Epidemiol Dept, Iquitos, Loreto, Peru	Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Johns Hopkins University	Mena, CF (corresponding author), Univ San Francisco Quito, Inst Geog, Quito, Ecuador.; Pan, W (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC USA.	wkp@duke.edu; cmena@usfq.edu.ec	Zaitchik, Benjamin/AAB-3298-2020; Mena, Carlos F./AAI-3570-2020	Zaitchik, Benjamin/0000-0002-0698-0658; Mena, Carlos F./0000-0003-0825-6476; Feingold, Beth/0000-0001-6670-5845	NASA [NNH13ZDA001N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD065563] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding was provided by NASA (NNH13ZDA001N-Health to Pan).; Funding was provided by NASA (NNH13ZDA001N-Health to Pan). Malaria data were provided by DIRESA-Loreto Epidemiology Department. Spatial data from each community were provided by CA (PC) and WP (TC). Special thanks to Paige Meier who provided extensive feedback on the manuscript.	Alonso WJ, 2006, MED VET ENTOMOL, V20, P157, DOI 10.1111/j.1365-2915.2006.00623.x; Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; [Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], 2015, REG PROF WORLD MAL R, P122; Bautista CT, 2006, AM J TROP MED HYG, V75, P1216, DOI 10.4269/ajtmh.2006.75.1216; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bharti AR, 2006, AM J TROP MED HYG, V75, P610, DOI 10.4269/ajtmh.2006.75.610; Bomblies A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-308; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Carrillo-Larco RM, 2014, PEERJ, V2, DOI 10.7717/peerj.345; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; FORATTINI OP, 1987, REV SAUDE PUBL, V21, P291, DOI 10.1590/S0034-89101987000400002; Fornadel CM, 2010, AM J TROP MED HYG, V83, P848, DOI 10.4269/ajtmh.2010.10-0242; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Griffing SM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-303; Gu W, 2009, T R SOC TROP MED HYG, V103, P1; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Illangakoon C, 2014, 2014 IEEE CAN INT HU, P1; Instituto nacional de estadistica e informatica (INEI), 2014, REV INF, P1; Jarvis A, 2008, HOLE FILLED SEAMLESS; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lana JT, 2012, THESIS; Lansang MAD, 1997, ACTA TROP, V63, P257, DOI 10.1016/S0001-706X(96)00625-0; Luke S., 2005, SIMULATION, P1; Marshall JM, 2016, TRENDS PARASITOL, V32, P752, DOI 10.1016/j.pt.2016.07.004; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Mbogo CNM, 1996, MED VET ENTOMOL, V10, P251, DOI 10.1111/j.1365-2915.1996.tb00739.x; McCall PJ, 2002, TRENDS PARASITOL, V18, P429, DOI 10.1016/S1471-4922(02)02370-X; McKenzie FE, 2007, J PARASITOL, V93, P627, DOI 10.1645/GE-1052R.1; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; de Barros FSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022388; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Mosha JF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-53; Neumann K, 2015, HUM ECOL, V43, P309, DOI 10.1007/s10745-015-9733-5; Nourein AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016948; Parker BS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-178; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pizzitutti F., 2014, JASSS-J ARTIF SOC S, V17, P1; Pizzitutti F, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1030-7; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Pullan RL, 2010, PLASMODIUM INFECT IT, P1; Reinbold-Wasson DD, 2012, AM J TROP MED HYG, V86, P459, DOI 10.4269/ajtmh.2012.11-0547; ROZENDAAL JA, 1989, J AM MOSQUITO CONTR, V5, P351; Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Turell MJ, 2008, J MED ENTOMOL, V45, P1165, DOI 10.1603/0022-2585(2008)45[1165:SDBAHA]2.0.CO;2; URIEL Kitron, 1998, LANDSCAPE ECOLOGY EP; Utzinger J, 2002, NATURE, V419, P431, DOI 10.1038/419431a; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Warrell DA, 2002, ESSENTIAL MALARIOLOG; WHO, 2016, WORLD MALARIA REPORT; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	71	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193493	10.1371/journal.pone.0193493	http://dx.doi.org/10.1371/journal.pone.0193493			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509795	Green Published, gold, Green Submitted			2022-12-27	WOS:000426813200014
J	Ramadan, RM; Gasser, SM; El-Mahallawy, MS; Supsup, KH; El Bakly, AM				Ramadan, Rahab M.; Gasser, Safa M.; El-Mahallawy, Mohamed S.; Supsup, Karim Hammad; El Bakly, Ahmed M.			A memetic optimization algorithm for multi-constrained multicast routing in ad hoc networks	PLOS ONE			English	Article							GENETIC ALGORITHM; ENERGY-EFFICIENT	A mobile ad hoc network is a conventional self-configuring network where the routing optimization problem-subject to various Quality-of-Service (QoS) constraints-represents a major challenge. Unlike previously proposed solutions, in this paper, we propose a memetic algorithm (MA) employing an adaptive mutation parameter, to solve the multicast routing problem with higher search ability and computational efficiency. The proposed algorithm utilizes an updated scheme, based on statistical analysis, to estimate the best values for all MA parameters and enhance MA performance. The numerical results show that the proposed MA improved the delay and jitter of the network, while reducing computational complexity as compared to existing algorithms.	[Ramadan, Rahab M.; El Bakly, Ahmed M.] Arab Acad Sci Technol & Maritime Transport, Dept Basic & Appl Sci, Cairo, Egypt; [Gasser, Safa M.; El-Mahallawy, Mohamed S.; Supsup, Karim Hammad] Arab Acad Sci Technol & Maritime Transport, Dept Elect & Commun, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport; Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport	Ramadan, RM (corresponding author), Arab Acad Sci Technol & Maritime Transport, Dept Basic & Appl Sci, Cairo, Egypt.	rahabmz@aast.edu						Abbass H. A., 2001, P GEN EV COMP C GECC, P807; Abdelhaq M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120715; Abdelkader TAMM, 2008, THESIS; Al-Nahari A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156670; Alajmi A., 2014, INT J SUSTAINABLE BU, V3, P18, DOI [10.1016/j.ijsbe.2014.07.003, DOI 10.1016/J.IJSBE.2014.07.003]; ALANDER JT, 1992, COMPUTER SYSTEMS AND SOFTWARE ENGINEERING, P65, DOI 10.1109/CMPEUR.1992.218485; Back T., 1994, Proceedings of the First IEEE Conference on Evolutionary Computation. IEEE World Congress on Computational Intelligence (Cat. No.94TH0650-2), P531, DOI 10.1109/ICEC.1994.350004; Back T., 1996, Foundations of Intelligent Systems. 9th International Symposium, ISMIS '96. Proceedings, P158; Baumann R., 2007, 262 TIK ETH ZENTR CO; Bitam S, 2013, J NETW COMPUT APPL, V36, P981, DOI 10.1016/j.jnca.2012.01.023; Chen L, 2005, IEEE J SEL AREA COMM, V23, P561, DOI 10.1109/JSAC.2004.842560; Cheng H, 2010, ENG APPL ARTIF INTEL, V23, P806, DOI 10.1016/j.engappai.2010.01.021; Chitra C., 2011, THESIS; De Jong K.A., 1975, THESIS ANN ARBOR; De Oliveira HCB, 2006, 6 INT C HYBR INT SYS, P1; Dey D. K., 2014, COMPUSOFT INT J ADV, V3, P1116; FOGARTY TC, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P104; GREFENSTETTE JJ, 1986, IEEE T SYST MAN CYB, V16, P122, DOI 10.1109/TSMC.1986.289288; Haghighat AT, 2003, KNOWL-BASED SYST, V16, P305, DOI 10.1016/S0950-7051(03)00032-7; Haupt R. L., 2000, Applied Computational Electromagnetics Society Journal, V15, P94; Hessler C., 1990, P 1 WORKSH PAR PROBL, P23; Huang CJ, 2009, ENG APPL ARTIF INTEL, V22, P1188, DOI 10.1016/j.engappai.2009.03.004; Hwang RH, 2000, J INF SCI ENG, V16, P885; Keppel G., 1982, DESIGN ANAL RES HDB; Khuri S., 1994, PROC GENET ALGORITHM, P86; Khuri S., 1994, P ACM S APPL COMPUTI, P188, DOI DOI 10.1145/326619.326694.(HTTP://D0LACM.0RG/10.1145/326619.326694); Koyama Akio, 2008, International Journal of High Performance Computing and Networking, V5, P381, DOI 10.1504/IJHPCN.2008.025557; Liang MX, 2017, NAT COMPUT, V16, P85, DOI 10.1007/s11047-016-9545-6; Lu T, 2013, IEEE COMMUN LETT, V17, P31, DOI 10.1109/LCOMM.2012.112012.121467; Man KF, 1997, GENETIC ALGORITHMS C; McCall J, 2005, J COMPUT APPL MATH, V184, P205, DOI 10.1016/j.cam.2004.07.034; MUHLENBEIN H, 1992, PARALLEL PROBLEM SOLVING FROM NATURE, 2, P15; Onwuka E., 2011, J RES NATL DEV TRANS; Pham D. T., 2006, INTELLIGENT PRODUCTI, P454, DOI [10.1016/B978-008045157-2/50081-X, DOI 10.1016/B978-008045157-2/50081-X]; Rudolph G, 2001, IEEE T EVOLUT COMPUT, V5, P410, DOI 10.1109/4235.942534; Sabar NR, 2016, LECT NOTES COMPUT SC, V9810, P406, DOI 10.1007/978-3-319-42911-3_34; Sabar NR, 2015, INT C PAR DISTRIB SY, P60, DOI 10.1109/ICPADS.2015.16; Santhi G., 2014, THESIS; SCHAFFER JD, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P51; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Skiena S. S., 2008, ALGORITHM DESIGN MAN; SRINIVAS M, 1994, IEEE T SYST MAN CYB, V24, P656, DOI 10.1109/21.286385; Tseng SY, 2008, EXPERT SYST APPL, V35, P1473, DOI 10.1016/j.eswa.2007.08.018; Vadivel R, 2012, PROC TECH, V4, P703, DOI 10.1016/j.protcy.2012.05.114; Wang ZY, 2001, COMPUT COMMUN, V24, P685, DOI 10.1016/S0140-3664(00)00273-5; Yuan B, 2007, STUD COMPUT INTELL, V54, P121; Zhang L, 2009, COMPUT COMMUN, V32, P105, DOI 10.1016/j.comcom.2008.09.023	48	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193142	10.1371/journal.pone.0193142	http://dx.doi.org/10.1371/journal.pone.0193142			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509760	gold, Green Published, Green Submitted			2022-12-27	WOS:000426813200010
J	Honma, K; Abe, S; Endo, T; Uno, N; Oshimura, M; Ohbayashi, T; Kazuki, Y				Honma, Kazuhisa; Abe, Satoshi; Endo, Takeshi; Uno, Narumi; Oshimura, Mitsuo; Ohbayashi, Tetsuya; Kazuki, Yasuhiro			Development of a multiple-gene-loading method by combining multi-integration system-equipped mouse artificial chromosome vector and CRISPR-Cas9	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION; REPORTER	Mouse artificial chromosome (MAC) vectors have several advantages as gene delivery vectors, such as stable and independent maintenance in host cells without integration, transferability from donor cells to recipient cells via microcell-mediated chromosome transfer (MMCT), and the potential for loading a megabase-sized DNA fragment. Previously, a MAC containing a multi-integrase platform (MI-MAC) was developed to facilitate the transfer of multiple genes into desired cells. Although the MI system can theoretically hold five geneloading vectors (GLVs), there are a limited number of drugs available for the selection of multiple-GLV integration. To overcome this issue, we attempted to knock out and reuse drug resistance genes (DRGs) using the CRISPR-Cas9 system. In this study, we developed new methods for multiple-GLV integration. As a proof of concept, we introduced five GLVs in the MI-MAC by these methods, in which each GLV contained a gene encoding a fluorescent or luminescent protein (EGFP, mCherry, BFP, Eluc, and Cluc). Genes of interest (GOI) on the MI-MAC were expressed stably and functionally without silencing in the host cells. Furthermore, the MI-MAC carrying five GLVs was transferred to other cells by MMCT, and the resultant recipient cells exhibited all five fluorescence/luminescence signals. Thus, the MI-MAC was successfully used as a multiple-GLV integration vector using the CRISPRCas9 system. The MI-MAC employing these methods may resolve bottlenecks in developing multiple-gene humanized models, multiple-gene monitoring models, disease models, reprogramming, and inducible gene expression systems.	[Honma, Kazuhisa; Uno, Narumi; Kazuki, Yasuhiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan; [Abe, Satoshi; Uno, Narumi; Oshimura, Mitsuo; Kazuki, Yasuhiro] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan; [Endo, Takeshi] Tottori Ind Promot Org, Tottori, Tottori, Japan; [Ohbayashi, Tetsuya] Tottori Univ, Res Ctr Biosci & Technol, Div Lab Anim Sci, Yonago, Tottori, Japan	Tottori University; Tottori University; Tottori University	Kazuki, Y (corresponding author), Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan.; Kazuki, Y (corresponding author), Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan.	kazuki@grapp.methottori-u.ac.jp	Narumi, Uno/AAP-3936-2021	Narumi, Uno/0000-0002-4218-1167; Kazuki, Yasuhiro/0000-0003-4818-4710	Takeda Science Foundation; Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS); Japan Agency for Medical Research and Development, AMED; JSPS KAKENHI [25221308, 15H04285]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by The Takeda Science Foundation (Y.K.), the Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y.K. and M.O.), the Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS) (Y.K.), the Basic Science and Platform Technology Program for Innovative Biological Medicine from Japan Agency for Medical Research and Development, AMED (Y.K.), and JSPS KAKENHI Grant Numbers 25221308 (M.O.) and 15H04285 (Y.K.). There was no additional external funding received for this study.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Endo T, 2016, YONAGO ACTA MED, V59, P174; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Hansen K, 2012, JOVE-J VIS EXP, DOI 10.3791/3304; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kameyama Y, 2010, BIOTECHNOL BIOENG, V105, P1106, DOI 10.1002/bit.22619; Katoh M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-37; Kazuki K, 2013, BIOCHEM BIOPH RES CO, V442, P44, DOI 10.1016/j.bbrc.2013.10.171; Kazuki Y, 2011, GENE THER, V18, P384, DOI 10.1038/gt.2010.147; Kazuki Y, 2013, HUM MOL GENET, V22, P578, DOI 10.1093/hmg/dds468; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kokura K, 2016, J GENE MED, V18, P273, DOI 10.1002/jgm.2925; Kurosaki H, 2011, J HUM GENET, V56, P727, DOI 10.1038/jhg.2011.88; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Nakajima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010011; Oshimura M, 2015, CHROMOSOME RES, V23, P111, DOI 10.1007/s10577-014-9459-z; Ren XY, 2005, STEM CELLS, V23, P1608, DOI 10.1634/stemcells.2005-0021; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Suzuki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110404; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takiguchi M, 2014, ACS SYNTH BIOL, V3, P903, DOI 10.1021/sb3000723; Tedesco FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002342; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Tsuchiya M, 2016, FEBS LETT, V590, P2671, DOI 10.1002/1873-3468.12262; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Watanabe T, 2010, ANAL BIOCHEM, V402, P107, DOI 10.1016/j.ab.2010.03.014; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Yoshimura Y, 2015, TRANSGENIC RES, V24, P717, DOI 10.1007/s11248-015-9884-6	29	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193642	10.1371/journal.pone.0193642	http://dx.doi.org/10.1371/journal.pone.0193642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505588	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200024
J	Critchell, K; Hoogenboom, MO				Critchell, Kay; Hoogenboom, Mia O.			Effects of microplastic exposure on the body condition and behaviour of planktivorous reef fish (Acanthochromis polyacanthus)	PLOS ONE			English	Article							PLASTIC INGESTION; NORTH-SEA; FOOD ACQUISITION; 1ST OBSERVATIONS; TERRITORY SIZE; MYTILUS-EDULIS; DEMERSAL FISH; SOCIAL RANK; MARINE; JUVENILE	The effect of a pollutant on the base of the food web can have knock-on effects for trophic structure and ecosystem functioning. In this study we assess the effect of microplastic exposure on juveniles of a planktivorous fish ( Acanthochromis polyacanthus), a species that is widespread and abundant on Indo-Pacific coral reefs. Under five different plastic concentration treatments, with plastics the same size as the natural food particles ( mean 2mm diameter), there was no significant effect of plastic exposure on fish growth, body condition or behaviour. The amount of plastics found in the gastro-intestinal ( GI) tract was low, with a range of one to eight particles remaining in the gut of individual fish at the end of a 6-week plastic-exposure period, suggesting that these fish are able to detect and avoid ingesting microplastics in this size range. However, in a second experiment the number of plastics in the GI tract vastly increased when plastic particle size was reduced to approximately one quarter the size of the food particles, with a maximum of 2102 small (<300 mu m diameter) particles present in the gut of individual fish after a 1-week plastic exposure period. Under conditions where food was replaced by plastic, there was a negative effect on the growth and body condition of the fish. These results suggest plastics could become more of a problem as they break up into smaller size classes, and that environmental changes that lead to a decrease in plankton concentrations combined with microplastic presence is likely have a greater influence on fish populations than microplastic presence alone.	[Critchell, Kay; Hoogenboom, Mia O.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Critchell, Kay] James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia; [Hoogenboom, Mia O.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	James Cook University; James Cook University; James Cook University	Critchell, K (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.; Critchell, K (corresponding author), James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia.	kay.critchell@my.jcu.edu.au	Critchell, Kay/E-3150-2017; Hoogenboom, Mia O/D-3664-2012; Critchell, Kay/M-8859-2019	Critchell, Kay/0000-0003-0599-2355; Hoogenboom, Mia O/0000-0003-3709-6344; Critchell, Kay/0000-0003-0599-2355				Acampora H, 2014, MAR POLLUT BULL, V78, P63, DOI 10.1016/j.marpolbul.2013.11.009; Adams CE, 1998, AQUACULTURE, V167, P17, DOI 10.1016/S0044-8486(98)00302-0; ADAMS CE, 1995, ENVIRON BIOL FISH, V43, P213, DOI 10.1007/BF00002494; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Askey PJ, 2006, N AM J FISH MANAGE, V26, P1020, DOI 10.1577/M06-035.1; Avio CG, 2015, MAR ENVIRON RES, V111, P18, DOI 10.1016/j.marenvres.2015.06.014; Bakir A, 2012, MAR POLLUT BULL, V64, P2782, DOI 10.1016/j.marpolbul.2012.09.010; Bengfort M, 2014, ECOL COMPLEX, V20, P185, DOI 10.1016/j.ecocom.2014.10.003; Berry KLE, 2016, SCI REP-UK, V6, DOI 10.1038/srep25894; Besseling E, 2013, ENVIRON SCI TECHNOL, V47, P593, DOI 10.1021/es302763x; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Browne MA, 2007, INTEGR ENVIRON ASSES, V3, P559, DOI 10.1002/ieam.5630030412; CARPENTE.EJ, 1972, SCIENCE, V178, P749, DOI 10.1126/science.178.4062.749; Carson HS, 2011, MAR POLLUT BULL, V62, P1708, DOI 10.1016/j.marpolbul.2011.05.032; CHELLAPPA S, 1995, J FISH BIOL, V47, P775, DOI 10.1111/j.1095-8649.1995.tb06002.x; Chua EM, 2014, ENVIRON SCI TECHNOL, V48, P8127, DOI 10.1021/es405717z; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; David BO, 2007, ANIM BEHAV, V74, P259, DOI 10.1016/j.anbehav.2006.08.015; de Sa LC, 2015, ENVIRON POLLUT, V196, P359, DOI 10.1016/j.envpol.2014.10.026; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Desforges JPW, 2014, MAR POLLUT BULL, V79, P94, DOI 10.1016/j.marpolbul.2013.12.035; Bello A, 2013, DIS AQUAT ORGAN, V106, P93, DOI 10.3354/dao02641; Dunbrack RL, 1996, J FISH BIOL, V48, P615, DOI 10.1111/j.1095-8649.1996.tb01456.x; Eerkes-Medrano D, 2015, WATER RES, V75, P63, DOI 10.1016/j.watres.2015.02.012; ELLIOTT JM, 1975, FRESHWATER BIOL, V5, P287, DOI 10.1111/j.1365-2427.1975.tb00142.x; ELLIOTT JM, 1973, OECOLOGIA, V12, P329, DOI 10.1007/BF00345047; ELLIOTT JM, 1976, J ANIM ECOL, V45, P923, DOI 10.2307/3590; EMERY AR, 1973, B MAR SCI, V23, P649; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Farrell P, 2013, ENVIRON POLLUT, V177, P1, DOI 10.1016/j.envpol.2013.01.046; Foekema EM, 2013, ENVIRON SCI TECHNOL, V47, P8818, DOI 10.1021/es400931b; FORRESTER GE, 1991, ANIM BEHAV, V42, P701, DOI 10.1016/S0003-3472(05)80116-2; Garcia-Berthou E, 1999, J FISH BIOL, V55, P135, DOI 10.1111/j.1095-8649.1999.tb00663.x; Garvey JE, 2004, ECOLOGY, V85, P2860, DOI 10.1890/03-0329; Goncharov A, 2009, ENVIRON HEALTH PERSP, V117, P1454, DOI 10.1289/ehp.0800134; Carman VG, 2014, MAR POLLUT BULL, V78, P56, DOI 10.1016/j.marpolbul.2013.11.012; Hall NM, 2015, MAR BIOL, V162, P725, DOI 10.1007/s00227-015-2619-7; Hermsen E, 2017, MAR POLLUT BULL, V122, P253, DOI 10.1016/j.marpolbul.2017.06.051; HOBSON ES, 1978, FISH B-NOAA, V76, P133; Hoogenboom MO, 2013, BEHAV ECOL, V24, P253, DOI 10.1093/beheco/ars161; Hoss D, 1989, INGESTION PLASTICS T; HUGHES NF, 1992, CAN J FISH AQUAT SCI, V49, P1994, DOI 10.1139/f92-222; Hurst TP, 2005, MAR ECOL PROG SER, V293, P233, DOI 10.3354/meps293233; Imre I, 2004, OECOLOGIA, V138, P371, DOI 10.1007/s00442-003-1432-z; do Sul JAI, 2014, ENVIRON POLLUT, V185, P352, DOI 10.1016/j.envpol.2013.10.036; Kinan I, 2000, MARINE ORNITHOLOGY, V28; LOW RM, 1971, ECOLOGY, V52, P648, DOI 10.2307/1934153; Lusher AL, 2013, MAR POLLUT BULL, V67, P94, DOI 10.1016/j.marpolbul.2012.11.028; Ma ZH, 2015, AQUAC RES, V46, P2593, DOI 10.1111/are.12413; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moret-Ferguson S, 2010, MAR POLLUT BULL, V60, P1873, DOI 10.1016/j.marpolbul.2010.07.020; Neves D, 2015, MAR POLLUT BULL, V101, P119, DOI 10.1016/j.marpolbul.2015.11.008; OBRIEN WJ, 1976, ECOLOGY, V57, P1304, DOI 10.2307/1935055; PEREIRA JJ, 1993, ARCH ENVIRON CON TOX, V24, P427, DOI 10.1007/BF01146157; PHILLIPS RR, 1979, ANIM BEHAV, V27, P1113, DOI 10.1016/0003-3472(79)90059-9; Pierce Kathryn E., 2004, Marine Ornithology, V32, P187; Possatto FE, 2011, MAR POLLUT BULL, V62, P1098, DOI 10.1016/j.marpolbul.2011.01.036; R Core Team, 2016, R LANG ENV STAT COMP; Rebolledo ELB, 2013, MAR POLLUT BULL, V67, P200, DOI 10.1016/j.marpolbul.2012.11.035; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Romeo T, 2015, MAR POLLUT BULL, V95, P358, DOI 10.1016/j.marpolbul.2015.04.048; Rummel CD, 2016, MAR POLLUT BULL, V102, P134, DOI 10.1016/j.marpolbul.2015.11.043; RYAN PG, 1988, MAR POLLUT BULL, V19, P125, DOI 10.1016/0025-326X(88)90708-4; RYAN PG, 1987, MAR ENVIRON RES, V23, P175, DOI 10.1016/0141-1136(87)90028-6; Ryer CH, 2009, MAR ECOL PROG SER, V391, P97, DOI 10.3354/meps08168; Savoca MS, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1000; Setala O, 2014, ENVIRON POLLUT, V185, P77, DOI 10.1016/j.envpol.2013.10.013; SPARKS RE, 1972, J FISH RES BOARD CAN, V29, P1356, DOI 10.1139/f72-208; SPEAR LB, 1995, MAR ENVIRON RES, V40, P123, DOI 10.1016/0141-1136(94)00140-K; Staddon J., 2016, ADAPTIVE BEHAV LEARN; Thompson IC., 2009, PHILOS T R SOC BIOL, V1, P1; Toobaie A, 2013, ANIM BEHAV, V85, P241, DOI 10.1016/j.anbehav.2012.10.032; Tsang YY, 2017, MAR POLLUT BULL, V115, P20, DOI 10.1016/j.marpolbul.2016.11.003; Van Cauwenberghe L, 2015, ENVIRON POLLUT, V199, P10, DOI 10.1016/j.envpol.2015.01.008; Vendel AL, 2017, MAR POLLUT BULL, V117, P448, DOI 10.1016/j.marpolbul.2017.01.081; Verlis KM, 2013, MAR POLLUT BULL, V72, P244, DOI 10.1016/j.marpolbul.2013.03.017; Watts AJR, 2014, ENVIRON SCI TECHNOL, V48, P8823, DOI 10.1021/es501090e; Wright SL, 2013, CURR BIOL, V23, pR1031, DOI 10.1016/j.cub.2013.10.068; Zhao SY, 2014, MAR POLLUT BULL, V86, P562, DOI 10.1016/j.marpolbul.2014.06.032	81	115	122	15	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193308	10.1371/journal.pone.0193308	http://dx.doi.org/10.1371/journal.pone.0193308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494635	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200038
J	Diederich, B; Wartmann, R; Schadwinkel, H; Heintzmann, R				Diederich, Benedict; Wartmann, Rolf; Schadwinkel, Harald; Heintzmann, Rainer			Using machine-learning to optimize phase contrast in a low-cost cellphone microscope	PLOS ONE			English	Article							FOURIER PTYCHOGRAPHY; ILLUMINATION; INTENSITY; RETRIEVAL	Cellphones equipped with high-quality cameras and powerful CPUs as well as GPUs are widespread. This opens new prospects to use such existing computational and imaging resources to perform medical diagnosis in developing countries at a very low cost. Many relevant samples, like biological cells or waterborn parasites, are almost fully transparent. As they do not exhibit absorption, but alter the light's phase only, they are almost invisible in brightfield microscopy. Expensive equipment and procedures for microscopic contrasting or sample staining often are not available. Dedicated illumination approaches, tailored to the sample under investigation help to boost the contrast. This is achieved by a programmable illumination source, which also allows to measure the phase gradient using the differential phase contrast (DPC) [1, 2] or even the quantitative phase using the derived qDPC approach [3]. By applying machine-learning techniques, such as a convolutional neural network (CNN), it is possible to learn a relationship between samples to be examined and its optimal light source shapes, in order to increase e.g. phase contrast, from a given dataset to enable real-time applications. For the experimental setup, we developed a 3D-printed smartphone microscope for less than 100 $ using off-the-shelf components only such as a low-cost video projector. The fully automated system assures true Koehler illumination with an LCD as the condenser aperture and a reversed smartphone lens as the microscope objective. We show that the effect of a varied light source shape, using the pre-trained CNN, does not only improve the phase contrast, but also the impression of an improvement in optical resolution without adding any special optics, as demonstrated by measurements.	[Diederich, Benedict; Wartmann, Rolf; Schadwinkel, Harald] Carl Zeiss Microscopy GmbH, Res Dept, Gottingen, Germany; [Diederich, Benedict; Heintzmann, Rainer] Leibniz Inst Photon Technol, Albert Einstein Str 9, D-07745 Jena, Germany; [Diederich, Benedict; Heintzmann, Rainer] Friedrich Schiller Univ Jena, Inst Phys Chem, Helmholtzweg 4, D-07743 Jena, Germany; [Diederich, Benedict; Heintzmann, Rainer] Friedrich Schiller Univ Jena, Abbe Ctr Photon, Helmholtzweg 4, D-07743 Jena, Germany	Carl Zeiss AG; Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Diederich, B (corresponding author), Carl Zeiss Microscopy GmbH, Res Dept, Gottingen, Germany.; Diederich, B (corresponding author), Leibniz Inst Photon Technol, Albert Einstein Str 9, D-07745 Jena, Germany.; Diederich, B (corresponding author), Friedrich Schiller Univ Jena, Inst Phys Chem, Helmholtzweg 4, D-07743 Jena, Germany.; Diederich, B (corresponding author), Friedrich Schiller Univ Jena, Abbe Ctr Photon, Helmholtzweg 4, D-07743 Jena, Germany.	benedict.diederich@ipht-jena.de	Heintzmann, Rainer/AAY-4849-2020	Heintzmann, Rainer/0000-0002-4950-1936	Carl-Zeiss Microscopy GmbH Gottingen as a RD project; free state of Thuringia	Carl-Zeiss Microscopy GmbH Gottingen as a RD project; free state of Thuringia(European Commission)	The work was funded by the Carl-Zeiss Microscopy GmbH Gottingen as a R&D project and by the free state of Thuringia. The funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. The specific roles of these authors are articulated in the 'author contributions' section. Hereby I declare that Carl Zeiss Microscopy GmbH did not play a role in the design of the study and the experimental setups. CZ supported the study with professional lab equipment, like the microscope and the microscope objective lenses. The contributing authors were free in formulating their working hypothesis and the ways to proof it.	Abadi M., 2016, TENSORFLOW LARGE SCA; Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/bf02956173, DOI 10.1007/BF02956173, 10.1007/ BF02956173]; Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; Behrens J., 1915, Z WISSENSCHAFTLICHE, V32, P508; Bian Z., 2015, THESIS, V746; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Cobb N., 1998, FAST OPTICAL PROCESS; Diederich B., 2017, BEAMERSCOPE TENSORFL; Diederich B., 2017, BEAMERSCOPE ANDROID; Diederich B., 2017, BEAMERSCOPE CAD GITH; Diederich B., 2017, MATLAB; Eberhart R.C., 2007, COMPUTATIONAL INTELL; Electronics L, LG CONS BUS EL; Garetto A, 2012, ADV OPT TECHNOL, V1, P289, DOI 10.1515/aot-2012-0124; Granik Y, 2004, J MICROLITH MICROFAB, V3, P509, DOI 10.1117/1.1794708; Greenbaum A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076475; Gross H, 2006, HDB OPTICAL SYSTEMS, V2; HAMILTON DK, 1984, J MICROSC-OXFORD, V135, P275, DOI 10.1111/j.1365-2818.1984.tb02533.x; Hofmann C., 1980, OPTISCHE ABBILDUNG; HOPKINS HH, 1953, PROC R SOC LON SER-A, V217, P408, DOI 10.1098/rspa.1953.0071; Iglesias I, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026015; Jung D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07703-w; Kamilov US, 2015, OPTICA, V2, P517, DOI 10.1364/OPTICA.2.000517; Kingma D, 2014, OPTIMIZATION; Krizhevsky A., P 25 INT C NEUR INF, P1097; Kumar M., 2010, THESIS; Larry Page SB, GOOGLE BILDER; LeCun Y., 1990, ADV NEURAL INFORM PR, V2, P396, DOI DOI 10.1111/DSU.12130; Liebling M, 2004, J OPT SOC AM A, V21, P367, DOI 10.1364/JOSAA.21.000367; Liu Z, 2015, INT SOC OPTICS PHOTO; Losa GA, 2011, ENCY MOL CELL BIOL M; Mehta SB, 2009, OPT LETT, V34, P1924, DOI 10.1364/OL.34.001924; Ou XZ, 2015, OPT EXPRESS, V23, P3472, DOI 10.1364/OE.23.003472; Phillips ZF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124938; Ryde N., 2006, LINEAR PHASE IMAGING, V214, P7; Siedentopf H, 1902, ANN PHYS, V315, P1, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; Skandarajah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096906; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604; Switz NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095330; Tian L, 2014, BIOMED OPT EXPRESS, V5, P2376, DOI 10.1364/BOE.5.002376; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Wu XF, 2014, OPT EXPRESS, V22, P3924, DOI 10.1364/OE.22.003924; Yamazoe K., 2008, STACKED PUPIL SHIFT, V25, P3111; Yamazoe K, 2009, J MICRO-NANOLITH MEM, V8, DOI 10.1117/1.3206980; Zheng G, MICROSCOPY, P1; Zuo C, 2015, OPT LASER ENG, V71, P20, DOI 10.1016/j.optlaseng.2015.03.006	49	19	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192937	10.1371/journal.pone.0192937	http://dx.doi.org/10.1371/journal.pone.0192937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494620	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200017
J	Herindrainy, P; Rabenandrasana, MAN; Andrianirina, ZZ; Rakotoarimanana, FMJ; Padget, M; de Lauzanne, A; Ndir, A; Kermorvant-Duchemin, E; Garin, B; Piola, P; Collard, JM; Guillemot, D; Huynh, BT; Delarocque-Astagneau, E				Herindrainy, Perlinot; Rabenandrasana, Mamitiana Alain Noah; Andrianirina, Zafitsara Zo; Rakotoarimanana, Feno Manitra Jacob; Padget, Michael; de Lauzanne, Agathe; Ndir, Awa; Kermorvant-Duchemin, Elsa; Garin, Benoit; Piola, Patrice; Collard, Jean-Marc; Guillemot, Didier; Huynh, Bich-Tram; Delarocque-Astagneau, Elisabeth		BIRDY Study Grp	Acquisition of extended spectrum beta-lactamase-producing enterobacteriaceae in neonates: A community based cohort in Madagascar	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE ACQUISITION; CESAREAN-SECTION RATES; GRAM-NEGATIVE BACILLI; INTENSIVE-CARE-UNIT; RISK-FACTORS; ESCHERICHIA-COLI; LOW-INCOME; ANTIMICROBIAL RESISTANCE; PREGNANT-WOMEN; FECAL CARRIAGE	In low and middle income countries ( LMICs), where the burden of neonatal sepsis is the highest, the spread of extended spectrum beta-lactamase-producing enterobacteriaceae ( ESBL-PE) in the community, potentially contributing to the neonatal mortality, is a public health concern. Data regarding the acquisition of ESBL-PE during the neonatal period are scarce. The routes of transmission are not well defined and particularly the possible key role played by pregnant women. This study aimed to understand the neonatal acquisition of ESBL-PE in the community in Madagascar. The study was conducted in urban and semi-rural areas. Newborns were included at birth and followed-up during their first month of life. Maternal stool samples at delivery and six stool samples in each infant were collected to screen for ESBL-PE. A Cox proportional hazards model was performed to identify factors associated with the first ESBL-PE acquisition. The incidence rate of ESBL-PE acquisition was 10.4 cases/1000 newborn-days [ 95% CI: 8.0-13.4 cases per 1000 newborn-days]. Of the 83 ESBL-PE isolates identified, Escherichia coli was the most frequent species ( n = 28, 34.1%), followed by Klebsiella pneumoniae ( n = 20, 24.4%). Cox multivariate analysis showed that independent risk factors for ESBL-PE acquisition were low birth weight ( adjusted Hazard-ratio ( aHR) = 2.7, 95% CI [ 1.2; 5.9]), cesarean-section, ( aHR = 3.4, 95% CI [ 1.7; 7.1]) and maternal use of antibiotics at delivery ( aHR = 2.2, 95% CI [ 1.1; 4.5]). Our results confirm that mothers play a significant role in the neonatal acquisition of ESBL-PE. In LMICs, public health interventions during pregnancy should be reinforced to avoid unnecessary caesarean section, unnecessary antibiotic use at delivery and low birth weight newborns.	[Herindrainy, Perlinot; Rakotoarimanana, Feno Manitra Jacob; Piola, Patrice] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Rabenandrasana, Mamitiana Alain Noah; Garin, Benoit; Collard, Jean-Marc] Inst Pasteur Madagascar, Expt Bacteriol Unit, Antananarivo, Madagascar; [Andrianirina, Zafitsara Zo] Ctr Hosp Soavinandriana, Peadiat Ward, Antananarivo, Madagascar; [Padget, Michael; Guillemot, Didier; Huynh, Bich-Tram; Delarocque-Astagneau, Elisabeth] UVSQ, INSERM, Inst Pasteur, Biostat Biomath Pharmacoepidemiol & Infect Dis Un, Paris, France; [de Lauzanne, Agathe] Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia; [Ndir, Awa] Inst Pasteur, Epidemiol & Infect Dis Unit, Dakar, Senegal; [Kermorvant-Duchemin, Elsa] Paris Descartes Univ, Paris, France; [Kermorvant-Duchemin, Elsa] Enfants Malades Univ Hosp, AP HP, Dept Neonatol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite	Huynh, BT (corresponding author), UVSQ, INSERM, Inst Pasteur, Biostat Biomath Pharmacoepidemiol & Infect Dis Un, Paris, France.	bich-tram.huynh@pasteur.fr	Collard, Jean-Marc/Q-2342-2019; Guillemot, Didier/AAN-3051-2020; delarocque-astagneau, elisabeth/E-4706-2016	Collard, Jean-Marc/0000-0002-1490-3978; Huynh, Bich-Tram/0000-0001-6340-9557; Herindrainy, Perlinot/0000-0002-5146-8100; Guillemot, Didier/0000-0002-8497-1765; delarocque-astagneau, elisabeth/0000-0002-5129-9300	Department of International Cooperation of the Principality of Monaco; Institut Pasteur	Department of International Cooperation of the Principality of Monaco; Institut Pasteur(European Commission)	This work was undertaken as part of the Bacterial Infections and antibiotic Resistant Diseases among Young children (BIRDY) project (http://www.birdyprogram.org/), which is made possible by the funding of the Department of International Cooperation of the Principality of Monaco. Also this work was supported by the Institut Pasteur (PTR call). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hady H, 2008, J PERINATOL, V28, P685, DOI 10.1038/jp.2008.73; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; Andriatahina T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-204; [Anonymous], 2015, REC JANV, pV1; Baral Pankaj, 2012, BMC Res Notes, V5, P38, DOI 10.1186/1756-0500-5-38; Basu S, 2015, EUR J CLIN MICROBIOL, V34, P215, DOI 10.1007/s10096-014-2232-6; Bebell LM, 2014, GLOB HEART, V9, P347, DOI 10.1016/j.gheart.2014.08.009; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Beukes LS, 2017, INT J HYG ENVIR HEAL, V220, P1279, DOI 10.1016/j.ijheh.2017.08.002; Bhattacharya S, 2013, VIRULENCE, V4, P172, DOI 10.4161/viru.23326; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bourlioux P, 2003, AM J CLIN NUTR, V78, P675, DOI 10.1093/ajcn/78.4.675; Buekens P, 2003, BRIT MED J, V326, P136, DOI 10.1136/bmj.326.7381.136; Carl MA, 2014, CLIN INFECT DIS, V58, P1211, DOI 10.1093/cid/ciu084; Collado MC, 2012, GUT MICROBES, V3, P352, DOI 10.4161/gmic.21215; Chan GJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001502; Chereau F, 2015, ANTIMICROB AGENTS CH, V59, P3652, DOI 10.1128/AAC.00029-15; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Crivaro V, 2007, J HOSP INFECT, V67, P135, DOI 10.1016/j.jhin.2007.07.026; Das P, 2011, J MED MICROBIOL, V60, P1651, DOI 10.1099/jmm.0.033803-0; Denkel LA, 2014, J ANTIMICROB CHEMOTH, V69, P2230, DOI 10.1093/jac/dku097; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Geyesus T, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0892-y; Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x; Graham K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3541-8; Herindrainy P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022738; Hijazi SM, 2016, J INFECT DEV COUNTR, V10, P947, DOI 10.3855/jidc.7593; Hsu AJ, 2014, CLIN INFECT DIS, V58, P1439, DOI 10.1093/cid/ciu069; Huynh B-T, 2017, EMERG INFECT DIS; Huynh BT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0843-x; Karanika S, 2016, CLIN INFECT DIS, V63, P310, DOI 10.1093/cid/ciw283; Koleva PT, 2015, BIRTH DEFECTS RES C, V105, P265, DOI 10.1002/bdrc.21117; Kothari C, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-136; Li X, 2017, INT J ANTIMICROB AG; Liu L, 2016, REPROD MATERNAL NEWB, V2; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Lohr IH, 2013, J ANTIMICROB CHEMOTH, V68, P1043, DOI 10.1093/jac/dks502; Mammina C, 2007, AM J INFECT CONTROL, V35, P222, DOI 10.1016/j.ajic.2006.04.210; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Mylonas I, 2011, ARCH GYNECOL OBSTET, V283, P7, DOI 10.1007/s00404-010-1646-3; Nelson JP, 2017, PAN AFR MED J, V26, DOI 10.11604/pamj.2017.26.64.9555; Nordberg V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076597; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Peretz A, 2016, DIAGN MICROBIOL INFE; Persaud RR, 2015, J MATERN-FETAL NEO M, V28, P1190, DOI 10.3109/14767058.2014.947578; Platell JL, 2011, ANTIMICROB AGENTS CH, V55, P3782, DOI 10.1128/AAC.00306-11; Rettedal S, 2015, J PERINATOL, V35, P907, DOI 10.1038/jp.2015.82; Rettedal S, 2013, SCAND J INFECT DIS, V45, P54, DOI 10.3109/00365548.2012.713116; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P3135, DOI 10.1128/AAC.00139-09; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Shakil S, 2010, J TROP PEDIATRICS, V56, P90, DOI 10.1093/tropej/fmp060; Shallcross LJ, 2014, BRIT J GEN PRACT, V64, P604, DOI 10.3399/bjgp14X682561; Stanton CK, 2006, STUD FAMILY PLANN, V37, P41, DOI 10.1111/j.1728-4465.2006.00082.x; Stoesser N, 2015, J ANTIMICROB CHEMOTH, V70, P1893, DOI 10.1093/jac/dkv021; Tellevik MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168024; Vardakas KZ, 2012, J ANTIMICROB CHEMOTH, V67, P2793, DOI 10.1093/jac/dks301; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; World Health Organization, 2018, LEVELS TRENDS CHILD; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	66	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193325	10.1371/journal.pone.0193325	http://dx.doi.org/10.1371/journal.pone.0193325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494706	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200039
J	Hogwood, J; Naggi, A; Torri, G; Page, C; Rigsby, P; Mulloy, B; Gray, E				Hogwood, J.; Naggi, A.; Torri, G.; Page, C.; Rigsby, P.; Mulloy, B.; Gray, E.			The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system	PLOS ONE			English	Article							HEPARIN-COFACTOR-II; ADVERSE CLINICAL EVENTS; OVERSULFATED CHONDROITIN; DERMATAN SULFATE; CONTACT SYSTEM; HUMAN-PLASMA; FACTOR-XII; INHIBITOR; CONTAMINANT; THROMBIN	Oversulfated chondroitin sulfate ( OSCS) was identified as a contaminant in certain heparin preparations as the cause of adverse reactions in patients. OSCS was found to possess both plasma anticoagulant activity and the ability to activate prekallikrein to kallikrein. Differentially sulfated chondroitin sulfates were prepared by synthetic modification of chondroitin sulfate and were compared to the activity of OSCS purified from contaminated heparin. Whilst chondroitin sulfate was found to have minimal anticoagulant activity, increasing sulfation levels produced an anticoagulant response which we directly show for the first time is mediated through heparin cofactor II. However, the tetra-sulfated preparations did not possess any higher anticoagulant activity than several tri-sulfated variants, and also had lower heparin cofactor II mediated activity. Activation of prekallikrein was concentration dependent for all samples, and broadly increased with the degree of sulfation, though the di-sulfated preparation was able to form more kallikrein than some of the tri-sulfated preparations. The ability of the samples to activate the kinin system, as measured by bradykinin, was observed to be through kallikrein generation. These results show that whilst an increase in sulfation of chondroitin sulfate did cause an increase in anticoagulant activity and activation of the kinin system, there may be subtler structural interactions other than sulfation at play given the different responses observed.	[Hogwood, J.; Rigsby, P.; Gray, E.] Natl Inst Biol Stand & Controls, Blanche Lane, Potters Bar, Herts, England; [Hogwood, J.; Page, C.; Mulloy, B.; Gray, E.] Kings Coll London, Inst Pharmaceut Sci, Sacker Inst Pulm Pharmacol, London, England; [Naggi, A.; Torri, G.] Inst Chem & Biochem Res G Ronzoni, Milan, Italy	National Institute for Biological Standards & Control; University of London; King's College London	Hogwood, J (corresponding author), Natl Inst Biol Stand & Controls, Blanche Lane, Potters Bar, Herts, England.; Hogwood, J (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Sacker Inst Pulm Pharmacol, London, England.	john.hogwood@nibsc.org		Rigsby, Peter/0000-0002-8954-9475; Torri, Giangiacomo/0000-0002-2077-1203; Hogwood, John/0000-0002-2595-1510				Adam A, 2010, BIOMATERIALS, V31, P5741, DOI 10.1016/j.biomaterials.2010.03.074; [Anonymous], 2008, EUROPEAN PHARMACOPOE, V01, P50300; [Anonymous], 2008, EUROPEAN PHARMACOPOE, V01, P20705; Bertini S, 2005, BIOMACROMOLECULES, V6, P168, DOI 10.1021/bm049693s; Bjorkqvist J, 2014, THROMB HAEMOSTASIS, V112, P868, DOI 10.1160/TH14-04-0311; Boothello RS, 2015, METHODS MOL BIOL, V1229, P335, DOI 10.1007/978-1-4939-1714-3_27; Carranza YE, 2008, BLOOD COAGUL FIBRIN, V19, P483, DOI 10.1097/MBC.0b013e3282f2a99e; Citarella F, 1997, BRIT J HAEMATOL, V99, P197, DOI 10.1046/j.1365-2141.1997.3513165.x; Corbier A, 2011, TOXICOL SCI, V121, P417, DOI 10.1093/toxsci/kfr072; Dace R, 1997, THROMB RES, V87, P113, DOI 10.1016/S0049-3848(97)00110-2; Fareed J, 2008, SEMIN THROMB HEMOST, V34, P119, DOI 10.1055/s-0028-1086092; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Hogwood J, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10030059; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; MAIMONE MM, 1991, J BIOL CHEM, V266, P14830; Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X; McMahon AW, 2010, PHARMACOEPIDEM DR S, V19, P921, DOI 10.1002/pds.1991; Mulloy B, 2014, ANAL BIOANAL CHEM, V406, P4815, DOI 10.1007/s00216-014-7940-3; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; PRATT CW, 1989, ANN NY ACAD SCI, V556, P104; PRATT CW, 1992, J BIOL CHEM, V267, P8789; Qian Y, 2010, CLIN APPL THROMB-HEM, V16, P261, DOI 10.1177/1076029610362073; SCULLY MF, 1988, BIOCHEM J, V254, P547, DOI 10.1042/bj2540547; Sommers CD, 2012, J PHARMACEUT BIOMED, V67-68, P28, DOI 10.1016/j.jpba.2012.04.017; TOLLEFSEN DM, 1981, J CLIN INVEST, V68, P589, DOI 10.1172/JCI110292; Tollefsen DM, 2002, ARCH PATHOL LAB MED, V126, P1394; VANDERGRAAF F, 1982, BLOOD, V59, P1225; Xu XY, 2002, INT J BIOL MACROMOL, V30, P151, DOI 10.1016/S0141-8130(02)00015-6; Zhang FM, 2011, ANAL BIOANAL CHEM, V401, P2793, DOI 10.1007/s00216-011-5367-7	31	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193482	10.1371/journal.pone.0193482	http://dx.doi.org/10.1371/journal.pone.0193482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494632	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200053
J	Rahmer, J; Stehning, C; Gleich, B				Rahmer, Juergen; Stehning, Christian; Gleich, Bernhard			Remote magnetic actuation using a clinical scale system	PLOS ONE			English	Article							MICROROBOTS; NAVIGATION	Remote magnetic manipulation is a powerful technique for controlling devices inside the human body. It enables actuation and locomotion of tethered and untethered objects without the need for a local power supply. In clinical applications, it is used for active steering of catheters in medical interventions such as cardiac ablation for arrhythmia treatment and for steering of camera pills in the gastro-intestinal tract for diagnostic video acquisition. For these applications, specialized clinical-scale field applicators have been developed, which are rather limited in terms of field strength and flexibility of field application. For a general-purpose field applicator, flexible field generation is required at high field strengths as well as high field gradients to enable the generation of both torques and forces on magnetic devices. To date, this requirement has only been met by small-scale experimental systems. We have built a highly versatile clinical-scale field applicator that enables the generation of strong magnetic fields as well as strong field gradients over a large workspace. We demonstrate the capabilities of this coil-based system by remote steering of magnetic drills through gel and tissue samples with high torques on well-defined curved trajectories. We also give initial proof that, when equipped with high frequency transmit-receive coils, the machine is capable of real-time magnetic particle imaging while retaining a clinical-scale bore size. Our findings open the door for image-guided radiation-free remote magnetic control of devices at the clinical scale, which may be useful in minimally invasive diagnostic and therapeutic medical interventions.	[Rahmer, Juergen; Gleich, Bernhard] Philips GmbH Innovat Technol, Res Labs, Hamburg, Germany; [Stehning, Christian] Philips GmbH Market DACH, Hamburg, Germany	Philips; Philips Research	Rahmer, J (corresponding author), Philips GmbH Innovat Technol, Res Labs, Hamburg, Germany.	juergen.rahmer@philips.com		Rahmer, Jurgen/0000-0001-8514-4801	Bundesministerium fur Bildung and Forschung (German Federal Ministry of Education and Research) [13GW0069C, 13N11086]	Bundesministerium fur Bildung and Forschung (German Federal Ministry of Education and Research)	This work was supported by Bundesministerium fur Bildung and Forschung (German Federal Ministry of Education and Research), Grant numbers 13GW0069C and 13N11086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Philips GmbH Market DACH: The funder provided support in the form of salaries for author CS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Philips GmbH Innovative Technologies: The funder provided support for authors JR and BG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abbott JJ, 2007, IEEE T ROBOT, V23, P1247, DOI 10.1109/TRO.2007.910775; Abbott JJ, 2009, INT J ROBOT RES, V28, P1434, DOI 10.1177/0278364909341658; Ali A, 2016, IEEE T BIO-MED ENG, V63, P679, DOI 10.1109/TBME.2016.2525785; Armacost MP, 2007, J CARDIOVASC ELECTR, V18, pS26, DOI 10.1111/j.1540-8167.2007.00708.x; Bontus C, 2015, IEEE T MAGN, V51, DOI 10.1109/TMAG.2014.2326003; Borgert J, 2013, BIOMED ENG-BIOMED TE, V58, P551, DOI 10.1515/bmt-2012-0064; Carpi F, 2011, IEEE T BIO-MED ENG, V58, P231, DOI 10.1109/TBME.2010.2087332; Chautems Christophe, 2017, 2017 IEEE International Conference on Robotics and Automation (ICRA), P4837, DOI 10.1109/ICRA.2017.7989562; Diller E., 2013, FNT ROBOTICS, V2, P143, DOI [10.1561/2300000023, DOI 10.1561/2300000023]; Diller E, 2014, 6 DEGREES OF FREEDOM; Felfoul O, 2016, SCI REP-UK, V6, DOI 10.1038/srep33567; Ferguson RM, 2015, IEEE T MED IMAGING, V34, P1077, DOI 10.1109/TMI.2014.2375065; Gang ES, 2011, CIRC ARRHYTHM ELECTR; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Gleich B., 2010, P INT SOC MAGN RESON, V18, P218; Ishiyama K, 2001, SENSOR ACTUAT A-PHYS, V91, P141, DOI 10.1016/S0924-4247(01)00517-9; Jeong S, 2016, MED ENG PHYS, V38, P403, DOI 10.1016/j.medengphy.2016.01.001; Keller H, 2012, P IEEE RAS-EMBS INT, P859, DOI 10.1109/BioRob.2012.6290795; Kummer MP, 2010, IEEE T ROBOT, V26, P1006, DOI 10.1109/TRO.2010.2073030; Lalande V, 2010, IEEE ENG MED BIO, P1874, DOI 10.1109/IEMBS.2010.5627150; Latulippe M, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4941925; Latulippe M, 2015, IEEE T ROBOT, V31, P1353, DOI 10.1109/TRO.2015.2489518; Lawaczeck R, 1997, ACTA RADIOL, V38, P584, DOI 10.1080/02841859709174391; Li JX, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aam6431; Martel S, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aam8119; Martel S, 2013, J MICRO-BIO ROBOT, V8, P41, DOI 10.1007/s12213-012-0054-0; Nelson BJ, 2010, ANNU REV BIOMED ENG, V12, P55, DOI 10.1146/annurev-bioeng-010510-103409; Nothnagel N, 2016, IEEE T BIO-MED ENG, V63, P2286, DOI 10.1109/TBME.2016.2524070; Peyer KE, 2013, CHEM-EUR J, V19, P28, DOI 10.1002/chem.201203364; Rahmer J, 2017, IEEE T MED IMAGING, V36, P1449, DOI 10.1109/TMI.2017.2679099; Rahmer J, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aal2845; Rahmer J, 2012, IEEE T MED IMAGING, V31, P1289, DOI 10.1109/TMI.2012.2188639; Rahmer Jurgen, 2009, BMC Med Imaging, V9, P4, DOI 10.1186/1471-2342-9-4; Rey JF, 2012, GASTROINTEST ENDOSC, V75, P373, DOI 10.1016/j.gie.2011.09.030; Saritas EU, 2012, SPRINGER PROC PHYS, V140, P325; Schmale I., 2013, 2013 International Workshop on Magnetic Particle Imaging (IWMPI), DOI 10.1109/IWMPI.2013.6528346; Schmale I, 2015, IEEE T MAGN, V51, DOI 10.1109/TMAG.2014.2322940; Servant A, 2015, ADV MATER, V27, P2981, DOI 10.1002/adma.201404444; Shamsudhin N, 2017, MED PHYS, V44, pE91, DOI [10.1002/mp.12299, 10.1002/mp.12446]; Tottori S, 2012, ADV MATER, V24, P811, DOI 10.1002/adma.201103818; Tremblay C, 2015, IFMBE PROC, V45, P379, DOI 10.1007/978-3-319-11128-5_95; Weizenecker J, 2007, PHYS MED BIOL, V52, P6363, DOI 10.1088/0031-9155/52/21/001; Weizenecker J, 2009, PHYS MED BIOL, V54, pL1, DOI 10.1088/0031-9155/54/5/L01; Xi W, 2013, NANOSCALE, V5, P1294, DOI 10.1039/c2nr32798h; Xu TT, 2015, MICROMACHINES-BASEL, V6, P1346, DOI 10.3390/mi6091346; Yesin KB, 2006, INT J ROBOT RES, V25, P527, DOI 10.1177/0278364906065389; Yu C, 2010, SENSOR ACTUAT A-PHYS, V161, P297, DOI 10.1016/j.sna.2010.04.037	47	48	48	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193546	10.1371/journal.pone.0193546	http://dx.doi.org/10.1371/journal.pone.0193546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494647	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200064
J	de Jong, MRW; Visser, L; Huls, G; Diepstra, A; van Vugt, M; Ammatuna, E; van Rijn, RS; Vellenga, E; van den Berg, A; Fehrmann, RSN; van Meerten, T				de Jong, Mathilde R. W.; Visser, Lydia; Huls, Gerwin; Diepstra, Arjan; van Vugt, Marcel; Ammatuna, Emanuele; van Rijn, Rozemarijn S.; Vellenga, Edo; van den Berg, Anke; Fehrmann, Rudolf S. N.; van Meerten, Tom			Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach	PLOS ONE			English	Article							IMPAIR ANTITUMOR-ACTIVITY; MONOCLONAL-ANTIBODY; WEE1 KINASE; RITUXIMAB; RECEPTOR; CHOP; INHIBITORS; EXPRESSION; IBRUTINIB; PATHWAY	Forty percent of patients with diffuse large B-cell lymphoma (DLBCL) show resistant disease to standard chemotherapy (CHOP) in combination with the anti-CD20 monoclonal antibody rituximab (R). Although many new anti-cancer drugs were developed in the last years, it is unclear which of these drugs can be safely combined to improve standard therapy without antagonizing anti-CD20 efficacy. In this study, we aimed to identify rituximab compatible drug-target combinations for DLBCL. For this, we collected gene expression profiles of 1,804 DLBCL patient samples. Subsequently, we performed a guilt-by-association analysis with MS4A1 (CD20) and prioritized the 500 top-ranked CD20-associated gene probes for drug-target interactions. This analysis showed the well-known genes involved in DLBCL pathobiology, but also revealed several genes that are relatively unknown in DLBCL, such as WEE1 and PARP1. To demonstrate potential clinical relevance of these targets, we confirmed high protein expression of WEE1 and PARP1 in patient samples. Using clinically approved WEE1 and PARP1 inhibiting drugs in combination with rituximab, we demonstrated significantly improved DLBCL cell killing, also in rituximab-insensitive cell lines. In conclusion, as exemplified by WEE1 and PARP1, our CD20-based genome-wide analysis can be used as an approach to identify biological relevant drug-targets that are rituximab compatible and may be implemented in phase 1/2 clinical trials to improve DLBCL treatment.	[de Jong, Mathilde R. W.; Huls, Gerwin; Ammatuna, Emanuele; Vellenga, Edo; van Meerten, Tom] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands; [Visser, Lydia; Diepstra, Arjan; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [van Vugt, Marcel; Fehrmann, Rudolf S. N.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [van Rijn, Rozemarijn S.] Med Ctr Leeuwarden, Dept Hematooncol, Leeuwarden, Netherlands	University of Groningen; University of Groningen; University of Groningen; Medical Center Leeuwarden	van Meerten, T (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands.	t.van.meerten@umcg.nl	van den Berg, Anke/H-1718-2011; Fehrmann, Rudolf/E-2551-2011	van den Berg, Anke/0000-0002-8894-2638; Fehrmann, Rudolf/0000-0002-7516-315X; Diepstra, Arjan/0000-0001-9239-1050	Bas Mulder grant from KWF Kankerbestrijding [RUG 2013-5960]; Netherlands Organization for Scientific Research (NWO-VENI grant) [916-16025]; Mandema Stipendium; Bas Mulder grant of KWF Kankerbestrijding [RUG 2014-6727]	Bas Mulder grant from KWF Kankerbestrijding; Netherlands Organization for Scientific Research (NWO-VENI grant)(Netherlands Organization for Scientific Research (NWO)); Mandema Stipendium; Bas Mulder grant of KWF Kankerbestrijding	This research was supported by a Bas Mulder grant from KWF Kankerbestrijding (RUG 2013-5960), and a grant from the Netherlands Organization for Scientific Research (NWO-VENI grant 916-16025) and a Mandema Stipendium (awarded to R.S.N. Fehrmann), and by a Bas Mulder grant of KWF Kankerbestrijding (RUG 2014-6727) and a Mandema Stipendium (awarded to T. van Meerten). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bojarczuk K, 2014, LEUKEMIA, V28, P1163, DOI 10.1038/leu.2014.12; Chanan-Khan A, 2016, LANCET ONCOL, V17, P200, DOI 10.1016/S1470-2045(15)00465-9; Chen JQ, 2013, J PROTEOME RES, V12, P2354, DOI 10.1021/pr400162t; Chila R, 2015, ONCOTARGET, V6, P3394, DOI 10.18632/oncotarget.2583; Cozen W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4856; Da Roit F, 2015, HAEMATOLOGICA, V100, P77, DOI 10.3324/haematol.2014.107011; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; de Miranda NFCC, 2013, J EXP MED, V210, P1729, DOI 10.1084/jem.20122842; Derenzini N, 2015, ONCOTARGET, V6, P6553, DOI 10.18632/oncotarget.2720; Do K, 2015, J CLIN ONCOL, V33, P3409, DOI 10.1200/JCO.2014.60.4009; Engelberts PJ, 2016, J IMMUNOL, V197, P4829, DOI 10.4049/jimmunol.1600811; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Flinn IW, 2016, EUR J CANCER, V54, P11, DOI 10.1016/j.ejca.2015.10.005; Franke A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016596; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Garcia TB, 2017, MOL CANC THER; Gaynor ER, 2001, J CLIN ONCOL, V19, P750, DOI 10.1200/JCO.2001.19.3.750; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Jazirehi AR, 2005, CANCER RES, V65, P264; Johnson NA, 2009, BLOOD, V113, P3773, DOI 10.1182/blood-2008-09-177469; Kheirallah S, 2010, BLOOD, V115, P985, DOI 10.1182/blood-2009-08-237537; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Maddocks K, 2015, BLOOD, V125, P242, DOI 10.1182/blood-2014-08-597914; Maifrede S, 2017, MOL CANCER RES, V15, P967, DOI 10.1158/1541-7786.MCR-16-0468; Matheson CJ, 2016, TRENDS PHARMACOL SCI, V37, P872, DOI 10.1016/j.tips.2016.06.006; Myklebust JH, 2016, BLOOD; Niemann CU, 2013, SEMIN CANCER BIOL, V23, P410, DOI 10.1016/j.semcancer.2013.09.001; OBrien S, 2014, BLOOD, V124, P1994; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pavlasova G, 2016, BLOOD, V128, P1609, DOI 10.1182/blood-2016-04-709519; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; REFF ME, 1994, BLOOD, V83, P435; Restelli V, 2016, BRIT J HAEMATOL, V28, P3360; Satpathy S., 2015, MOL SYST BIOL, V11, P810, DOI [10.15252/msb.20145880, DOI 10.15252/MSB.20145880]; Schmitt A, 2017, CANCER RES, V77, P3040, DOI 10.1158/0008-5472.CAN-16-3398; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; Tang J, 2017, P NATL ACAD SCI USA, V114, pE7441, DOI 10.1073/pnas.1705013114; Tangutoori S, 2017, CANCER RES, V77, pB48; Van den Neste E, 2016, BONE MARROW TRANSPL, V51, P51, DOI 10.1038/bmt.2015.213; van Meerten T, 2006, CLIN CANCER RES, V12, P4027, DOI 10.1158/1078-0432.CCR-06-0066; VANIMHOFF GW, 2016, J CLIN ONCOL; Voropaeva EN, 2017, MOL BIOL+, V51, P53, DOI 10.1134/S0026893316060224; Wagner AH, 2016, NUCLEIC ACIDS RES, V44, pD1036, DOI 10.1093/nar/gkv1165; Wang C, 2017, TRANSL ONCOL, V10, P190, DOI 10.1016/j.tranon.2017.01.007; Wang X, 2017, HAEMATOLOGICA; Williamson CT, 2012, EMBO MOL MED, V4, P515, DOI 10.1002/emmm.201200229; Winiarska M, 2014, MABS-AUSTIN, V6, P1300, DOI 10.4161/mabs.32106; Xu-Monette ZY, 2012, BLOOD, V120, P3986, DOI 10.1182/blood-2012-05-433334; Young RM, 2013, NAT REV DRUG DISCOV, V12, P229, DOI 10.1038/nrd3937	53	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193098	10.1371/journal.pone.0193098	http://dx.doi.org/10.1371/journal.pone.0193098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489886	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000054
J	Everink, IHJ; van Haastregt, JCM; Evers, SMAA; Kempen, GIJM; Schols, JMGA				Everink, Irma H. J.; van Haastregt, Jolanda C. M.; Evers, Silvia M. A. A.; Kempen, Gertrudis I. J. M.; Schols, Jos M. G. A.			An economic evaluation of an integrated care pathway in geriatric rehabilitation for older patients with complex health problems	PLOS ONE			English	Article							TRANSITIONS INTERVENTION; HOSPITAL DISCHARGE; COST-EFFECTIVENESS; LIFE	Background Integrated care pathways which cover multiple care settings are increasingly used as a tool to structure care, enhance coordination and improve transitions between care settings. However, little is known about their economic impact. The objective of this study is to determine the cost-effectiveness and cost-utility of an integrated care pathway designed for patients with complex health problems transferring from the hospital, a geriatric rehabilitation facility and primary care. Methods This economic evaluation was performed from a societal perspective alongside a prospective cohort study with two cohorts of patients. The care as usual cohort was included before implementation of the pathway and the care pathway cohort after implementation of the pathway. Both cohorts were measured over nine months, during which intervention costs, healthcare costs, patient and family costs were identified. The outcome measures were dependence in activities of daily living (measured with the KATZ-15) and quality adjusted life years (EQ-5D-3L). Costs and effects were bootstrapped and various sensitivity analyses were performed to assess robustness of the results. Results After nine months, the average societal costs were significantly lower for patients in the care pathway cohort ( 50,791) versus patients in the care as usual cohort ( 62,170; CI = -22,090, -988). Patients in the care pathway cohort had better scores on the KATZ-15 (1.04), indicating cost-effectiveness. No significant differences were found between the two groups on QALY scores (0.01). Conclusions The results of this study indicate that the integrated care pathway is a cost-effective intervention. Therefore, dissemination of the integrated care pathway on a wider scale could be considered. This would provide us the opportunity to confirm the findings of our study in larger economic evaluations. When looking at QALYs, no effects were found. Therefore, it is also recommended to explore if therapy in geriatric rehabilitation could also pay attention to other quality of life-related domains, such as mood and social participation.	[Everink, Irma H. J.; van Haastregt, Jolanda C. M.; Evers, Silvia M. A. A.; Kempen, Gertrudis I. J. M.; Schols, Jos M. G. A.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Hlth Serv Res, Maastricht, Netherlands; [Everink, Irma H. J.; van Haastregt, Jolanda C. M.; Evers, Silvia M. A. A.; Kempen, Gertrudis I. J. M.; Schols, Jos M. G. A.] Maastricht Univ, Fac Hlth Med & Life Sci, CAPHRI, Maastricht, Netherlands; [Evers, Silvia M. A. A.] Ctr Econ Evaluat, Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands; [Schols, Jos M. G. A.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Family Med, Maastricht, Netherlands	Maastricht University; Maastricht University; Trimbos Institute; Maastricht University	Everink, IHJ (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Dept Hlth Serv Res, Maastricht, Netherlands.; Everink, IHJ (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, CAPHRI, Maastricht, Netherlands.	i.everink@maastrichtuniversity.nl	Kempen, Gertrudis I/H-5978-2016; Evers, Silvia/ABG-2128-2020; Evers, Silvia MAA/K-9720-2015; Kempen, Gertrudis/Y-8796-2019	Kempen, Gertrudis I/0000-0002-7053-2198; Evers, Silvia/0000-0003-1026-570X; Evers, Silvia MAA/0000-0003-1026-570X; Kempen, Gertrudis/0000-0002-7053-2198	Dutch National Care for the Elderly Program; Dutch Organization for Health Research and Development (ZonMw) [314070401]	Dutch National Care for the Elderly Program; Dutch Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was funded by The Dutch National Care for the Elderly Program and sponsored by The Dutch Organization for Health Research and Development (ZonMw #314070401) to J.M.G.A.S. The funding source had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2009, INT J EVID-BASED HEA, V7, P61, DOI 10.1111/j.1744-1609.2009.00127.x; [Anonymous], 2015, KOST METH KOST REF E; [Anonymous], 2012, INT J INTEGR CARE; BACHMANN S, 2010, BRIT MED J, V340, pC1718, DOI DOI 10.1136/BMJ.C1718; Boltz M., 2012, EVIDENCE BASED GERIA; Broughton EI, 2011, INT J CARE COORD, V15, P76, DOI 10.1258/jicp.2011.011004; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Courtney M, 2009, J AM GERIATR SOC, V57, P395, DOI 10.1111/j.1532-5415.2009.02138.x; Dautremont JF, 2013, J OTOLARYNGOL-HEAD N, V42, DOI 10.1186/1916-0216-42-59; De Bleser Leentje, 2006, J Nurs Manag, V14, P553, DOI 10.1111/j.1365-2934.2006.00702.x; Deneckere S, 2012, SOC SCI MED, V75, P264, DOI 10.1016/j.socscimed.2012.02.060; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Everink IHJ, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-016-1974-5; Everink Irma Helga Johanna, 2015, Tijdschr Gerontol Geriatr, V46, P104, DOI 10.1007/s12439-015-0125-5; Fields Jane, 2013, Health Manag Technol, V34, P10; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Hendriks MRC, 2013, MED DECIS MAKING, V33, P998, DOI 10.1177/0272989X13482045; Holtzer-Goor KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138225; Husereau D, 2013, INT J TECHNOL ASSESS, V29, P117, DOI 10.1017/S0266462313000160; Institute of Medicine of the National Academies, 2007, PREVENTING MEDICATIO; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Kane RL, 1997, MED CARE, V35, pJS4; Kim S, 2003, J ARTHROPLASTY, V18, P69, DOI 10.1054/arth.2003.50030; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Krummenauer F, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-338; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Lin YK, 2011, J MED SYST, V35, P203, DOI 10.1007/s10916-009-9357-7; Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673; McCloskey R, 2004, J ADV NURS, V46, P186, DOI 10.1111/j.1365-2648.2003.02978.x; Mesteig M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-1; Nolte E, 2014, WHAT IS EVIDENCE EC; Olsson LE, 2009, J ADV NURS, V65, P1626, DOI 10.1111/j.1365-2648.2009.05017.x; Patrick L, 2001, J AM GERIATR SOC, V49, P1471, DOI 10.1046/j.1532-5415.2001.4911239.x; Richardson G, 2004, HEALTH ECON, V13, P1203, DOI 10.1002/hec.901; Rosstad T, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-121; Stange KC, 2009, ANN FAM MED, V7, P100, DOI 10.1370/afm.971; van Asselt ADI, 2009, PHARMACOECONOMICS, V27, P519, DOI 10.2165/00019053-200927060-00007; Van Herck P, 2004, J INTEGRATED CARE PA, V8, P95, DOI DOI 10.1177/147322970400800302; Van Houdt S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-296; Voss R, 2011, ARCH INTERN MED, V171, P1232, DOI 10.1001/archinternmed.2011.278; Wells JL, 2003, ARCH PHYS MED REHAB, V84, P898, DOI 10.1016/S0003-9993(02)04930-4; Zwaap J, 2015, KOSTENEFFECTIVITEIT	43	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191851	10.1371/journal.pone.0191851	http://dx.doi.org/10.1371/journal.pone.0191851			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489820	Green Submitted, gold, Green Published			2022-12-27	WOS:000426276000010
J	Kauschke, V; Gebert, A; Calin, M; Eckert, J; Scheich, S; Heiss, C; Lips, KS				Kauschke, Vivien; Gebert, Annett; Calin, Mariana; Eckert, Juergen; Scheich, Sebastian; Heiss, Christian; Lips, Katrin Susanne			Effects of new beta-type Ti-40Nb implant materials, brain-derived neurotrophic factor, acetylcholine and nicotine on human mesenchymal stem cells of osteoporotic and non osteoporotic donors	PLOS ONE			English	Article							MARROW STROMAL CELLS; BIOMEDICAL APPLICATIONS; TITANIUM-ALLOY; IN-VITRO; BONE; EXPRESSION; DIFFERENTIATION; OSTEOBLAST; RECEPTORS; PROLIFERATION	Introduction Treatment of osteoporotic fractures is still challenging and an urgent need exists for new materials, better adapted to osteoporotic bone by adjusted Young's modulus, appropriate surface modification and pharmaceuticals. Materials and methods Titanium-40-niobium alloys, mechanically ground or additionally etched and titanium-6-aluminium-4-vanadium were analyzed in combination with brain-derived neurotrophic factor, acetylcholine and nicotine to determine their effects on human mesenchymal stem cells in vitro over 21 days using lactate dehydrogenase and alkaline phosphatase assays, live cell imaging and immunofluorescence microscopy. Results Cell number of human mesenchymal stem cells of osteoporotic donors was increased after 14 d in presence of ground titanium-40-niobium or titanium-6-aluminium-4-vanadium, together with brain-derived neurotrophic factor. Cell number of human mesenchymal stem cells of non osteoporotic donors increased after 21 d in presence of titanium-6-aluminium-4-vanadium without pharmaceuticals. No significant increase was measured for ground or etched titanium-40-niobium after 21 d. Osteoblast differentiation of osteoporotic donors was significantly higher than in non osteoporotic donors after 21 d in presence of etched, ground titanium-40-niobium or titanium-6-aluminium-4-vanadium accompanied by all pharmaceuticals tested. In presence of all alloys tested brain-derived neurotrophic factor, acetylcholine and nicotine increased differentiation of cells of osteoporotic donors and accelerated it in that no competing interests exist. non osteoporotic donors. Conclusion We conclude that ground titanium-40-niobium and brain-derived neurotrophic factor might be most suitable for subsequent in vivo testing.	[Kauschke, Vivien; Scheich, Sebastian; Heiss, Christian; Lips, Katrin Susanne] Justus Liebig Univ Giessen, Expt Trauma Surg, Giessen, Germany; [Gebert, Annett; Calin, Mariana] Leibniz Inst Solid State & Mat Res Dresden, Dresden, Germany; [Eckert, Juergen] Austrian Acad Sci, Erich Schmid Inst Mat Sci, Leoben, Austria; [Eckert, Juergen] Univ Leoben, Dept Mat Phys, Leoben, Austria; [Heiss, Christian] Univ Hosp Giessen Marburg, Dept Trauma Hand & Reconstruct Surg, Campus Giessen, Giessen, Germany	Justus Liebig University Giessen; Leibniz Institute for Solid State & Materials Research Dresden; Austrian Academy of Sciences; University of Leoben; University Hospital of Giessen & Marburg	Kauschke, V (corresponding author), Justus Liebig Univ Giessen, Expt Trauma Surg, Giessen, Germany.	Vivien.Kauschke@chiru.med.uni-giessen.de	Calin, Mariana/J-6398-2015; Eckert, Jurgen/U-8328-2019	Eckert, Jurgen/0000-0003-4112-3181; Kauschke, Vivien/0000-0002-4342-6875; Calin, Mariana/0000-0002-4852-2583	Deutsche Forschungsgemeinschaft, Sonderforschungsbereich Transregio 79	Deutsche Forschungsgemeinschaft, Sonderforschungsbereich Transregio 79	This work was supported by Deutsche Forschungsgemeinschaft, Sonderforschungsbereich Transregio 79 (projects B7 and M1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiga A, 2006, ACTA MED OKAYAMA, V60, P267; Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002; Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7; Asri RIM, 2017, MAT SCI ENG C-MATER, V77, P1261, DOI 10.1016/j.msec.2017.04.102; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Cai XX, 2010, INT J ORAL SCI, V2, P74, DOI 10.4248/IJOS10039; Chung R, 2014, J ENDOCRINOL, V221, P63, DOI 10.1530/JOE-13-0539; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Cordeiro JM, 2017, MAT SCI ENG C-MATER, V71, P1201, DOI 10.1016/j.msec.2016.10.025; Costa-Rodrigues J, 2018, J CELL PHYSIOL, V233, P1029, DOI 10.1002/jcp.25956; de Andrade DP, 2015, MAT SCI ENG C-MATER, V56, P538, DOI 10.1016/j.msec.2015.07.026; En-Nosse M, 2009, CELL TISSUE RES, V338, P203, DOI 10.1007/s00441-009-0871-1; Engelhart S, 2017, CUTIS, V99, P245; Garg P, 2017, ORTHOP SURG, V9, P13, DOI 10.1111/os.12304; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Guo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30558; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Helth A, 2017, J MECH BEHAV BIOMED, V65, P137, DOI 10.1016/j.jmbbm.2016.08.017; Helth A, 2014, J BIOMED MATER RES B, V102, P31, DOI 10.1002/jbm.b.32976; Ida-Yonemochi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169201; Kilian O, 2014, ANN ANAT, V196, P286, DOI 10.1016/j.aanat.2014.06.001; Kim BS, 2012, LIFE SCI, V90, P109, DOI 10.1016/j.lfs.2011.10.019; Liu PS, 2011, EUR J PHARMACOL, V650, P34, DOI 10.1016/j.ejphar.2010.09.031; Nauth A, 2011, J ORTHOP TRAUMA, V25, pS51, DOI 10.1097/BOT.0b013e31821b8c52; Nicoara M, 2016, ACTA BIOMATER, V36, P323, DOI 10.1016/j.actbio.2016.03.020; Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970; Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037; Nune KC, 2017, DENT MATER, V33, P152, DOI 10.1016/j.dental.2016.11.005; Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Pauksch L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114740; PECK WA, 1993, AM J MED, V94, P646; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Rothem DE, 2009, J BONE MINER METAB, V27, P555, DOI 10.1007/s00774-009-0075-5; Sato T, 2010, FEBS LETT, V584, P817, DOI 10.1016/j.febslet.2010.01.001; Shen Y, 2013, J CELL BIOCHEM, V114, P1720, DOI 10.1002/jcb.24512; Shotorbani BB, 2017, MAT SCI ENG C-MATER, V71, P1192, DOI 10.1016/j.msec.2016.10.013; Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013; Su YW, 2018, J CELL PHYSIOL, V233, P2133, DOI 10.1002/jcp.25936; Tang JM, 2012, J CELL BIOCHEM, V113, P2704, DOI 10.1002/jcb.24148; Tsai TL, 2017, STEM CELL REP, V8, P387, DOI 10.1016/j.stemcr.2017.01.004; Valenti MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020363; Wang C, 2016, APPL BIONICS BIOMECH, V2016, P1, DOI DOI 10.3389/FPLS.2016.01082; Wang CD, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.238; Wenisch S, 2005, BONE, V36, P74, DOI 10.1016/j.bone.2004.09.019; Yamashiro T, 2001, BONE, V28, P404, DOI 10.1016/S8756-3282(01)00405-7; Zhang ZT, 2017, MOL MED REP, V15, P1362, DOI 10.3892/mmr.2017.6110	48	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193468	10.1371/journal.pone.0193468	http://dx.doi.org/10.1371/journal.pone.0193468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489907	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000079
J	Li, JJ; Qu, XC; Tian, J; Zhang, JT; Cheng, JX				Li, Junjie; Qu, Xiaochao; Tian, Jie; Zhang, Jian-Ting; Cheng, Ji-Xin			Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation	PLOS ONE			English	Article							BREAST-CANCER CELLS; DRUG-RESISTANCE; OVEREXPRESSION; METABOLISM; GROWTH	Recent advances have recognized metabolic reprogramming as an underlying mechanism for cancer drug resistance. However, the role of cholesterol metabolism in drug resistance remain elusive. Herein, we report an increased accumulation of cholesteryl ester in gemcitabine-resistant pancreatic ductal adenocarcinoma (PDAC) cells. A potent inhibitor of acylCoA cholesterol acyltransferase-1 (ACAT-1), avasimibe, effectively suppressed proliferation of gemcitabine-resistant PDAC cells. Combination of avasimibe and gemcitabine showed strong synergistic effect in suppressing PDAC cell viability in vitro and tumor growth in vivo. Immunoblotting analysis suggests downregulation of Akt by avasimibe is likely to contribute to the synergism. Collectively, our study demonstrates a new combinational therapeutic strategy to overcome gemcitabine resistance for PDAC treatment.	[Li, Junjie; Cheng, Ji-Xin] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Qu, Xiaochao; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Zhang, Jian-Ting] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Cheng, Ji-Xin] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Cheng, Ji-Xin] Boston Univ, Dept Biomed Engn, Dept Elect & Comp Engn, Boston, MA 02215 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Xidian University; Chinese Academy of Sciences; Institute of Automation, CAS; Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Boston University	Cheng, JX (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Cheng, JX (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.; Cheng, JX (corresponding author), Boston Univ, Dept Biomed Engn, Dept Elect & Comp Engn, Boston, MA 02215 USA.	jxcheng@bu.edu	Tian, Jie/H-1190-2011; Li, Junjie/B-1424-2017	Tian, Jie/0000-0003-0498-0432; Li, Junjie/0000-0003-4542-300X; Zhang, Jian-Ting/0000-0002-2803-9914; Cheng, Ji-Xin/0000-0002-5607-6683	DoD Award [W81XWH-14-1-0557]; National Natural Science Foundation of China [81227901, 81530058]	DoD Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by DoD Award W81XWH-14-1-0557 to J-XC and the National Natural Science Foundation of China (grant numbers 81227901 and 81530058) to XQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Bandyopadhyay S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179558; Bemlih S, 2010, CANCER BIOL THER, V9, P1025, DOI 10.4161/cbt.9.12.11875; Bivona TG, 2016, NAT MED, V22, P472, DOI 10.1038/nm.4091; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; Kim MP, 2008, CLIN CANCER RES, V14, P1284, DOI 10.1158/1078-0432.CCR-07-2247; Lee SSY, 2015, ACS NANO, V9, P2420, DOI 10.1021/nn504025a; Li J, 2016, ONCOGENE, V35, P6378, DOI 10.1038/onc.2016.168; Liscovitch M, 2000, TRENDS BIOCHEM SCI, V25, P530, DOI 10.1016/S0968-0004(00)01668-6; Liu HL, 2008, MOL CANCER THER, V7, P263, DOI 10.1158/1535-7163.MCT-07-0445; Liu HL, 2013, J LIPID RES, V54, P776, DOI 10.1194/jlr.M033811; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Lu CW, 2011, AM J PATHOL, V179, P1405, DOI 10.1016/j.ajpath.2011.05.050; Mulas MF, 2011, CELL PROLIFERAT, V44, P360, DOI 10.1111/j.1365-2184.2011.00758.x; Murphy D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-14; Ng SSW, 2001, CLIN CANCER RES, V7, P3269; Paillasse MR, 2009, J LIPID RES, V50, P2203, DOI 10.1194/jlr.M800668-JLR200; Poirot M, 2012, CURR OPIN PHARMACOL, V12, P683, DOI 10.1016/j.coph.2012.09.007; Rahman M, 2015, METABOLITES, V5, P571, DOI 10.3390/metabo5040571; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Silvente-Poirot S, 2014, SCIENCE, V343, P1445, DOI 10.1126/science.1252787; Tadros S, 2017, CANCER RES, V77, P5503, DOI 10.1158/0008-5472.CAN-16-3062; Wu Xi, 2014, Advances in Biological Regulation, V54, P214, DOI 10.1016/j.jbior.2013.09.004; Yang W, 2016, NATURE, V531, P651, DOI 10.1038/nature17412; Yang Youyun, 2011, Int J Biochem Mol Biol, V2, P89; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019; Zahreddine H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00028; Zhao L, 2017, J IMMUNOTHER, V15; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zhao YH, 2011, CANCER RES, V71, P4585, DOI 10.1158/0008-5472.CAN-11-0127	32	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193318	10.1371/journal.pone.0193318	http://dx.doi.org/10.1371/journal.pone.0193318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489864	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000065
J	Sunwoo, JS; Hwangbo, Y; Kim, WJ; Chu, MK; Yun, CH; Yang, KI				Sunwoo, Jun-Sang; Hwangbo, Young; Kim, Won-Joo; Chu, Min Kyung; Yun, Chang-Ho; Yang, Kwang Ik			Prevalence, sleep characteristics, and comorbidities in a population at high risk for obstructive sleep apnea: A nationwide questionnaire study in South Korea	PLOS ONE			English	Article							CHRONIC INTERMITTENT HYPOXIA; POSITIVE AIRWAY PRESSURE; BERLIN QUESTIONNAIRE; PHYSICAL-ACTIVITY; RESPIRATORY DISTURBANCE; RESISTANT HYPERTENSION; DAYTIME SLEEPINESS; CLINICAL-PRACTICE; IDENTIFY PATIENTS; VASCULAR-DISEASE	Objective To determine the prevalence, sleep characteristics, and comorbidities associated with a high risk for obstructive sleep apnea (OSA) in the Korean adult population. Methods We analyzed data from 2,740 subjects who responded to a nationwide questionnaire survey of sleep characteristics. Those who qualified under two or more symptom categories of the Berlin questionnaire were defined as "at high risk for OSA". We investigated their socio-demographic information, sleep habits, and medical and psychiatric comorbidities. Logistic regression analyses were performed to identify factors and consequences significantly associated with a high risk for OSA. Results The prevalence of a high risk for OSA was 15.8% (95% confidence interval [CI] 14.5-17.2%). Multiple logistic regression analysis showed that old age (>= 70 years, odds ratio [OR] 2.68) and body mass index >= 25 kg/m(2) (OR 10.75) were significantly related with a high risk for OSA, whereas regular physical activity (OR 0.70) had a protective effect. Subjective sleep characteristics associated with a high risk for OSA were perceived insufficient sleep (OR 1.49), excessive daytime sleepiness (OR 1.88), and insomnia (OR 3.70). In addition, hypertension (OR 5.83), diabetes mellitus (OR 2.54), hyperlipidemia (OR 2.85), and anxiety (OR 1.63) were comorbid conditions independently associated with a high risk for OSA. Conclusions This is the first study to demonstrate the prevalence of a high risk for OSA in a nationwide representative sample of the Korean adult population. These findings elucidate the epidemiology and clinical characteristics of those at high risk for OSA.	[Sunwoo, Jun-Sang] Soonchunhyang Univ, Dept Neurol, Coll Med, Seoul Hosp, Seoul, South Korea; [Hwangbo, Young] Soonchunhyang Univ, Coll Med, Dept Prevent Med, Cheonan, South Korea; [Kim, Won-Joo] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea; [Chu, Min Kyung] Hallym Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Yun, Chang-Ho] Seoul Natl Univ, Bundang Hosp, Bundang Clin Neurosci Ctr, Dept Neurol, Seongnam, South Korea; [Yang, Kwang Ik] Soonchunhyang Univ, Coll Med, Cheonan Hosp, Sleep Disorders Ctr,Dept Neurol, Cheonan, South Korea	Soonchunhyang University; Soonchunhyang University; Yonsei University; Yonsei University Health System; Hallym University; Seoul National University (SNU); Soonchunhyang University	Kim, WJ (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea.; Yang, KI (corresponding author), Soonchunhyang Univ, Coll Med, Cheonan Hosp, Sleep Disorders Ctr,Dept Neurol, Cheonan, South Korea.	kzoo@yuhs.ac; neurofan@schmc.ac.kr		Kim, Won-Joo/0000-0002-5850-010X; Hwangbo, Young/0000-0002-8447-8372; Chu, Min Kyung/0000-0001-6221-1346; Sunwoo, Jun-Sang/0000-0001-8834-0568	Korean Neurological Association [KNA-10-MI-03]; Soonchunhyang University Research Fund	Korean Neurological Association; Soonchunhyang University Research Fund	This study was supported by grants from Korean Neurological Association (grant # KNA-10-MI-03) and Soonchunhyang University Research Fund (grant # N/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi N, 2008, SLEEP BREATH, V12, P39, DOI 10.1007/s11325-007-0125-y; Altman NG, 2012, SLEEP MED, V13, P1261, DOI 10.1016/j.sleep.2012.08.005; Amra B, 2011, SLEEP BREATH, V15, P425, DOI 10.1007/s11325-010-0353-4; AncoliIsrael S, 1996, SLEEP, V19, P277, DOI 10.1093/sleep/19.4.277; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; Martinez-Garcia MA, 2015, EUR RESPIR J, V46, P142, DOI 10.1183/09031936.00064214; Awad KM, 2012, AM J MED, V125, P485, DOI 10.1016/j.amjmed.2011.11.025; Beneto A, 2009, SLEEP MED REV, V13, P287, DOI 10.1016/j.smrv.2008.09.006; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Bjornsdottir E, 2012, J SLEEP RES, V21, P131, DOI 10.1111/j.1365-2869.2011.00972.x; Botros N, 2009, AM J MED, V122, P1122, DOI 10.1016/j.amjmed.2009.04.026; Campos-Rodriguez F, 2016, AM J RESP CRIT CARE, V194, P1286, DOI 10.1164/rccm.201602-0265OC; Costa LE, 2015, HEART, V101, P1288, DOI 10.1136/heartjnl-2014-307276; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Garbarino S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166262; Garbarino S, 2016, SLEEP, V39, P1211, DOI 10.5665/sleep.5834; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Gus M, 2008, AM J HYPERTENS, V21, P832, DOI 10.1038/ajh.2008.184; Hiestand DM, 2006, CHEST, V130, P780, DOI 10.1378/chest.130.3.780; Hrubos-Strom H, 2011, J SLEEP RES, V20, P162, DOI 10.1111/j.1365-2869.2010.00861.x; Huai PC, 2013, HYPERTENSION, V62, P1021, DOI 10.1161/HYPERTENSIONAHA.113.01965; Hwangbo Y, 2016, J CLIN NEUROL, V12, P194, DOI 10.3988/jcn.2016.12.2.194; Hwangbo Y, 2013, SLEEP MED, V14, P549, DOI 10.1016/j.sleep.2013.02.009; Iftikhar IH, 2014, LUNG, V192, P175, DOI 10.1007/s00408-013-9511-3; Jordan AS, 2014, LANCET, V383, P736, DOI 10.1016/S0140-6736(13)60734-5; Kang K, 2014, J CLIN NEUROL, V10, P42, DOI 10.3988/jcn.2014.10.1.42; Kang K, 2013, SLEEP BREATH, V17, P803, DOI 10.1007/s11325-012-0767-2; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Kendzerska T, 2014, AM J RESP CRIT CARE, V190, P218, DOI 10.1164/rccm.201312-2209OC; Kim J, 2004, AM J RESP CRIT CARE, V170, P1108, DOI 10.1164/rccm.200404-519OC; Kimoff RJ, 1996, SLEEP, V19, pS61, DOI 10.1093/sleep/19.suppl_9.S61; Krakow B, 2001, CHEST, V120, P1923, DOI 10.1378/chest.120.6.1923; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Li JG, 2007, J APPL PHYSIOL, V102, P557, DOI 10.1152/japplphysiol.01081.2006; Liu Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-84; Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022; Luyster FS, 2010, J CLIN SLEEP MED, V6, P196; Magnavita N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111347; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marshall NS, 2008, SLEEP, V31, P1079; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; McArdle N, 2007, AM J RESP CRIT CARE, V175, P190, DOI 10.1164/rccm.200602-270OC; Mendelson M, 2014, RESP CARE, V59, P1218, DOI 10.4187/respcare.02948; Moreno CRC, 2004, CHRONOBIOL INT, V21, P871, DOI 10.1081/CBI-200036880; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; PAFFENBARGER RS, 1983, AM J EPIDEMIOL, V117, P245, DOI 10.1093/oxfordjournals.aje.a113537; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peppard PE, 2004, SLEEP, V27, P480, DOI 10.1093/sleep/27.3.480; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Pillar G, 1998, CHEST, V114, P697, DOI 10.1378/chest.114.3.697; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Quan SF, 2007, SLEEP BREATH, V11, P149, DOI 10.1007/s11325-006-0095-5; Rahaghi Franck, 1999, Sleep Breath, V3, P119, DOI 10.1007/s11325-999-0119-z; Redline S, 1998, SEM RESP CRIT CARE M, V19, P113; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Savransky V, 2007, AM J RESP CRIT CARE, V175, P1290, DOI 10.1164/rccm.200612-1771OC; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Sunwoo JS, 2017, SLEEP MED, V40, P4, DOI 10.1016/j.sleep.2017.08.020; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Young T, 2003, AM J RESP CRIT CARE, V167, P1181, DOI 10.1164/rccm.200209-1055OC; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Yue WH, 2003, CAN J PSYCHIAT, V48, P318, DOI 10.1177/070674370304800507	70	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193549	10.1371/journal.pone.0193549	http://dx.doi.org/10.1371/journal.pone.0193549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489913	Green Published, gold			2022-12-27	WOS:000426276000088
J	Kumar, S; Knox, RE; Singh, AK; DePauw, RM; Campbell, HL; Isidro-Sanchez, J; Clarke, FR; Pozniak, CJ; N'Daye, A; Meyer, B; Sharpe, A; Ruan, YF; Cuthbert, RD; Somers, D; Fedak, G				Kumar, Sachin; Knox, Ron E.; Singh, Asheesh K.; DePauw, Ron M.; Campbell, Heather L.; Isidro-Sanchez, Julio; Clarke, Fran R.; Pozniak, Curtis J.; N'Daye, Amidou; Meyer, Brad; Sharpe, Andrew; Ruan, Yuefeng; Cuthbert, Richard D.; Somers, Daryl; Fedak, George			High-density genetic mapping of a major QTL for resistance to multiple races of loose smut in a tetraploid wheat cross	PLOS ONE			English	Article							HEXAPLOID BREAD WHEAT; TRITICUM-AESTIVUM; USTILAGO-TRITICI; LINKAGE MAP; CONSENSUS MAP; DURUM; MARKERS; INHERITANCE; INTEGRATION; VIRULENCE	Loose smut, caused by Ustilago tritici (Pers.) Rostr., is a systemic disease of tetraploid durum wheat (Triticum turgidum L.). Loose smut can be economically controlled by growing resistant varieties, making it important to find and deploy new sources of resistance. Blackbird, a variety of T. turgidum L. subsp. carthicum (Nevski) A. Love & D. Love, carries a high level of resistance to loose smut. Blackbird was crossed with the loose smut susceptible durum cultivar Strongfield to produce a doubled haploid (DH) mapping population. The parents and progenies were inoculated with U. tritici races T26, T32 and T33 individually and as a mixture at Swift Current, Canada in 2011 and 2012 and loose smut incidence (LSI) was assessed. Genotyping of the DH population and parents using an Infinium iSelect 90K single nucleotide polymorphism (SNP) array identified 12,952 polymorphic SNPs. The SNPs and 426 SSRs (previously genotyped in the same population) were mapped to 16 linkage groups spanning 3008.4 cM at an average inter-marker space of 0.2 cM in a highdensity genetic map. Composite interval mapping analysis revealed three significant quantitative trait loci (QTL) for loose smut resistance on chromosomes 3A, 6B and 7A. The loose smut resistance QTL on 6B (QUt.spa-6B.2) and 7A (QUt.spa-7A.2) were derived from Blackbird. Strongfield contributed the minor QTL on 3A (QUI.spa-3A.2). The resistance on 6B was a stable major QTL effective against all individual races and the mixture of the three races; it explained up to 74% of the phenotypic variation. This study is the first attempt in durum wheat to identify and map loose smut resistance QTL using a high-density genetic map. The QTL QUt.spa-6B.2 would be an effective source for breeding resistance to multiple races of the loose smut pathogen because it provides near-complete broad resistance to the predominant virulence on the Canadian prairies.	[Kumar, Sachin] Chaudhary Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India; [Knox, Ron E.; Campbell, Heather L.; Clarke, Fran R.; Meyer, Brad; Ruan, Yuefeng; Cuthbert, Richard D.] Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada; [Singh, Asheesh K.] Iowa State Univ, 1501 Agron Hall, Ames, IA USA; [DePauw, Ron M.] Adv Wheat Technol, Swift Current, SK, Canada; [Isidro-Sanchez, Julio] Univ Coll Dublin, Sch Agr & Food Sci, Dublin, Ireland; [Pozniak, Curtis J.; N'Daye, Amidou] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Pozniak, Curtis J.; N'Daye, Amidou] Univ Saskatchewan, Crop Dev Ctr, Saskatoon, SK, Canada; [Sharpe, Andrew] Univ Saskatchewan, Global Inst Food Secur, Saskatoon, SK, Canada; [Somers, Daryl] Vineland Res & Innovat Ctr, Vineland Stn, ON, Canada; [Fedak, George] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada	Chaudhary Charan Singh University; Agriculture & Agri Food Canada; Iowa State University; University College Dublin; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Agriculture & Agri Food Canada	Kumar, S (corresponding author), Chaudhary Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India.; Knox, RE (corresponding author), Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada.	sachinkpsingh@gmail.com; ron.knox@agr.gc.ca	Sanchez, Julio Isidro/L-3174-2015; Kumar, Sachin/AAC-1148-2021	Sanchez, Julio Isidro/0000-0002-9044-3221; Kumar, Sachin/0000-0003-2282-1937; Cuthbert, Richard/0000-0002-1640-4929	Agriculture and Agri-Food Canada; Western Grains Research Foundation; Genome Canada; Agriculture and Agri-Food Canada (AAFC); Western Grains Research Foundation (WGRF); Genome Canada (Canadian Triticum Advancement through Genomics)	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Western Grains Research Foundation; Genome Canada(Genome Canada); Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada); Western Grains Research Foundation (WGRF); Genome Canada (Canadian Triticum Advancement through Genomics)	This work was supported by the Agriculture and Agri-Food Canada (to REK); Western Grains Research Foundation (to REK); Genome Canada (to REK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Malina Poppy, Alison Banman, Theresa Colenutt, Angela Doane and Alana Balliett for their technical help. This study was financially supported by Agriculture and Agri-Food Canada (AAFC), Western Grains Research Foundation (WGRF) and Genome Canada (Canadian Triticum Advancement through Genomics).	Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Avni R, 2014, MOL BREEDING, V34, P1549, DOI 10.1007/s11032-014-0176-2; Blanco A, 1998, THEOR APPL GENET, V97, P721, DOI 10.1007/s001220050948; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; CHURCHILL GA, 1994, GENETICS, V138, P963; Clarke JM, 2009, CAN J PLANT SCI, V89, P505, DOI 10.4141/CJPS08168; Clarke JM, 2005, CAN J PLANT SCI, V85, P901, DOI 10.4141/P04-189; Clarke JM, 2005, CAN J PLANT SCI, V85, P651, DOI 10.4141/P04-119; DEPAUW RM, 1992, CROP SCI, V32, P838, DOI 10.2135/cropsci1992.0011183X003200030069x; DHITAPHICHIT P, 1989, THEOR APPL GENET, V78, P897, DOI 10.1007/BF00266678; Esteras C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-80; Fowler DB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152185; Gadaleta A, 2009, THEOR APPL GENET, V118, P1015, DOI 10.1007/s00122-008-0958-1; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13; Iehisa JCM, 2014, DNA RES, V21, P555, DOI 10.1093/dnares/dsu020; Kassa MT, 2014, MOL BREEDING, V33, P569, DOI 10.1007/s11032-013-9973-2; Knox RE, 2014, CAN J PLANT PATHOL, V36, P187, DOI 10.1080/07060661.2014.905497; Knox RE, 2002, CAN J PLANT PATHOL, V24, P316; Knox RE, 1999, CAN J PLANT PATHOL, V21, P174, DOI 10.1080/07060669909501209; Knox R, 2012, CABI PLANT PROT SER, P160, DOI 10.1079/9781845938185.0160; Korzun V, 1999, THEOR APPL GENET, V98, P1202, DOI 10.1007/s001220051185; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KRIVCHENKO VI, 1984, GENETIKA+, V20, P1337; Lidon FC, 2014, EMIR J FOOD AGR, V26, P693, DOI 10.9755/ejfa.v26i8.17066; Lin Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0250-2; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Lotti C, 2000, PLANT BREEDING, V119, P393, DOI 10.1046/j.1439-0523.2000.00526.x; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Maccaferri M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-873; Mantovani P, 2008, MOL BREEDING, V22, P629, DOI 10.1007/s11032-008-9205-3; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; Martinez-Garcia PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078634; McIntosh R., 2013, CATALOGUE GENE SYMBO; Menzies JG, 2009, CAN J PLANT PATHOL, V31, P265, DOI 10.1080/07060660909507601; Menzies JG, 2003, CAN J PLANT PATHOL, V25, P62, DOI 10.1080/07060660309507050; Menzies JG, 2007, CAN PLANT DIS SURV, V87, P69; NIELSEN J, 1983, PLANT DIS, V67, P860, DOI 10.1094/PD-67-860; NIELSEN J, 1982, CAN J BOT, V60, P1191, DOI 10.1139/b82-148; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Peleg Z, 2008, THEOR APPL GENET, V117, P103, DOI 10.1007/s00122-008-0756-9; Procunier JD, 1997, GENOME, V40, P176, DOI 10.1139/g97-025; Randhawa HS, 2009, EUPHYTICA, V169, P151, DOI 10.1007/s10681-009-9903-x; Rawlings JO, 1988, APPL REGRESSION ANAL, P250; Russo MA, 2014, MOL BREEDING, V34, P1579, DOI 10.1007/s11032-014-0181-5; SAS, 1999, SAS STAT SOFTW CHANG; Sharma I, 2011, CEREAL RES COMMUN, V39, P376, DOI 10.1556/CRC.39.2011.3.7; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; SHINOHARA M, 1976, Review of Plant Protection Research, V9, P124; Singh AK, 2014, CAN J PLANT SCI, V94, P1289, DOI [10.4141/CJPS-2014-048, 10.4141/cjps-2014-048]; Somers DJ, 2006, GENOME, V49, P1586, DOI 10.1139/G06-127; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Syukov VV, 2015, RUSSIAN J GENET, V5, P55; Thomas PL, 1997, CAN J PLANT PATHOL, V19, P161, DOI 10.1080/07060669709500546; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; You FM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-354; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zanke C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00217; Zou ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053541	69	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192261	10.1371/journal.pone.0192261	http://dx.doi.org/10.1371/journal.pone.0192261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485999	Green Published, gold, Green Submitted			2022-12-27	WOS:000426242400007
J	Hernandez, CR; Fernandez, MN; Sanmartin, AP; Roibas, CM; Dominguez, LC; Rial, MIB; Cid, NB; Villar, AF				Ramos Hernandez, Cristina; Nunez Fernandez, Marta; Pallares Sanmartin, Abel; Mouronte Roibas, Cecilia; Cerdeira Dominguez, Luz; Botana Rial, Maria Isabel; Blanco Cid, Nagore; Fernandez Villar, Alberto			Validation of the portable Air-Smart Spirometer	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; REFERENCE VALUES	Background The Air-Smart Spirometer is the first portable device accepted by the European Community (EC) that performs spirometric measurements by a turbine mechanism and displays the results on a smartphone or a tablet. Methods In this multicenter, descriptive and cross-sectional prospective study carried out in 2 hospital centers, we compare FEV1, FVC, FEV1/FVC ratio measured with the Air Smart-Spirometer device and a conventional spirometer, and analyze the ability of this new portable device to detect obstructions. Patients were included for 2 consecutive months. We calculate sensitivity, specificity, positive and negative predictive value (PPV and NPV) and likelihood ratio (LR+, LR-) as well as the Kappa Index to evaluate the concordance between the two devices for the detection of obstruction. The agreement and relation between the values of FEV1 and FVC in absolute value and the FEV1/FVC ratio measured by both devices were analyzed by calculating the intraclass correlation coefficient (ICC) and the Pearson correlation coefficient (r) respectively. Results 200 patients (100 from each center) were included with a mean age of 57 (+/- 14) years, 110 were men (55%). Obstruction was detected by conventional spirometry in 73 patients (40.1%). Using a FEV1/FVC ratio smaller than 0.7 to detect obstruction with the Air Smart-Spirometer, the kappa index was 0.88, sensitivity (90.4%), specificity (97.2%), PPV (95.7%), NPV (93.7%), positive likelihood ratio (32.29), and negative likelihood ratio (0.10). The ICC and r between FEV1, FVC, and FEV1/FVC ratio measured by the Air Smart Spirometer and the conventional spirometer were all higher than 0.94. Conclusion The Air-Smart Spirometer is a simple and very precise instrument for detecting obstructive airway diseases. It is easy to use, which could make it especially useful non-specialized care and in other areas.	[Ramos Hernandez, Cristina; Nunez Fernandez, Marta; Mouronte Roibas, Cecilia; Cerdeira Dominguez, Luz; Botana Rial, Maria Isabel; Fernandez Villar, Alberto] Univ Hosp Complex Vigo, Dept Pneumonol, Pontevedra, Spain; [Ramos Hernandez, Cristina; Mouronte Roibas, Cecilia; Botana Rial, Maria Isabel; Fernandez Villar, Alberto] Neumo Vigo L I Inst Hlth Res South Galicia IISGS, Vigo, Pontevedra, Spain; [Pallares Sanmartin, Abel; Blanco Cid, Nagore] Hosp Complex Pontevedra, Dept Pneumonol, Vigo, Pontevedra, Spain		Hernandez, CR (corresponding author), Univ Hosp Complex Vigo, Dept Pneumonol, Pontevedra, Spain.; Hernandez, CR (corresponding author), Neumo Vigo L I Inst Hlth Res South Galicia IISGS, Vigo, Pontevedra, Spain.	cristina.ramos.hernandez@sergas.es		, IIS Galicia Sur/0000-0003-3812-7413; RAMOS HERNANDEZ, CRISTINA/0000-0001-5626-7810; FERNANDEZ-VILLAR, ALBERTO/0000-0001-7407-5249				Arne M, 2010, RESP MED, V104, P550, DOI 10.1016/j.rmed.2009.10.023; Barr RG, 2008, RESP CARE, V53, P433; Becker AB, 2017, CURR OPIN ALLERGY CL, V17, P99, DOI 10.1097/ACI.0000000000000346; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Cooper BG, 2011, BREATHE, V7, P259, DOI 10.1183/20734735.026310; Diez JD, 2004, ARCH BRONCONEUMOL, V40, P431; Duong-Quy S, 2009, REV MAL RESPIR, V26, P267, DOI 10.1016/S0761-8425(09)72583-5; Garcia-Rio F, 2013, ARCH BRONCONEUMOL, V49, P388, DOI 10.1016/j.arbres.2013.04.001; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Kaufmann M, 2009, RESPIRATION, V78, P161, DOI 10.1159/000197466; Quanjer PH, 2011, EUR RESPIR J, V37, P720, DOI 10.1183/09031936.00135110; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Represas CR, 2010, ARCH BRONCONEUMOL, V46, P426, DOI 10.1016/j.arbres.2010.04.008; Represas-Represas C, 2016, PLOS ONE, V4, P11; Represas-Represas C, 2013, ARCH BRONCONEUMOL, V49, P378, DOI 10.1016/j.arbres.2013.01.001; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Toda R, 2009, INTERNAL MED, V48, P513, DOI 10.2169/internalmedicine.48.1781; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP	18	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0192789	10.1371/journal.pone.0192789	http://dx.doi.org/10.1371/journal.pone.0192789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474502	gold, Green Published			2022-12-27	WOS:000426049500039
J	Luo, LN; Aubrecht, J; Li, DZ; Warner, RL; Johnson, KJ; Kenny, J; Colangelo, JL				Luo, Lina; Aubrecht, Jiri; Li, Dingzhou; Warner, Roscoe L.; Johnson, Kent J.; Kenny, Julia; Colangelo, Jennifer L.			Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; NONALCOHOLIC STEATOHEPATITIS; OBSTRUCTIVE-CHOLESTASIS; DUCT LIGATION; MICE; MOUSE; PROTECTS	To assess the potential of individual bile acids (IBA) and their profiles as mechanistic biomarkers of liver injury for humans in real world situations, we interrogated samples collected under minimum controlled conditions (ie subjects were not fasted). Total bile acids (TBA) have been considered to be biomarkers of liver injury for decades, and more recently, monitoring of IBA has been proposed for differentiation of variety of etiologies of liver injury. We established a LC-MS/MS methodology to analyze nine IBA, generated reference ranges, and examined effects of age, gender, and ethnicity for each IBA. Furthermore, we evaluated the ability of IBA and their profiles to detect hepatic injury in subjects with a broad range of liver impairments. To date, our study utilized the largest total cohort of samples (N = 645) that were divided into 2 groups, healthy or liver impaired, to evaluate IBA as biomarkers. The TBA serum levels in the Asian ethnic group trended higher when compared to other ethnic groups, and the serum concentrations of IBA, such as glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), chenodeoxycholic acid (CDCA), and taurochenoxycholic acid (TCDCA) were significantly increased. To our knowledge, this report is the first to describe ethnic differences in serum concentrations of IBAs. In patients with hepatic impairments, with the exception of deoxycholic acid (DCA), the concentrations of IBAs were significantly elevated when compared with healthy subjects. The conjugated bile acids displayed greater differences between healthy subjects and subjects with hepatic impairments than non-conjugated bile acids. Furthermore, the subjects with hepatic impairments exhibited distinct profiles (signatures) of IBAs that clustered subjects according the nature of their liver impairments. Although additional studies are needed, our data suggested that the analysis of IBA has the potential to become useful for differentiation of various forms of liver injury.	[Luo, Lina] Pfizer Inc, Pharmacokinet Dynam & Metab, Med Design, Groton, CT 06340 USA; [Aubrecht, Jiri; Li, Dingzhou; Colangelo, Jennifer L.] Pfizer Inc, Drug Safety Res & Dev, Groton, CT 06340 USA; [Warner, Roscoe L.; Johnson, Kent J.] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA; [Kenny, Julia] Univ Prince Edward Isl, Charlottetown, PE, Canada	Pfizer; Pfizer; University of Michigan System; University of Michigan; University of Prince Edward Island	Luo, LN (corresponding author), Pfizer Inc, Pharmacokinet Dynam & Metab, Med Design, Groton, CT 06340 USA.	lina.luo@pfizer.com	Li, Dingzhou/AHC-2117-2022		Pfizer Inc.	Pfizer Inc.(Pfizer)	The project was funded by Pfizer Inc. in forms of research grant to K.J.J. (University of Michigan). Pfizer Inc. provided support in the form of salaries for authors [L.L., J.A., D.L., J.K., and J.L.C.] and reviewed the final manuscript but the funding organization did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Aithal GP, 2015, MEDICINE, V43, P590; Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Amacher DE, 2005, CLIN CHEM, V51, P1796, DOI 10.1373/clinchem.2005.049908; [Anonymous], 2016, TEST ID BAFS; Bathena SPR, 2015, TOXICOL SCI, V143, P308, DOI 10.1093/toxsci/kfu228; Bathena SPR, 2015, TOXICOL SCI, V143, P296, DOI 10.1093/toxsci/kfu227; Bechmann LP, 2013, HEPATOLOGY, V57, P1394, DOI 10.1002/hep.26225; Costarelli V, 2006, NUTR FOOD SCI, V36, P153, DOI 10.1108/00346650610664887; Crosignani A, 2011, CLIN CHIM ACTA, V412, P2037, DOI 10.1016/j.cca.2011.07.028; Ferslew BC, 2015, DIGEST DIS SCI, V60, P3318, DOI 10.1007/s10620-015-3776-8; Frommherz L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153959; Fu ZD, 2014, J LIPID RES, V55, P2576, DOI 10.1194/jlr.M053124; Fu ZD, 2013, TOXICOL APPL PHARM, V273, P680, DOI 10.1016/j.taap.2013.10.020; Garcia-Canaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803; Guicciardi ME, 2013, COMPREHENSIVE PHYSL, V3; Hofmann AF, 1999, BILE ACIDS GOOD BAD, P24; Humbert L, 2012, J CHROMATOGR B, V899, P135, DOI 10.1016/j.jchromb.2012.05.015; Jang JH, 2012, HEPATOLOGY, V56, P209, DOI 10.1002/hep.25626; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; KAWASAKI H, 1986, TOHOKU J EXP MED, V150, P353, DOI 10.1620/tjem.150.353; Khurana S, 2011, CTS-CLIN TRANSL SCI, V4, P210, DOI 10.1111/j.1752-8062.2011.00272.x; Kullak-Ublick GA, 2017, GUT, V66, P1154, DOI 10.1136/gutjnl-2016-313369; Lake AD, 2013, TOXICOL APPL PHARM, V268, P132, DOI 10.1016/j.taap.2013.01.022; Li T, 2012, J LIPID, V2012, P9; Luo L, 2013, TOXICOLOGICAL SCI; Masubuchi N, CHEMICOBIOLOGICAL IN; MURPHY GM, 1972, GUT, V13, P201, DOI 10.1136/gut.13.3.201; Onakpoya IJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0553-2; Pean N, 2013, HEPATOLOGY, V58, P1451, DOI 10.1002/hep.26463; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Scherer M, 2009, J CHROMATOGR B, V877, P3920, DOI 10.1016/j.jchromb.2009.09.038; SHAFFER EA, 1978, AM J DIG DIS, V23, P392, DOI 10.1007/BF01072920; STARKEY BJ, 1982, CLIN CHIM ACTA, V119, P165, DOI 10.1016/0009-8981(82)90329-1; Steiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025006; Sugita T, 2015, GASTROENTEROLOGY RES, V2015, P10; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Tribe RM, 2010, AM J GASTROENTEROL, V105, P585, DOI 10.1038/ajg.2009.633; Trottier J, 2011, CLIN PHARMACOL THER, V90, P279, DOI 10.1038/clpt.2011.124; Trottier J, 2012, DIGEST LIVER DIS, V44, P303, DOI 10.1016/j.dld.2011.10.025; Trottier J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022094; Woolbright BL, 2014, TOXICOL SCI, V142, P436, DOI 10.1093/toxsci/kfu195; Woolbright BL, 2013, TOXICOL APPL PHARM, V273, P524, DOI 10.1016/j.taap.2013.09.023; Woolbright BL, 2012, WORLD J GASTROENTERO, V18, P4985, DOI 10.3748/wjg.v18.i36.4985; Xie GX, 2015, J PROTEOME RES, V14, P850, DOI 10.1021/pr500920q; Zhang YC, 2012, LIVER INT, V32, P58, DOI 10.1111/j.1478-3231.2011.02662.x	45	81	85	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193824	10.1371/journal.pone.0193824	http://dx.doi.org/10.1371/journal.pone.0193824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513725	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800079
J	Wijkstrom, J; Jayasumana, C; Dassanayake, R; Priyawardane, N; Godakanda, N; Siribaddana, S; Rings, A; Hultenby, K; Soderberg, M; Elinder, CG; Wernerson, A				Wijkstrom, Julia; Jayasumana, Channa; Dassanayake, Rajeewa; Priyawardane, Nalin; Godakanda, Nimali; Siribaddana, Sisira; Rings, Anneli; Hultenby, Kjell; Soderberg, Magnus; Elinder, Carl-Gustaf; Wernerson, Annika			Morphological and clinical findings in Sri Lankan patients with chronic kidney disease of unknown cause (CKDu): Similarities and differences with Mesoamerican Nephropathy	PLOS ONE			English	Article							NORTH CENTRAL PROVINCE; CHRONIC-RENAL-FAILURE; UNCERTAIN ETIOLOGY; FRACTIONAL EXCRETION; SUGARCANE CUTTERS; CADMIUM LEVELS; HEAVY-METALS; HANTAVIRUS; EXPOSURE; URINE	In Sri Lanka, an endemic of chronic kidney disease of unknown origin (CKDu) is affecting rural communities. The endemic has similarities with Mesoamerican Nephropathy (MeN) in Central America, however it has not yet been clarified if the endemics are related diagnostic entities. We designed this study of kidney biopsies from patients with CKDu in Sri Lanka to compare with MeN morphology. Eleven patients with CKDu were recruited at the General Hospital, Polonnaruwa, using similar inclusion and exclusion criteria as our previous MeN studies. Inclusion criteria were 20-65 years of age and plasma creatinine 100-220 mu mol/ L. Exclusion criteria were diabetes mellitus, uncontrolled hypertension and albuminuria >1g/24h. Kidney biopsies, blood and urine samples were collected, and participants answered a questionnaire. Included participants were between 27-61 years of age and had a mean eGFR of 38 +/- 14 ml/min/1.73m(2). Main findings in the biopsies were chronic glomerular and tubulointerstitial damage with glomerulosclerosis (8-75%), glomerular hypertrophy and mild to moderate tubulointerstitial changes. The morphology was more heterogeneous and interstitial inflammation and vascular changes were more common compared to our previous studies of MeN. In two patients the biopsies showed morphological signs of acute pyelonephritis but urine cultures were negative. Electrolyte disturbances with low levels of serum sodium, potassium, and/or magnesium were common. In the urine, only four patients displayed albuminuria, but many patients exhibited elevated alpha-1-microglobulin and magnesium levels. This is the first study reporting detailed biochemical and clinical data together with renal morphology, including electron microscopy, from Sri Lankan patients with CKDu. Our data show that there are many similarities in the biochemical and morphological profile of the CKDu endemics in Central America and Sri Lanka, supporting a common etiology.	[Wijkstrom, Julia; Elinder, Carl-Gustaf; Wernerson, Annika] Karolinska Inst, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Jayasumana, Channa] Rajarata Univ Sri Lanka, Fac Med, Dept Pharmacol, Saliyapura, Sri Lanka; [Dassanayake, Rajeewa; Priyawardane, Nalin; Godakanda, Nimali] Gen Hosp, Renal Unit, Polonnaruwa, Sri Lanka; [Siribaddana, Sisira] Rajarata Univ Sri Lanka, Fac Med, Saliyapura, Sri Lanka; [Rings, Anneli; Soderberg, Magnus] Karolinska Univ Hosp, Clin Pathol & Cytol, Stockholm, Sweden; [Hultenby, Kjell] Karolinska Inst, Div CRC, Dept Lab Med, Stockholm, Sweden; [Soderberg, Magnus] AstraZeneca, IMED Biotech Unit, Pathol Drug Safety & Metab, Gothenburg, Sweden	Karolinska Institutet; Rajarata University of Sri Lanka; Rajarata University of Sri Lanka; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; AstraZeneca	Wijkstrom, J (corresponding author), Karolinska Inst, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	julia.wijkstrom@ki.se	Siribaddana, Sisira/I-2295-2016	Siribaddana, Sisira/0000-0001-5821-2557; Wijkstrom, Julia/0000-0001-6183-5878	Karolinska Institutet; Stockholm County Council; Martin Rind Foundation; International Society of Nephrology; Swedish Research Council [2016-05825]; Ministry of Health in Sri Lanka; Sri Lanka Embassy in Stockholm	Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Martin Rind Foundation; International Society of Nephrology; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministry of Health in Sri Lanka; Sri Lanka Embassy in Stockholm	This study was funded by the regional agreement on medical training and clinical research (ALF) between Karolinska Institutet and Stockholm County Council, the Martin Rind Foundation, the International Society of Nephrology, and the Swedish Research Council (Swedish Research Links 2016-05825). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Astra Zeneca provided support in the form of salaries for one author [MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; The authors would like to thank the staff at the General Hospital Polonnaruwa for their support during the study; the Ministry of Health in Sri Lanka and the Sri Lanka Embassy in Stockholm for their support and assistance with administrative issues; and the Njur-KBC Research Department and Eva Blomen at Karolinska University Hospital for technical assistance.	Agency for Toxic Substances and Disease Registry, 2013, TOXGUIDE UR; Agency for Toxic Substances and Disease Registry, 2012, TOXGUIDE VAN; Akerstrom M, 2013, TOXICOL APPL PHARM, V268, P286, DOI 10.1016/j.taap.2013.02.009; [Anonymous], 2007, TOXGUIDE ARS; [Anonymous], 2012, ENVIRON HEALTH PREV, DOI [DOI 10.1007/S12199-011-0224-Z, 10.1007/s12199-011-0224-z]; Athuraliya NTC, 2011, KIDNEY INT, V80, P1212, DOI 10.1038/ki.2011.258; Athuraliya T N C, 2009, Ceylon Med J, V54, P23; Badurdeen Z, 2016, CLIN NEPHROL, V86, pS106, DOI 10.5414/CNP86S115; Bandara JMRS, 2008, ENVIRON GEOCHEM HLTH, V30, P465, DOI 10.1007/s10653-007-9129-6; Bandara JMRS, 2010, TOXICOL LETT, V198, P33, DOI 10.1016/j.toxlet.2010.04.016; Bello AK, 2017, JAMA-J AM MED ASSOC, V317, P1864, DOI 10.1001/jama.2017.4046; Bernard A, 2004, BIOMETALS, V17, P519, DOI 10.1023/B:BIOM.0000045731.75602.b9; Caldwell KL, 2009, J EXPO SCI ENV EPID, V19, P59, DOI 10.1038/jes.2008.32; Castano A, 2012, INT J HYG ENVIR HEAL, V215, P191, DOI 10.1016/j.ijheh.2011.09.001; Chandrajith R, 2011, ENVIRON GEOCHEM HLTH, V33, P267, DOI 10.1007/s10653-010-9339-1; Colvin R.B., 2019, DIAGN PATHOL; Cunningham J, 2012, CLIN KIDNEY J, V5, P39, DOI 10.1093/ndtplus/sfr166; De Silva P, 2016, PLOS NEGLECT TROP D, V10, P17; ELISAF M, 1995, POSTGRAD MED J, V71, P211, DOI 10.1136/pgmj.71.834.211; Elisaf M, 1997, MAGNESIUM RES, V10, P315; Fischer RSB, 2017, KIDNEY INT IN PRESS; Gamage CD, 2017, INT J INFECT DIS, V57, P77, DOI 10.1016/j.ijid.2017.02.004; Garcia-Trabanino R, 2015, ENVIRON RES, V142, P746, DOI 10.1016/j.envres.2015.07.007; George J, 1998, VIRAL IMMUNOL, V11, P103, DOI 10.1089/vim.1998.11.103; Glassock RJ, 2012, KIDNEY INT, V82, P270, DOI 10.1038/ki.2012.65; Gokmen MR, 2013, ANN INTERN MED, V158, P469, DOI 10.7326/0003-4819-158-6-201303190-00006; Gokmen MR, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4000; Herrera R, 2014, MEDICC REV, V16, P39, DOI 10.37757/MR2014.V16.N2.7; Hotez PJ, 2014, INT J PARASITOL, V44, P597, DOI 10.1016/j.ijpara.2014.04.001; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jarup L, 2000, OCCUP ENVIRON MED, V57, P668, DOI 10.1136/oem.57.10.668; Jayasekara KB, 2015, J EPIDEMIOL, V25, P275, DOI 10.2188/jea.JE20140074; Jayasumana C, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0109-2; Jayasumana C, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-6; Jayatilake N, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-180; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Lee JW, 2012, INT J HYG ENVIR HEAL, V215, P449, DOI 10.1016/j.ijheh.2012.01.002; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Murray KO, 2015, MICROBES INFECT, V17, P671, DOI 10.1016/j.micinf.2015.08.005; Nanayakkara Shanika, 2012, Environmental Health and Preventive Medicine, V17, P213, DOI 10.1007/s12199-011-0243-9; Paschal DC, 1998, ENVIRON RES, V76, P53, DOI 10.1006/enrs.1997.3793; PETER JB, 1994, LANCET, V343, P181, DOI 10.1016/S0140-6736(94)90976-8; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Roels HA, 1999, RENAL FAILURE, V21, P251, DOI 10.3109/08860229909085087; Roncal-Jimenez C, 2016, AM J KIDNEY DIS, V67, P20, DOI 10.1053/j.ajkd.2015.08.021; Selvarajah M, 2016, Indian J Nephrol, V26, P357; Sommar JN, 2014, J EXPO SCI ENV EPID, V24, P51, DOI 10.1038/jes.2013.4; Sunil-Chandra NP, 2015, EPIDEMIOL INFECT, V143, P2081, DOI 10.1017/S0950268814003707; United States Environmental Protection Agency EPA, 1994, METH 200 8 DET RAC E; UpToDate, MES NEPHR; UpToDate, EV AD PAT HYP; Wanigasuriya K, 2014, MEDICC REV, V16, P61, DOI 10.37757/MR2014.V16.N2.10; Wanigasuriya KP, 2007, T ROY SOC TROP MED H, V101, P1013, DOI 10.1016/j.trstmh.2007.05.006; Weaver VM, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0105-6; Wegman D., 2016, MESOAMERICAN NEPHROP; Weiner DE, 2013, CLIN J AM SOC NEPHRO, V8, P504, DOI 10.2215/CJN.05050512; Wesseling C, 2016, ENVIRON RES, V147, P125, DOI 10.1016/j.envres.2016.02.002; Wijetunge S, 2015, Indian J Nephrol, V25, P274, DOI 10.4103/0971-4065.145095; Wijkstrom J, 2017, AM J KIDNEY DIS, V69, P626, DOI 10.1053/j.ajkd.2016.10.036; Wijkstrom J, 2013, AM J KIDNEY DIS, V62, P908, DOI 10.1053/j.ajkd.2013.05.019	60	47	48	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193056	10.1371/journal.pone.0193056	http://dx.doi.org/10.1371/journal.pone.0193056			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513702	Green Submitted, gold, Green Published			2022-12-27	WOS:000426896800034
J	Yang, JH; Yu, X; Yang, Y; Yang, ZQ				Yang, Jing-Hu; Yu, Xiang; Yang, Yi; Yang, Zeng-Qiang			Physical simulation and theoretical evolution for ground fissures triggered by underground coal mining	PLOS ONE			English	Article							SOIL-STRUCTURE INTERACTION; SUBSIDENCE; SURFACE; BASIN; MINE; SEAM	Underground coal mining activities are prone to cause movement and breakage in geological strata and also lead to mining subsidence and even ground fissures. Along the direction working panel advancing, ground fissures may occur in roof in front and/or behind working panel. However, the investigations of previous similarity tests in lab only emphasize on the region behind working panel. By improving strata material property in construction and mounting artificial pressure devices, two physical simulation tests were conducted and successfully investigated the simulated results. Then, the mechanical model of "cantilever beam and elastic foundation beam" was proposed to calculate the stress distribution and the crack initiation angle in overlying strata and it well explains the mechanisms of ground fissures generation and propagation. Results show that, the maximum internal force in roof always occurred in front of working panel. However, because the void space in gob due to excavation is large enough to cause the bend and rotation of roof strata, compare to the triaxially compressed region in front of working panel, the roof always broke off at some positions above gob since the stress concentration resulting from such bend and rotation of strata could easily reach the limit strength of strata rocks. Also, the length of cantilever beam changed dynamically as respect to the panel advancing and the breakage intervals. Thus, the breakage position where the internal force first reached the limit tensile strength is not fixed and there will be two different kinds of relative positions between the crack initiation point and the working panel. The crack initiation direction is always perpendicular to the internal force, and the crack propagation direction is affected by the initiation angle, overburden-separation degree and the position of the hydraulic shields. If there is no overburden-separation or less, the roofs will break off as a composite beam and the propagation direction will be roughly along the central line between the initial broken point and the support position. Otherwise, the roof strata will bend with the support shields moving forward, then the fracture angle will be close to the initiation angle and the fault surface will be stepped.	[Yang, Jing-Hu; Yu, Xiang; Yang, Yi; Yang, Zeng-Qiang] China Univ Min & Technol Beijing, Sch Resource & Safety Engn, Beijing, Peoples R China; [Yang, Jing-Hu] China Univ Min & Technol Beijing, Beijing Key Lab Precise Min Intergrowth Energy &, Beijing, Peoples R China	China University of Mining & Technology; China University of Mining & Technology	Yang, JH (corresponding author), China Univ Min & Technol Beijing, Sch Resource & Safety Engn, Beijing, Peoples R China.; Yang, JH (corresponding author), China Univ Min & Technol Beijing, Beijing Key Lab Precise Min Intergrowth Energy &, Beijing, Peoples R China.	yjh_cumtb@126.com			National Basic Research Program (973 Program) [2013CB227903]	National Basic Research Program (973 Program)(National Basic Research Program of China)	This research was supported by the National Basic Research Program (973 Program) (2013CB227903) to JHY. The URL is http://973.cumt.edu.cn/xb/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fernandez MI, 2005, ENG GEOL, V80, P1, DOI 10.1016/j.enggeo.2005.02.004; Can E, 2011, SCI RES ESSAYS, V6, P1317, DOI DOI 10.5897/SRE10.1017; Can E, 2012, INT J COAL GEOL, V89, P62, DOI 10.1016/j.coal.2011.08.006; Deck O, 2003, ENG STRUCT, V25, P435, DOI 10.1016/S0141-0296(02)00184-0; Deck O, 2010, COMPUT GEOTECH, V37, P802, DOI 10.1016/j.compgeo.2010.07.001; Diaz-Fernandez ME, 2010, COMPUTAT GEOSCI, V14, P83, DOI 10.1007/s10596-009-9134-1; Diez R.R., 2000, GEOTECH GEOL ENG, V18, P289, DOI [10.1023/A:1016650120053, DOI 10.1023/A:1016650120053]; Duzgun HSB, 2005, INT J COAL GEOL, V64, P104, DOI 10.1016/j.coal.2005.03.008; Hadi Haeri, 2013, ARAB J GEOSCI, V8, P2841; Haeri H, 2014, J CENT SOUTH UNIV, V21, P2404, DOI 10.1007/s11771-014-2194-y; [胡振琪 Hu Zhenqi], 2014, [煤炭学报, Journal of China Coal Society], V39, P11; Ju JF, 2015, INT J ROCK MECH MIN, V78, P27, DOI 10.1016/j.ijrmms.2015.05.003; Jung HC, 2007, ENG GEOL, V92, P1, DOI 10.1016/j.enggeo.2007.02.007; Kratzsch H., 1983, MINING SUBSIDENCE EN; Li X, 2004, ENG GEOL, V76, P93, DOI 10.1016/j.enggeo.2004.06.008; Long Y., 1981, CALCULATION ELASTIC; Nicieza CG, 2005, INT J ROCK MECH MIN, V42, P372, DOI 10.1016/j.ijrmms.2004.12.003; Peng JB, 2013, ENG GEOL, V155, P19, DOI 10.1016/j.enggeo.2013.01.001; Saeidi A, 2009, ENG STRUCT, V31, P2275, DOI 10.1016/j.engstruct.2009.04.010; Torano J, 2000, INT J ROCK MECH MIN, V37, P1161, DOI 10.1016/S1365-1609(00)00046-0; Wang Xi GY, 2010, COOPERATIVE EC SCI, V12, P10, DOI DOI 10.1016/J.NEULET.2010.12.038; Whittaker B.N., 1989, SUBSIDENCE OCCURRENC, DOI 10.1016/0148-9062(90)95372-8; Xu NG, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/531518; Zhao HJ, 2013, ENVIRON EARTH SCI, V68, P1903, DOI 10.1007/s12665-012-1877-7; Zhu X.-J., 2014, ELECT J GEOTECHNICAL, V19, P9543	25	12	13	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192886	10.1371/journal.pone.0192886	http://dx.doi.org/10.1371/journal.pone.0192886			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513703	gold, Green Published, Green Submitted			2022-12-27	WOS:000426896800024
J	Singh, V; Bala, M; Bhargava, A; Kakran, M; Bhatnagar, R				Singh, Vikram; Bala, Manju; Bhargava, Aradhana; Kakran, Monika; Bhatnagar, Ravi			In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; THERAPY; SYNERGY; SUSCEPTIBILITY; AZITHROMYCIN; INDIA; CEFTRIAXONE; FAILURE; PROFILE; ETEST	Background Recent WHO guidelines recommend dual therapy with ceftriaxone or cefixime plus azithromycin for gonorrhea. Azithromycin in combination with gentamicin or spectinomycin has been recommended in treatment failure cases. Due to emergence of multi-drug resistant (MDR) and extensively-drug resistant (XDR) Neisseria gonorrhoeae strains, it is important to look for efficacy of these combinations and also of others that might be used in future. Therefore, we aimed to evaluate in vitro synergy of 21 dual combinations including current and alternative WHO recommended treatment regimens and other dual combinations. Methods and findings The potential utility of in-vitro interactions of 21 combinations was investigated against 95 N. gonorrhoeae strains including 79 MDR and one XDR strain collected during March 2013 to July 2017 and fractional inhibitory concentration index (FICI) was calculated. These 21 combinations comprised of two WHO currently recommended (cefixime+ azithromycin, ceftriaxone+azithromycin); two WHO recommended in treatment failure cases (azithromycin + gentamicin, spectinomycin+azithromycin) and other 17 combinations. Results FICI of the four WHO recommended antimicrobial combinations were higher (> 1.0) than the five novel combinationbreeds (FICI range 0.603-0.951) in the study i.e. gentamicin+ertapenem, moxifloxacin+ertapenem, spectinomycin+ertapenem, azithromycin+moxifloxacin, cefixime+ gentamicin. No antagonistic effect of the above four WHO recommended combinations except spectinomycin+azithromycin (FICI = 4.25) was observed for the XDR strain. Out of above five novel combinations, four combinations produced high synergistic effects in overall 95 strains and also for the XDR strain with FICI of 0.13 to 0.38. Antagonistic effects varying from 3.2 to 12.6% were observed for 10 out of 21 tested combinations (azithromycin in combination with gentamicin and spectinomycin; ceftriaxone with moxifloxacin, gentamicin, spectinomycin and ertapenem; spectinomycin with moxifloxacin and gentamicin; cefixime and gentamicin combination with moxifloxacin). Conclusion WHO recommended cefixime+azithromycin, ceftriaxone+azithromycin combinations having no antagonism indicates their continuing clinical utility. Highest antagonism without any synergistic effect for the WHO recommended spectinomycin+azithromycin in treatment failure cases suggests that this combination should be evaluated further both in vitro and in vivo. Highest synergistic or additive effect without any antagonistic effect of the above five novel combinations suggests that these may be recommended for treatment in future.	[Singh, Vikram; Bala, Manju; Bhargava, Aradhana; Kakran, Monika] VMMC, Apex Reg STI Training Res & Reference Lab, New Delhi, India; [Singh, Vikram; Bala, Manju; Bhargava, Aradhana; Kakran, Monika] Safdarjang Hosp, New Delhi, India; [Singh, Vikram; Bhatnagar, Ravi] SunRise Univ, Alwar, Rajasthan, India	Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital	Bala, M (corresponding author), VMMC, Apex Reg STI Training Res & Reference Lab, New Delhi, India.; Bala, M (corresponding author), Safdarjang Hosp, New Delhi, India.	manjubala_2@hotmail.com		Singh, Vikram/0000-0003-2737-8102	Indian Council of Medical Research, India [5/3/3/4/2013-ECD-I]; RFC [ECD/ADHOC/41/2014-15]	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); RFC	This study was funded by Indian Council of Medical Research, India (ID No. 5/3/3/4/2013-ECD-I dated 13.3.15, RFC NO. ECD/ADHOC/41/2014-15) to MB.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AB Biodisk, 2007, ET APPL SHEET M00005; Alirol E, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002366; Bala M, 2016, ANTIMICROB AGENTS CH, V60, P7518, DOI 10.1128/AAC.01907-16; Bala M, 2016, J ANTIMICROB CHEMOTH, V71, P1856, DOI 10.1093/jac/dkw102; Bala M, 2015, SEX TRANSM DIS, V42, P218, DOI 10.1097/OLQ.0000000000000261; Bala M, 2013, SEX TRANSM INFECT, V89, P28, DOI 10.1136/sextrans-2012-050904; Bala M, 2011, SEX TRANSM DIS, V38, P1056, DOI 10.1097/OLQ.0b013e31822e6361; Barbee LA, 2014, J ANTIMICROB CHEMOTH, V69, P1572, DOI 10.1093/jac/dkt540; Bell SM, 2016, ANTIBIOTIC SUSCEPTIB, P56; Brown LB, 2010, SEX TRANSM DIS, V37, P169, DOI 10.1097/OLQ.0b013e3181bf575c; Centers for Disease Control and Prevention, 2017, CTR DIS CONTR PREV S; Fifer H, 2016, NEW ENGL J MED, V374, P2504, DOI 10.1056/NEJMc1512757; Furuya Ryusaburo, 2006, Journal of Infection and Chemotherapy, V12, P172, DOI 10.1007/s10156-006-0445-z; Furuya R, 2013, J INFECT CHEMOTHER, V19, P1218, DOI 10.1007/s10156-013-0597-6; Golparian D, 2013, SEX TRANSM INFECT, V89, pA114, DOI 10.1136/sextrans-2013-051184.0351; Kirkcaldy RD, 2014, CLIN INFECT DIS, V59, P1083, DOI 10.1093/cid/ciu521; Lee H, 2017, DIAGN MICR INFEC DIS, V87, P160, DOI 10.1016/j.diagmicrobio.2016.10.022; Lorian V., 1996, ANTIBIOTICS LAB MED, Vxvi, P1238; National AIDS Control Organisation, 2014, NAT GUID PREV MAN CO; Pereira R, 2013, J ANTIMICROB CHEMOTH, V68, P640, DOI 10.1093/jac/dks449; Singh V, 2017, SEX TRANS DIS; Singh V, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000969; Unemo M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1029-2; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Unemo M, 2014, ANTIMICROB AGENTS CH, V58, P624, DOI 10.1128/AAC.02093-13; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P3603, DOI 10.1128/AAC.00326-12; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Wind CM, 2015, INT J ANTIMICROB AG, V45, P305, DOI 10.1016/j.ijantimicag.2014.10.020; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI DOI 10.1017/CBO9781107415324.004; World Health Organization, 2012, GLOB ACT PLAN CONTR	31	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193678	10.1371/journal.pone.0193678	http://dx.doi.org/10.1371/journal.pone.0193678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509792	gold, Green Published, Green Submitted			2022-12-27	WOS:000426813200024
J	Tamura, R; Hukushima, K				Tamura, Ryo; Hukushima, Koji			Bayesian optimization for computationally extensive probability distributions	PLOS ONE			English	Article							RENORMALIZATION-GROUP METHOD; COMPUTER-MODELS; EFFICIENT; SIMULATIONS; CALIBRATION; SYSTEMS	An efficient method for finding a better maximizer of computationally extensive probability distributions is proposed on the basis of a Bayesian optimization technique. A key idea of the proposed method is to use extreme values of acquisition functions by Gaussian processes for the next training phase, which should be located near a local maximum or a global maximum of the probability distribution. Our Bayesian optimization technique is applied to the posterior distribution in the effective physical model estimation, which is a computationally extensive probability distribution. Even when the number of sampling points on the posterior distributions is fixed to be small, the Bayesian optimization provides a better maximizer of the posterior distributions in comparison to those by the random search method, the steepest descent method, or the Monte Carlo method. Furthermore, the Bayesian optimization improves the results efficiently by combining the steepest descent method and thus it is a powerful tool to search for a better maximizer of computationally extensive probability distributions.	[Tamura, Ryo] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Tamura, Ryo; Hukushima, Koji] Natl Inst Mat Sci, Res & Serv Div Mat Data & Integrated Syst, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan; [Tamura, Ryo] Univ Tokyo, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778568, Japan; [Hukushima, Koji] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	National Institute for Materials Science; National Institute for Materials Science; University of Tokyo; University of Tokyo	Tamura, R (corresponding author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.; Tamura, R; Hukushima, K (corresponding author), Natl Inst Mat Sci, Res & Serv Div Mat Data & Integrated Syst, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.; Tamura, R (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778568, Japan.; Hukushima, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan.	tamura.ryo@nims.go.jp; hukusima@phys.c.u-tokyo.ac.jp	Hukushima, Koji/C-6840-2009; TAMURA, Ryo/J-4231-2015	Hukushima, Koji/0000-0003-1153-1758; TAMURA, Ryo/0000-0002-0349-358X	Nippon Sheet Glass Foundation for Materials Science and Engineering; JSPS, Japan [25120010, 25610102]	Nippon Sheet Glass Foundation for Materials Science and Engineering; JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	R. T. was partially supported by the Nippon Sheet Glass Foundation for Materials Science and Engineering (http://nsg-zaidan.or.jp/index_en.html). K. H. was partially supported by a Grants-in-Aid for Scientific Research from JSPS, Japan (http://www.jsps.go.jp/english/index.html) (Grant No. 25120010 and 25610102).	Balachandran PV, 2016, SCI REP-UK, V6, DOI 10.1038/srep19660; Benassi Romain, 2011, Learning and Intelligent Optimization. 5th International Conference, LION 5. Selected Papers, P176, DOI 10.1007/978-3-642-25566-3_13; Bishop C.M., 2006, PATTERN RECOGN; Chevalier C, 2012, HAL00732512V2; COX DD, 1992, 1992 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN, AND CYBERNETICS, VOLS 1 AND 2, P1241, DOI 10.1109/ICSMC.1992.271617; Desautels T, 2014, J MACH LEARN RES, V15, P3873; Heaton M. J., 2017, METHODS ANAL LARGE S; Higdon D, 2004, SIAM J SCI COMPUT, V26, P448, DOI 10.1137/S1064827503426693; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; JAKLIC J, 1994, PHYS REV B, V49, P5065, DOI 10.1103/PhysRevB.49.5065; Jones DR, 1998, J GLOBAL OPTIM, V13, P455, DOI 10.1023/A:1008306431147; Ju SH, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.021024; Kawashima N, 2004, J PHYS SOC JPN, V73, P1379, DOI 10.1143/JPSJ.73.1379; Kennedy MC, 2001, J R STAT SOC B, V63, P425, DOI 10.1111/1467-9868.00294; Kiyohara S, 2016, JPN J APPL PHYS, V55, DOI 10.7567/JJAP.55.045502; LAI TL, 1985, ADV APPL MATH, V6, P4, DOI 10.1016/0196-8858(85)90002-8; Landau D.P., 2014, GUIDE MONTE CARLO SI, DOI 10.1017/cbo9781139696463; LIN HQ, 1990, PHYS REV B, V42, P6561, DOI 10.1103/PhysRevB.42.6561; Liu F, 2009, BAYESIAN ANAL, V4, P119, DOI 10.1214/09-BA404; Mockus J., 1989, BAYESIAN APPROACH GL; Nishino T, 1996, J PHYS SOC JPN, V65, P891, DOI 10.1143/JPSJ.65.891; NISHINO T, 1995, J PHYS SOC JPN, V64, P3598, DOI 10.1143/JPSJ.64.3598; Packwood DM, 2017, APPL PHYS EXPRESS, V10, DOI 10.7567/APEX.10.065502; Pelikan M, 1999, GECCO-99: PROCEEDINGS OF THE GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P525; Rahimi A, 2007, ADV NEURAL INFORM PR, V20; SANDVIK AW, 1991, PHYS REV B, V43, P5950, DOI 10.1103/PhysRevB.43.5950; Seko A, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.144110; Seko A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.054303; Shahriari B, 2016, P IEEE, V104, P148, DOI 10.1109/JPROC.2015.2494218; Snoek J., 2012, P ADV NEUR INF PROC, P1; Suwa H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.120603; Tamura R, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.064407; Toyoura K, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.054112; Ueno Tsuyoshi, 2016, Materials Discovery, V4, P18, DOI 10.1016/j.md.2016.04.001; Wang FG, 2001, PHYS REV LETT, V86, P2050, DOI 10.1103/PhysRevLett.86.2050; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863; Yamaji Y, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.107201	38	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193785	10.1371/journal.pone.0193785	http://dx.doi.org/10.1371/journal.pone.0193785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505596	Green Submitted, Green Published, gold			2022-12-27	WOS:000426548200032
J	Iwata, M; Hara, K; Kamura, Y; Honoki, H; Fujisaka, S; Ishiki, M; Usui, I; Yagi, K; Fukushima, Y; Takano, A; Kato, H; Murakami, S; Higuchi, K; Kobashi, C; Fukuda, K; Koshimizu, Y; Tobe, K				Iwata, Minoru; Hara, Kazuo; Kamura, Yutaka; Honoki, Hisae; Fujisaka, Shiho; Ishiki, Manabu; Usui, Isao; Yagi, Kunimasa; Fukushima, Yasuo; Takano, Atsuko; Kato, Hiromi; Murakami, Shihou; Higuchi, Kiyohiro; Kobashi, Chikaaki; Fukuda, Kazuhito; Koshimizu, Yukiko; Tobe, Kazuyuki			Ratio of low molecular weight serum adiponectin to the total adiponectin value is associated with type 2 diabetes through its relation to increasing insulin resistance	PLOS ONE			English	Article							PLASMA ADIPONECTIN; RISK-FACTOR; ADIPOSE; PROTEIN; LEVEL; PIOGLITAZONE; GLUCOSE; ASTHMA; FORM	Aim Among the three adiponectin isoforms, a lower ratio of high molecular weight (HMW) adiponectin to total adiponectin (TA) is well known to cause insulin resistance and type 2 diabetes (T2D). However, how the levels of other adiponectin isoforms, such as the middle molecular weight (MMW) and low molecular weight (LMW) isoforms, and their relative ratio to TA change in T2D subjects has not been determined. Therefore, we investigated the association of these adiponectin-related parameters with T2D. Methods We examined the associations between adiponectin-related parameters and diabetes in a group of 394 T2D subjects and 374 controls (1st group) randomly selected from among the participants in our previous study. The associations between these parameters and the HOMA-IR in a 2nd group, consisting of the subjects remaining in the 1st group after the exclusion of subjects receiving diabetic medication, were also examined. Result In the 1st group, after adjusting for confounding factor, the levels of all the adiponectin isoforms and the HMW/TA ratio were significantly lower among the diabetic subjects than among the controls (all P values < 0.01). On the contrary, the LMW/TA ratio was significantly higher among the diabetic subjects (P < 0.01) and was positively associated with T2D (odds ratio = 8.64, P < 0.01). In the 2nd group, the HMW/TA ratio was inversely associated with the HOMA-IR; however, the LMW/TA ratio was positively associated with the HOMA-IR (beta for LMW/TA ratio = 0.89, SE = 0.24, P < 0.001), similar to the association with T2D. The MMW/TA ratio was not associated with T2D or the HOMA-IR. Conclusion The current investigation demonstrated that, unlike the reduction in the levels of all the adiponectin isoforms and the HMW/TA ratio, an increased LMW/TA ratio was associated with T2D through its relation to insulin resistance.	[Iwata, Minoru; Kamura, Yutaka; Honoki, Hisae; Fujisaka, Shiho; Ishiki, Manabu; Usui, Isao; Yagi, Kunimasa; Tobe, Kazuyuki] Toyama Univ, Fac Med, Dept Internal Med 1, Toyama, Toyama, Japan; [Iwata, Minoru] Toyama Univ, Hlth Adm Ctr, Toyama, Toyama, Japan; [Hara, Kazuo] Jichi Med Univ, Saitama Med Ctr, Dept Comprehens Med, Div Endocrinol & Metab,Omiya Ku, Saitama, Japan; [Hara, Kazuo] Tokyo Med Univ, Dept Diabetol Endocrinol & Metab, Shinjuku Ku, Tokyo, Japan; [Fukushima, Yasuo] Asahi Gen Hosp, Dept Internal Med, Asahi, Toyama, Japan; [Takano, Atsuko] Saiseikai Takaoka Hosp, Dept Internal Med, Div Endocrinol & Metab, Takaoka, Toyama, Japan; [Kato, Hiromi] Japan Community Hlth Care Org Takaoka Fushiki Hos, Dept Internal Med, Div Endocrinol & Metab, Takaoka, Toyama, Japan; [Murakami, Shihou] Toyama Rosai Hosp, Dept Internal Med, Div Endocrinol & Metab, Uozu, Toyama, Japan; [Higuchi, Kiyohiro] JA Niigata Kouseiren Itoigawa Gen Hosp, Dept Internal Med, Itoigawa, Niigata, Japan; [Kobashi, Chikaaki] Kamiichi Gen Hosp, Dept Internal Med, Kamiichi, Toyama, Japan; [Fukuda, Kazuhito] Fukuda Clin, Dept Internal Med, Himi, Toyama, Japan; [Koshimizu, Yukiko] Urata Clin, Dept Internal Med, Kanazawa, Ishikawa, Japan	University of Toyama; University of Toyama; Jichi Medical University; Tokyo Medical University	Iwata, M (corresponding author), Toyama Univ, Fac Med, Dept Internal Med 1, Toyama, Toyama, Japan.; Iwata, M (corresponding author), Toyama Univ, Hlth Adm Ctr, Toyama, Toyama, Japan.	iwamino-tym@umin.ac.jp	Yagi, Kunimasa/AAA-8666-2021	Yagi, Kunimasa/0000-0002-6805-6428; Iwata, MInoru/0000-0003-2161-1313	Ministry of Education, Culture, Sports, Science and Technology, Japan [24510276]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (approved number 24510276). There were no additional funding sources for this study.	Bouskila M, 2005, INT J OBESITY, V29, pS17, DOI 10.1038/sj.ijo.0802908; Crispim F, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-20; Daimon M, 2003, DIABETES CARE, V26, P2015, DOI 10.2337/diacare.26.7.2015; Delaigle AM, 2004, ENDOCRINOLOGY, V145, P5589, DOI 10.1210/en.2004-0503; Drzewoski J, 2006, CURR MED RES OPIN, V22, P1921, DOI 10.1185/030079906X132424; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Ebinuma H, 2006, CLIN CHIM ACTA, V372, P47, DOI 10.1016/j.cca.2006.03.014; Gavin JR, 1999, DIABETES CARE, V22, pS5; Goto M, 2014, OBESITY, V22, P401, DOI 10.1002/oby.20553; Graessler J, 2011, GERONTOLOGY, V57, P316, DOI 10.1159/000316575; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Hayashikawal Y, 2015, ENDOCR J, V62, P695, DOI 10.1507/endocrj.EJ14-0626; Hiramatsu S, 2004, DIABETES OBES METAB, V6, P231, DOI 10.1111/j.1462-8902.2004.00333.x; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Inadera Hidekuni, 2008, Int J Med Sci, V5, P248; Isobe T, 2005, EUR J ENDOCRINOL, V153, P91, DOI 10.1530/eje.1.01930; Iwase Masanori, 2008, Diabetes Res Clin Pract, V82, pe19, DOI 10.1016/j.diabres.2008.09.001; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kamura Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165523; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Katsiki N, 2011, EXPERT OPIN THER TAR, V15, P401, DOI 10.1517/14728222.2011.553609; Kotani K, 2012, J ATHEROSCLER THROMB, V19, P787, DOI 10.5551/jat.11833; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsumoto Y, 2013, ENDOCR J, V60, P119, DOI 10.1507/endocrj.EJ12-0277; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Nagasaka S, 2003, DIABETES CARE, V26, P2215, DOI 10.2337/diacare.26.7.2215; Nakano Y, 2006, J LIPID RES, V47, P1572, DOI 10.1194/jlr.D600010-JLR200; Nishimura R, 2007, J PEDIATR-US, V151, P545, DOI 10.1016/j.jpeds.2007.07.047; Ochiai H, 2008, ENDOCR J, V55, P549, DOI 10.1507/endocrj.K07E-107; Ohbuchi Y, 2014, INT J CLIN ONCOL, V19, P667, DOI 10.1007/s10147-013-0603-0; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Peake PW, 2005, EUR J ENDOCRINOL, V153, P409, DOI 10.1530/eje.1.01978; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Rubenstein JH, 2009, GUT, V58, P1583, DOI 10.1136/gut.2008.171553; Satoh Hiroki, 2010, Nutr Metab Cardiovasc Dis, V20, pe9, DOI 10.1016/j.numecd.2009.05.009; Seino Y, 2007, METABOLISM, V56, P1493, DOI 10.1016/j.metabol.2007.06.015; Snehalatha C, 2003, DIABETES CARE, V26, P3226, DOI 10.2337/diacare.26.12.3226; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Steffes MW, 2004, ANN EPIDEMIOL, V14, P492, DOI 10.1016/j.annepidem.2003.10.006; Su JR, 2016, HORM METAB RES, V48, P92, DOI 10.1055/s-0035-1569287; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wolf AM, 2006, J HEPATOL, V44, P537, DOI 10.1016/j.jhep.2005.08.019; Zhu N, 2010, J CLIN ENDOCR METAB, V95, P5097, DOI 10.1210/jc.2010-0716	50	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192609	10.1371/journal.pone.0192609	http://dx.doi.org/10.1371/journal.pone.0192609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494595	gold, Green Submitted, Green Published			2022-12-27	WOS:000426363200012
J	Phillips, YF; Towsey, M; Roe, P				Phillips, Yvonne F.; Towsey, Michael; Roe, Paul			Revealing the ecological content of long-duration audio-recordings of the environment through clustering and visualisation	PLOS ONE			English	Article							SOUNDSCAPE ECOLOGY; ACOUSTIC INDEXES; CLASSIFICATION; LANDSCAPE	Audio recordings of the environment are an increasingly important technique to monitor biodiversity and ecosystem function. While the acquisition of long-duration recordings is becoming easier and cheaper, the analysis and interpretation of that audio remains a significant research area. The issue addressed in this paper is the automated reduction of environmental audio data to facilitate ecological investigations. We describe a method that first reduces environmental audio to vectors of acoustic indices, which are then clustered. This can reduce the audio data by six to eight orders of magnitude yet retain useful ecological information. We describe techniques to visualise sequences of cluster occurrence ( using for example, diel plots, rose plots) that assist interpretation of environmental audio. Colour coding acoustic clusters allows months and years of audio data to be visualised in a single image. These techniques are useful in identifying and indexing the contents of long-duration audio recordings. They could also play an important role in monitoring long-term changes in species abundance brought about by habitat degradation and/or restoration.	[Phillips, Yvonne F.; Towsey, Michael; Roe, Paul] Queensland Univ Technol, Sci & Engn Fac, Brisbane, Qld, Australia	Queensland University of Technology (QUT)	Phillips, YF (corresponding author), Queensland Univ Technol, Sci & Engn Fac, Brisbane, Qld, Australia.	y.phillips@hdr.qut.edu.au			Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	Yvonne Phillips acknowledges the receipt of an Australian Government Research Training Program Scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Australian Government Bureau of Meteorology (BOM), 2016, CLIM STAT AUSTR LOC; Barchiesi D, 2015, IEEE SIGNAL PROC MAG, V32, P16, DOI 10.1109/MSP.2014.2326181; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Depraetere M, 2012, ECOL INDIC, V13, P46, DOI 10.1016/j.ecolind.2011.05.006; Dunn J.C., 1974, J CYBERNETICS, V4, P95, DOI 10.1080/01969727408546059; Farina A, 2016, BIOSEMIOTICS-NETH, V9, P227, DOI 10.1007/s12304-016-9266-3; Farina A, 2013, BIOACOUSTICS, V22, P175, DOI 10.1080/09524622.2012.761571; Gasc A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065311; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Kasten EP, 2012, ECOL INFORM, V12, P50, DOI 10.1016/j.ecoinf.2012.08.001; Kononenko I, 2007, CLUSTER ANAL MACHINE, P359; KRAUSE BL, 1992, LITERARY REV, V36, P40; Ladroue C., 2012, POLAR HISTOGRAM PRET; Lemon J., 2006, R R NEWS, V6, P12; Maechler M., 2015, R PACKAGE CLUSTER CL; Nakazawa M., 2015, FMSB R PACKAGE VERSI; Nowinszky L, 2010, APPL ECOL ENV RES, V8, P51, DOI 10.15666/aeer/0801_051062; Phillips Y., 2018, ENV LONG DURATION AU; Phillips Y., 2017, METHOD CLUSTER LONG; Phillips Y., 2018, CLUSTER LIST GYMPIE; Pieretti N, 2011, ECOL INDIC, V11, P868, DOI 10.1016/j.ecolind.2010.11.005; Pijanowski BC, 2011, LANDSCAPE ECOL, V26, P1213, DOI 10.1007/s10980-011-9600-8; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Pizzey G., 2014, FIELD GUIDE BIRDS AU; Rodriguez A, 2014, ECOL INFORM, V21, P133, DOI 10.1016/j.ecoinf.2013.12.006; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rychtarikova M, 2013, APPL ACOUST, V74, P240, DOI 10.1016/j.apacoust.2011.01.004; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Sueur J, 2015, BIOSEMIOTICS-NETH, V8, P493, DOI 10.1007/s12304-015-9248-x; Sueur J, 2014, ACTA ACUST UNITED AC, V100, P772, DOI 10.3813/AAA.918757; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; Sun JWC, 2005, BIOL CONSERV, V121, P419, DOI 10.1016/j.biocon.2004.05.017; Towsey M, 2014, ECOLOGICAL INFORM, V21, P210; Towsey M., 2017, CALCULATION ACOUSTIC, P1; Towsey M., 2016, AUDIO ANAL SOFTWARE; Towsey M, 2014, PROCEDIA COMPUT SCI, V29, P703, DOI 10.1016/j.procs.2014.05.063; Towsey M, 2014, ECOL INFORM, V21, P1, DOI 10.1016/j.ecoinf.2014.02.002; Truskinger A, 2015, IEE, P111; Truskinger A, 2014, 2014 IEEE FOURTH INTERNATIONAL CONFERENCE ON BIG DATA AND CLOUD COMPUTING (BDCLOUD), P91, DOI 10.1109/BDCloud.2014.29; Tucker D, 2014, LANDSCAPE ECOL, V29, P745, DOI 10.1007/s10980-014-0015-1; Venables WN., 2002, MODERN APPL STAT S; Wildlife Acoustics, 2017, WILDL AC BIOAC MON S; Wong B, 2011, NAT METHODS, V8, P441, DOI 10.1038/nmeth.1618	46	45	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193345	10.1371/journal.pone.0193345	http://dx.doi.org/10.1371/journal.pone.0193345			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494629	gold, Green Submitted, Green Published			2022-12-27	WOS:000426363200040
J	Pollari, R; Milstein, JN				Pollari, Russell; Milstein, Joshua N.			Accounting for polarization in the calibration of a donut beam axial optical tweezers	PLOS ONE			English	Article							SPECTROSCOPY; TRAPS	Advances in light shaping techniques are leading to new tools for optical trapping and micro manipulation. For example, optical tweezers made from Laguerre-Gaussian or donut beams display an increased axial trap strength and can impart angular momentum to rotate a specimen. However, the application of donut beam optical tweezers to precision, biophysical measurements remains limited due to a lack of methods for calibrating such devices sufficiently. For instance, one notable complication, not present when trapping with a Gaussian beam, is that the polarization of the trap light can significantly affect the tweezers' strength as well as the location of the trap. In this article, we show how to precisely calibrate the axial trap strength as a function of height above the coverslip surface while accounting for focal shifts in the trap position arising from radiation pressure, mismatches in the index of refraction, and polarization induced intensity variations. This provides a foundation for implementing a donut beam optical tweezers capable of applying precise axial forces.	[Pollari, Russell; Milstein, Joshua N.] Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON, Canada; [Pollari, Russell; Milstein, Joshua N.] Univ Toronto, Dept Phys, Toronto, ON, Canada	University of Toronto; University Toronto Mississauga; University of Toronto	Milstein, JN (corresponding author), Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON, Canada.; Milstein, JN (corresponding author), Univ Toronto, Dept Phys, Toronto, ON, Canada.	josh.milstein@utoronto.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN 418251-13]; Canada Foundation for Innovation [PN 30735]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	RP and JNM acknowledge support from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca, RGPIN 418251-13) and the Canada Foundation for Innovation (www.innovation.ca, PN 30735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Bokor N, 2005, OPT EXPRESS, V13, P10440, DOI 10.1364/OPEX.13.010440; Brau RR, 2006, BIOPHYS J, V91, P1069, DOI 10.1529/biophysj.106.082602; Chen B, 2009, J OPT SOC AM A, V26, P862, DOI 10.1364/JOSAA.26.000862; Davis JA, 1999, APPL OPTICS, V38, P5004, DOI 10.1364/AO.38.005004; Dholakia K, 2011, NAT PHOTONICS, V5, P335, DOI [10.1038/NPHOTON.2011.80, 10.1038/nphoton.2011.80]; Ferrer JM, 2009, CURR PHARM BIOTECHNO, V10, P502, DOI 10.2174/138920109788922182; Friese MEJ, 1996, APPL OPTICS, V35, P7112, DOI 10.1364/AO.35.007112; Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007; Gu M, 2000, ADV OPTICAL IMAGING, V75; Hao XA, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/11/115707; HE H, 1995, J MOD OPTIC, V42, P217, DOI 10.1080/09500349514550171; Heller I, 2014, CHEM REV, V114, P3087, DOI 10.1021/cr4003006; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Jeffries GDM, 2007, NANO LETT, V7, P415, DOI 10.1021/nl0626784; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Ng J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.103601; Pollari R, 2015, OPT EXPRESS, V23, P28857, DOI 10.1364/OE.23.028857; Schaffer E, 2007, LANGMUIR, V23, P3654, DOI 10.1021/la0622368; Simpson NB, 1998, J MOD OPTIC, V45, P1943, DOI 10.1080/09500349808231712; Simpson NB, 1996, J MOD OPTIC, V43, P2485, DOI 10.1080/09500349608230675; van Dijk MA, 2004, J PHYS CHEM B, V108, P6479, DOI 10.1021/jp049805+; Yehoshua S, 2015, BIOPHYS J, V108, P2759, DOI 10.1016/j.bpj.2015.05.014; Youngworth KS, 2000, OPT EXPRESS, V7, P77, DOI 10.1364/OE.7.000077; Zhao YQ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.073901	26	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193402	10.1371/journal.pone.0193402	http://dx.doi.org/10.1371/journal.pone.0193402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474494	Green Submitted, Green Published, gold			2022-12-27	WOS:000426049500101
J	Caranfa, JT; Nguyen, E; Ali, R; Francis, I; Zichichi, A; Bosco, E; Coleman, CI; Baker, WL; Kohn, CG				Caranfa, Jonathan T.; Nguyen, Elaine; Ali, Rafay; Francis, Iregi; Zichichi, Albert; Bosco, Elliott; Coleman, Craig I.; Baker, William L.; Kohn, Christine G.			Mechanical endovascular therapy for acute ischemic stroke: An indirect treatment comparison between Solitaire and Penumbra thrombectomy devices	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; ASSOCIATION; ALTEPLASE	Background Randomized controlled trials (RCTs) have compared mechanical endovascular therapy (MET) in addition to intravenous tissue plasminogen activator (IVtPA) to IVtPA alone for the management of acute ischemic stroke (AIS). Direct comparative studies between individual METs are not available. In lieu of head-to-head randomized control trials, we performed an adjusted indirect treatment comparison (ITC) meta-analysis to assess the comparative efficacy and safety of different METs, Solitaire+IVtPA and Penumbra+IVtPA in AIS patients. Methods and findings We searched MEDLINE, the Cochrane Central Register of Controlled Trials and Embase from January 1, 2005 through April 1, 2017 for RCTs in AIS patients, comparing a single MET+IVtPA to IVtPA alone and reporting shift in ordinal modified Rankin Scale (mRS) score at 90 days. Secondary endpoints included 90 day mortality and symptomatic intracranial hemorrhage (sICH). Endpoints were pooled using traditional random effects meta-analysis methods, producing odds ratios and 95% confidence intervals. Adjusted ITCs using pooled estimates were then performed. Three studies (SWIFT PRIME, EXTEND-IA, THERAPY) were included; two evaluating the Solitaire stent retriever and one the Penumbra system. Traditional meta-analysis demonstrated that each MET+IVtPA resulted in increased odds of improving ordinal mRS score vs. IVtPA alone, but did not alter the odds of death or sICH. Adjusted ITC showed no significant difference between the METs for any outcome. Conclusion No significant difference in efficacy or safety between the Solitaire and Penumbra devices was observed.	[Caranfa, Jonathan T.] Univ Connecticut, Sch Med, Farmington, CT USA; [Nguyen, Elaine] Idaho State Univ, Coll Pharm, Meridian, ID USA; [Ali, Rafay; Francis, Iregi] Univ St Joseph, Sch Pharm, Hartford, CT USA; [Zichichi, Albert; Bosco, Elliott] Univ Connecticut, Sch Pharm, Storrs, CT USA; [Coleman, Craig I.; Baker, William L.] Univ Connecticut, Sch Pharm, Hartford, CT 06112 USA; [Coleman, Craig I.; Baker, William L.] UConn Hartford Hosp Evidence Based Med, Hartford, CT USA; [Kohn, Christine G.] Univ Connecticut, Sch Med, Hartford Hosp Evidence Based Med, Hartford, CT 06112 USA	University of Connecticut; Idaho; Idaho State University; University of Connecticut; University of Connecticut; University of Connecticut	Kohn, CG (corresponding author), Univ Connecticut, Sch Med, Hartford Hosp Evidence Based Med, Hartford, CT 06112 USA.	ckohn@uchc.edu	Nguyen, Elaine/ABG-6132-2021	Nguyen, Elaine/0000-0001-6695-3187; Bosco, Elliott/0000-0003-2422-4861; Coleman, Craig/0000-0003-4868-7158; Baker, William/0000-0003-2172-0931				Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Health Quality Ontario, 2016, Ont Health Technol Assess Ser, V16, P1; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Lapergue B, 2017, INT J STROKE; Mocco J, 2016, STROKE, V47, P2331, DOI 10.1161/STROKEAHA.116.013372; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061	11	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0191657	10.1371/journal.pone.0191657	http://dx.doi.org/10.1371/journal.pone.0191657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513676	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800006
J	van der Kooij, K; Wijdenes, LO; Rigterink, T; Overvliet, KE; Smeets, JBJ				van der Kooij, Katinka; Wijdenes, Leonie Oostwoud; Rigterink, Tessa; Overvliet, Krista E.; Smeets, Joeren B. J.			Reward abundance interferes with error-based learning in a visuomotor adaptation task	PLOS ONE			English	Article							MOTOR CONTROL; EXPLICIT; SKILL; REINFORCEMENT; MODELS	The brain rapidly adapts reaching movements to changing circumstances by using visual feedback about errors. Providing reward in addition to error feedback facilitates the adaptation but the underlying mechanism is unknown. Here, we investigate whether the proportion of trials rewarded (the 'reward abundance') influences how much participants adapt to their errors. We used a 3D multi-target pointing task in which reward alone is insufficient for motor adaptation. Participants (N = 423) performed the pointing task with feedback based on a shifted hand-position. On a proportion of trials we gave them rewarding feedback that their hand hit the target. Half of the participants only received this reward feedback. The other half also received feedback about endpoint errors. In different groups, we varied the proportion of trials that was rewarded. As expected, participants who received feedback about their errors did adapt, but participants who only received reward-feedback did not. Critically, participants who received abundant rewards adapted less to their errors than participants who received less reward. Thus, reward abundance negatively influences how much participants learn from their errors. Probably participants used a mechanism that relied more on the reward feedback when the reward was abundant. Because participants could not adapt to the reward, this interfered with adaptation to errors.	[van der Kooij, Katinka; Rigterink, Tessa; Smeets, Joeren B. J.] Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands; [Wijdenes, Leonie Oostwoud] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Overvliet, Krista E.] Univ Hamburg, Dept Biol Psychol & Neuropsychol, Hamburg, Germany	Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Hamburg	van der Kooij, K (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands.	k.vander.kooij@vu.nl	Oostwoud Wijdenes, Leonie/M-1262-2015; Smeets, Jeroen/B-4198-2008; Overvliet, Krista/J-9214-2014	Oostwoud Wijdenes, Leonie/0000-0002-7264-7853; Smeets, Jeroen/0000-0002-3794-0579; Overvliet, Krista/0000-0002-3537-8172; van der Kooij, Katinka/0000-0002-4190-7827	Stichting Technologie en Wetenschap (STW) Open Technologie Programma (OTP) [12668]; European Commission; Marie-Curie IEF fellowship [624297]; FP7 Marie-Curie IEF fellowship [624297]; FP7 Marie-Curie IEF fellowship by the European Commission [624297]	Stichting Technologie en Wetenschap (STW) Open Technologie Programma (OTP); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie-Curie IEF fellowship; FP7 Marie-Curie IEF fellowship; FP7 Marie-Curie IEF fellowship by the European Commission	Katinka van der Kooij and Joeren Smeets were funded by Stichting Technologie en Wetenschap (STW) Open Technologie Programma (OTP) grant 12668 awarded to Joeren Smeets and European Commission. Krista Overvliet was additionally funded by Marie-Curie IEF fellowship grant number 624297. Leonie Oostwoud Wijdenes and Tessa Rigterink received no funding for this research. The funders played no role in the research. Krista Overvliet was additionally funded by FP7 Marie-Curie IEF fellowship grant number 624297. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was part of Science Live, the innovative research programme of Science Center NEMO that enables scientists to carry out real, publishable, peer-reviewed research using NEMO visitors as volunteers. The research was funded by Stichting Technologie en Wetenschap (STW) Open Technologie Programma (OTP) grant 12668 awarded to Jeroen Smeets. We thank Jasper van de Lagemaat for testing participants in the museum, Tim Groeneboom (www.timgroeneboom.com) for programming the experiment and Stefan de Graaff (www.stefandegraaff.nl) for the video impression of the experiment. KO was supported by a FP7 Marie-Curie IEF fellowship by the European Commission (624297).	Bond KM, 2015, J NEUROPHYSIOL, V113, P3836, DOI 10.1152/jn.00009.2015; Brenner E, 2011, EXP BRAIN RES, V213, P153, DOI 10.1007/s00221-011-2786-9; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Cheng S, 2007, J NEUROPHYSIOL, V97, P3057, DOI 10.1152/jn.00897.2006; Dayan E, 2014, LEARN MEMORY, V21, P140, DOI 10.1101/lm.032417.113; Festini SB, 2016, EXP BRAIN RES, V234, P1385, DOI 10.1007/s00221-015-4542-z; Gajda K, 2016, EXP BRAIN RES, V234, P2859, DOI 10.1007/s00221-016-4688-3; Galea JM, 2015, NAT NEUROSCI, V18, P597, DOI 10.1038/nn.3956; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Huberdeau DM, 2015, J NEUROPHYSIOLOGY, V114; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Mawase F, 2017, J NEUROSCI, V37, P2673, DOI 10.1523/JNEUROSCI.3303-16.2017; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Nikooyan AA, 2015, J NEUROPHYSIOL, V113, P633, DOI 10.1152/jn.00032.2014; Pekny SE, 2015, J NEUROSCI, V35, P4015, DOI 10.1523/JNEUROSCI.3244-14.2015; Peled A, 2012, J MOTOR BEHAV, V44, P185, DOI 10.1080/00222895.2012.672349; Redding GM, 2006, J EXP PSYCHOL HUMAN, V32, P1006, DOI 10.1037/0096-1523.32.4.1006; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Shadmehr R, 2016, CURR BIOL, V26, P1929, DOI 10.1016/j.cub.2016.05.065; Shmuelof L, 2012, J NEUROSCI, V32, P14617, DOI 10.1523/JNEUROSCI.2184-12.2012; Song Y, 2017, EXPT BRAIN RES, P1; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Therrien AS, 2016, BRAIN, V139, P101, DOI 10.1093/brain/awv329; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Kooij K, 2016, EXP BRAIN RES, V234, P1441, DOI 10.1007/s00221-015-4540-1; Widmer M, 2016, PROG BRAIN RES, V229, P303, DOI 10.1016/bs.pbr.2016.05.006; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wu HG, 2014, NATURE NEUROSCIENCE	31	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193002	10.1371/journal.pone.0193002	http://dx.doi.org/10.1371/journal.pone.0193002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513681	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800028
J	Alodaibi, FA; Fritz, JM; Thackeray, A; Koppenhaver, SL; Hebert, JJ				Alodaibi, Faris A.; Fritz, Julie M.; Thackeray, Anne; Koppenhaver, Shane L.; Hebert, Jeffrey J.			The Fear Avoidance Model predicts short-term pain and disability following lumbar disc surgery	PLOS ONE			English	Article							LOW-BACK-PAIN; COGNITIVE-BEHAVIORAL FACTORS; BELIEFS QUESTIONNAIRE FABQ; BECK DEPRESSION INVENTORY; PSYCHOMETRIC PROPERTIES; CATASTROPHIZING SCALE; RISK-FACTORS; PSYCHOSOCIAL VARIABLES; MUSCULOSKELETAL PAIN; POSTOPERATIVE PAIN	Objective To examine the prognostic value of the Fear Avoidance Model (FAM) variables when predicting pain intensity and disability 10-weeks postoperative following lumbar disc surgery. Methods We recruited patients scheduled for first-time, single level lumbar disc surgery. The following aspects of the FAM were assessed at preoperative baseline and after 10 postoperative weeks: numeric pain rating scale (0 +/- 10) for leg and back pain intensity separately, Pain Catastrophizing Scale (PCS), Fear Avoidance Beliefs Questionnaire (FABQ), Beck Depression Inventory (BDI), Oswestry Disability Questionnaire (ODI), and the International Physical Activity Questionnaire (IPAQ). Multivariate regression models were used to examine the best combination of baseline FAM variables to predict the 10-week leg pain, back pain, and disability. All multivariate models were adjusted for age and sex. Results 60 patients (30 females, mean [SD] age = 40.4 [9.5]) were enrolled. All FAM measures correlated with disability at baseline. Adding FAM variables to each of the stepwise multiple linear regression model explained a significant amount of the variance in disability (Adj. R-2 =.38, p <.001), leg pain intensity (Adj. R-2 =.25, p =.001), and back pain intensity Adj. R-2 =.32, p <.001 at 10-weeks). After adjusting for age and gender, BDI and FABQ-work subscale were the only significant predictors added to each of the prediction models for the 10week clinical outcome (leg pain, back pain, and ODI). Conclusion BDI and FABQ-work subscale variables are associated with baseline pain intensity and disability and predict short-term pain and disability following lumbar disc surgery. Measuring these variables in patients being considered for lumbar disc surgery may improve patient outcome.	[Alodaibi, Faris A.] King Saud Univ, Coll Appl Med Sci, Dept Rehabil Sci, Riyadh, Saudi Arabia; [Fritz, Julie M.; Thackeray, Anne] Univ Utah, Sch Hlth, Dept Phys Therapy, Salt Lake City, UT USA; [Koppenhaver, Shane L.] Baylor Univ, Doctoral Phys Therapy Program, Waco, TX 76798 USA; [Hebert, Jeffrey J.] Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA, Australia; [Hebert, Jeffrey J.] Univ New Brunswick, Fac Kinesiol, Fredericton, NB, Canada	King Saud University; Utah System of Higher Education; University of Utah; Baylor University; Murdoch University; University of New Brunswick	Alodaibi, FA (corresponding author), King Saud Univ, Coll Appl Med Sci, Dept Rehabil Sci, Riyadh, Saudi Arabia.	falodaibi@ksu.edu.sa	Alodaibi, Faris/L-9739-2013; Fritz, Julie/AAC-5638-2021	Alodaibi, Faris/0000-0003-4471-768X; Hebert, Jeffrey/0000-0002-6959-325X	Orthopaedic Section of the American Physical Therapy Association; Research Centre, College of Applied Medical Sciences, King Said University	Orthopaedic Section of the American Physical Therapy Association; Research Centre, College of Applied Medical Sciences, King Said University	This study received funding from the Orthopaedic Section of the American Physical Therapy Association. The study was also supported by the Research Centre, College of Applied Medical Sciences, King Said University. The funding sources had no role in the planning, conducting, or reporting of this study.	Alodaibi FA, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-40; Arpino L, 2004, NEUROL SCI, V25, P145, DOI 10.1007/s10072-004-0248-x; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Benoist M, 2002, JOINT BONE SPINE, V69, P155, DOI 10.1016/S1297-319X(02)00385-8; Celestin J, 2009, PAIN MED, V10, P639, DOI 10.1111/j.1526-4637.2009.00632.x; Chaichana KL, 2010, J NEUROSURG, V113, P286, DOI 10.3171/2010.2.JNS091010; Childs JD, 2005, SPINE, V30, P1331, DOI 10.1097/01.brs.0000164099.92112.29; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Cleland JA, 2008, EUR SPINE J, V17, P70, DOI 10.1007/s00586-007-0511-y; Craig C, MED SCI SPORTS EXERC, P1381; Crombez G, 2003, PAIN, V104, P639, DOI 10.1016/S0304-3959(03)00121-0; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; D'Eon JL, 2004, J BEHAV MED, V27, P361, DOI 10.1023/B:JOBM.0000042410.34535.64; DeBerard MS, 2009, SPINE J, V9, P193, DOI 10.1016/j.spinee.2008.02.001; den Boer JJ, 2006, PAIN, V123, P45, DOI 10.1016/j.pain.2006.02.008; den Boer JJ, 2006, EUR SPINE J, V15, P527, DOI 10.1007/s00586-005-0910-x; Fairbank J C, 1980, Physiotherapy, V66, P271; Fritz JM, 2002, PHYS THER, V82, P973, DOI 10.1093/ptj/82.10.973; Fritz JM, 2001, PHYS THER, V81, P776, DOI 10.1093/ptj/81.2.776; Gagliese L, 2005, PAIN, V117, P412, DOI 10.1016/j.pain.2005.07.004; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Gibson JNA, 1999, SPINE, V24, P1820, DOI 10.1097/00007632-199909010-00012; Graver V, 1999, BRIT J NEUROSURG, V13, P178, DOI 10.1080/02688699943952; Harris CA, 2008, PAIN, V137, P609, DOI 10.1016/j.pain.2007.10.022; HASENBRING M, 1994, SPINE, V19, P2759, DOI 10.1097/00007632-199412150-00004; Haugen AJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-183; Hebert JJ, 2015, BRIT J SPORT MED, V49, P100, DOI 10.1136/bjsports-2013-092402; Johansson AC, 2010, DISABIL REHABIL, V32, P521, DOI 10.3109/09638280903177243; JUNGE A, 1995, SPINE, V20, P460, DOI 10.1097/00007632-199502001-00009; Khan RS, 2011, AM J SURG, V201, P122, DOI 10.1016/j.amjsurg.2010.02.007; Kleinstueck FS, 2011, EUR SPINE J, V20, P1166, DOI 10.1007/s00586-010-1670-9; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Lundberg M, 2011, SPINE, V36, P1547, DOI 10.1097/BRS.0b013e3181f61660; Moffett JAK, 2004, SPINE, V29, P1167, DOI 10.1097/00007632-200406010-00002; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; Papaioannou M, 2009, PAIN MED, V10, P1452, DOI 10.1111/j.1526-4637.2009.00730.x; Pavlin DJ, 2005, CLIN J PAIN, V21, P83, DOI 10.1097/00002508-200501000-00010; Poiraudeau S, 2006, PAIN, V124, P305, DOI 10.1016/j.pain.2006.04.019; Puolakka K, 2008, EUR SPINE J, V17, P386, DOI 10.1007/s00586-007-0552-2; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Ryan CG, 2009, AUST J PHYSIOTHER, V55, P53, DOI 10.1016/S0004-9514(09)70061-3; Silverplats K, 2010, EUR SPINE J, V19, P1459, DOI 10.1007/s00586-010-1433-7; Staerkle R, 2004, EUR SPINE J, V13, P332, DOI 10.1007/s00586-003-0663-3; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Swinkels-Meewisse EJCM, 2003, MANUAL THER, V8, P29, DOI 10.1054/math.2002.0484; Theunissen M, 2012, CLIN J PAIN, V28, P819, DOI 10.1097/AJP.0b013e31824549d6; Valat JP, 2010, BEST PRACT RES CL RH, V24, P241, DOI 10.1016/j.berh.2009.11.005; Vianin M, 2008, J CHIROPR MED, V7, P161, DOI 10.1016/j.jcm.2008.07.001; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193566	10.1371/journal.pone.0193566	http://dx.doi.org/10.1371/journal.pone.0193566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY1CC	29505603	Green Published, gold, Green Submitted			2022-12-27	WOS:000426548200020
J	Almotwaa, S; Elrobh, M; AbdulKarim, H; Alanazi, M; Aldaihan, S; Shaik, J; Arafa, M; Warsy, AS				Almotwaa, Sahar; Elrobh, Mohamed; AbdulKarim, Huda; Alanazi, Mohamed; Aldaihan, Sooad; Shaik, Jilani; Arafa, Maha; Warsy, Arjumand Sultan			Genetic polymorphism and expression of HSF1 gene is significantly associated with breast cancer in Saudi females	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; HSP90 INHIBITORS; GROWTH; PROTEIN; TRANSFORMATION; TUMORIGENESIS; METASTASIS; APOPTOSIS; THERAPY; TUMORS	The transcription factor, heat shock factor 1 (HSF1), influences the expression of heat shock proteins as well as other activities like the induction of tumor suppressor genes, signal transduction pathway, and glucose metabolism. We hypothesized that single nucleotide polymorphisms (SNPs) in HSF1 gene might affect its expression or function which might have an influence on the development of breast cancer. The study group included 242 individuals (146 breast cancer patients and 96 healthy controls). From the cancer patients, genomic DNA was extracted from 96 blood samples and 50 Formalin-Fixed Paraffin Embedded (FFPE) tissues, while from the controls DNA were extracted from blood only. Genotype was carried out for four SNPs in the HSF1 gene (rs78202224, rs35253356, rs4977219 and rs34404564) using Taqman genotyping assay method. The HSF1 expression was investigated using immunohistochemistry on FFPE tissues (cancer tissue and adjacent normal tissue). The SNP rs78202224 (G>T) was significantly associated with increased risk of breast cancer. The combined TT + GT genotype (OR: 6.91; p: 0.035) and the T allele showed high risk (OR: 5.81; p: 0.0085) for breast cancer development. The SNP rs34404564 (A>G) had a protective effect against the development of breast cancer. The genotype AG (OR: 0.41; p = 0.0059) and GG+AG (OR: 0.52; p: 0.026) occurred at a significantly lower frequency in the breast cancer patients compared to the frequency in healthy controls. No significant relationship was identified between either rs35253356 (A>G) or rs4977219 (A>C) and breast cancer in Saudi. The HSF1 protein expression was higher in all invasive and in situ breast carcinoma compared to the normal tissue. A stronger positive staining for HSF1 was found in the nucleus compared to the cytoplasm. Our results show that HSF1 gene expression is elevated in breast cancer tissue and two of the studied SNPs correlate significantly with cancer development.	[Almotwaa, Sahar; Elrobh, Mohamed; Alanazi, Mohamed; Aldaihan, Sooad] King Saud Univ, Dept Biochem, Coll Sci, Riyadh, Saudi Arabia; [AbdulKarim, Huda] King Fahad Med City Hosp, Comprehens Canc Ctr, Hematol Oncol Unit, Riyadh, Saudi Arabia; [Shaik, Jilani] King Saud Univ, Dept Biochem, Coll Sci, Genome Res Chair, Riyadh, Saudi Arabia; [Arafa, Maha] King Saud Univ, Dept Pathol, Coll Med, Riyadh, Saudi Arabia; [Warsy, Arjumand Sultan] King Saud Univ, Cent Lab, Ctr Sci & Med Studies Girls, Riyadh, Saudi Arabia	King Saud University; King Fahad Medical City; King Saud University; King Saud University; King Saud University	Warsy, AS (corresponding author), King Saud Univ, Cent Lab, Ctr Sci & Med Studies Girls, Riyadh, Saudi Arabia.	aswarsy@ksu.edu.sa	almotwaa, sahar/GQY-9950-2022; Warsy, Arjumand/D-5274-2015; Elrobh, Mohamed S/H-5696-2012	almotwaa, sahar/0000-0003-1378-7140; Warsy, Arjumand/0000-0001-6957-203X; , Mohamed/0000-0003-1967-8850	King Saud University; King Abdulaziz city of Science and Technology	King Saud University(King Saud University); King Abdulaziz city of Science and Technology	The authors are grateful to the Deanship of Scientific Research, King Saud University for funding through Vice Deanship of Scientific Research Chairs. The authors also acknowledge the support of King Abdulaziz city of Science and Technology.; The authors are grateful to the Deanship of Scientific Research, King Saud University for funding through Vice Deanship of Scientific Research Chairs. The authors also acknowledge the support of King Abdulaziz city of Science and Technology.	Alanazi MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059555; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Calderwood SK, 2012, J CELL BIOCHEM, V113, P1096, DOI 10.1002/jcb.23461; Chen YY, 2013, ONCOTARGET, V4, P816, DOI 10.18632/oncotarget.991; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; Dudeja V, 2011, AM J PHYSIOL-GASTR L, V300, pG948, DOI 10.1152/ajpgi.00346.2010; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Hoang AT, 2000, AM J PATHOL, V156, P857, DOI 10.1016/S0002-9440(10)64954-1; Home T, 2015, CANCER RES, V75, P907, DOI 10.1158/0008-5472.CAN-14-2905; Ishiwata J, 2012, INT J ONCOL, V40, P47, DOI 10.3892/ijo.2011.1178; Jiang SF, 2015, TUMOR BIOL, V36, P4923, DOI 10.1007/s13277-015-3674-x; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kang GY, 2015, ONCOTARGET, V6, P29712, DOI 10.18632/oncotarget.5073; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Mercier PA, 1997, J BIOL CHEM, V272, P14147, DOI 10.1074/jbc.272.22.14147; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Neckers L, 2003, NATURE, V425, P357, DOI 10.1038/425357a; Nguyen CH, 2013, BIOCHEM J, V452, P321, DOI 10.1042/BJ20130098; Sam SS, 2012, PATHOL RES PRACT, V208, P705, DOI 10.1016/j.prp.2012.08.008; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Sarkar R, 2012, BIOCHEM BIOPH RES CO, V427, P80, DOI 10.1016/j.bbrc.2012.09.006; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; Tsutsumi S, 2009, FUTURE ONCOL, V5, P679, DOI 10.2217/FON.09.30; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Vydra N, 2014, CURR CANCER DRUG TAR, V14, P144, DOI 10.2174/1568009614666140122155942; Wang B, 2015, BREAST CANCER RES TR, V153, P57, DOI 10.1007/s10549-015-3521-1; Xi CX, 2012, J BIOL CHEM, V287, P35646, DOI 10.1074/jbc.M112.377481; Yamaki H, 2011, J ANTIBIOT, V64, P635, DOI 10.1038/ja.2011.60	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193095	10.1371/journal.pone.0193095	http://dx.doi.org/10.1371/journal.pone.0193095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494616	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200022
J	Bottcher, L; Herrmann, HJ; Gersbach, H				Bottcher, Lucas; Herrmann, Hans J.; Gersbach, Hans			Clout, activists and budget: The road to presidency	PLOS ONE			English	Article							PUBLIC-OPINION; EVOLUTION	Political campaigns involve, in the simplest case, two competing campaign groups which try to obtain a majority of votes. We propose a novel mathematical framework to study political campaign dynamics on social networks whose constituents are either political activists or persuadable individuals. Activists are convinced and do not change their opinion and they are able to move around in the social network to motivate persuadable individuals to vote according to their opinion. We describe the influence of the complex interplay between the number of activists, political clout, budgets, and campaign costs on the campaign result. We also identify situations where the choice of one campaign group to send a certain number of activists already pre-determines their victory. Moreover, we show that a candidate's advantage in terms of political clout can overcome a substantial budget disadvantage or a lower number of activists, as illustrated by the US presidential election 2016.	[Bottcher, Lucas; Herrmann, Hans J.] ETH, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland; [Herrmann, Hans J.] Univ Fed Ceara, Dept Fus, Fortaleza, Ceara, Brazil; [Gersbach, Hans] ETH, Zurichbergstr 18, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade Federal do Ceara; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bottcher, L (corresponding author), ETH, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland.	lucasb@ethz.ch		Bottcher, Lucas/0000-0003-1700-1897	ETH Risk Center; ERC FlowCCS of the European Research Council [FP7-319968]; ERC [FP7-319968 FlowCCS]	ETH Risk Center; ERC FlowCCS of the European Research Council; ERC(European Research Council (ERC)European Commission)	We acknowledge financial support from the ETH Risk Center and ERC Advanced grant number FP7-319968 FlowCCS of the European Research Council. We thank Moritz Hoferer for his input regarding the strategic choices of activists and for proofreading the manuscript. L.B. wants to thank Sergio Solorzano for interesting discussions.; This work was supported by the ETH Risk Center (http://www.riskcenter.ethz.ch/) and ERC Advanced grant number FP7-319968 FlowCCS (https://erc.europa.eu/fag-programme/fp7) to HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, CAMBRIDGE ANAL PLATF; Bottcher L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16571; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Bottcher L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14763-5; Bottcher L, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.088301; Bottcher L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41729; Bottcher L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178062; Carson JamieL., 2015, POLITICS C ELECTIONS; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Chwe MSY, 1999, AM J SOCIOL, V105, P128, DOI 10.1086/210269; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Edwards-Levy Ariel, 2016, HUFF POST       0111; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Francia PL, 2017, SOC SCI COMPUT REV; Gersbach H., 2017, REDESIGNING DEMOCRAC; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gleeson JP, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021004; Gleeson JP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026106; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Insidegov. com, 2016, COMP PRES CAN 2016; Jacobson GC, 2015, ANNU REV POLIT SCI, V18, P31, DOI 10.1146/annurev-polisci-072012-113556; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kenski K., 2010, OBAMA VICTORY MEDIA; Krapivsky PL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238701; Marro J., 2005, NONEQUILIBRIUM PHASE; Poll Chart, 2016, HUFFPOST POLLSTER; Ramos M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10032; Ramswell PQ, 2017, EUR POLIT SCI, V16, P217, DOI 10.1057/s41304-017-0112-0; Rodrik D., 2017, 23559 NAT BUR EC RES; Rogers EM., 2010, INTEGRATED APPROACH; Schwammle V, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.066108; Shao J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018701; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527	38	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193199	10.1371/journal.pone.0193199	http://dx.doi.org/10.1371/journal.pone.0193199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494627	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200029
J	Mayordomo, AC; Silva, JE; Gorlino, CV; Arias, JL; Beron, W; Di Genaro, MS				Constanza Mayordomo, Andrea; Eduardo Silva, Juan; Virginia Gorlino, Carolina; Luis Arias, Jose; Beron, Walter; Silvia Di Genaro, Maria			IL-12/23p40 overproduction by dendritic cells leads to an increased Th1 and Th17 polarization in a model of Yersinia enterocolitica-induced reactive arthritis in TNFRp55(-/-) mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; REGULATORY T-CELLS; IMMUNE-RESPONSE; TNF-ALPHA; FACTOR RECEPTOR; PEYERS-PATCHES; INTERLEUKIN-12; ACTIVATION; CYTOKINE; EXPRESSION	Dendritic cells ( DCs) play critical functions in the initiation of immune responses. Understanding their role in reactive arthritis ( ReA) will help delineate the pathogenesis of this arthropathy. In early studies, we detected IL-12/23p40 deregulation in Yersinia entercolitica ( Ye)-induced ReA in TNFRp55-deficient ( TNFRp55(-/-)) mice. In this study, we assessed the contribution of DCs in this overproduction. First, greater levels of IL-12/23p40, IFN-gamma and IL-17A were confirmed in supernatants of lipopolysaccharide ( LPS)-stimulated TNFRp55(-/-) splenocytes obtained on arthritis onset ( day 14 after Ye infection). Later, DCs were identified as a precise source of IL-12/23p40 since increased frequency of splenic IL-12/23p40(+) DCs was detected in TNFRp55(-/-) mice. After robust in vivo amplification of DCs by injection of Fms-like tyrosine kinase 3-Ligand ( Flt3L)-transfected BL16 melanoma, DCs were purified. These cells recapitulated the higher production of IL-12/23p40 under TNFRp55deficiency. In agreement with these results, TNFRp55(-/-) DCs promoted Th1 and Th17 programs by co-culture with WT CD4(+) lymphocytes. A mechanistic study demonstrated that JNK and p38 MAPK pathways are involved in IL-12/23p40 overproduction in purified TNFRp55(-/)- DCs as well as in the JAWS II cell line. This deregulation was once again attributed to TNFRp55 deficiency since CAY10500, a specific inhibitor of this pathway, compromised TNF-mediated IL-12/23p40 control in LPS-stimulated WT DCs. Simultaneously, this inhibition reduced IL-10 production, suggesting its role mediating IL-12/23p40 regulation by TNFRp55 pathway. These results provide experimental data on the existence of a TNFRp55-mediated anti-inflammatory circuit in DCs. Moreover, these cells may be considered as a novel target in the treatment of ReA.	[Constanza Mayordomo, Andrea; Eduardo Silva, Juan; Virginia Gorlino, Carolina; Luis Arias, Jose; Silvia Di Genaro, Maria] Univ Nacl San Luis, Fac Qum Bioquim & Farm, Div Inmunol, San Luis, Argentina; [Eduardo Silva, Juan; Silvia Di Genaro, Maria] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Invest Biol IMIBIO, San Luis, Argentina; [Beron, Walter] Univ Nacl Cuyo, CONICET, Inst Histol & Embriol, Fac Ciencias Med, Mendoza, Argentina	Universidad Nacional de San Luis; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Di Genaro, MS (corresponding author), Univ Nacl San Luis, Fac Qum Bioquim & Farm, Div Inmunol, San Luis, Argentina.; Di Genaro, MS (corresponding author), Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Invest Biol IMIBIO, San Luis, Argentina.	sdigena@unsl.edu.ar		Mayordomo, Andrea Constanza/0000-0002-0399-9644	National Agency for Promotion of Science and Technology [PICT-2011-0732]; Universidad Nacional de San Luis [PROICO-2-1114]; Alexander von Humboldt Foundation; CONICET-DFG cooperation Project	National Agency for Promotion of Science and Technology(ANPCyT); Universidad Nacional de San Luis; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); CONICET-DFG cooperation Project	This work was supported by grants from the National Agency for Promotion of Science and Technology (PICT-2011-0732), the Universidad Nacional de San Luis (PROICO-2-1114), the Alexander von Humboldt Foundation, and the CONICET-DFG cooperation Project to MSDG. CVG, WB and MSDG are members of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); ACM, JLA and JES are fellows from the CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Autenrieth IB, 1996, J MED MICROBIOL, V44, P285, DOI 10.1099/00222615-44-4-285; Autenrieth IB, 1996, INFECT IMMUN, V64, P1357, DOI 10.1128/IAI.64.4.1357-1368.1996; AUTENRIETH IB, 1993, IMMUNOBIOLOGY, V187, P1; AUTENRIETH IB, 1992, INFECT IMMUN, V60, P1140, DOI 10.1128/IAI.60.3.1140-1149.1992; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blandizzi C, 2014, INT J IMMUNOPATH PH, V27, P1, DOI 10.1177/03946320140270S101; Bohn E, 1998, INFECT IMMUN, V66, P2213, DOI 10.1128/IAI.66.5.2213-2220.1998; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; Cargnelutti E, 2013, IMMUNOL CELL BIOL, V91, P159, DOI 10.1038/icb.2012.65; Carter JD, 2009, ARTHRITIS RHEUM, V60, P1311, DOI 10.1002/art.24431; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen X, 2011, FEBS LETT, V585, P3611, DOI 10.1016/j.febslet.2011.04.025; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Di Genaro MS, 2007, RHEUMATOLOGY, V46, P590, DOI 10.1093/rheumatology/kel348; Di Genaro MS, 2003, INFECT IMMUN, V71, P1804, DOI 10.1128/IAI.71.4.1804-1812.2003; Diebold SS, 2008, IMMUNOL CELL BIOL, V86, P389, DOI 10.1038/icb.2008.26; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Elicabe RJ, 2010, J IMMUNOL, V185, P4485, DOI 10.4049/jimmunol.0902245; Glatigny S, 2012, ARTHRITIS RHEUM-US, V64, P110, DOI 10.1002/art.33321; Granfors K, 1998, ARTHRITIS RHEUM, V41, P855, DOI 10.1002/1529-0131(199805)41:5<855::AID-ART12>3.0.CO;2-J; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Inman RD, 2009, ADV EXP MED BIOL, V649, P300; Jiang XZ, 2008, INFECT IMMUN, V76, P2392, DOI 10.1128/IAI.01584-07; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kobayashi T, 2012, J IMMUNOL, V189, P1792, DOI 10.4049/jimmunol.1200042; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; KVIEN TK, 1994, J RHEUMATOL, V21, P115; Leirisalo-Repo M, 2005, SCAND J RHEUMATOL, V34, P251, DOI 10.1080/03009740500202540; Leung BP, 2002, J IMMUNOL, V169, P7071, DOI 10.4049/jimmunol.169.12.7071; Lis K, 2014, ARCH MED SCI, V10, P1175, DOI 10.5114/aoms.2014.47827; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Ma XJ, 2001, MICROBES INFECT, V3, P121, DOI 10.1016/S1286-4579(00)01359-9; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Mitoma H, 2016, CYTOKINE, P30468; Mitsuhashi M, 2004, J LEUKOCYTE BIOL, V76, P322, DOI 10.1189/jlb.1203641; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; Quan JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141550; Selmi C, 2014, AUTOIMMUN REV, V13, P546, DOI 10.1016/j.autrev.2014.01.005; Singh R, 2007, J RHEUMATOL, V34, P2285; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Uliczka F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002117; Valimaki E, 2013, SCAND J RHEUMATOL, V42, P294, DOI 10.3109/03009742.2012.754940; Vieira LQ, 1996, J IMMUNOL, V157, P827; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Williams-Skipp C, 2009, ARTHRITIS RHEUM-US, V60, P408, DOI 10.1002/art.24260; Wright P, 2013, CURR OPIN RHEUMATOL, V25, P440, DOI 10.1097/BOR.0b013e32836202dc; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19; Yu MB, 2017, RHEUMATOL INT, V37, P1043, DOI 10.1007/s00296-017-3671-z; Zakharova M, 2005, J IMMUNOL, V175, P5024, DOI 10.4049/jimmunol.175.8.5024; Zhang Y, BLOOD; Zhu C, 2001, J BIOL CHEM, V276, P18519, DOI 10.1074/jbc.M100440200	55	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193573	10.1371/journal.pone.0193573	http://dx.doi.org/10.1371/journal.pone.0193573			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494692	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200067
J	Li, YC; Chao, A; Yang, LY; Huang, HY; Huang, YT; Kuo, HH; Wang, CJ				Li, Yi-Chieh; Chao, Angel; Yang, Lan-Yang; Huang, Hui-Yu; Huang, Yi-Ting; Kuo, Hsin-Hong; Wang, Chin-Jung			Electrothermal bipolar vessel sealing device (LigaSure (TM)) versus conventional diathermy in laparoscopic myomectomy: A propensity-matched analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INSTRUMENTS; MONOPOLAR; OUTCOMES; SPREAD	The purpose of this study was to compare the safety and efficacy of an electrothermal bipolar vessel sealing device (LigaSure (TM)) and traditional electrical cauterization in laparoscopic myomectomy (LM). A total of 756 patients with symptomatic uterine myomas who underwent LM were reviewed retrospectively. A total of 225 cases of LM using LigaSure (TM) (LML group) were compared with a control group treated with traditional electrical cauterization (LME group) under propensity-matched analysis. Outcome measures for both groups were compared, such as operative time, blood loss (BL), complications, need for blood transfusion, hospital expenses, and hospital stay. Six subgroups were divided according to main myoma size and energy source. No cases required switching to abdominal myomectomy. The number of myomas removed, BL, need for blood transfusion, and complications were not significantly different, whereas hospital stay was longer in the LME group than in the LML group and total hospital expenses were higher in the LML group (p < 0.001). The overall operation duration was significantly longer in the LML group but was not significantly different for main myoma > 10 cm (LML vs LME, 121.58 +/- 41.77 vs 121.69 +/- 44.95, p = 0.99); this likely reflects the operative efficiency on using LigaSure (TM) to manage large tumors. Significant linear correlations between myoma weight and operative time and BL were seen in both groups. Conventional diathermy is more effective for small-to-medium myomas. Use of the LigaSure (TM) was efficient for myomas > 10 cm.	[Li, Yi-Chieh; Chao, Angel; Huang, Yi-Ting; Kuo, Hsin-Hong; Wang, Chin-Jung] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Li, Yi-Chieh; Chao, Angel; Huang, Yi-Ting; Kuo, Hsin-Hong; Wang, Chin-Jung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Yang, Lan-Yang] Chang Gung Mem Hosp, Linkou Med Ctr, Clin Trial Ctr, Biostat Unit, Taoyuan, Taiwan; [Huang, Hui-Yu] Chang Gung Mem Hosp Taipei, Dept Obstet & Gynecol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Wang, CJ (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Taoyuan, Taiwan.; Wang, CJ (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	wang2260@cgmh.org.tw		Yang, Lan-Yan/0000-0002-6305-540X	Chang Gung Medical Foundation [CORPG3G1021, CORPG3G1041]; Chang Gung Memorial Hospital, Linkou [CLRPG340599]	Chang Gung Medical Foundation; Chang Gung Memorial Hospital, Linkou	This work was supported by Chang Gung Medical Foundation (grant CORPG3G1021 and CORPG3G1041), Chang Gung Memorial Hospital, Linkou (CLRPG340599).	Ahlering TE, 2006, J ENDOUROL, V20, P586, DOI 10.1089/end.2006.20.586; Buckley VA, 2015, J MINIM INVAS GYN, V22, P11, DOI 10.1016/j.jmig.2014.08.007; Hefermehl LJ, 2014, BJU INT, V114, P245, DOI 10.1111/bju.12498; Heniford BT, 2001, SURG ENDOSC-ULTRAS, V15, P799, DOI 10.1007/s004640080025; Janssen PF, 2011, BJOG-INT J OBSTET GY, V118, P1568, DOI 10.1111/j.1471-0528.2011.03089.x; Janssen PF, 2012, SURG ENDOSC, V26, P2884, DOI 10.1007/s00464-012-2274-8; Jin C, 2009, EUR J OBSTET GYN R B, V145, P14, DOI 10.1016/j.ejogrb.2009.03.009; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Lee CL, 2009, TAIWAN J OBSTET GYNE, V48, P335, DOI 10.1016/S1028-4559(09)60321-1; Lethaby A, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000547; SEMM K, 1979, ENDOSCOPY, V11, P85, DOI 10.1055/s-0028-1098329; Sizzi O, 2007, J MINIM INVAS GYN, V14, P453, DOI 10.1016/j.jmig.2007.01.013; Sutton PA, 2010, BRIT J SURG, V97, P428, DOI 10.1002/bjs.6901; Vilos GA, 2013, J MINIM INVAS GYN, V20, P279, DOI 10.1016/j.jmig.2013.02.013; Wang CJ, 2006, SURG ENDOSC, V20, P1427, DOI 10.1007/s00464-005-0509-7	15	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193611	10.1371/journal.pone.0193611	http://dx.doi.org/10.1371/journal.pone.0193611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494652	gold, Green Submitted, Green Published			2022-12-27	WOS:000426363200075
J	Penitente, JM; Villadiego, FAC; Silva, FFE; Camilo, BS; Leon, VG; Peixoto, T; Diaz, E; Okano, D; Maitan, P; Lima, D; Guimaraes, SF; Siqueira, JB; Pinho, R; Guimaraes, JD				Penitente-Filho, Jurandy Mauro; Castano Villadiego, Faider Alberto; Fonseca e Silva, Fabyano; Camilo, Breno Soares; Leon, Victor Gomez; Peixoto, Thiago; Diaz, Edgar; Okano, Denise; Maitan, Paula; Lima, Daniel; Guimaraes, Simone Facioni; Siqueira, Jeanne Broch; Pinho, Rogerio; Guimaraes, Jose Domingos			Can scrotal circumference-based selection discard bulls with good productive and reproductive potential?	PLOS ONE			English	Article							ADDITIVE GENETIC-RELATIONSHIPS; HEIFER PREGNANCY; NONLINEAR MODELS; SPERM PRODUCTION; GROWTH; TRAITS; PARAMETERS; PERFORMANCE; CARCASS; AGE	Nonlinear mixed models were used to describe longitudinal scrotal circumference (SC) measurements of Nellore bulls. Models comparisons were based on Akaike's information criterion, Bayesian information criterion, error sum of squares, adjusted R-2 and percentage of convergence. Sequentially, the best model was used to compare the SC growth curve in bulls divergently classified according to SC at 18-21 months of age. For this, bulls were classified into five groups: SC < 28cm; 28cm <= SC < 30cm, 30cm <= SC < 32cm, 32cm <= SC < 34cm and SC >= 34cm. Michaelis-Menten model showed the best fit according to the mentioned criteria. In this model, beta(1) is the asymptotic SC value and beta(2) represents the time to half-final growth and may be related to sexual precocity. Parameters of the individual estimated growth curves were used to create a new dataset to evaluate the effect of the classification, farms, and year of birth on beta(1) and beta(2) parameters. Bulls of the largest SC group presented a larger predicted SC along all analyzed periods; nevertheless, smaller SC group showed predicted SC similar to intermediate SC groups (28cm <= SC < 32cm), around 1200 days of age. In this context, bulls classified as improper for reproduction at 18-21 months old can reach a similar condition to those considered as good condition. In terms of classification at 18-21 months, asymptotic SC was similar among groups, farms and years; however, beta(2) differed among groups indicating that differences in growth curves are related to sexual precocity. In summary, it seems that selection based on SC at too early ages may lead to discard bulls with suitable reproductive potential.	[Penitente-Filho, Jurandy Mauro; Castano Villadiego, Faider Alberto; Camilo, Breno Soares; Leon, Victor Gomez; Peixoto, Thiago; Diaz, Edgar; Okano, Denise; Maitan, Paula; Lima, Daniel; Pinho, Rogerio; Guimaraes, Jose Domingos] Univ Fed Vicosa, Dept Vet, Vicosa, MG, Brazil; [Fonseca e Silva, Fabyano; Guimaraes, Simone Facioni] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Siqueira, Jeanne Broch] Univ Fed Vales Jequitinhonha & Mucuri, Inst Agr Sci, Unai, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM)	Penitente, JM (corresponding author), Univ Fed Vicosa, Dept Vet, Vicosa, MG, Brazil.	penitentefilho@yahoo.com.br	Silva, Fabyano Fonseca/D-8158-2017; Silva, Fabyano/Y-9223-2019; Penitente-Filho, Jurandy/G-3017-2012; facioni guimaraes, simone eliza/HHZ-5341-2022	Penitente-Filho, Jurandy/0000-0002-8592-4020; Okano, Denise/0000-0002-6176-806X; facioni guimaraes, simone eliza/0000-0003-3704-8131	CAPES (Coordenacao de Aperfeico amento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)	CAPES (Coordenacao de Aperfeico amento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	JMPF received financial support from CAPES (Coordenacao de Aperfeico amento de Pessoal de Nivel Superior - http://www.capes.gov.br/), Post-doctoral fellowship. Other financial support was received from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - http://cnpq.br/) and FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - http://www.fapemig.br/).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2006, SAS MIXED MODELS; Bailey TL, 1998, THERIOGENOLOGY, V49, P581, DOI 10.1016/S0093-691X(98)00009-0; Bailey TL, 1996, THERIOGENOLOGY, V46, P881, DOI 10.1016/S0093-691X(96)00245-2; Barbosa V, 2010, BIOSCI J, V26, P789; Barth AD, 2000, CAN VET J, V41, P541; Bergmann JAG, 1998, C BRASILEIRO RACAS Z, V3, P145; Bilgin OC, 2004, SMALL RUMINANT RES, V52, P155, DOI 10.1016/S0921-4488(03)00251-7; Brinks J. S., 1994, Factors affecting calf crop., P363; Brody S., 1945, BIOENERGETICS GROWTH; Buzanskas ME, 2017, THERIOGENOLOGY, V92, P204, DOI 10.1016/j.theriogenology.2016.09.057; Cabrera ME, 2002, ARQUIVOS CIENCIA VET, V5, P225; Carreira JT, 2017, BASIC CLIN ANDROL, V27, DOI 10.1186/s12610-017-0056-9; Costa e Silva EV, 2015, REV BRAS REPROD ANIM, V39, P22; COULTER GH, 1979, THERIOGENOLOGY, V11, P297, DOI 10.1016/0093-691X(79)90072-4; Eler JP, 2006, GENET MOL RES, V5, P569; Eler JP, 2004, J ANIM SCI, V82, P2519; Ferraz J. B. S., 2007, Revista Brasileira de Reproducao Animal, V31, P167; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; Fortes MRS, 2014, ANDROLOGY-US, V2, P370, DOI 10.1111/j.2047-2927.2014.00196.x; Gompertz B., 1825, PHILOS T R SOC LOND, V115, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; GRESSLER SL, 2000, REV BRAS ZOOTECN, V29, P427, DOI DOI 10.1590/S1516-35982000000200016; Grossi DA, 2009, J ANIM BREED GENET, V126, P387, DOI 10.1111/j.1439-0388.2008.00791.x; Henry M, 2013, BUFFALO BULL, V32, P439; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Kizilkaya K, 2006, ARCH GEFLUGELKD, V70, P181; KNIGHTS SA, 1984, J ANIM SCI, V58, P887, DOI 10.2527/jas1984.584887x; Loaiza-Echeverri AM, 2013, THERIOGENOLOGY, V79, P751, DOI 10.1016/j.theriogenology.2012.11.031; Lopez S, 2000, J ANIM SCI, V78, P1816; Lunstra D.D., 1982, BEEF RES PROGR PROG, V1, P26; LUNSTRA DD, 1978, J ANIM SCI, V46, P1054, DOI 10.2527/jas1978.4641054x; Marques EG, 2013, BIOSCI J, V29, P159; Meloun M, 1996, SBIRKA ULOH STAT ZPR; Michaelis L, 1913, BIOCHEM Z, V49, P333; Moser DW, 1996, J ANIM SCI, V74, P2052; Nieto LM, 2006, VET ZOOLOGIA UNIPAR, V9, P99; NOTTER DR, 1985, J ANIM SCI, V60, P622, DOI 10.2527/jas1985.603622x; Notter DR, 1993, RELATIONSHIP YEARLIN, P180; OLTJEN JW, 1986, J ANIM SCI, V62, P86, DOI 10.2527/jas1986.62186x; Peek MS, 2002, OECOLOGIA, V132, P175, DOI 10.1007/s00442-002-0954-0; Pereira E, 2001, ARQ BRAS MED VET ZOO, V53, P720, DOI 10.1590/S0102-09352001000600019; Quirino CR, 1999, THERIOGENOLOGY, V52, P25, DOI 10.1016/S0093-691X(99)00107-7; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rochetti RL, 2007, REUN SOC BRAS ZOOT, V44; ROOK AJ, 1993, J AGR SCI, V121, P97, DOI 10.1017/S002185960007684X; Santana ML, 2015, THERIOGENOLOGY, V83, P1534, DOI 10.1016/j.theriogenology.2015.02.003; Santana ML, 2012, ANIMAL, V6, P565, DOI 10.1017/S1751731111001856; SAS, 2002, SAS STAT US GUID STA; Schinckel A. P., 2004, Professional Animal Scientist, V20, P79; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sesana RC, 2007, BRASILEIRA ZOOTECNIA, V44; Silva AEDF, 2002, REV BRAS ZOOTECN, V31, P1157, DOI 10.1590/S1516-35982002000500012; Silva LSPM, 2014, THESIS; Silveira FG, 2010, THESIS; Silveira TD, 2010, REV BRAS ZOOTECN, V39, P503, DOI 10.1590/S1516-35982010000300008; Siqueira J. B., 2013, Revista Brasileira de Reproducao Animal, V37, P3; Souza LD, 2013, REV BRAS ZOOTECN, V42, P651, DOI 10.1590/S1516-35982013000900007; TOELLE VD, 1985, J ANIM SCI, V60, P89, DOI 10.2527/jas1985.60189x; Unanian MM, 2000, REV BRAS ZOOTECN, V29, P136, DOI 10.1590/S1516-35982000000100019; Van Melis MH, 2010, J ANIM SCI, V88, P3809, DOI 10.2527/jas.2009-2127; Vargas CA, 1998, J ANIM SCI, V76, P2536; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Yokoo MJ, 2007, REV BRAS ZOOTECN, V36, P1761, DOI 10.1590/S1516-35982007000800008	64	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193103	10.1371/journal.pone.0193103	http://dx.doi.org/10.1371/journal.pone.0193103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494597	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200023
J	Serjeant, GR; Chin, N; Asnani, MR; Serjeant, BE; Mason, KP; Hambleton, IR; Knight-Madden, JM				Serjeant, Graham R.; Chin, Nicki; Asnani, Monika R.; Serjeant, Beryl E.; Mason, Karlene P.; Hambleton, Ian R.; Knight-Madden, Jennifer M.			Causes of death and early life determinants of survival in homozygous sickle cell disease: The Jamaican cohort study from birth	PLOS ONE			English	Article							BETA-GLOBIN GENE; ALPHA-THALASSEMIA; ADVERSE OUTCOMES; RISK-FACTORS; CHILDREN; MORTALITY; ANEMIA; POPULATION; PREVALENCE; PREDICTION	Globally, the majority of persons born with sickle cell disease do not have access to hydroxyurea or more expensive interventions. The objectives were to estimate the survival in homozygous sickle cell disease, unbiased by symptomatic selection and to ascertain the causes of death in a pre-hydroxyurea population. The utility of early life biomarkers and genetically determined phenotypes to predict survival was assessed. A cohort study based on neonatal diagnosis was undertaken at the Sickle Cell Unit, a specialist clinic delivering care to persons with sickle cell disease in Jamaica. Screening of 100,000 deliveries detected 315 babies with homozygous sickle cell disease of whom 311 have been followed from birth for periods up to 43 years. Pneumococcal prophylaxis and teaching mothers splenic palpation were important, inexpensive interventions. Anticipatory guidance, routine care and out-patient acute care were provided. Each participant was classified as alive, dead, or defaulted (usually emigration). Causes of death were ascertained from clinical records and/or post-mortem reports. Survival was assessed using the Kaplan-Meier function. Sex-adjusted Cox semi-parametric proportional hazards and Weibull modelling were used to assess the effects on survival of biomarkers. Survival to 40 years was 55.5% (95% CI 48.7% to 61.7%). Acute Chest Syndrome (n = 31) and septicemia (n = 14) were significant causes of death at all ages. Acute splenic sequestration (n = 12) was the most common cause of early deaths. Survival was significantly shorter in those with lower hemoglobin at 1 year, high total nucleated count at 1 year, and a history of dactylitis ever. In these hydroxyurea naive patients, survival into midlife was common. Causes of death were often age specific and some may be preventable. Early life biomarkers predictive of decreased survival in SS disease identify a patient group likely to benefit from close clinical supervision and potentially high risk therapies.	[Serjeant, Graham R.; Serjeant, Beryl E.; Mason, Karlene P.] Sickle Cell Trust Jamaica, Kingston, Jamaica; [Chin, Nicki; Asnani, Monika R.; Knight-Madden, Jennifer M.] Univ West Indies, Caribbean Inst Hlth Res, Sickle Cell Unit, Kingston, Jamaica; [Hambleton, Ian R.] Univ West Indies, Chron Dis Res Ctr, Caribbean Inst Hlth Res, Cave Hill, Barbados	University West Indies Mona Jamaica; University West Indies Mona Jamaica; University West Indies Cave Hill Campus	Knight-Madden, JM (corresponding author), Univ West Indies, Caribbean Inst Hlth Res, Sickle Cell Unit, Kingston, Jamaica.	jennifer.knightmadden@uwimona.edu.jm	Hambleton, Ian/AAP-3519-2020	Hambleton, Ian/0000-0002-5638-9794	Medical Research Council of Great Britain; University of the West Indies; Caribbean Public Health Agency; National Health Fund of Jamaica	Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of the West Indies; Caribbean Public Health Agency; National Health Fund of Jamaica	The Cohort Study was established with funding from the Medical Research Council of Great Britain. Recent work was supported by the University of the West Indies, the Caribbean Public Health Agency, and the National Health Fund of Jamaica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2004, BRIT J HAEMATOL, V126, P606, DOI 10.1111/j.1365-2141.2004.05025.x; BALKARAN B, 1992, J PEDIATR-US, V120, P360, DOI 10.1016/S0022-3476(05)80897-2; BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; EMOND AM, 1985, J PEDIATR-US, V107, P201, DOI 10.1016/S0022-3476(85)80125-6; Fadlon E, 1998, BLOOD, V91, P266, DOI 10.1182/blood.V91.1.266.266_266_274; Gardner K, 2016, BLOOD, V128, P1436, DOI 10.1182/blood-2016-05-716910; Hamideh D, 2013, PEDIATR BLOOD CANCER, V60, P1482, DOI 10.1002/pbc.24557; Hardie R, 2009, ANN TROP PAEDIATR, V29, P197, DOI 10.1179/027249309X12467994693851; JOHN AB, 1984, BRIT MED J, V288, P1567, DOI 10.1136/bmj.288.6430.1567; King L, 2007, J MED SCREEN, V14, P117, DOI 10.1258/096914107782066185; King L, 2011, W INDIAN MED J, V60, P177; King L, 2011, ARCH DIS CHILD, V96, P1135, DOI 10.1136/archdischild-2011-300628; King LGC, 2015, J PEDIATR-US, V167, P702, DOI 10.1016/j.jpeds.2015.06.028; Lanzkron S, 2013, PUBLIC HEALTH REP, V128, P110, DOI 10.1177/003335491312800206; Lee A, 1995, BRIT MED J, V311, P1600, DOI 10.1136/bmj.311.7020.1600; Maitra P, 2017, HAEMATOLOGICA, V102, P626, DOI 10.3324/haematol.2016.153791; MEARS JG, 1983, BLOOD, V62, P286; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; NAGEL RL, 1990, SEMIN HEMATOL, V27, P342; Old J M, 1996, Methods Mol Med, V5, P169, DOI 10.1385/0-89603-346-5:169; ORKIN SH, 1984, ANNU REV GENET, V18, P131; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Quinn CT, 2008, BLOOD, V111, P544, DOI 10.1182/blood-2007-07-100719; ROGERS DW, 1978, BRIT MED J, V1, P1515, DOI 10.1136/bmj.1.6126.1515; SERJEANT BE, 1974, CLIN CHEM, V20, P666; SERJEANT GR, 1986, BRIT J HAEMATOL, V64, P253, DOI 10.1111/j.1365-2141.1986.tb04117.x; Serjeant GR, 2001, SICKLE CELL DIS; Serjeant GR, 2007, NEW ENGL J MED, V356, P642, DOI 10.1056/NEJMc066547; THOMAS AN, 1982, BRIT MED J, V285, P633, DOI 10.1136/bmj.285.6342.633; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; Wang Y, 2015, GENET MED, V17, P452, DOI 10.1038/gim.2014.123; Wierenga KJJ, 2001, LANCET, V357, P680, DOI 10.1016/S0140-6736(00)04132-5; Wonkam A, 2014, AM J HEMATOL, V89, P664, DOI 10.1002/ajh.23711	35	29	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0192710	10.1371/journal.pone.0192710	http://dx.doi.org/10.1371/journal.pone.0192710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494636	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200013
J	Vilardell, J; Girardi, C; Marin, O; Cozza, G; Pinna, LA; Ruzzene, M				Vilardell, Jordi; Girardi, Cristina; Marin, Oriano; Cozza, Giorgio; Pinna, Lorenzo A.; Ruzzene, Maria			The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131	PLOS ONE			English	Article							PROTEIN-KINASE CK2; SECONDARY STRUCTURE PREDICTION; CASEIN KINASE-2; SUBSTRATE RECOGNITION; CONSENSUS SEQUENCES; MOLECULAR-DYNAMICS; BREAST-CANCER; PHOSPHORYLATION; SPECIFICITY; REGULATOR	CK2 is a pleiotropic S/T protein kinase ( formerly known as casein kinase 2) which is attracting increasing interest as therapeutic target, and the identification of its substrates is a crucial step in determining its involvement in different pathological conditions. We recently found that S131 of Akt2 ( homologous to the well established CK2 target S129 of Akt1) is not phosphorylated by CK2 either in vitro or in vivo, although the consensus sequence recognized by CK2 ( S/T-x-x-E/D/pS/pT) is conserved in it. Here, by exploiting synthetic peptides, in cell transfection experiments, and computational analysis, we show that a single sequence element, a T at position n+1, hampers phosphorylation, causing an alpha-helix structure organization which prevents the recognition of its own consensus by CK2. Our results highlight the role of negative determinants as crucial modulators of CK2 targeting and corroborate the concept that Akt1 and Akt2 display isoform specific features. Experiments with synthetic peptides suggest that Akt2 S131 could be phosphorylated by kinases of the Plk ( Polo-like kinase) family, which are insensitive to the presence of the n+1 T. The low phylogenetic conservation of the Akt2 sequence around S131, as opposed to the extremely well-conserved Akt1 homologous sequence, would indicate a dominant positive role in the selective pressure only for the Akt1 phosphoacceptor site committed to undergo phosphorylation by CK2. By contrast, Akt2 S131 may mediate the response to specific physio/pathological conditions, being consequently shielded against basal CK2 targeting.	[Vilardell, Jordi; Girardi, Cristina; Marin, Oriano; Pinna, Lorenzo A.; Ruzzene, Maria] Univ Padua, Dept Biomed Sci, Padua, Italy; [Cozza, Giorgio] Univ Padua, Dept Mol Med, Padua, Italy; [Pinna, Lorenzo A.; Ruzzene, Maria] CNR, Neurosci Inst, Padua, Italy	University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Ruzzene, M (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.; Ruzzene, M (corresponding author), CNR, Neurosci Inst, Padua, Italy.	maria.ruzzene@unipd.it		COZZA, GIORGIO/0000-0002-5155-4682; Ruzzene, Maria/0000-0001-8712-8151	"Associazione Italiana per la Ricerca sul Cancro", AIRC [IG-14180]; University of Padova	"Associazione Italiana per la Ricerca sul Cancro", AIRC; University of Padova	This work was supported by "Associazione Italiana per la Ricerca sul Cancro", AIRC project IG-14180 to LAP, by University of Padova (institutional funds to MR, and Progetto Giovani Ricercatori to GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Borgo C, 2017, SCI REP-UK, V7, DOI 10.1038/srep42409; Carpino LA, 2001, J ORG CHEM, V66, P5245, DOI 10.1021/jo001616+; Castello J, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010007; Chin YR, 2011, CELL ADHES MIGR, V5, P211, DOI 10.4161/cam.5.3.15790; Clark AR, 2014, BIOCHEM SOC T, V42, P1349, DOI 10.1042/BST20140160; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Di Maira G, 2009, CELL MOL LIFE SCI, V66, P3363, DOI 10.1007/s00018-009-0108-1; Foka P, 2014, CELL MOL LIFE SCI, V71, P4243, DOI 10.1007/s00018-014-1621-4; Girardi C, 2014, BBA-MOL CELL RES, V1843, P1865, DOI 10.1016/j.bbamcr.2014.04.020; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Heron-Milhavet L, 2011, HISTOL HISTOPATHOL, V26, P651, DOI 10.14670/HH-26.651; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Ka SO, 2015, SCI REP-UK, V5, DOI 10.1038/srep14816; Koch S, 2013, MUCOSAL IMMUNOL, V6, P136, DOI 10.1038/mi.2012.57; MARCHIORI F, 1988, BIOCHIM BIOPHYS ACTA, V971, P332; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; MARIN O, 1992, FEBS LETT, V301, P111, DOI 10.1016/0014-5793(92)80221-2; MARIN O, 1994, BIOCHEM BIOPH RES CO, V198, P898, DOI 10.1006/bbrc.1994.1128; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Najm P, 2014, CELL ADHES MIGR, V8, P29, DOI 10.4161/cam.28024; Ottaviani D, 2017, HUM MOL GENET, V26, P611, DOI 10.1093/hmg/ddw420; Pagano MA, 2010, BIOCHEM J, V426, P19, DOI 10.1042/BJ20090813; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; PERICH JW, 1992, BIOCHEMISTRY-US, V31, P5893, DOI 10.1021/bi00140a027; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Rossi M, 2015, P NATL ACAD SCI USA, V112, pE6818, DOI 10.1073/pnas.1519430112; Ruzzene Maria, 2017, Advances in Biological Regulation, V64, P1, DOI 10.1016/j.jbior.2017.03.002; Ruzzene M, 2010, METHOD ENZYMOL, V484, P495, DOI [10.1016/S0076-6879(10)84024-8, 10.1016/B978-0-12-381298-8.00024-1]; Salvi M, 2012, BBA-PROTEINS PROTEOM, V1824, P1366, DOI 10.1016/j.bbapap.2012.07.003; Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013; Sarno S, 1997, BIOCHEMISTRY-US, V36, P11717, DOI 10.1021/bi9705772; SARNO S, 1995, BIOCHEM BIOPH RES CO, V206, P171, DOI 10.1006/bbrc.1995.1024; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Wadhwa B, 2017, ANTI-CANCER DRUG, V28, P569, DOI 10.1097/CAD.0000000000000496; Yang YD, 2017, METHODS MOL BIOL, V1484, P55, DOI 10.1007/978-1-4939-6406-2_6	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193479	10.1371/journal.pone.0193479	http://dx.doi.org/10.1371/journal.pone.0193479			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494643	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200052
J	Kallakuri, S; Pace, E; Lu, HC; Luo, H; Cavanaugh, J; Zhang, JS				Kallakuri, Srinivasu; Pace, Edward; Lu, Huichao; Luo, Hao; Cavanaugh, John; Zhang, Jinsheng			Time course of blast-induced injury in the rat auditory cortex	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; AXONAL INJURY; COCHLEAR NUCLEUS; INDUCED TINNITUS; HEARING-LOSS; ACOUSTIC OVERSTIMULATION; EXPOSURE; OVERPRESSURE; DEGENERATION; MODEL	Blast exposure is an increasingly significant health hazard and can have a range of debilitating effects, including auditory dysfunction and traumatic brain injury. To assist in the development of effective treatments, a greater understanding of the mechanisms of blast induced auditory damage and dysfunction, especially in the central nervous system, is critical. To elucidate this area, we subjected rats to a unilateral blast exposure at 22 psi, measured their auditory brainstem responses (ABRs), and histologically processed their brains at 1 day, 1 month, and 3-month survival time points. The left and right auditory cortices was assessed for astrocytic reactivity and axonal degenerative changes using glial fibrillary acidic protein immunoreactivity and a silver impregnation technique, respectively. Although only unilateral hearing loss was induced, astrocytosis was bilaterally elevated at 1 month post-blast exposure compared to shams, and showed a positive trend of elevation at 3 months post-blast. Axonal degeneration, on the other hand, appeared to be more robust at 1 day and 3 months post-blast. Interestingly, while ABR threshold shifts recovered by the 1 and 3-month time-points, a positive correlation was observed between rats' astrocyte counts at 1 month post-blast and their threshold shifts at 1 day post-blast. Taken together, our findings suggest that central auditory damage may have occurred due to biomechanical forces from the blast shockwave, and that different indicators/types of damage may manifest over different timelines.	[Kallakuri, Srinivasu; Lu, Huichao; Cavanaugh, John] Wayne State Univ, Coll Engn, Dept Biomed Engn, Detroit, MI USA; [Pace, Edward; Luo, Hao; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48202 USA; [Zhang, Jinsheng] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI 48202 USA	Wayne State University; Wayne State University; Wayne State University	Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48202 USA.; Zhang, JS (corresponding author), Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI 48202 USA.	jinzhang@med.wayne.edu	张, 锦胜/GXF-8167-2022	Zhang, Jinsheng/0000-0002-8311-2678	US Department of Defense [W81XWH-11-2-0031]	US Department of Defense(United States Department of Defense)	This work was supported by the US Department of Defense (grant award W81XWH-11-2-0031).	Carron SF, 2016, J COMP NEUROL, V524, P3530, DOI 10.1002/cne.24014; Chang YM, 2004, NEUROREPORT, V15, P1699, DOI 10.1097/01.wnr.0000134584.10207.1a; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Kallakuri S, 2015, J NEUROSCI RURAL PRA, V6, P481, DOI 10.4103/0976-3147.169767; Karch Stephanie J, 2016, US Army Med Dep J, P52; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kim JJ, 2004, J NEUROSCI RES, V77, P829, DOI 10.1002/jnr.20211; Kim JN, 1997, HEARING RES, V103, P169, DOI 10.1016/S0378-5955(96)00173-6; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Liberman MC, 2017, HEARING RES, V349, P138, DOI 10.1016/j.heares.2017.01.003; Licona NE, 2016, ARCH PHYS MED REHABI; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Luo H., 2016, NEUROSCIENCE; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; Nawashiro H, 2002, ACTA NEUROCHIR SUPPL, V81, P269; Nordmann AS, 2000, HEARING RES, V139, P13, DOI 10.1016/S0378-5955(99)00163-X; OUYANG J, 2017, SCI REPORTS, V7, P19374; ROBERTSON D, 1983, HEARING RES, V9, P263, DOI 10.1016/0378-5955(83)90031-X; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith L, 2002, HEARING RES, V169, P1, DOI 10.1016/S0378-5955(02)00461-6; SPOENDLIN H, 1971, ACTA OTO-LARYNGOL, V71, P166, DOI 10.3109/00016487109125346; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071	39	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193389	10.1371/journal.pone.0193389	http://dx.doi.org/10.1371/journal.pone.0193389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489862	Green Submitted, gold, Green Published			2022-12-27	WOS:000426276000069
J	Hasler, RM; Stucky, S; Bahler, H; Exadaktylos, AK; Neff, F				Hasler, Rebecca Maria; Stucky, Sandra; Bahler, Heinz; Exadaktylos, Aristomenis K.; Neff, Frank			The dead and the dying - a difficult part of EMS transport: A Swiss cross-sectional study	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; CHEST COMPRESSION; ROOM MANAGEMENT; SURVIVAL; TRIAL; RESUSCITATION; TIME	Objective Most deaths occur in the pre-hospital setting, whereas mortality in the emergency department (ED) is low (<1 %). However, our clinical impression is that some patients are being transported to hospital in devastating conditions with no likelihood of survival, but demanding extensive hospital resources. The decision on whether to transport a dying person to hospital or not is a difficult task for emergency medical services (EMS) personnel. As there is little epidemiological data about these patients, this paper aims to describe this special population. Methods Retrospective cross-sectional study on adult patients transported by ground ambulance to the ED of a Swiss university hospital, who died during their stay in the ED between January 2008 and December 2012. Data was collected on the basis of ambulance report forms and discharge summaries of the ED. Results One hundred and sixty-one patients were analysed. Most deaths were due to cardiovascular diseases (43%). Only 9% of patients died of trauma. The median age was 70 years (IQR 56-81 years) and 70% (n = 112) were men. Trauma patients were significantly younger (median age 55 years, p<0.001). The overall mortality rate was 0.9% for all patients transported by EMS to the ED. About one third of all patients received cardiopulmonary resuscitation (CPR) from bystanders (n = 53). The most common electrocardiogram (ECG) findings were asystole (n = 57) and pulseless electrical activity (n = 91). Fifty percent (n = 64) of the resuscitated patients were defibrillated. Three quarters (n = 115, 72%) of all patients were intubated on site. The mechanical chest compression device Lucas (TM) 2 was mainly used in cases of cardiovascular or uncertain cause of death and did not reduce the operating time on site. Conclusion The low ED mortality rate of 0.9% shows that only a few dying patients are transported to hospital. However, transport to hospital has to be carefully evaluated, especially for elderly patients with asystole or PEA due to medical conditions. The low CPR rate from bystanders demonstrates that public CPR training should be promoted further. The use of Lucas (TM) 2 did not reduce the operating time on site. For further investigations, comparison with survivors would be needed.	[Hasler, Rebecca Maria; Stucky, Sandra; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Inselspital, Dept Emergency Med, Bern, Switzerland; [Hasler, Rebecca Maria; Bahler, Heinz; Neff, Frank] Sanitdtspolizei Bern, Emergency Med Serv Bern, Bern, Switzerland; [Neff, Frank] Univ Hosp Bern, Inselspital, Dept Anesthesiol & Pain Therapy, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Hasler, RM (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, Bern, Switzerland.; Hasler, RM (corresponding author), Sanitdtspolizei Bern, Emergency Med Serv Bern, Bern, Switzerland.	rebecca.hasler@insel.ch						Al-Shaqsi Sultan, 2010, Oman Med J, V25, P320, DOI 10.5001/omj.2010.92; [Anonymous], 2005, NOTF RETT; Baker M, 2006, EMERG MED J, V23, P601, DOI 10.1136/emj.2005.028134; Brinkrolf P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178938; Couper K, 2015, CURR OPIN CRIT CARE, V21, P188, DOI 10.1097/MCC.0000000000000200; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Hasler RM, 2014, J TRAUMA ACUTE CARE, V77, P757, DOI 10.1097/TA.0000000000000452; Hussmann B, 2012, MED KLIN-INTENSIVMED, V107, P217, DOI 10.1007/s00063-012-0093-2; Kleber C, 2012, WORLD J SURG, V36, P2125, DOI 10.1007/s00268-012-1650-9; Machold W, 2008, RADIOLOGE, V48, P442, DOI 10.1007/s00117-008-1654-5; NAWAR EW, 2007, ADV DATA VITAL HLTH, V386; Perkins GD, 2015, LANCET, V385, P947, DOI 10.1016/S0140-6736(14)61886-9; Rubertsson S, 2014, JAMA-J AM MED ASSOC, V311, P53, DOI 10.1001/jama.2013.282538; Rutschmann OT, 2017, EUR J EMERG MED; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; The American Heart Association, 2000, CIRCULATION S, V102; Tiah L, 2014, WEST J EMERG MED, V15, P749, DOI 10.5811/westjem.2014.9.20291; TraumaRegister DGU, 2014, INJURY, V45, pS14, DOI 10.1016/j.injury.2014.08.012; Wang HE, 2011, RESUSCITATION, V82, P378, DOI 10.1016/j.resuscitation.2010.12.014; Wik L, 2014, RESUSCITATION, V85, P741, DOI 10.1016/j.resuscitation.2014.03.005	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0191879	10.1371/journal.pone.0191879	http://dx.doi.org/10.1371/journal.pone.0191879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29485991	Green Submitted, Green Published, gold			2022-12-27	WOS:000426242400004
J	Figueredo, MCS; Herrera, JCM; Giraldos, MS; Leiva, IL; Campos, AL; Garcia, CM; Mayor, SG; Utumchandani, SK; Asencio, JMM				Saucedo Figueredo, Maria Carmen; Morilla Herrera, Juan Carlos; San Alberto Giraldos, Mercedes; Lopez Leiva, Inmaculada; Leon Campos, Alvaro; Marti Garcia, Celia; Garcia Mayor, Silvia; Kaknani Utumchandani, Shakira; Morales Asencio, Josd Miguel			Validation of the Spanish version of the Edinburgh Feeding Evaluation in Dementia Scale for older people with dementia	PLOS ONE			English	Article							CROSS-CULTURAL VALIDATION; INGESTIVE SKILLS; LOW FOOD; DIFFICULTY; MALNUTRITION; TRANSLATION; DYSPHAGIA; BURDEN; ADULTS	Aims To adapt the Edinburgh Feeding Evaluation in Dementia Scale (EdFED) for use in a Spanish-speaking population and to assess its validity and reliability in patients with dementia. Method A cross-sectional study was carried out in two stages: 1. Cross-cultural adaptation (translation, back-translation, review by committee of experts, pilot test and weighting of results); 2. Clinimetric validation comprising interobserver reliability assessment, test-retest reliability and internal consistency. To determine construct validity, confirmatory factorial analysis and principal components analysis were performed by oblique rotations. Criteria validity was analysed using the Pearson correlation (p<0.05) with the BMI, MNA and analytical values of albumin, transferrin, cholesterol, absolute lymphocytes and total proteins. Data collection was carried out for six months in 2016 in nursing homes and Alzheimer's day centers in the province of Milaga (Spain), at nine centers, with 262 patients (aged over 60 years and presenting feeding difficulties), 20 nurses, 20 professional caregivers and 103 family caregivers. Results A version of EdFED culturally adapted to Spanish was obtained. The sample presented the following characteristics: 76.3% women, mean age 82.3 years (SD: 7.9); MNA 18.73 (SD: 4.44); BMI 23.99 (SD: 4.72); serum albumin 3.79 mg/dl (SD: 0.36). A Cronbach's alpha of 0.88 was obtained, with an inter-item global correlation of 0.43 and a homogeneity index ranging from 0.42 to 0.73. The exploratory factor analysis reproduced the three-factor model identified by the original authors, explaining 62.32% of the total variance. The criterion validity showed a good inverse correlation with MNA and a moderate one with albumin, total proteins, transferrin and BMI. Discussion The Spanish version of EdFED is reliable and valid for use in elderly people with dementia. The most appropriate for our environment is the three-factor model, which maintains the original factors, with a slight redistribution of the items.	[Saucedo Figueredo, Maria Carmen] Los Boliches Hlth Ctr, Costa Sol Primary Hlth Care Dist, Malaga, Spain; [Morilla Herrera, Juan Carlos] Primary Hlth Care Dist, Nursing Home Unit Malaga Guadalhorce, Malaga, Spain; [Morilla Herrera, Juan Carlos] Univ Malaga, Fac Hlth Sci, Malaga, Spain; [San Alberto Giraldos, Mercedes] Costa Sol Primary Hlth Care Dist, La Lobilla Hlth Ctr, Malaga, Spain; [Lopez Leiva, Inmaculada; Marti Garcia, Celia; Garcia Mayor, Silvia; Morales Asencio, Josd Miguel] Univ Malaga, Fac Hlth Sci, Dept Nursing, Malaga, Spain; [Leon Campos, Alvaro] Comillas Univ, Dept Nursing, Salamanca, Spain; [Kaknani Utumchandani, Shakira] Red Cross Sch Nursing, Seville, Spain	Universidad de Malaga; Universidad de Malaga; Comillas Pontifical University	Figueredo, MCS (corresponding author), Los Boliches Hlth Ctr, Costa Sol Primary Hlth Care Dist, Malaga, Spain.	marisaucedofigueredo@hotmail.com	Martí, Celia/I-4502-2017; MORALES-ASENCIO, JOSE MIGUEL/B-4996-2008	Martí, Celia/0000-0003-2656-8473; MORALES-ASENCIO, JOSE MIGUEL/0000-0001-7911-7487; Morilla Herrera, Juan Carlos/0000-0003-3814-4440; Saucedo Figueredo, Maria Carmen/0000-0001-8815-4079	FPS Proyectos de Investigacion Atencion Primaria [AP_0004_2015]; Fundacion Publica Andaluza para la investigacion de Malaga en Biomedicina y Salud	FPS Proyectos de Investigacion Atencion Primaria; Fundacion Publica Andaluza para la investigacion de Malaga en Biomedicina y Salud	This study was funded 25.000 epsilon by FPS Proyectos de Investigacion Atencion Primaria, AP_0004_2015, Fundacion Publica Andaluza para la investigacion de Malaga en Biomedicina y Salud, http://www.juntadeandalucia.es/fundacionprogresoysalud/gestionconvocatorias/.	Amella E J, 2002, J Nutr Health Aging, V6, P117; Gonzalez MB, 2016, NUTR HOSP, V33, P739, DOI 10.20960/nh.286; Bagnasco A, 2013, LINGUISTIC CULTURAL; Bagnasco A, 2015, APPL NURS RES, V28, P391, DOI 10.1016/j.apnr.2015.02.003; Blandford G, 1998, LOSS EAT BEHAV ALZHE, P47; Blandford G, 1998, RES PRACT ALZHEIMERS; Chang CC, 2005, J CLIN NURS, V14, P1185, DOI 10.1111/j.1365-2702.2005.01240.x; Chang CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171770; Chang CC, 2011, AM J NURS, V111, P36, DOI 10.1097/01.NAJ.0000396553.01996.5e; Clave P, 2005, MED CLIN-BARCELONA, V124, P742, DOI 10.1157/13075447; Clave Pere, 2007, Cir Esp, V82, P62; Coyne M L, 1997, Clin Nurs Res, V6, P275, DOI 10.1177/105477389700600307; Perez JID, 2014, NUTR HOSP, V29, P797, DOI 10.3305/nh.2014.29.4.7275; Durnbaugh T., 1993, AM J ALZHEIMERS CARE, V8, P22; Gomez-Busto Fernando, 2009, Rev Esp Geriatr Gerontol, V44 Suppl 2, P29, DOI 10.1016/j.regg.2008.07.006; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; IMSERSO, 2012, INF 2012 PERS MAYOR; Instituto de Mayores y Servicios Sociales (IMSERSO), 2010, ENC MAYOR 2010; International Test Commission-ITC, 2005, ITC GUID TRANSL AD T; Kaiser MJ, 2010, J AM GERIATR SOC, V58, P1734, DOI 10.1111/j.1532-5415.2010.03016.x; Lambert HC, 2003, DYSPHAGIA, V18, P101, DOI 10.1007/s00455-002-0091-2; Lambert HC, 2006, AM J OCCUP THER, V60, P409, DOI 10.5014/ajot.60.4.409; LeClerc CM, 1998, GERIATR NURS, V19, P261, DOI 10.1016/S0197-4572(98)90099-4; LeClerc CM, 2004, ALZHEIMERS CARE Q, V5, P123; Lin LC, 2003, ALZ DIS ASSOC DIS, V17, P230, DOI 10.1097/00002093-200310000-00006; Lin LC, 2008, J ADV NURS, V62, P116, DOI 10.1111/j.1365-2648.2008.04596.x; Lin LC, 2010, J CLIN NURS, V19, P53, DOI 10.1111/j.1365-2702.2009.02962.x; Liu W, 2014, J CLIN NURS, V23, P45, DOI 10.1111/j.1365-2702.2012.04250.x; Lozoya RM, 2013, NUTR HOSP, V28, P1438, DOI 10.3305/nh.2013.28.5.6782; Mora Fernandez J., 1999, SERIES CLIN GERIATRI; Morais A, 2009, PEDIAT CONTIN, V7, P348; Moriyama IM, 1968, INDICATORS SOCIAL CH; OMS, 2017, OMS 10 FACTS AG HLTH; OMS, 2015, OMS WORLD REP AG HLT; OMS, 2015, OMS FACTS AG; OMS, 2012, DEM PUBL HLTH PRIOR; ONU, 2015, WORLD POP AG 2015; Palmer BL, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000308961.99857.33; Phillips L R, 1993, J Nurs Meas, V1, P41; Vila MP, 2010, NUTR HOSP, V25, P1020, DOI 10.3305/nh.2010.25.6.5064; Rabat Restrepo JM, 2004, MEDIDAS ANTROPOM6TRI; Ravasco P, 2010, NUTR HOSP, V25, P57; Reed PS, 2005, GERONTOLOGIST, V45, P74, DOI 10.1093/geront/45.suppl_1.74; Reyes Ortega G., 1996, ANO GERONTOLOGICO, V10-N, P353; Riviere S, 2002, INT J GERIATR PSYCH, V17, P950, DOI 10.1002/gps.724; Sergi G, 2013, P NUTR SOC, V72, P160, DOI 10.1017/S0029665112002753; STATSOFT Inc, 2012, STAT DAT AN SOFTW SY; Steele CM, 1997, DYSPHAGIA, V12, P43, DOI 10.1007/PL00009517; Steinbaugh M.L., 1986, AM DIET ASS 69 ANN M; Stockdell R, 2008, AM J NURS, V108, P46, DOI 10.1097/01.NAJ.0000327831.51782.8e; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Todorovic V., 2003, MUST EXPLANATORY BOO; Tully M W, 1998, J Nutr Health Aging, V2, P119; Walrand S, 2001, AM J CLIN NUTR, V74, P670; Watson R, 1997, INT J NURS STUD, V34, P405, DOI 10.1016/S0020-7489(97)00033-3; WATSON R, 1994, J ADV NURS, V20, P283, DOI 10.1046/j.1365-2648.1994.20020283.x; WATSON R, 1993, J ADV NURS, V18, P25, DOI 10.1046/j.1365-2648.1993.18010025.x; Watson R., 1993, ESTIMATING RELATIVE; Watson R, 2012, J CLIN NURS, V21, P2736, DOI 10.1111/j.1365-2702.2011.03893.x	59	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0192690	10.1371/journal.pone.0192690	http://dx.doi.org/10.1371/journal.pone.0192690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7BV	29486002	gold, Green Published			2022-12-27	WOS:000426242400009
J	Gonzalez-Sanchez, ME; Cuquerella, M; Alunda, JM				Elena Gonzalez-Sanchez, Maria; Cuquerella, Montserrat; Alunda, Jose M.			Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose	PLOS ONE			English	Article							GASTROINTESTINAL NEMATODE; ANTHELMINTIC RESISTANCE; IMMUNE-RESPONSE; INFECTION; SHEEP; PROTECTION; VACCINES; PROTEIN; CHALLENGE; PARASITES	Haemonchus contortus is the most pathogenic gastrointestinal helminth of small ruminants. Natural or experimental repeated infections and several native antigens confer a partially protective immune response but vaccination with subunit antigens has been elusive. Promising results have been obtained with a recombinant form of a somatic antigen (rHc23). In this paper we present the results obtained in vaccination trials in lambs using two dosages of rHc23 and standard adjuvants. Six-months old Manchego females lambs were vaccinated with rHc23 (50 or 200 mu g/dose) adjuvanted with 1mL aluminum hydroxide on days -42, -28 and -14 or with 200 mu g/dose rHc23 and 5 mg Quil A on days -49, -28 and -7. Control lambs were kept receiving only the adjuvants the same days or no treatment. Moreover one group did not receive any treatment or infection. On day 0 vaccinated lambs, untreated animals and those receiving the adjuvant were infected per os with a monospecific single infection of 4000 L3 of H. contortus. Infection was kept for 58 days and follow-up included the determination of serum specific antibody response (ELISA, WB), hematological parameters (eosinophil counts, hematocrit) and fecal egg counts (epg). Absence of hematocrit alterations, reduction of helminth's eggs output and abomasal parasite burden at the end of the experiment were the efficacy criteria of vaccination with the recombinant. Immunization with both adjuvants and antigen dosages elicited strong antibody responses particularly with Quil A. Vaccinated groups showed significant reduction of fecal egg excretion and abomasal helminth burdens. Highest protection of lambs against challenge was achieved with aluminum hydroxide and 200 mu g/dose rHc23 with a reduction of over 70% of the abomasal burden and over 80% of fecal egg output. Results suggest that rHc23 could be a valuable recombinant candidate for vaccination against haemonchosis. No clear relationship was found between antibody levels and protection this pointing towards involvement of both humoral and cellular components in the protective response elicited by rHc23.	[Elena Gonzalez-Sanchez, Maria; Cuquerella, Montserrat; Alunda, Jose M.] Univ Complutense Madrid, Fac Vet Med, Dept Anim Hlth, Madrid, Spain	Complutense University of Madrid	Alunda, JM (corresponding author), Univ Complutense Madrid, Fac Vet Med, Dept Anim Hlth, Madrid, Spain.	jmalunda@ucm.es	Cuquerella, Montserrat/R-8294-2018; Gonzalez, Elena/AAB-4455-2020	Cuquerella, Montserrat/0000-0002-0091-1328; Gonzalez, Elena/0000-0003-0448-7023; Alunda, Jose Maria/0000-0002-1491-8627	Spanish Ministerio de Economia y Competitividad [AGL2014-54049-R]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	Research was funded by the Spanish Ministerio de Economia y Competitividad, grant AGL2014-54049-R. Funders had no role in the study design, experiments carried out, analysis and publication.	Albrecht L, 2006, J ANIM SCI, V84, P124; Amarante AFT, 2005, VET PARASITOL, V128, P99, DOI 10.1016/j.vetpar.2004.11.021; Atmar RL, 2007, VACCINE, V25, P5367, DOI 10.1016/j.vaccine.2007.05.002; Bakker N, 2004, VACCINE, V22, P618, DOI 10.1016/j.vaccine.2003.08.025; BARNES EH, 1995, PARASITOL TODAY, V11, P56, DOI 10.1016/0169-4758(95)80117-0; Cachat E, 2010, PARASITE IMMUNOL, V32, P414, DOI 10.1111/j.1365-3024.2010.01208.x; CUQUERELLA M, 1991, VET PARASITOL, V38, P131, DOI 10.1016/0304-4017(91)90123-D; De Matos A.F.I.M., 2017, SMALL RUMINANT RES, V151, P1; Emery DL, 2016, INT J PARASITOL, V46, P755, DOI 10.1016/j.ijpara.2016.07.001; Estcourt MJ, 2005, EUR J IMMUNOL, V35, P2532, DOI 10.1002/eji.200535184; Fawzi EM, 2015, VET PARASITOL, V211, P54, DOI 10.1016/j.vetpar.2015.04.029; Fawzi EM, 2014, INT J PARASITOL, V44, P429, DOI 10.1016/j.ijpara.2014.02.009; GAMBLE HR, 1992, VET PARASITOL, V41, P211, DOI 10.1016/0304-4017(92)90081-J; Gauly M, VET PARASITOL, V30, P55; Gomez-Munoz MT, 1999, VET PARASITOL, V81, P281, DOI 10.1016/S0304-4017(98)00260-X; Jacobs HJ, 1999, VACCINE, V17, P362, DOI 10.1016/S0264-410X(98)00206-0; Kandil OM, 2017, VET WORLD, V10, P758, DOI 10.14202/vetworld.2017.758-763; Kaplan RM, 2012, VET PARASITOL, V186, P70, DOI 10.1016/j.vetpar.2011.11.048; Kotze AC, 2016, ADV PARASIT, V93, P397, DOI 10.1016/bs.apar.2016.02.012; Lacroux C, 2006, VET RES, V37, P607, DOI 10.1051/vetres:2006022; MAFF (Ministry of Agriculture Fisheries and Food), 1971, MAN VET PAR LAB TECH; Matthews JB, 2016, PARASITE IMMUNOL, V38, P744, DOI 10.1111/pim.12391; McRae KM, 2015, PARASITE IMMUNOL, V37, P605, DOI 10.1111/pim.12290; Meeusen ENT, 2000, PARASITOL TODAY, V16, P95, DOI 10.1016/S0169-4758(99)01607-5; Meier L, 2016, VET PARASITOL, V229, P15, DOI 10.1016/j.vetpar.2016.08.024; Newton SE, 1999, PARASITOL TODAY, V15, P116, DOI 10.1016/S0169-4758(99)01399-X; Nicholls EF, 2010, ANN NY ACAD SCI, V1213, P46, DOI 10.1111/j.1749-6632.2010.05787.x; Piedrafita D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078357; Quan FS, 2009, J VIROL, V83, P4489, DOI 10.1128/JVI.02035-08; Redmond DL, 2004, VACCINE, V22, P4252, DOI 10.1016/j.vaccine.2004.04.028; Rojo-Montejo S, 2011, VET PARASITOL, V175, P220, DOI 10.1016/j.vetpar.2010.10.028; Rose H, 2015, VET REC, V176, DOI 10.1136/vr.102982; Schallig HDFH, 1997, PARASITOLOGY, V114, P293, DOI 10.1017/S0031182096008517; Spickler AR, 2003, J VET INTERN MED, V17, P273, DOI 10.1892/0891-6640(2003)017&lt;0273:AIVVMO&gt;2.3.CO;2; Stills HF, 2005, ILAR J, V46, P280, DOI 10.1093/ilar.46.3.280; WILLADSEN P, 1995, PARASITOLOGY, V110, pS43, DOI 10.1017/S0031182000001487; Yanming S, 2007, PARASITE IMMUNOL, V29, P319, DOI 10.1111/j.1365-3024.2007.00949.x	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193118	10.1371/journal.pone.0193118	http://dx.doi.org/10.1371/journal.pone.0193118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513692	Green Submitted, gold, Green Published			2022-12-27	WOS:000426896800039
J	Morales, G; Moragrega, C; Montesinos, E; Llorente, I				Morales, Gerard; Moragrega, Concepcio; Montesinos, Emilio; Llorente, Isidre			Effects of leaf wetness duration and temperature on infection of Prunus by Xanthomonas arboricola pv. pruni	PLOS ONE			English	Article							DISEASE WARNING SYSTEM; BACTERIAL SPOT; PERENNIAL RYEGRASS; FRUIT-TREES; STONE FRUIT; MODELS; ALMOND; PEACH	Xanthomonas arboricola pv. pruni is the causal agent of bacterial spot disease of stone fruits and almond. The bacterium is distributed throughout the major stone-fruit-producing areas of the World and is considered a quarantine organism in the European Union according to the Council Directive 2000/29/EC, and by the European and Mediterranean Plant Protection Organization. The effect of leaf wetness duration and temperature on infection of Prunus by X arboricola pv. pruni was determined in controlled environment experiments. Potted plants of the peach-almond hybrid GF-677 were inoculated with bacterial suspensions and exposed to combinations of six leaf wetness durations (from 0 to 24 h) and seven fixed temperatures (from 5 to 35 degrees C) during the infection period. Then, plants were transferred to a biosafety greenhouse, removed from bags, and incubated at optimal conditions for disease development. Although leaf wetness was required for infection of Prunus by X arboricola pv. pruni, temperature had a greater effect than leaf wetness duration on disease severity. The combined effect of wetness duration and temperature on disease severity was quantified using a modification of the Weibull equation proposed by Duthie. The reduced-form of Duthie's model obtained by nonlinear regression analysis fitted well to data (R = 0.87 and R-adj(2) = 0.85), and all parameters were significantly different from 0. The estimated optimal temperature for infection by X arboricola pv. pruni was 28.9 degrees C. Wetness periods longer than 10 h at temperatures close to 20 degrees C, or 5 h at temperatures between 25 and 35 degrees C were necessary to cause high disease severity. The predictive capacity of the model was evaluated using an additional set of data obtained from new wetness duration-temperature combinations. In 92% of the events the observed severity agreed with the predicted level of infection risk. The risk chart derived from the reduced form of Duthie's model can be used to estimate the potential risk for infection of Prunus by X arboricola pv. pruni based on observed or forecasted temperature and wetness duration.	[Morales, Gerard; Moragrega, Concepcio; Montesinos, Emilio; Llorente, Isidre] Univ Girona, Inst Food & Agr Technol XaRTA CIDSAV, Girona, Spain	Universitat de Girona	Llorente, I (corresponding author), Univ Girona, Inst Food & Agr Technol XaRTA CIDSAV, Girona, Spain.	isidre.llorente@udg.edu	MORAGREGA, CONCEPCIÓ/H-4441-2017; MONTESINOS, EMILIO/H-5246-2015; Morales, Gerard/O-1522-2015; Llorente, Isidre/L-7211-2017	MORAGREGA, CONCEPCIÓ/0000-0001-6270-9611; MONTESINOS, EMILIO/0000-0003-4455-8332; Morales, Gerard/0000-0002-4535-3438; Llorente, Isidre/0000-0003-1893-8649	Ministerio de Educacion, Ciencia y Deporte of Spain [AGL2013-41405-R, FPU13/04123]; University of Girona [SING12/13, MPCUdG2016/085, BR 2013/31]; European Union's Seventh Framework Programme for research, technological development and demonstration [613678]; Ministerio de Educacion, Ciencia y Deporte from Spain	Ministerio de Educacion, Ciencia y Deporte of Spain; University of Girona; European Union's Seventh Framework Programme for research, technological development and demonstration; Ministerio de Educacion, Ciencia y Deporte from Spain	Ministerio de Educacion, Ciencia y Deporte (AGL2013-41405-R, FPU13/04123) of Spain (https://www.mecd.gob.es/). University of Girona (SING12/13, MPCUdG2016/085) (www.udg.edu). European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement number 613678 (DROPSA) (dropsaproject.eu). GM was the recipient of predocotoral fellowships from the University of Girona (BR 2013/31) (www.udg.edu)) and from Ministerio de Educacion, Ciencia y Deporte from Spain (https://www.mecd.gob.es/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaskaveg JE, 2005, EPIDEMIOLOGY MANAGEN, P281; Arauz LF, 2010, PHYTOPATHOLOGY, V100, P959, DOI 10.1094/PHYTO-100-9-0959; Baker R, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3857; Battilani P., 1999, Journal of Plant Pathology, V81, P161; Beresford RM, 2017, PHYTOPATHOLOGY, V107, P184, DOI 10.1094/PHYTO-04-16-0166-R; Billing E, 1999, ACTA HORTIC, V489, P399; Boudon S, 2005, PHYTOPATHOLOGY, V95, P1081, DOI 10.1094/PHYTO-95-1081; Bugiani R, 2008, IOBC WPRS B, V54, P565; Carisse O, 2000, PHYTOPATHOLOGY, V90, P1120, DOI 10.1094/PHYTO.2000.90.10.1120; Duthie JA, 1997, PHYTOPATHOLOGY, V87, P1088, DOI 10.1094/PHYTO.1997.87.11.1088; EPPO, 2017, XANTH ARB PV PRUN XA; EPPO, 2006, EPPO B, V36, P129, DOI DOI 10.1111/J.1365-2338.2006.00925.X; Furuya H, 2009, PHYTOPATHOLOGY, V99, P951, DOI 10.1094/PHYTO-99-8-0951; Garcin A, 2009, INFOS CTIFL, V254, P30; Garcin A., 2011, INFOS CTIFL, V268, P26; Garcin A, 2005, XANTHOMONAS ARBRES F; Gross MK, 1998, PLANT DIS, V82, P1012, DOI 10.1094/PDIS.1998.82.9.1012; Janse JD, 2012, J PLANT PATHOL, V94, pS5; Kim KS, 2006, PLANT DIS, V90, P650, DOI 10.1094/PD-90-0650; Lalancette N, 2007, PLANT DIS, V91, P1122, DOI 10.1094/PDIS-91-9-1122; Lamichhane JR, 2014, PLANT DIS, V98, P1600, DOI 10.1094/PDIS-08-14-0831-FE; Lightner Gary W., 1992, Computers and Electronics in Agriculture, V7, P249, DOI 10.1016/S0168-1699(05)80023-7; Linvill DE, 2002, ACTA HORTIC, P689; Llorente I, 2000, PLANT DIS, V84, P631, DOI 10.1094/PDIS.2000.84.6.631; Madden LV, 2000, PLANT DIS, V84, P549, DOI 10.1094/PDIS.2000.84.5.549; MAGAREY RD, 2007, INTEGR MANAG PLANT P, P3; Maniatis T., 1982, MOL CLONING; MONTESINOS E, 1995, PHYTOPATHOLOGY, V85, P586, DOI 10.1094/Phyto-85-586; Morales G, 2016, ACTA HORTIC, V1149, P1, DOI [10.17660/ActaHortic.2016.1149.1, 10.1109/PESGM.2016.7741838]; Morales G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177583; Palacio-Bielsa A, 2010, PLANT DIS, V94, P786, DOI 10.1094/PDIS-94-6-0786B; RANDHAWA PS, 1985, PHYTOPATHOLOGY, V75, P1060, DOI 10.1094/Phyto-75-1060; Sant'Ana AS, 2012, FOOD MICROBIOL, V30, P267, DOI 10.1016/j.fm.2011.11.003; Scortichini M, 2010, J PLANT PATHOL, V92, pS73; Smith E., 1903, SCIENCE, V17, P456, DOI DOI 10.1126/SCIENCE.17.420.114-A; Smith IM, 1997, QUARANTINE PESTS EUR, P1096; Smith T. J., 1993, ACTA HORTIC, V338, P153, DOI DOI 10.17660/ACTAHORTIC.1993.338.21; Stefani E, 2010, J PLANT PATHOL, V92, pS99; THOMSON SV, 1977, CALIF AGR, V31, P12; Uddin W, 2003, PHYTOPATHOLOGY, V93, P336, DOI 10.1094/PHYTO.2003.93.3.336; Vanneste J. L., 2005, New Zealand Plant Protection, V58, P101; Wu LJ, 1999, PHYTOPATHOLOGY, V89, P653, DOI 10.1094/PHYTO.1999.89.8.653; YOUNG JM, 1977, J APPL BACTERIOL, V42, P345, DOI 10.1111/j.1365-2672.1977.tb00702.x; Zehr EI, 1996, PLANT DIS, V80, P339, DOI 10.1094/PD-80-0339	44	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193813	10.1371/journal.pone.0193813	http://dx.doi.org/10.1371/journal.pone.0193813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513713	Green Submitted, Green Published, gold			2022-12-27	WOS:000426896800078
J	Hoischen, C; Yavas, S; Wohland, T; Diekmann, S				Hoischen, Christian; Yavas, Sibel; Wohland, Thorsten; Diekmann, Stephan			CENP-C/H/I/K/M/T/W/N/L and hMis12 but not CENP-S/X participate in complex formation in the nucleoplasm of living human interphase cells outside centromeres	PLOS ONE			English	Article							CROSS-CORRELATION SPECTROSCOPY; BUDDING YEAST KINETOCHORE; FLUORESCENCE CORRELATION SPECTROSCOPY; OUTER KINETOCHORE; CHROMOSOME SEGREGATION; A NUCLEOSOMES; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; MIS12 COMPLEX; HISTONE H3	Kinetochore proteins assemble onto centromeric chromatin and regulate DNA segregation during cell division. The inner kinetochore proteins bind centromeres while most outer kinetochore proteins assemble at centromeres during mitosis, connecting the complex to microtubules. Here, we measured the co-migration between protein pairs of the constitutive centromere associated network (CCAN) and hMis12 complexes by fluorescence cross-correlation spectroscopy (FCCS) in the nucleoplasm outside centromeres in living human interphase cells. FCCS is a method that can tell if in living cells two differently fluorescently labelled molecules migrate independently, or co-migrate and thus are part of one and the same soluble complex. We also determined the apparent dissociation constants (Kd) of the hetero-dimers CENP-T/W and CENP-S/X. We measured co-migration between CENP-K and CENP-T as well as between CENP-M and CENP-T but not between CENP-T/W and CENP-S/X. Furthermore, CENP-C co-migrated with CENP-H, and CENP-K with CENP-N as well as with CENP-L. Thus, in the nucleoplasm outside centromeres, a large fraction of the CENP-H/I/K/M proteins interact with CENP-C, CENP-N/L and CENP-T/W but not with CENP-S/X. Our FCCS analysis of the Mis12 complex showed that hMis12, Nsl1, Dsn1 and Nnf1 also form a complex outside centromeres of which at least hMis12 associated with the CENP-C/H/I/K/M/T/W/N/L complex.	[Hoischen, Christian; Diekmann, Stephan] FLI, Leibniz Inst Aging, Mol Biol, Jena, Germany; [Yavas, Sibel; Wohland, Thorsten] Natl Univ Singapore, Dept Biol Sci, Lee Wee Kheng Buildung, Singapore, Singapore; [Yavas, Sibel; Wohland, Thorsten] Natl Univ Singapore, Dept Chem, Lee Wee Kheng Buildung, Singapore, Singapore; [Yavas, Sibel; Wohland, Thorsten] Natl Univ Singapore, Ctr Bioimaging Sci, Lee Wee Kheng Buildung, Singapore, Singapore	Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); National University of Singapore; National University of Singapore; National University of Singapore	Hoischen, C; Diekmann, S (corresponding author), FLI, Leibniz Inst Aging, Mol Biol, Jena, Germany.; Wohland, T (corresponding author), Natl Univ Singapore, Dept Biol Sci, Lee Wee Kheng Buildung, Singapore, Singapore.; Wohland, T (corresponding author), Natl Univ Singapore, Dept Chem, Lee Wee Kheng Buildung, Singapore, Singapore.; Wohland, T (corresponding author), Natl Univ Singapore, Ctr Bioimaging Sci, Lee Wee Kheng Buildung, Singapore, Singapore.	christian.hoischen@leibniz-fli.de; twohland@nus.edu.sg; diekmann@fli-leibniz.de	WOHLAND, THORSTEN/R-6404-2019; Wohland, Thorsten/H-8285-2012	Wohland, Thorsten/0000-0002-0148-4321	Deutsche Forschungsgemeinschaft (DFG) [SPP1128, SPP1395]; Singapore Ministry of Education (SINGA Scholarship) [MOE2016-T2-2-121]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Singapore Ministry of Education (SINGA Scholarship)	This study was supported by Deutsche Forschungsgemeinschaft (DFG), SPP1128 (SD), SPP1395 (SD); and Singapore Ministry of Education (SINGA Scholarship), MOE2016-T2-2-121 (SY and TW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Altunkaya GP, 2016, CURR BIOL, V26, P2370, DOI 10.1016/j.cub.2016.07.005; Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Basilico F, 2014, ELIFE, V3, DOI 10.7554/eLife.02978; Baudendistel N, 2005, CHEMPHYSCHEM, V6, P984, DOI 10.1002/cphc.200400639; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bui M, 2012, CELL, V150, P317, DOI 10.1016/j.cell.2012.05.035; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; D'Archivio S, 2017, J CELL BIOL, V216, P379, DOI 10.1083/jcb.201608043; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Diekmann S, 2014, PHYS LIFE REV, V11, P1, DOI 10.1016/j.plrev.2013.11.011; Dimitrova YN, 2016, CELL, V167, P1014, DOI 10.1016/j.cell.2016.10.011; Dornblut C, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130229; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Eskat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044717; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; Faesen AC, 2017, NATURE, V542, P498, DOI 10.1038/nature21384; Falk SJ, 2015, SCIENCE, V348, P699, DOI 10.1126/science.1259308; Fang J., 2015, GENE DEV, V29, P1; Folco HD, 2015, CURR BIOL, V25, P348, DOI 10.1016/j.cub.2014.11.060; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Foo YH, 2012, BIOPHYS J, V102, P1174, DOI 10.1016/j.bpj.2012.01.040; Fukagawa T, 2014, DEV CELL, V30, P497, DOI 10.1016/j.devcel.2014.08.016; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Guo LY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15775; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Hellwig D, 2009, EUR BIOPHYS J BIOPHY, V38, P781, DOI 10.1007/s00249-009-0498-x; Hellwig D, 2011, J CELL SCI, V124, P3871, DOI 10.1242/jcs.088625; Hellwig D, 2008, J BIOPHOTONICS, V1, P245, DOI 10.1002/jbio.200810014; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Hinshaw SM, 2013, CELL REP, V5, P29, DOI 10.1016/j.celrep.2013.08.036; Hoffmann S, 2016, CELL REP, V17, P2394, DOI 10.1016/j.celrep.2016.10.084; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hori T, 2013, J CELL BIOL, V200, P45, DOI 10.1083/jcb.201210106; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hornung P, 2014, J CELL BIOL, V206, P509, DOI 10.1083/jcb.201403081; Huis int Veld PJ, 2016, ELIFE, V24; Hwang LC, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1862614; Hwang LC, 2004, CHEMPHYSCHEM, V5, P549, DOI 10.1002/cphc.200301057; Hwang LC, 2006, BIOPHYS J, V91, P715, DOI 10.1529/biophysj.105.074120; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Kagawa N, 2014, CHROMOSOME RES, V22, P293, DOI 10.1007/s10577-014-9404-1; Kato H, 2013, SCIENCE, V340, P1110, DOI 10.1126/science.1235532; Kim S, 2015, J CELL BIOL, V208, P181, DOI 10.1083/jcb.201407074; Klare K, 2015, J CELL BIOL, V210, P11, DOI 10.1083/jcb.201412028; Kohl T, 2005, ADV BIOCHEM ENG BIOT, V95, P107; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Lacoste N, 2014, MOL CELL, V53, P631, DOI 10.1016/j.molcel.2014.01.018; Ladurner R, 2016, CELL, V167, P889, DOI 10.1016/j.cell.2016.10.036; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Logsdon GA, 2015, J CELL BIOL, V208, P521, DOI 10.1083/jcb.201412011; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Malik HS, 2002, P NATL ACAD SCI USA, V99, P1449, DOI 10.1073/pnas.032664299; Matson DR, 2014, J CELL BIOL, V205, P541, DOI 10.1083/jcb.201307137; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; McKinley KL, 2015, MOL CELL, V60, P886, DOI 10.1016/j.molcel.2015.10.027; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; Mendiburo MJ, 2011, SCIENCE, V334, P686, DOI 10.1126/science.1206880; Monier K, 2007, J CELL SCI, V120, P101, DOI 10.1242/jcs.03326; Mosalaganti S, 2017, J CELL BIOL, V216, P961, DOI 10.1083/jcb.201611060; Musacchio A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010005; Nagpal H, 2016, CHROMOSOMA, V125, P645, DOI 10.1007/s00412-016-0608-3; Nagpal H, 2015, MOL BIOL CELL, V26, P3768, DOI 10.1091/mbc.E15-07-0531; Nechemia-Arbely Y, 2017, J CELL BIOL, V216, P607, DOI 10.1083/jcb.201608083; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Nishino T, 2013, EMBO J, V32, P424, DOI 10.1038/emboj.2012.348; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Okada M, 2009, MOL BIOL CELL, V20, P3986, DOI 10.1091/mbc.E09-01-0065; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Pan D, 2017, ELIFE, V6, DOI 10.7554/eLife.23352; Pan XT, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2740053; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Pesenti ME, 2016, CURR OPIN STRUC BIOL, V37, P152, DOI 10.1016/j.sbi.2016.03.003; Petrovic A, 2016, CELL, V167, P1028, DOI 10.1016/j.cell.2016.10.005; Petrovic A, 2014, MOL CELL, V53, P591, DOI 10.1016/j.molcel.2014.01.019; Petrovic A, 2010, J CELL BIOL, V190, P835, DOI 10.1083/jcb.201002070; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Poddar A, 1999, MOL MICROBIOL, V31, P349, DOI 10.1046/j.1365-2958.1999.01179.x; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; Prendergast L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001082; Przewloka MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000478; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Rago F, 2015, CURR BIOL, V25, P671, DOI 10.1016/j.cub.2015.01.059; Ries J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113009; Rosic S, 2014, J CELL BIOL, V207, P335, DOI 10.1083/jcb.201404097; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Ruttinger S, 2008, J MICROSC-OXFORD, V232, P343, DOI 10.1111/j.1365-2818.2008.02105.x; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Samejima I, 2015, J CELL BIOL, V211, P1141, DOI 10.1083/jcb.201508072; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Sanyal K, 1998, MOL GEN GENET, V260, P242, DOI 10.1007/s004380050892; Sathyan KM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14678; Schalch T, 2016, CHROMOSOMA; Schleiffer A, 2012, NAT CELL BIOL, V14, P604, DOI 10.1038/ncb2493; Schmitzberger F, 2012, EMBO REP, V13, P216, DOI 10.1038/embor.2012.1; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shi XK, 2009, BIOPHYS J, V97, P678, DOI 10.1016/j.bpj.2009.05.006; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Stankovic A, 2017, MOL CELL, V65, P231, DOI 10.1016/j.molcel.2016.11.021; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Sugata N, 1999, J BIOL CHEM, V274, P27343, DOI 10.1074/jbc.274.39.27343; Tachiwana H, 2015, CELL REP, V11, P22, DOI 10.1016/j.celrep.2015.03.013; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Takeuchi K, 2014, NUCLEIC ACIDS RES, V42, P1644, DOI 10.1093/nar/gkt1124; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; Thakur J, 2016, GENOME RES, V26, P1178, DOI 10.1101/gr.204784.116; Tschernyschkow S, 2013, PROG BIOPHYS MOL BIO, V113, P33, DOI 10.1016/j.pbiomolbio.2013.03.010; Vargiu G, 2017, P NATL ACAD SCI USA, V114, P3133, DOI 10.1073/pnas.1614145114; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Weir JR, 2016, NATURE, V537, P249, DOI 10.1038/nature19333; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Westermann S, 2013, TRENDS CELL BIOL, V23, P260, DOI 10.1016/j.tcb.2013.01.010; Westhorpe FG, 2013, CURR OPIN CELL BIOL, V25, P334, DOI 10.1016/j.ceb.2013.02.001; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yang C., 2020, ELIFE, DOI [10.7554/eLife.51339, DOI 10.7554/ELIFE.02482, 10.7554/eLife.02482, DOI 10.7554/ELIFE.03254]; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	146	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0192572	10.1371/journal.pone.0192572	http://dx.doi.org/10.1371/journal.pone.0192572			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509805	Green Submitted, Green Published, gold			2022-12-27	WOS:000426813200004
J	Ghimire, PR; Agho, KE; Renzaho, AMN; Dibley, M; Raynes-Greenow, C				Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore; Renzaho, Andre M. N.; Dibley, Michael; Raynes-Greenow, Camille			Association between health service use and diarrhoea management approach among caregivers of under-five children in Nepal	PLOS ONE			English	Article							COMMUNITY CASE-MANAGEMENT; ORAL REHYDRATION THERAPY; CHILDHOOD DIARRHEA; NATIONAL CONTROL; NUTRITION; DISEASES; PROGRAM; INTERVENTIONS; PNEUMONIA; MOTHERS	Introduction Diarrhoea among children under-five is a serious public health problem in many developing countries, including Nepal. This study aimed to examine the association between health service utilization and diarrhoea management approaches among children under-five years in Nepal. Methods The combined 2001, 2006 and 2011 Nepal Demographic and Health Survey (NDHS) data sets were examined and the sample included 2,655 children aged 0-59 months who had diarrhoea 2-weeks prior to the each survey. Multilevel logistic regression analyses that adjust for clustering and sampling weight were used to examine the association between health service utilization and diarrhoea management approaches (Oral Rehydration Solution, increased fluids and/or continued feeding). Results The prevalence of extra fluids decreased significantly from 27% in 2001 to 15% in 2011 while that of ORS increased significantly from 32% in 2001 to 40% in 2011. The prevalence of continued feeding fluctuated between 83-89%. Multivariate analysis revealed that care-givers whose children received treatment or advice from health care providers during diarrhoea were 5.78 times more likely to treat diarrhoea with Oral Rehydration Solution (ORS) [adjusted Odds Ratio (aOR) 5.78, 95% confidence interval (CI) 4.50, 7.44-, 1.56 (aOR 1.56, 95% CI 1.19, 2.05) times more likely to offer extra fluids, and 2.25 (aOR 2.25, 95% CI 1.50, 3.39) times more likely to use continued feeding than those who did not seek advice. Conclusions Our findings indicate that health service utilization significantly improves diarrhoea management among under-five children. However, a broader national diarrhoeal disease control program to further reduce diarrhoea related morbidity and mortality in Nepal should focus on educating caregivers about the importance of the use of ORS as well as increase fluid intake to children under-five years with diarrhoea.	[Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Renzaho, Andre M. N.] Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia; [Dibley, Michael; Raynes-Greenow, Camille] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia	Western Sydney University; Western Sydney University; University of Sydney	Ghimire, PR (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	prameshraj@hotmail.com	Agho, Kingsley/AAW-5622-2021; Agho, Kingsley/AAE-9971-2020; Renzaho, Andre M.N./AAH-7679-2021	Agho, Kingsley/0000-0003-4111-3207; Ghimire, Pramesh/0000-0002-7902-7294; Ghimire, Pramesh Raj/0000-0003-2816-0463; RENZAHO, ANDRE/0000-0002-6844-0833				Agho KE, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-2; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Ansari Mukhtar, 2012, BMC Res Notes, V5, P576, DOI 10.1186/1756-0500-5-576; Baltazar JC, 2002, B WORLD HEALTH ORGAN, V80, P637; Bhandari G P, 2013, J Nepal Health Res Counc, V11, P6; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Collaborators Global Burden of Diseases, 2017, LANCET INFECT DIS; Datta Vikram, 2001, Indian Journal of Pediatrics, V68, P1035, DOI 10.1007/BF02722350; Duggan C, 1997, J PEDIATR-US, V131, P801, DOI 10.1016/S0022-3476(97)70024-6; Ghimire M, 2010, B WORLD HEALTH ORGAN, V88, P216, DOI 10.2471/BLT.09.065649; Ghimire PR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181332; Gurung H, 2005, NEPAL REGIONAL STRAT; HUDELSON PM, 1993, SOC SCI MED, V37, P97, DOI 10.1016/0277-9536(93)90322-U; International Federation of Red Cross and Red Crescent Socities, 2009, DIARRH OUTBR KILLS 1; Jha Nilambar, 2006, Nepal Med Coll J, V8, P27; JINADU MK, 1988, INT J NURS STUD, V25, P185, DOI 10.1016/0020-7489(88)90045-4; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KUMAR V, 1985, J TROP PEDIATRICS, V31, P109, DOI 10.1093/tropej/31.2.109; Masiha S. A., 2015, J RAWALPINDI MED COL, V19, P51; Mengistie B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1029; MILLER P, 1995, SOC SCI MED, V40, pS1, DOI 10.1016/0277-9536(95)00001-N; Ministry of Health and Population (MOHP) [Nepal] New ERA & ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health and Population Nepal, 2007, NEP DEM HLTH SURV 20; Ministry of Health [Nepal] New ERA ORC Macro, 2002, NEP DEM HLTH SURV 20; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Nanyonjo A, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0202-y; Nel E., 2010, S AFRICAN J CLIN NUT, V23, P15; OLANGO P, 1990, SOC SCI MED, V31, P1245, DOI 10.1016/0277-9536(90)90131-B; Olson CK, 2011, AM J TROP MED HYG, V85, P1134, DOI 10.4269/ajtmh.2011.11-0178; Pahwa S, 2010, J HEALTH POPUL NUTR, V28, P553; Pokhrel D, 2004, J WATER HEALTH, V2, P71, DOI 10.2166/wh.2004.0007; ROHDE J, 1988, Indian Pediatrics, V25, P914; Santosham M, 2010, LANCET, V376, P63, DOI 10.1016/S0140-6736(10)60356-X; UNICEF, 2014, PNEUM DIARRH TACKL D; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; World Health Organization, 2005, TREATM DIARRH MAN PH	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0191988	10.1371/journal.pone.0191988	http://dx.doi.org/10.1371/journal.pone.0191988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494611	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200007
J	Irvine, L; Crombie, IK; Swanson, V; Dimova, ED; Melson, AJ; Fraser, TM; Barbour, R; Rice, PM; Allan, S				Irvine, Linda; Crombie, Iain K.; Swanson, Vivien; Dimova, Elena D.; Melson, Ambrose J.; Fraser, Tracey M.; Barbour, Rosaline; Rice, Peter M.; Allan, Sheila			Design and feasibility testing of a novel group intervention for young women who binge drink in groups	PLOS ONE			English	Article							BRIEF MOTIVATIONAL INTERVENTIONS; BRIEF ALCOHOL INTERVENTIONS; COLLEGE-STUDENTS; PRIMARY-CARE; REDUCES DRINKING; CONSEQUENCES; METAANALYSIS; FRIENDSHIP; NORMS	Background Young women frequently drink alcohol in groups and binge drinking within these natural drinking groups is common. This study describes the design of a theoretically and empirically based group intervention to reduce binge drinking among young women. It also evaluates their engagement with the intervention and the acceptability of the study methods. Methods Friendship groups of women aged 18-35 years, who had two or more episodes of binge drinking (>6 UK units on one occasion; 48g of alcohol) in the previous 30 days, were recruited from the community. A face-to-face group intervention, based on the Health Action Process Approach, was delivered over three sessions. Components of the intervention were woven around fun activities, such as making alcohol free cocktails. Women were followed up four months after the intervention was delivered. Results The target of 24 groups ( comprising 97 women) was recruited. The common pattern of drinking was infrequent, heavy drinking ( mean consumption on the heaviest drinking day was UK 18.1 units). Process evaluation revealed that the intervention was delivered with high fidelity and acceptability of the study methods was high. The women engaged positively with intervention components and made group decisions about cutting down. Twenty two groups set goals to reduce their drinking, and these were translated into action plans. Retention of individuals at follow up was 87%. Conclusions This study successfully recruited groups of young women whose patterns of drinking place them at high risk of acute harm. This novel approach to delivering an alcohol intervention has potential to reduce binge drinking among young women. The high levels of engagement with key steps in the behavior change process suggests that the group intervention should be tested in a full randomised controlled trial.	[Irvine, Linda; Crombie, Iain K.; Dimova, Elena D.; Melson, Ambrose J.; Fraser, Tracey M.] Univ Dundee, Sch Med, Div Populat Hlth Sci, Dundee, Scotland; [Swanson, Vivien] Univ Stirling, Fac Nat Sci, Psychol Div, Stirling, Scotland; [Barbour, Rosaline] Open Univ, Fac Wellbeing Educ & Language Studies, Milton Keynes, Bucks, England; [Rice, Peter M.] Univ Dundee, Sch Med, Div Neurosci, Dundee, Scotland; [Allan, Sheila] Dundee City Council, Dundee, Scotland; [Dimova, Elena D.] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland; [Melson, Ambrose J.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	University of Dundee; University of Stirling; Open University - UK; University of Dundee; University of Stirling; University of Glasgow	Irvine, L (corresponding author), Univ Dundee, Sch Med, Div Populat Hlth Sci, Dundee, Scotland.	m.a.j.irvine@dundee.ac.uk	Dimova, Elena/I-1703-2019	Dimova, Elena/0000-0002-3256-7170; Irvine, Linda/0000-0002-8527-876X; Melson, Ambrose/0000-0003-1415-3801	National Prevention Research Initiative [MR/J000485/1]; Medical Research Council [MR/J000485/1] Funding Source: researchfish; MRC [MR/J000485/1] Funding Source: UKRI	National Prevention Research Initiative(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Prevention Research Initiative, MR/J000485/1 to LI (https://www.mrc.ac.uk/research/initiatives/national-prevention-research-initiative-npri/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Anderson AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086171; Bardsley D, 2017, SCOTTISH HLTH SURVEY; Bertholet N, 2014, ALCOHOL CLIN EXP RES, V38, P853, DOI 10.1111/acer.12274; BIEN TH, 1993, ADDICTION, V88, P315, DOI 10.1111/j.1360-0443.1993.tb00820.x; Borsari B, 2015, J CONSULT CLIN PSYCH, V83, P56, DOI 10.1037/a0037635; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Brueton VC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003835; Carey KB, 2016, J CONSULT CLIN PSYCH, V84, P619, DOI 10.1037/a0040275; Craig P., 2008, DEV EVALUATING COMPL; Dupree CH, 2016, ADDICT RES THEORY, V24, P40, DOI 10.3109/16066359.2015.1060966; Engineer R, 2003, HOME OFFICE RES STUD; Ethen M, 2009, MATERN CHILD HLTH J, V13, P274, DOI 10.1007/s10995-008-0328-2; Foster JH, 2014, ALCOHOL ALCOHOLISM, V49, P213, DOI 10.1093/alcalc/agt135; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1001; Hagger MS, 2016, PSYCHOL HEALTH, V31, P814, DOI 10.1080/08870446.2016.1146719; Harkin B, 2016, PSYCHOL BULL, V142, P198, DOI 10.1037/bul0000025; Health and Social Care Information Centre, 2013, HLTH SURV ENGL 2012; Health Development Agency and University of Wales College of Medicine, 2002, MAN FAST ALC SCREEN; Hingson R, 2005, ANNU REV PUBL HEALTH, V26, P259, DOI 10.1146/annurev.publhealth.26.021304.144652; Home Office, 2012, GOV ALC STRAT; Huh D, 2015, ALCOHOL CLIN EXP RES, V39, P919, DOI 10.1111/acer.12714; Johnston KL, 2003, PSYCHOL HEALTH, V18, P63, DOI 10.1080/0887044021000037835; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; LaBrie JW, 2008, PSYCHOL ADDICT BEHAV, V22, P141, DOI 10.1037/0893-164X.22.1.141; LaBrie JW, 2008, PSYCHOL ADDICT BEHAV, V22, P149, DOI 10.1037/0893-164X.22.1.149; LaBrie JW, 2007, ADDICT BEHAV, V32, P2549, DOI 10.1016/j.addbeh.2007.05.014; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Lange JE, 2011, ADDICT RES THEORY, V19, P312, DOI 10.3109/16066359.2010.507895; Lange JE, 2006, AM J DRUG ALCOHOL AB, V32, P261, DOI 10.1080/00952990500479597; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; MacLean S, 2016, SOCIOLOGY, V50, P93, DOI 10.1177/0038038514557913; MacNeela P, 2011, J HEALTH PSYCHOL, V16, P284, DOI 10.1177/1359105310372977; Michie S, 2012, ADDICTION, V107, P1431, DOI 10.1111/j.1360-0443.2012.03845.x; Miller WR, 2015, BEHAV COGN PSYCHOTH, V43, P129, DOI 10.1017/S1352465813000878; Miller WR, 2013, MOTIVATIONAL INTERVI, V3rd; Moore G, 2015, PROCESS EVALUATION C; Nazareth I, 2011, ALCOHOL ALCOHOLISM, V46, P600, DOI 10.1093/alcalc/agr078; Neighbors C, 2007, J STUD ALCOHOL DRUGS, V68, P556, DOI 10.15288/jsad.2007.68.556; Niland P, 2013, INT J DRUG POLICY, V24, P530, DOI 10.1016/j.drugpo.2013.05.013; O'Donnell A, 2014, ALCOHOL ALCOHOLISM, V49, P66, DOI 10.1093/alcalc/agt170; Office of National Statistics, 2017, AD DRINK HAB GREAT B; Previte J, 2015, J BUS RES, V68, P2146, DOI 10.1016/j.jbusres.2015.03.014; Raistrick D, 2006, REV EFFECTIVENESS TR; Ritchie J., 2014, QUALITATIVE RES PRAC, V2nd; Ritchie J., 1994, ANAL QUALITATIVE DAT, P173, DOI [10.4324/9780203413081, DOI 10.4324/9780203413081_CHAPTER_9]; ROSS L, 1977, J EXP SOC PSYCHOL, V13, P279, DOI 10.1016/0022-1031(77)90049-X; Royal College of Obstetricians and Gynaecologists, 2006, ALC CONS OUTC PREGN; Samson JE, 2015, J STUD ALCOHOL DRUGS, V76, P530, DOI 10.15288/jsad.2015.76.530; Schoenfeld ER, 2000, ANN EPIDEMIOL, V10, P432, DOI 10.1016/S1047-2797(00)00067-3; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; Scottish Funding Council, 2015, HIGH ED STUD QUAL SC; Scottish Government, 2004, SCOTTISH INDEX MULTI; Seaman P, 2010, DRINKING TO BELONG; Skagerstrom J, 2011, J WOMENS HEALTH, V20, P901, DOI 10.1089/jwh.2010.2216; Sobell L.C., 2011, GROUP THERAPY SUBSTA; Sobell LC, 2003, ASSESSING ALCOHOL PR, P75; Southern DA, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-57; Szmigin I, 2008, INT J DRUG POLICY, V19, P359, DOI 10.1016/j.drugpo.2007.08.009; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Tough SC, 2005, CAN FAM PHYSICIAN, V51, P1199; Townshend JM, 2014, ALCOHOL CLIN EXP RES, V38, P1143, DOI 10.1111/acer.12333; Twigg L, 2013, SOC SCI MED, V91, P162, DOI 10.1016/j.socscimed.2013.03.023; UyBico SJ, 2007, J GEN INTERN MED, V22, P852, DOI 10.1007/s11606-007-0126-3	67	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193434	10.1371/journal.pone.0193434	http://dx.doi.org/10.1371/journal.pone.0193434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494683	Green Accepted, gold, Green Published			2022-12-27	WOS:000426363200049
J	Rumbou, A; Candresse, T; Marais, A; Theil, S; Langer, J; Jalkanen, R; Buttner, C				Rumbou, Artemis; Candresse, Thierry; Marais, Armelle; Theil, Sebastien; Langer, Juliane; Jalkanen, Risto; Buttner, Carmen			A novel badnavirus discovered from Betula sp. affected by birch leaf-roll disease	PLOS ONE			English	Article							PLANT-VIRUS; POPULATION; PUBESCENS; VIROIDS; POLLEN; BEECH	In declining birches (Betula sp.) from different European stands affected by the "birch leafroll disease" (BLRD) a novel virus is identified by means of RNA-Seq virome analysis. The virus represents a new member in the genus Badnavirus, family Caulimoviridae, tentatively named Birch leaf roll-associated virus (BLRaV) and it is the first badnavirus found to infect birch. Complete genome sequences (7,862-7,864 nucleotides) of three viral isolates of Finnish and German origin have been determined. The virus sequences show a typical badnavirus organization with three major open reading frames (ORFs) and a fourth potential ORF overlapping with the end of ORF3. ORFs 1-2-3 show low level of amino acid identity to the corresponding proteins encoded by other badnaviruses, reaching a maximum of 44% identity (ORF3). Grapevine vein-clearing virus appears as the closest badnavirus when considering the polymerase region. So far, we can exclude evidence for presence of endogenous BLRaV elements in the birch genome, while evidence for the episomal activity of BLRaV is provided. The viral population holds significant haplotype diversity, while co-infection by different BLRaV variants are observed in single hosts. BLRaV presence is associated with the BLRD in both silver (B. pendula) and downy birch (B. pubescens). These results challenge the earlier hypothesis of a causal role of Cherry leaf roll virus in BLRD. Further work is now needed to finally prove that BLRaV is the causal agent for the BLRD.	[Rumbou, Artemis; Langer, Juliane; Buttner, Carmen] Humboldt Univ, Fac Life Sci, Albrecht Daniel Thaer Inst, Div Phytomed, Berlin, Germany; [Candresse, Thierry; Marais, Armelle; Theil, Sebastien] French Natl Inst Agr Res INRA, UMR BFP 1332, Equipe Virol, Villenave Dornon, France; [Jalkanen, Risto] Nat Resources Inst Luke, Finnish Forest Res Inst Metla, Rovaniemi Unit, Rovaniemi, Finland	Humboldt University of Berlin; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Natural Resources Institute Finland (Luke)	Rumbou, A (corresponding author), Humboldt Univ, Fac Life Sci, Albrecht Daniel Thaer Inst, Div Phytomed, Berlin, Germany.	artemis.rumbou@agrar.hu-berlin.de	Rumbou, Artemis/AAD-5694-2019	Rumbou, Artemis/0000-0002-7237-7355; Candresse, Thierry/0000-0001-9757-1835	COST Action [FA1407]	COST Action(European Cooperation in Science and Technology (COST))	The work was supported by the COST Action FA1407 - DIVAS (Deep Investigation on Viral-Associated Sequences) European Cooperation in the field of Scientific and Technical Research Application of next generation sequencing for the study and diagnosis of plant viral diseases in agriculture Short Term Scientific Mission performed by Dr. Artemis Rumbou in INRA, Villenave d'Ornon Cedex, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Bhat AI, 2016, BADNAVIRUSES CURREN, V8; Borah BK, 2013, MOL PLANT PATHOL, V14, P759, DOI 10.1111/mpp.12046; Buttner C., 2011, VIRUS VIRUS LIKE DIS, P119; Gayral P, 2010, J VIROL, V84, P7346, DOI 10.1128/JVI.00401-10; Geering ADW, 2005, J GEN VIROL, V86, P511, DOI 10.1099/vir.0.80261-0; GEERING ADW, 2012, VIRUS TAXONOMY, P438; Hohn Thomas, 2008, P53, DOI 10.1007/978-3-540-75763-4_4; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1; Hynynen J, 2010, FORESTRY, V83, P103, DOI 10.1093/forestry/cpp035; International Committee on Taxonomy of Viruses (ICTV), 2016, VIRUS TAXONOMY; Jalkanen R., 2013, Endophytes for plant protection: the state of the art. Proceedings of the 5th International Symposium on Plant Protection and Plant Health in Europe, Humboldt University Berlin, Berlin-Dahlem, Germany, 26-29 May, 2013, P305; Jalkanen R, 2007, SILVA FENN, V41, P755, DOI 10.14214/sf.927; JONES AT, 1990, J PHYTOPATHOL, V129, P339, DOI 10.1111/j.1439-0434.1990.tb04311.x; Kazmi SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134147; Kibbe W. A., 2007, NUCL ACIDS RES, V35; Langer J, 2016, FOREST PATHOL, V46, P595, DOI 10.1111/efp.12276; Maliogka VI, 2015, VIRUS RES, V203, P47, DOI 10.1016/j.virusres.2015.03.003; MASSALSKI PR, 1988, ANN APPL BIOL, V112, P415, DOI 10.1111/j.1744-7348.1988.tb02080.x; MASSALSKI PR, 1984, PLANT PATHOL, V33, P255, DOI 10.1111/j.1365-3059.1984.tb02647.x; Massart S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00045; Massart S, 2014, VIRUS RES, V188, P90, DOI 10.1016/j.virusres.2014.03.029; NIENHAUS F, 1989, ANNU REV PHYTOPATHOL, V27, P165; Rebenstorf K, 2006, J VIROL, V80, P2453, DOI 10.1128/JVI.80.5.2453-2462.2006; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Rumbou A, 2016, SCAND J FOREST RES, V31, P546, DOI 10.1080/02827581.2016.1165283; Staginnus C, 2006, TRENDS PLANT SCI, V11, P485, DOI 10.1016/j.tplants.2006.08.008; von Bargen S, 2009, SILVA FENN, V43, P727, DOI 10.14214/sf.169; Wang N, 2013, MOL ECOL, V22, P3098, DOI 10.1111/mec.12131; Werner R, 1997, EUR J FOREST PATHOL, V27, P309; Wu QF, 2015, ANNU REV PHYTOPATHOL, V53, P425, DOI 10.1146/annurev-phyto-080614-120030; Zhang Y, 2011, PHYTOPATHOLOGY, V101, P1081, DOI 10.1094/PHYTO-02-11-0034	32	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193888	10.1371/journal.pone.0193888	http://dx.doi.org/10.1371/journal.pone.0193888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494687	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200100
J	Winder, JY; Roos, RAC				Winder, Jessica Y.; Roos, Raymund A. C.			Premanifest Huntington's disease: Examination of oculomotor abnormalities in clinical practice	PLOS ONE			English	Article							AGE-RELATED-CHANGES; TRINUCLEOTIDE REPEAT; RATING-SCALE; OF-ONSET; LENGTH	Introduction Different oculomotor abnormalities have been reported to occur in premanifest Huntington's disease. The aim of this study is to investigate which oculomotor items of the Unified Huntington's Disease Rating Scale (UHDRS) are affected in premanifest individuals compared to healthy controls, and if CAG repeat length and age are correlated with oculomotor abnormalities in premanifest Huntington's disease gene carriers. Methods We compared baseline data of 70 premanifest individuals and 27 controls who participated in the Enroll-HD study at the Leiden University Medical Center, the Netherlands. Premanifest gene carriers were divided in individuals near to disease onset and individuals far from disease onset. Results Using a logistic regression model, only horizontal ocular pursuit of the six oculomotor items of the UHDRS was significantly more frequently affected in premanifest individuals close to disease onset compared to controls (p = 0.044, OR 13.100). Age was significantly higher in premanifest individuals with affected horizontal ocular pursuit (p = 0.016, OR 1.115) and with affected vertical ocular pursuit (p = 0.030, OR 1.065) compared to premanifest individuals without ocular pursuit deficits. Conclusions Our results suggest that horizontal ocular pursuit is the only affected oculomotor item of the UHDRS in premanifest individuals and could be used to assess early clinical signs of Huntington's disease. Saccade initiation and saccade velocity do not seem useful for detecting differences between premanifest individuals and controls.	[Winder, Jessica Y.; Roos, Raymund A. C.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Winder, JY (corresponding author), Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands.	j.y.winder@lumc.nl			CHDI Foundation Inc.	CHDI Foundation Inc.	The LUMC received payment from the CHDI Foundation Inc. for participating in the Enroll HD study. The CHDI Foundation Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades CA, 2007, NEUROREPORT, V18, P1133, DOI 10.1097/WNR.0b013e32821c560d; Biglan KM, 2009, MOVEMENT DISORD, V24, P1763, DOI 10.1002/mds.22601; Blekher T, 2006, NEUROLOGY, V67, P394, DOI 10.1212/01.wnl.0000227890.87398.c1; Blekher TM, 2004, VISION RES, V44, P2729, DOI 10.1016/j.visres.2004.06.006; Cubo E, 2016, NEUROLOGY, V87, P571, DOI 10.1212/WNL.0000000000002944; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Hicks SL, 2008, PROG BRAIN RES, V171, P555, DOI 10.1016/S0079-6123(08)00678-X; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kirkwood SC, 2000, ARCH NEUROL-CHICAGO, V57, P1040, DOI 10.1001/archneur.57.7.1040; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MOSCHNER C, 1994, J GERONTOL, V49, pM235, DOI 10.1093/geronj/49.5.M235; Reilmann R., 2009, AKTUELLE NEUROL, V36, pP474, DOI DOI 10.1055/S-0029-1238568; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Seferlis F, 2015, J VESTIBUL RES-EQUIL, V25, P57, DOI 10.3233/VES-150548; Siesling S, 1997, MOVEMENT DISORD, V12, P229, DOI 10.1002/mds.870120214; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Youssov K, 2013, MOVEMENT DISORD, V28, P1995, DOI 10.1002/mds.25678	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193866	10.1371/journal.pone.0193866	http://dx.doi.org/10.1371/journal.pone.0193866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494703	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200097
J	Dittbrenner, BJ; Pollock, MM; Schilling, JW; Olden, JD; Lawler, JJ; Torgersen, CE				Dittbrenner, Benjamin J.; Pollock, Michael M.; Schilling, Jason W.; Olden, Julian D.; Lawler, Joshua J.; Torgersen, Christian E.			Modeling intrinsic potential for beaver (Castor canadensis) habitat to inform restoration and climate change adaptation	PLOS ONE			English	Article							POPULATION; WASHINGTON; MANAGEMENT; SCIENCE; STREAMS; TOOL; DAM	Through their dam-building activities and subsequent water storage, beaver have the potential to restore riparian ecosystems and offset some of the predicted effects of climate change by modulating streamflow. Thus, it is not surprising that reintroducing beaver to watersheds from which they have been extirpated is an often-used restoration and climate-adaptation strategy. Identifying sites for reintroduction, however, requires detailed information about habitat factors-information that is not often available at broad spatial scales. Here we explore the potential for beaver relocation throughout the Snohomish River Basin in Washington, USA with a model that identifies some of the basic building blocks of beaver habitat suitability and does so by relying solely on remotely sensed data. More specifically, we developed a generalized intrinsic potential model that draws on remotely sensed measures of stream gradient, stream width, and valley width to identify where beaver could become established if suitable vegetation were to be present. Thus, the model serves as a preliminary screening tool that can be applied over relatively large extents. We applied the model to 5,019 stream km and assessed the ability of the model to correctly predict beaver habitat by surveying for beavers in 352 stream reaches. To further assess the potential for relocation, we assessed land ownership, use, and land cover in the landscape surrounding stream reaches with varying levels of intrinsic potential. Model results showed that 33% of streams had moderate or high intrinsic potential for beaver habitat. We found that no site that was classified as having low intrinsic potential had any sign of beavers and that beaver were absent from nearly three quarters of potentially suitable sites, indicating that there are factors preventing the local population from occupying these areas. Of the riparian areas around streams with high intrinsic potential for beaver, 38% are on public lands and 17% are on large tracts of privately-owned timber land. Thus, although there are a large number of areas that could be suitable for relocation and restoration using beavers, current land use patterns may substantially limit feasibility in these areas.	[Dittbrenner, Benjamin J.; Lawler, Joshua J.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Pollock, Michael M.] NOAA, Northwest Fisheries Sci Ctr, Seattle, WA USA; [Schilling, Jason W.] Tulalip Tribes Nat Resources, Tulalip, WA USA; [Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Torgersen, Christian E.] Univ Washington, US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Cascadia Field Stn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle	Dittbrenner, BJ (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	castor@uw.edu	Olden, Julian D/A-8535-2010	Dittbrenner, Benjamin/0000-0001-7980-5597; Olden, Julian/0000-0003-2143-1187	U.S Environmental Protection Agency's FY Noncompetitive Tribal Projects for Restoration and Protection of Puget Sound, Federal [PA-00J322-01]; Conservation, Research and Education Opportunities International's CREOi award	U.S Environmental Protection Agency's FY Noncompetitive Tribal Projects for Restoration and Protection of Puget Sound, Federal; Conservation, Research and Education Opportunities International's CREOi award	This research was funded by the U.S Environmental Protection Agency's FY 2011 Noncompetitive Tribal Projects for Restoration and Protection of Puget Sound, Federal Grant Number PA-00J322-01, to JWS & BJD; and Conservation, Research and Education Opportunities Internationals 2015 CREOi award to BJD. http://blogs.nwifc.org/psp/2015/02/final-progress-report-deliverables-22/ http://creoi.org/the-skykomish-beaver-project-building-educational-opportunities-for-aspiring-ecologists-2/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AW., 1982, FWSOBS82; Anderson J. T., 2014, P 4 INT C FUTURE ENV; [Anonymous], 2014, GEN TECHNICAL REPORT; Barnes DM, 1997, J WILDLIFE MANAGE, V61, P1371, DOI 10.2307/3802140; Bartz KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124415; Beechie T, 2014, WATER RESOUR RES, V50, P39, DOI 10.1002/2013WR013629; Benda L, 2007, FOREST SCI, V53, P206; Burnett K., 2003, AQUATIC PROTECTED AR, P144; Castro J., 2015, BEAVER RESTORATION G; Cowardin LM., 2005, WATER ENCY; Cox Daniel R., 2009, Transactions of the Illinois State Academy of Science, V102, P55; Davies JR, 2007, J AM WATER RESOUR AS, V43, P414, DOI 10.1111/j.1752-1688.2007.00032.x; Elsner MM, 2010, CLIMATIC CHANGE, V102, P225, DOI 10.1007/s10584-010-9855-0; Gibson PP, 2014, AQUAT CONSERV, V24, P391, DOI 10.1002/aqc.2432; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; HOWARD RJ, 1985, J WILDLIFE MANAGE, V49, P19, DOI 10.2307/3801833; Janzen K, 2011, CAN WATER RESOUR J, V36, P331, DOI 10.4296/cwrj3604846; JENKINS S H, 1979, Mammalian Species, P1, DOI 10.2307/3503787; JENKINS SH, 1975, OECOLOGIA, V21, P157, DOI 10.1007/BF00345558; JOHNSTON CA, 1990, ECOLOGY, V71, P1617, DOI 10.2307/1938297; Johnston CA, 1986, BOUNDARY DYNAMICS AQ, V57, P47; Kemp PS, 2012, FISH FISH, V13, P158, DOI 10.1111/j.1467-2979.2011.00421.x; Law A, 2016, FRESHWATER BIOL, V61, P486, DOI 10.1111/fwb.12721; Macfarlane WW, 2015, GEOMORPHOLOGY; Mackie Richard, 1997, TRADING MOUNTAINS BR; MCCOMB WC, 1990, GREAT BASIN NAT, V50, P273; Mote P, 2008, HYDROL EARTH SYST SC, V12, P193, DOI 10.5194/hess-12-193-2008; Naiman RJ, 1999, HYDROBIOLOGIA, V410, P79, DOI 10.1023/A:1003768102188; Parker H, 2014, WILDLIFE BIOL, V20, P267, DOI 10.2981/wlb.00040; Perkins TE, 2000, THESIS; Petro V.M., 2013, THESIS; Pollock MM, 2014, BIOSCIENCE, V64, P279, DOI 10.1093/biosci/biu036; Pollock MM, 2004, N AM J FISH MANAGE, V24, P749, DOI 10.1577/M03-156.1; Pollock MM, 2003, AM FISH S S, V37, P213; Pollock MM, 1994, LINKING SPECIES ECOS, P117; Raymond CL, 2013, SUSTAINABILITY-BASEL, V5, P136, DOI 10.3390/su5010136; Retzer J., 1956, USDA TECHNICAL B; Robinson S, 2007, ARCTIC, V60, P430; Scheuerell MD, 2006, CAN J FISH AQUAT SCI, V63, P1596, DOI 10.1139/F06-056; Snodgrass JW, 1997, J APPL ECOL, V34, P1043, DOI 10.2307/2405293; Snodgrass JW, 1998, ECOLOGY, V79, P928, DOI 10.2307/176590; Snohomish Basin Salmon Recovery Forum, 2005, SNOH RIV BAS SALM CO; Snyder R V., 1970, MT BAKER NATL FOREST; Stavros EN, 2014, INT J WILDLAND FIRE, V23, P899, DOI 10.1071/WF13169; Stevens CE, 2007, BIOL CONSERV, V134, P1, DOI 10.1016/j.biocon.2006.07.017; Suzuki N, 1998, NORTHWEST SCI, V72, P102; Westbrook CJ, 2011, RIVER RES APPL, V27, DOI 10.1002/rra.1359; Whitfield CJ, 2015, AMBIO, V44, P7, DOI 10.1007/s13280-014-0575-y; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1	49	30	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192538	10.1371/journal.pone.0192538	http://dx.doi.org/10.1371/journal.pone.0192538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489853	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000030
J	Griebeler, EM; Werner, J				Griebeler, Eva Maria; Werner, Jan			Formal comment on: Myhrvold (2016) Dinosaur metabolism and the allometry of maximum growth rate. PLoS ONE; 11(11): e0163205	PLOS ONE			English	Editorial Material							BODY TEMPERATURES; LIFE-HISTORY; BONE-GROWTH; PATTERNS; PHYSIOLOGY; BIRDS; DIET; ECOLOGY; HOMEOTHERMY; ENDOTHERMY	In his 2016 paper, Myhrvold criticized ours from 2014 on maximum growth rates (G(max), maximum gain in body mass observed within a time unit throughout an individual's ontogeny) and thermoregulation strategies (ectothermy, endothermy) of 17 dinosaurs. In our paper, we showed that Gmax values of similar-sized extant ectothermic and endothermic vertebrates overlap. This strongly questions a correct assignment of a thermoregulation strategy to a dinosaur only based on its Gmax and (adult) body mass (M). Contrary, Gmax separated similar-sized extant reptiles and birds (Sauropsida) and Gmax values of our studied dinosaurs were similar to those seen in extant similar-sized (if necessary scaled-up) fast growing ectothermic reptiles. Myhrvold examined two hypotheses (H1 and H2) regarding our study. However, we did neither infer dinosaurian thermoregulation strategies from group-wide averages (H1) nor were our results based on that Gmax and metabolic rate (MR) are related (H2). In order to assess whether single dinosaurian Gmax values fit to those of extant endotherms (birds) or of ectotherms (reptiles), we already used a method suggested by Myhrvold to avoid H1, and we only discussed pros and cons of a relation between Gmax and MR and did not apply it (H2). We appreciate Myhrvold's efforts in eliminating the correlation between Gmax and M in order to statistically improve vertebrate scaling regressions on maximum gain in body mass. However, we show here that his mass-specific maximum growth rate (kC) replacing G(max) (= MkC) does not model the expected higher mass gain in larger than in smaller species for any set of species. We also comment on, why we considered extant reptiles and birds as reference models for extinct dinosaurs and why we used phylogenetically-informed regression analysis throughout our study. Finally, we question several arguments given in Myhrvold in order to support his results.	[Griebeler, Eva Maria; Werner, Jan] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut, Evolutionary Ecol, Mainz, Germany	Johannes Gutenberg University of Mainz	Griebeler, EM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut, Evolutionary Ecol, Mainz, Germany.	em.griebeler@uni-mainz.de		Griebeler, Eva Maria/0000-0003-2166-487X				Abraham CL, 2004, MAR ECOL PROG SER, V274, P235, DOI 10.3354/meps274235; Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; BOAG PT, 1987, AUK, V104, P155, DOI 10.1093/auk/104.2.155; BRATTSTROM BH, 1965, AM MIDL NAT, V73, P376, DOI 10.2307/2423461; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Case TJ, 1978, PALEOBIOLOGY, V53, P243; Clarke A, 2010, BIOL REV, V85, P703, DOI 10.1111/j.1469-185X.2010.00122.x; Clarke A, 2010, J ANIM ECOL, V79, P610, DOI 10.1111/j.1365-2656.2010.01672.x; COLBERT EH, 1947, COPEIA, P141; DIEHL S, 1995, ECOLOGY, V76, P1712, DOI 10.2307/1940705; Duncan RP, 2007, ECOLOGY, V88, P324, DOI 10.1890/0012-9658(2007)88[324:TTMTOE]2.0.CO;2; Eagle RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9296; ELSE PL, 1985, J COMP PHYSIOL B, V156, P3, DOI 10.1007/BF00692920; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2014, ANNU REV EARTH PL SC, V42, P675, DOI 10.1146/annurev-earth-060313-054858; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fluharty FL, 2000, J ANIM SCI, V78, P1759; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; Griebeler EM, 2016, ECOL EVOL, V2016, P1; Griebeler EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074317; Griebeler EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067012; Guderley H.E., 1996, Society for Experimental Biology Seminar Series, V59, P127; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hulbert AJ, 1999, J THEOR BIOL, V199, P257, DOI 10.1006/jtbi.1999.0955; HULBERT AJ, 1990, NEWS PHYSIOL SCI, V5, P25; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Hull D., 1973, P167; Klein N, 2016, CR PALEVOL, V15, P142, DOI 10.1016/j.crpv.2015.02.009; Klein N, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140440; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Lance VA, 2003, EXP GERONTOL, V38, P801, DOI 10.1016/S0531-5565(03)00112-8; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Leon M., 1986, Handbook of Behavioral Neurobiology, V8, P297; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; LOWELL BB, 2000, NATURE, V353, P748; Madenjian CP, 1998, T AM FISH SOC, V127, P236, DOI 10.1577/1548-8659(1998)127&lt;0236:OASPID&gt;2.0.CO;2; MAGNUSSON WE, 1993, J HERPETOL, V27, P53, DOI 10.2307/1564905; MCCLURE PA, 1980, ECOL MONOGR, V50, P199, DOI 10.2307/1942479; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; Montes L, 2007, BIOL J LINN SOC, V92, P63, DOI 10.1111/j.1095-8312.2007.00881.x; Muller DWH, 2012, OIKOS, V121, P102, DOI 10.1111/j.1600-0706.2011.19505.x; Myhrvold NP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163205; Myhrvold NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081917; Nagy KA, 2000, HERPETOL MONOGR, V14, P378, DOI 10.2307/1467052; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAULY D, 1980, J CONSEIL, V39, P175; Pough F.H., 2003, HERPETOLOGY, V3rd; Ricklefs RE, 1987, FUNCT ECOL, V1, P151, DOI 10.2307/2389719; RICKLEFS RE, 1979, BIOL REV, V54, P269, DOI 10.1111/j.1469-185X.1979.tb01013.x; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; RICKLEFS RE, 1979, AUK, V96, P10; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Ritz J, 2010, HERPETOL J, V20, P213; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sander P. Martin, 2011, P276; Schmidt KE, 2001, J EXP ZOOL, V289, P66, DOI 10.1002/1097-010X(20010101/31)289:1<66::AID-JEZ7>3.0.CO;2-Q; SCHMIDTNIELSON K, 1997, ANIMAL PHYSL; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Seebacher F, 2005, J COMP PHYSIOL B, V175, P533, DOI 10.1007/s00360-005-0007-1; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; SPOTILA JR, 1973, AM NAT, V107, P391, DOI 10.1086/282842; Starck J. Matthias, 1998, Oxford Ornithology Series, V8, P381; Symonds M. R. E., 2014, MODERN PHYLOGENETIC, P105, DOI DOI 10.1007/978-3-662-43550-2_5; Visser GH, 1995, AUK, V112, P192, DOI 10.2307/4088778; VLECK CM, 1979, PHYSIOL ZOOL, V52, P363, DOI 10.1086/physzool.52.3.30155757; WALDSCHMIDT A, 1988, COMP BIOCHEM PHYS A, V90, P169, DOI 10.1016/0300-9629(88)91024-9; Werner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088834; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2010, NATURE, V464, P691, DOI 10.1038/464691a; Willmer P., 2005, ENV PHYSL ANIMALS, V2nd; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844	79	3	3	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0163205	10.1371/journal.pone.0184756	http://dx.doi.org/10.1371/journal.pone.0184756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489816	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000001
J	Russo, N; Hagmann, CE; Andrews, R; Black, C; Silberman, M; Shea, N				Russo, Natalie; Hagmann, Carl Erick; Andrews, Rosemary; Black, Conner; Silberman, Magenta; Shea, Nicole			Validation of the CARE stimulus set of 640 animal pictures: Name agreement and quality ratings	PLOS ONE			English	Article							IMAGE AGREEMENT; VISUAL COMPLEXITY; WORD-FREQUENCY; AGE; ACQUISITION; NORMS; FAMILIARITY; SNODGRASS; MEMORY; VARIABILITY	Stimulus sets are valuable tools that can facilitate the work of researchers designing experiments. Images of faces, and line drawings of objects have been developed and validated, however, pictures of animals, that do not contain backgrounds, have not been made available. Here we present image agreement and quality ratings for a set of 640 color images of animals on a transparent background, across 60 different basic categories (e.g. cat, dog, frog, bird), some with few, and others with many exemplars. These images were normed on 302 participants. Image agreement was measured both with respect to the proportion of participants that provided the same name as well as the H-statistic for each image. Image quality was measured both overall, and with respect to the accuracy of participants' naming of the basic category. Word frequency of each basic and superordinate category based on the English Lexicon Project (Balota, et al., 2007) and the HAL database (Kucera & Francis, 1976) are provided as are Age of Acquisition (Kuperman, Stadthagen-Gonzalez, & Brysbaert, 2012) data.	[Russo, Natalie; Hagmann, Carl Erick; Black, Conner; Silberman, Magenta; Shea, Nicole] Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA; [Andrews, Rosemary] Furmam Univ, Dept Neurosci, Greenville, SC USA; [Hagmann, Carl Erick] Terakeet LLC, 333 W Washington St, Syracuse, NY USA; [Black, Conner] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Silberman, Magenta] Univ Utah, Dept Educ Psychol, Salt Lake City, UT 84112 USA	Syracuse University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Utah System of Higher Education; University of Utah	Russo, N (corresponding author), Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA.	nrusso@syr.edu		Black, Conner J./0000-0002-9596-5790; Russo, Natalie/0000-0001-5229-3552	Hill Collaboration for Environmental Medicine	Hill Collaboration for Environmental Medicine	This work was supported by Hill Collaboration for Environmental Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; [Anonymous], 2006, MACARTHUR BATES COMM; Arnold NR, 2015, PSYCHOL RES-PSYCH FO, V79, P882, DOI 10.1007/s00426-014-0608-y; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Barbarotto R, 2002, NEUROPSYCHOLOGIA, V40, P1637, DOI 10.1016/S0028-3932(02)00029-5; Barry C, 1997, Q J EXP PSYCHOL-A, V50, P560, DOI 10.1080/783663595; Bonin P, 2003, BEHAV RES METH INS C, V35, P158, DOI 10.3758/BF03195507; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CARROLL JB, 1973, Q J EXP PSYCHOL, V25, P85, DOI 10.1080/14640747308400325; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; Dahan D, 2001, COGNITIVE PSYCHOL, V42, P317, DOI 10.1006/cogp.2001.0750; Dalrymple KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079131; Deng J, 2010, LECT NOTES COMPUT SC, V6315, P71, DOI 10.1007/978-3-642-15555-0_6; GILHOOLY KJ, 1979, MEM COGNITION, V7, P214, DOI 10.3758/BF03197541; Kuperman V, 2012, BEHAV RES METHODS, V44, P978, DOI 10.3758/s13428-012-0210-4; LACHMAN R, 1974, J VERB LEARN VERB BE, V13, P613, DOI 10.1016/S0022-5371(74)80049-6; LACHMAN R, 1973, J EXP PSYCHOL, V99, P199, DOI 10.1037/h0034633; Mathworks, 2005, MATLAB LANG TECHN CO; MORRISON CM, 1992, MEM COGNITION, V20, P705, DOI 10.3758/BF03202720; PAIVIO A, 1989, MEM COGNITION, V17, P163, DOI 10.3758/BF03197066; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Schendan HE, 2007, PSYCHON B REV, V14, P612, DOI 10.3758/BF03196810; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Snodgrass JG, 1996, BEHAV RES METH INSTR, V28, P516, DOI 10.3758/BF03200540; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144; Wagemans J, 2008, PERCEPTION, V37, P207, DOI 10.1068/p5825; WAXMAN S, 1986, COGNITIVE DEV, V1, P139, DOI 10.1016/S0885-2014(86)80016-8; Wu YC, 1999, OBJECTIVE VISUAL COM; Wyble Brad, 2018, STREAM OPEN SCI FRAM; Zhou Bolei, 2014, ADV NEURAL INFORM PR, P7, DOI DOI 10.5555/2968826.2968881	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192906	10.1371/journal.pone.0192906	http://dx.doi.org/10.1371/journal.pone.0192906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489882	gold, Green Submitted, Green Published			2022-12-27	WOS:000426276000045
J	Soeters, HM; Koivogui, L; de Beer, L; Johnson, CY; Diaby, D; Ouedraogo, A; Toure, F; Bangoura, FO; Chang, MA; Chea, N; Dotson, EM; Finlay, A; Fitter, D; Hamel, MJ; Hazim, C; Larzelere, M; Park, BJ; Rowe, AK; Thompson-Paul, AM; Twyman, A; Barry, M; Ntaw, G; Diallo, AO				Soeters, Heidi M.; Koivogui, Lamine; de Beer, Lindsey; Johnson, Candice Y.; Diaby, Dianka; Ouedraogo, Abdoulaye; Toure, Fatoumata; Bangoura, Fode Ousmane; Chang, Michelle A.; Chea, Nora; Dotson, Ellen M.; Finlay, Alyssa; Fitter, David; Hamel, Mary J.; Hazim, Carmen; Larzelere, Maribeth; Park, Benjamin J.; Rowe, Alexander K.; Thompson-Paul, Angela M.; Twyman, Anthony; Barry, Moumie; Ntaw, Godlove; Diallo, Alpha Oumar			Infection prevention and control training and capacity building during the Ebola epidemic in Guinea	PLOS ONE			English	Article							HEALTH-CARE WORKERS; VIRUS DISEASE; LIBERIA	Background During the 2014-2016 Ebola epidemic in West Africa, a key epidemiological feature was disease transmission within healthcare facilities, indicating a need for infection prevention and control (IPC) training and support. Methods IPC training was provided to frontline healthcare workers (HCW) in healthcare facilities that were not Ebola treatment units, as well as to IPC trainers and IPC supervisors placed in healthcare facilities. Trainings included both didactic and hands-on components, and were assessed using pre-tests, post-tests and practical evaluations. We calculated median percent increase in knowledge. Results From October December 2014, 20 IPC courses trained 1,625 Guineans: 1,521 HCW, 55 IPC trainers, and 49 IPC supervisors. Median test scores increased 40% (interquartile range [IQR]: 19-86%) among HCW, 15% (IQR: 8-33%) among IPC trainers, and 21% (IQR: 15-30%) among IPC supervisors (all P<0.0001) to post-test scores of 83%, 93%, and 93%, respectively. Conclusions IPC training resulted in clear improvements in knowledge and was feasible in a public health emergency setting. This method of IPC training addressed a high demand among HCW. Valuable lessons were learned to facilitate expansion of IPC training to other prefectures; this model may be considered when responding to other large outbreaks.	[Soeters, Heidi M.; de Beer, Lindsey; Johnson, Candice Y.; Chang, Michelle A.; Chea, Nora; Dotson, Ellen M.; Finlay, Alyssa; Fitter, David; Hamel, Mary J.; Hazim, Carmen; Larzelere, Maribeth; Park, Benjamin J.; Rowe, Alexander K.; Thompson-Paul, Angela M.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Koivogui, Lamine] Inst Natl Sante Publ, Conakry, Guinea; [Diaby, Dianka; Ntaw, Godlove] Catholic Relief Serv, Conakry, Guinea; [Ouedraogo, Abdoulaye; Bangoura, Fode Ousmane; Twyman, Anthony] WHO, Conakry, Guinea; [Toure, Fatoumata] Hop Natl Donka, Conakry, Guinea; [Barry, Moumie; Diallo, Alpha Oumar] Guinea Minist Hlth & Publ Hyg, Conakry, Guinea	Centers for Disease Control & Prevention - USA; World Health Organization	Soeters, HM (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	HMSoeters@cdc.gov	Soeters, Heidi/H-3271-2019; Thompson-Paul, Angela/N-7067-2016	Soeters, Heidi/0000-0002-9415-9340; Thompson-Paul, Angela/0000-0003-1186-9150; Hazim, Carmen/0000-0002-6024-9815; Johnson, Candice/0000-0002-2544-3110	United States Agency for International Development; CDC Foundation; Rio Tinto Group	United States Agency for International Development(United States Agency for International Development (USAID)); CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Rio Tinto Group	IPC trainings were supported by the United States Agency for International Development, CDC Foundation, and Rio Tinto Group. CDC staff were provided in kind during the response. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper C, 2016, BMC MED, V14, DOI 10.1186/s12916-015-0548-4; Grinnell M, 2015, MMWR-MORBID MORTAL W, V64, P1083, DOI 10.15585/mmwr.mm6438a6; Kilmarx PH, 2014, MMWR-MORBID MORTAL W, V63, P1168; Matanock A, 2014, MMWR-MORBID MORTAL W, V63, P1077; WHO, 2016, EB RESP ROADM SIT RE; World Health Organization, 2015, EB RESP ROADM SIT RE	6	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193291	10.1371/journal.pone.0193291	http://dx.doi.org/10.1371/journal.pone.0193291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489885	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000062
J	Karlsson, E; Shin, JH; Westman, G; Eriksson, LA; Olsson, L; Mapell, V				Karlsson, Emma; Shin, Jae Ho; Westman, Gunnar; Eriksson, Leif A.; Olsson, Lisbeth; Mapell, Valeria			In silico and in vitro studies of the reduction of unsaturated alpha,beta bonds of trans-2-hexenedioic acid and 6-amino-trans-2-hexenoic acid - Important steps towards biobased production of adipic acid	PLOS ONE			English	Article							OLD YELLOW ENZYME; HIGH-LEVEL CONVERSION; L-LYSINE; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; LIGAND-BINDING; BIOSYNTHESIS; PATHWAY; AMINOTRANSFERASE; PURIFICATION	The biobased production of adipic acid, a precursor in the production of nylon, is of great interest in order to replace the current petrochemical production route. Glucose-rich lignocellulosic raw materials have high potential to replace the petrochemical raw material. A number of metabolic pathways have been proposed for the microbial conversion of glucose to adipic acid, but achieved yields and titers remain to be improved before industrial applications are feasible. One proposed pathway starts with lysine, an essential metabolite industrially produced from glucose by microorganisms. However, the drawback of this pathway is that several reactions are involved where there is no known efficient enzyme. By changing the order of the enzymatic reactions, we were able to identify an alternative pathway with one unknown enzyme less compared to the original pathway. One of the reactions lacking known enzymes is the reduction of the unsaturated a,6 bond of 6-amino-trans-2-hexenoic acid and trans-2-hexenedioic acid. To identify the necessary enzymes, we selected N-ethylmaleimide reductase from Escherichia coli and Old Yellow Enzyme 1 from Saccharomyces pastorianus. Despite successful in silico docking studies, where both target substrates could fit in the enzyme pockets, and hydrogen bonds with catalytic residues of both enzymes were predicted, no in vitro activity was observed. We hypothesize that the lack of activity is due to a difference in electron withdrawing potential between the naturally reduced aldehyde and the carboxylate groups of our target substrates. Suggestions for protein engineering to induce the reactions are discussed, as well as the advantages and disadvantages of the two metabolic pathways from lysine. We have highlighted bottlenecks associated with the lysine pathways, and proposed ways of addressing them.	[Karlsson, Emma; Shin, Jae Ho; Olsson, Lisbeth; Mapell, Valeria] Chalmers Univ Technol, Div Ind Biotechnol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Westman, Gunnar] Dept Chem & Chem Engn, Div Chem & Biochem, Gothenburg, Sweden; [Eriksson, Leif A.] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Olsson, L (corresponding author), Chalmers Univ Technol, Div Ind Biotechnol, Dept Biol & Biol Engn, Gothenburg, Sweden.	lisbeth.olsson@chalmers.se	Westman, Gunnar/D-4499-2015; Mapelli, Valeria/E-4434-2014; shin, Jaeho/K-6792-2013; Eriksson, Leif A/D-1226-2012	Mapelli, Valeria/0000-0001-8724-3221; shin, Jaeho/0000-0002-5874-9765; Eriksson, Leif A/0000-0001-5654-3109	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) [2013-78]; Swedish Research Council (VR) [20143914]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council)	The study was funded by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) under the strategic programme of "Research for Transition to a Bio-based Economy and within the collaborative project BioBuF (Project no. 2013-78) www.biobuf.se. The Swedish National Infrastructure for Computing (SNIC) is acknowledged for providing computing time. L.A.E. acknowledges the Swedish Research Council (VR) for funding (no. 20143914).	Babu T, 2015, PROCESS BIOCHEM, V50, P2066, DOI 10.1016/j.procbio.2015.09.018; Becker J, 2012, CURR OPIN BIOTECH, V23, P631, DOI 10.1016/j.copbio.2011.11.012; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Brenna E, 2015, J MOL CATAL B-ENZYM, V114, P77, DOI 10.1016/j.molcatb.2014.12.011; Brenna E, 2013, ORG BIOMOL CHEM, V11, P2988, DOI 10.1039/c3ob40076j; Burgard A. P., 2016, US patent, Patent No. [9,382,556 B2, 9382556, 9,382,556]; Deng Y, 2015, J APPL MICROBIOL, V119, P1057, DOI 10.1111/jam.12905; Fisher Scientific Inc T, DET AM AC CELL CULT; Forsythe RG, 1997, COMPUT APPL BIOSCI, V13, P537; FOX KM, 1994, STRUCTURE, V2, P1089, DOI 10.1016/S0969-2126(94)00111-1; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; GOUGH JA, 1983, J MOL BIOL, V166, P1, DOI 10.1016/S0022-2836(83)80047-3; HAMMER T, 1991, J BASIC MICROB, V31, P43, DOI 10.1002/jobm.3620310109; HAMMER T, 1992, J BASIC MICROB, V32, P21, DOI 10.1002/jobm.3620320106; Hansson T, 1998, J COMPUT AID MOL DES, V12, P27, DOI 10.1023/A:1007930623000; HERMES JD, 1985, BIOCHEMISTRY-US, V24, P2959, DOI 10.1021/bi00333a023; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Joo JC, 2017, CHEM SCI, V8, P1406, DOI 10.1039/c6sc02842j; Kallscheuer N, 2016, APPL MICROBIOL BIOT, P1; Kind S, 2014, METAB ENG, V25, P113, DOI 10.1016/j.ymben.2014.05.007; Kind S, 2010, METAB ENG, V12, P341, DOI 10.1016/j.ymben.2010.03.005; KINZEL JJ, 1983, J BACTERIOL, V155, P417, DOI 10.1128/JB.155.1.417-419.1983; KISS RD, 1992, BIOTECHNOL BIOENG, V39, P565, DOI 10.1002/bit.260390512; Kohli RM, 1998, J BIOL CHEM, V273, P32763, DOI 10.1074/jbc.273.49.32763; KUNO S, 1985, BIOL CHEM H-S, V366, P463, DOI 10.1515/bchm3.1985.366.1.463; Li Z., 2016, SCI REP, V6; Liu HB, 2013, RSC ADV, V3, P1666, DOI 10.1039/c2ra22374k; Lonsdale R, 2015, J AM CHEM SOC, V137, P14733, DOI 10.1021/jacs.5b08687; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Marx A, 1997, BIOTECHNOL BIOENG, V56, P168, DOI 10.1002/(SICI)1097-0290(19971020)56:2<168::AID-BIT6>3.0.CO;2-N; MAVROVOUNIOTIS ML, 1991, J BIOL CHEM, V266, P14440; Mimitsuka T, 2007, BIOSCI BIOTECH BIOCH, V71, P2130, DOI 10.1271/bbb.60699; Miura K, 1997, BIOL PHARM BULL, V20, P110; Moritz B, 2002, METAB ENG, V4, P295, DOI 10.1006/mben.2002.0233; Oh YH, 2015, J IND MICROBIOL BIOT, V42, P1481, DOI 10.1007/s10295-015-1678-6; Padhi SK, 2009, J AM CHEM SOC, V131, P3271, DOI 10.1021/ja8081389; Park SJ, 2014, BIOTECHNOL J, V9, P1322, DOI 10.1002/biot.201400156; Parthasarathy A, 2011, BIOCHEMISTRY-US, V50, P3540, DOI 10.1021/bi1020056; Pesic M, 2017, CHEMISTRYSELECT, V2, P3866, DOI 10.1002/slct.201700724; Pompeu YA, 2013, ACS CATAL, V3, P2376, DOI 10.1021/cs400622e; Raemakers-Franken P. C., 2009, U.S. Patent, Patent No. [7491520 (B2), 7491520, US7491520 B2]; Rohles CM, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0553-0; SCHMIDT H, 1988, FEMS MICROBIOL LETT, V49, P203; Shin JH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0566-8; Simon H, 1998, STUD NAT PROD CHEM, V20, P817; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Stueckler C, 2010, DALTON T, V39, P8472, DOI 10.1039/c002971h; Swiderska MA, 2007, THESIS; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; TISCHER W, 1979, EUR J BIOCHEM, V97, P103, DOI 10.1111/j.1432-1033.1979.tb13090.x; Toogood HS, 2011, CHEMBIOCHEM, V12, P738, DOI 10.1002/cbic.201000662; Turk SCHJ, 2016, ACS SYNTH BIOL, V5, P65, DOI 10.1021/acssynbio.5b00129; VAZ ADN, 1995, BIOCHEMISTRY-US, V34, P4246, DOI 10.1021/bi00013a014; Walton AZ, 2013, HDB FLAVOPROTEINS, V2; Warburg O, 1932, NATURWISSENSCHAFTEN, V20, P980, DOI 10.1007/BF01504728; WILLIAMS A, 2000, NEW DIR ORG, P1; Williams RE, 2002, MICROBIOL-SGM, V148, P1607, DOI 10.1099/00221287-148-6-1607; Williams RE, 2004, APPL ENVIRON MICROB, V70, P3566, DOI 10.1128/AEM.70.6.3566-3574.2004; Winkler CK, 2012, J BIOTECHNOL, V162, P381, DOI 10.1016/j.jbiotec.2012.03.023; Yu JL, 2014, BIOTECHNOL BIOENG, V111, P2580, DOI 10.1002/bit.25293	62	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193503	10.1371/journal.pone.0193503	http://dx.doi.org/10.1371/journal.pone.0193503			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474495	gold, Green Published, Green Submitted			2022-12-27	WOS:000426049500122
J	Sivarajah, S; Smith, SM; Thomas, SC				Sivarajah, Sivajanani; Smith, Sandy M.; Thomas, Sean C.			Tree cover and species composition effects on academic performance of primary school students	PLOS ONE			English	Article							NATURAL-ENVIRONMENT; BUILT ENVIRONMENT; ACHIEVEMENT; RESTORATION; EXPOSURE; ANXIETY	Human exposure to green space and vegetation is widely recognized to result in physical and mental health benefits; however, to date, the specific effects of tree cover, diversity, and species composition on student academic performance have not been investigated. We compiled standardized performance scores in Grades 3 and 6 for the collective student body in 387 schools across the Toronto District School Board (TDSB), and examined variation in relation to tree cover, tree diversity, and tree species composition based on comprehensive inventories of trees on school properties combined with aerial-photo-based assessments of tree cover. Analyses accounted for variation due to socioeconomic factors using the learning opportunity index (LOI), a regional composite index of external challenges to learning that incorporates income and other factors, such as students with English as a second language. As expected, LOI had the greatest influence on student academic performance; however, the proportion of tree cover, as distinct from other types of "green space" such as grass, was found to be a significant positive predictor of student performance, accounting for 13% of the variance explained in a statistical model predicting mean student performance assessments. The effects of tree cover and species composition were most pronounced in schools that showed the highest level of external challenges, suggesting the importance of urban forestry investments in these schools.	[Sivarajah, Sivajanani; Smith, Sandy M.; Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON, Canada	University of Toronto	Sivarajah, S (corresponding author), Univ Toronto, Fac Forestry, Toronto, ON, Canada.	sivalanani.sivarajah@mail.utoronto.ca	Sivarajah, Janani/AAN-8663-2020; THOMAS, Sean C./B-6089-2008	Sivarajah, Janani/0000-0002-0530-4615; THOMAS, Sean C./0000-0002-0686-2483	NSERC; Toronto District School Board, Sustainability Office; Toronto District School Board (TDSB); Toronto District School Board; Canadian Natural Sciences and Engineering Research Council	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Toronto District School Board, Sustainability Office; Toronto District School Board (TDSB); Toronto District School Board; Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Sean C. Thomas and Sandy M. Smith were supported by individual NSERC Discovery grants (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/index_eng.asp). Toronto District School Board, Sustainability Office offered additional financial support (http://www.tdsb.on.ca/).; The authors gratefully acknowledge funding from the Toronto District School Board (TDSB) and support of staff from the Sustainability Office of the TDSB (in particular Richard Christie, Bruce Day, and Gail Bornstein). Thanks also to Professors W.A. Kenney and D.Puric-Mladenovic for allowing the use of their NeighbourWoods data and the Education Quality and Accountability (EQAO) Office for the student body standardized test scores for each school, and M. Lukas Seehausen and Susan Frye for providing helpful comments on an early version of the manuscript. This research was funded by the Toronto District School Board, and grants from the Canadian Natural Sciences and Engineering Research Council.	Altschul I., 2012, J SOC SOC WORK RES, V3, P13, DOI [10.5243/jsswr.2012.2, 10.5243/jsswr, DOI 10.5243/JSSWR.2012.2]; [Anonymous], 1989, EXPERIENCE NATURE; Ashcraft MH, 2001, J EXP PSYCHOL GEN, V130, P224, DOI 10.1037/0096-3445.130.2.224; Caro D.H., 2009, CANADIAN J ED, V32, P558; Chambers EA, 2004, GENDER EDUC, V16, P327, DOI 10.1080/09540250042000251470; City of Toronto, WELLB TOR; City of Toronto, FOR LAND COV PARKS R; Cummins SK, 2001, PEDIATR CLIN N AM, V48, P1241, DOI 10.1016/S0031-3955(05)70372-2; Dyment JE, 2008, HEALTH EDUC RES, V23, P952, DOI 10.1093/her/cym059; Eamon MK, 2005, J YOUTH ADOLESCENCE, V34, P163, DOI 10.1007/s10964-005-3214-x; Fjortoft I., 2004, CHILDREN YOUTH ENV, V14, P21, DOI DOI 10.7721/CHILYOUTENVI.14.2.0021; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Hansmann Ralf, 2007, Urban Forestry & Urban Greening, V6, P213, DOI 10.1016/j.ufug.2007.08.004; Hartig T, 2003, J ENVIRON PSYCHOL, V23, P109, DOI 10.1016/S0272-4944(02)00109-3; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Herrington S, 1998, LANDSCAPE URBAN PLAN, V42, P191, DOI 10.1016/S0169-2046(98)00087-5; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Maas J, 2008, ENVIRON PLANN, V41, P1763; Magurran A.E., 2013, ECOLOGICAL DIVERSITY; Matsuoka RH, 2010, LANDSCAPE URBAN PLAN, V97, P273, DOI 10.1016/j.landurbplan.2010.06.011; McCoy LP, 2005, J EDUC RES, V98, P131, DOI 10.3200/JOER.98.3.131-135; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Nowak David J., 2006, Urban Forestry & Urban Greening, V4, P115, DOI 10.1016/j.ufug.2006.01.007; Park BJ, 2011, LANDSCAPE URBAN PLAN, V102, P24, DOI 10.1016/j.landurbplan.2011.03.005; Pretty J, 2005, INT J ENVIRON HEAL R, V15, P319, DOI 10.1080/09603120500155963; RICHARDSON FC, 1972, J COUNS PSYCHOL, V19, P551, DOI 10.1037/h0033456; Takano T, 2002, J EPIDEMIOL COMMUN H, V56, P913, DOI 10.1136/jech.56.12.913; Taylor AF, 2001, ENVIRON BEHAV, V33, P54, DOI 10.1177/00139160121972864; Toronto District School Board, LEARN OPP IND EL; Tranter P.J., 2004, CHILD GEOGR, V2, P131, DOI [10.1080/1473328032000168813, DOI 10.1080/1473328032000168813]; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Villeneuve PJ, 2012, ENVIRON RES, V115, P51, DOI 10.1016/j.envres.2012.03.003; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548	33	42	43	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193254	10.1371/journal.pone.0193254	http://dx.doi.org/10.1371/journal.pone.0193254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX4LV	29474503	gold, Green Published, Green Submitted			2022-12-27	WOS:000426049500071
J	Bergstrom, BE; Abdelkhalek, A; Younis, W; Hammac, GK; Townsend, WM; Seleem, MN				Bergstrom, Benjamin E.; Abdelkhalek, Ahmed; Younis, Waleed; Hammac, G. Kenitra; Townsend, Wendy M.; Seleem, Mohamed N.			Antibacterial activity and safety of commercial veterinary cationic steroid antibiotics and neutral superoxidized water	PLOS ONE			English	Article							METHICILLIN-RESISTANT STAPHYLOCOCCUS; ACID AQUEOUS-SOLUTION; ANTIMICROBIAL PEPTIDES; POLYMYXIN-B; PSEUDOMONAS-AERUGINOSA; CERAGENINS; PH; INFECTIONS; PREVALENCE; EFFICACY	Antibiotic resistance of bacteria common to the ocular surface is an evolving problem. Thus, novel treatment options with new modes of action are required. We investigated the antibacterial activity and safety of three commercially available topical veterinary ophthalmic products (cationic steroid antibiotics, products A and B, and a neutral superoxidized water, product C) to determine their potential use as antimicrobial alternatives. The minimum inhibitory concentrations (MIC) of the three products were determined against 17 antibiotic resistant bacterial clinical isolates from the ocular surface. Using a standard cytotoxicity assay, the products at varying concentrations were evaluated with a corneal fibroblast cell line and a macrophage- like cell line to determine their potential toxic effect in vitro. The commercial ophthalmic solutions, ofloxacin 0.3%, tobramycin 0.3% and gentamicin 0.3% were used as positive controls for the MIC and tobramycin 0.3% was used as positive control for the cytotoxicity assays. For the MIC, Product C showed no inhibition of growth for any organisms, while Products A and B showed inhibition of growth similar to slightly less than the positive controls. For the cytotoxicity assays, Product C exhibited minimal toxicity while Products A and B exhibited toxicity similar to the controls. In conclusion, Product C had no antibacterial activity in these assays, while Products A and B had antibacterial profiles similar to slightly less than common topical ophthalmic antibiotics and cytotoxicity profiles similar to common topical ophthalmic antibiotics. To our knowledge, this is the first report on the antibacterial activity and safety of the cationic steroid antibiotics and superoxidized water.	[Bergstrom, Benjamin E.; Townsend, Wendy M.] Purdue Univ, Coll Vet Med, Dept Vet Clin Sci, W Lafayette, IN 47907 USA; [Abdelkhalek, Ahmed; Younis, Waleed; Hammac, G. Kenitra; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Townsend, WM (corresponding author), Purdue Univ, Coll Vet Med, Dept Vet Clin Sci, W Lafayette, IN 47907 USA.	townsenw@purdue.edu	Seleem, Mohamed/H-2774-2018; Younis, Wlaeed/AAA-1743-2022	Seleem, Mohamed/0000-0003-0939-0458; Younis, Wlaeed/0000-0001-5572-0142; Townsend, Wendy/0000-0001-8761-9380	Purdue University Armstrong Fund for Research in Anomalies of the Eye	Purdue University Armstrong Fund for Research in Anomalies of the Eye	Publication costs were supported by the Purdue University Armstrong Fund for Research in Anomalies of the Eye.	[Anonymous], 2015, M07 A10 METHODS DILU; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Bruch MD, 1999, J AM CHEM SOC, V121, P11993, DOI 10.1021/ja992376m; Chin JN, 2008, J ANTIMICROB CHEMOTH, V61, P365, DOI 10.1093/jac/dkm457; Chin JN, 2007, ANTIMICROB AGENTS CH, V51, P1268, DOI 10.1128/AAC.01325-06; Clarkson RM, 2001, AUST DENT J, V46, P269, DOI 10.1111/j.1834-7819.2001.tb00291.x; da Silva FP, 2012, PEPTIDES, V36, P308, DOI 10.1016/j.peptides.2012.05.014; Ding BW, 2004, J AM CHEM SOC, V126, P13642, DOI 10.1021/ja046909p; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Epand RF, 2010, ANTIMICROB AGENTS CH, V54, P3708, DOI 10.1128/AAC.00380-10; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Howell MD, 2009, J INVEST DERMATOL, V129, P2668, DOI 10.1038/jid.2009.120; Inoue Y, 1997, ARTIF ORGANS, V21, P28; Iwasawa A, 1996, Kansenshogaku Zasshi, V70, P915; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kang MH, 2014, CAN VET J, V55, P678; Kapur V, 2011, INDIAN J SURG, V73, P48, DOI 10.1007/s12262-010-0189-y; Landa-Solis C, 2005, J HOSP INFECT, V61, P291, DOI 10.1016/j.jhin.2005.04.021; Ledbetter EC, 2016, VET OPHTHALMOL, V19, P220, DOI [10.1111/vop.12287, 10.1111/vop.12200]; Lee IH, 1997, INFECT IMMUN, V65, P2898, DOI 10.1128/IAI.65.7.2898-2903.1997; Len SV, 2002, J AGR FOOD CHEM, V50, P209, DOI 10.1021/jf010822v; Li CH, 1998, J AM CHEM SOC, V120, P2961, DOI 10.1021/ja973881r; Loy JD, 2014, J VET DIAGN INVEST, V26, P761, DOI 10.1177/1040638714551403; Martinez JA, 2011, EVALUATION BACTERIAL; Martinez JA, 2015, P 47 ANN C AM COLL V; Martinez-Munive A., 2005, P AM COLL SURG 91 AN, P190; Mohammad H, 2015, CURR PHARM DESIGN, V21, P2073, DOI 10.2174/1381612821666150310102702; Moscoso M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101037; Mouney MC, 2015, VET OPHTHALMOL, V18, P123, DOI 10.1111/vop.12130; Nagant C, 2013, MICROBIOLOGYOPEN, V2, P318, DOI 10.1002/mbo3.77; Nelson D, 2000, Gastrointest Endosc Clin N Am, V10, P319; NELSON JD, 1990, CURR EYE RES, V9, P277, DOI 10.3109/02713689009044524; Normark BH, 2002, J INTERN MED, V252, P91, DOI 10.1046/j.1365-2796.2002.01026.x; Ohno H, 2000, SURG TODAY, V30, P1055, DOI 10.1007/s005950070035; Papagianni M, 2003, BIOTECHNOL ADV, V21, P465, DOI 10.1016/S0734-9750(03)00077-6; Polat ZA, 2011, J OCUL PHARMACOL TH, V27, P1, DOI 10.1089/jop.2010.0041; Rutala WA, 2001, EMERG INFECT DIS, V7, P348, DOI 10.3201/eid0702.010241; Saha S, 2008, J APPL MICROBIOL, V105, P822, DOI 10.1111/j.1365-2672.2008.03820.x; Sakashita Mikako, 2002, Kansenshogaku Zasshi, V76, P373; Sampson MN, 2002, J HOSP INFECT, V52, P227; Sauer K, 2009, BIOFOULING, V25, P45, DOI 10.1080/08927010802441412; Savage PB, 2002, FEMS MICROBIOL LETT, V217, P1; Seitz B, 1996, INVEST OPHTH VIS SCI, V37, P656; Sekiya S, 1997, ARTIF ORGANS, V21, P32; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Srimal S, 1996, BIOCHEM J, V315, P679, DOI 10.1042/bj3150679; Suter A, 2016, P 47 ANN C AM COLL V, P32; Tanaka H, 1996, J HOSP INFECT, V34, P43, DOI 10.1016/S0195-6701(96)90124-3; Thomas CJ, 1998, J AM CHEM SOC, V120, P12428, DOI 10.1021/ja981777j; Tincu JA, 2003, J BIOL CHEM, V278, P13546, DOI 10.1074/jbc.M211332200; van 't Hof W, 2001, BIOL CHEM, V382, P597, DOI 10.1515/BC.2001.072; Walker S, 1996, P NATL ACAD SCI USA, V93, P1585, DOI 10.1073/pnas.93.4.1585	52	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193217	10.1371/journal.pone.0193217	http://dx.doi.org/10.1371/journal.pone.0193217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513686	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800044
J	Dahlmann, J; Awad, G; Dolny, C; Weinert, S; Richter, K; Fischer, KD; Munsch, T; Lessmann, V; Volleth, M; Zenker, M; Chen, Y; Merkl, C; Schnieke, A; Baraki, H; Kutschka, I; Kensah, G				Dahlmann, Julia; Awad, George; Dolny, Carsten; Weinert, Soenke; Richter, Karin; Fischer, Klaus-Dieter; Munsch, Thomas; Lessmann, Volkmar; Volleth, Marianne; Zenker, Martin; Chen, Yaoyao; Merkl, Claudia; Schnieke, Angelika; Baraki, Hassina; Kutschka, Ingo; Kensah, George			Generation of functional cardiomyocytes from rat embryonic and induced pluripotent stem cells using feeder-free expansion and differentiation in suspension culture	PLOS ONE			English	Article							CARDIAC DIFFERENTIATION; INFARCT MODEL; HEARTS; MYOCYTES; MOUSE; TRANSPLANTATION; INTEGRATION; BLASTOCYSTS; MATURATION; SURVIVAL	The possibility to generate cardiomyocytes from pluripotent stem cells in vitro has enormous significance for basic research, disease modeling, drug development and heart repair. The concept of heart muscle reconstruction has been studied and optimized in the rat model using rat primary cardiovascular cells or xenogeneic pluripotent stem cell derived-cardiomyocytes for years. However, the lack of rat pluripotent stem cells (rPSCs) and their cardiovascular derivatives prevented the establishment of an authentic clinically relevant syngeneic or allogeneic rat heart regeneration model. In this study, we comparatively explored the potential of recently available rat embryonic stem cells (rESCs) and induced pluripotent stem cells (riPSCs) as a source for cardiomyocytes (CMs). We developed feeder cell-free culture conditions facilitating the expansion of undifferentiated rPSCs and initiated cardiac differentiation by embryoid body (EB)-formation in agarose microwell arrays, which substituted the robust but labor-intensive hanging drop (HD) method. Ascorbic acid was identified as an efficient enhancer of cardiac differentiation in both rPSC types by significantly increasing the number of beating EBs (3.6 +/- 1.6-fold for rESCs and 17.6 +/- 3.2-fold for riPSCs). These optimizations resulted in a differentiation efficiency of up to 20% cTnT pos rPSC-derived CMs. CMs showed spontaneous contractions, expressed cardiac markers and had typical morphological features. Electrophysiology of riPSC-CMs revealed different cardiac subtypes and physiological responses to cardio-active drugs. In conclusion, we describe rPSCs as a robust source of CMs, which is a prerequisite for detailed preclinical studies of myocardial reconstruction in a physiologically and immunologically relevant small animal model.	[Dahlmann, Julia; Awad, George; Dolny, Carsten; Baraki, Hassina; Kutschka, Ingo; Kensah, George] Otto von Guericke Univ, Clin Cardiothorac Surg, Magdeburg, Germany; [Weinert, Soenke] Otto von Guericke Univ, Clin Cardiol & Angiol, Magdeburg, Germany; [Richter, Karin; Fischer, Klaus-Dieter] Otto von Guericke Univ, Inst Biochem & Cell Biol, Magdeburg, Germany; [Munsch, Thomas; Lessmann, Volkmar] Otto von Guericke Univ, Inst Physiol, Magdeburg, Germany; [Volleth, Marianne; Zenker, Martin] Otto von Guericke Univ, Inst Human Genet, Magdeburg, Germany; [Chen, Yaoyao] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England; [Merkl, Claudia; Schnieke, Angelika] Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany; [Dahlmann, Julia; Awad, George; Baraki, Hassina; Kutschka, Ingo; Kensah, George] Univ Med Ctr Gottingen, DZHK German Ctr Cardiovasc Res, Clin Thorac & Cardiovasc Surg, Partner Site Gottingen, Gottingen, Germany	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; University of Cambridge; Technical University of Munich; German Centre for Cardiovascular Research; University of Gottingen	Kensah, G (corresponding author), Otto von Guericke Univ, Clin Cardiothorac Surg, Magdeburg, Germany.; Kensah, G (corresponding author), Univ Med Ctr Gottingen, DZHK German Ctr Cardiovasc Res, Clin Thorac & Cardiovasc Surg, Partner Site Gottingen, Gottingen, Germany.	george.kensah@mectuni-goettingen.de	Leßmann, Volkmar/E-8125-2013; Dahlmann, Julia/GPP-6981-2022	Leßmann, Volkmar/0000-0002-6863-323X; Weinert, Sonke/0000-0002-7201-0836; Schnieke, Angelika/0000-0002-5761-9635	German Research Foundation [KU-2752]; European Commission FP7 Project EURATRANS [HEALTH-F4-2010-241504]; Biotechnology and Biological Sciences Research Council of the United Kingdom [BB/H012737/1]; BBSRC [BB/H012737/1] Funding Source: UKRI	German Research Foundation(German Research Foundation (DFG)); European Commission FP7 Project EURATRANS; Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the German Research Foundation [KU-2752; DFG grant to HB and IK, www.dfg.de], the European Commission FP7 Project EURATRANS [grant no. HEALTH-F4-2010-241504; grant to YC; www.euratrans.eu] and the Biotechnology and Biological Sciences Research Council of the United Kingdom [grant no. BB/H012737/1; grant to YC; www.bbsrc.ac.uk]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Beckmann A, 2016, HISTOCHEM CELL BIOL, P1; Bergstrom G, 2015, LAB CHIP, V15, P3242, DOI 10.1039/c5lc00449g; Blair K, 2012, BIOL OPEN, V1, P58, DOI 10.1242/bio.2011029; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burridge PW, 2016, NAT MED, V22, P547, DOI 10.1038/nm.4087; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Cao N, 2011, CELL RES, V21, P1316, DOI 10.1038/cr.2011.48; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Chen YY, 2013, STEM CELL REP, V1, P209, DOI 10.1016/j.stemcr.2013.07.003; Chen Z, 2016, EUROPEAN HEART J; Chong J. J., 2014, NATURE; Dahlmann J, 2013, BIOMATERIALS, P1; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Funakoshi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19111; Gerbin KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131446; Hamta A, 2006, CYTOGENET GENOME RES, V115, P158, DOI 10.1159/000095237; Hartman ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093033; Ivanyuk D, 2015, CELL PHYSIOL BIOCHEM, V36, P810, DOI 10.1159/000430140; Jung JJ, 2014, STEM CELL REP, V2, P592, DOI 10.1016/j.stemcr.2014.03.006; Kadota S, 2017, STEM CELL REP, V8, P278, DOI 10.1016/j.stemcr.2016.10.009; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kawamura T, 2016, STEM CELL REP, V6, P312, DOI 10.1016/j.stemcr.2016.01.012; Ke Q, 2013, HUM MOL GENET, V22, P2221, DOI 10.1093/hmg/ddt074; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kempf H, 2014, STEM CELL REP, V3, P1132, DOI 10.1016/j.stemcr.2014.09.017; Kensah G, 2012, EUROPEAN HEART J, V34; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Kokkinopoulos I, 2016, DEV DYNAM, V245, P157, DOI [10.1002/DVDY.24366, 10.1002/dvdy.24366]; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lamm N, 2016, CELL STEM CELL, V18, P253, DOI 10.1016/j.stem.2015.11.003; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liskovykh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027345; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Mannhardt I, 2016, STEM CELL REP, V7, P29, DOI 10.1016/j.stemcr.2016.04.011; Masumoto H., 2016, SCI REP, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Masumoto H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06716; Matsumoto Takeshi, 2015, Saikaku Tsushin, V31, P1; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Merkl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055170; Min JY, 2002, J APPL PHYSIOL, V92, P288, DOI 10.1152/jappl.2002.92.1.288; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Ogasawara T, 2017, SCI REP, P1; Oyamada M, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00085; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Patten RD, 2009, CIRC-HEART FAIL, V2, P138, DOI 10.1161/CIRCHEARTFAILURE.108.839761; Peterson SE, 2014, J BIOL CHEM, P289; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Sato H, 2006, BIOCHEM BIOPH RES CO, V342, P107, DOI 10.1016/j.bbrc.2006.01.116; Seabright M., 1971, LANCET, V2; Shao Y, 2014, NAT PROTOC, P9; Shiba Y, 2016, NATURE, V538, P388, DOI 10.1038/nature19815; Shiba Y, 2014, J CARDIOVASC PHARM T, V19, P368, DOI 10.1177/1074248413520344; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Thomson A, 2008, CLONING STEM CELLS, V10, P89, DOI 10.1089/clo.2007.0072; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Veerman CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30967; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wendel JS, 2015, STEM CELL TRANSL MED, V4, P1324, DOI 10.5966/sctm.2015-0044; Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433; Zimmermann WH, 2002, CIRCULATION, V106, pI151, DOI 10.1161/01.cir.0000032876.55215.10	67	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192652	10.1371/journal.pone.0192652	http://dx.doi.org/10.1371/journal.pone.0192652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513687	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800019
J	Frisk, M; Jonsson, A; Sellman, S; Flisberg, P; Ronnqvist, M; Wennergren, U				Frisk, Mikael; Jonsson, Annie; Sellman, Stefan; Flisberg, Patrik; Roennqvist, Mikael; Wennergren, Uno			Route optimization as an instrument to improve animal welfare and economics in pre-slaughter logistics	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; MEAT QUALITY; STRESS RESPONSES; TRANSPORT TIME; CATTLE; VEHICLE; JOURNEY; DURATION; PIGS	Each year, more than three million animals are transported from farms to abattoirs in Sweden. Animal transport is related to economic and environmental costs and a negative impact on animal welfare. Time and the number of pick-up stops between farms and abattoirs are two key parameters for animal welfare. Both are highly dependent on efficient and qualitative transportation planning, which may be difficult if done manually. We have examined the benefits of using route optimization in cattle transportation planning. To simulate the effects of various planning time windows and transportation time regulations and number of pick-up stops along each route, we have used data that represent one year of cattle transport. Our optimization model is a development of a model used in forestry transport that solves a general pick-up and delivery vehicle routing problem. The objective is to minimize transportation costs. We have shown that the length of the planning time window has a significant impact on the animal transport time, the total driving time and the total distance driven; these parameters that will not only affect animal welfare but also affect the economy and environment in the pre-slaughter logistic chain. In addition, we have shown that changes in animal transportation regulations, such as minimizing the number of allowed pick-up stops on each route or minimizing animal transportation time, will have positive effects on animal welfare measured in transportation hours and number of pick-up stops. However, this leads to an increase in working time and driven distances, leading to higher transportation costs for the transport and negative environmental impact.	[Frisk, Mikael; Sellman, Stefan; Wennergren, Uno] Linkoping Univ, IFM, Dept Phys Chem & Biol, Linkoping, Sweden; [Jonsson, Annie] Skovde Univ, Sch Biosci, Skovde, Sweden; [Flisberg, Patrik] Forestry Res Inst Sweden, Uppsala, Sweden; [Roennqvist, Mikael] Univ Laval, Dept Genie Mecan, Laval, PQ, Canada	Linkoping University; Skogforsk; Laval University	Frisk, M (corresponding author), Linkoping Univ, IFM, Dept Phys Chem & Biol, Linkoping, Sweden.	mikael.frisk@liu.se	Ronnqvist, Mikael/S-9045-2017	Ronnqvist, Mikael/0000-0002-1940-6129; Sellman, Stefan/0000-0002-5595-8780	VINNOVA	VINNOVA(Vinnova)	The authors received funding from VINNOVA for this work (www.vinnova.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell E, 2014, RAPPORT, P47; Algers A, 2006, 10 SWED U AGR SCI DE; Andersson G, 2008, CAN J FOREST RES, V38, P1784, DOI 10.1139/X08-017; [Anonymous], 2014, HANDB DJURTR VERS 3; Aradom S., 2012, Journal of Agricultural Science and Technology A, V2, P544; Aradom S., 2013, THESIS, V98; Atkinson S., 2000, THESIS; Becker T., 2000, BRIT FOOD J, V3, P158; Bulitta F. S., 2015, Journal of Service Science and Management, V8, P161; Carlsson F, 2007, EUR REV AGRIC ECON, V34, P321, DOI 10.1093/erae/jbm025; Cockram MS, 2007, APPL ANIM BEHAV SCI, V106, P234, DOI 10.1016/j.applanim.2007.01.006; Cordeau JF, 2002, J OPER RES SOC, V53, P512, DOI 10.1057/palgrave/jors/2601319; Cordeau JF, 2001, J OPER RES SOC, V52, P928, DOI 10.1057/palgrave.jors.2601163; Dawkins MS, 2017, ANIM PROD SCI, V57, P201, DOI 10.1071/AN15383; Diaz Eugenia, 2008, COMPUTERS OPERATIONS, V35, P3213; Ferguson DM, 2008, MEAT SCI, V80, P12, DOI 10.1016/j.meatsci.2008.05.004; Flisberg P, 2012, CANADIAN J FOREST RE, V42, P1784; Flisberg P, 2009, COMPUT OPER RES, V36, P1122, DOI 10.1016/j.cor.2007.12.012; Frisk M, 2010, EUR J OPER RES, V205, P448, DOI 10.1016/j.ejor.2010.01.015; Gebresenbet G., 2012, Journal of Agricultural Science and Technology A, V2, P800; Gebresenbet G., 2011, Australian Journal of Agricultural Engineering, V2, P31; Gebresenbet G, 2005, TECHNICAL REPORT; Gebresenbet G, 2011, BIOSYST ENG, V110, P10, DOI 10.1016/j.biosystemseng.2011.05.007; Grandin T, 2014, LIVESTOCK HANDLING AND TRANSPORT, 4TH EDITION, P1, DOI 10.1079/9781780643212.0000; Gribkovskaia I., 2006, International Journal of Physical Distribution & Logistics Management, V36, P136, DOI 10.1108/09600030610656459; Hakansson N, 2016, ANIM WELFARE, V25, P255, DOI 10.7120/09627286.25.2.255; Hartung J, 2003, VET RES COMMUN, V27, P525, DOI 10.1023/B:VERC.0000014212.81294.78; Helgesson A., 2000, 242 SWED U AGR SCI D; Hoffman DE, 1998, J AM VET MED ASSOC, V212, P668; Huertas SM, 2010, ANIM WELFARE, V19, P281; Jordbruksverket, SVER OFF STAT; Kristoffersson J., 2004, SVENSK VETERINARTIDN, V12, P11; la Lama GCMD, 2011, J APPL ANIM WELF SCI, V14, P109, DOI 10.1080/10888705.2011.551622; Ljungberg D, 2006, BIOSYST ENG; Malena M, 2007, ACTA VET BRNO, V76, pS109, DOI 10.2754/avb200776S8S109; Manteca i Vilanova F. X., 2007, Animal health, animal welfare and biosecurity. Proceedings of the 13th International Congress in Animal Hygiene, Tartu, Estonia, 17-21 June, 2007. Volume 2, P702; Maria GA, 2006, LIVEST SCI, V103, P250, DOI 10.1016/j.livsci.2006.05.011; Miranda-de la Lama GC, 2017, MEAT SCI, V125, P106, DOI 10.1016/j.meatsci.2016.12.001; Miranda-de la Lama GC, 2014, MEAT SCI, V98, P9, DOI 10.1016/j.meatsci.2014.04.005; Miranda-de la Lama GC, 2011, TROP ANIM HEALTH PRO, V43, P915, DOI 10.1007/s11250-011-9783-7; Mota-Rojas D, 2006, MEAT SCI, V73, P404, DOI 10.1016/j.meatsci.2005.11.012; Nielsen BL, 2011, ANIMAL, V5, P415, DOI 10.1017/S1751731110001989; Noremark M, 2010, TRANSBOUND EMERG DIS, V57, P225, DOI 10.1111/j.1865-1682.2010.01140.x; Oppen J, 2010, COMPUT OPER RES, V37, P1308, DOI 10.1016/j.cor.2009.09.014; Peeters E, 2008, ANIM WELFARE, V17, P189; Perez MP, 2002, MEAT SCI, V61, P425, DOI 10.1016/S0309-1740(01)00216-9; Phillips CJC, 2008, LONG DISTANCE TRANSPORT AND WELFARE OF FARM ANIMALS, P137, DOI 10.1079/9781845934033.0137; Raussi S, 2005, APPL ANIM BEHAV SCI, V93, P1, DOI 10.1016/j.applanim.2004.12.001; Romero MH, 2013, MEAT SCI, V95, P256, DOI 10.1016/j.meatsci.2013.05.014; Ruiz-de-la-Torre JL, 2001, VET REC, V148, P227, DOI 10.1136/vr.148.8.227; Schwartzkopf-Genswein KS, 2012, MEAT SCI, V92, P227, DOI 10.1016/j.meatsci.2012.04.010; Svenson G, 2016, IEEE T INTELL TRANSP, V17, P1772, DOI 10.1109/TITS.2015.2503424; Tateo A, 2012, J VET BEHAV, V7, P33, DOI 10.1016/j.jveb.2011.04.007; Vanhonacker F, 2014, J AGR ENVIRON ETHIC, V27, P153, DOI 10.1007/s10806-013-9479-2; Villarroel M, 2003, MEAT SCI, V63, P353, DOI 10.1016/S0309-1740(02)00093-1; Villarroel M, 2001, VET REC, V149, P173, DOI 10.1136/vr.149.6.173; Warriss P.D, 2000, MEAT SCI INTRO TEXT; WRAY C, 1991, EPIDEMIOL INFECT, V107, P521, DOI 10.1017/S0950268800049219	59	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193223	10.1371/journal.pone.0193223	http://dx.doi.org/10.1371/journal.pone.0193223			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513704	gold, Green Published, Green Submitted			2022-12-27	WOS:000426896800045
J	Marrone, L; Bus, C; Schondorf, D; Fitzgerald, JC; Kubler, M; Schmid, B; Reinhardt, P; Reinhardt, L; Deleidi, M; Levin, T; Meixner, A; Klink, B; Glatza, M; Gloeckner, CJ; Gasser, T; Sterneckert, J				Marrone, Lara; Bus, Christine; Schoendorf, David; Fitzgerald, Julia Catherine; Kuebler, Manuela; Schmid, Benjamin; Reinhardt, Peter; Reinhardt, Lydia; Deleidi, Michela; Levin, Tanya; Meixner, Andrea; Klink, Barbara; Glatza, Michael; Gloeckner, Christian Johannes; Gasser, Thomas; Sterneckert, Jared			Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; GENE; MUTATIONS; MITOPHAGY; CELL; AGE; NEURODEGENERATION; DUPLICATION; DEGRADATION; DYSFUNCTION	Induced pluripotent stem cells (iPSCs) have recapitulated several aspects of Parkinson's disease (PD), but most iPSCs are derived from familial cases, which account for only about 15% of patients. Thus, while the emphasis has justifiably been on using iPSCs to model rare familial cases, models for the most common forms of PD are critically lacking. Here, we report the generation of an iPSC-based model of idiopathic PD (iPD) with or without RS1491923, which is a common risk variant in the LRRK2 locus. Consistent with GWA studies, we found large variability in our datasets. However, iPSC-derived neurons carrying the risk allele emerged for displaying subtle disturbances of cellular degradative systems, in line with familial PD models. We also observed that treatment with the LRRK2 inhibitor CZC25146 slightly reduced a marker of aSYN pathology in all iPD lines. Future iPSC-based studies may need to be structured similarly to large GWA studies in order to obtain relevant statistical power. However, results from this pilot study suggest that iPSC-based modeling represents an attractive way to investigate idiopathic diseases.	[Marrone, Lara; Reinhardt, Peter; Reinhardt, Lydia; Levin, Tanya; Glatza, Michael; Sterneckert, Jared] DFG Ctr Regenerat Therapies Tech Univ Dresden CRT, Dresden, Germany; [Bus, Christine; Schoendorf, David; Fitzgerald, Julia Catherine; Kuebler, Manuela; Schmid, Benjamin; Deleidi, Michela; Gasser, Thomas] Univ Tubingen, Ctr Neurol, Dept Neurodegenerat Dis, Tubingen, Germany; [Bus, Christine; Schoendorf, David; Fitzgerald, Julia Catherine; Kuebler, Manuela; Schmid, Benjamin; Deleidi, Michela; Gasser, Thomas] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Bus, Christine; Schoendorf, David; Fitzgerald, Julia Catherine; Kuebler, Manuela; Deleidi, Michela; Meixner, Andrea; Gloeckner, Christian Johannes; Gasser, Thomas] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Reinhardt, Lydia; Glatza, Michael] Max Planck Inst Mol Biomed, Munster, Germany; [Klink, Barbara] Tech Univ Dresden, Med Fak Carl Gustav Carus, Inst Klin Genet, Dresden, Germany; [Gloeckner, Christian Johannes] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Schmid, Benjamin] Bioneer AS, Horsholm, Denmark; [Reinhardt, Peter] AbbVie Deutschland GmbH & Co KG, Neurosci Discovery Biol Dept, Ludwigshafen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Bioneer A/S; AbbVie	Sterneckert, J (corresponding author), DFG Ctr Regenerat Therapies Tech Univ Dresden CRT, Dresden, Germany.; Gasser, T (corresponding author), Univ Tubingen, Ctr Neurol, Dept Neurodegenerat Dis, Tubingen, Germany.; Gasser, T (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany.; Gasser, T (corresponding author), German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany.	thomas.gasser@uni-tuebingen.de; jared.sternecked@gtu-dresden.de	Gloeckner, Christian Johannes/R-5374-2019; Gasser, Thomas/GNH-5293-2022	Gasser, Thomas/0000-0002-1069-1146; Deleidi, Michela/0000-0003-0357-0124; Gloeckner, Christian Johannes/0000-0001-6494-6944; Sterneckert, Jared/0000-0002-7688-3124; Klink, Barbara/0000-0002-8753-8238	Hans and Ilse Breuer Stiftung; Michael J. Fox Foundation for Parkinson's Research; Deutsche Forschungsgemeinschaft (DFG) [GA 402/18-1]; DFG Research Center [DFG FZ 111]; DFG Cluster of Excellence [DFG EXC 168]	Hans and Ilse Breuer Stiftung; Michael J. Fox Foundation for Parkinson's Research; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Research Center(German Research Foundation (DFG)); DFG Cluster of Excellence(German Research Foundation (DFG))	Lara Marrone was sponsored by a fellowship from the Hans and Ilse Breuer Stiftung. This work was supported by a grant from the Michael J. Fox Foundation for Parkinson's Research, GA 402/18-1 from the Deutsche Forschungsgemeinschaft (DFG) awarded to both T. G. and J.S. as well as by DFG Research Center (DFG FZ 111) and Cluster of Excellence (DFG EXC 168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731; Botta-Orfila T, 2012, J MOL NEUROSCI, V48, P245, DOI 10.1007/s12031-012-9820-7; Bravo-San Pedro JM, 2012, CELL MOL LIFE SCI; Brockmann K, 2013, MOVEMENT DISORD, V28, P1217, DOI 10.1002/mds.25469; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Daher JPL, 2015, J BIOL CHEM, V290, P19433, DOI 10.1074/jbc.M115.660001; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Galter D, 2006, ANN NEUROL, V59, P714, DOI 10.1002/ana.20808; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Giesert F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063778; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Golub Y, 2009, PARKINSONISM RELAT D, V15, P539, DOI 10.1016/j.parkreldis.2008.10.008; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Illarioshkin SN, 2007, EUR J NEUROL, V14, P413, DOI 10.1111/j.1468-1331.2007.01685.x; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Li JQ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-47; Liu GH, 2012, NATURE; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nimsanor N, 2016, STEM CELL RES, V17, P550, DOI 10.1016/j.scr.2016.09.019; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paull D, 2015, NAT METHODS, V12, P885, DOI [10.1038/NMETH.3507, 10.1038/nmeth.3507]; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Ramsden N, 2011, ACS CHEM BIOL, V6, P1021, DOI 10.1021/cb2002413; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Schwab AJ, 2015, STEM CELL REP, V5, P1039, DOI 10.1016/j.stemcr.2015.11.004; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Trabzuni D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070724; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Volpicelli-Daley LA, 2016, J NEUROSCI, V36, P7415, DOI 10.1523/JNEUROSCI.3642-15.2016; Wang B, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0065-1; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Williams-Gray CH, 2006, J NEUROL NEUROSUR PS, V77, P665, DOI 10.1136/jnnp.2005.085019; Yao C, 2013, HUM MOL GENET, V22, P328, DOI 10.1093/hmg/dds431; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	50	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192497	10.1371/journal.pone.0192497	http://dx.doi.org/10.1371/journal.pone.0192497			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513666	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800015
J	Romanelli, A; Affinito, A; Avitabile, C; Catuogno, S; Ceriotti, P; Laboni, M; Modica, J; Condorelli, G; Catalucci, D				Romanelli, Alessandra; Affinito, Alessandra; Avitabile, Concetta; Catuogno, Silvia; Ceriotti, Paola; Laboni, Margherita; Modica, Jessica; Condorelli, Geroloma; Catalucci, Daniele			An anti-PDGFR ss aptamer for selective delivery of small therapeutic peptide to cardiac cells	PLOS ONE			English	Article							CALCIUM-CHANNEL; GROWTH-FACTOR; CA2+ CHANNEL; LIGANDS; PROTEIN; HEART	Small therapeutic peptides represent a promising field for the treatment of pathologies such as cardiac diseases. However, the lack of proper target-selective carriers hampers their translation towards a potential clinical application. Aptamers are cell-specific carriers that bind with high affinity to their specific target. However, some limitations on their conjugation to small peptides and the functionality of the resulting aptamer-peptide chimera exist. Here, we generated a novel aptamer-peptide chimera through conjugation of the PDGFR ss-targeting Gint4. T aptamer to MP, a small mimetic peptide that via targeting of the Ca-v ss 2 subunit of the L-type calcium channel (LTCC) can recover myocardial function in pathological heart conditions associated with defective LTCC function. The conjugation reaction was performed by click chemistry in the presence of N,N,N', N',N"-pentamethyldiethylenetriamine as a Cu (I) stabilizing agent in a DMSO-free aqueous buffer. When administered to cardiac cells, the Gint4. T-MP aptamer-peptide chimera was successfully internalized in cells, allowing the functional targeting of MP to LTCC. This approach represents the first example of the use of an internalizing aptamer for selective delivery of a small therapeutic peptide to cardiac cells.	[Romanelli, Alessandra] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Affinito, Alessandra; Laboni, Margherita; Condorelli, Geroloma] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Avitabile, Concetta] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Catuogno, Silvia; Condorelli, Geroloma] CNR, Inst Expt Endocrinol & Oncol G Salvatore, IEOS, Naples, Italy; [Ceriotti, Paola; Modica, Jessica; Catalucci, Daniele] Humanitas Clin & Res Ctr, Milan, Italy; [Catalucci, Daniele] CNR, Inst Genet & Biomed Res, Milan Unit, Milan, Italy; [Laboni, Margherita] Bracco Imaging SpA, Turin, Italy	University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Bracco	Condorelli, G (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.; Condorelli, G (corresponding author), CNR, Inst Expt Endocrinol & Oncol G Salvatore, IEOS, Naples, Italy.; Catalucci, D (corresponding author), Humanitas Clin & Res Ctr, Milan, Italy.; Catalucci, D (corresponding author), CNR, Inst Genet & Biomed Res, Milan Unit, Milan, Italy.	gecondor@unina.it; daniele.catalucci@cnr.it	Catuogno, Silvia/AAB-9969-2019; Catalucci, Daniele/B-6745-2015; Affinito, Alessandra/Q-7859-2018	Catuogno, Silvia/0000-0002-1653-4205; Catalucci, Daniele/0000-0001-7041-6114; Modica, Jessica/0000-0002-4986-8009; Avitabile, Concetta/0000-0001-5542-6920; Affinito, Alessandra/0000-0002-3887-6513	Italian Ministry of Health [GR-2011-02352546]; AIRC - IG [18473]; Federazione Italiana Ricerca sul Cancro (FIRC); Italian Ministry of Health [GR-2011-02352546]; AIRC - IG [18473]; Federazione Italiana Ricerca sul Cancro (FIRC)	Italian Ministry of Health(Ministry of Health, Italy); AIRC - IG(Fondazione AIRC per la ricerca sul cancro); Federazione Italiana Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); AIRC - IG(Fondazione AIRC per la ricerca sul cancro); Federazione Italiana Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Ministry of Health (http://www.salute.gov.it/portale/ home html; GR-2011-02352546) to DC and by Associazione Italiana Ricerca sul Cancro (http://www.airc.it/aiutare-la-ricerca/bomboniere-solidali.aps?ets_cmmk=3123&ets_sgmt=16923&gclid=cjwKEAjwvYPKBRCYr5GLgNCJ_isSJABqwfw7 DMtnt2m8pISbXCI0XMmSHgRPg495q6IIUt4jeXObjhoCIrrw_wcB; AIRC - IG 2016 Id. 18473) to GC. MI was supported by the Federazione Italiana Ricerca sul Cancro (FIRC, http://www.fondazionefirc.it) Post-Doctoral Research Fellowship.	Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241; Avitabile C, 2013, BBA-GEN SUBJECTS, V1830, P3767, DOI 10.1016/j.bbagen.2013.01.026; Blaich A, 2012, J BIOL CHEM, V287, P22616, DOI 10.1074/jbc.M112.357921; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Brugada P, 2013, EUR HEART J, V34, P3610, DOI 10.1093/eurheartj/eht113; Camorani S, 2014, MOL THER, V22, P828, DOI 10.1038/mt.2013.300; Catuogno S, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040069; Catuogno S, 2015, J CONTROL RELEASE, V210, P147, DOI 10.1016/j.jconrel.2015.05.276; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; Chintalgattu V, 2010, J CLIN INVEST, V120, P472, DOI 10.1172/JCI39434; Christ T, 2004, CIRCULATION, V110, P2651, DOI 10.1161/01.CIR.0000145659.80212.6A; El-Sagheer AH, 2010, P NATL ACAD SCI USA, V107, P15329, DOI 10.1073/pnas.1006447107; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Esposito CL, 2016, J CONTROL RELEASE, V238, P43, DOI 10.1016/j.jconrel.2016.07.032; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227; Hacker DE, 2017, ACS CHEM BIOL, V12, P795, DOI 10.1021/acschembio.6b01006; Kaspar AA, 2013, DRUG DISCOV TODAY, V18, P807, DOI 10.1016/j.drudis.2013.05.011; Lee J, 2013, ANAL CHEM, V85, P9692, DOI 10.1021/ac402038t; Miragoli M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan6205; Paredes E, 2011, CHEMBIOCHEM, V12, P125, DOI 10.1002/cbic.201000466; Patel A, 2014, THER DELIV, V5, P337, DOI [10.4155/TDE.14.5, 10.4155/tde.14.5]; Ramesh S, 2016, BIOMATER SCI-UK, V4, P1713, DOI 10.1039/c6bm00688d; Rusconi F, 2016, CIRCULATION, V134, P534, DOI 10.1161/CIRCULATIONAHA.116.021347; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; Thiel WH, 2016, MOL THERAPY J AM SOC; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Weiss N, 2014, PATHOLOGIES CALCIUM, Vxviii; Zahid M, 2015, MOLECULES, V20, P13055, DOI 10.3390/molecules200713055; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199	30	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193392	10.1371/journal.pone.0193392	http://dx.doi.org/10.1371/journal.pone.0193392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513717	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800057
J	Ye, BB; Chu, ZS; Wu, AP; Hou, ZY; Wang, SR				Ye, Bibi; Chu, Zhaosheng; Wu, Aiping; Hou, Zeying; Wang, Shengrui			Optimum water depth ranges of dominant submersed macrophytes in a natural freshwater lake	PLOS ONE			English	Article							CERATOPHYLLUM-DEMERSUM; COMMUNITY COMPOSITION; DIVERSITY; BIOMASS; PLANTS; LIGHT; EUTROPHICATION; VEGETATION; WETLAND; GROWTH	Macrophytes show a zonal distribution along the lake littoral zone because of their specific preferred water depths while the optimum growth water depths of dominant submersed macrophytes in natural lakes are not well known. We studied the seasonal biomass and frequency patterns of dominant and companion submersed macrophytes along the water depth gradient in Lake Erhai in 2013. The results showed that the species richness and community biomass showed hump-back shaped patterns along the water depth gradient both in polydominant and monodominant communities. Biomass percentage of Potamogenton maackianus showed a hump-back pattern while biomass percentages of Ceratophyllum demersum and Vallisneria natans appeared U-shaped patterns across the water depth gradient in polydominant communities whereas biomass percentage of V. natans increased with the water depth in monodominant communities. Dominant species demonstrated a broader distribution range of water depth than companion species. Frequency and biomass of companion species declined drastically with the water depth whereas those of dominant species showed non-linear patterns across the water depth gradient. Namely, along the water depth gradient, biomass of P. maackianus and V. natans showed hump-back patterns and biomasses of C. demersum displayed a U-shaped pattern in the polydominant communities but biomass of V. natans demonstrated a hump-back pattern in the monodominant communities; frequency of P. maackianus showed a hump-back pattern and C. demersum and V. natans maintained high frequencies in the two types of communities. We can speculate that in Lake Erhai the optimum growth water depths of P. maackianus and C. demersum in the polydominant communities are 2.5-4.5 m and 1-2 m or 5-6 m, respectively and that of V. natans is 3-5 m in the polydominant communities and 2.5-5 m in the monodominant communities. This is the first report that the optimum water depth ranges in the horizontal direction of three dominant submersed macrophytes in a natural freshwater lake were determined.	[Ye, Bibi; Chu, Zhaosheng; Hou, Zeying; Wang, Shengrui] CRAES, Res Ctr Lake Ecol & Environm, State Environm Protect Key Lab Lake Pollut Contro, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Wu, Aiping] Hunan Agr Univ, Coll Biosci & Biotechnol, Ecol Dept, Hunan Prov Key Lab Rural Ecosyst Hlth Dongting La, Changsha, Hunan, Peoples R China	Chinese Research Academy of Environmental Sciences; Hunan Agricultural University	Chu, ZS (corresponding author), CRAES, Res Ctr Lake Ecol & Environm, State Environm Protect Key Lab Lake Pollut Contro, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.; Wu, AP (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Ecol Dept, Hunan Prov Key Lab Rural Ecosyst Hlth Dongting La, Changsha, Hunan, Peoples R China.	chuzs@craes.org.cn; wuaip8101@126.com	Wu, Aiping/AAU-8710-2020		Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07105-002]; State Scholarship Found of China Scholarship Council (CSC) [2016-3035]; National Natural Science Foundation of China [31301725]	Major Science and Technology Program for Water Pollution Control and Treatment; State Scholarship Found of China Scholarship Council (CSC); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is financially supported by Major Science and Technology Program for Water Pollution Control and Treatment (2012ZX07105-002), the State Scholarship Found of China Scholarship Council (CSC) (No: 2016-3035) and the National Natural Science Foundation of China (No. 31301725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao T, 2011, FRESHWATER BIOL, V56, P1620, DOI 10.1111/j.1365-2427.2011.02601.x; CHAMBERS PA, 1987, J ECOL, V75, P621, DOI 10.2307/2260194; Chen JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep34028; Chu CJ, 2008, ECOL LETT, V11, P1189, DOI 10.1111/j.1461-0248.2008.01228.x; Chu ZhaoSheng, 2014, Research of Environmental Sciences, V27, P1; Dong BL, 2014, J GREAT LAKES RES, V40, P646, DOI 10.1016/j.jglr.2014.04.007; Ervin GN, 2002, OECOLOGIA, V130, P626, DOI 10.1007/s00442-001-0844-x; Fu H, 2014, FRESHWATER BIOL, V59, P2462, DOI 10.1111/fwb.12443; Fu Hui, 2013, Hupo Kexue, V25, P854; Gross EM, 2003, HYDROBIOLOGIA, V506, P583, DOI 10.1023/B:HYDR.0000008539.32622.91; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Istvanovics V, 2008, AQUAT BOT, V88, P317, DOI 10.1016/j.aquabot.2007.12.008; Jones JI, 2002, J ECOL, V90, P12, DOI 10.1046/j.0022-0477.2001.00620.x; Kahmen A, 2005, OECOLOGIA, V142, P606, DOI 10.1007/s00442-004-1749-2; Li Enhua, 2011, Hupo Kexue, V23, P738; Li Wei, 2014, Hupo Kexue, V26, P585; Liu WZ, 2012, ENVIRON SCI POLLUT R, V19, P858, DOI 10.1007/s11356-011-0616-z; Liu WZ, 2010, HYDROBIOLOGIA, V644, P289, DOI 10.1007/s10750-010-0151-9; MADSEN JD, 1989, HYDROBIOLOGIA, V171, P111, DOI 10.1007/BF00008171; Maemets H, 2005, HYDROBIOLOGIA, V547, P175, DOI 10.1007/s10750-005-4158-6; Matthiessen B, 2006, ECOL LETT, V9, P652, DOI 10.1111/j.1461-0248.2006.00916.x; May L, 2010, HYDROBIOLOGIA, V646, P123, DOI 10.1007/s10750-010-0176-0; Ni LY, 2001, J FRESHWATER ECOL, V16, P249, DOI 10.1080/02705060.2001.9663809; Pelechata A, 2010, OCEANOL HYDROBIOL ST, V39, P95, DOI 10.2478/v10009-010-0004-x; Schultz JC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00324; Schutten J, 2004, ANN BOT-LONDON, V93, P333, DOI 10.1093/aob/mch043; Smith RGB, 2007, PLANT ECOL, V188, P103, DOI 10.1007/s11258-006-9151-2; Sousa WTZ, 2010, AQUAT BOT, V92, P40, DOI 10.1016/j.aquabot.2009.10.002; Timoney KP, 2006, ECOSCIENCE, V13, P308, DOI 10.2980/i1195-6860-13-3-308.1; Wells RDS, 1997, NEW ZEAL J MAR FRESH, V31, P449, DOI 10.1080/00288330.1997.9516778; Wersal RM, 2006, WETLANDS, V26, P313, DOI 10.1672/0277-5212(2006)26[313:EFABAD]2.0.CO;2; Xu AnLun, 2011, Transactions of Atmospheric Sciences, V34, P225; Yuan GX, 2016, ENVIRON EXP BOT, V122, P94, DOI 10.1016/j.envexpbot.2015.09.009; Zhang L, 2015, ENVIRON EARTH SCI, V74, P3887, DOI 10.1007/s12665-015-4136-x	34	21	23	10	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193176	10.1371/journal.pone.0193176	http://dx.doi.org/10.1371/journal.pone.0193176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513707	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800042
J	Krause, RGE; Goldring, JPD				Krause, Robert G. E.; Goldring, J. P. Dean			Phosphoethanolamine-N-methyltransferase is a potential biomarker for the diagnosis of P. knowlesi and P. falciparum malaria	PLOS ONE			English	Article							HISTIDINE-RICH PROTEIN; PARASITE LACTATE-DEHYDROGENASE; ISOTHERMAL AMPLIFICATION ASSAY; PLASMODIUM-KNOWLESI; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; MONOCLONAL-ANTIBODIES; HUMAN INFECTIONS; EGG-YOLK; MALAYSIA	Background Plasmodium knowlesi is recognised as the main cause of human malaria in Southeast Asia. The disease is often misdiagnosed as P. falciparum or P. malariae infections by microscopy, and the disease is difficult to eliminate due to its presence in both humans and monkeys. P. knowlesi infections can rapidly cause severe disease and require prompt diagnosis and treatment. No protein biomarker exists for the rapid diagnostic test (RDT) detection of P. knowlesi infections. Plasmodium knowlesi infections can be diagnosed by PCR. Methods and principal findings Phosphoethanolamine-N-methyltransferase (PMT) is involved in malaria lipid biosynthesis and is not found in the human host. The P. falciparum, P. vivax and P. knowlesi PMT proteins were recombinantly expressed in BL21(DE3) Escherichia coli host cells, affinity purified and used to raise antibodies in chickens. Antibodies against each recombinant PMT protein all detected all three recombinant proteins and the native 29 kDa P. falciparum PMT protein on western blots and in ELISA. Antibodies against a PMT epitope (PLENNQYT-DEGVKC) common to all three PMT orthologues detected all three proteins. Antibodies against unique peptides from each orthologue of PMT, PfCEVEHKYLHENKE, PvVYSI-KEYNSLKDC, PkLYPTDEYNSLKDC detected only the parent protein in western blots and P. falciparum infected red blood cell lysates or blood lysates spiked with the respective proteins. Similar concentrations of PfPMT and the control, PfLDH, were detected in the same parasite lysate. The recombinant PfPMT protein was detected by a human anti-malaria antibody pool. Conclusion PMT, like the pan-specific LDH biomarker used in RDT tests, is both soluble, present at comparable concentrations in the parasite and constitutes a promising antimalarial drug target. PMT is absent from the human proteome. PMT has the potential as a biomarker for human malaria and in particular as the first P. knowlesi specific protein with diagnostic potential for the identification of a P. knowlesi infection.	[Krause, Robert G. E.; Goldring, J. P. Dean] Univ KwaZulu Natal, Biochem, Pietermaritzburg, South Africa	University of Kwazulu Natal	Goldring, JPD (corresponding author), Univ KwaZulu Natal, Biochem, Pietermaritzburg, South Africa.	goldringd@ukzn.ac.za		Goldring, James Philip Dean/0000-0001-6713-9515; Krause, Robert/0000-0003-1558-0397	South African National Research Foundation [92740]; South African Medical Research Council; University of KwaZulu-Natal; South African National Research Foundation; Medical Research Council	South African National Research Foundation(National Research Foundation - South Africa); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of KwaZulu-Natal; South African National Research Foundation(National Research Foundation - South Africa); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the South African National Research Foundation. Grant No: 92740 (http://www.nrf.ac.za/) to DG; South African Medical Research Council to DG. Self Initiated Grant Goldring 2011 (http://www.mrc.ac.za/) to DG; University of KwaZulu-Natal to DG; South African National Research Foundation. Post Doctoral funding to RGEK and DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Ben Mamoun (Yale University School of Medicine) for vectors expressing the three PMT orthologues, all members of the Goldring laboratory, Theresa Coetzer for reading the manuscript and Annemarie Krause for blood collections. We thank the South African National Research Foundation, Medical Research Council and the University of KwaZulu-Natal for funding. RK thanks the South African NRF for PostDoctoral funding.	Ashley EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-241; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Aydin-Schmidt B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-349; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; Bobenchik AM, 2013, P NATL ACAD SCI USA, V110, P18262, DOI 10.1073/pnas.1313965110; Bobenchik AM, 2011, FEMS MICROBIOL REV, V35, P609, DOI 10.1111/j.1574-6976.2011.00267.x; Bobenchik AM, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Britton S, 2016, AM J TROP MED HYG, V95, P120, DOI 10.4269/ajtmh.15-0670; Burke A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43779; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Carlander D, 1999, UPSALA J MED SCI, V104, P179, DOI 10.3109/03009739909178961; CARMENES RS, 1989, BIOCHEM BIOPH RES CO, V159, P687, DOI 10.1016/0006-291X(89)90049-1; CHIN W, 1965, SCIENCE, V149, P865, DOI 10.1126/science.149.3686.865; Chiodini P, 2017, AM J HEMATOL, V92, P716, DOI 10.1002/ajh.24697; Choveaux David, 2012, Methods Mol Biol, V869, P585, DOI 10.1007/978-1-61779-821-4_53; Choveaux DL, 2015, EXP PARASITOL, V148, P30, DOI 10.1016/j.exppara.2014.11.001; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; Dechamps S, 2010, J LIPID RES, V51, P81, DOI 10.1194/jlr.M900166-JLR200; Deme AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-34; Fatih FA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-425; Figtree M, 2010, EMERG INFECT DIS, V16, P672, DOI 10.3201/eid1604.091624; FONG YL, 1971, T ROY SOC TROP MED H, V65, P839, DOI 10.1016/0035-9203(71)90103-9; Fornace KM, 2016, J INFECT DIS, V213, P784, DOI 10.1093/infdis/jiv475; Foster D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-60; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; FRIGUET B, 1983, J IMMUNOL METHODS, V60, P351, DOI 10.1016/0022-1759(83)90292-2; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Garg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09064; GASSMANN M, 1990, FASEB J, V4, P2528, DOI 10.1096/fasebj.4.8.1970792; Ginsburg H., 2017, MALARIA PARASITE MET; GOLDRING JD, 1992, BRIT J HAEMATOL, V81, P413, DOI 10.1111/j.1365-2141.1992.tb08249.x; Goldring JPD, 2003, BIOCHEM MOL BIOL EDU, V31, P185, DOI 10.1002/bmb.2003.494031030213; Grigg MJ, 2017, LANCET PLANET HEALTH, V1, pE97, DOI [10.1016/S2542-5196(17)30031-1, 10.1016/s2542-5196(17)30031-1]; Grigg MJ, 2014, J CLIN MICROBIOL, V52, P2053, DOI 10.1128/JCM.00181-14; Ho MF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-480; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; Hurdayal R, 2010, PEPTIDES, V31, P525, DOI 10.1016/j.peptides.2010.01.002; Iseki H, 2010, J CLIN MICROBIOL, V48, P2509, DOI 10.1128/JCM.00331-10; Jeslyn WPS, 2011, VECTOR-BORNE ZOONOT, V11, P131, DOI 10.1089/vbz.2010.0024; Jiang N, 2010, EMERG INFECT DIS, V16, P1476, DOI 10.3201/eid1609.100339; Jongwutiwes S, 2011, EMERG INFECT DIS, V17, P1799, DOI 10.3201/eid1710.110349; Kaushal Deep C., 1995, Indian Journal of Experimental Biology, V33, P6; Khim N, 2011, EMERG INFECT DIS, V17, P1900, DOI 10.3201/eid1710.110355; Knowles R, 1932, Ind Med Gaz, V67, P301; Krause RGE, 2017, EXP PARASITOL, V179, P7, DOI 10.1016/j.exppara.2017.05.007; Krause RGE, 2015, IMMUNOL INVEST, V44, P627, DOI 10.3109/08820139.2015.1070268; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau YL, 2016, AM J TROP MED HYG, V94, P336, DOI 10.4269/ajtmh.15-0569; Lau YL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-197; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Lee SG, 2012, BIOORG MED CHEM LETT, V22, P4990, DOI 10.1016/j.bmcl.2012.06.032; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Leow CH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-277; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; Marchand RP, 2011, EMERG INFECT DIS, V17, P1232, DOI 10.3201/eid1707.101551; Martin SK, 2009, AM J TROP MED HYG, V80, P516, DOI 10.4269/ajtmh.2009.80.516; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; McCoy J P Jr, 2001, Curr Protoc Cytom, VChapter 5, DOI 10.1002/0471142956.cy0501s00; McCutchan TF, 2008, EMERG INFECT DIS, V14, P1750, DOI 10.3201/eid1411.080840; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Piera KA, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1676-9; Piper R, 1999, AM J TROP MED HYG, V60, P109, DOI 10.4269/ajtmh.1999.60.109; Ravaoarisoa E, 2010, MABS-AUSTIN, V2, P416, DOI 10.4161/mabs.12438; Ravyn MD, 1999, AM J TROP MED HYG, V61, P171, DOI 10.4269/ajtmh.1999.61.171; Richards J, 2017, LANCET PLANET HEALTH, V1, pE83, DOI 10.1016/S2542-5196(17)30053-0; Schade R, 2001, FOODS; Semenova VA, 2004, CLIN DIAGN LAB IMMUN, V11, P919, DOI 10.1128/CDLI.11.5.919-923.2004; Sermwittayawong N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-36; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2016, MICROBIOL AUST, V37, P39, DOI 10.1071/MA16014; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Singh V, 2012, PROTEIN EXPRES PURIF, V84, P195, DOI 10.1016/j.pep.2012.05.008; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAYLOR TE, 1992, CLIN EXP IMMUNOL, V90, P357, DOI 10.1111/j.1365-2249.1992.tb05851.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Verma P, 2013, INDIAN J MED RES, V138, P977; White NJ, 2008, CLIN INFECT DIS, V46, P172, DOI 10.1086/524889; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHO, 2016, WORLD MAL REP 2016; Witola WH, 2006, J BIOL CHEM, V281, P21305, DOI 10.1074/jbc.M603260200; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Witola WH, 2007, EUKARYOT CELL, V6, P1618, DOI 10.1128/EC.00229-07; Yusof R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-168	92	9	10	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193833	10.1371/journal.pone.0193833	http://dx.doi.org/10.1371/journal.pone.0193833			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505599	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200033
J	Lee, H; Lee, D; Moon, J; Jung, J; Kong, D; Kim, H; Won, D				Lee, Hakjun; Lee, Donghoon; Moon, Jongho; Jung, Jaewook; Kong, Dongwoo; Kim, Hyoungshick; Won, Dongho			An improved anonymous authentication scheme for roaming in ubiquitous networks	PLOS ONE			English	Article							KEY AGREEMENT SCHEME; WIRELESS SENSOR NETWORKS; USER AUTHENTICATION; SECURE; SERVICE; EFFICIENT; DESIGN; INTERNET; PROTOCOL	With the evolution of communication technology and the exponential increase of mobile devices, the ubiquitous networking allows people to use our data and computing resources anytime and everywhere. However, numerous security concerns and complicated requirements arise as these ubiquitous networks are deployed throughout people's lives. To meet the challenge, the user authentication schemes in ubiquitous networks should ensure the essential security properties for the preservation of the privacy with low computational cost. In 2017, Chaudhry et al. proposed a password-based authentication scheme for the roaming in ubiquitous networks to enhance the security. Unfortunately, we found that their scheme remains insecure in its protection of the user privacy. In this paper, we prove that Chaudhry et al.' s scheme is vulnerable to the stolen-mobile device and user impersonation attacks, and its drawbacks comprise the absence of the incorrect login-input detection, the incorrectness of the password change phase, and the absence of the revocation provision. Moreover, we suggest a possible way to fix the security flaw in Chaudhry et al's scheme by using the biometric-based authentication for which the bio-hash is applied in the implementation of a three-factor authentication. We prove the security of the proposed scheme with the random oracle model and formally verify its security properties using a tool named ProVerif, and analyze it in terms of the computational and communication cost. The analysis result shows that the proposed scheme is suitable for resource-constrained ubiquitous environments.	[Lee, Hakjun; Lee, Donghoon; Moon, Jongho; Jung, Jaewook; Kong, Dongwoo] Sungkyunkwan Univ, Dept Elect & Comp Engn, 2066 Seoburo, Suwon 16419, Gyeonggido, South Korea; [Kim, Hyoungshick; Won, Dongho] Sungkyunkwan Univ, Dept Comp Engn, 2066 Seoburo, Suwon 16419, Gyeonggido, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Won, D (corresponding author), Sungkyunkwan Univ, Dept Comp Engn, 2066 Seoburo, Suwon 16419, Gyeonggido, South Korea.	dhwon@security.re.kr	Lee, Hakjun/ABA-9412-2021		National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2010-0020210]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2010-0020210), http://www.nrf.re.kr/index.	Amin R, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0258-7; Amin R, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0217-3; Blanchet B., 2016, FDN TRENDS PRIVACY S, V1, P1, DOI /10.1561/3300000004; Chaturvedi A, 2017, J INF SECUR APPL, V32, P15, DOI 10.1016/j.jisa.2016.11.002; Chaudhry SA, 2018, MULTIMED TOOLS APPL, V77, P5503, DOI 10.1007/s11042-017-4464-9; Chaudhry SA, 2017, WIRELESS PERS COMMUN, V96, P5355; Chaudhry SA, 2017, CLUSTER COMPUT, V20, P1223, DOI 10.1007/s10586-017-0783-x; Chaudhry SA, 2016, SECUR COMMUN NETW, V9, P5016, DOI 10.1002/sec.1672; Chaudhry SA, 2018, J SUPERCOMPUT, V74, P3504, DOI 10.1007/s11227-015-1601-y; Chaudhry SA, 2015, SECUR COMMUN NETW, V8, P3782, DOI 10.1002/sec.1299; Choi Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176250; Choo KKR, 2014, INFORM SCIENCES, V281, P182, DOI 10.1016/j.ins.2014.05.041; Das AK., 2013, NETWORKING SCI, V2, P12, DOI DOI 10.1007/S13119-012-0009-8; Das AK, 2012, INFORM SCIENCES, V209, P80, DOI 10.1016/j.ins.2012.04.036; Fan W., 2016, ANN TELECOMMUN, V72, P1; Farash MS, 2017, INT J COMMUN SYST, V30, DOI 10.1002/dac.3019; Feng Q, 2017, FUTURE GENERATION CO; Gope P, 2015, WIRELESS PERS COMMUN, V82, P2231, DOI 10.1007/s11277-015-2344-z; He DJ, 2011, WIRELESS PERS COMMUN, V61, P465, DOI 10.1007/s11277-010-0033-5; Ignatenko T, 2009, IEEE T INF FOREN SEC, V4, P956, DOI 10.1109/TIFS.2009.2033228; Islam SMR, 2015, IEEE ACCESS, V3, P678, DOI 10.1109/ACCESS.2015.2437951; Jiang Q, 2016, J SUPERCOMPUT, V72, P3826, DOI 10.1007/s11227-015-1610-x; Jiang Q, 2017, COMPUT ELECTR ENG, V63, P182, DOI 10.1016/j.compeleceng.2017.03.016; Jiang Q, 2017, IEEE ACCESS, V5, P3376, DOI 10.1109/ACCESS.2017.2673239; Jiang Q, 2018, IEEE SYST J, V12, P2039, DOI 10.1109/JSYST.2016.2574719; Jiang Q, 2013, WIRELESS PERS COMMUN, V68, P1477, DOI 10.1007/s11277-012-0535-4; Jin ATB, 2004, PATTERN RECOGN, V37, P2245, DOI 10.1016/j.patcog.2004.04.011; Jung J, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030644; Jung J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184232; Kang D, 2016, SECUR COMMUN NETW, V9, P1462, DOI 10.1002/sec.1432; Karuppiah M, 2017, WIRELESS PERS COMMUN, V93, P383, DOI 10.1007/s11277-016-3672-3; Khan Imran, 2016, J SUPERCOMPUT, P1; Kumari S, 2017, MULTIMED TOOLS APPL, V76, P13581, DOI 10.1007/s11042-016-3771-x; Kumari S, 2017, PEER PEER NETW APPL, V10, P92, DOI 10.1007/s12083-015-0409-0; Kumari S, 2017, FUTURE GENER COMP SY, V68, P320, DOI 10.1016/j.future.2016.10.004; Kumari S, 2016, MULTIMED TOOLS APPL, V75, P1135, DOI 10.1007/s11042-014-2361-z; Kumari S, 2015, AD HOC NETW, V27, P159, DOI 10.1016/j.adhoc.2014.11.018; Kumari S, 2016, INT J COMMUN SYST, V29, P441, DOI 10.1002/dac.2853; Lambrechts J, 2016, SMART SENSOR MEAS IN, V18, P1, DOI 10.1007/978-3-319-28358-6; Lee CC, 2006, IEEE T IND ELECTRON, V53, P1683, DOI 10.1109/TIE.2006.881998; Lee Y, 2010, COMPUT ELECTR ENG, V36, P213, DOI 10.1016/j.compeleceng.2009.08.007; Lu YR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126323; Mishra D, 2017, MULTIMED TOOLS APPL, P1; Mishra D., 2017, CRYPTOLOGIA, P1; Mishra D, 2015, J INF SECUR APPL, V23, P44, DOI 10.1016/j.jisa.2015.06.001; Mishra D, 2014, EXPERT SYST APPL, V41, P8129, DOI 10.1016/j.eswa.2014.07.004; Mishra D, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0041-1; Moon J, 2016, J MED SYST, V40, DOI 10.1007/s10916-015-0422-0; Moon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145263; Mun H, 2012, MATH COMPUT MODEL, V55, P214, DOI 10.1016/j.mcm.2011.04.036; Nam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116709; Odelu V, 2017, WIRELESS PERS COMMUN, V96, P2351, DOI 10.1007/s11277-017-4302-4; Odelu V, 2017, FUTURE GENER COMP SY, V68, P74, DOI 10.1016/j.future.2016.09.009; Rabari C, 2015, CAMB J REG ECON SOC, V8, P27, DOI 10.1093/cjres/rsu021; Reddy AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154308; Srinivas J, 2017, J AMBIENT INTELLIGEN, V9, P1; Srinivas J, 2017, AD HOC NETW, V54, P147, DOI 10.1016/j.adhoc.2016.11.002; Srinivas J, 2017, WIRELESS PERS COMMUN, V96, P6273, DOI 10.1007/s11277-017-4476-9; Wang D, 2016, ASIA CCS'16: PROCEEDINGS OF THE 11TH ACM ASIA CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P475, DOI 10.1145/2897845.2897916; Wazid M, 2016, SECUR COMMUN NETW, V9, P4103, DOI 10.1002/sec.1591; Wen FT, 2013, WIRELESS PERS COMMUN, V73, P993, DOI 10.1007/s11277-013-1243-4; Wu CC, 2008, IEEE COMMUNICATIONS, V12, P222; Wu F, 2017, J NETW COMPUT APPL, V89, P72, DOI 10.1016/j.jnca.2016.12.008; Wu F, 2017, ANN TELECOMMUN, V72, P131, DOI 10.1007/s12243-016-0547-2; Xu LL, 2015, J MED SYST, V39, DOI 10.1007/s10916-014-0179-x; Yeh C. K., 2009, INT J NETWORK SECURI, V9, P227; Zhao DW, 2014, WIRELESS PERS COMMUN, V78, P247, DOI 10.1007/s11277-014-1750-y; Zhu JM, 2004, IEEE T CONSUM ELECTR, V50, P231, DOI 10.1109/TCE.2004.1277867	68	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193366	10.1371/journal.pone.0193366	http://dx.doi.org/10.1371/journal.pone.0193366			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505575	gold, Green Published			2022-12-27	WOS:000426548200012
J	Olech, M; Valas, S; Kuzmak, J				Olech, Monika; Valas, Stephen; Kuzmak, Jacek			Epidemiological survey in single-species flocks from Poland reveals expanded genetic and antigenic diversity of small ruminant lentiviruses	PLOS ONE			English	Article							CAPRINE-ARTHRITIS-ENCEPHALITIS; PHYLOGENETIC ANALYSIS; MIXED FLOCKS; IMMUNODOMINANT EPITOPE; NATURAL TRANSMISSION; ANTIBODY-RESPONSE; SUBTYPE B1; SHEEP; VIRUS; GOATS	Small ruminant lentivirus (SRLV) infections are widespread in Poland and circulation of subtypes A1, A12, A13, B1 and B2 was detected. The present work aimed at extending previous study based on the analysis of a larger number of animals from single-species flocks. Animals were selected for genetic analysis based on serological reactivity towards a range of recombinant antigens derived from Gag and Env viral proteins. Phylogenetic analysis revealed the existence of subtypes B2 and A12 in both goats and sheep and subtypes A1 and B1 in goats only. In addition, two novel subtypes, A16 and A17, were found in goats. Co-infections with strains belonging to different subtypes within A and B groups were detected in 1 sheep and 4 goats originating from four flocks. Although the reactivity of serum samples towards the recombinant antigens confirmed immunological relatedness between Gag epitopes of different subtypes and the cross-reactive nature of Gag antibodies, eleven serum samples failed to react with antigens representing all subtypes detected up-to-date in Poland, highlighting the limitations of the serological diagnosis. These data showed the complex nature of SRLV subtypes circulating in sheep and goats in Poland and the need for improving SRLV-related diagnostic capacity.	[Olech, Monika; Kuzmak, Jacek] Natl Vet Res Inst, Dept Biochem, Pulawy, Poland; [Valas, Stephen] Anses Niort Lab, Niort, France	National Veterinary Institute - National Research Institute	Olech, M (corresponding author), Natl Vet Res Inst, Dept Biochem, Pulawy, Poland.	monika.olech@piwet.pulawy.pl		Olech, Monika/0000-0002-8356-5423	KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food"; Ministry of Science and Higher Education [05-1/KNOW2/2015]; National Science Centre [2016/21/D/NZ7/00626]	KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food"; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre(National Science Centre, Poland)	This study was funded by the KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food", Ministry of Science and Higher Education Resolution no. 05-1/KNOW2/2015 and National Science Centre project no. 2016/21/D/NZ7/00626.	Andreani G, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-392; [Anonymous], 2017, PREV VET MED, V147, P66; [Anonymous], 2015, PRESENCE ANTIBODIES; Carrozza ML, 2009, VET MICROBIOL, V137, P369, DOI 10.1016/j.vetmic.2009.01.032; CORK LC, 1974, J INFECT DIS, V129, P134, DOI 10.1093/infdis/129.2.134; de Andres X, 2013, VET IMMUNOL IMMUNOP, V152, P277, DOI 10.1016/j.vetimm.2012.12.017; Deubelbeiss M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-65; Fras M, 2013, INFECT GENET EVOL, V19, P97, DOI 10.1016/j.meegid.2013.06.019; Germain K, 2006, VIRUS RES, V120, P156, DOI 10.1016/j.virusres.2006.03.002; Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003; Gjerset B, 2006, J GEN VIROL, V87, P573, DOI 10.1099/vir.0.81201-0; GOGOLEWSKI RP, 1985, J GEN VIROL, V66, P1233, DOI 10.1099/0022-1317-66-6-1233; Grego E, 2005, VET MICROBIOL, V106, P179, DOI 10.1016/j.vetmic.2004.12.007; Grego E, 2002, CLIN DIAGN LAB IMMUN, V9, P828, DOI 10.1128/CDLI.9.4.828-832.2002; Grego E, 2007, J GEN VIROL, V88, P3423, DOI 10.1099/vir.0.83292-0; Hayward JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-76; Kuhar U, 2013, VET MICROBIOL, V162, P201, DOI 10.1016/j.vetmic.2012.08.024; L'Homme Y, 2015, VIROLOGY, V475, P159, DOI 10.1016/j.virol.2014.11.006; Lacerenza D, 2006, VET IMMUNOL IMMUNOP, V112, P264, DOI 10.1016/j.vetimm.2006.03.016; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mordasini F, 2006, J CLIN MICROBIOL, V44, P981, DOI 10.1128/JCM.44.3.981-991.2006; NARAYAN O, 1989, J GEN VIROL, V70, P1617, DOI 10.1099/0022-1317-70-7-1617; Olech M, 2012, VIRUS RES, V163, P528, DOI 10.1016/j.virusres.2011.11.019; Pisoni G, 2005, VIROLOGY, V339, P147, DOI 10.1016/j.virol.2005.06.013; Pisoni G, 2007, J VIROL, V81, P4948, DOI 10.1128/JVI.00126-07; Rachid A, 2013, J GEN VIROL, V94, P634, DOI 10.1099/vir.0.044768-0; Ramirez H, 2011, VET J, V190, P169, DOI 10.1016/j.tvjl.2010.09.005; Ramirez H, 2013, VIRUSES-BASEL, V5, P1175, DOI 10.3390/v5041175; Reina R, 2010, VET MICROBIOL, V144, P24, DOI 10.1016/j.vetmic.2009.12.020; Santry LA, 2013, VIRUS RES, V175, P30, DOI 10.1016/j.virusres.2013.03.019; Shah C, 2004, VIROLOGY, V319, P12, DOI 10.1016/j.virol.2003.09.047; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valas S, 1997, VIROLOGY, V237, P307, DOI 10.1006/viro.1997.8800; Valas S, 2000, J VIROL, V74, P6178, DOI 10.1128/JVI.74.13.6178-6185.2000	34	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e193892	10.1371/journal.pone.0193892	http://dx.doi.org/10.1371/journal.pone.0193892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505612	Green Submitted, Green Published, gold			2022-12-27	WOS:000426548200040
J	Monteiro, LMC; Cruz, GND; Fontes, JM; Salles, TRDS; Boechat, MCB; Monteiro, AC; Moreira, MEL				Costa Monteiro, Lucia Maria; de Oliveira Cruz, Glaura Nisya; Fontes, Juliana Marin; Dias Saad Salles, Tania Regina; Bastos Boechat, Marcia Cristina; Monteiro, Ana Carolina; Lopes Moreira, Maria Elizabeth			Neurogenic bladder findings in patients with Congenital Zika Syndrome: A novel condition	PLOS ONE			English	Article							NEUROPATHIC BLADDER; VIRUS-INFECTION; URINARY-TRACT; CHILDREN; INFANTS; BRAZIL	Introduction Congenital Zika Syndrome ( CZS) has been associated with microcephaly and other central nervous system abnormalities including areas that have been implicated in the control of the lower urinary tract. As such, this descriptive case series has aimed to investigate whether CZS is linked with neurogenic bladder. Identifying such an association is paramount in the effort to recognize CZS complications that have putative treatment options that could mitigate the impact of CZS in infected children. Methods Following IRB approval, urological assessment was performed in all patients referred to our clinic between June 2016 and May 2017 who presented with confirmed CZS-associated microcephaly. The research protocol consisted of obtaining clinical history, laboratory tests, lower and upper urinary tract ultrasounds, as well as a diagnostic urodynamic evaluation. ZIKA virus infection was previously confirmed by maternal history and positive PCR in babies and mothers. Microcephaly and other central nervous system abnormalities were established based on neurological assessment and associated imaging of the central nervous system ( CT head and/or Brain MRI). Results Twenty-two consecutive CZS patients were tested and confirmed to have neurogenic bladder. Of the 22 patients assessed, 21 presented with an overactive bladder combined with reduced bladder capacity and elevated detrusor filling pressures. Clinically significant increases in postvoid residual ( PVR) were confirmed in 40% of cases while a urinary tract infection ( UTI) was identified in 23% of cases. Conclusion Neurogenic bladder, a known treatable health condition, was confirmed in 100% of patients tested in this study, most presenting with high-risk urodynamic patterns known to lead to renal damage when left untreated. Follow up studies are necessary to provide further insight onto long-term disease progression and to investigate the response to standard therapies for neurogenic bladder. Nonetheless, we emphasize the importance of proactive management of neurogenic bladder and prompt referral so as to help mitigate CZS disease burden for patients and their families.	[Costa Monteiro, Lucia Maria; de Oliveira Cruz, Glaura Nisya; Fontes, Juliana Marin] Fiocruz MS, Dept Pediat Urodynam & Dysfunct Voiding, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil; [Dias Saad Salles, Tania Regina] Fiocruz MS, Dept Pediat Neurol, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil; [Bastos Boechat, Marcia Cristina] Fiocruz MS, Dept Pediat Radiol & Imagining, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil; [Monteiro, Ana Carolina] Univ Calif Los Angeles, Dept Internal Med, Los Angeles, CA USA; [Lopes Moreira, Maria Elizabeth] Fiocruz MS, Dept Neonatol, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; Fundacao Oswaldo Cruz	Monteiro, LMC (corresponding author), Fiocruz MS, Dept Pediat Urodynam & Dysfunct Voiding, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, RJ, Brazil.	lucia@iff.fiocruz.br	Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Costa Monteiro, Lucia Maria/O-7903-2014	Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Costa Monteiro, Lucia Maria/0000-0002-7612-7249; Costa Monteiro, Ana Carolina/0000-0002-1501-4435; Marin Fontes, Juliana/0000-0003-4098-7324	CNPq; CAPES (Brazil) [440580/2016-1]; National Plan to Prevent and Combat ZIKA (MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS) [14/2016]; FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Plan to Prevent and Combat ZIKA (MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The research is funded by a grant from CNPq and CAPES (Brazil), process number 440580/2016-1, from the National Plan to Prevent and Combat ZIKA (MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit/ No 14/2016 - Prevencao e Com bate ao virus Zika). Lucia M Costa Monteiro is the grant coordinator. Maria Elizabeth Lopes Moreira is funded by FAPERJ.	Bauer SB, 2015, NEUROUROL URODYNAM, V34, P640, DOI 10.1002/nau.22783; Bauer SB, 2012, NEUROUROL URODYNAM, V31, P610, DOI 10.1002/nau.22247; Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Costa Monteiro LM, 2017, CRITERIA EVALUATE NE; Costa Monteiro LM, 2017, J PEDIAT RIO J, DOI 10.1016/j.jped.2016.11.010; de Groat WC, 2014, COMPREHENSIVE PHYSL, P327; de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584; Dik P, 2006, EUR UROL, V49, P908, DOI 10.1016/j.eururo.2005.12.056; Drzewiecki BA, 2011, J UROLOGY, V186, P1190, DOI 10.1016/j.juro.2011.02.2692; Filler G, 2012, INT UROL NEPHROL, V44, P817, DOI 10.1007/s11255-010-9894-5; Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814; Gostin LO, 2016, LANCET INFECT DIS, V16, P1099, DOI 10.1016/S1473-3099(16)30332-2; Kari JA, 2006, PEDIATR NEPHROL, V21, P517, DOI 10.1007/s00467-006-0034-5; Lehnert T, 2012, INT UROL NEPHROL, V44, P335, DOI 10.1007/s11255-011-0030-y; Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2; MCGUIRE EJ, 1981, J UROLOGY, V126, P205, DOI 10.1016/S0022-5347(17)54449-3; McKibben MJ, 2015, UROL CLIN N AM, V42, P527, DOI 10.1016/j.ucl.2015.05.006; Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5; Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272; Olandoski KP, 2011, CLINICS, V66, P189, DOI 10.1590/S1807-59322011000200002; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1; Rodriguez-Ruiz M, 2016, ACTAS UROL ESP, V40, P37, DOI [10.1016/j.acuroe.2015.11.005, 10.1016/j.acuro.2015.06.002]; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; STEINHARDT GF, 1988, J UROLOGY, V140, P1293, DOI 10.1016/S0022-5347(17)42028-3; Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901; Verpoorten C, 2008, PEDIATR NEPHROL, V23, P717, DOI 10.1007/s00467-007-0691-z; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6	30	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193514	10.1371/journal.pone.0193514	http://dx.doi.org/10.1371/journal.pone.0193514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494684	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200059
J	Ferretti, C; Sarti, FM; Nitrini, R; Ferreira, FF; Brucki, SMD				Ferretti, Ceres; Sarti, Flavia M.; Nitrini, Ricardo; Ferreira, Fernando F.; Brucki, Sonia M. D.			An assessment of direct and indirect costs of dementia in Brazil	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ECONOMIC-IMPACT; HEALTH; ASSOCIATION; PREVALENCE; OUTCOMES; PEOPLE; BURDEN; RISK	Background To analyze costs associated with dementia based on a cross-sectional study in the Brazilian health system. Methods Direct and indirect costs were estimated by conducting comprehensive interviews on the use of resources in a sample of 156 patients with dementia treated at an outpatient memory clinic of a tertiary hospital. A regression model was used to determine the main determinants of costs associated with dementia. Results Global costs of dementia were US$1,012.35; US$1,683.18 and US$1,372.30 per patient/month for mild, moderate and severe stages, respectively. Indirect costs ranged from US $536.62 to US$545.17 according to severity. Dementia costs were influenced by medication, FAST score, and educational level of caregiver. Discussion The study represents an original contribution toward establishing direct and indirect costs of dementia in Brazil. Results indicate significant economic impacts, including projection of annual costs of US$16,548.24 per patient.	[Ferretti, Ceres; Nitrini, Ricardo; Brucki, Sonia M. D.] Univ Sao Paulo, Sch Med, Cognit & Behav Neurol Unit, Dept Neurol, Sao Paulo, SP, Brazil; [Ferretti, Ceres] Univ Taubate, Dept Nursing & Nutr, Taubate, SP, Brazil; [Sarti, Flavia M.; Ferreira, Fernando F.] Univ Sao Paulo, USP Leste, Escola Artes Ciencias & Humanidades, Sao Paulo, SP, Brazil; [Brucki, Sonia M. D.] Hosp Santa Marcelina, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Taubate; Universidade de Sao Paulo	Ferretti, C (corresponding author), Univ Sao Paulo, Sch Med, Cognit & Behav Neurol Unit, Dept Neurol, Sao Paulo, SP, Brazil.; Ferretti, C (corresponding author), Univ Taubate, Dept Nursing & Nutr, Taubate, SP, Brazil.	cereseloah@gmail.com	Brucki, Sonia/L-4201-2019; Sarti, Flavia Mori/D-4767-2009; del Lucena Ferretti, Ceres Eloah/U-5810-2019	Brucki, Sonia/0000-0002-8303-6732; Sarti, Flavia Mori/0000-0003-2834-2005; Ferretti, Ceres Eloah del Lucena/0000-0001-5615-8489				Albanese E, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-153; Allegri RF, 2007, INT PSYCHOGERIATR, V19, P705, DOI 10.1017/S1041610206003784; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Alzheimer's Disease International /, 2013, REL ADI BUP DEM AM C; Brookmeyer R, 2002, ARCH NEUROL-CHICAGO, V59, P1764, DOI 10.1001/archneur.59.11.1764; Brucki Sonia Maria Dozzi, 2014, Dement. neuropsychol., V8, P345, DOI 10.1590/S1980-57642014DN84000007; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Burla A C, 2013, CIENC SAUDE COLETIVA, V18, P2949; Cesar KG, 2015, J NEUROL SCI, V357, pE123, DOI 10.1016/j.jns.2015.08.396; Chow SC., 2007, SAMPLE SIZE CALCULAT, V2nd; DeKosky ST, 2014, JAMA NEUROL, V71, P273, DOI 10.1001/jamaneurol.2013.6031; Engedal Knut, 2016, Dement. neuropsychol., V10, P74, DOI 10.1590/S1980-5764-2016DN1002002; Facchini L.A., 2006, CIENC SAUDE COLETIVA, V11, P669, DOI [10.1590/S1413-81232006000300015, DOI 10.1590/S1413-81232006000300015]; Ferretti CEL, 2013, DESCRIPTION METHODS; Ferretti Ceres Eloah Lucena, 2015, Dement. neuropsychol., V9, P42, DOI 10.1590/S1980-57642015DN91000007; Ferri CP, 2012, REV BRAS PSIQUIATR, V34, P371, DOI 10.1016/j.rbp.2012.08.005; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2014, PESQ NAC SAUD 2013; Laks J, 2016, INT J GERIATR PSYCH, V31, P176, DOI 10.1002/gps.4309; Liu, 2008, DESIGN ANAL BIOAVAIL; Liu Z., 2012, EC COSTS DEMENTIA LO; Lopes MA, 2012, J ALZHEIMERS DIS, V32, P307, DOI 10.3233/JAD-2012-120847; Malachias Mvb, 2016, Arq Bras Cardiol, V107, P1, DOI 10.5935/abc.20160151; Mausbach BT, 2013, AM J GERIAT PSYCHIAT, V21, P5, DOI 10.1016/j.jagp.2012.10.001; Mendes Eugênio Vilaça, 2013, Estud. av., V27, P27, DOI 10.1590/S0103-40142013000200003; Meyer HJC, 2016, S AFR PHARM J, V83, P48; Neri AL, 2013, CAD SAUDE PUBLICA, V29, P778, DOI 10.1590/S0102-311X2013000800015; Gutierrez BAO, 2014, CIENC SAUDE COLETIVA, V19, P4479, DOI 10.1590/1413-812320141911.03562013; Parkinson M, 2017, J PUBLIC HEALTH-UK, V39, pE290, DOI 10.1093/pubmed/fdw100; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Poblador-Plou B, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-84; Prince M., 2015, WORLD ALZHEIMER REPO, DOI DOI 10.1111/j.0963-7214.2004.00293.x; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Brandao CMR, 2011, VALUE HEALTH, V14, pS71, DOI 10.1016/j.jval.2011.05.028; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Scazufca Marcia, 2002, Rev. Bras. Psiquiatr., V24, P12, DOI 10.1590/S1516-44462002000100006; Sclan S G, 1992, Int Psychogeriatr, V4 Suppl 1, P55; Serra-Prat M, 2016, EUR GERIATR MED, V7, P531, DOI 10.1016/j.eurger.2016.09.005; Veras Renato Peixoto, 2007, Arch. Clin. Psychiatry (São Paulo), V34, P5; WHO, 2015, 1 WHO MIN C GLOB ACT; Wimo A, 2014, J INTERN MED, V275, P304, DOI 10.1111/joim.12167; Wimo A, 2010, WORLD ALZHEIMER REPO; Wimo A, 2009, HLTH EC ASPECTS DEME; Wimo A, 2017, ALZHEIMERS DEMENT, V13, P1, DOI 10.1016/j.jalz.2016.07.150; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P429, DOI 10.1016/j.jalz.2012.06.008; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; World Health Organization (WHO), 2012, EP IMP DEM CURR STAT; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; Xu JF, 2017, B WORLD HEALTH ORGAN, V95, P18, DOI [10.2471/BLT.15.167726, 10.2471/blt.15.167726]; Zarit SH, 2012, AGING MENT HEALTH, V16, P673, DOI 10.1080/13607863.2012.692768	49	25	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193209	10.1371/journal.pone.0193209	http://dx.doi.org/10.1371/journal.pone.0193209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494693	Green Published, gold			2022-12-27	WOS:000426363200031
J	Marchant, A; Hawton, K; Stewart, A; Montgomery, P; Singaravelu, V; Lloyd, K; Purdy, N; Daine, K; John, A				Marchant, Amanda; Hawton, Keith; Stewart, Ann; Montgomery, Paul; Singaravelu, Vinod; Lloyd, Keith; Purdy, Nicola; Daine, Kate; John, Ann			A systematic review of the relationship between internet use, self-harm and suicidal behaviour in young people: The good, the bad and the unknown (vol 12, e0181722, 2017)	PLOS ONE			English	Correction														Montgomery, Paul/0000-0001-8008-1370	HCRW_ [HCRW_SCS-14-11] Funding Source: Medline; ESRC [ES/N012267/2] Funding Source: UKRI	HCRW_; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Marchant A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181722	1	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193937	10.1371/journal.pone.0193937	http://dx.doi.org/10.1371/journal.pone.0193937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494676	Green Submitted, gold, Green Published			2022-12-27	WOS:000426363200102
J	Mlakar, M; Puddu, PE; Somrak, M; Bonfiglio, S; Lustrek, M				Mlakar, Miha; Puddu, Paolo Emilio; Somrak, Maja; Bonfiglio, Silvio; Lustrek, Mitja		Chiron & HeartMan Res Projects	Mining telemonitored physiological data and patient-reported outcomes of congestive heart failure patients	PLOS ONE			English	Article							EJECTION FRACTION; MORTALITY; ASSOCIATIONS; ALGORITHM; PRESSURE	This paper addresses patient-reported outcomes (PROs) and telemonitoring in congestive heart failure (CHF), both increasingly important topics. The interest in CHF trials is shifting from hard end-points such as hospitalization and mortality, to softer end-points such health-related quality of life. However, the relation of these softer end-points to objective parameters is not well studied. Telemonitoring is suitable for collecting both patient-reported outcomes and objective parameters. Most telemonitoring studies, however, do not take full advantage of the available sensor technology and intelligent data analysis. The Chiron clinical observational study was performed among 24 CHF patients (17 men and 7 women, age 62.9 +/- 9.4 years, 15 NYHA class II and 9 class III, 10 of ishaemic, aetiology, 6 dilated, 2 valvular, and 6 of multiple aetiologies or cardiomyopathy) in Italy and UK. A large number of physiological and ambient parameters were collected by wearable and other devices, together with PROs describing how well the patients felt, over 1,086 days of observation. The resulting data were mined for relations between the objective parameters and the PROs. The objective parameters (humidity, ambient temperature, blood pressure, SpO2, and sweeting intensity) could predict the PROs with accuracies up to 86% and AUC up to 0.83, making this the first report providing evidence for ambient and physiological parameters to be objectively related to PROs in CHF patients. We also analyzed the relations in the predictive models, gaining some insights into what affects the feeling of health, which was also generally not attempted in previous investigations. The paper strongly points to the possibility of using PROs as primary end-points in future trials.	[Mlakar, Miha; Somrak, Maja; Lustrek, Mitja] Jozef Stefan Inst, Dept Intelligent Syst, Ljubljana, Slovenia; [Puddu, Paolo Emilio] Sapienza Univ Rome, Dept Cardiovasc Resp Nephrol Anesthesiol & Geriat, Rome, Italy; [Bonfiglio, Silvio] Fimi Barco, Saronno, Italy	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Sapienza University Rome	Mlakar, M (corresponding author), Jozef Stefan Inst, Dept Intelligent Syst, Ljubljana, Slovenia.	miha.mlakar@ijs.si			ARTEMIS Joint Undertaking [2009-1-100228]; HeartMan project; European Union's Horizon research and innovation program [689660]; consortium of the HeartMan project	ARTEMIS Joint Undertaking; HeartMan project; European Union's Horizon research and innovation program; consortium of the HeartMan project	The consortium of the HeartMan project, which partially funded this research, consists of Jozef Stefan Institute, Sapienza University, Ghent University, National Research Council, ATOS Spain SA, SenLab, KU Leuven, MEGA Electronics Ltd and European Heart Network. We specifically thank Aljosa Vodopija, John M. Morgan, Nick Curzen, George Koulaouzidis, Michele Schiariti, Concetta Torromeo and also others who helped in making this paper.; This research described in this paper partially was carried out in the Chiron project (https://artemis-ia.eu/project/17-chiron.html), which was co-funded by the ARTEMIS Joint Undertaking (grant agreement # 2009-1-100228) and by national authorities, and partially in the HeartMan project (http://cordis.europa.eu/project/rcn/199014_en.html), which received funding from the European Unions Horizon 2020 research and innovation program under grant agreement No 689660. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna E, 2004, ST CLASS DAT ANAL, P639; Anker SD, 2014, EUR HEART J, V35, P2001, DOI 10.1093/eurheartj/ehu205; Balmain BN, 2017, J CARDIAC FAILURE; Bashi N, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6571; Bonfiglio S, 2012, FOSTERING CONTINUUM; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cook C, 2014, INT J CARDIOL, V171, P368, DOI 10.1016/j.ijcard.2013.12.028; Cubbon RM, 2015, HEART; Demsar J, 2006, J MACH LEARN RES, V7, P1; Donnelly M, 2012, 10 INT C SMART HOM H; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Fisher R, 2016, MACH LEARN APPL ICML; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; Gnanasakthy A, 2012, VALUE HEALTH, V15, P437, DOI 10.1016/j.jval.2011.11.032; Goggins WB, 2017, INT J CARDIOL, V228, P537, DOI 10.1016/j.ijcard.2016.11.106; Goldie J, 2015, ANN GLOB HEALTH, V81, P333, DOI 10.1016/j.aogh.2015.07.003; Grady KL, 2012, SURVIVAL RECOMMENDAT; Greene SJ, 2013, JACC-HEART FAIL, V1, P488, DOI 10.1016/j.jchf.2013.08.005; Hall M., 2009, SIGKDD EXPLOR NEWSL, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Jackson CE, 2015, EUR HEART J, V36, P1106, DOI 10.1093/eurheartj/ehu490; Kang Y, 2016, CIN-COMPUT INFORM NU, V34, P175, DOI 10.1097/CIN.0000000000000223; Kotb A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118681; Koulaouzidis G, 2016, INT J CARDIOL, V216, P78, DOI 10.1016/j.ijcard.2016.04.149; Ledwidge MT, 2013, EUR J HEART FAIL, V15, P447, DOI 10.1093/eurjhf/hfs186; Lee TT, 2006, AM HEART J, V151, P76, DOI 10.1016/j.ahj.2005.03.009; Lustrek M, 2012, CIRC SYST ISCAS 2012; Lustrek M, MINING TELEMONITORIN; Lustrek M, 2012, P 15 INT MULT INF SO; Maheshwari S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0761; Mazomenos EB, 2013, IEEE J BIOMED HEALTH, V17, P459, DOI 10.1109/TITB.2012.2231312; Metra M, 2013, TACHYCARDIA HEART FA; MORGAN CL, 1963, NEW ENGL J MED, V268, P580, DOI 10.1056/NEJM196303142681104; Naughton MT, 2015, J THORAC DIS, V7, P1298, DOI 10.3978/j.issn.2072-1439.2015.07.02; Pecchia L, 2011, IEEE T BIO-MED ENG, V58, P800, DOI 10.1109/TBME.2010.2092776; Piras P, 2015, INT WORKSH STAT ATL; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Puddu PE, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-100; Puddu PE, 2009, EUR J CARDIOV PREV R, V16, P583, DOI 10.1097/HJR.0b013e32832d49e1; Puddu PE, 2014, SYSTEMS DESIGN REMOT, P1; Puddu PE, 2012, INT C SMART HOM HLTH; Rish I., 2001, IJCAI 2001 WORKSHOP, P41, DOI DOI 10.1039/B104835J; Sousa C, 2014, REV PORT CARDIOL, V33, P229, DOI 10.1016/j.repc.2013.10.013; Sun Y., 2008, P 2008 SIAM INT C DA; Tripoliti EE, 2017, COMPUT STRUCT BIOTEC, V15, P26, DOI 10.1016/j.csbj.2016.11.001; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; van Buuren S, 2011, J STAT SOFTW, V45, P1; WebMD Medical Reference from Healthwise, HEART FAIL LESS COMM; WHO, 2002, RED RISKS PROM HLTH; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269	54	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0190323	10.1371/journal.pone.0190323	http://dx.doi.org/10.1371/journal.pone.0190323			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494601	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200003
J	Yamazaki, H; Ishida, M; Hinokio, R; Yamashiki, YA; Azuma, R				Yamazaki, Hideo; Ishida, Masanobu; Hinokio, Ryoichi; Yamashiki, Yosuke Alexandre; Azuma, Ryokei			Spatiotemporal distribution and fluctuation of radiocesium in Tokyo Bay in the five years following the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident	PLOS ONE			English	Article							ATOMIC-BOMB; NISHIYAMA RESERVOIR; CESIUM ADSORPTION; CLAY-MINERALS; SEDIMENTS; CS-137; MICROPARTICLES; PLUTONIUM; MIGRATION; FIXATION	A monitoring survey was conducted from August 2011 to July 2016 of the spatiotemporal distribution in the 400 km(2) area of the northern part of Tokyo Bay and in rivers flowing into it of radiocesium released from the Fukushima Daiichi Nuclear Power Plant ( FDNPP) accident. The average inventory in the river mouth ( 10 km(2)) was 131 kBq.m(-2) and 0.73 kBq.m(-2) in the central bay ( 330 km(2)) as the decay corrected value on March 16, 2011. Most of the radiocesium that flowed into Tokyo Bay originated in the northeastern section of the Tokyo metropolitan area, where the highest precipitation zone of Cs-137 in soil was almost the same level as that in Fukushima City, then flowed into and was deposited in the Old-Edogawa River estuary, deep in Tokyo Bay. The highest precipitation of radiocesium measured in the high contaminated zone was 460 kBq.m(-2). The inventory in sediment off the estuary of Old-Edogawa was 20.1 kBq.m(-2) in August 2011 immediately after the accident, but it increased to 104 kBq.m(-2) in July 2016. However, the radiocesium diffused minimally in sediments in the central area of Tokyo Bay in the five years following the FDNPP accident. The flux of radiocesium off the estuary decreased slightly immediately after the accident and conformed almost exactly to the values predicted based on its radioactive decay. Contrarily, the inventory of radiocesium in the sediment has increased. It was estimated that of the 8.33 TBq precipitated from the atmosphere in the catchment regions of the rivers Edogawa and Old-Edogawa, 1.31 TBq migrated through rivers and was deposited in the sediments of the Old-Edogawa estuary by July 2016. Currently, 0.25 TBq.yr(-1) of radiocesium continues to flow into the deep parts of Tokyo Bay.	[Yamazaki, Hideo; Ishida, Masanobu] Kindai Univ, Grad Sch Sci & Engn, Higashiosaka, Osaka, Japan; [Hinokio, Ryoichi] Ryukoku Univ, Fac Sci & Technol, Otsu, Shiga, Japan; [Yamashiki, Yosuke Alexandre] Kyoto Univ, Grad Sch Adv Integrated Studies Human Survivabil, Kyoto, Kyoto, Japan; [Azuma, Ryokei] Osaka Inst Technol, Dept Civil Engn & Urban Design, Osaka, Osaka, Japan	Kindai University (Kinki University); Ryukoku University; Kyoto University; Osaka Institute of Technology	Ishida, M (corresponding author), Kindai Univ, Grad Sch Sci & Engn, Higashiosaka, Osaka, Japan.	masanobuijp1989@gmail.com			 [24310014];  [26289155];  [15J10109];  [26303004];  [24110006]; Grants-in-Aid for Scientific Research [26303004] Funding Source: KAKEN	; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the following: Grant number: 24310014 (HY), https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-24310014/. Principal investigator is Hideo Yamazaki. He plays roles in Conceptualization, Investigation, Writing - Review & Editing. Grant number: 26289155 (HY, RA), https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-2289155/. Co-investigators are Hideo Yamazaki and Ryokei Azuma. Ryokei Azuma plays a role in Formal Analysis. Grant number: 15J10109 (MI), https://www.jsps.go.jp/j-pd/data/saiyo_ichiran/h27_dc1_09_sougou.pdf [in Japanese]. The URL is described the adopters for JSPS DC1; Under the URL, the overview of DC1 is described; https://www.jsps.go.jp/english/e-pd/index.html. Principal investigator is Masanobu Ishida. He plays roles in Data Curation, Formal Analysis, Investigation, Methodology, Project Administration, Visualization and Writing - Original Draft Preparation. Grant number: 26303004 (RA, HY), https://kaken.ni.ac.jp/en/grant/KAKENHI-PROJECT-26303004/. Principal investigator is Ryokei Azuma. Co-investigator is Hideo Yamazaki. Grant number: 24110006 (YY), https://kaken.ni.ac.jp/en/grant/KAKENHI-PLANNED-24110006/. Co-investigator is Yosuke Yamashiki. He plays a role in Formal Analysis and Investigation.	Abe Y, 2014, ANAL CHEM, V86, P8521, DOI 10.1021/ac501998d; Adachi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02554; [Anonymous], 2014, FUK DAIICH NUCL POW; [Anonymous], 2020, FUK DAIICH ACC; Aoyama M, 2008, RADIOACTIVITY ENV, P137; Bera G, 2015, ESTUAR COAST SHELF S, V157, P32, DOI 10.1016/j.ecss.2015.02.004; Bostick BC, 2002, ENVIRON SCI TECHNOL, V36, P2670, DOI 10.1021/es0156892; Chaisan K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02520; EVANS DW, 1983, GEOCHIM COSMOCHIM AC, V47, P1041, DOI 10.1016/0016-7037(83)90234-X; Forstner U, 1983, METAL POLLUTION AQUA, P121; Forstner U., 1983, METAL POLLUTION AQUA, P247; Furuki G, 2017, SCI REP-UK, V7, DOI 10.1038/srep42731; Gallego E, 2006, J ENVIRON RADIOACTIV, V85, P247, DOI 10.1016/j.jenvrad.2004.10.017; GOHDA S, 1987, BUNSEKI KAGAKU, V36, P199; GSI (Geospatial Information Authority of Japan), 2014, EXT SIT DISTR MAP RA; Hakanson L, 2004, J ENVIRON RADIOACTIV, V77, P247, DOI 10.1016/j.jenvrad.2004.03.010; Hakanson L, 2004, J ENVIRON RADIOACTIV, V73, P267, DOI 10.1016/j.jenvrad.2003.10.003; HIRAO Y, 1986, GEOCHEM J, V20, P1, DOI 10.2343/geochemj.20.1; IAEA (International Atomic Energy Agency), 2006, IAEA RAD ASS REP SER; Investigation Committee on the Accident at Fukushima Nuclear Power Stations of Tokyo Electric Power Company, 2012, FIN REP; Ishida M, 2017, PLOS ONE, V12, P1; Itoh S, 2014, SOIL SCI PLANT NUTR, V60, P540, DOI 10.1080/00380768.2014.907735; JCAC (Japan Chemical Analysis Center), RAD SURV DAT JAP ENV; JCG (Japan Coast Guard), REP RAD SURV RES SUR; Kakehi S, 2016, J ENVIRON RADIOACTIV, V153, P1, DOI 10.1016/j.jenvrad.2015.11.015; Kashiwa City Government, 2013, DEC PROJ KASH CIT; Koibuchi Y, 2013, COASTAL PROCESSES, V169, P191; Komori M, 2013, BUNSEKI KAGAKU, V62, P475, DOI 10.2116/bunsekikagaku.62.475; MEXT (Ministry of Education Culture Sports Science and Technology of Japan), 2012, RES SURV RES DISTR S; MLIT (Ministry of Land Infrastructure Transport and Tourism of Japan), RIV MAN REP 2015; MLIT (Ministry of Land Infrastructure Transport and Tourism of Japan), 2015, OV KANT TOH HEAV RAI; MLIT (Ministry of Land Infrastructure Transport and Tourism of Japan), 2005, OV TOK BAY CATCHM AR; Monte L, 2005, J ENVIRON RADIOACTIV, V79, P273, DOI 10.1016/j.jenvrad.2004.08.002; Motokawa R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06585; NDJ (The National Diet of Japan), 2012, OFF REP FUK NUCL ACC; Nishizawa Y, 2016, J NUCL SCI TECHNOL, V53, P468, DOI 10.1080/00223131.2015.1071721; NRA (Nuclear Regulation Authority Japan), 2013, READ SEA WAT TOK BAY; NSAC (Nuclear Science Advisory Committee), 1980, NSAC801; Oikawa S, 2013, BUNSEKI KAGAKU, V62, P455, DOI 10.2116/bunsekikagaku.62.455; Pratama MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08408; Qin HB, 2012, GEOCHEM J, V46, P297, DOI 10.2343/geochemj.2.0214; Saegusa H, 2016, J ENVIRON RADIOACTIV, V164, P36, DOI 10.1016/j.jenvrad.2016.04.020; Saito-Kokubu Y, 2008, J ENVIRON RADIOACTIV, V99, P211, DOI 10.1016/j.jenvrad.2007.11.010; Saito-Kokubu Y, 2007, J RADIOANAL NUCL CH, V273, P183, DOI 10.1007/s10967-007-0733-9; Saito-Kokubu Y, 2007, APPL RADIAT ISOTOPES, V65, P465, DOI 10.1016/j.apradiso.2006.10.010; SAWHNEY BL, 1972, CLAY CLAY MINER, V20, P93, DOI 10.1346/CCMN.1972.0200208; Sekiguchi H, 2013, J JSCE, V69, P691; Smith JT, 2004, ENVIRON SCI TECHNOL, V38, P850, DOI 10.1021/es0300463; STUMM W, 1996, AQUAT CHEM, P818; Stumm W., 1996, AQUAT CHEM, P516; Tanaka K, 2015, J ENVIRON RADIOACTIV, V139, P390, DOI 10.1016/j.jenvrad.2014.05.002; Thill A, 2001, CONT SHELF RES, V21, P2127, DOI 10.1016/S0278-4343(01)00047-4; Tokuda Y., 2016, RADIOLOGICAL ISSUES, P3; Tsuruta H., 2012, Chikyukagaku (Geochemistry), V46, P99; USGS (US Geological Survey), 1973, GEOLOGICAL SURVEY PR; USNRC (US Nuclear Regulatory Commision), 1989, PROGR ENV IMP STAT R; Yamada M, 2000, J RADIOANAL NUCL CH, V245, P273, DOI 10.1023/A:1006741917854; Yamaguchi N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20548; Yamasaki S, 2016, SCI TOTAL ENVIRON, V551, P155, DOI 10.1016/j.scitotenv.2016.01.155; Yamashiki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03714; Yasuhara M, 2005, MAR MICROPALEONTOL, V55, P63, DOI 10.1016/j.marmicro.2005.02.005; Zachara JM, 2002, GEOCHIM COSMOCHIM AC, V66, P193, DOI 10.1016/S0016-7037(01)00759-1	62	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193414	10.1371/journal.pone.0193414	http://dx.doi.org/10.1371/journal.pone.0193414			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494667	Green Published, gold			2022-12-27	WOS:000426363200044
J	Zaniboni, M				Zaniboni, Massimiliano			Short-term action potential memory and electrical restitution: A cellular computational study on the stability of cardiac repolarization under dynamic pacing	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; VENTRICULAR-FIBRILLATION; CYCLE LENGTH; CALCIUM CURRENT; ALTERNANS; HYSTERESIS; MECHANISM; DURATION; EXCITABILITY; DEPENDENCE	Electrical restitution ( ER) is a major determinant of repolarization stability and, under fast pacing rate, it reveals memory properties of the cardiac action potential ( AP), whose dynamics have never been fully elucidated, nor their ionic mechanisms. Previous studies have looked at ER mainly in terms of changes in AP duration ( APD) when the preceding diastolic interval ( DI) changes and described dynamic conditions where this relationship shows hysteresis which, in turn, has been proposed as a marker of short-term AP memory and repolarization stability. By means of numerical simulations of a non-propagated human ventricular AP, we show here that measuring ER as APD versus the preceding cycle length ( CL) provides additional information on repolarization dynamics which is not contained in the companion formulation. We focus particularly on fast pacing rate conditions with a beat-to-beat variable CL, where memory properties emerge from APD vs CL and not from APD vs DI and should thus be stored in APD and not in DI. We provide an ion-currents characterization of such conditions under periodic and random CL variability, and show that the memory stored in APD plays a stabilizing role on AP repolarization under pacing rate perturbations. The gating kinetics of L-type calcium current seems to be the main determinant of this safety mechanism. We also show that, at fast pacing rate and under otherwise identical pacing conditions, a periodically beat-to-beat changing CL is more effective than a random one in stabilizing repolarization. In summary, we propose a novel view of short-term AP memory, differentially stored between systole and diastole, which opens a number of methodological and theoretical implications for the understanding of arrhythmia development.	[Zaniboni, Massimiliano] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci, Parma, Italy; [Zaniboni, Massimiliano] Univ Parma, Ctr Excellence Toxicol Res CERT, Parma, Italy	University of Parma; University of Parma	Zaniboni, M (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci, Parma, Italy.; Zaniboni, M (corresponding author), Univ Parma, Ctr Excellence Toxicol Res CERT, Parma, Italy.	massimiliano.zaniboni@unipr.it	Zaniboni, Massimiliano/M-8144-2015	Zaniboni, Massimiliano/0000-0001-8808-2239	University of Parma, Italy	University of Parma, Italy	This work was supported by the local funding of the University of Parma, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Agarwal A, 2012, IEEE ENG MED BIO, P673, DOI 10.1109/EMBC.2012.6346021; Banville I, 2004, J CARDIOVASC ELECTR, V15, P455, DOI 10.1046/j.1540-8167.2004.03330.x; BASS BG, 1975, AM J PHYSIOL, V228, P1717, DOI 10.1152/ajplegacy.1975.228.6.1717; Berger CM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058101; Berger RD, 2004, CIRC RES, V94, P567, DOI 10.1161/01.RES.0000124605.03595.E4; Boyett M. R, 1987, J PHYSL, V285, P359; Carmeliet Edward, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS2, DOI 10.1111/j.1540-8167.2006.00378.x; Cheng JH, 1999, CARDIOVASC RES, V43, P135, DOI 10.1016/S0008-6363(99)00061-9; Cherry EM, 2007, AM J PHYSIOL-HEART C, V292, pH43, DOI 10.1152/ajpheart.00955.2006; Cherry EM, 2017, CHAOS, V27, DOI 10.1063/1.4999354; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; CHIALVO DR, 1990, CIRC RES, V66, P525, DOI 10.1161/01.RES.66.2.525; Choi BR, 2004, J CARDIOVASC ELECTR, V15, P1188, DOI 10.1046/j.1540-8167.2004.04070.x; Crotti L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-18; Dvir H, 2014, BIOPHYS J, V107, P1023, DOI 10.1016/j.bpj.2014.07.004; Dvir H, 2013, BIOPHYS J, V105, P533, DOI 10.1016/j.bpj.2013.06.012; ELHARRAR V, 1983, AM J PHYSIOL, V244, pH782, DOI 10.1152/ajpheart.1983.244.6.H782; Fenton FH, 1999, PHYS REV LETT, V83, P3964, DOI 10.1103/PhysRevLett.83.3964; Fossa AA, 2006, J PHARMACOL EXP THER, V316, P498, DOI 10.1124/jpet.105.095471; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; Franz MR, 2003, J CARDIOVASC ELECTR, V14, pS140, DOI 10.1046/j.1540.8167.90303.x; Garny A, 2008, PHILOS T R SOC A, V366, P3017, DOI 10.1098/rsta.2008.0094; Gelzer ARM, 2008, CIRCULATION, V118, P1123, DOI 10.1161/CIRCULATIONAHA.107.738013; Gilmour RF, 2002, J CARDIOVASC ELECTR, V13, P1150, DOI 10.1046/j.1540-8167.2002.01150.x; Guzman KM, 2010, PACE, V33, P451, DOI 10.1111/j.1540-8159.2009.02637.x; Hall GM, 1999, PHYS REV LETT, V82, P2995, DOI 10.1103/PhysRevLett.82.2995; Ideker RE, 2002, J CARDIOVASC ELECTR, V13, P1173, DOI 10.1046/j.1540-8167.2002.01173.x; Jing LY, 2010, J ELECTROCARDIOL, V43, P425, DOI 10.1016/j.jelectrocard.2010.02.006; Kalb SS, 2004, J CARDIOVASC ELECTR, V15, P698, DOI 10.1046/j.1540-8167.2004.03550.x; Kimotsuki T, 2010, J BIOL PHYS, V36, P299, DOI 10.1007/s10867-009-9185-5; Lemay M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002399; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; McIntyre SD, 2014, J THEOR BIOL, V350, P90, DOI 10.1016/j.jtbi.2014.02.015; NOLASCO JB, 1968, J APPL PHYSIOL, V25, P191, DOI 10.1152/jappl.1968.25.2.191; O'Hara T, 2012, AM J PHYSIOL-HEART C, V302, pH1023, DOI 10.1152/ajpheart.00785.2011; OPTHOF T, 1987, J MOL CELL CARDIOL, V19, P923, DOI 10.1016/S0022-2828(87)80621-1; Otani NF, 1997, J THEOR BIOL, V187, P409, DOI 10.1006/jtbi.1997.0447; Papaioannou VE, 2013, CURR CARDIOL REV, V9, P82, DOI 10.2174/1573403X11309010010; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Roden DM, 2006, J INTERN MED, V259, P59, DOI 10.1111/j.1365-2796.2005.01589.x; Shattock MJ, 2017, CARDIOVASC RES, V113, P817, DOI 10.1093/cvr/cvx063; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Tolkacheva EG, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031904; Tolkacheva EG, 2007, J BIOL PHYS, V33, P35, DOI 10.1007/s10867-007-9040-5; Watanabe MA, 2002, AM J PHYSIOL-HEART C, V282, pH1534, DOI 10.1152/ajpheart.00351.2001; Watanabe MA, 2001, J CARDIOVASC ELECTR, V12, P196, DOI 10.1046/j.1540-8167.2001.00196.x; Weiss JN, 2000, CIRC RES, V87, P1103, DOI 10.1161/01.RES.87.12.1103; Wu R, 2004, CIRC RES, V94, P634, DOI 10.1161/01.RES.0000119322.87051.A9; Xie YF, 2009, AM J PHYSIOL-HEART C, V297, pH775, DOI 10.1152/ajpheart.00341.2009; Yehia AR, 1999, CHAOS, V9, P916, DOI 10.1063/1.166465; Zaniboni M., 2017, EP EUROPACE, V19, P141; Zaniboni M, 2007, EXP PHYSIOL, V92, P859, DOI 10.1113/expphysiol.2007.037986; Zaniboni M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100242; Zlochiver S, 2017, CHAOS, V27, DOI 10.1063/1.4999355	56	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193416	10.1371/journal.pone.0193416	http://dx.doi.org/10.1371/journal.pone.0193416			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494628	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200045
J	Colombo, C; Podlipnik, C; Lo Presti, L; Niikura, M; Bennet, AJ; Bernardi, A				Colombo, Cinzia; Podlipnik, Crtomir; Lo Presti, Leonardo; Niikura, Masahiro; Bennet, Andrew J.; Bernardi, Anna			Design and synthesis of constrained bicyclic molecules as candidate inhibitors of influenza A neuraminidase	PLOS ONE			English	Article							RECEPTOR AGONISTS; CYCLIC ENONES; DRUG DESIGN; IN-VITRO; OSELTAMIVIR; VIRUS; POTENT; ACID; RESISTANCE; ZANAMIVIR	The rise of drug-resistant influenza A virus strains motivates the development of new antiviral drugs, with different structural motifs and substitution. Recently, we explored the use of a bicyclic (bicyclo[3.1.0] hexane) analogue of sialic acid that was designed to mimic the conformation adopted during enzymatic cleavage within the neuraminidase (NA; sialidase) active site. Given that our first series of compounds were at least four orders of magnitude less active than available drugs, we hypothesized that the new carbon skeleton did not elicit the same interactions as the cyclohexene frameworks used previously. Herein, we tried to address this critical point with the aid of molecular modeling and we proposed new structures with different functionalization, such as the introduction of free ammonium and guanidinium groups and ether side chains other than the 3-pentyl side chain, the characteristic side chain in Oseltamivir. A highly simplified synthetic route was developed, starting from the cyclopropanation of cyclopentenone and followed by an aziridination and further functionalization of the five-member ring. This allowed the efficient preparation of a small library of new bicyclic ligands that were characterized by enzyme inhibition assays against influenza A neuraminidases N1, its H274Y mutant, and N2. The results show that none of the new structural variants synthesized, including those containing guanidinium groups rather than free ammonium ions, displayed activity against influenza A neuraminidases at concentrations less than 2 mM. We conclude that the choice and positioning of functional groups on the bicyclo[3.1.0] hexyl system still need to be properly tuned for producing complementary interactions within the catalytic site.	[Colombo, Cinzia; Lo Presti, Leonardo; Bernardi, Anna] Univ Milan, Dipartimento Chim, Milan, Italy; [Colombo, Cinzia; Bennet, Andrew J.] Simon Fraser Univ, Dept Chem, Burnaby, BC, Canada; [Podlipnik, Crtomir] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Niikura, Masahiro] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada	University of Milan; Simon Fraser University; University of Ljubljana; Simon Fraser University	Colombo, C (corresponding author), Univ Milan, Dipartimento Chim, Milan, Italy.; Colombo, C (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC, Canada.	cinzia.colombo@unimi.it	Bernardi, Anna/A-1167-2012; Lo Presti, Leonardo/K-4281-2012; Podlipnik, Crtomir/R-6467-2019; Colombo, Cinzia/I-9376-2016	Bernardi, Anna/0000-0002-1258-2007; Lo Presti, Leonardo/0000-0001-6361-477X; Podlipnik, Crtomir/0000-0002-8429-0273	People Programme of the European Union's Seventh Framework Programme by a Marie Curie Outgoing Fellowship under REA grant [PIOF-GA-2012-327579]; Slovenian Research Agency [P1-0201]	People Programme of the European Union's Seventh Framework Programme by a Marie Curie Outgoing Fellowship under REA grant; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The research leading to these results received funding from the People Programme of the European Union's Seventh Framework Programme by a Marie Curie Outgoing Fellowship to Dr. Cinzia Colombo under REA grant agreement PIOF-GA-2012-327579. Dr. Crtomir Podlipnik acknowledges for support of Slovenian Research Agency via research program P1-0201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, OECHEM TK 2 1 1; [Anonymous], 2016, SCHROD REL 2016 2 SC; [Anonymous], 2014, XPREP; [Anonymous], 2012, **NON-TRADITIONAL**; Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; BOCHE G, 1994, ANGEW CHEM INT EDIT, V33, P115, DOI 10.1002/anie.199401151; Bruker AXS Inc, 2014, SADABS; Chan J, 2012, J AM CHEM SOC, V134, P3748, DOI 10.1021/ja208564y; Chan J, 2011, J AM CHEM SOC, V133, P2989, DOI 10.1021/ja109199p; Chan J, 2010, NAT CHEM BIOL, V6, P405, DOI 10.1038/nchembio.352; Colombo C, 2017, ADV PHYS ORG CHEM, V51, P99, DOI 10.1016/bs.apoc.2017.09.001; De Vincentiis F, 2010, CHEM-ASIAN J, V5, P1652, DOI 10.1002/asia.201000040; Dominguez C, 1997, TETRAHEDRON-ASYMMETR, V8, P511, DOI 10.1016/S0957-4166(97)00001-3; Farren-Dai M, 2017, J ORGANIC CHEM; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gonzalez R, 2005, BIOORGAN MED CHEM, V13, P6556, DOI 10.1016/j.bmc.2005.07.036; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Menjo Y, 2011, ORG LETT, V13, P5744, DOI 10.1021/ol2023054; Miriyala B, 2004, TETRAHEDRON, V60, P1463, DOI 10.1016/j.tet.2003.12.024; Mohan S, 2010, J MED CHEM, V53, P7377, DOI 10.1021/jm100822f; Mooney CA, 2014, J MED CHEM, V57, P3154, DOI 10.1021/jm401977j; Nakazato A, 2000, J MED CHEM, V43, P4893, DOI 10.1021/jm000346k; Niikura M, 2011, ANTIVIR RES, V90, P160, DOI 10.1016/j.antiviral.2011.03.180; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Raab M, 2011, J MOL MODEL, V17, P1445, DOI 10.1007/s00894-010-0852-z; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Wu Y, 2016, J VIROL, V90, P10693, DOI 10.1128/JVI.01703-16; Yang J, 2016, REV MED VIROL, V26, P242, DOI 10.1002/rmv.1879; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06; Yeung YY, 2006, J AM CHEM SOC, V128, P6310, DOI 10.1021/ja0616433; Yong YF, 1997, J ORG CHEM, V62, P1540, DOI 10.1021/jo962196k; Zanin M, 2016, CELL HOST MICROBE, V19, P159, DOI 10.1016/j.chom.2016.01.001	42	6	6	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193623	10.1371/journal.pone.0193623	http://dx.doi.org/10.1371/journal.pone.0193623			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489903	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000097
J	Eshoo, PF; Johnson, A; Duangdala, S; Hansel, T				Eshoo, Paul Frederick; Johnson, Arlyne; Duangdala, Sivilay; Hansel, Troy			Design, monitoring and evaluation of a direct payments approach for an ecotourism strategy to reduce illegal hunting and trade of wildlife in Lao PDR	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; COMMUNITY; POPULATIONS; BENEFITS	Ecotourism as a strategy for achieving biodiversity conservation often results in limited conservation impact relative to its investment and revenue return. In cases where an ecotourism strategy has been used, projects are frequently criticized for not providing sufficient evidence on how the strategy has reduced threats or improved the status of the biodiversity it purports to protect. In Lao PDR, revenue from ecotourism has not been directly linked to or dependent on improvements in biodiversity and there is no evidence that ecotourism enterprises have contributed to conservation. In other developing countries, direct payments through explicit contracts in return for ecosystem services have been proposed as a more cost-effective means for achieving conservation, although further research is needed to evaluate the impact of this approach. To address this need, a new model was tested in the Nam Et-Phou Louey National Protected Area (NPA) in Lao PDR using a direct payments approach to create ecotourism incentives for villagers to increase wildlife populations. Over a four-year period, we monitored along a theory of change to evaluate assumptions about the linkages between intermediate results and biological outcomes. Preliminary results show a negative correlation between ecotourism benefits and hunting infractions in target villages; no increase in hunting sign in the ecotourism sector of the NPA relative to a threefold increase in hunting sign across the NPA's non-tourism sectors; and an overall increase in wildlife sightings. This case provides key lessons on the design of a direct payments approach for an ecotourism strategy, including how to combine threat monitoring and data on wildlife sightings to evaluate strategy effectiveness, on setting rates for wildlife sightings and village fees, and the utility of the approach for protecting very rare species.	[Eshoo, Paul Frederick; Johnson, Arlyne; Duangdala, Sivilay; Hansel, Troy] Wildlife Conservat Soc Lao PDR, Vientiane Lao Pdr, Laos; [Johnson, Arlyne] Fdn Success, Bethesda, MD USA		Eshoo, PF (corresponding author), Wildlife Conservat Soc Lao PDR, Vientiane Lao Pdr, Laos.	pauleshoo@gmail.com	Johnson, Arlyne/AAJ-5005-2021		US Fish and Wildlife Service, Rhino and Tiger Fund [9-G031 (RT-0883)]	US Fish and Wildlife Service, Rhino and Tiger Fund	Funded by US Fish and Wildlife Service, Rhino and Tiger Fund, Grant Agreement No. 9-G031 (RT-0883). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2006, POVERTY DEV BIODIVER, P647; [Anonymous], 2012, S A P I E N S; Baral AN, 2013, THESIS; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Bhula R., 2009, BUSINESS PLAN ECOTOU; Biggs D, 2017, CONSERV BIOL, V31, P5, DOI 10.1111/cobi.12796; Brown Jeff, 2009, Gibbon Journal, V5, P28; Clements T, 2010, ECOL ECON, V69, P1283, DOI 10.1016/j.ecolecon.2009.11.010; Ducourtieux O, 2005, DEV CHANGE, V36, P499, DOI 10.1111/j.0012-155X.2005.00421.x; Epprecht M, 2008, GEOGRAPHICA BERNEN G; Ferraro PJ, 2002, LAND ECON, V78, P339, DOI 10.2307/3146894; Ferraro PJ, 2002, SCIENCE, V298, P1718, DOI 10.1126/science.1078104; Gray TNE, 2017, SCIENCE, V355, P255, DOI 10.1126/science.aal4463; Harrison D., 2007, CURRENT ISSUES TOURI, V10, P194, DOI DOI 10.2167/CIT310.0; Higginbottom K., 2004, WILDLIFE TOURISM IMP; Higginbottom K, 2001, POSITIVE EFFECTS WIL; Johannesen AB, 2005, RESOUR ENERGY ECON, V27, P208, DOI 10.1016/j.reseneeco.2004.10.001; Johnson A, 2006, ANIM CONSERV, V9, P421, DOI 10.1111/j.1469-1795.2006.00049.x; Johnson A., 2012, EVIDENCE BASED CONSE, P73; Johnson A, 2016, BIOL CONSERV, V202, P99, DOI 10.1016/j.biocon.2016.08.018; Keane A, 2011, J APPL ECOL, V48, P1164, DOI 10.1111/j.1365-2664.2011.02034.x; Kill A, 2015, THESIS; Kiss A, 2004, TRENDS ECOL EVOL, V19, P232, DOI 10.1016/j.tree.2004.03.010; Larsen M., 2010, EC ASSESSMENT FUTURE; Lim JE, 2017, THESIS; Lynam AJ, 2006, WILDLIFE PROTECTION; Margoluis R, 2013, ECOL SOC, V18, DOI 10.5751/ES-05610-180322; Milne S, 2009, ORYX, V43, P530, DOI 10.1017/S0030605309990330; Ministry of Economics and Finance and Ministry of Environment Cambodia, 2003, CAMB NAT REP PROT AR, P53; Molina Murillo S. A., 2014, INT J DEV SUSTAINABI, V6, P1287; Moorman RS, 2006, ENVIRON CONSERV, V33, P89, DOI 10.1017/S0376892906002955; Nicholls H, 2004, PLOS BIOL, V2, P1256, DOI 10.1371/journal.pbio.0020310; Niesten E, 2004, INT FOREST REV, V6, P56, DOI 10.1505/ifor.6.1.56.32065; Nooren H., 2001, WILDLIFE TRADE LAOS; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Parsler J., 1997, Tourism and sustainability: principles to practice., P347; Roe D, 2014, ENVIRON EVID, V3, DOI 10.1186/2047-2382-3-6; Salafsky N, 2001, CONSERV BIOL, V15, P1585, DOI 10.1046/j.1523-1739.2001.00220.x; Saypanya S., 2013, CONSERV EVID, V10, P29; Stem CJ, 2003, SOC NATUR RESOUR, V16, P387, DOI 10.1080/08941920309177; Stokes EJ, 2010, INTEGR ZOOL, V5, P363, DOI 10.1111/j.1749-4877.2010.00223.x; Stronza A., 2007, J ECOTOURISM, V6, P210, DOI [DOI 10.2167/JOE177.0, 10.2167/joe177.0]; Swart JAA, 2003, SCIENCE, V299, P1981; Wells M. P., 2004, GETTING BIODIVERSITY, P397	44	18	18	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0186133	10.1371/journal.pone.0186133	http://dx.doi.org/10.1371/journal.pone.0186133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489821	gold, Green Submitted, Green Published			2022-12-27	WOS:000426276000002
J	Gianino, MM; Lenzi, J; Bonaudo, M; Fantini, MP; Siliquini, R; Ricciardi, W; Damiani, G				Gianino, Maria Michela; Lenzi, Jacopo; Bonaudo, Marco; Fantini, Maria Pia; Siliquini, Roberta; Ricciardi, Walter; Damiani, Gianfranco			The switch between cataract surgical settings: Evidence from a time series analysis across 20 EU countries	PLOS ONE			English	Article							SURGERY; CARE; OUTPATIENT; OUTCOMES; EUROPE	Objectives To analyze trajectories of cataract surgery rates and to confirm the switch between inpatient cases and day surgery or outpatient cases. Design Pooled, cross-sectional, time series analysis. Methods Data on 20 European countries from 2004 to 2014 retrieved from the OECD. Results The number of cataract surgery cases per 100,000 population has increased since 2004 (b = 31.1, p < 0.001, 95% CI = 26.7, 35.6). A reversal of the inpatient cases and same-day cases was found: the first ones decreased (b = -14.7, p < 0.001, 95% CI = -17.7, -11.8) while day surgery and outpatient cases increased (b = 37.5, p < 0.001, 95% CI = 31.6, 43.4, and b = 8.3, p = 0.001, 95% CI = 3.6, 13.1, respectively). Since 2004, the ratio of day surgery and outpatient cases to inpatient cases has grown significantly (b = 3.3, p < 0.001, 95% CI = 2.5, 4.0), reaching a share of 31.7 in 2014. However, this slope of 3.3 was not constant and slowed over the years: from 4.5 per year during the first five years to 1.9 in the second five. No association was found between cataract surgery rate and two regressors: elderly people, and health care expenditure per capita. Conclusion EU countries have preserved cataract surgery, and this preservation is probably affected by the switch from inpatient to same-day surgery, thanks to the decrease in the cost and equivalent clinical outcomes. However, the slope of the switch slowed over time. Consequently, health care systems must support this process of change especially through reforms in financial and organizational fields.	[Gianino, Maria Michela; Bonaudo, Marco; Siliquini, Roberta] Univ Torino, Dept Publ Hlth Sci & Pediat, Turin, Italy; [Lenzi, Jacopo; Fantini, Maria Pia] Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Ricciardi, Walter; Damiani, Gianfranco] Univ Cattolica Sacro Cuore, Dept Publ Hlth, Rome, Italy	University of Turin; University of Bologna; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Gianino, MM (corresponding author), Univ Torino, Dept Publ Hlth Sci & Pediat, Turin, Italy.	mariola.gianino@unito.it	Lenzi, Jacopo/W-4835-2017; Ricciardi, Walter/K-3342-2018; Damiani, Gianfranco/K-2782-2016; Ricciardi, Walter/AAB-2056-2019	Lenzi, Jacopo/0000-0003-2882-4223; Damiani, Gianfranco/0000-0003-3028-6188; Ricciardi, Walter/0000-0002-5655-688X; Bonaudo, Marco/0000-0001-9278-8998; Gianino, Maria Michela/0000-0003-4239-7475				Allen D, 2006, BMJ-BRIT MED J, V333, P128, DOI 10.1136/bmj.333.7559.128; [Anonymous], 2015, HLTH GLANC 2015; Arnold M, 2000, DEUTSCHLAND NIEDERLA, P203; Castells X, 2001, J CLIN EPIDEMIOL, V54, P23, DOI 10.1016/S0895-4356(00)00271-7; Castoro C, 2007, DAY SURG MAKING IT H; Chang DF, 2005, BRIT J OPHTHALMOL, V89, P1073, DOI 10.1136/bjo.2005.068213; Cillino S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-16; Fattore G, 2008, HEALTH ECON, V17, pS71, DOI 10.1002/hec.1324; Fedorowicz Z, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004242.pub3; Fedorowicz Z, 2006, SAUDI MED J, V27, P1296; Gavurova B, 2016, SYSTEM DAY SURG SLOV; Greene W. H., 1993, ECONOMETRIC ANAL; Heijl A, 2007, OPHTHALMOLOGY, V114, P201, DOI 10.1016/j.ophtha.2006.08.033; Henry JA, 2015, WORLD J SURG, V39, P822, DOI 10.1007/s00268-014-2937-9; Hsiao C., 2003, ANAL PANEL DATA, Vsecond; Keenan T, 2007, BRIT J OPHTHALMOL, V91, P901, DOI 10.1136/bjo.2006.108977; Kocur I, 2002, BRIT J OPHTHALMOL, V86, P847, DOI 10.1136/bjo.86.8.847; Kroneman MW, 2001, AMBUL SURG, V9, P147; Lundstrom M, 2012, J CATARACT REFR SURG, V38, P1086, DOI 10.1016/j.jcrs.2012.03.006; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Mock CN, 2015, LANCET, V385, P2209, DOI 10.1016/S0140-6736(15)60091-5; Mojon-Azzi SM, 2007, GRAEF ARCH CLIN EXP, V245, P1041, DOI 10.1007/s00417-007-0550-4; Ramke J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172342; Reinhard B, 2011, DIAGNOSIS RELATED GR; SAYRS L., 1989, POOLED TIME SERIES A; SORGATZ H, 1994, ZBL CHIR, V119, P455; Weingessel B, 2008, WIEN KLIN WOCHENSCHR, V120, P756, DOI 10.1007/s00508-008-1113-3	27	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192620	10.1371/journal.pone.0192620	http://dx.doi.org/10.1371/journal.pone.0192620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489834	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000036
J	Rostami, P; Ashcroft, DM; Tully, MP				Rostami, Paryaneh; Ashcroft, Darren M.; Tully, Mary P.			A formative evaluation of the implementation of a medication safety data collection tool in English healthcare settings: A qualitative interview study using normalisation process theory	PLOS ONE			English	Article							ERRORS; DESIGN	Background Reducing medication-related harm is a global priority; however, impetus for improvement is impeded as routine medication safety data are seldom available. Therefore, the Medication Safety Thermometer was developed within England's National Health Service. This study aimed to explore the implementation of the tool into routine practice from users' perspectives. Method Fifteen semi-structured interviews were conducted with purposely sampled National Health Service staff from primary and secondary care settings. Interview data were analysed using an initial thematic analysis, and subsequent analysis using Normalisation Process Theory. Results Secondary care staff understood that the Medication Safety Thermometer's purpose was to measure medication safety and improvement. However, other uses were reported, such as pinpointing poor practice. Confusion about its purpose existed in primary care, despite further training, suggesting unsuitability of the tool. Decreased engagement was displayed by staff less involved with medication use, who displayed less ownership. Nonetheless, these advocates often lacked support from management and frontline levels, leading to an overall lack of engagement. Many participants reported efforts to drive scale-up of the use of the tool, for example, by securing funding, despite uncertainty around how to use data. Successful improvement was often at ward-level and went unrecognised within the wider organisation. There was mixed feedback regarding the value of the tool, often due to a perceived lack of "capacity". However, participants demonstrated interest in learning how to use their data and unexpected applications of data were reported. Conclusion Routine medication safety data collection is complex, but achievable and facilitates improvements. However, collected data must be analysed, understood and used for further work to achieve improvement, which often does not happen. The national roll-out of the tool has accelerated shared learning; however, a number of difficulties still exist, particularly in primary care settings, where a different approach is likely to be required.	[Rostami, Paryaneh; Ashcroft, Darren M.; Tully, Mary P.] Univ Manchester, MAHSC, Sch Hlth Sci, Div Pharm & Optometry, Manchester, Lancs, England; [Ashcroft, Darren M.] Greater Manchester Patient Safety Translat Res Ct, NIHR, Manchester, England; [Tully, Mary P.] Univ Manchester, Sch Hlth Sci, Div Informat Imaging & Data Sci, Manchester Hlth E Res Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester	Rostami, P (corresponding author), Univ Manchester, MAHSC, Sch Hlth Sci, Div Pharm & Optometry, Manchester, Lancs, England.	Paryaneh.Rostami@Manchester.ac.uk	Rostami, Paryaneh/N-3370-2018; Ashcroft, Darren/G-3244-2015	Tully, Mary/0000-0003-2100-3983; Ashcroft, Darren/0000-0002-2958-915X	Haelo; University of Manchester; University of Manchester Library	Haelo; University of Manchester; University of Manchester Library	The authors would like to thank all healthcare staff who participated in this study. The authors would also like to thank Haelo for funding this research and assisting with recruitment. The authors would also like to thank the University of Manchester for providing funds for the open access fees for this publication.; PR is a PhD student funded by the Haelo (www.Haelo.org.uk), an independent improvement and innovation centre hosted by Salford Royal NHS Foundation Trust. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of Haelo. Additionally, the University of Manchester Library provided the funding for the open access fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarov A, 2015, DRUG SAFETY, V38, P671, DOI 10.1007/s40264-015-0304-x; Avery AJ, 2012, LANCET, V379, P1310, DOI 10.1016/S0140-6736(11)61817-5; Baqir W, 2015, INT J PHARM PRACT, V23, P327, DOI 10.1111/ijpp.12172; Barber ND, 2009, QUAL SAF HEALTH CARE, V18, P341, DOI 10.1136/qshc.2009.034231; Baxter R, 2016, BMJ QUAL SAF, V25, P190, DOI 10.1136/bmjqs-2015-004386; Bell BG, 2017, BMJ OPEN, V7; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Bryman A, 2015, SOCIAL RES METHODS; Cousins D, 2015, DRUG SAFETY, V38, P349, DOI 10.1007/s40264-015-0270-3; Cousins DH, 2012, BRIT J CLIN PHARMACO, V74, P597, DOI 10.1111/j.1365-2125.2011.04166.x; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Haelo, NHS SAF THERM HAEL; Hashjin AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086014; Khatri N, 2009, HEALTH CARE MANAGE R, V34, P312, DOI 10.1097/HMR.0b013e3181a3b709; Knebel E, 2003, HLTH PROFESSIONS ED; MacFarlane A, 2012, QUAL HEALTH RES, V22, P607, DOI 10.1177/1049732311431898; May C, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-18; May CR, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0506-3; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; McEvoy R, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-2; Murray E, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-63; NICE, 2015, MED OPT SAF EFF US M; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Ojeleye O, 2014, BRIT J CLIN PHARMACO, V78, P401, DOI 10.1111/bcp.12347; Phippen A, 2017, BMJ QUAL IMPROV REP, V6; Power M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011886; Power M, 2014, INT J QUAL HEALTH C, V26, P287, DOI 10.1093/intqhc/mzu043; Provost LP., 2011, HLTH CARE DATA GUIDE; Rostami P, 2017, INT J QUAL HEALTH C, V29, P301, DOI 10.1093/intqhc/mzw149; Shekelle PG, 2010, AHRQ PUBLICATION; Soo Stephanie, 2009, Healthc Q, V12 Spec No Patient, P123; Stocks SJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5501; Taylor MJ, 2014, BMJ QUAL SAF, V23, P290, DOI 10.1136/bmjqs-2013-001862; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tully Mary P, 2014, Can J Hosp Pharm, V67, P31	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192224	10.1371/journal.pone.0192224	http://dx.doi.org/10.1371/journal.pone.0192224			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489842	gold, Green Submitted, Green Published			2022-12-27	WOS:000426276000021
J	Wakelin, S; Tillard, G; van Ham, R; Ballard, R; Farquharson, E; Gerard, E; Geurts, R; Brown, M; Ridgway, H; O'Callaghan, M				Wakelin, Steven; Tillard, Guylene; van Ham, Robert; Ballard, Ross; Farquharson, Elizabeth; Gerard, Emily; Geurts, Rene; Brown, Matthew; Ridgway, Hayley; O'Callaghan, Maureen			High spatial variation in population size and symbiotic performance of Rhizobium leguminosarum bv. trifolii with white clover in New Zealand pasture soils	PLOS ONE			English	Article							NITROGEN-FIXATION; RAINFALL; LEGUMES; CLIMATE	Biological nitrogen fixation through the legume-rhizobia symbiosis is important for sustainable pastoral production. In New Zealand, the most widespread and valuable symbiosis occurs between white clover (Trifolium repens L.) and Rhizobium leguminosarum bv. trifolii (Rlt). As variation in the population size (determined by most probable number assays; MPN) and effectiveness of N-fixation (symbiotic potential; SP) of Rlt in soils may affect white clover performance, the extent in variation in these properties was examined at three different spatial scales: (1) From 26 sites across New Zealand, (2) at farm-wide scale, and (3) within single fields. Overall, Rlt populations ranged from 95 to >1 x 10(8) per g soil, with variation similar at the three spatial scales assessed. For almost all samples, there was no relationship between rhizobia population size and ability of the population to fix N during legume symbiosis (SP). When compared with the commercial inoculant strain, the SP of soils ranged between 14 to 143% efficacy. The N-fixing ability of rhizobia populations varied more between samples collected from within a single hill country field (0.8 ha) than between 26 samples collected from diverse locations across New Zealand. Correlations between SP and calcium and aluminium content were found in all sites, except within a dairy farm field. Given the general lack of association between SP and MPN, and high spatial variability of SP at single field scale, provision of advice for treating legume seed with rhizobia based on field-average MPN counts needs to be carefully considered.	[Wakelin, Steven; Gerard, Emily; Brown, Matthew; O'Callaghan, Maureen] AgResearch Ltd, Lincoln Sci Ctr, Christchurch, New Zealand; [Tillard, Guylene] Inst Natl Super Sci Agron, Dijon, France; [van Ham, Robert; Geurts, Rene] Wageningen Univ, Lab Mol Biol, Wageningen, Netherlands; [Ballard, Ross; Farquharson, Elizabeth] South Australian Res & Dev Inst, Urrbrae, SA, Australia; [Ridgway, Hayley] Lincoln Univ, Fac Agr & Life Sci, Christchurch, New Zealand; [Wakelin, Steven] Scion Res Ltd, Christchurch, New Zealand; [Ridgway, Hayley] Plant & Food Res, Christchurch, New Zealand	AgResearch - New Zealand; Wageningen University & Research; South Australian Research & Development Institute (SARDI); Lincoln University - New Zealand; New Zealand Institute for Plant & Food Research Ltd	Wakelin, S (corresponding author), AgResearch Ltd, Lincoln Sci Ctr, Christchurch, New Zealand.; Wakelin, S (corresponding author), Scion Res Ltd, Christchurch, New Zealand.	Steve.A.Wakelin@scionresearch.com	Wakelin, Steve/C-3170-2011	Wakelin, Steve/0000-0002-1167-8699	P21 programme 'Legumes in challenging environments'; New Zealand Ministry of Business Innovation and Employment (MBIE); DairyNZ within the "Improving forage legume-rhizobia performance" programme [C10X1308]	P21 programme 'Legumes in challenging environments'; New Zealand Ministry of Business Innovation and Employment (MBIE)(New Zealand Ministry of Business, Innovation and Employment (MBIE)); DairyNZ within the "Improving forage legume-rhizobia performance" programme	Work at Whangara was supported by the P21 programme 'Legumes in challenging environments' (SW), and access to the farm was provided by the Whangara B5 group. The wider aspects of this programme are funded by the New Zealand Ministry of Business Innovation and Employment (MBIE) (SW) and DairyNZ within the "Improving forage legume-rhizobia performance" programme (C10X1308) (SW). None of the authors work for commercial enterprises; we are all either university or government funded staff or students.	Abberton M. T., 2006, Aspects of Applied Biology, P81; Annicchiarico P, 2015, CRIT REV PLANT SCI, V34, P327, DOI 10.1080/07352689.2014.898462; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bell NL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01946; Bragg JG, 2015, NEW PHYTOL, V207, P953, DOI 10.1111/nph.13410; BROCKWELL J, 1963, APPL MICROBIOL, V11, P377, DOI 10.1128/AEM.11.5.377-383.1963; Caradus JR, 1996, GRASSLAND RES PRACTI, V6, P1; CARROLL BJ, 1983, Z PFLANZENPHYSIOL, V110, P77, DOI 10.1016/S0044-328X(83)80218-9; Cichota R, 2008, NEW ZEAL J AGR RES, V51, P317, DOI 10.1080/00288230809510463; Deaker R, 2004, SOIL BIOL BIOCHEM, V36, P1275, DOI 10.1016/j.soilbio.2004.04.009; Delestre C, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0110-1; Drew EA, 2012, CROP PASTURE SCI, V63, P467, DOI 10.1071/CP12032; Drew EA, 2011, CROP PASTURE SCI, V62, P903, DOI 10.1071/CP11047; GAUR YD, 1980, NEW ZEAL J AGR RES, V23, P529; Gemell LG, 2005, AUST J EXP AGR, V45, P161, DOI 10.1071/EA03151; Graham P. H., 2008, V7, P23; Greenwood RM, 1965, P NZ GRASSLAND ASS, V26, P95; Hill RJ Laboratories, SOIL TESTS INT; HOGLUND JH, 1979, NEW ZEAL J EXP AGR, V7, P45, DOI 10.1080/03015521.1979.10426162; HURLEY MA, 1983, J APPL BACTERIOL, V55, P159, DOI 10.1111/j.1365-2672.1983.tb02660.x; Ledgard SF, 1999, J AGR SCI-CAMBRIDGE, V132, P215, DOI 10.1017/S002185969800625X; Lowther W. L., 2011, Proceedings of the New Zealand Grassland Association, V73, P93; Rhys G.J., 1981, NZ J EXP AGR, V9, P327; RONSON CW, 1995, GRASSLAND RES PRACTI, V6, P87; Scott R. S., 1977, Proceedings of the New Zealand Grassland Association, V38, P151; Sessitsch A, 2002, CRIT REV PLANT SCI, V21, P323, DOI 10.1080/0735-260291044278; Tait A, 2005, J APPL METEOROL, V44, P1315, DOI 10.1175/JAM2279.1; Tozer KN, 2013, PR N Z GRASSL ASSOC, V75, P215; Unkovich M., 2008, Measuring plant-associated nitrogen fixation in agricultural systems; van Ham R, 2016, APPL SOIL ECOL, V108, P371, DOI 10.1016/j.apsoil.2016.09.016; Wakelin SA, 2016, AUSTRALAS PLANT PATH, V45, P289, DOI 10.1007/s13313-016-0411-x; Wakelin SA, 2013, NEW ZEAL J AGR RES, V56, P248, DOI 10.1080/00288233.2013.822003; Williams W. M., 1987, White clover., P323; WILSON PW, 1947, BACTERIOL REV, V11, P41, DOI 10.1128/MMBR.11.1.41-73.1947; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999	35	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192607	10.1371/journal.pone.0192607	http://dx.doi.org/10.1371/journal.pone.0192607			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489845	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000035
J	Roux-Sibilon, A; Rutge, F; Aptel, F; Attye, A; Guyader, N; Boucart, M; Chiquet, C; Peyrin, C				Roux-Sibilon, Alexia; Rutge, Floriane; Aptel, Florent; Attye, Arnaud; Guyader, Nathalie; Boucart, Muriel; Chiquet, Christophe; Peyrin, Carole			Scene and human face recognition in the central vision of patients with glaucoma	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; EYE-MOVEMENTS; FIELD; PERCEPTION; ORGANIZATION; PERFORMANCE; CONTRAST; FEATURES; DENSITY; SEARCH	Primary open-angle glaucoma (POAG) firstly mainly affects peripheral vision. Current behavioral studies support the idea that visual defects of patients with POAG extend into parts of the central visual field classified as normal by static automated perimetry analysis. This is particularly true for visual tasks involving processes of a higher level than mere detection. The purpose of this study was to assess visual abilities of POAG patients in central vision. Patients were assigned to two groups following a visual field examination (Humphrey 24-2 SITA-Standard test). Patients with both peripheral and central defects and patients with peripheral but no central defect, as well as age-matched controls, participated in the experiment. All participants had to perform two visual tasks where low-contrast stimuli were presented in the central 6 of the visual field. A categorization task of scene images and human face images assessed high-level visual recognition abilities. In contrast, a detection task using the same stimuli assessed low-level visual function. The difference in performance between detection and categorization revealed the cost of high-level visual processing. Compared to controls, patients with a central visual defect showed a deficit in both detection and categorization of all low-contrast images. This is consistent with the abnormal retinal sensitivity as assessed by perimetry. However, the deficit was greater for categorization than detection. Patients without a central defect showed similar performances to the controls concerning the detection and categorization of faces. However, while the detection of scene images was well-maintained, these patients showed a deficit in their categorization. This suggests that the simple loss of peripheral vision could be detrimental to scene recognition, even when the information is displayed in central vision. This study revealed subtle defects in the central visual field of POAG patients that cannot be predicted by static automated perimetry assessment using Humphrey 24-2 SITA-Standard test.	[Roux-Sibilon, Alexia; Peyrin, Carole] Univ Grenoble Alpes, CNRS, LPNC, Grenoble, France; [Rutge, Floriane; Aptel, Florent; Chiquet, Christophe] Univ Hosp, Dept Ophthalmol, Grenoble, France; [Attye, Arnaud; Guyader, Nathalie] Univ Hosp, Dept Neuroradiol & MRI, Grenoble, France; [Guyader, Nathalie] Univ Grenoble Alpes, CNRS, GIPSA Lab, UMR 5210, Grenoble, France; [Boucart, Muriel] Univ Lille, CNRS, SCALab, UMR 9193, Lille, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille	Roux-Sibilon, A (corresponding author), Univ Grenoble Alpes, CNRS, LPNC, Grenoble, France.	alexia.roux-sibilon1@univ-grenoble-alpes.fr	Roux-Sibilon, Alexia/AAL-5540-2020; Attyé, Arnaud/AAM-7762-2020	Attyé, Arnaud/0000-0002-0233-0367; Aptel, Florent/0000-0003-1537-9992	University Grenoble Alpes PhD grant "AGIR-POLE-CSB"; Fondation de France grant "Berthe Fouassier	University Grenoble Alpes PhD grant "AGIR-POLE-CSB"; Fondation de France grant "Berthe Fouassier	ARS was supported by University Grenoble Alpes PhD grant "AGIR-POLE-CSB", https://www.commuraute-univ-greroble-alpes.frfripresentation/annonces/agir-pole-634391htm4-CE3S. FR was supported by Fondation de France grant "Berthe Fouassier, https://www.fondationdefrance.org.fr/fondation/fondation-berthe-fouassier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Boucart M, 2013, INVESTIG OPHTHALMOL; Boucart Muriel, 2016, J Vis, V16, P10, DOI 10.1167/16.2.10; Brown HDH, 2016, OPHTHAL PHYSL OPT, V36, P240, DOI 10.1111/opo.12293; Burton R, 2014, GRAEF ARCH CLIN EXP, V252, P1621, DOI 10.1007/s00417-014-2752-x; Cabeza R, 2000, PSYCHOL SCI, V11, P429, DOI 10.1111/1467-9280.00283; Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Crabb DP, 2016, EYE, V30, P304, DOI 10.1038/eye.2015.244; Crabb DP, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00312; Crabb DP, 2013, OPHTHALMOLOGY, V120, P1120, DOI 10.1016/j.ophtha.2012.11.043; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Dai H, 2013, HUM BRAIN MAPP, V34, P2455, DOI 10.1002/hbm.22079; Dive S, 2016, J GLAUCOMA, V25, pE889, DOI 10.1097/IJG.0000000000000402; Duncan RO, 2007, PROG RETIN EYE RES, V26, P38, DOI 10.1016/j.preteyeres.2006.10.001; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2005, VIS COGN, V12, P954, DOI 10.1080/13506280444000607; Frezzotti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105931; Gerente VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126362; Glen FC, 2013, VISION RES, V82, P42, DOI 10.1016/j.visres.2013.02.010; Glen FC, 2012, INVEST OPHTH VIS SCI, V53, P3629, DOI 10.1167/iovs.11-8538; Goffaux V, 2007, J EXP PSYCHOL HUMAN, V33, P995, DOI 10.1037/0096-1523.33.4.995; Grill-Spector K, 2001, VISION RES; Gupta N, 2007, SURV OPHTHALMOL, V52, pS122, DOI 10.1016/j.survophthal.2007.08.006; Guyader N, 2017, VISION RES, V133, P100, DOI 10.1016/j.visres.2016.12.019; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hawkins AS, 2003, J GLAUCOMA, V12, P134, DOI 10.1097/00061198-200304000-00008; Hood DC, 2013, PROG RETIN EYE RES; Jebara Najate, 2009, Adv Cogn Psychol, V5, P42, DOI 10.2478/v10053-008-0065-5; Kauffmann L, 2015, NEUROIMAGE; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P203, DOI 10.1167/iovs.08-2496; Larson AM, 2009, CONTRIBUTIONS CENTRA; Lenoble Q, VISUAL OBJECT CATEGO; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Marechal M, 2014, ACTA OPHTHALMOL, V92, DOI 10.1111/j.1755-3768.2014.T039.x; McKendrick AM, 2005, INVESTIG OPHTHALMOL; McKone E, 2009, PSYCHON B REV, V16, P778, DOI 10.3758/PBR.16.5.778; Nelson P, 1999, BRIT J OPHTHALMOL, V83, P546, DOI 10.1136/bjo.83.5.546; Qing GP, 2010, INVEST OPHTH VIS SCI, V51, P4627, DOI 10.1167/iovs.09-4834; Ramanoel S, 2015, PLOS ONE, V10; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Smith ND, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-45; Smith ND, 2011, OPHTHAL PHYSL OPT, V31, P225, DOI 10.1111/j.1475-1313.2011.00836.x; Tanaka JW, 2014, ATTEN PERCEPT PSYCHO, V76, P1000, DOI 10.3758/s13414-014-0628-0; Weber AJ, 2000, INVEST OPHTH VIS SCI, V41, P1370; Yucel YH, 2001, INVEST OPHTH VIS SCI, V42, P3216	50	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0193465	10.1371/journal.pone.0193465	http://dx.doi.org/10.1371/journal.pone.0193465			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX6NQ	29481572	Green Published, Green Submitted, gold			2022-12-27	WOS:000426202700012
J	Abdul-Cader, MS; Amarasinghe, A; Palomino-Tapia, V; Ahmed-Hassan, H; Bakhtawar, K; Nagy, E; Sharif, S; Gomis, S; Abdul-Careem, MF				Abdul-Cader, Mohamed Sarjoon; Amarasinghe, Aruna; Palomino-Tapia, Victor; Ahmed-Hassan, Hanaa; Bakhtawar, Khawaja; Nagy, Eva; Sharif, Shayan; Gomis, Susantha; Abdul-Careem, Mohamed Faizal			In ovo CpG DNA delivery increases innate and adaptive immune cells in respiratory, gastrointestinal and immune systems post-hatch correlating with lower infectious laryngotracheitis virus infection	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; BURSAL DISEASE VIRUS; RECEPTOR 2 LIGAND; LIPOTEICHOIC ACID; BACTERIAL-DNA; B-CELLS; CHICKENS; OLIGODEOXYNUCLEOTIDES; MOTIFS; ACTIVATION	Cytosine-guanosine deoxynucleotides (CpG) DNA can be delivered in ovo at embryo day (ED) 18 for the stimulation of toll-like receptor (TLR) 21 signaling pathway that ultimately protects chickens against a number of bacterial and viral infections. There is a dearth of information understanding the mechanisms of protection induced by in ovo delivered CpG DNA. The objective of this study was to determine the immune cell changes post-hatch following in ovo delivery of the TLR21 ligand, CpG DNA. In order to quantify changes of percentage of KUL01+, IgM+ B, cluster of differentiation (CD) 4+ and CD8a+ cells, trachea, lung, duodenum, large intestine, spleen and bursa of Fabricius were collected on day 1 post-hatch. We found increased recruitments of KUL01+ cells, in organs of these body systems post-hatch following in ovo delivery of CpG DNA. Although IgM+ B cells, CD4+ and CD8a+ cells were increased in lungs and immune system organs, these cells were not quantifiable from the trachea, duodenum and large intestine immediately following the hatch. Furthermore, when CpG DNA is delivered in ovo and subsequently infected with infectious laryngotracheitis virus (ILTV) post-hatch on day 1, CpG DNA reduces morbidity and mortality resulting from ILTV infection. This study provides insights into the mechanisms of host responses elicited following in ovo delivery of CpG DNA in avian species.	[Abdul-Cader, Mohamed Sarjoon; Amarasinghe, Aruna; Palomino-Tapia, Victor; Ahmed-Hassan, Hanaa; Bakhtawar, Khawaja; Abdul-Careem, Mohamed Faizal] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Hlth Res Innovat Ctr, Calgary, AB, Canada; [Ahmed-Hassan, Hanaa] Cairo Univ, Fac Vet Med, Zoonoses Dept, Giza, Egypt; [Nagy, Eva; Sharif, Shayan] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Gomis, Susantha] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK, Canada	University of Calgary; Egyptian Knowledge Bank (EKB); Cairo University; University of Guelph; University of Saskatchewan	Abdul-Careem, MF (corresponding author), Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Hlth Res Innovat Ctr, Calgary, AB, Canada.	faizal.abdulcareem@ucalgary.ca	Careem, Faizal/H-8005-2019; Palomino, Víctor/GYI-8959-2022	Careem, Faizal/0000-0002-9974-7600; 	Canadian Poultry Research Council [AMN088]; Alberta Agriculture and Forestry [2016R003R]; Natural Sciences and Engineering Research Council of Canada [CRDPJ/491522-2015]	Canadian Poultry Research Council; Alberta Agriculture and Forestry; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Canadian Poultry Research Council (http://cp-rc.ca), AMN088, received by MFA; the Alberta Agriculture and Forestry (http://www.agric.gov.ab.ca/app21/ministrypage), 2016R003R, received by MFA; and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), CRDPJ/491522-2015, received by MFA.	Abdul-Cader MS, 2017, J GEN VIROL, V98, P1209, DOI 10.1099/jgv.0.000787; Abdul-Cader MS, 2017, VIRAL IMMUNOL, P1; Abdul-Cader MS, 2016, CYTOSINE GUANOSINE D; Abdul-Careem MF, 2015, MAIN CHALLENGES POUL; Ashkar AA, 2003, J VIROL, V77, P8948, DOI 10.1128/JVI.77.16.8948-8956.2003; Bar-Shira E, 2003, DEV COMP IMMUNOL, V27, P147, DOI 10.1016/S0145-305X(02)00076-9; Bhat A, 2010, MOL IMMUNOL, V47, P1337, DOI 10.1016/j.molimm.2009.12.011; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Brisbin JT, 2012, BENEF MICROBES, V3, P205, DOI 10.3920/BM2012.0014; Brownlie R, 2009, MOL IMMUNOL, V46, P3163, DOI 10.1016/j.molimm.2009.06.002; Buchanan BM, 2011, CELL IMMUNOL, V271, P16, DOI 10.1016/j.cellimm.2011.05.016; Bui VN, 2011, J VET MED SCI, V73, P209, DOI 10.1292/jvms.10-0356; Chrzastek K, 2013, POL J VET SCI, V16, P551, DOI 10.2478/pjvs-2013-0076; Dalpke AH, 2004, INT J MED MICROBIOL, V294, P345, DOI 10.1016/j.ijmm.2004.07.005; Davila E, 2002, BLOOD, V100, P2537, DOI 10.1182/blood-2002-02-0401; Dunon D, 1997, J EXP MED, V186, P977, DOI 10.1084/jem.186.7.977; Dunon D, 1998, DEV COMP IMMUNOL, V22, P279, DOI 10.1016/S0145-305X(98)00010-X; FAHEY KJ, 1990, J GEN VIROL, V71, P2401, DOI 10.1099/0022-1317-71-10-2401; Gomis S, 2004, AVIAN DIS, V48, P813, DOI 10.1637/7194-041204R; Haddadi S, 2015, DEV COMP IMMUNOL, V48, P22, DOI 10.1016/j.dci.2014.08.011; Haddadi S, 2013, VET IMMUNOL IMMUNOP, V155, P270, DOI 10.1016/j.vetimm.2013.08.005; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HONDA T, 1994, J VET MED SCI, V56, P1051, DOI 10.1292/jvms.56.1051; Jiang T, 2011, ANTIVIR RES, V89, P124, DOI 10.1016/j.antiviral.2010.11.013; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg Arthur M, 2004, Curr Oncol Rep, V6, P88, DOI 10.1007/s11912-004-0019-0; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Loncoman CA, 2017, APPL ENV MICROBIOLOG; LOWENTHAL JW, 1994, IMMUNOL CELL BIOL, V72, P115, DOI 10.1038/icb.1994.18; Macfarlane DE, 1997, IMMUNOLOGY, V91, P586, DOI 10.1046/j.1365-2567.1997.00301.x; MacKinnon KM, 2009, VET IMMUNOL IMMUNOP, V127, P371, DOI 10.1016/j.vetimm.2008.10.001; Mahmood MS, 2006, VACCINE, V24, P4838, DOI 10.1016/j.vaccine.2006.03.016; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Park Mi-Hee, 2012, Immune Netw, V12, P27, DOI 10.4110/in.2012.12.1.27; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pontarollo RA, 2002, VET IMMUNOL IMMUNOP, V84, P43, DOI 10.1016/S0165-2427(01)00379-8; Qureshi MA, 2000, DEV COMP IMMUNOL, V24, P103, DOI 10.1016/S0145-305X(99)00067-1; St Paul Michael, 2012, BMC Res Notes, V5, P616, DOI 10.1186/1756-0500-5-616; St Paul M, 2012, VET IMMUNOL IMMUNOP, V149, P237, DOI 10.1016/j.vetimm.2012.07.008; Taghavi A, 2008, AVIAN DIS, V52, P398, DOI 10.1637/8196-121907-Reg; Taghavi Azita, 2009, Current Drug Delivery, V6, P76; Thapa S, 2015, VET IMMUNOL IMMUNOP, V164, P170, DOI 10.1016/j.vetimm.2015.02.006; Thapa S, 2015, VIRUSES-BASEL, V7, P1832, DOI 10.3390/v7041832; Villanueva AI, 2011, DEV COMP IMMUNOL, V35, P28, DOI 10.1016/j.dci.2010.08.001; Wang C, 1999, AVIAN DIS, V43, P590, DOI 10.2307/1592661; Wang XQ, 2003, AVIAN DIS, V47, P1305, DOI 10.1637/6045; Wattrang E, 2009, VET IMMUNOL IMMUNOP, V131, P218, DOI 10.1016/j.vetimm.2009.04.013; WHO, 2007, REC LAB PROC DET AV, P7; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Xie H, 2003, DEV COMP IMMUNOL, V27, P823, DOI 10.1016/S0145-305X(03)00079-X; Yi AK, 1998, J IMMUNOL, V160, P5898	51	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193964	10.1371/journal.pone.0193964	http://dx.doi.org/10.1371/journal.pone.0193964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513732	gold, Green Published, Green Submitted			2022-12-27	WOS:000426896800093
J	Gillet, C; Darling, KEA; Senn, N; Cavassini, M; Hugli, O				Gillet, Cleo; Darling, Katharine E. A.; Senn, Nicolas; Cavassini, Matthias; Hugli, Olivier			Targeted versus non-targeted HIV testing offered via electronic questionnaire in a Swiss emergency department: A randomized controlled study	PLOS ONE			English	Article							CARE; INFECTION; UNIVERSAL; RISK	Background In Switzerland, the national HIV testing recommendations propose targeted testing. Although the emergency department (ED) is mentioned specifically as a site where HIV testing should take place, the testing rate in our ED is 1% of patients seen. The aim of this study was to use electronic tablets to offer testing to ED patients and to examine whether non-targeted screening increased testing rates compared to targeted testing. Methods This randomised, cross-over design study took place at Lausanne University Hospital, Switzerland, between August and November 2015. Eligible patients were randomised to a targeted testing or a non-targeted screening arm. Using electronic tablets, targeted arm patients completed a risk factor assessment; patients with risk factors were offered free rapid HIV testing. Non-targeted arm patients received information about HIV and HIV testing on their tablet and were then offered testing. In a second step, patients who declined testing were crossed over to the other strategy. The primary endpoint was the HIV testing rate per arm. Results Eighty patients were recruited to each study arm. In the targeted arm, 17 patients (of 80, 21%) had at least one risk factor and were offered testing, of whom eight (of 17, 47%) accepted. HIV testing rate in the targeted arm was 10% (8/80) compared to 48% (38/80) in the non-targeted arm (P<0.001). Secondary cross-screening, where targeted arm patients without risk factors were offered non-targeted screening, increased the testing rate in the targeted arm to 45% (36/80). Among patients offered testing, the acceptance rate did not differ between targeted and non-targeted arms, at 48% and 53%, respectively (P = 0.9) Discussion In our centre, non-targeted HIV screening resulted in a higher testing rate than targeted testing due to more patients being offered a test. The acceptance rate of testing offered did not differ between targeted and non-targeted arms. Electronic tablets were well-received by patients and easy to use. We conclude that non-targeted HIV screening using electronic tablets would increase the HIV testing rate in our ED.	[Gillet, Cleo] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Darling, Katharine E. A.; Cavassini, Matthias] Lausanne Univ Hosp, Infect Dis Serv, Lausanne, Switzerland; [Senn, Nicolas] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Hugli, Olivier] Lausanne Univ Hosp, Emergency Dept, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Darling, KEA (corresponding author), Lausanne Univ Hosp, Infect Dis Serv, Lausanne, Switzerland.	Katharine.Darling@chuv.ch	Hugli, Olivier/AAA-7057-2020; cavassini, matthias/F-8987-2017	Darling, Katharine/0000-0003-1449-3873; Hugli, Olivier/0000-0003-2312-1625; cavassini, matthias/0000-0003-0933-7833	Infectious Diseases Service at Lausanne University Hospital	Infectious Diseases Service at Lausanne University Hospital	This study was funded by the Infectious Diseases Service at Lausanne University Hospital using existing funds.	Adebajo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081981; Branson BM, 2006, RECOMMENDATIONS REPO, V55, P1; Burns F, 2013, HIV MED, V14, P10, DOI 10.1111/hiv.12056; Chesney MA, 1999, AM BEHAV SCI, V42, P1162, DOI 10.1177/00027649921954822; Choo EK, 2012, ACAD EMERG MED, V19, P318, DOI 10.1111/j.1553-2712.2012.01299.x; Darling KEA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072812; Darling KEA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039299; Darling KE, 2012, POSTGRAD MED J; Epstein RM, 1998, ANN INTERN MED, V128, P435, DOI 10.7326/0003-4819-128-6-199803150-00003; Favre-Bulle T, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14206; Gerrard M, 1996, PSYCHOL BULL, V119, P390, DOI 10.1037/0033-2909.119.3.390; Haukoos JS, 2008, ANN EMERG MED, V51, P303, DOI 10.1016/j.annemergmed.2007.10.028; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Haute Autorite de Sante, 2009, HIV INF SCREEN FRANC; Jones J, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-708; Kohler P, 2015, AIDS, V29, P2509, DOI 10.1097/QAD.0000000000000878; Kreuter MW, 1999, ANN BEHAV MED, V21, P276, DOI 10.1007/BF02895958; Lyons MS, 2013, JAIDS-J ACQ IMM DEF, V64, P315, DOI 10.1097/QAI.0b013e3182a21611; Merchant RC, 2009, ACAD EMERG MED, V16, P1143, DOI 10.1111/j.1553-2712.2009.00537.x; Montoy JCC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6895; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Office fe A de A ral de la sante A publique, DEP VIH EFF IN MED P; Office fe A de A ral de la sante A publique, 2013, B OFSP, V47, P847; Office fe A de A ral de la sante A publique, 2010, B OFSP, V11, P364; Office federal de la sante publique, 2007, B OFSP, P371; Pisculli ML, 2011, AIDS BEHAV, V15, P734, DOI 10.1007/s10461-010-9837-2; Portnoy DB, 2008, PREV MED, V47, P3, DOI 10.1016/j.ypmed.2008.02.014; Pradeep TG, 2012, CORNEA, V31, P1282, DOI 10.1097/ICO.0b013e3182479aed; Prosperini L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168376; Takahashi TA, 2005, J GEN INTERN MED, V20, P618, DOI 10.1111/j.1525-1497.2005.0112.x; Vilpert S., 2013, 32013 OBS SUISS SANT	31	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0190767	10.1371/journal.pone.0190767	http://dx.doi.org/10.1371/journal.pone.0190767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513659	Green Submitted, gold, Green Published			2022-12-27	WOS:000426896800003
J	Viana, JPG; Siqueira, MVBM; Araujo, FL; Grando, C; Sujii, PS; Silvestre, ED; Novello, M; Pinheiro, JB; Cavallari, MM; Brancalion, PHS; Rodrigues, RR; de Souza, AP; Catchen, J; Zucchi, MI				Gomes Viana, Joao Paulo; Bohrer Monteiro Siqueira, Marcos Vinicius; Araujo, Fabiano Lucas; Grando, Carolina; Sujii, Patricia Sanae; Silvestre, Ellida de Aguiar; Novello, Mariana; Pinheiro, Jose Baldin; Cavallari, Marcelo Mattos; Brancalion, Pedro H. S.; Rodrigues, Ricardo Ribeiro; de Souza, Anete Pereira; Catchen, Julian; Zucchi, Maria I.			Genomic diversity is similar between Atlantic Forest restorations and natural remnants for the native tree Casearia sylvestris Sw.	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; POPULATION-GENETICS; R-PACKAGE; CONSERVATION; DISPERSAL; FABACEAE; POLLEN; POWER; BASE	The primary focus of tropical forest restoration has been the recovery of forest structure and tree taxonomic diversity, with limited attention given to genetic conservation. Populations reintroduced through restoration plantings may have low genetic diversity and be genetically structured due to founder effects and genetic drift, which limit the potential of restoration to recover ecologically resilient plant communities. Here, we studied the genetic diversity, genetic structure and differentiation using single nucleotide polymorphisms (SNP) markers between restored and natural populations of the native tree Casearia sylvestris in the Atlantic Forest of Brazil. We sampled leaves from approximately 24 adult individuals in each of the study sites: two restoration plantations (27 and 62 years old) and two forest remnants. We prepared and sequenced a genotyping-by-sequencing library, SNP markers were identified de novo using Stacks pipeline, and genetic parameters and structure analyses were then estimated for populations. The sequencing step was successful for 80 sampled individuals. Neutral genetic diversity was similar among restored and natural populations (A(R) = 1.72 +/- 0.005; H-O = 0.135 +/- 0.005; H-E = 0.167 +/- 0.005; F-IS = 0.16 +/- 0.022), which were not genetically structured by population subdivision. In spite of this absence of genetic structure by population we found genetic structure within populations but even so there is not spatial genetic structure in any population studied. Less than 1% of the neutral alleles were exclusive to a population. In general, contrary to our expectations, restoration plantations were then effective for conserving tree genetic diversity in human-modified tropical landscapes. Furthermore, we demonstrate that genotyping-by-sequencing can be a useful tool in restoration genetics.	[Gomes Viana, Joao Paulo; Grando, Carolina; Sujii, Patricia Sanae; Silvestre, Ellida de Aguiar; Novello, Mariana] Univ Estadual Campinas, Grad Program Genet & Mol Biol, Campinas, SP, Brazil; [Bohrer Monteiro Siqueira, Marcos Vinicius] Univ Sagrado Coracao, Bauru, SP, Brazil; [Araujo, Fabiano Lucas] Agron Inst Campinas, Grad Program Trop & Subtrop Agr, Campinas, SP, Brazil; [Pinheiro, Jose Baldin] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Piracicaba, SP, Brazil; [Cavallari, Marcelo Mattos] EMBRAPA, Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil; [Brancalion, Pedro H. S.] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Forest Sci, Piracicaba, SP, Brazil; [Rodrigues, Ricardo Ribeiro] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Biol, Piracicaba, SP, Brazil; [de Souza, Anete Pereira] Univ Estadual Campinas, Dept Plant Biol, Campinas, SP, Brazil; [Catchen, Julian] Univ Illinois, Dept Anim Biol, Champaign, IL USA; [Zucchi, Maria I.] Agencia Paulista Tecnol Agronegocios, Piracicaba, SP, Brazil	Universidade Estadual de Campinas; Universidade do Sagrado Coracao; Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Illinois System; University of Illinois Urbana-Champaign	Zucchi, MI (corresponding author), Agencia Paulista Tecnol Agronegocios, Piracicaba, SP, Brazil.	mizucchi@apta.sp.gov.br	Cavallari, Marcelo M/A-5304-2017; siqueira, marcos vinicius bohrer monteiro/ABG-2520-2020; Rodrigues, Ricardo Ribeiro/D-5557-2012; Pinheiro, Jose Baldin B/D-2818-2012; DE SOUZA, ANETE PEREIRA/B-8663-2012; Viana, João Paulo JPGV Gomes/K-1178-2012; Brancalion, Pedro/D-6995-2012; Zucchi, Maria Imaculada/AAC-8157-2019; Grando, Carolina/I-2594-2013; Zucchi, Maria Imaculada/D-2637-2012	siqueira, marcos vinicius bohrer monteiro/0000-0002-6541-0903; Rodrigues, Ricardo Ribeiro/0000-0003-4818-0736; Pinheiro, Jose Baldin B/0000-0003-1294-2081; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Viana, João Paulo JPGV Gomes/0000-0002-9217-9604; Brancalion, Pedro/0000-0001-8245-4062; Zucchi, Maria Imaculada/0000-0002-4863-1843; Grando, Carolina/0000-0002-0944-1633; Zucchi, Maria Imaculada/0000-0002-4863-1843	Sao Paulo Research Foundation (FAPESP) [2011/50296-8, 2013/05762-6, 2016/05765-3]; National Council for Scientific and Technological Development of Brazil (CNPq) [304817/2015-5, 310446/2015-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank the Sao Paulo Research Foundation (FAPESP) for the financial support (#2011/50296-8). PHSB and MIZ thank the National Council for Scientific and Technological Development of Brazil (CNPq) for a productivity grant (#304817/2015-5 and #310446/2015-5). JPGV thanks the Sao Paulo Research Foundation (FAPESP) for the research grants provided (#2013/05762-6 and #2016/05765-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KR, 2016, NAT REV GENET, V17, P81, DOI 10.1038/nrg.2015.28; Andrianoelina O, 2006, BIODIVERS CONSERV, V15, P1109, DOI 10.1007/s10531-004-2178-6; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 2016, INT STANDARDS PRACTI, DOI DOI 10.1111/rec.12261; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Araujo FL, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019105; Arroyo-Rodriguez V, 2017, BIOL REV, V92, P326, DOI 10.1111/brv.12231; Barbosa A.A.A., 1997, THESIS; Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bittencourt JVM, 2007, HEREDITY, V99, P580, DOI 10.1038/sj.hdy.6801019; Brancalion PHS, 2012, RESTOR ECOL, V20, P704, DOI 10.1111/j.1526-100X.2011.00839.x; Burgarella C, 2007, ANN FOREST SCI, V64, P757, DOI 10.1051/forest:2007055; Caballero A, 2013, GENETICS, V195, P1373, DOI 10.1534/genetics.113.158410; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Cavallari MM, 2010, ANN BOT-LONDON, V106, P627, DOI 10.1093/aob/mcq151; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chen H., 2016, VENNDIAGRAM GENERATE; de Rezende CL, 2015, BIODIVERS CONSERV, V24, P2255, DOI 10.1007/s10531-015-0980-y; Dias Marilda Carvalho, 1998, Revista Brasileira de Botanica, V21, P183, DOI 10.1590/S0100-84041998000200011; Dick CW, 2003, MOL ECOL, V12, P753, DOI 10.1046/j.1365-294X.2003.01760.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Etter Paul D, 2012, Methods Mol Biol, V888, P135, DOI 10.1007/978-1-61779-870-2_9; Marmontel CVF, 2013, BIOSCI J, V29, P2042; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Ganzhorn SM, 2015, ENDANGER SPECIES RES, V26, P189, DOI 10.3354/esr00645; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Hamrick James L., 1996, P203; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Holl KD, 2017, SCIENCE, V355, P455, DOI 10.1126/science.aam5432; Jombart, 2020, HIERFSTAT ESTIMATION; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kahilainen A, 2014, GLOB ECOL CONSERV, V2, P315, DOI 10.1016/j.gecco.2014.10.013; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kettenring KM, 2014, J APPL ECOL, V51, P339, DOI 10.1111/1365-2664.12202; Kettle CJ, 2008, BIOL CONSERV, V141, P1953, DOI 10.1016/j.biocon.2008.05.008; Lamb D, 2011, WORLD FORESTS, V8, P1, DOI 10.1007/978-90-481-9870-2; Leidner AK, 2011, CONSERV BIOL, V25, P1022, DOI 10.1111/j.1523-1739.2011.01720.x; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Lloyd H, 2011, RESTOR ECOL, V19, P74, DOI 10.1111/j.1526-100X.2009.00542.x; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Martins K, 2016, CONSERV GENET, V17, P509, DOI 10.1007/s10592-015-0800-7; Mijangos JL, 2015, MOL ECOL, V24, P22, DOI 10.1111/mec.12995; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Otalora MG, 2011, BIODIVERS CONSERV, V20, P1239, DOI 10.1007/s10531-011-0025-0; Paquette SR., 2012, POPGENKIT USEFUL FUN, P1; Ramalho Mauro, 2004, Acta Bot. Bras., V18, P37, DOI 10.1590/S0102-33062004000100005; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ritchie AL, 2012, RESTOR ECOL, V20, P441, DOI 10.1111/j.1526-100X.2011.00791.x; Rodrigues RR, 2009, BIOL CONSERV, V142, P1242, DOI 10.1016/j.biocon.2008.12.008; Sato T, 2006, HEREDITY, V96, P79, DOI 10.1038/sj.hdy.6800748; Schaberg PG, 2008, FOREST ECOL MANAG, V256, P855, DOI 10.1016/j.foreco.2008.06.038; Sezen UU, 2005, SCIENCE, V307, P891, DOI 10.1126/science.1105034; Silva A. F. da, 2003, Revista Arvore, V27, P311, DOI 10.1590/S0100-67622003000300006; Silva T.R.S., 2002, FLORA FANEROGAMICA E, V2, P101; SOS Mata Atlantica INPE, 2015, ATL REM FLOR MAT ATL; TABARELLI M, 1993, REV I FLORESTAL SAO, V0005, P00095; Thomas E, 2014, FOREST ECOL MANAG, V333, P66, DOI 10.1016/j.foreco.2014.07.015; Toro MA, 2005, PHILOS T R SOC B, V360, P1367, DOI 10.1098/rstb.2005.1680; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Vranckx G, 2012, CONSERV BIOL, V26, P228, DOI 10.1111/j.1523-1739.2011.01778.x; [No title captured]	68	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192165	10.1371/journal.pone.0192165	http://dx.doi.org/10.1371/journal.pone.0192165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513673	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800010
J	Davey, DJ; Farley, E; Gomba, Y; Coates, T; Myer, L				Davey, Dvora Joseph; Farley, Elise; Gomba, Yolanda; Coates, Thomas; Myer, Landon			Sexual risk during pregnancy and postpartum periods among HIV-infected and -uninfected South African women: Implications for primary and secondary HIV prevention interventions	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; BEHAVIOR; ACQUISITION; COUNTRIES	Background HIV acquisition in pregnancy and breastfeeding contributes significantly toward pediatric HIV infection. However, little is known about how sexual behavior changes during pregnancy and postpartum periods which will help develop targeted HIV prevention and transmission interventions, including pre-exposure prophylaxis (PrEP). Methods Cross-sectional study in HIV-infected and uninfected pregnant and postpartum women in Cape Town, South Africa. Interviewers collected survey data on demographic, sexual behaviors, and alcohol use among pregnant and post-partum women. We report descriptive results of sexual behavior by trimester and postpartum period, and results of multivariable logistic regression stratified by pregnancy status. Results We enrolled 377 pregnant and postpartum women (56% pregnant, 40% HIV-infected). During pregnancy, 98% of women reported vaginal sex (8% anal sex, 44% oral sex) vs. 35% and 88% during the periods 0-6 and 7-12 months postpartum, respectively (p<0.05). More pregnant women reported having >1 partner in the past 12-months compared to postpartum women (18% vs. 13%, respectively, p<0.05). Sex frequency varied by trimester with greatest mean sex acts occurring during first trimester and >6-months postpartum (13 mean sex acts in first trimester; 17 mean sex acts >6-months postpartum). Pregnant women had increased odds of reporting condomless sex at last sex (aOR = 2.96; 95%CI = 1.84-4.78) and ever having condomless sex in past 3-months (aOR = 2.65; 95%CI = 1.30-5.44) adjusting for age, HIV status, and sex frequency compared to postpartum women. Conclusion We identified that sexual behaviors and risk behaviors were high and changing during pregnancy and postpartum periods, presenting challenges to primary and secondary HIV prevention efforts, including PrEP delivery to pregnant and breastfeeding women.	[Davey, Dvora Joseph; Farley, Elise; Gomba, Yolanda; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Davey, Dvora Joseph] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Davey, Dvora Joseph; Coates, Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of Cape Town; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Davey, DJ (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa.; Davey, DJ (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA.; Davey, DJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	dvoradavey@ucla.edu	Farley, E/HHM-4227-2022	Farley, Elise/0000-0003-4457-4068; Joseph-Davey, Dvora/0000-0001-6290-9293	NIH/FIC [R25TW009340];  [NIH-NIAID-T32DA023356]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634] Funding Source: NIH RePORTER	NIH/FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	DJD received funding from NIH-NIAID-T32DA023356 and NIH/FIC R25TW009340. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2016, PEDIATR INFECT DIS J, V35, P894, DOI 10.1097/INF.0000000000001199; Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; Businge CB, 2016, GLOB HLTH ACTION, V9, P1; Chersich MF, 2008, AIDS, V22, pS27, DOI 10.1097/01.aids.0000341775.94123.75; Davey DLJ, 2016, SEX TRANSM DIS, V43, P450, DOI 10.1097/OLQ.0000000000000460; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dinh TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125525; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Fonner VA, 2016, AIDS; Heffron R, 2016, CURRENT HIV AIDS REP, V5, P1; Irungu E, 2012, AIDS, V26, P997, DOI 10.1097/QAD.0b013e3283524ca1; Johnson LF, 2012, JAIDS-J ACQ IMM DEF, V59, P417, DOI 10.1097/QAI.0b013e3182432f27; Joseph Davey D, 2017, AIDS; Karim QA, 2012, AIDS BEHAV, V16, P1870, DOI 10.1007/s10461-012-0209-y; Kinuthia J, 2017, JAIDS-J ACQ IMM DEF, V74, P142, DOI 10.1097/QAI.0000000000001225; Kinuthia J, 2015, AIDS, V29, P2025, DOI 10.1097/QAD.0000000000000793; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; Mofenson LM, 2017, AIDS, V31, P213, DOI 10.1097/QAD.0000000000001313; Moodley D, 2011, J INFECT DIS, V203, P1231, DOI 10.1093/infdis/jir017; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Myer L, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20045; Peltzer K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-57; Pintye J., 2016, CLIN INFECT DIS, V28; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Tomlinson PhDa, 2014, PREV SCI, V15, P277; World Health Organization, 2017, POLICY BRIEF; Zembe YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051998	28	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0192982	10.1371/journal.pone.0192982	http://dx.doi.org/10.1371/journal.pone.0192982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509759	Green Published, Green Submitted, gold			2022-12-27	WOS:000426813200008
J	Romero, V; Fitzpatrick, P; Roulier, S; Duncan, A; Richardson, MJ; Schmidt, RC				Romero, Veronica; Fitzpatrick, Paula; Roulier, Stephanie; Duncan, Arnie; Richardson, Michael J.; Schmidt, R. C.			Evidence of embodied social competence during conversation in high functioning children with autism spectrum disorder	PLOS ONE			English	Article							DIAGNOSTIC OBSERVATION SCHEDULE; LONG-RANGE CORRELATIONS; JOINT ATTENTION; FALSE BELIEF; REPETITIVE BEHAVIORS; LANGUAGE IMPAIRMENT; BODY MOVEMENT; COMMUNICATION; COMPLEXITY; ANTICIPATION	Even high functioning children with Autism Spectrum Disorder (ASD) exhibit impairments that affect their ability to carry out and maintain effective social interactions in multiple contexts. One aspect of subtle nonverbal communication that might play a role in this impairment is the whole-body motor coordination that naturally arises between people during conversation. The current study aimed to measure the time-dependent, coordinated whole-body movements between children with ASD and a clinician during a conversational exchange using tools of nonlinear dynamics. Given the influence that subtle interpersonal coordination has on social interaction feelings, we expected there to be important associations between the dynamic motor movement measures introduced in the current study and the measures used traditionally to categorize ASD impairment (ADOS-2, joint attention and theory of mind). The study found that children with ASD coordinated their bodily movements with a clinician, that these movements were complex and that the complexity of the children's movements matched that of the clinician's movements. Importantly, the degree of this bodily coordination was related to higher social cognitive ability. This suggests children with ASD are embodying some degree of social competence during conversations. This study demonstrates the importance of further investigating the subtle but important bodily movement coordination that occurs during social interaction in children with ASD.	[Romero, Veronica; Richardson, Michael J.] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Romero, Veronica; Roulier, Stephanie; Schmidt, R. C.] Coll Holy Cross, Dept Psychol, Worcester, MA 01610 USA; [Fitzpatrick, Paula] Assumption Coll, Dept Psychol, Worcester, MA USA; [Duncan, Arnie] Cincinnati Childrens Hosp Med Ctr, Dept Dev & Behav Pediat, Cincinnati, OH 45229 USA; [Richardson, Michael J.] Macquarie Univ, Fac Human Sci, Dept Psychol, Sydney, NSW, Australia; [Richardson, Michael J.] Macquarie Univ, Fac Human Sci, Percept Act Res Ctr, Sydney, NSW, Australia	University System of Ohio; University of Cincinnati; College of the Holy Cross; Assumption College; Cincinnati Children's Hospital Medical Center; Macquarie University; Macquarie University	Romero, V (corresponding author), Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA.; Romero, V (corresponding author), Coll Holy Cross, Dept Psychol, Worcester, MA 01610 USA.	vromero@holycross.edu	Duncan, Amie/I-5789-2019; Romero, Veronica/ABI-1513-2020	Richardson, Michael/0000-0001-9159-2774; Duncan, Amie/0000-0002-6317-4302; Romero, Veronica/0000-0003-4086-6303	National Institute of Mental Health of the National Institute of Health [R21MH094659, F31MH108331]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH108331] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institute of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institute of Mental Health of the National Institute of Health (https://www.nih.govi) under award numbers R21MH094659 (PF, AD, MJR, RCS) and F31MH108331 (VR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney DH, 2014, J EXP PSYCHOL GEN, V143, P2304, DOI 10.1037/xge0000021; American Psychiatric Organisation, 2000, DIAGN STAT MAN MENT; American Psychiatric Organization, 2013, DIAGNOSTIC STAT MANU; Ashenfelter KT, 2009, J EXP PSYCHOL HUMAN, V35, P1072, DOI 10.1037/a0015017; BaronCohen S, 1997, CHILD DEV, V68, P48; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BERNIERI FJ, 1988, J NONVERBAL BEHAV, V12, P120, DOI 10.1007/BF00986930; Bishop D.V.M., 2000, SPEECH LANGUAGE IMPA; Broaders SC, 2010, PSYCHOL SCI, V21, P623, DOI 10.1177/0956797610366082; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Charman T, 1997, DEV PSYCHOL, V33, P781, DOI 10.1037/0012-1649.33.5.781; Charman T, 2003, PHILOS T R SOC B, V358, P315, DOI 10.1098/rstb.2002.1199; Coey CA, 2015, ATTEN PERCEPT PSYCHO, V77, P1423, DOI 10.3758/s13414-015-0842-4; Cuccaro ML, 2003, CHILD PSYCHIAT HUM D, V34, P3, DOI 10.1023/A:1025321707947; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Duncan AW, 2015, AUTISM, V19, P64, DOI 10.1177/1362361313510068; Dutta S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00274; FINE J, 1994, J AUTISM DEV DISORD, V24, P315, DOI 10.1007/BF02172230; Fitzpatrick P, 2013, 5 JOINT ACT M BERL; Fitzpatrick P, 2017, AUTISM RES, V10, P1687, DOI 10.1002/aur.1808; Fitzpatrick P, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00021; Fowler CA, 2008, UNDERST COMPLEX SYST, P261, DOI 10.1007/978-3-540-74479-5_13; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Fusaroli R., 2013, 35 ANN C COGN SCI SO; Glazebrook CM, 2006, MOTOR CONTROL, V10, P244, DOI 10.1123/mcj.10.3.244; Grahe JE, 1999, J NONVERBAL BEHAV, V23, P253, DOI 10.1023/A:1021698725361; Gratier M., 2009, COMMUNICATIVE MUSICA, P301; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 2001, PHYSICA A, V302, P138, DOI 10.1016/S0378-4371(01)00460-5; Hausdorff JM, 1997, J APPL PHYSIOL, P82; Hus V, 2014, J AUTISM DEV DISORD, V44, P1996, DOI 10.1007/s10803-014-2080-3; Ihlen EAF, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00141; Issartel J, 2006, J MOTOR BEHAV, V38, P139, DOI 10.3200/JMBR.38.2.139-159; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Kelty-Stephen DG, 2013, ECOL PSYCHOL, V25, P1, DOI 10.1080/10407413.2013.753804; Kim SH, 2013, NEUROSCIENCE AUTISM, P25; Kim SH, 2010, AUTISM RES, V3, P162, DOI 10.1002/aur.142; Kupper Z, 2010, SCHIZOPHR RES, V121, P90, DOI 10.1016/j.schres.2010.03.032; Lam KSL, 2008, J CHILD PSYCHOL PSYC, V49, P1193, DOI 10.1111/j.1469-7610.2008.01944.x; Lambrechts A, 2014, PROCD SOC BEHV, V126, P214, DOI 10.1016/j.sbspro.2014.02.380; Leekam S, 1997, BRIT J DEV PSYCHOL, V15, P77, DOI 10.1111/j.2044-835X.1997.tb00726.x; Lord C., 2012, LOS ANGELES W PSYCHO; Louwerse MM, 2012, COGNITIVE SCI, V36, P1404, DOI 10.1111/j.1551-6709.2012.01269.x; Luckett T, 2002, J AUTISM DEV DISORD, V32, P127, DOI 10.1023/A:1014844722931; Marmelat V, 2012, EXP BRAIN RES, V222, P137, DOI 10.1007/s00221-012-3202-9; Marsh KL, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00004; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; Mastrogiuseppe M, 2015, AUTISM, V19, P469, DOI 10.1177/1362361314528390; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Morales CJ, 2002, ANN BIOMED ENG, V30, P588, DOI 10.1114/1.1478082; Mundy P, 1997, MENT RETARD DEV D R, V3, P343; MUNDY P, 1990, J AUTISM DEV DISORD, V20, P115, DOI 10.1007/BF02206861; MUNDY P, 1986, J CHILD PSYCHOL PSYC, V27, P657, DOI 10.1111/j.1469-7610.1986.tb00190.x; Norbury CF, 2002, INT J LANG COMM DIS, V37, P227, DOI 10.1080/13682820210136269; Paxton A, 2013, BEHAV RES METHODS, V45, P329, DOI 10.3758/s13428-012-0249-2; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PERNER J, 1987, BRIT J DEV PSYCHOL, V5, P125, DOI 10.1111/j.2044-835X.1987.tb01048.x; Peterson CC, 2002, CHILD DEV, V73, P1442, DOI 10.1111/1467-8624.00482; Rajendran G, 2007, DEV REV, V27, P224, DOI 10.1016/j.dr.2007.02.001; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Rankin SK, 2009, MUSIC PERCEPT INTERD, P26; Richardson MJ, 2014, ROUTLEDGE HBK PHILOS, P39; Roelofs RL, 2017, BRAIN IMPAIR, V18, P138, DOI 10.1017/BrImp.2016.31; Romero V, 2016, BEHAV RES METHODS, P1; Romero V, 2016, SPRINGER PROC PHYS, V180, P227, DOI 10.1007/978-3-319-29922-8_12; Schmidt RC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00633; Schmidt RC, 2012, J NONVERBAL BEHAV, V36, P263, DOI 10.1007/s10919-012-0138-5; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; Schmit JM, 2005, EXP BRAIN RES, V163, P370, DOI 10.1007/s00221-004-2185-6; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Serletis D, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056008; Shimizu Y, 2002, FRACTALS, V10, P103, DOI 10.1142/S0218348X02001130; Smith IM, 1998, COGNITIVE NEUROPSYCH, V15, P747, DOI 10.1080/026432998381087; Sparaci L, WHAT WHY UNDERSTANDI; Sparaci L, UNTRIVIAL PURSUIT ME; Stephen DG, 2008, PHYSICA A, V387, P5271, DOI 10.1016/j.physa.2008.05.015; Stevenson JL, 2017, PERCEPT MOTOR SKILL, V124, P777, DOI 10.1177/0031512517710379; Tager-Flusberg H., 2000, UNDERSTANDING OTHER; Tager-Flusberg H, 2007, CURR DIR PSYCHOL SCI, V16, P311, DOI 10.1111/j.1467-8721.2007.00527.x; TAGERFLUSBERG H, 1991, J CHILD PSYCHOL PSYC, V32, P1123, DOI 10.1111/j.1469-7610.1991.tb00353.x; Tanguay PE, 1998, J AM ACAD CHILD PSY, V37, P271, DOI 10.1097/00004583-199803000-00011; Thurner S, 2002, AUDIOL NEURO-OTOL, V7, P240, DOI 10.1159/000063740; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; Van Orden GC, 2003, J EXP PSYCHOL GEN, V132, P331, DOI 10.1037/0096-3445.132.3.331; Van Orden GC, 2011, HBK PHILOS SCI, V10, P629; Varlet M, 2012, PLOS ONE, P7; Warreyn P, 2005, J DEV PHYS DISABIL, V17, P55, DOI 10.1007/s10882-005-2201-1; Washburn A, 2015, J EXP PSYCHOL HUMAN, V41, P1166, DOI 10.1037/xhp0000080; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; Young EC, 2005, LANG SPEECH HEAR SER, V36, P62, DOI 10.1044/0161-1461(2005/006); Zorick T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068360	94	23	23	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193906	10.1371/journal.pone.0193906	http://dx.doi.org/10.1371/journal.pone.0193906			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY1CC	29505608	gold, Green Published			2022-12-27	WOS:000426548200042
J	Solocinski, J; Osgood, QA; Rosiek, E; Underwood, L; Zikanov, O; Chakraborty, N				Solocinski, Jason; Osgood, Quinn A.; Rosiek, Eric; Underwood, Lukas; Zikanov, Oleg; Chakraborty, Nilay			Development of a surface tension mediated technique for dry stabilization of mammalian cells	PLOS ONE			English	Article							DESICCATION TOLERANCE; ANHYDROBIOSIS; VITRIFICATION; PRESERVATION; EVOLUTION	Dry state preservation at ambient temperatures (lyopreservation) is a biomimetic alternative to low temperature stabilization (cryopreservation) of biological materials. Lyopreservation is hypothesized to rely upon the creation of a glassy environment, which is commonly observed in desiccation-tolerant organisms. Non-uniformities in dried samples have been indicated as one of the reasons for instability in storage outcome. The current study presents a simple, fast, and uniform surface tension based technique that can be implemented for lyopreservation of mammalian cells. The technique involves withdrawing cells attached to rigid substrates to be submerged in a solution of lyoprotectant and then withdrawing the samples at a specific rate to an inert environment. This creates a uniform thin film of desiccated lyoprotectant due to sudden change of surface tension. The residual moisture contents at different locations in the desiccated film was quantified using a spatially resolved Raman microspectroscopy technique. Post-desiccation cellular viability and growth are quantified using fluorescent microscopy and dye exclusion assays. Cellular injury following desiccation is evaluated by bioenergetic quantification of metabolic functions using extracellular flux analysis and by a Raman microspectroscopic analysis of change in membrane structure. The technique developed here addresses an important bottleneck of lyoprocessing which requires the fast and uniform desiccation of cellular samples.	[Solocinski, Jason; Osgood, Quinn A.; Rosiek, Eric; Underwood, Lukas; Zikanov, Oleg; Chakraborty, Nilay] Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA; [Osgood, Quinn A.] OtziBio LLC, Livonia, MI USA	University of Michigan System; University of Michigan	Chakraborty, N (corresponding author), Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA.	nilay@umich.edu	Chakraborty, Nilay/AAK-4812-2020	Chakraborty, Nilay/0000-0001-8138-3506; Osgood, Quinn/0000-0002-8233-5634	NSF [SusChEM 1510072, CHE 1609440]; University of Michigan [U038726, U051381]	NSF(National Science Foundation (NSF)); University of Michigan(University of Michigan System)	This research was supported by the NSF (www.nsf.gov) grant numbers SusChEM 1510072 and CHE 1609440. Authors would also like to acknowledge University of Michigan (www.umich.edu) grant numbers U038726 (NC) and U051381 (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JP, 2004, ENG DESICCATION TOLE, P563; Aksan A, 2004, LANGMUIR, V20, P5521, DOI 10.1021/la0355186; Bonifacio A, 2015, ANAL BIOANAL CHEM, V407, P1089, DOI 10.1007/s00216-014-8321-7; Chakraborty N, 2008, BIOTECHNOL BIOENG, V100, P782, DOI 10.1002/bit.21801; Chakraborty N, 2012, CRYOBIOLOGY, V64, P91, DOI 10.1016/j.cryobiol.2011.11.007; Chakraborty N, 2011, ANN BIOMED ENG, V39, P1582, DOI 10.1007/s10439-011-0253-1; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Crowe JH, 2000, NAT BIOTECHNOL, V18, P145, DOI 10.1038/72580; CROWE JH, 1982, CRYOBIOLOGY, V19, P317, DOI 10.1016/0011-2240(82)90160-2; Crowe JH, 2013, CRYOBIOLOGY, V66, P348; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Edwards C, 2015, LANGMUIR, V31, P11020, DOI 10.1021/acs.langmuir.5b02148; Elliott GD, 2008, BIOPRESERV BIOBANK, V6, DOI 10.1089/bio.2008.0011; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; GREEN JL, 1989, J PHYS CHEM-US, V93, P2880, DOI 10.1021/j100345a006; He XM, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336304; Johnson PE, 2015, ACS NANO, V9, P6961, DOI 10.1021/acsnano.5b01139; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; LEENAARS AFM, 1990, LANGMUIR, V6, P1701, DOI 10.1021/la00101a014; Li S, 2012, P NATL ACAD SCI USA, V109, P20859, DOI 10.1073/pnas.1214893109; Liu TT, 2014, PHYS LETT A, V378, P1191, DOI 10.1016/j.physleta.2014.02.024; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; Nuzzo M, 2015, LANGMUIR, V31, P10946, DOI 10.1021/acs.langmuir.5b02023; Oliver MJ, 2000, PLANT ECOL, V151, P85, DOI 10.1023/A:1026550808557; Potts M, 1999, EUR J PHYCOL, V34, P319, DOI 10.1017/S0967026299002267; Ragoonanan V, 2008, BIOPHYS J, V94, P2212, DOI 10.1529/biophysj.107.110684; Vogl CJ, 2012, P ROY SOC A-MATH PHY, V468, P3348, DOI 10.1098/rspa.2012.0170; Wolke K, 1996, SOLID STATE TECHNOL, V39, P87; Wolkers WF, 2010, SPECTROSC-INT J, V24, P525, DOI 10.1155/2010/576151; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Zikanov O, 2001, J ENG MATH, V40, P249, DOI 10.1023/A:1017596621570	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193160	10.1371/journal.pone.0193160	http://dx.doi.org/10.1371/journal.pone.0193160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505556	Green Published, gold, Green Submitted			2022-12-27	WOS:000426548200005
J	Sharp, A; Landry, SP; Maheu, M; Champoux, F				Sharp, Andreanne; Landry, Simon P.; Maheu, Maxime; Champoux, Francois			Deafness alters the spatial mapping of touch	PLOS ONE			English	Article							CROSSED-HANDS DEFICIT; TEMPORAL-ORDER; CONGENITALLY DEAF; REFERENCE FRAME; TACTILE; CHILDREN; VISION; DISCRIMINATION; LOCALIZATION; INTEGRATION	Auditory input plays an important role in the development of body-related processes. The absence of auditory input in deafness is understood to have a significant, and even irreversible, impact on these processes. The ability to map touch on the body is an important element of body-related processing. In this research, the crossed-arm temporal order judgment (TOJ) task was used to evaluate the spatial mapping of touch. This task elicits a conflict between visual and somatosensory body-related information through a change in posture. We used the crossed-arm TOJ task to evaluate the spatial mapping of touch in deaf participants. Results suggested that a change in posture had a greater impact on congenitally deaf participant TOJ than for hearing participants. This provides the first evidence for the role of early auditory exposure on spatial mapping of touch. More importantly, most deaf participants had auditory prosthetics which provided auditory input. This suggests an important, and possibly irreversible, impact of early auditory deprivation on this body-related process.	[Sharp, Andreanne; Landry, Simon P.; Maheu, Maxime; Champoux, Francois] Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ, Canada	Universite de Montreal	Sharp, A (corresponding author), Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ, Canada.	andreanne.sharp@umontreal.ca		Landry, Simon/0000-0001-7102-8324	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05211]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2016-05211 (FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JB, 2015, CURR BIOL, V25, pR978, DOI 10.1016/j.cub.2015.08.055; Azanon E, 2007, EXP BRAIN RES, V182, P537, DOI 10.1007/s00221-007-1011-3; Azanon E, 2010, CURR BIOL, V20, P1304, DOI 10.1016/j.cub.2010.05.063; Bavelier D, 2001, J NEUROSCI, V21, P8931, DOI 10.1523/JNEUROSCI.21-22-08931.2001; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bolognini N, 2012, J COGNITIVE NEUROSCI, V24, P276, DOI 10.1162/jocn_a_00135; Bremner AJ, 2008, J EXP PSYCHOL GEN, V137, P149, DOI 10.1037/0096-3445.137.1.149; Cadieux ML, 2013, MULTISENS RES, V26, P465, DOI 10.1163/22134808-00002423; Cadieux ML, 2010, EXP BRAIN RES, V204, P431, DOI 10.1007/s00221-010-2268-5; Crollen V, 2017, SCI REP, V7; Cushing SL, 2013, OTOL NEUROTOL, V34, P422, DOI 10.1097/MAO.0b013e31827b4ba0; Figliozzi F, 2005, J COGNITIVE NEUROSCI, V17, P1638, DOI 10.1162/089892905774597272; Gallace A, 2005, NEUROSCI LETT, V379, P63, DOI 10.1016/j.neulet.2004.12.052; Handzel O, 2006, OTOL NEUROTOL, V27, P57, DOI 10.1097/01.mao.0000188658.36327.8f; Heed T., 2012, NEURAL BASEMULTISE; Heed T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158829; Heed T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00076; Heed T, 2012, J EXP PSYCHOL HUMAN, V38, P386, DOI 10.1037/a0024059; Heimler B, 2014, EXP BRAIN RES, V232, P1335, DOI 10.1007/s00221-014-3852-x; Houde MS, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5260671; Kaga K, 2008, INT J AUDIOL, V47, P590, DOI 10.1080/14992020802331222; Kobor I, 2006, NEUROSCI LETT, V400, P163, DOI 10.1016/j.neulet.2006.02.037; Kral A, 2012, TRENDS NEUROSCI, V35, P111, DOI 10.1016/j.tins.2011.09.004; Landry SP, 2017, MULTISENS RES; Levanen S, 2001, NEUROSCI LETT, V301, P75, DOI 10.1016/S0304-3940(01)01597-X; Ley P, 2013, NEUROPSYCHOLOGIA, V51, P1119, DOI 10.1016/j.neuropsychologia.2013.03.004; Lopez C, 2016, CURR OPIN NEUROL, V29, P74, DOI 10.1097/WCO.0000000000000286; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Moallem TM, 2010, J ACOUST SOC AM, V127, P3696, DOI 10.1121/1.3397432; Noel JP, 2016, NEUROPSYCHOLOGIA, V82, P84, DOI 10.1016/j.neuropsychologia.2016.01.005; Pagel B, 2009, DEVELOPMENTAL SCI, V12, P929, DOI 10.1111/j.1467-7687.2009.00845.x; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Schicke T, 2006, P NATL ACAD SCI USA, V103, P11808, DOI 10.1073/pnas.0601486103; Seymour JL, 2017, HEARING RES, V343, P162, DOI 10.1016/j.heares.2016.09.007; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Tien HC, 2002, OTOLARYNG HEAD NECK, V127, P260, DOI 10.1067/mhn.2002.128555; van Dijk R, 2013, EXP BRAIN RES, V230, P283, DOI 10.1007/s00221-013-3653-7; Wada M, 2004, NEUROPSYCHOLOGIA, V42, P1887, DOI 10.1016/j.neuropsychologia.2004.05.009; Xu XD, 2015, CLIN NEUROPHYSIOL, V126, P1624, DOI 10.1016/j.clinph.2014.10.216; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	40	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0192993	10.1371/journal.pone.0192993	http://dx.doi.org/10.1371/journal.pone.0192993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY0AM	29499045	Green Published, Green Submitted, gold			2022-12-27	WOS:000426472300006
J	Kumlert, R; Chaisiri, K; Anantatat, T; Stekolnikov, AA; Morand, S; Prasartvit, A; Makepeace, BL; Sungvornyothin, S; Paris, DH				Kumlert, Rawadee; Chaisiri, Kittipong; Anantatat, Tippawan; Stekolnikov, Alexandr A.; Morand, Serge; Prasartvit, Anchana; Makepeace, Benjamin L.; Sungvornyothin, Sungsit; Paris, Daniel H.			Autofluorescence microscopy for paired-matched morphological and molecular identification of individual chigger mites (Acari: Trombiculidae), the vectors of scrub typhus	PLOS ONE			English	Article							MITOCHONDRIAL PSEUDOGENES; ORIENTIA-TSUTSUGAMUSHI; LEPTOTROMBIDIUM ACARI; GENE	4 Background Conventional gold standard characterization of chigger mites involves chemical preparation procedures (i.e. specimen clearing) for visualization of morphological features, which however contributes to destruction of the arthropod host DNA and any endosymbiont or pathogen DNA harbored within the specimen. Methodology/Principal findings In this study, a novel work flow based on autofluorescence microscopy was developed to enable identification of trombiculid mites to the species level on the basis of morphological traits without any special preparation, while preserving the mite DNA for subsequent geno-typing. A panel of 16 specifically selected fluorescence microscopy images of mite features from available identification keys served for complete chigger morphological identification to the species level, and was paired with corresponding genotype data. We evaluated and validated this method for paired chigger morphological and genotypic ID using the mitochondrial cytochrome c oxidase subunit I gene (coi) in 113 chigger specimens representing 12 species and 7 genera (Leptotrombidium, Ascoschoengastia, Gahrliepia, Walchia, Blankaartia, Schoengastia and Schoutedenichia) from the Lao People's Democratic Republic (Lao PDR) to the species level (complete characterization), and 153 chiggers from 5 genera (Leptotrombidium, Ascoschoengastia, Helenicula, Schoengastiella and Walchia) from Thailand, Cambodia and Lao PDR to the genus level. A phylogenetic tree constructed from 77 coi gene sequences (approximately 640 bp length, n = 52 new coi sequences and n = 25 downloaded from GenBank), demonstrated clear grouping of assigned morphotypes at the genus levels, although evidence of both genetic polymorphism and morphological plasticity was found. Conclusions/Significance With this new methodology, we provided the largest collection of characterized coi gene sequences for trombiculid mites to date, and almost doubled the number of available characterized coi gene sequences with a single study. The ability to provide paired phenotypic-genotypic data is of central importance for future characterization of mites and dissecting the molecular epidemiology of mites transmitting diseases like scrub typhus.	[Kumlert, Rawadee; Chaisiri, Kittipong; Sungvornyothin, Sungsit] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Kumlert, Rawadee; Prasartvit, Anchana] Minist Publ Hlth, Dept Dis Control, Bangkok, Thailand; [Chaisiri, Kittipong] Univ Liverpool, Dept Infect Biol, Inst Infect & Global Hlth, Liverpool Sci Pk IC2, Liverpool, Merseyside, England; [Anantatat, Tippawan; Paris, Daniel H.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Stekolnikov, Alexandr A.] Russian Acad Sci, Zool Inst, Univ Skaya Embankment 1, St Petersburg, Russia; [Morand, Serge] Kasetsart Univ, Fac Vet Technol, CNRS, ISEM,CIRAD ASTRE, Bangkok, Thailand; [Paris, Daniel H.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Paris, Daniel H.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Paris, Daniel H.] Univ Basel, Fac Med, Basel, Switzerland	Mahidol University; Ministry of Public Health - Thailand; University of Liverpool; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Kasetsart University; University of Oxford; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Geneva	Paris, DH (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.; Paris, DH (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.; Paris, DH (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Paris, DH (corresponding author), Univ Basel, Fac Med, Basel, Switzerland.	daniel.paris@swisstph.ch	Paris, Daniel/AFV-4762-2022; Morand, Serge/M-5433-2018; Paris, Daniel/GLN-7566-2022; Stekolnikov, Alexandr A/G-7966-2011; Chaisiri, Kittipong/S-8166-2016	Morand, Serge/0000-0003-3986-7659; Stekolnikov, Alexandr A/0000-0001-7548-2671; Chaisiri, Kittipong/0000-0001-6795-3541	National Research Council of Thailand; LKS Strategic Award [LG34]; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT)); LKS Strategic Award; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand	This study was supported in part by a scholarship granted to Rawadee Kumlert for FY2017, as a thesis grant for doctoral degree students from the National Research Council of Thailand, the LKS Strategic Award (LG34) "The Natural Immune Response in Pediatric Scrub Typhus in Chiang Rai" (DHP was the PI), and a supportive research grant for the PhD thesis of Rawadee Kumlert from the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. We would also like to thank Dr. Aulia Rahmi Pawestri for interesting and productive scientific discussions.; This study was supported in part by a scholarship for doctoral degree students from the National Research Council of Thailand granted to Rawadee Kumlert for the FY2017; the LKS Strategic Award (LG34) "The Natural Immune Response in Pediatric Scrub Typhus in Chiang Rai" (DHP is PI); and a supportive research grant from the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand to Rawadee Kumlert for writing her PhD thesis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON L. E., 1954, BRYOLOGIST, V57, P242; Beland F A, 1999, Toxic Rep Ser, P1; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Chaisiri K., 2016, MOL ECOLOGY CHIGGER; Chaisiri K, 2016, J MED ENTOMOL, V53, P321, DOI 10.1093/jme/tjv244; DOHANY AL, 1978, AM J TROP MED HYG, V27, P1261, DOI 10.4269/ajtmh.1978.27.1261; Ewing H. E., 1944, JOUR PARASITOL, V30, P339, DOI 10.2307/3272686; Fernandes S. J. S., 2003, STUDIES TROMBICULID; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GOFF ML, 1982, J MED ENTOMOL, V19, P221, DOI 10.1093/jmedent/19.3.221; Henderson Rosa C., 2001, Systematic and Applied Acarology Special Publications, V7, P1; Herbreteau V., 2011, FIELD LAB PROTOCOLS; James SL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004723; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Krantz G. W., 2008, MANUAL ACAROLOGY, V3rd; Lee HI, 2011, VECTOR-BORNE ZOONOT, V11, P209, DOI 10.1089/vbz.2009.0180; Liviac D, 2010, WATER RES, V44, P2638, DOI 10.1016/j.watres.2010.01.026; Moniuszko H, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1339-2; Moniuszko H, 2015, EXP APPL ACAROL, V67, P123, DOI 10.1007/s10493-015-9925-0; Nadchatram M, 1974, PICTORIAL KEY SUBFAM; Paris DH, 2013, AM J TROP MED HYG, V89, P301, DOI 10.4269/ajtmh.13-0064; Park SW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003814; Peng P- Y, 2016, PARASITOL RES; Pereira SL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-17; Phommasone K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002163; Pogacnik M, 1998, ACTA DERM-VENEREOL, V7, P173; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; REE H-I, 1991, Korean Journal of Parasitology, V29, P87, DOI 10.3347/kjp.1991.29.1.87; Santibanez P, 2015, ROLE CHIGGERS HUMAN; SASA M, 1961, ANNU REV ENTOMOL, V6, P221, DOI 10.1146/annurev.en.06.010161.001253; Schaudien D, 2007, DIAGN MOL PATHOL, V16, P153, DOI 10.1097/PDM.0b013e31803c558a; Shao RF, 2006, J MOL EVOL, V63, P251, DOI 10.1007/s00239-005-0196-y; Shatrov AB, 2008, ANN ZOOLOGICI; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stekolnikov AA, 2013, ZOOTAXA, V3728, P1; Takhampunya R, 2014, AM J TROP MED HYG, V90, P139, DOI 10.4269/ajtmh.13-0393; Taylor AJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003971; TRAUB R., 1957, STUD INST MED RES MALAYA, V28, P297; Traub R, 1956, SMITHSONIAN MISCELLA, V128, P1; UPTON MS, 1993, B ENTOMOL RES, V83, P267, DOI 10.1017/S0007485300034763; Vercammen-Grandjean P. H., 1975, CHIGGER MITES WORLD; Weitzel T, 2016, NEW ENGL J MED, V375, P954, DOI 10.1056/NEJMoa1603657; Womersley H., 1952, Records of the South Australian Museum, V10, P1; Zander RH, 1997, BRYOLOGIST, V100, P380; Zhang L, 2012, MUTAT RES-GEN TOX EN, V741, P89, DOI 10.1016/j.mrgentox.2011.11.004	45	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193163	10.1371/journal.pone.0193163	http://dx.doi.org/10.1371/journal.pone.0193163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494599	Green Published, Green Accepted, gold			2022-12-27	WOS:000426363200026
J	Sporlein, C; Schlueter, E				Spoerlein, Christoph; Schlueter, Elmar			How education systems shape cross-national ethnic inequality in math competence scores: Moving beyond mean differences	PLOS ONE			English	Article							LOCATION SCALE-MODEL; STUDENT-ACHIEVEMENT; WESTERN SOCIETIES; 2ND-GENERATION; TRACKING; IMMIGRANTS; DESTINATION; COUNTRIES; VARIANCE; CHILDREN	Here we examine a conceptualization of immigrant assimilation that is based on the more general notion that distributional differences erode across generations. We explore this idea by reinvestigating the efficiency-equality trade-off hypothesis, which posits that stratified education systems educate students more efficiently at the cost of increasing inequality in overall levels of competence. In the context of ethnic inequality in math achievement, this study explores the extent to which an education system's characteristics are associated with ethnic inequality in terms of both the group means and group variances in achievement. Based on data from the 2012 PISA and mixed-effect location scale models, our analyses revealed two effects: on average, minority students had lower math scores than majority students, and minority students' scores were more concentrated at the lower end of the distribution. However, the ethnic inequality in the distribution of scores declined across generations. We did not find compelling evidence that stratified education systems increase mean differences in competency between minority and majority students. However, our analyses revealed that in countries with early educational tracking, minority students' math scores tended to cluster at the lower end of the distribution, regardless of compositional and school differences between majority and minority students.	[Spoerlein, Christoph] Otto Friedrich Univ, Chair Sociol & Anal Social Struct, Bamberg, Germany; [Schlueter, Elmar] Justus Liebig Univ, Inst Sociol, Giessen, Germany	Otto Friedrich University Bamberg; Justus Liebig University Giessen	Schlueter, E (corresponding author), Justus Liebig Univ, Inst Sociol, Giessen, Germany.	elmar.schlueter@sowi.uni-giessen.de	Schlueter, Elmar/K-9664-2017	Schlueter, Elmar/0000-0003-3880-4111	Deutsche Forschungsgemeinschaft (DFG) [SP 1569/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) by grant-nr. SP 1569/1-1 to the first author CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R., 2011, NEXT GENERATION IMMI, DOI 10.18574/nyu/9780814707425.001.0001; Alba R. D., 2003, REMAKING AM MAINSTRE; Alba R, 2011, ANNU REV SOCIOL, V37, P395, DOI 10.1146/annurev-soc-081309-150219; Algan Y, 2010, ECON J, V120, pF4, DOI 10.1111/j.1468-0297.2009.02338.x; Allmendinger J., 1989, EUROPEAN SOCIOLOGICA, V5, P231, DOI [10.1093/oxfordjournals.esr.a036524, DOI 10.1093/OXFORDJOURNALS.ESR.A036524]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumert J., 2006, HERKUNFTSBEDINGTE DI, V1st, DOI 10.1007/978-3- 531-90082-7_4; Betts JR, 2000, ECON EDUC REV, V19, P1, DOI 10.1016/S0272-7757(98)00044-2; Bobo LD, 2003, SOC PSYCHOL QUART, V66, P319, DOI 10.2307/1519832; Bol T, 2014, SOC FORCES, V92, P1545, DOI 10.1093/sf/sou003; Borgna C, 2014, EUR SOCIOL REV, V30, P670, DOI 10.1093/esr/jcu067; Boudon Raymond, 1974, ED OPPORTUNITY SOCIA; Braumoeller BF, 2006, POLIT ANAL, V14, P268, DOI 10.1093/pan/mpj009; Bygren M, 2016, SOCIOL EDUC, V89, P118, DOI 10.1177/0038040716642498; Castles Stephen, 2009, AGE MIGRATION INT PO; COOK RD, 1983, BIOMETRIKA, V70, P1, DOI 10.1093/biomet/70.1.1; Dronkers J, 2012, EUR EDUC RES J, V11, P11, DOI 10.2304/eerj.2012.11.1.11; Dustmann C, 2012, ECON POLICY, P143, DOI 10.1111/j.1468-0327.2011.00275.x; Esser H., 2016, ETHNISCHE UNGLEICHHE, P331, DOI DOI 10.1007/978-3-658-04322-3_8; Esser H, 2015, 90822015 IZA; Esser H, 2006, SPRACHE INTEGRATION; Figlio DN, 2002, J URBAN ECON, V51, P497, DOI 10.1006/juec.2001.2255; Gamoran A, 1989, AJS, V94, P415; Geukes K, 2016, J RES PERS; Gordon M. M., 1964, ASSIMILATION AM LIFE; Griga D, 2014, EUR SOCIOL REV, V30, P275, DOI 10.1093/esr/jct031; Hanushek EA, 2006, ECON J, V116, pC63, DOI 10.1111/j.1468-0297.2006.01076.x; Hanushek EA, 2011, HBK ECON, V3, P89, DOI 10.1016/S0169-7218(11)03002-4; Hattie JAC, 2009, VISIBLE LEARNING: A SYNTHESIS OF OVER 800 META-ANALYSES RELATING TO ACHIEVEMENT, P1; Heath A., 2007, UNEQUAL CHANCES ETHN; Heath A. F., 2014, UNEQUAL ATTAINMENT E; Heath AF, 2008, ANNU REV SOCIOL, V34, P211, DOI 10.1146/annurev.soc.34.040507.134728; Hedeker D, 2008, BIOMETRICS, V64, P627, DOI 10.1111/j.1541-0420.2007.00924.x; INMAN HF, 1989, COMMUN STAT THEORY, V18, P3851, DOI 10.1080/03610928908830127; Jackson M., 2013, DETERMINED SUCCEED P; Jacob K, 2013, INT MIGR, V51, P38, DOI 10.1111/imig.12108; Kalter F, 2006, Z SOZIOL, V35, P144; Kao G, 2003, ANNU REV SOCIOL, V29, P417, DOI 10.1146/annurev.soc.29.010202.100019; Kerckhoff AC, 2001, SOCIOL EDUC, P3; Kristen C, 2007, ETHNICITIES, V7, P343, DOI 10.1177/1468796807080233; Kristen C, 2016, ETHNICITIES, V16, P180, DOI 10.1177/1468796815616157; KULIK CLC, 1982, AM EDUC RES J, V19, P415, DOI 10.2307/1162722; Le Donne N, 2014, EUR SOCIOL REV, V30, P329, DOI 10.1093/esr/jcu040; Leckie G, 2014, J EDUC BEHAV STAT, V39, P307, DOI 10.3102/1076998614546494; Levels M, 2008, ETHNIC RACIAL STUD, V31, P1404, DOI 10.1080/01419870701682238; Levels M, 2008, AM SOCIOL REV, V73, P835, DOI 10.1177/000312240807300507; Montt G, 2011, SOCIOL EDUC, V84, P49, DOI 10.1177/0038040710392717; OCED, 2013, PISA 2012 ASS AN FRA; OECD, 2006, IMMIGRANT STUDENTS S; Park R.E., 1950, RACE CULTURE; Pettigrew TF, 1998, ANNU REV SOCIOL, V24, P77, DOI 10.1146/annurev.soc.24.1.77; PORTES A, 1993, ANN AM ACAD POLIT SS, V530, P74, DOI 10.1177/0002716293530001006; R Development Core Team, 2009, R LANG ENV STAT COMP; Rast P, 2012, MULTIVAR BEHAV RES, V47, P177, DOI 10.1080/00273171.2012.658328; Reeskens T., 2006, ETHNIC RACIAL STUD, V37, P2493; Retelsdorf J, 2012, BRIT J EDUC PSYCHOL, V82, P647, DOI 10.1111/j.2044-8279.2011.02051.x; Riederer B, 2015, EUR SOCIOL REV, V31, P628, DOI 10.1093/esr/jcv063; Rumbaut RG., 2001, ETHNICITIES CHILDREN; Schneeweis N, 2011, J POPUL ECON, V24, P1281, DOI 10.1007/s00148-009-0271-6; Schnepf SV, 2007, J POPUL ECON, V20, P527, DOI 10.1007/s00148-006-0102-y; Schutz G, 2008, KYKLOS, V61, P279, DOI 10.1111/j.1467-6435.2008.00402.x; Simonsen K. B., 2016, EUROPEAN J POLITICAL, V55, P1475; Sohn A., 2015, SSRN ELECT J; Spoerlein C, 2014, SOC SCI RES, V43, P1, DOI 10.1016/j.ssresearch.2013.07.016; Trautwein U, 2006, J EDUC PSYCHOL, V98, P788, DOI 10.1037/0022-0663.98.4.788; UNESCO, 2016, WORLD DAT ED 6 ED 20; UNU-WIDER, 2015, WORLD INC IN DAT WII; Van de Werfhorst HG, 2010, ANNU REV SOCIOL, V36, P407, DOI 10.1146/annurev.soc.012809.102538; van den Bergh L, 2010, AM EDUC RES J, V47, P497, DOI 10.3102/0002831209353594; Van Houtte M, 2012, ACTA SOCIOL, V55, P73, DOI 10.1177/0001699311431595; van Tubergen F, 2005, AM J SOCIOL, V110, P1412, DOI 10.1086/428931; van Tubergen F, 2004, AM SOCIOL REV, V69, P704, DOI 10.1177/000312240406900505; Voas D, 2012, ANNU REV SOCIOL, V38, P525, DOI 10.1146/annurev-soc-071811-145455; Western B, 2009, SOCIOL METHODOL, V39, P293, DOI 10.1111/j.1467-9531.2009.01222.x; World Bank, 2016, EXP ED TOT GOV EXP; Wossmann L., 2009, J I COMP, V7, P26	76	8	8	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193738	10.1371/journal.pone.0193738	http://dx.doi.org/10.1371/journal.pone.0193738			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494677	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200094
J	Yang, YQ; Yin, HX; Yuan, HB; Jiang, YW; Dong, CW; Deng, YL				Yang, Yan-Qin; Yin, Hong-Xu; Yuan, Hai-Bo; Jiang, Yong-Wen; Dong, Chun-Wang; Deng, Yu-Liang			Characterization of the volatile components in green tea by IRAE-HS-SPME/GC-MS combined with multivariate analysis	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; CHROMATOGRAPHY-MASS SPECTROMETRY; SIMULTANEOUS DISTILLATION-EXTRACTION; 2-DIMENSIONAL GAS-CHROMATOGRAPHY; PU-ERH TEA; ASSISTED EXTRACTION; GC-MS; CAPILLARY-ELECTROPHORESIS; BIOACTIVE CONSTITUENTS; AROMA COMPONENTS	In the present work, a novel infrared-assisted extraction coupled to headspace solid-phase microextraction ( IRAE-HS-SPME) followed by gas chromatography-mass spectrometry ( GC-MS) was developed for rapid determination of the volatile components in green tea. The extraction parameters such as fiber type, sample amount, infrared power, extraction time, and infrared lamp distance were optimized by orthogonal experimental design. Under optimum conditions, a total of 82 volatile compounds in 21 green tea samples from different geographical origins were identified. Compared with classical water-bath heating, the proposed technique has remarkable advantages of considerably reducing the analytical time and high efficiency. In addition, an effective classification of green teas based on their volatile profiles was achieved by partial least square-discriminant analysis ( PLS-DA) and hierarchical clustering analysis ( HCA). Furthermore, the application of a dual criterion based on the variable importance in the projection ( VIP) values of the PLS-DA models and on the category from one-way univariate analysis ( ANOVA) allowed the identification of 12 potential volatile markers, which were considered to make the most important contribution to the discrimination of the samples. The results suggest that IRAE-HS-SPME/GC-MS technique combined with multivariate analysis offers a valuable tool to assess geographical traceability of different tea varieties.	[Yang, Yan-Qin; Yin, Hong-Xu; Yuan, Hai-Bo; Jiang, Yong-Wen; Dong, Chun-Wang; Deng, Yu-Liang] Chinese Acad Agr Sci, Tea Res Inst, Minist Agr, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Yuan, HB; Jiang, YW (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Minist Agr, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China.	192168092@tricaas.com; jiangyw@tricaas.com		Yang, Yanqin/0000-0001-8793-9157	Natural Science Foundation of Zhejiang Province [LQ18C160006]; National Natural Science Foundation of China [31471651]; Science and Technology Innovation Project of the Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2014-TRICAAS]; Three Rural Six Project Foundation of Zhejiang Province [SN2014017]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Project of the Chinese Academy of Agricultural Sciences; Three Rural Six Project Foundation of Zhejiang Province	This work was supported by the Natural Science Foundation of Zhejiang Province (LQ18C160006), the National Natural Science Foundation of China (31471651), the Science and Technology Innovation Project of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-2014-TRICAAS) and the Three Rural Six Project Foundation of Zhejiang Province (SN2014017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasalvar C, 2012, J AGR FOOD CHEM, V60, P6323, DOI 10.1021/jf301498p; Baba R, 2014, J AGR FOOD CHEM, V62, P8308, DOI 10.1021/jf502308a; Bhuyan DJ, 2015, IND CROP PROD, V69, P290, DOI 10.1016/j.indcrop.2015.02.044; Cai Y, 2011, FOOD CHEM, V127, P1872, DOI 10.1016/j.foodchem.2011.02.026; Chan CH, 2011, J CHROMATOGR A, V1218, P6213, DOI 10.1016/j.chroma.2011.07.040; Chen YL, 2010, J SEP SCI, V33, P2888, DOI 10.1002/jssc.201000234; Cuevas FJ, 2016, FOOD CHEM, V199, P479, DOI 10.1016/j.foodchem.2015.12.049; Du LP, 2014, FOOD RES INT, V57, P61, DOI 10.1016/j.foodres.2014.01.008; Duan HT, 2010, J CHROMATOGR A, V1217, P4511, DOI 10.1016/j.chroma.2010.04.069; Fu YJ, 2012, J SEP SCI, V35, P468, DOI 10.1002/jssc.201100816; Fu YJ, 2011, J SEP SCI, V34, P3272, DOI 10.1002/jssc.201100649; Gan ZB, 2012, FOOD CHEM, V130, P1122, DOI 10.1016/j.foodchem.2011.08.018; Giannetti V, 2017, FOOD CONTROL, V78, P215, DOI 10.1016/j.foodcont.2017.02.036; Guo S, 2017, FUEL, V208, P499, DOI 10.1016/j.fuel.2017.07.032; He CJ, 2016, ANAL METHODS-UK, V8, P4727, DOI 10.1039/c6ay00700g; Hou WQ, 2016, MICROCHEM J, V128, P75, DOI 10.1016/j.microc.2016.04.011; Hu YC, 2014, J SEP SCI, V37, P404, DOI 10.1002/jssc.201301102; Cuevas FJ, 2017, FOOD CHEM, V221, P1930, DOI 10.1016/j.foodchem.2016.11.156; Kumazawa K, 2002, J AGR FOOD CHEM, V50, P5660, DOI 10.1021/jf020498j; Kwon TY, 2013, J AGR FOOD CHEM, V61, P8514, DOI 10.1021/jf402487a; Lv S., 2014, PLOS ONE, V9; Magagna F, 2017, FOOD CHEM, V225, P276, DOI 10.1016/j.foodchem.2017.01.003; Qin ZH, 2013, FOOD RES INT, V53, P864, DOI 10.1016/j.foodres.2013.02.005; Rega B, 2009, FOOD CHEM, V112, P9, DOI 10.1016/j.foodchem.2008.05.028; San AT, 2017, FOOD CHEM, V221, P613, DOI 10.1016/j.foodchem.2016.11.130; Sheibani E, 2016, J FOOD SCI, V81, pC348, DOI 10.1111/1750-3841.13203; Tang JC, 2016, APPL ENERG, V169, P696, DOI 10.1016/j.apenergy.2016.02.042; Tang ZT, 2016, J CHROMATOGR A, V1461, P18, DOI 10.1016/j.chroma.2016.07.047; Wu Y, 2016, CHEM CENTRAL J, P10; Wu YS, 2016, CYTA-J FOOD, V14, P423, DOI 10.1080/19476337.2015.1123298; Xu YQ, 2016, FOOD ANAL METHOD, V9, P1188, DOI 10.1007/s12161-015-0303-7; Yang CQ, 2017, ANAL METHODS-UK, V9, P2144, DOI [10.1039/c7ay00011a, 10.1039/C7AY00011A]; Yang YQ, 2016, J SEP SCI, V39, P4192, DOI 10.1002/jssc.201600503; Yang YQ, 2016, J SEP SCI, V39, P1173, DOI 10.1002/jssc.201501185; Yang YQ, 2011, TALANTA, V86, P356, DOI 10.1016/j.talanta.2011.09.028; Ye J, 2016, ANAL METHODS-UK, V8, P593, DOI 10.1039/c5ay02652k; Yener S, 2016, TALANTA, V152, P45, DOI 10.1016/j.talanta.2016.01.050; Zheng J, 2014, FOOD RES INT, V56, P77, DOI 10.1016/j.foodres.2013.12.011; Zhu Y, 2016, SEP PURIF TECHNOL, V164, P146, DOI 10.1016/j.seppur.2016.03.028	39	26	34	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193393	10.1371/journal.pone.0193393	http://dx.doi.org/10.1371/journal.pone.0193393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494626	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200043
J	Adil, M; Lee, K; Zaid, HM; Latiff, NRA; Alnarabiji, MS				Adil, Muhammad; Lee, Keanchuan; Zaid, Hasnah Mohd; Latiff, Noor Rasyada Ahmad; Alnarabiji, Mohamad Sahban			Experimental study on electromagnetic-assisted ZnO nanofluid flooding for enhanced oil recovery (EOR)	PLOS ONE			English	Article							NANOPARTICLES; SANDSTONE	Recently, nano-EOR has emerged as a new frontier for improved and enhanced oil recovery (IOR & EOR). Despite their benefits, the nanoparticles tend to agglomerate at reservoir conditions which cause their detachment from the oil/water interface, and are consequently retained rather than transported through a porous medium. Dielectric nanoparticles including ZnO have been proposed to be a good replacement for EOR due to their high melting point and thermal properties. But more importantly, these particles can be polarized under electromagnetic (EM) irradiation, which provides an innovative smart Nano-EOR process denoted as EM-Assisted Nano-EOR. In this study, parameters involved in the oil recovery mechanism under EM waves, such as reducing mobility ratio, lowering interfacial tensions (IFT) and altering wettability were investigated. Two-phase displacement experiments were performed in sandpacks under the water-wet condition at 95 degrees C, with permeability in the range of 265-300 mD. A crude oil from Tapis oil field was employed; while ZnO nanofluids of two different particle sizes (55.7 and 117.1 nm) were prepared using 0.1 wt. % nanoparticles that dispersed into brine (3 wt. % NaCl) along with SDBS as a dispersant. In each flooding scheme, three injection sequential scenarios have been conducted: (i) brine flooding as a secondary process, (ii) surfactant/nano/EM-assisted nano flooding, and (iii) second brine flooding to flush nanoparticles. Compare with surfactant flooding (2% original oil in place/OOIP) as tertiary recovery, nano flooding almost reaches 8.5-10.2% of OOIP. On the other hand, EM-assisted nano flooding provides an incremental oil recovery of approximately 9-10.4% of OOIP. By evaluating the contact angle and interfacial tension, it was established that the degree of IFT reduction plays a governing role in the oil displacement mechanism via nano-EOR, compare to mobility ratio. These results reveal a promising way to employ water-based ZnO nanofluid for enhanced oil recovery purposes at a relatively high reservoir temperature.	[Adil, Muhammad; Lee, Keanchuan; Zaid, Hasnah Mohd; Latiff, Noor Rasyada Ahmad] Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Tronoh, Perak, Malaysia; [Alnarabiji, Mohamad Sahban] Univ Teknol PETRONAS, Dept Chem Engn, Tronoh, Perak, Malaysia	Universiti Teknologi Petronas; Universiti Teknologi Petronas	Lee, K (corresponding author), Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Tronoh, Perak, Malaysia.	lee.kc@utp.edu.my	Alnarabiji, Mohamad/AAH-6736-2019; Muhammad, Adil/AAH-9333-2020	Muhammad, Adil/0000-0001-8269-2984	Universiti Teknologi PETRONAS [YUTP 0153AA-E17]; Universiti Teknologi PETRONAS	Universiti Teknologi PETRONAS; Universiti Teknologi PETRONAS	The corresponding author, Lee Kean Chuan, received a funding from Universiti Teknologi PETRONAS under the grant YUTP 0153AA-E17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Universiti Teknologi PETRONAS for funding the research.	Abu El Ela M, 2012, OIL GAS J, V110, P84; Adil M, 2016, AIP C P, V1787; Adil M, 2016, ENERG FUEL, V30, P6169, DOI 10.1021/acs.energyfuels.6b01116; Adil M, 2015, AIP CONF PROC, V1669, DOI 10.1063/1.4919154; Ahmed T, 2010, RESERVOIR ENGINEERING HANDBOOK, 4TH EDITION, P733; Al-Mjeni R., 2010, OILFIELD REV, V22, P16; [Anonymous], 2012, AB DHAB INT PETR C E; Carcoana A., 1992, APPL ENHANCED OIL RE, P135; Chang H.L., 2006, J PET TECHNOL, V58, P84, DOI [10.2118/89175-JPT, DOI 10.2118/89175-JPT]; CHATZIS I, 1984, SOC PETROL ENG J, V24, P555, DOI 10.2118/10114-PA; Craig F.F, 1980, MONOGR SER SOC PET E, V3; Cui MM, 2013, SCIENCE, V342, P460, DOI 10.1126/science.1242852; Donaldson EC., 1985, ENHANCED OIL RECOVER; Ehtesabi H, 2014, ENERG FUEL, V28, P423, DOI 10.1021/ef401338c; Green D.W., 1998, ENHANCED OIL RECOVER; GUPTA SP, 1979, SOC PETROL ENG J, V19, P116, DOI 10.2118/7063-PA; Hendraningrat L, 2014, UNLOCKING POTENTIAL; Hendraningrat L, 2013, SPE RESERVOIR CHARAC; Hendraningrat L, 2013, J PETROL SCI ENG, V111, P128, DOI 10.1016/j.petrol.2013.07.003; Latimer N., 2011, 2011 NAT POSTGR C, P1; Li X, 2010, SPE W REG M; Manousaki E, 2004, WATER RES, V38, P3751, DOI 10.1016/j.watres.2004.06.002; Miranda C., 2012, SOC PETR ENG SPE INT, V2012; Moore T., 1955, 30 ANN FALL M PETR B; Morrow N. R., 1990, J PETROL TECHNOL, V42, P1; Morrow NR., 1987, REV EFFECTS INITIAL; Ogolo N.A., 2012, SPE SAUD AR SECT TEC; Pwaga S., 2010, COMP STUDY DIFFERENT; Roustaei A., 2013, EGYPT J PET, V22, P427, DOI [DOI 10.1016/J.EJPE.2013.06.010, 10.1016/j.ejpe.2013.06.010]; Shandrygin AN, 2008, SPE ANN TECHN C EXH; Tang GQ, 1997, SPE RESERVOIR ENG, V12, P269, DOI 10.2118/36680-PA; Torsater O, 2012, SPE KUW INT PETR C E; Vargo J., 1999, SPE ROCK MOUNT REG M; Viksund B.G., 1998, P 1998 INT S SOC COR; Wu Y., 2009, EXPT STUDY POLYM ENH; Zaid HM, 2017, INT J NANOTECHNOL, V14, P284, DOI 10.1504/IJNT.2017.082478; Zaid HM, 2016, AIP C P, V1787; Zhang TT, 2015, SPE J, V20, P667, DOI 10.2118/166346-PA	38	45	46	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193518	10.1371/journal.pone.0193518	http://dx.doi.org/10.1371/journal.pone.0193518			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489897	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000084
J	Beaulieu, M; Breton, M; Brousselle, A				Beaulieu, Marianne; Breton, Mylaine; Brousselle, Astrid			Conceptualizing 20 years of engaged scholarship: A scoping review	PLOS ONE			English	Review							KNOWLEDGE TRANSLATION; DEFINITION; UNIVERSITY; RELEVANCE; SERVICE; TIME	Engaged scholarship, a movement that has been growing steadily since 1995, offers a new way of bridging gaps between the university and civil society. Numerous papers and reports have been published since Boyer's foundational discourse in 1996. Yet, beyond a growing interest in orienting universities' missions, we observed a lack a formal definition and conceptualization of this movement. Based on a scoping review of the literature over the past 20 years, the objective of this article is to propose a conceptualization of engaged scholarship. More specifically, we define its values, principles, and processes. We conclude with a discussion of the implications of this new posture for faculty and students, as well as for the university as an institution.	[Beaulieu, Marianne; Breton, Mylaine; Brousselle, Astrid] Ctr Rech Charles Le Moyne Saguenay Lac St Jean In, Longueuil, PQ, Canada; [Beaulieu, Marianne; Breton, Mylaine; Brousselle, Astrid] Univ Sherbrooke, Dept Sci Sante Communautaire, Longueuil, PQ, Canada; [Brousselle, Astrid] Univ Victoria, Sch Publ Adm, Victoria, BC, Canada	University of Sherbrooke; University of Victoria	Brousselle, A (corresponding author), Ctr Rech Charles Le Moyne Saguenay Lac St Jean In, Longueuil, PQ, Canada.; Brousselle, A (corresponding author), Univ Sherbrooke, Dept Sci Sante Communautaire, Longueuil, PQ, Canada.; Brousselle, A (corresponding author), Univ Victoria, Sch Publ Adm, Victoria, BC, Canada.	astrid@uvic.ca		Brousselle, Astrid/0000-0003-4237-2518; Breton, Mylaine/0000-0001-5713-9618; beaulieu, marianne/0000-0001-5416-2847	Fonds de recherche du Quebec-Sante (Canada); Centre de recherche Charles-Le Moyne - Saguenay-Lac-Saint-Jean sur les innovations en sante; Canada Research Chair in Evaluation on Health System Improvement; Canada Research Chair in Clinical Governance in Primary Health Care; Fonds de recherche du Quebec-Sante (FRQS); Centre de recherche Charles-Le Moyne Saguenay-Lac-Saint-Jean sur les innovations en sante; Canadian Institutes of Health Research	Fonds de recherche du Quebec-Sante (Canada); Centre de recherche Charles-Le Moyne - Saguenay-Lac-Saint-Jean sur les innovations en sante; Canada Research Chair in Evaluation on Health System Improvement; Canada Research Chair in Clinical Governance in Primary Health Care; Fonds de recherche du Quebec-Sante (FRQS); Centre de recherche Charles-Le Moyne Saguenay-Lac-Saint-Jean sur les innovations en sante; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Fonds de recherche du Quebec-Sante (Canada), the Centre de recherche Charles-Le Moyne - Saguenay-Lac-Saint-Jean sur les innovations en sante, the Canada Research Chair in Evaluation on Health System Improvement and the Canada Research Chair in Clinical Governance in Primary Health Care.; The authors are grateful to the Fonds de recherche du Quebec-Sante (FRQS) and to the Centre de recherche Charles-Le Moyne Saguenay-Lac-Saint-Jean sur les innovations en sante which funded Marianne Beaulieu's postdoctoral awards. We would also like to thank the Canadian Institutes of Health Research which funded Astrid Brousselle's Canada Research Chair in Evaluation on Health System Improvement and Mylaine Breton's Canada Research Chair in Clinical Governance in Primary Health Care.	Adshead M, 2015, SOC ALTERN, V34, P13; Arksey, 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Barge JK, 2008, J APPL COMMUN RES, V36, P251, DOI 10.1080/00909880802172277; Barker D., 2004, J HIGHER ED OUTREACH, V9, P1; Barreno L, 2013, RES REPORT; Bhattacharyya G, 2013, ETHNIC RACIAL STUD, V36, P1359, DOI 10.1080/01419870.2013.791399; Bowen SJ, 2013, ARCH PHYS MED REHAB, V94, pS3, DOI 10.1016/j.apmr.2012.04.037; Boyer EL., 1996, B AM ACAD ARTS SCI, V1, P11, DOI DOI 10.2307/3824459; Bridger J.C., 2006, J HIGHER ED OUTREACH, V11, P163, DOI [10.1080/15575330609490151, DOI 10.1080/15575330609490151]; Britner P.A., 2012, J HIGHER ED OUTREACH, V16, P61; Browman Geroge P, 2003, Healthc Pap, V3, P10; Brown LD, 2003, ACTION RES LOND, V1, P81, DOI DOI 10.1177/14767503030011006; Burrage J, 2005, NURS OUTLOOK, V53, P220, DOI 10.1016/j.outlook.2005.02.003; Calleson DC, 2005, ACAD MED, V80, P317, DOI 10.1097/00001888-200504000-00002; Campbell H, 2012, PLAN THEORY PRACT, V13, P349, DOI 10.1080/14649357.2012.711508; Cargo M, 2008, ANNU REV PUBL HEALTH, V29, P325, DOI 10.1146/annurev.publhealth.29.091307.083824; Checkoway B., 2013, J HIGHER ED OUTREACH, V17, P7; Colbeck C. L., 2006, NEW DIRECTIONS I RES, V129, P7; Colbeck CL., 2006, NEW DIRECTIONS TEACH, V2006, P17, DOI DOI 10.1002/tl.221; Colledge T. H., 2014, INT J SERVO LEARN EN, P97, DOI 1O.24908/ijsle.vOiO.5587; Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013; Contandriopoulos D, 2010, HEALTH POLICY, V95, P144, DOI 10.1016/j.healthpol.2009.11.018; Cooper T, 2013, J HIGHER ED THEORY P, V13, P57; Cuthill M., 2010, THE AUSTRALASIAN JOU, V5, P126; Cuthill M, 2014, AUST UNIV REV, V56, P36; Cuthill M, 2010, GATEWAYS, V3, P20, DOI 10.5130/ijcre.v3i0.584; DeLugan R.M., 2014, J HIGHER ED OUTREACH, V18, P155; Doberneck DianeM., 2010, J HIGHER ED OUTREACH, V14, P5, DOI DOI 10.1080/1461380990010206; Douglas S, 2012, S AFR REV SOCIOL, V43, P27, DOI 10.1080/21528586.2012.694241; Finkelstein M. A., 2001, J HIGHER OUTREACH ED, V6, P35; Fitzgerald H., 2012, J HIGHER ED OUTREACH, V16, P7, DOI DOI 10.1080/0022250X.1999.9990219; Frankham J, 2012, CONTEMP SOC SCI, V7, P73, DOI 10.1080/21582041.2012.658431; Franz N, 2009, J HIGHER ED OUTREACH, V13, P31; Furco A, 2010, BRIT J EDUC STUD, V58, P375, DOI 10.1080/00071005.2010.527656; Gelmon S.B., 2013, CHANG MAG HIGH LEARN, V45, P58, DOI [10.1080/00091383.2013.806202, DOI 10.1080/00091383.2013.806202]; Gibson C. M., 2012, J HIGHER ED OUTREACH, P235; Giles D. E., 2008, J HIGHER ED OUTREACH, V12, P97; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Hartelius EJ, 2010, Q J SPEECH, V96, P436, DOI 10.1080/00335630.2010.521180; Karp I, 2012, ARTS HUM HIGH EDUC, V11, P285, DOI 10.1177/1474022212437007; Leshner AI, 2015, SCIENCE, V347, P459, DOI 10.1126/science.aaa7477; McCormack B, 2011, J RES NURS, V16, P111, DOI 10.1177/1744987110393419; Mitchell J, 2012, GERONTOL GERIATR EDU, V33, P337, DOI 10.1080/02701960.2012.702168; Morton MA, 2013, TEACHING LEARNING IN, V16; Nemire RE, 2009, AM J PHARM EDUC, V73, DOI 10.5688/aj730467; Paynter S, 2014, J COMMUNITY ENGAGEME, V17, P48; Potter MA, 2009, PUBLIC HEALTH REP, V124, pA1; Ramaley JA, 2009, METROPOLITAN U, V20, P139; Sandmann L, 2006, J PHYS THERAPY ED, V20, P80, DOI DOI 10.1097/00001416-200610000-00013; Sandmann Lorilee, 2008, J HIGHER ED OUTREACH, V12, P47; Sandmann LR., 2008, J HIGHER ED OUTREACH, V12, P91; Schneider C. G., 2001, LIBERAL EDUC, V87, P18; Schwab K., 2014, SCHOLE J LEISURE STU, V29; Shackford-Bradley J., 2013, PARTNERSHIPS J SERVI, V4, P137; Silka L., 2013, TAMARA J CRITICAL OR, V11, P41; Toma JD, 1997, J HIGH EDUC, V68, P679, DOI 10.2307/2959968; Tsui AS, 2013, HUM RESOUR DEV Q, V24, P137, DOI 10.1002/hrdq.21161; Van de Ven AH, 2006, ACAD MANAGE REV, V31, P822; Vogelgesang LJ, 2010, REV HIGH EDUC, V33, P437; Wood M., 2003, J HIGHER ED OUTREACH, V8, P165	60	48	48	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193201	10.1371/journal.pone.0193201	http://dx.doi.org/10.1371/journal.pone.0193201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489870	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000057
J	Buijs, RVC; Leemans, EL; Greuter, M; Tielliu, IFJ; Zeebregts, CJ; Willems, TP				Buijs, Ruben V. C.; Leemans, Eva L.; Greuter, Marcel; Tielliu, Ignace F. J.; Zeebregts, Clark J.; Willems, Tineke P.			Quantification of abdominal aortic calcification: Inherent measurement errors in current computed tomography imaging	PLOS ONE			English	Article							CORONARY-ARTERY CALCIUM; CARDIOVASCULAR EVENTS; CT; ATHEROSCLEROSIS; REPRODUCIBILITY; RECONSTRUCTION; PREDICTOR; RATES	Objective Quantification software for coronary calcification is often used to measure abdominal aortic calcification on computed tomography (CT) images. However, there is no evidence substantiating the reliability and accuracy of these tools in this setting. Differences in coronary and abdominal CT acquisition and presence of intravascular contrast may affect the results of these tools. Therefore, this study investigates the effects of CT acquisition parameters and iodine contrast on automated quantification of aortic calcium on CT. Methods Calcium scores, provided in volume and mass, were assessed by automated calcium quantification software on CT scans. First, differences in calcium scores between the abdominal and coronary CT scanning protocols were assessed by imaging a thorax phantom containing calcifications of 9 metrical variations. Second, aortic calcification was quantified in 50 unenhanced and contrast-enhanced clinical abdominal CT scans at a calcification threshold of 299 Hounsfield Units (HU). Also, the lowest possible HU threshold for calcifications was calculated per individual patient and compared to a 130 HU threshold between contrast enhanced and unenhanced CT images, respectively. Results No significant differences in volume and mass scores between the abdominal and the coronary CT protocol were found. However, volume and mass of all calcifications were overestimated compared to the physical volume and mass (volume range: 0-649%; mass range: 0-2619%). In comparing unenhanced versus contrast-enhanced CT images showed significant volume differences for both thresholds, as well as for mass differences for the 130 vs patient-specific threshold (230 +/- 22.6 HU). Conclusion Calcification scoring on CT angiography tends to grossly overestimate volume and mass suggesting a low accuracy and reliability. These are reduced further by interference of intravascular contrast. Future studies applying calcium quantification tools on CT angiography imaging should acknowledge these issues and apply corrective measures to ensure the validity of their outcomes.	[Buijs, Ruben V. C.; Tielliu, Ignace F. J.; Zeebregts, Clark J.] Univ Groningen, Univ Med Ctr Groningen, Div Vasc Surg, Dept Surg, Groningen, Netherlands; [Leemans, Eva L.] Acad Med Ctr, Dept Biomech Engn & Phys, Amsterdam, Netherlands; [Leemans, Eva L.] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Greuter, Marcel; Willems, Tineke P.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Zeebregts, CJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Vasc Surg, Dept Surg, Groningen, Netherlands.	czeebregts@hotmail.com	Greuter, Marcel J W/B-4363-2013	Greuter, Marcel J W/0000-0001-5721-9159; Leemans, Eva/0000-0002-3640-9938				3Mensio structural heart, 2017, 3MENSIO STRUCT HEART; Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Criqui MH, 2014, ARTERIOSCL THROM VAS, V34, P1574, DOI 10.1161/ATVBAHA.114.303268; Doherty TM, 2004, ENDOCR REV, V25, P629, DOI 10.1210/er.2003-0015; Golestani R, 2010, ANN MED, V42, P539, DOI 10.3109/07853890.2010.515604; Goncalves FB, 2012, HEART, V98, P988, DOI 10.1136/heartjnl-2011-301464; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Groen JM, 2007, INVEST RADIOL, V42, P848, DOI 10.1097/RLI.0b013e318154c549; Komen N, 2011, ACTA RADIOL, V52, P943, DOI 10.1258/ar.2011.110189; Komen N, 2011, AM J SURG, V201, P759, DOI 10.1016/j.amjsurg.2010.01.033; McCollough CH, 2007, RADIOLOGY, V243, P527, DOI 10.1148/radiol.2432050808; Pallant J., 2007, SPSS SURVIVAL MANUAL, V3rd ed.; Parikh NI, 2008, AM J CARDIOL, V102, P440, DOI 10.1016/j.amjcard.2008.04.007; Rolf A, 2013, INT J CARDIOVAS IMAG, V29, P1819, DOI 10.1007/s10554-013-0258-y; Saremi A, 2010, DIABETES CARE, V33, P2642, DOI 10.2337/dc10-1388; Stortecky S, 2014, EUROINTERVENTION, V10, P339, DOI 10.4244/EIJV10I3A59; VanWagner LB, 2014, ATHEROSCLEROSIS, V235, P599, DOI 10.1016/j.atherosclerosis.2014.05.962; Weininger M, 2012, RADIOLOGY, V265, P70, DOI 10.1148/radiol.12112532	19	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193419	10.1371/journal.pone.0193419	http://dx.doi.org/10.1371/journal.pone.0193419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489868	Green Submitted, gold, Green Published			2022-12-27	WOS:000426276000074
J	Miyagishi, Y; Ikeda, T; Takahashi, T; Kudo, K; Morise, H; Minabe, Y; Kikuchi, M				Miyagishi, Yoshiaki; Ikeda, Takashi; Takahashi, Tetsuya; Kudo, Kiwamu; Morise, Hirofumi; Minabe, Yoshio; Kikuchi, Mitsuru			Gamma-band auditory steady-state response after frontal tDCS: A double-blind, randomized, crossover study	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; MOTOR CORTEX EXCITABILITY; TRANSCRANIAL ELECTRICAL-STIMULATION; NONINVASIVE BRAIN-STIMULATION; CURRENT THERAPY; SCHIZOPHRENIA; OSCILLATIONS; MEG; METAANALYSIS; MODULATION	The effects of transcranial direct current stimulation (tDCS) likely depend on cortical N-methyl-D-aspartic acid (NMDA) neurotransmission; however, no previous studies have reported tDCS-mediated modulation of cortical NMDA neurotransmission in humans. The gamma-band auditory steady-state response (ASSR) to a 40 Hz stimulation likely reflects the integrity of cortical NMDA neurotransmission. The present study tested whether the effect of tDCS is reflected in gamma-band ASSRs during a 40 Hz stimulation. Using a double-blind, randomized, crossover study, we performed magnetoen-cephalography (MEG) and measured the ASSR in 24 healthy participants during 40 Hz of auditory stimulation after prefrontal tDCS (2 mA) or sham (i.e., placebo) treatment. Our results failed to reveal significant differences in any brain between the two conditions after the application of a frequency of approximately 40 Hz. Based on these results, the ASSR is an insufficient method to detect the effect of tDCS on cortical NMDA neurotransmission. Unexpectedly, the results revealed an enhanced beta-band event related spectral perturbation (ERSP) in the left motor cortex after tDCS compared with that observed after the sham stimuli. Given that beta-band oscillations reflect many functions in motor cortices, the tDCS for the frontal areas had some effect on the left motor cortex while the participants were focusing on not pressing the button with their right index finger. An additional study with an adequate psychological task is necessary to draw a conclusion regarding this unexpected result.	[Miyagishi, Yoshiaki; Minabe, Yoshio] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan; [Ikeda, Takashi; Minabe, Yoshio; Kikuchi, Mitsuru] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Takahashi, Tetsuya] Univ Fukui, Hlth Adm Ctr, Fukui, Japan; [Kudo, Kiwamu; Morise, Hirofumi] Ricoh Co Ltd, Res & Dev Div, Ricoh Inst Future Technol, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; University of Fukui; Ricoh Company, Ltd.	Ikeda, T (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan.	tikeda@med.kanazawa-u.ac.jp		Ikeda, Takashi/0000-0001-9550-5033; Morise, Hirofumi/0000-0002-8749-9822	Centre of Innovation Program from the Japan Science and Technology Agency	Centre of Innovation Program from the Japan Science and Technology Agency	This work was supported by the Centre of Innovation Program from the Japan Science and Technology Agency (https://www.coistream.osakau.ac.jp/en) to Y.Minabe. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ricoh Company, Ltd. provided support in the form of salaries for authors, KK and HM, but did not have any additional role in the study design, data	Alegre M, 2004, EXP BRAIN RES, V159, P14, DOI 10.1007/s00221-004-1928-8; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Baudewig J, 2001, MAGN RESON MED, V45, P196, DOI 10.1002/1522-2594(200102)45:2<196::AID-MRM1026>3.0.CO;2-1; Beeli G, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-33; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Bose A, 2017, SCHIZOPHRENIA RES; Brunoni AR, 2017, NEW ENGL J MED, V376, P2523, DOI 10.1056/NEJMoa1612999; Brunoni AR, 2013, JAMA PSYCHIAT, V70, P383, DOI 10.1001/2013.jamapsychiatry.32; Coffman BA, 2014, NEUROIMAGE, V85, P895, DOI 10.1016/j.neuroimage.2013.07.083; Edgar JC, 2014, NEUROIMAGE-CLIN, V4, P122, DOI 10.1016/j.nicl.2013.11.004; Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098; Fox D, 2011, NATURE, V472, P156, DOI 10.1038/472156a; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hamm JP, 2012, SCHIZOPHR RES, V138, P1, DOI 10.1016/j.schres.2012.04.003; Hamm JP, 2011, BIOL PSYCHIAT, V69, P989, DOI 10.1016/j.biopsych.2010.11.021; Hill AT, 2016, BRAIN STIMUL, V9, P197, DOI 10.1016/j.brs.2015.10.006; Hirano Y, 2015, JAMA PSYCHIAT, V72, P813, DOI 10.1001/jamapsychiatry.2014.2642; Horvath JC, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00002; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Kirihara K, 2012, BIOL PSYCHIAT, V71, P873, DOI 10.1016/j.biopsych.2012.01.016; Krishnan GP, 2009, NEUROIMAGE, V47, P1711, DOI 10.1016/j.neuroimage.2009.03.085; Kuo MF, 2014, NEUROIMAGE, V85, P948, DOI 10.1016/j.neuroimage.2013.05.117; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Leocani L, 2001, CLIN NEUROPHYSIOL, V112, P923, DOI 10.1016/S1388-2457(01)00530-2; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Medeiros Liciane Fernandes, 2012, Front Psychiatry, V3, P110, DOI 10.3389/fpsyt.2012.00110; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Muthukumaraswamy SD, 2013, NEUROIMAGE, V69, P223, DOI 10.1016/j.neuroimage.2012.12.038; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Rass O, 2012, SCHIZOPHR RES, V136, P143, DOI 10.1016/j.schres.2012.01.003; Sivarao DV, 2016, NEUROPSYCHOPHARMACOL, V41, P2232, DOI 10.1038/npp.2016.17; Sivarao DV, 2015, ANN NY ACAD SCI, V1344, P27, DOI 10.1111/nyas.12739; Soltaninejad Z, 2015, J ATTEN DISORD; Spencer KM, 2008, BIOL PSYCHIAT, V64, P369, DOI 10.1016/j.biopsych.2008.02.021; Swann N, 2009, J NEUROSCI, V29, P12675, DOI 10.1523/JNEUROSCI.3359-09.2009; Tada M, 2016, CEREB CORTEX, V26, P1027, DOI 10.1093/cercor/bhu278; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tan HRM, 2015, NEUROIMAGE, V122, P417, DOI 10.1016/j.neuroimage.2015.07.055; Teale P, 2008, NEUROIMAGE, V42, P1481, DOI 10.1016/j.neuroimage.2008.06.020; Thune H, 2016, JAMA PSYCHIAT, V73, P1145, DOI 10.1001/jamapsychiatry.2016.2619; Truong DQ, 2014, BRAIN STIMUL, V7, P521, DOI 10.1016/j.brs.2014.03.009; Tsuchimoto R, 2011, SCHIZOPHR RES, V133, P99, DOI 10.1016/j.schres.2011.07.020; Turi Z, 2012, CLIN EEG NEUROSCI, V43, P200, DOI 10.1177/1550059412444978; Wilson TW, 2008, CEREB CORTEX, V18, P371, DOI 10.1093/cercor/bhm062	47	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193422	10.1371/journal.pone.0193422	http://dx.doi.org/10.1371/journal.pone.0193422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489895	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000075
J	Svart, M; Gormsen, LC; Hansen, J; Zeidler, D; Gejl, M; Vang, K; Aanerud, J; Moeller, N				Svart, Mads; Gormsen, Lars C.; Hansen, Jakob; Zeidler, Dora; Gejl, Michael; Vang, Kim; Aanerud, Joel; Moeller, Niels			Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial	PLOS ONE			English	Article							BETA-HYDROXYBUTYRATE; ENERGY-METABOLISM; OXIDATIVE STRESS; BRAIN METABOLISM; KETOGENIC DIET; ALZHEIMERS; BODIES; FUEL; OUTCOMES; HYPOXIA	Ketone bodies are neuroprotective in neurological disorders such as epilepsy. We randomly studied nine healthy human subjects twice with and without continuous infusion of 3-hydroxybutyrate-to define potential underlying mechanisms, assessed regionally (parietal, occipital, temporal, cortical grey, and frontal) by PET scan. During 3-hydroxybutyrate infusions concentrations increased to 5.5 0.4 mmol/l and cerebral glucose utilisation decreased 14%, oxygen consumption remained unchanged, and cerebral blood flow increased 30%. We conclude that acute 3-hydroxybutyrate infusion reduces cerebral glucose uptake and increases cerebral blood flow in all measured brain regions, without detectable effects on cerebral oxygen uptake though oxygen extraction decreased. Increased oxygen supply concomitant with unchanged oxygen utilisation may contribute to the neuroprotective effects of ketone bodies.	[Svart, Mads; Moeller, Niels] Aarhus Univ Hosp, Dept Internal Med & Endocrinol, Aarhus, Denmark; [Svart, Mads; Moeller, Niels] Aarhus Univ Hosp, Dept Clin Med, Aarhus, Denmark; [Gormsen, Lars C.; Vang, Kim; Aanerud, Joel] Aarhus Univ Hosp, Dept Nucl Med, Aarhus, Denmark; [Gormsen, Lars C.; Vang, Kim; Aanerud, Joel] Aarhus Univ Hosp, PET Ctr, Aarhus, Denmark; [Hansen, Jakob] Aarhus Univ Hosp, Dept Forens Med, Sect Forens Chem, Aarhus, Denmark; [Zeidler, Dora] Aarhus Univ Hosp, Dept Clin Med, CFIN, Aarhus, Denmark; [Zeidler, Dora] Aarhus Univ Hosp, Dept Clin Med, MINDLab, Aarhus, Denmark; [Gejl, Michael] Aarhus Univ, Inst Biomed, Aarhus, Denmark; [Gejl, Michael] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Svart, M (corresponding author), Aarhus Univ Hosp, Dept Internal Med & Endocrinol, Aarhus, Denmark.; Svart, M (corresponding author), Aarhus Univ Hosp, Dept Clin Med, Aarhus, Denmark.	mvsv@clin.au.dk	Hansen, Jakob/W-1318-2017; Moller, Niels/E-5091-2011; Gormsen, Lars Christian/C-6531-2017; Gormsen, Lars Christian/C-6531-2017	Hansen, Jakob/0000-0002-4115-2858; Moller, Niels/0000-0001-5627-7322; Gormsen, Lars Christian/0000-0001-6937-704X; Gormsen, Lars Christian/0000-0002-0144-1305; , Mads/0000-0002-9574-0612	Danish Council for Strategic Research [0603-00479B]; Aase Danielsen Fund [10-001731]; Ferd.Og Ellen Hindsgauls Fund [J.nr.102559]; Danish Medical Association [Jnr.2016-1840/1]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Aase Danielsen Fund; Ferd.Og Ellen Hindsgauls Fund; Danish Medical Association	This work was funded by the Danish Council for Strategic Research (grant no.0603-00479B), Aase Danielsen Fund(10-001731), Ferd.Og Ellen Hindsgauls Fund (J.nr.102559), and the Danish Medical Association(Jnr.2016-1840/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOMQVIST G, 1984, J CEREBR BLOOD F MET, V4, P629, DOI 10.1038/jcbfm.1984.89; Bouteldja N, 2014, METABOLISM, V63, P1375, DOI 10.1016/j.metabol.2014.08.001; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; CHANG ASY, 1993, CAN J PHYSIOL PHARM, V71, P465, DOI 10.1139/y93-068; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Edwards C, 2014, AGING-US, V6, P621, DOI 10.18632/aging.100683; Forstermann U, 2017, CIRC RES, V120, P713, DOI 10.1161/CIRCRESAHA.116.309326; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Graham MM, 2002, J NUCL MED, V43, P1157; Hasselbalch SG, 1996, AM J PHYSIOL-ENDOC M, V270, pE746, DOI 10.1152/ajpendo.1996.270.5.E746; HOYER S, 1985, ARCH GERONTOL GERIAT, V4, P193, DOI 10.1016/0167-4943(85)90001-9; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; KIRSCH JR, 1980, STROKE, V11, P506, DOI 10.1161/01.STR.11.5.506; Korsholm K, 2013, CLIN NUCL MED, V38, P38, DOI 10.1097/RLU.0b013e31827082c4; Linde R, 2006, J CEREBR BLOOD F MET, V26, P170, DOI 10.1038/sj.jcbfm.9600177; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Marosi K, 2016, J NEUROCHEM, V139, P769, DOI 10.1111/jnc.13868; Mikkelsen KH, 2015, J CLIN ENDOCR METAB, V100, P636, DOI 10.1210/jc.2014-2608; Mosconi L, 2013, CLIN TRANSL IMAGING, V1, P217, DOI 10.1007/s40336-013-0026-y; Mudaliar S, 2016, DIABETES CARE, V39, P1115, DOI 10.2337/dc16-0542; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; OHTA S, 1992, J CEREBR BLOOD F MET, V12, P179, DOI 10.1038/jcbfm.1992.28; Ohta S, 1996, J CEREBR BLOOD F MET, V16, P765, DOI 10.1097/00004647-199609000-00002; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; RANDLE PJ, 1963, LANCET, V1, P785; REDIES C, 1989, AM J PHYSIOL, V256, pE805, DOI 10.1152/ajpendo.1989.256.6.E805; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; Schonfeld P, 2013, J CEREBR BLOOD F MET, V33, P1493, DOI 10.1038/jcbfm.2013.128; Shen XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039256; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Sleiman SF, 2016, ELIFE, V5, DOI 10.7554/eLife.15092; Sorensen LK, 2013, CLIN BIOCHEM, V46, P1877, DOI 10.1016/j.clinbiochem.2013.08.011; Veech RL, 2001, IUBMB LIFE, V51, P241; Vlassenko AG, 2006, P NATL ACAD SCI USA, V103, P1964, DOI 10.1073/pnas.0510632103; Yin JX, 2015, J CEREBR BLOOD F MET, V35, P1783, DOI 10.1038/jcbfm.2015.123; Zhang YF, 2013, J CEREBR BLOOD F MET, V33, P1307, DOI 10.1038/jcbfm.2013.87; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	41	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0190556	10.1371/journal.pone.0190556	http://dx.doi.org/10.1371/journal.pone.0190556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489818	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000004
J	Tseng, CM; Lin, IC; Chang, CY; Wang, HP; Chen, CC; Mo, LR; Lin, JT; Tai, CM				Tseng, Chao-Ming; Lin, I-Chang; Chang, Chi-Yang; Wang, Hsiu-Po; Chen, Chih-Cheng; Mo, Lein-Ray; Lin, Jaw-Town; Tai, Chi-Ming			Role of computed tomography angiography on the management of overt obscure gastrointestinal bleeding (vol 12, e0172754, 2017)	PLOS ONE			English	Correction															E-Da Hospital, Taiwan [EDAHP105041]	E-Da Hospital, Taiwan	In the Funding section, the grant number from the funder E-Da Hospital, Taiwan is listed incorrectly. The correct grant number is: EDAHP105041.	Tseng CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172754	1	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193793	10.1371/journal.pone.0193793	http://dx.doi.org/10.1371/journal.pone.0193793			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489894	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000101
J	Zhao, SK; Kang, R; Deng, T; Luo, LM; Wang, JM; Li, EM; Luo, JT; Liu, LH; Wan, SP; Zhao, ZG				Zhao, Shankun; Kang, Ran; Deng, Tuo; Luo, Lianmin; Wang, Jiamin; Li, Ermao; Luo, Jintai; Liu, Luhao; Wan, ShawPong; Zhao, Zhigang			Comparison of two cannulation methods for assessment of intracavernosal pressure in a rat model	PLOS ONE			English	Article							CORPORAL VENOOCCLUSIVE DYSFUNCTION; CAVERNOUS NERVE INJURY; ERECTILE FUNCTION; ELECTRICAL-STIMULATION; EXPRESSION; CASTRATION; APOPTOSIS; RESPONSES	Intracavernous pressure (ICP) measurement is a well-established technique for assessing the erectile function, which was performed by cannulating either crus or shaft of the penis. However, there are no studies concerning the experimental performance of the two cannulation sites yet. The aim of this study was to compare the measuring outcomes using two different cannulation sites. To validate the capacity of our study, both normal and the castration-induced erectile dysfunction rat models were conducted. Fifty adult male Sprague-Daw-ley rats were randomized equally into two groups: an intact group and a castration group. Five rats from each group firstly underwent different stimulation parameters to detect the optimal erectile responses. The residual rats in each group were further assigned into two subgroups (n = 10 per subgroup) according to two different cannulation sites (crus or shaft of the corpus cavernosum). The ICP values were compared between groups after different interventions. The optimal parameters for mean maximum ICP were recorded at 2.5 V and a frequency of 15 Hz. The rats under the two different cannulation sites tended to show similar ICP values in both the intact and the castration groups. However, the success rate in monitoring ICP was significantly higher in the groups cannulating into the shaft of the penis compared to the crus (100% vs. 70%; P = 0.02). Our data suggested that the method of cannulation into the penile shaft could serve as a better alternative for the ICP measurement in rats.	[Zhao, Shankun; Deng, Tuo; Luo, Lianmin; Wang, Jiamin; Li, Ermao; Luo, Jintai; Liu, Luhao; Wan, ShawPong; Zhao, Zhigang] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol & Androl,Guangdong Prov Key Lab Urol, Guangzhou, Guangdong, Peoples R China; [Kang, Ran] Nanhua Univ, Affiliated Hosp 1, Dept Urol, Hengyang, Hunan, Peoples R China	Guangzhou Medical University; University of South China	Zhao, ZG (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol & Androl,Guangdong Prov Key Lab Urol, Guangzhou, Guangdong, Peoples R China.	zgzhaodr@126.com	Zhao, Shankun/AAN-2819-2020	Zhao, Shankun/0000-0002-0305-3912; Deng, Tuo/0000-0003-0206-2179; zhao, zhigang/0000-0003-3147-8544				Agmo A, 1997, BRAIN RES PROTOC, V1, P203, DOI 10.1016/S1385-299X(96)00036-0; Bernabe J, 1999, AM J PHYSIOL-REG I, V276, pR441, DOI 10.1152/ajpregu.1999.276.2.R441; Cellek S, 2012, J SEX MED, V9, P2770, DOI 10.1111/j.1743-6109.2012.02916.x; Cho MC, 2015, J UROLOGY, V193, P1716, DOI 10.1016/j.juro.2014.10.099; Choo SH, 2015, ANDROLOGY-US, V3, P309, DOI 10.1111/andr.12004; Chua RG, 2009, MOL CELL ENDOCRINOL, V303, P67, DOI 10.1016/j.mce.2009.02.001; Davila HH, 2004, UROLOGY, V64, P1261, DOI 10.1016/j.urology.2004.07.012; Escrig A, 2002, BIOL REPROD, V66, P185, DOI 10.1095/biolreprod66.1.185; Giuliano F, 2004, PHYSIOL BEHAV, V83, P189, DOI 10.1016/j.physbeh.2004.08.014; HEATON JPW, 1991, J UROLOGY, V145, P1099, DOI 10.1016/S0022-5347(17)38543-9; Hedlund P, 1999, BRIT J PHARMACOL, V127, P349, DOI 10.1038/sj.bjp.0702556; Hu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102583; Jin HR, 2010, J SEX MED, V7, P3351, DOI 10.1111/j.1743-6109.2010.01942.x; Kataoka T, 2013, INT J IMPOT RES, V25, P201, DOI 10.1038/ijir.2013.21; LIU L, 2017, UROLOGY, V103, P271, DOI DOI 10.1016/j.urology.2017.02.006; Mehta N, 2008, J SEX MED, V5, P1278, DOI 10.1111/j.1743-6109.2008.00854.x; Melman A, 2003, J UROLOGY, V170, P285, DOI 10.1097/01.ju.0000063375.12512.6e; Mizusawa H, 2001, BRIT J PHARMACOL, V132, P1333, DOI 10.1038/sj.bjp.0703938; Mulhall JP, 2014, BJU INT, V113, P656, DOI 10.1111/bju.12175; Pan LJ, 2008, J ANDROL, V29, P55, DOI 10.2164/jandrol.107.003392; Pongkan W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122503; QUINLAN DM, 1989, J UROLOGY, V141, P656, DOI 10.1016/S0022-5347(17)40926-8; Rehman J, 1997, AM J PHYSIOL-HEART C, V272, pH1960, DOI 10.1152/ajpheart.1997.272.4.H1960; Rehman J, 1998, UROLOGY, V51, P640, DOI 10.1016/S0090-4295(97)00693-6; Schaumburg HH, 2007, BJU INT, V99, P916, DOI 10.1111/j.1464-410X.2006.06726.x; Sezen SF, 2000, J ANDROL, V21, P311; Shabsigh R, 1998, UROLOGY, V52, P723, DOI 10.1016/S0090-4295(98)00233-7; SJOSTRAND NO, 1979, ACTA PHYSIOL SCAND, V106, P199, DOI 10.1111/j.1748-1716.1979.tb06390.x; Song LJ, 2014, BJU INT, V114, P133, DOI 10.1111/bju.12348; Srilatha B, 2006, UROLOGY, V67, P642, DOI 10.1016/j.urology.2005.10.007; Wang XJ, 2015, INT UROL NEPHROL, V47, P1105, DOI 10.1007/s11255-015-1011-3; Wu C, 2016, EXPERT OPIN DRUG DIS, V11, P185, DOI 10.1517/17460441.2016.1126243; Zhang MG, 2012, J SEX MED, V9, P1328, DOI 10.1111/j.1743-6109.2012.02661.x; Zhang XH, 2005, EUR UROL, V47, P409, DOI 10.1016/j.eururo.2004.10.021; Zhao SK, 2016, UROLOGY, V91, DOI 10.1016/j.urology.2016.02.021; Zhao WX, 2009, J SEX MED, V6, P1885, DOI 10.1111/j.1743-6109.2009.01300.x	36	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193543	10.1371/journal.pone.0193543	http://dx.doi.org/10.1371/journal.pone.0193543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486011	gold, Green Published			2022-12-27	WOS:000426242400021
J	Hoppes, CW; Sparto, PJ; Whitney, SL; Furman, JM; Huppert, TJ				Hoppes, Carrie W.; Sparto, Patrick J.; Whitney, Susan L.; Furman, Joseph M.; Huppert, Theodore J.			Functional near-infrared spectroscopy during optic flow with and without fixation	PLOS ONE			English	Article							OPTOKINETIC STIMULATION; VESTIBULAR CORTEX; SIGNAL INCREASES; MOTION SICKNESS; CORTICAL AREAS; BRAIN-FUNCTION; REHABILITATION; FMRI; VECTION; TOMOGRAPHY	Background and purpose Individuals with visual vertigo describe symptoms of dizziness, disorientation, and/or impaired balance in environments with conflicting visual and vestibular information or complex visual stimuli. Physical therapists often prescribe habituation exercises using optic flow to treat these symptoms, but there are no evidence-based guidelines for delivering optic flow and it is unclear how the brain processes such stimuli. The purposes of this study were to use functional near-infrared spectroscopy (fNIRS) to explore cerebral activation during optic flow, and determine if visual fixation had a modulating effect on brain activity. Methods Fifteen healthy participants (7 males and 8 females; mean age 41 years old) stood in a virtual reality environment and viewed optic flow moving unidirectionally in the yaw plane with and without fixation. Changes in cerebral activation were recorded from the bilateral fronto-temporo-parietal and occipital lobes using fNIRS. Results Cerebral activation was greater with visual motion than while viewing a stationary scene. Greater cerebral activation in the bilateral fronto-temporo-parietal lobes was observed when optic flow was viewed with fixation. Discussion and conclusions Optic flow activates the bilateral fronto-temporo-parietal regions of the cerebral cortex. This activation is greater while viewing optic flow and a fixation target, providing preliminary evidence supporting the use of a fixation target during habituation exercises.	[Hoppes, Carrie W.; Sparto, Patrick J.; Whitney, Susan L.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA 15213 USA; [Furman, Joseph M.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Huppert, Theodore J.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Sparto, Patrick J.; Whitney, Susan L.; Furman, Joseph M.] UPMC, Eye & Ear Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hoppes, CW (corresponding author), Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA 15213 USA.	cwh27@pitt.edu	Huppert, Theodore/HGB-3534-2022	Sparto, Patrick/0000-0002-8351-3789; Hoppes, Carrie/0000-0001-5104-7448; Huppert, Theodore/0000-0001-8426-5759	Pittsburgh Claude D. Pepper Older Americans Independence Center [P30 AG024827]; Eye and Ear Foundation; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	Pittsburgh Claude D. Pepper Older Americans Independence Center; Eye and Ear Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Partial support for this project was funded by a grant from the Pittsburgh Claude D. Pepper Older Americans Independence Center [P30 AG024827, 2012] and the Eye and Ear Foundation.	Barker JW, 2013, BIOMED OPT EXPRESS, V4, P1366, DOI 10.1364/BOE.4.001366; Becker-Bense S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-81; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Boas DA, 2005, APPL OPTICS, V44, P1957, DOI 10.1364/AO.44.001957; Boff K.R., 1986, HDB PERCEPTION HUMAN; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; BRONSTEIN AM, 1995, J NEUROL NEUROSUR PS, V59, P472, DOI 10.1136/jnnp.59.5.472; Cope M, 1988, Adv Exp Med Biol, V222, P183; Della-Justina HM, 2015, EXP BRAIN RES, V233, P237, DOI 10.1007/s00221-014-4107-6; Deutschlander A, 2008, BRAIN, V131, P1025, DOI 10.1093/brain/awn035; Deutschlander A, 2004, HUM BRAIN MAPP, V21, P143, DOI 10.1002/hbm.10155; Deutschlander A, 2002, HUM BRAIN MAPP, V16, P92, DOI 10.1002/hbm.10030; Dieterich M, 2003, EXP BRAIN RES, V148, P117, DOI 10.1007/s00221-002-1267-6; Dieterich M, 1998, BRAIN, V121, P1479, DOI 10.1093/brain/121.8.1479; Fasold O, 2002, NEUROIMAGE, V17, P1384, DOI 10.1006/nimg.2002.1241; Fushiki H, 2000, J VESTIBUL RES-EQUIL, V10, P151; Gianaros PJ, 2001, AVIAT SPACE ENVIR MD, V72, P115; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Herold F, 2017, HUM MOVEMENT SCI, V51, P51, DOI 10.1016/j.humov.2016.11.002; Huppert T., 2016, NEUROPHOTONICS, P3; Huppert TJ, 2009, FRONT NEUROSCI, P393; Indovina I, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00334; Karim H, 2012, GAIT POSTURE, V35, P367, DOI 10.1016/j.gaitpost.2011.10.007; Kleinschmidt A, 2002, NEUROIMAGE, V16, P873, DOI 10.1006/nimg.2002.1181; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Palmisano S, 2015, FRONT PSYCHOL, P6; Pavlou M, 2004, J NEUROL, V251, P983, DOI 10.1007/s00415-004-0476-2; Pavlou M, 2013, NEUROREHAB NEURAL RE, V27, P208, DOI 10.1177/1545968312461715; Pavlou M, 2010, J NEUROL PHYS THER, V34, P105, DOI 10.1097/NPT.0b013e3181dde6bf; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Seno T, 2011, ATTEN PERCEPT PSYCHO, V73, P1467, DOI 10.3758/s13414-011-0129-3; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Staab Jeffrey P, 2012, Continuum (Minneap Minn), V18, P1118, DOI 10.1212/01.CON.0000421622.56525.58; Stephan T, 2005, NEUROIMAGE, V26, P721, DOI 10.1016/j.neuroimage.2005.02.049; STERN RM, 1990, AVIAT SPACE ENVIR MD, V61, P712; Strangman G, 2003, NEUROIMAGE, V18, P865, DOI 10.1016/S1053-8119(03)00021-1; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Szturm T, 1994, J Vestib Res, V4, P461; Tarita-Nistor L, 2006, J VESTIBUL RES-EQUIL, V16, P265; Uesaki M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00775; Van Ombergen A, 2017, NEUROIMAGE-CLIN, V14, P538, DOI 10.1016/j.nicl.2017.02.020; VITTE E, 1994, EXP BRAIN RES, V102, P141; Wijeakumar S, 2013, J NEAR INFRARED SPEC, V21, P231, DOI 10.1255/jnirs.1056	46	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193710	10.1371/journal.pone.0193710	http://dx.doi.org/10.1371/journal.pone.0193710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513720	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800070
J	Miyauchi, E; Furuta, T; Ohtsuki, S; Tachikawa, M; Uchida, Y; Sabit, H; Obuchi, W; Baba, T; Watanabe, M; Terasaki, T; Nakada, M				Miyauchi, Eisuke; Furuta, Takuya; Ohtsuki, Sumio; Tachikawa, Masanori; Uchida, Yasuo; Sabit, Hemragul; Obuchi, Wataru; Baba, Tomoko; Watanabe, Michitoshi; Terasaki, Tetsuya; Nakada, Mitsutoshi			Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HIGH-GRADE GLIOMAS; CELL LUNG-CANCER; POTENTIAL SERUM BIOMARKERS; PANCREATIC-CANCER; UP-REGULATION; TRANSPORTER PROTEINS; PROGNOSTIC VALUE; PLASMA GELSOLIN; MARKER	Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment of glioblastoma (GBM). Here, in order to identify biomarker candidates in plasma of GBM patients, we performed quantitative comparisons of the plasma proteomes of GBM patients (n = 14) and healthy controls (n = 15) using SWATH mass spectrometry analysis. The results were validated by means of quantitative targeted absolute proteomics analysis. As a result, we identified eight biomarker candidates for GBM (leucine-rich alpha-2-glycoprotein (LRG1), complement component C9 (C9), C-reactive protein (CRP), alpha-1-antichymotrypsin (SERPINA3), apolipoprotein B-100 (APOB), gelsolin (GSN), Ig alpha-1 chain C region (IGHA1), and apolipoprotein A-IV (APOA4)). Among them, LRG1, C9, CRP, GSN, IGHA1, and APOA4 gave values of the area under the receiver operating characteristics curve of greater than 0.80. To investigate the relationships between the biomarker candidates and GBM biology, we examined correlations between plasma concentrations of biomarker candidates and clinical presentation (tumor size, progression-free survival time, or overall survival time) in GBM patients. The plasma concentrations of LRG1, CRP, and C9 showed significant positive correlations with tumor size (R-2 = 0.534, 0.495, and 0.452, respectively).	[Miyauchi, Eisuke; Tachikawa, Masanori; Uchida, Yasuo; Obuchi, Wataru; Baba, Tomoko; Watanabe, Michitoshi; Terasaki, Tetsuya] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi, Japan; [Furuta, Takuya] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan; [Furuta, Takuya; Sabit, Hemragul; Nakada, Mitsutoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Neurosurg, Kanazawa, Ishikawa, Japan; [Ohtsuki, Sumio] Kumamoto Univ, Dept Pharmaceut Microbiol, Fac Life Sci, Kumamoto, Kumamoto, Japan	Tohoku University; Kurume University; Kanazawa University; Kumamoto University	Terasaki, T (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi, Japan.	terasaki.tetsuya@m.tohoku.ac.jp	Terasaki, Tetsuya/K-6730-2012; Nakada, Mitsutoshi/B-2790-2012; Ohtsuki, Sumio/S-4360-2016	Terasaki, Tetsuya/0000-0002-6332-7575; Nakada, Mitsutoshi/0000-0001-9419-6101; Ohtsuki, Sumio/0000-0003-4634-7133; Miyauchi, Eisuke/0000-0003-0258-2633	AMED-CREST [16gm0710013h0103]; Japan Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [16K15645, 17K15012] Funding Source: KAKEN	AMED-CREST; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aids from AMED-CREST (16gm0710013h0103) from Japan Agency for Medical Research and Development (http://www.amed.go.jp/) (to SO). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; BAUMANN H, 1987, J BIOL CHEM, V262, P9756; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Chong PK, 2010, PROTEOMICS, V10, P3210, DOI 10.1002/pmic.201000127; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Furukawa K, 2015, PANCREAS, V44, P93, DOI 10.1097/MPA.0000000000000205; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gautam P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046153; Giganti MG, 2016, ONCOL LETT, V12, P2119, DOI 10.3892/ol.2016.4887; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Gollapalli K, 2012, PROTEOMICS, V12, P2378, DOI 10.1002/pmic.201200002; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Guergova-Kuras M, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010298-1, 10.1074/mcp.M111.010298]; Guo XC, 2011, J CRIT CARE, V26, P608, DOI 10.1016/j.jcrc.2011.02.007; Hormigo A, 2006, CLIN CANCER RES, V12, P5698, DOI 10.1158/1078-0432.CCR-06-0181; Iliadis G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-3; Ilzecka J, 2006, EUR CYTOKINE NETW, V17, P276; Iwamoto FM, 2011, NEURO-ONCOLOGY, V13, P1244, DOI 10.1093/neuonc/nor117; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Jayaram S, 2014, EXPERT REV PROTEOMIC, V11, P621, DOI 10.1586/14789450.2014.939634; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Kataoka H, 2002, PATHOL INT, V52, P89, DOI 10.1046/j.1440-1827.2002.01320.x; Khakzad MR, 2012, RES AUTISM SPECT DIS, V6, P1032, DOI 10.1016/j.rasd.2011.10.002; Kros JM, 2015, NEURO-ONCOLOGY, V17, P343, DOI 10.1093/neuonc/nou207; Kumar DM, 2010, J PROTEOME RES, V9, P5557, DOI 10.1021/pr1001737; Lee JG, 2009, LUNG CANCER, V63, P106, DOI 10.1016/j.lungcan.2008.04.011; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Lin Y, 2009, NEURO-ONCOLOGY, V11, P468, DOI 10.1215/15228517-2008-114; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Liu Y, 2013, EXPERT REV MOL DIAGN, V13, P811, DOI 10.1586/14737159.2013.845089; Liu YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051748; Lokamani I, 2014, PATHOL ONCOL RES, V20, P119, DOI 10.1007/s12253-013-9670-9; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Luo DY, 2017, ONCOTARGETS THER, V10, P2173, DOI 10.2147/OTT.S133022; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Miyauchi E, 2016, MOL PHARMACEUT, V13, P2631, DOI 10.1021/acs.molpharmaceut.6b00085; Nakamura K, 2016, PROTEOMICS, V15, P3508; Nijaguna MB, 2015, J PROTEOMICS, V128, P251, DOI 10.1016/j.jprot.2015.07.026; Nikiteas NI, 2005, WORLD J GASTROENTERO, V11, P1639; Nurdin A, 2016, J PHARM SCI-US, V105, P3440, DOI 10.1016/j.xphs.2016.08.013; Ohnishi M, 2009, PATHOL INT, V59, P797, DOI 10.1111/j.1440-1827.2009.02447.x; Park J, 2017, ONCOTARGET, V8, P42761, DOI 10.18632/oncotarget.17463; Petrik V, 2008, CLIN CHEM, V54, P713, DOI 10.1373/clinchem.2007.096792; Pierredon S, 2017, ONCOL LETT, V13, P4965, DOI 10.3892/ol.2017.6096; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Popescu ID, 2014, PROTEOME SCI, V12, DOI 10.1186/s12953-014-0047-0; Quaranta M, 2007, TUMORI J, V93, P275; Radunovic M, 2016, J BUON, V21, P597; Rauniyar N, 2017, BIOMARK INSIGHTS, V12, DOI 10.1177/1177271917710948; ROBEY FA, 1987, J BIOL CHEM, V262, P7053; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Shao SY, 2015, BBA-PROTEINS PROTEOM, V1854, P519, DOI 10.1016/j.bbapap.2014.12.012; SHEPHARD EG, 1989, J IMMUNOL, V143, P2974; SHEPHARD EG, 1990, J IMMUNOL, V145, P1469; Shieh DB, 2006, ORAL ONCOL, V42, P599, DOI 10.1016/j.oraloncology.2005.10.021; Shirai R, 2009, BIOCHEM BIOPH RES CO, V382, P776, DOI 10.1016/j.bbrc.2009.03.104; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Somasundaram K, 2009, EXPERT REV MOL DIAGN, V9, P695, DOI 10.1586/ERM.09.52; Song SH, 2012, QJM-INT J MED, V105, P973, DOI 10.1093/qjmed/hcs113; Stark AM, 2005, SURG NEUROL, V63, P162, DOI 10.1016/j.surneu.2004.01.028; Strojnik T, 2014, ANTICANCER RES, V34, P339; TANAKA M, 1995, CANCER RES, V55, P3228; Tas F, 2005, MED ONCOL, V22, P353, DOI 10.1385/MO:22:4:353; Uchida Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-21; Wang HH, 2008, CRIT CARE, V12, DOI 10.1186/cc6988; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Winston JS, 2001, BREAST CANCER RES TR, V65, P11, DOI 10.1023/A:1006446108411; Wu JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114495; Yang J, 2004, LUNG CANCER-J IASLC, V46, P29, DOI 10.1016/j.lungcan.2004.03.022; Yokoyama K, 1998, J LIPID RES, V39, P103; Yoneyama T, 2013, J PROTEOME RES, V12, P753, DOI 10.1021/pr3008144; Zhong D, 2015, TUMOR BIOL, V36, P4271, DOI 10.1007/s13277-015-3065-3; Zhou JY, 2017, ONCOTARGET, V8, P18712, DOI 10.18632/oncotarget.9409; Zhou M, 2010, CANCER RES, V70, P7534, DOI 10.1158/0008-5472.CAN-10-0815	80	56	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193799	10.1371/journal.pone.0193799	http://dx.doi.org/10.1371/journal.pone.0193799			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513714	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800076
J	Rattay, P; von der Lippe, E; Mauz, E; Richter, F; Holling, H; Lange, C; Lampert, T				Rattay, Petra; von der Lippe, Elena; Mauz, Elvira; Richter, Felicitas; Hoelling, Heike; Lange, Cornelia; Lampert, Thomas			Health and health risk behaviour of adolescents-Differences according to family structure. Results of the German KiGGS cohort study	PLOS ONE			English	Article							11 EUROPEAN COUNTRIES; PARENT FAMILIES; MENTAL-HEALTH; DEPRESSIVE SYMPTOMS; SINGLE-PARENT; CHILDREN; DIVORCE; SMOKING; ASSOCIATIONS; DRINKING	Objective This study's aim was to investigate the association between family structure and different health-related outcomes in adolescence (self-rated health, emotional and behavioural problems, health-related quality of life, regular smoking, and heavy episodic drinking). Furthermore, we analysed the extent to which socio-economic status, family cohesion and the pre-transition health status explain family structure-related health disparities. Methods We used longitudinal data from the first two waves of the German KiGGS cohort study carried out by the Robert Koch Institute (baseline: 2003-2006, follow-up: 2009-2012). The sample comprised 4,692 respondents aged 11 to 17 years. Using data from both waves, effects of family structure on health status at follow-up were calculated applying linear and logistic regression models. Results We found that adolescents continuously living with both birth parents were in good health. Adolescents whose parents separated after the baseline survey, reported poorer health and were more likely to smoke. The transition from stepfamily to single parent family was also associated with a higher risk of regular smoking. Lower health-related quality of life as well as higher scores for emotional and behavioural problems occurred in almost all non-nuclear family structures, although not all effects were statistically significant. No significant effects of family structure on heavy episodic drinking were found. While family cohesion mediated the effects of family structure on adolescents' health, the mediating effect of socio-economic status was small. After controlling for pre-transition health, the effects were even lower. Conclusions Because the direct effects of family structure on adolescents' health were small and family cohesion was found to be an important mediator in the association between family structure and adolescents' health, prevention programmes and interventions should be directed towards the parent-adolescent relationship rather than just the family structure, in order to minimize the psychosocial stress of adolescents during the period of family transition.	[Rattay, Petra; von der Lippe, Elena; Mauz, Elvira; Richter, Felicitas; Hoelling, Heike; Lange, Cornelia; Lampert, Thomas] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany	Robert Koch Institute	Rattay, P (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.	p.rattay@rki.de			German Federal Ministry of Health; German Federal Ministry of Education and Research; Robert Koch Institute	German Federal Ministry of Health; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Robert Koch Institute	The "German Health Interview and Examination Survey for Children and Adolescents" (KiGGS) was funded by the German Federal Ministry of Health, the German Federal Ministry of Education and Research, and the Robert Koch Institute. All authors are employees of the Robert Koch Institute. The funders had no role in analysis or preparation of the manuscript.	Amato PR, 2010, J MARRIAGE FAM, V72, P650, DOI 10.1111/j.1741-3737.2010.00723.x; Amato PR, 2001, J FAM PSYCHOL, V15, P355, DOI 10.1037/0893-3200.15.3.355; BABOR TR, 1992, WHO PUBLICATION; Berger LM, 2008, J MARRIAGE FAM, V70, P625, DOI 10.1111/j.1741-3737.2008.00510.x; Bernardi F, EFFECTS FAMILY FORMS; Bjarnason T, 2003, J STUD ALCOHOL, V64, P200, DOI 10.15288/jsa.2003.64.200; Bjarnason T, 2003, ADDICTION, V98, P815, DOI 10.1046/j.1360-0443.2003.00395.x; Blackwell Debra L, 2010, Vital Health Stat 10, P1; Bramlett MD, 2007, HEALTH AFFAIR, V26, P549, DOI 10.1377/hlthaff.26.2.549; Breivik K, 2006, SCAND J PSYCHOL, V47, P61, DOI 10.1111/j.1467-9450.2006.00493.x; Brown SL, 2010, J RES ADOLESCENCE, V20, P259, DOI 10.1111/j.1532-7795.2010.00636.x; Bzostek SH, 2008, J MARRIAGE FAM, V70, P950, DOI 10.1111/j.1741-3737.2008.00538.x; Bzostek SH, 2012, SOC FORCES, V90, P817, DOI 10.1093/sf/sos005; Cavanagh SE, 2008, J FAM ISSUES, V29, P944, DOI 10.1177/0192513X07311232; Chapple S., 2009, OECD SOCIAL EMPLOYME; Collishaw S, 2007, SOC SCI MED, V65, P2576, DOI 10.1016/j.socscimed.2007.06.010; Crawford LA, 2008, J FAM ISSUES, V29, P155, DOI 10.1177/0192513X07304461; Daly M., 2008, FDN EVOLUTIONARY PSY, P381; Federal Ministry for Family Affairs Senior Citizens Women and Youth (Germany), 2014, FAM REP 2014 BEN EFF; Feldhaus M, 2015, Z FAMILIENFORSCH, V27, P32, DOI 10.3224/zff.v27i1.18586; Fomby P, 2007, AM SOCIOL REV, V72, P181, DOI 10.1177/000312240707200203; Francesconi M, 2010, DIW WOCHENBERICHT, P2; Gobbi G, 2015, CAN J PSYCHIAT, V60, P417, DOI 10.1177/070674371506001002; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Griesbach D, 2003, SOC SCI MED, V56, P41, DOI 10.1016/S0277-9536(02)00014-X; Hagen C, 2010, FAMILIENMEDIZIN DEUT, P176; Hetherington EM, 2003, PERSPEKTIVEN KINDER; Holling H, 2008, GESUNDHEITSWESEN, V70, P154, DOI 10.1055/s-2008-1062741; Houben-van Herten M, 2015, PLOS ONE, V10; Klocke A, 2012, GESUNDHEITSWESEN, V74, pS70, DOI 10.1055/s-0032-1312634; Krueger PM, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0038-0; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Kurth BM, 2016, KINDER JUGENDMED, V16, P176, DOI DOI 10.1055/s-0037-1616317; Lampert T, 2014, BUNDESGESUNDHEITSBLA, V57, P762, DOI 10.1007/s00103-014-1974-8; Lange M, 2014, BUNDESGESUNDHEITSBLA, V57, P747, DOI 10.1007/s00103-014-1973-9; Lee D, 2015, AM SOCIOL REV, V80, P738, DOI 10.1177/0003122415592129; Ley K, 2005, PRAX KINDERPSYCHOL K, V54, P802; Liu JT, 2014, SCI REP-UK, V4, DOI 10.1038/srep07049; Mack KY, 2015, DEVIANT BEHAV, V36, P740, DOI 10.1080/01639625.2014.977117; Magnuson K, 2009, J MARRIAGE FAM, V71, P575, DOI 10.1111/j.1741-3737.2009.00620.x; McMunn AM, 2001, SOC SCI MED, V53, P423, DOI 10.1016/S0277-9536(00)00346-4; Palmarsdottir H. M. L, 2015, THESIS; Rattay P, 2014, BUNDESGESUNDHEITSBLA, V57, P860, DOI 10.1007/s00103-014-1988-2; Razaz-Rahmati N, 2012, PUBLIC HEALTH NURS, V29, P191, DOI 10.1111/j.1525-1446.2011.00979.x; Ruutel E, 2014, INT J ENV RES PUB HE, V11, P12700, DOI 10.3390/ijerph111212700; Ryan RM, 2013, DEV PSYCHOL, V49, P1219, DOI 10.1037/a0029397; Scharte M, 2013, EUR J PUBLIC HEALTH, V23, P469, DOI 10.1093/eurpub/cks062; Schlack R., 2013, SCHEIDEN TUT WEH ELT, P122; Schneewind KA., 1988, FAMILIENDIAGNOSTIK, P232, DOI [10.1007/978-3-642-72868-6_14, DOI 10.1007/978-3-642-72868-6_14]; Seyda S, 2009, Z FAMILIENFORSCH, V21, P168; SokolKatz J, 1997, ADOLESCENCE, V32, P199; Steinbach A., 2008, Z BEVOLKERUNGSWISSEN, V33, P153, DOI DOI 10.1007/S12523-009-0009-2; Strohschein L, 2005, J MARRIAGE FAM, V67, P1286, DOI 10.1111/j.1741-3737.2005.00217.x; Sun YM, 2001, J MARRIAGE FAM, V63, P697, DOI 10.1111/j.1741-3737.2001.00697.x; Teubner M., 2002, STIEFFAMILIEN DEUTSC, P23; The KIDSCRREN Group Europe, 2006, KIDSCR QUEST QUAL LI; Thuen F., 2015, J DIVORCE REMARRIAGE, V56, P451, DOI 10.1080/10502556.2015.1058659; Tobias M, 2010, AUST NZ J PUBL HEAL, V34, P274, DOI 10.1111/j.1753-6405.2010.00526.x; Tomcikova Z, 2015, CENT EUR J PUBL HEAL, V23, P54, DOI 10.21101/cejph.a3951; Walper S, 2015, CPOS, V40; Walper S, 2006, JACOBS FOUND SER ADO, P238, DOI 10.1017/CBO9780511616259.011; Willfuhr KP, 2013, BIODEMOGR SOC BIOL, V59, P191, DOI 10.1080/19485565.2013.833803; Ziol-Guest KM, 2014, FAM RELAT, V63, P424, DOI 10.1111/fare.12071	63	15	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192968	10.1371/journal.pone.0192968	http://dx.doi.org/10.1371/journal.pone.0192968			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513693	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800027
J	Schaefer, M; Sahin, T; Berstecher, B				Schaefer, Michael; Sahin, Tamay; Berstecher, Benjamin			Why do open-label placebos work? A randomized controlled trial of an open-label placebo induction with and without extended information about the placebo effect in allergic rhinitis	PLOS ONE			English	Article							NONCONSCIOUS ACTIVATION; CLINICAL-TRIALS; RESPONSES; PAIN	Background Several studies demonstrated that placebo treatment may have a significant impact on many different symptoms. While in the traditional view concealment of the placebo is essential, recent studies report intriguing evidence that placebos may work even without deception. For example, it has been demonstrated that open-label placebos can improve symptoms in allergic rhinitis. However, the mechanisms of how placebos without concealment work remain unknown. Trial design In order to examine expectancy effects we conducted a randomized controlled trial (N = 46), in which patients with allergic symptoms received either placebos without deception or no pills at all. In half of those patients we induced positive expectations about the placebo effect. After two weeks we tested whether symptoms and quality of life had changed. Results Results revealed that open-label placebos improved allergic symptoms more than the control group. Inducing positive expectations had no effects on the improvement of allergic symptoms (the primary and more objective outcome), but on mental sum scores of the quality of life questionnaire. Conclusions Placebos without deception can improve symptoms in allergic rhinitis. Positive expectations do not contribute to the efficacy of open-label placebos, but seem to have an effect on more global and subjective well-being (mental or emotional quality of life).	[Schaefer, Michael; Sahin, Tamay; Berstecher, Benjamin] Med Sch Berlin, Calandrellistr, Berlin, Germany		Schaefer, M (corresponding author), Med Sch Berlin, Calandrellistr, Berlin, Germany.	michael.schaefer@medicalschool-berlin.de						ABRAMSON HAROLD A., 1956, ANN ALLERGY, V14, P145; Benedetti F, 2010, PAIN, V148, P357, DOI 10.1016/j.pain.2009.10.009; Blease CR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j463; Carvalho C, 2016, PAIN, V157, P2766, DOI 10.1097/j.pain.0000000000000700; Charlesworth James E G, 2017, J Evid Based Med, V10, P97, DOI 10.1111/jebm.12251; CZUBALSKI K, 1976, ACTA OTO-LARYNGOL, V81, P484, DOI 10.3109/00016487609107504; del Cuvillo A, 2011, J INVEST ALLERG CLIN, V21, P40; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Fuchs T, 2009, CURR OPIN PSYCHIATR, V22, P570, DOI 10.1097/YCO.0b013e3283318e5c; Jensen KB, 2015, CEREB CORTEX, V25, P3903, DOI 10.1093/cercor/bhu275; Jensen KB, 2012, P NATL ACAD SCI USA, V109, P15959, DOI 10.1073/pnas.1202056109; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kay AB, 2000, BRIT MED BULL, V56, P843, DOI 10.1258/0007142001903481; Kelley JM, 2012, PSYCHOTHER PSYCHOSOM, V81, P312, DOI 10.1159/000337053; Lakoff George., 1999, PHILOS FLESH EMBODIE; PARK LC, 1965, ARCH GEN PSYCHIAT, V12, P336; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Sandler AD, 2008, CHILD CARE HLTH DEV, V34, P104, DOI 10.1111/j.1365-2214.2007.00797.x; Schaefer M, 2016, PSYCHOTHER PSYCHOSOM, V85, P373, DOI 10.1159/000447242; Varela FJ, 2017, EMBODIED MIND COGNIT; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wheatley LM, 2015, NEW ENGL J MED, V372, P456, DOI 10.1056/NEJMcp1412282	23	60	60	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192758	10.1371/journal.pone.0192758	http://dx.doi.org/10.1371/journal.pone.0192758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY5TA	29513699	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800021
J	Cotrim, CA; Soares, JSM; Kobe, B; Menossi, M				Cotrim, Camila A.; Soares, Jose Sergio M.; Kobe, Bostjan; Menossi, Marcelo			Crystal structure and insights into the oligomeric state of UDP-glucose pyrophosphorylase from sugarcane	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; METABOLISM; LOCALIZATION; MECHANISM; SYNTHASE	UDP-glucose pyrophosphorylase (UGPase) is found in all organisms and catalyses the formation of UDP-glucose. In sugarcane, UDP-glucose is a branch-point in the carbon channelling into other carbohydrates, such as sucrose and cellulose, which are the major factors for sugarcane productivity. In most plants, UGPase has been described to be enzymatically active in the monomeric form, while in human and yeast, homo-octamers represent the active form of the protein. Here, we present the crystal structure of UGPase from sugarcane (ScUGPase-1) at resolution of 2.0 angstrom. The crystals of ScUGPase-1 reveal the presence of two molecules in the asymmetric unit and the multi-angle light scattering analysis shows that ScUGPase-1 forms a mixture of species ranging from monomers to larger oligomers in solution, suggesting similarities with the orthologs from yeast and human.	[Cotrim, Camila A.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Cotrim, Camila A.; Kobe, Bostjan] Univ Queensland, Australia Infect Dis Res Ctr, Brisbane, Qld, Australia; [Soares, Jose Sergio M.; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao Microbiol & Imunol, Campinas, SP, Brazil; [Cotrim, Camila A.] Griffith Univ, Griffith Inst Drug Discovery, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Universidade de Sao Paulo; Universidade Estadual de Campinas; Griffith University	Cotrim, CA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.; Cotrim, CA (corresponding author), Univ Queensland, Australia Infect Dis Res Ctr, Brisbane, Qld, Australia.; Menossi, M (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao Microbiol & Imunol, Campinas, SP, Brazil.; Cotrim, CA (corresponding author), Griffith Univ, Griffith Inst Drug Discovery, Brisbane, Qld, Australia.	c.cotrim@griffith.edu.au; menossi@lgf.ib.unicamp.br	Soares, Jose Sergio/D-6450-2014; Cotrim, Camila A/Q-9560-2019; Kobe, Bostjan/D-1292-2009; Menossi, Marcelo/A-4364-2012	Soares, Jose Sergio/0000-0003-3908-0741; Cotrim, Camila A/0000-0002-9176-5767; Kobe, Bostjan/0000-0001-9413-9166; Menossi, Marcelo/0000-0002-9211-3787	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/15576-5, 2008/06767-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Grant 2013/15576-5 - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - http://www.fapesp.br/; grant 2008/06767-3 - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - http://www.fapesp.br/ to JSMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Bar-Peled M, 2011, ANNU REV PLANT BIOL, V62, P127, DOI 10.1146/annurev-arplant-042110-103918; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fuhring J, 2013, ACS CATAL, V3, P2976, DOI 10.1021/cs4007777; Fuehring JI, 2015, SCI REP-UK, V5, DOI 10.1038/srep09618; Gibeaut DM, 2000, PLANT PHYSIOL BIOCH, V38, P69, DOI 10.1016/S0981-9428(00)00167-4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KLECZKOWSKI LA, 1994, PHYTOCHEMISTRY, V37, P1507, DOI 10.1016/S0031-9422(00)89568-0; Kleczkowski LA, 2005, PHYTOCHEMISTRY, V66, P2815, DOI 10.1016/j.phytochem.2005.09.034; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Marino K, 2010, GLYCOBIOLOGY, V20, P1619, DOI 10.1093/glycob/cwq115; Martz F, 2002, BIOCHEM J, V367, P295, DOI 10.1042/BJ20020772; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mccoy JG, 2007, J MOL BIOL, V366, P830, DOI 10.1016/j.jmb.2006.11.059; Meng M, 2009, BBA-PROTEINS PROTEOM, V1794, P1734, DOI 10.1016/j.bbapap.2009.08.009; Payyavula RS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0265-8; Roeben A, 2006, J MOL BIOL, V364, P551, DOI 10.1016/j.jmb.2006.08.079; Soares JSM, 2014, J BIOL CHEM, V289, P33364, DOI 10.1074/jbc.M114.590125; Steiner T, 2007, J BIOL CHEM, V282, P13003, DOI 10.1074/jbc.M609984200; Toroser D, 1998, FEBS LETT, V435, P110, DOI 10.1016/S0014-5793(98)01048-5; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Winter H, 2000, CRIT REV BIOCHEM MOL, V35, P253, DOI 10.1080/10409230008984165	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193667	10.1371/journal.pone.0193667	http://dx.doi.org/10.1371/journal.pone.0193667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494650	Green Submitted, gold, Green Published			2022-12-27	WOS:000426363200079
J	Sato, A; Shibuya, H				Sato, Atsushi; Shibuya, Hiroshi			Glycogen synthase kinase 3 beta functions as a positive effector in the WNK signaling pathway	PLOS ONE			English	Article							ALANINE-RICH KINASE; NEUROPATHY TYPE-II; PROTEIN-KINASE; SPAK; COTRANSPORTERS; OSR1; PHOSPHORYLATION; MUTATIONS; GENE	The with no lysine (WNK) protein kinase family is conserved among many species. Some mutations in human WNK gene are associated with pseudohypoaldosteronism type II, a form of hypertension, and hereditary sensory and autonomic neuropathy type 2A. In kidney, WNK regulates the activity of STE20/SPS1-related, proline alanine-rich kinase and/or oxidative-stress responsive 1, which in turn regulate ion co-transporters. The misregulation of this pathway is involved in the pathogenesis of pseudohypoaldosteronism type II. In the neural system, WNK is involved in the specification of the cholinergic neuron, but the pathogenesis of hereditary sensory and autonomic neuropathy type 2A is still unknown. To better understand the WNK pathway, we isolated WNK-associated genes using Drosophila. We identified Glycogen synthase kinase 3 beta (GSK3 beta)/Shaggy (Sgg) as a candidate gene that was shown to interact with the WNK signaling pathway in both Drosophila and mammalian cells. Furthermore, GSK3 beta was involved in neural specification downstream of WNK. These results suggest that GSK3 beta/Sgg functions as a positive effector in the WNK signaling pathway.	[Sato, Atsushi; Shibuya, Hiroshi] TMDU, Dept Mol Cell Biol & Joint Usage, Res Ctr Intractable Dis, Med Res Inst,Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Shibuya, H (corresponding author), TMDU, Dept Mol Cell Biol & Joint Usage, Res Ctr Intractable Dis, Med Res Inst,Bunkyo Ku, Tokyo, Japan.	shibuya.mcb@mri.tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26460386]; Nanken-Kyoten, TMDU [17M03]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nanken-Kyoten, TMDU	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 26460386, to Dr. Atsushi Sato; and Nanken-Kyoten, TMDU, 17M03, to Prof. Hiroshi Shibuya.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kahle KT, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0163; Lawrence P.A., 1986, P229; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Naguro I, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2283; Nishida H, 2012, HYPERTENSION, V60, P981, DOI 10.1161/HYPERTENSIONAHA.112.201509; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Riviere JB, 2004, ANN NEUROL, V56, P572, DOI 10.1002/ana.20237; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Sato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055301; Serysheva E, 2013, EMBO REP, V14, P718, DOI 10.1038/embor.2013.88; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Tamari M, 1999, J HUM GENET, V44, P116, DOI 10.1007/s100380050121; Tu SW, 2011, P NATL ACAD SCI USA, V108, P1385, DOI 10.1073/pnas.1018567108; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Woodgett J R, 2001, Sci STKE, V2001, pre12, DOI 10.1126/stke.2001.100.re12; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009	28	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193204	10.1371/journal.pone.0193204	http://dx.doi.org/10.1371/journal.pone.0193204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494638	gold, Green Submitted, Green Published			2022-12-27	WOS:000426363200030
J	Baarbe, JK; Yielder, P; Haavik, H; Holmes, MWR; Murphy, BA				Baarbe, Julianne K.; Yielder, Paul; Haavik, Heidi; Holmes, Michael W. R.; Murphy, Bernadette Ann			Subclinical recurrent neck pain and its treatment impacts motor training-induced plasticity of the cerebellum and motor cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; CERVICAL-SPINE; SHORT-TERM; POSITION; RANGE; MANIPULATION; MOTION; PROPRIOCEPTION; CONNECTIVITY	The cerebellum processes pain inputs and is important for motor learning. Yet, how the cerebellum interacts with the motor cortex in individuals with recurrent pain is not clear. Functional connectivity between the cerebellum and motor cortex can be measured by a twin coil transcranial magnetic stimulation technique in which stimulation is applied to the cerebellum prior to stimulation over the motor cortex, which inhibits motor evoked potentials (MEPs) produced by motor cortex stimulation alone, called cerebellar inhibition (CBI). Healthy individuals without pain have been shown to demonstrate reduced CBI following motor acquisition. We hypothesized that CBI would not reduce to the same extent in those with mild recurrent neck pain following the same motor acquisition task. We further hypothesized that a common treatment for neck pain (spinal manipulation) would restore reduced CBI following motor acquisition. Motor acquisition involved typing an eight-letter sequence of the letters Z,P,D,F with the right index finger. Twenty-seven neck pain participants received spinal manipulation (14 participants, 18-27 years) or sham control (13 participants, 19-24 years). Twelve healthy controls (20-27 years) also participated. Participants had CBI measured; they completed manipulation or sham control followed by motor acquisition; and then had CBI re-measured. Following motor acquisition, neck pain sham controls remained inhibited (58 +/- 33% of test MEP) vs. healthy controls who disinhibited (98 +/- 49% of test MEP, P<0.001), while the spinal manipulation group facilitated (146 +/- 95% of test MEP, P<0.001). Greater inhibition in neck pain sham vs. healthy control groups suggests that neck pain may change cerebellar-motor cortex interaction. The change to facilitation suggests that spinal manipulation may reverse inhibitory effects of neck pain.	[Baarbe, Julianne K.] Univ Hlth Network, Krembil Res Inst, Div Neurol, Toronto, ON, Canada; [Baarbe, Julianne K.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Yielder, Paul; Murphy, Bernadette Ann] Univ Ontario, Inst Technol, Fac Hlth Sci, Oshawa, ON, Canada; [Yielder, Paul] Deakin Univ, Sch Med, Fac Hlth, Waurn Ponds, Vic, Australia; [Haavik, Heidi] Ctr Chiropract Res, New Zealand Coll Chiropract, Auckland, New Zealand; [Holmes, Michael W. R.] Brock Univ, Dept Kinesiol, Fac Appl Hlth Sci, St Catharines, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Ontario Tech University; Deakin University; Brock University	Murphy, BA (corresponding author), Univ Ontario, Inst Technol, Fac Hlth Sci, Oshawa, ON, Canada.	Bernadette.Murphy@uoit.ca	Haavik, Heidi/AAG-1084-2021; Holmes, Mike/AAA-9582-2019	Haavik, Heidi/0000-0001-7182-2085; Holmes, Mike/0000-0002-1918-1695; Murphy, Bernadette/0000-0001-9832-5740	Australian Spinal Research Foundation [LG 2013-22]; Natural Sciences and Engineering Research Council of Canada Discovery Grants; Canada Foundation for Innovation - John R Evans Leaders Fund; Canadian Institutes of Health Research - Frederick Banting and Charles Best Canada Graduate Scholarships; Ontario Graduate Scholarships; University of Ontario Institute of Technology	Australian Spinal Research Foundation; Natural Sciences and Engineering Research Council of Canada Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation - John R Evans Leaders Fund(Canada Foundation for Innovation); Canadian Institutes of Health Research - Frederick Banting and Charles Best Canada Graduate Scholarships(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarships(Ontario Graduate Scholarship); University of Ontario Institute of Technology	The authors received funding from the Australian Spinal Research Foundation (LG 2013-22) (BM, MH, HH), Natural Sciences and Engineering Research Council of Canada Discovery Grants (BM), and Canada Foundation for Innovation - John R Evans Leaders Fund (BM). Graduate student funding was provided through Canadian Institutes of Health Research - Frederick Banting and Charles Best Canada Graduate Scholarships (JKB), Ontario Graduate Scholarships (JKB), and University of Ontario Institute of Technology (JKB). Other than funding from these agencies, the authors have no competing interests to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Baarbe J, 2014, J NEUROPHYSIOL, V111, P715, DOI 10.1152/jn.00661.2013; Bank PJM, 2013, EUR J PAIN, V17, P145, DOI 10.1002/j.1532-2149.2012.00186.x; Barr MS, 2013, J NEUROIMMUNE PHARM, V8, P535, DOI 10.1007/s11481-012-9383-y; Borsook D, 2007, PAIN, V132, P8, DOI 10.1016/j.pain.2007.09.006; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; Boudreau S, 2007, PAIN, V132, P169, DOI 10.1016/j.pain.2007.07.019; Canadian Chiropractic Association, 2005, J Can Chiropr Assoc, V49, P158; Cao DY, 2013, J MANIP PHYSIOL THER, V36, P68, DOI 10.1016/j.jmpt.2013.01.004; Caumo W, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00357; Coombes SA, 2016, PAIN, V157, P117, DOI 10.1097/j.pain.0000000000000337; Coronado RA, 2012, J ELECTROMYOGR KINES, V22, P752, DOI 10.1016/j.jelekin.2011.12.013; Daligadu J, 2013, J MANIP PHYSIOL THER, V36, P10; Daskalakis ZJ, 2004, J PHYSIOL-LONDON, V557, P689, DOI 10.1113/jphysiol.2003.059808; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Fisher KM, 2009, CLIN NEUROPHYSIOL, V120, P2109, DOI 10.1016/j.clinph.2009.08.021; Gay CW, 2014, J MANIP PHYSIOL THER, V37, P614, DOI 10.1016/j.jmpt.2014.09.001; Guerraz M, 2011, ACTA PSYCHOL, V136, P390, DOI 10.1016/j.actpsy.2011.01.004; Guzman J, 2008, SPINE, V33, pS14, DOI 10.1097/BRS.0b013e3181643efb; Haavik H, 2011, J MANIP PHYSIOL THER, V34, P88, DOI 10.1016/j.jmpt.2010.12.009; Haavik-Taylor H., 2007, CHIROPR J AUST, V37, P106, DOI DOI 10.3316/INFORMIT.234919797047272; Huang X, 2017, MOL PSYCHIATR, V22, P1274, DOI 10.1038/mp.2017.143; HUBKA MJ, 1994, J MANIP PHYSIOL THER, V17, P591; JULL G, 1988, MED J AUSTRALIA, V148, P233, DOI 10.5694/j.1326-5377.1988.tb99431.x; Knox JJ, 2005, EXP BRAIN RES, V165, P107, DOI 10.1007/s00221-005-2293-y; Knox J, 2006, BEHAV NEUROSCI, V120, P1211, DOI 10.1037/0735-7044.120.6.1211; Kristjansson E, 2003, CLIN REHABIL, V17, P768, DOI 10.1191/0269215503cr676oa; Lee HJ, 2005, SPINE, V30, pE60, DOI 10.1097/01.brs.0000152160.28052.a2; Lee HJ, 2004, SPINE, V29, P33, DOI 10.1097/01.BRS.0000103944.10408.BA; Lee HY, 2008, MANUAL THER, V13, P419, DOI 10.1016/j.math.2007.04.001; Magstim, 2002, MAGST BIST SYST OP M; Manto M, 2007, CEREBELLUM, V6, P3, DOI 10.1080/14734220701234690; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Manzoni D, 2007, CEREBELLUM, V6, P24, DOI 10.1080/14734220601132135; Martin PG, 2009, J NEUROPHYSIOL, V102, P606, DOI 10.1152/jn.91348.2008; Mhalla A, 2010, PAIN, V149, P495, DOI 10.1016/j.pain.2010.03.009; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Niazi IK, 2015, EXP BRAIN RES, V233, P1165, DOI 10.1007/s00221-014-4193-5; Noda Y, 2015, PSYCHOL MED, V45, P3411, DOI 10.1017/S0033291715001609; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulus I, 2008, J REHABIL MED, V40, P426, DOI 10.2340/16501977-0189; Pelletier R, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0480-y; Penhune VB, 2002, J NEUROSCI, V22, P1397, DOI 10.1523/JNEUROSCI.22-04-01397.2002; Pinto AD, 2001, EXP BRAIN RES, V140, P505, DOI 10.1007/s002210100862; Popa LS, 2013, CEREBELLUM, V12, P331, DOI 10.1007/s12311-013-0452-4; RHEALT W, 1992, Journal of Orthopaedic and Sports Physical Therapy, V15, P147; Rossi S, 2003, CLIN NEUROPHYSIOL, V114, P1351, DOI 10.1016/S1388-2457(03)00073-7; Ruscheweyh R, 2014, PAIN, V155, P1303, DOI 10.1016/j.pain.2014.04.006; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Sjolander P, 2008, MANUAL THER, V13, P122, DOI 10.1016/j.math.2006.10.002; Taylor HH, 2008, J MANIP PHYSIOL THER, V31, P115, DOI 10.1016/j.jmpt.2007.12.011; UGAWA Y, 1995, ANN NEUROL, V37, P703, DOI 10.1002/ana.410370603; Uthaikhup S, 2012, ARCH GERONTOL GERIAT, V55, P667, DOI 10.1016/j.archger.2012.01.013; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Waberski TD, 2008, NEUROSCI LETT, V435, P137, DOI 10.1016/j.neulet.2008.02.020; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; YOUDAS JW, 1992, PHYS THER, V72, P770, DOI 10.1093/ptj/72.11.770; Zabihhosseinian M, 2015, CLIN BIOMECH, V30, P397, DOI 10.1016/j.clinbiomech.2015.03.020	62	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193413	10.1371/journal.pone.0193413	http://dx.doi.org/10.1371/journal.pone.0193413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489878	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000073
J	Chen, H; Chen, XY; Liu, HT				Chen, Heng; Chen, Xinying; Liu, Haitao			How does language change as a lexical network? An investigation based on written Chinese word co-occurrence networks	PLOS ONE			English	Article							COMPLEX NETWORKS; HIERARCHICAL ORGANIZATION; MODULARITY; LENGTH; EVOLUTION; SYSTEM	Language is a complex adaptive system, but how does it change? For investigating this process, four diachronic Chinese word co-occurrence networks have been built based on texts that were written during the last 2,000 years. By comparing the network indicators that are associated with the hierarchical features in language networks, we learn that the hierarchy of Chinese lexical networks has indeed evolved over time at three different levels. The connections of words at the micro level are continually weakening; the number of words in the meso-level communities has increased significantly; and the network is expanding at the macro level. This means that more and more words tend to be connected to medium-central words and form different communities. Meanwhile, fewer high-central words link these communities into a highly efficient small-world network. Understanding this process may be crucial for understanding the increasing structural complexity of the language system.	[Chen, Heng; Liu, Haitao] Guangdong Univ Foreign Studies, Ctr Linguist & Appl Linguist, Guangzhou, Guangdong, Peoples R China; [Chen, Xinying] Xi An Jiao Tong Univ, Sch Foreign Studies, Xian, Shaanxi, Peoples R China; [Liu, Haitao] Zhejiang Univ, Dept Linguist, Hangzhou, Zhejiang, Peoples R China; [Liu, Haitao] Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China	Guangdong University of Foreign Studies; Xi'an Jiaotong University; Zhejiang University; Zhejiang University	Liu, HT (corresponding author), Guangdong Univ Foreign Studies, Ctr Linguist & Appl Linguist, Guangzhou, Guangdong, Peoples R China.; Liu, HT (corresponding author), Zhejiang Univ, Dept Linguist, Hangzhou, Zhejiang, Peoples R China.; Liu, HT (corresponding author), Zhejiang Univ, Ningbo Inst Technol, Ningbo, Zhejiang, Peoples R China.	lhtzju@yeah.net	Chen, Heng/Q-3590-2017; Liu, Haitao/HIR-1601-2022; Liu, Haitao/A-6053-2011; Chen, Heng/GOJ-8064-2022; Chen, Heng/AAB-1784-2019	Chen, Heng/0000-0003-3678-9827; Liu, Haitao/0000-0003-1724-4418; Chen, Heng/0000-0003-3678-9827; Chen, Xinying/0000-0002-5052-4991	National Social Science Foundation of China [12, ZD224, 17AYY021]; Fundamental Research Funds for the Central Universities Program of Big Data PLUS Language Universals and Cognition, Zhejiang University; MOE Project of the Center for Linguistics and Applied Linguistics, Guangdong University of Foreign Studies	National Social Science Foundation of China; Fundamental Research Funds for the Central Universities Program of Big Data PLUS Language Universals and Cognition, Zhejiang University; MOE Project of the Center for Linguistics and Applied Linguistics, Guangdong University of Foreign Studies	This work was supported by the National Social Science Foundation of China (Grant No. 12&ZD224) to HC, Fundamental Research Funds for the Central Universities Program of Big Data PLUS Language Universals and Cognition, Zhejiang University, and the National Social Science Foundation of China (Grant No. 17AYY021) to HL, and the MOE Project of the Center for Linguistics and Applied Linguistics, Guangdong University of Foreign Studies to HC and HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov O, 2011, J QUANT LINGUIST, V18, P291, DOI 10.1080/09296174.2011.608602; Akimushkin C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170527; Amancio DR, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/03/P03005; Amancio DR, 2012, PHYSICA A, V391, P4406, DOI 10.1016/j.physa.2012.04.011; Amancio DR, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/18002; Amancio DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136076; [Anonymous], 2010, NETWORKS INTRO NETWO, DOI DOI 10.1093/ACPROF:OSO/9780199206650.001.0001; Barabasi AL, 2003, LECT NOTES PHYS, V625, P46; Barcelo-Coblijn L, 2012, ADAPT BEHAV, V20, P427, DOI 10.1177/1059712312455439; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Beckner C, 2009, LANG LEARN, V59, P1; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boltz W.G, 1994, ORIGIN EARLY DEV CHI; Borge-Holthoefer J, 2010, ENTROPY-SWITZ, V12, P1264, DOI 10.3390/e12051264; Borodkin K, 2016, COGNITION, V156, P60, DOI 10.1016/j.cognition.2016.07.014; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cancho RFI, 2007, INT J BIFURCAT CHAOS, V17, P2453, DOI 10.1142/S021812740701852X; Cancho RFI, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051915; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Chao YR, 1946, LANGUAGE, V22, P4, DOI 10.2307/410329; Chen H, 2017, QUANT LINGUIST, V71, P37; Chen HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129903; Chomsky N., 2002, JANUA LINGUARUM; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cong J, 2014, PHYS LIFE REV, V11, P598, DOI 10.1016/j.plrev.2014.04.004; De Francis J., 1984, CHINESE LANGUAGE FAC; Ellis N., 2016, MONOGRAPH SUPPLEMENT, V66, P1; Ellis NC, 2006, APPL LINGUIST, V27, P558, DOI 10.1093/applin/aml028; ERDOS P, 1960, B INT STATIST INST, V38, P343; Ge Liangyan, 2001, OUT MARGINS RISE CHI; Gegov E., 2012, COMPUTATIONAL INTELL; Gros C, 2008, COMPLEX ADAPTIVE DYN; Halliday M A K, 2013, HALLIDAYS INTRO FUNC, V4th, DOI DOI 10.4324/9780203783771; Herbst T, 2007, TRENDS LINGUIST-STUD, V187, P1, DOI 10.1515/9783110198775; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jiang JY, 2015, LANG SCI, V50, P93, DOI 10.1016/j.langsci.2015.04.002; Karuza EA, 2016, TRENDS COGN SCI, V20, P629, DOI 10.1016/j.tics.2016.06.003; Ke JY, 2008, J QUANT LINGUIST, V15, P70, DOI 10.1080/09296170701794286; Kretzschmar WA, 2009, LINGUISTICS OF SPEECH, P1; Lahiri S., 2013, ARXIV PREPRINT ARXIV; Larsen-Freeman D, 2008, MOD LANG J, V92, P200; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li P, 2004, NEURAL NETWORKS, V17, P1345, DOI 10.1016/j.neunet.2004.07.004; Liu H., 2007, LINGUISTIC SCI, V6, P32; Liu H., 2018, COMPLEXITY IN PRESS, V2018; Liu HT, 2008, PHYSICA A, V387, P3048, DOI 10.1016/j.physa.2008.01.069; Liu HT, 2014, J CHINESE LINGUIST, V42, P1; Liu HT, 2013, CHINESE SCI BULL, V58, P1139, DOI 10.1007/s11434-013-5711-8; Liu HT, 2009, POZ STUD CONTEMP LIN, V45, P509, DOI 10.2478/v10010-009-0025-3; MassipBonet A, 2013, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-32817-6; McWhorter J, 2011, LINGUISTIC SIMPLICIT, V1; Mcwhorter John, 2003, POWER BABEL NATURAL; Meara P, 2016, SECOND LANG LEARN, P193, DOI 10.1007/978-3-319-33272-7_12; Mehler A., 2016, THEORETICAL FRAMEWOR; Mehri A, 2012, PHYSICA A, V391, P2429, DOI 10.1016/j.physa.2011.12.011; MILLER GA, 1994, PSYCHOL REV, V101, P343; Miyagawa S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00071; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Niazi MA, 2013, COGNITIVE AGENT BASE; Nowak MA, 2000, NATURE, V404, P495, DOI 10.1038/35006635; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Pastreich Emanuel, 2001, COLUMBIA HIST CHINES, P1067; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Pinker S, 2000, LANGUAGE INSTINCT; Pulleyblank Edwin G., 1995, OUTLINE CLASSICAL CH; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rice ML, 2010, J SPEECH LANG HEAR R, V53, P333, DOI 10.1044/1092-4388(2009/08-0183); Simon H.A., 1996, SCI ARTIFICIAL, V3rd ed; Sole RV, 2010, COMPLEXITY, V15, P20, DOI 10.1002/cplx.20305; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xu S, 2015, HIST CHINESE DIALECT; Zipf GK, 1950, J CLIN PSYCHOL, V6, P306	74	15	16	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192545	10.1371/journal.pone.0192545	http://dx.doi.org/10.1371/journal.pone.0192545			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489837	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000031
J	Zhan, Y; Marchand, CH; Maes, A; Mauries, A; Sun, Y; Dhaliwal, JS; Uniacke, J; Arragain, S; Jiang, H; Gold, ND; Martin, VJJ; Lemaire, SD; Zerges, W				Zhan, Yu; Marchand, Christophe H.; Maes, Alexandre; Mauries, Adeline; Sun, Yi; Dhaliwal, James S.; Uniacke, James; Arragain, Simon; Jiang, Heng; Gold, Nicholas D.; Martin, Vincent J. J.; Lemaire, Stephane D.; Zerges, William			Pyrenoid functions revealed by proteomics in Chlamydomonas reinhardtii	PLOS ONE			English	Article							IMMUNOLOGICAL COMPARISONS; CONCENTRATING MECHANISM; CHLOROPLAST RIBOSOME; SMALL-SUBUNIT; GREEN-ALGAE; PROTEIN; RNA; RUBISCO; MUTANTS; IDENTIFICATION	Organelles are intracellular compartments which are themselves compartmentalized. Biogenic and metabolic processes are localized to specialized domains or microcompartments to enhance their efficiency and suppress deleterious side reactions. An example of intra-organellar compartmentalization is the pyrenoid in the chloroplasts of algae and hornworts. This microcompartment enhances the photosynthetic CO2-fixing activity of the Calvin-Benson cycle enzyme Rubisco, suppresses an energetically wasteful oxygenase activity of Rubisco, and mitigates limiting CO2 availability in aquatic environments. Hence, the pyrenoid is functionally analogous to the carboxysomes in cyanobacteria. However, a comprehensive analysis of pyrenoid functions based on its protein composition is lacking. Here we report a proteomic characterization of the pyrenoid in the green alga Chlamydomonas reinhardtii. Pyrenoid-enriched fractions were analyzed by quantitative mass spectrometry. Contaminant proteins were identified by parallel analyses of pyrenoid-deficient mutants. This pyrenoid proteome contains 190 proteins, many of which function in processes that are known or proposed to occur in pyrenoids: e.g. the carbon concentrating mechanism, starch metabolism or RNA metabolism and translation. Using radioisotope pulse labeling experiments, we show that pyrenoid-associated ribosomes could be engaged in the localized synthesis of the large subunit of Rubisco. New pyrenoid functions are supported by proteins in tetrapyrrole and chlorophyll synthesis, carotenoid metabolism or amino acid metabolism. Hence, our results support the long-standing hypothesis that the pyrenoid is a hub for metabolism. The 81 proteins of unknown function reveal candidates for new participants in these processes. Our results provide biochemical evidence of pyrenoid functions and a resource for future research on pyrenoids and their use to enhance agricultural plant productivity. Data are available via ProteomeXchange with identifier PXD004509.	[Zhan, Yu; Sun, Yi; Dhaliwal, James S.; Uniacke, James; Arragain, Simon; Jiang, Heng; Gold, Nicholas D.; Martin, Vincent J. J.; Zerges, William] Concordia Univ, Dept Biol, Montreal, PQ, Canada; [Zhan, Yu; Sun, Yi; Dhaliwal, James S.; Uniacke, James; Arragain, Simon; Jiang, Heng; Gold, Nicholas D.; Martin, Vincent J. J.; Zerges, William] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada; [Marchand, Christophe H.; Maes, Alexandre; Mauries, Adeline; Lemaire, Stephane D.] Sorbonne Univ, UPMC Univ Paris 06, CNRS,Inst Biol Physicochim, UMR8226,Lab Biol Mol & Cellulaire Eucaryotes, 13 Rue Pierre & Marie Curie, Paris, France; [Uniacke, James] Univ Guelph, Dept Mol & Cellular Biol, Sci Complex, Guelph, ON, Canada; [Arragain, Simon] Univ Calif Davis, Chem Dept, Davis, CA 95616 USA	Concordia University - Canada; Concordia University - Canada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Guelph; University of California System; University of California Davis	Zerges, W (corresponding author), Concordia Univ, Dept Biol, Montreal, PQ, Canada.; Zerges, W (corresponding author), Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada.; Lemaire, SD (corresponding author), Sorbonne Univ, UPMC Univ Paris 06, CNRS,Inst Biol Physicochim, UMR8226,Lab Biol Mol & Cellulaire Eucaryotes, 13 Rue Pierre & Marie Curie, Paris, France.	stephane.lemaire@ibpc.fr; william.zerges@concordia.ca	Lemaire, Stéphane D/A-3530-2008; Arragain, Simon/AAA-6356-2019; MARCHAND, Christophe H/B-5854-2008	Lemaire, Stéphane D/0000-0001-6442-0547; Arragain, Simon/0000-0002-6500-0066; MARCHAND, Christophe H/0000-0002-0729-3841; Maes, Alexandre/0000-0002-7966-1340; Dhaliwal, James/0000-0001-8851-7562; Sun, Yi/0000-0002-2366-7153	Natural Sciences and Engineering Research Council of Canada [217566]; L'Agence Nationale de la Recherche (France) [ANR-12-BSV5-0019 REDPR02, ANR-LABX-011, ANR-11-EQPX-0008]; CYNTHIOL [12-BSV6-011]; Foundation pour la Recherche Medicale [DBI20141231801]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); L'Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); CYNTHIOL; Foundation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by 217566 from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca.) (WZ); ANR-12-BSV5-0019 REDPR02, ANR-LABX-011, and ANR-11-EQPX-0008 from L'Agence Nationale de la Recherche (France) (http://www.agence-nationale-recherche.fr/en/) and CYNTHIOL, 12-BSV6-011 (SDL); and DBI20141231801 Foundation pour la Recherche Medicale (https://www.frm.org/) (A Maes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball S.G., 2009, CHLAMYDOMONAS SOURCE, P1; Bienvenut WV, 2011, PROTEOMICS, V11, P1734, DOI 10.1002/pmic.201000634; Bollenbach TJ, 2009, PLANT MOL BIOL, V69, P541, DOI 10.1007/s11103-008-9436-z; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; Engel BD, 2015, ELIFE, V4, DOI 10.7554/eLife.04889; Eriksson M, 1996, P NATL ACAD SCI USA, V93, P12031, DOI 10.1073/pnas.93.21.12031; Fang W, 2012, PLANT CELL, V24, P1876, DOI 10.1105/tpc.112.097949; FLEMING GH, 1987, MOL GEN GENET, V206, P226, DOI 10.1007/BF00333578; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; Genkov T, 2010, J BIOL CHEM, V285, P19833, DOI 10.1074/jbc.M110.124230; GOLDBERG I, 1970, Journal of Cell Biology, V44, P572, DOI 10.1083/jcb.44.3.572; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Hayakawa H, 2001, BIOCHEMISTRY-US, V40, P9977, DOI 10.1021/bi010595q; Hippler M, 2001, PLANT J, V28, P595, DOI 10.1046/j.1365-313X.2001.01175.x; Joyard J, 2010, PROG LIPID RES, V49, P128, DOI 10.1016/j.plipres.2009.10.003; Jungnick N, 2014, PHOTOSYNTH RES, V121, P159, DOI 10.1007/s11120-014-0004-x; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; KERBY NW, 1978, PLANTA, V142, P91, DOI 10.1007/BF00385125; Kerfeld CA, 2016, CURR OPIN PLANT BIOL, V31, P66, DOI 10.1016/j.pbi.2016.03.009; KUCHITSU K, 1988, PROTOPLASMA, V144, P17, DOI 10.1007/BF01320276; Leister D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00255; Long BM, 2005, CAN J BOT, V83, P746, DOI 10.1139/B05-058; Lundquist PK, 2012, PLANT PHYSIOL, V158, P1172, DOI 10.1104/pp.111.193144; Mackinder LCM, 2016, P NATL ACAD SCI USA, V113, P5958, DOI 10.1073/pnas.1522866113; Mason CB, 2006, NAT PROTOC, V1, P2227, DOI 10.1038/nprot.2006.348; MCKAY RML, 1991, CAN J BOT, V69, P1040, DOI 10.1139/b91-134; Meyer MT, 2012, P NATL ACAD SCI USA, V109, P19474, DOI 10.1073/pnas.1210993109; MIYAMURA S, 1991, PROTOPLASMA, V161, P192, DOI 10.1007/BF01322731; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; OKADA M, 1991, CAN J BOT, V69, P1053, DOI 10.1139/b91-135; Phinney BS, 2005, J PROTEOME RES, V4, P497, DOI 10.1021/pr049791k; Ramazanov ZRM, 1994, PLANTA, V195, P7; RANDOLPHANDERSON BL, 1989, J MOL EVOL, V29, P68, DOI 10.1007/BF02106183; Rawat M, 1996, PLANTA, V198, P263; RIS H, 1962, J CELL BIOL, V13, P383, DOI 10.1083/jcb.13.3.383; Sambrook J., 2001, MOL CLONING LAB MANU; Satagopan S, 2004, J BIOL CHEM, V279, P14240, DOI 10.1074/jbc.M313215200; Schottkowski M, 2012, P NATL ACAD SCI USA, V109, P19286, DOI 10.1073/pnas.1209860109; Shukla M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051913; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Tirumani S, 2014, PLANT MOL BIOL, V85, P277, DOI 10.1007/s11103-014-0183-z; Uniacke J, 2008, J CELL BIOL, V182, P641, DOI 10.1083/jcb.200805125; Uniacke J, 2007, PLANT CELL, V19, P3640, DOI 10.1105/tpc.107.054882; Uniacke J, 2011, METHODS MOL BIOL, V714, P15, DOI 10.1007/978-1-61779-005-8_2; Uniacke J, 2009, P NATL ACAD SCI USA, V106, P1439, DOI 10.1073/pnas.0811268106; Wang YJ, 2015, PLANT J, V82, P429, DOI 10.1111/tpj.12829; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu JH, 2008, BIOCHEM BIOPH RES CO, V372, P288, DOI 10.1016/j.bbrc.2008.05.058; Wu JH, 2009, BIOCHEMISTRY-US, V48, P2012, DOI 10.1021/bi801752p; Yamaguchi K, 2003, J BIOL CHEM, V278, P33774, DOI 10.1074/jbc.M301934200; Yamaguchi K, 2002, PLANT CELL, V14, P2957, DOI 10.1105/tpc.004341; Yang JJ, 1997, J BIOL CHEM, V272, P12874, DOI 10.1074/jbc.272.19.12874; Zhan Y, 2015, J CELL SCI, V128, P4210, DOI 10.1242/jcs.175232	56	28	30	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0185039	10.1371/journal.pone.0185039	http://dx.doi.org/10.1371/journal.pone.0185039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481573	Green Published, gold			2022-12-27	WOS:000426202700001
J	Dong, B; Peng, Y; Wang, ZQ; Adegbija, O; Hui, J; Ma, J; Ma, YH				Dong, Bin; Peng, Yang; Wang, Zhiqiang; Adegbija, Odewumi; Hui, Jie; Ma, Jun; Ma, Ying-Hua			Joint association between body fat and its distribution with all-cause mortality: A data linkage cohort study based on NHANES (1988-2011)	PLOS ONE			English	Article							MASS INDEX; PHYSICAL-ACTIVITY; RISK; CIRCUMFERENCE; ADIPOSITY; NUTRITION	Objective Although obesity is recognized as an important risk of mortality, how the amount and distribution of body fat affect mortality risk is unclear. Furthermore, whether fat distribution confers any additional risk of mortality in addition to fat amount is not understood. Methods This data linkage cohort study included 16415 participants (8554 females) aged 18 to 89 years from National Health and Nutrition Examination Survey III (1988-1994) and its linked mortality data (31 December 2011). Cox proportional hazard models and parametric survival models were used to estimate the association between body fat percentage (BF%), based on bioelectrical impedance analysis, and waist-hip ratio (WHR) with mortality. Results A total of 4999 deaths occurred during 19-year follow-up. A U-shaped association between BF% and mortality was found in both sexes, with the adjusted hazard ratios for other groups between 1.02 (95% confidence interval: 0.89, 1.18) and 2.10 (1.47, 3.01) when BF% groups of 25-30% in males and 30-35% in females were used as references. A non-linear relationship between WHR and mortality was detected in males, with the adjusted hazard ratios among other groups ranging from 1.05 (0.94, 1.18) to 1.52 (1.15, 2.00) compared with the WHR category of 0.95-1.0. However in females, the death risk constantly increased across the WHR spectrum. Joint impact of BF% and WHR suggested males with BF% of 25-30% and WHR of 0.95-1.0 and females with BF% of 30-35% and WHR <0.9 were associated with the lowest mortality risk and longest survival age compared with their counterparts in other categories. Conclusions This study supported the use of body fat distribution in addition to fat amount in assessing the risk of all-cause mortality.	[Dong, Bin; Ma, Jun; Ma, Ying-Hua] Peking Univ, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China; [Peng, Yang; Wang, Zhiqiang; Adegbija, Odewumi] Univ Queensland, Sch Med, Ctr Chron Dis, Herston, Qld, Australia; [Hui, Jie] Inst Urban Indigenous Hlth, Brisbane, Qld, Australia	Peking University; University of Queensland	Ma, YH (corresponding author), Peking Univ, Sch Publ Hlth, Hlth Sci Ctr, Beijing, Peoples R China.	yinghuama@bjmu.edu.cn	Adegbija, Odewumi/N-1434-2019; Peng, Yang/J-8980-2016	Peng, Yang/0000-0002-9119-5506; Adegbija, Odewumi/0000-0001-6517-3795; Hu, Jie/0000-0003-2940-6525	National Health and Medical Research Council [APP1042343]; University of Queensland International Scholarship [44078179]; Excellent Talents Fund Program of Peking University Health Science Center [BMU2017YJ002]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland International Scholarship; Excellent Talents Fund Program of Peking University Health Science Center	This study was funded by the National Health and Medical Research Council (APP1042343), University of Queensland International Scholarship (44078179) and the Excellent Talents Fund Program of Peking University Health Science Center (BMU2017YJ002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2016, JAMA-J AM MED ASSOC, V315, P1989, DOI 10.1001/jama.2016.4666; Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Andersen SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138429; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2716; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Chen Y, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5446; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; National Clinical Guideline Centre (UK), 2014, OB ID ASS MAN OV WEI; Parker ED, 2009, AM J EPIDEMIOL, V169, P837, DOI 10.1093/aje/kwn395; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Reis JP, 2009, OBESITY, V17, P1232, DOI 10.1038/oby.2008.664; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; World Health Organization, 1995, PHYS STAT US INT ANT; Yerrakalva D, 2015, OBESITY, V23, P1944, DOI 10.1002/oby.21181; Zong G, 2016, OBESITY IN PRESS	23	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193368	10.1371/journal.pone.0193368	http://dx.doi.org/10.1371/journal.pone.0193368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474498	Green Submitted, Green Published, gold			2022-12-27	WOS:000426049500096
J	Mapoure, NY; Budzi, MN; Eloumou, SAFB; Malongue, A; Okalla, C; Luma, HN				Mapoure, N. Y.; Budzi, M. N.; Eloumou, S. A. F. B.; Malongue, A.; Okalla, C.; Luma, H. N.			Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PERIPHERAL NEUROPATHY; EXTRAHEPATIC MANIFESTATIONS; VIRUS; PREVALENCE; INFECTION; DYSFUNCTION; IMPAIRMENT; DISORDERS; RNA	Background Chronic hepatitis C infection is a major public health concern, with a high burden in SubSaharan Africa. There is growing evidence that chronic hepatitis C virus (HCV) infection causes neurological complications. This study aimed at assessing the prevalence and factors associated with neurological manifestations in chronic hepatitis C patients. Methods Through a cross-sectional design, a semi-structured questionnaire was used to collect data from consecutive chronic HCV infected patients attending the outpatient gastroenterology unit of the Douala General Hospital (DGH). Data collection was by interview, patient record review (including HCV RNA quantification, HCV genotyping and the assessment of liver fibrosis and necroinflammatory activity), clinical examination complemented by 3 tools; Neuropathic pain diagnostic questionnaire, Brief peripheral neuropathy screen and mini mental state examination score. Data were analysed using Statistical package for social sciences version 20 for windows. Results Of the 121 chronic hepatitis C patients (51.2% males) recruited, 54.5% (95% Confidence interval: 46.3%, 62.8%) had at least one neurological manifestation, with peripheral nervous system manifestations being more common (50.4%). Age >= 55 years (Adjusted Odds Ratio: 4.82, 95% CI: 1.02 +/- 18.81, p = 0.02), longer duration of illness (AOR: 1.012, 95% CI: 1.00 +/- 1.02, p = 0.01) and high viral load (AOR: 3.40, 95% CI: 1.20 +/- 9.64, p = 0.02) were significantly associated with neurological manifestations. Peripheral neuropathy was the most common neurological manifestation (49.6%), presenting mainly as sensory neuropathy (47.9%). Age >= 55 years (AOR: 6.25, 95% CI: 1.33 +/- 29.08, p = 0.02) and longer duration of illness (AOR: 1.01, 1.00 +/- 1.02, p = 0.01) were significantly associated with peripheral neuropathy. Conclusion Over half of the patients with chronic hepatitis C attending the DGH have a neurological manifestation, mainly presenting as sensory peripheral neuropathy. Routine screening of chronic hepatitis C patients for peripheral neuropathy is therefore necessary, with prime focus on those with older age and longer duration of illness.	[Mapoure, N. Y.; Eloumou, S. A. F. B.] Univ Douala, Fac Med & Pharmaceut Sci, Dept Clin Sci, Douala, Cameroon; [Mapoure, N. Y.; Eloumou, S. A. F. B.; Malongue, A.; Okalla, C.; Luma, H. N.] Douala Gen Hosp, Dept Internal Med, Douala, Cameroon; [Budzi, M. N.] Univ Buea, Fac Hlth Sci, Buea, Cameroon; [Okalla, C.] Univ Douala, Fac Med & Pharmaceut Sci, Dept Biol Sci, Douala, Cameroon; [Luma, H. N.] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med, Yaounde, Cameroon	University of Yaounde I	Mapoure, NY (corresponding author), Univ Douala, Fac Med & Pharmaceut Sci, Dept Clin Sci, Douala, Cameroon.; Mapoure, NY (corresponding author), Douala Gen Hosp, Dept Internal Med, Douala, Cameroon.	mapoureypcouba@gmail.com		MAPOURE, Yacouba Njankouo/0000-0003-3304-6171				Abulhassan M, 2008, J TAIBAH UNIV MED SC, V3, P25, DOI 10.1016/S1658-3612(08)70041-6; Adinolfi LE, 2015, WORLD J GASTROENTERO, V21, P2269, DOI 10.3748/wjg.v21.i8.2269; Al-Soud A. A., 2011, The Journal of American Science, V7, P282; Authier FJ, 2003, NEUROLOGY, V60, P808, DOI 10.1212/01.WNL.0000044399.71601.EA; Biasiotta A, 2014, J NEUROL, V261, P725, DOI 10.1007/s00415-014-7261-7; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3; Cacoub P, 1999, ARTHRITIS RHEUM-US, V42, P2204, DOI 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D; Cacoub P, 2014, DIGEST LIVER DIS, V46, pS165, DOI 10.1016/j.dld.2014.10.005; Cherry CL, 2005, NEUROLOGY, V65, P1778, DOI 10.1212/01.wnl.0000187119.33075.41; El lehleh Ayman M, 2010, ALEXIANDRIA J, V8, P35; Fontana RJ, 2005, J HEPATOL, V43, P614, DOI 10.1016/j.jhep.2005.04.006; Forton DM, 2006, EUR J GASTROEN HEPAT, V18, P333, DOI 10.1097/00042737-200604000-00005; Forton DM, 2002, HEPATOLOGY, V35, P433, DOI 10.1053/jhep.2002.30688; Ghoneimy ATE, 2009, ARAB J GASTROENTEROL, V10, P82; Gomes I, 2006, ARQ NEURO-PSIQUIAT, V64, P600, DOI 10.1590/S0004-282X2006000400014; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hilsabeck RC, 2003, J INT NEUROPSYCHOL S, V9; Jember G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0295-5; Karoney MJ, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.44.2199; Khalek MAA, 2012, EGYPT RHEUMATOL, V34, P91, DOI 10.1016/j.ejr.2012.04.001; Kramer L, 2002, J HEPATOL, V37, P349, DOI 10.1016/S0168-8278(02)00172-1; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Luma HN, 2016, INT J INFECT DIS, V45, P53, DOI 10.1016/j.ijid.2016.02.013; Mathew S, 2016, WORLD J HEPATOL, V8, P545, DOI 10.4254/wjh.v8.i12.545; McAndrews MP, 2005, HEPATOLOGY, V41, P801, DOI 10.1002/hep.20635; Mohamed AA, 2015, WORLD J HEPATOL, V7, P2676, DOI 10.4254/wjh.v7.i26.2676; Monaco S, 2015, WORLD J GASTROENTERO, V21, P11974, DOI 10.3748/wjg.v21.i42.11974; Mora N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1584-1; Nabil Abd El Fatah Al kafrawy, 2014, WOLTERS KLUWER HLTH, V27, P458; Perry W, 2008, DIGEST DIS SCI, V53, P307, DOI 10.1007/s10620-007-9896-z; Radkowski M, 2002, J VIROL, V76, P600, DOI 10.1128/JVI.76.2.600-608.2002; Santoro L, 2006, J NEUROL NEUROSUR PS, V77, P626, DOI 10.1136/jnnp.2005.081570; Sterling Richard K, 2006, Curr Gastroenterol Rep, V8, P53, DOI 10.1007/s11894-006-0064-y; Szymanowicz A, 2007, SPECTRA BIOL, V26, P47; Tellez-Zenteno Jose Francisco, 2003, J Clin Neuromuscul Dis, V4, P109; Weissenborn K, 2005, AIDS, V19, pS93, DOI 10.1097/01.aids.0000192076.03443.6d; World Health Organisation, 2016, WHO HEP C FACTSH; Yoon MS, 2011, J NEUROL, V258, P80, DOI 10.1007/s00415-010-5686-1; Zaltron S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-S2-S2; Zaltron S, 1998, ITAL J GASTROENTEROL, V30, P391; Zampino R, 2013, WORLD J HEPATOL, V5, P528, DOI 10.4254/wjh.v5.i10.528	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0192406	10.1371/journal.pone.0192406	http://dx.doi.org/10.1371/journal.pone.0192406			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513678	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800014
J	Nilsson, B; Hansen, BW				Nilsson, Birgitte; Hansen, Benni Winding			Timing of embryonic quiescence determines viability of embryos from the calanoid copepod, Acartia tonsa (Dana)	PLOS ONE			English	Article							ZOOPLANKTON EGG BANKS; SILKWORM BOMBYX-MORI; NEWLY-LAID EGGS; SCHISTOCERCA-GREGARIA; ECDYSTEROID LEVELS; COLD-STORAGE; RESTING EGGS; PLANKTONIC COPEPODS; MARINE COPEPODS; EMBRYOGENESIS	Like 41 other calanoid copepods, Acartia tonsa, are capable of inducing embryonic quiescence when experiencing unfavorable environmental conditions. The ecdysone-signaling cascade is known to have a key function in developmental processes like embryogenesis and molting of arthropods, including copepods. We examined the role of ecdysteroid-phosphate phosphatase (EPPase), ecdysone receptor (EcR), 8 fushi tarazu transcription factor 1 (BFTZ-F1), and the ecdysteroid-regulated early gene E74 (E74), which represent different levels of the ecdysone-signaling cascade in our calanoid model organism. Progression of embryogenesis was monitored and hatching success determined to evaluate viability. Embryos that were induced quiescence before the gastrulation stage would stay in gastrulation during the rest of quiescence and exhibited a slower pace of hatching as compared to subitaneous embryos. In contrast, embryos developed further than gastrulation would stay in gastrulation or later stages during quiescence and showed a rapid pace in hatching after quiescence termination. Expression patterns suggested two peaks of the biological active ecdysteroids, 20-hydroxyecdysone (20E). The first peak of 20E was expressed in concert with the beginning of embryogenesis originating from yolk-conjugated ecdysteroids, based on EPPase expression. The second peak is suggested to originate from de novo synthesized 20E around the limb bud stage. During quiescence, the expression patterns of EPPase, EcR, 8FTZ-F1, and E74 were either decreasing or not changing over time. This suggests that the ecdysone-signaling pathway play a key role in the subitaneous development of A. tonsa embryogenesis, but not during quiescence. The observation is of profound ecological and practical relevance for the dynamics of egg banks.	[Nilsson, Birgitte; Hansen, Benni Winding] Roskilde Univ, Dept Sci & Environm, Univ Vej 1, Roskilde, Denmark	Roskilde University	Hansen, BW (corresponding author), Roskilde Univ, Dept Sci & Environm, Univ Vej 1, Roskilde, Denmark.	bhansen@ruc.dk	Hansen, Benni W/K-3299-2015	Hansen, Benni W/0000-0003-1145-561X; Nilsson, Birgitte/0000-0002-6143-8394	Villum Foundation [Project AMPHICOP] [8960]	Villum Foundation [Project AMPHICOP]	This work was supported by the Villum Foundation [Project AMPHICOP no. 8960, to B.W.H.].	Asada M, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu043; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; BORDESALLEAUME N, 1987, INT J INVER REP DEV, V11, P109, DOI 10.1080/01688170.1987.10510270; BOWNES M, 1988, P NATL ACAD SCI USA, V85, P1554, DOI 10.1073/pnas.85.5.1554; Chen F, 1997, MAR BIOL, V127, P587, DOI 10.1007/s002270050049; DINAN LN, 1981, J INSECT PHYSIOL, V27, P51, DOI 10.1016/0022-1910(81)90032-9; Drillet G, 2006, AQUACULTURE, V254, P714, DOI 10.1016/j.aquaculture.2005.11.018; Drillet G, 2006, AQUAC RES, V37, P756, DOI 10.1111/j.1365-2109.2006.01489.x; GANDE AR, 1979, J INSECT PHYSIOL, V25, P669, DOI 10.1016/0022-1910(79)90117-3; GHARIB B, 1981, EXPERIENTIA, V37, P1107, DOI 10.1007/BF02085039; GLASS H, 1978, CELL TISSUE RES, V194, P237; GOLTZENE F, 1978, H-S Z PHYSIOL CHEM, V359, P1427, DOI 10.1515/bchm2.1978.359.2.1427; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; Hairston NG, 2002, INTEGR COMP BIOL, V42, P481, DOI 10.1093/icb/42.3.481; Hansen BW, 2010, J PLANKTON RES, V32, P305, DOI 10.1093/plankt/fbp122; Hansen BW, 2016, AQUACULT INT, V24, P949, DOI 10.1007/s10499-015-9963-y; Hansen BW, 2016, AQUACULTURE, V457, P131, DOI 10.1016/j.aquaculture.2016.02.024; Hansen BW, 2012, J COMP PHYSIOL B, V182, P613, DOI 10.1007/s00360-012-0646-y; Holm MW, 2018, J PLANKTON RES, V40, P2, DOI 10.1093/plankt/fbx062; Holmstrup M, 2006, AQUAC RES, V37, P625, DOI 10.1111/j.1365-2109.2006.01472.x; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; LAGUEUX M, 1981, MOL CELL ENDOCRINOL, V24, P325, DOI 10.1016/0303-7207(81)90007-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makka T, 2002, ARCH INSECT BIOCHEM, V51, P111, DOI 10.1002/arch.10055; Marcus NH, 1996, HYDROBIOLOGIA, V320, P141, DOI 10.1007/BF00016815; Martini A, 2011, B INSECTOL, V64, P253; Nilsson B, 2014, J PLANKTON RES, V36, P513, DOI 10.1093/plankt/fbt099; Niwa R, 2014, BIOSCI BIOTECH BIOCH, V78, P1283, DOI 10.1080/09168451.2014.942250; PAFFENHOFER GA, 1988, MAR ECOL PROG SER, V42, P33, DOI 10.3354/meps042033; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; R T. R Core Team, 2017, R LANG ENV STAT COMP; SABATINI ME, 1990, CRUSTACEANA, V59, P53, DOI 10.1163/156854090X00282; Shahin R, 2016, INSECT MOL BIOL, V25, P138, DOI 10.1111/imb.12207; Sichlau MH, 2011, MAR BIOL, V158, P665, DOI 10.1007/s00227-010-1590-6; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; STOTTRUP JG, 1986, AQUACULTURE, V52, P87, DOI 10.1016/0044-8486(86)90028-1; STOTTRUP JG, 1990, J EXP MAR BIOL ECOL, V141, P87, DOI 10.1016/0022-0981(90)90216-Y; Subramoniam T, 2000, COMP BIOCHEM PHYS C, V125, P135, DOI 10.1016/S0742-8413(99)00098-5; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Tawfik AI, 1999, ARCH INSECT BIOCHEM, V41, P134, DOI 10.1002/(SICI)1520-6327(1999)41:3&lt;134::AID-ARCH4&gt;3.0.CO;2-6; Thompson PA, 2012, AUSTRAL ECOLOGY; Turner JT, 2004, ZOOL STUD, V43, P255; Vitiello V, 2016, ECOTOXICOLOGY, V25, P1033, DOI 10.1007/s10646-016-1660-8; Yamada M, 2000, DEVELOPMENT, V127, P5083; YANG CM, 1977, CRUSTACEANA, V33, P33, DOI 10.1163/156854077X00205; Zirbel MJ, 2007, LIMNOL OCEANOGR-METH, V5, P106, DOI 10.4319/lom.2007.5.106	47	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193727	10.1371/journal.pone.0193727	http://dx.doi.org/10.1371/journal.pone.0193727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513715	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800073
J	van Westen, E; Poelen, MCM; van den Dobbelsteen, GPJM; Oloo, EO; Ochs, MM; Rots, NY; van Els, CACM				van Westen, Els; Poelen, Martien C. M.; van den Dobbelsteen, Germie P. J. M.; Oloo, Eliud O.; Ochs, Martina M.; Rots, Nynke Y.; van Els, Cecile A. C. M.			Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1	PLOS ONE			English	Article							PNEUMOCOCCAL PROTEIN VACCINE; INFANT MURINE MODEL; TRIVALENT RECOMBINANT PCPA; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL COLONIZATION; CRYSTAL-STRUCTURE; PROTECTION; IMMUNIZATION; MICE; INFECTION	Detoxified pneumolysin, PlyD1, is a protein vaccine candidate that induces protection against infections with Streptococcus pneumoniae in mouse models. Despite extensive knowledge on antibody responses against PlyD1, limited information is available about PlyD1 induced T cell recognition. Here we interrogated epitope breadth and functional characteristics of the T cell response to PlyD1 in two mouse strains. BALB/c (H-2(d)) and C57BL/6 (H-2(b)) mice were vaccinated with Al(OH)(3)-adjuvanted or non-adjuvanted PlyD1, or placebo, on day 0, 21 and 42 and were sacrificed at day 56 for collection of sera and spleens. Vaccination with adjuvanted and non-adjuvanted PlyD1 induced anti-pneumolysin IgG antibodies with neutralizing capacity in both mouse strains. Adjuvantation of PlyD1 enhanced the serological responses in both strains. In vitro restimulation of splenocytes with PlyD1 and 18-mer synthetic peptides derived from pneumolysin revealed specific proliferative and cytokine responses. For both mouse strains, one immunodominant and three subdominant natural epitopes were identified. Overlap between H-2(d) and H-2(b) restricted T cell epitopes was limited, yet similarities were found between epitopes processed in mice and predicted to be immunogenic in humans. H-2(d) restricted T cell epitopes were localized in pneumolysin domains 2 and 3, whereas H-2(b) epitopes were scattered over the protein. Cytokine responses show mostly a Th2 profile, with low levels of Th1 cytokines, in both mouse strains. In conclusion, PlyD1 evokes T cell responses in mice directed against multiple epitope regions, that is dependent on Major Histocompatibility Complex (MHC) background. These results are important to understand human PlyD1 T cell immunogenicity, to guide cell mediated immunity studies in the context of vaccine development.	[van Westen, Els; Poelen, Martien C. M.; van den Dobbelsteen, Germie P. J. M.; Rots, Nynke Y.; van Els, Cecile A. C. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Oloo, Eliud O.] Sanofi Pasteur, Cambridge, MA USA; [Ochs, Martina M.] Sanofi Pasteur, Marcy Letoile, France; [van den Dobbelsteen, Germie P. J. M.] Janssen, Bacterial Vaccines, Leiden, Netherlands; [Oloo, Eliud O.] Schrodinger Inc, Cambridge, MA USA	Netherlands National Institute for Public Health & the Environment; Sanofi-Aventis; Johnson & Johnson; Janssen Pharmaceuticals	van Els, CACM (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	Cecile.van.Els@rivm.nl						ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683, DOI 10.1128/IAI.62.12.5683-5688.1994; Annunziato F, 2015, J ALLERGY CLIN IMMUN, V135, P626, DOI 10.1016/j.jaci.2014.11.001; Basset A, 2007, INFECT IMMUN, V75, P5460, DOI 10.1128/IAI.00773-07; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blanchard-Rohner G, 2011, EXPERT REV VACCINES, V10, P673, DOI 10.1586/erv.11.14; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Brooks WA, 2015, VACCINE, V33, P4610, DOI 10.1016/j.vaccine.2015.06.078; Converso TR, 2017, VACCINE, V35, P149, DOI 10.1016/j.vaccine.2016.11.027; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; Gray C, 2014, MUCOSAL IMMUNOL, V7, P705, DOI 10.1038/mi.2013.89; Jefferies JMC, 2010, J MED MICROBIOL, V59, P808, DOI 10.1099/jmm.0.018663-0; Kamtchoua T, 2013, VACCINE, V31, P327, DOI 10.1016/j.vaccine.2012.11.005; KANCLERSKI K, 1987, J CLIN MICROBIOL, V25, P222, DOI 10.1128/JCM.25.2.222-225.1987; Kaur R, 2014, INFECT IMMUN, V82, P5069, DOI 10.1128/IAI.02124-14; Khan MN, 2014, J INFECT DIS, V210, P1658, DOI 10.1093/infdis/jiu321; Kirkham LAS, 2006, J CLIN MICROBIOL, V44, P151, DOI 10.1128/JCM.44.1.151-159.2006; Kirkham LAS, 2006, INFECT IMMUN, V74, P586, DOI 10.1128/IAI.74.1.586-593.2006; Korchev YE, 1998, BIOCHEM J, V329, P571; Lawrence SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14352; Ljutic B, 2012, VACCINE, V30, P2981, DOI 10.1016/j.vaccine.2012.02.038; Lock RA, 1996, MICROB PATHOGENESIS, V21, P71, DOI 10.1006/mpat.1996.0044; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lu YJ, 2010, VACCINE, V28, P7468, DOI 10.1016/j.vaccine.2010.09.031; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Mann B, 2014, J INFECT DIS, V209, P1116, DOI 10.1093/infdis/jit502; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; Marshall JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13293; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Miyaji EN, 2013, CELL MOL LIFE SCI, V70, P3303, DOI 10.1007/s00018-012-1234-8; Moffitt KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043445; Moffitt KL, 2012, VACCINE, V30, P4316, DOI 10.1016/j.vaccine.2012.01.034; Moise L, 2013, HUM VACC IMMUNOTHER, V9, P1577, DOI 10.4161/hv.24615; Oloo EO, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191148; PATON JC, 1983, INFECT IMMUN, V40, P548, DOI 10.1128/IAI.40.2.548-552.1983; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rossjohn J, 1998, J MOL BIOL, V284, P449, DOI 10.1006/jmbi.1998.2167; Rubins JB, 1997, INFECT IMMUN, V65, P2975, DOI 10.1128/IAI.65.7.2975-2977.1997; Salha D, 2012, INFECT IMMUN, V80, P2212, DOI 10.1128/IAI.06348-11; Southwood S, 1998, J IMMUNOL, V160, P3363; Suarez-Alvarez B, 2003, IMMUNOL LETT, V88, P227, DOI 10.1016/S0165-2478(03)00081-6; van Pee K, 2017, ELIFE, V6, DOI 10.7554/eLife.23644; Verhoeven D, 2014, CLIN VACCINE IMMUNOL, V21, P1037, DOI 10.1128/CVI.00052-14; Verhoeven D, 2014, VACCINE, V32, P3205, DOI 10.1016/j.vaccine.2014.04.004; WALKER JA, 1987, INFECT IMMUN, V55, P1184, DOI 10.1128/IAI.55.5.1184-1189.1987; Wall EC, 2012, CLIN INFECT DIS, V54, P701, DOI 10.1093/cid/cir926; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Wilson R, 2015, MUCOSAL IMMUNOL, V8, P627, DOI 10.1038/mi.2014.95; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Xu Q, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.01.011; Xu QF, 2017, VACCINE, V35, P337, DOI 10.1016/j.vaccine.2016.11.046; Zafar MA, 2017, CELL HOST MICROBE, V21, P73, DOI 10.1016/j.chom.2016.12.005	51	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193650	10.1371/journal.pone.0193650	http://dx.doi.org/10.1371/journal.pone.0193650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509778	Green Submitted, Green Published, gold			2022-12-27	WOS:000426813200019
J	Yanagisawa, S; Baker, JR; Vuppusetty, C; Koga, T; Colley, T; Fenwick, P; Donnelly, LE; Barnes, PJ; Ito, K				Yanagisawa, Satoru; Baker, Jonathan R.; Vuppusetty, Chaitanya; Koga, Takeshi; Colley, Thomas; Fenwick, Peter; Donnelly, Louise E.; Barnes, Peter J.; Ito, Kazuhiro			The dynamic shuttling of SIRT1 between cytoplasm and nuclei in bronchial epithelial cells by single and repeated cigarette smoke exposure	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DEPENDENT HISTONE DEACETYLASE; OXIDATIVE STRESS; INFLAMMATION; GLUTATHIONE; INHIBITION; PROTEIN; METABOLISM; CANCER; MICE	SIRT1 (silent information regulator 2 homolog 1) is a crucial cellular survival protein especially in oxidative stress environments, and has been thought to locate within the nuclei, but also known to shuttle between cytoplasm and nuclei in some cell types. Here, we show for the first time the dynamics of SIRT1 in the presence of single or concurrent cigarette smoke extract (CSE) exposure in human bronchial epithelial cells (HBEC). In BEAS-2B HBEC or primary HBEC, SIRT1 was localized predominantly in cytoplasm, and the CSE (3%) induced nuclear translocation of SIRT1 from cytoplasm in the presence of L-buthionine sulfoximine (an irreversible inhibitor of Y-glutamylcystein synthetase), mainly through the activation of phosphatidylinositol 3-kinase (PI3K) alpha subunit. This SIRT1 nuclear shuttling was associated with FOXO3a nuclear translocation and the strong induction of several anti-oxidant genes including superoxide dismutase (SOD) 2 and 3; therefore seemed to be an adaptive response. When BEAS-2B cells were pretreated with repeated exposure to a lower concentration of CSE (0.3%), the CSE-induced SIRT1 shuttling and resultant SOD2/3 mRNA induction were significantly impaired. Thus, this result offers a useful cell model to mimic the impaired anti-oxidant capacity in cigarette smoking-associated lung disease such as chronic obstructive pulmonary disease.	[Yanagisawa, Satoru; Baker, Jonathan R.; Vuppusetty, Chaitanya; Koga, Takeshi; Colley, Thomas; Fenwick, Peter; Donnelly, Louise E.; Barnes, Peter J.; Ito, Kazuhiro] Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Sect, London, England	Imperial College London	Ito, K (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Airway Dis Sect, London, England.	k.ito@imperial.ac.uk	Yanagisawa, Satoru/D-8292-2018; Ito, Kazuhiro/AAF-5994-2019	Yanagisawa, Satoru/0000-0003-3895-5518; Barnes, Peter/0000-0002-5122-4018; Donnelly, Louise/0000-0002-0753-5425	Wellcome Trust Programme Grant [093080/Z/10/Z]; Banyu Life Science Foundation International fellowship; Wellcome Trust; Pulmocide Ltd	Wellcome Trust Programme Grant(Wellcome Trust); Banyu Life Science Foundation International fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); Pulmocide Ltd	This study was supported by the Wellcome Trust Programme Grant (093080/Z/10/Z). S.Y is a recipient of a Banyu Life Science Foundation International fellowship. CV and JB are recipients of a Wellcome Trust grant shown above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pulmocide Ltd also provided support in the form of salaries for authors [KI, TC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Wellcome Trust Programme Grant (093080/Z/10/Z). S.Y is a recipient of a Banyu Life Science Foundation International fellowship. CV and JB are recipients of a Wellcome Trust grant shown above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pulmocide Ltd provided support in the form of salaries for authors [KI, TC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Byles V, 2010, INT J BIOL SCI, V6, P599; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Chen IY, 2006, J BIOL CHEM, V281, P19369, DOI 10.1074/jbc.M601443200; Chen Z, 2013, ANTIOXID REDOX SIGN, V19, P1522, DOI 10.1089/ars.2012.4803; Dong X Charlie, 2012, Diabetes Manag (Lond), V2, P243; DREW R, 1984, BIOCHEM PHARMACOL, V33, P2989, DOI 10.1016/0006-2952(84)90598-7; Engelen MPKJ, 2000, AM J RESP CRIT CARE, V161, P98, DOI 10.1164/ajrccm.161.1.9901031; Faes S, 2015, INT J MOL SCI, V16, P21138, DOI 10.3390/ijms160921138; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Ghigo A, 2010, BIOESSAYS, V32, P185, DOI 10.1002/bies.200900150; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ito K, 2007, J PHARMACOL EXP THER, V321, P1, DOI 10.1124/jpet.106.111674; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Martinez-Redondo Paloma, 2013, Genes Cancer, V4, P148, DOI 10.1177/1947601913483767; Marwick JA, 2009, AM J RESP CRIT CARE, V179, P542, DOI 10.1164/rccm.200810-1570OC; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Meng CB, 2011, J INNOV OPT HEAL SCI, V4, P133, DOI 10.1142/S1793545811001356; Mercado N, 2011, J PHARMACOL EXP THER, V337, P465, DOI 10.1124/jpet.110.175950; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mitani A, 2016, AM J RESP CRIT CARE, V193, P143, DOI 10.1164/rccm.201503-0593OC; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Olmos Y, 2013, ANTIOXID REDOX SIGN, V19, P1507, DOI 10.1089/ars.2012.4713; Rahman I, 1999, AM J PHYSIOL-LUNG C, V277, pL1067, DOI 10.1152/ajplung.1999.277.6.L1067; Rahman S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-11; Rosenberg MI, 2002, CELL, V109, P447, DOI 10.1016/S0092-8674(02)00732-8; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Salminen A, 2013, INT J MOL SCI, V14, P3834, DOI 10.3390/ijms14023834; Song NY, 2012, ANN NY ACAD SCI, V1271, P10, DOI 10.1111/j.1749-6632.2012.06762.x; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Stunkel W, 2011, J BIOMOL SCREEN, V16, P1153, DOI 10.1177/1087057111422103; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC; Turgut T, 2014, J THORAC DIS, V6, P765, DOI 10.3978/j.issn.2072-1439.2014.04.24; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V293, pL1156, DOI 10.1152/ajplung.00081.2007; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Yao HW, 2014, AM J PHYSIOL-LUNG C, V306, pL816, DOI 10.1152/ajplung.00323.2013; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Zheng ZH, 2011, MOL PHARMACOL, V80, P657, DOI 10.1124/mol.111.072546	48	36	37	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193921	10.1371/journal.pone.0193921	http://dx.doi.org/10.1371/journal.pone.0193921			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509781	gold, Green Published, Green Submitted			2022-12-27	WOS:000426813200043
J	Ma, QQ; Fan, XD; Li, T; Hao, YY; Ma, F				Ma, Qiang-Qiang; Fan, Xiu-De; Li, Tao; Hao, Yuan-Yuan; Ma, Feng			Short- and long-term prognostic value of hyponatremia in patients with acute coronary syndrome: A systematic review and meta-analysis	PLOS ONE			English	Review							IN-HOSPITAL OUTCOMES; ACUTE HEART-FAILURE; MYOCARDIAL-INFARCTION; MORTALITY; SODIUM; SURVIVORS; ADMISSION; DISEASE; MARKER; RISK	Hyponatremia is relevant to heart failure, liver cirrhosis and stroke, but the prognostic value of serum sodium levels in patients with acute coronary syndrome are still unclear. So we did a systematic review and meta-analysis to assess the prognostic value of hyponatremia on adverse events in patients after ACS. We systematically searched PubMed, Embase and Cochrane Library to find literatures which studied the prognostic value of hyponatremia in patients with ACS. Our main endpoints were the all-cause mortality and heart failure in the short-and long-term. Of 369 identified studies, 20 studies were included in our analysis. Compared with the normal natrium, hyponatremia was significantly associated with the increased risks of all-cause mortality within 30 days (RR: 2.18; 95% CI: 1.96-2.42) and during the follow-ups (HR: 1.74; 95% CI: 1.56-1.942). For the second endpoint of short-and long-term heart failure, the pooled effect sizes in hyponatremia patients were 1.72(95% CI: 1.38-2.14) and 1.69(95% CI: 1.12-2.55) respectively. In conclusion, hyponatremia has a significant prognostic value for short-and long-term adverse event in patients after ACS, the dynamic monitoring of serum sodium levels may could help physicians to identify high risk ACS patients and to stratify risk for optimal management.	[Ma, Qiang-Qiang; Li, Tao; Hao, Yuan-Yuan; Ma, Feng] Xian Cent Hosp, Dept Cardiol, Xian, Shaanxi, Peoples R China; [Fan, Xiu-De] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Infect Dis, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Ma, F (corresponding author), Xian Cent Hosp, Dept Cardiol, Xian, Shaanxi, Peoples R China.	masam@163.com		fan, xiude/0000-0001-7413-080X				[Anonymous], 2014, J EVOLUTION MED DENT; Aziz F, 2011, CHEST, V140; Bae MH, 2017, HEART VESSELS, V32, P126, DOI 10.1007/s00380-016-0854-6; Bae MH, 2015, KOREAN J INTERN MED, V30, P450, DOI 10.3904/kjim.2015.30.4.450; Bozbay M, 2012, TURK KARDIYOLOJI DER, V40, P255; Burkhardt K, 2015, EUR J PREV CARDIOL, V22, P1419, DOI 10.1177/2047487314557963; Choi JS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007023; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; Devi KB, 2017, JMS J MED SOC, V31, P119; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Goldberg A, 2006, ARCH INTERN MED, V166, P781, DOI 10.1001/archinte.166.7.781; Goldberg A, 2004, AM J MED, V117, P242, DOI 10.1016/j.amjmed.2004.03.022; Graham LN, 2003, CIRCULATION, V107, pE53; Havranek S, 2011, SCAND J CLIN LAB INV, V71, P38, DOI 10.3109/00365513.2010.535012; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang WY, 2012, CEREBROVASC DIS, V34, P55, DOI 10.1159/000338906; Jenq CC, 2010, J CLIN GASTROENTEROL, V44, P220, DOI 10.1097/MCG.0b013e3181aabbcd; Klopotowski M, 2009, MED SCI MONITOR, V15, pCR477; Kovesdy CP, 2012, CIRCULATION, V125, P677, DOI 10.1161/CIRCULATIONAHA.111.065391; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Latini R, 2004, EUR HEART J, V25, P292, DOI 10.1016/j.ehj.2003.10.030; Lazzeri C, 2012, AM J CARDIOL, V110, P1419, DOI 10.1016/j.amjcard.2012.07.004; Lee SE, 2012, HEART, V98, P1798, DOI 10.1136/heartjnl-2012-302334; Merchant BC, 2015, CIRCULATION, V132; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Palmer BR, 2008, EUR HEART J, V29, P2489, DOI 10.1093/eurheartj/ehn383; Plakht Y, 2015, J CARDIOL, V65, P216, DOI 10.1016/j.jjcc.2014.06.001; Qureshi W, 2013, CLIN RES CARDIOL, V102, P637, DOI 10.1007/s00392-013-0576-z; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Rodrigues B, 2014, J STROKE CEREBROVASC, V23, P850, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.011; Roth GA, 2015, CIRCULATION, V132, P1667, DOI 10.1161/CIRCULATIONAHA.114.008720; Schou M, 2011, EUR J CLIN INVEST, V41, P1237, DOI 10.1111/j.1365-2362.2011.02532.x; Singla I, 2007, AM J CARDIOL, V100, P406, DOI 10.1016/j.amjcard.2007.03.039; Tada Y, 2011, CIRC J, V75, P1927, DOI 10.1253/circj.CJ-10-0945; Tang Q, 2011, INTERNAL MED, V50, P969, DOI 10.2169/internalmedicine.50.4703; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Waikar SS, 2011, AM J MED, V124, P77, DOI 10.1016/j.amjmed.2010.07.029; Wang Lan-feng, 2006, Zhonghua Xin Xue Guan Bing Za Zhi, V34, P243; Wells G., 2014, S SYST REV BAS; Yang XD, 2003, J CARDIOVASC PHARM, V42, P132, DOI 10.1097/00005344-200307000-00020	43	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193857	10.1371/journal.pone.0193857	http://dx.doi.org/10.1371/journal.pone.0193857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499058	Green Published, gold, Green Submitted			2022-12-27	WOS:000426472300025
J	Ndlovu, Z; Fajardo, E; Mbofana, E; Maparo, T; Garone, D; Metcalf, C; Bygrave, H; Kao, K; Zinyowera, S				Ndlovu, Zibusiso; Fajardo, Emmanuel; Mbofana, Elton; Maparo, Tatenda; Garone, Daniela; Metcalf, Carol; Bygrave, Helen; Kao, Kekeletso; Zinyowera, Sekesai			Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SCALE-UP; CARE; MORTALITY	Background HIV Viral Load and Early Infant Diagnosis technologies in many high burden settings are restricted to centralized laboratory testing, leading to long result turnaround times and patient attrition. GeneXpert (Cepheid, CA, USA) is a polyvalent near point-of-care platform and is widely implemented for Xpert MTB/RIF diagnosis. This study sought to evaluate the operational feasibility of integrated HIV VL, EID and MTB/RIF testing in new GeneXpert platforms. Methods Whole blood samples were collected from consenting patients due for routine HIV VL testing and DBS samples from infants due for EID testing, at three rural health facilities in Zimbabwe. Sputum samples were collected from all individuals suspected of TB. GeneXpert testing was reserved for all EID, all TB suspects and priority HIV VL at each site. Blood samples were further sent to centralized laboratories for confirmatory testing. GeneXpert polyvalent testing results and patient outcomes, including infrastructural and logistical requirements are reported. The study was conducted over a 10-month period. Results The fully automated GeneXpert testing device, required minimal training and biosafety considerations. A total of 1,302 HIV VL, 277 EID and 1,581 MTB/RIF samples were tested on a four module GeneXpert platform in each study site. Xpert HIV-1 VL testing was prioritized for patients who presented with advanced HIV disease, pregnant women, adolescents and suspected ART failures patients. On average, the study sites had a GeneXpert utilization rate of 50.4% (Gutu Mission Hospital), 63.5% (Murambinda Mission Hospital) and 17.5% (Chimombe Rural Health Centre) per month. GeneXpert polyvalent testing error rates remained lower than 4% in all sites. Decentralized EID and VL testing on Xpert had shorter overall median TAT (1 day [IQR: 0-4] and 1 day [IQR: 0-1] respectively) compared to centralized testing (17 days [IQR: 13-21] and 26 days [IQR: 23-32] respectively). Among patients with VL >1000 copies/ml (73/640; 11.4%) at GMH health facility, median time to enhanced adherence counselling was 8 days and majority of those with documented outcomes had re-suppressed VL (20/32; 62.5%). Median time to ART initiation among Xpert EID positive infants at GMH was 1 day [IQR: 0-1]. Conclusion Implementation of near point-of-care GeneXpert platform for integrated multi-disease testing within district and sub-district healthcare settings is feasible and will increase access to VL, and EID testing to priority populations. Quality management systems including monitoring of performance indicators, together with regular on-site supervision are crucial, and near-POC test results must be promptly actioned-on by clinicians for patient management.	[Ndlovu, Zibusiso; Metcalf, Carol; Bygrave, Helen] Southern Africa Med Unit, Med Sans Frontieres, Cape Town, South Africa; [Fajardo, Emmanuel] Access Campaign, Med Sans Frontieres, Geneva, Switzerland; [Mbofana, Elton; Maparo, Tatenda; Garone, Daniela] Med Sans Frontieres, Harare, Zimbabwe; [Kao, Kekeletso] Fdn Innovat New Diagnost, Geneva, Switzerland; [Zinyowera, Sekesai] Minist Hlth & Child Care, Natl Microbiol Reference Lab, Harare, Zimbabwe	Doctors Without Borders; Foundation For Innovative New Diagnostics	Ndlovu, Z (corresponding author), Southern Africa Med Unit, Med Sans Frontieres, Cape Town, South Africa.	ndlovinizee@gmail.com	Ndlovu, Zibusiso/AAC-5605-2021	Ndlovu, Zibusiso/0000-0003-0386-8641	FIND	FIND	Foundation for Innovative New Diagnostics (FIND=> https://www.finddx.org/) supported in the acquisition of GeneXpert reagents and Medecins Sans Frontieres (MSF) provided support for aqcusition of GeneXpert platforms. The financial support from FIND went straight to Cepheid (manufactuer of reagents for HIV and TB diagnosis). The opinions expressed herein are those of the authors and do not necessarily reflect the views of Medecins Sans Frontieres, National Microbiology Reference Laboratory or Foundation for Innovative New Diagnostics.	Abbott Molecular Inc. USA, ABB REAL TIM HIV 1; Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2013, POLICY; [Anonymous], CEPH GENEXPERT OMN; BioMerieux Clinial Diagnostics, 2009, BIOMERIEUX CLINIAL D; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cepheid GeneXpert HIV-1 Quant HIV-1 Qual MTB/Rif, CEPH GENEXPERT HIV 1; Cepheid Inc, 2016, GENEXPERT SAF DAT SH; Clouse K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171384; Desai M, 2017, THE LANCET HIV; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; Essajee S, 2017, JAIDS-J ACQ IMM DEF, V75, pS51, DOI [10.1097/qai.0000000000001319, 10.1097/QAI.0000000000001319]; Essajee S, 2015, J INT AIDS SOC, V18, P14, DOI 10.7448/IAS.18.7.20299; Fonjungo PN, 2016, AIDS, V30, P1317, DOI 10.1097/QAD.0000000000001031; Global Laboratory Initiative (GLI), ADV TB DIAGN; Hsiao NY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152672; Jani I, 2017, C RETR OPP INF CROI; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Joloba M, 2016, J INFECT DIS, V213, pS41, DOI 10.1093/infdis/jiw035; Kebede Y, 2016, J INFECT DIS, V213, pS59, DOI 10.1093/infdis/jiv576; Kiyaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078609; Mashamba-Thompson T, 2017, DIAGNOSTICS, V7; Medecins Sans Frontieres, 2016, MAK VIR LOAD ROUT SU; Meyers A, 2016, AFRICAN J LAB MED, V2; Moore C, 2013, J HOSP INFECT, V85, P1, DOI 10.1016/j.jhin.2013.06.005; Mor O, 2015, J CLIN MICROBIOL, V10, P1128; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Roberts T, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17324; Roche Molecular Diagnostics, ROCH CAB AMPLIPREP C; Schumacher S, 2015, INT J TUBERCULOSIS L, V19; Ssonko C, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21654; Stevens W, 2017, JAIDS; Stevens W, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0173-7; UNAIDS, 2016, GET FAST TRACK LIFE; Vojnov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155256; Waldrop G, TROPICAL MED INT HLT; WHO, 2016, PROGR REP 2016; World Health Organization, 2016, THE END TB STRAT; World Health Organization, 2014, UPD XPERT MTB RIF IM; World Health Organization, 2016, PQDX025907000 WHO; World Health Organization, 2017, CONS AD US MULT TEST	44	48	48	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193577	10.1371/journal.pone.0193577	http://dx.doi.org/10.1371/journal.pone.0193577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499042	Green Submitted, Green Published, gold			2022-12-27	WOS:000426472300015
J	Chae, S; Jung, SW; Park, HS				Chae, Sanghoon; Jung, Sung-Weon; Park, Hyung-Soon			In vivo biomechanical measurement and haptic simulation of portal placement procedure in shoulder arthroscopic surgery	PLOS ONE			English	Article							ROTATOR-CUFF REPAIR; SURGICAL SIMULATOR; KNEE ARTHROSCOPY; LEARNING-CURVE; SKILLS; ACQUISITION; FEEDBACK	A survey of 67 experienced orthopedic surgeons indicated that precise portal placement was the most important skill in arthroscopic surgery. However, none of the currently available virtual reality simulators include simulation / training in portal placement, including haptic feedback of the necessary puncture force. This study aimed to: (1) measure the in vivo force and stiffness during a portal placement procedure in an actual operating room and (2) implement active haptic simulation of a portal placement procedure using the measured in vivo data. We measured the force required for port placement and the stiffness of the joint capsule during portal placement procedures performed by an experienced arthroscopic surgeon. Based on the acquired mechanical property values, we developed a cable-driven active haptic simulator designed to train the portal placement skill and evaluated the validity of the simulated haptics. Ten patients diagnosed with rotator cuff tears were enrolled in this experiment. The maximum peak force and joint capsule stiffness during posterior portal placement procedures were 66.46 (+/- 10.76N) and 2560.82(+/- 252.92) N/m, respectively. We then designed an active haptic simulator using the acquired data. Our cable-driven mechanism structure had a friction force of 3.763 +/- 0.341 N, less than 6% of the mean puncture force. Simulator performance was evaluated by comparing the target stiffness and force with the stiffness and force reproduced by the device. R-squared values were 0.998 for puncture force replication and 0.902 for stiffness replication, indicating that the in vivo data can be used to implement a realistic haptic simulator.	[Chae, Sanghoon] Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Jung, Sung-Weon] Sungkyunkwan Univ, Samsung Changwon Hosp, Sch Med, Dept Orthopaed Surg, Chang Won, South Korea; [Park, Hyung-Soon] Korea Adv Inst Sci & Technol KAIST, Dept Mech Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Advanced Institute of Science & Technology (KAIST)	Park, HS (corresponding author), Korea Adv Inst Sci & Technol KAIST, Dept Mech Engn, Daejeon, South Korea.	hyungspark@kaist.ac.kr	Park, Hyung-Soon/B-3334-2010	Park, Hyung-Soon/0000-0003-4274-7420; Chae, Sang-Hoon/0000-0002-7143-5074	Korean National Research Foundation [NRF-2017R1A2B4011961]; Translational Research Center for Rehabilitation Robots, Korea National Rehabilitation Center, Ministry of Health Welfare, Korea [NRCTR-EX16002]	Korean National Research Foundation(National Research Foundation of Korea); Translational Research Center for Rehabilitation Robots, Korea National Rehabilitation Center, Ministry of Health Welfare, Korea	This work was supported by Korean National Research Foundation (Grant No.: NRF-2017R1A2B4011961, (https://www.nrf.re.kr/eng/main). This study was also supported by a grant (NRCTR-EX16002) of the Translational Research Center for Rehabilitation Robots, Korea National Rehabilitation Center, Ministry of Health & Welfare, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2008, J SURG RES, V145, P80, DOI 10.1016/j.jss.2007.04.027; Aim F, 2016, ARTHROSCOPY, V32, P224, DOI 10.1016/j.arthro.2015.07.023; Allin S, 2002, HAPT INT VIRT ENV TE; Andersen C, 2011, ACTA ORTHOP, V82, P90, DOI 10.3109/17453674.2011.552776; Bey MJ, 2005, J SHOULDER ELB SURG, V14, P201, DOI 10.1016/j.jse.2004.06.016; Buess E, 2005, ARTHROSCOPY, V21, P597, DOI 10.1016/j.arthro.2005.01.002; Colaco HB, 2017, J SURG EDUC, V74, P47, DOI 10.1016/j.jsurg.2016.07.006; Dankelman J, 2008, WORLD J SURG, V32, P149, DOI 10.1007/s00268-007-9150-z; DEORIO JK, 1984, J BONE JOINT SURG AM, V66A, P563, DOI 10.2106/00004623-198466040-00011; Frank RM, 2014, ARTHROSCOPY, V30, P121, DOI 10.1016/j.arthro.2013.09.084; Fucentese SF, 2015, KNEE SURG SPORT TR A, V23, P1077, DOI 10.1007/s00167-014-2888-6; Gandhi MJ, 2015, ARTHROSCOPY, V31, P1671, DOI 10.1016/j.arthro.2015.03.019; Guttmann D, 2005, ARTHROSCOPY, V21, P394, DOI 10.1016/j.arthro.2004.12.006; Hui Y, 2013, INT J COMPUT ASS RAD, V8, P945, DOI 10.1007/s11548-013-0833-7; Kneebone R, 2009, BRIT MED J PUBLISHIN; Kohn, 2000, ERR IS HUMAN BUILDIN; Lim YJ, 2009, SURG ENDOSC, V23, P1298, DOI 10.1007/s00464-008-0154-z; Mabrey J. D., 2002, ARTHROSCOPY, V18, P1; Madan SS, 2014, SIMUL HEALTHC, V9, P127, DOI 10.1097/SIH.0b013e3182a86165; McCarthy AD, 2006, CLIN ORTHOP RELAT R, P13, DOI 10.1097/01.blo.0000194678.10130.ff; Meyer M, 2007, ARTHROSCOPY, V23, P529, DOI 10.1016/j.arthro.2006.12.022; Morris PJ, 2004, BMJ-BRIT MED J, V328, P1133, DOI 10.1136/bmj.328.7448.1133; Motola I, 2013, MED TEACH, V35, pE1511, DOI 10.3109/0142159X.2013.818632; Nho SJ, 2007, J BONE JOINT SURG AM, V89A, P127, DOI 10.2106/JBJS.G.00583; NOTTAGE WM, 1993, ORTHOP CLIN N AM, V24, P19; O'Neill PJ, 2002, ARTHROSCOPY, V18, P795, DOI 10.1053/jars.2002.31699; Oh JH, 2008, ARTHROSCOPY, V24, P983, DOI 10.1016/j.arthro.2008.06.007; Pedowitz R, 2002, ARTHROSCOPY, V18, P1; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Podder T, 2006, MED PHYS, V33, P2915, DOI 10.1118/1.2218061; Randelli P, 2015, EFFECTIVE TRAINING A; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; STANISH WD, 1995, ARTHROSCOPY, V11, P458, DOI 10.1016/0749-8063(95)90201-5; Tay BK, 2006, IEEE T BIO-MED ENG, V53, P2129, DOI 10.1109/TBME.2006.879474; Thomas Geb W, 2014, Iowa Orthop J, V34, P181; Ward JW, 1998, FUTURE GENER COMP SY, V14, P243, DOI 10.1016/S0167-739X(98)00028-4	36	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193736	10.1371/journal.pone.0193736	http://dx.doi.org/10.1371/journal.pone.0193736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494691	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200092
J	Cui, JT; Yan, WJ; Xu, SX; Wang, QF; Zhang, WH; Liu, WJ; Ni, AP				Cui, Jingtao; Yan, Wenjuan; Xu, Shaoxia; Wang, Qiaofeng; Zhang, Weihong; Liu, Wenjing; Ni, Anping			Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NONHUMAN PRIMATE MODEL; BABOON; IMMUNOGENICITY; EXPRESSION; INDUCTION; TRANSPLANTATION; GENERATION; ADVANTAGES; NEURONS	Background Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC) which is prevalent in South China, and its association with systemic lupus erythematosus (SLE) or other autoimmune diseases has not been studied in the mainland of China. The EBV serological tests have been performed on patients with various diseases or manifestations for years at our institution and their values need to be evaluated. Methods For routine medical purposes, anti-EB viral capsid antigen (VCA) IgG, IgA and IgM antibodies, anti-EBV diffuse early antigen (EA-D) IgA antibodies, and anti- EBV nuclear antigen-1 (EBNA-1) IgG antibodies were tested with commercial enzyme-linked immunosorbent assay (ELISA) in patients visiting Peking Union Medical College Hospital between 2013 and 2017. The test results were analyzed in this retrospective study. Results There were a total of 11122 serum samples available to be tested in the study. As indicators of past EBV infection, the prevalence of VCA-IgG/EBNA1-IgG were 66.6%/58.5%, 84.3%/78.8%, 92.9%/87.0% and 98.5%/95.4% in patients aged under 5 years, 6-10 years, 11-20 years and 21-30 years old, respectively, and these values maintained at this highest rate as age increased further. The prevalence of VCA-IgM, as a parameter of acute EBV infection, was 14.6%, 10.2%, 10.4%, 6.3% and 3.1% in patients aged under 5 years, 6-10 years, 11-20 years, 21-30 years, 31-40 years old, respectively, and decreased to 2%similar to 3% in older patients. Patients with elevated serum liver enzymes were more likely to have a higher prevalence of EA/D IgA antibody (P < 0.01) and young patients (<= 30 years) with lymphadenopathy were more likely to have higher prevalence of VCA-IgM antibody (P < 0.01). The prevalence of VCA-IgA and EAD-IgA were 87.0% and 59.2% in NPC patients, respectively, and both were significantly higher (P < 0.001) than that in non-NPC patients. The prevalence of VCA-IgA was 45.4% and 25.6% in SLE patients and patients with other autoimmune diseases, respectively, which were significantly (P < 0.001) and mildly (P = 0.039) higher than their controls. In pediatric SLE patients between 6 and 10 years old, the prevalence of VCA-IgG, VCA-IgA and EBNA1-IgG was 100%, 59.5% and 100%, respectively, all being significantly higher than the age (6-10y) related controls (P<0.01). In the 705 cerebral spinal fluid (CSF) specimens, VCA-IgG, VCA-IgM, VCA-IgA and EAD-IgA were found to be positive in 12.1%, 0.15%, 0.25% and 0.25%, respectively. There were 157 paired specimens (CSF and serum were collected simultaneously) and VCA-IgG was identified as positive in 12.7% of the CSF and 100% of the serum specimens. Conclusions Around 98% of Chinese patients were infected with EBV before 30 years of age and the highest rate of acute EBV infection were observed in patients under 5 years old. EBV infection was found to be associated with elevated serum liver enzymes, NPC and SLE. Acute anti-EBV antibody was valued for young patients with lymphadenopathy but limited value for CNS neuropathy.	[Ni, Anping] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Labs, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ni, AP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Labs, Beijing, Peoples R China.	niap@pumch.cn			Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation	Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation	This work is funded through a grant to J.M. from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; CACCONE A, 1989, EVOLUTION, V43, P925, DOI 10.1111/j.1558-5646.1989.tb02540.x; Chen IC, 2016, STEM CELLS DEV, V25, P1698, DOI 10.1089/scd.2016.0221; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Drukker M, 2008, STEMBOOK, DOI http://dx.doi.org/10.3824/stembook.1.14.1; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Grow DA, 2016, STEM CELL RES, V17, P352, DOI 10.1016/j.scr.2016.08.013; Grow DA, 2016, STEM CELL TRANSL MED, V5, P1133, DOI 10.5966/sctm.2015-0073; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Ledford H, 2011, NATURE, V477, P526, DOI 10.1038/477526a; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik Nasir, 2013, Methods Mol Biol, V997, P23, DOI 10.1007/978-1-62703-348-0_3; McFarlane D, 2011, J GERONTOL A-BIOL, V66, P1309, DOI 10.1093/gerona/glr146; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Moore AR, 2009, CEREB CORTEX, V19, P1795, DOI 10.1093/cercor/bhn206; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; Mull AN, 2014, STEM CELL RES, V12, P539, DOI 10.1016/j.scr.2014.01.002; Murthy KK, 2006, VACCINE, V24, P4622, DOI 10.1016/j.vaccine.2005.08.047; Navara CS, 2007, STEM CELLS, V25, P2695, DOI 10.1634/stemcells.2007-0286; Navara CS, 2013, CELL REPROGRAM, V15, P495, DOI 10.1089/cell.2012.0093; NAVARA CS, 2007, CURR PROTOC STEM CEL, pCH1; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Perry DL, 2012, VIRUSES-BASEL, V4, P2400, DOI 10.3390/v4102400; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rogers J, 1997, AM J HUM GENET, V61, P489, DOI 10.1086/515527; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; Simerly CR, 2009, STEM CELL RES, V2, P178, DOI 10.1016/j.scr.2009.02.004; Stacy S, 2008, J IMMUNOL, V181, P109, DOI 10.4049/jimmunol.181.1.109; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Sundberg M, 2013, STEM CELLS, V31, P1548, DOI 10.1002/stem.1415; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Todorova D, 2016, STEM CELLS, V34, P510, DOI 10.1002/stem.2227; VandeBerg J.L., 2009, BABOON BIOMEDICAL RE; VandeBerg JL, 1997, J MED PRIMATOL, V26, P113, DOI 10.1111/j.1600-0684.1997.tb00042.x; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wu YH, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/767195; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2015, CELL STEM CELL, V17, P353, DOI 10.1016/j.stem.2015.07.021; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	47	19	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193171	10.1371/journal.pone.0193171	http://dx.doi.org/10.1371/journal.pone.0193171			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494658	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200028
J	Stone, MJ; Catterall, CP; Stork, NE				Stone, Marisa J.; Catterall, Carla P.; Stork, Nigel E.			Edge effects and beta diversity in ground and canopy beetle communities of fragmented subtropical forest	PLOS ONE			English	Article							SPECIES RESPONSES; VERTICAL STRATIFICATION; HABITAT EDGES; ASSEMBLAGES; CONSERVATION; MICROCLIMATE; METAANALYSIS	Clearing of dry forests globally creates edges between remnant forest and open anthropogenic habitats. We used flight intercept traps to evaluate how forest beetle communities are influenced by distance from such edges, together with vertical height, spatial location, and local vegetation structure, in an urbanising region ( Brisbane, Australia). Species composition ( but not total abundance or richness) differed greatly between ground and canopy. Species composition also varied strongly among sites at both ground and canopy levels, but almost all other significant effects occurred only at ground level, where: species richness declined from edge to interior; composition differed between positions near edges (<10 m) and interiors (>50 m); high local canopy cover was associated with greater total abundance and richness and differing composition; and greater distances to the city centre were associated with increased total abundances and altered composition. Analyses of individual indicator species associated with this variation enabled further biological interpretations. A global literature synthesis showed that most spatially well-replicated studies of edge effects on ground-level beetles within forest fragments have likewise found that positions within tens of metres from edges with open anthropogenic habitats had increased species richness and different compositions from forest interior sites, with fewer effects on abundance. Accordingly, negative edge effects will not prevent relatively small compact fragments ( if >10-20 ha) from supporting forest-like beetle communities, although indirect consequences of habitat degradation remain a threat. Retention of multiple spatially scattered forest areas will also be important in conserving forest-dependent beetles, given high levels of between-site diversity.	[Stone, Marisa J.; Catterall, Carla P.; Stork, Nigel E.] Griffith Univ, Griffith Sch Environm, Environm Futures Res Inst, Nathan, Qld, Australia	Griffith University	Stone, MJ (corresponding author), Griffith Univ, Griffith Sch Environm, Environm Futures Res Inst, Nathan, Qld, Australia.	marisa.stone@griffithuni.edu.au		Stork, Nigel/0000-0001-7812-2452	Griffith University's School of Environment and Environmental Futures Research Institute	Griffith University's School of Environment and Environmental Futures Research Institute	This project was funded by Griffith University's School of Environment and Environmental Futures Research Institute.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2015, MAPS AV COND; Barnes AD, 2014, BIOL CONSERV, V170, P28, DOI 10.1016/j.biocon.2013.12.006; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P17; Campbell RE, 2011, ECOL APPL, V21, P3147, DOI 10.1890/10-2390.1; Catterall C, 1997, CONSERVATION OUTSIDE, P367; Catterall CP, 2010, DIVERS DISTRIB, V16, P559, DOI 10.1111/j.1472-4642.2010.00665.x; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Guimaraes CDD, 2014, ENVIRON ENTOMOL, V43, P537, DOI 10.1603/EN13190; Didham RK, 2014, PAC SCI, V68, P493, DOI 10.2984/68.4.4; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Dodonov P, 2013, PLANT ECOL, V214, P1345, DOI 10.1007/s11258-013-0256-0; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ewers RM, 2008, P NATL ACAD SCI USA, V105, P5426, DOI 10.1073/pnas.0800460105; Ewers RM, 2007, CONSERV BIOL, V21, P926, DOI 10.1111/j.1523-1739.2007.00720.x; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; FOA, 2015, FOR AUST 2013; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; Gaublomme E, 2008, BIOL CONSERV, V141, P2585, DOI 10.1016/j.biocon.2008.07.022; Gaublomme E, 2014, INSECT CONSERV DIVER, V7, P82, DOI 10.1111/icad.12036; Grimbacher PS, 2006, AUSTRAL ECOL, V31, P458, DOI 10.1111/j.1442-9993.2006.01606.x; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Hsieh TC, 2014, INEXT ONLINE INTERPO; Knapp M, 2013, BIOL CONSERV, V164, P22, DOI 10.1016/j.biocon.2013.04.012; Kotze DJ, 2001, BIODIVERS CONSERV, V10, P443, DOI 10.1023/A:1016606209906; Lacasella F, 2015, BIODIVERS CONSERV, V24, P447, DOI 10.1007/s10531-014-0825-0; MacGregor-Fors I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056794; Magura T, 2017, ECOL EVOL, V7, P1009, DOI 10.1002/ece3.2722; Major RE, 2003, BIOL CONSERV, V113, P35, DOI 10.1016/S0006-3207(02)00347-6; MEA (Millennium Ecosystem Assessment), 2005, MILL EC ASS EC HUM W; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Noreika N, 2012, J INSECT CONSERV, V16, P867, DOI 10.1007/s10841-012-9474-3; Normann C, 2016, FOREST ECOL MANAG, V361, P421, DOI 10.1016/j.foreco.2015.11.002; Oksanen J., 2022, R PACKAGE VERSION; Peyras M, 2013, J INSECT CONSERV, V17, P807, DOI 10.1007/s10841-013-9563-y; R Core Team, 2015, R LANG ENV STAT COMP; Resasco J, 2017, ECOGRAPHY, V40, P109, DOI 10.1111/ecog.02546; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Roberts D.W., 2016, LABDSV ORDINATION MU; Rosch V, 2015, OECOLOGIA, V179, P209, DOI 10.1007/s00442-015-3315-5; Sattler P., 1999, CONSERVATION STATUS; SOFR, 2015, AUSTR STAT FOR REP 2; Stork NE, 2006, P ROY SOC B-BIOL SCI, V273, P1969, DOI 10.1098/rspb.2006.3521; Stork NE, 2016, AUSTRAL ECOL, V41, P168, DOI 10.1111/aec.12286; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Villada-Bedoya S, 2017, BIOTROPICA, V49, P195, DOI 10.1111/btp.12373	52	8	9	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193369	10.1371/journal.pone.0193369	http://dx.doi.org/10.1371/journal.pone.0193369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494680	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200041
J	Stec, D; Arakawa, K; Michalczyk, L				Stec, Daniel; Arakawa, Kazuharu; Michalczyk, Lukasz			An integrative description of Macrobiotus shonaicus sp nov (Tardigrada: Macrobiotidae) from Japan with notes on its phylogenetic position within the hufelandi group	PLOS ONE			English	Article							RAMAZZOTTIUS-SUBANOMALUS BISEROV; EUTARDIGRADA MACROBIOTIDAE; ANNOTATED ZOOGEOGRAPHY; PHYLUM TARDIGRADA; DNA; VARIABILITY; REVISION; AMERICA; MAFFT	Tardigrade research in Japan dates back over 100 years, and to date, 167 species of this ecdysozoan phylum have been reported from the country. Of these species, the Macrobiotus hufelandi complex has been represented only by the nominal taxon of this group, Macrobiotus hufelandi. In this article, a new species of the hufelandi group from Japan, Macrobiotus shonaicus sp. nov., is described using integrative taxonomy. In addition to the detailed morphological and morphometric data, obtained using phase contrast light microscopy (PCM) and scanning electron microscopy (SEM), we provide DNA sequences of four molecular markers (both nuclear and mitochondrial). The new species belongs to the persimilis subgroup and is most similar to M. anemone from USA, M. naskreckii from Mozambique, and M. patagonicus from Argentina, but it can be easily distinguished from these species by the presence of thin flexible filaments on terminal discs of the egg process. By the latter character, the new species is most similar to M. paulinae and M. polypiformis, but it can be easily distinguished from them by having a solid egg surface between egg processes (i.e., without pores or reticulum). A phylogenetic analysis of available DNA sequences of the COI marker for the hufelandi group revealed that the new species clusters with the two other species that exhibit filaments on egg process discs (M. paulinae and M. polypiformis) and with two species that have entire egg processes modified into filaments (M. kristenseni and M. scoticus). All five species form a clade distinct from all other sequenced species of the hufelandi group with typical mushroom-or inverted goblet-shaped egg processes, which may suggest that the ancestor of the five species with atypical egg processes had a mutation allowing derivations from the mushroom or inverted chalice-like shape of egg processes.	[Stec, Daniel; Michalczyk, Lukasz] Jagiellonian Univ, Inst Zool & Biomed Res, Gronostajowa 9, Krakow, Poland; [Arakawa, Kazuharu] Keio Univ, Inst Adv Biosci, Mizukami 246-2, Tsuruoka, Yamagata, Japan	Jagiellonian University; Keio University	Arakawa, K (corresponding author), Keio Univ, Inst Adv Biosci, Mizukami 246-2, Tsuruoka, Yamagata, Japan.	gaou@sfc.keio.ac.jp	Stec, Daniel/AAL-3532-2020; Michalczyk, Lukasz/D-1362-2009	Michalczyk, Lukasz/0000-0002-2912-4870; Stec, Daniel/0000-0001-6876-0717; Arakawa, Kazuharu/0000-0002-2893-4919	Polish National Science Centre [2016/22/E/NZ8/00417]; KAKENHI from the Japan Society for the Promotion of Science (JSPS) [17H03620]; Yamagata Prefectural Government; Tsuruoka City, Japan	Polish National Science Centre; KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamagata Prefectural Government; Tsuruoka City, Japan	We thank Nozomi Abe and Naoko Ishii for technical support in tardigrade culturing. The study was supported by the Sonata Bis program of the Polish National Science Centre (grant no. 2016/22/E/NZ8/00417 to LM), by a KAKENHI Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS) (grant no. 17H03620 to KA), and partly by research funds from the Yamagata Prefectural Government and Tsuruoka City, Japan (to KA). The Chlorella vulgaris used to feed the tardigrades was provided courtesy of Chlorella Industry Co. LTD.; This work was supported by the Sonata Bis programme of the Polish National Science Centre (grant no. 2016/22/E/NZ8/00417 to LM): study design, data collection and analysis, decision to publish and preparation of the manuscript; KAKENHI Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS) (grant no. 17H03620 to KA): data collection; Yamagata Prefectural Government and Tsuruoka City, Japan (to KA): data collection.	[Anonymous], 1834, MACROBIOTUS HUFELAND; Arakawa K, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.63; Bakowski M, 2016, ANN ZOOL, V66, P155, DOI 10.3161/00034541ANZ2016.66.2.001; BERTOLANI R, 1993, ZOOL SCR, V22, P127, DOI 10.1111/j.1463-6409.1993.tb00347.x; Bertolani R., 2011, Zoologiya Bespozvonochnykh, V8, P23; Bertolani R, 2014, MOL PHYLOGENET EVOL, V76, P110, DOI 10.1016/j.ympev.2014.03.006; Bertolani Roberto, 2011, Zootaxa, V2997, P19; BINDA M G, 1972, Bollettino delle Sedute della Accademia Gioenia di Scienze Naturali in Catania, V11, P47; Binda M.G., 1986, Animalia (Catania), V11, P85; BISEROV VI, 1990, ZOOL ZH, V69, P5; Casquet J, 2012, MOL ECOL RESOUR, V12, P136, DOI 10.1111/j.1755-0998.2011.03073.x; Cesari M, 2011, ZOOTAXA, P42; Cesari M, 2009, MOL ECOL RESOUR, V9, P699, DOI 10.1111/j.1755-0998.2009.02538.x; Ciobanu DA, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.429.7755; Cuenot L., 1932, Faune de France Paris, V24, P1; Degma P, 2009, ACTUAL CHECKLIST TAR; Doyere LMF, 1840, ANN SCI NATURELLES 2, V14, P269; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontoura P, 2017, ZOOTAXA, V4263, P450, DOI 10.11646/zootaxa.4263.3.2; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Guidetti R, 2005, ZOOL SCR, V34, P235, DOI 10.1111/j.1463-6409.2005.00193.x; Guidetti R, 2013, J NAT HIST, V47, P2409, DOI 10.1080/00222933.2013.800610; Guil N, 2012, CLADISTICS, V28, P21, DOI 10.1111/j.1096-0031.2011.00364.x; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hinton JA, 2016, GA J SCI, V74, pa14; Iijima I., 1889, TXB ZOOLOGY; Kaczmarek L, 2017, ZOOTAXA, V4363, P101, DOI 10.11646/zootaxa.4363.1.4; Kaczmarek L, 2016, ZOOTAXA, V4203, P1, DOI 10.11646/zootaxa.4203.1.1; Kaczmarek Lukasz, 2004, Genus (Wroclaw), V15, P141; Kaczmarek L, 2015, ZOOTAXA, V3923, P1, DOI 10.11646/zootaxa.3923.1.1; Kaczmarek L, 2014, ZOOTAXA, V3790, P357, DOI 10.11646/zootaxa.3790.2.5; Kaczmarek Lukasz, 2009, Acta Zoologica Cracoviensia Ser B-Invertebrata, V52B, P87, DOI 10.3409/azc.52b_1-2.87-99; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kosztyla P, 2016, ZOOL J LINN SOC-LOND, V178, P765, DOI 10.1111/zoj.12409; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Marley NJ, 2011, ZOOTAXA, P51, DOI 10.11646/zootaxa.2819.1.2; MAUCCI W, 1988, Revista Chilena de Entomologia, V16, P5; Mcinnes SJ, 2017, ZOOTAXA, V4284, P1, DOI 10.11646/zootaxa.4284.1.1; Meyer HA, 2014, SOUTHEAST NAT, V13, P117, DOI DOI 10.1656/058.013.S511; Meyer HA, 2017, P BIOL SOC WASH, V130, P98, DOI 10.2988/16-00009; Michalczyk L, 2003, ZOOTAXA, V331, P1, DOI DOI 10.11646/ZOOTAXA.331.1.1; Michalczyk L, 2012, ZOOTAXA, P1; Michalczyk L, 2013, J LIMNOL, V72, P175, DOI 10.4081/jlimnol.2013.s1.e22; Mironov Sergey V., 2012, Zootaxa, V3253, P54; Morek W, 2016, ZOOL J LINN SOC-LOND, V178, P785, DOI 10.1111/zoj.12457; Morek W, 2016, CONTRIB ZOOL, V85, P173, DOI 10.1163/18759866-08502003; Murray J., 1907, T ROY SOC EDINBURGH, V45, P669, DOI DOI 10.1017/S0080456800011789; Murray J., 1911, P ROY IRISH ACAD, V31, P1, DOI DOI 10.5962/BHL.TITLE.64352; Nelson DR, 2015, ECOLOGY AND GENERAL BIOLOGY, VOL I: THORP AND COVICH'S FRESHWATER INVERTEBRATES, 4TH EDITION, P347, DOI 10.1016/B978-0-12-385026-3.00017-6; Pilato G., 1981, Animalia (Catania), V8, P51; Pilato G., 1983, ANIMALIA, V10, P262; Pilato Giovanni, 2003, Zootaxa, V258, P1; Plate L., 1888, ZOOLOGISCHE JB, V3, P487, DOI DOI 10.5962/BHL.PART.1265; Rambaut A., 2014, TRACER V16; Richters, 1926, HDB ZOOLOGIE, VIII, P58; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossi G, 2009, ZOOTAXA, P21, DOI 10.11646/zootaxa.2095.1.3; Roszkowska M, 2017, EUR J TAXON, V327, P1, DOI 10.5852/ejt.2017.327; Schill RO, 2010, ORG DIVERS EVOL, V10, P287, DOI 10.1007/s13127-010-0025-z; SCHUSTER RO, 1980, T AM MICROSC SOC, V99, P284, DOI 10.2307/3226004; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stec D, SYSTEMATICS BIODIVER; Stec D, 2017, ANN ZOOL, V67, P181, DOI 10.3161/00034541ANZ2017.67.2.001; Stec D, 2017, ZOOTAXA, V4300, P403, DOI 10.11646/zootaxa.4300.3.4; Stec D, 2016, ZOOTAXA, V4208, P176, DOI 10.11646/zootaxa.4208.2.5; Stec D, 2016, ZOOL J LINN SOC-LOND, V178, P776, DOI 10.1111/zoj.12404; Stec D, 2015, ZOOTAXA, V4052, P501, DOI 10.11646/zootaxa.4052.5.1; Suzuki AC, 2017, DIVERS COMMON ANIM, P267, DOI 10.1007/978-4-431-56432-4_10; Thulin G, 1928, HEREDITAS, V11, P207, DOI 10.1111/j.1601-5223.1928.tb02488.x; Welnicz W, 2011, J ZOOL SYST EVOL RES, V49, P34, DOI 10.1111/j.1439-0469.2010.00595.x; Yoshida Y, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002266; Zeller C., 2010, THESIS, P105	76	29	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192210	10.1371/journal.pone.0192210	http://dx.doi.org/10.1371/journal.pone.0192210			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489835	gold, Green Published, Green Submitted			2022-12-27	WOS:000426276000020
J	da Silva, FC; Iop, RD; de Oliveira, LC; Boll, AM; de Alvarenga, JGS; Gutierres, PJ; de Melo, LMAB; Xavier, A; da Silva, R				da Silva, Franciele Cascaes; Iop, Rodrigo da Rosa; de Oliveira, Laiana Candido; Boll, Alice Mathea; Souza de Alvarenga, Jose Gustavo; Barbosa Gutierres Filho, Paulo Jose; Aguiar Bezerra de Melo, Lidia Mara; Xavier, Andre Junqueira; da Silva, Rudney			Effects of physical exercise programs on cognitive function in Parkinson's disease patients: A systematic review of randomized controlled trials of the last 10 years	PLOS ONE			English	Review							MINI-MENTAL-STATE; NONMOTOR SYMPTOMS; AEROBIC EXERCISE; EXECUTIVE FUNCTION; ARGENTINE TANGO; SCREENING TOOL; OLDER-ADULTS; DEMENTIA; IMPAIRMENT; MOTOR	Background Given the relative importance of cognitive impairment, there was considerable interest in identifying the cognitive profile of PD patients, in order to ensure specific and appropriate therapeutic interventions. Purpose To determine the effects of physical exercise programs on cognitive function in PD patients, compared with the control group. Data sources Medline, Cochrane, Scopus, PEDro and Web of Science (last searched in September 2016). Study selection Randomized clinical trials examining the effects of physical exercise programs and cognitive function in PD patients. Nine studies fulfilled the selection criteria and were included in this review. Data extraction Characteristics of the publication, characteristics of the participants, test used for cognitive screening, cognitive domain assessed, tools used to assess cognitive function, characteristics of the experimental intervention, characteristics of the control group, mean results and standard deviation of function cognitive. The PEDro score was used to evaluate methodological quality. Data synthesis Most eligible studies showed good methodological quality based on the PEDro scale. Studies have shown that adapted tango for PD patients, cognitive training combined with motor training, and treadmill training promote the preservation or improvement of cognitive function in PD patients. Limitations The diversity of cognitive tests used to assess cognitive function and the high heterogeneity identified between the physical exercise programs. Conclusions Physical exercise programs promote positive and significant effects on global cognitive function, processing speed, sustained attention and mental flexibility in PD patients, at a mild to moderate stage for patients with a 6-year clinical diagnosis of PD. However, treadmill training performed 3 times a week for about 60 minutes and for a period of 24 weeks produced larger improvements in cognition.	[da Silva, Franciele Cascaes; Iop, Rodrigo da Rosa; de Oliveira, Laiana Candido; Boll, Alice Mathea; da Silva, Rudney] Univ Estado Santa Catarina, Ctr Hlth Sci & Sports, Adapted Phys Act Lab, Florianopolis, SC, Brazil; [Souza de Alvarenga, Jose Gustavo; Barbosa Gutierres Filho, Paulo Jose; Aguiar Bezerra de Melo, Lidia Mara] Univ Brasilia, Fac Phys Educ, Brasilia, DF, Brazil; [Xavier, Andre Junqueira] Univ Southern Santa Catarina, Med Course, Florianopolis, SC, Brazil	Universidade do Estado de Santa Catarina; Universidade de Brasilia; Universidade do Sul de Santa Catarina	da Silva, FC (corresponding author), Univ Estado Santa Catarina, Ctr Hlth Sci & Sports, Adapted Phys Act Lab, Florianopolis, SC, Brazil.	francascaes@yahoo.com.br	Silva, Rudney/C-3189-2017; Filho, Paulo Gutierres/ABG-4019-2021	Silva, Rudney/0000-0002-9386-0039; Filho, Paulo Gutierres/0000-0001-7753-0825; Silva, Franciele Cascaes/0000-0002-4444-9403				Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Aarsland D, 2001, NEUROLOGY, V56, P730, DOI 10.1212/WNL.56.6.730; Aarsland D, 2017, NAT REV NEUROL; Aarsland D, 2016, PARKINSONISM RELAT D, V22, pS144, DOI 10.1016/j.parkreldis.2015.09.034; Barbosa ER, 2013, ARQ NEURO-PSIQUIAT, V71, P203, DOI 10.1590/0004-282X20130001; Biundo R, 2014, PARKINSONISM RELAT D, V20, P394, DOI 10.1016/j.parkreldis.2014.01.009; Broeders M, 2013, J INT NEUROPSYCH SOC, V19, P695, DOI 10.1017/S1355617713000295; Caballol N, 2007, MOVEMENT DISORD, V22, pS358, DOI 10.1002/mds.21677; Campanholo Kenia Repiso, 2014, Dement. neuropsychol., V8, P26, DOI 10.1590/S1980-57642014DN81000005; Carod-Artal FJ, 2007, MOVEMENT DISORD, V22, P91, DOI 10.1002/mds.21216; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Cruise KE, 2011, ACTA NEUROL SCAND, V123, P13, DOI 10.1111/j.1600-0404.2010.01338.x; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Cusso ME, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00035; de Lau LML, 2005, ARCH NEUROL-CHICAGO, V62, P1265, DOI 10.1001/archneur.62.8.1265; Dubbelink KTEO, 2014, NEUROLOGY, V82, P263, DOI 10.1212/WNL.0000000000000034; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Duchesne C, 2015, BRAIN COGNITION, V99, P68, DOI 10.1016/j.bandc.2015.07.005; Duncan RP, 2012, NEUROREHAB NEURAL RE, V26, P132, DOI 10.1177/1545968311421614; Ekker MS, 2016, PARKINSONISM RELAT D, V22, pS73, DOI 10.1016/j.parkreldis.2015.08.031; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster ER, 2013, ARCH PHYS MED REHAB, V94, P240, DOI 10.1016/j.apmr.2012.07.028; Gallagher DA, 2010, MOVEMENT DISORD, V25, P2493, DOI 10.1002/mds.23394; Gill DJ, 2008, MOVEMENT DISORD, V23, P1043, DOI 10.1002/mds.22017; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Hackney ME, 2009, J REHABIL MED, V41, P475, DOI 10.2340/16501977-0362; Hamdan Amer C., 2009, Psychol. Neurosci., V2, P199, DOI 10.3922/j.psns.2009.2.012; Hanagasi HA, 2017, J NEUROL SCI, V374, P26, DOI 10.1016/j.jns.2017.01.012; Hashimoto H, 2015, COMPLEMENT THER MED, V23, P210, DOI 10.1016/j.ctim.2015.01.010; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hindle JV, 2013, MOVEMENT DISORD, V28, P1034, DOI 10.1002/mds.25377; Hobson P, 2004, MOVEMENT DISORD, V19, P1043, DOI 10.1002/mds.20216; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Kalron A, 2015, NEUROREHABILITATION, V37, P273, DOI 10.3233/NRE-151260; Kattenstroth JC, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00005; Kulisevsky J, 2009, MOVEMENT DISORD, V24, P1103, DOI 10.1002/mds.22506; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lee A, 2016, NEUROL CLIN, V34, P955, DOI 10.1016/j.ncl.2016.06.012; Lischka AR, 2012, CAN J AGING, V31, P295, DOI 10.1017/S0714980812000220; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Mahieux F, 1998, J NEUROL NEUROSUR PS, V64, P178, DOI 10.1136/jnnp.64.2.178; McKee KE, 2013, J MOTOR BEHAV, V45, P519, DOI 10.1080/00222895.2013.834288; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKinlay A, 2010, J INT NEUROPSYCH SOC, V16, P268, DOI 10.1017/S1355617709991299; McNeely ME, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00239; Meireles Joana, 2012, Front Neurol, V3, P88, DOI 10.3389/fneur.2012.00088; Melo LM, 2007, REV PSIQ CLIN, V34, P176; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Murray DK, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-5; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Muslimovic D, 2009, J INT NEUROPSYCH SOC, V15, P426, DOI 10.1017/S1355617709090614; Nadeau A, 2014, MED SCI SPORT EXER, V46, P645, DOI 10.1249/MSS.0000000000000144; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nocera Joe R, 2013, J Yoga Phys Ther, V3, DOI 10.4172/2157-7595.1000137; Nocera JR, 2010, NEUROCASE, V16, P301, DOI 10.1080/13554790903559663; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Pedersen KF, 2013, JAMA NEUROL, V70, P580, DOI 10.1001/jamaneurol.2013.2110; Petzinger GM, 2013, LANCET NEUROL, V12, P716, DOI 10.1016/S1474-4422(13)70123-6; Picelli A, 2016, FUNCT NEUROL, V31, P25; Pompeu JE, 2012, PHYSIOTHERAPY, V98, P196, DOI 10.1016/j.physio.2012.06.004; Paris AP, 2011, MOVEMENT DISORD, V26, P1251, DOI 10.1002/mds.23688; Reynolds GO, 2016, MOVEMENT DISORD, V31, P23, DOI 10.1002/mds.26484; Riedel O, 2008, J NEUROL, V255, P255, DOI 10.1007/s00415-008-0720-2; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Romann Aline Juliane, 2012, Dement. neuropsychol., V6, P2, DOI 10.1590/S1980-57642012DN06010002; Romenets SR, 2015, COMPLEMENT THER MED, V23, P175, DOI 10.1016/j.ctim.2015.01.015; Schneider JS, 2010, PARKINSONISM RELAT D, V16, P507, DOI 10.1016/j.parkreldis.2010.06.001; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Souza RG, 2007, ARQ NEURO-PSIQUIAT, V65, P787, DOI 10.1590/S0004-282X2007000500010; Svenningsson P, 2012, LANCET NEUROL, V11, P697, DOI 10.1016/S1474-4422(12)70152-7; Tabak R, 2013, J NEUROL PHYS THER, V37, P58, DOI 10.1097/NPT.0b013e31829219bc; Tanaka K, 2009, BRAIN COGNITION, V69, P435, DOI 10.1016/j.bandc.2008.09.008; Tang YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152716; Van Uem JMT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151997; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Wind AW, 1997, INT J GERIATR PSYCH, V12, P101, DOI 10.1002/(SICI)1099-1166(199701)12:1<101::AID-GPS469>3.0.CO;2-R; Yarnall AJ, 2014, NEUROLOGY, V82, P308, DOI 10.1212/WNL.0000000000000066; Zadikoff C, 2008, MOVEMENT DISORD, V23, P297, DOI 10.1002/mds.21837	82	75	76	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193113	10.1371/journal.pone.0193113	http://dx.doi.org/10.1371/journal.pone.0193113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7BV	29486000	Green Submitted, Green Published, gold			2022-12-27	WOS:000426242400014
J	Northrup, JM; Gerber, BD				Northrup, Joseph M.; Gerber, Brian D.			A comment on priors for Bayesian occupancy models	PLOS ONE			English	Article							SPECIES DISTRIBUTION; HIERARCHICAL-MODELS; POPULATIONS; PREDICTION; ECOLOGISTS; SELECTION; OREGON	Understanding patterns of species occurrence and the processes underlying these patterns is fundamental to the study of ecology. One of the more commonly used approaches to investigate species occurrence patterns is occupancy modeling, which can account for imperfect detection of a species during surveys. In recent years, there has been a proliferation of Bayesian modeling in ecology, which includes fitting Bayesian occupancy models. The Bayesian framework is appealing to ecologists for many reasons, including the ability to incorporate prior information through the specification of prior distributions on parameters. While ecologists almost exclusively intend to choose priors so that they are "uninformative" or "vague", such priors can easily be unintentionally highly informative. Here we report on how the specification of a "vague" normally distributed (i.e., Gaussian) prior on coefficients in Bayesian occupancy models can unintentionally influence parameter estimation. Using both simulated data and empirical examples, we illustrate how this issue likely compromises inference about species-habitat relationships. While the extent to which these informative priors influence inference depends on the data set, researchers fitting Bayesian occupancy models should conduct sensitivity analyses to ensure intended inference, or employ less commonly used priors that are less informative (e.g., logistic or t prior distributions). We provide suggestions for addressing this issue in occupancy studies, and an online tool for exploring this issue under different contexts.	[Northrup, Joseph M.] Oregon State Univ, Dept Forest Ecosyst & Soc, Forest Biodivers Res Network, Corvallis, OR 97331 USA; [Northrup, Joseph M.] Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, Peterborough, ON, Canada; [Gerber, Brian D.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA	Oregon State University; Ministry of Natural Resources & Forestry; University of Rhode Island	Northrup, JM (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Forest Biodivers Res Network, Corvallis, OR 97331 USA.; Northrup, JM (corresponding author), Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, Peterborough, ON, Canada.	joe.northrup@gmail.com	Northrup, Joseph/AAM-2874-2020	Northrup, Joseph/0000-0001-6319-4138	Forest Research Laboratory in the College of Forestry at Oregon State University	Forest Research Laboratory in the College of Forestry at Oregon State University	J.M. Northrup was funded by a grant to M.G. Betts and J.W. Rivers from the Forest Research Laboratory in the College of Forestry at Oregon State University.	Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Dorazio RM, 2016, POPUL ECOL, V58, P31, DOI 10.1007/s10144-015-0503-4; Dorazio RM, 2011, BIODIVERSITY LOSS IN A CHANGING PLANET, P277; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Friedman J, 2001, SPRINGER SERIES STAT, V10; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2021, BAYESIAN DATA ANAL; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Gerber BD, 2015, J ANIM ECOL, V84, P1299, DOI 10.1111/1365-2656.12370; Gopalaswamy AM, 2012, ECOLOGY, V93, P1741, DOI 10.1890/11-2110.1; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hines JE., 2006, PRESENCESOFTWARE EST; Hobbs N.T., 2015, BAYESIAN MODELS, DOI [DOI 10.1515/9781400866557, 10.1515/9781400866557]; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; Jones JE, 2011, ECOLOGY, V92, P2299, DOI 10.1890/10-2403.1; Kery M., 2016, APPL HIERARCHICAL MO, V1; Laake J.L, 2013, RMARK R INTERFACE AN; Lele SR, 2007, ECOL LETT, V10, P551, DOI 10.1111/j.1461-0248.2007.01047.x; Lele SR, 2009, ECOL APPL, V19, P581, DOI 10.1890/08-0549.1; Lemoine NP, 2016, ECOLOGY, V97, P2554, DOI 10.1002/ecy.1506; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; Northrup JM, 2015, GLOBAL CHANGE BIOL, V21, P3961, DOI 10.1111/gcb.13037; Northrup JM, 2014, EVOL APPL, V7, P937, DOI 10.1111/eva.12189; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Ohmann JL, 2002, CAN J FOREST RES, V32, P725, DOI [10.1139/x02-011, 10.1139/X02-011]; Plummer M., 2015, JAGS VERSION 4 0 0 U; Plummer M., 2015, RJAGS BAYESIAN GRAPH; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Royle J. A., 2008, HIERARCHICAL MODELIN; Seaman JW, 2012, AM STAT, V66, P77, DOI 10.1080/00031305.2012.695938; Team RC., 2013, R LANG ENV STAT COMP; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	39	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0192819	10.1371/journal.pone.0192819	http://dx.doi.org/10.1371/journal.pone.0192819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX6NQ	29481554	Green Published, Green Submitted, gold			2022-12-27	WOS:000426202700005
J	Tichy, A; Kabacik, S; O'Brien, G; Pejchal, J; Sinkorova, Z; Kmochova, A; Sirak, I; Malkova, A; Beltran, CG; Gonzalez, JR; Grepl, J; Majewski, M; Ainsbury, E; Zarybnicka, L; Vachelova, J; Zavrelova, A; Davidkova, M; Stastna, MM; Abend, M; Pernot, E; Cardis, E; Badie, C				Tichy, Ales; Kabacik, Sylwia; O'Brien, Grainne; Pejchal, Jaroslav; Sinkorova, Zuzana; Kmochova, Adela; Sirak, Igor; Malkova, Andrea; Beltran, Caterina Gomila; Gonzalez, Juan Ramon; Grepl, Jakub; Majewski, Matthaeus; Ainsbury, Elizabeth; Zarybnicka, Lenka; Vachelova, Jana; Zavrelova, Alzbeta; Davidkova, Marie; Stastna, Marketa Markova; Abend, Michael; Pernot, Eileen; Cardis, Elisabeth; Badie, Christophe			The first in vivo multiparametric comparison of different radiation exposure biomarkers in human blood	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; BLOCK MICRONUCLEUS ASSAY; PERIPHERAL-BLOOD; BIOLOGICAL DOSIMETRY; CHROMOSOME-ABERRATIONS; RADIOTHERAPY PATIENTS; IONIZING-RADIATION; CANCER-PATIENTS; DOSE ASSESSMENT; BONE-MARROW	The increasing risk of acute large-scale radiological/nuclear exposures of population underlines the necessity of developing new, rapid and high throughput biodosimetric tools for estimation of received dose and initial triage. We aimed to compare the induction and persistence of different radiation exposure biomarkers in human peripheral blood in vivo. Blood samples of patients with indicated radiotherapy (RT) undergoing partial body irradiation (PBI) were obtained soon before the first treatment and then after 24 h, 48 h, and 5 weeks; i.e. after 1, 2, and 25 fractionated RT procedures. We collected circulating peripheral blood from ten patients with tumor of endometrium (1.8 Gy per fraction) and eight patients with tumor of head and neck (2.0-2.121 Gy per fraction). Incidence of dicentrics and micronuclei was monitored as well as determination of apoptosis and the transcription level of selected radiation-responsive genes. Since mitochondrial DNA (mtDNA) has been reported to be a potential indicator of radiation damage in vitro, we also assessed mtDNA content and deletions by novel multiplex quantitative PCR. Cytogenetic data confirmed linear dose dependent increase in dicentrics (p <0.01) and micronuclei (p <0.001) in peripheral blood mononuclear cells after PBI. Significant up-regulations of five previously identified transcriptional biomarkers of radiation exposure (PHPT1, CCNG1, CDKN1A, GADD45, and SESN1) were also found (p < 0.01). No statistical change in mtDNA deletion levels was detected; however, our data indicate that the total mtDNA content decreased with increasing number of RT fractions. Interestingly, the number of micronuclei appears to correlate with late radiation toxicity (r(2) = 0.9025) in endometrial patients suggesting the possibility of predicting the severity of RT-related toxicity by monitoring this parameter. Overall, these data represent, to our best knowledge, the first study providing a multiparametric comparison of radiation biomarkers in human blood in vivo, which have potential for improving biological dosimetry.	[Tichy, Ales; Sinkorova, Zuzana; Kmochova, Adela; Grepl, Jakub; Zarybnicka, Lenka] Univ Def Brno, Dept Radiobiol, Fac Mil Hlth Sci, Hradec Kralove, Czech Republic; [Tichy, Ales] Univ Hosp, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Kabacik, Sylwia; O'Brien, Grainne; Ainsbury, Elizabeth; Badie, Christophe] Publ Hlth England, Radiat Effects Dept, Canc Mech & Biomarkers Grp, Ctr Radiat Chem & Environm Hazards, Didcot, Oxon, England; [Pejchal, Jaroslav] Univ Def Brno, Fac Mil Hlth Sci, Dept Toxicol, Hradec Kralove, Czech Republic; [Sirak, Igor; Grepl, Jakub; Zavrelova, Alzbeta] Univ Hosp, Dept Radiotherapy & Oncol, Hradec Kralove, Czech Republic; [Sirak, Igor; Grepl, Jakub; Zavrelova, Alzbeta] Univ Hosp, Dept Internal Med Hematol 4, Hradec Kralove, Czech Republic; [Malkova, Andrea] Charles Univ Prague, Fac Med Hradec Kralove, Dept Hyg & Prevent Med, Hradec Kralove, Czech Republic; [Beltran, Caterina Gomila; Gonzalez, Juan Ramon; Pernot, Eileen; Cardis, Elisabeth] Inst Global Hlth, Barcelona, Spain; [Majewski, Matthaeus; Abend, Michael] Bundeswehr Inst Radiobiol, Munich, Germany; [Vachelova, Jana; Davidkova, Marie] Czech Acad Sci, Nucl Phys Inst, Dept Radiat Dosimetry, Prague, Czech Republic; [Stastna, Marketa Markova] Hosp Na Bulovce, Inst Hematol & Blood Transfus, Prague, Czech Republic; [Pernot, Eileen] Itec Serv, Cenon, France	University of Defence - Czech Republic; University Hospital Hradec Kralove; Public Health England; University of Defence - Czech Republic; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; ISGlobal; Czech Academy of Sciences; Nuclear Physics Institute of the Czech Academy of Sciences; Bulovka University Hospital; Institute of Hematology Prague	Badie, C (corresponding author), Publ Hlth England, Radiat Effects Dept, Canc Mech & Biomarkers Grp, Ctr Radiat Chem & Environm Hazards, Didcot, Oxon, England.	christophe.badie@phe.gov.uk	Pejchal, Jaroslav/AAJ-1177-2020; Sinkorova, Zuzana/AFU-6164-2022; Šinkorová, Zuzana/AAI-8955-2021; Gonzalez, Juan R/B-7860-2018; Cardis, Elisabeth/C-3904-2017; Davidkova, Marie/G-7845-2014; Malkova, Andrea/B-1013-2017; Tichy, Ales/A-3368-2013; Badie, Christophe/L-5890-2019; Vachelova, Jana/H-6781-2014; Sirak, Igor/T-7769-2017	Pejchal, Jaroslav/0000-0003-2228-7922; Sinkorova, Zuzana/0000-0003-0396-7447; Gonzalez, Juan R/0000-0003-3267-2146; Cardis, Elisabeth/0000-0003-0999-6839; Davidkova, Marie/0000-0003-1057-3091; Malkova, Andrea/0000-0001-9444-8065; Tichy, Ales/0000-0002-8262-5703; Sirak, Igor/0000-0002-5972-3866; Grepl, Jakub/0000-0003-0732-1344; Ainsbury, Elizabeth/0000-0001-8076-6978	National Institutes of Health [GC006900-34]; Ministry of Defence of the Czech Republic; Ministry of Interior Affairs of the Czech Republic [VH20172020010]; Newcastle University; Public Health of England, Health Protection Research Unit (HPRU)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Defence of the Czech Republic; Ministry of Interior Affairs of the Czech Republic; Newcastle University; Public Health of England, Health Protection Research Unit (HPRU)	This work was supported by the National Institutes of Health (Centre for Minimally Invasive radiation Biodosimetry, sub-award no: GC006900-34) (EC), Ministry of Defence of the Czech Republic (long-term organization development plan Medical Aspects of Weapons of Mass Destruction of the Faculty of Military Health Sciences, University of Defence), Ministry of Interior Affairs of the Czech Republic (project VH20172020010) (AT), the Radiation Theme of the Newcastle University and Public Health of England, Health Protection Research Unit (HPRU) (CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend M, 2016, RADIAT RES, V185, P109, DOI 10.1667/RR14221.1; Badie C, 2008, BRIT J CANCER, V98, P1845, DOI 10.1038/sj.bjc.6604381; Badie C, 2016, CLIN ONCOL-UK, V28, P619, DOI 10.1016/j.clon.2016.06.002; Badie C, 2013, RADIAT RES, V180, P138, DOI 10.1667/RR3236.1; Bertucci A, 2016, RADIAT ENVIRON BIOPH, V55, P53, DOI 10.1007/s00411-015-0628-z; Blakely WF, 2005, HEALTH PHYS, V89, P494, DOI 10.1097/01.HP.0000175913.36594.a4; Brzoska K, 2015, RADIAT ENVIRON BIOPH, V54, P353, DOI 10.1007/s00411-015-0603-8; CARBONELL F, 1983, RADIAT RES, V93, P453, DOI 10.2307/3576025; Cerna M, 2007, INT J HYG ENVIR HEAL, V210, P495, DOI 10.1016/j.ijheh.2007.01.005; Chaudhry MA, 2008, J BIOMED SCI, V15, P557, DOI 10.1007/s11373-008-9253-z; Fenech M, 2006, MUTAT RES-FUND MOL M, V600, P58, DOI 10.1016/j.mrfmmm.2006.05.028; Fernandes TS, 2008, BRAZ ARCH BIOL TECHN, V51, P97, DOI 10.1590/S1516-89132008000700016; Gershkevitsh E, 2002, STRAHLENTHER ONKOL, V178, P36, DOI 10.1007/s00066-002-0886-y; Guo Y, 2012, MUTAT RES-GEN TOX EN, V744, P154, DOI 10.1016/j.mrgentox.2012.02.006; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Kmochova A, 2016, J APPL BIOMED, V14, P19, DOI 10.1016/j.jab.2015.07.001; Lue SW, 2015, RADIAT RES, V184, P134, DOI 10.1667/RR13991.1; Manning G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00412; Manning G, 2017, INT J RADIAT BIOL, V93, P87, DOI 10.1080/09553002.2016.1227105; Manning G, 2013, INT J RADIAT BIOL, V89, P512, DOI 10.3109/09553002.2013.769694; Martin DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep23658; Matsuoka A, 1996, J RADIAT RES, V37, P257, DOI 10.1269/jrr.37.257; O'Brien G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19043-w; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Paul S, 2011, RADIAT RES, V175, P257, DOI 10.1667/RR2420.1; Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887; Port M, 2017, RADIAT RES, V188, P156, DOI 10.1667/RR14612.1; Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078; Repin M, 2017, RADIAT RES, V187, P492, DOI 10.1667/RR011CC.1; Roch-Lefevre S, 2010, BRIT J RADIOL, V83, P759, DOI 10.1259/bjr/21022597; Rothkamm K, 2013, RADIAT RES, V180, P111, DOI 10.1667/RR3231.1; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Silva-Barbosa I, 2005, GENET MOL BIOL, V28, P452, DOI 10.1590/S1415-47572005000300021; Sreedevi B, 2001, RADIAT PROT DOSIM, V94, P317, DOI 10.1093/oxfordjournals.rpd.a006505; Vinnikov VA, 2017, GENOME INTEGR, V8; Wen Q, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-133; Wen Q, 2011, LEUKEMIA RES, V35, P1044, DOI 10.1016/j.leukres.2010.12.026; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zeegers Dimphy, 2017, Genome Integr, V8, P6, DOI 10.4103/2041-9414.198911	39	28	31	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2018	13	2							e0193412	10.1371/journal.pone.0193412	http://dx.doi.org/10.1371/journal.pone.0193412			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX4LV	29474504	Green Published, gold, Green Submitted			2022-12-27	WOS:000426049500103
J	Sorensen, DM; Holemans, T; van Veen, S; Martin, S; Arslan, T; Haagendahl, IW; Holen, HW; Hamouda, NN; Eggermont, J; Palmgren, M; Vangheluwe, P				Sorensen, Danny Mollerup; Holemans, Tine; van Veen, Sarah; Martin, Shaun; Arslan, Tugce; Haagendahl, Ida Winther; Holen, Henrik Weida; Hamouda, Norin Nabil; Eggermont, Jan; Palmgren, Michael; Vangheluwe, Peter			Parkinson disease related ATP13A2 evolved early in animal evolution	PLOS ONE			English	Article							P-TYPE ATPASE; SECRETORY PATHWAY; ALPHA-SYNUCLEIN; LYSOSOMAL DYSFUNCTION; PHYLOGENETIC ANALYSIS; TRANSPORT ATPASES; HOMEOSTASIS; MUTATIONS; PARK9; CA2+	Several human P5-type transport ATPases are implicated in neurological disorders, but little is known about their physiological function and properties. Here, we investigated the relationship between the five mammalian P5 isoforms ATP13A1-5 in a comparative study. We demonstrated that ATP13A1-4 isoforms undergo autophosphorylation, which is a hallmark P-type ATPase property that is required for substrate transport. A phylogenetic analysis of P5 sequences revealed that ATP13A1 represents Glade P5A, which is highly conserved between fungi and animals with one member in each investigated species. The ATP13A2-5 isoforms belong to Glade P5B and diversified from one isoform in fungi and primitive animals to a maximum of four in mammals by successive gene duplication events in vertebrate evolution. We revealed that ATP13A1 localizes in the endoplasmic reticulum (ER) and experimentally demonstrate that ATP13A1 likely contains 12 transmembrane helices. Conversely, ATP13A2-5 isoforms reside in overlapping compartments of the endosomal system and likely contain 10 transmembrane helices, similar to what was demonstrated earlier for ATP13A2. ATP13A1 complemented a deletion of the yeast P5A ATPase SPF1, while none of ATP13A2-5 could complement either the loss of SPF1 or that of the single P5B ATPase YPK9 in yeast. Thus, ATP13A1 carries out a basic ER function similar to its yeast counterpart Spf1p that plays a role in ER related processes like protein folding and processing. ATP13A2-5 isoforms diversified in mammals and are expressed in the endosomal system where they may have evolved novel complementary or partially redundant functions. While most P5-type ATPases are widely expressed, some P5B-type ATPases (ATP13A4 and ATP13A5) display a more limited tissue distribution in the brain and epithelial glandular cells, where they may exert specialized functions. At least some P5B isoforms are of vital importance for the nervous system, since ATP13A2 and ATP13A4 are linked to respectively Parkinson disease and autism spectrum disorders.	[Sorensen, Danny Mollerup; Holemans, Tine; van Veen, Sarah; Martin, Shaun; Arslan, Tugce; Hamouda, Norin Nabil; Eggermont, Jan; Vangheluwe, Peter] Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, Leuven, Belgium; [Sorensen, Danny Mollerup; Haagendahl, Ida Winther; Holen, Henrik Weida; Palmgren, Michael] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark	KU Leuven; University of Copenhagen	Vangheluwe, P (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Lab Cellular Transport Syst, Leuven, Belgium.	peter.vangheluwe@kuleuven.be	Palmgren, Michael/A-9808-2013; van Veen, Sarah/AAG-9847-2021; Vangheluwe, Peter/P-5476-2017; Sorensen, Danny Mollerup/C-2166-2015	Palmgren, Michael/0000-0002-9982-6114; van Veen, Sarah/0000-0002-7639-7847; Vangheluwe, Peter/0000-0002-7822-2944; Eggermont, Jan/0000-0002-8497-1159; Sorensen, Danny Mollerup/0000-0002-5254-6780	Interuniversity Poles of Attraction of the Belgian Science Policy Office [P7/13]; KU Leuven [0T/13/091, C16/15/073]; FWO [1503117N, SBO Neuro-TRAFFIC 5006617N]; Queen Elisabeth Medical Foundation; Danish National Research Foundation	Interuniversity Poles of Attraction of the Belgian Science Policy Office; KU Leuven(KU Leuven); FWO(FWO); Queen Elisabeth Medical Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was funded by the Interuniversity Poles of Attraction of the Belgian Science Policy Office (P7/13 to P.V.; http:/www.belspo.be/IAP/), the KU Leuven (0T/13/091 and C16/15/073 to P.V.; https://www.kuleuven.be/), FWO (1503117N and SBO Neuro-TRAFFIC 5006617N to P.V.; http://www.fwo.be), the Queen Elisabeth Medical Foundation (to P.V.; http://www.fmre-gske.be/index.html) and the Danish National Research Foundation (to M.P.; http://dg.dk/en/). T. H. and S.v.V. are research fellows of the Flanders Research Foundation FWO (http://www.fwo.be/). D.S.M. is paid from the Danish Natural Science Research Council (OrphanPumps). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ando A, 2005, MOL GENET GENOMICS, V273, P497, DOI 10.1007/s00438-005-1153-6; Baron S, 2010, BBA-BIOMEMBRANES, V1798, P1512, DOI 10.1016/j.bbamem.2010.03.023; Benedetto A, 2009, CHEM REV, V109, P4862, DOI 10.1021/cr800536y; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bras J, 2012, HUM MOL GENET, V21, P2646, DOI 10.1093/hmg/dds089; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Corradi GR, 2012, J BIOL CHEM, V287, P30477, DOI 10.1074/jbc.M112.363465; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Covy JP, 2012, J NEUROSCI RES, V90, P2306, DOI 10.1002/jnr.23112; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Crosiers D, 2011, PARKINSONISM RELAT D, V17, P135, DOI 10.1016/j.parkreldis.2010.10.011; Pinto FD, 2012, NEUROCHEM INT, V60, P243, DOI 10.1016/j.neuint.2012.01.002; Dehay B, 2012, P NATL ACAD SCI USA, V109, P9611, DOI 10.1073/pnas.1112368109; Di Fonzo A, 2007, NEUROLOGY, V68, P1557, DOI 10.1212/01.wnl.0000260963.08711.08; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estrada-Cuzcano A MS, 2016, BRAIN; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; Farias FHG, 2011, NEUROBIOL DIS, V42, P468, DOI 10.1016/j.nbd.2011.02.009; FELSENSTEIN D, 1985, J INFECT DIS, V152, P198, DOI 10.1093/infdis/152.1.198; Fujita M, 2010, FEBS LETT, V584, P1670, DOI 10.1016/j.febslet.2009.10.079; Gan-Or Z, 2015, AUTOPHAGY, V11, P1443, DOI 10.1080/15548627.2015.1067364; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Grunewald A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.035; Gusdon AM, 2012, NEUROBIOL DIS, V45, P962, DOI 10.1016/j.nbd.2011.12.015; Heinick A, 2010, FASEB J, V24, P206, DOI 10.1096/fj.09-135889; Holemans T, 2015, P NATL ACAD SCI USA, V112, P9040, DOI 10.1073/pnas.1508220112; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jakobsen MK, 2005, GENE DEV, V19, P2757, DOI 10.1101/gad.357305; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kong SMY, 2014, HUM MOL GENET, V23, P2816, DOI 10.1093/hmg/ddu099; Krumpe K, 2012, MOL BIOL CELL, V23, P3927, DOI 10.1091/mbc.E11-12-0994; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; Lambie EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077202; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Lelong E, 2011, CELL MICROBIOL, V13, P246, DOI 10.1111/j.1462-5822.2010.01532.x; Lesca G, 2012, EPILEPSIA, V53, P1526, DOI 10.1111/j.1528-1167.2012.03559.x; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Martin S, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/9531917; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Ning YP, 2008, NEUROLOGY, V70, P1491, DOI 10.1212/01.wnl.0000310427.72236.68; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Park JS, 2014, HUM MOL GENET, V23, P2802, DOI 10.1093/hmg/ddt623; POST RL, 1973, J BIOL CHEM, V248, P6993; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ramonet D, 2012, HUM MOL GENET, V21, P1725, DOI 10.1093/hmg/ddr606; Rinaldi DE, 2015, BBA-BIOMEMBRANES, V1848, P1646, DOI 10.1016/j.bbamem.2015.04.008; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santoro L, 2011, NEUROGENETICS, V12, P33, DOI 10.1007/s10048-010-0259-0; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Schneider SA, 2010, MOVEMENT DISORD, V25, P979, DOI 10.1002/mds.22947; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schultheis PJ, 2013, HUM MOL GENET, V22, P2067, DOI 10.1093/hmg/ddt057; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Sorensen DM, 2015, BBA-GEN SUBJECTS, V1850, P524, DOI 10.1016/j.bbagen.2014.05.008; Sorensen DM, 2012, J BIOL CHEM, V287, P28336, DOI 10.1074/jbc.M112.387191; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Suzuki C, 2001, BIOSCI BIOTECH BIOCH, V65, P2405, DOI 10.1271/bbb.65.2405; Tan JQ, 2011, J BIOL CHEM, V286, P29654, DOI 10.1074/jbc.M111.233874; Tsunemi T, 2014, HUM MOL GENET, V23, P2791, DOI 10.1093/hmg/ddt572; Usenovic M, 2012, AUTOPHAGY, V8, P987, DOI 10.4161/auto.20256; Vallipuram J, 2010, CELL MOL NEUROBIOL, V30, P233, DOI 10.1007/s10571-009-9445-8; van Veen S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00048; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Weingarten LS, 2012, CELL MOL BIOL LETT, V17, P153, DOI 10.2478/s11658-011-0039-3; Wohlke A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002304; Worthey EA, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-29	76	29	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193228	10.1371/journal.pone.0193228	http://dx.doi.org/10.1371/journal.pone.0193228			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505581	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000426548200008
J	Fleminger, J; Goldacre, B				Fleminger, Jessica; Goldacre, Ben			Prevalence of clinical trial status discrepancies: A cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register	PLOS ONE			English	Article							PUBLICATION	Objective Trial registries are a key source of information for clinicians and researchers. While building OpenTrials, an open database of public trial information, we identified errors and omissions in registries, including discrepancies between descriptions of the same trial in different registries. We set out to ascertain the prevalence of discrepancies in trial completion status using a cohort of trials registered on both the European Union Clinical Trials Register (EUCTR) and ClinicalTrials.gov. Study design and setting We used matching titles and registry IDs provided by both registries to build a cohort of dual-registered trials. Completion statuses were compared; we calculated descriptive statistics on the prevalence of discrepancies. Results 11,988 dual-registered trials were identified. 1,496 did not provide a comparable completion status, leaving 10,492 trials. 16.2% were discrepant on completion status. The majority of discrepancies (90.5%) were a 'completed' trial on ClinicalTrials. gov inaccurately marked as 'ongoing' on EUCTR. Overall, 33.9% of dual-registered trials described as 'ongoing' on EUCTR were listed as 'completed' on ClinicalTrials.gov. Conclusion Completion status on registries is commonly inaccurate. Previous work on publication bias may underestimate non-reporting. We describe simple steps registry owners and trialists could take to improve accuracy.	[Fleminger, Jessica; Goldacre, Ben] Univ Oxford, Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England	University of Oxford	Goldacre, B (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England.	ben.goldacre@pho.ox.ac.uk		Fleminger, Jessica/0000-0002-5744-5137; Goldacre, Ben/0000-0002-5127-4728	Laura and John Arnold Foundation [BZR00320]	Laura and John Arnold Foundation	BG is funded by the Laura and John Arnold Foundation to conduct work on research integrity (grant number BZR00320) (http://www.arnoldfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Goldacre B, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1290-8; Huic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025258; Jones CW, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017719; Moja Lorenzo P, 2009, Trials, V10, P56, DOI 10.1186/1745-6215-10-56; Organisation WH, 2012, INT STAND CLIN TRIAL; Reid EK, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0070-y; Rewarding true inquiry and diligence in research, 2015, LANCET, V385, P2121; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Schmucker C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114023; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080	11	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193088	10.1371/journal.pone.0193088	http://dx.doi.org/10.1371/journal.pone.0193088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513684	gold, Green Published, Green Submitted			2022-12-27	WOS:000426896800035
J	Wang, X; Pinto-Duarte, A; Behrens, MM; Zhou, XJ; Sejnowski, TJ				Wang, Xin; Pinto-Duarte, Antonio; Behrens, M. Margarita; Zhou, Xianjin; Sejnowski, Terrence J.			Ketamine independently modulated power and phase-coupling of theta oscillations in Sp4 hypomorphic mice	PLOS ONE			English	Article							NMDA-RECEPTOR ENCEPHALITIS; TRANSCRIPTION FACTOR SP4; PSYCHIATRIC-DISORDERS; PREFRONTAL SYNCHRONY; BIPOLAR DISORDER; SCHIZOPHRENIA; MEMORY; EEG; MODEL; EXPRESSION	Reduced expression of Sp4, the murine homolog of human SP4, a risk gene of multiple psychiatric disorders, led to N-methyl-D-aspartate ( NMDA) hypofunction in mice, producing behavioral phenotypes reminiscent of schizophrenia, including hypersensitivity to ketamine. As accumulating evidence on molecular mechanisms and behavioral phenotypes established Sp4 hypomorphism as a promising animal model, systems-level neural circuit mechanisms of Sp4 hypomorphism, especially network dynamics underlying cognitive functions, remain poorly understood. We attempted to close this gap in knowledge in the present study by recording multi-channel epidural electroencephalogram ( EEG) from awake behaving wildtype and Sp4 hypomorphic mice. We characterized cortical theta-band power and phase-coupling phenotypes, a known neural circuit substrate underlying cognitive functions, and further studied the effects of a subanesthetic dosage of ketamine on theta abnormalities unique to Sp4 hypomorphism. Sp4 hypomorphic mice had markedly elevated theta power localized frontally and parietally, a more pronounced theta phase progression along the neuraxis, and a stronger frontal-parietal theta coupling. Acute subanesthetic ketamine did not affect theta power in wildtype animals but significantly reduced it in Sp4 hypomorphic mice, nearly completely neutralizing their excessive frontal/parietal theta power. Ketamine did not significantly alter cortical theta phase progression in either wildtype or Sp4 hypomorphic animals, but significantly strengthened cortical theta phase-coupling in wildtype, but not in Sp4 hypomorphic animals. Our results suggested that the resting-state phenotypes of cortical theta oscillations unique to Sp4 hypomorphic mice closely mimicked a schizophrenic endophenotype. Further, ketamine independently modulated Sp4 hypomorphic anomalies in theta power and phase-coupling, suggesting separate underlying neural circuit mechanisms.	[Wang, Xin; Pinto-Duarte, Antonio; Behrens, M. Margarita; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Zhou, Xianjin] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Wang, X (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	xinw@salk.edu	Sejnowski, Terrence/AAV-5558-2021; Pinto-Duarte, Antonio/B-6392-2008	Pinto-Duarte, Antonio/0000-0002-2215-7653; Wang, Xin/0000-0003-3270-3782	Life Sciences Research Foundation (US); Fundacao Calouste Gulbenkian; Brain and Behavior Research Foundation [YI19582]; National Institute of Mental Health [MH091407, MH073991]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091407] Funding Source: NIH RePORTER	Life Sciences Research Foundation (US); Fundacao Calouste Gulbenkian(European Commission); Brain and Behavior Research Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by Life Sciences Research Foundation (US) to XW, Fundacao Calouste Gulbenkian to APD, Brain and Behavior Research Foundation (YI19582 to XW), National Institute of Mental Health (MH091407) to MMB, National Institute of Mental Health (MH073991) to XZ, Howard Hughes Medical Institute to TJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou C, 2015, SCHIZOPHR RES, V161, P299, DOI 10.1016/j.schres.2014.12.018; Benchenane K, 2011, CURR OPIN NEUROBIOL, V21, P475, DOI 10.1016/j.conb.2011.01.004; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Boutros NN, 2008, SCHIZOPHR RES, V99, P225, DOI 10.1016/j.schres.2007.11.020; Chan E, 2007, NEUROSCIENCE, V144, P604, DOI 10.1016/j.neuroscience.2006.08.080; Choi JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148272; Cousijn H, 2015, HUM BRAIN MAPP, V36, P2387, DOI 10.1002/hbm.22778; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Di Lorenzo G, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00234; Duzel E, 2010, CURR OPIN NEUROBIOL, V20, P143, DOI 10.1016/j.conb.2010.01.004; Fuentemilla L, 2010, CURR BIOL, V20, P606, DOI 10.1016/j.cub.2010.01.057; Gao XM, 2000, AM J PSYCHIAT, V157, P1141, DOI 10.1176/appi.ajp.157.7.1141; Garakh Z, 2015, CLIN NEUROPHYSIOL, V126, P2090, DOI 10.1016/j.clinph.2014.12.031; Greenwood TA, 2011, AM J PSYCHIAT, V168, P930, DOI 10.1176/appi.ajp.2011.10050723; Hanslmayr S, 2013, HUM BRAIN MAPP, V34, P2266, DOI 10.1002/hbm.22064; Heisler LE, 2005, NUCLEIC ACIDS RES, V33, P2952, DOI 10.1093/nar/gki582; Higa K.K., 2015, INT J NEUROPSYCHOPH, P1; Holcomb HH, 2005, NEUROPSYCHOPHARMACOL, V30, P2275, DOI 10.1038/sj.npp.1300824; Hong LE, 2008, ARCH GEN PSYCHIAT, V65, P1008, DOI 10.1001/archpsyc.65.9.1008; Horvath G, 2016, BEHAV BRAIN RES, V307, P65, DOI 10.1016/j.bbr.2016.03.051; Iizuka T, 2008, NEUROLOGY, V70, P504, DOI 10.1212/01.wnl.0000278388.90370.c3; Ji B, 2013, PLOS ONE, V8; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kim JW, 2015, NEUROSCI LETT, V589, P126, DOI 10.1016/j.neulet.2014.12.064; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Lakatos P, 2013, J NEUROSCI, V33, P11692, DOI 10.1523/JNEUROSCI.0010-13.2013; Lanre-Amos T, 2010, FRONT PSYCHIATRY, V1, P1; Law A.J., 2001, NEUROCHEM NEUROREP, V12, P959; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Martin-Sanchez A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00197; Mathes B, 2015, INT FEDERATION CLIN, V127, P419; Narayanan B, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.76; Pinacho R, 2011, BIPOLAR DISORD, V13, P474, DOI 10.1111/j.1399-5618.2011.00941.x; Popov T, 2015, PSYCHOPHYSIOLOGY, V52, P648, DOI 10.1111/psyp.12393; Reinhart RMG, 2015, P NATL ACAD SCI USA, V112, P9448, DOI 10.1073/pnas.1504196112; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Saia G, 2014, J NEUROCHEM, V129, P743, DOI 10.1111/jnc.12657; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; SPONHEIM SR, 1994, PSYCHOPHYSIOLOGY, V31, P37, DOI 10.1111/j.1469-8986.1994.tb01023.x; Sun X, 2014, DEV NEUROBIOL, V2; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Tomimatsu Y, 2015, SCHIZOPHR RES, V166, P171, DOI 10.1016/j.schres.2015.05.002; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Wang X, 2010, NEURO PHYSIOL COMPUT, P1195; Wang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep14964; Weickert CS, 2013, MOL PSYCHIATR, V18, P1185, DOI 10.1038/mp.2012.137; Young AMJ, 2015, NEUROSCIENCE, V287, P157, DOI 10.1016/j.neuroscience.2014.12.014; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621; Zhou XJ, 2010, HUM MOL GENET, V19, P3797, DOI 10.1093/hmg/ddq298; Zhou XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005196	56	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193446	10.1371/journal.pone.0193446	http://dx.doi.org/10.1371/journal.pone.0193446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513708	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800061
J	Rajpal, S; Kumar, A; Joe, W				Rajpal, Sunil; Kumar, Abhishek; Joe, William			Economic burden of cancer in India: Evidence from cross-sectional nationally representative household survey, 2014	PLOS ONE			English	Article							HEALTH-CARE; DESCRIPTIVE EPIDEMIOLOGY; CERVICAL-CANCER; BREAST-CANCER; AGE; EXPENDITURE; POPULATION; NUTRITION; DIAGNOSIS; PAYMENTS	With the ongoing demographic and epidemiological transition, cancer is emerging as a major public health concern in India. This paper uses nationally representative household survey to examine the overall prevalence and economic burden of cancer in India. The age-standardized prevalence of cancer is estimated to be 97 per 100,000 persons with greater prevalence in urban areas. The evidence suggests that cancer prevalence is highest among the elderly and also among females in the reproductive age groups. Cancer displays a significant socioeconomic gradient even after adjusting for age-sex specifics and clustering in a multilevel regression framework. We find that out of pocket expenditure on cancer treatment is among the highest for any ailment. The average out of pocket spending on inpatient care in private facilities is about three-times that of public facilities. Furthermore, treatment for about 40 percent of cancer hospitalization cases is financed mainly through borrowings, sale of assets and contributions from friends and relatives. Also, over 60 percent of the households who seek care from the private sector incur out of pocket expenditure in excess of 20 percent of their annual per capita household expenditure. Given the catastrophic implications, this study calls for a disease-based approach towards financing such high-cost ailment. It is suggested that universal cancer care insurance should be envisaged and combined with existing accident and life insurance policies for the poorer sections in India. In concluding, we call for policies to improve cancer survivorship through effective prevention and early detection. In particular, greater public health investments in infrastructure, human resources and quality of care deserve priority attention.	[Rajpal, Sunil; Kumar, Abhishek; Joe, William] Delhi Univ Enclave, Inst Econ Growth, North Campus, Delhi, India	University of Delhi	Rajpal, S (corresponding author), Delhi Univ Enclave, Inst Econ Growth, North Campus, Delhi, India.	sunilrajpa127@gmail.com		Rajpal, Sunil/0000-0001-8607-1878				[Anonymous], 2017, MIN HLTH FAM WELF GO; BATTISTA RN, 1988, ANNU REV PUBL HEALTH, V9, P21; Berer M, 2008, REPROD HEALTH MATTER, V16, P4, DOI 10.1016/S0968-8080(08)32429-X; Berki S, 1998, HEALTHAFFAIRS, V5, P138; Bloom DE, 2014, EC NONCOMMUNICABLE D; Brown ML, 2001, ANNU REV PUBL HEALTH, V22, P91, DOI 10.1146/annurev.publhealth.22.1.91; BURCH PRJ, 1985, BRIT MED J, V290, P710, DOI 10.1136/bmj.290.6469.710-a; Chakravarthi I, 2013, ECON POLIT WEEKLY, V48, P20; Colditz GA, 2012, ANNU REV PUBL HEALTH, V33, P137, DOI 10.1146/annurev-publhealth-031811-124627; Confortini CC, 2015, HEALTH POLICY PLANN, V30, P1350, DOI 10.1093/heapol/czu134; Dale W, 2012, JNCI-J NATL CANCER I, V104, P581, DOI 10.1093/jnci/djs145; Dame P, 1977, ECON POLIT WEEKLY, P1844; Dinshaw K A, 2010, HLTH ADM, V17, P10; Erreygers G, 2009, J HEALTH ECON, V28, P504, DOI 10.1016/j.jhealeco.2008.02.003; Gajalakshmi CK, 1996, CANCER CAUSE CONTROL, V7, P520, DOI 10.1007/BF00051884; Gajalakshmi CK, 1998, CANCER CAUSE CONTROL, V9, P131, DOI 10.1023/A:1008822008788; Gajalakshmi V, 2012, CANCER CAUSE CONTROL, V23, P91, DOI 10.1007/s10552-012-9905-1; Gallus S, 2009, CANCER CAUSE CONTROL, V20, P1303, DOI 10.1007/s10552-009-9350-y; Gonzalez JM, 2005, J COMMUNITY PSYCHOL, V33, P611, DOI 10.1002/jcop.20071; Heck JE, 2008, CANCER CAUSE CONTROL, V19, P1329, DOI 10.1007/s10552-008-9204-z; Hiatt RA, 2004, EUR J EPIDEMIOL, V19, P821; Joe W, 2015, HEALTH POLICY PLANN, V30, P728, DOI 10.1093/heapol/czu050; Joseph F, 1982, ANNU REV PUBL HEALTH, V3, P80; Kaarthigeyan K, 2012, INDIAN J MED PAEDIAT, V33, P7, DOI 10.4103/0971-5851.96961; Kirkova J, 2012, AM J HOSP PALLIAT ME, V29, P139, DOI 10.1177/1049909111410965; Krieger N, 2005, CANCER CAUSE CONTROL, V16, P5, DOI 10.1007/s10552-004-1251-5; Kruk ME, 2009, HEALTH AFFAIR, V28, P1056, DOI 10.1377/hlthaff.28.4.1056; Leckie G, 2011, 17 STAT US GROUP M L; Leckie G, 2013, J STAT SOFTW, V52, P1; Li CI, 2000, CANCER CAUSE CONTROL, V11, P805, DOI 10.1023/A:1008942616092; Long ER., 1928, HIST PATHOLOGY; Madison T, 2004, AM J PUBLIC HEALTH, V94, P2104, DOI 10.2105/AJPH.94.12.2104; Mahal A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071853; Mallath MK, 2014, LANCET ONCOL, V15, pE205, DOI 10.1016/S1470-2045(14)70115-9; Marshall JR, 1996, CANCER CAUSE CONTROL, V7, P101, DOI 10.1007/BF00115642; Mathew A, 2008, BRIT J CANCER, V99, P207, DOI 10.1038/sj.bjc.6604423; McNeil C, 2013, JNCI-J NATL CANCER I, V105, P585, DOI 10.1093/jnci/djt104; Modugu HR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1048; Mohanti BK, 2011, ECON POLIT WEEKLY, V46, P112; Nagulapalli S, 2014, ECON POLIT WEEKLY, V49, P64; Nandakumar A, 1996, CANCER CAUSE CONTROL, V7, P405, DOI 10.1007/BF00052665; National Cancer Registry Program, 2016, INC DISR RENDS INC R; National Sample Survey Organisation, 2015, KEY IND SOC CONS IND; O'Donnell O, 2008, J HEALTH ECON, V27, P460, DOI 10.1016/j.jhealeco.2007.08.005; Okonkwo OL, 2008, JNCI-J NATL CANCER I, V18, P1290; Pfizer Facts, 2008, BURD CANC AS; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Rajkumar R, 2000, CANCER CAUSE CONTROL, V11, P433, DOI 10.1023/A:1008900425151; Ramadas K, 2008, CANCER DETECT PREV, V32, P109, DOI 10.1016/j.cdp.2008.02.008; Rock CL, 2000, ANNU REV PUBL HEALTH, V21, P47, DOI 10.1146/annurev.publhealth.21.1.47; Schlotterbeck ME, 1949, AM J NURS, V49, P300, DOI 10.1097/00000446-194905000-00025; Schottenfeld D, 2005, ANNU REV PUBL HEALTH, V26, P37, DOI 10.1146/annurev.publhealth.26.021304.144402; Sinha G, 2006, J NATL CANCER I, V98, P1516, DOI 10.1093/jnci/djj458; Sreedevi A, 2015, INT J WOMENS HEALTH, V7, P405, DOI 10.2147/IJWH.S50001; StataCorp, 2013, STAT STAT SOFTW REL; Swaminathan R, 2009, CANCER EPIDEMIOL, V33, P89, DOI 10.1016/j.canep.2009.06.012; Takiar R, 2010, ASIAN PAC J CANCER P, V11, P1045; Trichopoulos D, 1996, SCI AM, V275, P80, DOI 10.1038/scientificamerican0996-80; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wagstaff A., 2008, MEASURING FINANCIAL; Weinberg AD, 2010, CANCER CAUSE CONTROL, V21, P2015, DOI 10.1007/s10552-010-9649-8; WHO, 2011, NCD COUNTR PROF; WHO, 2006, CANC CONTR KNOWL ACT; World Health Organization, 2010, NMH FACT SHEET JAN 2; World Health Organization, 2014, WORLD STAT REP; World Health Organization, 2015, WORLD STAT REP; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yeole BB, 2003, CANCER CAUSE CONTROL, V14, P945, DOI 10.1023/B:CACO.0000007965.61579.b2; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007	71	65	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2018	13	2							e0193320	10.1371/journal.pone.0193320	http://dx.doi.org/10.1371/journal.pone.0193320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX6NQ	29481563	Green Published, gold, Green Submitted			2022-12-27	WOS:000426202700010
J	Bod'ova, K; Mitchell, GJ; Harpaz, R; Schneidman, E; Tkacik, G				Bod'ova, Katarina; Mitchell, Gabriel J.; Harpaz, Roy; Schneidman, Elad; Tkacik, Gasper			Probabilistic models of individual and collective animal behavior	PLOS ONE			English	Article							SOCIAL INFORMATION; DECISION-MAKING; FISH; SIMULATION; MOVEMENT; SYSTEMS; RULES	Recent developments in automated tracking allow uninterrupted, high-resolution recording of animal trajectories, sometimes coupled with the identification of stereotyped changes of body pose or other behaviors of interest. Analysis and interpretation of such data represents a challenge: the timing of animal behaviors may be stochastic and modulated by kinematic variables, by the interaction with the environment or with the conspecifics within the animal group, and dependent on internal cognitive or behavioral state of the individual. Existing models for collective motion typically fail to incorporate the discrete, stochastic, and internal-state- dependent aspects of behavior, while models focusing on individual animal behavior typically ignore the spatial aspects of the problem. Here we propose a probabilistic modeling framework to address this gap. Each animal can switch stochastically between different behavioral states, with each state resulting in a possibly different law of motion through space. Switching rates for behavioral transitions can depend in a very general way, which we seek to identify from data, on the effects of the environment as well as the interaction between the animals. We represent the switching dynamics as a Generalized Linear Model and show that: (i) forward simulation of multiple interacting animals is possible using a variant of the Gillespie's Stochastic Simulation Algorithm; (ii) formulated properly, the maximum likelihood inference of switching rate functions is tractably solvable by gradient descent; (iii) model selection can be used to identify factors that modulate behavioral state switching and to appropriately adjust model complexity to data. To illustrate our framework, we apply it to two synthetic models of animal motion and to real zebrafish tracking data.	[Bod'ova, Katarina; Mitchell, Gabriel J.; Tkacik, Gasper] IST Austria, Campus 1, A-3400 Klosterneuburg, Austria; [Bod'ova, Katarina] Comenius Univ, Fac Math Phys & Informat, Dept Math Anal & Numer Math, Bratislava 84248, Slovakia; [Harpaz, Roy; Schneidman, Elad] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Institute of Science & Technology - Austria; Comenius University Bratislava; Weizmann Institute of Science	Bod'ova, K (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.; Bod'ova, K (corresponding author), Comenius Univ, Fac Math Phys & Informat, Dept Math Anal & Numer Math, Bratislava 84248, Slovakia.	kbodova@ist.ac.at	Bodova, Katarina/AAX-4565-2021	Bodova, Katarina/0000-0002-7214-0171; schneidman, elad/0000-0001-8653-9848; Tkacik, Gasper/0000-0002-6699-1455; Harpaz, Roy/0000-0001-9587-3389	Human Frontier Science Program [RGP0065/2012]; Human Frontier Science Program (HFSP)	Human Frontier Science Program(Human Frontier Science Program); Human Frontier Science Program (HFSP)(Human Frontier Science Program)	This work was supported by the Human Frontier Science Program RGP0065/2012 (GT, ES).; This work was supported by the Human Frontier Science Program (HFSP) grant to GT and ES.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Davis MH, 1993, MARKOV PROCESSES OPT, V7, P7; Detrain C, 2006, PHYS LIFE REV, V3, P162, DOI 10.1016/j.plrev.2006.07.001; Gautrais J, 2009, J MATH BIOL, V58, P429, DOI 10.1007/s00285-008-0198-7; Ghosh MK, 1997, SIAM J CONTROL OPTIM, V35, P1952, DOI 10.1137/S0363012996299302; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Girdhar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128668; GOLDSTEIN S, 1951, Q J MECH APPL MATH, V4, P129, DOI 10.1093/qjmam/4.2.129; Harpaz R, 2017, P NATL ACAD SCI USA, V114, P10149, DOI 10.1073/pnas.1703817114; Hu JH, 2000, LECT NOTES COMPUT SC, V1790, P160; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Kac Marc, 1974, ROCKY MOUNTAIN J MAT, V4; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Kennedy MJ, 2017, PHYS BIOL, V14; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; McCullagh P, 1989, LOG LINEAR MODELS GE, P193; Nagy M, 2010, ARXIV10105394; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Nelder J. A., 1972, GEN LINEAR MODELS; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pola G., 2003, P IFAC C AN DES HYBR, P45, DOI DOI 10.3182/20050703-6-CZ-1902.00396; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; Seeley T., 1995, WISDOM HIVE SOCIAL P; Shemesh Y, 2013, ELIFE, V2, DOI [10.7554/eLife.00759, 10.7554/eLife.03602]; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Strandburg-Peshkin A, 2015, SCIENCE, V348, P1358, DOI 10.1126/science.aaa5099; Sumpter DJT, 2003, BEHAV ECOL SOCIOBIOL, V53, P131, DOI 10.1007/s00265-002-0549-0; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226	38	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193049	10.1371/journal.pone.0193049	http://dx.doi.org/10.1371/journal.pone.0193049			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513700	Green Submitted, Green Published, gold			2022-12-27	WOS:000426896800032
J	Barbet-Massin, M; Rome, Q; Villemant, C; Courchamp, F				Barbet-Massin, Morgane; Rome, Quentin; Villemant, Claire; Courchamp, Franck			Can species distribution models really predict the expansion of invasive species?	PLOS ONE			English	Article							VESPA-VELUTINA LEPELETIER; CLIMATIC NICHE SHIFTS; BIOLOGICAL INVASIONS; LAND-USE; FUTURE; RISK; EUROPE; CONSERVATISM; EQUILIBRIUM; NIGRITHORAX	Predictive studies are of paramount importance for biological invasions, one of the biggest threats for biodiversity. To help and better prioritize management strategies, species distribution models (SDMs) are often used to predict the potential invasive range of introduced species. Yet, SDMs have been regularly criticized, due to several strong limitations, such as violating the equilibrium assumption during the invasion process. Unfortunately, validation studies-with independent data-are too scarce to assess the predictive accuracy of SDMs in invasion biology. Yet, biological invasions allow to test SDMs usefulness, by retrospectively assessing whether they would have accurately predicted the latest ranges of invasion. Here, we assess the predictive accuracy of SDMs in predicting the expansion of invasive species. We used temporal occurrence data for the Asian hornet Vespa velutina nigrithorax, a species native to China that is invading Europe with a very fast rate. Specifically, we compared occurrence data from the last stage of invasion (independent validation points) to the climate suitability distribution predicted from models calibrated with data from the early stage of invasion. Despite the invasive species not being at equilibrium yet, the predicted climate suitability of validation points was high. SDMs can thus adequately predict the spread of V. v. nigrithorax, which appears to be-at least partially-climatically driven. In the case of V. v. nigrithorax, SDMs predictive accuracy was slightly but significantly better when models were calibrated with invasive data only, excluding native data. Although more validation studies for other invasion cases are needed to generalize our results, our findings are an important step towards validating the use of SDMs in invasion biology.	[Barbet-Massin, Morgane; Courchamp, Franck] Univ Paris Saclay, Univ Paris Sud, CNRS, AgroParisTech,Ecol Syst & Evolut, Orsay, France; [Rome, Quentin; Villemant, Claire] Sorbonne Univ, CNRS, UPMC, EPHE,ISYEB,MNHN,UMR 7205, Paris, France; [Rome, Quentin] Museum Natl Hist Nat, CNRS, AFB, UMS Patrimoine Nat 2006, Paris, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN)	Barbet-Massin, M (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, AgroParisTech,Ecol Syst & Evolut, Orsay, France.	morganebm@gmail.com	Rome, Quentin/AAD-1870-2019; Courchamp, Franck/ABE-7204-2020	Rome, Quentin/0000-0002-7055-8064; Courchamp, Franck/0000-0001-7605-4548	INVACOST project (ANR & Fondation BNP Paribas), Biodiversa Eranet (FFII), France AgriMer (Programme communautaire pour l'Apiculture); MEDDE (Ministere de l'Ecologie, du Developpement Durable et de l'Energie); MAAF (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret)	INVACOST project (ANR & Fondation BNP Paribas), Biodiversa Eranet (FFII), France AgriMer (Programme communautaire pour l'Apiculture)(French National Research Agency (ANR)); MEDDE (Ministere de l'Ecologie, du Developpement Durable et de l'Energie); MAAF (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret)	This work was supported by the INVACOST project (ANR & Fondation BNP Paribas), Biodiversa Eranet (FFII), France AgriMer (Programme communautaire pour l'Apiculture, 2008-2011 and 2013-2016), the MEDDE (Ministere de l'Ecologie, du Developpement Durable et de l'Energie) and the MAAF (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret).; This work was supported by the INVACOST project (ANR & Fondation BNP Paribas), Biodiversa Eranet (FFII), France AgriMer (Programme communautaire pour l'Apiculture, 2008-2011 and 2013-2016), the MEDDE (Ministere de l'Ecologie, du Developpement Durable et de l'Energie) and the MAAF (Ministere de l'Agriculture, de l'Agroalimentaire et de la Foret). We are most thankful all persons and organizations that provided records of hornet nests in France and in Europe (their list is available on the INPN website).	Alsos IG, 2012, P ROY SOC B-BIOL SCI, V279, P2042, DOI 10.1098/rspb.2011.2363; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Arca M, 2015, BIOL INVASIONS, V17, P2357, DOI 10.1007/s10530-015-0880-9; Areias-Guerreiro J, 2016, HYSTRIX, V27, DOI 10.4404/hystrix-27.1-11867; Barbet-Massin M, 2015, GLOBAL CHANGE BIOL, V21, P2917, DOI 10.1111/gcb.12905; Barbet-Massin M, 2014, DIVERS DISTRIB, V20, P1285, DOI 10.1111/ddi.12229; Barbet-Massin M, 2013, BIOL CONSERV, V157, P4, DOI 10.1016/j.biocon.2012.09.015; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Bertolino S, 2016, APPL ENTOMOL ZOOL, P1; Bessa AS, 2016, INSECT CONSERV DIVER, V9, P27, DOI 10.1111/icad.12140; Bosso L, 2017, ENVIRON MANAGE, V60, P304, DOI 10.1007/s00267-017-0882-8; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Bradshaw CJA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12986; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Crall AW, 2013, ECOL APPL, V23, P60, DOI 10.1890/12-0465.1; Domisch S, 2013, GLOBAL CHANGE BIOL, V19, P752, DOI 10.1111/gcb.12107; Early R, 2014, GLOBAL ECOL BIOGEOGR, V23, P1356, DOI 10.1111/geb.12208; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Giljohann KM, 2011, J APPL ECOL, V48, P1286, DOI 10.1111/j.1365-2664.2011.02016.x; Goldarazena A., 2015, Bulletin OEPP, V45, P133, DOI 10.1111/epp.12185; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hattab T, 2017, DIVERS DISTRIB, V23, P806, DOI 10.1111/ddi.12566; Haxaire Jean, 2006, Bulletin de la Societe Entomologique de France, V111, P194; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jarnevich CS, 2015, ECOL INFORM, V29, P6, DOI 10.1016/j.ecoinf.2015.06.007; Jarnevich CS, 2010, INVAS PLANT SCI MANA, V3, P365, DOI 10.1614/IPSM-08-073.1; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jones CC, 2012, FOREST ECOL MANAG, V284, P69, DOI 10.1016/j.foreco.2012.07.024; Keeling MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06212-0; Kramer AM, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1883; Lauzeral C, 2011, GLOBAL ECOL BIOGEOGR, V20, P407, DOI 10.1111/j.1466-8238.2010.00611.x; Lecocq T, 2016, CONSERV LETT, V9, P281, DOI 10.1111/conl.12215; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; Lopez S., 2011, Bulletin OEPP, V41, P439, DOI 10.1111/j.1365-2338.2011.02513.x; Mainali KP, 2015, GLOBAL CHANGE BIOL, V21, P4464, DOI 10.1111/gcb.13038; Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121; Marini MA, 2009, BIOL CONSERV, V142, P3039, DOI 10.1016/j.biocon.2009.08.002; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Milanesio D, 2017, ECOL EVOL, V7, P4599, DOI 10.1002/ece3.3053; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Mouquet N, 2015, J APPL ECOL, V52, P1293, DOI 10.1111/1365-2664.12482; Parravicini V, 2015, ECOL LETT, V18, P246, DOI 10.1111/ele.12401; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Porporato M, 2014, REDIA, V97, P189; Robinet C., 2016, J APPL ECOL; Rodrigues JFM, 2016, FRESHWATER BIOL, V61, P1119, DOI 10.1111/fwb.12772; Rodriguez-Rey M, 2013, ECOL MODEL, V256, P1, DOI 10.1016/j.ecolmodel.2013.01.024; Rome Q, 2015, J APPL ENTOMOL, V139, P771, DOI 10.1111/jen.12210; Rome Quentin, 2013, Bulletin de la Societe Entomologique de France, V118, P21; Seebens H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14435; Sheppard CS, 2014, GLOBAL CHANGE BIOL, V20, P2800, DOI 10.1111/gcb.12531; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Strubbe D, 2013, GLOBAL ECOL BIOGEOGR, V22, P962, DOI 10.1111/geb.12050; Team RC., 2013, R LANG ENV STAT COMP; Thuiller W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4118; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tingley R, 2017, ECOGRAPHY; Tulloch AIT, 2014, CONSERV BIOL, V28, P1462, DOI 10.1111/cobi.12403; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; Villemant C, 2011, BIOL CONSERV, V144, P2142, DOI 10.1016/j.biocon.2011.04.009; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; West AM, 2016, ECOL INFORM, V36, P126, DOI 10.1016/j.ecoinf.2016.11.001; Witt R, 2015, AMPULEX, V7, P42	74	96	98	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193085	10.1371/journal.pone.0193085	http://dx.doi.org/10.1371/journal.pone.0193085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4RM	29509789	Green Submitted, Green Published, gold			2022-12-27	WOS:000426813200009
J	Cozma, S; Ghiciuc, CM; Damian, L; Pasquali, V; Saponaro, A; Lupusoru, EC; Patacchioli, FR; Dima-Cozma, LC				Cozma, Sebastian; Ghiciuc, Cristina Mihaela; Damian, Lisandra; Pasquali, Vittorio; Saponaro, Angelo; Lupusoru, Elena Catalina; Patacchioli, Francesca Romana; Dima-Cozma, Lucia Corina			Distinct activation of the sympathetic adreno-medullar system and hypothalamus pituitary adrenal axis following the caloric vestibular test in healthy subjects	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; OBSTRUCTIVE SLEEP-APNEA; STRESS-INDUCED CHANGES; PSYCHOLOGICAL STRESS; DHEA-S; CORTISOL; STIMULATION; SCALE; DYSREGULATIONS; IMBALANCE		[Cozma, Sebastian] Univ Med & Pharm Grigore T Popa, Rehabil Hosp, Sch Med, Dept Otorhinolaryngol, Iasi, Romania; [Ghiciuc, Cristina Mihaela; Damian, Lisandra; Lupusoru, Elena Catalina] Univ Med & Pharm Grigore T Popa, Sch Med, Dept Pharmacol, Iasi, Romania; [Pasquali, Vittorio] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Saponaro, Angelo; Patacchioli, Francesca Romana] Sapienza Univ Rome, Dept Physiol & Pharmacol V Erspamer, Rome, Italy; [Dima-Cozma, Lucia Corina] Univ Med & Pharm Grigore T Popa, Rehabil Hosp, Sch Med, Dept Internal Med, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Sapienza University Rome; Sapienza University Rome; Grigore T Popa University of Medicine & Pharmacy	Patacchioli, FR (corresponding author), Sapienza Univ Rome, Dept Physiol & Pharmacol V Erspamer, Rome, Italy.	francesca.patacchioli@uniroma1.it	Patacchioli, Francesca R/D-3336-2009; Cozma, Sebastian/AAV-2996-2020; Ghiciuc, Cristina Mihaela/AAA-3942-2019; Patacchioli, Francesca Romana/AAD-4183-2022	Ghiciuc, Cristina Mihaela/0000-0003-1791-0425; Patacchioli, Francesca Romana/0000-0001-9672-2603; Pasquali, Vittorio/0000-0003-1294-0254	University of Medicine and Pharmacy "Grigore T. Popa" - Iasi - Romania [29234]	University of Medicine and Pharmacy "Grigore T. Popa" - Iasi - Romania	This study was supported by grant no 29234/December 20th, 2013 from the University of Medicine and Pharmacy "Grigore T. Popa" - Iasi - Romania. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn RS, 2007, YONSEI MED J, V48, P379, DOI 10.3349/ymj.2007.48.3.379; Aiken L.S., 1991, MULTIPLE REGRESSION; Akizuki K, 2014, J PHYS THER SCI, V26, P1059, DOI 10.1589/jpts.26.1059; Ali N, 2012, PHYSIOL BEHAV, V106, P65, DOI 10.1016/j.physbeh.2011.10.003; Archana R, 2016, BIOMED RES-INDIA, V27, P985; Biaggioni I, 1998, J VESTIBUL RES-EQUIL, V8, P35, DOI 10.1016/S0957-4271(97)00033-5; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; British Society of Audiology (BSA), 2010, REC PROC CAL TEST; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Cohen J., 2003, APPL MULTIPLE REGRES, V3rd ed., DOI DOI 10.4324/9780203774441; Cohen S, 2008, SOCIAL PSYCHOL HLTH, P31; Cortelli P, 2012, AUTON NEUROSCI-BASIC, V169, P7, DOI 10.1016/j.autneu.2012.02.005; COSTA F, 1995, CLIN AUTON RES, V5, P289, DOI 10.1007/BF01818894; Cozma S, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20165577, 10.1590/1414-431x20165577]; Dagilas A, 2005, OTOL NEUROTOL, V26, P476, DOI 10.1097/01.mao.0000169785.15083.28; Damian L, 2016, NEUROENDOCRINOL LETT, V37, P155; Delle Chiaie R, 2013, PSYCHOTHER PSYCHOSOM, V82, P264, DOI 10.1159/000348609; Duracinsky M, 2007, VALUE HEALTH, V10, P273, DOI 10.1111/j.1524-4733.2007.00182.x; Gananca Mauricio Malavasi, 2009, Braz J Otorhinolaryngol, V75, P2; Ghiciuc CM, 2016, BRAZ J OTORHINOLAR, V82, P529, DOI 10.1016/j.bjorl.2015.09.004; Ghiciuc CM, 2013, CHRONOBIOL INT, V30, P1024, DOI 10.3109/07420528.2013.795155; Ghiciuc CM, 2011, NEUROENDOCRINOL LETT, V32, P475; Gordis EB, 2008, HORM BEHAV, V53, P96, DOI 10.1016/j.yhbeh.2007.09.002; Hackney AC, 2008, J ATHL TRAINING, V43, P631, DOI 10.4085/1062-6050-43.6.631; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hallgren E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17627; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hammam E, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00334; Jauregui-Renaud K, 2000, BRAIN RES BULL, V53, P17, DOI 10.1016/S0361-9230(00)00304-X; Jonsson P, 2010, PSYCHONEUROENDOCRINO, V35, P1397, DOI 10.1016/j.psyneuen.2010.04.003; Kang Y, 2010, NURS HEALTH SCI, V12, P477, DOI 10.1111/j.1442-2018.2010.00562.x; Kasbekar AV, 2010, J LARYNGOL OTOL, V124, P616, DOI 10.1017/S0022215110000472; Katz ED, 2014, CLIN PROCEDURES EMER, P1434; Kerman IA, 2000, AM J PHYSIOL-REG I, V279, pR118, DOI 10.1152/ajpregu.2000.279.1.R118; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; KOHN PM, 1992, J BEHAV MED, V15, P221, DOI 10.1007/BF00848327; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Nater UM, 2013, PSYCHONEUROENDOCRINO, V38, P3167, DOI 10.1016/j.psyneuen.2013.09.008; Patacchioli FR, 2015, CLIMACTERIC, V18, P528, DOI 10.3109/13697137.2015.1008444; Patacchioli FR, 2003, J ENDOCRINOL INVEST, V26, pRC23, DOI 10.1007/BF03349149; Patacchioli FR, 2014, PEDIATR PULM, V49, P1145, DOI 10.1002/ppul.22972; Patacchioli Francesca Romana, 2006, J Headache Pain, V7, P90, DOI 10.1007/s10194-006-0274-6; Pippi R, 2014, J BIOL REG HOMEOS AG, V28, P147; Saman Y., 2012, FRONT NEUROL, V3, P1; Schumacher S, 2013, PSYCHONEUROENDOCRINO, V38, P729, DOI 10.1016/j.psyneuen.2013.02.003; Simeoni S, 2011, STRESS, V14, P282, DOI 10.3109/10253890.2010.545458; Takai N, 2004, ARCH ORAL BIOL, V49, P963, DOI 10.1016/j.archoralbio.2004.06.007; Wolf JM, 2008, BIOL PSYCHOL, V78, P20, DOI 10.1016/j.biopsycho.2007.12.004; YATES BJ, 1994, J NEUROPHYSIOL, V71, P2087, DOI 10.1152/jn.1994.71.6.2087; Yumuk V, 2015, OBESITY FACTS, V8, P402, DOI 10.1159/000442721	52	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2018	13	3							e0193963	10.1371/journal.pone.0193963	http://dx.doi.org/10.1371/journal.pone.0193963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY4RM	29509800	gold, Green Submitted, Green Published			2022-12-27	WOS:000426813200047
J	Chung, HT; Kim, JH; Kim, JW; Paek, SH; Kim, DG; Chun, KJ; Kim, TH; Kim, YK				Chung, Hyun-Tai; Kim, Jeong Hun; Kim, Jin Wook; Paek, Sun Ha; Kim, Dong Gyu; Chun, Kook Jin; Kim, Tae Hoon; Kim, Yong Kyun			Assessment of image co-registration accuracy for frameless gamma knife surgery	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RADIOSURGERY	Image co-registration is used in frameless gamma knife radiosurgery (GKSRS) to assign a stereotactic coordinate system and verify patient setup before irradiation. The accuracy of co-registration with cone beam computed tomography (CBCT) images of a Gamma Knife Icon TM (GK Icon) was assessed, and the effects of the region of co-registration (ROC) were studied. CBCT-to-CBCT co-registration is used for patient setup verification, and its accuracy was examined by co-registering CBCT images taken at various configurations with a reference CBCT series. The accuracy of stereotactic coordinate assignment was investigated by co-registering stereotactic CT images with CBCT images taken at various configurations. An anthropomorphic phantom was used, and the coordinates of fifteen landmarks inside the phantom were measured. The co-registration accuracy between stereotactic magnetic resonance (MR) and CBCT images was evaluated using images from forty-one patients. The positions of the anterior and posterior commissures were measured in both a fiducial marker-based system and a co-registered system. To assess the effects of MR image distortions, co-registration was performed with four different ranges, and the accuracy of the results was compared. Co-registration between CBCT images gave a mean three-dimensional deviation of 0.2 +/- 0.1 mm. The co-registration of stereotactic CT images with CBCT images produced a mean deviation of 0.5 +/- 0.2 mm. The co-registration of MR images with CBCT images resulted in the smallest three-dimensional difference (0.8 +/- 0.3 mm) when a co-registration region covering the skull base area was applied. The image co-registration errors in frameless GKSRS were similar to the imaging errors of frame-based GKSRS. The lower portion of the patient's head, including the base of the skull, is recommended for the ROC.	[Chung, Hyun-Tai; Paek, Sun Ha; Kim, Dong Gyu] Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Chung, Hyun-Tai; Kim, Jeong Hun; Kim, Jin Wook; Paek, Sun Ha; Kim, Dong Gyu] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Chun, Kook Jin] Korea Univ, Dept Accelerator Sci, Sejong Campus, Sejong, South Korea; [Kim, Tae Hoon; Kim, Yong Kyun] Hanyang Univ, Coll Engn, Dept Nucl Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Korea University; Hanyang University	Chung, HT (corresponding author), Seoul Natl Univ, Coll Med, Dept Neurosurg, Seoul, South Korea.; Chung, HT (corresponding author), Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea.	htchung@snu.ac.kr	Kim, Yong Kyun/E-6084-2017	Kim, Yong Kyun/0000-0002-3633-7065; Kim, Tae Hoon/0000-0002-3085-6980; Chung, Hyun-Tai/0000-0001-8243-2568; Kim, Jeong Hun/0000-0003-2957-1766	National Research Foundation of Korea [NRF-2015M2A2A4A02044802]; Korea Evaluation Institute of Industrial Technology [10069168]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Evaluation Institute of Industrial Technology	This study was supported by grant no. NRF-2015M2A2A4A02044802 from National Research Foundation of Korea (www.nrf,re.kr) (HTC) and grant no. 10069168 from Korea Evaluation Institute of Industrial Technology (www.keit.re.kr) (KJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cernica G, 2006, MED PHYS, V33, P941, DOI 10.1118/1.2179751; Elekta AB, 2015, AUTOMATIC POSITIONAL, P1; Elekta Instrument AB, 2015, CISC VIS NETW IND GL; Li W, 2016, INT J RADIAT ONCOL, V96, P214, DOI 10.1016/j.ijrobp.2016.04.011; Ma LJ, 2008, MED PHYS, V35, P5110, DOI 10.1118/1.2987669; Nakazawa H, 2014, J RADIAT RES, V55, P924, DOI 10.1093/jrr/rru027; Neumann JO, 2015, STEREOT FUNCT NEUROS, V93, P380, DOI 10.1159/000441233; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Pappas EP, 2016, PHYS MED BIOL, V61, P6993, DOI 10.1088/0031-9155/61/19/6993; Schlesinger DJ, 2009, TXB STEREOTACTIC FUN, P897; Watanabe Y, 2008, J NEUROSURG, V109, P21, DOI 10.3171/JNS/2008/109/12/S5	11	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193809	10.1371/journal.pone.0193809	http://dx.doi.org/10.1371/journal.pone.0193809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0AM	29499061	Green Published, gold, Green Submitted			2022-12-27	WOS:000426472300023
J	Manafo, E; Petermann, L; Vandall-Walker, V; Mason-Lai, P				Manafo, Elizabeth; Petermann, Lisa; Vandall-Walker, Virginia; Mason-Lai, Ping			Patient and public engagement in priority setting: A systematic rapid review of the literature	PLOS ONE			English	Review							ENGAGING PATIENTS; EVIDENCE BASE; HEALTH; INVOLVEMENT; CLINICIAN; PARTICIPATION; COMMUNITY; CARE; PARTNERSHIP; TRANSLATION	Background Current research suggests that while patients are becoming more engaged across the health delivery spectrum, this involvement occurs most often at the pre-preparation stage to identify 'high-level' priorities in health ecosystem priority setting, and at the preparation phase for health research. Objective The purpose of this systematic rapid review of the literature is to describe the evidence that does exist in relation to patient and public engagement priority setting in both health ecosystem and health research. Data sources HealthStar (via OVID); CINAHL; Proquest Databases; and Scholar's Portal. Study eligibility criteria i) published in English; ii) published within the timeframe of 2007-Current (10 years) unless the report/article was formative in synthesizing key considerations of patient engagement in health ecosystem and health research priority setting; iii) conducted in Canada, the US, Europe, UK, Australia/New Zealand, or Scandinavian countries. Study appraisal and synthesis i) Is the research valid, sound, and applicable?; ii) what outcomes can we potentially expect if we implement the findings from this research?; iii) will the target population (i.e., health researchers and practitioners) be able to use this research?. A summary of findings from each of the respective processes was synthesized to highlight key information that would support decision-making for researchers when determining the best priority setting process to apply for their specific patient-oriented research. Results Seventy articles from the UK, US, Canada, Netherlands and Australia were selected for review. Results were organized into two tiers of public and patient engagement in prioritization: Tier 1-Deliberative and Tier 2-Consultative. Highly structured patient and public engagement planning activities include the James Lind Alliance Priority Setting Partnerships (UK), Dialogue Method (Netherlands), Global Evidence Mapping (Australia), and the Deep Inclusion Method/CHoosing All Together (US). Limitations The critical study limitations include challenges in comprehensively identifying the patient engagement literature for review, bias in article selection due to the identified scope, missed information due to a more limited use of exhaustive search strategies (e.g., in-depth hand searching), and the heterogeneity of reported study findings. Conclusion The four public and patient engagement priority setting processes identified were successful in setting priorities that are inclusive and objectively based, specific to the priorities of stakeholders engaged in the process. The processes were robust, strategic and aimed to promote equity in patient voices. Key limitations identified a lack of evaluation data on the success and extent in which patients were engaged. Issues pertaining to feasibility of stakeholder engagement, coordination, communication and limited resources were also considered.	[Manafo, Elizabeth; Petermann, Lisa; Vandall-Walker, Virginia; Mason-Lai, Ping] Alberta SPOR SUPPORT Unit, Patient Engagement Platform, Edomonton, AB, Canada		Manafo, E (corresponding author), Alberta SPOR SUPPORT Unit, Patient Engagement Platform, Edomonton, AB, Canada.	emanafo@athabascau.ca		Petermann, Lisa/0000-0002-0181-292X	Canadian Institute for Health Research (CIHR) - Strategy for Patient Oriented Research (SPOR) and Alberta Innovates	Canadian Institute for Health Research (CIHR) - Strategy for Patient Oriented Research (SPOR) and Alberta Innovates	AbSPORU gratefully acknowledges the funding received from the Canadian Institute for Health Research (CIHR) - Strategy for Patient Oriented Research (SPOR) and Alberta Innovates.	Abelson J, 2016, HEALTH EXPECT, V19, P817, DOI 10.1111/hex.12378; Abma TA, 2010, HEALTH EXPECT, V13, P160, DOI 10.1111/j.1369-7625.2009.00549.x; Amirav I, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-4127; Arkind J, 2015, J AM BOARD FAM MED, V28, P632, DOI 10.3122/jabfm.2015.05.150009; Armstrong MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174329; Baker GR, EVIDENCE BOOST REV R; Batchelor JM, 2013, BRIT J DERMATOL, V168, P577, DOI 10.1111/bjd.12040; Boivin A, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-24; Boney O, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-010006; Boote J, 2011, HEALTH POLICY, V102, P105, DOI 10.1016/j.healthpol.2011.05.002; Boote J, 2010, HEALTH POLICY, V95, P10, DOI 10.1016/j.healthpol.2009.11.007; Brocklehurst PR, 2015, GERODONTOLOGY, V32, P222, DOI 10.1111/ger.12199; Broerse JEW, 2010, BURNS, V36, P217, DOI 10.1016/j.burns.2009.04.004; Brooks F, 2008, INT J NURS STUD, V45, P3, DOI 10.1016/j.ijnurstu.2006.08.012; Canadian Mental Health Association, FACTS MENT ILLN; Carman N, 2013, HEALTHC FINANC MANAG, V67, P8; Chalmers I, LANCET, V380, pS43; Clavisi O, 2013, J CLIN EPIDEMIOL, V66, P496, DOI 10.1016/j.jclinepi.2012.04.002; Conklin A, 2015, HEALTH EXPECT, V18, P153, DOI 10.1111/hex.12038; Costa-Font J, 2015, SOC SCI MED, V146, P182, DOI 10.1016/j.socscimed.2015.10.042; Cox A, 2017, ONCOL NURS FORUM, V44, P192, DOI 10.1188/17.ONF.192-203; Deane KHO, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006434; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Elberse JE, 2011, HEALTH EXPECT, V14, P225, DOI 10.1111/j.1369-7625.2010.00647.x; Elwyn G, 2010, J EVAL CLIN PRACT, V16, P627, DOI 10.1111/j.1365-2753.2009.01262.x; Etchegary H, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2138-y; Flaman LM, 2010, GLOB HEALTH PROMOT, V17, P34, DOI 10.1177/1757975910365225; Forsythe LP, 2016, J GEN INTERN MED, V31, P13, DOI 10.1007/s11606-015-3450-z; Gadsby R, 2012, DIABETIC MED, V29, P1321, DOI 10.1111/j.1464-5491.2012.03755.x; Gallivan J., 2012, J PARTICIPATORY MED, V4, P32; Goold SD, 2017, HEALTH SERV RES, V52, P599, DOI 10.1111/1475-6773.12505; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Hewlett S, 2006, ARTHRIT RHEUM-ARTHR, V55, P676, DOI 10.1002/art.22091; Hibbard JH, 2013, HLTH AFFAIRS, V32; Ingram JR, 2014, BRIT J DERMATOL, V171, P1422, DOI 10.1111/bjd.13163; Jones JM, 2017, EUR UROL; Kelly S, 2015, AGE AGEING, V44, P985, DOI 10.1093/ageing/afv143; Khangura S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-10; Khodyakov D, 2017, HEALTH EXPECT, V20, P130, DOI 10.1111/hex.12444; Kielmann T, 2011, HEALTH EXPECT, V14, P321, DOI 10.1111/j.1369-7625.2010.00631.x; Knight SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162136; Layton A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008085; Lophatananon A, 2011, BJU INT, V108, P1040, DOI 10.1111/j.1464-410X.2011.10609.x; Madden M., 2016, RES INVOLVEMENT ENGA, V2, P1, DOI [10.1186/s40900-016-0026-y, DOI 10.1186/S40900-016-0026-Y]; Manafo E, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0282-4; Manns B, 2014, CLIN J AM SOC NEPHRO, V9, P1813, DOI 10.2215/CJN.01610214; Medlow S, 2015, EUR J CANCER CARE, V24, P590, DOI 10.1111/ecc.12291; Miller CL, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0171-2; Mitton C, 2009, HEALTH POLICY, V91, P219, DOI 10.1016/j.healthpol.2009.01.005; National Collaborating Centre for Methods and Tools, RAP REV METH IMPL; Nierse CJ, 2011, J INTELL DISABIL RES, V55, P411, DOI 10.1111/j.1365-2788.2011.01388.x; Northway R, 2014, BRIT J LEARN DISABIL, V42, P323, DOI 10.1111/bld.12080; Pandya-Wood R, 2017, RES INVOLVEMENT ENGA, V3; Patten S, 2006, SOC SCI MED, V63, P1121, DOI 10.1016/j.socscimed.2006.01.033; Piil K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010615; Pittens CACM, 2014, SCI PUBL POLICY, V41, P809, DOI 10.1093/scipol/scu010; Pratt B, 2016, SOC SCI MED, V151, P215, DOI 10.1016/j.socscimed.2016.01.018; Rees SE, 2017, CAN J DIABETES, V41, P156, DOI 10.1016/j.jcjd.2016.08.219; Research CIHI, 2016, STRAT PAT OR RES; Restall GJ, 2016, CAN J OCCUP THER, V83, P7, DOI 10.1177/0008417415577423; Rideout C, 2013, PROG COMM HLTH PARTN, V7, P331, DOI 10.1353/cpr.2013.0033; Rowe G, 2005, SCI TECHNOL HUM VAL, V30, P251, DOI 10.1177/0162243904271724; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; Sofolahan-Oladeinde Y, 2017, FAM PRACT, V34, P272, DOI 10.1093/fampra/cmx013; Solomon S, 2012, HASTINGS CENT REP, V42, P17, DOI 10.1002/hast.27; STANISZEWSKA S, 2017, BMJ CLIN RES ED, V358, DOI DOI 10.1136/BMJ.J3453; Szelest E, ROLE PATIENTS RES; Truitt AR, 2017, QUAL LIFE RES; van Merode T, 2016, Z EVIDENZ FORTBILD Q, V112, P11, DOI 10.1016/j.zefq.2016.01.005; van Middendorp JJ, 2016, SPINAL CORD, V54, P341, DOI 10.1038/sc.2015.199; Walton NA, 2007, HEALTH POLICY, V80, P444, DOI 10.1016/j.healthpol.2006.05.004	73	90	90	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2018	13	3							e0193579	10.1371/journal.pone.0193579	http://dx.doi.org/10.1371/journal.pone.0193579			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FY0AM	29499043	Green Submitted, gold, Green Published			2022-12-27	WOS:000426472300016
J	Ling, XY; Zhou, HM; Ni, YJ; Wu, C; Zhang, CJ; Zhu, ZP				Ling, Xiaoyan; Zhou, Hongmei; Ni, Yunjian; Wu, Cheng; Zhang, Caijun; Zhu, Zhipeng			Does dexmedetomidine have an antiarrhythmic effect on cardiac patients? A meta-analysis of randomized controlled trials	PLOS ONE			English	Article							POSTOPERATIVE ATRIAL-FIBRILLATION; BYPASS GRAFT-SURGERY; INTENSIVE-CARE-UNIT; RISK-FACTORS; SURGICAL-PATIENTS; ARRHYTHMIAS; SEDATION; PREVENTION; MANAGEMENT; MORTALITY	Background Cardiac surgery patients often experience several types of tachyarrhythmias after admission to the intensive care unit ( ICU), which increases mortality and morbidity. Dexmedetomidine ( DEX) is a popular medicine used for sedation in the ICU, and its other pharmacological characteristics are gradually being uncovered. Purpose To determine whether DEX has an antiarrhythmic effect after cardiac surgery. Methods The three primary databases MEDLINE, Embase ( OVID SP) and the Cochrane Central Register of Controlled Trials ( CENTRAL) were searched, and all English-language and randomized control-designed clinical publications comparing DEX to control medicines for sedation after elective cardiac surgery were included. Two colleagues independently extracted the data and performed other quality assessments. A subgroup analysis was performed according to the different medicines used and whether cardiopulmonary bypass ( CPB) was applied. All tachyarrhythmias that occurred in the atria and ventricles were analyzed. Results A total of 1295 patients in 9 studies met the selection criteria among 2587 studies that were screened. After quantitative synthesis, our results revealed that the DEX group was associated with a lower incidence of ventricular arrhythmia ( VA, OR 0.24, 95% CI 0.09 - 0.64, I-2 = 0%, P = 0.005) than the control group. Subgroup analysis did not reveal a significant difference between the DEX and propofol subgroups ( OR 0.13, 95% CI 0.03 - 0.56, I-2 = 0%, P = 0.007). Additionally, no difference in the incidence of atrial fibrillation ( AF) was observed regardless of the different control medicines ( OR 0.82, 95% CI 0.60 - 1.10, I-2 = 25%, P = 0.19) or whether CPB was applied. Conclusions This meta-analysis revealed that DEX has an antiarrhythmic effect that decreases the incidence of VA compared to other drugs used for sedation following cardiac surgery. DEX may not have an effect on AF, but cautious interpretation should be exercised due to high heterogeneity.	[Ling, Xiaoyan] Jiaxing Univ, Affiliated Hosp 2, Outpatient Nursing Dept, Jiaxing City, Zhejiang, Peoples R China; [Zhou, Hongmei; Ni, Yunjian; Wu, Cheng; Zhang, Caijun; Zhu, Zhipeng] Jiaxing Univ, Affiliated Hosp 2, Dept Anesthesiol, Jiaxing City, Zhejiang, Peoples R China	Jiaxing University; Jiaxing University	Zhu, ZP (corresponding author), Jiaxing Univ, Affiliated Hosp 2, Dept Anesthesiol, Jiaxing City, Zhejiang, Peoples R China.	Xiaozhu781126@163.com		zhu, zhipeng/0000-0001-5575-3833	Jiaxing Science and Technology Bureau [2016BY28019]; Zhejiang Provincial Health Department [2015KYB388]	Jiaxing Science and Technology Bureau; Zhejiang Provincial Health Department	We are grateful for funding from the Jiaxing Science and Technology Bureau (grant no: 2016BY28019) and the Zhejiang Provincial Health Department (grant no: 2015KYB388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2015, J CARDIOTHOR VASC AN, V29, P396, DOI 10.1053/j.jvca.2014.05.013; Banach M, 2008, THORAC CARDIOV SURG, V56, P20, DOI 10.1055/s-2007-989249; Banach M, 2006, CIRC J, V70, P438, DOI 10.1253/circj.70.438; Banach M, 2010, CURR VASC PHARMACOL, V8, P553, DOI 10.2174/157016110791330807; [曹芳芳 Cao Fangfang], 2014, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V39, P981; Chrysostomou C, 2008, ANESTH ANALG, V107, P1514, DOI 10.1213/ane.0b013e318186499c; Chrysostomou C, 2011, ANN THORAC SURG, V92, P964, DOI 10.1016/j.athoracsur.2011.04.099; Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165; Constantin JM, 2016, ANAESTH CRIT CARE PA, V35, P7, DOI 10.1016/j.accpm.2015.06.012; Corbett SM, 2005, CRIT CARE MED, V33, P940, DOI 10.1097/01.CCM.0000162565.18193.E5; Delaney JW, 2006, J THORAC CARDIOV SUR, V131, P1296, DOI 10.1016/j.jtcvs.2006.02.010; Djaiani G, 2016, ANESTHESIOLOGY, V124, P362, DOI 10.1097/ALN.0000000000000951; El-Chami MF, 2012, J AM COLL CARDIOL, V60, P2664, DOI 10.1016/j.jacc.2012.08.1011; Ettema RGA, 2014, INT J NURS STUD, V51, P251, DOI 10.1016/j.ijnurstu.2013.05.011; Fleisher LA, 2005, CHEST, V128, p17S, DOI 10.1378/chest.128.2_suppl.17S; FOGEL RI, 2000, CRIT CARE MED S, V28; Goksedef D, 2013, TURK GOGUS KALP DAMA, V21, P594, DOI 10.5606/tgkdc.dergisi.2013.7645; GREENSPON AJ, 1991, CIRCULATION, V84, P407; Ha ACT, 2016, CURR OPIN CARDIOL, V31, P183, DOI 10.1097/HCO.0000000000000264; HAYASHI Y, 1991, ANESTHESIOLOGY, V75, P113, DOI 10.1097/00000542-199107000-00018; Heintz KM, 2005, SURG CLIN N AM, V85, P1103, DOI 10.1016/j.suc.2005.09.003; Herr DL, 2003, J CARDIOTHOR VASC AN, V17, P576, DOI 10.1016/S1053-0770(03)00200-3; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Ji FH, 2013, CIRCULATION, V127, P1576, DOI 10.1161/CIRCULATIONAHA.112.000936; Kalisnik JM, 2006, HEART SURG FORUM, V9, pE661, DOI 10.1532/HSF98.2006-1020; KAMIBAYASHI T, 1995, ANESTHESIOLOGY, V83, P992, DOI 10.1097/00000542-199511000-00013; Karaman Y, 2015, J ANESTH, V29, P522, DOI 10.1007/s00540-015-1975-2; KesharyM LO, 2015, CRITICAL CARE MED, V43, P145; Koletsis EN, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-127; Lapar DJ, 2014, ANN THORAC SURG, V98, P527, DOI 10.1016/j.athoracsur.2014.03.039; Lin YY, 2012, CRIT CARE, V16, DOI 10.1186/cc11646; Liu X, 2016, J CARDIOTHOR VASC AN, V30, P1509, DOI 10.1053/j.jvca.2016.05.038; Liu X, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1480-5; Lomivorotov VV, 2016, J CARDIOTHOR VASC AN, V30, P200, DOI 10.1053/j.jvca.2015.08.003; Maniar Parimal B, 2003, Card Electrophysiol Rev, V7, P158, DOI 10.1023/A:1027467617722; Moak JP, 2013, PACE, V36, P1156, DOI 10.1111/pace.12163; Naaz S., 2014, J CLIN DIAGN RES, V8; Nguyen Viet, 2017, Anesthesiol Clin, V35, P233, DOI 10.1016/j.anclin.2017.01.009; Ommen SR, 1997, NEW ENGL J MED, V336, P1429, DOI 10.1056/NEJM199705153362006; Peretto G, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/615987; Peterson C, 2016, J CARDIOTHOR VASC AN, V30, P1419, DOI 10.1053/j.jvca.2016.05.042; Pfammatter Jean-Pierre, 2001, Pediatr Crit Care Med, V2, P217, DOI 10.1097/00130478-200107000-00005; Pichot C, 2012, J Intensive Care Med, V27, P219, DOI 10.1177/0885066610396815; Pires LA, 2002, J CARDIOVASC ELECTR, V13, P757, DOI 10.1046/j.1540-8167.2002.00757.x; Raiten J, 2015, SEMIN CARDIOTHORAC V, V19, P122, DOI 10.1177/1089253214551283; Ren JJ, 2013, EXP THER MED, V6, P497, DOI 10.3892/etm.2013.1183; Schleifer JW, 2013, CARDIOL CLIN, V31, P595, DOI 10.1016/j.ccl.2013.07.007; Shehabi Y, 2009, ANESTHESIOLOGY, V111, P1075, DOI 10.1097/ALN.0b013e3181b6a783; Sheu R, 2016, J CARDIOTHOR VASC AN, V30, P1422, DOI 10.1053/j.jvca.2016.05.043; Tadic M, 2011, MED SCI MONITOR, V17; Talwar Sachin, 2015, Asian Cardiovasc Thorac Ann, V23, P795, DOI 10.1177/0218492315585457; The Nordic Cochrane Centre TCC, 2014, REV MAN REV MAN VERS; Ting P, 2007, ANN ACAD MED SINGAP, V36, P974; Tobias JD, 2013, PEDIATR CARDIOL, V34, P779, DOI 10.1007/s00246-013-0659-7; Ueki M, 2014, ANAESTHESIA, V69, P693, DOI 10.1111/anae.12636; Worden JC, 2014, PHARMACOTHERAPY, V34, P1167, DOI 10.1002/phar.1485; Xiang H, 2014, INFLAMMATION, V37, P1763, DOI 10.1007/s10753-014-9906-1; Yadava M, 2016, HEART FAIL CLIN, V12, P299, DOI 10.1016/j.hfc.2015.08.023; Yildirim SV, 2008, TURKISH J PEDIATR, V50, P549; Zakkar M, 2015, PHARMACOL THERAPEUT, V154, P13, DOI 10.1016/j.pharmthera.2015.06.009	60	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193303	10.1371/journal.pone.0193303	http://dx.doi.org/10.1371/journal.pone.0193303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494685	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200037
J	Zhang, MX; Wu, QQ; Chen, Y; Duan, MB; Tian, G; Deng, XB; Sun, YK; Zhou, T; Zhang, GH; Chen, WS; Chen, JX				Zhang, Mingxin; Wu, Qianqian; Chen, Yao; Duan, Mubing; Tian, Ge; Deng, Xianbo; Sun, Yankuo; Zhou, Tong; Zhang, Guihong; Chen, Weisan; Chen, Jianxin			Inhibition of proanthocyanidin A2 on porcine reproductive and respiratory syndrome virus replication in vitro	PLOS ONE			English	Article							LELYSTAD-VIRUS; ALVEOLAR MACROPHAGES; ANTIVIRAL ACTIVITY; NATURAL-PRODUCTS; UNITED-STATES; SYNDROME PRRS; IDENTIFICATION; MECHANISM; EXTRACT; RNA	Porcine reproductive and respiratory syndrome virus (PRRSV) is a widely prevalent and endemic swine pathogen that causes significant economic losses for the global pig industry annually. Currently, the most prevalent strategy for PRRSV control remains the prevention of virus transmission, with highly effective therapeutic agents and vaccines still lacking. Proanthocyanidin A2 (PA2) belongs to the family of tea polyphenols, which have been reported to exhibit a range of biological activities including anti-oxidative, cardio-protective, anti-tumoural, anti-bacterial, anti-viral, and anti-inflammatory effects in vitro as well as in vivo. Here, we demonstrate that PA2 exhibits potent anti-viral activity against PRRSV infection in Marc-145 cells. Similar inhibitory effects were also found in porcine alveolar macrophages, the primary target cell type of PRRSV infection in pigs in vivo. For traditional type II PRRSV CH-la strain and high pathogenic GD-XH strain and GD-HD strain, PA2 exhibited broad-spectrum and comparable inhibitory activities in vitro with EC50 ranging from 2.2 to 3.2 mu g/ml. Treatment of PRRSV-infected Marc-145 cells with PA2 significantly inhibited viral RNA synthesis, viral protein expression and progeny virus production in a dose-dependent manner. In addition, PA2 treatment reduced gene expressions of cytokines (TNF-alpha, IFN-alpha, IL-1(3 and IL-6) induced by PRRSV infection in PAMs. Mechanistically, PA2 inhibited PRRSV replication by targeting multiple pathways including blockade of viral entry and progeny virus release. Altogether, our findings suggest that PA2 has the potential to serve as a novel prophylactic and therapeutic strategies against PRRSV infection.	[Zhang, Mingxin; Wu, Qianqian; Tian, Ge; Deng, Xianbo; Zhou, Tong; Chen, Jianxin] South China Agr Univ, Coll Vet Med, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Guangzhou, Guangdong, Peoples R China; [Chen, Yao; Sun, Yankuo; Zhang, Guihong] South China Agr Univ, Coll Vet Med, Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China; [Duan, Mubing; Chen, Weisan] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic, Australia	South China Agricultural University; South China Agricultural University; La Trobe University	Chen, JX (corresponding author), South China Agr Univ, Coll Vet Med, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Guangzhou, Guangdong, Peoples R China.; Zhang, GH (corresponding author), South China Agr Univ, Coll Vet Med, Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou, Guangdong, Peoples R China.; Chen, WS (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic, Australia.	guihongzh@scau.edu.cn; Weisan.Chen@latrobe.edu.au; jxchen@scau.edu.cn	Chen, Weisan/E-7828-2012	Chen, Weisan/0000-0002-5221-9771	National Natural Science Foundation of China [31572565, 30972217]; National Key Research and Development Program of China [2016YFD0501300, 2017YFD0501404]; Natural Science Foundation of Guangdong Province [2015A030313399]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (Grant No: 31572565, 30972217), the National Key Research and Development Program of China (Grant No: 2016YFD0501300, 2017YFD0501404) and the Natural Science Foundation of Guangdong Province (Grant No: 2015A030313399), all to JC.	Ahmad SF, 2014, INFLAMMATION, V37, P500, DOI 10.1007/s10753-013-9764-2; Ait-Ali T, 2007, VIRAL IMMUNOL, V20, P105, DOI 10.1089/vim.2006.0078; Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X; Baum A, 2010, AMINO ACIDS, V38, P1283, DOI 10.1007/s00726-009-0374-0; Charerntantanakul Wasin, 2012, World J Virol, V1, P23, DOI 10.5501/wjv.v1.i1.23; Cheng Hua-Yew, 2002, Antivir Chem Chemother, V13, P223; Cheng HY, 2005, J SCI FOOD AGR, V85, P10, DOI 10.1002/jsfa.1958; CONZELMANN KK, 1993, VIROLOGY, V193, P329, DOI 10.1006/viro.1993.1129; Dea S, 1995, Adv Exp Med Biol, V380, P95; Duan EZ, 2015, ANTIVIR RES, V120, P122, DOI 10.1016/j.antiviral.2015.06.001; Duan X, 1997, VET MICROBIOL, V56, P9, DOI 10.1016/S0378-1135(96)01347-8; Fine A M, 2000, Altern Med Rev, V5, P144; Fink Ryan C., 2009, Antiviral Chemistry & Chemotherapy, V19, P243; Gallina L, 2011, ANTIVIR RES, V92, P447, DOI 10.1016/j.antiviral.2011.10.004; Gescher K, 2011, J ETHNOPHARMACOL, V134, P468, DOI 10.1016/j.jep.2010.12.038; GREIG A, 1975, ARCH VIROL, V47, P287, DOI 10.1007/BF01317816; Guo CH, 2017, VET MICROBIOL, V201, P231, DOI 10.1016/j.vetmic.2017.01.033; Hanada K, 2005, MOL BIOL EVOL, V22, P1024, DOI 10.1093/molbev/msi089; Iwasawa A, 2009, BIOCONTROL SCI, V14, P107, DOI 10.4265/bio.14.107; Jiang X, 2017, BRAIN RES BULL, V135, P40, DOI 10.1016/j.brainresbull.2017.09.010; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Khatun A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0330-z; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kim WI, 2008, J CLIN MICROBIOL, V46, P1758, DOI 10.1128/JCM.01927-07; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Lee SM, 2005, VIROLOGY, V342, P47, DOI 10.1016/j.virol.2005.07.034; Li WG, 2001, ACTA PHARMACOL SIN, V22, P1117; Lunney JK, 2010, VIRUS RES, V154, P1, DOI 10.1016/j.virusres.2010.10.009; Luo R, 2011, ANTIVIR RES, V91, P99, DOI 10.1016/j.antiviral.2011.04.017; Ma SC, 2002, J ETHNOPHARMACOL, V79, P205, DOI 10.1016/S0378-8741(01)00389-0; Maldonado PD, 2005, J AGR FOOD CHEM, V53, P1996, DOI 10.1021/jf0483725; Mardassi H, 1996, VIROLOGY, V221, P98, DOI 10.1006/viro.1996.0356; MENG XJ, 1994, J GEN VIROL, V75, P1795, DOI 10.1099/0022-1317-75-7-1795; Meulenberg JJM, 1996, VIROLOGY, V225, P44, DOI 10.1006/viro.1996.0573; MEULENBERG JJM, 1995, VIROLOGY, V206, P155, DOI 10.1016/S0042-6822(95)80030-1; MEULENBERG JJM, 1993, J GEN VIROL, V74, P1697, DOI 10.1099/0022-1317-74-8-1697; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Murtaugh MP, 1996, VET IMMUNOL IMMUNOP, V54, P45, DOI 10.1016/S0165-2427(96)05698-X; Nauwynck HJ, 1999, J GEN VIROL, V80, P297, DOI 10.1099/0022-1317-80-2-297; NELSON EA, 1993, J CLIN MICROBIOL, V31, P3184, DOI 10.1128/JCM.31.12.3184-3189.1993; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Opriessnig T, 2011, ANTIVIR RES, V91, P36, DOI 10.1016/j.antiviral.2011.04.012; Qiao SL, 2011, VET MICROBIOL, V149, P213, DOI 10.1016/j.vetmic.2010.11.006; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh RP, 2004, INT J CANCER, V108, P733, DOI 10.1002/ijc.11620; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Song J, 2010, VIRUS GENES, V41, P241, DOI 10.1007/s11262-010-0507-2; Sun N, 2012, J ASIAN NAT PROD RES, V14, P721, DOI 10.1080/10286020.2012.685727; Sun Y, 2012, VIRUSES-BASEL, V4, P424, DOI 10.3390/v4040424; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; Wang LL, 2014, ANTIVIR RES, V105, P39, DOI 10.1016/j.antiviral.2014.02.010; Xie JX, 2013, MICROB PATHOGENESIS, V63, P30, DOI 10.1016/j.micpath.2013.05.013; Xu XY, 2010, J AGR FOOD CHEM, V58, P11667, DOI 10.1021/jf1033202; Xu Y, 2010, PHARMACOL BIOCHEM BE, V94, P447, DOI 10.1016/j.pbb.2009.10.007; YAMADA H, 1991, CURR OPIN BIOTECH, V2, P203, DOI 10.1016/0958-1669(91)90011-S; Yang Q, 2013, ANTIVIR RES, V97, P66, DOI 10.1016/j.antiviral.2012.11.004	57	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193309	10.1371/journal.pone.0193309	http://dx.doi.org/10.1371/journal.pone.0193309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489892	Green Published, gold, Green Submitted			2022-12-27	WOS:000426276000064
J	Heritage, B; Rees, CS; Hegney, DG				Heritage, Brody; Rees, Clare S.; Hegney, Desley G.			The ProQOL-21: A revised version of the Professional Quality of Life (ProQOL) scale based on Rasch analysis	PLOS ONE			English	Article							SECONDARY TRAUMATIC STRESS; COMPASSION FATIGUE; NURSES; EMBEDDEDNESS; SATISFACTION; BURNOUT	The Professional Quality of Life scale is a measure intended to provide practitioners and researchers with an indication of a caring professional's compassion satisfaction, burnout, and secondary traumatic stress. While this measure has been used extensively in nursing research, owing to the relevancy of patient-care associated satisfaction and fatigue within this profession, information regarding the construct validity of this measure is less well represented in the literature. We examined the construct validity of the Professional Quality of Life scale using a Rasch analysis procedure on each of its three scales, as a means of substantiating their measurement adequacy. Responses on the Professional Quality of Life scale from 1615 registered nurses (age (x) over bar =46.48 years, SD = 11.78) were analysed. While support for the measurement adequacy (invariance, person/item fit, and unidimensionality) of the compassion satisfaction scale was found, the burnout and secondary traumatic stress scales did not demonstrate adequate measurement properties. We instead present an alternative measurement model of these subscales, involving items from each, to form a robust measure of compassion fatigue, and provide recoding, scoring, and normed scores for both measures. Our findings indicate that use of the Professional Quality of Life scale's burnout and secondary traumatic stress scales may require caution, while our revised compassion satisfaction and fatigue scales provide robust measurement options for practitioners and researchers.	[Heritage, Brody] Murdoch Univ, Sch Psychol & Exercise Sci, Perth, WA, Australia; [Rees, Clare S.] Curtin Univ, Sch Psychol, Perth, WA, Australia; [Hegney, Desley G.] Cent Queensland Univ, Res Div, Brisbane, Qld, Australia; [Hegney, Desley G.] Univ Adelaide, Sch Nursing, Adelaide, SA, Australia	Murdoch University; Curtin University; Central Queensland University; University of Adelaide	Heritage, B (corresponding author), Murdoch Univ, Sch Psychol & Exercise Sci, Perth, WA, Australia.	b.heritage@murdoch.edu.au	Heritage, Brody/AAZ-3501-2021; Hegney, Desley/U-8004-2019; Heritage, Brody/AAY-5111-2021	Heritage, Brody/0000-0002-6437-7232; Hegney, Desley/0000-0003-1267-1760; Heritage, Brody/0000-0002-6437-7232				Australian Institute of Health and Welfare, 2017, NURS MIDW WORKF AIHW; Bond T. G., 2015, APPL RASCH MODEL FUN; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Bride BE, 2007, CLIN SOC WORK J, V35, P155, DOI 10.1007/s10615-007-0091-7; Burtson PL, 2010, J ADV NURS, V66, P1819, DOI 10.1111/j.1365-2648.2010.05336.x; Chang SJ, 2010, J INT BUS STUD, V41, P178, DOI 10.1057/jibs.2009.88; Cho E, 2015, ORGAN RES METHODS, V18, P207, DOI 10.1177/1094428114555994; Duarte J, 2016, INT J NURS STUD, V60, P1, DOI 10.1016/j.ijnurstu.2016.02.015; Figley C.R., 1995, COMPASSION FATIGUE C, DOI 10.1192/bjp.bp.114.150078; Galiana L, 2017, J PAIN SYMPTOM MANAG, V53, P598, DOI 10.1016/j.jpainsymman.2016.09.014; Hagquist C, 2006, ACSPRI SOC SCI METH; Hegney DG, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01613; Hooper C, 2010, J EMERG NURS, V36, P420, DOI 10.1016/j.jen.2009.11.027; Jennings FL, 2017, INTENS CRIT CARE NUR, V40, P35, DOI 10.1016/j.iccn.2017.01.002; Komachi MH, 2012, INT J NURS PRACT, V18, P155, DOI 10.1111/j.1440-172X.2012.02014.x; Linacre J., 1994, RASCH MEASUREMENT T, V7, P328; Linacre JM, 2016, USERS GUIDE WINSTEPS; Linacre John M, 2002, J Appl Meas, V3, P85; Malach-Pines A., 2005, INT J BIORESOUR STRE, V12, P78, DOI [10.1037/1072-5245.12.1.78, DOI 10.1037/1072-5245.12.1.78]; Meadors P, 2009, OMEGA-J DEATH DYING, V60, P103, DOI 10.2190/OM.60.2.a; Ng TWH, 2012, J APPL PSYCHOL, V97, P1233, DOI 10.1037/a0029089; Rasch G., 1960, PROBABILISTIC MODELS; Ray S.L., 2013, TRAUMATOLOGY, V19, P255, DOI [DOI 10.1177/1534765612471144, 10.1177/1534765612471144]; Rees CS, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01072; Samson T, 2016, J PAIN SYMPTOM MANAG, V52, P575, DOI 10.1016/j.jpainsymman.2016.03.019; Sawatzky JAV, 2012, J NURS MANAGE, V20, P696, DOI 10.1111/j.1365-2834.2012.01355.x; Smith AB, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-33; Stamm B.H, 2005, PROQOL MANUAL; Stamm BH, CONCISE PROQOL MANUA; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; VanGeest J, 2011, EVAL HEALTH PROF, V34, P487, DOI 10.1177/0163278711399572; Warr P, 2012, J OCCUP HEALTH PSYCH, V17, P129, DOI 10.1037/a0026859; Watts J, 2015, NURSE RES, V23, P30, DOI 10.7748/nr.23.2.30.s7; Wright BD, 1982, RATING SCALE ANAL; Yoder EA, 2010, APPL NURS RES, V23, P191, DOI 10.1016/j.apnr.2008.09.003; Zhang MA, 2012, HUM RESOUR MANAGE R, V22, P220, DOI 10.1016/j.hrmr.2012.02.004; Zwick R, 1999, J EDUC MEAS, V36, P1, DOI 10.1111/j.1745-3984.1999.tb00543.x	37	55	55	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193478	10.1371/journal.pone.0193478	http://dx.doi.org/10.1371/journal.pone.0193478			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489875	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000080
J	Mamat-Noorhidayah; Yazawa, K; Numata, K; Norma-Rashid, Y				Mamat-Noorhidayah; Yazawa, Kenjiro; Numata, Keiji; Norma-Rashid, Y.			Morphological and mechanical properties of flexible resilin joints on damselfly wings (Rhinocypha spp.)	PLOS ONE			English	Article							RUBBER-LIKE PROTEIN; NANOMECHANICAL PROPERTIES; INSECT; NANOINDENTATION; NANOSTRUCTURE	Resilin functions as an elastic spring that demonstrates extraordinary extensibility and elasticity. Here we use combined techniques, laser scanning confocal microscopy (LSCM) and scanning electron microscopy (SEM) to illuminate the structure and study the function of wing flexibility in damselflies, focusing on the genus Rhinocypha. Morphological studies using LSCM and SEM revealed that resilin patches and cuticular spikes were widespread along the longitudinal veins on both dorsal and ventral wing surfaces. Nanoindentation was performed by using atomic force microscopy (AFM), where the wing samples were divided into three sections (membrane of the wing, mobile and immobile joints). The resulting topographic images revealed the presence of various sizes of nanostructures for all sample sections. The elasticity range values were: membrane (0.04 to 0.16 GPa), mobile joint (1.1 to 2.0 GPa) and immobile joint (1.8 to 6.0 GPa). The elastomeric and glycine-rich biopolymer, resilin was shown to be an important protein responsible for the elasticity and wing flexibility.	[Mamat-Noorhidayah; Norma-Rashid, Y.] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Yazawa, Kenjiro; Numata, Keiji] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Res Div, Enzyme Res Team, Wako, Saitama, Japan	Universiti Malaya; RIKEN	Mamat-Noorhidayah (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	nhidayahm@siswa.um.edu.my	Norma-Rashid, Y/B-8028-2010; MAMAT, NOORHIDAYAH/AAK-6911-2020; Numata, Keiji/H-9751-2012	Norma-Rashid, Y/0000-0002-1450-1995; MAMAT, NOORHIDAYAH/0000-0001-5353-790X; Numata, Keiji/0000-0003-2199-7420; Yazawa, Kenjiro/0000-0001-7268-5983	International Program Associate (RIKEN, Japan); Japan Science and Technology Agency (JST) Impulsing Paradigm Change through Disruptive Technologies (ImPACT) Project; University of Malaya [PG065-2015A]	International Program Associate (RIKEN, Japan); Japan Science and Technology Agency (JST) Impulsing Paradigm Change through Disruptive Technologies (ImPACT) Project; University of Malaya(Universiti Malaya)	The study was supported by the International Program Associate (RIKEN, Japan), by Japan Science and Technology Agency (JST) Impulsing Paradigm Change through Disruptive Technologies (ImPACT) Project and by the University of Malaya Grant Numbers: PG065-2015A.	Alam P., 2014, NEW DEV POLYM COMPOS, P325; Alsteens D, 2008, PFLUG ARCH EUR J PHY, V456, P117, DOI 10.1007/s00424-007-0386-0; Andersen S. O., 1964, P1; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; Appel Esther, 2014, Zoologica (Stuttgart), V159, P1; Appel E, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046006; AZUMA A, 1985, J EXP BIOL, V116, P79; BAILEY K, 1961, BIOCHIM BIOPHYS ACTA, V48, P452, DOI 10.1016/0006-3002(61)90043-9; BORROR D. J., 1998, FIELD GUIDE INSECTS, VSecond; Burrows M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-41; Cabibbo M, 2012, MICRON, V43, P215, DOI 10.1016/j.micron.2011.07.016; Chapman RF, 2013, J CHEM INF MODEL, V5th; Ching-Hsin C, 2009, ADV MATER RES-SWITZ, V79-82, P1325, DOI 10.4028/www.scientific.net/AMR.79-82.1325; Combes SA, 2003, J EXP BIOL, V206, P2979, DOI 10.1242/jeb.00523; Costa PB, 2009, XIX IMEKO WORLD CONGRESS: FUNDAMENTAL AND APPLIED METROLOGY, PROCEEDINGS, P1028; Dirks JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043411; Donoughe S, 2011, J MORPHOL, V272, P1409, DOI 10.1002/jmor.10992; Floreano D, 2009, FLYING INSECTS AND ROBOTS, P1; Francius G, 2008, ENVIRON MICROBIOL, V10, P1344, DOI 10.1111/j.1462-2920.2007.01551.x; Ganguli R, 2010, EXP MECH, V50, P1183, DOI 10.1007/s11340-009-9316-8; Gorb SN, 1999, NATURWISSENSCHAFTEN, V86, P552, DOI 10.1007/s001140050674; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Hedrick TL, 2015, CAN J ZOOL, V93, P925, DOI 10.1139/cjz-2013-0196; Ho S, 2003, PROG AEROSP SCI, V39, P635, DOI 10.1016/j.paerosci.2003.04.001; Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006; Jongerius SR, 2010, EXP MECH, V50, P1323, DOI 10.1007/s11340-010-9411-x; JPK Instruments, 2017, DET EL MOD BIOL SAMP; Kempf M., 2000, APPL NOTE; Kim JY, 2006, J MATER RES, V21, P2975, DOI 10.1557/JMR.2006.0370; Kim WK, 2009, J THEOR BIOL, V260, P523, DOI 10.1016/j.jtbi.2009.07.015; King RJ., 2010, THESIS; Kreuz P, 2001, ANN BIOMED ENG, V29, P1054, DOI 10.1114/1.1424921; Marrocco J, 2010, ACSESS P; Matzke R, 2001, NAT CELL BIOL, V360, P7; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Mountcastle AM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0531; Neff D, 2000, ARTHROPOD STRUCT DEV, V29, P75, DOI 10.1016/S1467-8039(00)00014-1; Newman DJS., 1982, FUNCTIONAL WING MORP; Orr A.G., 2003, GUIDE DRAGONFLY BORN; Rajabi H, 2017, ACTA BIOMATER, V60, P330, DOI 10.1016/j.actbio.2017.07.034; Rajabi H, 2016, SCI REP-UK, V6, DOI 10.1038/srep39039; Rajabi H, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150610; Rajabi H, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/056003; Rajendran S, 2012, MICRON, V43, P1299, DOI 10.1016/j.micron.2011.10.017; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; RIEK EF, 1984, CAN J ZOOL, V62, P1150, DOI 10.1139/z84-166; Rockstein M., 1978, BIOCH INSECTS; Shuman DJ, 2007, MATER CHARACT, V58, P380, DOI 10.1016/j.matchar.2006.06.005; Shyy W, 2008, CAMB AERO SER, P1; Shyy W, 2010, PROG AEROSP SCI, V46, P284, DOI 10.1016/j.paerosci.2010.01.001; Song F, 2007, MAT SCI ENG A-STRUCT, V23, P281; Sun JY, 2010, IET NANOBIOTECHNOL, V4, P10, DOI 10.1049/iet-nbt.2009.0009; Sun JY, 2012, RSC ADV, V2, P12606, DOI 10.1039/c2ra21276e; Sun JY, 2007, P SPIE; Tamai M., 2007, THESIS; Tamburro AM, 2010, CHEMBIOCHEM, V11, P83, DOI 10.1002/cbic.200900460; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; van Eldijk MB, 2012, TOP CURR CHEM, V310, P71, DOI 10.1007/128_2011_205; VanLandingham MR, 2003, J RES NATL INST STAN, V108, P249, DOI 10.6028/jres.108.024; Wang Q, 2013, J APPL PHYS, V112; Wang XS, 2008, COMPOS SCI TECHNOL, V68, P186, DOI 10.1016/j.compscitech.2007.05.023; Wang ZJ, 2005, ANNU REV FLUID MECH, V37, P183, DOI 10.1146/annurev.fluid.36.050802.121940; Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006; WEISFOGH T, 1960, J EXP BIOL, V37, P889; Wootton R.J., 1991, Advances in Odonatology, V5, P153; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; WOOTTON RJ, 1981, J ZOOL, V193, P447; Wootton RJ, 1998, SCIENCE, V282, P749, DOI 10.1126/science.282.5389.749; Wootton Robin J., 2008, P261; Xiao KW, 2007, ACTA MECH SINICA, V23, P281, DOI 10.1007/s10409-007-0070-9; Zhao HX, 2012, ODONATOLOGICA, V41, P161; Zhao HX, 2010, CHINESE SCI BULL, V55, P1993, DOI 10.1007/s11434-010-3253-x	72	13	13	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193147	10.1371/journal.pone.0193147	http://dx.doi.org/10.1371/journal.pone.0193147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513694	Green Published, Green Submitted, gold			2022-12-27	WOS:000426896800041
J	Wang, WX; Said, A; Wang, BQ; Qu, GG; Xu, QQ; Liu, B; Shen, ZQ				Wang, Wenxiu; Said, Abdelrahman; Wang, Baoqin; Qu, Guanggang; Xu, Qingqing; Liu, Bo; Shen, Zhiqiang			Establishment and evaluation of the goose embryo epithelial (GEE) cell line as a new model for propagation of avian viruses	PLOS ONE			English	Article							CULTURE	In this study, we report the establishment and characterization of a new epithelial cell line, goose embryonated epithelial cell line (GEE), derived from embryonic goose tissue. The purified GEE cell line can efficiently grow over 65 passages in the M199 medium supplemented with 10% fetal bovine serum at 37 degrees C. Immunofluorescence assay was used to identify purified GEE cells as epithelial cell line by detecting expression of the Keratin-18 and -19. Further characterizations demonstrated that the GEE cell line can be continuously sub-cultured with (i) a high capacity to replicate for over 65 passages, (ii) a spontaneous epithelial-like morphology, (iii) constant chromosomal features and (iv) without an evidence of converting to tumorigenic cells either in vitro or in vivo study. Moreover, the GEE cell line can be effectively transfected with plasmids expressing reporter genes of different avian viruses, such as VP3, VP1 and F of goose parvo virus (GPV), duck hepatitis virus (DHV), and Newcastle disease virus (NDV), respectively. Finally, the established GEE cell line was evaluated for avian viruses infection susceptibility. Our results showed that the tested GPV, DHAV and NDV were capable to replicate in the new cell line with titers a comparatively higher to the ones detected in the traditional culture system. Accordingly, our established GEE cell line is apparently a suitable in vitro model for transgenic, and infection manipulation studies.	[Wang, Wenxiu; Qu, Guanggang; Xu, Qingqing; Shen, Zhiqiang] Anim Sci & Vet Med Acad, Binzhou, Shandong, Peoples R China; [Wang, Wenxiu; Liu, Bo; Shen, Zhiqiang] Shandong Lvdu Biosci & Technol Co Ltd, Binzhou, Shandong, Peoples R China; [Said, Abdelrahman] Natl Res Ctr, Parasitol & Anim Dis Dept, Giza, Egypt; [Wang, Baoqin] Binzhou Univ, Sch Bioengn, Binzhou, Peoples R China; [Said, Abdelrahman] Univ Saskatchewan, Vaccine & Infect Dis Org VIDO, Saskatoon, SK, Canada	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Binzhou University; University of Saskatchewan	Wang, WX; Shen, ZQ (corresponding author), Anim Sci & Vet Med Acad, Binzhou, Shandong, Peoples R China.; Wang, WX; Shen, ZQ (corresponding author), Shandong Lvdu Biosci & Technol Co Ltd, Binzhou, Shandong, Peoples R China.	wwx1997@126.com; bzshenzq@163.com	Said, Abdelrahman/AAL-2522-2020	Said, Abdo/0000-0002-3960-6670	Shandong research awards for outstanding Young and Middle-aged Scientist [BS2011SW026, ZR2016CB32]; Animal Science & Veterinary Medicine Academy; Shandong Lvdu Bio-Sciences &Technology Co. Ltd.; Shandong research awards for outstanding Young and Middle-aged Scientist of People's Republic of China [BS2011SW026, ZR2016CB32]	Shandong research awards for outstanding Young and Middle-aged Scientist; Animal Science & Veterinary Medicine Academy; Shandong Lvdu Bio-Sciences &Technology Co. Ltd.; Shandong research awards for outstanding Young and Middle-aged Scientist of People's Republic of China	This work was supported by Shandong research awards for outstanding Young and Middle-aged Scientist (BS2011SW026) and ZR2016CB32. Authors WW, GQ, QX, and ZS received support in the form of salaries from the Animal Science & Veterinary Medicine Academy. Authors BL received support in the form of salaries from Shandong Lvdu Bio-Sciences &Technology Co. Ltd. Authors WW and ZS have a part-time job in the Shandong Lvdu Bio-Sciences &Technology Co. Ltd beside their main job in Animal Science & Veterinary Medicine Academy. The specific roles of each authors are articulated in the author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Shandong research awards for outstanding Young and Middle-aged Scientist (BS2011SW026) and ZR2016CB32 of People's Republic of China. We thank Dr. Suresh Tikoo for the gift of the pCDNA-HA that we used in this study. We are grateful my colleague Dr. Li Shuguang, Miao Lizhong, and Zhang Songlin for excellent technical assistance.	Ahamed T., 2004, International Journal of Poultry Science, V3, P153; Aldarmahi Ahmed, 2017, J Microsc Ultrastruct, V5, P105, DOI 10.1016/j.jmau.2016.07.004; ALEXANDER DJ, 2012, THE VETERINARY RECOR; BEUG H, 1977, EXP CELL RES, V107, P417, DOI 10.1016/0014-4827(77)90363-9; BLOOM SE, 1969, J HERED, V60, P35, DOI 10.1093/oxfordjournals.jhered.a107925; CRISSMAN HA, 2010, CYTOMETRY, V1002, P84; DORMITZER PR, 1959, HUMAN VACCINES IMMUN; FU Y, 2012, JOURNAL OF VIROLOGIC, V5, P4; FUCHS E, 1988, TRENDS GENET, V4, P277, DOI 10.1016/0168-9525(88)90169-2; GEY GO, 1974, EXP CELL RES, V84, P63, DOI 10.1016/0014-4827(74)90380-2; HARDY CT, 1995, VIROLOGY, V1405, P5225; HU H, 1936, PLOS ONE; JAT PS, 1981, CELL; JELKMANN W, 1988, CELL TISSUE RES, V252, P429; KAMBARA H, 2011, JOURNAL OF VIROLOGY; Kong BW, 2007, VIRUS RES, V127, P106, DOI 10.1016/j.virusres.2007.03.028; Li Q, 2017, ANIM CELLS SYST, V21, P233, DOI 10.1080/19768354.2017.1354915; Mehrabanpour M. J., 2007, Archives of Razi Institute, V62, P7; MELIXETIAN MB, 1989, HYBRIDOMA; Meszaros I, 2014, AVIAN PATHOL, V43, P379, DOI 10.1080/03079457.2014.939941; QUARONI A, 1931, THE JOURNAL OF BIOLO; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROBERTSON JS, 1995, VACCINE, V13, P1583, DOI 10.1016/0264-410X(95)00085-F; Rzeski W, 2003, AN APPLICATION OF TH, P261; SAID A, 2008, VIROLOGY JOURNAL; SCHNEIDE.H, 1965, EXP CELL RES, V39, P631, DOI 10.1016/0014-4827(65)90066-2; SKINNER BM, 1957, BMC GENOMICS; SVOBODA KK, 2010, DEV DYNAM, V1002, P1637; Wang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110916; WANG W, 2015, VIRUS RESEARCH, V12, P21; WONG SS, 2012, CMR; YAMANO S, 2002, MOLECULAR BIOTECHNOL; ZIPPEL R, 2012, CYTOMETRY	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193876	10.1371/journal.pone.0193876	http://dx.doi.org/10.1371/journal.pone.0193876			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494688	gold, Green Submitted, Green Published			2022-12-27	WOS:000426363200098
J	Zhou, J; Zhang, ZP; Zhang, YC; Wei, Y; Jiang, ZP				Zhou, Jian; Zhang, Zhaopei; Zhang, Yichuan; Wei, Yuan; Jiang, Zeping			Effects of lead stress on the growth, physiology, and cellular structure of privet seedlings	PLOS ONE			English	Article							CHLOROPHYLL-A FLUORESCENCE; HEAVY-METAL; ROBINIA-PSEUDOACACIA; PHOTOSYNTHESIS; TOXICITY; ROOT; L.; ULTRASTRUCTURE; ACCUMULATION; MORPHOLOGY	In this study, we investigated the effects of different lead (Pb) concentrations (0, 200, 600, 1000, 1400 mg kg(-1) soil) on the growth, ion enrichment in the tissues, photosynthetic and physiological characteristics, and cellular structures of privet seedlings. We observed that with the increase in the concentrations of Pb, the growth of privet seedlings was restricted, and the level of Pb ion increased in the roots, stem, and leaves of the seedlings; however, most of the ions were concentrated in the roots. Moreover, a decreasing trend was observed for chlorophyll a, chlorophyll b, total chlorophyll, net photosynthesis (Pn), transpiration rate (Tr), stomatal conductance (Gs), sub-stomatal CO2 concentration (Ci), maximal photochemical efficiency (Fv/Fm), photochemical quenching (qP), and quantum efficiency of photosystem II (Phi PSII). In contrast, the carotene levels, minimum fluorescence (F-0), and non-photochemical quenching (qN) showed an increasing trend. Under Pb stress, the chloroplasts were swollen and deformed, and the thylakoid lamellae were gradually expanded, resulting in separation from the cell wall and eventual shrinkage of the nucleus. Using multiple linear regression analysis, we found that the content of Pb in the leaves exerted the maximum effect on the seedling growth. We observed that the decrease in photosynthetic activation energy, increase in pressure because of the excess activation energy, and decrease in the transpiration rate could result in maximum effect on the photosynthetic abilities of the seedlings under Pb stress. Our results should help in better understanding of the effects of heavy metals on plants and in assessing their potential for use in bioremediation.	[Zhou, Jian; Zhang, Yichuan] Henan Inst Sci & Technol, Sch Hort & Landscape Architecture, Xinxiang, Henan, Peoples R China; [Zhou, Jian; Wei, Yuan; Jiang, Zeping] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China; [Zhang, Zhaopei] Henan Inst Sci & Technol, Expt Ctr, Xinxiang, Henan, Peoples R China	Henan Institute of Science & Technology; Chinese Academy of Forestry; Research Institute of Forestry, CAF; Henan Institute of Science & Technology	Jiang, ZP (corresponding author), Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China.	jiangzp@caf.ac.cn	Zhang, Yichuan/GXZ-6873-2022		National Science & Technology Pillar Program; Research Institute of Forestry Chinese Academy of Forestry [2015BAD07B0103]; School of Horticulture and Landscape Architecture, Henan Institute of Science and Technology [162102110133, 162102310088]	National Science & Technology Pillar Program; Research Institute of Forestry Chinese Academy of Forestry; School of Horticulture and Landscape Architecture, Henan Institute of Science and Technology	This work was supported by: National Science & Technology Pillar Program during the 12th Five-Year Plan Period and the Research Institute of Forestry Chinese Academy of Forestry (http://www.most.gov.cn/) 2015BAD07B0103 to ZJ; and School of Horticulture and Landscape Architecture, Henan Institute of Science and Technology (http://www.hnkjt.gov.cn/) 162102110133 to JZ and 162102310088 to YZ.	Adams WW, 2001, PHOTOSYNTH RES, V67, P51, DOI 10.1023/A:1010688528773; Ahmad MSA, 2011, BIOL TRACE ELEM RES, V144, P1229, DOI 10.1007/s12011-011-9099-5; Akinci IE, 2010, AFR J AGR RES, V5, P416; Arya SK, 2013, NUCLEUS CALCUTTA, V56, P183, DOI 10.1007/s13237-013-0099-z; Bai XY, 2015, BIOL PLANTARUM, V59, P163, DOI 10.1007/s10535-014-0476-8; Bruno Gloria, 2007, Bol. Soc. Argent. Bot., V42, P231; Chen FC, 2016, HUNAN FORESTRY SCI T, V43, P64; Chen YiTai, 2012, Scientia Silvae Sinicae, V48, P22; CUNNINGHAM SD, 1995, TRENDS BIOTECHNOL, V13, P393, DOI 10.1016/S0167-7799(00)88987-8; Dabrowski P, 2015, ZEMDIRBYSTE, V102, P305; Dahmani-Muller H, 2000, ENVIRON POLLUT, V109, P231, DOI 10.1016/S0269-7491(99)00262-6; Fei F, 2006, J YUEYANG VOCATIONAL, V21, P61; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Huang Hua, 2008, Scientia Silvae Sinicae, V44, P145; Islam E, 2007, J HAZARD MATER, V147, P806, DOI 10.1016/j.jhazmat.2007.01.117; Jiang WS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-40; Jiao WT, 2012, ENVIRON POLLUT, V168, P44, DOI 10.1016/j.envpol.2012.03.052; Kang Wei, 2014, Journal of Plant Resources and Environment, V23, P78, DOI 10.3969/j.issn.1674-7895.2014.01.12; Kodera H, 2008, ANAL SCI, V24, P1545, DOI 10.2116/analsci.24.1545; Kopittke PM, 2007, ENVIRON POLLUT, V150, P280, DOI 10.1016/j.envpol.2007.01.011; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI 10.1515/9783110434330-015; Lamhamdi M, 2013, SAUDI J BIOL SCI, V20, P29, DOI 10.1016/j.sjbs.2012.09.001; Lamhamdi M, 2011, CR BIOL, V334, P118, DOI 10.1016/j.crvi.2010.12.006; Li CL, 2010, POLLUTION EVALUATION; [李贵 Li Gui], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P61; Li X, 2012, SCI WORLD J, DOI 10.1100/2012/936149; [李亚斌 Li Yabin], 2007, [电工技术学报, Transactions of China Electrotechnical Society], V22, P84; Li Y, 2007, P INT COMP SOFTW APP, P71; Li Zhi, 2004, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V30, P546; Liu Jian, 2007, Xibei Zhiwu Xuebao, V27, P2024; Liu Ying, 2016, Acta Prataculturae Sinica, V25, P254; Monfared SH, 2013, J FORESTRY RES, V24, P391, DOI 10.1007/s11676-012-0313-x; Ogwuegbu M.O.C., 2005, J ENV, V1, P66; OQUIST G, 1993, PLANTA, V189, P150, DOI 10.1007/BF00201355; Ragab GA, 2014, EGYPTIAN SOC EXPT BI, V10, P37; Rossini Oliva S, 2004, ENVIRON MONIT ASSESS, V96, P221, DOI 10.1023/B:EMAS.0000031729.62970.fa; Santos RW, 2015, PROTOPLASMA, V252, P1203, DOI 10.1007/s00709-014-0751-8; Segui SJ, 2005, PLANTA, V223, P223; Seregin IV, 2008, RUSS J PLANT PHYSL+, V55, P1, DOI 10.1134/S1021443708010019; Seregin IV, 2004, RUSS J PLANT PHYSL+, V51, P525, DOI 10.1023/B:RUPP.0000035747.42399.84; Shi Xiang, 2016, Forest Research, V29, P147; Tuba Z, 2010, CURR SCI INDIA, V98, P1505; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Winska-Krysiak M, 2015, J ELEMENTOL, V20, P491, DOI 10.5601/jelem.2014.19.4.721; Xu S, 2008, SCI CHINA SER C, V51, P827, DOI 10.1007/s11427-008-0112-y; Yan ZZ, 2011, MAR POLLUT BULL, V63, P438, DOI 10.1016/j.marpolbul.2011.04.027; Yang YR, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0145726, 10.1371/journal.pone.0120482]; [张富运 Zhanh Fuyun], 2012, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V32, P92; Zhou J, 2017, ENVIRON SCI POLLUT R, V24, P10718, DOI 10.1007/s11356-017-8713-2	50	58	63	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0191139	10.1371/journal.pone.0191139	http://dx.doi.org/10.1371/journal.pone.0191139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494617	Green Submitted, Green Published, gold			2022-12-27	WOS:000426363200005
J	Zhang, R; Ji, QL; Han, DL; Wan, HJ; Li, XJ; Luo, G; Xue, SL; Ma, SS; Yang, MM; Li, JQ				Zhang, Rui; Ji, Qiaoli; Han, Dianlei; Wan, Haijin; Li, Xiujuan; Luo, Gang; Xue, Shuliang; Ma, Songsong; Yang, Mingming; Li, Jianqiao			Phalangeal joints kinematics in ostrich (Struthio camelus) locomotion on sand	PLOS ONE			English	Article							BIPEDAL LOCOMOTION; MECHANICS; RATITES; SPEED; BIRDS	In ostriches, the toes are the only body parts that contact loose sand surfaces. Thus, toe interphalangeal joint motions may play vital biomechanical roles. However, there is little research on ostrich phalangeal joint movements while walking or running on sand. The results from the three-dimensional motion track analysis system Simi Motion show that gait pattern has no significant effect on the key indicators (angles at touch-down, mid-stance, liftoff and range of motion) of the toe joint angles. The motion of the toe phalanges when walking and running on sand is basically the same. The ground medium is the key factor that changes the toe postures adopted by ostriches during the stance phase in slow to fast locomotion. The 3rd toe and the 4th toe are connected by the interphalangeal ligament, and the motions of the MTP3 and MTP4 joints are highly synchronized on a loose sand substrate. The 3rd toe and 4th toe are coupled to maintain static balance in slow locomotion and dynamic balance in fast locomotion. In addition, the gait pattern has a marked effect on the range of forward displacement of the toenail (Y-TN). The ostrich toenail plays an important role in preventing slip and provides traction at push-off in a sandy environment. The metatarsophalangeal joint plays an important role in energy saving during fast locomotion on loose sand substrates. Simulation reveals that the particle velocity field, particle force field and sand particle disturbance in the running gait are denser than those in the walking gait.	[Zhang, Rui; Ji, Qiaoli; Han, Dianlei; Wan, Haijin; Li, Xiujuan; Luo, Gang; Xue, Shuliang; Ma, Songsong; Yang, Mingming; Li, Jianqiao] Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun, Jilin, Peoples R China	Jilin University	Zhang, R (corresponding author), Jilin Univ, Key Lab Bion Engn, Minist Educ, Changchun, Jilin, Peoples R China.	zhangrui@jlu.edu.cn		Zhang, Rui/0000-0001-9933-2475	National Natural Science Foundation of China [51675221, 51275199]; Science and Technology Development Planning Project of Jilin Province of China [20180101077JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning Project of Jilin Province of China	This study was supported by: the National Natural Science Foundation of China 51675221, the National Natural Science Foundation of China 51275199, and the Science and Technology Development Planning Project of Jilin Province of China 20180101077JC.	Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; ALEXANDER RM, 1979, J ZOOL, V187, P169; Deeming D. C., 2003, OSTRICH BIOL PRODUCT; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; El-Gendy SAA, 2012, VET RES COMMUN, V36, P129, DOI 10.1007/s11259-012-9522-1; Falkingham PL, 2014, P NATL ACAD SCI USA, V111, P18279, DOI 10.1073/pnas.1416252111; FOWLER ME, 1991, J ZOO WILDLIFE MED, V22, P204; Fung YC., 2013, BIOMECHANICS MECH PR; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Li C, 2013, SCIENCE, V339, P1408, DOI 10.1126/science.1229163; Li C, 2012, J EXP BIOL, V215, P3293, DOI 10.1242/jeb.061937; Rubenson J, 2004, P ROY SOC B-BIOL SCI, V271, P1091, DOI 10.1098/rspb.2004.2702; Rubenson J, 2007, J EXP BIOL, V210, P2548, DOI 10.1242/jeb.02792; Rubenson J, 2011, J R SOC INTERFACE, V8, P740, DOI 10.1098/rsif.2010.0466; Rui Z., 2017, PEERJ, V5, pe2587; Schache AG, 2011, MED SCI SPORT EXER, V43, P1260, DOI 10.1249/MSS.0b013e3182084929; Schaller NU, 2009, J ANAT, V214, P830, DOI 10.1111/j.1469-7580.2009.01083.x; Schaller NU, 2011, J EXP BIOL, V214, P1123, DOI 10.1242/jeb.043596; Stoessel A, 2012, J EXP BIOL, V215, P4055, DOI 10.1242/jeb.070458; WILLIAMS JB, 1993, ECOLOGY, V74, P390, DOI 10.2307/1939301; Zeng, 2014, THESIS; [张锐 Zhang Rui], 2017, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V48, P49	22	7	7	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0191986	10.1371/journal.pone.0191986	http://dx.doi.org/10.1371/journal.pone.0191986			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489844	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000015
J	Pak, K; Kim, K; Kim, MH; Eom, JS; Lee, MK; Cho, JS; Kim, YS; Kim, BS; Kim, SJ; Kim, IJ				Pak, Kyoungjune; Kim, Keunyoung; Kim, Mi-Hyun; Eom, Jung Seop; Lee, Min Ki; Cho, Jeong Su; Kim, Yun Seong; Kim, Bum Soo; Kim, Seong Jang; Kim, In Joo			A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT	PLOS ONE			English	Article							DIAGNOSIS; CT	We aimed to develop a decision tree model to improve diagnostic performance of positron emission tomography/computed tomography (PET/CT) to detect metastatic lymph nodes (LN) in non-small cell lung cancer (NSCLC). 115 patients with NSCLC were included in this study. The training dataset included 66 patients. A decision tree model was developed with 9 variables, and validated with 49 patients: short and long diameters of LNs, ratio of short and long diameters, maximum standardized uptake value (SUVmax) of LN, mean houns-field unit, ratio of LN SUVmax and ascending aorta SUVmax (LN/AA), and ratio of LN SUVmax and superior vena cava SUVmax. A total of 301 LNs of 115 patients were evaluated in this study. Nodular calcification was applied as the initial imaging parameter, and LN SUVmax (>= 3.95) was assessed as the second. LN/AA (>= 2.92) was required to high LN SUVmax. Sensitivity was 50% for training dataset, and 40% for validation dataset. However, specificity was 99.28% for training dataset, and 96.23% for validation dataset. In conclusion, we have developed a new decision tree model for interpreting mediastinal LNs. All LNs with nodular calcification were benign, and LNs with high LN SUVmax and high LN/AA were metastatic Further studies are needed to incorporate subjective parameters and pathologic evaluations into a decision tree model to improve the test performance of PET/CT.	[Pak, Kyoungjune; Kim, Keunyoung; Kim, In Joo] Pusan Natl Univ Hosp, Dept Nucl Med, Busan, South Korea; [Pak, Kyoungjune; Kim, Keunyoung; Kim, Mi-Hyun; Eom, Jung Seop; Lee, Min Ki; Cho, Jeong Su; Kim, In Joo] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Kim, Mi-Hyun; Eom, Jung Seop; Lee, Min Ki] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea; [Cho, Jeong Su] Pusan Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Busan, South Korea; [Kim, Yun Seong] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan, South Korea; [Kim, Yun Seong; Kim, Bum Soo; Kim, Seong Jang] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea; [Kim, Bum Soo; Kim, Seong Jang] Pusan Natl Univ, Yangsan Hosp, Dept Nucl Med, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Kim, IJ (corresponding author), Pusan Natl Univ Hosp, Dept Nucl Med, Busan, South Korea.; Kim, IJ (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.	pnuhnm@gmail.com	Pak, Kyoungjune/F-3004-2013; Pak, Kyoungjune/CAE-5230-2022	Pak, Kyoungjune/0000-0001-5051-1894	National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B03029352]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1B03029352 to KP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1B03029352).	Dwamena BA, 1999, RADIOLOGY, V213, P530, DOI 10.1148/radiology.213.2.r99nv46530; Ettinger DS, 2015, J NATL COMPR CANC NE, V13, P515, DOI 10.6004/jnccn.2015.0071; Figueroa AL, 2013, JACC-CARDIOVASC IMAG, V6, P1250, DOI 10.1016/j.jcmg.2013.08.006; Hwangbo B, 2009, CHEST, V135, P1280, DOI 10.1378/chest.08-2019; Institute NC, 2015, SEER STAT FACT SHEET; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim YN, 2012, EUR RADIOL, V22, P1537, DOI 10.1007/s00330-012-2388-3; Kim YK, 2007, CANCER-AM CANCER SOC, V109, P1068, DOI 10.1002/cncr.22518; Lee AY, 2014, NUCL MED MOLEC IMAG, V48, P41, DOI 10.1007/s13139-013-0244-2; Lee HS, 2009, ADDICT RES THEORY, V17, P622, DOI 10.3109/16066350802168613; Lee SM, 2012, EUR RADIOL, V22, P1556, DOI 10.1007/s00330-012-2395-4; Lu PO, 2014, LUNG CANCER, V85, P53, DOI 10.1016/j.lungcan.2014.04.004; Ose N, 2012, EUR J CARDIO-THORAC, V42, P89, DOI 10.1093/ejcts/ezr287; Pak K, 2015, ANN NUCL MED; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Vansteenkiste J, 2013, ANN ONCOL, V24, P89, DOI 10.1093/annonc/mdt241	16	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2018	13	2							e0193403	10.1371/journal.pone.0193403	http://dx.doi.org/10.1371/journal.pone.0193403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7BV	29486012	Green Published, Green Submitted, gold			2022-12-27	WOS:000426242400019
J	Ambe, Y; Aoi, S; Nachstedt, T; Manoonpong, P; Worgotter, F; Matsuno, F				Ambe, Yuichi; Aoi, Shinya; Nachstedt, Timo; Manoonpong, Poramate; Woergoetter, Florentin; Matsuno, Fumitoshi			Simple analytical model reveals the functional role of embodied sensorimotor interaction in hexapod gaits	PLOS ONE			English	Article							INTER-LEG COORDINATION; SELF-ORGANIZING MODEL; QUADRUPEDAL GAITS; INSECT LOCOMOTION; WALKING PATTERNS; BEHAVIOR; ORGANIZATION; DYNAMICS; MOVEMENTS; INSIGHTS	Insects have various gaits with specific characteristics and can change their gaits smoothly in accordance with their speed. These gaits emerge from the embodied sensorimotor interactions that occur between the insect's neural control and body dynamic systems through sensory feedback. Sensory feedback plays a critical role in coordinated movements such as locomotion, particularly in stick insects. While many previously developed insect models can generate different insect gaits, the functional role of embodied sensorimotor interactions in the interlimb coordination of insects remains unclear because of their complexity. In this study, we propose a simple physical model that is amenable to mathematical analysis to explain the functional role of these interactions clearly. We focus on a foot contact sensory feedback called phase resetting, which regulates leg retraction timing based on touchdown information. First, we used a hexapod robot to determine whether the distributed decoupled oscillators used for legs with the sensory feedback generate insect-like gaits through embodied sensorimotor interactions. The robot generated two different gaits and one had similar characteristics to insect gaits. Next, we proposed the simple model as a minimal model that allowed us to analyze and explain the gait mechanism through the embodied sensorimotor interactions. The simple model consists of a rigid body with massless springs acting as legs, where the legs are controlled using oscillator phases with phase resetting, and the governed equations are reduced such that they can be explained using only the oscillator phases with some approximations. This simplicity leads to analytical solutions for the hexapod gaits via perturbation analysis, despite the complexity of the embodied sensorimotor interactions. This is the first study to provide an analytical model for insect gaits under these interaction conditions. Our results clarified how this specific foot contact sensory feedback contributes to generation of insect-like ipsilateral interlimb coordination during hexapod locomotion.	[Ambe, Yuichi] Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Sci, Sendai, Miyagi, Japan; [Aoi, Shinya] Kyoto Univ, Grad Sch Engn, Dept Aeronaut & Astronaut, Kyoto, Japan; [Nachstedt, Timo; Woergoetter, Florentin] Georg August Univ Gottingen, Inst Phys 3, Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Manoonpong, Poramate] Univ Southern Denmark, Maersk Mc Kinney Moller Inst, Embodied Al & Neurorobot Lab, Ctr Biorobot, Odense M, Denmark; [Manoonpong, Poramate] Vidyasirimedhi Inst Sci & Technol, Sch Informat Sci & Technol, Bioinspired Robot & Neural Engn Lab, Rayong, Thailand; [Matsuno, Fumitoshi] Kyoto Univ, Grad Sch Engn, Dept Mech Engn & Sci, Kyoto, Japan	Tohoku University; Kyoto University; University of Gottingen; University of Southern Denmark; Vidyasirimedhi Institute of Science & Technology; Kyoto University	Ambe, Y (corresponding author), Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Sci, Sendai, Miyagi, Japan.	ambe@rm.is.tohoku.ac.jp	Manoonpong, Poramate/Y-8479-2018	Manoonpong, Poramate/0000-0002-4806-7576; Ambe, Yuichi/0000-0003-4725-5513; Matsuno, Fumitoshi/0000-0001-9685-3267	JSPS Institutional Program for Young Researcher Overseas Visits; JSPS [17H04914]; Bernstein Center for Computational Neuroscience II Goettingen (BCCN) [01GQ1005A]; Human Frontier Science Program [RGP0002/2017]; Centre for BioRobotics (CBR) at University of Southern Denmark (SDU, Denmark); HeKKSaGOn network	JSPS Institutional Program for Young Researcher Overseas Visits(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bernstein Center for Computational Neuroscience II Goettingen (BCCN); Human Frontier Science Program(Human Frontier Science Program); Centre for BioRobotics (CBR) at University of Southern Denmark (SDU, Denmark); HeKKSaGOn network	YA is supported by the JSPS Institutional Program for Young Researcher Overseas Visits, http://www.jsps.go.jp/english/e-daikokai/. SA is supported by the JSPS Grant-in-Aid for Young Scientists (A) (grant no. 17H04914), https://www.jsps.go.jp/english/e-grants/. PM and FW are supported by the Bernstein Center for Computational Neuroscience II Goettingen (BCCN grant 01GQ1005A, project D1), http://www.bccn-goettingen.de/. PM is supported by the Human Frontier Science Program (grant no. RGP0002/2017), http://www.hfsp.org/funding and the Centre for BioRobotics (CBR) at University of Southern Denmark (SDU, Denmark), https://www.sdu.dk/en/om_sdu/institutter_centre/mmmi_maersk_mckinney_moeller/forskning/forskningsprojekter. FW and FM are supported by the HeKKSaGOn network, http://www.hekksagon.net/61.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly supported by the JSPS Institutional Program for Young Researcher Overseas Visits, the HeKKSaGOn network, the JSPS Grant-in-Aid for Young Scientists (A) (grant no. 17H04914), the Bernstein Center for Computational Neuroscience II Goettingen (BCCN grant no. 01GQ1005A, project D1), the Centre for BioRobotics (CBR) at University of Southern Denmark (SDU, Denmark) and the Human Frontier Science Program (grant no. RGP0002/2017).	Akay T, 2004, J NEUROPHYSIOL, V92, P42, DOI 10.1152/jn.01271.2003; Akimoto K., 1999, Artificial Life and Robotics, V3, P102, DOI 10.1007/BF02481255; ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; Alexander RM, 2006, PRINCIPLES ANIMAL LO; Aoi S, 2017, FRONT NEUROROBOTICS, V11, DOI 10.3389/fnbot.2017.00039; Aoi S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0908; Aoi S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061909; Aoi S, 2008, ADV ROBOTICS, V22, P1697, DOI 10.1163/156855308X3689785; Arena P, 2004, IEEE T SYST MAN CY B, V34, P1823, DOI 10.1109/TSMCB.2004.828593; Bender JA, 2011, J EXP BIOL, V214, P2057, DOI 10.1242/jeb.056481; Borgmann A, 2011, BIOL CYBERN, V105, P399, DOI 10.1007/s00422-012-0473-y; Borgmann A, 2009, J NEUROSCI, V29, P2972, DOI 10.1523/JNEUROSCI.3155-08.2009; Buschges A, 2008, BRAIN RES REV, V57, P162, DOI 10.1016/j.brainresrev.2007.06.028; BUSCHGES A, 1995, J EXP BIOL, V198, P435; Buschges A, 2005, J NEUROPHYSIOL, V93, P1127, DOI 10.1152/jn.00615.2004; BUSCHGES A, 1995, J NEUROBIOL, V27, P488, DOI 10.1002/neu.480270405; Buschmann T, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/4/041001; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; CRUSE H, 1990, TRENDS NEUROSCI, V13, P15, DOI 10.1016/0166-2236(90)90057-H; CRUSE H, 1982, J EXP BIOL, V101, P161; Cruse H, 1998, NEURAL NETWORKS, V11, P1435, DOI 10.1016/S0893-6080(98)00067-7; Cruse H, 2007, PHILOS T R SOC A, V365, P221, DOI 10.1098/rsta.2006.1913; Daun-Gruhn S, 2011, J COMPUT NEUROSCI, V30, P255, DOI 10.1007/s10827-010-0254-3; Daun-Gruhn S, 2011, BIOL CYBERN, V105, P71, DOI 10.1007/s00422-011-0446-6; Delcomyn F, 2004, ANNU REV ENTOMOL, V49, P51, DOI 10.1146/annurev.ento.49.061802.123257; DELCOMYN F, 1971, J EXP BIOL, V54, P443; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037/0096-1523.21.1.183; Durr V, 2005, J EXP BIOL, V208, P2253, DOI 10.1242/jeb.01638; Durr V, 2004, ARTHROPOD STRUCT DEV, V33, P237, DOI 10.1016/j.asd.2004.05.004; Ekeberg O, 2004, ARTHROPOD STRUCT DEV, V33, P287, DOI 10.1016/j.asd.2004.05.002; Fujiki S, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012717; Fukuoka Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08169; Full RJ, 1999, J EXP BIOL, V202, P3325; Full RJ., 1997, HDB COMP PHYSL; Grabowska M, 2012, J EXP BIOL, V215, P4255, DOI 10.1242/jeb.073643; GRAHAM D, 1985, J EXP BIOL, V118, P287; GRAHAM D, 1972, J COMP PHYSIOL, V81, P23, DOI 10.1007/BF00693548; Holmes P, 2006, SIAM REV, V48, P207, DOI 10.1137/S0036144504445133; HUGHES GM, 1952, J EXP BIOL, V29, P267; Ijspeert AJ, 2014, SCIENCE, V346, P196, DOI 10.1126/science.1254486; JAYES AS, 1978, J ZOOL, V185, P289, DOI 10.1111/j.1469-7998.1978.tb03334.x; KIMURA S, 1993, BIOL CYBERN, V69, P183, DOI 10.1007/BF00198958; KIMURA S, 1994, BIOL CYBERN, V70, P505, DOI 10.1007/BF00198803; Kindermann T, 2001, ADAPT BEHAV, V9, P16, DOI 10.1177/105971230200900103; Kukillaya RP, 2007, BIOL CYBERN, V97, P379, DOI 10.1007/s00422-007-0180-2; Manoonpong P, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00012; Martius G., SOFTWARE LPZROBOTS; Owaki D, 2017, FRONT NEUROROBOTICS, V11, DOI 10.3389/fnbot.2017.00029; Owaki D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00348-9; Owaki D, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0669; Pearson K, 2006, TRENDS NEUROSCI, V29, P625, DOI 10.1016/j.tins.2006.08.007; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Rutter BL, 2007, IEEE INT CONF ROBOT, P630, DOI 10.1109/ROBOT.2007.363057; Schilling M, 2013, BIOL CYBERN, V107, P397, DOI 10.1007/s00422-013-0563-5; Schneider A, 2005, IEEE T SYST MAN CY B, V35, P1120, DOI 10.1109/TSMCB.2005.850147; SCHONER G, 1990, J THEOR BIOL, V142, P359, DOI 10.1016/S0022-5193(05)80558-2; Seipel JE, 2004, BIOL CYBERN, V91, P76, DOI 10.1007/s00422-004-0498-y; Steingrube S, 2010, NAT PHYS, V6, P224, DOI 10.1038/NPHYS1508; Szczecinski NS, 2014, BIOL CYBERN, V108, P1, DOI 10.1007/s00422-013-0573-3; Toth TI, 2016, J NEUROPHYSIOL, V115, P887, DOI 10.1152/jn.00693.2015; WILSON DM, 1966, ANNU REV ENTOMOL, V11, P103, DOI 10.1146/annurev.en.11.010166.000535; Wosnitza A, 2013, J EXP BIOL, V216, P480, DOI 10.1242/jeb.078139; XIONG XH, 2016, SYSTEMS MAN CYBERN A, V12, P1195, DOI DOI 10.1142/S1793042116500731; Xiong XF, 2014, ROBOT AUTON SYST, V62, P1777, DOI 10.1016/j.robot.2014.07.008; Zill SN, 2015, ARTHROPOD STRUCT DEV, V44, P541, DOI 10.1016/j.asd.2015.07.001; Zill SN, 2012, J NEUROPHYSIOL, V108, P1453, DOI 10.1152/jn.00274.2012	66	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192469	10.1371/journal.pone.0192469	http://dx.doi.org/10.1371/journal.pone.0192469			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489831	Green Published, Green Submitted, gold			2022-12-27	WOS:000426276000028
J	Plumper, T; Laroze, D; Neumayer, E				Pluemper, Thomas; Laroze, Denise; Neumayer, Eric			Regional inequalities in premature mortality in Great Britain	PLOS ONE			English	Article							HEALTH INEQUALITIES; UNITED-STATES; ENGLAND; INCOME; WALES; DIFFERENTIALS; IMPACT; AREAS	Premature mortality exhibits strong spatial patterns in Great Britain. Local authorities that are located further North and West, that are more distant from its political centre London and that are more urban tend to have a higher premature mortality rate. Premature mortality also tends to cluster among geographically contiguous and proximate local authorities. We develop a novel analytical research design that relies on spatial pattern recognition to demonstrate that an empirical model that contains only socio-economic variables can eliminate these spatial patterns almost entirely. We demonstrate that socioeconomic factors across local authority districts explain 81 percent of variation in female and 86 percent of variation in male premature mortality in 2012-14. As our findings suggest, policy-makers cannot hope that health policies alone suffice to significantly reduce inequalities in health. Rather, it requires strong efforts to reduce the inequalities in socio-economic factors, or living conditions for short, in order to overcome the spatial disparities in health, of which premature mortality is a clear indication.	[Pluemper, Thomas] Vienna Univ Econ & Business, Dept Socioecon, Vienna, Austria; [Laroze, Denise] Univ Santiago Chile, Ctr Expt Social Sci, Santiago, Chile; [Neumayer, Eric] London Sch Econ & Polit Sci LSE, Dept Geog & Environm, London, England	Vienna University of Economics & Business; Universidad de Santiago de Chile; University of London; London School Economics & Political Science	Plumper, T (corresponding author), Vienna Univ Econ & Business, Dept Socioecon, Vienna, Austria.	thomas.pluemper@wu.ac.at	Pluemper, Thomas/S-3241-2019; Plümper, Thomas/Q-4695-2016; Neumayer, Eric/ABF-3741-2021	Pluemper, Thomas/0000-0002-1461-0737; Plümper, Thomas/0000-0002-1461-0737; Neumayer, Eric/0000-0003-2719-7563				Acheson D., 1998, INDEPENDENT ENQUIRY; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Bambra C., 2016, HLTH DIVIDES YOU LIV; Deaton A., 2001, THEMES EC AGING, P129; Department of Health, 2003, TACKL HLTH IN PROGR; Doran T, 2004, BMJ-BRIT MED J, V328, P1043, DOI 10.1136/bmj.328.7447.1043; Duff GW, 2006, AM J CLIN NUTR, V83, p431S; Elo IT, 1996, SOC SCI MED, V42, P47, DOI 10.1016/0277-9536(95)00062-3; Gallager J., 2013, BBC NEWS; Hacking JM, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d508; Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181; Jones NR, 2013, HEALTH PLACE, V24, P90, DOI 10.1016/j.healthplace.2013.08.010; KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178; Knutsson A., 1988, SCAND J SOC MED SUPP, V44, P1; Langford IH, 1996, SOC SCI MED, V42, P897, DOI 10.1016/0277-9536(95)00188-3; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Law MR, 1998, J EPIDEMIOL COMMUN H, V52, P344, DOI 10.1136/jech.52.6.344; Mackenbach JP, 2011, J EPIDEMIOL COMMUNIT; Marmot M, 2002, HEALTH AFFAIR, V21, P31, DOI 10.1377/hlthaff.21.2.31; Marmot M., 2014, STRATEGIC REV HLTH I; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1994, DAEDALUS-US, V123, P197; MARMOT MG, 1984, LANCET, V1, P1003; Marmot M, 2014, AM J PUBLIC HEALTH, V104, pS517, DOI 10.2105/AJPH.2014.302200; Meijer M, 2012, HEALTH PLACE, V18, P391, DOI 10.1016/j.healthplace.2011.12.001; Mitchell R., 2000, INEQUALITIES LIFE DE; Muennig P., 2010, EC ED, P80; National Police Agency Traffic Bureau Traffic Planning Division, 2015, TACKL CAUS PREM MORT, P5; Neumayer E, 2016, POLIT SCI RES METH, V4, P175, DOI 10.1017/psrm.2014.40; Norman P, 2011, SOC SCI MED, V73, P1575, DOI 10.1016/j.socscimed.2011.09.034; Plumper T, 2018, JOPH IN PRESS; Plumper T, 2010, EUR J POLIT RES, V49, P418, DOI 10.1111/j.1475-6765.2009.01900.x; Reid M, 2011, B WORLD HEALTH ORGAN, V89, P706, DOI 10.2471/BLT.11.021011; Senior ML, 1998, REG STUD, V32, P265, DOI 10.1080/713693455; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; THOMAS B., 2010, BMJ, V341; van Doorslaer E, 2004, HEALTH ECON, V13, P609, DOI 10.1002/hec.918; vanDoorslaer E, 1997, J HEALTH ECON, V16, P93, DOI 10.1016/S0167-6296(96)00532-2; Wells Claudia, 2008, Health Stat Q, P6; Welsch R, 1980, REGRESSION DIAGNOSTI; Woods LM, 2005, J EPIDEMIOL COMMUN H, V59, P115, DOI 10.1136/jech.2003.013003	41	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0193488	10.1371/journal.pone.0193488	http://dx.doi.org/10.1371/journal.pone.0193488			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX7ND	29489918	Green Published, Green Accepted, gold			2022-12-27	WOS:000426276000082
J	Marlicz, W; Poniewierska-Baran, A; Rzeszotek, S; Bartoszewski, R; Skonieczna-Zydecka, K; Starzynska, T; Ratajczak, MZ				Marlicz, Wojciech; Poniewierska-Baran, Agata; Rzeszotek, Sylwia; Bartoszewski, Rafal; Skonieczna-Zydecka, Karolina; Starzynska, Teresa; Ratajczak, Mariusz Z.			A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer (Publication with Expression of Concern. See vol. 16, 2021)	PLOS ONE			English	Article; Publication with Expression of Concern							STEM/PROGENITOR CELLS EXPRESS; STIMULATING-HORMONE RECEPTOR; SEX-HORMONES; STEM-CELLS; BREAST-CANCER; RISK; GROWTH; PROLACTIN; DEGARELIX; THERAPY	Background Colorectal cancer (CRC) is a leading cause of death in the western world, and its incidence increases with patient age. It is also known that with age there occur changes in the levels of certain hormones, including an increase in the secretion of pituitary gonadotropins (PtGs) as a result of the loss of gonadal hormone feedback. We recently reported that functional PtG receptors are expressed in human lung cancer cells, rhabdomyosarcoma cells, and malignant hematopoietic stem cells. Findings Here we report for the first time that the receptors for follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are expressed in primary tumor samples isolated from CRC patients as well as in the established human CRC cell lines HTC116 and HTB37. Moreover, we also report that PtGs stimulate chemotaxis, adhesion, and proliferation of these cell lines. Conclusions Our results suggest that PtGs play an important and underappreciated role in CRC pathogenesis, and we call for further studies to better define their role in gastrointestinal malignancies and their direct effect on putative CRC cancer stem cells.	[Marlicz, Wojciech; Starzynska, Teresa] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland; [Poniewierska-Baran, Agata] Pomeranian Med Univ, Dept Physiol, Szczecin, Poland; [Poniewierska-Baran, Agata] Univ Szczecin, Fac Biol, Dept Immunol, Szczecin, Poland; [Rzeszotek, Sylwia] Pomeranian Med Univ, Dept Histol & Embryol, Szczecin, Poland; [Bartoszewski, Rafal] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland; [Skonieczna-Zydecka, Karolina] Pomeranian Med Univ, Dept Biochem & Human Nutr, Szczecin, Poland; [Ratajczak, Mariusz Z.] Univ Louisville, James Graham Brown Canc Ctr, Stem Cell Inst, Louisville, KY 40292 USA; [Ratajczak, Mariusz Z.] Warsaw Med Univ, Dept Regenerat Med, Warsaw, Poland	Pomeranian Medical University; Pomeranian Medical University; University of Szczecin; Pomeranian Medical University; Fahrenheit Universities; Medical University Gdansk; Pomeranian Medical University; University of Louisville; Medical University of Warsaw	Marlicz, W (corresponding author), Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland.; Poniewierska-Baran, A (corresponding author), Pomeranian Med Univ, Dept Physiol, Szczecin, Poland.; Poniewierska-Baran, A (corresponding author), Univ Szczecin, Fac Biol, Dept Immunol, Szczecin, Poland.	marlicz@hotmail.com; agata.poniewierska@gmail.com	Ratajczak, Mariusz Z/I-2376-2014; Poniewierska-Baran, Agata/AFQ-4324-2022; Bartoszewski, Rafal A/D-6311-2011; Skonieczna-Żydecka, Karolina/K-7252-2014; Rzeszotek, Sylwia/D-2158-2017; Starzynska, Teresa/B-1549-2015; Marlicz, Wojciech/G-5007-2013	Ratajczak, Mariusz Z/0000-0002-0071-0198; Poniewierska-Baran, Agata/0000-0001-6719-803X; Bartoszewski, Rafal A/0000-0002-2864-6757; Skonieczna-Żydecka, Karolina/0000-0002-3430-9079; Rzeszotek, Sylwia/0000-0002-2157-0315; Starzynska, Teresa/0000-0001-5573-2397; Marlicz, Wojciech/0000-0002-2649-5967	Harmonia NCN [UMO-2014/14/M/NZ3/00475]; Pomeranian Medical University, Department of Gastroenterology statutory funds	Harmonia NCN; Pomeranian Medical University, Department of Gastroenterology statutory funds	This work was partially supported by Harmonia NCN grant UMO-2014/14/M/NZ3/00475 to MZR and Pomeranian Medical University, Department of Gastroenterology statutory funds. We acknowledge Dr. Paul Todd for expert English proof reading in his native language.; This work was partially supported by Harmonia NCN grant UMO-2014/14/M/NZ3/00475 to MZR and Pomeranian Medical University, Department of Gastroenterology statutory funds (TS).	Abdelbaset-Ismail A, 2017, INT J ONCOL, V50, P317, DOI 10.3892/ijo.2016.3787; Abdelbaset-Ismail A, 2016, ONCOTARGET, V7, P3033, DOI 10.18632/oncotarget.6698; Abdelbaset-Ismail A, 2016, J CELL MOL MED, V20, P134, DOI 10.1111/jcmm.12712; Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; BELLONE G, 1995, J CELL PHYSIOL, V163, P221, DOI 10.1002/jcp.1041630202; Ben Khedher S, 2017, INT J CANCER, V141, P309, DOI 10.1002/ijc.30750; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Brusselaers N, 2017, INT J CANCER, V140, P1693, DOI 10.1002/ijc.30588; Camargo MC, 2012, CANCER EPIDEM BIOMAR, V21, P20, DOI 10.1158/1055-9965.EPI-11-0834; CESARIO TC, 1994, P SOC EXP BIOL MED, V205, P89; Chlebowski RT, 2014, STEROIDS, V90, P53, DOI 10.1016/j.steroids.2014.06.001; Clinton TN, 2017, EXPERT OPIN PHARMACO, V18, P825, DOI 10.1080/14656566.2017.1328056; Cohnheim J., 1875, VIRCHOWS ARCH, V65, P64, DOI DOI 10.1007/BF01978936; Deivaraju C, 2016, HORM MOL BIOL CLIN I, V28, P105, DOI 10.1515/hmbci-2016-0001; Feng DQ, 2017, ONCOL REP, V38, P1091, DOI 10.3892/or.2017.5784; Ferlitsch M, 2011, JAMA-J AM MED ASSOC, V306, P1352, DOI 10.1001/jama.2011.1362; Forman S, 1999, J BIOCHEM MOL TOXIC, V13, P11, DOI 10.1002/(SICI)1099-0461(1999)13:1<11::AID-JBT2>3.0.CO;2-R; Gao R, 2017, EUR J CLIN MICROBIOL; Gharwan H, 2015, ENDOCR-RELAT CANCER, V22, pR339, DOI 10.1530/ERC-14-0550; Ghiringhelli F, 2013, WORLD J GASTROENTERO, V19, P769, DOI 10.3748/wjg.v19.i5.769; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Huang WQ, 2001, LIFE SCI, V68, P1727; Huhtaniemi I, 2010, MOL CELL ENDOCRINOL, V329, P56, DOI 10.1016/j.mce.2010.04.028; Korbut E, 2012, J PHYSIOL PHARMACOL, V63, P565; Lin JH, 2013, CLIN GASTROENTEROL H, V11, P419, DOI 10.1016/j.cgh.2012.11.012; Lu YX, 2016, CANCER EPIDEMIOL, V41, P57, DOI 10.1016/j.canep.2016.01.006; Majek O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068077; Marlicz W, 2016, ONCOL REP, V36, P3635, DOI 10.3892/or.2016.5179; Sanchez AM, 2016, MOL CELL ENDOCRINOL, V437, P22, DOI 10.1016/j.mce.2016.08.009; Mierzejewska K, 2015, STEM CELLS DEV, V24, P927, DOI 10.1089/scd.2014.0546; Morch LS, 2016, EUR J EPIDEMIOL, V31, P481, DOI 10.1007/s10654-016-0116-z; Murphy N, 2017, BRIT J CANCER, V116, P117, DOI 10.1038/bjc.2016.345; Murphy N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv210; Parrott JA, 2001, MOL CELL ENDOCRINOL, V172, P213, DOI 10.1016/S0303-7207(00)00340-3; Poniewierska-Baran A, 2016, INT J ONCOL, V48, P1815, DOI 10.3892/ijo.2016.3439; Radu A, 2010, NEW ENGL J MED, V363, P1621, DOI 10.1056/NEJMoa1001283; Raica M, 2010, ANTICANCER RES, V30, P3981; Ratajczak MZ, 2017, LEUKEMIA, V31, P1671, DOI 10.1038/leu.2017.148; Ratajczak MZ, 2017, STEM CELL REV REP, V13, P443, DOI 10.1007/s12015-017-9728-2; Ratajczak MZ, 2017, CIRC RES, V120, P166, DOI 10.1161/CIRCRESAHA.116.309362; Ratajczak MZ, 2016, POL ARCH MED WEWN, V126, P879, DOI 10.20452/pamw.3644; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rennert G., 2016, BRIT J CANCER, V116, P1; Rick FG, 2015, UROL ONCOL-SEMIN ORI, V33, P270, DOI 10.1016/j.urolonc.2014.11.006; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Sayyid RK, 2017, CLIN CANCER RES, V23, P1974, DOI 10.1158/1078-0432.CCR-16-1790; Schernhammer ES, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3438; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siraj A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-246; Soto AM, 2004, BIOESSAYS, V26, P1097, DOI 10.1002/bies.20087; Szarynska M, 2016, POSTEP HIG MED DOSW, V70, P1469, DOI 10.5604/17322693.1227897; Szepeshazi K, 2007, INT J ONCOL, V30, P1485; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tripathy M, 2017, STEROIDS, V128, P23, DOI 10.1016/j.steroids.2017.10.005; VIRCHOW R, 1855, ARCH PATHOLOGISCHE A, V8, P23; Wang X, 2017, FREE RADICAL BIO MED, V105, P3, DOI 10.1016/j.freeradbiomed.2016.10.504; Wu S, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1143079; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166	59	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0189337	10.1371/journal.pone.0189337	http://dx.doi.org/10.1371/journal.pone.0189337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494614	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200001
J	Anderson, KB; Simasathien, S; Watanaveeradej, V; Weg, AL; Ellison, DW; Suwanpakdee, D; Klungthong, C; Phonpakobsin, T; Kerdpanich, P; Phiboonbanakit, D; Gibbons, RV; Fernandez, S; Macareo, LR; Yoon, IK; Jarman, RG				Anderson, Kathryn B.; Simasathien, Sriluck; Watanaveeradej, Veerachai; Weg, Alden L.; Ellison, Damon W.; Suwanpakdee, Detchvijitr; Klungthong, Chonticha; Phonpakobsin, Thipwipha; Kerdpanich, Phirangkul; Phiboonbanakit, Danabhand; Gibbons, Robert V.; Fernandez, Stefan; Macareo, Louis R.; Yoon, In-Kyu; Jarman, Richard G.			Clinical and laboratory predictors of influenza infection among individuals with influenza-like illness presenting to an urban Thai hospital over a five-year period	PLOS ONE			English	Article							TEST-NEGATIVE DESIGN; SEASONAL INFLUENZA; DIAGNOSTIC-TEST; YOUNG-CHILDREN; PERFORMANCE; VACCINE; ADULTS; IMPACT; TESTS	Early diagnosis of influenza infection maximizes the effectiveness of antiviral medicines. Here, we assess the ability for clinical characteristics and rapid influenza tests to predict PCR-confirmed influenza infection in a sentinel, cross-sectional study for influenza-like illness (ILI) in Thailand. Participants meeting criteria for acute ILI (fever >38 degrees C and cough or sore throat) were recruited from inpatient and outpatient departments in Bangkok, Thailand, from 2009-2014. The primary endpoint for the study was the occurrence of virologically-confirmed influenza infection (based upon detection of viral RNA by RT-PCR) among individuals presenting for care with ILI. Nasal and throat swabs were tested by rapid influenza test (QuickVue) and by RT-PCR. Vaccine effectiveness (VE) was calculated using the case test-negative method. Classification and Regression Tree (CART) analysis was used to predict influenza RT-PCR positivity based upon symptoms reported. We enrolled 4572 individuals with ILI; 32.7% had detectable influenza RNA by RT-PCR. Influenza cases were attributable to influenza B (38.6%), A(H1N1) pdm09 (35.1%), and A(H3N2) (26.3%) viruses. VE was highest against influenza A(H1N1) pdm09 virus and among adults. The most important symptoms for predicting influenza PCR-positivity among patients with ILI were cough, runny nose, chills, and body aches. The accuracy of the CART predictive model was 72.8%, with an NPV of 78.1% and a PPV of 59.7%. During epidemic periods, PPV improved to 68.5%. The PPV of the QuickVue assay relative to RT-PCR was 93.0% overall, with peak performance during epidemic periods and in the absence of oseltamivir treatment. Clinical criteria demonstrated poor predictive capability outside of epidemic periods while rapid tests were reasonably accurate and may provide an acceptable alternative to RT-PCR testing in resource-limited areas.	[Anderson, Kathryn B.; Weg, Alden L.; Ellison, Damon W.; Klungthong, Chonticha; Phonpakobsin, Thipwipha; Gibbons, Robert V.; Fernandez, Stefan; Macareo, Louis R.; Yoon, In-Kyu] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok, Thailand; [Anderson, Kathryn B.] Univ Minnesota, Dept Med, Div Gen Internal Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Simasathien, Sriluck; Watanaveeradej, Veerachai; Suwanpakdee, Detchvijitr; Kerdpanich, Phirangkul; Phiboonbanakit, Danabhand] Phramongkutklao Hosp, Dept Pediat, Bangkok, Thailand; [Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); University of Minnesota System; University of Minnesota Twin Cities; Phramongkutklao Hospital; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Anderson, KB (corresponding author), Armed Forces Res Inst Med Sci, Dept Virol, Bangkok, Thailand.; Anderson, KB (corresponding author), Univ Minnesota, Dept Med, Div Gen Internal Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	ande7622@umn.edu			Global Emerging Infections Surveillance and Response System	Global Emerging Infections Surveillance and Response System	This work was supported by Global Emerging Infections Surveillance and Response System (https://www.health.mil/Military-Health-Topics/Health-Readiness/Armed-Forces-Health-Surveillance-Branch/Global-Emerging-Infections-Surveillance-and-Response), Grant numbers: various. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashyam HS, 2005, AM J TROP MED HYG, V73, P240; Campe H, 2016, EPIDEMIOL INFECT, V144, P1045, DOI 10.1017/S0950268815002228; Centers for Disease Control and Prevention (CDC) CDC Realtime RT-PCR, 2007, I00705 CDCP; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; Ditsungnoen D, 2016, VACCINE, V34, P2141, DOI 10.1016/j.vaccine.2016.01.056; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Ferdinands JM, 2016, CLIN INFECT DIS; Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026; Gordon A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007907; Grohskopf LA, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6505a1; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; Kittikraisak W, 2016, PEDIATR INFECT DIS J, V35, pE318, DOI 10.1097/INF.0000000000001280; Lacroix S, 2015, J CLIN VIROL, V72, P141, DOI 10.1016/j.jcv.2015.08.002; Levy JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134318; Liao QH, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0127-0; Loubet P, 2016, J CLIN VIROL, V79, P68, DOI 10.1016/j.jcv.2016.04.005; Louie JK, 2010, EMERG INFECT DIS, V16, P824, DOI [10.3201/eid1605.091794, 10.3201/eid1605.091797]; Michiels B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-4; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Olsen SJ, 2014, PEDIATR INFECT DIS J, V33, P117, DOI 10.1097/INF.0000000000000089; Petrie JG, 2016, J INFECT DIS, V214, P1142, DOI 10.1093/infdis/jiw105; Rouleau I, 2009, J CLIN MICROBIOL, V47, P2699, DOI 10.1128/JCM.00762-09; Stebbins S, 2011, INFLUENZA OTHER RESP, V5, P104, DOI 10.1111/j.1750-2659.2010.00171.x; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; Vardakas KZ, 2016, ARCH VIROL, V161, P2511, DOI 10.1007/s00705-016-2941-5; Velasco JMS, 2010, J CLIN VIROL, V48, P120, DOI 10.1016/j.jcv.2010.03.010; World Health Organization, 2009, CDC PROT REALT RTPCR; Zimmerman RK, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1839-x	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2018	13	3							e0193050	10.1371/journal.pone.0193050	http://dx.doi.org/10.1371/journal.pone.0193050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY5TA	29513698	Green Published, gold, Green Submitted			2022-12-27	WOS:000426896800033
J	Li, DC; Jiang, Y; Lv, SS; Liu, XJ; Gu, JY; Chen, QF; Zhang, YH				Li, Decai; Jiang, Yang; Lv, Shanshan; Liu, Xiaojing; Gu, Jiyou; Chen, Qifeng; Zhang, Yanhua			Preparation of plasticized poly (lactic acid) and its influence on the properties of composite materials	PLOS ONE			English	Article							POLY(LACTIC ACID); MECHANICAL-PROPERTIES; CRYSTALLIZATION BEHAVIOR; POLY(ETHYLENE GLYCOL); THERMAL-PROPERTIES; PLA; BLENDS; STARCH; IMPROVEMENT; MORPHOLOGY	Plasticized poly ( lactic acid) ( PPLA) was prepared by melt blending poly ( lactic acid) ( PLA) with 10 wt% of poly ( ethylene glycol) ( PEG), with varied molecular weights range from 400 to 4000. The structure, thermal property, morphology, and surface free energy of the PPLA were investigated by Fourier transform infrared spectroscopy ( FTIR), differential scanning calorimeter ( DSC), thermogravimetric analysis ( TGA), scanning electron microscopy ( SEM), and contact angles ( CA). The resulting PPLA results indicated that the introduction of PEG to the blend systems resulted in a ductile fracture, a decrease in the melt temperature ( T-m) and glass transfer temperature ( T-g), and an increase in the degree of crystallization (chi(c)), which indicated an improved flexibility. In addition, the polarity of the PPLA increased and the surface free energy decreased. The resulting PPLA was subsequently used as matrix to blend with wood flour to prepare composites. The mechanical strength, melting behavior, thermal stability, and microscopy of the PPLA/wood flour composites were also evaluated. These results illustrated that the plasticized PPLA matrix was beneficial to the interfacial compatibility between the polar filler and the substrate.	[Li, Decai; Jiang, Yang; Lv, Shanshan; Liu, Xiaojing; Gu, Jiyou; Chen, Qifeng; Zhang, Yanhua] Northeast Forestry Univ, Coll Mat Sci & Engn, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China	Zhang, YH (corresponding author), Northeast Forestry Univ, Coll Mat Sci & Engn, Harbin, Heilongjiang, Peoples R China.	zhangyanhua@nefu.edu.cn			National Natural Science Foundation of China [31670569]; Fundamental Research Funds for the Central Universities [2572017E606, 2572016DB01]; National Forestry Public Welfare Industry Major Projects of Scientific Research [201504502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Forestry Public Welfare Industry Major Projects of Scientific Research	The work was supported by the National Natural Science Foundation of China (No. 31670569). This work was also supported by Fundamental Research Funds for the Central Universities (No. 2572017E606; 2572016DB01) and the National Forestry Public Welfare Industry Major Projects of Scientific Research (No. 201504502).	Akrami M, 2016, CARBOHYD POLYM, V144, P254, DOI 10.1016/j.carbpol.2016.02.035; Arrieta MP, 2014, POLYM DEGRAD STABIL, V108, P307, DOI 10.1016/j.polymdegradstab.2014.01.034; Dubey SP, 2017, VACUUM, V146, P655, DOI 10.1016/j.vacuum.2017.07.009; Gurau V, 2006, J POWER SOURCES, V160, P1156, DOI 10.1016/j.jpowsour.2006.03.016; Hassouna F, 2011, EUR POLYM J, V47, P2134, DOI 10.1016/j.eurpolymj.2011.08.001; Ho MP, 2015, COMPOS PART B-ENG, V81, P14, DOI 10.1016/j.compositesb.2015.05.048; Ljungberg N, 2002, J APPL POLYM SCI, V86, P1227, DOI 10.1002/app.11077; Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6; Meng XT, 2018, MATER DESIGN, V139, P188, DOI 10.1016/j.matdes.2017.11.012; Murariu M, 2008, POLYM ADVAN TECHNOL, V19, P636, DOI 10.1002/pat.1131; Oh HJ, 2014, POLYMER, V55, P1574, DOI 10.1016/j.polymer.2014.02.011; Okubo K, 2009, COMPOS PART A-APPL S, V40, P469, DOI 10.1016/j.compositesa.2009.01.012; Onteniente JP, 2000, STARCH-STARKE, V52, P112, DOI 10.1002/1521-379X(200006)52:4<112::AID-STAR112>3.0.CO;2-O; Ortega-Toro R, 2016, FOOD HYDROCOLLOID, V56, P9, DOI 10.1016/j.foodhyd.2015.11.029; Ouchi T, 2006, POLYMER, V47, P429, DOI 10.1016/j.polymer.2005.11.039; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; Ozkoc G, 2009, J APPL POLYM SCI, V114, P2481, DOI 10.1002/app.30772; Petchwattana N, 2014, POLYM BULL, V71, P1947, DOI 10.1007/s00289-014-1165-7; Phuphuak Y, 2013, POLYMER, V54, P7058, DOI 10.1016/j.polymer.2013.10.006; Qiu ZB, 2003, POLYMER, V44, P7781, DOI 10.1016/j.polymer.2003.10.045; Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t; Sarasua JR, 1998, MACROMOLECULES, V31, P3895, DOI 10.1021/ma971545p; Sharma P, 2013, IONICS, V19, P1285, DOI 10.1007/s11581-013-0851-z; Shibata M, 2004, J APPL POLYM SCI, V92, P3857, DOI 10.1002/app.20405; Shibata M, 2007, POLYMER, V48, P2768, DOI 10.1016/j.polymer.2007.02.065; Siddalingappa B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118824; Sun Y, 2015, J MATER CHEM A, V3, P3699, DOI 10.1039/c4ta05991c; Thakur S, 2017, VACUUM, V146, P342, DOI 10.1016/j.vacuum.2017.08.011; Wang H, 2001, J APPL POLYM SCI, V82, P1761, DOI 10.1002/app.2018; Young WB, 2015, J COMPOS MATER, V49, P2803, DOI 10.1177/0021998314554437; Yu T, 2015, COMPOS PART A-APPL S, V76, P20, DOI 10.1016/j.compositesa.2015.05.010	31	52	53	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193520	10.1371/journal.pone.0193520	http://dx.doi.org/10.1371/journal.pone.0193520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494654	Green Published, gold, Green Submitted			2022-12-27	WOS:000426363200061
J	Erturk, G; Hedstrom, M; Mattiasson, B; Ruzgas, T; Lood, R				Erturk, Gizem; Hedstrom, Martin; Mattiasson, Bo; Ruzgas, Tautgirdas; Lood, Rolf			Highly sensitive detection and quantification of the secreted bacterial benevolence factor RoxP using a capacitive biosensor: A possible early detection system for oxidative skin diseases	PLOS ONE			English	Article							MOLECULARLY IMPRINTED POLYMERS; PROPIONIBACTERIUM-ACNES; IMMUNOSENSOR; INFECTION; HYDROMIPS; DEFENSE; STRESS	The impact of the microbiota on our health is rapidly gaining interest. While several bacteria have been associated with disease, and others being indicated as having a probiotic effect, the individual biomolecules behind these alterations are often not known. A major problem in the study of these factors in vivo is their low abundance in complex environments. We recently identified the first secreted bacterial antioxidant protein, RoxP, from the skin commensal Propionibacterium acnes, suggesting its relevance for maintaining the redox homeostasis on the skin. In order to study the effect, and prevalence, of RoxP in vivo, a capacitive biosensor with a recognition surface based on molecular imprinting was used to detect RoxP on skin in vivo. In vitro analyses demonstrated the ability to detect and quantify RoxP in a concentration range of 1 x 10(-13) M to 1 x 10(-8) M from human skin swabs; with a limit of detection of 2.5 x 10(-19) M in buffer systems. Further, the biosensor was highly selective, not responding to any other secreted protein from P. acnes. Thus, it was possible to demonstrate the presence, and quantity, of RoxP on human skin. Therefore, the developed biosensor is a very promising tool for the detection of RoxP from clinical samples, offering a rapid, cost-effective and sensitive means of detecting low-abundant bacterial proteins in vivo in complex milieus.	[Erturk, Gizem; Lood, Rolf] Lund Univ, Biomed Ctr B14, Dept Clin Sci Lund, Div Infect Med, Lund, Sweden; [Hedstrom, Martin; Mattiasson, Bo] Lund Univ, Dept Biotechnol, Lund, Sweden; [Hedstrom, Martin; Mattiasson, Bo] CapSenze Biosyst AB, Lund, Sweden; [Ruzgas, Tautgirdas] Malmo Univ, Fac Hlth & Soc, Dept Biomed Sci, Malmo, Sweden	Lund University; Lund University; Malmo University	Lood, R (corresponding author), Lund Univ, Biomed Ctr B14, Dept Clin Sci Lund, Div Infect Med, Lund, Sweden.	Rolf.Lood@med.lu.se	Ruzgas, Tautgirdas/C-4646-2008	Ruzgas, Tautgirdas/0000-0003-0304-7528; Erturk Bergdahl, Gizem/0000-0001-9719-6609	Crafoord Foundation [20170669]; Foundation Tornspiran; Foundation Alfred Osterlund; Foundation Magnus Bergvall; Foundation Ake Wiberg; Foundation Langmanska Kulturfonden; Foundation Zoegas; Foundation Lars Hierta; Foundation Sigurd; Foundation Elsa Golje's Memory; Royal PhysiographicSociety Lund; Swedish Medical Society	Crafoord Foundation; Foundation Tornspiran; Foundation Alfred Osterlund; Foundation Magnus Bergvall; Foundation Ake Wiberg; Foundation Langmanska Kulturfonden; Foundation Zoegas; Foundation Lars Hierta; Foundation Sigurd; Foundation Elsa Golje's Memory; Royal PhysiographicSociety Lund; Swedish Medical Society	This work was supported by grants from the Crafoord Foundation (20170669) to TR, and the Foundations Tornspiran, Alfred Osterlund, Magnus Bergvall, Ake Wiberg, Langmanska Kulturfonden, Zoegas, Lars Hierta, Sigurd and Elsa Golje's Memory, the Royal PhysiographicSociety Lund, and the Swedish Medical Society to RL. Bo Mattiasson and Martin Hedstrom are associated with the company CapSenze, on whose instrument the analyses were performed, providing support in the form of instrument leasing, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The other funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Allhorn M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36412; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; Bek-Thomsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107908; Berggren C, 2001, ELECTROANALYSIS; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bossi O, 2008, J CELL BIOCHEM, V105, P194, DOI 10.1002/jcb.21817; El-Sharif HF, 2014, ANAL CHIM ACTA, V809, P155, DOI 10.1016/j.aca.2013.11.052; Erlandsson D, 2014, SENSOR ACTUAT B-CHEM, V190, P295, DOI 10.1016/j.snb.2013.08.076; Erturk G, 2017, ADV MOLECULARLY IMPR; Erturk G, 2016, BIOSENS BIOELECTRON, V86, P557, DOI 10.1016/j.bios.2016.07.046; Erturk G, 2016, J CHROMATOGR B, V1021, P30, DOI 10.1016/j.jchromb.2015.12.025; Erturk G, 2015, ANAL CHIM ACTA, V891, P120, DOI 10.1016/j.aca.2015.07.055; Erturk Gizem, 2014, Biotechnol Rep (Amst), V3, P65, DOI 10.1016/j.btre.2014.06.006; Ferrandiz ML, 2008, CURR PHARM DESIGN, V14, P473, DOI 10.2174/138161208783597399; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Grange PA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000527; Gutierrez R Alvaro V, 2015, Biotechnol Rep (Amst), V8, P144, DOI 10.1016/j.btre.2015.10.001; Haupt K, 2003, ANAL CHEM, V75, p376A, DOI 10.1021/ac031385h; Hawkins DM, 2006, BIOMACROMOLECULES, V7, P2560, DOI 10.1021/bm060494d; Hawkins DM, 2005, ANAL CHIM ACTA, V542, P61, DOI 10.1016/j.aca.2005.01.052; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Holmberg A, 2009, CLIN MICROBIOL INFEC, V15, P787, DOI 10.1111/j.1469-0691.2009.02747.x; Kadam DP, 2010, INDIAN J CLIN BIOCHE, V25, P388, DOI 10.1007/s12291-010-0043-9; Lebogang L, 2014, ANAL CHIM ACTA, V826, P69, DOI 10.1016/j.aca.2014.03.028; Lenain P, 2015, BIOSENS BIOELECTRON, V69, P34, DOI 10.1016/j.bios.2015.02.016; MCGINLEY KJ, 1978, APPL ENVIRON MICROB, V35, P62, DOI 10.1128/AEM.35.1.62-66.1978; McNaught AD, 1997, COMPENDIUM CHEM TERM, DOI DOI 10.1351/GOLDBOOK; Reddy SM, 2012, BIOMACROMOLECULES, V13, P3959, DOI 10.1021/bm301189f; Shu M, 2013, CURR MED CHEM, V20, P562; Sorensen M, 2010, J MICROBIOL METH, V83, P211, DOI 10.1016/j.mimet.2010.09.008; Teeparuksapun K, 2010, ANAL CHEM, V82, P8406, DOI 10.1021/ac102144a; Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281, DOI 10.1128/JCM.37.10.3281-3290.1999; Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473; Webster GF, 2002, BMJ-BRIT MED J, V325, P475, DOI 10.1136/bmj.325.7362.475; Wernersson E, BIOTECHNOL REP; Wilson R, 2013, EXPERT REV PROTEOMIC, V10, P135, DOI [10.1586/EPR.13.7, 10.1586/epr.13.7]	36	8	8	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193754	10.1371/journal.pone.0193754	http://dx.doi.org/10.1371/journal.pone.0193754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8RR	29494704	gold, Green Published, Green Submitted			2022-12-27	WOS:000426363200095
J	Alkhamis, MA; Gallardo, C; Jurado, C; Soler, A; Arias, M; Sanchez-Vizcaino, JM				Alkhamis, Moh A.; Gallardo, Carmina; Jurado, Cristina; Soler, Alejandro; Arias, Marisa; Sanchez-Vizcaino, Jose M.			Phylodynamics and evolutionary epidemiology of African swine fever p72-CVR genes in Eurasia and Africa	PLOS ONE			English	Article							ORNITHODOROS-ERRATICUS; AVIAN INFLUENZA; VIRUS; DYNAMICS; SPREAD; SURVEILLANCE; TRANSMISSION; INFERENCE; OUTBREAKS; SELECTION	African swine fever (ASF) is a complex infectious disease of swine that constitutes devastating impacts on animal health and the world economy. Here, we investigated the evolutionary epidemiology of ASF virus (ASFV) in Eurasia and Africa using the concatenated gene sequences of the viral protein 72 and the central variable region of isolates collected between 1960 and 2015. We used Bayesian phylodynamic models to reconstruct the evolutionary history of the virus, to identify virus population demographics and to quantify dispersal patterns between host species. Results suggest that ASFV exhibited a significantly high evolutionary rate and population growth through time since its divergence in the 18th century from East Africa, with no signs of decline till recent years. This increase corresponds to the growing pig trade activities between continents during the 19th century, and may be attributed to an evolutionary drift that resulted from either continuous circulation or maintenance of the virus within Africa and Eurasia. Furthermore, results implicate wild suids as the ancestral host species (root state posterior probability = 0.87) for ASFV in the early 1700s in Africa. Moreover, results indicate the transmission cycle between wild suids and pigs is an important cycle for ASFV spread and maintenance in pig populations, while ticks are an important natural reservoir that can facilitate ASFV spread and maintenance in wild swine populations. We illustrated the prospects of phylodynamic methods in improving risk-based surveillance, support of effective animal health policies, and epidemic preparedness in countries at high risk of ASFV incursion.	[Alkhamis, Moh A.] Kuwait Univ, Hlth Sci Ctr, Fac Publ Heath, Kuwait, Kuwait; [Alkhamis, Moh A.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Gallardo, Carmina; Soler, Alejandro; Arias, Marisa] INIA CISA, Ctr Invest Sanidad Anim, European Union Reference Lab African Swine Fever, Madrid, Spain; [Jurado, Cristina; Sanchez-Vizcaino, Jose M.] Univ Complutense Madrid, VISAVET Hlth Surveillance Ctr, Madrid, Spain; [Jurado, Cristina; Sanchez-Vizcaino, Jose M.] Univ Complutense Madrid, Anim Hlth Dept, Vet Sch, Madrid, Spain	Kuwait University; University of Minnesota System; University of Minnesota Twin Cities; Complutense University of Madrid; Complutense University of Madrid	Alkhamis, MA (corresponding author), Kuwait Univ, Hlth Sci Ctr, Fac Publ Heath, Kuwait, Kuwait.; Alkhamis, MA (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	malkahmi@umn.edu	Gallardo+Frontaura, Carmina/ABE-6878-2021; Arias, Maria Luisa/X-7566-2018; gallardo, Carmina/AAB-2386-2019	Arias, Maria Luisa/0000-0001-6044-2968; gallardo, Carmina/0000-0003-3293-306X; Alkhamis, Mohammad/0000-0001-6451-5247	Spanish Government; EU project ASFRISK, Evaluating and Controlling the Risk of African Swine Fever in the EU (DG-Research, EC, 7FP Grant) [KBBE211691]; EU Reference laboratory for ASF [UE-LR PPA/03]; EU project ASFORCE [311931, FP7 - KBBE.2012.1.3-02]; Spanish National Project RTA-PPA [RTA201 1-00060-C02-02]	Spanish Government(Spanish GovernmentEuropean Commission); EU project ASFRISK, Evaluating and Controlling the Risk of African Swine Fever in the EU (DG-Research, EC, 7FP Grant); EU Reference laboratory for ASF; EU project ASFORCE; Spanish National Project RTA-PPA	CJ is the recipient of a Spanish Government-funded PhD fellowship for the Training of Future Scholars (FPU) given by the Spanish Ministry of Education, Culture and Sports. This work was partly supported under the EU project ASFRISK, Evaluating and Controlling the Risk of African Swine Fever in the EU (DG-Research, EC, 7FP Grant Agreement, KBBE211691), and the EU Reference laboratory for ASF (grant no UE-LR PPA/03). EU project ASFORCE (Grant Agreement no311931, FP7 - KBBE.2012.1.3-02) and the Spanish National Project RTA-PPA (RTA201 1-00060-C02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CJ is the recipient of a Spanish Government-funded PhD fellowship for the Training of Future Scholars (FPU) given by the Spanish Ministry of Education, Culture and Sports.; This work was partly supported under the EU project ASFRISK, Evaluating and Controlling the Risk of African Swine Fever in the EU (DG-Research, EC, 7FP Grant Agreement, KBBE211691), and the EU Reference laboratory for ASF (grant no UE-LR PPA/03). We would like to thank all the staff at the EURL INIA-CISA who work in the sequencing department including, above all, Encarnacion Madueno and Oscar Nuero. We also specially thank Covadonga Perez, Alicia Simon and Elena Martin for performing laboratory techniques, including sampling processing and PCR amplification, for further sequence analysis. Gratitude extends to Imbi Nurmoja, Ieva Rozde, Gediminas Pridoktas, and Grzegorz Wozniakowski, the former heads of National Reference Labortories (NRLs) of Estonia, Latvia, Lithuania and Poland, for providing the samples. As an OIE Reference Laboratory, authors would like to thank the OIE for its support in our research on ASF as well as the EU project ASFORCE (Grant Agreement no 311931, FP7-KBBE.2012.1.3-02) and the Spanish National Project RTA-PPA (RTA201 1-00060-C02-02).	Achenbach J. E., 2016, TRANSBOUND EMERG DIS; Alizon S, 2014, VIRULENCE, V5, P825, DOI 10.4161/21505594.2014.976514; Alkhamis MA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00067; Alkhamis MA, 2015, VIRUSES-BASEL, V7, P3310, DOI 10.3390/v7062773; Arias M, 2002, TRENDS EMERGING VIRA, V1; Atuhaire DK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-247; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bastos AD P ML, 2003, ARCH VIROL, V148; Blench RM, 1999, ORIGINS DEV AFRICAN, P335; Boinas FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020383; Boinas FS, 2004, J GEN VIROL, V85, P2177, DOI 10.1099/vir.0.80058-0; Bosch J., 2016, TRANSBOUND EMERG DIS; Boshoff CI, 2007, VET MICROBIOL, V121, P45, DOI 10.1016/j.vetmic.2006.11.007; Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64; Chen RB, 2010, J MOL EVOL, V70, P98, DOI 10.1007/s00239-009-9312-8; Costard S, 2013, VIRUS RES, V173, P191, DOI 10.1016/j.virusres.2012.10.030; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; Dixon L., 2005, ASFARVIRIDAE VIRUS T; Dixon LK, 2013, VIRUS RES, V173, P3, DOI 10.1016/j.virusres.2012.10.020; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; EURL-ASF, 2013, STAND OP PROC GEN AF, P1; de Carvalho LMF, 2013, INFECT GENET EVOL, V13, P76, DOI 10.1016/j.meegid.2012.08.016; Fan Y, 2011, MOL BIOL EVOL, V28, P523, DOI 10.1093/molbev/msq224; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Fraczyk M, 2016, VET MICROBIOL, V193, P133, DOI 10.1016/j.vetmic.2016.08.018; Gallardo C, 2015, J CLIN MICROBIOL, V53, P2555, DOI 10.1128/JCM.00857-15; Gallardo C, 2009, VIRUS GENES, V38, P85, DOI 10.1007/s11262-008-0293-2; Gallardo C, 2014, EMERG INFECT DIS, V20, P1544, DOI 10.3201/eid2009.140554; Gallardo C, 2011, AFR J BIOTECHNOL, V10, P3488; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Griffiths RC, 1994, ANCESTRAL INFERENCE, P307; HARESNAPE JM, 1989, EPIDEMIOL INFECT, V102, P507, DOI 10.1017/S0950268800030223; HARNESNAPE JM, 1986, J HYG-CAMBRIDGE, V96, P535, DOI 10.1017/S0022172400066341; Jori F, 2009, ECOHEALTH, V6, P296, DOI 10.1007/s10393-009-0248-7; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lam TTY, 2012, MOL ECOL, V21, P3062, DOI 10.1111/j.1365-294X.2012.05577.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lubisi BA, 2007, VIRUS GENES, V35, P729, DOI 10.1007/s11262-007-0148-2; Luka P. D., 2016, TRANSBOUND EMERG DIS; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martinez-Lopez B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00314; Michaud V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069662; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Misinzo G, 2014, TROP ANIM HEALTH PRO, V46, P1199, DOI 10.1007/s11250-014-0628-z; MONTGOMERY R. Eustace, 1921, Journal of Comparative Pathology and Therapeutics, V34, P159; Muangkram Y, 2015, GENET MOL RES, V14, P4566, DOI 10.4238/2015.May.4.15; Mur L, 2016, TRANSBOUND EMERG DIS, V63, pE165, DOI 10.1111/tbed.12264; O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003; Oleaga-Perez A, 1994, VETPARASITOL, V52; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; PEREZSANCHEZ R, 1994, VET REC, V135, P207, DOI 10.1136/vr.135.9.207; Pietschmann J, 2016, BMC VET RES, V12, DOI 10.1186/s12917-015-0629-9; PLOWRIGH.W, 1974, RES VET SCI, V17, P106, DOI 10.1016/S0034-5288(18)33716-0; Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109; Quembo CJ, 2016, TRANSBOUND EMERG DIS, V63, P443, DOI 10.1111/tbed.12289; Quembo CJ, 2017, TRANSBOUND EMERG DIS; Rambaut A, 2016, VIRUS EVOLUTION, V2; Rambaut A., 2013, TRACER; Razavi N., 2008, KULLBACK LEIBLER DIV; Sanchez-Vizcaino JM, 2015, REV SCI TECH OIE, V34, P503, DOI 10.20506/rst.34.2.2375; Sanchez-Vizcaino JM, 2015, J COMP PATHOL, V152, P9, DOI 10.1016/j.jcpa.2014.09.003; Sanchez-Vizcaino JM, 2012, TRANSBOUND EMERG DIS, V59, P27, DOI 10.1111/j.1865-1682.2011.01293.x; Sanna G, 2016, TRANSBOUND EMERG DIS; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Simulundu E., 2017, TRANSBOUND EMERG DIS; Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Streicker DG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002720; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; SuYnchez Botija C., 1982, REV SCI TECH OIE, V1, P1065; The MathWorks Inc, 2016, MATL STAT TOOLB REL; Thomas LF, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0830-5; THOMSON GR, 1985, ONDERSTEPOORT J VET, V52, P201; WAHID, 2017, WAHID DAT; Xu JP, 2011, INFECT GENET EVOL, V11, P2125, DOI 10.1016/j.meegid.2011.07.002	82	31	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2018	13	2							e0192565	10.1371/journal.pone.0192565	http://dx.doi.org/10.1371/journal.pone.0192565			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX7ND	29489860	Green Submitted, Green Published, gold			2022-12-27	WOS:000426276000032
J	Caramiaux, B; Bevilacqua, F; Wanderley, MM; Palmer, C				Caramiaux, Baptiste; Bevilacqua, Federic; Wanderley, Marcelo M.; Palmer, Caroline			Dissociable effects of practice variability on learning motor and timing skills	PLOS ONE			English	Article							CONTEXTUAL INTERFERENCE; CONTINUOUS MOVEMENTS; TASK VARIATION; ACQUISITION; RETENTION; DISCRETE	Motor skill acquisition inherently depends on the way one practices the motor task. The amount of motor task variability during practice has been shown to foster transfer of the learned skill to other similar motor tasks. In addition, variability in a learning schedule, in which a task and its variations are interweaved during practice, has been shown to help the transfer of learning in motor skill acquisition. However, there is little evidence on how motor task variations and variability schedules during practice act on the acquisition of complex motor skills such as music performance, in which a performer learns both the right movements ( motor skill) and the right time to perform them ( timing skill). This study investigated the impact of rate ( tempo) variability and the schedule of tempo change during practice on timing and motor skill acquisition. Complete novices, with no musical training, practiced a simple musical sequence on a piano keyboard at different rates. Each novice was assigned to one of four learning conditions designed to manipulate the amount of tempo variability across trials ( large or small tempo set) and the schedule of tempo change ( randomized or non-randomized order) during practice. At test, the novices performed the same musical sequence at a familiar tempo and at novel tempi ( testing tempo transfer), as well as two novel ( but related) sequences at a familiar tempo ( testing spatial transfer). We found that practice conditions had little effect on learning and transfer performance of timing skill. Interestingly, practice conditions influenced motor skill learning ( reduction of movement variability): lower temporal variability during practice facilitated transfer to new tempi and new sequences; non-randomized learning schedule improved transfer to new tempi and new sequences. Tempo ( rate) and the sequence difficulty ( spatial manipulation) affected performance variability in both timing and movement. These findings suggest that there is a dissociable effect of practice variability on learning complex skills that involve both motor and timing constraints.	[Caramiaux, Baptiste; Bevilacqua, Federic] UPMC, CNRS, Ircam, UMR,STMS, Paris, France; [Caramiaux, Baptiste; Wanderley, Marcelo M.] McGill Univ, Schulich Sch Mus, Montreal, PQ, Canada; [Caramiaux, Baptiste; Palmer, Caroline] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Caramiaux, Baptiste] Univ Paris Sud, Univ Paris Saclay, INRIA, CNRS,LRI, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; McGill University; McGill University; Centre National de la Recherche Scientifique (CNRS); Inria; UDICE-French Research Universities; Universite Paris Saclay	Caramiaux, B (corresponding author), UPMC, CNRS, Ircam, UMR,STMS, Paris, France.; Caramiaux, B (corresponding author), McGill Univ, Schulich Sch Mus, Montreal, PQ, Canada.; Caramiaux, B (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.; Caramiaux, B (corresponding author), Univ Paris Sud, Univ Paris Saclay, INRIA, CNRS,LRI, Gif Sur Yvette, France.	baptiste.caramiaux@lri.fr		Caramiaux, Baptiste/0000-0002-4590-106X; Palmer, Caroline/0000-0003-4816-8067	EU Marie Sklodowska-Curie fellowship [H2020-MSCA-IF-2014, 659232]; Canada Research Chair; NSERC [298173]; RGPIN [2014-05672]	EU Marie Sklodowska-Curie fellowship; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); RGPIN	This research was funded in part by the by the EU Marie Sklodowska-Curie fellowship to Baptiste Caramiaux (Project MIM, H2020-MSCA-IF-2014, GA no. 659232), by Canada Research Chair and NSERC grant 298173 to Caroline Palmer, and by NSERC grant RGPIN 2014-05672 to Marcelo Wanderley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, DYNAMIC PATTERNS SEL; Bangert M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00598; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Carter CE, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01251; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Furuya S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-133; Goebl W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050901; HALL KG, 1994, PERCEPT MOTOR SKILL, V78, P835, DOI 10.2466/pms.1994.78.3.835; HOGAN N, 1984, J NEUROSCI, V4, P2745; Jones LL, 2007, PERCEPT MOTOR SKILL, V105, P883, DOI 10.2466/PMS.105.3.883-890; Loehr JD, 2007, EXP BRAIN RES, V178, P518, DOI 10.1007/s00221-006-0760-8; Loehr JD, 2009, J MOTOR BEHAV, V41, P128, DOI 10.3200/JMBR.41.2.128-136; Maes PJ, 2015, EXP BRAIN RES, V233, P263, DOI 10.1007/s00221-014-4108-5; MAGILL RA, 1990, HUM MOVEMENT SCI, V9, P241, DOI 10.1016/0167-9457(90)90005-X; Newell A., 1981, COGNITIVE SKILLS THE, P1; NEWELL KM, 1991, ANNU REV PSYCHOL, V42, P213, DOI 10.1146/annurev.ps.42.020191.001241; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; Rose LP, 2006, EFFECTS CONTEXTUAL I; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; SHEA JB, 1979, J EXP PSYCHOL-HUM L, V5, P179, DOI 10.1037/0278-7393.5.2.179; Shmuelof L, 2012, J NEUROPHYSIOL, V108, P578, DOI 10.1152/jn.00856.2011; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Stambaugh LA, 2010, UPDAT APPL RES MUSIC; Stambaugh LA, 2011, J RES MUSIC EDUC, V58, P368, DOI 10.1177/0022429410385945; Ste-Marie DM, 2004, J MOTOR BEHAV, V36, P115, DOI 10.3200/JMBR.36.1.115-126; Torres-Oviedo G, 2012, J NEUROPHYSIOL, V107, P346, DOI 10.1152/jn.00570.2011; Travlos AK, 2010, PERCEPT MOTOR SKILL, V110, P298, DOI 10.2466/PMS.110.1.298-312; Turnham EJA, 2012, J NEUROPHYSIOL, V107, P1111, DOI 10.1152/jn.00635.2011; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616; Wulf G, 1997, J EXP PSYCHOL LEARN, V23, P987, DOI 10.1037/0278-7393.23.4.987; Wymbs NF, 2016, CURR BIOL, V26, P338, DOI 10.1016/j.cub.2015.11.066; Zelaznik HN, 2005, J MOTOR BEHAV, V37, P395, DOI 10.3200/JMBR.37.5.395-403; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	38	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2018	13	3							e0193580	10.1371/journal.pone.0193580	http://dx.doi.org/10.1371/journal.pone.0193580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FX8RR	29494670	Green Published, Green Submitted, gold			2022-12-27	WOS:000426363200068
J	Foltynski, P				Foltynski, Piotr			Ways to increase precision and accuracy of wound area measurement using smart devices: Advanced app Planimator	PLOS ONE			English	Article								Introduction Wound surface area measurement is important as therapeutic decisions may depend on the change of wound surface area over time. Digital planimetry is a popular technique in wound area measurement. It is accurate and repeatable when calibration is performed with 2 rulers placed at opposite sides of a wound. The aim of the current study was improving accuracy and precision of wound area measurement using capabilities of smart devices. Methods The correction of area measurement based on calculated camera tilt angle and the calculation of calibration coefficient of linear dimensions as weighted average were proposed. These and other improvements were applied in the Planimator app for Android, which was then used in the study. Accuracy and precision of the Planimator app were compared to the Visitrak device, the SilhouetteMobile device, the AreaMe software, and to the digital planimetry based on 2-ruler calibration with pictures taken by the smartphone, compact, and D-SLR cameras. Areas of 40 wound shapes of area ranged from 0.14 to 31.72 cm(2) were measured with each device. Medians of relative errors (REs) were compared in the accuracy tests and standard deviations (SDs) of relative differences (RDs) were compared in the tests of precision. Results The median of REs for the Planimator app was not significantly different from the medians of REs for the digital planimetry based on pictures from the compact or D-SLR cameras, but it was significantly lower than the medians of REs for the Visitrak and SilhouetteMobile devices, the AreaMe software and the digital planimetry based on pictures from a smart phone camera. The SD of RDs for the Planimator app was not significantly different from the SDs of RDs for the digital planimetry based on pictures from the compact or D-SLR cameras, but it was significantly lower than the SDs of RDs for the Visitrak and SilhouetteMobile devices, the AreaMe software and the digital planimetry based on pictures from a smart phone camera. The Planimator app installed at a smartphone revealed to be 2-fold more accurate and 1.5-fold more precise than the measurements with using ImageJ software based on pictures taken with the same smartphone. Conclusions The Planimator app occurred to have the same accuracy and precision as measurements with digital planimetry with 2-ruler calibration and based on pictures from a compact camera or a D-SLR camera. This app showed better accuracy and precision than the Visitrak and SilhouetteMobile devices, the AreaMe software and the digital planimetry based on pictures from a smartphone camera.	[Foltynski, Piotr] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences	Foltynski, P (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland.	pfoltynski@ibib.waw.pl	Foltynski, Piotr/D-7708-2013	Foltynski, Piotr/0000-0002-6678-1968				[Anonymous], US, Patent No. 20150141841; Chang Angela Christine, 2011, Eplasty, V11, pe18; Foltynski P, WOUND SHAPES 1 D 20; Foltynski P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134622; Foltynski P, 2014, ARTIF ORGANS, V38, P346, DOI 10.1111/aor.12169; Foltynski P, 2013, DIABETES TECHNOL THE, V15, P711, DOI 10.1089/dia.2013.0026; Ladyzynski P, 2011, DIABETES TECHNOL THE, V13, P1101, DOI 10.1089/dia.2011.0082; Li PN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038069; Molik M, 2010, BIOCYBERN BIOMED ENG, V30, P3; Moore K, 2005, J Wound Care, V14, P229; Mrozikiewicz-Rakowska B, 2017, DIABETOLOGIA, V60, pS549; Pavlovcic U, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0031-7; Plassmann P, 1995, J Wound Care, V4, P269; Rennert R, 2009, ADV SKIN WOUND CARE, V22, P32, DOI 10.1097/01.ASW.0000343718.30567.cb; Ring EFJ, 2004, RHEUMATOLOGY, V43, P800, DOI 10.1093/rheumatology/keg009; Steed DL, 2006, WOUND REPAIR REGEN, V14, P680, DOI 10.1111/j.1524-475X.2006.00176.x; Treuillet S, 2009, IEEE T MED IMAGING, V28, P752, DOI 10.1109/TMI.2008.2012025; Wendland DM, 2017, J ACUTE CARE PHYS TH, V8, P42, DOI 10.1097/JAT.0000000000000050	18	16	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0192485	10.1371/journal.pone.0192485	http://dx.doi.org/10.1371/journal.pone.0192485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505569	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200001
J	Zinne, N; Krueger, M; Hoeltig, D; Tuemmler, B; Boyle, EC; Biancosino, C; Hoeffler, K; Braubach, P; Rajab, TK; Ciubotaru, A; Rohde, J; Waldmann, KH; Haverich, A				Zinne, Norman; Krueger, Marcus; Hoeltig, Doris; Tuemmler, Burkhard; Boyle, Erin C.; Biancosino, Christian; Hoeffler, Klaus; Braubach, Peter; Rajab, Taufiek K.; Ciubotaru, Anatol; Rohde, Judith; Waldmann, Karl-Heinz; Haverich, Axel			Treatment of infected lungs by ex vivo perfusion with high dose antibiotics and autotransplantation: A pilot study in pigs	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PNEUMONIA; COLISTIN; TRANSPLANTATION; RESISTANCE; THERAPY; MODEL	The emergence of multi-drug resistant bacteria threatens to end the era of antibiotics. Drug resistant bacteria have evolved mechanisms to overcome antibiotics at therapeutic doses and further dose increases are not possible due to systemic toxicity. Here we present a pilot study of ex vivo lung perfusion (EVLP) with high dose antibiotic therapy followed by auto transplantation as a new therapy of last resort for otherwise incurable multidrug resistant lung infections. Severe Pseudomonas aeruginosa pneumonia was induced in the lower left lungs (LLL) of 18 Mini-Lewe pigs. Animals in the control group (n = 6) did not receive colistin. Animals in the conventional treatment group (n = 6) received intravenous application of 2 mg/kg body weight colistin daily. Animals in the EVLP group (n = 6) had their LLL explanted and perfused ex vivo with a perfusion solution containing 200 mu g/ml colistin. After two hours of ex vivo treatment, autotransplantation of the LLL was performed. All animals were followed for 4 days following the initiation of treatment. In the control and conventional treatment groups, the infection-related mortality rate after five days was 66.7%. In the EVLP group, there was one infection-related mortality and one procedure-related mortality, for an overall mortality rate of 33.3%. Moreover, the clinical symptoms of infection were less severe in the EVLP group than the other groups. Ex vivo lung perfusion with very high dose antibiotics presents a new therapeutic option of last resort for otherwise incurable multidrug resistant pneumonia without toxic side effects on other organs.	[Zinne, Norman; Krueger, Marcus; Boyle, Erin C.; Biancosino, Christian; Hoeffler, Klaus; Ciubotaru, Anatol; Haverich, Axel] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Lower Saxony, Germany; [Hoeltig, Doris; Waldmann, Karl-Heinz] Univ Vet Med Hannover, Clin Swine Small Ruminants Forens Med & Ambulator, Hannover, Lower Saxony, Germany; [Tuemmler, Burkhard] Hannover Med Sch, Clin Paediat Pneumol Allergol & Neonatol, Hannover, Lower Saxony, Germany; [Tuemmler, Burkhard; Braubach, Peter; Haverich, Axel] German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Lower Saxony, Germany; [Braubach, Peter] Hannover Med Sch, Inst Pathol, Hannover, Lower Saxony, Germany; [Rajab, Taufiek K.] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Rajab, Taufiek K.] Harvard Med Sch, Boston, MA USA; [Rohde, Judith] Univ Vet Med Hannover, Inst Microbiol, Dept Infect Dis, Hannover, Lower Saxony, Germany	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; Hannover Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Veterinary Medicine Hannover, Foundation	Zinne, N (corresponding author), Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Lower Saxony, Germany.	zinne.norman@mh-hannover.de	Haverich, Axel/AAC-7552-2022; Krüger, Marcus/C-4809-2019	Boyle, Erin C./0000-0002-5963-3633	German Federal Ministry of Education and Research - DZL German Center for Lung Research [82DZL00201]; German Science Foundation - REBIRTH Cluster of Excellence [DFG EXC 62]	German Federal Ministry of Education and Research - DZL German Center for Lung Research; German Science Foundation - REBIRTH Cluster of Excellence	We report grants from German Federal Ministry of Education and Research - DZL German Center for Lung Research (82DZL00201; http://www.dzi.de/index.php.de/), grants from German Science Foundation - REBIRTH Cluster of Excellence (DFG EXC 62; http:///www.rebirth-hannover.de/de/home html), during the conduct of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner C, 2012, AM J TRANSPLANT, V12, P1839, DOI 10.1111/j.1600-6143.2012.04027.x; Bassetti M, 2014, FUTURE MICROBIOL, V9, P465, DOI 10.2217/fmb.14.7; Casanova J, 2011, ANESTH ANALG, V113, P742, DOI 10.1213/ANE.0b013e3182288e01; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Cypel M, 2012, J THORAC CARDIOV SUR, V144, P1200, DOI 10.1016/j.jtcvs.2012.08.009; Ferrari F, 2009, INTENS CARE MED, V35, P1792, DOI 10.1007/s00134-009-1605-2; Florescu DF, 2012, CLIN INFECT DIS, V54, P670, DOI 10.1093/cid/cir934; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Ghlissi Z, 2013, RENAL FAILURE, V35, P1130, DOI 10.3109/0886022X.2013.815091; HANNAN PCT, 1982, RES VET SCI, V33, P76, DOI 10.1016/S0034-5288(18)32364-6; Hoeltig D, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-14; Kruger M, 2016, INTERACT CARDIOV TH, V23, P358, DOI 10.1093/icvts/ivw160; Lu Q, 2012, ANESTHESIOLOGY, V117, P1335, DOI 10.1097/ALN.0b013e31827515de; Lu Q, 2010, INTENS CARE MED, V36, P1147, DOI 10.1007/s00134-010-1879-4; Luna CM, 2009, EUR RESPIR J, V33, P182, DOI 10.1183/09031936.00046308; Luna CM, 2007, CHEST, V132, P523, DOI 10.1378/chest.07-0185; Maas A, 2006, VACCINE, V24, P7226, DOI 10.1016/j.vaccine.2006.06.047; MacNair CR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02875-z; Mahida K, 2010, CURR MICROBIOL, V61, P19, DOI 10.1007/s00284-009-9570-0; Micek ST, 2015, CRIT CARE, V19, P1; Mortensen NP, 2009, LANGMUIR, V25, P3728, DOI 10.1021/la803898g; Nakajima D, 2016, AM J TRANSPLANT, V16, P1229, DOI 10.1111/ajt.13562; Phe K, 2014, ANTIMICROB AGENTS CH, V58, P2740, DOI 10.1128/AAC.02476-13; Ratjen F, 2006, J ANTIMICROB CHEMOTH, V57, P306, DOI 10.1093/jac/dki461; Sage E, 2014, EUR J CARDIO-THORAC, V46, P794, DOI 10.1093/ejcts/ezu245; Satoh S, 2001, CLIN EXP IMMUNOL, V126, P266, DOI 10.1046/j.1365-2249.2001.01656.x; Souilamas R, 2011, J HEART LUNG TRANSPL, V30, P847, DOI 10.1016/j.healun.2011.02.005; Sun HY, 2011, CHEST, V139, P1172, DOI 10.1378/chest.10-0167; Tamma PD, 2013, PEDIATR INFECT DIS J, V32, P17, DOI 10.1097/INF.0b013e3182703790; Tedja R, 2014, AM J INFECT CONTROL, V42, P542, DOI 10.1016/j.ajic.2013.12.009; TUMMLER B, 1991, J CLIN MICROBIOL, V29, P1265; Warnecke G, 2012, LANCET, V380, P1851, DOI 10.1016/S0140-6736(12)61344-0; Xiao H, 2013, BIOMED REP, V1, P589, DOI 10.3892/br.2013.94	33	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2018	13	3							e0193168	10.1371/journal.pone.0193168	http://dx.doi.org/10.1371/journal.pone.0193168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY1CC	29505574	Green Published, Green Submitted, gold			2022-12-27	WOS:000426548200006
